PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Ogino, Y; Asahi, T				Ogino, Yoshiyuki; Asahi, Toru			Model of complex chiral drug metabolic systems and numerical simulation of the remaining chirality toward analysis of dynamical pharmacological activity	JOURNAL OF THEORETICAL BIOLOGY			English	Article						Metabolic pathway of drug; Molecular chirality; Thalidomide; Chemical reaction network	IN-VITRO BIOTRANSFORMATION; SYMMETRY-BREAKING; CAPILLARY-ELECTROPHORESIS; HYDROXYLATED METABOLITES; LIQUID-CHROMATOGRAPHY; CIRCULAR-DICHROISM; SERUM-ALBUMIN; SOAI REACTION; THALIDOMIDE; STABILITY	In this study, systems of complicated pathways involved in chiral drug metabolism were investigated. The development of chiral drugs resulted in significant improvement in the remedies available for the treatment of various severe sicknesses. Enantiopure drugs undergo various biological transformations that involve chiral inversion and thus result in the generation of multiple enantiomeric metabolites. Identification of the specific active substances determining a given drug's efficacy among such a mixture of different metabolites remains a challenge. To comprehend this complexity, we constructed a mathematical model representing the complicated metabolic pathways simultaneously involving chiral inversion. Moreover, this model is applied to the metabolism of thalidomide, which has recently been revived as a potentially effective prescription drug for a number of intractable diseases. The numerical simulation results indicate that retained chirality in the metabolites reflects the original chirality of the unmetabolized drug, and a higher level of enantiomeric purity is preserved during spontaneous degradation. In addition, chirality remaining after equilibration is directly related to the rate constant not only for chiral inversion but also for generation and degradation. Furthermore, the retention of chirality is quantitatively predictable using this combination of kinetic parameters. Our simulation results well explain the behavior of thalidomide in the practical biological experimental data. Therefore, this model promises a comprehensive understanding of dynamic metabolic systems involving chiral drugs that express multiple enantiospecific drug efficacies. (C) 2015 Elsevier Ltd. All rights reserved.	[Ogino, Yoshiyuki; Asahi, Toru] Waseda Univ TWIns, Grad Sch Adv Sci & Engn, Dept Life Sci & Med Biosci, Shinjuku Ku, Tokyo 1628480, Japan	Asahi, T (reprint author), Waseda Univ TWIns, Grad Sch Adv Sci & Engn, Dept Life Sci & Med Biosci, Shinjuku Ku, 2-2 Wakamatsu Cho, Tokyo 1628480, Japan.	tasahi@waseda.jp			Japanese Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology, Japan	The authors greatly appreciate Masahito Tanaka and Takuya Taniguchi for fruitful discussion. This study was financially supported by Grant-in-Aid for JSPS fellows (to Y.O.) from the Japanese Society for the Promotion of Science and the Global COE "Practical Chemical Wisdom" program from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Brogioli D, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.031931; Hou JQ, 2010, J PHYS CHEM B, V114, P15301, DOI 10.1021/jp106683n; Reist M, 1998, CHEM RES TOXICOL, V11, P1521, DOI 10.1021/tx9801817; Watanabe T, 2010, J PHARMACOKINET PHAR, V37, P575, DOI 10.1007/s10928-010-9176-y; DAMATO RJ, 1994, P NATL ACAD SCI USA, V91, P4082, DOI 10.1073/pnas.91.9.4082; Sasabe J, 2012, P NATL ACAD SCI USA, V109, P627, DOI 10.1073/pnas.1114639109; Eriksson T, 2000, J PHARM PHARMACOL, V52, P807, DOI 10.1211/0022357001774660; Muller S, 2012, SIAM J APPL MATH, V72, P1926, DOI 10.1137/110847056; Lepper ER, 2004, J MED CHEM, V47, P2219, DOI 10.1021/jm0304820; SAVAGEAU MA, 1969, J THEOR BIOL, V25, P365, DOI 10.1016/S0022-5193(69)80026-3; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; van de Waterbeemd H, 2003, NAT REV DRUG DISCOV, V2, P192, DOI 10.1038/nrd1032; Blanco C, 2011, CHEM PHYS LETT, V505, P140, DOI 10.1016/j.cplett.2011.02.032; Yamazaki H, 2013, CHEM RES TOXICOL, V26, P486, DOI 10.1021/tx400008g; Kondepudi DK, 2001, ACCOUNTS CHEM RES, V34, P946, DOI 10.1021/ar010089t; Smith SW, 2009, TOXICOL SCI, V110, P4, DOI 10.1093/toxsci/kfp097; REIST M, 1995, CHIRALITY, V7, P396, DOI 10.1002/chir.530070603; Sontjens SHM, 2000, J AM CHEM SOC, V122, P7487, DOI 10.1021/ja000435m; Savic RM, 2007, J PHARMACOKINET PHAR, V34, P711, DOI 10.1007/s10928-007-9066-0; Meyring M, 2002, ANAL CHEM, V74, P3726, DOI 10.1021/ac0203138; Schoetz G, 2001, ELECTROPHORESIS, V22, P3185, DOI 10.1002/1522-2683(200109)22:15<3185::AID-ELPS3185>3.0.CO;2-V; Sahin O, 2007, P NATL ACAD SCI USA, V104, P6579, DOI 10.1073/pnas.0606827104; Shen Q, 2013, ACTA PHARMACOL SIN, V34, P998, DOI 10.1038/aps.2013.78; Hamase K, 2007, J CHROMATOGR A, V1143, P105, DOI 10.1016/j.chroma.2006.12.078; Shinar G, 2010, SCIENCE, V327, P1389, DOI 10.1126/science.1183372; Bauer KS, 1998, BIOCHEM PHARMACOL, V55, P1827, DOI 10.1016/S0006-2952(98)00046-X; BLASCHKE G, 1979, ARZNEIMITTEL-FORSCH, V29-2, P1640; Brucaner H., 2011, D AMINO ACID IN CHEM; Hashimoto Y, 2002, BIOORGAN MED CHEM, V10, P461, DOI 10.1016/S0968-0896(01)00308-X; Honarparvar B., 2013, CHEM REV; Hong ZY, 2010, CHIRALITY, V22, P355, DOI 10.1002/chir.20750; Huang YJ, 2005, BIOMED CHROMATOGR, V19, P488, DOI 10.1002/bmc.466; Islas JR, 2005, P NATL ACAD SCI USA, V102, P13743, DOI 10.1073/pnas.0503171102; Izumi H., 2007, J ORG CHEM, V72, P1; Kaszuba K, 2010, J PHYS CHEM B, V114, P8374, DOI 10.1021/jp909971f; Lee CJJ, 2011, TOXICOL SCI, V122, P146, DOI 10.1093/toxsci/kfr084; LI YB, 2011, P 2011 3 INT C FUT, P13, DOI DOI 10.1002/H0N.992; Lin G.Q., 2011, CHIRAL DRUGS CHEMIST; Lotem E. Y, 2004, P NATL ACAD SCI USA, V101, P5934, DOI DOI 10.1073/PNAS.0306752101; Matei I, 2012, J MOL MODEL, V18, P4381, DOI 10.1007/s00894-012-1444-x; Meyring M, 1999, ELECTROPHORESIS, V20, P2425, DOI 10.1002/(SICI)1522-2683(19990801)20:12<2425::AID-ELPS2425>3.0.CO;2-W; Meyring M, 2000, ELECTROPHORESIS, V21, P3270; Micskei K, 2008, J PHYS CHEM B, V112, P9196, DOI 10.1021/jp803334b; MILLS RFN, 1973, XENOBIOTICA, V3, P589; Mochizuki A, 2010, J THEOR BIOL, V266, P323, DOI 10.1016/j.jtbi.2010.06.007; Nakamura T, 2007, CHEM PHARM BULL, V55, P651, DOI 10.1248/cpb.55.651; Nishimura K., 1994, CHEM PHARM BULL, V42, P5; Ogino Y., 2015, IN PREPARATION; Savageau MA, 1998, BIOSYSTEMS, V47, P9, DOI 10.1016/S0303-2647(98)00020-3; SCHUMACH.H, 1965, BRIT J PHARM CHEMOTH, V25, P324; Suzuki T, 2010, PHASE TRANSIT, V83, P223, DOI 10.1080/01411591003605986; TESTA B, 1986, TRENDS PHARMACOL SCI, V7, P60, DOI 10.1016/0165-6147(86)90255-5; Therapontosa C., 2009, P NATL ACAD SCI USA, V106, P1; Voit E.O., 2013, ISRN BIOMATHEMATICS, V2013; Xuan Q, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.046116; Yamamoto T, 2009, BIOORG MED CHEM LETT, V19, P3973, DOI 10.1016/j.bmcl.2009.02.108	56	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0022-5193	1095-8541		J THEOR BIOL	J. Theor. Biol.	MAY 21	2015	373						117	131		10.1016/j.jtbi.2015.03.011		15	Biology; Mathematical & Computational Biology	Life Sciences & Biomedicine - Other Topics; Mathematical & Computational Biology	CH4KQ	WOS:000354002800011		
J	Iwai, H; Kuramoto, E; Yamanaka, A; Sonomura, T; Uemura, M; Goto, T				Iwai, H.; Kuramoto, E.; Yamanaka, A.; Sonomura, T.; Uemura, M.; Goto, T.			ASCENDING PARABRACHIO-THALAMO-STRIATAL PATHWAYS: POTENTIAL CIRCUITS FOR INTEGRATION OF GUSTATORY AND ORAL MOTOR FUNCTIONS	NEUROSCIENCE			English	Article						parabrachial nucleus; thalamus; corpus striatum; taste; rat	BIOTINYLATED DEXTRAN-AMINE; THALAMOSTRIATAL PROJECTIONS; DIFFERENTIAL PROJECTIONS; EXTENDED AMYGDALA; RAT; NUCLEUS; BRAIN; INTRALAMINAR; ANTEROGRADE; NEURONS	The medial parabrachial nucleus (MPB) and external part of the medial parabrachial nucleus (MPBE) relay gustatory, oral mechanosensory and other visceral information in the rat brain and reportedly project not only to the parvicellular part of the posteromedial ventral thalamic nucleus (VPMpc) but also to the ventrocaudal part of the intralaminar thalamic nuclei. Generally, the intralaminar thalamic nuclei project topographically to the caudate putamen (CPu); however, it is unclear where the ventrocaudal part of the intralaminar thalamic nuclei projects within the CPu. Thus, we visualized neural pathways from the MPB and MPBE to the CPu via the ventrocaudal part of the intralaminar thalamic nuclei using an anterograde tracer, biotinylated dextran amine, and a retrograde tracer, cholera toxin B subunit. We found that the MPB and MPBE sent a relatively stronger input to the ventrocaudal part of the intralaminar thalamic nuclei such as the oval paracentral thalamic nucleus (OPC), central medial thalamic nucleus (CM) and parafascicular thalamic nucleus (PF) and retroreuniens area (RRe) as compared to the VPMpc. In turn, these thalamic nuclei projected to the ventral part of the CPu with the topographical arrangement as follows: the OPC to the ventrocentral part of the CPu; ventrolateral part of the PF to the ventrolateral part of the CPu; and the caudal part of the CM, ventromedial part of the PF and RRe to the ventromedial part of the CPu. Further, we found that the VPMpc rather projected to the interstitial nucleus of the posterior limb of the anterior commissure than the CPu. The ventral part of the CPu is reported to be involved in jaw movement as well as food and water intake functions. Therefore, these parabrachio-thalamo-striatal pathways that we demonstrated here suggest that gustatory and oral mechanosensory information affects feeding behavior within the ventral part of the CPu. (C) 2015 IBRO. Published by Elsevier Ltd. All rights reserved.	[Iwai, H.; Kuramoto, E.; Yamanaka, A.; Uemura, M.; Goto, T.] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Oral Anat & Cell Biol, Kagoshima 8908544, Japan; [Sonomura, T.] Kanazawa Med Univ, Sch Med, Dept Anat 2, Kahoku, Ishikawa 9200293, Japan	Iwai, H (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Oral Anat & Cell Biol, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	haruki@dent.kagoshima-u.ac.jp			Asahi Glass Foundation; Takeda Science Foundation; Grant for Promoted Research from Kanazawa Medical University [S2014-9];  [24700833];  [26750043];  [25830034];  [26350592]	This work was supported by Grant-in-Aid for Young Scientists (B) (24700833 and 26750043 to HI, and 25830034 to EK) and Grant-in-Aid for Scientific Research (C) (26350592 to TS). This work was also supported by the Asahi Glass Foundation, the Takeda Science Foundation and Grant for Promoted Research from Kanazawa Medical University (S2014-9).	Alheid GF, 1999, ANN NY ACAD SCI, V877, P645, DOI 10.1111/j.1749-6632.1999.tb09294.x; Karimnamazi H, 1998, BRAIN RES, V813, P283, DOI 10.1016/S0006-8993(98)00951-2; HERBERT H, 1990, J COMP NEUROL, V293, P540, DOI 10.1002/cne.902930404; CECHETTO DF, 1987, J COMP NEUROL, V262, P27, DOI 10.1002/cne.902620104; BERENDSE HW, 1990, J COMP NEUROL, V299, P187, DOI 10.1002/cne.902990206; Zhang M, 2000, NEUROSCIENCE, V99, P267, DOI 10.1016/S0306-4522(00)00198-6; Vertes RP, 2012, NEUROSCIENCE, V219, P120, DOI 10.1016/j.neuroscience.2012.04.067; Erro ME, 2002, NEUROSCI RES, V42, P45; Lai H, 2000, BRAIN RES, V872, P208, DOI 10.1016/S0006-8993(00)02457-4; NORGREN R, 1975, BRAIN RES, V92, P123, DOI 10.1016/0006-8993(75)90531-4; FULWILER CE, 1984, BRAIN RES REV, V7, P229, DOI 10.1016/0165-0173(84)90012-2; Bester H, 1999, J COMP NEUROL, V405, P421; Kaur S, 2013, J NEUROSCI, V33, P7627, DOI 10.1523/JNEUROSCI.0173-13.2013; McDonald AJ, 1999, ANN NY ACAD SCI, V877, P309, DOI 10.1111/j.1749-6632.1999.tb09275.x; NORGREN R, 1976, J COMP NEUROL, V166, P17, DOI 10.1002/cne.901660103; Krout KE, 2000, J COMP NEUROL, V428, P475, DOI 10.1002/1096-9861(20001218)428:3<475::AID-CNE6>3.0.CO;2-9; Krout KE, 2002, J COMP NEUROL, V448, P53, DOI 10.1002/cne.10236; YASUI Y, 1991, J COMP NEUROL, V308, P293, DOI 10.1002/cne.903080212; VEENMAN CL, 1992, J NEUROSCI METH, V41, P239, DOI 10.1016/0165-0270(92)90089-V; Coolen LM, 1999, J NEUROSCI METH, V91, P1, DOI 10.1016/S0165-0270(99)00055-2; de Olmos J. S., 2004, RAT NERVOUS SYSTEM, P509; FEIL K, 1995, J COMP NEUROL, V353, P506, DOI 10.1002/cne.903530404; Groenewegen HJ, 2004, RAT NERVOUS SYSTEM, P407; Halsell CB, 1997, J NEUROPHYSIOL, V78, P920; Inoue K, 1997, PHARMACOL BIOCHEM BE, V58, P183, DOI 10.1016/S0091-3057(97)00004-X; Inui-Yamamoto C, 2010, NEUROSCIENCE, V167, P199, DOI 10.1016/j.neuroscience.2010.02.027; KOSHIKAWA N, 1989, EUR J PHARMACOL, V163, P227, DOI 10.1016/0014-2999(89)90191-X; Nakashima M, 2000, NEUROSCI RES, V36, P297, DOI 10.1016/S0168-0102(99)00129-7; Norgren R, 2004, RAT NERVOUS SYSTEM, V3rd, P891; Paxinos G, 1998, RAT BRAIN STEREOTAXI; Saper CB, 2014, RAT NERVOUS SYSTEM, P629; Shin JW, 2011, J CHEM NEUROANAT, V42, P1, DOI 10.1016/j.jchemneu.2011.05.003; Vertes RP, 2014, RAT NERVOUS SYSTEM, P335; Watson C, 2007, RAT BRAIN STEREOTAXI; WOLF G, 1968, J COMP NEUROL, V132, P519, DOI 10.1002/cne.901320403; YASUI Y, 1989, J COMP NEUROL, V290, P487, DOI 10.1002/cne.902900404	36	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	MAY 21	2015	294						1	13		10.1016/j.neuroscience.2015.02.045		13	Neurosciences	Neurosciences & Neurology	CF7AS	WOS:000352709100001		
J	Kurimoto, S; Jung, J; Tapadia, M; Lengfeld, J; Agalliu, D; Waterman, M; Mozaffar, T; Gupta, R				Kurimoto, S.; Jung, J.; Tapadia, M.; Lengfeld, J.; Agalliu, D.; Waterman, M.; Mozaffar, T.; Gupta, R.			ACTIVATION OF THE WNT/beta-CATENIN SIGNALING CASCADE AFTER TRAUMATIC NERVE INJURY	NEUROSCIENCE			English	Article						peripheral nerve; Wnt signaling; traumatic nerve injury; neuromuscular junction	NEUROMUSCULAR-JUNCTION; BETA-CATENIN; EPIGENETIC INACTIVATION; COLORECTAL-CANCER; IN-VIVO; WNT; AGRIN; EXPRESSION; SYNAPSE; MUSCLE	Recent data have shown that preservation of the neuromuscular junction (NMJ) after traumatic nerve injury helps to improve functional recovery with surgical repair via matrix metalloproteinase-3 (MMP3) blockade. As such, we sought to explore additional pathways that may augment this response. Wnt3a has been shown to inhibit acetylcholine receptor (AChR) clustering via beta-catenin-dependent signaling in the development of the NMJ. Therefore, we hypothesized that Wnt3a and beta-catenin are associated with NMJ destabilization following traumatic denervation. A critical size nerve defect was created by excising a 10-mm segment of the sciatic nerve in mice. Denervated muscles were then harvested at multiple time points for immunofluorescence staining, quantitative real-time PCR, and western blot analysis for Wnt3a and beta-catenin levels. Moreover, a novel Wnt/beta-catenin transgenic reporter mouse line was utilized to support our hypothesis of Wnt activation after traumatic nerve injury. The expression of Wnt3a mRNA was significantly increased by 2 weeks post-injury and remained upregulated for 2 months. Additionally, beta-catenin was activated at 2 months post-injury relative to controls. Correspondingly, immunohistochemical analysis of denervated transgenic mouse line TCF/Lef: H2B-GFP muscles demonstrated that the number of GFP-positive cells was increased at the motor endplate band. These collective data support that post-synaptic AChRs destabilize after denervation by a process that involves the Wnt/beta-catenin pathway. As such, this pathway serves as a potential therapeutic target to prevent the motor endplate degeneration that occurs following traumatic nerve injury. (C) 2015 IBRO. Published by Elsevier Ltd. All rights reserved.	[Kurimoto, S.; Jung, J.; Tapadia, M.; Mozaffar, T.; Gupta, R.] Univ Calif Irvine, Dept Orthopaed Surg, Irvine, CA 92697 USA; [Lengfeld, J.; Agalliu, D.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; [Waterman, M.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA; [Mozaffar, T.] Univ Calif Irvine, Dept Neurol, Irvine, CA 92697 USA; [Gupta, R.] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA; [Gupta, R.] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA; [Kurimoto, S.] Nagoya Univ, Dept Hand Surg, Grad Sch Med, Showa Ku, Nagoya, Aichi 4668550, Japan	Gupta, R (reprint author), Univ Calif Irvine, Dept Orthopaed Surg, 2226 Gillespie Neurosci Res Facil, Irvine, CA 92697 USA.	ranjang@uci.edu	KURIMOTO, Shigeru/J-3451-2015	KURIMOTO, Shigeru/0000-0003-1521-0038	NIH NINDS [2RO1NS049203-06A1]	This work was supported by NIH NINDS 2RO1NS049203-06A1.	Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Veeck J, 2006, ONCOGENE, V25, P3479, DOI 10.1038/sj.onc.1209386; Aguilera O, 2006, ONCOGENE, V25, P4116, DOI 10.1038/sj.onc.1209439; Seddon HJ, 1943, J PHYSIOL-LONDON, V102, P191; VALENZUELA DM, 1995, NEURON, V15, P573, DOI 10.1016/0896-6273(95)90146-9; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Zhang B, 2007, J NEUROSCI, V27, P3968, DOI 10.1523/JNEUROSCI.4691-06.2007; Ray WZ, 2010, EXP NEUROL, V223, P77, DOI 10.1016/j.expneurol.2009.03.031; Bentolila V, 1999, J BONE JOINT SURG AM, V81A, P20; Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006; Griffin JW, 2013, J BONE JOINT SURG AM, V95A, P2144, DOI 10.2106/JBJS.L.00704; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; MCMAHAN UJ, 1990, COLD SH Q B, V55, P407; Taniguchi H, 2005, ONCOGENE, V24, P7946, DOI 10.1038/sj.onc.1208910; Kim DH, 2003, J NEUROSURG, V98, P1005, DOI 10.3171/jns.2003.98.5.1005; Henriquez JP, 2008, P NATL ACAD SCI USA, V105, P18812, DOI 10.1073/pnas.0806300105; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Tung TH, 2010, J HAND SURG-AM, V35A, P332, DOI 10.1016/j.jhsa.2009.12.002; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; DeAlmeida VI, 2007, CANCER RES, V67, P5371, DOI 10.1158/0008-5472.CAN-07-0266; Bezakova G, 2001, J CELL BIOL, V153, P1441, DOI 10.1083/jcb.153.7.1441; Chao T, 2013, ANN NEUROL, V73, P210, DOI 10.1002/ana.23781; Cruciat CM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a015081; Ferrer-Vaquer A, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-121; FRANK E, 1975, ACTA PHYSIOL SCAND, V95, P66, DOI 10.1111/j.1748-1716.1975.tb10026.x; HARTZELL HC, 1972, J GEN PHYSIOL, V60, P248, DOI 10.1085/jgp.60.3.248; Henriquez JP, 2012, ACTA PHYSIOL, V204, P128, DOI 10.1111/j.1748-1716.2011.02295.x; Kang JR, 2011, J AM ACAD ORTHOP SUR, V19, pS28; Koles K, 2012, COLD SPRING HARB PER, V4; Lin WC, 2005, NEURON, V46, P569, DOI 10.1016/j.neuron.2005.04.002; Polakis P., 2012, COLD SPRING HARB PER, V4; Samuel MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046663; STEINBACH JH, 1981, J PHYSIOL-LONDON, V313, P513; Takamori M, 2012, ANN NY ACAD SCI, V1274, P14, DOI 10.1111/j.1749-6632.2012.06784.x; Wang J, 2008, J BIOL CHEM, V283, P21668, DOI 10.1074/jbc.M709939200; Wu HT, 2012, DEVELOPMENT, V139, P2392, DOI 10.1242/dev.080705	40	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	MAY 21	2015	294						101	108		10.1016/j.neuroscience.2015.02.049		8	Neurosciences	Neurosciences & Neurology	CF7AS	WOS:000352709100009		
J	Sasaki-Hamada, S; Yuri, Y; Hoshi, M; Oka, JI				Sasaki-Hamada, S.; Yuri, Y.; Hoshi, M.; Oka, J. -I.			IMMUNOHISTOCHEMICAL DETERMINATION OF THE SITE OF ANTIDEPRESSANT-LIKE EFFECTS OF GLUCAGON-LIKE PEPTIDE-2 IN ACTH-TREATED MICE	NEUROSCIENCE			English	Article						glucagon-like peptide-2; antidepressant; adrenocorticotropic hormone; c-fos protein; CRF; neurogenesis	DENTATE GYRUS; CELL-PROLIFERATION; RAT-BRAIN; DORSOMEDIAL HYPOTHALAMUS; DEPRESSED-PATIENTS; GENE-EXPRESSION; PANIC DISORDER; FOOD-INTAKE; STRESS; IMIPRAMINE	The intracerebroventicular administration (i.c.v.) of glucagon-like peptide-2 (GLP-2) had antidepressant-like effects on saline-treated mice in the forced-swim test. The GLP-2 treatment (3 lg, i.c.v.) for 6 days, but not that of imipramine had antidepressant-like effects on adrenocorticotropic hormone (ACTH)-treated mice. The immunohistochemical detection of the c-fos protein (Fos) revealed that the administration of GLP-2 induced Fos-immunoreactivity (Fos-IR) in the dorsomedial hypothalamic nucleus in saline-treated and ACTH-treated mice, and also in the hippocampal dentate gyrus in ACTH-treated mice, but not in saline-treated mice. In contrast, Fos-IR in the paraventricular nucleus of the hypothalamus decreased after the administration of GLP-2 to ACTH-treated mice. In ACTH-treated mice, the chronic administration of GLP-2 affected hippocampal neurogenesis, in addition to Fos-IR in hypothalamic GABAergic neurons and corticotrophin-releasing factor-containing neurons. These results suggest that GLP-2 acts on specific brain regions to regulate stress conditions, and induces antide-pressant-like effects under imipramine-resistant conditions, which may be associated with the modulation of the hypothalamic-pituitary-adrenal-axis. (C) 2015 IBRO. Published by Elsevier Ltd. All rights reserved.	[Sasaki-Hamada, S.; Yuri, Y.; Hoshi, M.; Oka, J. -I.] Tokyo Univ Sci, Fac Pharmaceut Sci, Pharmacol Lab, Noda, Chiba 2788510, Japan	Oka, JI (reprint author), Tokyo Univ Sci, Fac Pharmaceut Sci, Pharmacol Lab, 2641 Yamazaki, Noda, Chiba 2788510, Japan.	okaji@rs.noda.tus.ac.jp			JSPS [24590126]	This work was, in part, supported by JSPS KAKENHI Grant number 24590126.	Gould E, 1997, J NEUROSCI, V17, P2492; Herman JP, 2003, FRONT NEUROENDOCRIN, V24, P151, DOI 10.1016/j.yfrne.2003.07.001; ALTEMUS M, 1992, ARCH GEN PSYCHIAT, V49, P9; SHEKHAR A, 1995, PHARMACOL BIOCHEM BE, V50, P253, DOI 10.1016/0091-3057(94)00307-5; SWANSON LW, 1983, NEUROENDOCRINOLOGY, V36, P165, DOI 10.1159/000123454; Dhanvantari S, 1996, MOL ENDOCRINOL, V10, P342, DOI 10.1210/me.10.4.342; Bremner JD, 1997, AM J PSYCHIAT, V154, P624; Doi M, 2010, ACTA MED OKAYAMA, V64, P219; PORSOLT RD, 1978, EUR J PHARMACOL, V51, P291, DOI 10.1016/0014-2999(78)90414-4; Reif A, 2006, MOL PSYCHIATR, V11, P514, DOI 10.1038/sj.mp.4001791; DUNCAN GE, 1993, J NEUROSCI, V13, P3932; Fong AY, 2005, J COMP NEUROL, V493, P274, DOI 10.1002/cne.20758; Bjerknes M, 2001, P NATL ACAD SCI USA, V98, P12497, DOI 10.1073/pnas.211278098; Yusta B, 2000, GASTROENTEROLOGY, V119, P744, DOI 10.1053/gast.2000.16489; Putignano P, 2001, EUR J ENDOCRINOL, V145, P165, DOI 10.1530/eje.0.1450165; Kitamura Y, 2002, PHARMACOL BIOCHEM BE, V71, P63, DOI 10.1016/S0091-3057(01)00625-6; Tsigos C, 2002, J PSYCHOSOM RES, V53, P865, DOI 10.1016/S0022-3999(02)00429-4; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; RAADSHEER FC, 1994, NEUROENDOCRINOLOGY, V60, P436, DOI 10.1159/000126778; DALLMAN MF, 1987, RECENT PROG HORM RES, V43, P113; Kitamura Y, 2011, BIOL PHARM BULL, V34, P77, DOI 10.1248/bpb.34.77; CULLINAN WE, 1995, NEUROSCIENCE, V64, P477, DOI 10.1016/0306-4522(94)00355-9; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; Iwai T, 2009, BEHAV BRAIN RES, V204, P235, DOI 10.1016/j.bbr.2009.06.020; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; NEMEROFF CB, 1984, SCIENCE, V226, P1342, DOI 10.1126/science.6334362; Gould E, 1998, P NATL ACAD SCI USA, V95, P3168, DOI 10.1073/pnas.95.6.3168; Tanapat P, 2001, J COMP NEUROL, V437, P496, DOI 10.1002/cne.1297; SHEKHAR A, 1993, BRAIN RES, V627, P9, DOI 10.1016/0006-8993(93)90742-6; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Duman RS, 2004, BIOL PSYCHIAT, V56, P140, DOI 10.1016/j.biophysc.2004.02.033; Wong EYH, 2004, EUR J NEUROSCI, V20, P2491, DOI 10.1111/j.1460-9568.2004.03717.x; HALEY TJ, 1957, BRIT J PHARM CHEMOTH, V12, P12; McEwen BS, 2001, ANN NY ACAD SCI, V933, P265; ANTONI FA, 1984, PEPTIDES, V5, P519, DOI 10.1016/0196-9781(84)90080-9; Boldrini M, 2014, INT J NEUROPSYCHOPH, V17, P1923, DOI 10.1017/S1461145714000844; Chheda MG, 2001, NAT CELL BIOL, V3, P331, DOI 10.1038/35070000; Fontes MAP, 2011, NEUROSCIENCE, V184, P64, DOI 10.1016/j.neuroscience.2011.03.018; Iwai T, 2013, BEHAV BRAIN RES, V243, P153, DOI 10.1016/j.bbr.2013.01.010; KARL HJ, 1966, KLIN WOCHENSCHR, V44, P303, DOI 10.1007/BF01752277; Kitamura Y, 2002, PHARMACOL BIOCHEM BE, V72, P397, DOI 10.1016/S0091-3057(01)00769-9; Li BJ, 2013, J BIOCHEM MOL TOXIC, V27, P486, DOI 10.1002/jbt.21510; Lovshin JA, 2004, ENDOCRINOLOGY, V145, P3495, DOI 10.1210/en.2004-0100; Marshall RD, 2002, PSYCHIAT RES, V110, P219, DOI 10.1016/S0165-1781(02)00126-9; MOJSOV S, 1986, J BIOL CHEM, V261, P1880; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; Munroe DG, 1999, P NATL ACAD SCI USA, V96, P1569, DOI 10.1073/pnas.96.4.1569; Palkovits M, 1999, FRONT NEUROENDOCRIN, V20, P270, DOI 10.1006/frne.1999.0186; Paxinos G, 2003, MOUSE BRAIN STEREOTA; SAGAR SM, 1988, SCIENCE, V240, P1328, DOI 10.1126/science.3131879; Sasaki-Hamada S, 2012, NEUROSCIENCE, V212, P140, DOI 10.1016/j.neuroscience.2012.03.032; SCHATZBERG AF, 1985, J PSYCHIAT RES, V19, P57, DOI 10.1016/0022-3956(85)90068-8; SHEKHAR A, 1987, BRAIN RES, V420, P118, DOI 10.1016/0006-8993(87)90246-0; SHEKHAR A, 1994, BIOL PSYCHIAT, V36, P748; Tang- Christensen M, 2001, INT J OBESITY, V25, P42; Tang-Christensen M, 2000, NAT MED, V6, P802, DOI 10.1038/77535; Trudeau LE, 1996, NEURON, V17, P789, DOI 10.1016/S0896-6273(00)80210-X	58	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	MAY 21	2015	294						156	165		10.1016/j.neuroscience.2015.03.010		10	Neurosciences	Neurosciences & Neurology	CF7AS	WOS:000352709100012		
J	Perk, CG; Wickens, JR; Hyland, BI				Perk, C. G.; Wickens, J. R.; Hyland, B. I.			DIFFERING PROPERTIES OF PUTATIVE FAST-SPIKING INTERNEURONS IN THE STRIATUM OF TWO RAT STRAINS	NEUROSCIENCE			English	Article						striatum; amphetamine; electrophysiology; extracellular; single-unit; resting-state	ALTERED REINFORCEMENT MECHANISMS; DEFICIT HYPERACTIVITY DISORDER; FREELY MOVING RATS; GABAERGIC INTERNEURONS; SPINY NEURONS; IN-VIVO; FIRING PATTERNS; BASAL GANGLIA; NEOSTRIATUM; DOPAMINE	Local circuits within the striatum of the basal ganglia include a small number of gamma-aminobutyric acid (GABA)-ergic fast-spiking interneurons (FSI). The number of these cells is reduced in disorders of behavioral control, but it is unknown whether this is accompanied by altered electrophysiological properties. The genetically hypertensive (GH) rat strain exhibits impulsiveness and hyperactivity. We investigated if resting-state FSI activity is affected in this strain using extracellular recordings. We also examined the effect of systemic amphetamine (AMPH), a stimulant drug used in the treatment of these particular behavioral deficits. Putative FSI (pFSI) were encountered less often in GH rats compared to the Wistar control strain. pFSI in GH rats also exhibited a higher mean firing rate, higher intraburst firing rate, lower interburst interval, and shorter bursts compared to controls. AMPH increased the mean overall firing rate of Wistar rat pFSI but did not significantly alter the firing properties of this subtype in GH rats. These differences in the resting-state electrophysiological activity of pFSI in GH rats point to them as a cell type of particular interest in understanding striatal functioning across different strains. (C) 2015 IBRO. Published by Elsevier Ltd. All rights reserved.	[Perk, C. G.; Hyland, B. I.] Univ Otago, Brain Hlth Res Ctr, Otago Sch Med Sci, Dept Physiol, Dunedin 9054, New Zealand; [Perk, C. G.; Hyland, B. I.] Univ Otago, Brain Res New Zealand, Dunedin 9054, New Zealand; [Perk, C. G.; Wickens, J. R.] Univ Otago, Otago Sch Med Sci, Dept Anat, Dunedin 9054, New Zealand; [Wickens, J. R.] Okinawa Inst Sci & Technol, Neurobiol Res Unit, Kunigami, Okinawa 9040412, Japan	Perk, CG (reprint author), Univ Otago, Otago Sch Med Sci, Dept Anat, POB 913, Dunedin 9054, New Zealand.	chris.perk@otago.ac.nz	Hyland, Brian/F-7840-2012; Wickens, Jeffery/N-6055-2014	Hyland, Brian/0000-0001-7593-4885; Wickens, Jeffery/0000-0002-8795-1209	Health Research Council of NZ	We thank Associate Professor Sheila Williams for assistance with the statistical analysis and the Health Research Council of NZ for funding the research.	ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; KEMP JM, 1971, PHILOS T ROY SOC B, V262, P383, DOI 10.1098/rstb.1971.0102; Tripp G, 2001, J CHILD PSYCHOL PSYC, V42, P691, DOI 10.1017/S0021963001007430; Bilkey DK, 1999, J NEUROSCI METH, V92, P87, DOI 10.1016/S0165-0270(99)00102-8; Kreitzer AC, 2009, ANNU REV NEUROSCI, V32, P127, DOI 10.1146/annurev.neuro.051508.135422; Tripp G, 2008, J CHILD PSYCHOL PSYC, V49, P691, DOI 10.1111/j.1469-7610.2007.01851.x; Koos T, 1999, NAT NEUROSCI, V2, P467; Luk KC, 2001, NEUROSCIENCE, V104, P93, DOI 10.1016/S0306-4522(01)00038-0; SWANSON JM, 1993, EXCEPT CHILDREN, V60, P154; Kuczenski R, 1997, J NEUROCHEM, V68, P2032; Gage GJ, 2010, NEURON, V67, P466, DOI 10.1016/j.neuron.2010.06.034; Goldberg JA, 2011, NEUROSCIENCE, V198, P27, DOI 10.1016/j.neuroscience.2011.08.067; Koos T, 2002, J NEUROSCI, V22, P529; Solanto MV, 1998, BEHAV BRAIN RES, V94, P127, DOI 10.1016/S0166-4328(97)00175-7; Centonze D, 2003, J NEUROSCI, V23, P6245; Wickens JR, 1998, J NEUROPHYSIOL, V79, P2358; WILSON CJ, 1993, PROG BRAIN RES, V99, P277; Kalanithi PSA, 2005, P NATL ACAD SCI USA, V102, P13307, DOI 10.1073/pnas.0502624102; WILSON CJ, 1981, BRAIN RES, V220, P67, DOI 10.1016/0006-8993(81)90211-0; Sutherland KR, 2009, BEHAV BRAIN RES, V205, P372, DOI 10.1016/j.bbr.2009.07.011; Gernert M, 2000, J NEUROSCI, V20, P7052; Berke JD, 2004, NEURON, V43, P883, DOI 10.1016/j.neuron.2004.08.035; Bracci E, 2002, J NEUROPHYSIOL, V87, P2190, DOI 10.1152/jn.00754.2001; Kaneoke Y, 1996, J NEUROSCI METH, V68, P211; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; SOMOGYI P, 1979, BRAIN RES, V178, P3, DOI 10.1016/0006-8993(79)90084-2; Berke JD, 2008, J NEUROSCI, V28, P10075, DOI 10.1523/JNEUROSCI.2192-08.2008; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Sagvolden T, 1998, BEHAV BRAIN RES, V94, P61, DOI 10.1016/S0166-4328(97)00170-8; Tripp G, 2009, NEUROPHARMACOLOGY, V57, P579, DOI 10.1016/j.neuropharm.2009.07.026; Humphries MD, 2009, NEURAL NETWORKS, V22, P1174, DOI 10.1016/j.neunet.2009.07.018; Kiyatkin EA, 1999, BRAIN RES, V822, P88, DOI 10.1016/S0006-8993(99)01093-8; Marrone MC, 2006, EUR J NEUROSCI, V24, P2061, DOI 10.1111/j.1460-9568.2006.05083.x; Berridge CW, 2006, NEUROPSYCHOPHARMACOL, V31, P2332, DOI 10.1038/sj.npp.1301159; Blomeley CP, 2009, EUR J NEUROSCI, V29, P1604, DOI 10.1111/j.1460-9568.2009.06725.x; Dieu Y, 2005, BEHAV PHARMACOL, V16, P35, DOI 10.1097/00008877-200502000-00004; DIMOVA R, 1980, NEUROSCIENCE, V5, P1581, DOI 10.1016/0306-4522(80)90022-6; FOG R, 1970, PSYCHOPHARMACOLOGIA, V16, P305, DOI 10.1007/BF00404736; KAWAGUCHI Y, 1993, J NEUROSCI, V13, P4908; Lansink CS, 2010, EUR J NEUROSCI, V32, P494, DOI 10.1111/j.1460-9568.2010.07293.x; Li YH, 2013, J NEUROSCI, V33, P5065, DOI 10.1523/JNEUROSCI.5679-12.2013; Paxinos G., 1997, RAT BRAIN STEREOTAXI; Sandstrom MI, 2003, SYNAPSE, V47, P91, DOI 10.1002/syn.10142; Schmitzer-Torbert NC, 2008, NEUROSCIENCE, V153, P349, DOI 10.1016/j.neuroscience.2008.01.081; Schulz JM, 2011, J PHYSIOL-LONDON, V589, P4365, DOI 10.1113/jphysiol.2011.212944; SMIRK FH, 1958, NATURE, V182, P727, DOI 10.1038/182727a0; Sood P, 2009, J NEUROSCI METH, V185, P39, DOI 10.1016/j.jneumeth.2009.09.004; Tepper JM, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00150; Wickens JR, 2004, BEHAV BRAIN RES, V152, P393, DOI 10.1016/j.bbr.2003.10.023; Wiltschko AB, 2010, NEUROPSYCHOPHARMACOL, V35, P1261, DOI 10.1038/npp.2009.226	50	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	MAY 21	2015	294						215	226		10.1016/j.neuroscience.2015.02.051		12	Neurosciences	Neurosciences & Neurology	CF7AS	WOS:000352709100018		
J	Fienberg, AT; Alonzi, LP; Anastasi, A; Bjorkquist, R; Cauz, D; Fatemi, R; Ferrari, C; Fioretti, A; Fankenthal, A; Gabbanini, C; Gibbons, LK; Giovanetti, K; Goadhouse, SD; Gohn, WP; Gorringe, TP; Hertzog, DW; Iacovacci, M; Kammel, P; Kaspar, J; Kiburg, B; Li, L; Mastroianni, S; Pauletta, G; Peterson, DA; Pocanic, D; Smith, MW; Sweigart, DA; Tishchenko, V; Venanzoni, G; Van Wechel, TD; Wall, KB; Winter, P; Yai, K				Fienberg, A. T.; Alonzi, L. P.; Anastasi, A.; Bjorkquist, R.; Cauz, D.; Fatemi, R.; Ferrari, C.; Fioretti, A.; Fankenthal, A.; Gabbanini, C.; Gibbons, L. K.; Giovanetti, K.; Goadhouse, S. D.; Gohn, W. P.; Gorringe, T. P.; Hertzog, D. W.; Iacovacci, M.; Kammel, P.; Kaspar, J.; Kiburg, B.; Li, L.; Mastroianni, S.; Pauletta, G.; Peterson, D. A.; Pocanic, D.; Smith, M. W.; Sweigart, D. A.; Tishchenko, V.; Venanzoni, G.; Van Wechel, T. D.; Wall, K. B.; Winter, P.; Yai, K.			Studies of an array of PbF2 Cherenkov crystals with large-area SiPM readout	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT			English	Article						Lead-fluoride crystals; Silicon photomultiplier; Electromagnetic calorimeter	LEAD FLUORIDE-CRYSTALS; CALORIMETRY	The electromagnetic calorimeter for the new muon (g - 2) experiment at Fermilab will consist of arrays of PbF2 Cherenkov crystals read out by large-area silicon photo-multiplier (SiPM) sensors. We report here on measurements and simulations using 2.0-4.6 GeV electrons with a 28-element prototype array. All data were obtained using fast waveform digitizers to accurately capture signal pulse shapes vs. energy, impact position, angle, and crystal wrapping. The SiPMs were gain matched using a laser-based calibration system, which also provided a stabilization procedure that allowed gain correction to a level of 10(-4) per hour. After accounting for longitudinal fluctuation losses, those crystals wrapped in a white, diffusive wrapping exhibited an energy resolution sigma/E of (13.4 +/- 0.1)% /root E/GeV, while those wrapped in a black, absorptive wrapping had (4.6 +/- 0.3)%/ root E/GeV. The white-wrapped crystals having nearly twice the total light collection display a generally wider and impact-position-dependent pulse shape owing to the dynamics of the light propagation, in comparison to the black-wrapped crystals, which have a narrower pulse shape that is insensitive to impact position. (C) 2015 Elsevier B.V. All rights reserved.	[Fienberg, A. T.; Alonzi, L. P.; Hertzog, D. W.; Kammel, P.; Kaspar, J.; Kiburg, B.; Peterson, D. A.; Smith, M. W.; Van Wechel, T. D.; Wall, K. B.; Winter, P.; Yai, K.] Univ Washington, Seattle, WA 98195 USA; [Bjorkquist, R.; Fankenthal, A.; Gibbons, L. K.; Sweigart, D. A.] Cornell Univ, Ithaca, NY 14850 USA; [Anastasi, A.; Ferrari, C.; Fioretti, A.; Gabbanini, C.; Pauletta, G.; Venanzoni, G.] Ist Nazl Fis Nucl, Lab Nazl Frascati, I-00044 Frascati, Italy; [Cauz, D.; Pauletta, G.] Ist Nazl Fis Nucl, Sez Trieste & GC Udine, Udine, Italy; [Iacovacci, M.] Ist Nazl Fis Nucl, Sez Napoli, I-80125 Naples, Italy; [Ferrari, C.; Fioretti, A.; Gabbanini, C.] UOS Pisa, CNR, Ist Nazl Ott, Pisa, Italy; [Anastasi, A.] Univ Messina, Dipartimento Fis & Sci Terra, Messina, Italy; [Iacovacci, M.] Univ Naples Federico II, Naples, Italy; [Cauz, D.; Pauletta, G.] Univ Udine, I-33100 Udine, Italy; [Fatemi, R.; Gohn, W. P.; Gorringe, T. P.; Tishchenko, V.] Univ Kentucky, Lexington, KY 40506 USA; [Goadhouse, S. D.; Pocanic, D.] Univ Virginia, Charlottesville, VA 22904 USA; [Giovanetti, K.] James Madison Univ, Harrisonburg, VA 22807 USA; [Li, L.] Shanghai Jiao Tong Univ, Shanghai 200030, Peoples R China; [Li, L.] Shanghai Key Lab Particle Phys & Cosmol, Shanghai, Peoples R China; [Yai, K.] Osaka Univ, Grad Sch Sci, Osaka, Japan	Kaspar, J (reprint author), Univ Washington, Box 351560, Seattle, WA 98195 USA.	kaspar@uw.edu	Li, Liang/O-1107-2015	Li, Liang/0000-0001-6411-6107	Department of Energy (DOE) [DE-AC02-76SF00515]; National Science Foundation (NSF) [PHY-1337542]; DOE Office of Nuclear [DE-FG02-97ER41020]; DOE Office of High Energy Physics [DE-SC0008037]; NSF Physics Division [PHY-1205792, PHY-1307328, PHY-1307196, DGE-1144153]; Istituto Nazionale di Fisica Nucleare (Italy); National Natural Science Foundation of China [11375115]; Shanghai Pujiang Program [13PJ1404200]	We thank Adam Para for the initial suggestion to test PbF<INF>2</INF> as a candidate material and for excellent advice on evaluating and choosing SiPM products. Tianchi Zhao negotiated the original contract with SICCAS and helped evaluate early samples. Carsten Nast, Keith Jobe and Zenon Szalata hosted this effort at the SLAC ESTB facility, which is supported under Department of Energy (DOE) contract DE-AC02-76SF00515. This research was supported by the National Science Foundation (NSF) MRI program (PHY-1337542), by the DOE Offices of Nuclear (DE-FG02-97ER41020) and High Energy Physics (DE-SC0008037), by the NSF Physics Division (PHY-1205792, PHY-1307328, PHY-1307196, DGE-1144153), by the Istituto Nazionale di Fisica Nucleare (Italy), and by the National Natural Science Foundation of China (11375115) and the Shanghai Pujiang Program (13PJ1404200).	Achenbach P, 1998, NUCL INSTRUM METH A, V416, P357, DOI 10.1016/S0168-9002(98)00748-7; Achenbach P, 2001, NUCL INSTRUM METH A, V465, P318, DOI 10.1016/S0168-9002(01)00668-4; Anastasi A., COMMUNICATION; ANDERSON DF, 1990, NUCL INSTRUM METH A, V290, P385, DOI 10.1016/0168-9002(90)90553-I; APPUHN RD, 1994, NUCL INSTRUM METH A, V350, P208, DOI 10.1016/0168-9002(94)91166-5; Baunack S., 2011, PHYS RES A, V640, P58; Carey R., 2015, FERMILAB PROPOSAL 09; Hamamatsu, 2015, MPPC MODULES SELECTI; McNabb R, 2009, NUCL INSTRUM METH A, V602, P396, DOI 10.1016/j.nima.2009.01.007; Renker D, 2006, NUCL INSTRUM METH A, V567, P48, DOI 10.1016/j.nima.2006.05.060; Sedykh S., 2000, PHYS RES A, V455, P346, DOI DOI 10.1016/30168-90021; SIMON DA, 1993, NUCL INSTRUM METH A, V335, P86, DOI 10.1016/0168-9002(93)90259-K	12	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-9002	1872-9576		NUCL INSTRUM METH A	Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc. Equip.	MAY 21	2015	783						12	21		10.1016/j.nima.2015.02.028		10	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Particles & Fields; Spectroscopy	Instruments & Instrumentation; Nuclear Science & Technology; Physics; Spectroscopy	CE9CW	WOS:000352142200003		
J	Akatsu, Y; Yamaguchi, S; Mukoyama, S; Morikawa, T; Yamaguchi, T; Tsuchiya, K; Iwasaki, J; Akagi, R; Muramatsu, Y; Katsuragi, J; Fukawa, T; Endo, J; Takahashi, K; Sasho, T				Akatsu, Yorikazu; Yamaguchi, Satoshi; Mukoyama, Shunsuke; Morikawa, Tsuguo; Yamaguchi, Tadashi; Tsuchiya, Kan; Iwasaki, Junichi; Akagi, Ryuichiro; Muramatsu, Yuta; Katsuragi, Joe; Fukawa, Taisuke; Endo, Jun; Takahashi, Kazuhisa; Sasho, Takahisa			Accuracy of High-Resolution Ultrasound in the Detection of Meniscal Tears and Determination of the Visible Area of Menisci	JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME			English	Article							3-DIMENSIONAL ULTRASOUND; ARTHROSCOPIC FINDINGS; KNEE OSTEOARTHRITIS; SONOGRAPHY; MRI; MENISCECTOMY; DIAGNOSIS; LIGAMENT; INJURIES; LESIONS	Background: Imaging is of great importance in diagnosing meniscal tears. The aim of this study was to assess the accuracy of high-resolution ultrasound in the diagnosis of meniscal tears, with arthroscopic examination as the standard reference, after resolution was confirmed with a target-mounted reference phantom. An additional goal was to elucidate the area of the meniscus that could be visualized with the same ultrasound machine after placement of markers into the menisci of cadaveric knees. Methods: Seventy patients were included for the assessment of the accuracy of a high-resolution ultrasound machine with a 14.0 to 6.0-MHz linear transducer. The preoperative ultrasound diagnosis, in terms of the presence and type of tear, was compared with that in the surgical reports. In the cadaveric studies, nine needles were placed in the peripheral zone of the menisci at regular intervals and the number of needles that could be observed with the system was recorded. Results: The overall sensitivity, specificity, positive predictive value, and negative predictive value of ultrasound examination for meniscal tears were 88%, 85%, 85%, and 88%, respectively. These statistical parameters did not differ significantly between the medial and lateral menisci. The sensitivity for diagnosing horizontal, vertical, radial, flap, bucket-handle, and complex tears and for detecting discoid lateral menisci was 83%, 64%, 0%, 64%, 54%, 90%, and 80%, respectively. Ten percent of the lateral menisci could not be evaluated because of poor images. The cadaveric studies revealed that the ultrasound visualized the entire meniscus except for the anterior horn. Conclusions: The findings of this study suggest that ultrasound examination may be suitable for screening for meniscal tears. The fact that almost 10% of the lateral menisci could not be evaluated because of poor images appears to be a weakness of ultrasound.	[Akatsu, Yorikazu; Yamaguchi, Satoshi; Mukoyama, Shunsuke; Morikawa, Tsuguo; Yamaguchi, Tadashi; Tsuchiya, Kan; Iwasaki, Junichi; Akagi, Ryuichiro; Muramatsu, Yuta; Katsuragi, Joe; Fukawa, Taisuke; Endo, Jun; Takahashi, Kazuhisa; Sasho, Takahisa] Chiba Univ, Grad Sch Med, Dept Orthoped Surg, Chiba 2608670, Japan	Akatsu, Y (reprint author), Chiba Univ, Grad Sch Med, Dept Orthoped Surg, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	sasho@faculty.chiba-u.jp					LEVY IM, 1982, J BONE JOINT SURG AM, V64, P883; Nazarian LN, 2008, AM J ROENTGENOL, V190, P1621, DOI 10.2214/AJR.07.3385; Wareluk P, 2012, EUR J RADIOL, V81, P2366, DOI 10.1016/j.ejrad.2011.09.013; Bangard C, 2007, EUR J RADIOL, V64, P152, DOI 10.1016/j.ejrad.2007.02.012; Friedman L, 2003, J CLIN ULTRASOUND, V31, P85, DOI 10.1002/jcu.10140; KRAUSE WR, 1976, J BONE JOINT SURG AM, V58, P599; Friedman L, 2001, SKELETAL RADIOL, V30, P361; Achour NA, 2006, J RADIOL, V87, P35; Sampson MJ, 2008, CLIN RADIOL, V63, P1106, DOI 10.1016/j.crad.2008.04.008; FRIEDL W, 1991, ARCH ORTHOP TRAUM SU, V110, P132, DOI 10.1007/BF00395794; COOPER DE, 1991, CLIN SPORT MED, V10, P529; Anderson AF, 2011, AM J SPORT MED, V39, P926, DOI 10.1177/0363546511400533; Schub DL, 2012, J PEDIATR ORTHOPED, V32, P765, DOI 10.1097/BPO.0b013e3182619181; OCONNOR BL, 1984, J ANAT, V138, P15; DESMET AA, 1994, AM J ROENTGENOL, V162, P905; VOLOSHIN AS, 1983, J BIOMED ENG, V5, P157, DOI 10.1016/0141-5425(83)90036-5; Acebes C, 2013, RHEUMATOLOGY, V52, P1443, DOI 10.1093/rheumatology/ket110; Helwig P, 2007, KNEE, V14, P478, DOI 10.1016/j.knee.2007.07.007; Helwig P, 2006, ORTHOPADE, V35, P982, DOI 10.1007/s00132-006-0972-4; Shetty AA, 2008, J BONE JOINT SURG BR, V90B, P1045, DOI 10.1302/0301-620X.90B8.20189; Azzoni R, 2002, J CLIN ULTRASOUND, V30, P472, DOI 10.1002/jcu.10106; Jung JY, 2012, AM J ROENTGENOL, V198, pW173, DOI 10.2214/AJR.11.6979; SELBY B, 1987, AM J ROENTGENOL, V149, P549; Jee WH, 2003, AM J ROENTGENOL, V180, P93; Jacobson JA, 2009, AM J ROENTGENOL, V193, P619, DOI 10.2214/AJR.09.2841; McDermott ID, 2006, J BONE JOINT SURG BR, V88B, P1549, DOI 10.1302/0301-620X.88B12.18140; JOHNSON RJ, 1974, J BONE JOINT SURG AM, VA 56, P719; von Engelhardt LV, 2008, ARCH ORTHOP TRAUM SU, V128, P451, DOI 10.1007/s00402-007-0485-6; CASSER HR, 1990, ARCH ORTHOP TRAUM SU, V109, P150, DOI 10.1007/BF00440576; Najafi J, 2006, J ULTRAS MED, V25, P593; Terzidis IP, 2006, AM J SPORT MED, V34, P1170, DOI 10.1177/0363546506287939; Matava MJ, 1999, AM J SPORT MED, V27, P436; Kawaguchi K, 2012, ARTHRITIS RHEUM-US, V64, P173, DOI 10.1002/art.33319; Woodhouse JB, 2011, SEMIN ULTRASOUND CT, V32, P91, DOI 10.1053/j.sult.2010.12.002; Van Dyck P, 2013, J BONE JOINT SURG AM, V95A, P916, DOI 10.2106/JBJS.L.01195; Kocabey Y, 2004, ARTHROSCOPY, V20, P696, DOI 10.1016/j.arthro.2004.06.008; Arnoczky SP, 1999, CLIN ORTHOP RELAT R, pS244; BURR DB, 1982, CLIN ORTHOP RELAT R, P121; DEHAVEN KE, 1985, CLIN ORTHOP RELAT R, P31; Gokalp G, 2012, BRIT J RADIOL, V85, pE871, DOI 10.1259/bjr/74041910; Grassi W, 2014, CLIN EXP RHEUMATOL, V32, pS3; Khan Zaka, 2006, Acta Orthop Belg, V72, P72; MCGINTY JB, 1977, J BONE JOINT SURG AM, V59, P763; Pavlovich CP, 2014, UROL ONCOL, V32; Petersen L J, 1999, Ugeskr Laeger, V161, P5679; Smagin N. V., 2014, ACOUST PHYS, V60, P199; TAPPER EM, 1969, J BONE JOINT SURG AM, VA 51, P517; Yaniv Moshe, 2007, J Child Orthop, V1, P89, DOI 10.1007/s11832-007-0029-1	48	0	0	JOURNAL BONE JOINT SURGERY INC	NEEDHAM	20 PICKERING ST, NEEDHAM, MA 02192 USA	0021-9355	1535-1386		J BONE JOINT SURG AM	J. Bone Joint Surg.-Am. Vol.	MAY 20	2015	97A	10					799	806		10.2106/JBJS.N.01055		8	Orthopedics; Surgery	Orthopedics; Surgery	CU3IJ	WOS:000363417500005		
J	Yang, YR; Kim, DH; Seo, YK; Park, D; Jang, HJ; Choi, SY; Lee, YH; Lee, GH; Nakajima, K; Taniguchi, N; Kim, JM; Choi, EJ; Moon, HY; Kim, IS; Choi, JH; Lee, H; Ryu, SH; Cocco, L; Suh, PG				Yang, Yong Ryoul; Kim, Dae Hyun; Seo, Young-Kyo; Park, Dohyun; Jang, Hyun-Jun; Choi, Soo Youn; Lee, Yong Hwa; Lee, Gyun Hui; Nakajima, Kazuki; Taniguchi, Naoyuki; Kim, Jung-Min; Choi, Eun-Jeong; Moon, Hyo Youl; Kim, Il Shin; Choi, Jang Hyun; Lee, Ho; Ryu, Sung Ho; Cocco, Lucio; Suh, Pann-Ghill			Elevated O-GlcNAcylation promotes colonic inflammation and tumorigenesis by modulating NF-kappa B signaling	ONCOTARGET			English	Article						O-GlcNAcylation; O-GlcNAcase; colitis; colitis-associated cancer	GLCNAC TRANSFERASE; COLORECTAL-CANCER; BOWEL-DISEASE; INTESTINAL TUMORIGENESIS; IKK-BETA; ACTIVATION; COLITIS; TRANSCRIPTION; MICE; ACETYLGLUCOSAMINE	O-GlcNAcylation is a reversible post-translational modification. O-GlcNAc addition and removal is catalyzed by O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA), respectively. More recent evidence indicates that regulation of O-GlcNAcylation is important for inflammatory diseases and tumorigenesis. In this study, we revealed that O-GlcNAcylation was increased in the colonic tissues of dextran sodium sulfate (DSS)-induced colitis and azoxymethane (AOM)/DSS-induced colitis-associated cancer (CAC) animal models. Moreover, the O-GlcNAcylation level was elevated in human CAC tissues compared with matched normal counterparts. To investigate the functional role of O-GlcNAcylation in colitis, we used OGA heterozygote mice, which have an increased level of O-GlcNAcylation. OGA(+/-) mice have higher susceptibility to DSS-induced colitis than OGA(+/+) mice. OGA(+/-) mice exhibited a higher incidence of colon tumors than OGA(+/+) mice. In molecular studies, elevated O-GlcNAc levels were shown to enhance the activation of NF-kappa B signaling through increasing the binding of RelA/p65 to its target promoters. We also found that Thr-322 and Thr352 in the p65-O-GlcNAcylation sites are critical for p65 promoter binding. These results suggest that the elevated O-GlcNAcylation level in colonic tissues contributes to the development of colitis and CAC by disrupting regulation of NF-kappa B-dependent transcriptional activity.	[Yang, Yong Ryoul; Kim, Dae Hyun; Seo, Young-Kyo; Jang, Hyun-Jun; Choi, Soo Youn; Lee, Yong Hwa; Lee, Gyun Hui; Kim, Jung-Min; Moon, Hyo Youl; Kim, Il Shin; Choi, Jang Hyun; Suh, Pann-Ghill] Ulsan Natl Inst Sci & Technol, Sch Life Sci, Ulsan, South Korea; [Park, Dohyun; Jang, Hyun-Jun; Choi, Eun-Jeong; Ryu, Sung Ho] Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang, Kyungbuk, South Korea; [Nakajima, Kazuki; Taniguchi, Naoyuki] RIKEN, Dis Glyc Team, Syst Glycobiol Res Grp, RIKENMax Planck Joint Res Ctr,Global Res Cluster, Wako, Saitama, Japan; [Lee, Ho] Natl Canc Ctr, Canc Expt Resources Branch, Goyang Si, Gyeonggi Do, South Korea; [Cocco, Lucio] Univ Bologna, Cellular Signaling Lab, Dept Biomed & Neuromotor Sci, Bologna, Italy	Suh, PG (reprint author), Ulsan Natl Inst Sci & Technol, Sch Life Sci, Ulsan, South Korea.	pgsuh@unist.ac.kr			National Research Foundation of Korea (NRF) - Korean Government (MSIP) [2010-0028684]; Korean Government (MOE) [2013R1A1A2064434]	This work was supported by the National Research Foundation of Korea (NRF) Grant funded by the Korean Government (MSIP) (No. 2010-0028684), the Korean Government (MOE) (2013R1A1A2064434).	Song M, 2008, CELL SIGNAL, V20, P94, DOI 10.1016/j.cellsig.2007.09.002; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Chou TY, 2001, ADV EXP MED BIOL, V491, P413; Mi WY, 2011, BBA-MOL BASIS DIS, V1812, P514, DOI 10.1016/j.bbadis.2011.01.009; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Caldwell SA, 2010, ONCOGENE, V29, P2831, DOI 10.1038/onc.2010.41; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Asquith MJ, 2010, GASTROENTEROLOGY, V139, P519, DOI 10.1053/j.gastro.2010.04.045; Allison DF, 2012, P NATL ACAD SCI USA, V109, P16888, DOI 10.1073/pnas.1208468109; Golks A, 2007, EMBO J, V26, P4368, DOI 10.1038/sj.emboj.7601845; Housley MP, 2009, J BIOL CHEM, V284, P5148, DOI 10.1074/jbc.M808890200; Kawauchi K, 2009, P NATL ACAD SCI USA, V106, P3431, DOI 10.1073/pnas.0813210106; Yehezkel G, 2012, J BIOL CHEM, V287, P28755, DOI 10.1074/jbc.M112.345546; Slawson C, 2011, NAT REV CANCER, V11, P678, DOI 10.1038/nrc3114; Suzuki A, 2001, J EXP MED, V193, P471, DOI 10.1084/jem.193.4.471; Karrasch T, 2007, J IMMUNOL, V178, P6522; Shi Y, 2010, LEUKEMIA, V24, P1588, DOI 10.1038/leu.2010.152; Fukata M, 2005, AM J PHYSIOL-GASTR L, V288, pG1055, DOI 10.1152/ajpgi.00328.2004; Ozcan S, 2010, BBA-GENE REGUL MECH, V1799, P353, DOI 10.1016/j.bbagrm.2010.02.005; Ruan HB, 2012, CELL METAB, V16, P226, DOI 10.1016/j.cmet.2012.07.006; Ma ZY, 2013, J BIOL CHEM, V288, P15121, DOI 10.1074/jbc.M113.470047; Salcedo R, 2010, J EXP MED, V207, P1625, DOI 10.1084/jem.20100199; Schreiber S, 1998, GUT, V42, P477; Yang WH, 2008, P NATL ACAD SCI USA, V105, P17345, DOI 10.1073/pnas.0806198105; Steinbrecher KA, 2008, J IMMUNOL, V180, P2588; Itzkowitz SH, 2004, AM J PHYSIOL-GASTR L, V287, pG7, DOI 10.1152/ajpgi.00079.2004; Yi W, 2012, SCIENCE, V337, P975, DOI 10.1126/science.1222278; Kuo M, 2008, FEBS LETT, V582, P829, DOI 10.1016/j.febslet.2008.02.010; Lynch TP, 2012, J BIOL CHEM, V287, P11070, DOI 10.1074/jbc.M111.302547; Lazarus BD, 2009, INT J BIOCHEM CELL B, V41, P2134, DOI 10.1016/j.biocel.2009.03.008; Nakajima K, 2010, GLYCOBIOLOGY, V20, P865, DOI 10.1093/glycob/cwq044; Van Der Kraak L, 2010, ONCOTARGET, V1, P436; Yang YR, 2012, AGING CELL, V11, P439, DOI 10.1111/j.1474-9726.2012.00801.x; James LR, 2002, DIABETES, V51, P1146, DOI 10.2337/diabetes.51.4.1146; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Wullaert A, 2011, CELL RES, V21, P146, DOI 10.1038/cr.2010.175; Cario E, 2000, J IMMUNOL, V164, P966; Rakoff-Nahoum S, 2007, SCIENCE, V317, P124, DOI 10.1126/science.1140488; Pathak S, 2012, EMBO J, V31, P1394, DOI 10.1038/emboj.2012.8; Gu YC, 2010, CANCER RES, V70, P6344, DOI 10.1158/0008-5472.CAN-09-1887; Kojima M, 2004, ANTICANCER RES, V24, P675; COOPER HS, 1993, LAB INVEST, V69, P238; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Lind DS, 2001, SURGERY, V130, P363, DOI 10.1067/msy.2001.116672; Champattanachai V, 2013, PROTEOMICS; Hoshi N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2113; Not LG, 2007, SHOCK, V28, P345, DOI 10.1097/shk.0b013e3180487ebb; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Xing DQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024021; Yang YR, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.24; Zou LY, 2009, AM J PHYSIOL-HEART C, V296, pH515, DOI 10.1152/ajpheart.01025.2008	52	1	1	IMPACT JOURNALS LLC	ALBANY	6211 TIPTON HOUSE, STE 6, ALBANY, NY 12203 USA	1949-2553			ONCOTARGET	Oncotarget	MAY 20	2015	6	14					12529	12542				14	Oncology; Cell Biology	Oncology; Cell Biology	CO2SZ	WOS:000359008200058		
J	Abe, H; Yamazaki, K; Yoneda, K; Teramoto, A; Ogawa, M; Kawasaki, M; Kameyama, M				Abe, Hajime; Yamazaki, Keiichi; Yoneda, Kohri; Teramoto, Atsuko; Ogawa, Masao; Kawasaki, Masayasu; Kameyama, Masao			A comparison with indocyanine green fluorescence imaging method and computed tomography-lymphography in sentinel lymph node identification for early breast cancer patients.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Bell Land Gen Hosp, Breast Ctr, Sakai, Osaka, Japan; Bell Land Gen Hosp, Dept Surg, Sakai, Osaka, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e22206						1	Oncology	Oncology	CM9OA	WOS:000358036904581		
J	Abe, M; Kasamatsu, Y; Nobuhiro, K; Kuji, S; Tanaka, A; Takahashi, N; Takekuma, M; Hirashima, Y; Nishio, S; Itani, Y; Ichikawa, Y; Itonaga, Y; Hirakawa, T; Nasu, K; Miyagi, K; Murakami, J; Ito, K				Abe, Masakazu; Kasamatsu, Yuka; Nobuhiro, Kado; Kuji, Shiho; Tanaka, Aki; Takahashi, Nobutaka; Takekuma, Munetaka; Hirashima, Yasuyuki; Nishio, Shin; Itani, Yoshio; Ichikawa, Yoshikazu; Itonaga, Yui; Hirakawa, Tomoko; Nasu, Kaei; Miyagi, Kanoko; Murakami, Junko; Ito, Kimihiko			Efficacy and safety of olanzapine combined with aprepitant, palonosetron, and dexamethasone for the prevention of cisplatin-based chemotherapy-induced nausea and vomiting for gynecological cancer: KCOG G-1301 phase II trial.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Shizuoka Canc Ctr, Dept Gynecol Oncol, Shizuoka, Japan; Kurume Univ, Sch Med, Kurume, Fukuoka 830, Japan; Nara Prefectural Nara Hosp, Nara, Japan; Shizuoka Red Cross Hosp, Shizuoka, Japan; Oita Univ, Fac Med, Dept Obstet & Gynecol, Yufu, Japan; Kansai Rosai Hosp, Dept Obstet & Gynecol, Amagasaki, Hyogo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		TPS9639						1	Oncology	Oncology	CM9OA	WOS:000358036904898		
J	Agemi, Y; Miyazaki, K; Misumi, Y; Sato, A; Ishii, M; Nakamura, Y; Shimokawa, T; Okamoto, H				Agemi, Yoko; Miyazaki, Kazuhito; Misumi, Yuki; Sato, Akira; Ishii, Mari; Nakamura, Yukiko; Shimokawa, Tsuneo; Okamoto, Hiroaki			Prospective evaluation of the G8 and dementia screening scores (DSS) for frailty in elderly patients (pts) with lung cancer.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					[Agemi, Yoko; Miyazaki, Kazuhito; Misumi, Yuki; Sato, Akira; Ishii, Mari; Nakamura, Yukiko; Shimokawa, Tsuneo; Okamoto, Hiroaki] Yokohama Municipal Citizens Hosp, Dept Resp Med & Med Oncol, Yokohama, Kanagawa, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e20526						1	Oncology	Oncology	CM9OA	WOS:000358036904157		
J	Akagi, T; Inomata, M; Katayama, H; Mizusawa, J; Yamaguchi, T; Masaki, T; Fukunaga, Y; Murata, K; Okajima, M; Munakata, Y; Sato, T; Bandou, H; Yasui, M; Sekimoto, M; Watanabe, M; Sugihara, K; Konishi, F; Etoh, T; Shimada, Y; Kitano, S				Akagi, Tomonori; Inomata, Masafumi; Katayama, Hiroshi; Mizusawa, Junki; Yamaguchi, Takashi; Masaki, Tadahiko; Fukunaga, Yosuke; Murata, Kohei; Okajima, Masazumi; Munakata, Yasuhiro; Sato, Takeo; Bandou, HIroyuki; Yasui, Masayoshi; Sekimoto, Mitsugu; Watanabe, Masahiko; Sugihara, Kenichi; Konishi, Fumio; Etoh, Tsuyoshi; Shimada, Yasuhiro; Kitano, Seigo			A randomized controlled trial to evaluate laparoscopic versus open with Japanese D3 dissection for stage II,III colorectal cancer (CRC): First efficacy results from Japan Clinical Oncology Group Study JCOG0404	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Oita Univ, Dept Gastroenterol & Pediat Surg, Fac Med, Oita 87011, Japan; Natl Canc Ctr, Clin Oncol Grp Data Ctr Ctr Res Adm & Support, Tokyo 104, Japan; Kyoto Med Ctr, Kyoto, Japan; Kyorin Univ, Fac Med, Mitaka, Tokyo, Japan; Canc Inst Hosp, Gastroenterol Ctr, Tokyo, Japan; Suita Municipal Hosp, Dept Surg, Suita, Osaka, Japan; Hiroshima City Asa Hosp, Hiroshima, Japan; Nagano Municipal Hosp, Dept Gastroenterol, Nagano, Japan; Kitasato Univ, Sch Med, Tokyo, Kanagawa, Japan; Ishikawa Prefectural Cent Hosp, Kanazawa, Ishikawa, Japan; Kaizuka City Hosp, Kaizuka, Japan; Osaka Natl Hosp, Dept Surg, Osaka, Japan; Kitasato Univ, Dept Surg, Sch Med, Tokyo, Kanagawa, Japan; Tokyo Med & Dent Univ, Tokyo, Japan; Nerima Hikarigtaoka Hosp, Dept Surg, Tokyo, Japan; Oita Univ, Fac Med, Oita 87011, Japan; Natl Canc Ctr, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		3577						1	Oncology	Oncology	CM9OA	WOS:000358036900796		
J	Akahori, D; Ozawa, Y; Kouda, K; Abe, T; Enomoto, Y; Hasegawa, H; Tanahashi, M; Matsui, T; Niwa, H; Yokomura, K; Suda, T				Akahori, Daisuke; Ozawa, Yuichi; Kouda, Keigo; Abe, Takefumi; Enomoto, Yasunori; Hasegawa, Hirotsugu; Tanahashi, Masayuki; Matsui, Takashi; Niwa, Hiroshi; Yokomura, Koshi; Suda, Takafumi			Retrospective analysis comparing pulmonary toxicity between S-1 and docetaxel in non-small-cell lung cancer patients with preexisting interstitial lung disease.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Seirei Mikatahara Gen Hosp, Dept Resp Med, Resp Dis Ctr, Hamamatsu, Shizuoka, Japan; Seirei Mikatahara Gen Hosp, Div Thorac Surg, Resp Dis Ctr, Hamamatsu, Shizuoka, Japan; Hamamatsu Univ Sch Med, Dept Internal Med, Div 2, Hamamatsu, Shizuoka 4313192, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e19105						1	Oncology	Oncology	CM9OA	WOS:000358036903948		
J	Akamatsu, H; Mori, K; Kikuchi, T; Ueda, H; Akamatsu, K; Nakanishi, M; Koh, Y; Matsunaga, K; Yamamoto, N				Akamatsu, Hiroaki; Mori, Keita; Kikuchi, Takashi; Ueda, Hiroki; Akamatsu, Keiichiro; Nakanishi, Masanori; Koh, Yasuhiro; Matsunaga, Kazuto; Yamamoto, Nobuyuki			Overall response rate as a surrogate of progression-free survival with molecular targeted agents: A meta-analysis of phase III trials in advanced non-small cell lung cancer.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Wakayama Med Univ, Dept Internal Med 3, Wakayama, Japan; Shizuoka Canc Ctr Hosp, Clin Trial Coordinat Off, Shizuoka, Japan; Wakayama Med Univ, Wakayama, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e19142						1	Oncology	Oncology	CM9OA	WOS:000358036903980		
J	Akizawa, Y; Hirai, Y; Matsui, H				Akizawa, Yoshika; Hirai, Yasuo; Matsui, Hideo			Comparative performance analysis between two types of liquid-based endometrial cytology to detect endometrial cancer.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Tokyo Womens Med Univ, Tokyo, Japan; Tokyo Womens Med Univ, Shinjuku Ku, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e16526						1	Oncology	Oncology	CM9OA	WOS:000358036903322		
J	Angevin, E; Isambert, N; Trillet-Lenoir, VN; You, B; Alexandre, J; Zalcman, G; Viehl, P; Farace, F; Valleix, F; Podoll, T; Kuramochi, Y; Miyashita, I; Hosono, O; Dang, NH; Ohnuma, K; Yamada, T; Kaneko, Y; Morimoto, C				Angevin, Eric; Isambert, Nicolas; Trillet-Lenoir, Veronique N.; You, Benoit; Alexandre, Jerome; Zalcman, Gerard; Viehl, Philippe; Farace, Francoise; Valleix, Fanny; Podoll, Thomas; Kuramochi, Yu; Miyashita, Itaru; Hosono, Osamu; Dang, Nam H.; Ohnuma, Kei; Yamada, Taketo; Kaneko, Yutaro; Morimoto, Chikao			First-in-human phase I administration of YS110, a monoclonal antibody directed against the CD26 immunostimulatory molecule in advanced cancer patients.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Inst Gustave Roussy, Villejuif, France; Ctr Georges Francois Leclerc, Dijon, France; Ctr Hosp Lyon Sud, Pierre Benite, France; Ctr Hosp Lyon Sud, Lyon, France; Paris Descartes Univ, Cochin Pt Royal Hosp, AP HP, Dept Oncol, Paris, France; Caen Univ Hosp, Caen, France; FV Clin Subcontractor SynteractHCR France, Epiais Rhus, France; Ys AC, Redwood City, CA USA; Kissei Pharmaceut, Tokyo, Japan; Univ Tokyo, Inst Med Sci, Tokyo, Japan; Univ Florida, Gainesville, FL USA; Juntendo Univ, Tokyo, Japan; Keio Univ, Tokyo, Japan; Ys AC, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		2519						1	Oncology	Oncology	CM9OA	WOS:000358036900552		
J	Aoki, K; Suzuki, H; Nakamura, H; Motomura, K; Mizoguchi, M; Abe, T; Muragaki, Y; Wakabayashi, T; Ogawa, S; Natsume, A				Aoki, Kosuke; Suzuki, Hiromichi; Nakamura, Hideo; Motomura, Kazuya; Mizoguchi, Masahiro; Abe, Tatsuya; Muragaki, Yoshihiro; Wakabayashi, Toshihiko; Ogawa, Seishi; Natsume, Atsushi			Prognostic model of lower grade gliomas.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Nagoya Univ, Sch Med, Dept Neurosurg, Nagoya, Aichi 466, Japan; Kumamoto Univ, Dept Neurosurg, Kumamoto, Japan; Kyushu Univ, Grad Sch Med Sci, Dept Neurosurg, Fukuoka 812, Japan; Oita Univ, Sch Med, Dept Neurosurg, Oita 87011, Japan; Tokyo Womens Med Univ, Fac Adv Technosurg, Tokyo, Japan; Kyoto Univ, Dept Pathol & Tumor Biol, Kyoto, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		2038						1	Oncology	Oncology	CM9OA	WOS:000358036900497		
J	Atreya, CE; Van Cutsem, E; Bendell, JC; Andre, T; Schellens, JHM; Gordon, MS; Mcree, AJ; O'Dwyer, PJ; Muro, K; Tabernero, J; van Geel, R; Sidhu, R; Greger, JG; Rangwala, FA; Motwani, M; Wu, YH; Orford, KW; Corcoran, RB				Atreya, Chloe Evelyn; Van Cutsem, Eric; Bendell, Johanna C.; Andre, Thierry; Schellens, Jan H. M.; Gordon, Michael S.; McRee, Autumn Jackson; O'Dwyer, Peter J.; Muro, Kei; Tabernero, Josep; van Geel, Robin; Sidhu, Roger; Greger, James G.; Rangwala, Fatima A.; Motwani, Monica; Wu, Yuehui; Orford, Keith W.; Corcoran, Ryan Bruce			Updated efficacy of the MEK inhibitor trametinib (T), BRAF inhibitor dabrafenib (D), and anti-EGFR antibody panitumumab (P) in patients (pts) with BRAF V600E mutated (BRAFm) metastatic colorectal cancer (mCRC)	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Univ Calif San Francisco, San Francisco, CA 94143 USA; Univ Hosp Leuven, Leuven, Belgium; Sarah Cannon Res Inst, Nashville, TN USA; Hop St Antoine, F-75571 Paris, France; Netherlands Canc Inst, Amsterdam, Netherlands; Pinnacle Oncol Hematol, Scottsdale, AZ USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Univ Penn, Philadelphia, PA 19104 USA; Aichi Canc Ctr Hosp, Nagoya, Aichi 464, Japan; Vall dHebron Univ Hosp, Barcelona, Spain; Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Amsterdam, Netherlands; Amgen Inc, Thousand Oaks, CA 91320 USA; GlaxoSmithKline, Collegeville, PA USA; GlaxoSmithKline, Res Triangle Pk, NC USA; GlaxoSmithKline, Audubon, PA USA; Massachusetts Gen Hosp, Boston, MA 02114 USA								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		103						1	Oncology	Oncology	CM9OA	WOS:000358036900112		
J	Atsumi, J; Shimizu, K; Kaira, K; Nagashima, T; Ohtaki, Y; Obayashi, K; Kakegawa, S; Kawashima, O; Kamiyoshihara, M; Sugano, M; Takeyoshi, I				Atsumi, Jun; Shimizu, Kimihiro; Kaira, Kyoichi; Nagashima, Toshiteru; Ohtaki, Yoichi; Obayashi, Kai; Kakegawa, Seiichi; Kawashima, Osamu; Kamiyoshihara, Mitsuhiro; Sugano, Masayuki; Takeyoshi, Izumi			The impact of a Bim deletion polymorphism on the survival of patients with completely resected non-small cell lung cancer.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Gunma Univ, Grad Sch Med, Dept Thorac & Visceral Surg, Maebashi, Gumma 371, Japan; Gunma Univ, Grad Sch Med, Dept Oncol Clin Dev, Gunma, Japan; Gunma Univ, Grad Sch Med, Dept Thorac & Visceral Organ Surg, Maebashi, Gumma 371, Japan; Gunma Univ, Grad Sch Med, Dept Thorac Surg, Maebashi, Gumma 371, Japan; Gunma Univ, Grad Sch Med, Dept Visceral Organ Surg, Maebashi, Gumma 371, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		7531						1	Oncology	Oncology	CM9OA	WOS:000358036901661		
J	Awada, A; Colomer, R; Bondarenko, I; Inoue, K; Badwe, RA; Demetriou, G; Wang, XJ; Smirnov, V; Lee, SC; Mehta, AO; Kim, SB; Shen, ZZ; Bachelot, TD; Goswami, C; Deo, SVS; Bose, R; Wong, A; Xu, F; Bryce, R; Carey, LA				Awada, Ahmad; Colomer, Ramon; Bondarenko, Igor; Inoue, Kenichi; Badwe, Rajendra A.; Demetriou, Georgia; Wang, Xiaojia; Smirnov, Vitaly; Lee, Soo-Chin; Mehta, Ajay O.; Kim, Sung-Bae; Shen, Zhen-Zhou; Bachelot, Thomas Denis; Goswami, Chanchal; Deo, S. V. S.; Bose, Ron; Wong, Alvin; Xu, Feng; Bryce, Richard; Carey, Lisa A.			Efficacy and CNS progression analysis from the randomized phase 2 trial of neratinib plus paclitaxel vs trastuzumab plus paclitaxel as first-line treatment for HER2+metastatic breast cancer (NEfERTT)	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Inst Jules Bordet, B-1000 Brussels, Belgium; Hosp Univ La Princesa, Madrid, Spain; Dnipropetrovsk State Med Acad, Dnepropetrovsk, Ukraine; Saitama Canc Ctr, Saitama, Japan; Tata Mem Hosp, Parel, India; Univ Witwatersrand, Donald Gordon Med Ctr, Johannesburg, South Africa; Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China; Donetsk Reg Antitumor Ctr, Donetsk, Ukraine; Natl Univ Canc Inst, Singapore, Singapore; Cent India Canc Res Inst, Nagpur, Maharashtra, India; Asan Med Ctr, Seoul, South Korea; Shanghai Canc Ctr, Shanghai, Peoples R China; Ctr Leon Berard, F-69373 Lyon, France; BP Poddar Hosp & Med Res Ltd, Kolkata, India; AIIMS, Inst Rotary Canc Hosp, New Delhi, India; Washington Univ, Sch Med, St Louis, MO USA; Puma Biotechnol Inc, Los Angeles, CA USA; Univ N Carolina, Chapel Hill, NC USA								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		610						1	Oncology	Oncology	CM9OA	WOS:000358036901402		
J	Baba, Y; Harada, K; Ida, S; Kurashige, J; Hiyoshi, Y; Iwagami, S; Miyamoto, Y; Sakamoto, Y; Yoshida, N; Watanabe, M; Baba, H				Baba, Yoshifumi; Harada, Kazuto; Ida, Satoshi; Kurashige, Junji; Hiyoshi, Yukiharu; Iwagami, Shiro; Miyamoto, Yuji; Sakamoto, Yasuo; Yoshida, Naoya; Watanabe, Masayuki; Baba, Hideo			Prognostic and clinical impact of sarcopenia in esophageal squamous cell carcinoma	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Kumamoto, Japan; Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol Ctr, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e15035						1	Oncology	Oncology	CM9OA	WOS:000358036902823		
J	Bang, YJ; Chung, HC; Shankaran, V; Geva, R; Catenacci, DVT; Gupta, S; Eder, JP; Berger, R; Gonzalez, EJ; Ray, A; Dolled-Filhart, M; Emancipator, K; Pathiraja, K; Lunceford, JK; Cheng, JD; Koshiji, M; Muro, K				Bang, Yung-Jue; Chung, Hyun-Choel; Shankaran, Veena; Geva, Ravit; Catenacci, Daniel Virgil Thomas; Gupta, Shilpa; Eder, Joseph Paul; Berger, Raanan; Gonzalez, Edward J.; Ray, Archana; Dolled-Filhart, Marisa; Emancipator, Kenneth; Pathiraja, Kumudu; Lunceford, Jared K.; Cheng, Jonathan D.; Koshiji, Minori; Muro, Kei			Relationship between PD-L1 expression and clinical outcomes in patients with advanced gastric cancer treated with the anti-PD-1 monoclonal antibody pembrolizumab (MK-3475) in KEYNOTE-012	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Seoul Natl Univ Coll Med, Seoul, South Korea; Yonsei Univ Coll Med, Yonsei Canc Ctr, Seoul, South Korea; Univ Washington Sch Med, Div Med Oncol, Seattle, WA USA; Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, IL-69978 Tel Aviv, Israel; Univ Chicago, Chicago, IL 60637 USA; Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; Yale Canc Ctr, New Haven, CT USA; Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel; Merck & Co Inc, Kenilworth, NJ USA; Aichi Canc Ctr Hosp, Nagoya, Aichi 464, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		4001						1	Oncology	Oncology	CM9OA	WOS:000358036900840		
J	Basen-Engquist, K; Huang, HQ; Herzog, TJ; Armstrong, DK; Sabbatini, P; Walker, JL; Kim, BG; Fujiwara, K; Tewari, KS; O'Malley, DM; Coleman, RL				Basen-Engquist, Karen; Huang, Helen Q.; Herzog, Thomas J.; Armstrong, Deborah Kay; Sabbatini, Paul; Walker, Joan L.; Kim, Byoung Gie; Fujiwara, Keiichi; Tewari, Krishnansu Sujata; O'Malley, David M.; Coleman, Robert L.			Randomized phase III trial of carboplatin/paclitaxel alone (CP) or in combination with bevacizumab followed by bevacizumab (CPB) and secondary cytoreduction surgery in platinum-sensitive recurrent ovarian cancer: GOG0213, an NRG Oncology/GOG Study-Analysis of patient reported outcomes (PRO) on chemotherapy randomization.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; GOG Stat & Data Ctr, Rochester, NY USA; Univ Cincinnati, Inst Canc, Div Gynecol Oncol, Cincinnati, OH USA; Johns Hopkins Kimmel Canc Ctr, Baltimore, MD USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; OUHSC, Stephenson Canc Ctr, Oklahoma City, OK USA; Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea; Saitama Med Univ, Int Med Ctr, Hidaka, Japan; UC Irvine Med Ctr, Orange, CA USA; Ohio State Univ, Coll Med, Columbus, OH 43210 USA								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		5525						1	Oncology	Oncology	CM9OA	WOS:000358036901185		
J	Bianchini, G; Callari, M; Iwamoto, T; Riba, M; Vigano', L; Locatelli, A; Zambetti, M; Karn, T; Pusztai, L; Gianni, L				Bianchini, Giampaolo; Callari, Maurizio; Iwamoto, Takayuki; Riba, Michela; Vigano', Lucia; Locatelli, Alberta; Zambetti, Milvia; Karn, Thomas; Pusztai, Lajos; Gianni, Luca			Contribution of immune system and tumor-related interferon signaling to epirubicin response in triple-negative (TN) breast cancers.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Ist Sci San Raffaele, I-20132 Milan, Italy; Fdn IRCCS Ist Nazl Tumori, Milan, Italy; Okayama Univ Hosp, Okayama, Japan; Goethe Univ Frankfurt, Dept Obstet & Gynecol, D-60054 Frankfurt, Germany; Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT USA								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		1081						1	Oncology	Oncology	CM9OA	WOS:000358036900241		
J	Boku, N; Katakami, N; Fujita, S; Oda, K; Tauchi, K; Nakata, K; Shinozaki, K; Okuno, M; Kawai, Y; Kikukawa, H; Suzuki, R; Nakazawa, H; Kojima, H; Mizutani, M; Hara, T; Yokota, T; Suzuki, Y; Narabayashi, M				Boku, Narikazu; Katakami, Nobuyuki; Fujita, Shiro; Oda, Koji; Tauchi, Katsunori; Nakata, Ken; Shinozaki, Katsunori; Okuno, Motoyasu; Kawai, Yasukazu; Kikukawa, Hiroaki; Suzuki, Ryujiro; Nakazawa, Hideo; Kojima, Hiroshi; Mizutani, Mitsuhiro; Hara, Toru; Yokota, Takaaki; Suzuki, Yura; Narabayashi, Masaru			A phase II randomized, double-blind, placebo-controlled study to evaluate naldemedine for the treatment of opioid-induced constipation (OIC) in patients with cancer pain	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					St Marianna Univ, Sch Med, Kawasaki, Kanagawa, Japan; Inst Biomed Res & Innovat, Kobe, Hyogo, Japan; Aichi Hosp, Aichi Canc Ctr, Okazaki, Aichi, Japan; Aizawa Hosp, Matsumoto, Nagano, Japan; Sakai City Hosp, Sakai, Osaka, Japan; Hiroshima Prefectural Hosp, Hiroshima, Japan; Fukui Prefectural Hosp, Fukui, Japan; Kumamoto Med Ctr, Natl Hosp Org, Kumamoto, Japan; Toyohashi Municipal Hosp, Toyohashi, Aichi, Japan; Iwata City Hosp, Iwata, Japan; Univ Tsukuba Hosp, Ibaraki Clin Educ & Training Ctr, Tsukuba, Ibaraki, Japan; Mikawa Breast Canc Clin, Mikawa, Yamagata, Japan; Anjo Kosei Hosp, Anjo, Japan; Shionogi & Co Ltd, Osaka, Japan; Showa Univ Hosp, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		9594						1	Oncology	Oncology	CM9OA	WOS:000358036902089		
J	Booka, E; Imamura, CK; Hamamoto, Y; Mizukami, T; Gomi, D; Ichiyama, T; Tateishi, K; Takahashi, T; Kawakubo, H; Soejima, K; Takeuchi, H; Boku, N; Tanigawara, Y; Kitagawa, Y				Booka, Eisuke; Imamura, Chiyo K.; Hamamoto, Yasuo; Mizukami, Takuro; Gomi, Daisuke; Ichiyama, Takashi; Tateishi, Kazunari; Takahashi, Tsunehiro; Kawakubo, Hirofumi; Soejima, Kenzo; Takeuchi, Hiroya; Boku, Narikazu; Tanigawara, Yusuke; Kitagawa, Yuko			Development of dosing recommendation of S-1 for patients with impaired renal function by prospective pharmacokinetic study.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan; Keio Univ, Tokyo, Japan; Keio Univ, Sch Med, Tokyo, Japan; St Marianna Univ, Sch Med, Dept Clin Oncol, Kawasaki, Kanagawa, Japan; Shinshu Univ, Sch Med, Dept Comprehens Canc Therapy, Matsumoto, Nagano 390, Japan; Shinshu Univ, Sch Med, Dept Internal Med 1, Matsumoto, Nagano 390, Japan; Shinshu Univ, Matsumoto, Nagano 390, Japan; Natl Canc Ctr, Gastrointestinal Med Oncol Div, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e13578						1	Oncology	Oncology	CM9OA	WOS:000358036902571		
J	Brock, PR; Maibach, R; Childs, M; Rajput, K; Neuwelt, EA; Roebuck, D; Sullivan, MJ; Laithier, V; Ronghe, M; Lockwood, L; dall'Igna, P; Hiyama, E; Brichard, B; Skeen, J; Mateos, ME; Fabre, M; Rangaswami, AA; Capra, M; Czauderna, P; Morland, B				Brock, Penelope Rachel; Maibach, Rudolf; Childs, Margaret; Rajput, Kaukab; Neuwelt, Edward A.; Roebuck, Derek; Sullivan, Michael James; Laithier, Veronique; Ronghe, Milind; Lockwood, Liane; dall'Igna, Patrizia; Hiyama, Eiso; Brichard, Benedicte; Skeen, Jane; Mateos, Maria Elena; Fabre, Monique; Rangaswami, Arun Atreiya; Capra, Michael; Czauderna, Piotr; Morland, Bruce			Anti-tumor efficacy in SIOPEL 6: A multi-centre open label randomised phase III trial of the efficacy of sodium thiosulphate (STS) in reducing ototoxicity in patients receiving cisplatin (Cis) monotherapy for standard risk hepatoblastoma (SR-HB).	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Great Ormond St Hosp Sick Children, London, England; Int Breast Canc Study Grp, Bern, Switzerland; Nottingham Clin Trials Unit, Nottingham, England; Great Ormond St Hosp Sick Children, London, England; Oregon Hlth & Sci Univ, Portland, OR 97201 USA; Royal Childrens Hosp, Melbourne, Vic, Australia; CHU Besancon, F-25030 Besancon, France; Royal Hosp Sick Children, Glasgow G3 8SJ, Lanark, Scotland; Royal Childrens Hosp, Brisbane, Qld, Australia; Univ Padua, Paediat Haematol Oncol Div, Padua, Italy; Hiroshima Univ, Hiroshima, Japan; Clin Univ St Luc, B-1200 Brussels, Belgium; Starship Childrens Hosp, Auckland, New Zealand; Univ Hosp Reina Sofia, Cordoba, Spain; Inst Cancerol Gustave Roussy, Villejuif, France; Stanford Univ, Palo Alto, CA 94304 USA; Our Ladys Childrens Hosp, Dublin, Ireland; Med Univ Gdansk, Gdansk, Poland; Birmingham Childrens Hosp, Birmingham, W Midlands, England								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		10039						1	Oncology	Oncology	CM9OA	WOS:000358036900045		
J	Brose, MS; Schlumberger, M; Tahara, M; Wirth, LJ; Robinson, B; Elisei, R; Newbold, K; Kiyota, N; Hoff, AO; Dutcus, C; Song, J; Sherman, SI; Taylor, MH				Brose, Marcia S.; Schlumberger, Martin; Tahara, Makoto; Wirth, Lori J.; Robinson, Bruce; Elisei, Rossella; Newbold, Kate; Kiyota, Naomi; Hoff, Ana O.; Dutcus, Corina; Song, James; Sherman, Steven I.; Taylor, Matthew Hiram			Effect of age and lenvatinib treatment on overall survival for patients with I-131-refractory differentiated thyroid cancer in SELECT	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; Gustave Roussy, Dept Nucl Med & Endocrine Oncol, Villejuif, France; Univ Paris Sud, Villejuif, France; Natl Canc Ctr Hosp East, Dept Head & Neck Med Oncol, Kashiwa, Chiba, Japan; Massachusetts Gen Hosp, Boston, MA 02114 USA; Univ Sydney, Kolling Inst Med Res, Sydney, NSW 2006, Australia; Univ Pisa, Dept Clin & Expt Med, Endocrine Unit, Pisa, Italy; Royal Marsden Hosp Natl Hlth Serv Trust, London, England; Kobe Univ Hosp, Dept Med Oncol & Hematol, Kobe, Hyogo, Japan; Univ Sao Paulo, Inst Canc Estado Sao Paulo, Dept Endocrinol, Sao Paulo, Brazil; Eisai Inc, Woodcliff Lake, NJ USA; Univ Texas MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, Div Internal Med, Houston, TX 77030 USA; Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		6048						1	Oncology	Oncology	CM9OA	WOS:000358036901363		
J	Chan, A; Delaloge, S; Holmes, FA; Moy, B; Iwata, H; Harvey, VJ; Robert, NJ; Silovski, T; Gokmen, E; Von Minckwitz, G; Ejlertsen, B; Chia, SKL; Mansi, J; Barrios, CH; Gnant, M; Wong, A; Bryce, R; Yao, B; Martin, M				Chan, Arlene; Delaloge, Suzette; Holmes, Frankie Ann; Moy, Beverly; Iwata, Hiroji; Harvey, Vernon J.; Robert, Nicholas J.; Silovski, Tajana; Gokmen, Erhan; Von Minckwitz, Gunter; Ejlertsen, Bent; Chia, Stephen K. L.; Mansi, Janine; Barrios, Carlos H.; Gnant, Michael; Wong, Alvin; Bryce, Richard; Yao, Bin; Martin, Miguel			Neratinib after adjuvant chemotherapy and trastuzumab in HER2-positive early breast cancer: Primary analysis at 2 years of a phase 3, randomized, placebo-controlled trial (ExteNET).	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Breast Canc Res Ctr WA, Perth, WA, Australia; Curtin Univ, Perth, WA 6845, Australia; Inst Gustave Roussy, Villejuif, France; Texas Oncol PA, Houston, TX USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Aichi Canc Ctr, Chikusa Ku, Nagoya, Aichi 464, Japan; Auckland Hosp, Auckland, New Zealand; US Oncol Network, Virginia Canc Specialists, Fairfax, VA USA; Univ Hosp Tumors, UHC Sestre Milosrdnice, Zagreb, Croatia; Ege Univ, Fac Med, Div Med Oncol, Izmir, Turkey; GBG Forschungs GmbH, Luisenkrankenhaus, Dusseldorf, Neu Isenburg, Germany; Rigshosp, DK-2100 Copenhagen, Denmark; BC Canc Agcy, Vancouver, BC, Canada; Guys Hosp, London SE1 9RT, England; PUCRS Sch Med, Porto Alegre, RS, Brazil; Med Univ Vienna, Vienna, Austria; Puma Biotechnol Inc, Los Angeles, CA USA; Univ Complutense Madrid, Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		508						1	Oncology	Oncology	CM9OA	WOS:000358036901115		
J	Chau, I; Peck-Radosavljevic, M; Borg, C; Malfertheiner, P; Seitz, JF; Park, JO; Ryoo, BY; Yen, CJ; Kudo, M; Poon, RTP; Pastorelli, D; Blanc, JF; Chung, HC; Baron, AD; Okusaka, T; Cui, ZLL; Girvan, AC; Abada, P; Yang, L; Zhu, AX				Chau, Ian; Peck-Radosavljevic, Markus; Borg, Christophe; Malfertheiner, Peter; Seitz, Jean Francois; Park, Joon Oh; Ryoo, Baek-Yeol; Yen, Chia-Jui; Kudo, Masatoshi; Poon, Ronnie Tung-Ping; Pastorelli, Davide; Blanc, Jean-Frederic; Chung, Hyun Cheol; Baron, Ari David; Okusaka, Takuji; Cui, Zhanglin Lin; Girvan, Allicia C.; Abada, Paolo; Yang, Ling; Zhu, Andrew X.			Ramucirumab (RAM) as second-line treatment in patients (pts) with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome (PFO) results from the phase 3 REACH study.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Royal Marsden, London, England; Royal Marsden, Surrey, England; Vienna Gen Hosp, Dept Gastroenterol & Hepatol, Vienna, Austria; Med Univ, Vienna, Austria; Univ Hosp Besancon, Besancon, France; Univ Magdeburg, D-39106 Magdeburg, Germany; Hop Enfants La Timone, Marseille, France; Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea; Univ Ulsan, Coll Med, Dept Oncol, Asan Med Ctr, Seoul, South Korea; Natl Cheng Kung Univ Hosp, Tainan 70428, Taiwan; Kinki Univ, Sch Med, Dept Gastroenterol & Hepatol, Osaka, Japan; Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China; IRCCS, Ist Oncol Veneto, Oncol Med 1, Padua, Italy; Hop St Andre, Bordeaux, France; Yonsei Univ, Coll Med, Dept Internal Med, Yonsei Canc Ctr,Inst Canc Res,Div Med Oncol, Seoul, South Korea; Calif Pacific Med Ctr, San Francisco, CA USA; Natl Canc Ctr, Dept Hepatobiliary & Pancreat Oncol, Tokyo, Japan; Eli Lilly & Co, Indianapolis, IN 46285 USA; Eli Lilly & Co, Bridgewater, NJ USA; Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		4077						1	Oncology	Oncology	CM9OA	WOS:000358036900915		
J	Chen, J; Brooks, CL; McDonald, P; Schwartz, JD; Sakakibara, K; Saito, N; Sato, T; Kawabe, T; Rowinsky, EK				Chen, Janice; Brooks, Christopher L.; McDonald, Peter; Schwartz, Jonathan D.; Sakakibara, Keiichi; Saito, Naoya; Sato, Takuji; Kawabe, Takumi; Rowinsky, Eric Keith			Preclinical activity of SL-801, a reversible inhibitor of Exportin-1 (XPO1)/Chromosome Region Maintenance-1 (CRM1) in solid and hematologic cancers	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Stemline Therapeut, New York, NY USA; CanBas Co Ltd, Numazu, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e13543						1	Oncology	Oncology	CM9OA	WOS:000358036902545		
J	Chin, K; Ogura, M; Shinozaki, E; Suenaga, M; Ozaka, M; Ichimura, T; Wakatsuki, T; Matsushima, T; Mizunuma, N				Chin, Keisho; Ogura, Mariko; Shinozaki, Eiji; Suenaga, Mitsukuni; Ozaka, Masato; Ichimura, Takashi; Wakatsuki, Takeru; Matsushima, Tomohiro; Mizunuma, Nobuyuki			Outcome of marked tumor marker increase in patients with advanced gastric cancer during chemotherapy without progression	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					JFCR, Canc Inst Hosp, Dept Gastroenterol, Tokyo, Japan; JFCR, Canc Inst Hosp, Tokyo, Japan; JFCR, Canc Inst Hosp, Koto Ku, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e15034						1	Oncology	Oncology	CM9OA	WOS:000358036902822		
J	Cleary, JM; Mayer, RJ; Van Cutsem, E; Yamashita, F; Yoshisue, K; Ieiri, I; Ohtsu, A; Lenz, HJ				Cleary, James M.; Mayer, Robert J.; Van Cutsem, Eric; Yamashita, Fumiaki; Yoshisue, Kunihiro; Ieiri, Ichiro; Ohtsu, Atsushi; Lenz, Heinz-Josef			Population pharmacokinetic (PK) analysis of TAS-102 in patients (pts) with metastatic colorectal cancer (mCRC): Results from 3 phase 1 trials and the phase 3 RECOURSE trial.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Dana Farber Canc Inst, Boston, MA 02115 USA; Univ Hosp Leuven, Leuven, Belgium; Taiho Pharmaceut Co Ltd, Tokyo, Japan; Kyushu Univ, Fukuoka 812, Japan; Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan; Univ So Calif, Norris Comprehens Canc Ctr, Los Angeles, CA USA								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		2579						1	Oncology	Oncology	CM9OA	WOS:000358036900612		
J	Cohen, EEW; Licitra, LF; Fayette, J; Gauler, TC; Clement, PM; Grau, JJ; Del Campo, JM; Mailliez, A; Haddad, RI; Vermorken, JB; Tahara, M; Guigay, J; Geoffrois, L; Merlano, MC; Dupuis, NF; Burtness, B; Gibson, N; Solca, F; Ehrnrooth, E; Machiels, JPH				Cohen, Ezra E. W.; Licitra, Lisa F.; Fayette, Jerome; Gauler, Thomas Christoph; Clement, Paul M.; Jose Grau, Juan; Maria Del Campo, Jose; Mailliez, Audrey; Haddad, Robert I.; Vermorken, Jan B.; Tahara, Makoto; Guigay, Joel; Geoffrois, Lionnel; Merlano, Marco C.; Dupuis, Nicholas F.; Burtness, Barbara; Gibson, Neil; Solca, Flavio; Ehrnrooth, Eva; Machiels, Jean-Pascal H.			Biomarker analysis in recurrent and/or metastatic head and neck squamous cell carcinoma (R/M HNSCC) patients (pts) treated with second-line afatinib versus methotrexate (MTX): LUX-Head & Neck 1 (LUX-H&N1).	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					UC San Diego Moores Canc Ctr, La Jolla, CA USA; Fdn IRCCS Ist Nazl Tumori, Milan, Italy; Univ Lyon, Leon Berard Ctr, Lyon, France; Univ Lyon, Hosp Civils Lyon, Lyon, France; Univ Hosp Essen, West German Canc Ctr, Essen, Germany; Katholieke Univ Leuven, Dept Oncol, Leuven, Germany; Univ Barcelona, Hosp Clin Barcelona, Barcelona, Spain; Hosp Univ Vall DHebron, Dept Med Oncol, Barcelona, Spain; Ctr Oscar Lambret, F-59020 Lille, France; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Univ Antwerp Hosp, Edegem, Netherlands; East Hosp, Natl Canc Ctr, Kashiwa, Chiba, Japan; Gustave Roussy, Villejuif, France; Ctr Antoine Lacassagne, F-06054 Nice, France; Inst Cancerol Lorraine, Vandoeuvre Les Nancy, France; Azienda Osped Santa Croce & Carle, Cuneo, Italy; Biodesix Inc, Boulder, CO USA; Fox Chase Canc Ctr, New Haven, CT USA; Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria; Boehringer Ingelheim Denmark AS, Copenhagen, Denmark; Catholic Univ Louvain, Inst Roi Albert II, Serv Oncol Med, Clin Univ St Luc, B-1200 Brussels, Belgium; Catholic Univ Louvain, Inst Rech Clin & Expt Pole MIRO, B-1200 Brussels, Belgium								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		6023						1	Oncology	Oncology	CM9OA	WOS:000358036901336		
J	Daigo, Y; Takano, A; Teramoto, K; Nakamura, Y				Daigo, Yataro; Takano, Atsushi; Teramoto, Koji; Nakamura, Yusuke			Immunogenomics-based development of personalized immunotherapy for lung cancers.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Univ Tokyo, Inst Med Sci, Res Hosp, Tokyo, Japan; Univ Tokyo, Ctr Antibody & Vaccine, Tokyo, Japan; Shiga Univ Med Sci, Dept Med Oncol, Otsu, Shiga 52021, Japan; Univ Tokyo, Inst Med Sci, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		3019						1	Oncology	Oncology	CM9OA	WOS:000358036900653		
J	Deva, S; Baird, RD; Cresti, N; Garcia-Corbacho, J; Hogarth, L; Frenkel, EP; Kawaguchi, K; Arimura, A; Donaldson, K; Posner, J; Sarker, D; Jodrell, DI; Plummer, R; Spicer, JF				Deva, Sanjeev; Baird, Richard D.; Cresti, Nicola; Garcia-Corbacho, Javier; Hogarth, Linda; Frenkel, Eugene P.; Kawaguchi, Keiko; Arimura, Akinori; Donaldson, Kirsteen; Posner, John; Sarker, Debashis; Jodrell, Duncan Ian; Plummer, Ruth; Spicer, James F.			Phase I expansion of S-222611, a reversible inhibitor of EGFR and HER2, in advanced solid tumors, including patients with brain metastases.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Kings Coll London, London WC2R 2LS, England; Cambridge Univ Hosp, Cambridge, England; Newcastle Univ, No Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ Cambridge, Cambridge, England; Northern Ctr Canc Care, Newcastle Upon Tyne, Tyne & Wear, England; Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; Shionogi & Co Ltd, Osaka, Japan; Kings Coll Hosp London, Dept Oncol, London, England								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		2511						1	Oncology	Oncology	CM9OA	WOS:000358036900544		
J	Doi, T; Yoh, K; Shitara, K; Takahashi, H; Ueno, M; Kobayashi, S; Morimoto, M; Ohkawa, S; Okusaka, T; Ueno, H; Morizane, C; Shiba, S; Okano, N; Naruge, D; Nagashima, F; Furuse, J; Koba, K; Noguchi, K				Doi, Toshihiko; Yoh, Kiyotaka; Shitara, Kohei; Takahashi, Hideaki; Ueno, Makoto; Kobayashi, Satoshi; Morimoto, Manabu; Ohkawa, Shinichi; Okusaka, Takuji; Ueno, Hideki; Morizane, Chigusa; Shiba, Satoshi; Okano, Naohiro; Naruge, Daisuke; Nagashima, Fumio; Furuse, Junji; Koba, Kazuo; Noguchi, Kazuharu			First-in-man combination phase I study of TAS-114 and S-1 in patients (pts) with advanced solid tumors.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Natl Canc Ctr Hosp East, Chiba, Japan; Natl Canc Ctr Hosp East, Div Thorac Oncol, Kashiwa, Chiba, Japan; Natl Canc Ctr Hosp East, Dept GI Oncol, Kashiwa, Chiba, Japan; Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, Japan; Kanagawa Canc Ctr, Div Hepatobiliary & Pancreat Oncol, Yokohama, Kanagawa 2410815, Japan; Kanagawa Canc Ctr, Dept Hepatobiliary & Pancreat Med Oncol, Yokohama, Kanagawa 2410815, Japan; Kanagawa Canc Ctr, Div Hepatobiliary & Pancreat Oncol, Yokohama, Kanagawa 2410815, Japan; Natl Canc Ctr, Dept Hepatobiliary & Pancreat Oncol, Tokyo, Japan; Natl Canc Ctr, Div Hepatobiliary & Pancreat Oncol, Tokyo, Japan; Natl Canc Ctr, Tokyo, Japan; Kyorin Univ, Sch Med, Dept Internal Med, Med Oncol, Mitaka, Tokyo 181, Japan; Kyorin Univ Hosp, Tokyo, Japan; Kyorin Univ, Mitaka, Tokyo, Japan; Kyorin Univ, Sch Med, Dept Med Oncol, Tokyo, Japan; Taiho Pharmaceut Co Ltd, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		2544						1	Oncology	Oncology	CM9OA	WOS:000358036900577		
J	Doi, T; Piha-Paul, SA; Jalal, SI; Mai-Dang, H; Yuan, S; Koshiji, M; Csiki, I; Bennouna, J				Doi, Toshihiko; Piha-Paul, Sarina Anne; Jalal, Shadia Ibrahim; Mai-Dang, Hieu; Yuan, Sammy; Koshiji, Minori; Csiki, Ildiko; Bennouna, Jaafar			Pembrolizumab (MK-3475) for patients (pts) with advanced esophageal carcinoma: Preliminary results from KEYNOTE-028	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Natl Canc Ctr Hosp East, Chiba, Japan; Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Program 1, Houston, TX 77030 USA; Indiana Univ Sch Med, Indianapolis, IN 46202 USA; Merck & Co Inc, Kenilworth, NJ USA; Inst Cancerol Ouest, Nantes, France								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		4010						1	Oncology	Oncology	CM9OA	WOS:000358036900849		
J	Ellis, PA; Barrios, CH; Eiermann, W; Toi, M; Im, YH; Conte, PF; Martin, M; Pienkowski, T; Pivot, XB; Burris, HA; Strasak, A; Patre, M; Perez, EA				Ellis, Paul Anthony; Barrios, Carlos H.; Eiermann, Wolfgang; Toi, Masakazu; Im, Young-Hyuck; Conte, Pier Franco; Martin, Miguel; Pienkowski, Tadeusz; Pivot, Xavier B.; Burris, Howard A.; Strasak, Alexander; Patre, Monika; Perez, Edith A.			Phase III, randomized study of trastuzumab emtansine (T-DM1) +/- pertuzumab (P) vs trastuzumab plus taxane (HT) for first-line treatment of HER2-positive MBC: Primary results from the MARIANNE study.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Guys Hosp, London SE1 9RT, England; Sarah Cannon Res Inst, London, England; PUCRS Sch Med, Porto Alegre, RS, Brazil; Interdisciplinary Oncol Ctr, Munich, Germany; Kyoto Univ, Grad Sch Med, Kyoto, Japan; Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea; Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, Italy; Ist Oncol Veneto, Padua, Italy; Univ Complutense Madrid, Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain; Postgrad Med Educ Ctr, Warsaw, Poland; Univ Hosp Jean Minjoz, Besancon, France; Tennessee Oncol PLLC, Sarah Cannon Res Inst, Nashville, TN USA; F Hoffmann La Roche Ltd, Basel, Switzerland; Mayo Clin, Jacksonville, FL 32224 USA								0	3	3	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		507						1	Oncology	Oncology	CM9OA	WOS:000358036901114		
J	Enokida, T; Wakasugi, T; Yamazaki, T; Takahashi, M; Higuchi, Y; Hayashi, R; Fujii, S; Tahara, M				Enokida, Tomohiro; Wakasugi, Tetsuro; Yamazaki, Tomoko; Takahashi, Mari; Higuchi, Yoichi; Hayashi, Ryuichi; Fujii, Satoshi; Tahara, Makoto			A gene expression profile to predict recurrence of advanced tongue squamous cell carcinoma (TSCC): Discovery and external validation.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Natl Canc Ctr Hosp East, Div Head & Neck Med Oncol, Kashiwa, Chiba, Japan; Natl Canc Ctr Hosp East, Dept Digest Endoscopy, Kashiwa, Chiba, Japan; Natl Canc Ctr Hosp East, Div Pathol, Res Ctr Innovat Oncol, Kashiwa, Chiba, Japan; Natl Canc Ctr Hosp East, Head & Neck Surg Div, Kashiwa, Chiba, Japan; Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan; Natl Canc Ctr Hosp East, Dept Head & Neck Med Oncol, Kashiwa, Chiba, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		6032						1	Oncology	Oncology	CM9OA	WOS:000358036901346		
J	Felip, E; Orlov, S; Park, K; Yu, CJ; Tsai, CM; Nishio, M; Dols, MC; McKeage, MJ; Su, WC; Mok, T; Scagliotti, GV; Spigel, D; Branle, F; Emeremni, C; Quadrigli, M; Shaw, AT				Felip, Enriqueta; Orlov, Sergey; Park, Keunchil; Yu, Chong-Jen; Tsai, Chun-Ming; Nishio, Makoto; Dols, Manuel Cobo; McKeage, Mark James; Su, Wu-Chou; Mok, Tony; Scagliotti, Giorgio V.; Spigel, David; Branle, Fabrice; Emeremni, Chetachi; Quadrigli, Massimiliano; Shaw, Alice Tsang			ASCEND-3: A single-arm, open-label, multicenter phase II study of ceritinib in ALKi-naive adult patients (pts) with ALK-rearranged (ALK plus ) non-small cell lung cancer (NSCLC).	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Vall dHebron Univ, Barcelona, Spain; St Petersburg State Med Univ, Dept Thorac Oncol, St Petersburg, Russia; Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol & Oncol, Seoul, South Korea; Natl Taiwan Univ, Taipei 10764, Taiwan; Taipei Vet Gen Hosp, Taipei, Taiwan; Japanese Fdn Canc Res, Tokyo, Japan; Hosp Reg Univ Carlos Haya, Med Oncol Sect, Malaga, Spain; Auckland City Hosp, Auckland, New Zealand; Univ Auckland, Auckland 1, New Zealand; Natl Cheng Kung Univ Hosp, Tainan 70428, Taiwan; Chinese Univ Hong Kong, Shatin, Hong Kong, Peoples R China; Univ Turin, Turin, Italy; Sarah Cannon Res Inst, Med Oncol, Nashville, TN USA; Novartis Pharma AG, Basel, Switzerland; Novartis Pharmaceut, E Hanover, NJ USA; Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA								0	4	4	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		8060						1	Oncology	Oncology	CM9OA	WOS:000358036901772		
J	Friedlander, M; Stockler, MR; O'Connell, R; Joly, F; Lanceley, A; Hilpert, F; Okamoto, A; Aotani, E; Pignata, S; Donnellan, PP; Oza, AM; Avall-Lundqvist, E; Berek, JS; Sjoquist, KM; Gillies, K; Butow, P; King, MT				Friedlander, Michael; Stockler, Martin R.; O'Connell, Rachel; Joly, Florence; Lanceley, Anne; Hilpert, Felix; Okamoto, Aikou; Aotani, Eriko; Pignata, Sandro; Donnellan, Paul P.; Oza, Amit M.; Avall-Lundqvist, Elisabeth; Berek, Jonathan S.; Sjoquist, Katrin Marie; Gillies, Kim; Butow, Phyllis; King, Madeleine Trudy			Is it time to change the primary endpoint in clinical trials in recurrent ovarian cancer (ROC)?: Symptom burden and outcomes in patients with platinum resistant/ refractory (PRR) and potentially platinum sensitive ROC receiving >= 3 lines of chemotherapy (PPS >= 3)-The Gynecologic Cancer Intergroup (GCIG) Symptom Benefit Study (SBS).	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Prince Wales Canc Ctr, Randwick, NSW, Australia; Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW 2006, Australia; Univ Sydney, NHMRC Clin Trials Ctr, Camperdown, NSW, Australia; Ctr Francois Baclesse, F-14021 Caen, France; Univ Coll London Teaching Hosp, London, England; Univ Schleswig Holstein, Dept Obstet & Gynecol, Kiel, Germany; Jikei Univ, Sch Med, Tokyo, Japan; Kitasato Univ, Kitasato Acad Res Org, Minato Ku, Tokyo, Japan; Natl Canc Inst Naples, Naples, Italy; Galway Univ Hosp, Galway, Ireland; Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; Linkoping Univ, Dept Oncol, Linkoping, Sweden; Linkoping Univ, Dept Clin Expt Med, Linkoping, Sweden; Karolinska Inst, Linkoping, Sweden; Stanford Womens Canc Ctr, Stanford, CA USA; St George Hosp, Canc Care Ctr, Sydney, NSW, Australia; Univ Sydney, Sydney, NSW 2006, Australia; Univ Sydney, Psychooncol Cooperat Res Grp PoCoG, Sydney, NSW 2006, Australia			JOLY, Florence/L-7752-2015					0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		5536						1	Oncology	Oncology	CM9OA	WOS:000358036901197		
J	Fuchs, CS; Denker, AE; Tabernero, J; Van Cutsem, E; Ohtsu, A; Lam, B; Koshiji, M; Bang, YJ				Fuchs, Charles S.; Denker, Andrew E.; Tabernero, Josep; Van Cutsem, Eric; Ohtsu, Atsushi; Lam, Baohoang; Koshiji, Minori; Bang, Yung-Jue			Multicohort phase II KEYNOTE-059 study of pembrolizumab (MK-3475) for recurrent or metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Dana Farber Canc Inst, Boston, MA 02115 USA; Merck & Co Inc, Kenilworth, NJ USA; Vall dHebron Univ Hosp, Barcelona, Spain; Univ Hosp Leuven, Leuven Canc Inst, Leuven, Belgium; Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan; Seoul Natl Univ, Coll Med, Seoul, South Korea								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		TPS4135						1	Oncology	Oncology	CM9OA	WOS:000358036904743		
J	Fuchs, CS; Muro, K; Tomasek, J; Van Cutsem, E; Cho, JY; Oh, SC; Safran, H; Bodoky, G; Chau, I; Shimada, Y; Dumitru, F; Al-Batran, SE; Passalacqua, R; Ohtsu, A; Emig, M; Ferry, D; Chandrawansa, K; Hsu, YZ; Sashegyi, A; Wilke, H				Fuchs, Charles S.; Muro, Kei; Tomasek, Jiri; Van Cutsem, Eric; Cho, Jae Yong; Oh, Sang Cheul; Safran, Howard; Bodoky, Gyorgy; Chau, Ian; Shimada, Yasuhiro; Dumitru, Filip; Al-Batran, Salah-Eddin; Passalacqua, Rodolfo; Ohtsu, Atsushi; Emig, Michael; Ferry, David; Chandrawansa, Kumari; Hsu, Yanzhi; Sashegyi, Andreas; Wilke, Hansjochen			Prognostic factor analysis of overall survival (OS) in gastric cancer from two phase III studies of second-line ramucirumab (RAM) (REGARD and RAINBOW) using pooled individual patient (pt) data	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Dana Farber Canc Inst, Boston, MA 02115 USA; Aichi Canc Ctr Hosp, Nagoya, Aichi 464, Japan; Masaryk Univ, Fac Med, Masaryk Mem Canc Inst, Brno, Czech Republic; Univ Hosp Gasthuisberg, Digest Oncol, Leuven, Belgium; Gangnam Severance Hosp, Seoul, South Korea; Korea Univ Guro Hosp, Seoul, South Korea; Brown Univ, Oncol Res Grp, Providence, RI 02912 USA; Szent Laszlo Hosp, Budapest, Hungary; Royal Marsden, London, England; Royal Marsden, London, Surrey, England; Natl Canc Ctr, Tokyo, Japan; Spitalul Judetean Urgenta, Baia Mare, Romania; Univ Canc Ctr, Inst Clin Res, Frankfurt, Germany; Ist Ospitalieri Cremona, Cremona, Italy; Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Kashiwa, Chiba, Japan; Lilly Deutschland GmbH, Bad Homburg, Germany; Eli Lilly & Co, Indianapolis, IN 46285 USA; Eli Lilly & Co, Bridgewater, NJ USA; Kliniken Essen Mitte Ctr Pallat Care, Essen, Germany								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		4028						1	Oncology	Oncology	CM9OA	WOS:000358036900867		
J	Fujii, T; Kogawa, T; Wei, CM; Fouad, TM; Harano, K; Park, YS; Lim, B; Tripathy, D; Ueno, NT; Litton, JK				Fujii, Takeo; Kogawa, Takahiro; Wei, Caimiao; Fouad, Tamer Mahmoud; Harano, Kenichi; Park, Young Sam; Lim, Bora; Tripathy, Debu; Ueno, Naoto T.; Litton, Jennifer Keating			Association of body mass index with survival outcome in three breast cancer subtypes	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; Cairo Univ, Natl Canc Inst, Giza, Egypt; Musashikosugi Hosp, Nippon Med Sch, Dept Med Oncol, Kawasaki, Kanagawa, Japan			Lim, Bora/F-9978-2014	Lim, Bora/0000-0002-4182-6058				0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		1580						1	Oncology	Oncology	CM9OA	WOS:000358036900446		
J	Fujita, H; Gomori, A; Sakuragi, M; Hashimoto, A; Ito, K; Suzuki, T; Fujioka, Y; Yonekura, K; Aoyama, T; Matsubara, N; Doi, T; Iwasawa, Y				Fujita, Hidenori; Gomori, Akira; Sakuragi, Motomu; Hashimoto, Akihiro; Ito, Kenjiro; Suzuki, Takamasa; Fujioka, Yayoi; Yonekura, Kazuhiko; Aoyama, Takekazu; Matsubara, Nobuaki; Doi, Toshihiko; Iwasawa, Yoshikazu			TAS-115, a potent MET/VEGFRs-targeted kinase inhibitor with high tolerability, to suppress NSCLC-driven bone disruption	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Taiho Pharmaceut Co Ltd, Tsukuba, Ibaraki, Japan; Taiho Pharma USA Inc, Princeton, NJ USA; Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan; Natl Canc Ctr Hosp East, Chiba, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e22011						1	Oncology	Oncology	CM9OA	WOS:000358036904416		
J	Fujita, T; Tabata, K; Ishii, D; Matsumoto, K; Yoshida, K; Iwamura, M				Fujita, Tetsuo; Tabata, Ken-ichi; Ishii, Daisuke; Matsumoto, Kazumasa; Yoshida, Kazunari; Iwamura, Masatsugu			Prognostic impact of C-reactive protein kinetics for advanced renal cell carcinoma treated with sunitinib	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Kitasato Univ, Sch Med, Tokyo, Kanagawa, Japan; Kitasato Univ, Sch Med, Dept Urol, Tokyo, Kanagawa, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e15602						1	Oncology	Oncology	CM9OA	WOS:000358036903143		
J	Fujiwara, H; Shimoda, A; Ishikawa, Y; Takei, Y; Machida, S; Taneichi, A; Ohashi, M; Takahashi, Y; Morisawa, H; Koyanagi, T; Saga, Y; Suzuki, M				Fujiwara, Hiroyuki; Shimoda, Akihiro; Ishikawa, Yoshiki; Takei, Yuji; Machida, Shizuo; Taneichi, Akiyo; Ohashi, Mai; Takahashi, Yoshifumi; Morisawa, Hiroyuki; Koyanagi, Takahiro; Saga, Yasushi; Suzuki, Mitsuaki			The effects of message framing on cervical cancer screening: A randomized controlled trial.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Jichi Med Univ, Dept OBGYN, Shimotsuke, Tochigi, Japan; Canc Scan, Dept Publ Hlth, Tokyo, Japan; Univ Tokyo, Sch Publ Hlth, Dept Hlth & Social Behav, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e12568						1	Oncology	Oncology	CM9OA	WOS:000358036902375		
J	Fujiwara, Y; Yoshikawa, R; Tsujie, M; Kato, H; Takeyama, H; Kitani, K; Yukawa, M; Inoue, M				Fujiwara, Yoshinori; Yoshikawa, Reigetsu; Tsujie, Masanori; Kato, Hiroaki; Takeyama, Hiroshi; Kitani, Kotaro; Yukawa, Masao; Inoue, Masatoshi			CD44, a cancer stemness marker, to predict poor clinical outcome of esophageal cancer patients after neoadjuvant chemoradiotherapy.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Kinki Univ, Sch Med, Ikoma City, Japan; Kanzaki Hosp, Amagasaki, Hyogo, Japan; Osaka Natl Hosp, Osaka, Japan; Kinki Univ, Dept Surg, Osakasayama, Japan; Kinki Univ, Nara Hosp, Sch Med, Ikoma City, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e15068						1	Oncology	Oncology	CM9OA	WOS:000358036902849		
J	Fukuda, T; Wu, WW; Okada, M; Maeda, I; Kojima, Y; Hayami, R; Miyoshi, Y; Tsugawa, K; Ohta, T				Fukuda, Takayo; Wu, Wenwen; Okada, Maiko; Maeda, Ichiro; Kojima, Yasuyuki; Hayami, Ryosuke; Miyoshi, Yasuo; Tsugawa, Koichiro; Ohta, Tomohiko			Class I HDAC inhibitors inhibit the retention of BRCA1 and 53BP1 at the site of DNA damage	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					St Marianna Univ, Grad Sch Med, Dept Translat Oncol, Kawasaki, Kanagawa, Japan; St Marianna Univ, Sch Med, Dept Pathol, Kawasaki, Kanagawa, Japan; St Marianna Univ, Sch Med Hosp, Kawasaki, Kanagawa, Japan; St Marianna Univ, Grad Sch Med, Div Breast & Endocrine Surg, Dept Surg, Kawasaki, Kanagawa, Japan; Hyogo Coll Med, Nishinomiya, Hyogo 6638501, Japan; St Marianna Univ, Sch Med, Kawasaki, Kanagawa, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e13552						1	Oncology	Oncology	CM9OA	WOS:000358036902552		
J	Fukutomi, A; Mizusawa, J; Katayama, H; Nakamura, S; Ito, Y; Hiraoka, N; Ioka, T; Ueno, M; Ikeda, M; Sugimori, K; Shimizu, K; Okusaka, T; Ozaka, M; Yanagimoto, H; Nakamori, S; Azuma, T; Hosokawa, A; Sata, N; Mine, T; Furuse, J				Fukutomi, Akira; Mizusawa, Junki; Katayama, Hiroshi; Nakamura, Satoaki; Ito, Yoshinori; Hiraoka, Nobuyoshi; Ioka, Tatsuya; Ueno, Makoto; Ikeda, Masafumi; Sugimori, Kazuya; Shimizu, Kyoko; Okusaka, Takuji; Ozaka, Masato; Yanagimoto, Hiroaki; Nakamori, Shoji; Azuma, Takeshi; Hosokawa, Ayumu; Sata, Naohiro; Mine, Tetsuya; Furuse, Junji		JCOG	Randomized phase II study of S-1 and concurrent radiotherapy with versus without induction chemotherapy of gemcitabine for locally advanced pancreatic cancer (JCOG1106)	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Shizuoka Canc Ctr, Div Gastrointestinal Oncol, Shizuoka, Japan; Natl Canc Ctr, Clin Oncol Grp, Ctr Data, Ctr Res Adm & Support, Tokyo 104, Japan; Kyoto Prefectural Univ Med, Dept Radiol, Kyoto, Japan; Natl Canc Ctr, Dept Radiat Oncol, Tokyo, Japan; Natl Canc Ctr, Div Pathol & Clin Labs, Tokyo, Japan; Osaka Med Ctr Canc & Cardiovasc Dis, Dept Hepatobiliary & Pancreat Oncol, Osaka, Japan; Kanagawa Canc Ctr, Div Hepatobiliary & Pancreat Oncol, Yokohama, Kanagawa 2410815, Japan; Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, Japan; Yokohama City Univ, Gastroenterol Ctr, Med Ctr, Yokohama, Kanagawa 232, Japan; Tokyo Womens Med Univ, Inst Gastroenterol, Tokyo, Japan; Natl Canc Ctr, Dept Hepatobiliary & Pancreat Oncol, Tokyo, Japan; Japanese Fdn Canc Res, Canc Inst Hosp, Hepatobiliary & Pancreat Div, Tokyo, Japan; Kansai Med Univ, Hirakata Hosp, Dept Surg, Hirakata, Osaka, Japan; Osaka Natl Hosp, Dept Hepatobiliary & Pancreat Surg, Osaka, Japan; Kobe Univ, Dept Internal Med, Sch Med, Div Gastroenterol, Kobe, Hyogo 657, Japan; Toyama Univ, Dept Gastroenterol & Hematol, Fac Med, Toyama 930, Japan; Jichi Med Univ, Sch Med, Dept Surg, Shimotsuke, Japan; Tokai Univ, Sch Med, Dept Gastroenterol & Hepatol, Isehara, Kanagawa 25911, Japan; Kyorin Univ, Sch Med, Dept Med Oncol, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		4116						1	Oncology	Oncology	CM9OA	WOS:000358036900954		
J	Futamura, M; Nagao, Y; Ishihara, K; Takeuchi, M; Nakada, T; Kawaguchi, Y; Asano, M; Kumazawa, I; Shiroko, T; Mori, R; Morimitsu, K; Nawa, M; Takahashi, H; Morikawa, A; Sakashita, F; Takao, C; Hosono, Y; Asano, Y; Kanematsu, M; Yoshida, K				Futamura, Manabu; Nagao, Yasuko; Ishihara, Kazuhiro; Takeuchi, Makoto; Nakada, Takumi; Kawaguchi, Yoshihiro; Asano, Masayoshi; Kumazawa, Iwao; Shiroko, Takashi; Mori, Ryutaro; Morimitsu, Kasumi; Nawa, Masahito; Takahashi, Harumi; Morikawa, Akemi; Sakashita, Fumio; Takao, Chika; Hosono, Yoshiki; Asano, Yoshimi; Kanematsu, Masako; Yoshida, Kazuhiro			The PerSeUS-BC01 study: A phase II study of nab-PTX followed by EC as neoadjuvant chemotherapy in breast cancer patients.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Gifu Univ, Sch Med, Gifu 500, Japan; Gifu Prefectural Gen Med Ctr, Gifu, Japan; Gihoku Kosei Hosp, Gifu, Japan; Kizawa Mem Hosp, Minokamo, Japan; Gifu Municipal Hosp, Gifu, Japan; Murakami Mem Hosp, Gifu, Japan; Ena Municipal Hosp, Ena, Japan; Ibi Kosei Hosp, Ibigawa, Japan; Takayama Red Cross Hosp, Takayama, Japan; Gihoku Kosei Hosp, Gifu, Gifu, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e12000						1	Oncology	Oncology	CM9OA	WOS:000358036902230		
J	Giannakis, M; Shukla, S; Mu, JX; Nishihara, R; Yamauchi, M; Sukawa, Y; Qian, ZR; Nosho, K; Inamura, K; Bahl, S; Ng, K; Chan, AT; Meyerhardt, JA; Gabriel, SB; Lander, E; Wu, C; Getz, G; Fuchs, CS; Ogino, S; Garraway, LA				Giannakis, Marios; Shukla, Sachet; Mu, Jasmine Xinmeng; Nishihara, Reiko; Yamauchi, Mai; Sukawa, Yasutaka; Qian, Zhi Rong; Nosho, Katsuhiko; Inamura, Kentaro; Bahl, Samira; Ng, Kimmie; Chan, Andrew T.; Meyerhardt, Jeffrey A.; Gabriel, Stacey B.; Lander, Eric; Wu, Catherine; Getz, Gad; Fuchs, Charles S.; Ogino, Shuji; Garraway, Levi A.			Comprehensive molecular characterization of colorectal cancer reveals genomic predictors of immune cell infiltrates.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Dana Farber Canc Inst, Boston, MA 02115 USA; Broad Inst MIT & Harvard, Cambridge, MA USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Sapporo Med Univ, Sch Med, Sapporo, Hokkaido, Japan; Massachusetts Gen Hosp, Boston, MA 02114 USA; Broad Inst, Cambridge, MA USA; Brigham & Womens Hosp, Boston, MA 02115 USA								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		3505						1	Oncology	Oncology	CM9OA	WOS:000358036900725		
J	Goetz, MP; Toi, M; Klise, S; Frenzel, M; Bourayou, N; Di Leo, A				Goetz, Matthew P.; Toi, Masakazu; Klise, Suzanne; Frenzel, Martin; Bourayou, Nawel; Di Leo, Angelo			MONARCH 3: A randomized phase III study of anastrozole or letrozole plus abemaciclib, a CDK4/6 inhibitor, or placebo in first-line treatment of women with HR+, HER2-locoregionally recurrent or metastatic breast cancer (MBC).	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Mayo Clin, Rochester, MN USA; Kyoto Univ, Grad Sch Med, Kyoto, Japan; Eli Lilly & Co, Indianapolis, IN 46285 USA; Eli Lilly & Co, Suresnes, France; Sandro Pitigliani Med Oncol Unit, Prato, Italy								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		TPS624						1	Oncology	Oncology	CM9OA	WOS:000358036904816		
J	Goto, Y; Nokihara, H; Murakami, H; Shimizu, T; Seto, T; Krivoshik, AP; Keating, AT; Uegaki, K; Takeda, K; Komatsu, K; Morita, S; Fukuoka, M; Nakagawa, K				Goto, Yasushi; Nokihara, Hiroshi; Murakami, Haruyasu; Shimizu, Toshio; Seto, Takashi; Krivoshik, Andrew P.; Keating, Anne Therese; Uegaki, Koichi; Takeda, Kentaro; Komatsu, Kanji; Morita, Satoshi; Fukuoka, Masahiro; Nakagawa, Kazuhiko			ASP8273, a mutant-selective irreversible EGFR inhibitor in patients (pts) with NSCLC harboring EGFR activating mutations: Preliminary results of first-in-human phase I study in Japan.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Natl Canc Ctr, Tokyo, Japan; Shizuoka Canc Ctr, Div Thorac Oncol, Shizuoka, Japan; Kinki Univ, Fac Med, Osakasayama, Japan; Kyushu Natl Canc Ctr, Fukuoka, Japan; Astellas Pharma Global Dev Inc, Northbrook, IL USA; Astellas Pharma Inc, Chuo Ku, Tokyo, Japan; Kyoto Univ, Kyoto, Japan; Izumi Municipal Hosp, Izumi, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		8014						1	Oncology	Oncology	CM9OA	WOS:000358036901727		
J	Grothey, A; Falcone, A; Humblet, Y; Bouche, O; Mineur, L; Adenis, A; Tabernero, J; Yoshino, T; Lenz, HJ; Goldberg, RM; Xu, L; Wagner, A; Van Cutsem, E				Grothey, Axel; Falcone, Alfredo; Humblet, Yves; Bouche, Olivier; Mineur, Laurent; Adenis, Antoine; Tabernero, Josep; Yoshino, Takayuki; Lenz, Heinz-Josef; Goldberg, Richard M.; Xu, Lei; Wagner, Andrea; Van Cutsem, Eric			Subgroup analysis of patients with metastatic colorectal cancer (mCRC) treated with regorafenib (REG) in the CORRECT trial who had progression-free survival (PFS) longer than 4 months.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Mayo Clin, Rochester, MN USA; Azienda Osped Univ Pisana, Ist Toscano Tumori, Pisa, Italy; St Luc Univ Hosp, Brussels, Belgium; Ctr Hosp Univ Robert Debre, Reims, France; Inst St Catherine, Radiotherapy & Oncol GI & Liver Unit, Avignon, France; Ctr Oscar Lambret, Dept Med Oncol, F-59020 Lille, France; VHIO, Barcelona, Spain; Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan; Univ So Calif, Norris Comprehens Canc Ctr, Los Angeles, CA USA; Ohio State Univ, Ctr Comprehens Canc, Arthur G James Canc Hosp, Columbus, OH 43210 USA; Richard J Solove Res Inst, Columbus, OH USA; Bayer HealthCare Pharmaceut, Whippany, NJ USA; Bayer HealthCare Pharmaceut, Berlin, Germany; Univ Hosp Leuven, Leuven, Belgium								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e14579						1	Oncology	Oncology	CM9OA	WOS:000358036902683		
J	Hamaguchi, T; Shimada, Y; Mizusawa, J; Kinugasa, Y; Kanemitsu, Y; Ohue, M; Fujii, S; Takiguchi, N; Yatsuoka, T; Takii, Y; Ojima, H; Masuko, H; Kubo, Y; Mishima, H; Yamaguchi, T; Bandou, H; Sato, T; Kato, T; Nakamura, K; Fukuda, H				Hamaguchi, Tetsuya; Shimada, Yasuhiro; Mizusawa, Junki; Kinugasa, Yusuke; Kanemitsu, Yukihide; Ohue, Masayuki; Fujii, Shoichi; Takiguchi, Nobuhiro; Yatsuoka, Toshimasa; Takii, Yasumasa; Ojima, Hitoshi; Masuko, Hiroyuki; Kubo, Yoshiro; Mishima, Hideyuki; Yamaguchi, Takashi; Bandou, HIroyuki; Sato, Toshihiko; Kato, Takeshi; Nakamura, Kenichi; Fukuda, Haruhiko		JCOG Colorectal Canc Study Grp	Randomized phase III study of adjuvant chemotherapy with S-1 versus capecitabine (cape) in patients with stage III colon cancer (CC): Results of Japan Clinical Oncology Group study (JCOG0910).	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Natl Canc Ctr, Gastrointestinal Med Oncol Div, Tokyo, Japan; Natl Canc Ctr, Tokyo, Japan; Natl Canc Ctr, Japan Clin Oncol Grp, Data Ctr Ctr Res Adm & Support, Tokyo 104, Japan; Shizuoka Canc Ctr Hosp, Div Colon & Rectal Surg, Shizuoka, Japan; Osaka Med Ctr Canc & Cardiovasc Dis, Dept Surg, Osaka, Japan; Yokohama City Univ, Med Ctr, Yokohama, Kanagawa 232, Japan; Chiba Canc Ctr, Chiba 2608717, Japan; Saitama Canc Ctr, Saitama, Japan; Niigata Canc Ctr Hosp, Dept Surg, Niigata, Japan; Gunma Prefectural Canc Ctr, Gunma, Japan; Sapporo Kosei Gen Hosp, Sapporo, Hokkaido, Japan; Shikoku Canc Ctr, Shikoku, Ehime, Japan; Osaka Natl Hosp, Osaka, Japan; Kyoto Med Ctr, Kyoto, Japan; Ishikawa Prefectural Cent Hosp, Kanazawa, Ishikawa, Japan; Yamagata Prefectural Cent Hosp, Yamagata, Japan; Minoh City Hosp, Osaka, Japan; Natl Canc Ctr, Japan Clin Oncol Grp, Operat Off, Tokyo 104, Japan; Natl Canc Ctr, Japan Clin Oncol Grp, Ctr Data, Tokyo 104, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		3512						1	Oncology	Oncology	CM9OA	WOS:000358036900732		
J	Hamai, Y; Hihara, J; Furukawa, T; Yamakita, I; Okada, M				Hamai, Yoichi; Hihara, Jun; Furukawa, Takaoki; Yamakita, Ichiko; Okada, Morihito			Results of neoadjuvant chemoradiotherapy with docetaxel and 5-fluorouracil followed by esophagectomy to treat locally advanced esophageal cancer.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					[Hamai, Yoichi; Hihara, Jun; Furukawa, Takaoki; Yamakita, Ichiko; Okada, Morihito] Hiroshima Univ, Res Inst Radiat Biol & Med, Surg Oncol, Hiroshima, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e15084						1	Oncology	Oncology	CM9OA	WOS:000358036902862		
J	Hamanishi, J; Mandai, M; Ikeda, T; Minami, M; Kawaguchi, A; Matsumura, N; Abiko, K; Baba, T; Yamaguchi, K; Ueda, A; Hosoe, Y; Morita, S; Shimizu, A; Honjo, T; Konishi, I				Hamanishi, Junzo; Mandai, Masaki; Ikeda, Takafumi; Minami, Manabu; Kawaguchi, Atsushi; Matsumura, Noriomi; Abiko, Kaoru; Baba, Tsukasa; Yamaguchi, Ken; Ueda, Akihiko; Hosoe, Yuko; Morita, Satoshi; Shimizu, Akira; Honjo, Tasuku; Konishi, Ikuo			Durable tumor remission in patients with platinum-resistant ovarian cancer receiving nivolumab.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Kyoto Univ, Kyoto, Japan; Kinki Univ, Osaka, Japan; Kyoto Univ, Dept Biomed Stat & Bioinformat, Grad Sch Med, Kyoto, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		5570						1	Oncology	Oncology	CM9OA	WOS:000358036901235		
J	Harano, K; Hirakawa, A; Yunokawa, M; Nakamura, T; Satoh, T; Nishikawa, T; Aoki, D; Ito, K; Ito, K; Nakanishi, T; Susumu, N; Takehara, K; Watanabe, Y; Watari, H; Saito, T				Harano, Kenichi; Hirakawa, Akihiro; Yunokawa, Mayu; Nakamura, Toshiaki; Satoh, Toyomi; Nishikawa, Tadaaki; Aoki, Daisuke; Ito, Kimihiko; Ito, Kiyoshi; Nakanishi, Toru; Susumu, Nobuyuki; Takehara, Kazuhiro; Watanabe, Yoh; Watari, Hidemichi; Saito, Toshiaki			Optimal debulking surgery in patients with advanced uterine carcinosarcoma: A multi-institutional retrospective study from the Japanese Gynecologic Oncology Group.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Musashikosugi Hosp, Nippon Med Sch, Dept Med Oncol, Kawasaki, Kanagawa, Japan; Nagoya Univ, Ctr Adv Med & Clin Res, Nagoya, Aichi 4648601, Japan; Natl Canc Ctr, Tokyo, Japan; Kagoshima City Hosp, Dept Obstet & Gynecol, Kagoshima, Japan; Univ Tsukuba, Fac Med, Dept Obstet & Gynecol, Tsukuba, Ibaraki, Japan; Saitama Med Univ, Int Med Ctr, Dept Gynecol Oncol, Hidaka City, Japan; Keio Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 160, Japan; Kansai Rosai Hosp, Dept Obstet & Gynecol, Amagasaki, Hyogo, Japan; Tohoku Univ, Grad Sch Med, Dept Disaster Obstet & Gynecol, Sendai, Miyagi 980, Japan; Aichi Canc Ctr Hosp, Dept Gynecol Oncol, Nagoya, Aichi, Japan; NHO Shikoku Canc Ctr, Dept Gynecol Oncol, Matsuyama, Ehime, Japan; Tohoku Univ Hosp, Clin Res Innovat & Educ Ctr, Dept Clin Res Network, Sendai, Miyagi, Japan; Hokkaido Univ, Sapporo, Hokkaido, Japan; Kyushu Natl Canc Ctr, Dept Gynecol, Fukuoka, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		5591						1	Oncology	Oncology	CM9OA	WOS:000358036901258		
J	Hasegawa, Y; Miura, D; Ota, T; Yokouchi, J				Hasegawa, Yukihiro; Miura, Dai; Ota, Tomohiro; Yokouchi, Junichi			Phase I study of bi-weekly nab-paclitaxel and carboplatin with concurrent thoracic radiotherapy for locally advanced non-small cell lung cancer.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					[Hasegawa, Yukihiro; Miura, Dai; Ota, Tomohiro; Yokouchi, Junichi] Aomori Prefectural Cent Hosp, Aomori, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		7529						1	Oncology	Oncology	CM9OA	WOS:000358036901659		
J	Hashimoto, H; Murakami, M; Shinozaki, K; Nakanishi, R; Kawaguchi, H; Nishizaki, T; Senba, S				Hashimoto, Hiroki; Murakami, Michiyasu; Shinozaki, Kyoko; Nakanishi, Ryota; Kawaguchi, Hidetoshi; Nishizaki, Takashi; Senba, Shozo			Development of drug cost spreadsheet calculation tool for breast cancer therapy	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					[Hashimoto, Hiroki; Murakami, Michiyasu; Shinozaki, Kyoko; Nakanishi, Ryota; Kawaguchi, Hidetoshi; Nishizaki, Takashi; Senba, Shozo] Matsuyama Red Cross Hosp, Matsuyama, Ehime, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e17797						1	Oncology	Oncology	CM9OA	WOS:000358036903729		
J	Hayakawa, N; Kikuchi, E; Matshumoto, K; Morita, S; Shinoda, K; Kosaka, T; Mizuno, R; Shinojima, T; Asanuma, H; Miyajima, A; Oya, M				Hayakawa, Nozomi; Kikuchi, Eiji; Matshumoto, Kazuhiro; Morita, Shinya; Shinoda, Kazunobu; Kosaka, Takeo; Mizuno, Ryuichi; Shinojima, Toshiaki; Asanuma, Hiroshi; Miyajima, Akira; Oya, Mototsugu			Decision tree for the diagnosis of upper tract urothelial carcinoma: Can selective upper-tract urine cytology be omitted in diagnosis?	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					[Hayakawa, Nozomi; Kikuchi, Eiji; Matshumoto, Kazuhiro; Morita, Shinya; Shinoda, Kazunobu; Kosaka, Takeo; Mizuno, Ryuichi; Shinojima, Toshiaki; Asanuma, Hiroshi; Miyajima, Akira; Oya, Mototsugu] Keio Univ, Sch Med, Dept Urol, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e15638						1	Oncology	Oncology	CM9OA	WOS:000358036903176		
J	Hayashi, N; Bianchini, G; Murai, M; Suzuki, K; Uno, M; Uchida, S; Yagata, H; Yoshida, A; Iwamoto, T; Niikura, N; Nakamura, S; Yamauchi, H				Hayashi, Naoki; Bianchini, Giampaolo; Murai, Michiko; Suzuki, Koyu; Uno, Mieko; Uchida, Shiro; Yagata, Hiroshi; Yoshida, Atsushi; Iwamoto, Takayuki; Niikura, Naoki; Nakamura, Seigo; Yamauchi, Hideko			Low tumor-infiltrating lymphocytes (TILs) to predict and refine risk in patients not achieving a pathological complete response (pCR) in HER2-positive breast cancers.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					St Lukes Int Hosp, Tokyo, Japan; Hosp San Raffaele, I-20132 Milan, Italy; Okayama Univ Hosp, Okayama, Japan; Tokai Sch Med, Isehara, Kanagawa, Japan; Showa Univ, Sch Med, Tokyo 142, Japan; St Lukes Int Hosp, Cyu O Ku, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e11612						1	Oncology	Oncology	CM9OA	WOS:000358036902223		
J	Heng, DYC; Stukalin, I; Wells, C; Donskov, F; Rini, BI; Lee, JL; Bjarnason, GA; Beuselinck, B; Smoragiewicz, M; Alva, AS; Srinivas, S; Wood, L; Brugarolas, J; Pal, SK; Yuasa, T; Broom, RJ; Kanesvaran, R; Bamias, A; Knox, JJ; Choueiri, TK				Heng, Daniel Yick Chin; Stukalin, Igor; Wells, Connor; Donskov, Frede; Rini, Brian I.; Lee, Jae-Lyun; Bjarnason, Georg A.; Beuselinck, Benoit; Smoragiewicz, Martin; Alva, Ajjai Shivaram; Srinivas, Sandy; Wood, Lori; Brugarolas, James; Pal, Sumanta Kumar; Yuasa, Takeshi; Broom, Reuben James; Kanesvaran, Ravindran; Bamias, Aristotelis; Knox, Jennifer J.; Choueiri, Toni K.			Third-line therapy in metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC)	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Univ Calgary, Tom Baker Canc Ctr, Calgary, AB, Canada; Tom Baker Canc Clin, Calgary, AB, Canada; Aarhus Univ Hosp, Dept Oncol, DK-8000 Aarhus, Denmark; Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA; Univ Ulsan, Coll Med, Dept Oncol, Asan Med Ctr, Seoul, South Korea; Univ Toronto, Sunnybrook Odette Canc Ctr, Toronto, ON, Canada; Univ Hosp Leuven, Dept Gen Med Oncol, Leuven, Belgium; BC Canc Agcy, Vancouver, BC, Canada; Univ Michigan, Dept Internal Med, Div Hematol Oncol, Ann Arbor, MI 48109 USA; Stanford Univ, Med Ctr, Stanford, CA 94305 USA; Queen Elizabeth 2 Hlth Sci Ctr, Halifax, NS, Canada; Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; City Hope Natl Med Ctr, Duarte, CA 91010 USA; Japanese Fdn Canc Res, Canc Inst Hosp, Dept Urol, Tokyo, Japan; Auckland City Hosp, Auckland, New Zealand; Natl Canc Ctr Singapore, Singapore, Singapore; Univ Athens, Dept Clin Therapeut, Athens, Greece; Univ Toronto, Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; Dana Farber Canc Inst, Boston, MA 02115 USA								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e15578						1	Oncology	Oncology	CM9OA	WOS:000358036903121		
J	Hirai, Y; Matsui, H				Hirai, Yasuo; Matsui, Hideo			Prospective performance study of the liquid based endometrial cytology not inferior to suction endometrial tissue biopsy for the endometrial cancer screening.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Tokyo Womens Med Univ, Tokyo, Japan; Tokyo Womens Med Univ, Shinjuku Ku, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e16523						1	Oncology	Oncology	CM9OA	WOS:000358036903320		
J	Hiratsuka, T; Akagi, T; Empuku, S; Nakajima, K; Ueda, Y; Tojigamori, M; Shiroshita, H; Etoh, T; Ninomiya, S; Hiroishi, K; Yoshizumi, F; Takeuchi, Y; Sasaki, A; Tahara, K; Fujii, K; Shiromizu, A; Ishikawa, K; Matsumoto, T; Bando, T; Inomata, M				Hiratsuka, Takahiro; Akagi, Tomonori; Empuku, Shinichiro; Nakajima, Kentaro; Ueda, Yoshitake; Tojigamori, Manabu; Shiroshita, Hidefumi; Etoh, Tsuyoshi; Ninomiya, Shigeo; Hiroishi, Kazuaki; Yoshizumi, Fumitaka; Takeuchi, Yu; Sasaki, Atsushi; Tahara, Koichiro; Fujii, Kyuzo; Shiromizu, Akio; Ishikawa, Koichi; Matsumoto, Toshifumi; Bando, Toshio; Inomata, Masafumi			Preoperative chemoradiotherapy for locally advanced rectal cancer: Multicenter phase II clinical trial.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Oita Univ, Fac Med, Oita 87011, Japan; Oita Univ, Fac Med, Dept Gastroenterol & Pediat Surg, Oita, Japan; Nankai Med Ctr, Saiki, Japan; Oita Univ, Fac Med, Nakatsu, Japan; Oita Red Cross Hosp, Oita, Japan; Tsukumi Cent Hosp, Tsukumi, Japan; Beppu Med Ctr, Beppu, Oita, Japan; Oita Prefectual Hosp, Oita, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e14612						1	Oncology	Oncology	CM9OA	WOS:000358036902710		
J	Hiyama, E; Kurihara, S; Ueda, Y; Hishiki, T; Ida, K; Iehara, T; Oue, T; Yano, M; Watanabe, K; Hoshino, K; Ko, K; Tanaka, Y				Hiyama, Eiso; Kurihara, Sho; Ueda, Yuka; Hishiki, Tomoro; Ida, Kohmei; Iehara, Tomoko; Oue, Takaharu; Yano, Michihiro; Watanabe, Kenichiro; Hoshino, Ken; Ko, Katsuyoshi; Tanaka, Yukichi			Survival and late effects in the risk-stratified hepatoblastoma patients treated by JPLT-2 protocol.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Hiroshima Univ, Hiroshima, Japan; Hiroshima Univ Hosp, Hiroshima, Japan; Japanese Study Grp Pediat Liver Tumor, Hiroshima, Japan; Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pediat, Kyoto, Japan; Japanese Study Grp Pediat Liver Tumor, Osaka, Japan; Japanese Study Grp Pediat Liver Tumor, Tokyo, Japan; Japanese Study Grp Pediat Liver Tumor, Saitama, Japan; Japanese Study Grp Pediat Liver Tumor, Yokohama, Kanagawa, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		10021						1	Oncology	Oncology	CM9OA	WOS:000358036900026		
J	Hoffman, RM; Yano, S; Bouvet, M; Fujiwara, T; Tsuchiya, H; Miwa, S				Hoffman, Robert M.; Yano, Shuya; Bouvet, Michael; Fujiwara, Toshiyoshi; Tsuchiya, Hiroyuki; Miwa, Shinji			Cell-cycle fate-monitoring to identify individual chemosensitive and chemoresistant cancer cells in heterogeneous cancer populations.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					AntiCancer Inc, San Diego, CA USA; Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; Okayama Univ, Grad Sch, Okayama 7008530, Japan; Kanazawa Univ Hosp, Kanazawa, Ishikawa, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e13514						1	Oncology	Oncology	CM9OA	WOS:000358036902520		
J	Honma, Y; Terauchi, T; Tateishi, U; Kano, D; Nagashima, K; Okita, NT; Takashima, A; Iwasa, S; Kato, K; Hamaguchi, T; Shimada, Y; Boku, N; Yamada, Y				Honma, Yoshitaka; Terauchi, Takashi; Tateishi, Ukihide; Kano, Daisuke; Nagashima, Kengo; Okita, Natsuko T.; Takashima, Atsuo; Iwasa, Satoru; Kato, Ken; Hamaguchi, Tetsuya; Shimada, Yasuhiro; Boku, Narikazu; Yamada, Yasuhide			Imaging peritoneal metastasis of gastric cancer with PET/CT and the radiotracer F-18-fluorothymidine (F-18-FLT):Proof-of-concept study.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Natl Canc Ctr, Gastrointestinal Med Oncol Div, Tokyo, Japan; Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Canc Screening Div, Tokyo 104, Japan; Yokohama City Univ Med, Yokohama, Kanagawa, Japan; Natl Canc Ctr Hosp EAST, Kashiwa, Chiba, Japan; Chiba Univ Hosp, Clin Res Ctr, Chiba, Japan; Natl Canc Ctr, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		11013						1	Oncology	Oncology	CM9OA	WOS:000358036900272		
J	Horinouchi, H; Sekine, I; Sumi, M; Soejima, T; Satouchi, M; Nagakura, H; Isobe, H; Nishiyama, N; Harada, M; Ishizuka, N; Tamura, T; Ohe, Y				Horinouchi, Hidehito; Sekine, Ikuo; Sumi, Minako; Soejima, Toshinori; Satouchi, Miyako; Nagakura, Hisayasu; Isobe, Hiroshi; Nishiyama, Noriaki; Harada, Masao; Ishizuka, Naoki; Tamura, Tomohide; Ohe, Yuichiro			Final overall survival (OS) analysis of a multicenter phase II study of concurrent high-dose (72Gy) three-dimensional conformal radiotherapy (3D-RT) without elective nodal irradiation with chemotherapy using cisplatin (CDDP) and vinorelbine (VNR) in patients with stage III non-small cell lung cancer (NSCLC).	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Nant Canc Ctr Hosp, Tokyo, Japan; Chiba Canc Ctr, Chiba 2608717, Japan; Natl Canc Ctr, Tokyo, Japan; Hyogo Canc Ctr, Dept Radiat Oncol, Akashi, Hyogo, Japan; Hyogo Canc Ctr, Akashi, Hyogo, Japan; KKR Sapporo Med Ctr, Sapporo, Hokkaido, Japan; KKR Sapporo Med Ctr, Dept Med Oncol, Sapporo, Hokkaido, Japan; Natl Hosp Org Hokkaido Canc Ctr, Sapporo, Hokkaido, Japan; Natl Hosp Org Hokkaido Canc Ctr, Dept Resp Med, Sapporo, Hokkaido, Japan; Canc Inst Hosp, Clin Trial Dept, Tokyo, Japan; St Lukes Int Hosp, Tokyo, Japan; Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		7526						1	Oncology	Oncology	CM9OA	WOS:000358036901656		
J	Hosomi, Y; Tanai, C; Yoh, K; Goto, Y; Ohashi, Y; Kunitoh, H				Hosomi, Yukio; Tanai, Chiharu; Yoh, Kiyotaka; Goto, Yasushi; Ohashi, Yasuo; Kunitoh, Hideo			Management of patients with epidermal growth factor receptor mutation-positive (EGFRm plus ) non-small cell lung cancer (NSCLC) after radiological progression to first-line therapy with gefitinib.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan; NTT Med Ctr, Div Respirol, Tokyo, Japan; Natl Canc Ctr Hosp East, Div Thorac Oncol, Kashiwa, Chiba, Japan; Natl Canc Ctr, Tokyo, Japan; Chuo Univ, Dept Integrated Sci & Engn Sustainable Soc, Tokyo 112, Japan; Japanese Red Cross Med Ctr, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e19124						1	Oncology	Oncology	CM9OA	WOS:000358036903964		
J	Hosomi, Y; Yoh, K; Kasahara, K; Yamada, K; Takahashi, T; Tanaka, K; Hida, T; Yoshioka, H; Kato, T; Takeda, K; Nishio, M; Sakai, H; Maemondo, M; Takenoyama, M; Nokihara, H; Tatsumi, M; Nakamura, T; Enatsu, S; Tamura, T; Nakagawa, K				Hosomi, Yukio; Yoh, Kiyotaka; Kasahara, Kazuo; Yamada, Kazuhiko; Takahashi, Toshiaki; Tanaka, Kaoru; Hida, Toyoaki; Yoshioka, Hiroshige; Kato, Terufumi; Takeda, Koji; Nishio, Makoto; Sakai, Hiroshi; Maemondo, Makoto; Takenoyama, Mitsuhiro; Nokihara, Hiroshi; Tatsumi, Masumi; Nakamura, Takashi; Enatsu, Sotaro; Tamura, Tomohide; Nakagawa, Kazuhiko			Docetaxel plus ramucirumab (DR) versus docetaxel plus placebo (D) as second-line treatment for advanced non-small cell lung cancer (NSCLC): A randomized, phase II, double-blind, multicenter trial in Japan.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan; Natl Canc Ctr Hosp East, Div Thorac Oncol, Kashiwa, Chiba, Japan; Kanazawa Univ, Grad Sch Med Sci, Dept Resp Med, Cellular Transplantat Biol, Kanazawa, Ishikawa, Japan; Kurume Univ, Sch Med, Kurume, Fukuoka 830, Japan; Shizuoka Canc Ctr, Div Thorac Oncol, Shizuoka, Japan; Kiniki Univ, Fac Med, Osaka, Japan; Aichi Canc Ctr Hosp, Dept Thorac Oncol, Nagoya, Aichi 464, Japan; Kurashiki Cent Hosp, Kurashiki, Okayama, Japan; Kanagawa Cardiovasc & Resp Ctr, Yokohama, Kanagawa, Japan; Osaka City Gen Hosp, Dept Clin Oncol, Osaka, Japan; Japanese Fdn Canc Res, Tokyo, Japan; Saitama Canc Ctr, Saitama, Japan; Miyagi Canc Ctr, Sendai, Miyagi, Japan; Kyushu Canc Ctr, Natl Hosp Org, Fukuoka, Japan; Natl Canc Ctr, Tokyo, Japan; Eli Lilly Japan, Kobe, Hyogo, Japan; Lilly Res Labs Japan, Kobe, Hyogo, Japan; St Lukes Int Hosp, Tokyo, Japan; Kinki Univ, Fac Med, Osakasayama, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		8054						1	Oncology	Oncology	CM9OA	WOS:000358036901766		
J	Hotta, K; Ninomiya, K; Oze, I; Bessho, A; Murakami, T; Sone, N; Harita, S; Nogami, N; Kuyama, S; Tanimoto, M; Kiura, K				Hotta, Katsuyuki; Ninomiya, Kiichiro; Oze, Isao; Bessho, Akihiro; Murakami, Toshi; Sone, Naoyuki; Harita, Shingo; Nogami, Naoyuki; Kuyama, Shoichi; Tanimoto, Mitsune; Kiura, Katsuyuki			Three-arm randomized trial of sodium alginate, orally administered mucoprotective agent, for preventing radiation esophagitis in pts with locally advanced non-small-cell lung cancer (LA-NSCLC) receiving concurrent chemoradiotherapy (CRT): Okayama Lung Cancer Study Group 1401.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Okayama Univ Hosp, Dept Resp Med, Okayama, Japan; Aichi Canc Ctr, Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi 464, Japan; Japanese Red Cross Okayama Hosp, Dept Internal Med, Okayama, Japan; Onomichi Municipal Hosp, Dept Resp Med, Onomichi, Japan; Kurashiki Cent Hosp, Dept Resp Med, Kurashiki, Okayama, Japan; Chugoku Cent Hosp, Fukuyama, Hiroshima, Japan; Natl Hosp Org, Shikoku Canc Ctr, Clin Res Inst, Matsuyama, Ehime, Japan; NHO Iwakuni Clin Ctr, Dept Resp Med, Iwakuni, Japan; Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Hematol Oncol & Resp Med, Okayama, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		TPS9641						1	Oncology	Oncology	CM9OA	WOS:000358036904900		
J	Ichida, K; Suzuki, K; Takayama, Y; Muto, Y; Fukui, T; Kato, T; Saito, M; Watanabe, F; Kakizawa, N; Imoto, H; Tanaka, H; Kaneda, Y; Taniyama, Y; Tsujinaka, S; Takata, O; Miyakura, Y; Noda, H; Kiyozaki, H; Konishi, F; Rikiyama, T				Ichida, Kosuke; Suzuki, Koichi; Takayama, Yuji; Muto, Yuta; Fukui, Taro; Kato, Takaharu; Saito, Masaaki; Watanabe, Fumiaki; Kakizawa, Nao; Imoto, Hirofumi; Tanaka, Hiroyuki; Kaneda, Yuji; Taniyama, Yusuke; Tsujinaka, Shingo; Takata, Osamu; Miyakura, Yasuyuki; Noda, Hiroshi; Kiyozaki, Hirokazu; Konishi, Fumio; Rikiyama, Toshiki			Detection of satellite alpha transcript in sera, as a surrogate marker for the risk of development of multiple cancers in colorectal cancer patients.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Jichi Med Univ, Saitama Med Ctr, Saitama, Japan; Jichi Med Univ, Saitama Med Ctr, Dept Surg, Saitama, Japan; Nerima Hikarigtaoka Hosp, Dept Surg, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e22044						1	Oncology	Oncology	CM9OA	WOS:000358036904446		
J	Ichikawa, W; Uehara, K; Minamimura, K; Tanaka, C; Takii, Y; Miyauchi, H; Sadahiro, S; Shinozaki, K; Fukumoto, K; Otsuji, T; Kambara, T; Morita, S; Ando, Y; Okutani, Y; Sugihara, M; Sugiyama, T; Ohashi, Y; Sakata, Y				Ichikawa, Wataru; Uehara, Keisuke; Minamimura, Keisuke; Tanaka, Chihiro; Takii, Yasumasa; Miyauchi, Hideaki; Sadahiro, Sotaro; Shinozaki, Katsunori; Fukumoto, Kanehisa; Otsuji, Toshio; Kambara, Takeshi; Morita, Satoshi; Ando, Yuichi; Okutani, Yukihiro; Sugihara, Masahiro; Sugiyama, Toru; Ohashi, Yasuo; Sakata, Yuh			Impact of UGT1A1 genotype on prognosis in Japanese advanced colorectal cancer patients treated by irinotecan-based regimens.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Showa Univ, Sch Med, Div Med Oncol, Tokyo 142, Japan; Nagoya Univ, Grad Sch Med, Dept Surg Oncol, Nagoya, Aichi 4648601, Japan; Mitsui Mem Hosp, Tokyo 101, Japan; Gifu Prefectural Gen Med Ctr, Gifu, Japan; Niigata Canc Ctr Hosp, Dept Surg, Niigata, Japan; Chiba Univ, Grad Sch Med, Chiba, Japan; Tokai Univ, Hiratsuka, Kanagawa 25912, Japan; Hiroshima Prefectural Hosp, Hiroshima, Japan; Nishijin Hosp, Dept Surg, Kyoto, Japan; Dongo Hosp, Yamatotakada, Japan; Chugoku Cent Hosp, Japan Mutual Aid Assoc, Publ Sch Teachers, Fukuyama, Hiroshima, Japan; Kyoto Univ, Grad Sch Med, Dept Biomed Stat & Bioinformat, Kyoto, Japan; Nagoya Univ Hosp, Dept Clin Oncol & Chemotherapy, Nagoya, Aichi, Japan; Daiichi Sankyo Co Ltd, Tokyo, Japan; Iwate Med Univ, Morioka, Iwate 020, Japan; Chuo Univ, Dept Integrated Sci & Engn Sustainable Soc, Tokyo 112, Japan; Misawa City Hosp, Misawa, Japan			Ando, Yuichi/Q-1418-2015	Ando, Yuichi/0000-0002-6849-2297				0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		3525						1	Oncology	Oncology	CM9OA	WOS:000358036900745		
J	Ichimura, T; Chin, K; Shinozaki, E; Suenaga, M; Ogura, M; Matsushima, T; Mizunuma, N				Ichimura, Takashi; Chin, Keisho; Shinozaki, Eiji; Suenaga, Mitsukuni; Ogura, Mariko; Matsushima, Tomohiro; Mizunuma, Nobuyuki			The long term survival benefit of salvage chemoradiotherapy for local recurrence of esophageal cancer after curative surgery	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					JFCR, Canc Inst Hosp, Tokyo, Japan; JFCR, Canc Inst Hosp, Dept Gastroenterol, Tokyo, Japan; Canc Inst Hosp, Tokyo, Japan; JFCR, Canc Inst Hosp, Koto Ku, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e15041						1	Oncology	Oncology	CM9OA	WOS:000358036902827		
J	Iguchi, H; Nogami, N; Kozuki, T; Matsumoto, T; Tamura, K; Yamamoto, N; Shimomura, A; Hoshino, Y; Michibata, Y; Nii, M; Fujiwara, Y				Iguchi, Haruo; Nogami, Naoyuki; Kozuki, Toshiyuki; Matsumoto, Toshihiko; Tamura, Kenji; Yamamoto, Noboru; Shimomura, Akihiko; Hoshino, Yuji; Michibata, Yoshiko; Nii, Masahiro; Fujiwara, Yutaka			Phase I study to evaluate the safety and tolerability of MEDI4736, an anti-programmed cell death ligand-1 (PD-L1) antibody, in Japanese patients with advanced solid tumors.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Natl Hosp Org, Shikoku Canc Ctr, Clin Res Inst, Matsuyama, Ehime, Japan; Natl Canc Ctr, Tokyo, Japan; Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Tokyo 104, Japan; Natl Canc Ctr, Chuo Ku, Tokyo, Japan; AstraZeneca, Osaka, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		3039						1	Oncology	Oncology	CM9OA	WOS:000358036900673		
J	Ikeda, M; Shimizu, S; Sato, T; Morimoto, M; Inaba, Y; Kojima, Y; Hagihara, A; Kudo, M; Nakamori, S; Kaneko, S; Sugimoto, R; Tahara, T; Ohmura, T; Yasui, K; Sato, K; Ishii, H; Furuse, J; Okusaka, T				Ikeda, Masafumi; Shimizu, Satoshi; Sato, Tosiya; Morimoto, Manabu; Inaba, Yoshitaka; Kojima, Yasushi; Hagihara, Atsushi; Kudo, Masatoshi; Nakamori, Shoji; Kaneko, Shuichi; Sugimoto, Rie; Tahara, Toshiyuki; Ohmura, Takumi; Yasui, Kohichiroh; Sato, Keiko; Ishii, Hiroshi; Furuse, Junji; Okusaka, Takuji			Sorafenib plus intra-arterial cisplatin versus sorafenib alone in patients with advanced hepatocellular carcinoma: A randomized phase II trial.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, Japan; Kyoto Univ, Sch Publ Hlth, Dept Biostat, Kyoto, Japan; Kanagawa Canc Ctr, Dept Hepatobiliary & Pancreat Med Oncol, Yokohama, Kanagawa 2410815, Japan; Aichi Canc Ctr Hosp, Dept Intervent & Diagnost Radiol, Nagoya, Aichi 464, Japan; Natl Ctr Global Hlth & Med, Tokyo, Japan; Osaka City Univ Hosp, Dept Hepatol, Osaka, Japan; Kinki Univ, Sch Med, Dept Gastroenterol & Hepatol, Osaka, Japan; Osaka Natl Hosp, Dept Hepatobiliary & Pancreat Surg, Osaka, Japan; Kanazawa Univ Hosp, Dept Gastroenterol, Kanazawa, Ishikawa, Japan; Natl Hosp Org, Kyushu Canc Ctr, Dept Hepatobiliary Pancreatol, Fukuoka, Japan; Saiseikai Utsunomiya Hosp, Dept Gastroenterol, Utsunomiya, Tochigi, Japan; Sapporo Kosei Gen Hosp, Dept Gastroenterol, Sapporo, Hokkaido, Japan; Kyoto Prefectural Univ Med, Grad Sch Med Sci, Mol Gastroenterol & Hepatol, Kyoto, Japan; Kyoto Univ Hosp, Inst Adv Clin & Translat Sci, Kyoto 606, Japan; Shikoku Canc Ctr, Dept Med Oncol, Matsuyama, Ehime, Japan; Kyorin Univ, Sch Med, Dept Med Oncol, Tokyo, Japan; Natl Canc Ctr, Dept Hepatobiliary & Pancreat Oncol, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		4076						1	Oncology	Oncology	CM9OA	WOS:000358036900914		
J	Ikeda, M; Aramaki, T; Inaba, Y; Nakai, K; Doi, T; Okusaka, T				Ikeda, Masafumi; Aramaki, Takeshi; Inaba, Yoshitaka; Nakai, Kenya; Doi, Toshihiko; Okusaka, Takuji			Phase I study of ontuxizumab, a humanized monoclonal antibody (mAb) recognizing endosialin in Japanese patients (pts) with hepatocellular carcinoma (HCC).	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Natl Canc Ctr Hosp East, Chiba, Japan; Shizuoka Canc Ctr, Shizuoka, Japan; Aichi Canc Ctr Hosp, Dept Intervent & Diagnost Radiol, Nagoya, Aichi 464, Japan; Eisai & Co Ltd, Tokyo, Japan; Natl Canc Ctr, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		2521						1	Oncology	Oncology	CM9OA	WOS:000358036900554		
J	Ikeda, S; Kudoh, K; Sasaki, N; Takano, M; Goto, T; Kikuchi, R; Sakamoto, M; Kita, T; Susumu, N; Aoki, D; Kouta, H; Kikuchi, Y				Ikeda, Sayaka; Kudoh, Kazuya; Sasaki, Naoki; Takano, Masashi; Goto, Tomoko; Kikuchi, Ryoko; Sakamoto, Masaru; Kita, Tsunekazu; Susumu, Nobuyuki; Aoki, Daisuke; Kouta, Hiroko; Kikuchi, Yoshihiro			Synergistic effects of cabozantinib to temozolomide and bevacizumab in patients with heavily pretreated relapsed uterine leiomyosarcoma.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Tama Hokubu Med Ctr, Higashimurayama, Japan; Natl Def Med Coll, Tokorozawa, Saitama 359, Japan; Kyoundo Hosp, Tokyo, Japan; Nara Prefectural Nara Hosp, Nara, Japan; Keio Univ, Shinjuku Ku, Tokyo 108, Japan; Ohki Mem Kikuchi Canc Ctr Women, Tokorozawa, Saitama, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		5590						1	Oncology	Oncology	CM9OA	WOS:000358036901257		
J	Ikeda, Y; Takano, M; Kouta, H; Kudoh, K; Kita, T; Kikuchi, R; Miyamoto, M; Yoshikawa, T; Goto, T; Furuya, K; Tamada, Y; Suga, A; Kikuchi, Y				Ikeda, Yuji; Takano, Masashi; Kouta, Hiroko; Kudoh, Kazuya; Kita, Tsunekazu; Kikuchi, Ryoko; Miyamoto, Morikazu; Yoshikawa, Tomoyuki; Goto, Tomoko; Furuya, Kenichi; Tamada, Yutaka; Suga, Arata; Kikuchi, Yoshihiro			Weekly administration of bevacizumab, eribulin, and oxalilplatin in patients with platinum-resistant ovarian carcinomas: A phase II study with biomarker analysis.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Univ Tokyo, Tokyo, Japan; Natl Def Med Coll, Tokorozawa, Saitama 359, Japan; Ohki Mem Kikuchi Canc Ctr Women, Tokorozawa, Saitama, Japan; Tama Hokubu Med Ctr, Higashimurayama, Japan; Nara Prefectural Nara Hosp, Nara, Japan; Kyoundo Hosp, Tokyo, Japan; Tachikawa Hosp, Tachikawa, Tokyo, Japan; Koshigaya City Hosp, Koshigaya, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		5603						1	Oncology	Oncology	CM9OA	WOS:000358036901271		
J	Imai, K; Allard, MA; Benitez, CC; Vibert, E; Cunha, AS; Cherqui, D; Castaing, D; Baba, H; Adam, R				Imai, Katsunori; Allard, Marc Antoine; Benitez, Carlos Castro; Vibert, Eric; Cunha, Antonio Sa; Cherqui, Daniel; Castaing, Denis; Baba, Hideo; Adam, Rene			A simplified nomogram to predict long-term survival after conversion chemotherapy followed by hepatectomy for initially unresectable colorectal liver metastases	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Hop Paul Brousse, AP HP, Ctr Hepatobiliaire, Villejuif, France; Kumamoto Univ, Dept Surg Gastroenterol, Grad Sch Med Sci, Kumamoto, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		3551						1	Oncology	Oncology	CM9OA	WOS:000358036900770		
J	Imai, K; Benitez, CC; Allard, MA; Vibert, E; Cunha, AS; Cherqui, D; Castaing, D; Baba, H; Adam, R				Imai, Katsunori; Benitez, Carlos Castro; Allard, Marc Antoine; Vibert, Eric; Cunha, Antonio Sa; Cherqui, Daniel; Castaing, Denis; Baba, Hideo; Adam, Rene			Two-stage hepatectomy for extensive colorectal liver metastases: How to predict the failure to complete both sequential procedures?	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Hop Paul Brousse, AP HP, Ctr Hepatobiliaire, Villejuif, France; Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Kumamoto, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		3559						1	Oncology	Oncology	CM9OA	WOS:000358036900778		
J	Innocenti, F; Owzar, K; Jiang, C; Sibley, A; Niedzwiecki, D; Lenz, HJ; Bertagnolli, MM; Friedman, PN; Furukawa, Y; Kubo, M; Ratain, MJ; Blanke, CD; Venook, AP; McLeod, HL				Innocenti, Federico; Owzar, Kouros; Jiang, Chen; Sibley, Alexander; Niedzwiecki, Donna; Lenz, Heinz-Josef; Bertagnolli, Monica M.; Friedman, Paula N.; Furukawa, Yoichi; Kubo, Michiaki; Ratain, Mark J.; Blanke, Charles David; Venook, Alan P.; McLeod, Howard L.			A genome-wide association study (GWAS) of overall survival (OS) in 609 metastatic colorectal cancer (mCRC) patients treated with chemotherapy and biologics in CALGB 80405	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Univ N Carolina, Chapel Hill, NC USA; Duke Univ, Alliance Stat & Data Ctr, Durham, NC USA; Duke Univ Med Ctr, Durham, NC USA; Duke Canc Inst, Durham, NC USA; Duke Univ, Cary, NC USA; Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Univ Chicago, Chicago, IL 60637 USA; Univ Tokyo, Inst Med Sci, Na, Japan; RIKEN, Ctr Genom Med, Yokohama, Kanagawa, Japan; Oregon Hlth & Sci Univ, Portland, OR 97201 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		3599						1	Oncology	Oncology	CM9OA	WOS:000358036900818		
J	Inomata, K; Yagi, H; Shinoda, M; Matsubara, K; Hibi, T; Abe, Y; Kitago, M; Obara, H; Itano, O; Kitagawa, Y				Inomata, Kenta; Yagi, Hiroshi; Shinoda, Masahiro; Matsubara, Kentaro; Hibi, Taizo; Abe, Yuta; Kitago, Minoru; Obara, Hideaki; Itano, Osamu; Kitagawa, Yuko			Efficacy of locoregional treatment for hepatocellular carcinoma prior to living donor liver transplantation	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Keio Univ, Sch Med, Dept Surg, Shinjuku Ku, Tokyo 160, Japan; Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e15131						1	Oncology	Oncology	CM9OA	WOS:000358036902904		
J	Inoue, K; Tsubamoto, H; Sonoda, T; Ikuta, S; Tani, S; Yamanaka, N				Inoue, Kayo; Tsubamoto, Hiroshi; Sonoda, Takashi; Ikuta, Shinichi; Tani, Satoshi; Yamanaka, Naoki			Efficacy of combination chemotherapy with itraconazole for treating metastatic pancreatic cancer in the second-line setting.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Meiwa Hosp, Dept Med Oncol, Nishinomiya, Hyogo, Japan; Kohnan Hosp, Dept Med Oncol, Kobe, Hyogo, Japan; Meiwa Hosp, Dept Surg, Nishinomiya, Hyogo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e15255						1	Oncology	Oncology	CM9OA	WOS:000358036903015		
J	Ioka, T; Kanai, M; Kobayashi, S; Sakai, D; Kitasato, A; Yamaue, H; Hayashi, H; Chayahara, N; Takahashi, M; Yamada, T; Hatano, E; Goto, T; Fujimoto, J; Murakami, M; Kamei, K; Yoshimura, K				Ioka, Tatsuya; Kanai, Masashi; Kobayashi, Shogo; Sakai, Daisuke; Kitasato, Amane; Yamaue, Hiroki; Hayashi, Hideyuki; Chayahara, Naoko; Takahashi, Masahiro; Yamada, Takatsugu; Hatano, Etsuro; Goto, Takuma; Fujimoto, Jiro; Murakami, Masahiro; Kamei, Keiko; Yoshimura, Kenichi		KHBO1401-MITSUBA Study Grp	Randomised phase III study of gemcitabine, cisplatin plus S-1 (GCS) compared with gemcitabine plus cisplatin (GC) for unresectable or recurrent biliary tract cancer (KHBO1401-MITSUBA).	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Osaka Med Ctr Canc & Cardiovasc Dis, Hepatobiliary & Pancreat Oncol, Osaka, Japan; Kyoto Univ, Dept Clin Oncol & Pharmacogen, Grad Sch Med, Kyoto, Japan; Osaka Univ, Grad Sch Med, Dept Surg, Osaka, Japan; Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Osaka, Japan; Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg, Nagasaki 852, Japan; Wakayama Med Univ, Dept Surg 2, Wakayama, Japan; Hokkaido Univ Hosp, Dept Gastroenterol & Hepatol, Sapporo, Hokkaido 060, Japan; Kobe Univ Hosp, Dept Med, Div Med Oncol Hematol, Kobe, Hyogo, Japan; Grad Sch Med, Kobe, Hyogo, Japan; Tohoku Univ Hosp, Dept Clin Oncol, Sendai, Miyagi, Japan; Nara Med Univ, Dept Surg, Kashihara, Nara 634, Japan; Kyoto Univ Hosp, Kyoto 606, Japan; Asahikawa Med Coll, Div Gastroenterol & Hematol Oncol, Asahikawa, Hokkaido 078, Japan; Hyogo Coll Med, Dept Surg, Nishinomiya, Hyogo 6638501, Japan; Osaka Rosai Hosp, Dept Surg, Sakai, Osaka, Japan; Kinki Univ, Dept Surg, Fac Med, Osakasayama, Japan; Kanazawa Univ, Kanazawa, Ishikawa, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		TPS4141						1	Oncology	Oncology	CM9OA	WOS:000358036904749		
J	Ishii, M; Suehara, Y; Akaike, K; Mukaihara, K; Kubota, D; Okubo, T; Takagi, T; Yao, T; Kaneko, K; Saito, T				Ishii, Midori; Suehara, Yoshiyuki; Akaike, Keisuke; Mukaihara, Kenta; Kubota, Daisuke; Okubo, Taketo; Takagi, Tatsuya; Yao, Takashi; Kaneko, Kazuo; Saito, Tsuyoshi			Clinicopathological impact of protein phosphatase 2, regulatory subunit A, alpha mutations in gastrointestinal stromal tumors.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Juntendo Univ, Sch Med, Dept Orthopaed Surg, Tokyo 113, Japan; Juntendo Univ, Sch Med, Dept Human Pathol, Tokyo 113, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		10536						1	Oncology	Oncology	CM9OA	WOS:000358036900173		
J	Isobe, K; Hata, Y; Tochigi, N; Kakimoto, A; Mikami, T; Kaburaki, K; Makino, T; Otsuka, H; Sano, G; Sugino, K; Sakamoto, S; Takai, Y; Shibuya, K; Iyoda, A; Homma, S				Isobe, Kazutoshi; Hata, Yoshinobu; Tochigi, Naobumi; Kakimoto, Atsushi; Mikami, Tetsuo; Kaburaki, Kyohei; Makino, Takashi; Otsuka, Hahjime; Sano, Go; Sugino, Keishi; Sakamoto, Susumu; Takai, Yujiro; Shibuya, Kazutoshi; Iyoda, Akira; Homma, Sakae			BIM deletion polymorphism is not associated with BIM RNA expression or BIM immunohistochemistry intensity in epidermal growth factor receptor mutationpositive nonsmall cell lung cancer.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Toho Univ, Omori Med Ctr, Tokyo, Japan; Toho Univ, Omori Med Ctr, Dept Chest Surg, Tokyo, Japan; Toho Univ, Omori Med Ctr, Dept Surg Pathol, Tokyo, Japan; Toho Univ, Omori Med Ctr, Dept Resp Med, Tokyo, Japan; Toho Univ, Sch Med, Dept Pathol, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e22045						1	Oncology	Oncology	CM9OA	WOS:000358036904447		
J	Isozaki, H; Ichihara, E; Takigawa, N; Sendo, T; Tanimoto, M; Kiura, K				Isozaki, Hideko; Ichihara, Eiki; Takigawa, Nagio; Sendo, Toshiaki; Tanimoto, Mitsune; Kiura, Katsuyuki			Crizotinib to overcome alectinib-resistance in non-small cell lung cancer (NSCLC) harboring EML4-ALK.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Okayama Univ, Dept Hematol Oncol & Resp Med, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan; Kawasaki Med Univ, Dept Gen Internal Med 4, Okayama, Japan; Okayama Univ Hosp, Dept Resp Med, Okayama, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e19140						1	Oncology	Oncology	CM9OA	WOS:000358036903979		
J	Ito, T; Orita, H; Maekawa, H; Sakurada, M; Kushida, T; Senuma, K; Mizuguchi, K; Sato, K				Ito, Tomoaki; Orita, Hajime; Maekawa, Hiroshi; Sakurada, Mutsumi; Kushida, Tomoyuki; Senuma, Koji; Mizuguchi, Konomi; Sato, Koichi			Elevated levels of serum fatty acid synthase in patients with colorectal cancer.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					[Ito, Tomoaki; Orita, Hajime; Maekawa, Hiroshi; Sakurada, Mutsumi; Kushida, Tomoyuki; Senuma, Koji; Mizuguchi, Konomi; Sato, Koichi] Juntendo Univ, Shizuoka Hosp, Dept Surg, Izunokuni, Shizuoka, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e14540						1	Oncology	Oncology	CM9OA	WOS:000358036902661		
J	Iwamoto, M; Nakamura, F; Higashi, T				Iwamoto, Momoko; Nakamura, Fumiaki; Higashi, Takahiro			Variations in treatment practices among pediatric solid tumor patients in Japan.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Natl Canc Ctr, Minato Ku, Tokyo 104, Japan; Univ Tokyo, Grad Sch Med, Dept Publ Hlth Hlth Policy, Tokyo, Japan; Natl Canc Ctr, Div Hlth Serv Res, Ctr Canc Control & Informat Serv, Tokyo 104, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e17656						1	Oncology	Oncology	CM9OA	WOS:000358036903611		
J	Iwase, S; Kawaguchi, T; Miyaji, T; Ishiki, H; Ariyoshi, K; Yamaguchi, T				Iwase, Satoru; Kawaguchi, Takashi; Miyaji, Tempei; Ishiki, Hiroto; Ariyoshi, Keisuke; Yamaguchi, Takuhiro			Assessment of cancer-related fatigue, pain, and quality of life in cancer patients after palliative care team referral: A multicenter observational study (JORTC PAL-09).	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Univ Tokyo, Inst Med Sci, Res Hosp, Tokyo, Japan; Tokyo Univ Pharm & Life Sci, Dept Pract Pharm, Tokyo, Japan; JORTC, Tokyo, Japan; Univ Tokyo, Inst Med Sci, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e20550						1	Oncology	Oncology	CM9OA	WOS:000358036904177		
J	Iwase, T; Sangai, T; Fujimoto, H; Sakakibara, M; Nagashima, T; Miyazaki, M				Iwase, Toshiaki; Sangai, Takafumi; Fujimoto, Hiroshi; Sakakibara, Masahiro; Nagashima, Takeshi; Miyazaki, Masaru			The impact of body fat distribution on neo-adjuvant chemotherapy for advanced breast cancer.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Chiba Univ, Grad Sch Med, Dept Gen Surg, Chiba, Japan; Chiba Univ, Grad Sch Med, Chiba, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e11517						1	Oncology	Oncology	CM9OA	WOS:000358036902145		
J	Kainuma, O; Miura, F; Furukawa, D; Yamamoto, H; Cho, A; Nakagori, T; Sano, K; Asano, T				Kainuma, Osamu; Miura, Fumihiko; Furukawa, Daisuke; Yamamoto, Hiroshi; Cho, Akihiro; Nakagori, Toshio; Sano, Keiji; Asano, Takehide			Feasibility and efficacy study of gemcitabine plus cisplatin combination therapy after curative resection for biliary tract cancer	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Chiba Canc Ctr, Dept Surg Gastroenterol, Chiba 2608717, Japan; Teikyo Univ, Sch Med, Dept Surg, Tokyo 173, Japan; Tokai Univ, Sch Med, Dept Surg, Isehara, Kanagawa 25911, Japan; Tokai Univ, Sch Med, Dept Gastroentel Surg, Isehara, Kanagawa 25911, Japan; Chiba East Hosp, Natl Hosp Org, Dept Surg, Chiba, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e15148						1	Oncology	Oncology	CM9OA	WOS:000358036902917		
J	Kaira, K; Toyoda, M; Ohshima, Y; Oriuchi, N; Kanai, Y; Oyama, T; Yamada, M; Asao, T; Chikamatsu, K				Kaira, Kyoichi; Toyoda, Minoru; Ohshima, Yasuhiro; Oriuchi, Noboru; Kanai, Yoshikatsu; Oyama, Tetsunari; Yamada, Masanobu; Asao, Takayuki; Chikamatsu, Kazuaki			Clinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in tongue cancer.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Gunma Univ, Grad Sch Med, Dept Oncol Clin Dev, Gunma, Japan; Gunma Univ Hosp, Dept Otolaryngol Head & Neck Surg, Gunma, Japan; Japan Atom Energy Agcy, Med Radioisotope Applicat Grp, Quantum Beam Sci Directorate, Gunma, Japan; Gunma Univ, Dept Diagnost Radiol & Nucl Med, Grad Sch Med, Maebashi, Gumma 371, Japan; Osaka Univ, Grad Sch Med, Div Biosyst Pharmacol, Osaka, Japan; Gunma Univ, Div Diagnost Pathol, Grad Sch Med, Maebashi, Gumma 371, Japan; Gunma Univ, Dept Med & Mol Sci, Grad Sch Med, Gunma, Japan; Gunma Univ, Dept Oncol Clin Dev, Grad Sch Med, Gunma, Japan; Gunma Univ Hosp, Dept Otolaryngol Head & Neck Surg, Gunma, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e22204						1	Oncology	Oncology	CM9OA	WOS:000358036904579		
J	Kakeji, Y; Kodera, Y; Yoshida, K; Kochi, M; Takahashi, M; Kii, T; Ishiguro, A; Ishigure, K; Takagane, A; Matsui, T; Kaji, M; Ichikawa, W; Sano, T; Takeuchi, M; Fujii, M; Nakajima, T				Kakeji, Yoshihiro; Kodera, Yasuhiro; Yoshida, Kazuhiro; Kochi, Mitsugu; Takahashi, Masazumi; Kii, Takayuki; Ishiguro, Atsushi; Ishigure, Kiyoshi; Takagane, Akinori; Matsui, Takanori; Kaji, Masahide; Ichikawa, Wataru; Sano, Takeshi; Takeuchi, Masahiro; Fujii, Masashi; Nakajima, Toshifusa			Pre-planned feasibility and safety analyses of docetaxel/S-1 combination in a phase III study comparing docetaxel/S-1 with S-1 alone as postoperative adjuvant chemotherapy for stage III gastric cancer (JACCRO GC-07).	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Kobe Univ, Grad Sch Med, Dept Surg, Div Gastrointestinal Surg, Kobe, Hyogo 657, Japan; Nagoya Univ, Grad Sch Med, Dept Surg Gastroenterol, Nagoya, Aichi 4648601, Japan; Gifu Univ, Sch Med, Gifu 500, Japan; Nihon Univ, Sch Med, Tokyo, Japan; Yokohama Municipal Citizens Hosp, Yokohama, Kanagawa, Japan; Osaka Med Coll Hosp, Ctr Canc Chemotherapy, Osaka, Japan; Teine Keijinkai Hosp, Sapporo, Hokkaido, Japan; Konan Kosei Hosp, Konan, Japan; Hakodate Goryokaku Hosp, Hakodate, Hokkaido, Japan; Aichi Canc Ctr Hosp, Okazaki, Aichi, Japan; Toyama Prefectural Cent Hosp, Toyama, Japan; Showa Univ, Tokyo, Japan; Japanese Fdn Canc Res, Canc Inst Hosp, Dept Surg Gastroenterol, Tokyo, Japan; Kitasato Univ, Tokyo, Japan; Japan Clin Canc Res Org, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e15000						1	Oncology	Oncology	CM9OA	WOS:000358036902792		
J	Kantarjian, HM; Jabbour, E; Garcia-Manero, G; Kadia, TM; Dinardo, CD; Daver, NG; Borthakur, G; Jain, N; Waukau, J; Kwari, M; Anderson, BD; Iizuka, K; Jin, C; Plunkett, W				Kantarjian, Hagop M.; Jabbour, Elias; Garcia-Manero, Guillermo; Kadia, Tapan M.; Dinardo, Courtney Denton; Daver, Naval Guastad; Borthakur, Gautam; Jain, Nitin; Waukau, Jane; Kwari, Monica; Anderson, Barry Douglas; Iizuka, Kenzo; Jin, Cheng; Plunkett, William			First report of a phase I/II study of DFP-10917, a nucleoside analog, given by continuous infusion (CI) in patients (pts) with relapsed or refractory acute leukemia.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; Theradex, Princeton, NJ USA; Delta Fly Pharma Inc, Tokushima, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		7077						1	Oncology	Oncology	CM9OA	WOS:000358036901613		
J	Kashii, T; Tanabe, K; Kajiura, S; Miwa, T				Kashii, Tatsuhiko; Tanabe, Kouichi; Kajiura, Shinya; Miwa, Toshiro			The relationship between carnitine pharmacokinetics and fatigue in patients treated with cisplatin-containing chemotherapy.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Toyama Univ Hosp, Toyama, Japan; Toyama Univ, Fac Med, Dept Gastroenterol & Hematol, Toyama 930, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e20545						1	Oncology	Oncology	CM9OA	WOS:000358036904173		
J	Kataoka, A; Tokunaga, E; Masuda, N; Shien, T; Miyashita, M; Kawabata, K; Tomotaki, A; Miyata, H; Kinoshita, T; Tokuda, Y				Kataoka, Akemi; Tokunaga, Eriko; Masuda, Norikazu; Shien, Tadahiko; Miyashita, Mika; Kawabata, Kimiko; Tomotaki, Ai; Miyata, Hiroaki; Kinoshita, Takayuki; Tokuda, Yutaka			Results of prognostic analysis of young breast cancer patients (< 35 years of age) based on the Breast Cancer Registry of the Japanese Breast Cancer Society	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Japanese Fdn Canc Res, Canc Inst Hosp, Tokyo, Japan; Kyushu Univ, Dept Comprehens Clin Oncol, Fukuoka 812, Japan; Natl Hosp Org Osaka Natl Hosp, Osaka, Japan; Okayama Univ, Okayama, Japan; Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan; Saitama Prefectural Univ, Saitama, Japan; Univ Tokyo, Grad Sch Med, Dept Healthcare Qual Assessment, Tokyo, Japan; Natl Canc Ctr, Tokyo, Japan; Tokai Univ, Sch Med, Hiratsuka, Kanagawa 25912, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e12599						1	Oncology	Oncology	CM9OA	WOS:000358036902402		
J	Kato, M; Manabe, A; Ishimaru, S; Seki, M; Yoshida, K; Tomizawa, D; Hasegawa, D; Inukai, T; Arakawa, Y; Aoki, T; Okuya, M; Kaizu, K; Kato, K; Taneyama, Y; Ogawa, S; Koh, K; Tsuchida, M; Ohara, A				Kato, Motohiro; Manabe, Atsushi; Ishimaru, Sae; Seki, Masafumi; Yoshida, Kenichi; Tomizawa, Daisuke; Hasegawa, Daisuke; Inukai, Takeshi; Arakawa, Yuki; Aoki, Takahiro; Okuya, Mayuko; Kaizu, Kiyohiko; Kato, Keisuke; Taneyama, Yuichi; Ogawa, Seishi; Koh, Katsuyoshi; Tsuchida, Masahiro; Ohara, Akira			Long-term outcome of six months maintenance chemotherapy for ALL in children: TCCSG L92-13E study.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Univ Tokyo, Tokyo, Japan; St Lukes Int Hosp, Tokyo, Japan; Metropolitan Childrens Med Ctr, Tokyo, Japan; Natl Ctr Child Hlth & Dev, Tokyo, Japan; Univ Yamanashi, Tokyo, Japan; Saitama Childrens Med Ctr, Saitama, Japan; Dokkyo Med Univ, Shimotsuga, Japan; Nippon Med Univ, Tokyo, Japan; Ibaraki Childrens Hosp, Mito, Ibaraki, Japan; Chiba Childrens Hosp, Chiba, Japan; Kyoto Univ, Dept Pathol & Tumor Biol, Kyoto, Japan; Toho Univ, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		10032						1	Oncology	Oncology	CM9OA	WOS:000358036900038		
J	Katsuya, H; Shimokawa, M; Ishitsuka, K; Kawai, K; Amano, M; Utsunomiya, A; Hino, R; Hanada, S; Jo, T; Tsukasaki, K; Moriuchi, Y; Sueoka, E; Yoshida, S; Suzushima, H; Miyahara, M; Yamashita, K; Eto, T; Yamanaka, T; Suzumiya, J; Tamura, K				Katsuya, Hiroo; Shimokawa, Mototsugu; Ishitsuka, Kenji; Kawai, Kazuhiro; Amano, Masahiro; Utsunomiya, Atae; Hino, Ryosuke; Hanada, Shuichi; Jo, Tatsuro; Tsukasaki, Kunihiro; Moriuchi, Yukiyoshi; Sueoka, Eisaburo; Yoshida, Shinichiro; Suzushima, Hitoshi; Miyahara, Masaharu; Yamashita, Kiyoshi; Eto, Tetsuya; Yamanaka, Takeharu; Suzumiya, Junji; Tamura, Kazuo			Prognostic index for chronic and smoldering types adult T-cell leukemia/lymphoma.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Fukuoka Univ, Fukuoka 81401, Japan; Kyushu Natl Canc Ctr, Fukuoka, Japan; Kagoshima Univ, Grad Sch Med & Dent Sci, Kagoshima 890, Japan; Miyazaki Univ, Miyazaki, Japan; Imamura Bun In Hosp, Kagoshima, Japan; Univ Occupat & Environm Hlth, Kitakyushu, Fukuoka 807, Japan; Natl Hosp Org, Kagoshima Med Ctr, Kagoshima, Japan; Nagasaki Genbaku Hosp, Japanese Red Cross Soc, Nagasaki, Japan; Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 852, Japan; Sasebo City Gen Hosp, Sasebo, Japan; Saga Univ, Saga 840, Japan; Natl Hosp Org, Nagasaki Med Ctr, Ohmura, Japan; Kumamoto Shinto Gen Hosp, Kumamoto, Japan; Karatsu Red Cross Hosp, Karatsu, Japan; Miyazaki Prefectural Hosp, Miyazaki, Japan; Hamanomachi Hosp, Fukuoka, Japan; Yokohama City Univ, Yokohama, Kanagawa 232, Japan; Shimane Univ Hosp, Izumo, Shimane, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		8522						1	Oncology	Oncology	CM9OA	WOS:000358036901834		
J	Katsuya, Y; Horinouchi, H; Asao, T; Kitahara, S; Sunami, K; Seki, Y; Goto, Y; Kanda, S; Fujiwara, Y; Nokihara, H; Yamamoto, N; Tsuta, K; Watanabe, S; Ohe, Y				Katsuya, Yuki; Horinouchi, Hidehito; Asao, Tetsuhiko; Kitahara, Shinsuke; Sunami, Kuniko; Seki, Yoshitaka; Goto, Yasushi; Kanda, Shintaro; Fujiwara, Yutaka; Nokihara, Hiroshi; Yamamoto, Noboru; Tsuta, Koji; Watanabe, Shun-ichi; Ohe, Yuichiro			Programmed cell death 1 (PD-1) and its ligand (PD-L1) expression in thymic epithelial tumors (TETs): Impact on the treatment efficacy and alteration in expression after chemotherapy (C).	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Natl Canc Ctr, Tokyo, Japan; Nant Canc Ctr Hosp, Tokyo, Japan; Natl Canc Ctr, Dept Thorac Oncol, Tokyo, Japan; Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Tokyo 104, Japan; Natl Canc Ctr, Div Pathol, Tokyo, Japan; Natl Canc Ctr, Div Thorac Surg, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		7515						1	Oncology	Oncology	CM9OA	WOS:000358036901645		
J	Kawamoto, H; Yasui, N; Kawakubo, N; Nitani, C; Yoshimura, K; Kitano, S; Yoshimura, K; Kimura, T; Sato, A; Sasahara, Y; Taguchi, T; Hara, J				Kawamoto, Hiroshi; Yasui, Naoko; Kawakubo, Naonori; Nitani, Chika; Yoshimura, Kenichi; Kitano, Shigehisa; Yoshimura, Kiyoshi; Kimura, Toshimi; Sato, Akihiro; Sasahara, Yoji; Taguchi, Tomoaki; Hara, Junichi			Result of phase I/IIa multicenter trial for high risk and recurrent neuroblastoma: anti-GD2 antibody (dinutuximab) immunotherapies using M-CSF or G-CSF.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Natl Canc Ctr, Tokyo, Japan; Kyushu Univ, Fukuoka 812, Japan; Osaka City Gen Hosp, Osaka, Japan; Kanazawa Univ, Kanazawa, Ishikawa, Japan; Natl Canc Ctr, Dept Expt Therapeut, Div Canc Immunotherapy Exploratory Oncol Res, Tokyo, Japan; Natl Canc Ctr, Clin Trial Ctr, Natl Canc Ctr, Tokyo, Japan; Natl Canc Ctr, Tokyo 104, Japan; Tokyo Womens Med Univ, Tokyo, Japan; Natl Canc Ctr, Ctr Res Adm & Support, Kashiwa, Chiba, Japan; Tohoku Univ Hosp, Sendai, Miyagi, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e21018						1	Oncology	Oncology	CM9OA	WOS:000358036904357		
J	Kawamura, T; Kenmotsu, H; Wakuda, K; Ono, A; Taira, T; Naito, T; Murakami, H; Ohde, Y; Endo, M; Takahashi, T				Kawamura, Takahisa; Kenmotsu, Hirotsugu; Wakuda, Kazushige; Ono, Akira; Taira, Tetsuhiko; Naito, Tateaki; Murakami, Haruyasu; Ohde, Yasuhisa; Endo, Masahiro; Takahashi, Toshiaki			Rebiopsy rate for non-small cell lung cancer patients after EGFR-TKI failure in clinical setting: Toward the third-generation EGFR-TKI era.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Shizuoka Canc Ctr, Div Thorac Oncol, Shizuoka, Japan; Shizuoka Canc Ctr, Div Diagnost Radiol, Shizuoka, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e19080						1	Oncology	Oncology	CM9OA	WOS:000358036903927		
J	Kimura, T; Taniguchi, H; Ogasawara, T; Kondo, M; Suzuki, R; Yamamoto, M; Shindo, J; Hataji, O; Yoshida, N; Kojima, E; Hasegawa, Y; Saito, H				Kimura, Tomoki; Taniguchi, Hiroyuki; Ogasawara, Tomohiko; Kondo, Masashi; Suzuki, Ryujiro; Yamamoto, Masashi; Shindo, Joe; Hataji, Osamu; Yoshida, Norio; Kojima, Eiji; Hasegawa, Yoshinori; Saito, Hiroshi			Pemetrexed (Pem), carboplatin (Cb), and bevacizumab (Bev) in patients with nonsquamous NSCLC without or with activating EGFR mutation (CJLSG0909/0910).	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Tosei Gen Hosp, Seto, Japan; Red Cross Nagoya Daini Hosp, Nagoya, Aichi, Japan; Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4648601, Japan; Toyohashi Municipal Hosp, Toyohashi, Aichi, Japan; Nagoya Ekisaikai Hosp, Nagoya, Aichi, Japan; Ogaki Municipal Hosp, Ogaki, Japan; Matsusaka Municipal Hosp, Matsusaka, Japan; Kariya Toyota Gen Hosp, Kariya, Aichi, Japan; Komaki Municipal Hosp, Komaki, Japan; Nagoya Univ, Dept Resp Med, Grad Sch Med, Nagoya, Aichi 4648601, Japan; Aichi Hosp, Dept Resp Med, Aichi Canc Ctr, Okazaki, Aichi, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e19038						1	Oncology	Oncology	CM9OA	WOS:000358036903894		
J	Kinoshita, T; Yamamoto, N; Fujisawa, T; Takahashi, M; Doihara, H; Aogi, K; Wada, N				Kinoshita, Takayuki; Yamamoto, Naohito; Fujisawa, Tomomi; Takahashi, Masato; Doihara, Hiroyoshi; Aogi, Kenjiro; Wada, Noriaki			A multi-center prospective study of radiofrequency ablation without surgical excision for small breast carcinomas.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Natl Canc Ctr, Tokyo, Japan; Chiba Canc Ctr, Chiba 2608717, Japan; Gunma Prefectural Canc Ctr, Dept Breast Oncol, Gunma, Japan; Natl Hosp Org, Hokkaido Canc Ctr, Sapporo, Hokkaido, Japan; Okayama Univ, Dept Surg, Okayama 7008530, Japan; Natl Hosp Org, Shikoku Canc Ctr, Matsuyama, Ehime, Japan; Natl Canc Ctr Hosp East, Kasiwa, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e12043						1	Oncology	Oncology	CM9OA	WOS:000358036902266		
J	Kinugasa, Y; Ishiguro, M; Nakatani, E; Endo, T; Shinozaki, H; Takii, Y; Takahashi, Y; Mochizuki, H; Kotake, K; Kameoka, S; Takahashi, K; Watanabe, T; Watanabe, M; Boku, N; Tomita, N; Sugihara, K				Kinugasa, Yusuke; Ishiguro, Megumi; Nakatani, Eiji; Endo, Takeshi; Shinozaki, Hiroharu; Takii, Yasumasa; Takahashi, Yu; Mochizuki, Hidetaka; Kotake, Kenjiro; Kameoka, Shingo; Takahashi, Keiichi; Watanabe, Toshiaki; Watanabe, Masahiko; Boku, Narikazu; Tomita, Naohiro; Sugihara, Kenichi		ACT-CC Study Grp	S-1 as adjuvant chemotherapy for stage III colon cancer: Updated outcomes of ACTS-CC trial	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Shizuoka Canc Ctr Hosp, Div Colon & Rectal Surg, Shizuoka, Japan; Tokyo Med & Dent Univ, Dept Translat Oncol, Grad Sch, Tokyo, Japan; Translat Res Informat Ctr, Dept Stat Anal, Kobe, Hyogo, Japan; Japanese Red Cross Med Ctr, Dept Colorectal Surg, Tokyo, Japan; Saiseikai Utsunomiya Hosp, Dept Surg, Utsunomiya, Tochigi, Japan; Niigata Canc Ctr Hosp, Dept Surg, Niigata, Japan; Ogaki Municipal Hosp, Dept Surg, Gifu, Japan; Natl Def Med Coll, Saitama, Japan; Tochigi Canc Ctr, Dept Surg, Utsunomiya, Tochigi, Japan; Tokyo Womens Med Univ, Dept Surg 2, Tokyo, Japan; Tokyo Metropolitan Canc & Infect Dis Ctr Komagome, Dept Surg, Tokyo, Japan; Univ Tokyo, Dept Surg Oncol & Vasc Surg, Tokyo, Japan; Kitasato Univ, Dept Surg, Sch Med, Tokyo, Kanagawa, Japan; Natl Canc Ctr, Gastrointestinal Med Oncol Div, Tokyo, Japan; Hyogo Coll Med, Dept Surg, Div Lower GI, Nishinomiya, Hyogo, Japan; Tokyo Med & Dent Univ, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		3570						1	Oncology	Oncology	CM9OA	WOS:000358036900789		
J	Kitayama, J; Ishigami, H; Yamaguchi, H; Hanafusa, N				Kitayama, Joji; Ishigami, Hironori; Yamaguchi, Hironori; Hanafusa, Norio			Cell-free and Concentrated Ascites Reinfusion Therapy (CART) for management of massive malignant ascites in gastric cancer patients with peritoneal metastasis treated with intravenous and intraperitoneal administration of Paclitaxel with Oral S-1	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Univ Tokyo, Tokyo, Japan; Univ Tokyo, Dept Surg Oncol, Tokyo, Japan; Univ Tokyo, Dept Hemodialysis & Apheresis, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e15042						1	Oncology	Oncology	CM9OA	WOS:000358036902828		
J	Kitazono, S; Nishizawa, H; Kobayashi, H; Oguri, T; Tambo, Y; Yanagitani, N; Horiike, A; Ohyanagi, F; Horai, T; Nishio, M				Kitazono, Satoru; Nishizawa, Hironari; Kobayashi, Hiroshi; Oguri, Tomoyo; Tambo, Yuichi; Yanagitani, Noriko; Horiike, Atsushi; Ohyanagi, Fumiyoshi; Horai, Takeshi; Nishio, Makoto			EGFR mutation status of cell free serum DNA and clinical efficacy of afatinib in pretreated non-small cell lung cancer (NSCLC) harboring EGFR mutations.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Japanese Fdn Canc Res, Canc Inst Hosp, Koto Ku, Tokyo, Japan; Japanese Fdn Canc Res, Canc Inst Hosp, Thorac Oncol Ctr, Tokyo, Japan; Japanese Fdn Canc Resarch, Tokyo, Japan; Japanese Fdn Canc Reserch, Dept Thorac Oncol, Tokyo, Japan; Japanese Fdn Canc Res, Canc Inst Hosp, Dept Thorac Med Oncol, Tokyo, Japan; Japanese Fdn Canc Res, Canc Inst Hosp, Tokyo, Japan; Canc Inst Hosp, Koto Ku, Tokyo, Japan; Japanese Fdn Canc Res, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e19087						1	Oncology	Oncology	CM9OA	WOS:000358036903934		
J	Kogure, Y; Saka, H; Oki, M; Kitagawa, C; Nakahata, M; Tsuboi, R; Oka, S; Hori, K; Murakami, Y; Ise, Y				Kogure, Yoshihito; Saka, Hideo; Oki, Masahide; Kitagawa, Chiyoe; Nakahata, Masashi; Tsuboi, Rie; Oka, Saori; Hori, Kazumi; Murakami, Yasushi; Ise, Yuko			Efficacy of pemetrexed for EGFR mutated lung carcinoma between L858R and Exon 19 deletion.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Nagoya Med Ctr, Nagoya, Aichi, Japan; Natl Hosp Org Nagoya Med Ctr, Nagoya, Aichi, Japan; Nagoya Med Ctr, Dept Resp Med, Nagoya, Aichi, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e19073						1	Oncology	Oncology	CM9OA	WOS:000358036903920		
J	Kubo, T; Harita, S; Okada, T; Kamei, H; Hosokawa, S; Maeda, T; Kozuki, T; Fujiwara, K; Hotta, K; Takigawa, N; Tanimoto, M; Kiura, K				Kubo, Toshio; Harita, Shingo; Okada, Toshiaki; Kamei, Haruhito; Hosokawa, Shinobu; Maeda, Tadashi; Kozuki, Toshiyuki; Fujiwara, Keiichi; Hotta, Katsuyuki; Takigawa, Nagio; Tanimoto, Mitsune; Kiura, Katsuyuki			Phase II study of topotecan and cisplatin with sequential radiotherapy in elderly small cell lung cancer patients (Okayama Lung Cancer Study Group; OLCSG 0102).	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Okayama Univ Hosp, Dept Resp Med, Okayama, Japan; Chugoku Cent Hosp, Fukuyama, Hiroshima, Japan; Sumitomo Besshi Gen Hosp, Niihama, Japan; Okayama Red Cross Hosp, Okayama, Japan; Natl Hosp Org, Yamaguchi Ube Med Ctr, Ube, Yamaguchi, Japan; Natl Hosp Org, Shikoku Canc Ctr, Clin Res Inst, Matsuyama, Ehime, Japan; Okayama Med Ctr, Okayama, Japan; Kawasaki Med Univ, Dept Gen Internal Med 4, Okayama, Japan; Okayama Univ, Dept Hematol Oncol & Resp Med, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		7572						1	Oncology	Oncology	CM9OA	WOS:000358036901702		
J	Kuboki, Y; Nishina, T; Shinozaki, E; Yamazaki, K; Shitara, K; Okamoto, W; Kajiwara, T; Matsumoto, T; Tsushima, T; Mochizuki, N; Fukutani, M; Nakamoto, M; Hasegawa, H; Sugama, A; Nomura, S; Sato, A; Ohtsu, A; Yoshino, T				Kuboki, Yasutoshi; Nishina, Tomohiro; Shinozaki, Eiji; Yamazaki, Kentaro; Shitara, Kohei; Okamoto, Wataru; Kajiwara, Takeshi; Matsumoto, Toshihiko; Tsushima, Takahiro; Mochizuki, Nobuo; Fukutani, Miki; Nakamoto, Masako; Hasegawa, Hiromi; Sugama, Ayako; Nomura, Shogo; Sato, Akihiro; Ohtsu, Atsushi; Yoshino, Takayuki			An investigator initiated multicenter phase I/II study of TAS-102 with bevacizumab for metastatic colorectal cancer refractory to standard therapies (C-TASK FORCE)	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Natl Canc Ctr Hosp East, Dept GI Oncol, Kashiwa, Chiba, Japan; Natl Hosp Org, Shikoku Canc Ctr, Matsuyama, Ehime, Japan; Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol, Tokyo, Japan; Shizuoka Canc Ctr, Shizuoka, Japan; Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Kashiwa, Chiba, Japan; Shikoku Canc Ctr, Dept Gastrointestinal Med Oncol, Shizuoka, Ehime, Japan; Natl Hosp Org, Shikoku Canc Ctr, Clin Res Inst, Matsuyama, Ehime, Japan; Shizuoka Canc Ctr, Div Gastrointestinal Oncol, Shizuoka, Japan; Natl Canc Ctr Hosp East, Dept Pharm, Kashiwa, Chiba, Japan; Natl Canc Ctr, Ctr Res Adm & Support, Kashiwa, Chiba, Japan; Natl Canc Ctr, Ctr Res Adm & Support, Kashiwa, Chiba, Japan; Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Kashiwa, Chiba, Japan; Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan								0	1	1	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		3544						1	Oncology	Oncology	CM9OA	WOS:000358036900763		
J	Kudo, K; Hotta, K; Bessho, A; Nogami, N; Kozuki, T; Kuyama, S; Inoue, K; Harita, S; Okada, T; Genba, K; Fujii, M; Oda, N; Tanimoto, M; Kiura, K				Kudo, Kenichiro; Hotta, Katsuyuki; Bessho, Akihiro; Nogami, Naoyuki; Kozuki, Toshiyuki; Kuyama, Shoichi; Inoue, Koji; Harita, Shingo; Okada, Toshiaki; Genba, Kenichi; Fujii, Masanori; Oda, Naohiro; Tanimoto, Mitsune; Kiura, Katsuyuki			Development of skin rash within the 1st week is a potential surrogate marker of therapeutic effect in afatinib monotherapy in patients with EGFR-mt non-small-cell lung cancer (NSCLC): Okayama Lung Cancer Study Group Experience.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Okayama Univ Hosp, Dept Resp Med, Okayama, Japan; Japanese Red Cross Okayama Hosp, Dept Internal Med, Okayama, Japan; Natl Hosp Org Shikoku Canc Ctr, Clin Res Inst, Matsuyama, Ehime, Japan; NHO Iwakuni Clin Ctr, Dept Resp Med, Iwakuni, Japan; Ehime Prefectural Cent Hosp Resp Med, Matsuyama, Ehime, Japan; Chugoku Cent Hosp, Fukuyama, Hiroshima, Japan; Natl Hosp Org Fukuyama Med Ctr Resp Med, Fukuyama, Hiroshima, Japan; Japanese Red Cross Kobe Hosp, Dept Resp Med, Kobe, Hyogo, Japan; Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Hematol Oncol & Resp Med, Okayama, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e19051						1	Oncology	Oncology	CM9OA	WOS:000358036903905		
J	Kudo, M; Moriguchi, M; Numata, K; Hidaka, H; Tanaka, H; Ikeda, M; Kawazoe, S; Ohkawa, S; Sato, Y; Okusaka, T				Kudo, Masatoshi; Moriguchi, Michihisa; Numata, Kazushi; Hidaka, Hisashi; Tanaka, Hironori; Ikeda, Masafumi; Kawazoe, Seiji; Ohkawa, Shinichi; Sato, Yozo; Okusaka, Takuji			A randomized, double-blind, placebo-controlled phase III study of S-1 in patients with sorafenib-refractory advanced hepatocellular carcinoma (S-CUBE)	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Kinki Univ, Sch Med, Dept Gastroenterol & Hepatol, Osaka 589, Japan; Kyoto Prefectural Univ Med, Dept Gastroenterol, Kyoto, Japan; Yokohama City Univ, Med Ctr, Gastroenterol Ctr, Yokohama, Kanagawa 232, Japan; Kitasato Univ Hosp, Dept Gastroenterol, Kanagawa, Japan; Hosp Hyogo, Coll Med, Div Hepatobiliary & Pancreat Dis, Kobe, Hyogo, Japan; Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, Japan; Saga Ken Med Ctr KOSEIKAN, Dept Internal Med, Saga, Japan; Kanagawa Canc Ctr, Div Hepatobiliary & Pancreat Med Oncol, Yokohama, Kanagawa 2410815, Japan; Aichi Canc Ctr Hosp, Dept Diagnost & Intervent Radiol, Nagoya, Aichi 464, Japan; Natl Canc Ctr, Dept Hepatobiliary & Pancreat Oncol, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		4018						1	Oncology	Oncology	CM9OA	WOS:000358036900857		
J	Kudo, Y; Matsubayashi, J; Shimada, Y; Akata, S; Kato, Y; Kakihana, M; Kajiwara, N; Ohira, T; Nagao, T; Ikeda, N				Kudo, Yujin; Matsubayashi, Jun; Shimada, Yoshihisa; Akata, Soichi; Kato, Yasufumi; Kakihana, Masatoshi; Kajiwara, Naohiro; Ohira, Tatsuo; Nagao, Toshitaka; Ikeda, Norihiko			Correlation between high-resolution computed tomography findings and IASLC/ATS/ERS classification of small lung adenocarcinomas in Japanese patients.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Tokyo Med Univ, Dept Thorac Surg, Tokyo 1608402, Japan; Tokyo Med Univ, Dept Anat Pathol, Tokyo 1608402, Japan; Tokyo Med Univ, Dept Radiol, Tokyo 1608402, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		7543						1	Oncology	Oncology	CM9OA	WOS:000358036901673		
J	Kunieda, K; Makiyama, A; Noguchi, M; Kajiwara, T; Tamura, T; Takeda, K; Tsuji, Y; Minashi, K; Moriwaki, T; Sugimoto, N; Nagase, M; Negoro, Y; Tsuda, T; Shimodaira, H; Okano, N; Sakai, D; Yanagihara, K; Boku, N; Hyodo, I; Esaki, T				Kunieda, Kenji; Makiyama, Akitaka; Noguchi, Masaaki; Kajiwara, Takeshi; Tamura, Takao; Takeda, Koji; Tsuji, Yasushi; Minashi, Keiko; Moriwaki, Toshikazu; Sugimoto, Naotoshi; Nagase, Michitaka; Negoro, Yuji; Tsuda, Takashi; Shimodaira, Hideki; Okano, Naohiro; Sakai, Daisuke; Yanagihara, Kazuhiro; Boku, Narikazu; Hyodo, Ichinosuke; Esaki, Taito			Multicenter retrospective analysis for elderly patients with advanced gastric cancer (AGC) received first-line chemotherapy in clinical practice.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Shizuoka Canc Ctr, Dept GI Oncol, Shizuoka, Japan; Kyushu Hosp, Japan Community Healthcare Org, Dept Hematol Oncol, Fukuoka, Japan; Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Chiba, Japan; Shikoku Canc Ctr, Dept Gastrointestinal Med Oncol, Matsuyama, Ehime, Japan; Kinki Univ, Fac Med, Dept Med Oncol, Osaka, Japan; Osaka City Gen Hosp, Dept Clin Oncol, Osaka, Japan; Tonan Hosp, Dept Med Oncol, Sapporo, Hokkaido, Japan; Chiba Canc Ctr, Clin Trial Promot Dept, Chiba, Japan; Univ Tsukuba, Div Gastroenterol, Tsukuba, Ibaraki, Japan; Osaka Med Ctr Canc & Cardiovasc Dis, Gastrointestinal Oncol, Osaka, Japan; Jichi Med Univ, Dept Clin Oncol, Shimotsuke, Japan; Kochi Hlth Sci Ctr, Kochi, Japan; St Marianna Univ, Sch Med, Dept Clin Oncol, Kawasaki, Kanagawa, Japan; Tohoku Univ Hosp, Dept Clin Oncol, Sendai, Miyagi, Japan; Kyorin Univ, Sch Med, Dept Internal Med, Med Oncol, Mitaka, Tokyo 181, Japan; Osaka Univ, Grad Sch Med, Dept Frontier Sci Canc & Chemotherapy, Osaka, Japan; Kansai Elect Power Hosp, Dept Med Oncol, Osaka, Japan; St Marianna Univ, Sch Med, Kawasaki, Kanagawa, Japan; Univ Tsukuba, Tsukuba, Ibaraki, Japan; Natl Hosp Org, Kyushu Canc Ctr, Dept Gastrointestinal & Med Oncol, Fukuoka, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		4046						1	Oncology	Oncology	CM9OA	WOS:000358036900885		
J	Kuroda, A; Matsumoto, S; Nakamichi, T; Monji, S; Hashimoto, M; Takuwa, T; Kondo, N; Tsujimura, T; Nakano, T; Hasegawa, S				Kuroda, Ayumi; Matsumoto, Seiji; Nakamichi, Toru; Monji, Shoko; Hashimoto, Masaki; Takuwa, Teruhisa; Kondo, Nobuyuki; Tsujimura, Tohru; Nakano, Takashi; Hasegawa, Seiki			Determining association between activation of mTOR signal pathway and patient with malignant pleural mesothelioma who underwent a multimodality therapy including extrapleural pneumonectomy.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Hyogo Coll Med, Dept Thorac Surg, Nishinomiya, Hyogo 6638501, Japan; Hyogo Coll Med, Nishinomiya, Hyogo 6638501, Japan; Hyogo Coll Med, Nishinomiya, Jordan; Hyogo Coll Med, Dept Pathol, Nishinomiya, Hyogo 6638501, Japan; Hyogo Coll Med, Dept Internal Med, Div Resp Med, Nishinomiya, Hyogo 6638501, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e18543						1	Oncology	Oncology	CM9OA	WOS:000358036903847		
J	Kurozumi, S; Matsumoto, H; Tozuka, K; Hayashi, Y; Inoue, K; Nagai, SE; Oba, H; Horiguchi, J; Takeyoshi, I; Kurosumi, M				Kurozumi, Sasagu; Matsumoto, Hiroshi; Tozuka, Katsunori; Hayashi, Yuji; Inoue, Kenichi; Nagai, Shigenori E.; Oba, Hanako; Horiguchi, Jun; Takeyoshi, Izumi; Kurosumi, Masafumi			Impact of combining PgR score and original preoperative endocrine prognostic index (PEPI) score as a prognostic factor of neoadjuvant endocrine therapy using exemestane in postmenopausal ER-positive/HER2-negative breast cancer.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Saitama Canc Ctr, Div Breast Surg, Saitama, Japan; Saitama Canc Ctr, Saitama, Japan; Saitama Canc Ctr, Dept Pathol, Saitama, Japan; Gunma Univ Hosp, Maebashi, Gumma, Japan; Gunma Univ, Grad Sch Med, Dept Thorac & Visceral Organ Surg, Maebashi, Gumma 371, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		548						1	Oncology	Oncology	CM9OA	WOS:000358036901155		
J	Kusumoto, T; Ohta, M; Kimura, Y; Tsutsumi, N; Sugiyama, M; Kusumoto, E; Sakaguchi, Y; Ikejiri, K; Saeki, H; Oki, E; Maehara, Y				Kusumoto, Tetsuya; Ohta, Mitsuhiko; Kimura, Yasue; Tsutsumi, Norifumi; Sugiyama, Masahiko; Kusumoto, Eiji; Sakaguchi, Yoshihisa; Ikejiri, Koji; Saeki, Hiroshi; Oki, Eiji; Maehara, Yoshihiko			Validation of postoperative adjuvant chemotherapy for elderly patients with stage II/III gastric cancer	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Natl Kyushu Med Ctr, Clin Res Ctr, Canc Res Div, Fukuoka, Japan; Natl Kyushu Med Ctr, Dept Surg Gastroenterol, Fukuoka, Japan; Kyushu Univ, Dept Surg & Sci, Fukuoka 812, Japan; Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e15036						1	Oncology	Oncology	CM9OA	WOS:000358036902824		
J	Lee, C; Davies, LC; Wu, YL; Mitsudomi, T; Inoue, A; Rosell, R; Zhou, CC; Nakagawa, K; Throngprasert, S; Fukuoka, M; Gralla, RJ; Gebski, V; Mok, T; Yang, JCH				Lee, Chee; Davies, Lucy Claire; Wu, Yi-Long; Mitsudomi, Tetsuya; Inoue, Akira; Rosell, Rafael; Zhou, Caicun; Nakagawa, Kazuhiko; Throngprasert, Sumitra; Fukuoka, Masahiro; Gralla, Richard J.; Gebski, Val; Mok, Tony; Yang, James Chih-Hsin			The impact on overall survival (OS) of first-line gefitinib (G) and erlotinib (E) and of clinical factors in advanced non-small cell lung cancer (NSCLC) with activating epidermal growth factor receptor mutations (EGFR mut) based on meta-analysis of 1,231 patients (pts) enrolled in 6 major randomized trials.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					NHMRC Clin Trials Ctr, Sydney, NSW, Australia; Natl Hlth & Med Res Council, Clin Trials Ctr, Sydney, NSW, Australia; Guangdong Gen Hosp, Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China; Guangdong Acad Med Sci, Guangzhou, Guangdong, Peoples R China; Kinki Univ, Sch Med, Osaka 589, Japan; Tohoku Univ Hosp, Sendai, Miyagi, Japan; Hosp Badalona Germans Trias & Pujol, Canc Biol & Precis Med Program, Catalan Inst Oncol, Barcelona, Spain; Tongji Univ, Sch Med, Inst Canc, Dept Med Oncol,Shanghai Pulm Hosp, Shanghai 200092, Peoples R China; Kinki Univ, Fac Med, Osakasayama, Japan; Chiang Mai Univ, Chiang Mai 50000, Thailand; Izumi Municipal Hosp, Izumi, Japan; Albert Einstein Coll Med, Jacobi Med Ctr, Bronx, NY 10467 USA; Chinese Univ Hong Kong, Shatin, Hong Kong, Peoples R China; Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan; Natl Taiwan Univ, Grad Inst Oncol, Taipei 10764, Taiwan; Natl Taiwan Univ, Canc Res Ctr, Taipei 10764, Taiwan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		8072						1	Oncology	Oncology	CM9OA	WOS:000358036901784		
J	Lee, JJ; Seraj, J; Yoshida, K; Narurkar, M; Mizuguchi, H; Strychor, S; Fiejdasz, J; Faulkner, T; Pollice, L; Mason, S; Sun, WJ; Chu, E; Croft, M; Nguteren, J; Tedder, C; Beumer, JH				Lee, James J.; Seraj, Jabed; Yoshida, Kenichiro; Narurkar, Milind; Mizuguchi, Hirokazu; Strychor, Sandra; Fiejdasz, Jillian; Faulkner, Tyeler; Pollice, Laura; Mason, Scott; Sun, Weijing; Chu, Edward; Croft, Marie; Nguteren, James; Tedder, Charles; Beumer, Jan Hendrik			Mass balance study of TAS-102 using C-14 labeling analyzed by accelerator mass spectrometry.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Univ Pittsburgh, Pittsburgh, PA USA; Taiho Oncol Inc, Princeton, NJ USA; Taiho Pharmaceut Co Ltd, Tokushima, Japan; Taiho Pharma USA Inc, Union, NJ USA; UPCI Clin & Translat Res Ctr, Pittsburgh, PA USA; UPMC Canc Ctr, Pittsburgh, PA USA; Univ Pittsburgh, Hlth Sci Sch, Pittsburgh, PA USA; Xceleron Inc, Germantown, MD USA; INC Res LLC, Raleigh, NC USA; Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		2563						1	Oncology	Oncology	CM9OA	WOS:000358036900596		
J	Lenz, HJ; Tabernero, J; Yoshino, T; Oum'Hamed, Z; Vlassak, S; Sassi, M; Van Cutsem, E				Lenz, Heinz-Josef; Tabernero, Josep; Yoshino, Takayuki; Oum'Hamed, Zohra; Vlassak, Soetkin; Sassi, Mouna; Van Cutsem, Eric			LUME-Colon 1: A double-blind, randomized phase III study of nintedanib plus best supportive care (BSC) versus placebo plus BSC in patients with colorectal cancer (CRC) refractory to standard therapies.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Norris Comprehens Canc Ctr, Los Angeles, CA USA; Vall dHebron Inst Oncol, Barcelona, Spain; Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan; Boehringer Ingelheim France SAS, Reims, France; SCS Boehringer Ingelheim Comm V, Brussels, Belgium; Univ Hosp Leuven, Leuven, Belgium								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		TPS3625						1	Oncology	Oncology	CM9OA	WOS:000358036904728		
J	Lenz, HJ; Schumacher, F; Loupakis, F; Cremolini, C; Ning, Y; Stremitzer, S; Sunakawa, Y; Matsusaka, S; Okazaki, S; Zhang, W; Falcone, A				Lenz, Heinz-Josef; Schumacher, Fredrick; Loupakis, Fotios; Cremolini, Chiara; Ning, Yan; Stremitzer, Stefan; Sunakawa, Yu; Matsusaka, Satoshi; Okazaki, Satoshi; Zhang, Wu; Falcone, Alfredo			Effect of genetic variation on overall survival in a clinical trial of metastatic colorectal cancer (mCRC)	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Univ So Calif, Norris Comprehens Canc Ctr, Los Angeles, CA USA; Univ So Calif, Los Angeles, CA USA; Azienda Osped Univ Pisana, Ist Toscano Tumori, Pisa, Italy; Med Univ Vienna, Santa Monica, CA USA; Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		3562						1	Oncology	Oncology	CM9OA	WOS:000358036900781		
J	Leonard, J; Gribben, JG; Trnen, M; Scheinberg, P; Tobinai, K; Fowler, NH; Kilavuz, N; Fustier, P; Amoroso, B				Leonard, John; Gribben, John G.; Trnen, Marek; Scheinberg, Phillip; Tobinai, Kensei; Fowler, Nathan Hale; Kilavuz, Nurgul; Fustier, Pierre; Amoroso, Barbara		AUGMENT Trial Investigators	AUGMENT: A randomized, phase 3 trial in patients with relapsed/refractory (R/R) indolent non-Hodgkin lymphoma (iNHL) to compare efficacy and safety of lenalidomide plus rituximab (R-2) versus placebo plus rituximab.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					New York Presbyterian Hosp, Weill Cornell Med Coll, New York, NY USA; Barts Canc, Ctr Haematooncol, London, England; Charles Univ Prague, Gen Hosp, Fac Med 1, Prague, Czech Republic; Hosp Sao Jose, Antonio Ermirio de Moraes Canc Ctr, Clin Hematol, Sao Paulo, Brazil; Beneficencia Portuguesa, Sao Paulo, Brazil; Natl Canc Ctr, Tokyo, Japan; Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; Celgene Corp, Summit, NJ USA; Celgene, Boudry, Switzerland								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		TPS8603						1	Oncology	Oncology	CM9OA	WOS:000358036904865		
J	Li, HR; Choueiri, TK; Wells, C; Agarwal, N; Donskov, F; Lee, JL; Broom, RJ; Yuasa, T; Rini, BI; Pal, SK; Wood, L; Ernst, DS; Kollmannsberger, CK; Vaishampayan, UN; Rha, SY; Bjarnason, GA; Knox, JJ; Saleem, S; Beuselinck, B; Heng, DYC				Li, Haoran; Choueiri, Toni K.; Wells, Connor; Agarwal, Neeraj; Donskov, Frede; Lee, Jae-Lyun; Broom, Reuben James; Yuasa, Takeshi; Rini, Brian I.; Pal, Sumanta Kumar; Wood, Lori; Ernst, D. Scott; Kollmannsberger, Christian K.; Vaishampayan, Ulka N.; Rha, Sun Young; Bjarnason, Georg A.; Knox, Jennifer J.; Saleem, Sadia; Beuselinck, Benoit; Heng, Daniel Yick Chin			Characteristics of metastatic renal cell carcinoma (mRCC) patients treated with delayed targeted therapy: Results from the International mRCC Consortium (IMDC).	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Tom Baker Canc Clin, Calgary, AB, Canada; Dana Farber Canc Inst, Boston, MA 02115 USA; Tom Baker Canc Clin, Calgary, AB, Canada; Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; Aarhus Univ Hosp, Dept Oncol, DK-8000 Aarhus, Denmark; Univ Ulsan Coll Med, Dept Oncol, Asan Med Ctr, Seoul, South Korea; Auckland City Hosp, Auckland, New Zealand; Japanese Fdn Canc Res, Canc Inst Hosp, Dept Urol, Tokyo, Japan; Cleveland Clin Taussig Canc Inst, Cleveland, OH USA; City Hope Natl Med Ctr, Duarte, CA USA; Queen Elizabeth 2 Hlth Sci Ctr, Halifax, NS, Canada; London Reg Canc Ctr, London, ON N6A 4L6, Canada; BC Canc Agcy, Vancouver Canc Ctr, Vancouver, BC, Canada; Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA; Yonsei Univ Coll Med, Seoul, South Korea; Univ Toronto, Sunnybrook Odette Canc Ctr, Toronto, ON, Canada; Univ Toronto, Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; Univ Hosp Leuven, Dept Gen Med Oncol, Leuven, Belgium; Univ Calgary, Tom Baker Canc Ctr, Calgary, AB, Canada								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		4558						1	Oncology	Oncology	CM9OA	WOS:000358036901029		
J	Llovet, JM; Park, JW; Torres, F; Decaens, T; Boucher, E; Raoul, JL; Kudo, M; Chang, C; Boige, V; Assenat, E; Kang, YK; Lim, HY; Walters, I; Lencioni, R				Llovet, Josep M.; Park, Joong-Won; Torres, Ferran; Decaens, Thomas; Boucher, Eveline; Raoul, Jean-Luc; Kudo, Masatoshi; Chang, Charissa; Boige, Valerie; Assenat, Eric; Kang, Yoon-Koo; Lim, Ho-Yeong; Walters, Ian; Lencioni, Riccardo			Objective response by mRECIST to predict survival in hepatocellular carcinoma: A multivariate, time-dependent analysis from the phase III BRISK-PS study	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Mt Sinai Sch Med, Liver Canc Program, Div Liver Dis, New York, NY USA; Natl Canc Ctr, Ctr Liver Canc, Goyang, South Korea; Hosp Clin Barcelona, IDIBAPS, Biostat & Data Management Platform Core Facil, Barcelona, Spain; Hosp Henri Mondor, Serv Hepatogastroenterol, Creteil, France; Cent Eugene Marquis, Serv Oncol Med, Rennes, France; Inst Paoli Calmette, Serv Oncol Med, Marseille, France; Kinki Univ, Sch Med, Dept Gastroenterol & Hepatol, Osaka 589, Japan; Inst Gustave Roussy, Serv Gastroenterol, Villejuif, France; Hop St Eloi, Serv Hepatogastroenterol, Montpellier, France; Asan Med Ctr, Dept Oncol, Seoul, South Korea; Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol, Seoul, South Korea; Bristol Myers Squibb Co, Wallingford, CT 06492 USA; Univ Pisa, Sch Med, Div Diagnost Imaging & Intervent, I-56100 Pisa, Italy								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		4084						1	Oncology	Oncology	CM9OA	WOS:000358036900922		
J	Lonial, S; Dimopoulos, MA; Palumbo, A; White, D; Grosicki, S; Spicka, I; Walter-Croneck, A; Moreau, P; Mateos, MV; Magen-Nativ, H; Belch, A; Reece, DE; Beksac, M; Taniwaki, M; Rollig, C; Singhal, AK; Katz, J; Bleickardt, EW; Poulart, V; Richardson, PG				Lonial, Sagar; Dimopoulos, Meletios A.; Palumbo, Antonio; White, Darrell; Grosicki, Sebastian; Spicka, Ivan; Walter-Croneck, Adam; Moreau, Philippe; Mateos, Maria-Victoria; Magen-Nativ, Hila; Belch, Andrew; Reece, Donna Ellen; Beksac, Meral; Taniwaki, Masafumi; Roellig, Christoph; Singhal, Anil K.; Katz, Jessica; Bleickardt, Eric W.; Poulart, Valerie; Richardson, Paul G.		ELOQUENT-2 Investigators	ELOQUENT-2: A phase III, randomized, open-label study of lenalidomide (Len)/dexamethasone (dex) with/without elotuzumab (Elo) in patients (pts) with relapsed/refractory multiple myeloma (RRMM).	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA USA; Univ Athens, Athens 11528, Greece; AOU San Giovanni Battista Torino, Osped Molinette, Turin, Italy; Dalhousie Univ, QEII Hlth Sci Ctr, Halifax, NS, Canada; Silesian Med Univ, Fac Publ Hlth, Dept Canc Prevent, Katowice, Poland; Prague Gen Hosp, Prague, Czech Republic; Med Univ Lublin, Lublin, Poland; Univ Hosp, Nantes, France; Univ Hosp Salamanca IBSAL, Salamanca, Spain; Tel Aviv Univ, Ramat Aviv, Israel; Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; Univ Alberta, Edmonton, AB, Canada; Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada; Ankara Univ, TR-06100 Ankara, Turkey; Kyoto Prefectural Univ Med, Kyoto, Japan; Univ Klinikum TU, Dresden, Germany; AbbVie Biotherapeut Inc ABR, Redwood City, CA USA; Bristol Myers Squibb Co, Princeton, NJ USA; Bristol Myers Squibb Co, Wallingford, CT 06492 USA; Bristol Myers Squibb, Braine Lalleud, Belgium; Dana Farber Canc Inst, Boston, MA 02115 USA								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		8508						1	Oncology	Oncology	CM9OA	WOS:000358036901821		
J	Matsubara, N; Shitara, K; Naito, Y; Kuboki, Y; Ohno, I; Takahashi, H; Bando, H; Kojima, T; Fuse, N; Yamazaki, T; Hirayama, N; Fujita, H; Nishida, T; Doi, T				Matsubara, Nobuaki; Shitara, Kohei; Naito, Yoichi; Kuboki, Yasutoshi; Ohno, Izumi; Takahashi, Hideaki; Bando, Hideaki; Kojima, Takashi; Fuse, Nozomu; Yamazaki, Tomoko; Hirayama, Naoki; Fujita, Hidenori; Nishida, Toshirou; Doi, Toshihiko			First-in-human study of TAS-115, a novel oral MET/VEGFR inhibitor, in patients with advanced solid tumors.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan; Natl Canc Ctr Hosp East, Dept GI Oncol, Kashiwa, Chiba, Japan; Natl Canc Ctr Hosp East, Chiba, Japan; Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, Japan; Natl Canc Ctr Hosp East, Gastrointestinal Oncol Div, Kashiwa, Chiba, Japan; Natl Canc Ctr Hosp East, Div Head & Neck Med Oncol, Kashiwa, Chiba, Japan; Taiho Pharmaceut Co Ltd, Tokyo, Japan; Taiho Pharmaceut Co Ltd, Tsukuba, Ibaraki, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		2532						1	Oncology	Oncology	CM9OA	WOS:000358036900565		
J	Matsumoto, K; Takahashi, M; Sato, K; Takano, T; Ryushima, Y; Doi, M; Aogi, K; Fujiwara, K; Tamura, K; Hosoda, M; Tokunaga, S; Makiyama, A; Miyamoto, K; Hozumi, Y; Yanagihara, K; Imamura, CK; Chiba, Y; Nakamura, S; Saeki, T				Matsumoto, Koji; Takahashi, Masato; Sato, Kazuhiko; Takano, Toshimi; Ryushima, Yasuaki; Doi, Mihoko; Aogi, Kenjiro; Fujiwara, Kimiko; Tamura, Kenji; Hosoda, Mitsuchika; Tokunaga, Shinya; Makiyama, Akitaka; Miyamoto, Kaisuke; Hozumi, Yasuo; Yanagihara, Kazuhiro; Imamura, Chiyo K.; Chiba, Yasutaka; Nakamura, Shinichiro; Saeki, Toshiaki		WJOG	Palonosetron or granisetron for prevention of CINV in patients with breast cancer receiving dexamethasone and fosaprepitant following anthracycline plus cyclophosphamide (AC) regimen	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Hyogo Canc Ctr, Akashi, Hyogo, Japan; Hokkaido Canc Ctr, Natl Hosp Org, Sapporo, Hokkaido, Japan; Tokyo West Tokushukai Hosp, Tokyo, Japan; Toranomon Gen Hosp, Tokyo, Japan; Natl Canc Ctr East Hosp, Kashiwa, Chiba, Japan; Hiroshima Prefectural Hosp, Hiroshima, Japan; Shikoku Canc Ctr, Natl Hosp Org, Matsuyama, Ehime, Japan; Kinki Univ Hosp, Fac Med, Osaka, Japan; Natl Canc Ctr, Tokyo, Japan; Hokkaido Univ Hosp, Sapporo, Hokkaido, Japan; Osaka City Gen Hosp, Osaka, Japan; Kyushu Hosp, Kitakyushu, Fukuoka, Japan; Kyorin Univ, Sch Med, Mitaka, Tokyo 181, Japan; Jichi Med Univ, Shimotsuke, Japan; Kansai Elect Power Hosp, Dept Med Oncol, Osaka, Japan; Keio Univ, Tokyo, Japan; Kinki Univ Hosp, Osaka, Japan; WJOG, Osaka, Japan; Saitama Med Univ, Hidaka, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		9598						1	Oncology	Oncology	CM9OA	WOS:000358036902093		
J	Matsumoto, S; Nakamichi, T; Kuroda, A; Hashimoto, M; Takuwa, T; Kondo, N; Tsujimura, T; Nakano, T; Hasegawa, S				Matsumoto, Seiji; Nakamichi, Toru; Kuroda, Ayumi; Hashimoto, Masaki; Takuwa, Teruhisa; Kondo, Nobuyuki; Tsujimura, Tohru; Nakano, Takashi; Hasegawa, Seiki			ERCC1 in patients with Malignant Pleural Mesothelioma (MPM) treated by neoadjuvant chemotherapy followed by extrapleural pneumonectomy (EPP).	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Hyogo Coll Med, Nishinomiya, Hyogo 6638501, Japan; Hyogo Coll Med, Dept Thorac Surg, Nishinomiya, Hyogo 6638501, Japan; Hyogo Coll Med, Dept Pathol, Nishinomiya, Hyogo 6638501, Japan; Hyogo Coll Med, Dept Internal Med, Div Resp Med, Nishinomiya, Hyogo 6638501, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e18542						1	Oncology	Oncology	CM9OA	WOS:000358036903846		
J	Matsumoto, S; Yoh, K; Seto, T; Yokoyama, T; Murakami, H; Iwama, E; Sugawara, S; Ohe, Y; Takeda, K; Nishio, M; Satouchi, M; Shingyoji, M; Harada, D; Okuyama, T; Okamoto, N; Kohno, T; Tsuta, K; Ishii, G; Tsuchihara, K; Goto, K				Matsumoto, Shingo; Yoh, Kiyotaka; Seto, Takashi; Yokoyama, Takuma; Murakami, Haruyasu; Iwama, Eiji; Sugawara, Shunichi; Ohe, Yuichiro; Takeda, Koji; Nishio, Makoto; Satouchi, Miyako; Shingyoji, Masato; Harada, Daijiro; Okuyama, Takako; Okamoto, Norio; Kohno, Takashi; Tsuta, Koji; Ishii, Genichiro; Tsuchihara, Katsuya; Goto, Koichi			Nationwide genomic screening network for the development of novel targeted therapies in advanced non-small cell lung cancer (LC-SCRUM-Japan).	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Natl Canc Ctr Hosp East, Div Thorac Oncol, Kashiwa, Chiba, Japan; Kyushu Natl Canc Ctr, Fukuoka, Japan; Kyorin Univ Hosp, Mitakashi, Japan; Shizuoka Canc Ctr, Div Thorac Oncol, Shizuoka, Japan; Kyushu Univ, Fac Med Sci, Dept Comprehens Clin Oncol, Fukuoka 812, Japan; Sendai Kousei Hosp, Sendai, Miyagi, Japan; Natl Canc Ctr, Dept Thorac Oncol, Tokyo, Japan; Osaka City Gen Hosp, Dept Clin Oncol, Osaka, Japan; Japanese Fdn Canc Res, Tokyo, Japan; Hyogo Canc Ctr, Akashi, Hyogo, Japan; Chiba Canc Ctr, Div Respirol, Chiba 2608717, Japan; Natl Hosp Org Shikoku Canc Ctr, Dept Thorac Oncol & Med, Matsuyama, Ehime, Japan; Osaka Med Ctr Canc & Cardiovasc Dis, Dept Thorac Oncol, Osaka, Japan; Osaka Prefectual Med Ctr Resp & Allerg Dis, Osaka, Japan; Natl Canc Ctr, Res Inst, Tokyo 104, Japan; Natl Canc Ctr, Div Pathol, Tokyo, Japan; Natl Canc Ctr Hosp East, Div Pathol, Res Ctr Innovat Oncol, Kashiwa, Chiba, Japan; Natl Canc Ctr Hosp East, Div Translat Res, Res Ctr Innovat Oncol, Kashiwa, Chiba, Japan								0	1	1	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		8093						1	Oncology	Oncology	CM9OA	WOS:000358036901805		
J	Matsusaka, S; Wu, AH; Cao, S; Mizunuma, N; Chin, KS; Zhang, W; Yang, DY; Ning, Y; Stremitzer, S; Sunakawa, Y; Okazaki, S; Parekh, A; El-Khoueiry, RE; Mendez, A; Lenz, HJ				Matsusaka, Satoshi; Wu, Anna H.; Cao, Shu; Mizunuma, Nobuyuki; Chin, Keisho; Zhang, Wu; Yang, Dongyun; Ning, Yan; Stremitzer, Stefan; Sunakawa, Yu; Okazaki, Satoshi; Parekh, Anish; El-Khoueiry, Rita Elie; Mendez, Angela; Lenz, Heinz-Josef			Prognostic impact of Forkhead box-F1 (FOXF1) polymorphisms on the clinical outcome in gastric cancer patients	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Univ So Calif, Norris Comprehens Canc Ctr, Los Angeles, CA USA; Univ So Calif, Los Angeles, CA USA; Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		4039						1	Oncology	Oncology	CM9OA	WOS:000358036900878		
J	Matsuyama, H; Nagao, K; Hara, T; Kobayashi, K				Matsuyama, Hideyasu; Nagao, Kazuhiro; Hara, Takahiko; Kobayashi, Keita		Yamaguchi Uro-Oncology Grp	Long-term outcomes in bladder-preserving patients with muscle-invasive bladder cancer comparing radical cystectomy by propensity score-match analysis.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					[Matsuyama, Hideyasu; Nagao, Kazuhiro; Hara, Takahiko; Kobayashi, Keita; Yamaguchi Uro-Oncology Grp] Yamaguchi Univ, Sch Med, Dept Urol, Ube, Yamaguchi 755, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e15530						1	Oncology	Oncology	CM9OA	WOS:000358036903078		
J	McWilliams, RR; Ko, AH; Chiorean, EG; Kwak, EL; Lenz, HJ; Nadler, PI; Wood, DL; Fujimori, M; Morita, K; Inada, T; Kouji, H				McWilliams, Robert R.; Ko, Andrew H.; Chiorean, E. Gabriela; Kwak, Eunice Lee; Lenz, Heinz-Josef; Nadler, Paul I.; Wood, Debra L.; Fujimori, Masamoto; Morita, Kohei; Inada, Tetsuhi; Kouji, Hiroyuki			A phase Ib dose-escalation study of PRI-724, a CBP/beta-catenin modulator, plus gemcitabine (GEM) in patients with advanced pancreatic adenocarcinoma (APC) as second-line therapy after FOLFIRINOX or FOLFOX.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Mayo Clin, Rochester, MN USA; UC San Francisco Helen Diller Family Comprehens C, San Francisco, CA USA; Univ Washington, Seattle, WA 98195 USA; Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA; Nadler Pharma Assoc LLC, Randolph, NJ USA; Nadler Pharma Associates LLC, Randolph, NJ USA; PRISM Pharma Co Ltd, Yokohama, Kanagawa, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e15270						1	Oncology	Oncology	CM9OA	WOS:000358036903029		
J	Mitsunaga, S; Ikeda, M; Shimizu, S; Ohno, I; Takahashi, H; Okuyama, H; Hashimoto, Y; Watanabe, K; Umemoto, K; Ochiai, A				Mitsunaga, Shuichi; Ikeda, Masafumi; Shimizu, Satoshi; Ohno, Izumi; Takahashi, Hideaki; Okuyama, Hiroyuki; Hashimoto, Yusuke; Watanabe, Kazuo; Umemoto, Kumiko; Ochiai, Atsushi			S100A8/A9 as a potent serological marker in monitoring the activity of chemotherapy in pancreatic cancer.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, Japan; Natl Canc Ctr Hosp East, Res Ctr Innovat Oncol, Kashiwa, Chiba, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e15265						1	Oncology	Oncology	CM9OA	WOS:000358036903024		
J	Miura, D; Kadowaki, M; Tamura, N; Kawabata, H; Kinowaki, K; Fujii, T				Miura, Daishu; Kadowaki, Masami; Tamura, Nobuko; Kawabata, Hidetaka; Kinowaki, Keiichi; Fujii, Takeshi			Which is related baseline biomarker value or biomarker change to early recurrence in ER positive HER2-negative breast cancer with neoadjuvant endocrine therapy?	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Toranomon Gen Hosp, Tokyo, Japan; Toranomon Gen Hosp, Dept Breast & Endocrine Surg, Tokyo, Japan; Toranomon Gen Hosp, Dept Pathol, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e11569						1	Oncology	Oncology	CM9OA	WOS:000358036902188		
J	Miwa, S; Yano, S; Zhang, Y; Bouvet, M; Tsuchiya, H; Hoffman, RM; Zhao, M				Miwa, Shinji; Yano, Shuya; Zhang, Yong; Bouvet, Michael; Tsuchiya, Hiroyuki; Hoffman, Robert M.; Zhao, Ming			Prevention of experimental human breast cancer bone metastasis in nude mice by tumor-targeting Salmonella typhimurium A1-R.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					AntiCancer Inc, San Diego, CA USA; Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; Kanazawa Univ Hosp, Kanazawa, Ishikawa, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e13513						1	Oncology	Oncology	CM9OA	WOS:000358036902519		
J	Miwa, S; Zhang, Y; Bouvet, M; Tsuchiya, H; Hoffman, RM; Zhao, M				Miwa, Shinji; Zhang, Yong; Bouvet, Michael; Tsuchiya, Hiroyuki; Hoffman, Robert M.; Zhao, Ming			Inhibition of soft-tissue sarcoma lung metastasis by tumor-targeting Salmonella typhimurium A1-R.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					AntiCancer Inc, San Diego, CA USA; Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; Kanazawa Univ Hosp, Kanazawa, Ishikawa, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e13515						1	Oncology	Oncology	CM9OA	WOS:000358036902521		
J	Miyachi, M; Tsuchiya, K; Nitta, Y; Ouchi, K; Yoshida, H; Kikuchi, K; Kuwahara, Y; Iehara, T; Hosoi, H				Miyachi, Mitsuru; Tsuchiya, Kunihiko; Nitta, Yoshihiro; Ouchi, Kazutaka; Yoshida, Hideki; Kikuchi, Ken; Kuwahara, Yasumichi; Iehara, Tomoko; Hosoi, Hajime			Diagnostic and prognostic role of circulating miR-206 in rhabdomyosarcoma patients.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					[Miyachi, Mitsuru; Tsuchiya, Kunihiko; Nitta, Yoshihiro; Ouchi, Kazutaka; Yoshida, Hideki; Kikuchi, Ken; Kuwahara, Yasumichi; Iehara, Tomoko; Hosoi, Hajime] Kyoto Prefectural Univ Med, Dept Pediat, Grad Sch Med Sci, Kyoto 602, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		10038						1	Oncology	Oncology	CM9OA	WOS:000358036900044		
J	Miyashita, M; Sasano, H; Tamaki, K; Hirakawa, H; Watanabe, G; Tada, H; Suzuki, A; Ishida, T; Ishioka, C; Ohuchi, N				Miyashita, Minoru; Sasano, Hironobu; Tamaki, Kentaro; Hirakawa, Hisashi; Watanabe, Gou; Tada, Hiroshi; Suzuki, Akihiko; Ishida, Takanori; Ishioka, Chikashi; Ohuchi, Noriaki			Prognostic significance of tumor-infiltrating CD8+and FOXP3+lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan; Tohoku Univ Hosp, Sendai, Miyagi, Japan; Nahanishi Clin, Naha, Japan; Tohoku Kosai Hosp, Sendai, Miyagi, Japan; Tohoku Univ, Sendai, Miyagi 980, Japan; Tohoku Univ, Sch Med, Dept Surg Oncol, Sendai, Miyagi 980, Japan; Inst Dev Aging Canc, Sendai, Miyagi, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		510						1	Oncology	Oncology	CM9OA	WOS:000358036901117		
J	Miyata, Y; Tsutani, Y; Suzuki, K; Takamochi, K; Tanaka, F; Nakayama, H; Yamashita, Y; Tsuboi, M; Oda, M; Okada, M				Miyata, Yoshihiro; Tsutani, Yasuhiro; Suzuki, Kenji; Takamochi, Kazuya; Tanaka, Fumihiro; Nakayama, Haruhiko; Yamashita, Yoshinori; Tsuboi, Masahiro; Oda, Makoto; Okada, Morihito			A phase II feasibility study of preoperative chemotherapy with bevacizumab for resectable stage II/IIIA non-squamous non-small cell lung cancer.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Hiroshima Univ, Hiroshima, Japan; Juntendo Univ, Sch Med, Tokyo 113, Japan; Juntendo Univ, Tokyo, Japan; Univ Occupat & Environm Hlth, Kitakyushu, Japan; Kanagawa Canc Ctr, Yokohama, Kanagawa, Japan; Chugoku Canc Ctr, Kure Med Ctr, Dept Gen Thorac Surg, Kure, Hiroshima, Japan; Natl Canc Ctr Hosp East, Div Thorac Surg, Kashiwa, Chiba, Japan; Kanazawa Univ, Kanazawa, Ishikawa, Japan; Hiroshima Univ, Res Inst Radiat Biol & Med, Surg Oncol, Hiroshima, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		7552						1	Oncology	Oncology	CM9OA	WOS:000358036901682		
J	Miyoshi, T; Umemura, S; Matsumura, Y; Mimaki, S; Tada, S; Ishii, G; Matsumoto, S; Yoh, K; Niho, S; Ohmatsu, H; Aokage, K; Hishida, T; Yoshida, J; Nagai, K; Goto, K; Tsuboi, M; Tsuchihara, K				Miyoshi, Tomohiro; Umemura, Shigeki; Matsumura, Yuki; Mimaki, Sachiyo; Tada, Satoshi; Ishii, Genichiro; Matsumoto, Shingo; Yoh, Kiyotaka; Niho, Seiji; Ohmatsu, Hironobu; Aokage, Keiju; Hishida, Tomoyuki; Yoshida, Junji; Nagai, Kanji; Goto, Koichi; Tsuboi, Masahiro; Tsuchihara, Katsuya			Genomic profiling of large-cell neuroendocrine carcinoma of the lung.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Natl Canc Ctr Hosp East, Div Thorac Surg, Kashiwa, Chiba, Japan; Natl Canc Ctr Hosp East, Div Thorac Oncol, Kashiwa, Chiba, Japan; Natl Canc Ctr Hosp East, Res Ctr Innovat Oncol, Div Translat Res, Kashiwa, Chiba, Japan; Natl Canc Ctr Hosp East, Res Ctr Innovat Oncol, Div Pathol, Kashiwa, Chiba, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		7519						1	Oncology	Oncology	CM9OA	WOS:000358036901649		
J	Mizuno, R; Takahashi, R; Shinojima, T; Kosaka, T; Miyajima, A; Oya, M				Mizuno, Ryuichi; Takahashi, Ryohei; Shinojima, Toshiaki; Kosaka, Takeo; Miyajima, Akira; Oya, Mototsugu			Predictors of renal dysfunction during everolimus treatment in patients with metastatic renal cell carcinoma	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Keio Univ, Sch Med, Dept Urol, Tokyo, Japan; Keio Univ, Shinjuku Ku, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e15584						1	Oncology	Oncology	CM9OA	WOS:000358036903127		
J	Mok, T; Spigel, D; Felip, E; deMarinis, F; Ahn, MJ; Groen, HJM; Wakelee, HA; Hida, T; Crino, L; Nishio, M; Scagliotti, GV; Branle, F; Emeremni, C; Quadrigli, M; Zhang, J; Shaw, AT				Mok, Tony; Spigel, David; Felip, Enriqueta; deMarinis, Filippo; Ahn, Myung-Ju; Groen, Harry J. M.; Wakelee, Heather A.; Hida, Toyoaki; Crino, Lucio; Nishio, Makoto; Scagliotti, Giorgio V.; Branle, Fabrice; Emeremni, Chetachi; Quadrigli, Massimiliano; Zhang, Jie; Shaw, Alice Tsang			ASCEND-2: A single-arm, open-label, multicenter phase II study of ceritinib in adult patients (pts) with ALK-rearranged (ALK plus ) non-small cell lung cancer (NSCLC) previously treated with chemotherapy and crizotinib (CRZ).	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Chinese Univ Hong Kong, Shatin, Hong Kong, Peoples R China; Sarah Cannon Res Inst, Med Oncol, Nashville, TN USA; Vall dHebron Univ, Barcelona, Spain; European Inst Oncol, Thorac Oncol Div, Milan, Italy; Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea; Univ Groningen, Groningen, Netherlands; Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis, Groningen, Netherlands; Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA; Aichi Canc Ctr Hosp, Dept Thorac Oncol, Nagoya, Aichi 464, Japan; Osped S Maria Misericordia, Med Oncol, Perugia, Italy; Japanese Fdn Canc Res, Tokyo, Japan; Univ Turin, Turin, Italy; Novartis Pharma AG, Basel, Switzerland; Novartis Pharmaceut, E Hanover, NJ USA; Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA								0	3	3	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		8059						1	Oncology	Oncology	CM9OA	WOS:000358036901771		
J	Monk, BJ; Poveda, A; Vergote, I; Raspagliesi, F; Fujiwara, K; Bae, DS; Oaknin, A; Ray-Coquard, I; Provencher, DM; Karlan, BY; Lhomme, C; Richardson, G; Rincon, DG; Coleman, RL; Brize, A; Zhang, K; Vogl, FD; Bach, BA; Oza, AM				Monk, Bradley J.; Poveda, Andres; Vergote, Ignace; Raspagliesi, Francesco; Fujiwara, Keiichi; Bae, Duk-Soo; Oaknin, Ana; Ray-Coquard, Isabelle; Provencher, Diane M.; Karlan, Beth Y.; Lhomme, Catherine; Richardson, Gary; Rincon, Dolores Gallardo; Coleman, Robert L.; Brize, Arija; Zhang, Kathy; Vogl, Florian D.; Bach, Bruce A.; Oza, Amit M.			Impact of trebananib plus weekly paclitaxel on overall survival (OS) in patients (pts) with recurrent ovarian cancer and ascites: Results from the phase III TRINOVA-1 study.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Creighton Univ, Sch Med, Dign Hlth St Josephs Hosp & Med Ctr, Dept Obstet & Gynecol,Univ Arizona,Canc Ctr, Phoenix, AZ USA; Fdn Inst Valenciano Oncol, Area Clin Oncol Ginecol, Valencia, Spain; Univ Hosp Leuven, Dept Obstet & Gynecol, Kuleuven, Belgium; Fdn IRCCS, Ist Nazl Cura & Studio Tumori, Oncol Unit 4Gynecol, Milan, Italy; Saitama Med Univ, Int Med Ctr, Dept Gynecol Oncol, Hidaka, Japan; Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea; Vall dHebron Inst Oncol, Barcelona, Spain; Univ Lyon 1, Ctr Leon Berard, F-69365 Lyon, France; Ctr Hosp Univ Montreal, Div Gynecol Oncol, Montreal, PQ, Canada; Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Ctr, Womens Canc Program, Los Angeles, CA 90048 USA; Inst Gustave Roussy, Dept Med, Villejuif, France; Cabrini Hosp, Acad Haematol & Oncol, Malvern, Australia; Inst Nacl Cancerol, Subdirecc Med Interna, Mexico City, DF, Mexico; Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, Houston, TX 77030 USA; Riga Eastern Clin Univ Hosp, Latvian Oncol Ctr, Riga, Latvia; Amgen Inc, Global Biostat Sci, Thousand Oaks, CA 91320 USA; Amgen Inc, Global Dev Oncol, Thousand Oaks, CA 91320 USA; Princess Margaret Hosp, Dept Med, Toronto, ON M4X 1K9, Canada								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		5503						1	Oncology	Oncology	CM9OA	WOS:000358036901161		
J	Mori, M; Shimizu, C; Ogawa, A; Okusaka, T; Yoshida, S; Morita, T				Mori, Masanori; Shimizu, Chikako; Ogawa, Asao; Okusaka, Takuji; Yoshida, Saran; Morita, Tatsuya			Medical oncologists attitude toward end-of-life discussions: Effects of their experience, perceptions, and beliefs.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Seirei Hamamatsu Gen Hosp, Hamamatsu, Shizuoka, Japan; Natl Canc Ctr, Tokyo, Japan; Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan; Natl Canc Ctr, Dept Hepatobiliary & Pancreat Oncol, Tokyo, Japan; Natl Canc Ctr, Tokyo 104, Japan; Seirei Mikatahara Gen Hosp, Hamamatsu, Shizuoka, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e20503						1	Oncology	Oncology	CM9OA	WOS:000358036904136		
J	Morizane, C; Machida, N; Honma, Y; Okusaka, T; Boku, N; Kato, K; Mizusawa, J; Katayama, H; Hiraoka, N; Taniguchi, H; Ikeda, M; Shibuya, Y; Hosokawa, A; Mizuno, N; Sano, T; Tsuda, M; Yokosuka, O; Kitagawa, Y; Sasako, M; Furuse, J				Morizane, Chigusa; Machida, Nozomu; Honma, Yoshitaka; Okusaka, Takuji; Boku, Narikazu; Kato, Ken; Mizusawa, Junki; Katayama, Hiroshi; Hiraoka, Nobuyoshi; Taniguchi, Hirokazu; Ikeda, Masafumi; Shibuya, Yuichi; Hosokawa, Ayumu; Mizuno, Nobumasa; Sano, Takeshi; Tsuda, Masahiro; Yokosuka, Osamu; Kitagawa, Yuko; Sasako, Mitsuru; Furuse, Junji		JCOG	Randomized phase III study of etoposide plus cisplatin versus irinotecan plus cisplatin in advanced neuroendocrine carcinoma of the digestive system: A Japan Clinical Oncology Group study (JCOG1213).	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Natl Canc Ctr, Dept Hepatobiliary & Pancreat Oncol, Tokyo, Japan; Shizuoka Canc Ctr, Div Gastrointestinal Oncol, Shizuoka, Japan; Natl Canc Ctr, Gastrointestinal Med Oncol Div, Tokyo, Japan; Ctr Res Adm, Clin Oncol Grp Data Ctr, Tokyo, Japan; Support Natl Canc Ctr, Tokyo, Japan; Natl Canc Ctr, Res Inst, Div Mol Pathol, Tokyo 104, Japan; Natl Canc Ctr, Pathol Div & Clin Lab, Tokyo, Japan; East Hosp, Natl Canc Ctr, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, Japan; Kochi Hlth Sci Ctr, Dept Surg Gastroenterol, Kochi, Japan; Toyama Univ, Fac Med, Dept Gastroenterol & Hematol, Toyama 930, Japan; Aichi Canc Ctr Hosp, Dept Gastroenterol, Nagoya, Aichi 464, Japan; Canc Inst Hosp, Japanese Fdn Canc Res, Dept Surg Gastroenterol, Tokyo, Japan; Hyogo Canc Ctr, Dept Gastroenterol Oncol, Akashi, Hyogo, Japan; Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba, Japan; Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan; Hyogo Coll Med, Dept Surg, Nishinomiya, Hyogo 6638501, Japan; Kyorin Univ, Sch Med, Dept Med Oncol, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		TPS4143						1	Oncology	Oncology	CM9OA	WOS:000358036904751		
J	Murakami, Y; Saka, H; Oki, M; Kitagawa, C; Kogure, Y				Murakami, Yasushi; Saka, Hideo; Oki, Masahide; Kitagawa, Chiyoe; Kogure, Yoshihito			Efficacy of platinum rechallenge chemotherapy in sensitive relapsed small cell lung cancer after a long-term treatment-free interval.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Nagoya Med Ctr, Nagoya, Aichi, Japan; Natl Hosp Org, Nagoya Med Ctr, Nagoya, Aichi, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e18554						1	Oncology	Oncology	CM9OA	WOS:000358036903855		
J	Murata, A; Yoshida, K; Maeda, K; Ikejiri, K; Munemoto, Y; Sasaki, K; Matsuda, C; Kotake, M; Suenaga, T; Matsuda, H; Baba, H; Hamada, C; Oki, E; Emi, Y; Saji, S; Maehara, Y				Murata, Akihiko; Yoshida, Kazuhiro; Maeda, Kiyoshi; Ikejiri, Koji; Munemoto, Yoshinori; Sasaki, Kazuaki; Matsuda, Chu; Kotake, Masanori; Suenaga, Toyokuni; Matsuda, Hiroyuki; Baba, Hideo; Hamada, Chikuma; Oki, Eiji; Emi, Yasunori; Saji, Shigetoyo; Maehara, Yoshihiko			A randomized phase III trial comparing S-1 versus UFT as adjuvant chemotherapy for stage II/III rectal cancer (JFMC35-C1: ACTS-RC).	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Hirosaki Univ, Grad Sch Med, Dept Surg Gastroenterol, Hirosaki, Aomori, Japan; Gifu Univ, Dept Surg Oncol, Grad Sch Med, Gifu, Japan; Osaka City Univ, Dept Surg Oncol, Grad Sch Med, Osaka 558, Japan; Natl Kyushu Med Ctr, Dept Surg Gastroenterol, Fukuoka, Japan; Natl Kyushu Med Ctr, Clin Res Ctr, Canc Res Div, Fukuoka, Japan; Fukui Ken Saiseikai Hosp, Dept Surg, Fukui, Japan; Otaru Ekisaikai Hosp, Dept Surg, Otaru, Hokkaido, Japan; Osaka Gen Med Ctr, Dept Surg, Osaka, Japan; Kouseiren Takaoka Hosp, Dept Surg, Takaoka, Toyama, Japan; Nanpuh Hosp, Gastroenterol Surg, Kagoshima, Japan; Hiroshima Red Cross Hosp, Dept Surg, Hiroshima, Japan; Atom Bomb Survivors Hosp, Hiroshima, Japan; Kumamoto Univ, Dept Surg Gastroenterol, Grad Sch Med Sci, Kumamoto, Japan; Tokyo Univ Sci, Fac Engn, Tokyo 162, Japan; Kyushu Univ, Dept Surg & Sci, Grad Sch Med Sci, Fukuoka 812, Japan; Saiseikai Fukuoka Gen Hosp, Dept Surg, Fukuoka, Japan; Japanese Fdn Multidisciplinary Treatment Canc, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		3515						1	Oncology	Oncology	CM9OA	WOS:000358036900735		
J	Murata, S; Yamamoto, H; Yamaguchi, T; Kaida, S; Ishida, M; Takebayashi, K; Kodama, H; Tani, M				Murata, Satoshi; Yamamoto, Hiroshi; Yamaguchi, Tsuyoshi; Kaida, Sachiko; Ishida, Mitsuaki; Takebayashi, Katsushi; Kodama, Hirokazu; Tani, Masaji			A possible cellular source of peritoneal metastasis after curative distal gastrectomy for gastric cancer.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Shiga Univ Med Sci, Otsu, Shiga 52021, Japan; Shiga Univ Med Sci, Dept Surg, Otsu, Shiga 52021, Japan; Shiga Univ Med Sci, Dept Clin Lab Med, Otsu, Shiga 52021, Japan; Shiga Univ Med Sci, Div Diagnost Pathol, Otsu, Shiga 52021, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e15003						1	Oncology	Oncology	CM9OA	WOS:000358036902793		
J	Murata, T; Takahashi, M; Hayashida, T; Sugimoto, M; Jinno, H; Sunamura, M; Kitagawa, Y				Murata, Takeshi; Takahashi, Maiko; Hayashida, Tetsu; Sugimoto, Masahiro; Jinno, Hiromitsu; Sunamura, Makoto; Kitagawa, Yuko			Identification of potential salivary biomarkers for the early diagnosis of breast cancer.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan; Keio Univ, Sch Med, Tokyo, Japan; Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan; Tokyo Med Univ, Hachioji Med Ctr, Digest Surg & Transplantat Surg, Tokyo 1608402, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e22252						1	Oncology	Oncology	CM9OA	WOS:000358036904618		
J	Nagasaka, K; Taguchi, A; Kawana, K; Hashimoto, K; Plessy, C; Nakamura, H; Thomas, M; Oda, K; Kukimoto, I; Carninci, P; Banks, L; Osuga, Y; Fujii, T				Nagasaka, Kazunori; Taguchi, Ayumi; Kawana, Kei; Hashimoto, Kosuke; Plessy, Charles; Nakamura, Hiroe; Thomas, Miranda; Oda, Katsutoshi; Kukimoto, Iwao; Carninci, Piero; Banks, Lawrence; Osuga, Yutaka; Fujii, Tomoyuki			A new approach for screening cervical cancer by characterization of transcripts using CAGE technology.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Univ Tokyo, Dept Obstet & Gynecol, Tokyo, Japan; RIKEN Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa, Japan; Int Ctr Genet Engn & Biotechnol, Trieste, Italy; Univ Tokyo, Fac Med, Tokyo 113, Japan; Natl Inst Infect Dis, Pathogen Genom Ctr, Tokyo, Japan; Univ Tokyo, Fac Med, Dept Obstet & Gynecol, Tokyo 113, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e16514						1	Oncology	Oncology	CM9OA	WOS:000358036903311		
J	Naito, Y; Ohashi, Y; Yokota, I; Watanabe, T; Iwata, H; Ohsumi, S; Ohno, S; Hozumi, Y; Yamamoto, S; Takahashi, M; Aihara, T; Mukai, H				Naito, Yoichi; Ohashi, Yasuo; Yokota, Isao; Watanabe, Toru; Iwata, Hiroji; Ohsumi, Shozo; Ohno, Shinji; Hozumi, Yasuo; Yamamoto, Seiichiro; Takahashi, Masato; Aihara, Tomohiko; Mukai, Hirofumi			Impact of BMI on survival and toxicity in early breast cancer: An exploratory analysis of prospective randomized phase III study N-SAS BC02 and 03.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Natl Canc Ctr Hosp East, Chiba, Japan; Chuo Univ, Dept Integrated Sci & Engn, Sustainable Soc, Tokyo 112, Japan; Univ Tokyo, Dept Biostat, Tokyo, Japan; Hamamatsu Oncol Ctr, Hamamatsu, Shizuoka, Japan; Aichi Canc Ctr Hosp, Nagoya, Aichi 464, Japan; NHO Shikoku Canc Ctr, Dept Breast Oncol, Matsuyama, Ehime, Japan; Kyushu Natl Canc Ctr, Clin Res Inst, Fukuoka, Japan; Jichi Med Univ, Shimotsuke, Japan; Natl Canc Ctr, Tokyo 104, Japan; Hokkaido Canc Ctr, Natl Hosp Org, Sapporo, Hokkaido, Japan; Aihara Hosp, Mino, Japan; Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		11102						1	Oncology	Oncology	CM9OA	WOS:000358036900360		
J	Nakamura, K; Nakamura, M; Onikubo, T; Uchibori, K; Tauchi, K				Nakamura, Kumi; Nakamura, Masato; Onikubo, Toshihide; Uchibori, Kazuya; Tauchi, Katsunori			Phase II study of preventive effect of topical menthol for chemotherapy-induced peripheral neurotoxicity	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Aizawa Hosp, Matsumoto, Nagano, Japan; Aizawa Hosp, Aizawa Comprehens Canc Ctr, Matsumoto, Nagano, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		9610						1	Oncology	Oncology	CM9OA	WOS:000358036902105		
J	Nakano, K; Motoi, N; Tomomatsu, J; Gokita, T; Ae, K; Tanizawa, T; Shimoji, T; Matsumoto, S; Takahashi, S				Nakano, Kenji; Motoi, Noriko; Tomomatsu, Junichi; Gokita, Tabu; Ae, Keisuke; Tanizawa, Taisuke; Shimoji, Takashi; Matsumoto, Seiichi; Takahashi, Shunji			Risk factors of pneumothorax in advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatment	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Japanese Fdn Canc Res, Dept Med Oncol, Canc Inst Hosp, Tokyo, Japan; Japanese Fdn Canc Res, Inst Canc, Div Pathol, Tokyo 170, Japan; Japanese Fdn Canc Res, Canc Inst Hosp, Dept Orthoped Surg, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e21527						1	Oncology	Oncology	CM9OA	WOS:000358036904401		
J	Nakatsukasa, K; Taguchi, T; Sugimoto, R; Sakaguchi, K; Kotani, T; Hukuda, K; Kawakami, S; Hujiwara, I				Nakatsukasa, Katsuhiko; Taguchi, Tetsuya; Sugimoto, Riho; Sakaguchi, Kouichi; Kotani, Tatsuya; Hukuda, Kenichirou; Kawakami, Sadao; Hujiwara, Ikuya			Docetaxel, cyclophosphamide and trastuzumab as neoadjuvant chemotherapy in HER2-positive primary breast cancer.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Kyoto Prefectural Univ Med, Dept Endocrine & Breast Surg, Kyoto, Japan; Kyoto Prefectural Univ Med, Kyoto, Japan; Kyoto Daiichi Hosp, Japanese Red Cross Soc, Kyoto, Japan; Nantan Gen Hosp, Shiga, Japan; Fukuchiyama City Hosp, Hukuchiyama, Japan; Ayabe City Hosp, Ayabe, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		583						1	Oncology	Oncology	CM9OA	WOS:000358036901294		
J	Nakayama, I; Chin, K; Kumekawa, Y; Wakatsuki, T; Ogura, M; Ichimura, T; Takahari, D; Suenaga, M; Ozaka, M; Shinozaki, E; Mizunuma, N				Nakayama, Izuma; Chin, Keisho; Kumekawa, Yosuke; Wakatsuki, Takeru; Ogura, Mariko; Ichimura, Takashi; Takahari, Daisuke; Suenaga, Mitsukuni; Ozaka, Masato; Shinozaki, Eiji; Mizunuma, Nobuyuki			Clinical features and outcome of advanced or metastatic gastric cancer in young adult, analysis of 97 cacses	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Japanese Fdn Canc Res, Tokyo, Japan; Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol, Tokyo, Japan; Japanese Fdn Canc Res, Inst Canc, Koto Ku, Tokyo, Japan; Canc Inst Hosp, Dept Med Oncol, Tokyo, Japan; Canc Inst Hosp, Dept Gastroenterol, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e15022						1	Oncology	Oncology	CM9OA	WOS:000358036902810		
J	Narahara, H; Yasuda, K; Morita, K; Matsumoto, H; Yasunaga, Y; Inui, Y; Kawata, S; Takahashi, K; Teraoka, S				Narahara, Hiroyuki; Yasuda, Kayo; Morita, Kaori; Matsumoto, Hitoshi; Yasunaga, Yuichi; Inui, Yoshiaki; Kawata, Sumio; Takahashi, Katsuhito; Teraoka, Satoshi			Pazopanib for soft tissue sarcoma (STS) in the first-line setting with denosumab.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Hyogo Prefectural Nishinomiya Hosp, Nishinomiya, Hyogo, Japan; Hyogo Prefectural Nishinomiya Hosp, Dept Internal Med, Nishinomiya, Hyogo, Japan; Hyogo Prefectural Nishinomiya Hosp, Dept Clin Oncol, Nishinomiya, Hyogo, Japan; Osaka Med Ctr Canc & CV Dis, Dept Mol Med & Pathol, Osaka, Japan; Int Univ Hlth & Welf, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		10567						1	Oncology	Oncology	CM9OA	WOS:000358036900207		
J	Naya, Y; Oishi, M; Ueda, T; Nakanishi, H; Nakamura, T; Hongo, F; Kamoi, K; Okihara, K; Iwata, T; Kanazawa, M; Mikami, K; Miyashita, H; Miki, T				Naya, Yoshio; Oishi, Masakatsu; Ueda, Takashi; Nakanishi, Hiroyuki; Nakamura, Terukazu; Hongo, Fumiya; Kamoi, Kazumi; Okihara, Koji; Iwata, Tsuyoshi; Kanazawa, Motohiro; Mikami, Kazuya; Miyashita, Hiroaki; Miki, Tsuneharu		KPUM Oncology Study Grp	Effect of short term adjuvant intravesical chemotherapy on recurrence rates compared with one immediate postoperative intravesical chemotherapy in patients with non muscle invasive bladder carcinoma with low or intermediate recurrent risk.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Kyoto Prefectural Univ Med, Kyoto, Japan; Kyoto Prefectural Univ Med, Dept Urol, Kyoto, Japan; Kyoto Prefectural Univ Med, Dept Translat Canc Drug Dev, Kyoto, Japan; Kyoto Prefectural Univ Med, Dept Urol, Kyoto, Japan; Matsushita Mem Hosp, Dept Urol, Moriguchi, Osaka, Japan; Ohmihachiman City Hosp, Dept Urol, Ohmihachiman, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e15523						1	Oncology	Oncology	CM9OA	WOS:000358036903071		
J	Niho, S; Motegi, A; Kirita, K; Umemura, S; Matsumoto, S; Yoh, K; Ohmatsu, H; Toshima, M; Arahira, S; Onozawa, M; Goto, K; Akimoto, T				Niho, Seiji; Motegi, Atsushi; Kirita, Keisuke; Umemura, Shigeki; Matsumoto, Shingo; Yoh, Kiyotaka; Ohmatsu, Hironobu; Toshima, Masamichi; Arahira, Satoko; Onozawa, Masakatsu; Goto, Koichi; Akimoto, Tetsuo			Proton beam therapy (PBT) and concurrent chemotherapy using cisplatin (CDDP) and vinorelbine (VNR) for locally advanced non-small cell lung cancer (NSCLC).	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Natl Canc Ctr Hosp East, Div Thorac Oncol, Kashiwa, Chiba, Japan; Natl Canc Ctr Hosp East, Dept Radiat Oncol, Kashiwa, Chiba, Japan; Natl Canc Ctr Hosp East, Dept Thorac Oncol, Kashiwa, Chiba, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e18525						1	Oncology	Oncology	CM9OA	WOS:000358036903832		
J	Niikura, N; Tomotaki, A; Miyata, H; Iwamoto, T; Kawai, MS; Anan, K; Kinoshita, T; Masuda, S; Tsugawa, K; Tokuda, Y				Niikura, Naoki; Tomotaki, Ai; Miyata, Hiroaki; Iwamoto, Takayuki; Kawai, Masaaki S.; Anan, Keisei; Kinoshita, Takayuki; Masuda, Shinobu; Tsugawa, Koichiro; Tokuda, Yutaka			Neoadjuvant chemotherapy in the real world: A study of 22,819 patients from the Japanese National Clinical Database-Breast Cancer Registry.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Tokai Sch Med, Isehara, Kanagawa, Japan; Univ Tokyo, Grad Sch Med, Dept Healthcare Qual Assessment, Tokyo, Japan; Okayama Univ Hosp, Okayama, Japan; Miyagi Canc Ctr, Sendai, Miyagi, Japan; Kitakyushu Municipal Med Ctr, Kitakyushu, Fukuoka, Japan; Natl Canc Ctr, Tokyo, Japan; Nihon Univ, Sch Med, Tokyo, Japan; St Marianna Univ, Sch Med, Kawasaki, Kanagawa, Japan; Tokai Univ, Sch Med, Hiratsuka, Kanagawa 25912, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		588						1	Oncology	Oncology	CM9OA	WOS:000358036901299		
J	Ning, Y; Zhang, W; Hanna, DL; Mendez, A; Yang, DY; Sunakawa, Y; Stremitzer, S; Matsusaka, S; Okazaki, S; Parekh, A; El-Khoueiry, RE; Flores, B; Hauch, S; Barzi, A; El-Khoueiry, AB; Lenz, HJ				Ning, Yan; Zhang, Wu; Hanna, Diana L.; Mendez, Angela; Yang, Dongyun; Sunakawa, Yu; Stremitzer, Stefan; Matsusaka, Satoshi; Okazaki, Satoshi; Parekh, Anish; El-Khoueiry, Rita Elie; Flores, Becky; Hauch, Siegfried; Barzi, Afsaneh; El-Khoueiry, Anthony B.; Lenz, Heinz-Josef			Circulating tumor cell (CTC) EMT and stem cell biomarker expression predict overall survival (OS) in mCRC by a combined immunomagnetic qRT-PCR approach.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Univ So Calif, Norris Comprehens Canc Ctr, Los Angeles, CA USA; Univ So Calif, Norris Comprehens Canc Ctr, Pasadena, CA USA; Med Univ Vienna, Santa Monica, CA USA; Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol, Tokyo, Japan; Alere San Diego Inc, San Diego, CA USA; AdnaGen, Langenhagen, Germany; Univ So Calif, Los Angeles, CA USA								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		11018						1	Oncology	Oncology	CM9OA	WOS:000358036900277		
J	Nishida, T; Kitagawa, Y; Kurokawa, Y; Komatsu, Y; Ishioka, C; Doi, T; Yamada, Y; Ozaka, M; Cho, H; Kanda, T; Sugiyama, T; Sawaki, A; Kakeji, Y; Hirai, T; Hato, S; Baba, H; Shirao, K; Hirota, S; Kagimura, T				Nishida, Toshirou; Kitagawa, Yuko; Kurokawa, Yukinori; Komatsu, Yoshito; Ishioka, Chikashi; Doi, Toshihiko; Yamada, Yasuhide; Ozaka, Masato; Cho, Haruhiko; Kanda, Tetsuo; Sugiyama, Toshiro; Sawaki, Akira; Kakeji, Yoshihiro; Hirai, Toshihiro; Hato, Shinji; Baba, Hideo; Shirao, Kuniaki; Hirota, Seiichi; Kagimura, Tatsuo			ReGISTry Study of High Risk GIST Patients After Complete Resection: The adjuvant therapy and pathological diagnosis in Japan.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan; Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan; Osaka Univ, Dept Surg Gastroenterol, Grad Sch Med, Osaka, Japan; Hokkaido Univ Hosp, Ctr Canc, Div Canc Chemotherapy, Sapporo, Hokkaido 060, Japan; Inst Dev Aging Canc, Sendai, Miyagi, Japan; Natl Canc Ctr Hosp East, Chiba, Japan; Natl Canc Ctr, Gastrointestinal Med Oncol Div, Tokyo, Japan; Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol, Tokyo, Japan; Kanagawa Canc Ctr, Yokohama, Kanagawa 2410815, Japan; Sanjo Gen Hosp, Sanjo, Japan; Toyama Univ, Fac Med, Dept Gastroenterol & Hematol, Toyama 930, Japan; Kawasaki Med Univ, Kurashiki, Okayama, Japan; Kobe Univ, Div Gastrointestinal Surg, Dept Surg, Grad Sch Med, Kobe, Hyogo 657, Japan; Kawasaki Medcl Scholl, Kurashiki, Okayama, Japan; Natl Hosp Org, Shikoku Canc Ctr, Matsuyama, Ehime, Japan; Kumamoto Univ, Dept Surg Gastroenterol, Grad Sch Med Sci, Kumamoto, Japan; Oita Univ, Fac Med, Dept Med Oncol & Hematol, Oita 87011, Japan; Hyogo Coll Med, Dept Surg Pathol, Kobe, Hyogo, Japan; Fdn Biomed Res & Innovat, Translat Res Informat Ctr, Kobe, Hyogo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		10533						1	Oncology	Oncology	CM9OA	WOS:000358036900170		
J	Nishida, Y; Tsukushi, S; Urakawa, H; Hamada, S; Kozawa, E; Ikuta, K; Ando, Y; Ishiguro, N				Nishida, Yoshihiro; Tsukushi, Satoshi; Urakawa, Hiroshi; Hamada, Shunsuke; Kozawa, Eiji; Ikuta, Kunihiro; Ando, Yuichi; Ishiguro, Naoki			Low-dose chemotherapy with methotrexate and vinblastine for Japanese patients with desmoid tumors: Relationship to CTNNB1 mutational status.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4648601, Japan; Nagoya Univ Hosp, Dept Clin Oncol & Chemotherapy, Nagoya, Aichi, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e21524						1	Oncology	Oncology	CM9OA	WOS:000358036904398		
J	Nishikawa, R; Oseto, K; Nishikawa, H; Arakawa, A; Kai, K; Nasu, K; Morii-Kashima, M; Tsubamoto, H; Ito, K; Furukawa, N				Nishikawa, Ryutaro; Oseto, Kumiko; Nishikawa, Hiroshi; Arakawa, Atsushi; Kai, Kentaro; Nasu, Kaei; Morii-Kashima, Mina; Tsubamoto, Hiroshi; Ito, Kimihiko; Furukawa, Naoto			Usefulness of the patient self-administered cancer family history questionnaire in identification of gynecological cancer patients suspected of Lynch syndrome: KCOG-G1302 study	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Nagoya City Univ, Nagoya, Aichi, Japan; Nagoya City Univ, Grad Sch Med, Dept Obstet & Gynecol, Nagoya, Aichi, Japan; Nagoya City Univ Hosp, Nagoya, Aichi, Japan; Oita Univ, Fac Med, Dept Obstet & Gynecol, Yufu, Japan; Hyogo Coll Med, Dept Obstet & Gynecol, Nishinomiya, Hyogo 6638501, Japan; Hyogo Coll Med, Nishinomiya, Hyogo 6638501, Japan; Kansai Rosai Hosp, Dept Obstet & Gynecol, Amagasaki, Hyogo, Japan; Nara Med Univ, Dept Obstet & Gynecol, Kashihara, Nara 634, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		1518						1	Oncology	Oncology	CM9OA	WOS:000358036900385		
J	Nishimura, M; Yahagi, N; Itoi, T; Ochiai, Y; Matsuda, Y				Nishimura, Makoto; Yahagi, Naohisa; Itoi, Takao; Ochiai, Yasutoshi; Matsuda, Yoko			A translational study to investigate the role of carbohydrate sulfotransferase 15 for pancreatic cancer biology from in vitro to first-in-human clinical research.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Tokyo Metropolitan Geriatr Hosp, Tokyo 173, Japan; Keio Univ, Sch Med, Tokyo, Japan; Tokyo Med Univ, Tokyo 1608402, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e22201						1	Oncology	Oncology	CM9OA	WOS:000358036904576		
J	Nishio, M; Hida, T; Nakagawa, K; Sakai, H; Nogami, N; Atagi, S; Takahashi, T; Nokihara, H; Saka, H; Takenoyama, M; Fujita, S; Tanaka, H; Takeda, K; Satouchi, M; Isobe, H; Maemondo, M; Goto, K; Hirashima, T; Minato, K; Tamura, T				Nishio, Makoto; Hida, Toyoaki; Nakagawa, Kazuhiko; Sakai, Hiroshi; Nogami, Naoyuki; Atagi, Shinji; Takahashi, Toshiaki; Nokihara, Hiroshi; Saka, Hideo; Takenoyama, Mitsuhiro; Fujita, Shiro; Tanaka, Hiroshi; Takeda, Koji; Satouchi, Miyako; Isobe, Hiroshi; Maemondo, Makoto; Goto, Koichi; Hirashima, Tomonori; Minato, Koichi; Tamura, Tomohide			Phase II studies of nivolumab (anti-PD-1, BMS-936558, ONO-4538) in patients with advanced squamous (sq) or nonsquamous (non-sq) non-small cell lung cancer (NSCLC).	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Japanese Fdn Canc Res, Tokyo, Japan; Aichi Canc Ctr Hosp, Dept Thorac Oncol, Nagoya, Aichi 464, Japan; Kinki Univ, Fac Med, Osakasayama, Japan; Saitama Canc Ctr, Saitama, Japan; Shikoku Canc Ctr, Natl Hosp Org, Clin Res Inst, Matsuyama, Ehime, Japan; Kinki Chuo Chest Med Ctr, Osaka, Japan; Shizuoka Canc Ctr, Div Thorac Oncol, Shizuoka, Japan; Natl Canc Ctr, Tokyo, Japan; Nagoya Med Ctr, Nagoya, Aichi, Japan; Kyushu Canc Ctr, Natl Hosp Org, Fukuoka, Japan; Inst Biomed Res & Innovat, Kobe, Hyogo, Japan; Niigata Canc Ctr Hosp, Niigata, Japan; Osaka City Gen Hosp, Dept Clin Oncol, Osaka, Japan; Hyogo Canc Ctr, Akashi, Hyogo, Japan; KKR Sapporo Med Ctr, Dept Med Oncol, Sapporo, Hokkaido, Japan; Miyagi Canc Ctr, Sendai, Miyagi, Japan; Natl Canc Ctr Hosp East, Div Thorac Oncol, Kashiwa, Chiba, Japan; Osaka Prefectural Med Ctr Resp & Allerg Dis, Habikino, Osaka, Japan; Gunma Canc Ctr, Ota, Japan; St Lukes Int Hosp, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		8027						1	Oncology	Oncology	CM9OA	WOS:000358036901740		
J	Nokihara, H; Katakami, N; Hida, T; Imamura, F; Sakai, H; Atagi, S; Nishio, M; Helwig, C; Achiwa, H; Tamura, T				Nokihara, Hiroshi; Katakami, Nobuyuki; Hida, Toyoaki; Imamura, Fumio; Sakai, Hiroshi; Atagi, Shinji; Nishio, Makoto; Helwig, Christoph; Achiwa, Hiroyuki; Tamura, Tomohide			Phase I/II study of tecemotide cancer immunotherapy for Japanese patients with unresectable stage III non-small cell lung cancer (NSCLC).	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Natl Canc Ctr, Tokyo, Japan; Inst Biomed Res & Innovat, Kobe, Hyogo, Japan; Aichi Canc Ctr Hosp, Dept Thorac Oncol, Nagoya, Aichi 464, Japan; Osaka Med Ctr, Osaka, Japan; Saitama Canc Ctr, Saitama, Japan; Kinki Chuo Chest Med Ctr, Osaka, Japan; Japanese Fdn Canc Res, Tokyo, Japan; Merck KGaA, Darmstadt, Germany; Merck Serono Co Ltd, Tokyo, Japan; St Lukes Int Hosp, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		3036						1	Oncology	Oncology	CM9OA	WOS:000358036900670		
J	Nomura, S; Umemura, S; Yoh, K; Shinozaki, T; Shibata, T; Nakamura, K; Satouchi, M; Ohe, Y; Fukuda, H				Nomura, Shogo; Umemura, Shigeki; Yoh, Kiyotaka; Shinozaki, Tomohiro; Shibata, Taro; Nakamura, Kenichi; Satouchi, Miyako; Ohe, Yuichiro; Fukuda, Haruhiko			Survival impact of switching to different topoisomerase I or II inhibitors-based regimens (topo-I or topo-II) in extensive-disease small cell lung cancer (ED-SCLC): supplemental analysis from JCOG0509.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Natl Canc Ctr, Ctr Res Adm & Support, Kashiwa, Chiba, Japan; Natl Canc Ctr Hosp East, Div Thorac Oncol, Kashiwa, Chiba, Japan; Univ Tokyo, Dept Biostat, Tokyo, Japan; Natl Canc Ctr, JCOG Data Ctr, Tokyo 104, Japan; Natl Canc Ctr, Japan Clin Oncol Grp, Operat Off, Tokyo 104, Japan; Hyogo Canc Ctr, Akashi, Hyogo, Japan; Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan; Natl Canc Ctr, Japan Clin Oncol Grp, Ctr Data, Tokyo 104, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		7571						1	Oncology	Oncology	CM9OA	WOS:000358036901701		
J	Nosaki, K; Inamasu, E; Shimamatsu, S; Yoshida, T; Toyokawa, G; Hirai, F; Yamaguchi, M; Seto, T; Takenoyama, M; Ichinose, Y				Nosaki, Kaname; Inamasu, Eiko; Shimamatsu, Shin-ichiro; Yoshida, Tsukihisa; Toyokawa, Goji; Hirai, Fumihiko; Yamaguchi, Masafumi; Seto, Takashi; Takenoyama, Mitsuhiro; Ichinose, Yukito			Re-biopsy in advanced non-small cell lung cancer patients after the development of 3rd generation EGFR-TKI and new targeted therapies.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Kyushu Natl Canc Ctr, Dept Thorac Oncol, Fukuoka, Japan; Natl Hosp Org Kyushu Canc Ctr, Dept Thorac Oncol, Fukuoka, Japan; Kyushu Natl Canc Ctr, Fukuoka, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e19081						1	Oncology	Oncology	CM9OA	WOS:000358036903928		
J	Nozaki, S; Oshita, T; Nakatani, Y; Sasano, Y; Yamamoto, K; Hume, WE; Wada, Y; Ishii, A; Tanaka, M; Shiomi, S; Tsuyuguchi, N; Kodama, K; Watanabe, Y				Nozaki, Satoshi; Oshita, Tomoko; Nakatani, Yuka; Sasano, Yumi; Yamamoto, Kenichiro; Hume, W. Ewan; Wada, Yasuhiro; Ishii, Akira; Tanaka, Masaaki; Shiomi, Susumu; Tsuyuguchi, Naohiro; Kodama, Kazuya; Watanabe, Yasuyoshi			[F-18]AA-7: PET imaging in patients with suspected glioma.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					RIKEN Innovat Ctr RINC, Novel PET Diagnost Lab, Kobe, Hyogo, Japan; CLST, RIKEN, Kobe, Hyogo, Japan; NAGASE & CO LTD, Life & Healthcare Prod Dept, Kobe, Hyogo, Japan; Nagase ChemteX Corp, Dept Res & Dev, Tatsuno, Japan; Osaka City Univ, Grad Sch Med, Dept Physiol, Osaka 558, Japan; Osaka City Univ, Grad Sch Med, Dept Nucl Med, Osaka 558, Japan; Osaka City Univ, Grad Sch Med, Dept Neurosurg, Osaka 558, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		11066						1	Oncology	Oncology	CM9OA	WOS:000358036900325		
J	Nozawa, M; Sugiyama, T; Sugimoto, K; Nagai, T; Hatanaka, Y; Oki, T; Tahara, H; Matsuda, H; Uemura, H				Nozawa, Masahiro; Sugiyama, Takahide; Sugimoto, Koichi; Nagai, Tasuharu; Hatanaka, Yuji; Oki, Takashi; Tahara, Hideo; Matsuda, Hisao; Uemura, Hirotsugu			Phase II study of degarelix/bicalutamide combination for prostate cancer.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Kinki Univ, Fac Med, Dept Urol, Osaka, Japan; Takaishi Fujii Hosp, Takaishi, Japan; Kinki Univ, Fac Med, Sakai Hosp, Sakai, Osaka, Japan; Natl Hosp Org Osaka Miami Med Ctr, Kawachi Nagano, Japan; Saiseikai Tondabayashi Hosp, Tondabayashi, Japan; NTT Osaka Hosp, Osaka, Japan; Mimihara Gen Hosp, Sakai, Osaka, Japan; Kashimoto Hosp, Osaka, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e16005						1	Oncology	Oncology	CM9OA	WOS:000358036903182		
J	Ochiai, T; Nishimura, K; Watanabe, T; Kitajima, M; Nakatani, A; Sato, T; Kishine, K; Nagaoka, I; Futagawa, S				Ochiai, Takumi; Nishimura, Kazuhiko; Watanabe, Tomoo; Kitajima, Masayuki; Nakatani, Akinori; Sato, Tsuyoshi; Kishine, Kennji; Nagaoka, Isao; Futagawa, Shunji			Personalized first-line chemotherapy for advanced colorectal cancer using the collagen gel droplet-embedded culture drug sensitivity test.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Tobu Chiiki Hosp, Dept Surg, Tokyo Metropolitan Hlth & Med Treatment Corp, Tokyo, Japan; Tobu Chiiki Hosp, Tokyo Metropolitan Hlth & Med Treatment Corp, Tokyo, Japan; Juntendo Univ, Sch Med, Dept Host Def & Biochem Res, Tokyo 113, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e14523						1	Oncology	Oncology	CM9OA	WOS:000358036902647		
J	Ogita, S				Ogita, Shin			HBV reactivation, flare and fulminant hepatitis in patients receiving non-rituximab chemotherapy.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					[Ogita, Shin] St Lukes Int Hosp, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e20729						1	Oncology	Oncology	CM9OA	WOS:000358036904326		
J	Ogiya, R; Kumaki, N; Bianchini, G; Iwamoto, T; Hayashi, N; Tanaka, T; Niikura, N; Tokuda, Y				Ogiya, Rin; Kumaki, Nobue; Bianchini, Giampaolo; Iwamoto, Takayuki; Hayashi, Naoki; Tanaka, Toshiya; Niikura, Naoki; Tokuda, Yutaka			Comparison of tumor-infiltrating lymphocytes between primary and metastatic tumors in breast cancer patients.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Tokai Univ, Sch Med, Isehara, Kanagawa 25911, Japan; Hosp San Raffaele, I-20132 Milan, Italy; Okayama Univ Hosp, Okayama, Japan; St Lukes Int Hosp, Tokyo, Japan; Tokai Sch Med, Isehara, Kanagawa, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		11021						1	Oncology	Oncology	CM9OA	WOS:000358036900280		
J	Ogura, M; Tobinai, K; Shibata, T; Ando, K; Kurosawa, M; Gomyo, H; Uike, N; Tsukamoto, N; Fukuhara, N; Shimoyama, T; Taniwaki, M; Nosaka, K; Matsuno, Y; Hotta, T; Tsukasaki, K; Morishima, Y; Yamamoto, K				Ogura, Michinori; Tobinai, Kensei; Shibata, Taro; Ando, Kiyoshi; Kurosawa, Mitsutoshi; Gomyo, Hiroshi; Uike, Naokuni; Tsukamoto, Norifumi; Fukuhara, Noriko; Shimoyama, Tatsu; Taniwaki, Masafumi; Nosaka, Kisato; Matsuno, Yoshihiro; Hotta, Tomomitsu; Tsukasaki, Kunihiro; Morishima, Yasuo; Yamamoto, Kazuhito		JCOG-LSG	Phase II study of rituximab plus high-dose ara-C (HDAC)-containing chemotherapy (CTX) followed by ASCT in untreated mantle cell lymphoma (MCL): Japan Clinical Oncology Group study (JCOG0406)	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Natl Hosp Org Suzuka Natl Hosp, Suzuka, Japan; Natl Canc Ctr, Tokyo, Japan; Natl Canc Ctr, JCOG Data Ctr, Tokyo 104, Japan; Tokai Univ, Sch Med, Univ Hosp, Isehara, Kanagawa 25911, Japan; Hokkaido Canc Ctr, Sapporo, Hokkaido, Japan; Hyogo Canc Ctr, Akashi, Hyogo, Japan; Natl Hosp Org Kyushu Canc Ctr, Fukuoka, Japan; Gunma Univ Hosp, Maebashi, Gumma, Japan; Tohoku Univ Hosp, Sendai, Miyagi, Japan; Tokyo Metropolitan Komagome Hosp, Tokyo, Japan; Kyoto Prefectural Univ Med, Kyoto, Japan; Kumamoto Univ Hosp, Kumamoto, Japan; Hokkaido Univ Hosp, Sapporo, Hokkaido 060, Japan; Natl Canc Ctr, Tokyo 104, Japan; Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan; Aichi Canc Ctr, Res Inst, Nagoya, Aichi 464, Japan; Aichi Canc Ctr, Nagoya, Aichi 464, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		8565						1	Oncology	Oncology	CM9OA	WOS:000358036901877		
J	Ohe, Y; Nishio, M; Kiura, K; Seto, T; Nakagawa, K; Maemondo, M; Inoue, A; Hida, T; Yoshioka, H; Harada, M; Nogami, N; Murakami, H; Takeuchi, K; Shimada, T; Kuriki, H; Tanaka, T; Tamura, T				Ohe, Yuichiro; Nishio, Makoto; Kiura, Katsuyuki; Seto, Takashi; Nakagawa, Kazuhiko; Maemondo, Makoto; Inoue, Akira; Hida, Toyoaki; Yoshioka, Hiroshige; Harada, Masao; Nogami, Naoyuki; Murakami, Haruyasu; Takeuchi, Kengo; Shimada, Tadashi; Kuriki, Hiroshi; Tanaka, Tomohiro; Tamura, Tomohide			A phase I/II study with a CNS-penetrant, selective ALK inhibitor alectinib in ALK-rearranged non-small cell lung cancer (ALK plus NSCLC) patients (pts): Updates on progression free survival (PFS) and safety results from AF-001JP.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Natl Canc Ctr, Dept Thorac Oncol, Tokyo, Japan; Japanese Fdn Canc Res, Tokyo, Japan; Okayama Univ Hosp, Dept Resp Med, Okayama, Japan; Kyushu Natl Canc Ctr, Fukuoka, Japan; Kinki Univ, Facultyof Med, Osakasayama, Japan; Miyagi Canc Ctr, Sendai, Miyagi, Japan; Tohoku Univ Hosp, Sendai, Miyagi, Japan; Aichi Canc Ctr Hosp, Dept Thorac Oncol, Nagoya, Aichi 464, Japan; Kurashiki Cent Hosp, Kurashiki, Okayama, Japan; Natl Hosp Org Hokkaido Canc Ctr, Dept Resp Med, Sapporo, Hokkaido, Japan; Natl Hosp Org Shikoku Canc Ctr, Clin Res Inst, Matsuyama, Ehime, Japan; Shizuoka Canc Ctr, Div Thorac Oncol, Shizuoka, Japan; Japanese Fdn Canc Res, Inst Canc, Div Pathol, Tokyo 170, Japan; Chugai Pharmaceut Co Ltd, Tokyo, Japan; Natl Canc Ctr, Tokyo, Japan								0	2	2	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		8061						1	Oncology	Oncology	CM9OA	WOS:000358036901773		
J	Ohmoto, A; Morizane, C; Kubo, E; Takai, E; Shimada, K; Okusaka, T; Yachida, S				Ohmoto, Akihiro; Morizane, Chigusa; Kubo, Emi; Takai, Erina; Shimada, Kazuaki; Okusaka, Takuji; Yachida, Shinichi			Clinicopathologic and germline mutation analysis of young patients (age 40 and younger) with pancreatic ductal adenocarcinoma.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Natl Canc Ctr, Div Hepatobiliary & Pancreat Oncol, Tokyo, Japan; Natl Canc Ctr, Dept Hepatobiliary & Pancreat Oncol, Tokyo, Japan; Natl Canc Ctr, Div Canc Genom, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e15296						1	Oncology	Oncology	CM9OA	WOS:000358036903048		
J	Ohno, T; de Kerckhove, C; Mine, T; Yoshioka, H; Kosaka, M; Matsuda, K; de Kerckhove, M; Mori, Y; Matsuo, S; Azuma, T; Mishima, T; Inoue, S; Hamada, T; Eguchi, S				Ohno, Tsuyoshi; de Kerckhove, Charles; Mine, Takashi; Yoshioka, Hiroki; Kosaka, Mikiko; Matsuda, Kazuyuki; de Kerckhove, Maiko; Mori, Yoshihiro; Matsuo, Shigetoshi; Azuma, Takashi; Mishima, Takehiro; Inoue, Satoshi; Hamada, Takashi; Eguchi, Susumu			How compression therapy could be alleviating chemotherapy-induced peripheral neuropathy: A study of skin microcirculation homeostasis across all CIPN grades	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Nagasaki Prefecture Shimabara Hosp, Shimabara, Japan; Nagasaki Harbor Med Ctr City Hosp, Nagasaki, Japan; Nagasaki Univ, Dept Surg, Grad Sch Biomed Sci, Nagasaki 852, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e20670						1	Oncology	Oncology	CM9OA	WOS:000358036904280		
J	Ohtaki, Y; Yamane, A; Shimizu, K; Rokudai, S; Nagashima, T; Obayashi, K; Yamashita, Y; Taniyama, K; Mitsudomi, T; Yatabe, Y; Takeyoshi, I; Nishiyama, M				Ohtaki, Yoichi; Yamane, Arito; Shimizu, Kimihiro; Rokudai, Susumu; Nagashima, Toshiteru; Obayashi, Kai; Yamashita, Yoshinori; Taniyama, Kiyomi; Mitsudomi, Tetsuya; Yatabe, Yasushi; Takeyoshi, Izumi; Nishiyama, Masahiko			Features of prognosis, genetics and drug sensitivity of very elderly lung cancer patients.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Gunma Univ, Grad Sch Med, Dept Thorac & Visceral Organ Surg, Maebashi, Gumma 371, Japan; Gunma Univ, Maebashi, Gumma 371, Japan; Gunma Univ, Grad Sch Med, Dept Thorac & Visceral Surg, Maebashi, Gumma 371, Japan; Gunma Univ, Grad Sch Med, Dept Mol Pharmacol & Oncol, Maebashi, Gumma 371, Japan; Chugoku Canc Ctr, Kure Med Ctr, Dept Gen Thorac Surg, Hiroshima, Japan; Natl Hosp Org, Kure Med Ctr, Chugoku Canc Ctr, Hiroshima, Japan; Kinki Univ, Sch Med, Osaka 589, Japan; Aichi Canc Ctr Hosp, Dept Pathol & Mol Diagnost, Nagoya, Aichi 464, Japan; Gunma Univ, Grad Sch Med, Maebashi, Gunma 371, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e20540						1	Oncology	Oncology	CM9OA	WOS:000358036904169		
J	Ohtsu, A; Yoshino, T; Wahba, MM; Benedetti, FM; Mayer, RJ; Van Cutsem, E				Ohtsu, Atsushi; Yoshino, Takayuki; Wahba, Mona M.; Benedetti, Fabio M.; Mayer, Robert J.; Van Cutsem, Eric		RECOURSE Study Grp	Phase 3 RECOURSE trial of TAS-102 versus placebo with best supportive care in patients with metastatic colorectal cancer: Geographic subgroups	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan; Taiho Oncol Inc, Princeton, NJ USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Univ Hosp Leuven, Leuven, Belgium								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		3564						1	Oncology	Oncology	CM9OA	WOS:000358036900783		
J	Oki, E; Emi, Y; Saeki, H; Tokunaga, S; Beppu, T; Shirabe, K; Takatsuki, M; Uchida, S; Sakoda, M; Eguchi, S; Inomata, M; Akagi, Y; Natsugoe, S; Ogata, Y; Kakeji, Y; Baba, H; Iyama, K; Maehara, Y				Oki, Eiji; Emi, Yasunori; Saeki, Hiroshi; Tokunaga, Shoji; Beppu, Toru; Shirabe, Ken; Takatsuki, Mitsuhisa; Uchida, Shinji; Sakoda, Masahiko; Eguchi, Susumu; Inomata, Masafumi; Akagi, Yoshito; Natsugoe, Shoji; Ogata, Yutaka; Kakeji, Yoshihiro; Baba, Hideo; Iyama, Kenichi; Maehara, Yoshihiko			A central review of liver resectability and pathological tumor response after chemotherapy in patients with initially unresectable colorectal cancer liver metastases: Phase II trials of mFOLFOX6 plus bevacizumab (KSCC0802), and SOX (S-1 and oxaliplatin) plus cetuximab (KSCC1002).	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan; Saiseikai Fukuoka Gen Hosp, Dept Surg, Fukuoka, Japan; Kyushu Univ, Dept Surg & Sci, Fukuoka 812, Japan; Kyushu Univ Hosp, Med Informat Ctr, Fukuoka 812, Japan; Kumamoto Univ, Kumamoto, Japan; Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg, Nagasaki 852, Japan; Kurume Univ, Med Ctr, Dept Surg, Kurume, Fukuoka 830, Japan; Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Digest Surg Breast & Thyroid Surg, Kagoshima 890, Japan; Oita Univ, Fac Med, Dept Gastroenterol & Pediat Surg, Oita 87011, Japan; Kurume Univ, Dept Surg, Kurume, Fukuoka 830, Japan; Kagoshima Univ, Grad Sch, Kagoshima 890, Japan; Kurume Univ, Sch Med, Kurume Med Ctr, Kurume, Fukuoka 830, Japan; Kobe Univ, Grad Sch Med, Dept Surg, Div Gastrointestinal Surg, Kobe, Hyogo 657, Japan; Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Kumamoto, Japan; Kumamoto Gen Hosp, Kumamoto, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e14548						1	Oncology	Oncology	CM9OA	WOS:000358036902665		
J	Okuma, Y; Hosomi, Y; Miyamoto, S; Nakahara, Y; Okamura, T; Hishima, T				Okuma, Yusuke; Hosomi, Yukio; Miyamoto, Shingo; Nakahara, Yoshiro; Okamura, Tatsuru; Hishima, Tsunekazu			Correlation between S-1 treatment outcome and expression of biomarkers for refractory thymic carcinoma.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Thorac Oncol & Resp Med, Tokyo, Japan; Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan; Japanese Red Cross Med Ctr, Kawasaki, Kanagawa, Japan; Tokyo Metropolitan Komagome Hosp, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e18565						1	Oncology	Oncology	CM9OA	WOS:000358036903866		
J	Omori, S; Kenmotsu, H; Abe, M; Watanabe, R; Sugino, T; Wakuda, K; Ono, A; Taira, T; Naito, T; Murakami, H; Ohde, Y; Endo, M; Akiyama, Y; Nakajima, T; Takahashi, T				Omori, Shota; Kenmotsu, Hirotsugu; Abe, Masato; Watanabe, Reiko; Sugino, Takashi; Wakuda, Kazushige; Ono, Akira; Taira, Tetsuhiko; Naito, Tateaki; Murakami, Haruyasu; Ohde, Yasuhisa; Endo, Masahiro; Akiyama, Yasuto; Nakajima, Takashi; Takahashi, Toshiaki			Changes in PD-L1 expression in non-small cell lung cancer by immunohistochemical analysis	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Shizuoka Canc Ctr, Div Thorac Oncol, Shizuoka, Japan; Shizuoka Canc Ctr, Div Pathol, Shizuoka, Japan; Shizuoka Canc Ctr, Div Diagnost Radiol, Shizuoka, Japan; Shizuoka Canc Ctr, Div Immunotherapy, Res Inst, Shizuoka, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e22118						1	Oncology	Oncology	CM9OA	WOS:000358036904504		
J	Onoe, T; Tanioka, M; Yamaguchi, S; Sato, S; Shimada, M; Nishimura, M; Okame, S; Kojima, A; Kigawa, J; Fujiwara, K				Onoe, Takuma; Tanioka, Maki; Yamaguchi, Satoshi; Sato, Shinya; Shimada, Muneaki; Nishimura, Masato; Okame, Shinichi; Kojima, Atsumi; Kigawa, Junzo; Fujiwara, Kiyoshi			Dose-dense paclitaxel with cisplatin as perioperative chemotherapy for locally advanced cervical cancer: Early efficacy results of a multicenter phase II study.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Hyogo Canc Ctr, Dept Med Oncol, Akashi, Hyogo, Japan; Hyogo Canc Ctr, Gynecol Oncol, Akashi, Hyogo, Japan; Tottori Univ Hosp, Div Gynecol Oncol, Yonago, Tottori, Japan; Univ Tokushima, Grad Sch, Obstet & Gynecol, Tokushima 770, Japan; Shikoku Canc Ctr, Gynecol Oncol, Matsuyama, Ehime, Japan; Matsue City Hosp, Matsue, Shimane, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e16515						1	Oncology	Oncology	CM9OA	WOS:000358036903312		
J	Orita, H; Mizuguchi, K; Ito, T; Sakurada, M; Kushida, T; Maekawa, H; Sato, K				Orita, Hajime; Mizuguchi, Konomi; Ito, Tomoaki; Sakurada, Mutsumi; Kushida, Tomoyuki; Maekawa, Hiroshi; Sato, Koichi			Pfetin as a risk factor of recurrence in gastrointestinal stromal tumors (GIST).	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Juntendo Univ, Dept Surg, Shizuoka Hosp, Shizuoka, Japan; Juntendo Univ, Shizuoka Hosp, Dept Surg, Izunokuni, Shizuoka, Japan; Juntendo Shizuoka Hosp, Dept Surg, Shizuoka, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e21506						1	Oncology	Oncology	CM9OA	WOS:000358036904382		
J	Oshima, T; Sakamaki, K; Miyagi, Y; Yoshikawa, T; Shiozawa, M; Cho, H; Rino, Y; Kunisaki, C; Tsuburaya, A; Imada, T; Masuda, M				Oshima, Takashi; Sakamaki, Kentaro; Miyagi, Yohei; Yoshikawa, Takaki; Shiozawa, Manabu; Cho, Haruhiko; Rino, Yasushi; Kunisaki, Chikara; Tsuburaya, Akira; Imada, Toshio; Masuda, Munetaka			Stratification markers for the risk of recurrence after curative resection of stage II or III gastric cancer and potential clinical applications.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Yokohama City Univ, Gastroenterol Ctr, Yokohama, Kanagawa 232, Japan; Yokohama City Univ, Dept Biostat & Epidemiol, Yokohama, Kanagawa 232, Japan; Kanagawa Canc Ctr, Res Inst, Div Mol Pathol & Genet, Yokohama, Kanagawa 2410815, Japan; Kanagawa Canc Ctr, Dept Gastrointestinal Surg, Yokohama, Kanagawa 2410815, Japan; Kanagawa Canc Ctr, Yokohama, Kanagawa 2410815, Japan; Yokohama City Univ, Dept Surg, Yokohama, Kanagawa 232, Japan; Yokohama City Univ, Med Ctr, Yokohama, Kanagawa 232, Japan; Saiseikai Yokohamashi Nanbu Hosp, Yokohama, Kanagawa, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		11040						1	Oncology	Oncology	CM9OA	WOS:000358036900299		
J	Osumi, H; Shinozaki, E; Suenaga, M; Matsusaka, S; Ogura, M; Ozaka, M; Kumekawa, Y; Chin, K; Fujimoto, Y; Ueno, M; Mizunuma, N				Osumi, Hiroki; Shinozaki, Eiji; Suenaga, Mitsukuni; Matsusaka, Satoshi; Ogura, Mariko; Ozaka, Masato; Kumekawa, Yosuke; Chin, Keisho; Fujimoto, Yoshiya; Ueno, Masashi; Mizunuma, Nobuyuki			The transition of adjuvant chemotherapy for stage III colorectal cancer: A single institute experience in Japan.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol, Tokyo, Japan; Japanese Fdn Canc Res, Inst Canc, Koto Ku, Tokyo 170, Japan; Canc Inst Hosp, Gastroenterol Ctr, Tokyo, Japan; Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol Surg, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e14528						1	Oncology	Oncology	CM9OA	WOS:000358036902650		
J	Otsubo, R; Hirakawa, H; Oikawa, M; Yano, H; Shindo, H; Matsumoto, M; Baba, M; Fukushima, A; Shibata, K; Taniguchi, H; Nagayasu, T				Otsubo, Ryota; Hirakawa, Hiroshi; Oikawa, Masahiro; Yano, Hiroshi; Shindo, Hisakazu; Matsumoto, Megumi; Baba, Masayuki; Fukushima, Ayako; Shibata, Kenichiro; Taniguchi, Hideki; Nagayasu, Takeshi			Validation of a novel diagnostic kit using the semi-dry dot-blot method for detecting metastatic lymph nodes in breast cancer	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Nagasaki Univ Hosp, Div Surg Oncol, Nagasaki, Japan; Aiyuukai Mem Hosp, Chiba, Japan; Kyushu Natl Canc Ctr, Fukuoka, Japan; Nagasaki Univ Hosp, Nagasaki, Japan; Japanese Red Cross Nagasaki Genbaku Hosp, Nagasaki, Japan; Nagasaki Univ, Grad Sch Biomed Sci, Div Surg Oncol, Nagasaki 852, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e22129						1	Oncology	Oncology	CM9OA	WOS:000358036904515		
J	Ouchi, K; Takahashi, S; Yamada, Y; Tsuji, S; Tatsuno, K; Takahashi, H; Takahashi, N; Takahashi, M; Shimodaira, H; Aburatani, H; Ishioka, C				Ouchi, Kota; Takahashi, Shin; Yamada, Yasuhide; Tsuji, Shingo; Tatsuno, Kenji; Takahashi, Hidekazu; Takahashi, Naoki; Takahashi, Masanobu; Shimodaira, Hideki; Aburatani, Hiroyuki; Ishioka, Chikashi			DNA methylation profile to predict clinical outcome of anti-EGFR treatment in metastatic colorectal cancer.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Tohoku Univ, Sendai, Miyagi 980, Japan; Tohoku Univ Hosp, Sendai, Miyagi, Japan; Natl Canc Ctr, Gastrointestinal Med Oncol Div, Tokyo, Japan; Univ Tokyo, Tokyo, Japan; Tohoku Univ, Tohoku Univ Hosp, Sendai, Miyagi 980, Japan; Tohoku Univ Hosp, Dept Clin Oncol, Sendai, Miyagi, Japan; Univ Tokyo, Adv Sci & Technol Res Ctr, Genome Sci Div, Tokyo, Japan; Inst Dev Aging Canc, Sendai, Miyagi, Japan			Tatsuno, Kenji/B-1765-2008					0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e14574						1	Oncology	Oncology	CM9OA	WOS:000358036902679		
J	Oxnard, GR; Ramalingam, SS; Ahn, MJ; Kim, SW; Yu, HA; Saka, H; Horn, L; Goto, K; Ohe, Y; Cantarini, M; Frewer, P; Lahn, M; Yang, JCH				Oxnard, Geoffrey R.; Ramalingam, Suresh S.; Ahn, Myung-Ju; Kim, Sang-We; Yu, Helena Alexandra; Saka, Hideo; Horn, Leora; Goto, Koichi; Ohe, Yuichiro; Cantarini, Mireille; Frewer, Paul; Lahn, Michael; Yang, James Chih-Hsin			Preliminary results of TATTON, a multi-arm phase Ib trial of AZD9291 combined with MEDI4736, AZD6094 or selumetinib in EGFR-mutant lung cancer.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Dana Farber Canc Inst, Boston, MA 02115 USA; Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea; Univ Ulsan Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Nagoya Med Ctr, Nagoya, Aichi, Japan; Vanderbilt Ingram Canc Ctr, Nashville, TN USA; Natl Canc Ctr Hosp East, Div Thorac Oncol, Kashiwa, Chiba, Japan; Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan; AstraZeneca, Macclesfield, Cheshire, England; Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan; Natl Taiwan Univ, Grad Inst Oncol, Taipei 10764, Taiwan; Natl Taiwan Univ, Canc Res Ctr, Taipei 10764, Taiwan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		2509						1	Oncology	Oncology	CM9OA	WOS:000358036900542		
J	Oya, Y; Yoshida, T; Tanaka, K; Shimizu, J; Horio, Y; Sakao, Y; Hida, T; Yatabe, Y				Oya, Yuko; Yoshida, Tatsuya; Tanaka, Kosuke; Shimizu, Junichi; Horio, Yoshitsugu; Sakao, Yukinori; Hida, Toyoaki; Yatabe, Yasushi			Association between clinical outcome of first EGFR-TKIs and T790M mutation in NSCLC patients harboring EGFR mutation with acquired resistance to EGFR-TKIs.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Aichi Canc Ctr Hosp, Dept Thorac Oncol, Nagoya, Aichi 464, Japan; Aichi Canc Ctr Hosp, Dept Thorac Surg, Nagoya, Aichi 464, Japan; Aichi Canc Ctr Hosp, Dept Pathol & Mol Diagnost, Nagoya, Aichi 464, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e19123						1	Oncology	Oncology	CM9OA	WOS:000358036903963		
J	Ozasa, H; Hazama, S; Shimizu, R; Etoh, R; Inoue, Y; Kanekiyo, S; Shindo, Y; Suzuki, N; Takenouchi, H; Tsunedomi, R; Iizuka, N; Yoshino, S; Okuno, K; Sugiura, F; Fujita, Y; Hamamoto, Y; Fujita, T; Kawakami, Y; Nakamura, Y; Oka, M				Ozasa, Hiroaki; Hazama, Shoichi; Shimizu, Ryoichi; Etoh, Ryuichi; Inoue, Yuka; Kanekiyo, Shinsuke; Shindo, Yoshitaro; Suzuki, Nobuaki; Takenouchi, Hiroko; Tsunedomi, Ryouichi; Iizuka, Norio; Yoshino, Shigefumi; Okuno, Kiyotaka; Sugiura, Fumiaki; Fujita, Yusuke; Hamamoto, Yoshihiko; Fujita, Tomonobu; Kawakami, Yutaka; Nakamura, Yusuke; Oka, Masaaki			miR-196b and miR-486 as predictive biomarkers for the efficacy of the vaccine treatment: From the results of phase I and II studies for metastatic colorectal cancer.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Ogori Daiichi Gen Hosp, Dept Surg, Yamaguchi, Japan; Yamaguchi Univ, Grad Sch Med, Digest Surgey & Surg Oncol, Ube, Yamaguchi 755, Japan; Yamaguchi Univ, Grad Sch Med, Ube, Yamaguchi 755, Japan; Yamaguchi Univ, Grad Sch Med, Digest Surg & Surg Oncol, Ube, Yamaguchi 755, Japan; Kinki Univ, Fac Med, Dept Surg, Sayama, Osaka, Japan; Keio Univ, Sch Med, Tokyo, Japan; Inst Adv Med Res, Div Cellular Signaling, Tokyo, Japan; Univ Chicago, Chicago, IL 60637 USA; Yamaguchi Univ, Ube, Yamaguchi 755, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e14001						1	Oncology	Oncology	CM9OA	WOS:000358036902593		
J	Parekh, A; Sunakawa, Y; Cao, S; Matsusaka, S; Yang, DY; Zhang, W; Wakatsuki, T; Ning, Y; Stremitzer, S; Mendez, A; Okazaki, S; Elkhoueiry, R; Iqbal, S; Barzi, A; Azuma, M; Watanabe, M; Koizumi, W; Wu, AH; Lenz, HJ				Parekh, Anish; Sunakawa, Yu; Cao, Shu; Matsusaka, Satoshi; Yang, Dongyun; Zhang, Wu; Wakatsuki, Takeru; Ning, Yan; Stremitzer, Stefan; Mendez, Angela; Okazaki, Satoshi; Elkhoueiry, Rita; Iqbal, Syma; Barzi, Afsaneh; Azuma, Mizutomo; Watanabe, Masahiko; Koizumi, Wasaburo; Wu, Anna H.; Lenz, Heinz-Josef			Estrogen receptor beta (ER beta) gene polymorphisms as a predictor of overall survival in patients with gastric cancer (GC) from Japan and Los Angeles County (LAC)	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Univ So Calif, Norris Comprehens Canc Ctr, Los Angeles, CA USA; Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol, Tokyo, Japan; Kitasato Univ, Sch Med, Dept Gastroenterol, Kanagawa, Japan; Kitasato Univ, Sch Med, Dept Surg, Kanagawa, Japan; Kitasato Univ, Sch Med, Dept Gastroenterol, Sagamihara, Kanagawa 228, Japan; Univ So Calif, Los Angeles, CA USA								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		4036						1	Oncology	Oncology	CM9OA	WOS:000358036900875		
J	Parekh, A; Ning, Y; Stintzing, S; Loupakis, F; Zhang, W; Yang, DY; Sunakawa, Y; Stremitzer, S; Matsusaka, S; Okazaki, S; Elkhoueiry, R; Mendez, A; Barzi, A; Schirripa, M; Heinemann, V; Lenz, HJ				Parekh, Anish; Ning, Yan; Stintzing, Sebastian; Loupakis, Fotios; Zhang, Wu; Yang, Dongyun; Sunakawa, Yu; Stremitzer, Stefan; Matsusaka, Satoshi; Okazaki, Satoshi; Elkhoueiry, Rita; Mendez, Angela; Barzi, Afsaneh; Schirripa, Marta; Heinemann, Volker; Lenz, Heinz-Josef			Genetic variant of TWEAK to predict clinical outcome in mCRC patients (pts) treated with first line FOLFIRI and Bevacizumab (FOLFIRI/BEV) in FIRE-3 and TRIBE cohorts	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Norris Comprehens Canc Ctr USC, Los Angeles, CA USA; Univ So Calif, Norris Comprehens Canc Ctr, Los Angeles, CA USA; Univ Munich, Dept Oncol, Munich, Germany; Azienda Osped Univ Pisana, Ist Toscano Tumori, Pisa, Italy; Med Univ Vienna, Santa Monica, CA USA; Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol, Tokyo, Japan; Univ So Calif, Los Angeles, CA USA; Azienda Osped Univ Pisana, Pisa, Italy; Univ Munich, Klinikum Grosshadern, Dept Internal Med 3, D-80539 Munich, Germany; Univ Munich, Klinikum Grosshadern, Ctr Comprehens Canc, D-80539 Munich, Germany								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		3554						1	Oncology	Oncology	CM9OA	WOS:000358036900773		
J	Raje, NS; Terpos, E; Durie, BG; Garcia-Sanz, R; Shimizu, K; Willenbacher, W; Zhu, L; Warner, DJ; Palumbo, A				Raje, Noopur S.; Terpos, Evangelos; Durie, Brian G.; Garcia-Sanz, Ramon; Shimizu, Kazuyuki; Willenbacher, Wolfgang; Zhu, Li; Warner, Douglas J.; Palumbo, Antonio			Denosumab compared with zoledronic acid for the treatment of bone disease in adults with newly diagnosed multiple myeloma: An international, randomized, double-blind trial.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Massachusetts Gen Hosp, Boston, MA 02114 USA; Univ Athens, Sch Med, Alexandra Gen Hosp, GR-11527 Athens, Greece; Cedars Sinai Comp Canc Ctr, Los Angeles, CA USA; Univ Hosp Salamanca, Salamanca, Spain; Tokai Chuo Hosp, Nagoya, Aichi, Japan; Med Univ Innsbruck, A-6020 Innsbruck, Austria; Amgen Inc, Thousand Oaks, CA 91320 USA; AOU San Giovanni Battista Torino, Osped Molinette, Turin, Italy								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		TPS8611						1	Oncology	Oncology	CM9OA	WOS:000358036904873		
J	Ramalingam, SS; Yang, JCH; Lee, CK; Kurata, T; Kim, DW; John, T; Nogami, N; Ohe, Y; Rukazenkov, Y; Frewer, P; Cantarini, M; Ghiorghiu, S; Janne, PA				Ramalingam, Suresh S.; Yang, James Chih-Hsin; Lee, Chee Khoon; Kurata, Takayasu; Kim, Dong-Wan; John, Thomas; Nogami, Naoyuki; Ohe, Yuichiro; Rukazenkov, Yuri; Frewer, Paul; Cantarini, Mireille; Ghiorghiu, Serban; Janne, Pasi A.			AZD9291, a mutant-selective EGFR inhibitor, as first-line treatment for EGFR mutation-positive advanced non-small cell lung cancer (NSCLC): Results from a phase 1 expansion cohort.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan; Natl Taiwan Univ, Grad Inst Oncol, Taipei 10764, Taiwan; Natl Taiwan Univ, Canc Res Ctr, Taipei 10764, Taiwan; St George Hosp, Sydney, NSW, Australia; Kansai Med Univ, Hirakata Hosp, Osaka, Japan; Seoul Natl Univ Hosp, Seoul 110744, South Korea; Olivia Newton John Canc Res Inst, Heidelberg, Vic, Australia; Natl Hosp Org, Shikoku Canc Ctr, Clin Res Inst, Matsuyama, Ehime, Japan; Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan; AstraZeneca, Macclesfield, Cheshire, England; AstraZeneca, Cambridge, England; Dana Farber Canc Inst, Boston, MA 02115 USA								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		8000						1	Oncology	Oncology	CM9OA	WOS:000358036901713		
J	Ramaswami, R; Pinato, DJ; Kubota, K; Ishizuka, M; Arizumi, T; Kudo, M; Jang, JW; Kim, YW; Pirisi, M; Allara, E; Sharma, R				Ramaswami, Ramya; Pinato, David James; Kubota, Keiichi; Ishizuka, Mitsuru; Arizumi, Tadaaki; Kudo, Masatoshi; Jang, Jeong Won; Kim, Young Woon; Pirisi, Mario; Allara, Elias; Sharma, Rohini			Prognostic subclassification of Intermediate Hepatocellular Carcinoma (I-HCC): a multicentre cohort study with propensity score analysis	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Div Expt Med, London, England; Univ London Imperial Coll Sci Technol & Med, Dept Oncol, London, England; Dokkyo Med Univ, Dept Surg 2, Mibu, Tochigi, Japan; Dokkyo Med Univ, Mibu, Tochigi, Japan; Kinki Univ, Sch Med, Dept Gastroenterol & Hepatol, Osaka 589, Japan; Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea; Incheon St Marys Hosp, Dept Internal Med, Inchon, South Korea; Univ Piemonte Orientale, Dept Translat Med, Novara, Italy; Univ London Imperial Coll Sci Technol & Med, London, England								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e15139						1	Oncology	Oncology	CM9OA	WOS:000358036902909		
J	Rini, BI; Tomita, Y; Melichar, B; Ueda, T; Grunwald, V; Fishman, MN; Uemura, H; Oya, M; Bair, AH; Andrews, G; Pavlov, D; Jonasch, E				Rini, Brian I.; Tomita, Yoshihiko; Melichar, Bohuslav; Ueda, Takeshi; Gruenwald, Viktor; Fishman, Mayer N.; Uemura, Hirotsugu; Oya, Mototsugu; Bair, A. H.; Andrews, Glen; Pavlov, Dmitri; Jonasch, Eric			Overall survival analysis from a randomized phase II study of axitinib with or without dose titration for first-line metastatic renal cell carcinoma.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Cleveland Clin Taussig Canc Inst, Cleveland, OH USA; Yamagata Univ Sch Med, Dept Urol, Yamagata, Japan; Palacky Univ Med Sch, Olomouc, Czech Republic; Teaching Hosp, Olomouc, Czech Republic; Chiba Canc Ctr, Prostate Ctr, Chiba 2608717, Japan; Chiba Canc Ctr, Div Urol, Chiba 2608717, Japan; Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany; Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA; Kinki Univ Fac Med, Dept Urol, Osaka, Japan; Keio Univ, Shinjuku Ku, Tokyo 108, Japan; Pfizer Oncol, San Diego, CA USA; Pfizer Clin Dev, New York, NY USA; Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		4545						1	Oncology	Oncology	CM9OA	WOS:000358036901016		
J	Roncolato, FT; O'Connell, R; Joly, F; Lanceley, A; Hilpert, F; Okamoto, A; Aotani, E; Pignata, S; Donnellan, PP; Oza, AM; Avall-Lundqvist, E; Berek, JS; Sjoquist, KM; Gillies, K; Butow, P; Stockler, MR; King, MT; Friedlander, M				Roncolato, Felicia T.; O'Connell, Rachel; Joly, Florence; Lanceley, Anne; Hilpert, Felix; Okamoto, Aikou; Aotani, Eriko; Pignata, Sandro; Donnellan, Paul P.; Oza, Amit M.; Avall-Lundqvist, Elisabeth; Berek, Jonathan S.; Sjoquist, Katrin Marie; Gillies, Kim; Butow, Phyllis; Stockler, Martin R.; King, Madeleine Trudy; Friedlander, Michael			Baseline predictors of early treatment failure in patients with platinum resistant/refractory (PRR) and potentially platinum sensitive (PPS >= 3) recurrent ovarian cancer (ROC) receiving >= 3 lines of chemotherapy: The Gynaecologic Cancer Intergroup (GCIG) Symptom Benefit Study (SBS).	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Univ Sydney, NHMRC Clin Trials Ctr, ANZGOG, Camperdown, NSW, Australia; Univ Sydney, NHMRC Clin Trials Ctr, Camperdown, NSW, Australia; Ctr Francois Baclesse, F-14021 Caen, France; UCL, Teaching Hosp, London, England; Univ Schleswig Holstein, Dept Obstet & Gynecol, Kiel, Germany; Jikei Univ, Sch Med, Tokyo, Japan; Kitasato Univ, Kitasato Acad Res Org, Minato Ku, Tokyo, Japan; Natl Canc Inst Naples, Naples, Italy; Galway Univ Hosp, Galway, Ireland; Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; Linkoping Univ, Dept Oncol, Linkoping, Sweden; Linkoping Univ, Dept Clin Expt Med, Linkoping, Sweden; Karolinska Inst, Linkoping, Sweden; Stanford Womens Canc Ctr, Stanford, CA USA; Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW 2006, Australia; St George Hosp, Canc Care Ctr, Sydney, NSW, Australia; Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW 2006, Australia; Univ Sydney, Sydney, NSW 2006, Australia; Univ Sydney, Psychooncol Cooperat Res Grp PoCoG, Sydney, NSW 2006, Australia; Prince Wales Canc Ctr, Randwick, NSW, Australia			JOLY, Florence/L-7752-2015					0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		5564						1	Oncology	Oncology	CM9OA	WOS:000358036901228		
J	Saeki, S; Sasaki, J; Iwamoto, N; Inaba, M; Ushijima, S; Kishi, H; Fujii, S; Semba, H; Kashiwabara, K; Sakata, S; Kai, Y; Tsubata, Y; Isobe, T; Endo-Tsukude, C; Kohrogi, H; Saito, H; Hamada, A				Saeki, Sho; Sasaki, Jiichiro; Iwamoto, Norihiro; Inaba, Megumi; Ushijima, Sunao; Kishi, Hiroto; Fujii, Shinji; Semba, Hiroshi; Kashiwabara, Kosuke; Sakata, Shinya; Kai, Yuki; Tsubata, Yukari; Isobe, Takeshi; Endo-Tsukude, Chihiro; Kohrogi, Hirotsugu; Saito, Hideyuki; Hamada, Akinobu			Effect of genetic polymorphisms on erlotinib pharmacokinetics and toxicity in Japanese patients with non-small cell lung cancer.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Kumamoto Univ Hosp, Kumamoto, Japan; Kitasato Univ, Sch Med, Sagamihara, Kanagawa 228, Japan; Saiseikai Kumamoto Hosp, Kumamoto, Japan; Kumamoto City Hosp, Kumamoto, Japan; Kumamoto City Hosp, Kumamoto, Japan; Kumamoto Reg Med Ctr, Kumamoto, Japan; Kumamoto Univ, Kumamoto, Japan; Shimane Univ Hosp, Izumo, Shimane, Japan; Chugai Pharmaceut Co Ltd, Tokyo, Japan; Natl Canc Ctr, Res Inst, Tokyo 104, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e19104						1	Oncology	Oncology	CM9OA	WOS:000358036903947		
J	Saeki, T; Mukai, H; Aogi, K; Shigekawa, T; Ueda, S; Naito, Y; Matsubara, N; Takashima, S; Hara, F; Yamashita, T; Ohwada, S; Sasaki, Y				Saeki, Toshiaki; Mukai, Hirofumi; Aogi, Kenjiro; Shigekawa, Takashi; Ueda, Shigeto; Naito, Yoichi; Matsubara, Nobuaki; Takashima, Seiki; Hara, Fumikata; Yamashita, Tomonari; Ohwada, Shoichi; Sasaki, Yasutsuna			Phase I study of HER3 targeted antibody patritumab in combination with trastuzumab and paclitaxel in patients with HER2-overexpressing metastatic breast cancer (MBC).	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Saitama Med Univ, Hidaka, Japan; Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan; Natl Hosp Org, Shikoku Canc Ctr, Matsuyama, Ehime, Japan; Daiichi Sankyo Co Ltd, Tokyo, Japan; Showa Univ, Sch Med, Tokyo 142, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		584						1	Oncology	Oncology	CM9OA	WOS:000358036901295		
J	Saito, G; Sadahiro, S; Okada, K; Tanaka, A; Suzuki, T				Saito, Gota; Sadahiro, Sotaro; Okada, Kazutake; Tanaka, Akira; Suzuki, Toshiyuki			Monitoring of serum carcinoembryonic antigen levels after curative resection of colon cancer: Setting of cutoff values in accordance with preoperative values.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					[Saito, Gota; Sadahiro, Sotaro; Okada, Kazutake; Tanaka, Akira; Suzuki, Toshiyuki] Tokai Univ, Hiratsuka, Kanagawa 25912, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e14509						1	Oncology	Oncology	CM9OA	WOS:000358036902634		
J	Sakai, H; Katsumata, N; Matsuda, M; Kadokura, G				Sakai, Hitomi; Katsumata, Noriyuki; Matsuda, Masanori; Kadokura, Genmu			Seeking second opinions in oncology: Adherence of standard of care among first doctors.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Musashi Kosugi Hosp, Nippon Med Sch, Kawasaki, Kanagawa, Japan; Musashikosugi Hosp, Nippon Med Sch, Kawasaki, Kanagawa, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e20601						1	Oncology	Oncology	CM9OA	WOS:000358036904218		
J	Sakamoto, S; Kamada, S; Kawamura, K; Nihei, N; Imamoto, T; Naya, Y; Akakura, K; Suzuki, H; Ichikawa, T				Sakamoto, Shinichi; Kamada, Shuhei; Kawamura, Koji; Nihei, Naoki; Imamoto, Takashi; Naya, Yukio; Akakura, Koichiro; Suzuki, Hiroyoshi; Ichikawa, Tomohiko			The prognostic value of nadir testosterone levels in prostate cancer patients treated with combined androgen blockade in Japanese men.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Chiba Univ, Grad Sch Med, Dept Urol, Chiba, Japan; Chiba Univ Hosp, Chiba, Japan; Chiba Univ, Grad Sch Med, Chiba, Japan; Teikyo Univ, Chiba Med Ctr, Ichihara, Chiba, Japan; JCHO Tokyo Med Ctr, Dept Urol, Tokyo, Japan; Toho Univ, Sakura Med Ctr, Chiba 2748510, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e16049						1	Oncology	Oncology	CM9OA	WOS:000358036903223		
J	Sakamoto, Y; Ojima, H; Yamagishi, S; Morizane, C; Hosoi, H; Kondo, S; Ueno, H; Okusaka, T; Kanai, Y				Sakamoto, Yasunari; Ojima, Hidenori; Yamagishi, Seri; Morizane, Chigusa; Hosoi, Hiroko; Kondo, Shunsuke; Ueno, Hideki; Okusaka, Takuji; Kanai, Yae			Validation study of combination chemotherapy in vitro for biliary tract carcinoma	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Natl Canc Ctr, Div Hepatobiliary & Pancreat Oncol, Tokyo, Japan; Keio Univ, Sch Med, Dept Pathol, Tokyo 160, Japan; Natl Canc Ctr, Res Inst, Div Mol Pathol, Tokyo 104, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e15115						1	Oncology	Oncology	CM9OA	WOS:000358036902889		
J	Sakamoto, Y; Kokudo, N; Matsuyama, Y; Sakamoto, M; Kadoya, M; Kaneko, S; Ku, Y; Kudo, M; Takayama, T; Nakashima, O				Sakamoto, Yoshihiro; Kokudo, Norihiro; Matsuyama, Yutaka; Sakamoto, Michiie; Kadoya, Masumi; Kaneko, Shuichi; Ku, Yonson; Kudo, Masatoshi; Takayama, Tadatoshi; Nakashima, Osamu		Liver Canc Study Grp Japan	Proposal of a new staging system for intrahepatic cholangiocarcinoma: Analysis of surgical patients from a nationwide survey of Liver Cancer Study Group of Japan.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Univ Tokyo, Hepatobiliary Pancreat Surg Div, Tokyo, Japan; Univ Tokyo, Sch Publ Hlth, Dept Biostat, Tokyo, Japan; Keio Univ, Sch Med, Dept Pathol, Tokyo 160, Japan; Shinshu Univ, Sch Med, Dept Radiol, Matsumoto, Nagano 390, Japan; Kanazawa Univ Hosp, Kanazawa, Ishikawa, Japan; Kobe Univ, Grad Sch Med, Div Hepatobiliary Pancreat Surg, Kobe, Hyogo 657, Japan; Kinki Univ, Sch Med, Dept Gastroenterol & Hepatol, Osaka 589, Japan; Nihon Univ, Sch Med, Dept Digest Surg, Tokyo, Japan; Kurume Univ Hosp, Dept Clin Inspect, Kurume, Fukuoka, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		4075						1	Oncology	Oncology	CM9OA	WOS:000358036900913		
J	Sasaki, Y; Saji, S; Nagashima, F; Ando, Y; Miya, T; Ichikawa, W; Shimada, K				Sasaki, Yasutsuna; Saji, Shigehira; Nagashima, Fumio; Ando, Yuichi; Miya, Toshimichi; Ichikawa, Wataru; Shimada, Ken			How and when are Japanese patients with unresectable/metastatic cancer seeking a second opinion of treatment options? Analysis of patients backgrounds.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Showa Univ, Sch Med, Tokyo 142, Japan; Fukushima Med Univ, Sch Med, Fukushima, Japan; Kyorin Univ, Mitaka, Tokyo, Japan; Nagoya Univ Hosp, Dept Clin Oncol & Chemotherapy, Nagoya, Aichi, Japan; Tamanagayama Hosp, Nippon Med Sch, Tokyo, Japan; Showa Univ, Tokyo, Japan; Saitama Med Univ, Int Medial Ctr, Saitama, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e17544						1	Oncology	Oncology	CM9OA	WOS:000358036903515		
J	Sato, T; Nishimura, K; Nakayama, N; Motohashi, O; Segami, K; Hayashi, S; Kawabe, T; Aoyama, T; Hayashi, T; Yamada, T; Oshima, T; Rino, Y; Masuda, M; Ogata, T; Cho, H; Yoshikawa, T				Sato, Tsutomu; Nishimura, Ken; Nakayama, Norisuke; Motohashi, Osamu; Segami, Kenki; Hayashi, Shigeya; Kawabe, Taiichi; Aoyama, Toru; Hayashi, Tsutomu; Yamada, Takanobu; Oshima, Takashi; Rino, Yasushi; Masuda, Munetaka; Ogata, Takashi; Cho, Haruhiko; Yoshikawa, Takaki			Conversion surgery for stage IV gastric cancer: Feasibility, safety, and efficacy results	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Kanagawa Canc Ctr, Dept Gastrointestinal Surg, Yokohama, Kanagawa 2410815, Japan; Kanagawa Canc Ctr, Yokohama, Kanagawa 2410815, Japan; Kanagawa Canc Ctr, Dept Surg Gastroenterol, Yokohama, Kanagawa 2410815, Japan; Yokohama City Univ, Yokohama, Kanagawa 232, Japan; Yokohama City Univ, Gastroenterol Ctr, Yokohama, Kanagawa 232, Japan; Yokohama City Univ, Dept Surg, Yokohama, Kanagawa 232, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e15031						1	Oncology	Oncology	CM9OA	WOS:000358036902819		
J	Seiwert, TY; Haddad, RI; Gupta, S; Mehra, R; Tahara, M; Berger, R; Lee, SH; Burtness, B; Le, DT; Heath, K; Blum, A; Dolled-Filhart, M; Emancipator, K; Pathiraja, K; Cheng, JD; Chow, LQ				Seiwert, Tanguy Y.; Haddad, Robert I.; Gupta, Shilpa; Mehra, Ranee; Tahara, Makoto; Berger, Raanan; Lee, Se-Hoon; Burtness, Barbara; Le, Dung T.; Heath, Karl; Blum, Amy; Dolled-Filhart, Marisa; Emancipator, Kenneth; Pathiraja, Kumudu; Cheng, Jonathan D.; Chow, Laura Q.			Antitumor activity and safety of pembrolizumab in patients (pts) with advanced squamous cell carcinoma of the head and neck (SCCHN): Preliminary results from KEYNOTE-012 expansion cohort.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Univ Chicago, Chicago, IL 60637 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan; Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel; Seoul Natl Univ Hosp, Seoul 110744, South Korea; Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT USA; JHU, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; Merck & Co Inc, Kenilworth, NJ USA; Univ Washington, Dept Med, Div Oncol, Seattle, WA 98195 USA								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		LBA6008						1	Oncology	Oncology	CM9OA	WOS:000358036904640		
J	Seto, T; Sasaki, T; Yamanaka, T; Kunitake, N; Shimizu, J; Kodaira, T; Nishio, M; Kozuka, T; Takahashi, T; Harada, H; Yoshimura, N; Tsutsumi, S; Kitajima, H; Kataoka, M; Nakagawa, K; Nishimura, Y; Nakanishi, Y				Seto, Takashi; Sasaki, Tomonari; Yamanaka, Takeharu; Kunitake, Naonobu; Shimizu, Junichi; Kodaira, Takeshi; Nishio, Makoto; Kozuka, Takuyo; Takahashi, Toshiaki; Harada, Hideyuki; Yoshimura, Naruo; Tsutsumi, Shinichi; Kitajima, Hiromoto; Kataoka, Masaaki; Nakagawa, Kazuhiko; Nishimura, Yasumasa; Nakanishi, Yoichi			A randomized phase II study of TS-1 plus cisplatin versus vinorelbine plus cisplatin with concurrent thoracic radiotherapy for locally advanced non-small cell lung cancer (LA-NSCLC): WJOG 5008L.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Kyushu Natl Canc Ctr, Fukuoka, Japan; Yokohama City Univ, Yokohama, Kanagawa 232, Japan; Aichi Canc Ctr Hosp, Nagoya, Aichi 464, Japan; Japanese Fdn Canc Res, Canc Inst Hosp, Tokyo, Japan; Shizuoka Canc Ctr, Nagaizumi, Shizuoka, Japan; Osaka City Univ, Osaka 558, Japan; Shikoku Canc Ctr, Matsuyama, Ehime, Japan; Kinki Univ, Fac Med, Osakasayama, Japan; Kyushu Univ, Fukuoka 812, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		7512						1	Oncology	Oncology	CM9OA	WOS:000358036901642		
J	Shah, MA; Muro, K; Shitara, K; Tebbutt, NC; Bang, YJ; Lordick, F; Borodyansky, L; Li, C				Shah, Manish A.; Muro, Kei; Shitara, Kohei; Tebbutt, Niall C.; Bang, Yung-Jue; Lordick, Florian; Borodyansky, Laura; Li, Chiang			The BRIGHTER trial: A phase III randomized double-blind study of BBI608+weekly paclitaxel versus placebo (PBO) plus weekly paclitaxel in patients (pts) with pretreated advanced gastric and gastro-esophageal junction (GEJ) adenocarcinoma.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Weill Cornell Med Coll, New York, NY USA; Aichi Canc Ctr Hosp, Nagoya, Aichi 464, Japan; Natl Canc Ctr Hosp East, Dept GI oncol, Kashiwa, Chiba, Japan; Austin Hlth, Melbourne, Vic, Australia; Seoul Natl Univ, Coll Med, Seoul, South Korea; Univ Canc Ctr Leipzig, Leipzig, Germany; Boston Biomed Inc, Cambridge, MA USA								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		TPS4139						1	Oncology	Oncology	CM9OA	WOS:000358036904747		
J	Shankaran, V; Muro, K; Bang, YJ; Geva, R; Catenacci, DVT; Gupta, S; Eder, JP; Berger, R; Loboda, A; Albright, A; Cristescu, R; Murphy, E; McClanahan, T; Ayers, M; Nebozhyn, M; Lunceford, JK; Koshiji, M; Heath, K; Cheng, JD; Chung, HC				Shankaran, Veena; Muro, Kei; Bang, Yung-Jue; Geva, Ravit; Catenacci, Daniel Virgil Thomas; Gupta, Shilpa; Eder, Joseph Paul; Berger, Raanan; Loboda, Andrey; Albright, Andrew; Cristescu, Razvan; Murphy, Erin; McClanahan, Terri; Ayers, Mark; Nebozhyn, Michael; Lunceford, Jared K.; Koshiji, Minori; Heath, Karl; Cheng, Jonathan D.; Chung, Hyun-Choel			Correlation of gene expression signatures and clinical outcomes in patients with advanced gastric cancer treated with pembrolizumab (MK-3475).	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Univ Washington, Seattle, WA 98195 USA; Aichi Canc Ctr Hosp, Nagoya, Aichi 464, Japan; Seoul Natl Univ, Coll Med, Seoul, South Korea; Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, IL-69978 Tel Aviv, Israel; Univ Chicago, Chicago, IL 60637 USA; H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA; Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT USA; Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel; Merck & Co Inc, Kenilworth, NJ USA; Yonsei Univ, Coll Med, Yonsei Canc Ctr, Yonsei, South Korea								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		3026						1	Oncology	Oncology	CM9OA	WOS:000358036900660		
J	Shiga, K; Katagiri, K; Saitoh, D; Ogawa, T				Shiga, Kiyoto; Katagiri, Katsunori; Saitoh, Daisuke; Ogawa, Takenori			Concomitant chemoradiotherapy using docetaxel, cisplatin and 5-FU for the patients with advanced hypopharyngeal cancer: Second report.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Iwate Med Univ, Morioka, Iwate 020, Japan; Tohoku Univ Hosp, Sendai, Miyagi, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e17074						1	Oncology	Oncology	CM9OA	WOS:000358036903450		
J	Shimizu, C; Tanabe, Y; Hamada, A; Yunokawa, M; Takano, T; Koganemaru, S; Yukinori, O; Tamura, N; Fujiwara, Y; Tamura, K				Shimizu, Chikako; Tanabe, Yuko; Hamada, Akinobu; Yunokawa, Mayu; Takano, Toshimi; Koganemaru, Shigehiro; Yukinori, Ozaki; Tamura, Nobuko; Fujiwara, Yasuhiro; Tamura, Kenji			Association of paclitaxel-induced sensory peripheral neuropathy with the ABCB1 genetic variant and age.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Natl Canc Ctr, Tokyo, Japan; Toranomon Gen Hosp, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		11100						1	Oncology	Oncology	CM9OA	WOS:000358036900358		
J	Shin, T; Fukushima, M; Sato, R; Nishio, K; Yagi, H; Arai, G; Soh, S; Okada, H				Shin, Takeshi; Fukushima, Mai; Sato, Ryo; Nishio, Kojiro; Yagi, Hiroshi; Arai, Gaku; Soh, Shigehiro; Okada, Hiroshi			Vitrification using dimethyl sulfoxide free cryoprotectant as a cryopreservation method for fertility preservation of immature mouse testicular tissue.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					[Shin, Takeshi; Fukushima, Mai; Sato, Ryo; Nishio, Kojiro; Yagi, Hiroshi; Arai, Gaku; Soh, Shigehiro; Okada, Hiroshi] Dokkyo Med Univ, Koshigaya Hosp, Koshigaya, Saitama, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e20672						1	Oncology	Oncology	CM9OA	WOS:000358036904282		
J	Shindoh, J; Makuuchi, M; Matsuyama, Y; Mise, Y; Arita, J; Sakamoto, Y; Hasegawa, K; Kokudo, N				Shindoh, Junichi; Makuuchi, Masatoshi; Matsuyama, Yutaka; Mise, Yoshihiro; Arita, Junichi; Sakamoto, Yoshihiro; Hasegawa, Kiyoshi; Kokudo, Norihiro			Prognostic impact of complete removal of the tumor-bearing portal territory of the liver for hepatocellular carcinoma.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Toranomon Gen Hosp, Dept Digest Surg, Tokyo, Japan; Japanese Red Cross Med Ctr, Dept Hepatobiliary Pancreat Surg, Tokyo, Japan; Univ Tokyo, Sch Publ Hlth, Dept Biostat, Tokyo, Japan; Univ Tokyo, Hepatobiliary Pancreat Surg Div, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e15162						1	Oncology	Oncology	CM9OA	WOS:000358036902930		
J	Shinohara, N; Obara, W; Tatsugami, K; Naito, S; Kamba, T; Takahashi, M; Abe, T; Oba, K; Naito, S				Shinohara, Nobuo; Obara, Wataru; Tatsugami, Katsunori; Naito, Sei; Kamba, Tomomi; Takahashi, Masayuki; Abe, Takashige; Oba, Koji; Naito, Seiji			Prognosis of Japanese patients with metastatic renal cell carcinoma who underwent subsequent systemic therapy due to prior failure of VEGF-TKI therapy	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Hokkaido Univ, Grad Sch Med, Dept Urol, Sapporo, Hokkaido, Japan; Iwate Med Univ, Sch Med, Morioka, Iwate 020, Japan; Kyushu Univ, Grad Sch Med Sci, Fukuoka 812, Japan; Yamagata Univ, Sch Med, Dept Urol, Yamagata 990, Japan; Kyoto Univ, Grad Sch Med, Dept Urol, Kyoto, Japan; Univ Tokushima, Grad Sch, Dept Urol, Tokushima 770, Japan; Univ Tokyo, Sch Publ Hlth, Dept Biostat, Tokyo, Japan; Kyushu Univ, Grad Sch Med Sci, Dept Urol, Fukuoka, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e15615						1	Oncology	Oncology	CM9OA	WOS:000358036903154		
J	Shiota, M; Yokomizo, A; Takeuchi, A; Imada, K; Kiyoshima, K; Inokuchi, J; Tatsugami, K; Ohga, S; Nakamura, K; Honda, H; Naito, S				Shiota, Masaki; Yokomizo, Akira; Takeuchi, Ario; Imada, Kenjiro; Kiyoshima, Keijiro; Inokuchi, Junichi; Tatsugami, Katsunori; Ohga, Saiji; Nakamura, Katsumasa; Honda, Hiroshi; Naito, Seiji			Secondary bladder cancer after anticancer therapy for prostate cancer: Reduced comorbidity after androgen-deprivation therapy.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Kyushu Univ, Grad Sch Med Sci, Dept Urol, Fukuoka 812, Japan; Kyushu Univ, Grad Sch Med Sci, Fukuoka 812, Japan; Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Fukuoka 812, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e16002						1	Oncology	Oncology	CM9OA	WOS:000358036903180		
J	Shiraishi, K; Matsuyama, H				Shiraishi, Koji; Matsuyama, Hideyasu			Testicular sperm extraction and hCG-based hormonal treatment in cancer survivors with postchemotherapy azoospermia.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Yamaguchi Univ, Ube, Yamaguchi 755, Japan; Yamaguchi Univ, Grad Sch Med, Dept Urol, Ube, Yamaguchi 755, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e20621						1	Oncology	Oncology	CM9OA	WOS:000358036904236		
J	Shitara, K; Miki, I; Sudo, T; Fujii, S; Kuwata, T; Okamoto, W; Denda, T; Kajiwara, T; Yuki, S; Nakajima, TE; Takashima, A; Kawasaki, K; Tamura, T; Esaki, T; Yamanaka, T; Ochiai, A; Doi, T; Ohtsu, A; Hotta, T; Yoshino, T				Shitara, Kohei; Miki, Izumi; Sudo, Tomohisa; Fujii, Satoshi; Kuwata, Takeshi; Okamoto, Wataru; Denda, Tadamichi; Kajiwara, Takeshi; Yuki, Satoshi; Nakajima, Takako Eguchi; Takashima, Atsuo; Kawasaki, Kenta; Tamura, Takao; Esaki, Taito; Yamanaka, Takeharu; Ochiai, Atsushi; Doi, Toshihiko; Ohtsu, Atsushi; Hotta, Tomomitsu; Yoshino, Takayuki			The Nationwide Cancer Genome Screening Projects for Gastrointestinal Cancer in Japan (SCRUM-Japan GI-SCREEN): Efficient identification of actionable cancer genome alterations in advanced colorectal and non-colorectal gastrointestinal cancer (GI Screen 2013-01-CRC and 2015-01-Non CRC).	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan; Chiba Canc Ctr, Chiba 2608717, Japan; Shikoku Canc Ctr, Dept Gastrointestinal Med Oncol, Matsuyama, Ehime, Japan; Hokkaido Univ Hosp, Sapporo, Hokkaido 060, Japan; St Marianna Univ, Sch Med, Kawasaki, Kanagawa, Japan; Natl Canc Ctr, Gastrointestinal Med Oncol Div, Tokyo, Japan; Keio Univ, Sch Med, Yokohama, Kanagawa 223, Japan; Kinki Univ, Osaka, Japan; Natl Hosp Org, Kyushu Canc Ctr, Dept Gastrointestinal & Med Oncol, Fukuoka, Japan; Yokohama City Univ, Dept Biostat, Yokohama, Kanagawa 232, Japan; Natl Canc Ctr, Tokyo, Japan; Natl Canc Ctr Hosp East, Chiba, Japan; Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Kashiwa, Chiba, Japan; Natl Canc Ctr, Tokyo 104, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		TPS4134						1	Oncology	Oncology	CM9OA	WOS:000358036904742		
J	Shitara, K; Yamada, Y; Yoh, K; Naito, Y; Iwasa, S; Yamamoto, N; von Heydebreck, A; Achiwa, H; Doi, T				Shitara, Kohei; Yamada, Yasuhide; Yoh, Kiyotaka; Naito, Yoichi; Iwasa, Satoru; Yamamoto, Noboru; von Heydebreck, Anja; Achiwa, Hiroyuki; Doi, Toshihiko			Phase I, open-label, multi-ascending dose trial of avelumab (MSB0010718C), an anti-PD-L1 monoclonal antibody, in Japanese patients with advanced solid tumors.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan; Natl Canc Ctr, Gastrointestinal Med Oncol Div, Tokyo, Japan; Natl Canc Ctr Hosp East, Div Thorac Oncol, Kashiwa, Chiba, Japan; Natl Canc Ctr, Tokyo, Japan; Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Tokyo 104, Japan; Merck KGaA, Darmstadt, Germany; Merck Serono Co Ltd, Tokyo, Japan; Natl Canc Ctr Hosp East, Chiba, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		3023						1	Oncology	Oncology	CM9OA	WOS:000358036900657		
J	Shitara, K; Kuboki, Y; Nakamura, Y; Doi, A; Harada, K; Kawazoe, A; Doi, T; Yoshino, T; Yodo, Y; Yoshikawa, R; Ohtsu, A				Shitara, Kohei; Kuboki, Yasutoshi; Nakamura, Yoshiaki; Doi, Ayako; Harada, Kazuaki; Kawazoe, Akihito; Doi, Toshihiko; Yoshino, Takayuki; Yodo, Yasuhide; Yoshikawa, Reigetsu; Ohtsu, Atsushi			A phase I study of BBI608, a cancer stemness inhibitor, administered with paclitaxel (PTX) as combination therapy (Rx) for pretreated unresectable or recurrent gastric cancer.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Natl Canc Ctr Hosp East, Dept GI Oncol, Kashiwa, Chiba, Japan; Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan; Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Chiba, Japan; Natl Canc Ctr Hosp East, Chiba, Japan; Sumitomo Dainippon Pharma Co Ltd, Tokyo, Japan; Sumitomo Dainippon Pharma Co Ltd, Suita, Osaka, Japan; Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Kashiwa, Chiba, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e15089						1	Oncology	Oncology	CM9OA	WOS:000358036902867		
J	Shukuya, T; Yamanaka, T; Seto, T; Daga, H; Goto, K; Saka, H; Sugawara, S; Takahashi, T; Yokota, S; Kaneda, H; Kawaguchi, T; Nagase, S; Oguri, T; Iwamoto, Y; Nishimura, T; Hattori, Y; Nakagawa, K; Nakanishi, Y; Yamamoto, N				Shukuya, Takehito; Yamanaka, Takeharu; Seto, Takashi; Daga, Haruko; Goto, Koichi; Saka, Hideo; Sugawara, Shunichi; Takahashi, Toshiaki; Yokota, Soichiro; Kaneda, Hiroyasu; Kawaguchi, Tomoya; Nagase, Seisuke; Oguri, Tetsuya; Iwamoto, Yasuo; Nishimura, Takashi; Hattori, Yoshihiro; Nakagawa, Kazuhiko; Nakanishi, Yoichi; Yamamoto, Nobuyuki			Randomized phase III study of nedaplatin (N) plus docetaxel (D) versus cisplatin (C) plus D for advanced or relapsed squamous cell carcinoma of the lung (SqLC): WJOG5208L.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Juntendo Univ, Dept Resp Med, Tokyo, Japan; Yokohama City Univ, Dept Biostat, Yokohama, Kanagawa 232, Japan; Kyushu Natl Canc Ctr, Fukuoka, Japan; Osaka City Gen Hosp, Dept Clin Oncol, Osaka, Japan; Natl Canc Ctr Hosp East, Div Thorac Oncol, Kashiwa, Chiba, Japan; Nagoya Med Ctr, Nagoya, Aichi, Japan; Sendai Kousei Hosp, Sendai, Miyagi, Japan; Shizuoka Canc Ctr, Div Thorac Oncol, Shizuoka, Japan; Toneyama Natl Hosp, Dept Internal Med, Toyonaka, Osaka, Japan; Kinki Univ, Fac Med, Osaka, Japan; Osaka City Univ, Grad Sch Med, Osaka 558, Japan; Tokyo Med Univ, Tokyo 1608402, Japan; Nagoya City Univ, Grad Sch Med Sci, Dept Resp Med Allergy & Clin Immunol, Nagoya, Aichi, Japan; Hiroshima City Hosp, Hiroshima, Japan; Kyoto Katsura Hosp, Div Resp Med, Kyoto, Japan; Hyogo Canc Ctr, Akashi, Hyogo, Japan; Kinki Univ, Fac Med, Osakasayama, Japan; Kyushu Univ, Fukuoka 812, Japan; Wakayama Med Univ, Wakayama, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		8004						1	Oncology	Oncology	CM9OA	WOS:000358036901717		
J	Singh, S; Buzzoni, R; Carnaghi, C; Fazio, N; Pavel, ME; Wolin, EM; Tomasek, J; Raderer, M; Lahner, H; Lam, DH; Cauwel, H; Valle, JW; Delle Fave, G; Van Cutsem, E; Strosberg, JR; Tesselaar, ME; Shimada, Y; Oh, DY; Kulke, MH; Yao, JC				Singh, Simron; Buzzoni, Roberto; Carnaghi, Carlo; Fazio, Nicola; Pavel, Marianne E.; Wolin, Edward M.; Tomasek, Jiri; Raderer, Markus; Lahner, Harald; Lam, Du Hung; Cauwel, Helene; Valle, Juan W.; Delle Fave, Gianfranco; Van Cutsem, Eric; Strosberg, Jonathan R.; Tesselaar, Margot Et; Shimada, Yasuhiro; Oh, Do-Youn; Kulke, Matthew H.; Yao, James C.		RADIANT-4 Study Grp	Baseline demographics of patients from the randomized, placebo-controlled, double-blind, phase III RADIANT-4 study of everolimus in nonfunctional gastrointestinal (GI) or lung neuroendocrine tumors (NET).	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; Fdn IRCCS Ist Nazl Tumori, Milan, Italy; IRCCS Ist Clin Humanitas, Rozzano, Italy; European Inst Oncol, Milan, Italy; Charite Berlin Campus Virchow Klinikum, Berlin, Germany; Univ Kentucky, Markey Canc Ctr, Lexington, KY USA; Masaryk Univ, Fac Med, Masaryk Mem Canc Inst, Brno, Czech Republic; AKH, Univ Klin Innere Med 1, Vienna, Austria; Univ Klinikum Essen, Zentrum Innere Med, Essen, Germany; Novartis Pharmaceut, E Hanover, NJ USA; Novartis Pharma AG, Basel, Switzerland; Univ Manchester, Christie Hosp, Inst Canc Studies, Manchester, Lancs, England; Univ Roma La Sapienza, Azienda Osped St Andrea, Rome, Italy; Univ Hosp Gasthuisberg Leuven, Digest Oncol, Leuven, Belgium; KULeuven, Leuven, Belgium; Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA; Nederlands Kanker Inst Antoni van Leeuwenhoek, Amsterdam, Netherlands; Natl Canc Ctr, Tokyo, Japan; Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea; Dana Farber Canc Inst, Boston, MA 02115 USA; Univ Texas MD Anderson Canc Ctr, Dept GI Med Oncol, Houston, TX 77030 USA								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e15197						1	Oncology	Oncology	CM9OA	WOS:000358036902962		
J	Slamon, DJ; Hurvitz, SA; Chen, D; Andre, F; Tseng, LM; Jerusalem, GHM; Wilks, S; O'Regan, R; Isaacs, C; Toi, M; Burris, HA; He, W; Riester, M; Robinson, D; Taran, T; Gianni, L				Slamon, Dennis J.; Hurvitz, Sara A.; Chen, David; Andre, Fabrice; Tseng, Ling-Ming; Jerusalem, Guy Heinrich Maria; Wilks, Sharon; O'Regan, Ruth; Isaacs, Claudine; Toi, Masakazu; Burris, Howard A.; He, Wei; Riester, Markus; Robinson, Douglas; Taran, Tanya; Gianni, Luca			Predictive biomarkers of everolimus efficacy in HER2+advanced breast cancer: Combined exploratory analysis from BOLERO-1 and BOLERO-3.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Univ Calif Los Angeles, Sch Med, Translat Oncol Res Lab, Los Angeles, CA USA; Univ Calif Los Angeles, Healthcare Hematol Oncol Breast Oncol Program, Santa Monica, CA USA; Novartis Pharmaceut, E Hanover, NJ USA; Inst Gustave Roussy, Villejuif, France; Taipei Vet Gen Hosp, Dept Surg, Taipei, Taiwan; Ctr Hosp Univ, Liege, Belgium; US Oncol Canc Care Ctr South Texas, San Antonio, TX USA; Emory Univ, Atlanta, GA 30322 USA; Georgetown Lombardi Comprehens Canc Ctr, Washington, DC USA; Kyoto Univ, Grad Sch Med, Kyoto, Japan; Tennessee Oncol PLLC, Sarah Cannon Res Inst, Nashville, TN USA; Novartis Pharmaceut, E Hanover, NJ USA; Novartis Inst BioMed Res Inc, Cambridge, MA USA; Hosp San Raffaele, I-20132 Milan, Italy								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		512						1	Oncology	Oncology	CM9OA	WOS:000358036901119		
J	So, J; Zou, RY; Zhou, LH; Too, HP; Zhu, F; Teo, YY; Yap, CT; Rha, SY; Kono, K; Yoong, J; Yeoh, KG; Yong, WP				So, Jimmy; Zou, Ruiyang; Zhou, Lihan; Too, Heng-Phon; Zhu, Feng; Teo, Yik Ying; Yap, Celestial T.; Rha, Sun Young; Kono, Koji; Yoong, Joanne; Yeoh, Khay-Guan; Yong, Wei-Peng			A serum microRNA biomarker panel for detection of gastric cancer.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Natl Univ Singapore Hosp, Dept Surg, Singapore 117548, Singapore; MicroRNA X Express Singapore MiRXES, Singapore, Singapore; MiRXES, Singapore, Singapore; ASTAR, Singapore, Singapore; Natl Univ Singapore, Singapore 117548, Singapore; Yonsei Univ, Coll Med, Seoul, South Korea; Fukushima Med Univ, Fukushima, Japan; Natl Univ Canc Inst, Singapore, Singapore								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		4060						1	Oncology	Oncology	CM9OA	WOS:000358036900899		
J	Sone, T; Araya, T; Tambo, Y; Shibata, K; Nishikawa, S; Matsunuma, R; Kita, T; Kurokawa, K; Shirasaki, H; Nishitsuji, M; Hara, J; Nomura, S; Koba, H; Sakai, T; Touge, H; Ishiura, Y; Tamori, S; Kimura, H; Yoneda, T; Kasahara, K				Sone, Takashi; Araya, Tomoyuki; Tambo, Yuichi; Shibata, Kazuhiko; Nishikawa, Shingo; Matsunuma, Ryo; Kita, Toshiyuki; Kurokawa, Koji; Shirasaki, Hiroki; Nishitsuji, Masaru; Hara, Josuke; Nomura, Satoshi; Koba, Hayato; Sakai, Tamami; Touge, Hirokazu; Ishiura, Yoshihisa; Tamori, Shunichi; Kimura, Hideharu; Yoneda, Taro; Kasahara, Kazuo			A Phase II study to evaluate the efficacy of erlotinib in advanced NSCLC patients who have wild-type EGFR and EGFR gene amplification.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Kanazawa Univ, Dept Resp Med, Grad Sch Med Sci, Cellular Transplantat Biol, Kanazawa, Ishikawa, Japan; Natl Hosp Org, Kanazawa Med Ctr, Kanazawa, Ishikawa, Japan; Kanazawa Univ Hosp, Kanazawa, Ishikawa, Japan; Koseiren Takaoka Hosp, Takaoka, Toyama, Japan; Kanazawa Hosp, Kanazawa, Ishikawa, Japan; Komatsu Municipal Hosp, Komatsu, Japan; Fukuiken Saiseikai Hosp, Fukui, Japan; Ishikawa Prefectural Hosp, Kanazawa, Ishikawa, Japan; Kanazawa Municipal Hosp, Kanazawa, Ishikawa, Japan; Keiju Med Ctr, Nanao, Japan; Tottori Univ, Div Med Oncol & Mol Respirol, Tottori 680, Japan; Toyama Municipal Hosp, Toyama, Japan; Toyama Red Cross Hosp, Toyama, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e19028						1	Oncology	Oncology	CM9OA	WOS:000358036903888		
J	Sonpavde, G; Pond, GR; Rosenberg, JE; Bajorin, DF; Regazzi, AM; Mullane, SA; Niegisch, G; Albers, P; Necchi, A; di Lorenzo, G; Fougeray, R; Ko, YJ; Rozzi, A; Matsumoto, K; Lee, JL; Kitamura, H; Kume, H; Milowsky, MI; Choueiri, TK; Bellmunt, J				Sonpavde, Guru; Pond, Gregory Russell; Rosenberg, Jonathan E.; Bajorin, Dean F.; Regazzi, Ashley Marie; Mullane, Stephanie A.; Niegisch, Guenter; Albers, Peter; Necchi, Andrea; di Lorenzo, Giuseppe; Fougeray, Ronan; Ko, Yoo-Joung; Rozzi, Antonio; Matsumoto, Kazumasa; Lee, Jae-Lyun; Kitamura, Hiroshi; Kume, Haruki; Milowsky, Matthew I.; Choueiri, Toni K.; Bellmunt, Joaquim			Externally validated improved 5-factor prognostic model in patients (pts) receiving salvage systemic therapy for advanced urothelial carcinoma (UC)	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA; Ontario Clin Oncol Grp OCOG, Hamilton, ON, Canada; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Dana Farber Canc Inst, Bladder Canc Ctr, Brigham & Womens Canc Ctr, Boston, MA 02115 USA; Univ Dusseldorf, Dept Urol, Dusseldorf, Germany; Ist Nazl Tumori Milan, Milan, MI, Italy; Univ Naples Federico II, Med Oncol Unit, Dept Clin Med, Naples, Italy; Inst Rech Pierre Fabre, Boulogne, France; Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Toronto, ON M4N 3M5, Canada; Ist Neurotraumatol Italiano Grottaferrata, Clin Oncol Unit, Grottaferrata, Italy; Kitasato Inst, Dept Urol, Sch Med, Sagamihara, Kanagawa, Japan; Univ Ulsan, Asan Med Ctr, Dept Oncol, Coll Med, Seoul, South Korea; Sapporo Med Univ, Chuo Ku, Sapporo, Hokkaido, Japan; Univ Tokyo, Fac Med, Dept Urol, Tokyo 113, Japan; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		4527						1	Oncology	Oncology	CM9OA	WOS:000358036900995		
J	Spraggs, CF; Parham, LR; Warren, L; Williams, LS; Briley, LP; Fraser, D; Jiang, ZF; Aziz, Z; Tong, ZS; Moodley, SD; Mehta, AO; Jackson, N; Byrne, J; Andersson, M; Toi, M; Harris, L; Gralow, J; Crescenzo, R; Armour, AA				Spraggs, Colin F.; Parham, Laura Rae; Warren, Liling; Williams, Lisa Simone; Briley, Linda P.; Fraser, Dana; Jiang, Zefei; Aziz, Zeba; Tong, Zhongsheng; Moodley, Shun Devan; Mehta, Ajay O.; Jackson, Nicola; Byrne, Julie; Andersson, Michael; Toi, Masakazu; Harris, Lyndsay; Gralow, Julie; Crescenzo, Rocco; Armour, Alison A.			HLA-DRB1*07:01 biomarker characterization of hepatotoxicity during lapatinib combination therapies in ALTTO	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					GlaxoSmithKline, Stevenage, Herts, England; GlaxoSmithKline, Raleigh, NC USA; GlaxoSmithKline, London, England; Acad Mil Med Sci, Hosp Affiliated, Beijing, Peoples R China; Hameed Latif Hosp, Lahore, Pakistan; Tianjin Canc Hosp, Tianjin, Peoples R China; Univ Witwatersrand, Parktown, South Africa; Cent India Canc Res Inst, Nagpur, Maharashtra, India; GlaxoSmithKline, Collegeville, PA USA; Rigshosp, DK-2100 Copenhagen, Denmark; Kyoto Univ, Kyoto, Japan; Case Med Ctr, Cleveland, OH USA; Univ Washington, Seattle, WA 98195 USA								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		617						1	Oncology	Oncology	CM9OA	WOS:000358036901409		
J	Sudo, K; Kato, K; Kuwabara, H; Sasaki, Y; Takahashi, N; Shoji, H; Iwasa, S; Honma, Y; Okita, NT; Takashima, A; Hamaguchi, T; Yamada, Y; Boku, N				Sudo, Kazuki; Kato, Ken; Kuwabara, Hiroki; Sasaki, Yusuke; Takahashi, Naoki; Shoji, Hirokazu; Iwasa, Satoru; Honma, Yoshitaka; Okita, Natsuko T.; Takashima, Atsuo; Hamaguchi, Tetsuya; Yamada, Yasuhide; Boku, Narikazu			Patterns of local-regional relapse after complete response by definitive chemoradiotherapy for stage II/III (non-T4) esophageal squamous cell carcinoma.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Natl Canc Ctr, Tokyo, Japan; Natl Canc Ctr, Gastrointestinal Med Oncol Div, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		4045						1	Oncology	Oncology	CM9OA	WOS:000358036900884		
J	Sugawara, S; Takayama, K; Sato, A; Maemondo, M; Takamori, S; Sasada, T; Kakuma, T; Kishimoto, J; Yamada, A; Noguchi, M; Itoh, K; Nakanishi, Y				Sugawara, Shunichi; Takayama, Koichi; Sato, Atsushi; Maemondo, Makoto; Takamori, Shinzo; Sasada, Tetsuro; Kakuma, Tatsuyuki; Kishimoto, Junji; Yamada, Akira; Noguchi, Masanori; Itoh, Kyogo; Nakanishi, Yoichi			Randomized phase II study of docetaxel plus personalized peptide vaccination versus docetaxel plus placebo for patients previously treated for advanced wild-type EGFR non-small-cell lung cancer.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Sendai Kousei Hosp, Sendai, Miyagi, Japan; Kyushu Univ, Grad Sch Med Sci, Res Inst Dis Chest, Fukuoka 812, Japan; Hirosaki Univ, Grad Sch Med, Dept Med Oncol, Hirosaki, Aomori, Japan; Miyagi Canc Ctr, Sendai, Miyagi, Japan; Kurume Univ, Kurume, Fukuoka 830, Japan; Kanagawa Canc Ctr, Res Inst, Yokohama, Kanagawa 2410815, Japan; Kurume Univ, Sch Med, Biostat Ctr, Fukuoka, Japan; Kyushu Univ, Fukuoka 812, Japan; Kurume Univ, Sch Med, Canc Vaccine Res Ctr Innovat Canc Therapy, Kurume, Fukuoka 830, Japan; Kurume Univ, Sch Med, Kurume, Fukuoka 830, Japan; Kurume Univ, Sch Med, Canc Vaccine Ctr, Kurume, Fukuoka 830, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e14029						1	Oncology	Oncology	CM9OA	WOS:000358036902619		
J	Sugie, T; Kawaguchi, A; Ikeda, T; Toi, M				Sugie, Tomoharu; Kawaguchi, Atsushi; Ikeda, Takafumi; Toi, Masakazu			Near infrared imaging using indocyanine green for sentinel lymph node biopsy in women with early breast cancer: Results of a meta-analysis.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Kansai Med Univ, Hirakata Hosp, Hirakata, Osaka, Japan; Kyoto Univ, Kyoto, Japan; Kyoto Univ, Grad Sch Med, Kyoto, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e12044						1	Oncology	Oncology	CM9OA	WOS:000358036902267		
J	Sugiyama, K; Kojima, Y; Nagai, H; Odawara, T; Yotsumoto, M; Ajisawa, A; Hagiwara, S; Uehira, T; Miyakawa, T; Igari, H; Takahama, S; Nakamura, H; Okada, S				Sugiyama, Keiji; Kojima, Yuki; Nagai, Hirokazu; Odawara, Takashi; Yotsumoto, Mihoko; Ajisawa, Atsushi; Hagiwara, Shotaro; Uehira, Tomoko; Miyakawa, Toshikazu; Igari, Hidetoshi; Takahama, Soichirou; Nakamura, Hideta; Okada, Seiji			Long-term follow up of AIDS-related primary central nervous system lymphoma in the cART era.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Nagoya Med Ctr, Natl Hosp Org, Nagoya, Aichi, Japan; Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Nagoya, Aichi 4648601, Japan; Univ Tokyo, Inst Med Sci, Dept Infect Dis & Appl Immunol, Tokyo, Japan; Tokyo Med Univ, Dept Lab Med, Tokyo 1608402, Japan; Toshima Hosp, Tokyo Metropolitan Hlth & Med Treatment Corp, Tokyo, Japan; Natl Ctr Global Hlth & Med, Dept Hematol, Internal Med, Tokyo, Japan; Osaka Natl Hosp, Natl Hosp Org, Dept Infect Dis, Osaka, Japan; Kumamoto Univ Hosp, Dept Hematol & Infect Dis, Kumamoto, Japan; Chiba Univ Hosp, Div Control & Treatment Infect Dis, Chiba, Japan; Kyushu Med Ctr, Natl Hosp Org, AIDS HIV Combined Clin Ctr, Clin Res Inst, Fukuoka, Japan; Univ Ryukyus, Fac Med, Dept Internal Med 1, Nishihara, Okinawa 90301, Japan; Kumamoto Univ, Ctr AIDS Res, Kumamoto, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e19504						1	Oncology	Oncology	CM9OA	WOS:000358036903992		
J	Sumikawa, S; Kawazoe, H; Nakauchi, K; Miyajima, R; Ueno, M; Asai, H; Kojima, Y; Yakushijin, Y; Tanaka, A; Araki, H				Sumikawa, Satomi; Kawazoe, Hitoshi; Nakauchi, Kana; Miyajima, Risa; Ueno, Masaki; Asai, Hiroaki; Kojima, Yoh; Yakushijin, Yoshihiro; Tanaka, Akihiro; Araki, Hiroaki			Preventive effect of adding dexamethasone to a pre-warmed oxaliplatin solution and use of a hot compress for oxaliplatin-induced venous pain	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Ehime Univ Hosp, Div Pharm, Toon, Ehime, Japan; Ehime Univ Hosp, Div Nursing, Toon, Ehime, Japan; Ehime Univ Hosp, Ctr Canc, Toon, Ehime, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e20665						1	Oncology	Oncology	CM9OA	WOS:000358036904275		
J	Sunahara, M; Ono, Y; Tsunetoshi, Y; Sawano, T; Kasajima, H; Hara, Y; Suzuki, S; Toyama, S; Ogasawara, K; Kimura, J				Sunahara, Masao; Ono, Yosuke; Tsunetoshi, Yusuke; Sawano, Takeyuki; Kasajima, Hiroyuki; Hara, Yutaka; Suzuki, Shinsaku; Toyama, Shigeru; Ogasawara, Kazuhiro; Kimura, Jun			Video-assisted thoracoscopic transdiaphragmatic liver resection for malignant tumors located in the posterosuperior segments.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Hakodate Municipal Hosp, Inst Gastroenterol, Dept Surg, Hakodate, Hokkaido, Japan; Kushiro Rosai Hosp, Kushiro, Hokkaido, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e15161						1	Oncology	Oncology	CM9OA	WOS:000358036902929		
J	Suzuki, H; Aoki, K; Chiba, K; Sato, Y; Shiozawa, Y; Shiraishi, Y; Shimamura, T; Niida, A; Motomura, K; Ohka, F; Nakamura, H; Mizoguchi, M; Abe, T; Muragaki, Y; Watanabe, R; Ito, I; Wakabayashi, T; Ogawa, S; Natsume, A				Suzuki, Hiromichi; Aoki, Kosuke; Chiba, Kenichi; Sato, Yusuke; Shiozawa, Yusuke; Shiraishi, Yuichi; Shimamura, Teppei; Niida, Atsushi; Motomura, Kazuya; Ohka, Fumiharu; Nakamura, Hideo; Mizoguchi, Masahiro; Abe, Tatsuya; Muragaki, Yoshihiro; Watanabe, Reiko; Ito, Ichiro; Wakabayashi, Toshihiko; Ogawa, Seishi; Natsume, Atsushi			The landscape and clonal architecture in lower grade glioma	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Nagoya Univ, Sch Med, Dept Neurosurg, Nagoya, Aichi 466, Japan; Univ Tokyo, Inst Med Sci, Ctr Human Genome, Tokyo, Japan; Kyoto Univ, Dept Pathol & Tumor Biol, Kyoto, Japan; Nagoya Univ, Sch Med, Div Syst Biol, Nagoya, Aichi 466, Japan; Kumamoto Univ, Dept Neurosurg, Kumamoto, Japan; Kyushu Univ, Grad Sch Med Sci, Dept Neurosurg, Fukuoka 812, Japan; Oita Univ, Sch Med, Dept Neurosurg, Oita 87011, Japan; Tokyo Womens Med Univ, Fac Adv Techno Surg, Tokyo, Japan; Shizuoka Canc Ctr, Dept Clin Pathol, Shizuoka, Japan; Shizuoka Canc Ctr, Div Clin Pathol, Shizuoka, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		2008						1	Oncology	Oncology	CM9OA	WOS:000358036900467		
J	Suzuki, K				Suzuki, Keisuke			Spermatogenesis of tumor-bearing testes in germ cell testicular cancer patients	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					[Suzuki, Keisuke] Dokkyo Med Univ, Koshigaya Hosp, Saitama, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e15569						1	Oncology	Oncology	CM9OA	WOS:000358036903115		
J	Szasz, O; Andocs, G; Kondo, T; Rehman, MU; Papp, E; Vancsik, T; Krenacs, T				Szasz, Oliver; Andocs, Gabor; Kondo, Takashi; Rehman, Mati Ur; Papp, Edina; Vancsik, Tamas; Krenacs, Tibor			Heating of membrane rafts of cancer-cells	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					St Istvan Univ, Dept Biotech, Godollo, Hungary; Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Radiol Sci, Toyama 930, Japan; Pazmany P Catholic Univ, Fac Informat Technol & Bion, Budapest, Hungary; Semmelweis Univ, Dept Pathol & Expt Canc Res, H-1085 Budapest, Hungary; Dept Pathol & Expt Canc Res 1, Budapest, Hungary								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e22176						1	Oncology	Oncology	CM9OA	WOS:000358036904554		
J	Tahara, M; Schlumberger, M; Elisei, R; Habra, MA; Kiyota, N; Dutcus, C; Xu, JB; Zhu, JM; Hihara, T; McGrath, S; Matijevic, M; Kadowaki, T; Funahashi, Y; Sherman, SI				Tahara, Makoto; Schlumberger, Martin; Elisei, Rossella; Habra, Mouhammed Amir; Kiyota, Naomi; Dutcus, Corina; Xu, Jianbo; Zhu, Junming; Hihara, Taro; McGrath, Shannon; Matijevic, Mark; Kadowaki, Tadashi; Funahashi, Yasuhiro; Sherman, Steven I.			Pharmacodynamic biomarkers of outcomes in the phase III study of lenvatinib in I-131-refractory differentiated thyroid cancer (SELECT).	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Natl Canc Ctr Hosp East, Dept Head & Neck Med Oncol, Kashiwa, Chiba, Japan; Gustave Roussy, Dept Nucl Med & Endocrine Oncol, Villejuif, France; Univ Paris 11, Villejuif, France; Univ Pisa, Dept Endocrinol, Pisa, Italy; Univ Texas MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, Div Internal Med, Houston, TX 77030 USA; Kobe Univ Hosp, Dept Med, Div Med Oncol Hematol, Kobe, Hyogo, Japan; Grad Sch Med, Kobe, Hyogo, Japan; Eisai Inc, Woodcliff Lake, NJ USA; Eisai & Co Ltd, Tsukuba, Ibaraki, Japan; Eisai Inc, Andover, MA USA; Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		6014						1	Oncology	Oncology	CM9OA	WOS:000358036901326		
J	Takada, R; Ioka, T; Abe, Y; Hibino, K; Tamura, T; Fukutake, N; Ashida, R; Uehara, H; Ohkawa, K; Hirata, T; Kawaguchi, Y; Konishi, K; Teshima, T; Katayama, K				Takada, Ryoji; Ioka, Tatsuya; Abe, Yutaro; Hibino, Kenji; Tamura, Takeshi; Fukutake, Nobuyasu; Ashida, Reiko; Uehara, Hiroyuki; Ohkawa, Kazuyoshi; Hirata, Takero; Kawaguchi, Yoshifumi; Konishi, Koji; Teshima, Teruki; Katayama, Kazuhiro			The evaluation of the prognostic factors for locally advanced pancreatic cancer patients: A retrospective study from a single center.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Osaka Med Ctr Canc & Cardiovasc Dis, Dept Hepatobiliary & Pancreat Oncol, Osaka, Japan; Osaka Med Ctr Canc & Cardiovasc Dis, Hepatobiliary & Pancreat Oncol, Osaka, Japan; Osaka Med Ctr Canc & CVD, Dept Hepatobiliary & Pancreat Oncol, Osaka, Japan; Osaka Med Ctr Canc & CVD, Dept Hepatobiliaru & Pancreat Oncol, Osaka, Japan; Osaka Med Ctr Canc & Cardiovasc Dis, Osaka, Japan; Osaka Med Ctr Canc & Cardiovasc Dis, Dept Radiat Oncol, Osaka, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e15225						1	Oncology	Oncology	CM9OA	WOS:000358036902987		
J	Takagi, M; Katai, H; Mizusawa, J; Nakamura, K; Yoshikawa, T; Terashima, M; Ito, S; Teshima, S; Koeda, K; Sano, T; Fukushima, N; Yasuda, T; Asao, Y; Fujiwara, Y; Sasako, M				Takagi, Masakazu; Katai, Hitoshi; Mizusawa, Junki; Nakamura, Kenichi; Yoshikawa, Takaki; Terashima, Masanori; Ito, Seiji; Teshima, Shin; Koeda, Keisuke; Sano, Takeshi; Fukushima, Norimasa; Yasuda, Takeshi; Asao, Yoshito; Fujiwara, Yoshiyuki; Sasako, Mitsuru		Japan Clinical Oncology Grp	A phase III study of laparoscopy-assisted versus open distal gastrectomy with nodal dissection for clinical stage IA/IB gastric cancer (JCOG0912): Analysis of the safety and short-term clinical outcomes	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Shizuoka Prefectural Gen Hosp, Shizuoka, Japan; Natl Canc Ctr, Gastr Surg Div, Tokyo, Japan; Natl Canc Ctr, Japan Clin Oncol Grp, Ctr Data, Ctr Res Adm & Support, Tokyo 104, Japan; Natl Canc Ctr, Clin Oncol Grp, Operat Off, Tokyo 104, Japan; Kanagawa Canc Ctr, Dept Gastrointestinal Surg, Yokohama, Kanagawa 2410815, Japan; Shizuoka Canc Ctr, Div Gastr Surg, Nagaizumi, Shizuoka, Japan; Aichi Canc Ctr Hosp, Dept Surg Gastroenterol, Nagoya, Aichi 464, Japan; NHO Sendai Med Ctr, Dept Surg, Sendai, Miyagi, Japan; Iwate Med Univ, Sch Med, Dept Surg, Morioka, Iwate 020, Japan; Japanese Fdn Canc Res, Canc Inst Hosp, Dept Surg Gastroenterol, Tokyo, Japan; Yamagata Prefectural Cent Hosp, Dept Surg, Yamagata, Japan; Hyogo Canc Ctr, Dept Surg, Nishinomiya, Hyogo, Japan; Tenri Hosp, Dept Surg, Tenri, Nara 632, Japan; Osaka Med Ctr Canc & Cardiovasc Dis, Osaka, Japan; Hyogo Coll Med, Dept Surg, Nishinomiya, Hyogo 6638501, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		4017						1	Oncology	Oncology	CM9OA	WOS:000358036900856		
J	Takahashi, Y; Fujikawa, K; Sagawa, T; Yonemori, K; Tamura, K; Kodaira, M; Esaki, T; Shirakawa, T; Hirai, F; Yokoi, Y; Kawata, T; Hatano, B				Takahashi, Yasuo; Fujikawa, Koshi; Sagawa, Tamotsu; Yonemori, Kan; Tamura, Kenji; Kodaira, Makoto; Esaki, Taito; Shirakawa, Tsuyoshi; Hirai, Fumihiko; Yokoi, Yuki; Kawata, Toshio; Hatano, Ben			Safety and tolerability of the olaparib tablet formulation in Japanese patients (pts) with advanced solid tumors (ASTs)	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Hokkaido Canc Ctr, Dept Gastroenterol, Sapporo, Hokkaido, Japan; Natl Canc Ctr, Tokyo, Japan; Natl Canc Ctr, Dept Breast & Med Oncol, Tokyo, Japan; Kyushu Canc Ctr, Natl Hosp Org, Dept Gastrointestinal & Med Oncol, Fukuoka, Japan; Kyushu Canc Ctr, Natl Hosp Org, Dept Thorac Oncol, Fukuoka, Japan; AstraZeneca R&D, Osaka, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e13553						1	Oncology	Oncology	CM9OA	WOS:000358036902553		
J	Takamochi, K; Mogushi, K; Imashimizu, K; Fukui, M; Oh, S; Itoh, M; Hayashizaki, Y; Suzuki, K; Kawaji, H				Takamochi, Kazuya; Mogushi, Kaoru; Imashimizu, Kota; Fukui, Mariko; Oh, Shiaki; Itoh, Masayoshi; Hayashizaki, Yoshihide; Suzuki, Kenji; Kawaji, Hideya			Association between the EGFR or KRAS mutation status and the FDG-PET findings in surgically resected lung adenocarcinoma.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Juntendo Univ, Tokyo, Japan; Juntendo Univ, Sch Med, Ctr Genom & Regenerat Med, Tokyo 113, Japan; Juntendo Univ, Sch Med, Dept Gen Thorac Surg, Tokyo 113, Japan; Juntendo Univ, Sch Med, Tokyo 113, Japan; Juntendo Univ, Sch Med, Gen Thorac Surg, Tokyo 113, Japan; RIKEN Adv Ctr Comp & Commun, Prevent Med & Appl Genom Unit, Yokohama, Kanagawa, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		7535						1	Oncology	Oncology	CM9OA	WOS:000358036901665		
J	Takano, A; Nakamura, Y; Daigo, Y				Takano, Atsushi; Nakamura, Yusuke; Daigo, Yataro			Characterization of LASEP3 as a serological and prognostic biomarker and a therapeutic target for lung cancer.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Univ Tokyo, Ctr Antibody & Vaccine, Tokyo, Japan; Univ Chicago, Dept Med & Surg, Chicago, IL 60637 USA; Shiga Univ Med Sci, Dept Med Oncol, Otsu, Shiga 52021, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		11088						1	Oncology	Oncology	CM9OA	WOS:000358036900346		
J	Takano, M; Kouta, H; Kudoh, K; Kita, T; Kikuchi, R; Miyamoto, M; Yoshikawa, T; Goto, T; Furuya, K; Tamada, Y; Suga, A; Kikuchi, Y				Takano, Masashi; Kouta, Hiroko; Kudoh, Kazuya; Kita, Tsunekazu; Kikuchi, Ryoko; Miyamoto, Morikazu; Yoshikawa, Tomoyuki; Goto, Tomoko; Furuya, Kenichi; Tamada, Yutaka; Suga, Arata; Kikuchi, Yoshihiro			Combination therapy with temsirolimus and trabectedin for recurrent clear cell carcinoma of the ovary: A phase II study with biomarker analysis.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Natl Def Med Coll, Tokorozawa, Saitama 359, Japan; Tama Hokubu Med Ctr, Higashimurayama, Japan; Nara Prefectural Nara Hosp, Nara, Japan; Kyoundo Hosp, Tokyo, Japan; Tachikawa Hosp, Tachikawa, Tokyo, Japan; Koshigaya City Hosp, Koshigaya, Japan; Ohki Mem Kikuchi Canc Ctr Women, Tokorozawa, Saitama, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		5583						1	Oncology	Oncology	CM9OA	WOS:000358036901249		
J	Takayama, Y; Suzuki, K; Daito, T; Ichida, K; Fukui, T; Muto, Y; Kakizawa, N; Imoto, H; Taniyama, Y; Kaneda, Y; Tanaka, H; Watanabe, F; Kato, T; Hasegawa, F; Saito, M; Tsujinaka, S; Miyakura, Y; Noda, H; Konishi, F; Rikiyama, T				Takayama, Yuji; Suzuki, Koichi; Daito, Tsutomu; Ichida, Kosuke; Fukui, Taro; Muto, Yuta; Kakizawa, Nao; Imoto, Hirofumi; Taniyama, Yusuke; Kaneda, Yuji; Tanaka, Hiroyuki; Watanabe, Fumiaki; Kato, Takaharu; Hasegawa, Fumi; Saito, Masaaki; Tsujinaka, Shingo; Miyakura, Yasuyuki; Noda, Hiroshi; Konishi, Fumio; Rikiyama, Toshiki			Emergence of KRAS mutation in detection of circulating tumor DNA during treatments for metastatic gastrointestinal cancer patients.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Jichi Med Univ, Saitama Med Ctr, Saitama, Japan; Jichi Med Univ, Saitama Med Ctr, Dept Surg, Saitama, Japan; Biorad Labs KK, Osaka, Japan; Nerima Hikarigtaoka Hosp, Dept Surg, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		11026						1	Oncology	Oncology	CM9OA	WOS:000358036900285		
J	Takeda, K; Abe, T; Ohe, Y; Kudoh, S; Ichinose, Y; Okamoto, H; Yamamoto, N; Yoshioka, H; Minato, K; Sawa, T; Iwamoto, Y; Saka, H; Mizusawa, J; Mizutani, T; Nakamura, S; Ando, M; Yokoyama, A; Nakagawa, K; Saijo, N; Tamura, T				Takeda, Koji; Abe, Tetsuya; Ohe, Yuichiro; Kudoh, Shinzoh; Ichinose, Yukito; Okamoto, Hiroaki; Yamamoto, Nobuyuki; Yoshioka, Hiroshige; Minato, Koichi; Sawa, Toshiyuki; Iwamoto, Yasuo; Saka, Hideo; Mizusawa, Junki; Mizutani, Tomonori; Nakamura, Shinichiro; Ando, Masahiko; Yokoyama, Akira; Nakagawa, Kazuhiko; Saijo, Nagahiro; Tamura, Tomohide			Final overall survival results of a randomized phase III trial comparing weekly docetaxel plus cisplatin (DP) with 3-weekly docetaxel (D) monotherapy in elderly patients (pts) with advanced non-small-cell lung cancer (NSCLC): intergroup trial JCOG0803/WJOG4307L.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Osaka City Gen Hosp, Dept Clin Oncol, Osaka, Japan; Niigata Canc Ctr Hosp, Niigata, Japan; Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan; Osaka City Univ, Grad Sch Med, Osaka 558, Japan; Kyushu Natl Canc Ctr, Fukuoka, Japan; Yokohama Municipal Citizens Hosp, Yokohama, Kanagawa, Japan; Wakayama Med Univ, Wakayama, Japan; Kurashiki Cent Hosp, Kurashiki, Okayama, Japan; Gunma Canc Ctr, Ota, Japan; Gifu Municipal Hosp, Gifu, Japan; Hiroshima City Hosp, Hiroshima, Japan; Nagoya Med Ctr, Nagoya, Aichi, Japan; Natl Canc Ctr, Japan Clin Oncol Grp, Ctr Data, Ctr Res Adm & Support, Tokyo 104, Japan; Natl Canc Ctr, JCOG Data Ctr, Tokyo 104, Japan; WJOG, Osaka, Japan; Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan; Kinki Univ, Fac Med, Osakasayama, Japan; Japanese Soc Med Oncol, Tokyo, Japan; Natl Canc Ctr, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e19012						1	Oncology	Oncology	CM9OA	WOS:000358036903877		
J	Takeda, M; Seto, T; Hayashi, H; Okada, M; Azuma, K; Sugawara, S; Daga, H; Hirashima, T; Yonesaka, K; Urata, Y; Murakami, H; Saito, H; Kubo, A; Sawa, T; Miyahara, E; Nogami, N; Yamanaka, T; Nakanishi, Y; Nakagawa, K; Okamoto, I				Takeda, Masayuki; Seto, Takashi; Hayashi, Hidetoshi; Okada, Morihito; Azuma, Koichi; Sugawara, Shunichi; Daga, Haruko; Hirashima, Tomonori; Yonesaka, Kimio; Urata, Yoshiko; Murakami, Haruyasu; Saito, Haruhiro; Kubo, Akihito; Sawa, Toshiyuki; Miyahara, Eiji; Nogami, Naoyuki; Yamanaka, Takeharu; Nakanishi, Yoichi; Nakagawa, Kazuhiko; Okamoto, Isamu		West Japan Oncology Grp	Bevacizumab beyond disease progression after first-line treatment with bevacizumab plus chemotherapy inadvanced nonsquamous non-small cell lung cancer (WJOG 5910L): An open-label, randomized, phase II trial.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Kinki Univ, Fac Med, Dept Med Oncol, Osaka, Japan; Kyushu Natl Canc Ctr, Fukuoka, Japan; Kishiwada City Hosp, Dept Med Oncol, Osaka, Japan; Hiroshima Univ, Dept Surg Oncol, Hiroshima, Japan; Kurume Univ, Sch Med, Dept Internal Med, Div Respirol Neurol & Rheumatol, Kurume, Fukuoka 830, Japan; Sendai Kousei Hosp, Sendai, Miyagi, Japan; Osaka City Gen Hosp, Dept Clin Oncol, Osaka, Japan; Osaka Prefectural Med Ctr Resp & Allerg Dis, Habikino, Osaka, Japan; Izumi Municipal Hosp, Dept Med Oncol, Osaka, Japan; Hyogo Canc Ctr, Dept Thorac Oncol, Akashi, Hyogo, Japan; Shizuoka Canc Ctr, Div Thorac Oncol, Shizuoka, Japan; Kanagawa Canc Ctr, Yokohama, Kanagawa 2410815, Japan; Aichi Med Univ, Sch Med, Nagakute, Aichi 48011, Japan; Gifu Municipal Hosp, Gifu, Japan; Saiseikai Hiroshima Hosp, Dept Surg, Hiroshima, Japan; Shikoku Canc Ctr, Natl Hosp Org, Clin Res Inst, Matsuyama, Ehime, Japan; Yokohama City Univ, Yokohama, Kanagawa 232, Japan; Kyushu Univ, Fukuoka 812, Japan; Kinki Univ, Fac Med, Osakasayama, Japan; Kyushu Univ Hosp, Fukuoka 812, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		8056						1	Oncology	Oncology	CM9OA	WOS:000358036901768		
J	Takei, Y; Fujiwara, H; Machida, S; Taneichi, A; Takahashi, S; Takahashi, Y; Saga, Y; Suzuki, M				Takei, Yuji; Fujiwara, Hiroyuki; Machida, Shizuo; Taneichi, Akiyo; Takahashi, Suzuyo; Takahashi, Yoshifumi; Saga, Yasushi; Suzuki, Mitsuaki			Recurrence factors of stage I ovarian clear cell carcinoma.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					[Takei, Yuji; Fujiwara, Hiroyuki; Machida, Shizuo; Taneichi, Akiyo; Takahashi, Suzuyo; Takahashi, Yoshifumi; Saga, Yasushi; Suzuki, Mitsuaki] Jichi Med Univ, Dept OBGYN, Shimotsuke, Tochigi, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e16577						1	Oncology	Oncology	CM9OA	WOS:000358036903365		
J	Takekuma, M; Hirashima, Y; Umayahara, K; Noda, SE; Ohno, T; Miyagi, E; Hirahara, F; Hirata, E; Kondo, E; Tabata, T; Nagai, Y; Aoki, Y; Wakatsuki, M; Takeuchi, M; Toita, T; Takeshima, N; Takizawa, K				Takekuma, Munetaka; Hirashima, Yasuyuki; Umayahara, Kenji; Noda, Shin-ei; Ohno, Tatsuya; Miyagi, Etsuko; Hirahara, Fumiki; Hirata, Eiji; Kondo, Eiji; Tabata, Tsutomu; Nagai, Yutaka; Aoki, Yoichi; Wakatsuki, Masaru; Takeuchi, Masahiro; Toita, Takafumi; Takeshima, Nobuhiro; Takizawa, Ken			Phase II study of concurrent chemoradiotherapy with weekly CDDP/PTX in patients with locally advanced uterine cervical cancer: JACCRO-GY-01 trial.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Shizuoka Canc Ctr, Dept Gynecol Oncol, Shizuoka, Japan; Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gynecol, Tokyo, Japan; Gunma Univ Hosp, Dept Radiat Oncol, Maebashi, Gunma, Japan; Yokohama City Univ Med, Dept Obstet & Gynecol, Yokohama, Kanagawa, Japan; Hiroshima Univ Hosp, Dept Obstet & Gynecol, Hiroshima, Japan; Mie Univ Hosp, Dept Obstet & Gynecol, Tsu, Mie, Japan; Univ Ryukyus Hosp, Dept Obstet & Gynecol, Okinawa, Japan; Natl Inst Radiol Sci, Res Ctr Charged Particle Therapy, Chiba 260, Japan; Kitasato Univ, Tokyo, Japan; Univ Ryukyus Hosp, Dept Radiol, Okinawa, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		5587						1	Oncology	Oncology	CM9OA	WOS:000358036901253		
J	Takeuchi, H; Miyata, H; Ozawa, S; Udagawa, H; Osugi, H; Matsubara, H; Kitagawa, Y				Takeuchi, Hiroya; Miyata, Hiroaki; Ozawa, Soji; Udagawa, Harushi; Osugi, Harushi; Matsubara, Hisahiro; Kitagawa, Yuko			Comparison of open esophagectomy with minimally invasive esophagectomy: An observational nationwide study in Japan.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan; Univ Tokyo, Grad Sch Med, Dept Healthcare Qual Assessment, Tokyo, Japan; Tokai Univ, Sch Med, Dept Gastrointestinal Surg, Isehara, Kanagawa 25911, Japan; Toranomon Gen Hosp, Gastroenterol Surg, Tokyo, Japan; Osaka City Univ, Sch Med, Dept Surg, Osaka 545, Japan; Chiba Univ, Grad Sch Med, Chiba, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		4052						1	Oncology	Oncology	CM9OA	WOS:000358036900891		
J	Takeuchi, S; Shoji, T; Kagabu, M; Honda, T; Kojima, A; Nitta, Y; Sugiyama, T; Nakamura, Y				Takeuchi, Satoshi; Shoji, Tadahiro; Kagabu, Masahiro; Honda, Tatsuya; Kojima, Atsumi; Nitta, Yukari; Sugiyama, Toru; Nakamura, Yusuke			Phase 2 studies of multiple peptides cocktail vaccine for treatment-resistant cervical and ovarian cancer.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Iwate Med Univ, Morioka, Iwate 020, Japan; Iwate Med Univ, Sch Med, Morioka, Iwate 020, Japan; Shikoku Canc Ctr, Gynecol Oncol, Matsuyama, Ehime, Japan; Iwate Med Univ, Sch Med Gynecol, Morioka, Iwate 020, Japan; Univ Chicago, Chicago, IL 60637 USA								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		5567						1	Oncology	Oncology	CM9OA	WOS:000358036901231		
J	Tan, DSW; Seto, T; Leighl, NB; Riely, GJ; Sequist, LV; Felip, E; Wolf, J; Yang, JCH; Matushansky, I; Yu, XL; Schmitz, SFH; Cui, XM; Kim, DW				Tan, Daniel Shao-Weng; Seto, Takashi; Leighl, Natasha B.; Riely, Gregory J.; Sequist, Lecia V.; Felip, Enriqueta; Wolf, Juergen; Yang, James Chih-Hsin; Matushansky, Igor; Yu, Xiaolu; Schmitz, Shu-Fang Hsu; Cui, Xiaoming; Kim, Dong-Wan			First-in-human phase I study of EGF816, a third generation, mutant-selective EGFR tyrosine kinase inhibitor, in advanced non-small cell lung cancer (NSCLC) harboring T790M.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Natl Canc Ctr Singapore, Singapore, Singapore; Kyushu Natl Canc Ctr, Fukuoka, Japan; Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Vall dHebron Univ Hosp, Barcelona, Spain; Univ Hosp Cologne, Dept Internal Med 1, Cologne, Germany; Univ Hosp Cologne, Ctr Integrated Oncol Cologne Bonn, Cologne, Germany; Natl Taiwan Univ Hosp, Taipei, Taiwan; Natl Taiwan Univ, Taipei 10764, Taiwan; Novartis Pharmaceut, E Hanover, NJ USA; China Novartis Inst BioMed Res, Shanghai, Peoples R China; Novartis Pharma AG, Basel, Switzerland; Seoul Natl Univ Hosp, Seoul 110744, South Korea								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		8013						1	Oncology	Oncology	CM9OA	WOS:000358036901726		
J	Tanaka, H; Suzuki, N; Iguchi, H; Uesugi, K; Hirakawa, K; Amano, R; Aruga, A; Hatori, T; Hidenobu, I; Umeda, Y; Shimada, M; Yoshimatsu, K; Shimizu, R; Ozasa, H; Hayashi, H; Sakata, K; Ueno, T; Furukawa, H; Hazama, S; Oka, M				Tanaka, Hiroaki; Suzuki, Nobuaki; Iguchi, Haruo; Uesugi, Kazuhiro; Hirakawa, Kosei; Amano, Ryosuke; Aruga, Atsushi; Hatori, Takashi; Hidenobu, Ishizaki; Umeda, Yuzo; Shimada, Mitsuo; Yoshimatsu, Kazuhiko; Shimizu, Ryoichi; Ozasa, Hiroaki; Hayashi, Hiroto; Sakata, Koichiro; Ueno, Tomio; Furukawa, Hiroyuki; Hazama, Shoichi; Oka, Masaaki			A phase II study of novel three peptides combination with gemcitabine as a first-line therapy for advanced pancreatic cancer (VENUS-PC study).	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Osaka 558, Japan; Yamaguchi Univ, Grad Sch Med, Ube, Yamaguchi 755, Japan; Natl Hosp Org, Shikoku Canc Ctr, Clin Res Inst, Matsuyama, Ehime, Japan; Natl Hosp Org, Shikoku Canc Ctr, Matsuyama, Ehime, Japan; Osaka City Univ, Grad Sch Med, Osaka 558, Japan; Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Osaka 558, Japan; Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo, Japan; Tokyo Womens Med Univ, Tokyo, Japan; Miyazaki Univ, Sch Med, Dept Surg Oncol & Regulat Organ Funct, Miyazaki, Japan; Okayama Univ Hosp, Okayama, Japan; Univ Tokushima, Dept Surg, Tokushima 770, Japan; Tokyo Womens Med Univ, Med Ctr East, Tokyo, Japan; Ogori Daiichi Gen Hosp, Dept Surg, Yamaguchi, Japan; NHO, Dept Surg, Kanmon Med Ctr, Shimonoseki, Yamaguchi, Japan; Shimonoseki Med Ctr, Dept Surg, Shimonoseki, Yamaguchi, Japan; Yamaguchi Univ, Grad Sch Med, Dept Digest Surg & Surg Oncol, Ube, Yamaguchi 755, Japan; Yamaguchi Univ, Dept Pharm, Ube, Yamaguchi, Japan; Yamaguchi Univ, Grad Sch Med, Digest Surgey & Surg Oncol, Ube, Yamaguchi 755, Japan; Yamaguchi Univ, Ube, Yamaguchi 755, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		3045						1	Oncology	Oncology	CM9OA	WOS:000358036900679		
J	Tanaka, K; Kataoka, K; Mizusawa, J; Yonemoto, T; Morioka, H; Hiraga, H; Chuuman, H; Ohno, T; Matsumine, A; Abe, S; Matuso, K; Takahashi, M; Hiraoka, K; Fukuda, H; Iwamoto, Y				Tanaka, Kazuhiro; Kataoka, Kozo; Mizusawa, Junki; Yonemoto, Tsukasa; Morioka, Hideo; Hiraga, Hiroaki; Chuuman, Hirokazu; Ohno, Takatoshi; Matsumine, Akihiko; Abe, Satoshi; Matuso, Kosuke; Takahashi, Mitsuru; Hiraoka, Koji; Fukuda, Haruhiko; Iwamoto, Yukihide			A randomized phase II/III study, comparing perioperative adriamycin plus ifosfamide versus gemcitabine plus docetaxel for operable high grade soft tissue sarcomas in extremity or trunk: JCOG1306.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Oita Univ, Oita 87011, Japan; Natl Canc Ctr, Japan Clin Oncol Grp Operat Off, Tokyo 104, Japan; Natl Canc Ctr, Japan Clin Oncol Grp Data Ctr Ctr Res Adm & Suppo, Tokyo 104, Japan; Chiba Canc Ctr, Chiba 2608717, Japan; Keio Univ, Tokyo, Japan; Hokkaido Canc Ctr, Dept Orthopaed Surg, Sapporo, Hokkaido, Japan; Natl Canc Ctr, Tokyo, Japan; Gifu Univ, Gifu, Japan; Mie Univ, Tsu, Mie 514, Japan; Teikyo Univ, Tokyo 173, Japan; Yokohama City Univ, Yokohama, Kanagawa 232, Japan; Shizuoka Canc Ctr, Shizuoka, Japan; Kurume Univ, Sch Med, Dept Orthopaed Surg, Kurume, Fukuoka 830, Japan; Natl Canc Ctr, Japan Clin Oncol Grp Data Ctr, Tokyo 104, Japan; Kyushu Univ, Fukuoka 812, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		TPS10575						1	Oncology	Oncology	CM9OA	WOS:000358036904651		
J	Tanaka, N; Kobayashi, D; Ishigure, K; Mochizuki, Y; Nakayama, H; Morioka, Y; Misawa, K; Okada, T; Fujioka, A; Yamanaka, M; Uno, Y; Hasegawa, H; Matsumura, T; Kato, Y; Asai, Y; Tanaka, C; Ito, S; Fujiwara, M; Kojima, H; Kodera, Y				Tanaka, Nobutake; Kobayashi, Daisuke; Ishigure, Kiyoshi; Mochizuki, Yoshinari; Nakayama, Hiroshi; Morioka, Yuki; Misawa, Kazunari; Okada, Tomomi; Fujioka, Akira; Yamanaka, Masaya; Uno, Yasuaki; Hasegawa, Hirotaka; Matsumura, Tatsuki; Kato, Yoshiyasu; Asai, Yasuyuki; Tanaka, Chie; Ito, Seiji; Fujiwara, Michitaka; Kojima, Hiroshi; Kodera, Yasuhiro		Chubu Clinical Oncology Grp	Multi-institutional prospective study to explore the efficacy of oral nutritional supplements for the patients undergoing gastrectomy against gastric cancer (CCOG1301)	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Gifu Prefectural Tajimi Hosp, Tajimi, Japan; Nagoya Univ, Grad Sch Med, Dept Surg Gastroenterol, Nagoya, Aichi 4648601, Japan; Konan Kosei Hosp, Konan, Japan; Komaki Municipal Hosp, Komaki, Japan; Natl Hosp Org, Nagoya Med Ctr, Nagoya, Aichi, Japan; Ichinomiya Municipal Hosp, Ichinomiya, Aichi, Japan; Aichi Canc Ctr Hosp, Nagoya, Aichi 464, Japan; Aichi Hosp, Aichi Canc Ctr, Okazaki, Aichi, Japan; Tokai Cent Hosp, Kagamihara, Japan; Tosei Gen Hosp, Seto, Japan; Okazaki Municipal Hosp, Okazaki, Aichi, Japan; Yokkaichi Municipal Hosp, Yokaichi, Japan; Aichi Canc Ctr Hosp, Dept Surg Gastroenterol, Nagoya, Aichi 464, Japan; Aichi Canc Ctr Hosp, Okazaki, Aichi, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e15039						1	Oncology	Oncology	CM9OA	WOS:000358036902826		
J	Tanaka, S; Sato, I; Armstrong, TS; Cleeland, CS; Mendoza, TR; Mukasa, A; Narita, Y; Kamibeppu, K; Saito, N				Tanaka, Shota; Sato, Iori; Armstrong, Terri S.; Cleeland, Charles S.; Mendoza, Tito R.; Mukasa, Akitake; Narita, Yoshitaka; Kamibeppu, Kiyoko; Saito, Nobuhito			Validation study of the Japanese version of MD Anderson Symptom Inventory Brain Tumor Module.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Tokyo Univ Hosp, Tokyo 113, Japan; Univ Tokyo, Fac Med, Tokyo 113, Japan; Univ Texas Hlth Sci Ctr Houston, Sch Nursing, Houston, TX 77030 USA; Univ Texas MD Anderson Canc Ctr, Dept Symptom Res, Houston, TX 77030 USA; Natl Canc Ctr, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e17658						1	Oncology	Oncology	CM9OA	WOS:000358036903612		
J	Tani, T; Soejima, K; Naoki, K; Arai, D; Ishioka, K; Ohgino, K; Nishino, M; Kuroda, A; Yasuda, H; Betsuyaku, T				Tani, Tetsuo; Soejima, Kenzo; Naoki, Katsuhiko; Arai, Daisuke; Ishioka, Kouta; Ohgino, Keiko; Nishino, Makoto; Kuroda, Aoi; Yasuda, Hiroyuki; Betsuyaku, Tomoko			A phase II trial of induction Erlotinib followed by chemotherapy with Platinum plus Pemetrexed +/- Bevacizumab for EGFR mutation-positive non-squamous non-small cell lung cancer patients.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Keio Univ, Tokyo, Japan; Keio Univ, Sch Med, Tokyo, Japan; Keio Univ, Shinjuku Ku, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e19039						1	Oncology	Oncology	CM9OA	WOS:000358036903895		
J	Tei, S; Takashima, T; Kashiwagi, S; Kawajiri, H; Tokunaga, S; Nishimura, S; Yamagata, S; Nishimori, T; Mizuyama, Y; Sunami, T; Tezuka, K; Noda, S; Ikeda, K; Ogawa, Y; Onoda, N; Ishikawa, T; Kudoh, S; Takada, M; Hirakawa, K				Tei, Seika; Takashima, Tsutomu; Kashiwagi, Shinichiro; Kawajiri, Hidemi; Tokunaga, Shinya; Nishimura, Shigehiko; Yamagata, Shigehito; Nishimori, Takeo; Mizuyama, Yoko; Sunami, Tsuyoshi; Tezuka, Kenji; Noda, Satoru; Ikeda, Katsumi; Ogawa, Yoshinari; Onoda, Naoyoshi; Ishikawa, Tetsuro; Kudoh, Shinzoh; Takada, Minoru; Hirakawa, Kosei			A phase II, multicenter, single-arm study of eribulin mesilate as first-line therapy for HER2-negative locally advanced or metastatic breast cancer.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Seichokai Fuchu Hosp, Osakafu Izumishi Hikocho, Japan; Osaka City Univ, Grad Sch Med, Osaka 558, Japan; Osaka City Gen Hosp, Osaka, Japan; Sumitomo Hosp, Oska, Japan; Sumitomo Hosp, Osaka, Japan; Ikuwakai Mem Hosp, Osaka, Japan; Ohno Mem Hosp, Dept Surg, Osaka, Japan; Izumishiritu Hosp, Osaka, Japan; Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Osaka 558, Japan; Kashiwara Hosp, Nara, Japan; Koyo Hosp, Wakayama, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e12017						1	Oncology	Oncology	CM9OA	WOS:000358036902241		
J	Terashima, M; Makuuchi, R; Miki, Y; Tokunaga, M; Tanizawa, Y; Bando, E; Kawamura, T; Hatakeyama, K; Oshima, K; Ohnami, S; Urakami, K; Kusuhara, M; Yamaguchi, K				Terashima, Masanori; Makuuchi, Rie; Miki, Yuichiro; Tokunaga, Masanori; Tanizawa, Yutaka; Bando, Etsuro; Kawamura, Taiichi; Hatakeyama, Keiichi; Oshima, Keiichi; Ohnami, Shunpei; Urakami, Kennichi; Kusuhara, Masatoshi; Yamaguchi, Ken			Comprehensive molecular profiling of Japanese patients with gastric adenocarcinoma	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Shizuoka Canc Ctr, Div Gastr Surg, Nagaizumi, Shizuoka, Japan; Shizuoka Canc Ctr, Div Med Genet, Nagaizumi, Shizuoka, Japan; Shizuoka Canc Ctr, Canc Diagnost Res Div, Nagaizumi, Shizuoka, Japan; Shizuoka Canc Ctr, Reg Resource Div, Nagaizumi, Shizuoka, Japan; Shizuoka Canc Ctr, Res Inst, Nagaizumi, Shizuoka, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e15045						1	Oncology	Oncology	CM9OA	WOS:000358036902831		
J	Thompson, AM; Hadad, SM; Jordan, L; Roy, P; Purdie, C; Iwamoto, T; Pusztai, L; Moulder, SL				Thompson, Alastair Mark; Hadad, Sirwan M.; Jordan, Lee; Roy, Pankaj; Purdie, Colin; Iwamoto, Takayuki; Pusztai, Lajos; Moulder, Stacy L.			A prospective comparison of ER, PR, Ki67 and gene expression in paired sequential core biopsies of primary, untreated breast cancer.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; Univ Sheffield, Sheffield, S Yorkshire, England; NHS Tayside, Dundee, Scotland; Churchill Hosp, Oxford OX3 7LJ, England; Okayama Univ, Okayama 7008530, Japan; Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT USA								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		578						1	Oncology	Oncology	CM9OA	WOS:000358036901289		
J	Tokito, T; Azuma, K; Ishii, H; Yamada, K; Hoshino, T				Tokito, Takaaki; Azuma, Koichi; Ishii, Hidenobu; Yamada, Kazuhiko; Hoshino, Tomoaki			Retrospective analysis between PD-L1 expression and prognosis for stage III non-small cell lung cancer patients who received concurrent chemoradiotherapy.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					[Tokito, Takaaki; Azuma, Koichi; Ishii, Hidenobu; Yamada, Kazuhiko; Hoshino, Tomoaki] Kurume Univ, Sch Med, Dept Internal Med, Div Respirol Neurol & Rheumatol, Kurume, Fukuoka 830, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		7542						1	Oncology	Oncology	CM9OA	WOS:000358036901672		
J	Tokito, T; Yamada, K; Ichiki, M; Takahashi, K; Hisamatsu, Y; Azuma, K; Ishii, H; Shukuya, T; Takeoka, H; Nishikawa, K; Hoshino, T				Tokito, Takaaki; Yamada, Kazuhiko; Ichiki, Masao; Takahashi, Kazuhisa; Hisamatsu, Yasushi; Azuma, Koichi; Ishii, Hidenobu; Shukuya, Takehito; Takeoka, Hiroaki; Nishikawa, Kazuo; Hoshino, Tomoaki			A multicenter phase II study of S-1 combined with bevacizumab after platinum-based chemotherapy in patients with advanced non-squamous non-small cell lung cancer.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Kurume Univ, Sch Med, Div Respirol Neurol & Rheumatol, Dept Internal Med, Kurume, Fukuoka 830, Japan; Kyushu Med Ctr, Fukuoka, Japan; Juntendo Univ, Div Resp Med, Fac Med, Tokyo, Japan; Grad Sch Med, Tokyo, Japan; Oita Univ, Dept Med Oncol & Hematol, Fac Med, Oita 87011, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e19040						1	Oncology	Oncology	CM9OA	WOS:000358036903896		
J	Torri, V; Ando, M; Rulli, E; Floriani, IC; Kawaguchi, T; Isa, S; Gregorc, V; Novello, S; Barni, S; Cinquini, M; Marsoni, S; Farina, G; Garassino, MC				Torri, Valter; Ando, Masahiko; Rulli, Eliana; Floriani, Irene Claudia; Kawaguchi, Tomoya; Isa, Shun-ichi; Gregorc, Vanesa; Novello, Silvia; Barni, Sandro; Cinquini, Michela; Marsoni, Silvia; Farina, Gabriella; Garassino, Marina Chiara			Individual patients data analysis (IPD) of three randomized studies comparing erlotinib (E) with chemotherapy (CT) in patients with advanced wild-type epidermal growth factor receptor (wtEGFR) non-small cell lung cancer (NSCLC).	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					IRCCS Mario Negri Inst, Milan, Italy; Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan; IRCCS Mario Negri Inst Pharmacol Res, Milan, Italy; Osaka City Univ, Grad Sch Med, Osaka 558, Japan; Kinki Chuo Chest Med Ctr, Natl Hosp Org, Osaka, Japan; Ist Sci San Raffaele, Dept Oncol, I-20132 Milan, Italy; Azienda Osped Univ S Luigi Gonzaga, Orbassano, Italy; Azienda Osped Treviglio, Div Oncol, Treviglio, Italy; Fdn Piemonte Oncol IRCCS, Ist Candiolo, Candiolo, Italy; AO Fatebenefratelli & Oftalm, UO Oncol Med, Milan, Italy; Fdn IRCCS Ist Nazl Tumori, Milan, Italy								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		8048						1	Oncology	Oncology	CM9OA	WOS:000358036901761		
J	Toyoki, Y; Ishido, K; Kudo, D; Kimura, N; Hakamada, K				Toyoki, Yoshikazu; Ishido, Keinosuke; Kudo, Daisuke; Kimura, Norihisa; Hakamada, Kenichi			Adjuvant chemotherapy using s-1 improves survival in patients with resected advanced extra-hepatic bile duct cancer: A propensity score matching analysis.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Hirosaki Univ, Grad Sch Med, Dept Surg Gastroenterol, Hirosaki, Aomori, Japan; Hirosaki Univ, Grad Sch Med, Dept Gastroenterol, Hirosaki, Aomori, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e15170						1	Oncology	Oncology	CM9OA	WOS:000358036902938		
J	Tsubamoto, H; Sonoda, T; Inoue, K; Ikuta, S; Tani, S; Yamanaka, N				Tsubamoto, Hiroshi; Sonoda, Takashi; Inoue, Kayo; Ikuta, Shinichi; Tani, Satoshi; Yamanaka, Naoki			Impact of itraconazole after first-line chemotherapy on the survival of patients with distant metastatic biliary tract cancer	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Meiwa Hosp, Dept Med Oncol, Nishinomiya, Hyogo, Japan; Kohnan Hosp, Dept Med Oncol, Kobe, Hyogo, Japan; Meiwa Hosp, Dept Surg, Nishinomiya, Hyogo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e15145						1	Oncology	Oncology	CM9OA	WOS:000358036902914		
J	Tsubata, Y; Mori, Y; Nakao, M; Amano, Y; Hotta, T; Koba, N; Hamaguchi, M; Okimoto, T; Miura, K; Hoshino, T; Ohe, M; Hamaguchi, S; Sutani, A; Awaya, Y; Takeyama, H; Kuraki, T; Itakura, M; Isobe, T				Tsubata, Yukari; Mori, Yusuke; Nakao, Mika; Amano, Yoshihiro; Hotta, Takamasa; Koba, Naoya; Hamaguchi, Megumi; Okimoto, Tamio; Miura, Kiyotaka; Hoshino, Teppei; Ohe, Miki; Hamaguchi, Shunichi; Sutani, Akihisa; Awaya, Yukikazu; Takeyama, Hiroyasu; Kuraki, Takashige; Itakura, Masayuki; Isobe, Takeshi			Randomized translational study of 5-HT3 receptor antagonists for evaluation of chemotherapy-induced nausea and vomiting (CINV) related biomarker and prevention of CINV using questionnaires.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Shimane Univ Hosp, Izumo, Shimane, Japan; Shimane Univ, Izumo, Shimane, Japan; Shimane Prefectural Cent Hosp, Izumo, Shimane, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e20695						1	Oncology	Oncology	CM9OA	WOS:000358036904301		
J	Tsuchiya, T; Arai, J; Matsumoto, K; Miyazaki, T; Yamasaki, N; Nagayasu, T				Tsuchiya, Tomoshi; Arai, Junichi; Matsumoto, Keitaro; Miyazaki, Takuro; Yamasaki, Naoya; Nagayasu, Takeshi			Prognostic impact of earwax-type determinant ABCC11/MRP8 polymorphism in adjuvant chemotherapy with S-1 for non-small cell lung cancer.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					[Tsuchiya, Tomoshi; Arai, Junichi; Matsumoto, Keitaro; Miyazaki, Takuro; Yamasaki, Naoya; Nagayasu, Takeshi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg Oncol, Nagasaki 852, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e18508						1	Oncology	Oncology	CM9OA	WOS:000358036903816		
J	Tsuchiya, T; Nakamura, Y; Hayashi, N; Matsumoto, K; Miyazaki, T; Tabata, K; Fukuoka, J; Yamasaki, N; Nagayasu, T				Tsuchiya, Tomoshi; Nakamura, Yoichi; Hayashi, Nobuyuki; Matsumoto, Keitaro; Miyazaki, Takuro; Tabata, Kazuhiro; Fukuoka, Junya; Yamasaki, Naoya; Nagayasu, Takeshi			A phase II study of concurrent chemoradiotherapy with cisplatin and oral S-1, followed by surgery for locally advanced non-small cell lung cancer.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg Oncol, Nagasaki 852, Japan; Nagasaki Univ, Sch Med, Nagasaki 852, Japan; Japanese Red Cross Nagasaki Genbaku Hosp, Dept Radiol, Nagasaki, Japan; Nagasaki Grad Sch Biomed Sci, Dept Pathol, Nagasaki, Japan; Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 852, Japan; Nagasaki Univ, Grad Sch Biomed Sci, Div Surg Oncol, Nagasaki 852, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		7541						1	Oncology	Oncology	CM9OA	WOS:000358036901671		
J	Tsuji, A; Hamaguchi, T; Yamaguchi, K; Takeda, K; Uetake, H; Esaki, T; Amagai, K; Sugimoto, N; Baba, H; Kimura, M; Matsumura, Y; Nambu, Y				Tsuji, Akihito; Hamaguchi, Tetsuya; Yamaguchi, Kensei; Takeda, Koji; Uetake, Hiroyuki; Esaki, Taito; Amagai, Kenji; Sugimoto, Naotoshi; Baba, Hideo; Kimura, Masami; Matsumura, Yasuhiro; Nambu, Yoshihiro			A phase II study of NK012, a polymeric micelle formulation of SN-38, in colorectal cancer patients who had received prior oxaliplatin-based regimen.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Kochi Hlth Sci Ctr, Dept Med Oncol, Kochi, Japan; Natl Canc Ctr Hosp Tokyo, Tokyo, Japan; Saitama Canc Ctr, Div Gastroenterol, Ina, Saitama, Japan; Osaka City Gen Hosp, Dept Clin Oncol, Osaka, Japan; Tokyo Med & Dent Univ, Tokyo, Japan; Natl Hosp Org, Dept Gastrointestinal & Med Oncol, Kyushu Canc Ctr, Fukuoka, Japan; Ibaraki Cent Hosp, Dept Gastroenterol, Kasama, Ibaraki, Japan; Osaka Med Ctr Canc & Cardiovasc Dis, Gastrointestinal Oncol, Osaka, Japan; Kumamoto Univ, Dept Surg Gastroenterol, Grad Sch Med Sci, Kumamoto, Japan; Hitoyoshi Med Ctr, Kumamoto, Japan; Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan; NIPPON KAYAKU, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		3527						1	Oncology	Oncology	CM9OA	WOS:000358036900747		
J	Tsuji, T; Sakamori, Y; Ozasa, H; Ajimizu, H; Yagi, Y; Nagai, H; Mishima, M; Kim, YH				Tsuji, Takahiro; Sakamori, Yuichi; Ozasa, Hiroaki; Ajimizu, Hitomi; Yagi, Yoshitaka; Nagai, Hiroki; Mishima, Michiaki; Kim, Young Hak			Clinical significance of serum hepatocyte growth factor (sHGF) in patients with advanced non-small-cell lung cancer (NSCLC).	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto, Japan; Kyoto Univ Hosp, Kyoto 606, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e19098						1	Oncology	Oncology	CM9OA	WOS:000358036903942		
J	Tsuji, Y; Yamazaki, K; Oba, MS; Sakai, K; Nagase, M; Ueda, S; Tamagawa, H; Tamura, T; Moriwaki, T; Murata, K; Taira, K; Denda, T; Funai, S; Tsuda, T; Tsushima, T; Boku, N; Hyodo, I; Yamanaka, T; Tsurutani, J; Nishio, K				Tsuji, Yasushi; Yamazaki, Kentaro; Oba, Mari Saito; Sakai, Kazuko; Nagase, Michitaka; Ueda, Shinya; Tamagawa, Hiroshi; Tamura, Takao; Moriwaki, Toshikazu; Murata, Kohei; Taira, Koichi; Denda, Tadamichi; Funai, Sadao; Tsuda, Takashi; Tsushima, Takahiro; Boku, Narikazu; Hyodo, Ichinosuke; Yamanaka, Takeharu; Tsurutani, Junji; Nishio, Kazuto		West Japan Oncology Grp	Predictive biomarker analysis of early tumor shrinkage induced by FOLFIRI plus Bev for patients with metastatic colorectal cancer in WJOG4407G study.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Tonan Hosp, Dept Med Oncol, Sapporo, Hokkaido, Japan; Shizuoka Canc Ctr, Shizuoka, Japan; Yokohama City Univ, Med Ctr, Yokohama, Kanagawa 232, Japan; Kinki Univ, Sch Med, Osaka 589, Japan; Jichi Med Univ, Dept Clin Oncol, Shimotsuke, Japan; Kinki Univ, Dept Med Oncol, Fac Med, Osaka, Japan; Osaka Gen Med Ctr, Dept Surg, Osaka, Japan; Kinki Univ, Osaka, Japan; Univ Tsukuba, Div Gastroenterol, Tsukuba, Ibaraki, Japan; Suita Municipal Hosp, Dept Surg, Suita, Osaka, Japan; Osaka City Gen Hosp, Dept Clin Oncol, Osaka, Japan; Chiba Canc Ctr, Chiba 2608717, Japan; Kinki Univ, Sakai Hosp, Fac Med, Osaka, Japan; St Marianna Univ, Dept Clin Oncol, Sch Med, Kawasaki, Kanagawa, Japan; Shizuoka Canc Ctr, Div Gastrointestinal Oncol, Shizuoka, Japan; Natl Canc Ctr, Gastrointestinal Med Oncol Div, Tokyo, Japan; Univ Tsukuba, Tsukuba, Ibaraki, Japan; Yokohama City Univ, Yokohama, Kanagawa 232, Japan; Kinki Univ, Sch Med, Osakasayama, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e14616						1	Oncology	Oncology	CM9OA	WOS:000358036902713		
J	Tsushima, T; Nomura, M; Iwasa, S; Kato, K; Yasui, H; Muro, K; Boku, N				Tsushima, Takahiro; Nomura, Motoo; Iwasa, Satoru; Kato, Ken; Yasui, Hirofumi; Muro, Kei; Boku, Narikazu			Salvage chemotherapy versus best supportive care in patients with recurrent or metastatic squamous cell carcinoma of the esophagus refractory or intolerable to fluorouracil, platinum, and taxane.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Shizuoka Canc Ctr, Div Gastrointestinal Oncol, Shizuoka, Japan; Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi 464, Japan; Natl Canc Ctr, Gastrointestinal Med Oncol Div, Tokyo, Japan; Aichi Canc Ctr Hosp, Nagoya, Aichi 464, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e15101						1	Oncology	Oncology	CM9OA	WOS:000358036902877		
J	Turner, NC; Ro, J; Andre, F; Loi, S; Verma, S; Iwata, H; Harbeck, N; Loibl, S; Huang, C; Zhang, BK; Giorgetti, C; Randolph, S; Koehler, M; Cristofanilli, M				Turner, Nicholas C.; Ro, Jungsil; Andre, Fabrice; Loi, Sherene; Verma, Sunil; Iwata, Hiroji; Harbeck, Nadia; Loibl, Sibylle; Huang, Cynthia; Zhang, Bartlett Ke; Giorgetti, Carla; Randolph, Sophia; Koehler, Maria; Cristofanilli, Massimo			PALOMA3: A double-blind, phase III trial of fulvestrant with or without palbociclib in pre- and post-menopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer that progressed on prior endocrine therapy.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Royal Marsden, London, England; Royal Marsden, Sutton, Surrey, England; Natl Canc Ctr, Goyang Si, South Korea; Inst Gustave Roussy, Villejuif, France; Peter MacCallum Canc Ctr, East Melbourne, Australia; Sunnybrook Odette Canc Ctr, Toronto, ON, Canada; Aichi Canc Ctr Hosp, Nagoya, Aichi 464, Japan; Univ Munich, Otterfing, Germany; German Breast Grp, Neu Isenburg, Germany; Pfizer Oncol, New York, NY USA; Pfizer Inc, San Diego, CA USA; Pfizer, Milan, Italy; Pfizer Oncol, La Jolla, CA USA; Pfizer Oncol, Narberth, PA USA; Thomas Jefferson Univ, Philadelphia, PA 19107 USA								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		LBA502						1	Oncology	Oncology	CM9OA	WOS:000358036904639		
J	Uchida, J; Kato, K; Kukita, Y; Kumagai, T; Nishino, K; Daga, H; Nagatomo, I; Oba, S; Ito, Y; Takeda, K; Imamura, F; Inoue, T; Kimura, M				Uchida, Junji; Kato, Kikuya; Kukita, Yoji; Kumagai, Toru; Nishino, Kazumi; Daga, Haruko; Nagatomo, Izumi; Oba, Shigeyuki; Ito, Yuri; Takeda, Koji; Imamura, Fumio; Inoue, Takako; Kimura, Madoka			Genotyping and monitoring of circulating tumor DNA in lung cancer patients during the early period of EGFR-TKI treatment using deep sequencing.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Osaka Med Ctr Canc & Cardiovasc Dis, Uji, Japan; Osaka Med Ctr Canc & Cardiavasc Dis, Osaka, Japan; Osaka Med Ctr Canc & Cardiavasc Dis, Res Inst, Osaka, Japan; Osaka Med Ctr Canc & Cardiavasc Dis, Dept Thorac Oncol, Osaka, Japan; Osaka Med Ctr Canc & Cardiovasc Dis, Yao, Japan; Osaka City Gen Hosp, Dept Clin Oncol, Osaka, Japan; Osaka Univ, Grad Sch Med, Osaka, Japan; Kyoto Univ, Grad Sch Informat, Osaka, Japan; JST, PRESTO, Osaka, Japan; Osaka Med Ctr Canc & Cardiovasc Dis, Ctr Canc Control & Stat, Osaka, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e19083						1	Oncology	Oncology	CM9OA	WOS:000358036903930		
J	Udagawa, H; Niho, S; Kirita, K; Umemura, S; Matsumoto, S; Yoh, K; Ohmatsu, H; Goto, K				Udagawa, Hibiki; Niho, Seiji; Kirita, Keisuke; Umemura, Shigeki; Matsumoto, Shingo; Yoh, Kiyotaka; Ohmatsu, Hironobu; Goto, Koichi			Usefulness of denosumab to nonsquamous non-small cell lung cancer patients with bone metastases	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Natl Canc Ctr Hosp East, Dept Thorac Oncol, Kashiwa, Chiba, Japan; Natl Canc Ctr Hosp East, Div Thorac Oncol, Kashiwa, Chiba, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		9609						1	Oncology	Oncology	CM9OA	WOS:000358036902104		
J	Uematsu, N; Nakashima, T; Matsuda, T; Sako, N; Sakurai, K				Uematsu, Naoya; Nakashima, Takako; Matsuda, Takakuni; Sako, Nobutomo; Sakurai, Kazushi			Rebamipide liquid to prevent radiation-induced oral mucositis via attenuation of pro-inflammatory signaling.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Otsuka Pharmaceut Co Ltd, Inst New Drug Discovery 3, Tokushima, Japan; Otsuka Pharmaceut Co Ltd, Formulat Res Inst, Tokushima, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e20719						1	Oncology	Oncology	CM9OA	WOS:000358036904319		
J	Unno, M; Motoi, F; Kosuge, T; Ueno, H; Yamaue, H; Satoi, S; Sho, M; Honda, G; Matsumoto, I; Wada, K; Furuse, J; Furukawa, T; Ishida, K; Takase, K; Matsuyama, Y; Nakagawa, K; Katayose, Y				Unno, Michiaki; Motoi, Fuyuhiko; Kosuge, Tomoo; Ueno, Hideki; Yamaue, Hiroki; Satoi, Sohei; Sho, Masayuki; Honda, Goro; Matsumoto, Ippei; Wada, Keita; Furuse, Junji; Furukawa, Tohru; Ishida, Kazuyuki; Takase, Kei; Matsuyama, Yutaka; Nakagawa, Kei; Katayose, Yu			Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus surgery-first for resectable pancreatic carcer (Prep-02/JSAP05).	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Tohoku Univ, Dept Surg, Grad Sch Med, Sendai, Miyagi 980, Japan; Natl Canc Ctr, Tokyo, Japan; Natl Canc Ctr, Div Hepatobiliary & Pancreat Oncol, Tokyo, Japan; Wakayama Med Univ, Dept Surg 2, Wakayama, Japan; Kansai Med Univ, Dept Surg, Hirakata, Osaka, Japan; Nara Med Univ, Dept Surg, Kashihara, Nara 634, Japan; Komagome Hosp, Dept Surg, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan; Kinki Univ, Dept Surg, Osaka, Japan; Teikyo Univ, Dept Surg, Sch Med, Tokyo 173, Japan; Kyorin Univ, Sch Med, Dept Med Oncol, Tokyo, Japan; Tokyo Womens Med Univ, Inst Integrated Med Sci, Tokyo, Japan; Iwate Med Univ, Dept Mol Diagnosit Pathol, Morioka, Iwate 020, Japan; Tohoku Univ, Sch Med, Dept Diagnost Radiol, Sendai, Miyagi 980, Japan; Univ Tokyo, Dept Biostat, Sch Publ Hlth, Tokyo, Japan; Tohoku Univ, Grad Sch Med, Div Integrated Surg & Oncol, Sendai, Miyagi 980, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		TPS4151						1	Oncology	Oncology	CM9OA	WOS:000358036904759		
J	Van Cutsem, E; Benedetti, FM; Mizuguchi, H; Mayer, RJ; Ohtsu, A				Van Cutsem, Eric; Benedetti, Fabio M.; Mizuguchi, Hirokazu; Mayer, Robert J.; Ohtsu, Atsushi		RECOURSE Study Grp	TAS-102 vs placebo (PBO) in patients (pts) >= 65 years (y) with metastatic colorectal cancer (mCRC): An age-based analysis of the RECOURSE trial	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Univ Hosp Leuven, Leuven, Belgium; Taiho Oncol Inc, Princeton, NJ USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		3595						1	Oncology	Oncology	CM9OA	WOS:000358036900814		
J	Verstovsek, S; Vannucchi, AM; Griesshammer, M; Masszi, T; Durrant, S; Passamonti, F; Harrison, CN; Pane, F; Zachee, P; Hino, M; Moiraghi, B; Miller, CB; Rosti, V; Mesa, RA; Jones, MM; Zhen, HL; Li, JJ; Francillard, N; Habr, D; Kiladjian, JJ				Verstovsek, Srdan; Vannucchi, Alessandro M.; Griesshammer, Martin; Masszi, Tamas; Durrant, Simon; Passamonti, Francesco; Harrison, Claire N.; Pane, Fabrizio; Zachee, Pierre; Hino, Masayuki; Moiraghi, Beatriz; Miller, Carole Brennan; Rosti, Vittorio; Mesa, Ruben A.; Jones, Mark M.; Zhen, Huiling; Li, Jingjin; Francillard, Nathalie; Habr, Dany; Kiladjian, Jean-Jacques			Ruxolitinib in polycythemia vera: Follow-up from the RESPONSE trial.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; Univ Florence, Florence, Italy; Johannes Wesling Clin, Minden, Germany; St Istvan & St Laszio Hosp, Budapest, Hungary; Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia; Osped Circolo & Fdn Macchi, Varese, Italy; Guys & St Thomas NHS Fdn Trust, London, England; Univ Naples Federico II, Naples, Italy; ZNA Stuivenberg, Antwerp, Belgium; Osaka Univ, Grad Sch Med, Dept Clin Hematol & Diagnost, Osaka, Japan; Hosp Jose Maria Ramos Mejia, Buenos Aires, DF, Argentina; St Agnes Canc Inst, Baltimore, MD USA; IRCCS Policlin San Matteo Fdn, Ctr Study Myelofibrosis, Pavia, Italy; Mayo Clin, Ctr Canc, Scottsdale, AZ USA; Incyte Corp, Wilmington, DE USA; Novartis Pharmaceut, E Hanover, NJ USA; Novartis Pharma SAS, Rueil Malmaison, France; Hop St Louis, Paris, France; Paris Diderot Univ, Paris, France								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		7087						1	Oncology	Oncology	CM9OA	WOS:000358036901623		
J	Wada, S				Wada, Satoshi			Clinicopathological implications of newly defined immune checkpoints in extra-hepatic cholangiocarcinoma	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					[Wada, Satoshi] Kanagawa Canc Ctr, Yokohama, Kanagawa 2410815, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e15151						1	Oncology	Oncology	CM9OA	WOS:000358036902920		
J	Watanabe, N; Otsuka, S; Sasaki, Y; Yuasa, T; Shimada, K				Watanabe, Naoki; Otsuka, Shoko; Sasaki, Yoko; Yuasa, Takeshi; Shimada, Ken			Retrospective analysis of cardiac tolerability of concurrent administration of trastuzumab- and anthracycline-based regimen for breast cancer, to address one-year-term issues in LVEF.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Himeji Hosp, Japanese Red Cross Soc, Dept Breast Surg, Himeji, Hyogo, Japan; Himeji Hosp, Japanese Red Cross Soc, Himeji, Hyogo, Japan; Himeji Hosp, Japanese Red Cross Soc, Dept Pharmaceut, Himeji, Hyogo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e11590						1	Oncology	Oncology	CM9OA	WOS:000358036902207		
J	Watanabe, N; Iwamoto, T; Motoki, T; Sugiu, K; Omori, M; Ito, M; Yuasa, T; Ohtani, S; Sonobe, H; Higaki, K; Fujiwara, T; Matsuoka, J				Watanabe, Naoki; Iwamoto, Takayuki; Motoki, Takayuki; Sugiu, Kumi; Omori, Masako; Ito, Mitsuya; Yuasa, Takeshi; Ohtani, Shoichiro; Sonobe, Hiroshi; Higaki, Kenji; Fujiwara, Toshiyoshi; Matsuoka, Junji			Neoadjuvant chemotherapy with or without the concurrent hormone therapy that has downregulated estrogen level in estrogen receptor positive breast cancer: NACED randomized multicenter phase II trial.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Himeji Hosp, Dept Breast Surg, Japanese Red Cross Soc, Himeji, Hyogo, Japan; Okayama Univ Hosp, Okayama, Japan; Hiroshima City Hosp, Dept Breast Surg, Hiroshima, Japan; Japanese Red Cross Soc Himeji Hosp, Dept Breast Surg, Himeji, Hyogo, Japan; Hiroshima City Hiroshima Citizens Hosp, Hiroshima, Japan; Chugoku Cent Hosp, Hiroshima, Japan; Okayama Univ Grad Sch, Okayama, Japan; Okayama Univ Med Sch, Okayama, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e11501						1	Oncology	Oncology	CM9OA	WOS:000358036902130		
J	Yagata, H; Watanabe, T; Okada, H; Saito, M; Takayama, T; Imai, H; Yoshida, Y; Tamai, N; Nozawa, K; Yajima, T; Sangai, T; Yoshimura, A; Hasegawa, Y; Doi, T; Ohashi, Y; Shimozuma, K				Yagata, Hiroshi; Watanabe, Takanori; Okada, Hiroko; Saito, Mitsue; Takayama, Tomoko; Imai, Hirohisa; Yoshida, Yuko; Tamai, Nao; Nozawa, Keiko; Yajima, Tamiko; Sangai, Takafumi; Yoshimura, Akiyo; Hasegawa, Yoshie; Doi, Takako; Ohashi, Yasuo; Shimozuma, Kojiro			The difference of long-term hair recovery among chemotherapeutic regimens in breast cancer patients.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					St Lukes Int Hosp, Tokyo, Japan; Sendai Med Ctr, Natl Hosp Org, Sendai, Miyagi, Japan; Univ Tokyo, Tokyo, Japan; Juntendo Univ Hosp, Tokyo, Japan; Natl Canc Ctr, Tokyo 104, Japan; Natl Inst Publ Hlth, Saitama, Japan; Natl Canc Ctr, Tokyo, Japan; NPO Japan Clin Res Support Unit, Tokyo, Japan; Chiba Univ, Grad Sch Med, Chiba, Japan; Aichi Canc Ctr Hosp, Nagoya, Aichi 464, Japan; Hirosaki Municipal Hosp, Hirosaki, Aomori, Japan; Shonan Kinen Hosp, Breast Surg, Kamakura, Kanagawa, Japan; Chuo Univ, Tokyo 112, Japan; Ritsumeikan Univ, Kusatsu, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e17673						1	Oncology	Oncology	CM9OA	WOS:000358036903625		
J	Yamada, K; Kaise, H; Kimura, F; Hosonaga, M; Miyahara, K; Kawai, Y; Ueda, A; Teraoka, S; Yoshimura, M; Ishikawa, T				Yamada, Kimito; Kaise, Hiroshi; Kimura, Fuyou; Hosonaga, Mari; Miyahara, Kana; Kawai, Yuko; Ueda, Ai; Teraoka, Saeko; Yoshimura, Mana; Ishikawa, Takashi			Efficacy of Sr-89 to painful bone metastases for Japanese breast cancer patients.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Tokyo Med Univ Hosp, Dept Breast Surg, Tokyo, Japan; Tokyo Med Univ Hosp, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e12063						1	Oncology	Oncology	CM9OA	WOS:000358036902285		
J	Yamada, Y; Nishina, T; Iwasa, S; Shitara, K; Muro, K; Esaki, T; Hironaka, S; Yamaguchi, K; Machida, N; Satoh, T; von Heydebreck, A; Achiwa, H; Doi, T				Yamada, Yasuhide; Nishina, Tomohiro; Iwasa, Satoru; Shitara, Kohei; Muro, Kei; Esaki, Taito; Hironaka, Shuichi; Yamaguchi, Kensei; Machida, Nozomu; Satoh, Taroh; von Heydebreck, Anja; Achiwa, Hiroyuki; Doi, Toshihiko			A phase I dose expansion trial of avelumab (MSB0010718C), an anti-PD-L1 antibody, in Japanese patients with advanced gastric cancer.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Natl Canc Ctr, Tokyo, Japan; Natl Hosp Org, Shikoku Canc Ctr, Matsuyama, Ehime, Japan; Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan; Aichi Canc Ctr Hosp, Nagoya, Aichi 464, Japan; Natl Hosp Org, Kyushu Canc Ctr, Dept Gastrointestinal & Med Oncol, Fukuoka, Japan; Chiba Canc Ctr, Chiba 2608717, Japan; Saitama Canc Ctr, Saitama, Japan; Shizuoka Canc Ctr, Nagaizumi, Shizuoka, Japan; Osaka Univ, Grad Sch Med, Dept Frontier Sci Canc & Chemotherapy, Osaka, Japan; Merck KGaA, Darmstadt, Germany; Merck Serono Co Ltd, Tokyo, Japan; Natl Canc Ctr Hosp East, Chiba, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		4047						1	Oncology	Oncology	CM9OA	WOS:000358036900886		
J	Yamamoto, K; Ioroi, T; Shinomiya, K; Hirata, S; Harada, K; Suno, M; Nishioka, T; Kume, M; Makimoto, H; Nakagawa, T; Hirano, T; Bito, T; Nishigori, C; Miyake, H; Fujisawa, M; Hirai, M				Yamamoto, Kazuhiro; Ioroi, Takeshi; Shinomiya, Kazuaki; Hirata, Sachi; Harada, Kenichi; Suno, Manabu; Nishioka, Tatsuya; Kume, Manabu; Makimoto, Hiroo; Nakagawa, Tsutomu; Hirano, Takeshi; Bito, Toshinori; Nishigori, Chikako; Miyake, Hideaki; Fujisawa, Masato; Hirai, Midori			Association of single nucleotide polymorphisms (SNP) in STAT3 gene with hand-foot skin reaction in metastatic renal cell carcinoma patients treated with multi-kinase inhibitor.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Kobe Univ Hosp, Dept Pharm, Kobe, Hyogo, Japan; Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan; Kobe Univ, Grad Sch Med, Dept Urol, Kobe, Hyogo 657, Japan; Kobe Univ Hosp, Kobe, Hyogo, Japan; Kobe Univ, Grad Sch Med, Div Dermatol, Kobe, Hyogo 657, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e15622						1	Oncology	Oncology	CM9OA	WOS:000358036903161		
J	Yamamoto, M; Serizawa, T; Higuchi, Y; Sato, Y; Kawagishi, J; Yamanaka, K; Shuto, T; Akabane, A; Jokura, H; Yomo, S; Nagano, O; Aoyama, H				Yamamoto, Masaaki; Serizawa, Toru; Higuchi, Yoshinori; Sato, Yasunori; Kawagishi, Jun; Yamanaka, Kazuhiro; Shuto, Takashi; Akabane, Atsuya; Jokura, Hidefumi; Yomo, Shoji; Nagano, Osamu; Aoyama, Hidefumi			A multi-institutional prospective observational study of stereotactic radiosurgery (SRS) for patients with multiple brain metastases (BMs): Updated results of the JLGK0901 Study-Long-term results of irradiation-related complications and neurocognitive function (NCF)	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Katsuta Hosp Mito GammaHouse, Hitachi, Ibaraki, Japan; Tsukiji Neurol Clin, Tokyo Gamma Unit Ctr, Tokyo, Japan; Chiba Univ, Grad Sch Med, Dept Neurol Surg, Chiba, Japan; Chiba Univ, Grad Sch Med, Clin Res Ctr, Chiba, Japan; Furukawa Seiryo Hosp, Jiro Suzuki Mem Gamma House, Osaki, Japan; Osaka City Gen Hosp, Dept Neurosurg, Osaka, Japan; Yokohama Rosai Hosp, Dept Neurosurg, Yokohama, Kanagawa, Japan; NTT EC, Kanto Med Ctr, Gamma Knife Ctr, Tokyo, Japan; Sanai Hosp, Saitama Gamma Knife Ctr, Saitama, Japan; Chiba Cardiovasc Ctr, Gamma Knife House, Chiba, Japan; Niigata Univ, Grad Sch Med & Dent Sci, Dept Radiol, Niigata, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		2020						1	Oncology	Oncology	CM9OA	WOS:000358036900479		
J	Yamashita, N; Tokunaga, E; Inoue, Y; Tanaka, K; Nakashima, Y; Ando, K; Ogaki, K; Saeki, H; Oki, E; Maehara, Y				Yamashita, Nami; Tokunaga, Eriko; Inoue, Yuka; Tanaka, Kimihiro; Nakashima, Yuichiro; Ando, Koji; Ogaki, Kippei; Saeki, Hiroshi; Oki, Eiji; Maehara, Yoshihiko			Clinical significance of co-expression of E-cadherin and vimentin in invasive breast cancer	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Kyushu Univ, Dept Surg & Sci, Fukuoka 812, Japan; Kyushu Univ, Dept Comprehens Clin Oncol, Fukuoka 812, Japan; Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e22013						1	Oncology	Oncology	CM9OA	WOS:000358036904418		
J	Yanagimoto, H; Okusaka, T; Ishii, H; Furuse, J; Ohkawa, S; Fukutomi, A; Ioka, T; Sho, M; Nakamori, S; Kitano, M; Sugimori, K; Maguchi, H; Imaoka, H; Baba, H; Shimizu, A; Yokota, I; Ohashi, Y; Yamaue, H				Yanagimoto, Hiroaki; Okusaka, Takuji; Ishii, Hiroshi; Furuse, Junji; Ohkawa, Shinichi; Fukutomi, Akira; Ioka, Tatsuya; Sho, Masayuki; Nakamori, Shoji; Kitano, Masayuki; Sugimori, Kazuya; Maguchi, Hiroyuki; Imaoka, Hiroshi; Baba, Hideo; Shimizu, Atsushi; Yokota, Isao; Ohashi, Yasuo; Yamaue, Hiroki			Interim safety analysis of a randomized phase II trial comparing alternate-day oral therapy using S-1 with the standard regimen as a first-line treatment for patients with advanced pancreatic cancer	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Kansai Med Univ, Hirakata, Osaka, Japan; Natl Canc Ctr, Dept Hepatobiliary & Pancreat Oncol, Tokyo, Japan; Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol, Tokyo, Japan; Kyorin Univ, Sch Med, Dept Med Oncol, Tokyo, Japan; Kanagawa Canc Ctr, Div Hepatobiliary & Pancreat Oncol, Yokohama, Kanagawa 2410815, Japan; Shizuoka Canc Ctr, Shizuoka, Japan; Osaka Med Ctr Canc & Cardiovasc Dis, Hepatobiliary & Pancreat Oncol, Osaka, Japan; Nara Med Univ, Dept Surg, Kashihara, Nara 634, Japan; Osaka Natl Hosp, Dept Hepatobiliary & Pancreat Surg, Osaka, Japan; Kinki Univ, Osakasayama, Japan; Yokohama City Univ, Med Ctr, Yokohama, Kanagawa 232, Japan; Teine Keijinkai Hosp, Ctr Gastroenterol, Sapporo, Hokkaido, Japan; Aichi Canc Ctr Hosp, Nagoya, Aichi 464, Japan; Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Kumamoto, Japan; Wakayama Med Univ, Dept Surg 2, Wakayama, Japan; Univ Tokyo, Dept Biostat, Tokyo, Japan; Chuo Univ, Tokyo 112, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e15267						1	Oncology	Oncology	CM9OA	WOS:000358036903026		
J	Yang, HK; Tsujinaka, T; Nakamura, K; Kim, YW; Terashima, M; Han, SU; Iwasaki, Y; Hyung, WJ; Takagane, A; Park, BJ; Fujitani, K; Hahn, S; Sasako, M; Bang, YJ				Yang, Han-Kwang; Tsujinaka, Toshimasa; Nakamura, Kenichi; Kim, Young Woo; Terashima, Masanori; Han, Sang Uk; Iwasaki, Yoshiaki; Hyung, Woo Jin; Takagane, Akinori; Park, Byung-Joo; Fujitani, Kazumasa; Hahn, Seokyung; Sasako, Mitsuru; Bang, Yung-Jue			Randomized controlled trial of comparing gastrectomy (Gx) plus chemotherapy (CTX) with CTX alone in advanced gastric cancer (AGC) with a single non-curable factor: JCOG 0705/KGCA01 study (REGATTA)	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Seoul Natl Univ Hosp, Dept Surg, Seoul 110744, South Korea; Kaizuka City Hosp, Dept Surg, Kaizuka, Osaka, Japan; Natl Canc Ctr, Japan Clin Oncol Grp, Operat Off, Tokyo 104, Japan; Natl Canc Ctr, Goyang, South Korea; Shizuoka Canc Ctr, Div Gastr Surg, Nagaizumi, Shizuoka, Japan; Ajou Univ, Sch Med, Suwon 441749, South Korea; Tokyo Metropolitan Komagome Hosp, Tokyo, Japan; Yonsei Univ, Coll Med, Dept Surg, Seoul, South Korea; Hakodate Goryokaku Hosp, Hakodate, Hokkaido, Japan; Seoul Natl Univ, Coll Med, Seoul, South Korea; Osaka Prefectural Gen Med Ctr, Osaka, Japan; Hyogo Coll Med, Nishinomiya, Hyogo 6638501, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		200						1	Oncology	Oncology	CM9OA	WOS:000358036900458		
J	Yang, JCH; Ahn, MJ; Dickgreber, NJ; Halmos, B; Hirsh, V; Hochmair, MJ; Levy, BP; De Marinis, F; Mok, T; O'Byrne, K; Okamoto, I; Schuler, MH; Sebastian, M; Shah, RNH; Tan, EH; Yamamoto, N; Marten, A; Massey, D; Wind, S; Carbone, DP				Yang, James Chih-Hsin; Ahn, Myung-Ju; Dickgreber, Nicolas J.; Halmos, Balazs; Hirsh, Vera; Hochmair, Maximilian J.; Levy, Benjamin Philip; De Marinis, Filippo; Mok, Tony; O'Byrne, Kenneth; Okamoto, Isamu; Schuler, Martin H.; Sebastian, Martin; Shah, Riyaz N. H.; Tan, Eng-Huat; Yamamoto, Nobuyuki; Marten, Angela; Massey, Dan; Wind, Sven; Carbone, David Paul			Influence of dose adjustment on afatinib safety and efficacy in patients (pts) with advanced EGFR mutation-positive (EGFRm plus ) non-small cell lung cancer (NSCLC).	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Natl Taiwan Univ Hosp, Taipei, Taiwan; Natl Taiwan Univ, Taipei 10764, Taiwan; Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea; Mathias Spital Rheine, Thorac Oncol & Resp Care Med, Rheine, Germany; Columbia Univ, Med Ctr, New York, NY USA; McGill Univ, Montreal, PQ, Canada; Otto Wagner Hosp, Vienna, Austria; Mt Sinai Beth Israel Hosp, New York, NY USA; European Inst Oncol, Thorac Oncol Div, Milan, Italy; Chinese Univ Hong Kong, State Key Lab South China, Hong Kong Canc Inst, Hong Kong, Hong Kong, Peoples R China; Princess Alexandra Hosp, Brisbane, Qld 4102, Australia; Queensland Univ Technol, Brisbane, Qld 4001, Australia; Kyushu Univ Hosp, Ctr Clin & Translat Res, Fukuoka 812, Japan; Univ Duisburg Essen, West German Canc Ctr, Univ Hosp Essen, Essen, Germany; Goethe Univ Frankfurt, Med Ctr, D-60054 Frankfurt, Germany; Johannes Gutenberg Univ Mainz, Univ Med Ctr, D-55122 Mainz, Germany; Maidstone Hlth Author, Kent Oncol Ctr, Maidstone, Kent, England; Natl Canc Ctr, Singapore, Singapore; Wakayama Med Univ, Wakayama, Japan; Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany; Boehringer Ingelheim Ltd UK, Bracknell, Berks, England; Ohio State Univ, James Thorac Ctr, Wexner Med Ctr, Columbus, OH 43210 USA								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		8073						1	Oncology	Oncology	CM9OA	WOS:000358036901785		
J	Yano, S; Li, SK; Han, QH; Tan, YY; Bouvet, M; Fujiwara, T; Hoffman, RM				Yano, Shuya; Li, Shukuan; Han, Qinghong; Tan, Yuying; Bouvet, Michael; Fujiwara, Toshiyoshi; Hoffman, Robert M.			Effect of methionine-depletion via methioninase-treatment on cancer cells in S/G2 phase and chemosensitivity.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					AntiCancer Inc, San Diego, CA USA; Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; Okayama Univ, Grad Sch, Okayama 7008530, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e13512						1	Oncology	Oncology	CM9OA	WOS:000358036902518		
J	Yasojima, H; Yamamoto, H; Masuda, N; Aogi, K; Takahashi, M; Yonemori, K; Takeuchi, M; Hamada, A; Tamura, K; Sukigara, T; Nagasaka, R; Nakano, R; Tsujimoto, Y; Morioka, Y; Higuchi, K; Fujiwara, Y				Yasojima, Hiroyuki; Yamamoto, Harukaze; Masuda, Norikazu; Aogi, Kenjiro; Takahashi, Masato; Yonemori, Kan; Takeuchi, Masahiro; Hamada, Akinobu; Tamura, Kenji; Sukigara, Tamie; Nagasaka, Ritsuko; Nakano, Rie; Tsujimoto, Yukie; Morioka, Yuka; Higuchi, Kiyomi; Fujiwara, Yasuhiro			A phase I/II trial of olaparib in combination with eribulin in patients with advanced or metastatic triple negative breast cancer (TNBC) previously treated with anthracyclines and taxanes: First results from phase I	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Natl Hosp Org Osaka Natl Hosp, Osaka, Japan; Natl Canc Ctr Hosp Tokyo, Tokyo, Japan; Natl Hosp Org Shikoku Canc Ctr, Matsuyama, Ehime, Japan; Natl Hosp Org Hokkaido Canc Ctr, Sapporo, Hokkaido, Japan; Kitasato Univ, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		1038						1	Oncology	Oncology	CM9OA	WOS:000358036900120		
J	Yasui, H; Amore, B; Jiang, YZ; Murugappan, S; Doi, T				Yasui, Hirofumi; Amore, Benny; Jiang, Yizhou; Murugappan, Swaminathan; Doi, Toshihiko			A phase 1, open-label, dose escalation study of AMG 337 in Asian patients (pts) with advanced solid tumors	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Shizuoka Canc Ctr Hosp, Nagaizumi, Shizuoka, Japan; Amgen Inc, Seattle, WA USA; Amgen Inc, Thousand Oaks, CA 91320 USA; Natl Canc Ctr Hosp East, Chiba, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e13538						1	Oncology	Oncology	CM9OA	WOS:000358036902542		
J	Yazawa, T; Kaira, K; Shimizu, A; Nagashima, T; Ohtaki, Y; Obayashi, K; Asao, T; Oyama, T; Takeyoshi, I; Shimizu, K				Yazawa, Tomohiro; Kaira, Kyoichi; Shimizu, Akira; Nagashima, Toshiteru; Ohtaki, Yoichi; Obayashi, Kai; Asao, Takayuki; Oyama, Tetsunari; Takeyoshi, Izumi; Shimizu, Kimihiro			Prognostic significance of beta 2 adrenergic receptor expression in the patients with non-small cell lung cancer.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Gunma Univ, Grad Sch Med, Dept Thorac & Visceral Organ Surg, Maebashi, Gumma 371, Japan; Gunma Univ, Grad Sch Med, Dept Oncol Clin Dev, Gunma, Japan; Gunma Univ Hosp, Dept Dermatol, Gunma, Japan; Gunma Univ, Grad Sch Med, Dept Thorac & Visceral Organ Surg, Maebashi, Gumma 371, Japan; Gunma Univ, Grad Sch Med, Dept Thorac & Visceral Organ Surg, Maebashi, Gumma 371, Japan; Gunma Univ, Grad Sch Med, Dept Oncol Clin Dev, Gunma, Japan; Gunma Univ, Grad Sch Med, Div Diagnost Pathol, Maebashi, Gumma 371, Japan; Gunma Univ, Grad Sch Med, Dept Thorac & Visceral Surg, Maebashi, Gumma 371, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		11081						1	Oncology	Oncology	CM9OA	WOS:000358036900339		
J	Yokokawa, M; Imano, M; Furukawa, H; Nishimura, Y; Kurokawa, Y; Satoh, T; Sakai, D; Yasuda, T; Imamoto, H; Tsujinaka, T; Shimokawa, T; Shiozaki, H				Yokokawa, Masaki; Imano, Motohiro; Furukawa, Hiroshi; Nishimura, Yasumasa; Kurokawa, Yukinori; Satoh, Taroh; Sakai, Daisuke; Yasuda, Takushi; Imamoto, Haruhiko; Tsujinaka, Toshimasa; Shimokawa, Toshio; Shiozaki, Hitoshi			Phase 1 study of preoperative radiotherapy combined with S-1 plus cisplatin in clinically resectable type 4 or large type 3 gastric cancer: Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG1205).	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Kinki Univ, Fac Med, Dept Radiat Oncol, Osaka, Japan; Kinki Univ, Fac Med, Dept Surg, Osaka, Japan; Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Osaka, Japan; Osaka Univ, Grad Sch Med, Dept Frontier Sci Canc & Chemotherapy, Osaka, Japan; Kinki Univ, Fac Med, Osakasayama, Japan; Kaizuka City Hosp, Dept Surg, Osaka, Japan; Univ Yamanashi, Grad Sch Med & Engn, Kofu, Yamanashi, Japan; Kinki Univ, Dept Surg, Osakasayama, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e15207						1	Oncology	Oncology	CM9OA	WOS:000358036902971		
J	Yokota, T; Konishi, T; Tachibana, H; Yurikusa, T; Hamauchi, S; Sakai, K; Nishikawa, M; Sato, M; Taguri, M; Morita, S; Eguchi, T; Kubota, K; Zenda, S				Yokota, Tomoya; Konishi, Tetsuhito; Tachibana, Hiroyuki; Yurikusa, Takashi; Hamauchi, Satoshi; Sakai, Kensuke; Nishikawa, Masaya; Sato, Maho; Taguri, Masataka; Morita, Satoshi; Eguchi, Toru; Kubota, Kaoru; Zenda, Sadamoto			Multicenter phase II study of oral care program for head and neck cancer patients treated with chemoradiotherapy.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Shizuoka Canc Ctr, Shizuoka, Japan; Natl Canc Ctr Hosp East, Div Dent, Chiba, Japan; Aichi Canc Ctr Hosp, Div Radiat Oncol, Nagoya, Aichi 464, Japan; Shizuoka Canc Center, Div Dent & Oral Surg, Shizuoka, Japan; Shizuoka Canc Center, Div Gastrointestinal Oncol, Shizuoka, Japan; Sakai Dent Clin, Nagoya, Aichi, Japan; Nagoya Univ, Grad Sch Med, Oral & Maxillofacial Surg, Nagoya, Aichi 4648601, Japan; Yokohama City Univ, Med Ctr, Dept Biostat & Epidemiol, Yokohama, Kanagawa 232, Japan; Kyoto Univ Hosp, Inst Adv Clin & Translat Sci, Kyoto, Japan; Sunstar Shizuoka Inst, Shizuoka, Japan; Nippon Med Sch, Tokyo 113, Japan; Natl Canc Ctr East, Chiba, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e17003						1	Oncology	Oncology	CM9OA	WOS:000358036903388		
J	Yoneda, K; Tanaka, F; Kondo, N; Hashimoto, M; Takuwa, T; Matsumoto, S; Okumura, Y; Tsubota, N; Sato, A; Tsujimura, T; Kuribayashi, K; Tabata, C; Nakano, T; Hasegawa, S				Yoneda, Kazue; Tanaka, Fumihiro; Kondo, Nobuyuki; Hashimoto, Masaki; Takuwa, Teruhisa; Matsumoto, Seiji; Okumura, Yoshitomo; Tsubota, Noriaki; Sato, Ayuko; Tsujimura, Tohru; Kuribayashi, Kozo; Tabata, Chiharu; Nakano, Takashi; Hasegawa, Seiki			Circulating tumor cell (CTC) as a prognostic marker in primary lung cancer.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Univ Occupat & Environm Hlth, Kitakyushu, Fukuoka 807, Japan; Hyogo Coll Med, Dept Thorac Surg, Nishinomiya, Hyogo 6638501, Japan; Hyogo Coll Med, Nishinomiya, Hyogo 6638501, Japan; Itami City Hosp, Itami, Hyogo, Japan; Hyogo Coll Med, Dept Pathol, Nishinomiya, Hyogo 6638501, Japan; Hyogo Coll Med, Div Resp Med, Dept Internal Med, Nishinomiya, Hyogo 6638501, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e22041						1	Oncology	Oncology	CM9OA	WOS:000358036904444		
J	Yoshida, T; Oya, Y; Shimizu, J; Tanaka, K; Horio, Y; Hida, T; Yatabe, Y				Yoshida, Tatsuya; Oya, Yuko; Shimizu, Junichi; Tanaka, Kosuke; Horio, Yoshitsugu; Hida, Toyoaki; Yatabe, Yasushi			Impact of alectinib on survival after crizotinib failure in ALK-positive NSCLC patients.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Aichi Canc Ctr Hosp, Dept Thorac Oncol, Nagoya, Aichi 464, Japan; Aichi Canc Ctr Hosp, Dept Pathol & Mol Diagnost, Nagoya, Aichi 464, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e19138						1	Oncology	Oncology	CM9OA	WOS:000358036903977		
J	Yoshikawa, T; Tanabe, K; Ito, Y; Nishikawa, K; Fujitani, K; Matsui, T; Hayashi, T; Aoyama, T; Cho, H; Morita, S; Miyashita, Y; Tsuburaya, A; Sakamoto, J				Yoshikawa, Takaki; Tanabe, Kazuaki; Ito, Yuichi; Nishikawa, Kazuhiro; Fujitani, Kazumasa; Matsui, Takanori; Hayashi, Tsutomu; Aoyama, Toru; Cho, Haruhiko; Morita, Satoshi; Miyashita, Yumi; Tsuburaya, Akira; Sakamoto, Junichi			Subset analysis of COMPASS: A randomized 2X2 phase II trial comparing two and four courses of S-1/cisplatin (SC) and paclitaxel/cisplatin (PC) as neoadjuvant chemotherapy for locally advanced gastric cancer.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Kanagawa Canc Ctr, Dept Gastrointestinal Surg, Yokohama, Kanagawa 2410815, Japan; Hiroshima Univ, Hiroshima, Japan; Aichi Canc Ctr, Dept Surg Gastroenterol, Nagoya, Aichi 464, Japan; Osaka Natl Hosp, Dept Surg, Osaka, Japan; Osaka Prefectural Gen Med Ctr, Dept Surg, Osaka, Japan; Aichi Canc Ctr Hosp, Okazaki, Aichi, Japan; Kanagawa Canc Ctr, Yokohama, Kanagawa 2410815, Japan; Kyoto Univ, Grad Sch Med, Dept Biomed Stat & Bioinformat, Kyoto, Japan; NPO Epidemiol & Clin Res Informat Network, Okazaki, Aichi, Japan; Yokohama City Univ, Med Ctr, Dept Surg Gastroenterol, Yokohama, Kanagawa 232, Japan; Japanese Fdn Multidisciplinary Treatment Canc, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e15067						1	Oncology	Oncology	CM9OA	WOS:000358036902848		
J	Yoshimoto, N; Kawaguchi, T; Tamiya, A; Isa, S; Shimizu, S; Asai, K; Kudoh, S; Hirata, K				Yoshimoto, Naoki; Kawaguchi, Tomoya; Tamiya, Akihiro; Isa, Shun-ichi; Shimizu, Shigeki; Asai, Kazuhisa; Kudoh, Shinzoh; Hirata, Kazuto			Integrative analysis on expression of estrogen, environmental tobacco smoke and EGFR mutations from a prospective cohort study for never-smokers with non-small cell lung cancer.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Osaka City Univ, Grad Sch Med, Osaka 558, Japan; Natl Hosp Org, Kinki Chuo Chest Med Ctr, Osaka, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e18517						1	Oncology	Oncology	CM9OA	WOS:000358036903825		
J	Yoshinami, T; Masuda, N; Nakayama, T; Hara, F; Sagara, Y; Kawaguchi, H; Watanabe, K; Sato, M; Aogi, K; Higaki, K; Morimoto, T; Shigeoka, Y; Tokunaga, S; Morishima, H; Yanagita, Y; Tsurutani, J; Baba, S; Katayama, K; Morita, S; Ohtani, S				Yoshinami, Tetsuhiro; Masuda, Norikazu; Nakayama, Takahiro; Hara, Fumikata; Sagara, Yasuaki; Kawaguchi, Hidetoshi; Watanabe, Ken-ichi; Sato, Masako; Aogi, Kenjiro; Higaki, Kenji; Morimoto, Takashi; Shigeoka, Yasushi; Tokunaga, Shinya; Morishima, Hirotaka; Yanagita, Yasuhiro; Tsurutani, Junji; Baba, Shinichi; Katayama, Kazuhisa; Morita, Satoshi; Ohtani, Shoichiro			The utility of bi-weekly eribulin therapy for metastatic breast cancer: A Japanese multicenter phase II study (JUST-STUDY)	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Osaka Med Ctr Canc & Cardiovasc Dis, Osaka, Japan; NHO Osaka Natl Hosp, Osaka, Japan; Osaka Med Ctr Canc & Cardiovasc Dis, Dept Breast & Endocrine Surg, Osaka, Japan; NHO Shikoku Canc Ctr, Matsuyama, Ehime, Japan; Hakuaikai Med Corp Sagara HP, Kagoshima, Japan; Matsuyama Red Cross Hosp, Matsuyama, Ehime, Japan; NHO Hokkaido Canc Ctr, Sapporo, Hokkaido, Japan; Natl Hosp Org Shikoku Canc Ctr, Matsuyama, Ehime, Japan; Hiroshima City Hosp, Dept Breast Surg, Hiroshima, Japan; Yao Municipal Hosp, Yao, Osaka, Japan; Yodogawa Christians Hosp, Osaka, Japan; Osaka City Gen Hosp, Osaka, Japan; Osaka Rosai Hosp, Osaka, Japan; Gunma Prefectural Canc Ctr, Gunma, Japan; Kinki Univ, Sch Med, Osaka 589, Japan; Sagara Hosp, Kagoshima, Japan; Isesaki City Hosp, Gunma, Japan; Kyoto Univ, Grad Sch Med, Dept Biomed Stat & Bioinformat, Kyoto, Japan; Hiroshima City Hiroshima Citizens Hosp, Hiroshima, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		1026						1	Oncology	Oncology	CM9OA	WOS:000358036900108		
J	Yu, HA; Oxnard, GR; Spira, AI; Horn, L; Weiss, J; Feng, Y; West, HJ; Giaccone, G; Evans, TL; Kelly, RJ; Fleege, T; Poondru, S; Jie, F; Aoyama, K; Foley, MA; Whitcomb, D; Keating, AT; Krivoshik, AP				Yu, Helena Alexandra; Oxnard, Geoffrey R.; Spira, Alexander I.; Horn, Leora; Weiss, Jared; Feng, Yan; West, Howard Jack; Giaccone, Giuseppe; Evans, Tracey L.; Kelly, Ronan Joseph; Fleege, Tanya; Poondru, Srinivasu; Jie, Fei; Aoyama, Koji; Foley, Margaret A.; Whitcomb, Debbie; Keating, Anne Therese; Krivoshik, Andrew P.			Phase I dose escalation study of ASP8273, a mutant-selective irreversible EGFR inhibitor, in subjects with EGFR mutation positive NSCLC.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; US Oncol Res, Virginia Canc Specialists Res Inst, Fairfax, VA USA; Vanderbilt Ingram Canc Ctr, Nashville, TN USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Case Western Reserve Univ, Univ Hosp, Broadview Hts, OH USA; Swedish Canc Inst, Seattle, WA USA; NCI, NIH, Bethesda, MD 20892 USA; Univ Penn, Wynnewood, PA USA; Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA; Astellas Pharma Global Dev, Northbrook, IL USA; Astellas Pharma Inc, Northbrook, IL USA; Astellas Pharma, Tokyo, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		8083						1	Oncology	Oncology	CM9OA	WOS:000358036901795		
J	Yuki, S; Yoshino, T; Tsuchihara, K; Shinozaki, E; Muro, K; Nishina, T; Yamaguchi, K; Akagi, K; Yamazaki, K; Yamanaka, T; Nomura, S; Fujii, S; Esumi, H; Abe, Y; Ohtsu, A				Yuki, Satoshi; Yoshino, Takayuki; Tsuchihara, Katsuya; Shinozaki, Eiji; Muro, Kei; Nishina, Tomohiro; Yamaguchi, Kensei; Akagi, Kiwamu; Yamazaki, Kentaro; Yamanaka, Takeharu; Nomura, Shogo; Fujii, Satoshi; Esumi, Hiroyasu; Abe, Yukiko; Ohtsu, Atsushi			Clinical impact of expanded BRAF mutational status on the outcome for metastatic colorectal cancer patients with anti-EGFR antibody: An analysis of the BREAC trial (Biomarker Research for Anti-EGFR Monoclonal Antibodies by Comprehensive Cancer Genomics).	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Hokkaido Univ Hosp, Sapporo, Hokkaido 060, Japan; Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan; Natl Canc Ctr Hosp East, Div Translat Res, Res Ctr Innovat Oncol, Kashiwa, Chiba, Japan; Japanese Fdn Canc Res, Dept Gastroenterol, Canc Inst Hosp, Tokyo, Japan; Aichi Canc Ctr Hosp, Nagoya, Aichi 464, Japan; Natl Hosp Org Shikoku Canc Ctr, Matsuyama, Ehime, Japan; Saitama Canc Ctr, Div Gastroenterol, Saitama, Japan; Saitama Canc Ctr, Saitama, Japan; Shizuoka Canc Ctr, Shizuoka, Japan; Yokohama City Univ, Yokohama, Kanagawa 232, Japan; Natl Canc Ctr, Ctr Res Adm & Support, Kashiwa, Chiba, Japan; Natl Canc Ctr, Chiba, Japan; Tokyo Univ Sci, Res Inst Biomed Sci, Tokyo 162, Japan; G&G Sci Co Ltd, Fukushima, Japan; Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Kashiwa, Chiba, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		11038						1	Oncology	Oncology	CM9OA	WOS:000358036900297		
J	Zanna, C; Vaslin, A; Voss, MH; Heist, RS; Hierro, C; Supko, JG; Nakai, K; Ishii, N; Menetrey, A; Roubaudi-Fraschini, MC; Cordier, J; Douchain, J; Nicolas-Metral, V				Zanna, Claudio; Vaslin, Anne; Voss, Martin Henner; Heist, Rebecca Suk; Hierro, Cinta; Supko, Jeffrey G.; Nakai, Kiyohiko; Ishii, Nobuya; Menetrey, Annick; Roubaudi-Fraschini, Marie-Claude; Cordier, Julien; Douchain, Jerome; Nicolas-Metral, Valerie			Preliminary clinical pharmacokinetics and pharmacodynamics of Debio 1347 (CH5183284), a novel FGFR inhibitor.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Debiopharm Int SA, Lausanne, Switzerland; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; VHIO, Barcelona, Spain; Chugai Pharmaceut Co Ltd, Kamakura, Kanagawa, Japan								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		2540						1	Oncology	Oncology	CM9OA	WOS:000358036900573		
J	Zardavas, D; Te Marvelde, L; Milne, R; Joensuu, H; Moynahan, ME; Hennessy, B; Bieche, I; Saal, LH; Stal, O; Iacopetta, B; Jensen, JD; O'Toole, S; Barbareschi, M; Noguchi, S; Lerma, E; Wang, Q; Piccart-Gebhart, MJ; Sotiriou, C; Michiels, S; Loi, S				Zardavas, Dimitrios; Te Marvelde, Luc; Milne, Roger; Joensuu, Heikki; Moynahan, Mary Ellen; Hennessy, Bryan; Bieche, Ivan; Saal, Lao H.; Stal, Olle; Iacopetta, Barry; Jensen, Jeanette Dupont; O'Toole, Sandra; Barbareschi, Mattia; Noguchi, Shinzaburo; Lerma, Enrique; Wang, Qing; Piccart-Gebhart, Martine J.; Sotiriou, Christos; Michiels, Stefan; Loi, Sherene			Tumor PIK3CA genotype and prognosis: A pooled analysis of 4,241 patients (pts) with early-stage breast cancer (BC).	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Breast Int Grp, Brussels, Belgium; Peter MacCallum Canc Ctr, East Melbourne, Australia; Canc Council Victoria, Canc Epidemiol & Intelligence Div, Victoria, Australia; Helsinki Univ Hosp, Ctr Comprehens Canc, Helsinki, Finland; Univ Helsinki, Helsinki, Finland; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Beaumont Hosp, Dept Med Oncol, Dublin 9, Ireland; Inst Curie, Unit Pharmacogen, Paris, France; Lund Univ, Dept Clin Sci, Div Oncol & Pathol, Lund, Sweden; Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; Linkoping Univ, Dept Oncol, Linkoping, Sweden; Univ Western Australia, Perth, WA 6009, Australia; Odense Univ Hosp, Dept Oncol, DK-5000 Odense, Denmark; Royal Prince Alfred Hosp, Kinghorn Canc Ctr, Garvan Inst Med Res, Darlinghurst, NSW, Australia; Santa Chiara Hosp, Histopathol, Trento, Italy; Osaka Univ, Sch Med, Suita, Osaka 565, Japan; Hosp Santa Creu & Sant Pau, Dept Pathol, Barcelona, Spain; Ctr Leon Berard, F-69373 Lyon, France; Inst Jules Bordet, B-1000 Brussels, Belgium; Gustave Roussy, Serv Biostat & Epidemiol, Villejuif, France								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		516						1	Oncology	Oncology	CM9OA	WOS:000358036901123		
J	Zhang, W; Curtis, C; Stintzing, S; Heinemann, V; Parekh, A; Yang, DY; Cao, S; Ning, Y; Sunakawa, Y; Stremitzer, S; Matsusaka, S; Okazaki, S; El-Khoueiry, RE; Mendez, A; Barzi, A; El-Khoueiry, AB; Lenz, HJ				Zhang, Wu; Curtis, Chirstina; Stintzing, Sebastian; Heinemann, Volker; Parekh, Anish; Yang, Dongyun; Cao, Shu; Ning, Yan; Sunakawa, Yu; Stremitzer, Stefan; Matsusaka, Satoshi; Okazaki, Satoshi; El-Khoueiry, Rita Elie; Mendez, Angela; Barzi, Afsaneh; El-Khoueiry, Anthony B.; Lenz, Heinz-Josef			Profiling of differentially expressed genes in right and left side mCRC patients using nCounter customized gene expression assay.	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA; Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; Univ Munich, Dept Oncol, Munich, Germany; Univ Munich, Klinikum Grosshadern, Dept Internal Med 3, D-80539 Munich, Germany; Univ Munich, Klinikum Grosshadern, Ctr Comprehens Canc, D-80539 Munich, Germany; Med Univ Vienna, Santa Monica, CA USA; Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol, Tokyo, Japan; Univ So Calif, Los Angeles, CA USA								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		e14586						1	Oncology	Oncology	CM9OA	WOS:000358036902688		
J	Zhu, AX; Baron, AD; Malfertheiner, P; Kudo, M; Kawazoe, S; Pezet, D; Weissinger, F; Brandi, G; Barone, C; Okusaka, T; Wada, Y; Park, JO; Ryoo, BY; Cho, JY; Chung, HC; Li, CP; Yen, CJ; Lee, KD; Yang, L; Chau, I				Zhu, Andrew X.; Baron, Ari David; Malfertheiner, Peter; Kudo, Masatoshi; Kawazoe, Seiji; Pezet, Denis; Weissinger, Florian; Brandi, Giovanni; Barone, Carlo; Okusaka, Takuji; Wada, Yoshiyuki; Park, Joon Oh; Ryoo, Baek-Yeol; Cho, Jae Yong; Chung, Hyun Cheol; Li, Chung-Pin; Yen, Chia-Jui; Lee, Kuan-Der; Yang, Ling; Chau, Ian			Ramucirumab (RAM) as second-line treatment in patients (pts) with advanced hepatocellular carcinoma (HCC): Analysis of REACH pts by Child-Pugh (CP) score	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol					Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; Calif Pacific Med Ctr, San Francisco, CA USA; Univ Magdeburg, D-39106 Magdeburg, Germany; Kinki Univ, Sch Med, Dept Gastroenterol & Hepatol, Osaka 589, Japan; Saga Ken Med Ctr Koseikan, Saga, Japan; CHU Estaing, Clermont Ferrand, France; Evangel Krankenhaus Bielefeld, Bielefeld, Germany; Policlin St Orsola Malpighi, Bologna, Italy; Univ Cattolica Sacro Cuore, I-00168 Rome, Italy; Natl Canc Ctr, Dept Hepatobiliary & Pancreat Oncol, Tokyo, Japan; Natl Hosp Org, Kyushu Med Ctr, Fukuoka, Japan; Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea; Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea; Gangnam Severance Hosp, Seoul, South Korea; Yonsei Univ, Coll Med, Canc Metastasis Res Ctr, Yonsei Canc Ctr, Shinchon Dong, South Korea; Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol, Taipei, Taiwan; Natl Cheng Kung Univ Hosp, Tainan 70428, Taiwan; Chang Gung Mem Hosp, Chiayi, Taiwan; Eli Lilly & Co, Bridgewater, NJ USA; Royal Marsden, London, England; Royal Marsden, Surrey, England								0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2015	33	15		S		4108						2	Oncology	Oncology	CM9OA	WOS:000358036900946		
J	Narumi, S; Hasegawa, T				Narumi, Satoshi; Hasegawa, Tomonobu			TSH resistance revisited	ENDOCRINE JOURNAL			English	Review						TSH; TSH receptor; TSH resistance; Genetics; Mutation	THYROTROPIN-RECEPTOR GENE; CONGENITAL HYPOTHYROIDISM; THYROID-HORMONE; MUTATIONS; DEFICIENCY; HYPOPLASIA; CELLS	Genetic defects of hormone receptors are the most common form of end-organ hormone resistance. One example of such defects is TSH resistance, which is caused by biallelic inactivating mutations in the TSH receptor gene (TSHR). TSH, a master regulator of thyroid functions, affects virtually all cellular processes involving thyroid hormone production, including thyroidal iodine uptake, thyroglobulin iodination, reuptake of iodinated thyroglobulin and thyroid cell growth. Resistance to TSH results in defective thyroid hormone production from the neonatal period, namely congenital hypothyroidism. Classically, clinical phenotypes of TSH resistance due to inactivating TSHR mutations were thought to vary depending on the residual mutant receptor activity. Nonfunctional mutations in the two alleles produce severe thyroid hypoplasia with overt hypothyroidism (uncompensated TSH resistance), while hypomorphic mutations in at least one allele produce normal-sized thyroid gland with preserved hormone-producing capacity (compensated TSH resistance). More recently, a new subgroup of TSH resistance (nonclassic TSH resistance) that is characterized by paradoxically high thyroidal iodine uptake has been reported. In this article, the pathophysiology and clinical features of TSH resistance due to inactivating TSHR mutations are reviewed, with particular attention to the nonclassic form.	[Narumi, Satoshi; Hasegawa, Tomonobu] Keio Univ, Sch Med, Dept Pediat, Tokyo 1608582, Japan	Narumi, S (reprint author), Keio Univ, Sch Med, Dept Pediat, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	sat_naru@hotmail.com			Japan Society for the Promotion of Science [24791087]	The authors thank Prof. Takao Takahashi for fruitful discussion. This work was supported by a Grant-in-Aid for Scientific Research (C) (24791087) from the Japan Society for the Promotion of Science.	Abramowicz MJ, 1997, J CLIN INVEST, V99, P3018, DOI 10.1172/JCI119497; Kero J, 2007, J CLIN INVEST, V117, P2399, DOI 10.1172/JC130380; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Sanders J, 2007, THYROID, V17, P395, DOI 10.1089/thy.2007.0034; PARMA J, 1993, NATURE, V365, P649, DOI 10.1038/365649a0; Van Sande J, 2006, J CLIN ENDOCR METAB, V91, P1099, DOI 10.1210/jc.2005-1324; Grasberger H, 2007, J CLIN ENDOCR METAB, V92, P2816, DOI 10.1210/jc.2007-0366; Biebermann H, 1997, J CLIN ENDOCR METAB, V82, P3471, DOI 10.1210/jc.82.10.3471; CliftonBligh RJ, 1997, J CLIN ENDOCR METAB, V82, P1094, DOI 10.1210/jc.82.4.1094; deRoux N, 1996, J CLIN ENDOCR METAB, V81, P4229, DOI 10.1210/jc.81.12.4229; Gagne N, 1998, J CLIN ENDOCR METAB, V83, P1771, DOI 10.1210/jc.83.5.1771; Kleinau G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009745; Narumi S, 2009, J CLIN ENDOCR METAB, V94, P1317, DOI 10.1210/jc.2008-1767; Narumi S, 2011, J CLIN ENDOCR METAB, V96, pE1340, DOI 10.1210/jc.2011-0070; STANBURY JB, 1968, NEW ENGL J MED, V279, P1132, DOI 10.1056/NEJM196811212792103; SUNTHORNTHEPVARAKUL T, 1995, NEW ENGL J MED, V332, P155, DOI 10.1056/NEJM199501193320305; Tiosano D, 1999, THYROID, V9, P887, DOI 10.1089/thy.1999.9.887; YOSHIMURA M, 1993, J CLIN ENDOCR METAB, V77, P1009, DOI 10.1210/jc.77.4.1009	18	0	0	JAPAN ENDOCRINE SOC	KYOTO	75  YANAGINOBANBA NISHIIRU-MASUYA-CHO, SANJOU-DORI, NAKAGYOU-KU, KYOTO, 604-8111, JAPAN	0918-8959	1348-4540		ENDOCR J	Endocr. J.	MAY 20	2015	62	5					393	398				6	Endocrinology & Metabolism	Endocrinology & Metabolism	CM1KU	WOS:000357440600001		
J	Tanaka, K; Saisho, Y; Kawai, T; Tanaka, M; Meguro, S; Irie, J; Imai, T; Shigihara, T; Morimoto, J; Yajima, K; Atsumi, Y; Takei, I; Itoh, H				Tanaka, Kumiko; Saisho, Yoshifumi; Kawai, Toshihide; Tanaka, Masami; Meguro, Shu; Irie, Junichiro; Imai, Takatoshi; Shigihara, Toshikatsu; Morimoto, Jiro; Yajima, Ken; Atsumi, Yoshihito; Takei, Izumi; Itoh, Hiroshi			Efficacy and safety of liraglutide monotherapy compared With metformin in Japanese overweight/obese patients with type 2 diabetes	ENDOCRINE JOURNAL			English	Article						Liraglutide; Metformin; Type 2 diabetes; Japanese; Randomized controlled trial	DIPEPTIDYL PEPTIDASE-4 INHIBITORS; GLP-1 RECEPTOR AGONISTS; BETA-CELL FUNCTION; BODY-MASS INDEX; TREATMENT SATISFACTION; REPORTED OUTCOMES; OXIDATIVE STRESS; CONTROLLED-TRIAL; DOUBLE-BLIND; NON-ASIANS	There is little information on direct comparison between metformin and glucagon-like peptide-1 (GLP-1) receptor agonists in the Asian population. This study examined the efficacy and safety of liraglutide monotherapy compared with metformin monotherapy in overweight/obese Japanese patients with type 2 diabetes (T2DM). The study was a 24-week, open-labeled, randomized controlled study. Overweight or obese patients with T2DM aged 20-75 years with suboptimal glycemic control were randomized to liraglutide or metformin monotherapy. The primary endpoint was change in HbAlc at week 24. Secondary endpoints included changes in daily glycemic profile, body weight, incidence of hypoglycemia and other adverse events. The study, which was originally planned to enroll 50 subjects in each group, was ended with insufficient recruitment. A total of 46 subjects completed the study, and analysis was conducted in this cohort. Reduction in HbAlc at week 24 was comparable between the metformin (n = 24) and liraglutide (n = 22) groups (-0.95 +/- 0.80% vs. -0.80 +/- 0.88%, p = 0.77), while the liraglutide group reached maximal reduction more rapidly than did the metformin group. There was no significant difference in weight gain or incidence of hypoglycemia between the groups. Diarrhea was more frequent in the metformin group, while constipation was more frequent in the liraglutide group. There was no significant difference in treatment satisfaction between the groups. In conclusion, liraglutide and metformin monotherapy showed similar reduction in HbAlc during 24 weeks, with no difference in weight gain or incidence of hypoglycemia in overweight or obese Japanese patients with T2DM.	[Tanaka, Kumiko; Saisho, Yoshifumi; Kawai, Toshihide; Tanaka, Masami; Meguro, Shu; Irie, Junichiro; Itoh, Hiroshi] Keio Univ, Sch Med, Dept Internal Med, Tokyo 1608582, Japan; [Imai, Takatoshi] Yokohama Municipal Citizens Hosp, Dept Internal Med, Kanagawa, Japan; [Shigihara, Toshikatsu] Eiju Gen Hosp, Dept Internal Med, Tokyo, Japan; [Morimoto, Jiro] Japan Community Hlth Care Org Saitama Med Ctr, Dept Internal Med, Saitama, Japan; [Yajima, Ken] Tachikawa Hosp, Federat Natl Publ Serv Personnel Mutual Aid Assoc, Dept Internal Med, Tokyo, Japan; [Atsumi, Yoshihito] Eiju Gen Hosp, Ctr Diabet, Tokyo, Japan; [Takei, Izumi] Ichikawa Gen Hosp, Tokyo Dent Coll, Dept Internal Med, Chiba, Japan	Saisho, Y (reprint author), Keio Univ, Sch Med, Dept Internal Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	ysaisho@keio.jp			Keio University	This study was sponsored by Keio University and was supported by Keio University's general research funds. Keio University received unrestricted donations from Novo Nordisk Pharma Limited and from other pharmaceutical manufacturers. A portion of these combined donations contributed to covering the university's research-related expenses. The authors take full responsibility for the protocol design, study conduct and content of this manuscript.	Klonoff DC, 2008, CURR MED RES OPIN, V24, P275, DOI 10.1185/030079907X253870; Meier JJ, 2012, NAT REV ENDOCRINOL, V8, P728, DOI 10.1038/nrendo.2012.140; Saisho Y, 2011, ENDOCR J, V58, P315, DOI 10.1507/endocrj.K10E-399; Peyrot M, 2005, DIABETES CARE, V28, P2673, DOI 10.2337/diacare.28.11.2673; Umpierrez G, 2014, DIABETES CARE, V37, P2168, DOI 10.2337/dc13-2759; Kodani N, 2013, CLIN DRUG INVEST, V33, P563, DOI 10.1007/s40261-013-0098-5; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Kim YG, 2013, DIABETOLOGIA, V56, P696, DOI 10.1007/s00125-012-2827-3; Ishii H, 2011, CURR MED RES OPIN, V27, P643, DOI 10.1185/03007995.2010.551760; Bhaskaran K, 2014, LANCET, V384, P755, DOI 10.1016/S0140-6736(14)60892-8; Seino Y, 2008, DIABETES RES CLIN PR, V81, P161, DOI 10.1016/j.diabres.2008.03.018; Sarwar N, 2010, LANCET, V375, P2215; Russell-Jones D, 2012, DIABETES CARE, V35, P252, DOI 10.2337/dc11-1107; Garber AJ, 2013, ENDOCR PRACT, V19, P327, DOI 10.4158/EP12437.GL; Kodama K, 2013, DIABETES CARE, V36, P1789, DOI 10.2337/dc12-1235; Bi Y, 2013, DIABETES-METAB RES, V29, P664, DOI 10.1002/dmrr.2443; DEFRONZO RA, 1991, J CLIN ENDOCR METAB, V73, P1294; Aroda VR, 2012, CLIN THER, V34, P1247, DOI 10.1016/j.clinthera.2012.04.013; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Bak MJ, 2014, EUR J ENDOCRINOL, V170, P529, DOI 10.1530/EJE-13-0941; Schmidt WE, 2011, DIABETIC MED, V28, P715, DOI 10.1111/j.1464-5491.2011.03276.x; Kramer CK, 2013, ANN INTERN MED, V159, P758, DOI 10.7326/0003-4819-159-11-201312030-00008; Ashwell SG, 2008, DIABETES CARE, V31, P1112, DOI 10.2337/dc07-1183; Committee on the Standardization of Diabetes Mellitus-Related Laboratory Testing of Japan Diabetes Society, 2012, DIABETOL INT, V3, P8; Davies M, 2012, DIABETES OBES METAB, V14, P882, DOI 10.1111/j.1463-1326.2012.01595.x; Davies M, 2011, DIABETIC MED, V28, P333, DOI 10.1111/j.1464-5491.2010.03074.x; Esposito K, 2008, J CLIN ENDOCR METAB, V93, P1345, DOI 10.1210/jc.2007-2000; Inoue K, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-95; International Diabetes Federation, 2013, IDF DIABETES ATLAS; International Diabetes Federation, 2014, DIABETES RES CLIN PR, V104, P1; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI [10.2337/dc12-0413, 10.2337/dc12-041.3]; Kim YG, 2014, DIABETES OBES METAB, V16, P900, DOI 10.1111/dom.12293; Mori Y, 2011, DIABETES TECHNOL THE, V13, P1139, DOI 10.1089/dia.2011.0137; Okada K, 2014, ENDOCRINE, V47, P962, DOI 10.1007/s12020-014-0246-6; Retnakaran R, 2014, DIABETES CARE, V37, P3270, DOI 10.2337/dc14-0893; Rizzo M, 2014, J CLIN ENDOCR METAB, V100, P603; Robinson LE, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001986; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829; Tobias DK, 2014, NEW ENGL J MED, V370, P233, DOI 10.1056/NEJMoa1304501	39	2	3	JAPAN ENDOCRINE SOC	KYOTO	75  YANAGINOBANBA NISHIIRU-MASUYA-CHO, SANJOU-DORI, NAKAGYOU-KU, KYOTO, 604-8111, JAPAN	0918-8959	1348-4540		ENDOCR J	Endocr. J.	MAY 20	2015	62	5					399	409				11	Endocrinology & Metabolism	Endocrinology & Metabolism	CM1KU	WOS:000357440600002		
J	Tanaka, N; Hiura, Y				Tanaka, Nagaaki; Hiura, Yoshikazu			Effects of rapid-acting insulin analogues insulin glulisine and insulin aspart on postprandial glycemic excursion with single bout of exercise in patients with type 2 diabetes	ENDOCRINE JOURNAL			English	Article						Glulisine; Exercise; Hypoglycemia	SEVERE HYPOGLYCEMIA; FASTER ONSET; PHARMACOKINETICS; MORTALITY; LISPRO; OBESE	The analogue insulin glulisine (Glu) shows both more rapid onset and shorter duration of action compared with the other rapid-acting insulin analogues. The current study investigates these properties in regard to the occurrence of hypoglycemia related to exercise. A randomized, single-center, open-label, crossover study was conducted in 12 hospitalized type 2 diabetes patients (all male, mean SD age of 51.9 +/- 11.3 years; BMI: 25.5 +/- 3.9 kg/m(2); HbAlc: 11.2 +/- 2.4 %). Glu or insulin aspart (Asp) was subcutaneously administered just before breakfast. Insulin dosage was determined as the usual dose of pre-prandial rapid-acting insulin for patients treated with insulin therapy or as 0.1 unit/kg for patients treated with oral anti-hyperglycemic agents. Sixty min after the start of eating, the patients began aerobic exercise on a bicycle ergometer for 30 min at 50% of maximum heart rate. Hypoglycemic episodes (plasma glucose level < 70 mg/dL with or without symptoms) were observed more frequently in Asp group (p < 0.05). Post-exercise plasma glucose levels at 90, 120, and 150 min were significantly lower in Asp group (p < 0.05). In patients with BMI < 25 kg/m(2) (n = 6), post-exercise blood glucose levels were significantly lower in Asp group (p < 0.05), while in patients with BMI >= 25 kg/m(2) (n = 6) the difference was not significant. Glu may therefore be a suitable choice of rapid-acting insulin for patients with type 2 diabetes who are at high risk of post-exercise hypoglycemia.	[Tanaka, Nagaaki; Hiura, Yoshikazu] Osaka City Juso Hosp, Dept Diabet, Osaka 5320034, Japan	Tanaka, N (reprint author), Osaka City Juso Hosp, Dept Diabet, Yodogawa Ku, 2-12-27 Nonakakita, Osaka 5320034, Japan.	nagaakitanaka@nifty.com			Osaka City Juso Hospital	This study was supported by grants for medical research from Osaka City Juso Hospital. The authors declare that they have no conflicts of interest.	Patel A, 2008, NEW ENGL J MED, V358, P2560; American Diabetes Association, 2014, DIABETES CARE S1, V37, pS14, DOI [DOI 10.2337/DC14-S014, 10.2337/dc14-S014]; Seino Y, 2010, J DIABETES INVEST, V1, P212, DOI 10.1111/j.2040-1124.2010.00074.x; Heise T, 2007, DIABETES OBES METAB, V9, P746, DOI 10.1111/j.1463-1326.2007.00746.x; Dailey G, 2004, DIABETES CARE, V27, P2363, DOI 10.2337/diacare.27.10.2363; McCoy RG, 2012, DIABETES CARE, V35, P1897, DOI 10.2337/dc11-2054; Morrow L, 2013, DIABETES CARE, V36, P273, DOI 10.2337/dc12-0808; Riddle MC, 2010, DIABETES CARE, V33, P983, DOI 10.2337/dc09-1278; Zoungas S, 2010, NEW ENGL J MED, V363, P1410, DOI 10.1056/NEJMoa1003795; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545; Arnolds S, 2010, EXP CLIN ENDOCR DIAB, V118, P662, DOI 10.1055/s-0030-1252067; Becker RHA, 2008, CLIN PHARMACOKINET, V47, P7; Bolli GB, 2011, DIABETES OBES METAB, V13, P251, DOI 10.1111/j.1463-1326.2010.01343.x; CLAUSON PG, 1995, DIABETES CARE, V18, P986, DOI 10.2337/diacare.18.7.986; Luzio S, 2008, DIABETES RES CLIN PR, V79, P269, DOI 10.1016/j.diabres.2007.11.013; Maciejczyk M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095797; Ohta A, 2013, ENDOCR J, V60, P173	17	0	0	JAPAN ENDOCRINE SOC	KYOTO	75  YANAGINOBANBA NISHIIRU-MASUYA-CHO, SANJOU-DORI, NAKAGYOU-KU, KYOTO, 604-8111, JAPAN	0918-8959	1348-4540		ENDOCR J	Endocr. J.	MAY 20	2015	62	5					411	416				6	Endocrinology & Metabolism	Endocrinology & Metabolism	CM1KU	WOS:000357440600003		
J	Yamada, H; Saito, T; Aoki, A; Asano, T; Yoshida, M; Ikoma, A; Kusaka, I; Toyoshima, H; Kakei, M; Ishikawa, SE				Yamada, Hodaka; Saito, Tomoyuki; Aoki, Atsushi; Asano, Tomoko; Yoshida, Masashi; Ikoma, Aki; Kusaka, Ikuyo; Toyoshima, Hideo; Kakei, Masafumi; Ishikawa, San-e			Circulating betatrophin is elevated in patients with type 1 and type 2 diabetes	ENDOCRINE JOURNAL			English	Article						Betatrophin; Beta cells proliferation; Insulin resistance; Lipid metabolism	PANCREATIC BETA-CELL; ANGIOPOIETIN-LIKE PROTEIN; GLUCOSE-HOMEOSTASIS; LIPOPROTEIN-LIPASE; INDIVIDUALS; METABOLISM; ANGPTL3; OBESITY	There is evidence that betatrophin, a hormone derived from adipose tissue and liver, affects the proliferation of pancreatic beta cells in mice. The aim of this study was to examine circulating betatrophin concentrations in Japanese healthy controls and patients with type 1 and type 2 diabetes. A total of 76 subjects (12 healthy controls, 34 type 1 diabetes, 30 type 2 diabetes) were enrolled in the study. Circulating betatrophin was measured with an ELISA kit and clinical parameters related to betatrophin were analyzed statistically. Circulating betatrophin (Log transformed) was significantly increased in patients with diabetes compared with healthy subjects (healthy controls, 2.29 +/- 0.51; type 1 diabetes, 2.94 +/- 0.44; type 2 diabetes, 3.17 +/- 0.18; p<0.001, 4.1 to 5.4 times in pg/mL order). Age, HbA1c, fasting plasma glucose and Log triglyceride were strongly associated with Log betatrophin in all subjects (n=76) in correlation analysis. In type 1 diabetes, there was a correlation between Log betatrophin and Log CPR. These results provide the first evidence that circulating betatrophin is significantly elevated in Japanese patients with diabetes. The findings of this pilot study also suggest a possibility of association between the level of betatrophin and the levels of glucose and triglycerides.	[Yamada, Hodaka; Saito, Tomoyuki; Aoki, Atsushi; Asano, Tomoko; Yoshida, Masashi; Ikoma, Aki; Kusaka, Ikuyo; Toyoshima, Hideo; Kakei, Masafumi; Ishikawa, San-e] Jichi Med Univ, Saitama Med Ctr, Div Endocrinol & Metab, Saitama 3308503, Japan	Ishikawa, SE (reprint author), Jichi Med Univ, Saitama Med Ctr, Omiya Ku, 1-847 Amanuma Cho, Saitama 3308503, Japan.	saneiskw@jichi.ac.jp					Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Yi P, 2013, CELL, V153, P747, DOI 10.1016/j.cell.2013.04.008; Seino Y., 2010, Journal of the Japan Diabetes Society, V53, P450; Shimizugawa T, 2002, J BIOL CHEM, V277, P33742, DOI 10.1074/jbc.M203215200; Fenzl A, 2014, DIABETOLOGIA, V57, P1204, DOI 10.1007/s00125-014-3208-x; Espes D, 2014, DIABETOLOGIA, V57, P50, DOI 10.1007/s00125-013-3071-1; Quagliarini F, 2012, P NATL ACAD SCI USA, V109, P19751, DOI 10.1073/pnas.1217552109; Fu ZY, 2014, DIABETOLOGIA, V57, P2232, DOI 10.1007/s00125-014-3346-1; Fujimoto K, 2006, EXP ANIM TOKYO, V55, P27, DOI 10.1538/expanim.55.27; Zhang R, 2012, BIOCHEM BIOPH RES CO, V424, P786, DOI 10.1016/j.bbrc.2012.07.038; Gomez-Ambrosi J, 2014, J CLIN ENDOCR METAB, V99, pE2004, DOI 10.1210/jc.2014-1568; Jiao Y, 2014, DIABETES, V63, P1283, DOI 10.2337/db13-1435; Gusarova V, 2014, CELL, V159, P691, DOI 10.1016/j.cell.2014.09.027; Wang Y, 2013, P NATL ACAD SCI USA, V110, P16109, DOI 10.1073/pnas.1315292110; Fu ZY, 2013, BIOCHEM BIOPH RES CO, V430, P1126, DOI 10.1016/j.bbrc.2012.12.025; Peloso GM, 2014, AM J HUM GENET, V94, P223, DOI 10.1016/j.ajhg.2014.01.009; Zhang R, 2013, BIOCHEM BIOPH RES CO, V432, P401, DOI 10.1016/j.bbrc.2013.01.129; Espes D, 2014, INT J ENDOCRINOL, V2014, P323; Fu ZY, 2014, SCI REP-UK, V4, DOI 10.1038/srep05013; Hu H, 2014, DIABETES CARE, V37, P2718, DOI 10.2337/dc14-0602; Seymour PA, 2013, NEW ENGL J MED, V369, P777, DOI 10.1056/NEJMcibr1307038; Vetere A, 2014, NAT REV DRUG DISCOV, V13, P278, DOI 10.1038/nrd4231; Zhang R, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0133-8	23	2	2	JAPAN ENDOCRINE SOC	KYOTO	75  YANAGINOBANBA NISHIIRU-MASUYA-CHO, SANJOU-DORI, NAKAGYOU-KU, KYOTO, 604-8111, JAPAN	0918-8959	1348-4540		ENDOCR J	Endocr. J.	MAY 20	2015	62	5					417	421				5	Endocrinology & Metabolism	Endocrinology & Metabolism	CM1KU	WOS:000357440600004		
J	Kumagai, H; Zempo-Miyaki, A; Yoshikawa, T; Tsujimoto, T; Tanaka, K; Maeda, S				Kumagai, Hiroshi; Zempo-Miyaki, Asako; Yoshikawa, Toru; Tsujimoto, Takehiko; Tanaka, Kiyoji; Maeda, Seiji			Lifestyle modification increases serum testosterone level and decrease central blood pressure in overweight and obese men	ENDOCRINE JOURNAL			English	Article						Testosterone; Obesity; Central blood pressure; Lifestyle modification	CORONARY-HEART-DISEASE; BODY-MASS-INDEX; RISK-FACTORS; WEIGHT-LOSS; ENDOTHELIAL FUNCTION; ARTERIAL STIFFNESS; ANGINA THRESHOLD; EXERCISE; THERAPY; ASSOCIATION	Obesity has reached global epidemic proportions and is associated with multiple comorbidities, including cardiovascular disease. A novel predictor of cardiovascular disease is elevated central systolic blood pressure. In fact, lifestyle modifications have been shown to decrease the central systolic blood pressure in overweight and obese men. The mechanism underlying these changes has yet to be fully elucidated. Interestingly, testosterone has been found to have cardioprotective effects. Moreover, serum testosterone levels are lower in obese men than in normal weight men. However, it is still unclear whether testosterone participates in the decrease of central blood pressure in overweight and obese men following lifestyle modifications. So, the purpose of the present study was to investigate the effect of testosterone on central systolic blood pressure in overweight and obese men before and after the 12-week lifestyle modification program. Forty-four overweight and obese men completed a 12-week lifestyle modification program (aerobic exercise training and dietary modifications). For all participants, central systolic blood pressure and serum testosterone levels were measured before and after the program. After the program, central systolic blood pressure was significantly decreased while serum total testosterone levels were significantly increased in overweight and obese men. Moreover, we also found a significant negative relationship between the change in serum testosterone levels and that in central systolic blood pressure. The present study suggests that increased serum testosterone levels likely contribute to a decrease in central blood pressure in overweight and obese men.	[Kumagai, Hiroshi; Yoshikawa, Toru] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058574, Japan; [Zempo-Miyaki, Asako] Univ Ryutsu Keizai, Fac Sports & Hlth Sci, Ryugasaki, Japan; [Tsujimoto, Takehiko; Tanaka, Kiyoji; Maeda, Seiji] Univ Tsukuba, Fac Hlth & Sport Sci, Tsukuba, Ibaraki 3058574, Japan	Maeda, S (reprint author), Univ Tsukuba, Fac Hlth & Sport Sci, Div Sports Med, Tsukuba, Ibaraki 3058574, Japan.	maeda@taiiku.tsukuba.ac.jp					Aizawa K, 2011, MED SCI SPORT EXER, V43, P2072, DOI 10.1249/MSS.0b013e31821e9d74; Malkin CJ, 2004, HEART, V90, P871, DOI 10.1136/hrt.2003.021121; Straznicky NE, 2012, DIABETES OBES METAB, V14, P139, DOI 10.1111/j.1463-1326.2011.01497.x; English KM, 2000, CIRCULATION, V102, P1906; Simon D, 1997, J CLIN ENDOCR METAB, V82, P682, DOI 10.1210/jc.82.2.682; Higashino R, 2013, BLOOD PRESS MONIT, V18, P311, DOI 10.1097/MBP.0000000000000006; Yan LJL, 2006, JAMA-J AM MED ASSOC, V295, P190, DOI 10.1001/jama.295.2.190; Roman MJ, 2007, HYPERTENSION, V50, P197, DOI 10.1161/HYPERTENSIONAHA.107.089078; Miyaki A, 2009, AM J CARDIOL, V104, P823, DOI 10.1016/j.amjcard.2009.04.057; Mathur A, 2009, EUR J ENDOCRINOL, V161, P443, DOI 10.1530/EJE-09-0092; Rahmouni K, 2005, HYPERTENSION, V45, P9, DOI 10.1161/01.HYP.0000151325.83008.b4; Agabiti-Rosei E, 2007, HYPERTENSION, V50, P154, DOI 10.1161/HYPERTENSIONAHA.107.090068; Wong CY, 2006, AM J CARDIOL, V98, P1593, DOI 10.1016/j.amjcard.2006.07.037; Corona G, 2011, EUR J ENDOCRINOL, V165, P687, DOI 10.1530/EJE-11-0447; PASQUALI R, 1995, J CLIN ENDOCR METAB, V80, P654, DOI 10.1210/jc.80.2.654; Webb CM, 1999, CIRCULATION, V100, P1690; Akishita M, 2008, HYPERTENS RES, V31, P69, DOI 10.1291/hypres.31.69; Guelfi KJ, 2013, METABOLISM, V62, P235, DOI 10.1016/j.metabol.2012.08.002; Smith JC, 2001, J CLIN ENDOCR METAB, V86, P4261, DOI 10.1210/jc.86.9.4261; Foresta C, 2009, CLIN ENDOCRINOL, V71, P722, DOI 10.1111/j.1365-2265.2009.03549.x; GOEBELSM.U, 1973, J CLIN ENDOCR METAB, V36, P867; Hirata K, 2013, J HYPERTENS, V31, P508, DOI 10.1097/HJH.0b013e32835c1d45; Kumagai H, 2014, ARTERY RES, V8, P80; Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801; Miyaki A, 2009, ANGIOLOGY, V60, P351, DOI 10.1177/0003319708325449; Nichols W W, 2001, J Cardiovasc Pharmacol Ther, V6, P5, DOI 10.1177/107424840100600102; Okura T, 2004, ARTERIOSCL THROM VAS, V24, P923, DOI 10.1161/01.ATV.0000125702.26272.f6; Phillips CL, 2009, J CLIN SLEEP MED, V5, P416; Sato K, 2011, AM J PHYSIOL-ENDOC M, V301, pE274, DOI 10.1152/ajpendo.00564.2010; Tabara Y, 2013, AM J HYPERTENS, V26, P973, DOI 10.1093/ajh/hpt052; Takazawa K, 2012, J HYPERTENS, V30, P908, DOI 10.1097/HJH.0b013e3283524910; Tsujimoto T, 2012, J HYPERTENS, V30, P1122, DOI 10.1097/HJH.0b013e328352b879; Westerbacka J, 1999, DIABETES, V48, P821, DOI 10.2337/diabetes.48.4.821	33	0	0	JAPAN ENDOCRINE SOC	KYOTO	75  YANAGINOBANBA NISHIIRU-MASUYA-CHO, SANJOU-DORI, NAKAGYOU-KU, KYOTO, 604-8111, JAPAN	0918-8959	1348-4540		ENDOCR J	Endocr. J.	MAY 20	2015	62	5					423	430				8	Endocrinology & Metabolism	Endocrinology & Metabolism	CM1KU	WOS:000357440600005		
J	Shiraishi, M; Yamamoto, Y; Hirooka, N; Obuchi, Y; Tachibana, S; Makishima, M; Tanaka, Y				Shiraishi, Mieno; Yamamoto, Yoritsuna; Hirooka, Nobutaka; Obuchi, Yasuhiro; Tachibana, Shoichi; Makishima, Makoto; Tanaka, Yuji			A high concentration of triiodothyronine attenuates the stimulatory effect on hemin-induced erythroid differentiation of human erythroleukemia K562 cells	ENDOCRINE JOURNAL			English	Article						Triiodothyronine (T3); K562 cells; Erythroid differentiation; Hemin; Thyroid hormone(s)	THYROID-HORMONE; HUMAN HEMATOPOIESIS; LEUKEMIA-CELLS; LINE K-562; HYPERTHYROIDISM; ANEMIA; GLOBIN; ERYTHROPOIESIS; EXPRESSION; RECEPTOR	Although thyroid hormone is a known stimulator of erythropoietic differentiation, severe anemia is sometimes observed in patients with hyperthyroidism and this mechanism is not fully understood. The aim of this study was to investigate the effect of triiodothyronine (T3) on hemin-induced erythropoiesis. Human erythroleukemia K562 cells were used as an erythroid differentiation model. Cell differentiation was induced by hemin and the effect of pre-incubation with T3 (0.1 to 100 nM) was analyzed by measuring the benzidine-positive rate, hemoglobin content, CD71 expression (transferrin receptor), and mRNA expression for transcription factors related to erythropoiesis and thyroid hormone receptors (TRs). Hemin, a promoter of erythroid differentiation, increased the levels of mRNAs for TR alpha, TR beta, and retinoid X receptor alpha (RXR alpha), as well as those for nuclear factor-erythroid 2 (NFE2), GATA-binding protein 1 (GATA1) and GATA-binding protein 2 (GATA2). Lower concentrations of T3 had a stimulatory effect on hemin-induced hemoglobin production (1 and 10 nM), CD71 expression (0.1 nM), and a-globin mRNA expression (1 nM), while a higher concentration of T3 (100 nM) abrogated the stimulatory effect on these parameters. T3 at 100 nM did not affect cell viability and proliferation, suggesting that the abrogation of erythropoiesis enhancement was not due to toxicity. T3 at 100 nM also significantly inhibited expression of GATA2 and RXRa mRNA, compared to 1 nM T3. We conclude that a high concentration of T3 attenuates the classical stimulatory effect on erythropoiesis exerted by a low concentration of T3 in hemin-induced K562 cells.	[Shiraishi, Mieno; Hirooka, Nobutaka; Obuchi, Yasuhiro; Tanaka, Yuji] Natl Def Med Coll, Dept Gen Med, Tokorozawa, Saitama 3598513, Japan; [Yamamoto, Yoritsuna; Tachibana, Shoichi] Natl Def Med Coll, Res Inst, Div Environm Med, Tokorozawa, Saitama 3598513, Japan; [Makishima, Makoto] Nihon Univ, Sch Med, Dept Biomed Sci, Div Biochem, Tokyo 1738610, Japan	Tanaka, Y (reprint author), Natl Def Med Coll, Dept Gen Med, Namiki 3-2, Tokorozawa, Saitama 3598513, Japan.	yitanaka@ndmc.ac.jp					ANDREWS NC, 1993, NATURE, V362, P722, DOI 10.1038/362722a0; Ferreira R, 2005, MOL CELL BIOL, V25, P1215, DOI 10.1128/MCB.25.4.1215-1227.2005; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; Kendrick TS, 2008, BLOOD, V111, P3245, DOI 10.1182/blood-2007-07-101105; FORD HC, 1988, POSTGRAD MED J, V64, P735; Bresnick EH, 2010, J BIOL CHEM, V285, P31087, DOI 10.1074/jbc.R110.159079; Bauer A, 1998, EMBO J, V17, P4291, DOI 10.1093/emboj/17.15.4291; LOZZIO CB, 1975, BLOOD, V45, P321; Nakamichi I, 2005, J CLIN INVEST, V115, P3007, DOI 10.1172/JCI24912; CIOE L, 1981, CANCER RES, V41, P237; Tsiftsoglou AS, 2003, PHARMACOL THERAPEUT, V100, P257, DOI 10.1016/j.pharmthera.2003.09.002; FEIN HG, 1975, MED CLIN N AM, V59, P1133; BALIGA BS, 1993, CELL PROLIFERAT, V26, P519, DOI 10.1111/j.1365-2184.1993.tb00030.x; Chute JP, 2010, MOL ENDOCRINOL, V24, P1, DOI 10.1210/me.2009-0332; DAINIAK N, 1986, BLOOD, V68, P1289; DAS KC, 1975, J CLIN ENDOCR METAB, V40, P211; Fathallah H, 2008, BLOOD CELL MOL DIS, V40, P166, DOI 10.1016/j.bcmd.2007.08.001; GAUWERKY C, 1980, BLOOD, V56, P886; Gianoukakis AG, 2009, CLIN ENDOCRINOL, V70, P781, DOI 10.1111/j.1365-2265.2008.03382.x; Grymula K, 2007, CELL PROLIFERAT, V40, P302, DOI 10.1111/j.1365-2184.2007.00435.x; HOFFMAN R, 1979, BLOOD, V54, P1182; HORTON MA, 1981, SCAND J HAEMATOL, V27, P231; Ingley E, 2004, IUBMB LIFE, V56, P177, DOI 10.1080/15216540410001703956; Ingley E, 2001, J BIOL CHEM, V276, P43428, DOI 10.1074/jbc.M106645200; Iwasaki K, 2006, MOL CELL BIOL, V26, P2845, DOI 10.1128/MCB.26.7.2845-2856.2006; Kawa MP, 2010, EUR J ENDOCRINOL, V162, P295, DOI 10.1530/EJE-09-0875; Kawasaki N, 1996, ARCH BIOCHEM BIOPHYS, V328, P289, DOI 10.1006/abbi.1996.0175; KOEFFLER HP, 1980, BLOOD, V56, P344; MALGOR LA, 1975, BLOOD, V45, P671; MILLER CW, 1984, BLOOD, V63, P195; PERLMAN JA, 1983, J CHRON DIS, V36, P405, DOI 10.1016/0021-9681(83)90173-X; Perrin MC, 1997, HEMATOL CELL THER, V39, P19, DOI 10.1007/s00282-997-0019-2; POPOVIC WJ, 1977, J CLIN INVEST, V60, P907, DOI 10.1172/JCI108845; RIVLIN RS, 1969, ANN INTERN MED, V70, P507; ROWLEY PT, 1981, EXP HEMATOL, V9, P32; Sztiller-Sikorska M, 2009, BRIT J PHARMACOL, V157, P1451, DOI 10.1111/j.1476-5381.2009.00333.x; THOMPSON CC, 1989, P NATL ACAD SCI USA, V86, P3494, DOI 10.1073/pnas.86.10.3494; TONKONOW BL, 1982, BLOOD, V59, P738; TRAINOR CD, 1995, MOL ENDOCRINOL, V9, P1135, DOI 10.1210/me.9.9.1135; Wu XR, 2011, TOXICOL LETT, V203, P190, DOI 10.1016/j.toxlet.2011.03.012; Yamamoto Y, 2014, MOL CELL BIOCHEM, V391, P217, DOI 10.1007/s11010-014-2005-7; Yu HC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022907	42	0	0	JAPAN ENDOCRINE SOC	KYOTO	75  YANAGINOBANBA NISHIIRU-MASUYA-CHO, SANJOU-DORI, NAKAGYOU-KU, KYOTO, 604-8111, JAPAN	0918-8959	1348-4540		ENDOCR J	Endocr. J.	MAY 20	2015	62	5					431	440				10	Endocrinology & Metabolism	Endocrinology & Metabolism	CM1KU	WOS:000357440600006		
J	Sekiguchi, Y; Miyamoto, Y; Kasahara, I; Hara, Y; Tani, Y; Doi, M; Hirata, Y				Sekiguchi, Yoshihiro; Miyamoto, Yuki; Kasahara, Ichiro; Hara, Yoshihito; Tani, Yuji; Doi, Masaru; Hirata, Yukio			Ectopic ACTH syndrome caused by desmopressin-responsive thymic neuroendocrine tumor	ENDOCRINE JOURNAL			English	Article						Ectopic ACTH syndrome; Thymic neuroendocrine tumor; Selective venous sampling; Desmopressin; V1b gene expression	DEPENDENT CUSHINGS-SYNDROME; CORTICOTROPIN-RELEASING HORMONE; ADRENOCORTICOTROPIN-SECRETING TUMORS; DIFFERENTIAL-DIAGNOSIS; CARCINOID-TUMOR; EXPRESSION; EXPERIENCE; MANAGEMENT; CISPLATIN; ETOPOSIDE	A 32-year-old Chinese woman with rapid weight gain and progressive edema was found to have typical Cushingoid features. Her endocrine data were consistent with a diagnosis of ACTH-dependent Cushing's syndrome. To differentiate ectopic ACTH syndrome (EAS) from Cushing's disease (CD), various dynamic endocrine and imaging tests were performed. Her ACTH response was negative to corticotropin-releasing hormone (CRH) and positive to desmopressin. Magnetic resonance imaging of the pituitary showed no mass lesion. Computed tomography scan of the chest revealed a large mass (21 x 15 mm) in the anterior mediastinum, where positron emission tomography showed accumulation of [F-18] fluorodeoxyglucose. Selective venous sampling showed marked step-up in ACTH level in the internal thoracic vein but not in the cavernous sinus after CRH stimulation. These data are compatible with the diagnosis of EAS. The resected tumor was pathologically consistent with thymic neuroendocrine tumor (NET) positive for ACTH by immunohistochemistry and abundant V1b receptor gene expression by RT-PCR. Postoperatively, her circulating ACTH/cortisol levels became normalized, and responded to stimulation with CRH but not with desmopressin. Her Cushingoid appearance gradually disappeared, and she was free from recurrence 5 years after surgery. This is a rare case of desmopressin-responsive EAS caused by thymic NET with predominant V1b gene expression, which was successfully localized by imaging modalities combined with selective venous sampling.	[Sekiguchi, Yoshihiro; Miyamoto, Yuki; Hara, Yoshihito] Ohme Municipal Gen Hosp, Div Endocrinol & Diabetol, Ohme, Tokyo 1980042, Japan; [Kasahara, Ichiro] Ohme Municipal Gen Hosp, Div Pathol, Ohme, Tokyo 1980042, Japan; [Tani, Yuji] Kitasato Univ, Sch Med, Div Endocrinol & Metab, Sagamihara, Kanagawa 2520374, Japan; [Doi, Masaru] Doi Med Clin, Kumamoto 8615255, Japan; [Hirata, Yukio] Inst Biomed Res & Innovat Hosp, Kobe, Hyogo 6500047, Japan	Sekiguchi, Y (reprint author), Ohme Municipal Gen Hosp, Div Endocrinol & Diabetol, 4-16-5 Higashi Ohme, Ohme, Tokyo 1980042, Japan.	sekiguti@mghp.ome.tokyo.jp					deKeyzer Y, 1996, J CLIN INVEST, V97, P1311, DOI 10.1172/JCI118547; Beuschlein F, 2002, ENDOCRIN METAB CLIN, V31, P191, DOI 10.1016/S0889-8529(01)00025-1; Ilias I, 2005, J CLIN ENDOCR METAB, V90, P4955, DOI 10.1210/jc.2004-2527; Kaltsas GA, 1999, J CLIN ENDOCR METAB, V84, P487, DOI 10.1210/jc.84.2.487; OLDFIELD EH, 1991, NEW ENGL J MED, V325, P897, DOI 10.1056/NEJM199109263251301; Moran CA, 2000, AM J CLIN PATHOL, V114, P100; MOERTEL CG, 1991, CANCER, V68, P227, DOI 10.1002/1097-0142(19910715)68:2<227::AID-CNCR2820680202>3.0.CO;2-I; Isidori AM, 2006, J CLIN ENDOCR METAB, V91, P371, DOI 10.1210/jc.2005-1542; Newell-Price J, 1998, ENDOCR REV, V19, P647, DOI 10.1210/er.19.5.647; Doi M, 2010, ENDOCR J, V57, P1061, DOI 10.1507/endocrj.K10E-265; Salgado LR, 2006, EUR J ENDOCRINOL, V155, P725, DOI 10.1530/eje.1.02278; Yao JC, 2008, J CLIN ONCOL, V26, P3063, DOI 10.1200/JCO.2007.15.4377; de Perrot M, 2002, ANN THORAC SURG, V73, P675, DOI 10.1016/S0003-4975(01)02713-8; Zemskova MS, 2010, J CLIN ENDOCR METAB, V95, P1207, DOI 10.1210/jc.2009-2282; Neary NM, 2012, J CLIN ENDOCR METAB, V97, P2223, DOI 10.1210/jc.2011-3355; Pacak K, 2004, J CLIN ENDOCR METAB, V89, P2214, DOI 10.1210/jc.2003-031812; Newell-Price J, 2006, LANCET, V367, P1605, DOI 10.1016/S0140-6736(06)68699-6; Tani Y, 2011, ENDOCR J, V58, P297, DOI 10.1507/endocrj.K10E-389; Fukai I, 1999, ANN THORAC SURG, V67, P208, DOI 10.1016/S0003-4975(98)01063-7; DRURY PL, 1982, BRIT MED J, V284, P9; HIRANO T, 1995, J NUCL MED, V36, P2243; Kimura N, 1996, J CLIN ENDOCR METAB, V81, P390, DOI 10.1210/jc.81.1.390; KOIDE Y, 1985, ENDOCRINOL JAPON, V32, P615; Machado MC, 2008, EUR J ENDOCRINOL, V158, P605, DOI 10.1530/EJE-07-0659; Mizoguchi Y, 2007, HORM RES, V67, P257, DOI 10.1159/000098548; NewellPrice J, 1997, J CLIN ENDOCR METAB, V82, P176, DOI 10.1210/jc.82.1.176; Ohta K, 2000, ENDOCR J, V47, P487, DOI 10.1507/endocrj.47.487; PASS HI, 1990, ANN THORAC SURG, V50, P52; Sakai Y, 1997, ENDOCR J, V44, P687, DOI 10.1507/endocrj.44.687; Sato Haruhiro, 2010, Tokai J Exp Clin Med, V35, P78; Suda T, 2009, ENDOCR J, V56, P469; Takagi J, 2006, INTERNAL MED, V45, P81, DOI 10.2169/internalmedicine.45.1427; Takahashi T, 2003, INTERNAL MED, V42, P1197, DOI 10.2169/internalmedicine.42.1197; Tsagarakis S, 2002, J CLIN ENDOCR METAB, V87, P1646, DOI 10.1210/jc.87.4.1646; Ujihara M, 2001, ENDOCR J, V48, P19, DOI 10.1507/endocrj.48.19; WICK MR, 1980, MAYO CLIN PROC, V55, P246; Yano M, 2006, ANN THORAC SURG, V81, P366, DOI 10.1016/j.athoracsur.2004.07.084	37	0	0	JAPAN ENDOCRINE SOC	KYOTO	75  YANAGINOBANBA NISHIIRU-MASUYA-CHO, SANJOU-DORI, NAKAGYOU-KU, KYOTO, 604-8111, JAPAN	0918-8959	1348-4540		ENDOCR J	Endocr. J.	MAY 20	2015	62	5					441	447				7	Endocrinology & Metabolism	Endocrinology & Metabolism	CM1KU	WOS:000357440600007		
J	Sasaki, T; Hiraga, H; Yokota-Hashimoto, H; Kitamura, T				Sasaki, Tsutomu; Hiraga, Haruna; Yokota-Hashimoto, Hiromi; Kitamura, Tadahiro			Miglitol protects against age-dependent weight gain in mice: A potential role of increased UCP1 content in brown adipose tissue	ENDOCRINE JOURNAL			English	Article						Alpha glucosidase inhibitor; Obesity; Brown adipose tissue; UCP1; Energy expenditure	ALPHA-GLUCOSIDASE INHIBITORS; OBESITY; HUMANS	Miglitol is an absorbable alpha-glucosidase inhibitor that is used to control post-prandial hyperglycemia. We previously found that miglitol stimulates brown adipose tissue and prevents diet-induced obesity in mice that are fed a high-fat, high-carbohydrate diet. In this study, we examined whether miglitol can also protect against aging-dependent weight gain in mice that are fed a normal chow diet. Male C57B1/6J mice were fed normal chow with or without miglitol (800 ppm) for 12 weeks, starting at 12 weeks of age. Food intake and body weight were monitored. After 12 weeks, adiposity, energy expenditure, and locomotor activities were measured. After sacrifice, weight of the epididymal white adipose tissue and adipocyte size were measured. Finally, Ucp1 gene expression and UCP1 protein abundance in brown adipose tissue were quantified by RT-PCR and Western analyses, respectively. Miglitol prevented age-related weight gain without affecting growth of the animals. Miglitol-treated mice showed reduced adiposity and increased oxygen consumption compared to controls, accompanied by higher UCP1 protein abundance in brown adipose tissue. Food intake and locomotor activities were not affected. These results suggest that miglitol can protect against age-dependent weight gain. Elucidating the molecular targets of miglitol in brown adipose tissue and optimizing drug delivery and efficacy may provide new strategies to combat obesity.	[Sasaki, Tsutomu; Hiraga, Haruna; Yokota-Hashimoto, Hiromi; Kitamura, Tadahiro] Gunma Univ, Inst Mol & Cellular Regulat, Lab Metab Signal, Maebashi, Gumma 3718512, Japan	Kitamura, T (reprint author), Gunma Univ, Inst Mol & Cellular Regulat, Lab Metab Signal, 3-39-15 Showa Machi, Maebashi, Gumma 3718512, Japan.	kitamura@gunma-u.ac.jp			Sanwa Kagaku Kenkyusho Co. (Nagoya, Japan)	TK received grants and lecture fees from Sanwa Kagaku Kenkyusho Co. (Nagoya, Japan), and this work was partially supported by a grant from Sanwa Kagaku Kenkyusho Co.	van de Laar FA, 2005, DIABETES CARE, V28, P154, DOI 10.2337/diacare.28.1.154; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Yoneshiro T, 2011, OBESITY, V19, P1755, DOI 10.1038/oby.2011.125; Sasaki T, 2013, ENDOCR J, V60, P1117, DOI 10.1507/endocrj.EJ13-0333; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803; Kim HJ, 2012, ENDOCRINOLOGY, V153, P659, DOI 10.1210/en.2011-1635; Doak CM, 2012, OBES REV, V13, P174, DOI 10.1111/j.1467-789X.2011.00943.x; Sels J P, 1999, Expert Opin Pharmacother, V1, P149, DOI 10.1517/14656566.1.1.149; Sugihara H, 2014, J DIABETES INVEST, V5, P206, DOI 10.1111/jdi.12135	11	0	0	JAPAN ENDOCRINE SOC	KYOTO	75  YANAGINOBANBA NISHIIRU-MASUYA-CHO, SANJOU-DORI, NAKAGYOU-KU, KYOTO, 604-8111, JAPAN	0918-8959	1348-4540		ENDOCR J	Endocr. J.	MAY 20	2015	62	5					469	473				5	Endocrinology & Metabolism	Endocrinology & Metabolism	CM1KU	WOS:000357440600010		
J	Watanabe, S; Sanuki, R; Sugita, Y; Imai, W; Yamazaki, R; Kozuka, T; Ohsuga, M; Furukawa, T				Watanabe, Satoshi; Sanuki, Rikako; Sugita, Yuko; Imai, Wataru; Yamazaki, Ryoji; Kozuka, Takashi; Ohsuga, Mizuki; Furukawa, Takahisa			Prdm13 Regulates Subtype Specification of Retinal Amacrine Interneurons and Modulates Visual Sensitivity	JOURNAL OF NEUROSCIENCE			English	Article						amacrine cell; interneuron; Prdm13; retina; subtype specification; visual function	PHOTORECEPTOR CELL FATE; TRANSGENIC MOUSE LINE; EMBRYONIC STEM-CELLS; MAMMALIAN RETINA; RAT RETINA; OSCILLATORY POTENTIALS; HORIZONTAL CELLS; RABBIT RETINA; HOMEOBOX GENE; ROD PATHWAY	Amacrine interneurons, which are highly diversified in morphological, neurochemical, and physiological features, play crucial roles in visual information processing in the retina. However, the specification mechanisms and functions in vision for each amacrine subtype are not well understood. We found that the Prdm13 transcriptional regulator is specifically expressed in developing and mature amacrine cells in the mouse retina. Most Prdm13-positive amacrine cells are Calbindin-and Calretinin-positive GABAergic or glycinergic neurons. Absence of Prdm13 significantly reduces GABAergic and glycinergic amacrines, resulting in a specific defect of the S2/S3 border neurite bundle in the inner plexiform layer. Forced expression of Prdm13 distinctively induces GABAergic and glycinergic amacrine cells but not cholinergic amacrine cells, whereas Ptf1a, an upstream transcriptional regulator of Prdm13, induces all of these subtypes. Moreover, Prdm13-deficient mice showed abnormally elevated spatial, temporal, and contrast sensitivities in vision. Together, these results show that Prdm13 regulates development of a subset of amacrine cells, which newly defines an amacrine subtype to negatively modulate visual sensitivities. Our current study provides new insights into mechanisms of the diversification of amacrine cells and their function in vision.	[Watanabe, Satoshi; Sanuki, Rikako; Sugita, Yuko; Imai, Wataru; Yamazaki, Ryoji; Kozuka, Takashi; Ohsuga, Mizuki; Furukawa, Takahisa] Osaka Univ, Inst Prot Res, Lab Mol & Dev Biol, Suita, Osaka 5650871, Japan; [Watanabe, Satoshi; Sanuki, Rikako; Sugita, Yuko; Yamazaki, Ryoji; Furukawa, Takahisa] Core Res Evolut Sci & Technol, JST, Suita, Osaka 5650871, Japan; [Watanabe, Satoshi] Kyoto Univ, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan	Furukawa, T (reprint author), Osaka Univ, Inst Prot Res, Lab Mol & Dev Biol, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	takahisa.furukawa@protein.osaka-u.ac.jp			Core Research for Evolutional Science and Technology from Japan Science and Technology Agency; Specially Designated Research Promotion and Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Takeda Science Foundation; Uehara Memorial Foundation; Suzuken Memorial Foundation; Novartis Foundation (Japan) for the Promotion of Science; Osaka University Faculty of Medicine Medical Doctor Scientist Training Program;  [13J02346]	This work was supported by Core Research for Evolutional Science and Technology from Japan Science and Technology Agency; Grants-in-Aid for Scientific Research on Innovative Areas; Grant-in-Aid for Scientific Research (B); Core Research for Evolutional Science and Technology Fellows (13J02346); Specially Designated Research Promotion and Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan; the Takeda Science Foundation; the Uehara Memorial Foundation; the Suzuken Memorial Foundation; and the Novartis Foundation (Japan) for the Promotion of Science. Mizuki Ohsuga is supported by the Osaka University Faculty of Medicine Medical Doctor Scientist Training Program. We thank Drs. Christopher V. Wright, Yoshiya Kawaguchi, and Yasuhiro Nakano for the Ptf1a-Cre mouse; Drs. Takahiko Matsuda and Constance L. Cepko for the pCIG plasmid; Dr. Francisco Zafra for the anti-Glyt1 antibody; and Akiko Tani, Mikiko Kadowaki, Aiko Ishimaru, Yoko Tojima, Katsura Hasegawa, Hiroko Abe, and Showna Kennedy for technical assistance.	Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Masland RH, 2012, NEURON, V76, P266, DOI 10.1016/j.neuron.2012.10.002; Elshatory Y, 2007, J COMP NEUROL, V503, P182, DOI 10.1002/cne.21390; Kay JN, 2011, NAT NEUROSCI, V14, P965, DOI 10.1038/nn.2859; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Koike C, 2007, MOL CELL BIOL, V27, P8318, DOI 10.1128/MCB.01209-07; Fujitani Y, 2006, DEVELOPMENT, V133, P4439, DOI 10.1242/dev.02598; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Gollisch T, 2010, NEURON, V65, P150, DOI 10.1016/j.neuron.2009.12.009; Feng L, 2006, DEVELOPMENT, V133, P4815, DOI 10.1242/dev.02664; Macneil MA, 1999, J COMP NEUROL, V413, P305; Sanuki R, 2011, NAT NEUROSCI, V14, P1125, DOI 10.1038/nn.2897; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Li SG, 2004, NEURON, V43, P795, DOI 10.1016/j.neuron.2004.08.041; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Ross SE, 2012, NEURON, V73, P292, DOI 10.1016/j.neuron.2011.09.035; Stahl JS, 2004, VISION RES, V44, P3401, DOI 10.1016/j.visres.2004.09.011; ZAFRA F, 1995, J NEUROSCI, V15, P3952; Muranishi Y, 2011, J NEUROSCI, V31, P16792, DOI 10.1523/JNEUROSCI.3109-11.2011; MacNeil MA, 1998, NEURON, V20, P971, DOI 10.1016/S0896-6273(00)80478-X; Chang JC, 2013, DEV CELL, V25, P182, DOI 10.1016/j.devcel.2013.02.015; Volgyi B, 1997, BRAIN RES, V763, P79, DOI 10.1016/S0006-8993(97)00405-8; Sugita Y, 2013, EUR J NEUROSCI, V38, P2823, DOI 10.1111/ejn.12284; Bassett EA, 2012, DEV DYNAM, V241, P814, DOI 10.1002/dvdy.23762; Hanotel J, 2014, DEV BIOL, V386, P340, DOI 10.1016/j.ydbio.2013.12.024; Menger N, 1998, J COMP NEUROL, V401, P34, DOI 10.1002/(SICI)1096-9861(19981109)401:1<34::AID-CNE3>3.0.CO;2-P; Knop GC, 2011, J NEUROSCI, V31, P4780, DOI 10.1523/JNEUROSCI.6235-10.2011; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Mojumder DK, 2008, MOL VIS, V14, P1600; Wachtmeister L, 1998, PROG RETIN EYE RES, V17, P485, DOI 10.1016/S1350-9462(98)00006-8; Elshatory Y, 2007, J NEUROSCI, V27, P12707, DOI 10.1523/JNEUROSCI.3951-07.2007; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; Cossart R, 2011, CURR OPIN NEUROBIOL, V21, P160, DOI 10.1016/j.conb.2010.10.003; Gabriel R, 1998, NEUROSCI LETT, V247, P179, DOI 10.1016/S0304-3940(98)00323-1; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Pettitt SJ, 2009, NAT METHODS, V6, P493, DOI 10.1038/nmeth.1342; Sato S, 2007, GENESIS, V45, P502, DOI 10.1002/dvg.20318; Ding Q, 2009, J NEUROSCI, V29, P3992, DOI 10.1523/JNEUROSCI.5237-08.2009; HEYNEN H, 1985, VISION RES, V25, P1365, DOI 10.1016/0042-6989(85)90214-7; WASSLE H, 1995, J COMP NEUROL, V361, P537, DOI 10.1002/cne.903610315; Balasubramanian R, 2014, CURR OPHTHALMOL REP, V2, P100; Büttner Ulrich, 2007, Dev Ophthalmol, V40, P76; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Distler C, 1999, VISION RES, V39, P3909, DOI 10.1016/S0042-6989(99)00122-4; GELLMAN RS, 1990, VISUAL NEUROSCI, V5, P107; GRUNERT U, 1993, J COMP NEUROL, V335, P523, DOI 10.1002/cne.903350405; Iuvone PM, 1986, RETINA MODEL CELL 2, P1; Jiang HS, 2009, J NEUROSCI, V29, P10449, DOI 10.1523/JNEUROSCI.3048-09.2009; Kolb H, 1995, WEBVISION ORG RETINA; Lee S, 2014, NEURON, V84, P708, DOI 10.1016/j.neuron.2014.10.021; Liu H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2793; Mo ZQ, 2004, DEVELOPMENT, V131, P1607, DOI 10.1242/dev.01071; Nakhai H, 2007, DEVELOPMENT, V134, P1151, DOI 10.1242/dev.02781; Omori Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019685; Sinclair JR, 2004, J NEUROSCI, V24, P1459, DOI 10.1523/JNEUROSCI.3959-03.2004; Tabata H, 2010, J VIS, V10, P131	57	1	1	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	MAY 20	2015	35	20					8004	8020		10.1523/JNEUROSCI.0089-15.2015		17	Neurosciences	Neurosciences & Neurology	CL0YW	WOS:000356670000023		
J	Fujihashi, M; Mnpotra, JS; Mishra, RK; Pai, EF; Kotra, LP				Fujihashi, Masahiro; Mnpotra, Jagjeet S.; Mishra, Ram Kumar; Pai, Emil F.; Kotra, Lakshmi P.			Orotidine Monophosphate Decarboxylase - A Fascinating Workhorse Enzyme with Therapeutic Potential	JOURNAL OF GENETICS AND GENOMICS			English	Review						Pyrimidine biosynthesis; Orotidine monophosphate decarboxylase; Ligand-enzyme interactions; Antimalarial agents	VINYL CARBANION INTERMEDIATE; 5'-MONOPHOSPHATE DECARBOXYLASE; PLASMODIUM-FALCIPARUM; OROTIDINE-5'-MONOPHOSPHATE DECARBOXYLASE; OMP DECARBOXYLASE; ACTIVE-SITE; 5'-PHOSPHATE DECARBOXYLASE; TRANSITION-STATE; OROTIDINE-5'-PHOSPHATE DECARBOXYLASE; 5-MONOPHOSPHATE DECARBOXYLASE	Orotidine 5'-monophosphate decarboxylase (ODCase) is known as one of the most proficient enzymes. The enzyme catalyzes the last reaction step of the de novo pyrimidine biosynthesis, the conversion from orotidine 5'-monophosphate (OMP) to uridine 5'-monophosphate. The enzyme is found in all three domains of life, Bacteria, Eukarya and Archaea. Multiple sequence alignment of 750 putative ODCase sequences resulted in five distinct groups. While the universally conserved DxKxxDx motif is present in all the groups, depending on the groups, several characteristic motifs and residues can be identified. Over 200 crystal structures of ODCases have been determined so far. The structures, together with biochemical assays and computational studies, elucidated that ODCase utilized both transition state stabilization and substrate distortion to accelerate the decarboxylation of its natural substrate. Stabilization of the vinyl anion intermediate by a conserved lysine residue at the catalytic site is considered the largest contributing factor to catalysis, while bending of the carboxyl group from the plane of the aromatic pyrimidine ring of OMP accounts for substrate distortion. A number of crystal structures of ODCases complexed with potential drug candidate molecules have also been determined, including with 6-iodo-uridine, a potential antimalarial agent.	[Fujihashi, Masahiro] Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto 6068502, Japan; [Mnpotra, Jagjeet S.] Univ N Carolina, Dept Chem & Biochem, Greensboro, NC 27412 USA; [Pai, Emil F.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Pai, Emil F.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Pai, Emil F.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Pai, Emil F.] Princess Margaret Canc Ctr, Univ Hlth Network, Toronto, ON M5G 1L7, Canada; [Kotra, Lakshmi P.] Ctr Mol Design & Preformulat, Toronto, ON M5G 1L7, Canada; [Kotra, Lakshmi P.] Toronto Gen Res Inst, Univ Hlth Network, Toronto, ON M5G 1L7, Canada; [Kotra, Lakshmi P.] Univ Toronto, Leslie Dan Fac Pharm, Dept Pharmaceut Sci, Toronto, ON M5S 3M2, Canada	Kotra, LP (reprint author), Ctr Mol Design & Preformulat, Toronto, ON M5G 1L7, Canada.	lkotra@uhnres.utoronto.ca			Canada Research Chair; Canadian Institutes of Health Research [MOP62704, DDP-79122]; ISTPCanada [ICRD08-15]; Ministry of Research and Innovation (Ontario, Canada); BioDiscovery Toronto;  [24570130]	We are grateful to Prof. Kunio Miki for his continuous support of this work, to Dr. Toyokazu Ishida for helpful discussions. RKM was an exchange student from Birla Institute of Technology & Science, Pilani, India. This work was partly supported by a Grant-in-Aid for Scientific Research (C) (24570130 to M.F.). E.F.P. gratefully acknowledges support through a Canada Research Chair. L.P.K. acknowledges the funding support over the years from Canadian Institutes of Health Research (MOP62704 to EFP and LPK; DDP-79122 to LPK, KCK and EFP), ISTPCanada (ICRD08-15), Ministry of Research and Innovation (Ontario, Canada) and BioDiscovery Toronto.	Amyes TL, 2008, J AM CHEM SOC, V130, P1574, DOI 10.1021/ja710384t; Anderson I, 2005, FEMS MICROBIOL LETT, V250, P175, DOI 10.1016/j.femsle.2005.07.008; Stasolla C, 2003, J PLANT PHYSIOL, V160, P1271, DOI 10.1078/0176-1617-01169; ZEIKUS JG, 1972, J BACTERIOL, V109, P707; SCOTT HV, 1986, MOL BIOCHEM PARASIT, V18, P3, DOI 10.1016/0166-6851(86)90045-9; Wittmann JG, 2008, STRUCTURE, V16, P82, DOI 10.1016/j.str.2007.10.020; Miller BG, 2001, J BIOL CHEM, V276, P15174, DOI 10.1074/jbc.M011429200; Morrey JD, 2002, ANTIVIR RES, V55, P107, DOI 10.1016/S0166-3542(02)00013-X; Amyes TL, 2012, BIOCHEMISTRY-US, V51, P4630, DOI 10.1021/bi300585e; Vedadi M, 2007, MOL BIOCHEM PARASIT, V151, P100, DOI 10.1016/j.molbiopara.2006.10.011; Van Vleet JL, 2008, BIOCHEMISTRY-US, V47, P798, DOI 10.1021/bi701664n; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Jashes M, 1996, ANTIVIR RES, V29, P309, DOI 10.1016/0166-3542(96)80226-9; Mundra S, 2014, FUTURE MED CHEM, V6, P165, DOI 10.4155/fmc.13.198; Langley DB, 2008, BIOCHEMISTRY-US, V47, P3842, DOI 10.1021/bi702390k; Wu N, 2000, P NATL ACAD SCI USA, V97, P2017, DOI 10.1073/pnas.050417797; Amyes TL, 2005, J AM CHEM SOC, V127, P15708, DOI 10.1021/ja055493s; Spong K, 2013, J AM CHEM SOC, V135, P18343, DOI 10.1021/ja4107513; Goryanova B, 2013, BIOCHEMISTRY-US, V52, P7500, DOI 10.1021/bi401117y; Miller BG, 2001, BIOCHEMISTRY-US, V40, P6227, DOI 10.1021/bi0028993; Porter DJT, 2000, BIOCHEMISTRY-US, V39, P11788, DOI 10.1021/bi001199v; Miller BG, 2000, P NATL ACAD SCI USA, V97, P2011, DOI 10.1073/pnas.030409797; Appleby TC, 2000, P NATL ACAD SCI USA, V97, P2005, DOI 10.1073/pnas.259441296; Barnett SA, 2008, BIOCHEMISTRY-US, V47, P7785, DOI 10.1021/bi800939k; Barnett SA, 2010, BIOCHEMISTRY-US, V49, P824, DOI 10.1021/bi902174q; BEAK P, 1973, J AM CHEM SOC, V95, P7919, DOI 10.1021/ja00804a088; Bello AM, 2007, J MED CHEM, V50, P915, DOI 10.1021/jm060827p; Bello AM, 2008, J MED CHEM, V51, P439, DOI 10.1021/jm7010673; Bello AM, 2009, J MED CHEM, V52, P1648, DOI 10.1021/jm801224t; Chan KK, 2009, BIOCHEMISTRY-US, V48, P5518, DOI 10.1021/bi900623r; Crandall IE, 2013, J MED CHEM, V56, P2348, DOI 10.1021/jm301678j; Desai BJ, 2012, BIOCHEMISTRY-US, V51, P8665, DOI 10.1021/bi301188k; Desai BJ, 2014, P NATL ACAD SCI USA, V111, P15066, DOI 10.1073/pnas.1411772111; DIX DE, 1979, CANCER RES, V39, P4485; French JB, 2011, J BIOL CHEM, V286, P20930, DOI 10.1074/jbc.M111.228213; Fujihashi M, 2013, J AM CHEM SOC, V135, P17432, DOI 10.1021/ja408197k; Fujihashi M, 2013, J BIOL CHEM, V288, P9011, DOI 10.1074/jbc.M112.427252; Fujihashi M, 2005, J AM CHEM SOC, V127, P15048, DOI 10.1021/ja054865u; Fujihashi M, 2009, J MOL BIOL, V387, P1199, DOI 10.1016/j.jmb.2009.02.037; Fujihashi Masahiro, 2014, Journal of the Crystallographic Society of Japan, V56; HAMMOND DJ, 1982, BIOCHIM BIOPHYS ACTA, V718, P1, DOI 10.1016/0304-4165(82)90002-2; Harris P, 2000, BIOCHEMISTRY-US, V39, P4217, DOI 10.1021/bi992952r; Harris P, 2002, J MOL BIOL, V318, P1019, DOI 10.1016/S0022-2836(02)00200-0; Heinrich D, 2009, CHEM-EUR J, V15, P6619, DOI 10.1002/chem.200900397; Hu H, 2008, J AM CHEM SOC, V130, P14493, DOI 10.1021/ja801202j; Iiams Vanessa, 2011, Biochemistry, V50, P8497, DOI 10.1021/bi2012355; KIMSEY HH, 1992, J BIOL CHEM, V267, P819; Kotra L. P., 2005, Inhibitors of orotidine monophosphate decarboxylase (ODCase) activity, Patent No. [WO2007038859 A1, 2007038859]; Krungkrai SR, 2005, BIOCHEMISTRY-US, V44, P1643, DOI 10.1021/bi048439h; Lee J.K., 2004, OROTIDINE MONOPHOSPH; Lee TS, 2001, J AM CHEM SOC, V123, P12837, DOI 10.1021/ja011096f; LEVINE HL, 1980, BIOCHEMISTRY-US, V19, P4993, DOI 10.1021/bi00563a010; Lewis M, 2011, J MED CHEM, V54, P2891, DOI 10.1021/jm101642g; Makiuchi T, 2007, GENE, V394, P78, DOI 10.1016/j.gene.2007.02.009; Meza-Avina ME, 2010, BIOORGAN MED CHEM, V18, P4032, DOI 10.1016/j.bmc.2010.04.017; Miller BG, 1998, BIOORG CHEM, V26, P283, DOI 10.1006/bioo.1998.1105; Miller BG, 2000, BIOCHEMISTRY-US, V39, P8113, DOI 10.1021/bi000818x; Miller BG, 2002, ANNU REV BIOCHEM, V71, P847, DOI 10.1146/annurev.biochem.71.110601.135446; Phillips LM, 2005, J ORG CHEM, V70, P1211, DOI 10.1021/jo040279s; Poduch E, 2006, J MED CHEM, V49, P4937, DOI 10.1021/jm060202r; Poduch E, 2008, J MED CHEM, V51, P432, DOI 10.1021/jm700968x; Purohit MK, 2012, J MED CHEM, V55, P9988, DOI 10.1021/jm301176r; RADFORD A, 1988, GENOME, V30, P501; RADZICKA A, 1995, SCIENCE, V267, P90, DOI 10.1126/science.7809611; RATHOD PK, 1983, J BIOL CHEM, V258, P2852; SEYMOUR KK, 1994, BIOCHEMISTRY-US, V33, P5268, DOI 10.1021/bi00183a033; SHOSTAK K, 1992, BIOCHEMISTRY-US, V31, P12155, DOI 10.1021/bi00163a026; SILVERMAN RB, 1982, J AM CHEM SOC, V104, P6434, DOI 10.1021/ja00387a047; SMILEY JA, 1992, BIOCHEMISTRY-US, V31, P12162, DOI 10.1021/bi00163a027; Smiley JA, 1999, BIOORG CHEM, V27, P297, DOI 10.1006/bioo.1999.1140; Smiley JA, 2001, BIOORG CHEM, V29, P96, DOI 10.1006/bioo.2001.1201; Takashima Y, 2012, J BIOCHEM, V152, P133, DOI 10.1093/jb/mvs070; Tokuoka K, 2008, J BIOCHEM, V143, P69, DOI 10.1093/jb/mvm193; Toth K, 2010, J AM CHEM SOC, V132, P7018, DOI 10.1021/ja102408k; Toth K, 2009, BIOCHEMISTRY-US, V48, P8006, DOI 10.1021/bi901064k; Toth K, 2007, J AM CHEM SOC, V129, P12946, DOI 10.1021/ja076222f; Traut TW, 2000, J BIOL CHEM, V275, P28675, DOI 10.1074/jbc.M003468200; Tsang WY, 2012, J AM CHEM SOC, V134, P14580, DOI 10.1021/ja3058474; Wood BM, 2010, BIOCHEMISTRY-US, V49, P3514, DOI 10.1021/bi100443a; Wu N, 2002, BIOCHEMISTRY-US, V41, P4002, DOI 10.1021/bi015758p; Wu N, 2002, J BIOL CHEM, V277, P28080, DOI 10.1074/jbc.M202362200; Yablonski MJ, 1996, J BIOL CHEM, V271, P10704; Yuan J, 2011, PROTEIN SCI, V20, P1891, DOI 10.1002/pro.728	83	0	0	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1673-8527	1873-5533		J GENET GENOMICS	J. Genet. Genomics	MAY 20	2015	42	5					221	234		10.1016/j.jgg.2015.04.005		14	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	CJ8IM	WOS:000355743500005		
J	Shimada, Y; Kuninaga, S; Ariyoshi, M; Zhang, B; Shiina, Y; Takahashi, Y; Umemoto, N; Nishimura, Y; Enari, H; Tanaka, T				Shimada, Yasuhito; Kuninaga, Shisei; Ariyoshi, Michiko; Zhang, Beibei; Shiina, Yasuhiko; Takahashi, Yoshinori; Umemoto, Noriko; Nishimura, Yuhei; Enari, Hiroyuki; Tanaka, Toshio			E2F8 promotes hepatic steatosis through FABP3 expression in diet-induced obesity in zebrafish	NUTRITION & METABOLISM			English	Article						Fatty liver; Obesity; Zebrafish; High-fat feeding; DNA microarray; Two-dimensional electrophoresis; Cross-species analysis	ACID-BINDING PROTEIN; FATTY LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; DANIO-RERIO; INSULIN-RESISTANCE; PEROXISOME-PROLIFERATOR; TRANSCRIPTOME ANALYSIS; LIPID-ACCUMULATION; METABOLIC SYNDROME; GENE-EXPRESSION	Background: Diet-induced hepatic steatosis is highly associated with nonalcoholic fatty liver disease, which is related to the development of metabolic syndrome. While advanced stage nonalcoholic hepatic steatosis and steatohepatitis (NASH) result ultimately in fibrosis and cirrhosis, the molecular basis for lipid droplet formation is poorly understood. Common pathways underlie the pathology of mammalian obesity and the zebrafish diet-induced obesity model (DIO-zebrafish) used in this study. Methods: Our analysis involved a combination of transcriptome (DNA microarray) and proteome (two-dimensional electrophoresis) methods using liver tissue from DIO-zebrafish to find candidate genes involved in hepatic steatosis. We conducted intraperitoneal injection (i.p.) of morpholino antisense oligonucleotides (MOs) for each gene into DIO-zebrafish. We also conducted in vitro overexpression in human cells. Additionally, we examined gene expression during feeding experiments involving anti-obesity compounds, creatine and anserine. Results: We found that fatty acid binding protein 3 (fabp3) and E2F transcription factors were upregulated in hepatic steatosis. E2f8 MO i.p. suppressed fabp3 expression in liver, and ameliorated hepatic steatosis. In human cells (HepG2), E2F8 overexpression promoted FABP3 expression. Additionally, co-administration of creatine and anserine suppressed obesity associated phenotypes including hepatic steatosis as indicated by e2f8 and fabp3 down regulation. Conclusion: We discovered that the e2f8-fabp3 axis is important in the promotion of hepatic steatosis in DIO-zebrafish. The combination of transcriptome and proteome analyses using the disease model zebrafish allow identification of novel pathways involved in human diseases.	[Shimada, Yasuhito; Ariyoshi, Michiko; Zhang, Beibei; Umemoto, Noriko; Nishimura, Yuhei; Tanaka, Toshio] Mie Univ, Grad Sch Med, Dept Mol & Cellular Pharmacol Pharmacogen & Pharm, Tsu, Mie 514, Japan; [Shimada, Yasuhito; Umemoto, Noriko; Nishimura, Yuhei; Tanaka, Toshio] Mie Univ, Grad Sch Med, Dept Syst Pharmacol, Tsu, Mie 514, Japan; [Shimada, Yasuhito; Nishimura, Yuhei; Tanaka, Toshio] Mie Univ, Med Zebrafish Res Ctr, Tsu, Mie 514, Japan; [Shimada, Yasuhito; Nishimura, Yuhei; Tanaka, Toshio] Mie Univ, Life Sci Res Ctr, Dept Bioinformat, Tsu, Mie 514, Japan; [Shimada, Yasuhito; Nishimura, Yuhei; Tanaka, Toshio] Mie Univ Ind Technol Innovat, Dept Omics Med, Tsu, Mie, Japan; [Kuninaga, Shisei; Shiina, Yasuhiko; Takahashi, Yoshinori; Enari, Hiroyuki] Maruha Nichiro Corp, Cent Res Inst, Ibaraki, Japan	Tanaka, T (reprint author), Mie Univ, Grad Sch Med, Dept Mol & Cellular Pharmacol Pharmacogen & Pharm, 2-174 Edobashi, Tsu, Mie 514, Japan.	tanaka@doc.medic.mie-u.ac.jp					Akbal E, 2009, ENDOCRINE, V36, P433, DOI 10.1007/s12020-009-9243-6; Chen HZ, 2012, NAT CELL BIOL, V14, P1192, DOI 10.1038/ncb2595; Thumser AE, 2014, CURR OPIN CLIN NUTR, V17, P124, DOI 10.1097/MCO.0000000000000031; Liu RZ, 2003, EUR J BIOCHEM, V270, P3223, DOI 10.1046/j.1432-1033.2003.03705.x; Kennedy AR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1724, DOI 10.1152/ajpendo.00717.2006; Deminice R, 2011, J NUTR, V141, P1799, DOI 10.3945/jn.111.144857; Her GM, 2003, FEBS LETT, V538, P125, DOI 10.1016/S0014-5793(03)00157-1; Rooney K, 2002, METABOLISM, V51, P518, DOI 10.1053/meta.2002.31330; Zang LQ, 2011, ZEBRAFISH, V8, P203, DOI 10.1089/zeb.2011.0726; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Christensen J, 2005, NUCLEIC ACIDS RES, V33, P5458, DOI 10.1093/nar/gki855; McCullough AJ, 2002, J CLIN GASTROENTEROL, V34, P255, DOI 10.1097/00004836-200203000-00013; Angulo P, 2002, J GASTROEN HEPATOL, V17, pS186, DOI 10.1046/j.1440-1746.17.s1.10.x; Blanchet E, 2011, NAT CELL BIOL, V13, P1146, DOI 10.1038/ncb2309; Qin XM, 2008, HEPATOLOGY, V48, P432, DOI 10.1002/hep.22334; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Asp P, 2009, GENE DEV, V23, P37, DOI 10.1101/gad.1727309; HENDERSON RJ, 1987, PROG LIPID RES, V26, P281, DOI 10.1016/0163-7827(87)90002-6; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Song Y, 2007, FASEB J, V21, P2042, DOI 10.1096/fj.06-7503com; Affo S, 2013, GUT, V62, P452, DOI 10.1136/gutjnl-2011-301146; Marrero JA, 2002, HEPATOLOGY, V36, P1349, DOI 10.1053/jhep.2002.36939; Ashburner M, 2000, NAT GENET, V25, P25; Pagano G, 2002, HEPATOLOGY, V35, P367, DOI 10.1053/jhep.2002.30690; Wang XH, 2011, J PHARMACOL SCI, V117, P129, DOI 10.1254/jphs.11097FP; Duval C, 2010, DIABETES, V59, P3181, DOI 10.2337/db10-0224; Moore JB, 2010, P NUTR SOC, V69, P211, DOI 10.1017/S0029665110000030; Stoletov K, 2009, CIRC RES, V104, P952, DOI 10.1161/CIRCRESAHA.108.189803; Basar O, 2013, HERZ, V38, P417, DOI 10.1007/s00059-012-3714-x; Holtta-Vuori M, 2010, BIOCHEM J, V429, P235, DOI 10.1042/BJ20100293; Berlanga Alba, 2014, Clin Exp Gastroenterol, V7, P221, DOI 10.2147/CEG.S62831; Binas B, 1999, FASEB J, V13, P805; Field AE, 2005, PEDIATRICS, V116, pE214, DOI 10.1542/peds.2004-2022; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gonzales JM, 2012, J AM ASSOC LAB ANIM, V51, P412; Hasumura T, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-73; Hiramitsu M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03708; Hyder A, 2010, ISLETS, V2, P174, DOI 10.4161/isl.2.3.11454; Karbek B, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-37; Kotelnikova Ekaterina, 2010, Journal of Bioinformatics and Computational Biology, V8, P593, DOI 10.1142/S0219720010004732; Liu HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065644; Liu YQ, 2013, MOL MED REP, V8, P806, DOI 10.3892/mmr.2013.1586; Matsuda A, 2009, LIFE SCI, V84, P903, DOI 10.1016/j.lfs.2009.04.004; Mercader J, 2009, AM J PHYSIOL-ENDOC M, V297, pE184, DOI 10.1152/ajpendo.00163.2009; Neuschwander-Tetri BA, 2010, HEPATOLOGY, V52, P774, DOI 10.1002/hep.23719; Oka Takehiko, 2010, BMC Physiol, V10, P21, DOI 10.1186/1472-6793-10-21; Shimada Y, 2013, INT J OBES LOND, V38, P1053; Shimada Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052549; Suwa A, 2010, FEBS J, V277, P677, DOI 10.1111/j.1742-4658.2009.07513.x; Tainaka T, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-88; Takahashi Y, 2008, NIPPON SUISAN GAKK, V74, P1075, DOI 10.2331/suisan.74.1075; Venkatachalam AB, 2013, GENE, V520, P14, DOI 10.1016/j.gene.2013.02.034; Wang XJ, 2013, INT J MOL SCI, V14, P13826, DOI 10.3390/ijms140713826; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Zang L, 2014, J FUNCT FOODS, V10, P499, DOI 10.1016/j.jff.2014.08.002; Zang LQ, 2013, ZEBRAFISH, V10, P425, DOI 10.1089/zeb.2012.0862	58	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1743-7075			NUTR METAB	Nutr. Metab.	MAY 20	2015	12								17	10.1186/s12986-015-0012-7		12	Nutrition & Dietetics	Nutrition & Dietetics	CK2GX	WOS:000356029900001		
J	Qin, JX; Zhang, M; Li, CT; Miao, NN; Zhang, Y; Qiu, JH				Qin, Jia-xiang; Zhang, Min; Li, Cheng-tao; Miao, Ni-na; Zhang, Yi; Qiu, Jian-hui			Studies on the Effect of Isomerism in Main Chain on Enzymatic Degradation of PBS-based Copolymers with Combination of Molecular Modeling	ACTA POLYMERICA SINICA			Chinese	Article						Enzymatic degradation; Copolyesters; Pseudomonas cepacia lipase; Degradation products; molecular docking	FORCE-FIELD; LIPASES; POLY(EPSILON-CAPROLACTONE); POLYMERS	The enzymatic degradation of poly (butylene succinate-co-1,4-cyclohexane dimethanol succinate) (PBS-co-CHDMS), poly (butylene succinate-co-butylene 1, 4-cyclohexanedicarboxylic acid) (PBS-co-BCHDA) and poly (butylene succinate) (PBS) were performed with the aim to gain more underlying information about the degradation rules and differences in organic solvent. Among various hydrolytic enzymes the lipase from Pseudomonas cepacia (PC) was chosen for the studies. The rules of enzymatic degradation were investigated by. molecular weight variation and MALDI-TOF-MS analysis of the degradation products. Additionally, mechanism of the combination between substrate and enzyme was studied with molecular docking. The results indicated that PBS-based copolymers showed an obvious degradation in chloroform. Compared to PBS-co-BCHDA, PBS-co-CHDMSs all showed a greater degradation rate after 60 h enzymatic degradation. Particularly maximum degradation was observed in PBS-co-10% CHDMS with a degradation ratio of ratio about 85%. The enzymatic degradation of PBS-based copolymers produced not only linear segments, but also cyclic oligomers. Furthermore, PBS-co-CHDMS produced more oligomers than PBS-co-BCHDA. According to the results of molecular docking, the free energy of binding between PC lipase and substrate in chloroform was in the order of CMSCM > BSCM > BCAB > BSB. That is, the docking of substrate containing 1, 4-cyclohexane dimethanol succinate(CHDMS) in the active site of PC lipase was more stable than any other ones.	[Qin, Jia-xiang; Zhang, Min; Li, Cheng-tao; Miao, Ni-na; Zhang, Yi] Shaanxi Univ Sci & Technol, Minist Educ, Key Lab Auxiliary Chem & Technol Chem Ind, Xian 710021, Peoples R China; [Qiu, Jian-hui] Akita Prefecture Univ, Syst Sci & Technol, Akita 0150055, Japan	Zhang, M (reprint author), Shaanxi Univ Sci & Technol, Minist Educ, Key Lab Auxiliary Chem & Technol Chem Ind, Xian 710021, Peoples R China.	zhangmin@sust.edu.cn					Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Villeneuve P, 2000, J MOL CATAL B-ENZYM, V9, P113, DOI 10.1016/S1381-1177(99)00107-1; Tian HY, 2012, PROG POLYM SCI, V37, P237, DOI 10.1016/j.progpolymsci.2011.06.004; Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Chang QL, 1999, ENZYME MICROB TECH, V25, P290, DOI 10.1016/S0141-0229(99)00072-1; Hiroshi U, 1996, MACROMOLECULES, V28, p7046 ~7050; Pastorino L, 2004, ENZYME MICROB TECH, V35, P321, DOI 10.1016/j.enzmictec.2004.05.005; Sivalingam G, 2003, POLYM DEGRAD STABIL, V79, P413, DOI 10.1016/S0141-3910(02)00357-9; Sivalingam G, 2003, CHEM ENG SCI, V58, P2911, DOI 10.1016/S0009-2509(03)00155-6; Sivalingam G, 2004, J APPL POLYM SCI, V91, P2391, DOI 10.1002/app.13394; [张敏 Zhang Min], 2012, [塑料, Plastics], V41, P5	13	0	0	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1000-3304			ACTA POLYM SIN	Acta Polym. Sin.	MAY 20	2015		5					500	507				8	Polymer Science	Polymer Science	CJ6AG	WOS:000355574800002		
J	Ma, M; Hasegawa, Y; Koibuchi, N; Toyama, K; Uekawa, K; Nakagawa, T; Lin, B; Kim-Mitsuyama, S				Ma, MingJie; Hasegawa, Yu; Koibuchi, Nobutaka; Toyama, Kensuke; Uekawa, Ken; Nakagawa, Takashi; Lin, Bowen; Kim-Mitsuyama, Shokei			DPP-4 inhibition with linagliptin ameliorates cognitive impairment and brain atrophy induced by transient cerebral ischemia in type 2 diabetic mice	CARDIOVASCULAR DIABETOLOGY			English	Article						Cerebral ischemia; Cognitive function; Brain atrophy; Oxidative stress; blood-brain barrier	DIPEPTIDYL PEPTIDASE-4 INHIBITOR; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; HYPERTENSIVE-RATS; DB/DB MICE; ALZHEIMERS-DISEASE; SGLT2 INHIBITOR; INJURY; OBESE; NEPHROPATHY	Background: It is unclear whether dipeptidylpeptidase-4 (DPP-4) inhibition can counteract the impairment of cognitive function and brain injury caused by transient cerebral ischemia in type 2 diabetes. The present study was undertaken to test our hypothesis that linagliptin, a DPP-4 inhibitor, administration following transient cerebral ischemia can ameliorate cognitive impairment and brain injury in diabetic mice. Methods: db/db mice, a model of obese type 2 diabetes, were subjected to transient cerebral ischemia by 17 min of bilateral common carotid artery occlusion (BCCAO), and were administered (1) vehicle or (2) linagliptin for 8 weeks or 1 week. For the long-term experiment on 8 weeks of linagliptin treatment, cognitive function, and volume and neuronal cell number of hippocampus and cortex were estimated in each group of mice. For the short-term experiment on 1 week of linagliptin treatment, cerebral IgG extravasation, Iba-1 positive cell number (reactive microglia), oxidative stress, and claudin-5 and gp91phox protein levels were measured in each group of mice. Results: Linagliptin administration almost completely suppressed the circulating DPP-4 activity in db/db mice, but did not significantly reduce blood glucose or ameliorate glucose intolerance in db/db mice. Linagliptin administration following transient cerebral ischemia significantly counteracted cognitive impairment in diabetic mice, as estimated by water maze test and passive avoidance test. Linagliptin administration ameliorated the decrease in cerebral volume and neuronal cell number in hippocampus and cortex of diabetic mice. Linagliptin administration significantly reduced the increase in cerebral IgG extravasation and the increase in reactive microglia caused by transient cerebral ischemia in diabetic mice. Furthermore, linagliptin significantly suppressed the increase in cerebral oxidative stress in transient cerebral ischemia-subjected diabetic mice. Furthermore, linagliptin significantly increased cerebral claudin-5 and significantly decreased gp91phox in diabetic mice subjected to transient cerebral ischemia. Conclusions: DPP-4 inhibition with linagliptin counteracted cognitive impairment and brain atrophy induced by transient cerebral ischemia in diabetic mice, independently of blood glucose lowering effect. This cerebroprotective effect of linagliptin was associated with the suppression of blood-brain barrier disruption and the attenuation of cerebral oxidative stress. Thus, our present work highlights DPP-4 inhibition as a promising therapeutic strategy for cognitive impairment and cerebral vascular complications in type 2 diabetes.	[Ma, MingJie; Hasegawa, Yu; Koibuchi, Nobutaka; Toyama, Kensuke; Uekawa, Ken; Nakagawa, Takashi; Lin, Bowen; Kim-Mitsuyama, Shokei] Kumamoto Univ, Grad Sch Med Sci, Dept Pharmacol & Mol Therapeut, Kumamoto 8608556, Japan	Kim-Mitsuyama, S (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Pharmacol & Mol Therapeut, 1-1-1 Honjo, Kumamoto 8608556, Japan.	mitsuyam@gpo.kumamoto-u.ac.jp			Boehringer Ingelheim	This work was partially supported by a grant from Boehringer Ingelheim,.	Matsuzaki T, 2010, NEUROLOGY, V75, P764, DOI 10.1212/WNL.0b013e3181eee25f; During MJ, 2003, NAT MED, V9, P1173, DOI 10.1038/nm919; Nakaji K, 2006, STROKE, V37, P2816, DOI 10.1161/01.STR.0000244808.17972.55; Patil HR, 2012, AM J CARDIOL, V110, P826, DOI 10.1016/j.amjcard.2012.04.061; Panchapakesan U, 2013, CLIN SCI, V124, P17, DOI 10.1042/CS20120167; Toyama K, 2014, ARTERIOSCL THROM VAS, V34, P616, DOI 10.1161/ATVBAHA.113.302440; Biessels GJ, 2014, LANCET DIABETES ENDO, V2, P246, DOI 10.1016/S2213-8587(13)70088-3; Aroor AR, 2013, ENDOCRINOLOGY, V154, P2501, DOI 10.1210/en.2013-1096; Dong YF, 2011, FASEB J, V25, P2911, DOI 10.1096/fj.11-182873; Zhong JX, 2013, ATHEROSCLEROSIS, V226, P305, DOI 10.1016/j.atherosclerosis.2012.09.012; Popescu BO, 2009, J NEUROL SCI, V283, P99, DOI 10.1016/j.jns.2009.02.321; Chen L, 2012, CURR MOL MED, V12, P995; GOLDSTEIN LB, 1990, J NEUROSCI METH, V31, P101, DOI 10.1016/0165-0270(90)90154-8; Uekawa K, 2014, J STROKE CEREBROVASC, V23, P1429, DOI 10.1016/j.jstrokecerebrovasdis.2013.12.004; Wardlaw JM, 2003, STROKE, V34, P806, DOI 10.1161/01.STR.0000058480.77236.B3; Dong YF, 2011, J PHARMACOL EXP THER, V339, P358, DOI 10.1124/jpet.111.182576; Pintana H, 2013, J ENDOCRINOL, V218, P1, DOI 10.1530/JOE-12-0521; Nagakura T, 2003, METABOLISM, V52, P81, DOI 10.1053/meta.2003.50014; Kosaraju J, 2013, NEUROPHARMACOLOGY, V72, P291, DOI 10.1016/j.neuropharm.2013.04.008; Darsalia V, 2013, DIABETES, V62, P1289, DOI 10.2337/db12-0988; Fox CS, 2007, CIRCULATION, V115, P1544, DOI 10.1161/CIRCULATIONAHA.106.658948; Schrijvers EMC, 2010, NEUROLOGY, V75, P1982, DOI 10.1212/WNL.0b013e3181ffe4f6; Hainsworth AH, 2008, J CEREBR BLOOD F MET, V28, P1877, DOI 10.1038/jcbfm.2008.91; D'Amico M, 2010, EXP GERONTOL, V45, P202, DOI 10.1016/j.exger.2009.12.004; Campbell M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1852; Campbell M, 2011, EMBO MOL MED, V3, P235, DOI 10.1002/emmm.201100126; Dong YF, 2010, J HYPERTENS, V28, P1554, DOI 10.1097/HJH.0b013e328338bb11; Dong YF, 2010, DIABETOLOGIA, V53, P180, DOI 10.1007/s00125-009-1575-5; Emerging Risk Factors C, 2010, LANCET, V375, P2215; Fukuda M, 2010, J HYPERTENS, V28, P340, DOI 10.1097/HJH.0b013e32833366cd; Gault VA, 2015, DIABETES OBES METAB, V17, P403, DOI 10.1111/dom.12432; Kim-Mitsuyama Shokei, 2005, Stroke, V36, P1083; Koibuchi N, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0157-0; Lin B, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0148-1; Nistala R, 2014, OBESITY, V22, P2172, DOI 10.1002/oby.20833; Roy S, 2007, LIFE SCI, V81, P72, DOI 10.1016/j.lfs.2007.04.026; Russell-Jones D, 2012, CLIN ENDOCRINOL, V77, P489, DOI 10.1111/j.1365-2265.2012.04483.x; Sharkovska Y, 2014, J HYPERTENS, V32, P2211, DOI 10.1097/HJH.0000000000000328; Sueta D, 2014, ATHEROSCLEROSIS, V236, P101, DOI 10.1016/j.atherosclerosis.2014.06.016; Tsai TH, 2015, J HYPERTENS, V33, P1001, DOI 10.1097/HJH.0000000000000529; Yang D, 2013, BRAIN RES, V1517, P104, DOI 10.1016/j.brainres.2013.04.015	41	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2840			CARDIOVASC DIABETOL	Cardiovasc. Diabetol.	MAY 20	2015	14									10.1186/s12933-015-0218-z		13	Cardiac & Cardiovascular Systems; Endocrinology & Metabolism	Cardiovascular System & Cardiology; Endocrinology & Metabolism	CK1LX	WOS:000355969900001		
J	Sanada, M; Ikeda, K; Hasegawa, T				Sanada, Motoyuki; Ikeda, Koki; Hasegawa, Toshikazu			Shape and spatial working memory capacities are mostly independent	FRONTIERS IN PSYCHOLOGY			English	Article						working memory capacity; visual working memory; spatial working memory; visuo-spatial sketchpad; dual task	PRIMATE PREFRONTAL CORTEX; SHORT-TERM-MEMORY; VISUAL-SEARCH; OBJECT; DISSOCIATION	Whether visual working memory (WM) consists of a common storage resource or of multiple subsystems has been a controversial issue. Logie (1995) suggested that it can be divided into visual (for color, shape, objects, etc.) and spatial WM (for location). However, a recent study reported evidence against this hypothesis. Using a dual task paradigm, Wood (2011) showed interference between shape and spatial WM capacities, suggesting that they share a common resource limitation. We re-examined this finding controlling possible confounding factors, including the way to present spatial location cues, task order, and type of WM load to be manipulated. The same pattern of results was successfully reproduced, but only in a highly powered experiment (N = 90), and therefore the size of interference was estimated to be quite small (d = 0.24). Thus, these data offer a way to reconcile seemingly contradicting previous findings. On the one hand, some part of the storage system is genuinely shared by shape and spatial WM systems, confirming the report of Wood (2011). On the other hand, the amount of the overlap is only minimal, and therefore the two systems should be regarded as mostly independent from each other, supporting the classical visuo-spatial separation hypothesis.	[Sanada, Motoyuki; Hasegawa, Toshikazu] Univ Tokyo, Dept Cognit & Behav Sci, Grad Sch Art & Sci, Tokyo 1538902, Japan; [Sanada, Motoyuki; Ikeda, Koki] Japan Soc Promot Sci, Tokyo, Japan; [Ikeda, Koki] Chukyo Univ, Dept Psychol, Nagoya, Aichi, Japan	Sanada, M (reprint author), Univ Tokyo, Dept Cognit & Behav Sci, Grad Sch Art & Sci, Meguro Ku, Komaba 3-8-1, Tokyo 1538902, Japan.	sanada@darwin.c.u-tokyo.ac.jp			Research Fellowships of the Japan Society for the Promotion of Science (JSPS) for Young Scientists [2410159]	This study was supported by the Research Fellowships of the Japan Society for the Promotion of Science (JSPS) for Young Scientists (No. 2410159 to MS). We are grateful to Kei Miyazaki for statistical suggestions, and Sho Tsuji for proof-reading our manuscript. https://osf.io/49ure/	Oh SH, 2004, PSYCHON B REV, V11, P275, DOI 10.3758/BF03196570; Rushworth MFS, 1997, J NEUROSCI, V17, P4829; Woodman GF, 2004, PSYCHON B REV, V11, P269, DOI 10.3758/BF03196569; WILSON FAW, 1993, SCIENCE, V260, P1955, DOI 10.1126/science.8316836; Rao SC, 1997, SCIENCE, V276, P821, DOI 10.1126/science.276.5313.821; Lecerf T, 2005, EUR J COGN PSYCHOL, V17, P47, DOI 10.1080/09541440340000420; Wheeler ME, 2002, J EXP PSYCHOL GEN, V131, P48, DOI 10.1037//0096-3445.131.1.48; Jiang YH, 2000, J EXP PSYCHOL LEARN, V26, P683, DOI 10.1037//0278-7393.26.3.683; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; MISHKIN M, 1983, TRENDS NEUROSCI, V6, P414, DOI 10.1016/0166-2236(83)90190-X; Woodman GF, 2001, PSYCHOL SCI, V12, P219, DOI 10.1111/1467-9280.00339; Courtney SM, 1998, SCIENCE, V279, P1347, DOI 10.1126/science.279.5355.1347; Wood JN, 2011, ATTEN PERCEPT PSYCHO, V73, P420, DOI 10.3758/s13414-010-0048-8; Baddeley A. D., 1974, PSYCHOL LEARN MOTIV, V8, P47, DOI DOI 10.1016/S0079-7421(08)60452-1; Courtney SM, 1996, CEREB CORTEX, V6, P39, DOI 10.1093/cercor/6.1.39; Logie R. H., 1991, MENTAL IMAGES HUMAN, P105; Logie R. H., 1995, VISUOSPATIAL WORKING; Luck S. J., 2008, VISUAL MEMORY, DOI [10.1093/acprof:oso/9780195305487.001.0001, DOI 10.1093/ACPROF:OSO/9780195305487.003.0003]; Postle BR, 2000, NEUROIMAGE, V11, P409, DOI 10.1006/nimg.2000.0570; TRESCH MC, 1993, NEUROPSYCHOLOGIA, V31, P211, DOI 10.1016/0028-3932(93)90085-E; Zhang W., 2012, PERCEPTION CONSCIOUS, P369	21	0	0	FRONTIERS RESEARCH FOUNDATION	LAUSANNE	PO BOX 110, LAUSANNE, 1015, SWITZERLAND	1664-1078			FRONT PSYCHOL	Front. Psychol.	MAY 20	2015	6								581	10.3389/fpsyg.2015.00581		13	Psychology, Multidisciplinary	Psychology	CJ4VJ	WOS:000355485500001		
J	Adam, J; Adamova, D; Aggarwal, MM; Rinella, GA; Agnello, M; Agrawal, N; Ahammed, Z; Ahmed, I; Ahn, SU; Aimo, I; Aiola, S; Ajaz, M; Akindinov, A; Alam, SN; Aleksandrov, D; Alessandro, B; Alexandre, D; Molina, RA; Alici, A; Alkin, A; Alme, J; Alt, T; Altinpinar, S; Altsybeev, I; Prado, CAG; Andrei, C; Andronic, A; Anguelov, V; Anielski, J; Anticic, T; Antinori, F; Antonioli, P; Aphecetche, L; Appelshauser, H; Arcelli, S; Armesto, N; Arnaldi, R; Aronsson, T; Arsene, IC; Arslandok, M; Augustinus, A; Averbeck, R; Azmi, MD; Bach, M; Badala, A; Baek, YW; Bagnasco, S; Bailhache, R; Bala, R; Baldisseri, A; Ball, M; Pedrosa, FBD; Baral, RC; Barbano, AM; Barbera, R; Barile, F; Barnafoldi, GG; Barnby, LS; Barret, V; Bartalini, P; Bartke, J; Bartsch, E; Basile, M; Bastid, N; Basu, S; Bathen, B; Batigne, G; Camejo, AB; Batyunya, B; Batzing, PC; Bearden, IG; Beck, H; Bedda, C; Behera, NK; Belikov, I; Bellini, F; Martinez, HB; Bellwied, R; Belmont, R; Belmont-Moreno, E; Belyaev, V; Bencedi, G; Beole, S; Berceanu, I; Bercuci, A; Berdnikov, Y; Berenyi, D; Bertens, RA; Berzano, D; Betev, L; Bhasin, A; Bhat, IR; Bhati, AK; Bhattacharjee, B; Bhom, J; Bianchi, L; Bianchi, N; Bianchin, C; Bielcik, J; Bielcikova, J; Bilandzic, A; Biswas, S; Bjelogrlic, S; Blanco, F; Blau, D; Blume, C; Bock, F; Bogdanov, A; Boggild, H; Boldizsar, L; Bombara, M; Book, J; Borel, H; Borissov, A; Borri, M; Bossu, F; Botje, M; Botta, E; Bottger, S; Braun-Munzinger, P; Bregant, M; Breitner, T; Broker, TA; Browning, TA; Broz, M; Brucken, EJ; Bruna, E; Bruno, GE; Budnikov, D; Buesching, H; Bufalino, S; Buncic, P; Busch, O; Buthelezi, Z; Buxton, JT; Caffarri, D; Cai, X; Caines, H; Diaz, LC; Caliva, A; Villar, EC; Camerini, P; Carena, F; Carena, W; Castellanos, JC; Castro, AJ; Casula, EAR; Cavicchioli, C; Sanchez, CC; Cepila, J; Cerello, P; Chang, B; Chapeland, S; Chartier, M; Charvet, JL; Chattopadhyay, S; Chattopadhyay, S; Chelnokov, V; Cherney, M; Cheshkov, C; Cheynis, B; Barroso, VC; Chinellato, DD; Chochula, P; Choi, K; Chojnacki, M; Choudhury, S; Christakoglou, P; Christensen, CH; Christiansen, P; Chujo, T; Chung, SU; Cicalo, C; Cifarelli, L; Cindolo, F; Cleymans, J; Colamaria, F; Colella, D; Collu, A; Colocci, M; Balbastre, GC; del Valle, ZC; Connors, ME; Contreras, JG; Cormier, TM; Morales, YC; Maldonado, IC; Cortese, P; Cosentino, MR; Costa, F; Crochet, P; Albino, RC; Cuautle, E; Cunqueiro, L; Dahms, T; Dainese, A; Danu, A; Das, D; Das, I; Das, S; Dash, A; Dash, S; De, S; De Caro, A; de Cataldo, G; de Cuveland, J; De Falco, A; De Gruttola, D; De Marco, N; De Pasquale, S; Deloff, A; Denes, E; D'Erasmo, G; Di Bari, D; Di Mauro, A; Di Nezza, P; Corchero, MAD; Dietel, T; Dillenseger, P; Divia, R; Djuvsland, O; Dobrin, A; Dobrowolski, T; Gimenez, DD; Donigus, B; Dordic, O; Dubey, AK; Dubla, A; Ducroux, L; Dupieux, P; Ehlers, RJ; Elia, D; Engel, H; Erazmus, B; Erdal, HA; Eschweiler, D; Espagnon, B; Esposito, M; Estienne, M; Esumi, S; Evans, D; Evdokimov, S; Eyyubova, G; Fabbietti, L; Fabris, D; Faivre, J; Fantoni, A; Fasel, M; Feldkamp, L; Felea, D; Feliciello, A; Feofilov, G; Ferencei, J; Tellez, AF; Ferreiro, EG; Ferretti, A; Festanti, A; Figiel, J; Figueredo, MAS; Filchagin, S; Finogeev, D; Fionda, FM; Fiore, EM; Fleck, MG; Floris, M; Foertsch, S; Foka, P; Fokin, S; Fragiacomo, E; Francescon, A; Frankenfeld, U; Fuchs, U; Furget, C; Furs, A; Girard, MF; Gaardhoje, JJ; Gagliardi, M; Gago, AM; Gallio, M; Gangadharan, DR; Ganoti, P; Gao, C; Garabatos, C; Garcia-Solis, E; Gargiulo, C; Gasik, P; Germain, M; Gheata, A; Gheata, M; Ghidini, B; Ghosh, P; Ghosh, SK; Gianotti, P; Giubellino, P; Giubilato, P; Gladysz-Dziadus, E; Glassel, P; Ramirez, AG; Gonzalez-Zamora, P; Gorbunov, S; Gorlich, L; Gotovac, S; Grabski, V; Graczykowski, LK; Grelli, A; Grigoras, A; Grigoras, C; Grigoriev, V; Grigoryan, A; Grigoryan, S; Grinyov, B; Grion, N; Grosse-Oetringhaus, JF; Grossiord, JY; Grosso, R; Guber, F; Guernane, R; Guerzoni, B; Gulbrandsen, K; Gulkanyan, H; Gunji, T; Gupta, A; Gupta, R; Haake, R; Haaland, O; Hadjidakis, C; Haiduc, M; Hamagaki, H; Hamar, G; Hanratty, LD; Hansen, A; Harris, JW; Hartmann, H; Harton, A; Hatzifotiadou, D; Hayashi, S; Heckel, ST; Heide, M; Helstrup, H; Herghelegiu, A; Corral, GH; Hess, BA; Hetland, KF; Hilden, TE; Hillemanns, H; Hippolyte, B; Hristov, P; Huang, M; Humanic, TJ; Hussain, N; Hussain, T; Hutter, D; Hwang, DS; Ilkaev, R; Ilkiv, I; Inaba, M; Ionita, C; Ippolitov, M; Irfan, M; Ivanov, M; Ivanov, V; Jacholkowski, A; Jacobs, PM; Jahnke, C; Jang, HJ; Janik, MA; Jayarathna, PHSY; Jena, C; Jena, S; Bustamante, RTJ; Jones, PG; Jung, H; Jusko, A; Kalinak, P; Kalweit, A; Kamin, J; Kang, JH; Kaplin, V; Kar, S; Uysal, AK; Karavichev, O; Karavicheva, T; Karpechev, E; Kebschull, U; Keidel, R; Keijdener, DLD; Keil, M; Khan, KH; Khan, MM; Khan, P; Khan, SA; Khanzadeev, A; Kharlov, Y; Kileng, B; Kim, B; Kim, DW; Kim, DJ; Kim, H; Kim, JS; Kim, M; Kim, M; Kim, S; Kim, T; Kirsch, S; Kisel, I; Kiselev, S; Kisiel, A; Kiss, G; Klay, JL; Klein, C; Klein, J; Klein-Bosing, C; Kluge, A; Knichel, ML; Knospe, AG; Kobayashi, T; Kobdaj, C; Kofarago, M; Kohler, MK; Kollegger, T; Kolojvari, A; Kondratiev, V; Kondratyeva, N; Kondratyuk, E; Konevskikh, A; Kovalenko, V; Kowalski, M; Kox, S; Meethaleveedu, GK; Kral, J; Kralik, I; Kravcakova, A; Krelina, M; Kretz, M; Krivda, M; Krizek, F; Kryshen, E; Krzewicki, M; Kubera, AM; Kucera, V; Kucheriaev, Y; Kugathasan, T; Kuhn, C; Kuijer, PG; Kulakov, I; Kumar, J; Kumar, L; Kurashvili, P; Kurepin, A; Kurepin, AB; Kuryakin, A; Kushpil, S; Kweon, MJ; Kwon, Y; La Pointe, SL; La Rocca, P; Fernandes, CL; Lakomov, I; Langoy, R; Lara, C; Lardeux, A; Lattuca, A; Laudi, E; Lea, R; Leardini, L; Lee, GR; Legrand, I; Lehnert, J; Lemmon, RC; Lenti, V; Leogrande, E; Monzon, IL; Leoncino, M; Levai, P; Li, S; Li, X; Lien, J; Lietava, R; Lindal, S; Lindenstruth, V; Lippmann, C; Lisa, MA; Ljunggren, HM; Lodato, DF; Loenne, PI; Loggins, VR; Loginov, V; Loizides, C; Lopez, X; Torres, EL; Lowe, A; Lu, XG; Luettig, P; Lunardon, M; Luparello, G; Maevskaya, A; Mager, M; Mahajan, S; Mahmood, SM; Maire, A; Majka, RD; Malaev, M; Cervantes, IM; Malinina, L; Mal'Kevich, D; Malzacher, P; Mamonov, A; Manceau, L; Manko, V; Manso, F; Manzari, V; Marchisone, M; Mares, J; Margagliotti, GV; Margotti, A; Margutti, J; Marin, A; Markert, C; Marquard, M; Martashvili, I; Martin, NA; Blanco, JM; Martinengo, P; Martinez, MI; Garcia, GM; Martynov, Y; Mas, A; Masciocchi, S; Masera, M; Masoni, A; Massacrier, L; Mastroserio, A; Matyja, A; Mayer, C; Mazer, J; Mazzoni, MA; Mcdonald, D; Meddi, F; Menchaca-Rocha, A; Meninno, E; Perez, JM; Meres, M; Miake, Y; Mieskolainen, MM; Mikhaylov, K; Milano, L; Milosevic, J; Minervini, LM; Mischke, A; Mishra, AN; Miskowiec, D; Mitra, J; Mitu, CM; Mohammadi, N; Mohanty, B; Molnar, L; Zetina, LM; Montes, E; Morando, M; De Godoy, DAM; Moretto, S; Morreale, A; Morsch, A; Muccifora, V; Mudnic, E; Muhlheim, D; Muhuri, S; Mukherjee, M; Muller, H; Mulligan, JD; Munhoz, MG; Murray, S; Musa, L; Musinsky, J; Nandi, BK; Nania, R; Nappi, E; Naru, MU; Nattrass, C; Nayak, K; Nayak, TK; Nazarenko, S; Nedosekin, A; Nellen, L; Ng, F; Nicassio, M; Niculescu, M; Niedziela, J; Nielsen, BS; Nikolaev, S; Nikulin, S; Nikulin, V; Nilsen, BS; Noferini, F; Nomokonov, P; Nooren, G; Norman, J; Nyanin, A; Nystrand, J; Oeschler, H; Oh, S; Oh, SK; Ohlson, A; Okatan, A; Okubo, T; Olah, L; Oleniacz, J; Da Silva, ACO; Onderwaater, J; Oppedisano, C; Velasquez, AO; Oskarsson, A; Otwinowski, J; Oyama, K; Ozdemir, M; Pachmayer, Y; Pagano, P; Paic, G; Pajares, C; Pal, SK; Pan, J; Pandey, AK; Pant, D; Papikyan, V; Pappalardo, GS; Pareek, P; Park, WJ; Parmar, S; Passfeld, A; Patalakha, DI; Paticchio, V; Paul, B; Pawlak, T; Peitzmann, T; Da Costa, HP; De Oliveira, EP; Peresunko, D; Lara, CEP; Peskov, V; Pestov, Y; Petracek, V; Petrov, V; Petrovici, M; Petta, C; Piano, S; Pikna, M; Pillot, P; Pinazza, O; Pinsky, L; Piyarathna, DB; Ploskon, M; Planinic, M; Pluta, J; Pochybova, S; Podesta-Lerma, PLM; Poghosyan, MG; Polichtchouk, B; Poljak, N; Poonsawat, W; Pop, A; Porteboeuf-Houssais, S; Porter, J; Pospisil, J; Prasad, SK; Preghenella, R; Prino, F; Pruneau, CA; Pshenichnov, I; Puccio, M; Puddu, G; Pujahari, P; Punin, V; Putschke, J; Qvigstad, H; Rachevski, A; Raha, S; Rajput, S; Rak, J; Rakotozafindrabe, A; Ramello, L; Raniwala, R; Raniwala, S; Rasanen, SS; Rascanu, BT; Rathee, D; Rauf, AW; Razazi, V; Read, KF; Real, JS; Redlich, K; Reed, RJ; Rehman, A; Reichelt, P; Reicher, M; Reidt, F; Renfordt, R; Reolon, AR; Reshetin, A; Rettig, F; Revol, JP; Reygers, K; Riabov, V; Ricci, RA; Richert, T; Richter, M; Riedler, P; Riegler, W; Riggi, F; Ristea, C; Rivetti, A; Rocco, E; Cahuantzi, MR; Manso, AR; Roed, K; Rogochaya, E; Rohr, D; Rohrich, D; Romita, R; Ronchetti, F; Ronflette, L; Rosnet, P; Rossi, A; Roukoutakis, F; Roy, A; Roy, C; Roy, P; Montero, AJR; Rui, R; Russo, R; Ryabinkin, E; Ryabov, Y; Rybicki, A; Sadovsky, S; Safarik, K; Sahlmuller, B; Sahoo, P; Sahoo, R; Sahoo, S; Sahu, PK; Saini, J; Sakai, S; Saleh, MA; Salgado, CA; Salzwedel, J; Sambyal, S; Samsonov, V; Castro, XS; Sandor, L; Sandoval, A; Sano, M; Santagati, G; Sarkar, D; Scapparone, E; Scarlassara, F; Scharenberg, RP; Schiaua, C; Schicker, R; Schmidt, C; Schmidt, HR; Schuchmann, S; Schukraft, J; Schulc, M; Schuster, T; Schutz, Y; Schwarz, K; Schweda, K; Scioli, G; Scomparin, E; Scott, R; Seeder, KS; Segato, G; Seger, JE; Sekiguchi, Y; Selyuzhenkov, I; Senosi, K; Seo, J; Serradilla, E; Sevcenco, A; Shabanov, A; Shabetai, A; Shadura, O; Shahoyan, R; Shangaraev, A; Sharma, A; Sharma, N; Shigaki, K; Shtejer, K; Sibiriak, Y; Siddhanta, S; Sielewicz, KM; Siemiarczuk, T; Silvermyr, D; Silvestre, C; Simatovic, G; Singaraju, R; Singh, R; Singha, S; Singhal, V; Sinha, BC; Sinha, T; Sitar, B; Sitta, M; Skaali, TB; Skjerdal, K; Slupecki, M; Smirnov, N; Snellings, RJM; Snellman, TW; Sogaard, C; Soltz, R; Song, J; Song, M; Song, Z; Soramel, F; Sorensen, S; Spacek, M; Spiriti, E; Sputowska, I; Spyropoulou-Stassinaki, M; Srivastava, BK; Stachel, J; Stan, I; Stefanek, G; Steinpreis, M; Stenlund, E; Steyn, G; Stiller, JH; Stocco, D; Strmen, P; Suaide, AAP; Sugitate, T; Suire, C; Suleymanov, M; Sultanov, R; Sumbera, M; Symons, TJM; Szabo, A; de Toledo, AS; Szarka, I; Szczepankiewicz, A; Szymanski, M; Takahashi, J; Tanaka, N; Tangaro, MA; Takaki, JDT; Peloni, AT; Tariq, M; Tarzila, MG; Tauro, A; Munoz, GT; Telesca, A; Terasaki, K; Terrevoli, C; Teyssier, B; Thader, J; Thomas, D; Tieulent, R; Timmins, AR; Toia, A; Trogolo, S; Trubnikov, V; Trzaska, WH; Tsuji, T; Tumkin, A; Turrisi, R; Tveter, TS; Ullaland, K; Uras, A; Usai, GL; Utrobicic, A; Vajzer, M; Vala, M; Palomo, LV; Vallero, S; Van der Maarel, J; Van Hoorne, JW; van Leeuwen, M; Vanat, T; Vyvre, PV; Varga, D; Vargas, A; Vargyas, M; Varma, R; Vasileiou, M; Vasiliev, A; Vauthier, A; Vechernin, V; Veen, AM; Veldhoen, M; Velure, A; Venaruzzo, M; Vercellin, E; Limon, SV; Vernet, R; Verweij, M; Vickovic, L; Viesti, G; Viinikainen, J; Vilakazi, Z; Baillie, OV; Vinogradov, A; Vinogradov, L; Vinogradov, Y; Virgili, T; Vislavicius, V; Viyogi, YP; Vodopyanov, A; Volkl, MA; Voloshin, K; Voloshin, SA; Volpe, G; von Haller, B; Vorobyev, I; Vranic, D; Vrlakova, J; Vulpescu, B; Vyushin, A; Wagner, B; Wagner, J; Wang, H; Wang, M; Wang, Y; Watanabe, D; Weber, M; Weber, SG; Wessels, JP; Westerhoff, U; Wiechula, J; Wikne, J; Wilde, M; Wilk, G; Wilkinson, J; Williams, MCS; Windelband, B; Winn, M; Yaldo, CG; Yamaguchi, Y; Yang, H; Yang, P; Yano, S; Yasnopolskiy, S; Yin, Z; Yokoyama, H; Yoo, IK; Yurchenko, V; Yushmanov, I; Zaborowska, A; Zaccolo, V; Zaman, A; Zampolli, C; Zanoli, HJC; Zaporozhets, S; Zarochentsev, A; Zavada, P; Zaviyalov, N; Zbroszczyk, H; Zgura, IS; Zhalov, M; Zhang, H; Zhang, X; Zhang, Y; Zhao, C; Zhigareva, N; Zhou, D; Zhou, Y; Zhou, Z; Zhu, H; Zhu, J; Zhu, X; Zichichi, A; Zimmermann, A; Zimmermann, MB; Zinovjev, G; Zyzak, M				Adam, J.; Adamova, D.; Aggarwal, M. M.; Rinella, G. Aglieri; Agnello, M.; Agrawal, N.; Ahammed, Z.; Ahmed, I.; Ahn, S. U.; Aimo, I.; Aiola, S.; Ajaz, M.; Akindinov, A.; Alam, S. N.; Aleksandrov, D.; Alessandro, B.; Alexandre, D.; Alfaro Molina, R.; Alici, A.; Alkin, A.; Alme, J.; Alt, T.; Altinpinar, S.; Altsybeev, I.; Alves Garcia Prado, C.; Andrei, C.; Andronic, A.; Anguelov, V.; Anielski, J.; Anticic, T.; Antinori, F.; Antonioli, P.; Aphecetche, L.; Appelshaeuser, H.; Arcelli, S.; Armesto, N.; Arnaldi, R.; Aronsson, T.; Arsene, I. C.; Arslandok, M.; Augustinus, A.; Averbeck, R.; Azmi, M. D.; Bach, M.; Badala, A.; Baek, Y. W.; Bagnasco, S.; Bailhache, R.; Bala, R.; Baldisseri, A.; Ball, M.; Pedrosa, F. Baltasar Dos Santos; Baral, R. C.; Barbano, A. M.; Barbera, R.; Barile, F.; Barnafoeldi, G. G.; Barnby, L. S.; Barret, V.; Bartalini, P.; Bartke, J.; Bartsch, E.; Basile, M.; Bastid, N.; Basu, S.; Bathen, B.; Batigne, G.; Camejo, A. Batista; Batyunya, B.; Batzing, P. C.; Bearden, I. G.; Beck, H.; Bedda, C.; Behera, N. K.; Belikov, I.; Bellini, F.; Martinez, H. Bello; Bellwied, R.; Belmont, R.; Belmont-Moreno, E.; Belyaev, V.; Bencedi, G.; Beole, S.; Berceanu, I.; Bercuci, A.; Berdnikov, Y.; Berenyi, D.; Bertens, R. A.; Berzano, D.; Betev, L.; Bhasin, A.; Bhat, I. R.; Bhati, A. K.; Bhattacharjee, B.; Bhom, J.; Bianchi, L.; Bianchi, N.; Bianchin, C.; Bielcik, J.; Bielcikova, J.; Bilandzic, A.; Biswas, S.; Bjelogrlic, S.; Blanco, F.; Blau, D.; Blume, C.; Bock, F.; Bogdanov, A.; Boggild, H.; Boldizsar, L.; Bombara, M.; Book, J.; Borel, H.; Borissov, A.; Borri, M.; Bossu, F.; Botje, M.; Botta, E.; Boettger, S.; Braun-Munzinger, P.; Bregant, M.; Breitner, T.; Broker, T. A.; Browning, T. A.; Broz, M.; Brucken, E. J.; Bruna, E.; Bruno, G. E.; Budnikov, D.; Buesching, H.; Bufalino, S.; Buncic, P.; Busch, O.; Buthelezi, Z.; Buxton, J. T.; Caffarri, D.; Cai, X.; Caines, H.; Diaz, L. Calero; Caliva, A.; Calvo Villar, E.; Camerini, P.; Carena, F.; Carena, W.; Castellanos, J. Castillo; Castro, A. J.; Casula, E. A. R.; Cavicchioli, C.; Ceballos Sanchez, C.; Cepila, J.; Cerello, P.; Chang, B.; Chapeland, S.; Chartier, M.; Charvet, J. L.; Chattopadhyay, S.; Chattopadhyay, S.; Chelnokov, V.; Cherney, M.; Cheshkov, C.; Cheynis, B.; Barroso, V. Chibante; Chinellato, D. D.; Chochula, P.; Choi, K.; Chojnacki, M.; Choudhury, S.; Christakoglou, P.; Christensen, C. H.; Christiansen, P.; Chujo, T.; Chung, S. U.; Cicalo, C.; Cifarelli, L.; Cindolo, F.; Cleymans, J.; Colamaria, F.; Colella, D.; Collu, A.; Colocci, M.; Balbastre, G. Conesa; del Valle, Z. Conesa; Connors, M. E.; Contreras, J. G.; Cormier, T. M.; Morales, Y. Corrales; Cortes Maldonado, I.; Cortese, P.; Cosentino, M. R.; Costa, F.; Crochet, P.; Cruz Albino, R.; Cuautle, E.; Cunqueiro, L.; Dahms, T.; Dainese, A.; Danu, A.; Das, D.; Das, I.; Das, S.; Dash, A.; Dash, S.; De, S.; De Caro, A.; de Cataldo, G.; de Cuveland, J.; De Falco, A.; De Gruttola, D.; De Marco, N.; De Pasquale, S.; Deloff, A.; Denes, E.; D'Erasmo, G.; Di Bari, D.; Di Mauro, A.; Di Nezza, P.; Corchero, M. A. Diaz; Dietel, T.; Dillenseger, P.; Divia, R.; Djuvsland, O.; Dobrin, A.; Dobrowolski, T.; Domenicis Gimenez, D.; Doenigus, B.; Dordic, O.; Dubey, A. K.; Dubla, A.; Ducroux, L.; Dupieux, P.; Ehlers, R. J.; Elia, D.; Engel, H.; Erazmus, B.; Erdal, H. A.; Eschweiler, D.; Espagnon, B.; Esposito, M.; Estienne, M.; Esumi, S.; Evans, D.; Evdokimov, S.; Eyyubova, G.; Fabbietti, L.; Fabris, D.; Faivre, J.; Fantoni, A.; Fasel, M.; Feldkamp, L.; Felea, D.; Feliciello, A.; Feofilov, G.; Ferencei, J.; Fernandez Tellez, A.; Ferreiro, E. G.; Ferretti, A.; Festanti, A.; Figiel, J.; Figueredo, M. A. S.; Filchagin, S.; Finogeev, D.; Fionda, F. M.; Fiore, E. M.; Fleck, M. G.; Floris, M.; Foertsch, S.; Foka, P.; Fokin, S.; Fragiacomo, E.; Francescon, A.; Frankenfeld, U.; Fuchs, U.; Furget, C.; Furs, A.; Girard, M. Fusco; Gaardhoje, J. J.; Gagliardi, M.; Gago, A. M.; Gallio, M.; Gangadharan, D. R.; Ganoti, P.; Gao, C.; Garabatos, C.; Garcia-Solis, E.; Gargiulo, C.; Gasik, P.; Germain, M.; Gheata, A.; Gheata, M.; Ghidini, B.; Ghosh, P.; Ghosh, S. K.; Gianotti, P.; Giubellino, P.; Giubilato, P.; Gladysz-Dziadus, E.; Glaessel, P.; Ramirez, A. Gomez; Gonzalez-Zamora, P.; Gorbunov, S.; Goerlich, L.; Gotovac, S.; Grabski, V.; Graczykowski, L. K.; Grelli, A.; Grigoras, A.; Grigoras, C.; Grigoriev, V.; Grigoryan, A.; Grigoryan, S.; Grinyov, B.; Grion, N.; Grosse-Oetringhaus, J. F.; Grossiord, J. -Y.; Grosso, R.; Guber, F.; Guernane, R.; Guerzoni, B.; Gulbrandsen, K.; Gulkanyan, H.; Gunji, T.; Gupta, A.; Gupta, R.; Haake, R.; Haaland, O.; Hadjidakis, C.; Haiduc, M.; Hamagaki, H.; Hamar, G.; Hanratty, L. D.; Hansen, A.; Harris, J. W.; Hartmann, H.; Harton, A.; Hatzifotiadou, D.; Hayashi, S.; Heckel, S. T.; Heide, M.; Helstrup, H.; Herghelegiu, A.; Herrera Corral, G.; Hess, B. A.; Hetland, K. F.; Hilden, T. E.; Hillemanns, H.; Hippolyte, B.; Hristov, P.; Huang, M.; Humanic, T. J.; Hussain, N.; Hussain, T.; Hutter, D.; Hwang, D. S.; Ilkaev, R.; Ilkiv, I.; Inaba, M.; Ionita, C.; Ippolitov, M.; Irfan, M.; Ivanov, M.; Ivanov, V.; Jacholkowski, A.; Jacobs, P. M.; Jahnke, C.; Jang, H. J.; Janik, M. A.; Jayarathna, P. H. S. Y.; Jena, C.; Jena, S.; Jimenez Bustamante, R. T.; Jones, P. G.; Jung, H.; Jusko, A.; Kalinak, P.; Kalweit, A.; Kamin, J.; Kang, J. H.; Kaplin, V.; Kar, S.; Uysal, A. Karasu; Karavichev, O.; Karavicheva, T.; Karpechev, E.; Kebschull, U.; Keidel, R.; Keijdener, D. L. D.; Keil, M.; Khan, K. H.; Khan, M. M.; Khan, P.; Khan, S. A.; Khanzadeev, A.; Kharlov, Y.; Kileng, B.; Kim, B.; Kim, D. W.; Kim, D. J.; Kim, H.; Kim, J. S.; Kim, M.; Kim, M.; Kim, S.; Kim, T.; Kirsch, S.; Kisel, I.; Kiselev, S.; Kisiel, A.; Kiss, G.; Klay, J. L.; Klein, C.; Klein, J.; Klein-Boesing, C.; Kluge, A.; Knichel, M. L.; Knospe, A. G.; Kobayashi, T.; Kobdaj, C.; Kofarago, M.; Koehler, M. K.; Kollegger, T.; Kolojvari, A.; Kondratiev, V.; Kondratyeva, N.; Kondratyuk, E.; Konevskikh, A.; Kovalenko, V.; Kowalski, M.; Kox, S.; Meethaleveedu, G. Koyithatta; Kral, J.; Kralik, I.; Kravcakova, A.; Krelina, M.; Kretz, M.; Krivda, M.; Krizek, F.; Kryshen, E.; Krzewicki, M.; Kubera, A. M.; Kucera, V.; Kucheriaev, Y.; Kugathasan, T.; Kuhn, C.; Kuijer, P. G.; Kulakov, I.; Kumar, J.; Kumar, L.; Kurashvili, P.; Kurepin, A.; Kurepin, A. B.; Kuryakin, A.; Kushpil, S.; Kweon, M. J.; Kwon, Y.; La Pointe, S. L.; La Rocca, P.; Lagana Fernandes, C.; Lakomov, I.; Langoy, R.; Lara, C.; Lardeux, A.; Lattuca, A.; Laudi, E.; Lea, R.; Leardini, L.; Lee, G. R.; Legrand, I.; Lehnert, J.; Lemmon, R. C.; Lenti, V.; Leogrande, E.; Leon Monzon, I.; Leoncino, M.; Levai, P.; Li, S.; Li, X.; Lien, J.; Lietava, R.; Lindal, S.; Lindenstruth, V.; Lippmann, C.; Lisa, M. A.; Ljunggren, H. M.; Lodato, D. F.; Loenne, P. I.; Loggins, V. R.; Loginov, V.; Loizides, C.; Lopez, X.; Lopez Torres, E.; Lowe, A.; Lu, X. -G.; Luettig, P.; Lunardon, M.; Luparello, G.; Maevskaya, A.; Mager, M.; Mahajan, S.; Mahmood, S. M.; Maire, A.; Majka, R. D.; Malaev, M.; Maldonado Cervantes, I.; Malinina, L.; Mal'Kevich, D.; Malzacher, P.; Mamonov, A.; Manceau, L.; Manko, V.; Manso, F.; Manzari, V.; Marchisone, M.; Mares, J.; Margagliotti, G. V.; Margotti, A.; Margutti, J.; Marin, A.; Markert, C.; Marquard, M.; Martashvili, I.; Martin, N. A.; Blanco, J. Martin; Martinengo, P.; Martinez, M. I.; Garcia, G. Martinez; Martynov, Y.; Mas, A.; Masciocchi, S.; Masera, M.; Masoni, A.; Massacrier, L.; Mastroserio, A.; Matyja, A.; Mayer, C.; Mazer, J.; Mazzoni, M. A.; Mcdonald, D.; Meddi, F.; Menchaca-Rocha, A.; Meninno, E.; Perez, J. Mercado; Meres, M.; Miake, Y.; Mieskolainen, M. M.; Mikhaylov, K.; Milano, L.; Milosevic, J.; Minervini, L. M.; Mischke, A.; Mishra, A. N.; Miskowiec, D.; Mitra, J.; Mitu, C. M.; Mohammadi, N.; Mohanty, B.; Molnar, L.; Montano Zetina, L.; Montes, E.; Morando, M.; De Godoy, D. A. Moreira; Moretto, S.; Morreale, A.; Morsch, A.; Muccifora, V.; Mudnic, E.; Muehlheim, D.; Muhuri, S.; Mukherjee, M.; Mueller, H.; Mulligan, J. D.; Munhoz, M. G.; Murray, S.; Musa, L.; Musinsky, J.; Nandi, B. K.; Nania, R.; Nappi, E.; Naru, M. U.; Nattrass, C.; Nayak, K.; Nayak, T. K.; Nazarenko, S.; Nedosekin, A.; Nellen, L.; Ng, F.; Nicassio, M.; Niculescu, M.; Niedziela, J.; Nielsen, B. S.; Nikolaev, S.; Nikulin, S.; Nikulin, V.; Nilsen, B. S.; Noferini, F.; Nomokonov, P.; Nooren, G.; Norman, J.; Nyanin, A.; Nystrand, J.; Oeschler, H.; Oh, S.; Oh, S. K.; Ohlson, A.; Okatan, A.; Okubo, T.; Olah, L.; Oleniacz, J.; Oliveira Da Silva, A. C.; Onderwaater, J.; Oppedisano, C.; Ortiz Velasquez, A.; Oskarsson, A.; Otwinowski, J.; Oyama, K.; Ozdemir, M.; Pachmayer, Y.; Pagano, P.; Paic, G.; Pajares, C.; Pal, S. K.; Pan, J.; Pandey, A. K.; Pant, D.; Papikyan, V.; Pappalardo, G. S.; Pareek, P.; Park, W. J.; Parmar, S.; Passfeld, A.; Patalakha, D. I.; Paticchio, V.; Paul, B.; Pawlak, T.; Peitzmann, T.; Da Costa, H. Pereira; De Oliveira Filho, E. Pereira; Peresunko, D.; Lara, C. E. Perez; Peskov, V.; Pestov, Y.; Petracek, V.; Petrov, V.; Petrovici, M.; Petta, C.; Piano, S.; Pikna, M.; Pillot, P.; Pinazza, O.; Pinsky, L.; Piyarathna, D. B.; Ploskon, M.; Planinic, M.; Pluta, J.; Pochybova, S.; Podesta-Lerma, P. L. M.; Poghosyan, M. G.; Polichtchouk, B.; Poljak, N.; Poonsawat, W.; Pop, A.; Porteboeuf-Houssais, S.; Porter, J.; Pospisil, J.; Prasad, S. K.; Preghenella, R.; Prino, F.; Pruneau, C. A.; Pshenichnov, I.; Puccio, M.; Puddu, G.; Pujahari, P.; Punin, V.; Putschke, J.; Qvigstad, H.; Rachevski, A.; Raha, S.; Rajput, S.; Rak, J.; Rakotozafindrabe, A.; Ramello, L.; Raniwala, R.; Raniwala, S.; Rasanen, S. S.; Rascanu, B. T.; Rathee, D.; Rauf, A. W.; Razazi, V.; Read, K. F.; Real, J. S.; Redlich, K.; Reed, R. J.; Rehman, A.; Reichelt, P.; Reicher, M.; Reidt, F.; Renfordt, R.; Reolon, A. R.; Reshetin, A.; Rettig, F.; Revol, J. -P.; Reygers, K.; Riabov, V.; Ricci, R. A.; Richert, T.; Richter, M.; Riedler, P.; Riegler, W.; Riggi, F.; Ristea, C.; Rivetti, A.; Rocco, E.; Rodriguez Cahuantzi, M.; Manso, A. Rodriguez; Roed, K.; Rogochaya, E.; Rohr, D.; Rohrich, D.; Romita, R.; Ronchetti, F.; Ronflette, L.; Rosnet, P.; Rossi, A.; Roukoutakis, F.; Roy, A.; Roy, C.; Roy, P.; Rubio Montero, A. J.; Rui, R.; Russo, R.; Ryabinkin, E.; Ryabov, Y.; Rybicki, A.; Sadovsky, S.; Safarik, K. .; Sahlmuller, B.; Sahoo, P.; Sahoo, R.; Sahoo, S.; Sahu, P. K.; Saini, J.; Sakai, S.; Saleh, M. A.; Salgado, C. A.; Salzwedel, J.; Sambyal, S.; Samsonov, V.; Castro, X. Sanchez; Sandor, L.; Sandoval, A.; Sano, M.; Santagati, G.; Sarkar, D.; Scapparone, E.; Scarlassara, F.; Scharenberg, R. P.; Schiaua, C.; Schicker, R.; Schmidt, C.; Schmidt, H. R.; Schuchmann, S.; Schukraft, J.; Schulc, M.; Schuster, T.; Schutz, Y.; Schwarz, K.; Schweda, K.; Scioli, G.; Scomparin, E.; Scott, R.; Seeder, K. S.; Segato, G.; Seger, J. E.; Sekiguchi, Y.; Selyuzhenkov, I.; Senosi, K.; Seo, J.; Serradilla, E.; Sevcenco, A.; Shabanov, A.; Shabetai, A.; Shadura, O.; Shahoyan, R.; Shangaraev, A.; Sharma, A.; Sharma, N.; Shigaki, K.; Shtejer, K.; Sibiriak, Y.; Siddhanta, S.; Sielewicz, K. M.; Siemiarczuk, T.; Silvermyr, D.; Silvestre, C.; Simatovic, G.; Singaraju, R.; Singh, R.; Singha, S.; Singhal, V.; Sinha, B. C.; Sinha, T.; Sitar, B.; Sitta, M.; Skaali, T. B.; Skjerdal, K.; Slupecki, M.; Smirnov, N.; Snellings, R. J. M.; Snellman, T. W.; Sogaard, C.; Soltz, R.; Song, J.; Song, M.; Song, Z.; Soramel, F.; Sorensen, S.; Spacek, M.; Spiriti, E.; Sputowska, I.; Spyropoulou-Stassinaki, M.; Srivastava, B. K.; Stachel, J.; Stan, I.; Stefanek, G.; Steinpreis, M.; Stenlund, E.; Steyn, G.; Stiller, J. H.; Stocco, D.; Strmen, P.; Suaide, A. A. P.; Sugitate, T.; Suire, C.; Suleymanov, M.; Sultanov, R.; Sumbera, M.; Symons, T. J. M.; Szabo, A.; de Toledo, A. Szanto; Szarka, I.; Szczepankiewicz, A.; Szymanski, M.; Takahashi, J.; Tanaka, N.; Tangaro, M. A.; Takaki, J. D. Tapia; Peloni, A. Tarantola; Tariq, M.; Tarzila, M. G.; Tauro, A.; Tejeda Munoz, G.; Telesca, A.; Terasaki, K.; Terrevoli, C.; Teyssier, B.; Thaeder, J.; Thomas, D.; Tieulent, R.; Timmins, A. R.; Toia, A.; Trogolo, S.; Trubnikov, V.; Trzaska, W. H.; Tsuji, T.; Tumkin, A.; Turrisi, R.; Tveter, T. S.; Ullaland, K.; Uras, A.; Usai, G. L.; Utrobicic, A.; Vajzer, M.; Vala, M.; Palomo, L. Valencia; Vallero, S.; Van der Maarel, J.; Van Hoorne, J. W.; van Leeuwen, M.; Vanat, T.; Vyvre, P. Vande; Varga, D.; Vargas, A.; Vargyas, M.; Varma, R.; Vasileiou, M.; Vasiliev, A.; Vauthier, A.; Vechernin, V.; Veen, A. M.; Veldhoen, M.; Velure, A.; Venaruzzo, M.; Vercellin, E.; Vergara Limon, S.; Vernet, R.; Verweij, M.; Vickovic, L.; Viesti, G.; Viinikainen, J.; Vilakazi, Z.; Baillie, O. Villalobos; Vinogradov, A.; Vinogradov, L.; Vinogradov, Y.; Virgili, T.; Vislavicius, V.; Viyogi, Y. P.; Vodopyanov, A.; Voelkl, M. A.; Voloshin, K.; Voloshin, S. A.; Volpe, G.; von Haller, B.; Vorobyev, I.; Vranic, D.; Vrlakova, J.; Vulpescu, B.; Vyushin, A.; Wagner, B.; Wagner, J.; Wang, H.; Wang, M.; Wang, Y.; Watanabe, D.; Weber, M.; Weber, S. G.; Wessels, J. P.; Westerhoff, U.; Wiechula, J.; Wikne, J.; Wilde, M.; Wilk, G.; Wilkinson, J.; Williams, M. C. S.; Windelband, B.; Winn, M.; Yaldo, C. G.; Yamaguchi, Y.; Yang, H.; Yang, P.; Yano, S.; Yasnopolskiy, S.; Yin, Z.; Yokoyama, H.; Yoo, I. -K.; Yurchenko, V.; Yushmanov, I.; Zaborowska, A.; Zaccolo, V.; Zaman, A.; Zampolli, C.; Zanoli, H. J. C.; Zaporozhets, S.; Zarochentsev, A.; Zavada, P.; Zaviyalov, N.; Zbroszczyk, H.; Zgura, I. S.; Zhalov, M.; Zhang, H.; Zhang, X.; Zhang, Y.; Zhao, C.; Zhigareva, N.; Zhou, D.; Zhou, Y.; Zhou, Z.; Zhu, H.; Zhu, J.; Zhu, X.; Zichichi, A.; Zimmermann, A.; Zimmermann, M. B.; Zinovjev, G.; Zyzak, M.		ALICE collaboration	Forward-backward multiplicity correlations in pp collisions at root s=0.9, 2.76 and 7 TeV	JOURNAL OF HIGH ENERGY PHYSICS			English	Article						Hadron-Hadron Scattering	CHARGED-PARTICLE MULTIPLICITY; TRANSVERSE-MOMENTUM CORRELATIONS; RANGE RAPIDITY CORRELATIONS; DUAL PARTON MODEL; HIGH-ENERGIES; NUCLEAR COLLISIONS; E+E ANNIHILATION; PBARP-COLLISIONS; STRING FUSION; LONG	The strength of forward-backward (FB) multiplicity correlations is measured by the ALICE detector in proton-proton (pp) collisions at = 0.9, 2.76 and 7 TeV. The measurement is performed in the central pseudorapidity region (|eta| < 0.8) for the transverse momentum p (T) > 0.3 GeV/c. Two separate pseudorapidity windows of width (delta eta) ranging from 0.2 to 0.8 are chosen symmetrically around eta = 0. The multiplicity correlation strength (b (corr)) is studied as a function of the pseudorapidity gap (eta (gap)) between the two windows as well as the width of these windows. The correlation strength is found to decrease with increasing eta (gap) and shows a non-linear increase with delta eta. A sizable increase of the correlation strength with the collision energy, which cannot be explained exclusively by the increase of the mean multiplicity inside the windows, is observed. The correlation coefficient is also measured for multiplicities in different configurations of two azimuthal sectors selected within the symmetric FB eta-windows. Two different contributions, the short-range (SR) and the long-range (LR), are observed. The energy dependence of b (corr) is found to be weak for the SR component while it is strong for the LR component. Moreover, the correlation coefficient is studied for particles belonging to various transverse momentum intervals chosen to have the same mean multiplicity. Both SR and LR contributions to b (corr) are found to increase with p (T) in this case. Results are compared to PYTHIA and PHOJET event generators and to a string-based phenomenological model. The observed dependencies of b (corr) add new constraints on phenomenological models.	[Takaki, J. D. Tapia] Univ Kansas, Lawrence, KS 66045 USA; [Grigoryan, A.; Gulkanyan, H.; Papikyan, V.] Yerevan Phys Inst, AI Alikhanyan Natl Sci Lab, Yerevan 375036, Armenia; [Martinez, H. Bello; Cortes Maldonado, I.; Fernandez Tellez, A.; Martinez, M. I.; Rodriguez Cahuantzi, M.; Tejeda Munoz, G.; Vargas, A.; Vergara Limon, S.] Benemerita Univ Autonoma Puebla, Puebla, Mexico; [Alkin, A.; Chelnokov, V.; Grinyov, B.; Martynov, Y.; Shadura, O.; Trubnikov, V.; Yurchenko, V.; Zinovjev, G.] Bogolyubov Inst Theoret Phys, Kiev, Ukraine; [Das, S.; Ghosh, S. K.; Prasad, S. K.; Raha, S.] Bose Inst, Dept Phys, Kolkata, India; [Das, S.; Ghosh, S. K.; Prasad, S. K.; Raha, S.] Bose Inst, Ctr Astroparticle Phys & Space Sci, Kolkata, India; [Pestov, Y.] Budker Inst Nucl Phys, Novosibirsk 630090, Russia; [Klay, J. L.] Calif Polytech State Univ San Luis Obispo, San Luis Obispo, CA 93407 USA; [Bartalini, P.; Cai, X.; Gao, C.; Li, S.; Song, Z.; Wang, M.; Yang, P.; Yin, Z.; Zhang, H.; Zhang, Y.; Zhou, D.; Zhu, H.; Zhu, J.; Zhu, X.] Cent China Normal Univ, Wuhan, Peoples R China; [Vernet, R.] IN2P3, Ctr Calcul, Villeurbanne, France; [Ceballos Sanchez, C.; Lopez Torres, E.; Shtejer, K.] Ctr Aplicac Tecnol & Desarrollo Nucl CEA DEN, Havana, Cuba; [Blanco, F.; Corchero, M. A. Diaz; Gonzalez-Zamora, P.; Montes, E.; Rubio Montero, A. J.; Serradilla, E.] CIEMAT, Ctr Invest Energet Medioambientales & Tecnol, E-28040 Madrid, Spain; [Contreras, J. G.; Cruz Albino, R.; Herrera Corral, G.; Montano Zetina, L.; Rodriguez Cahuantzi, M.] CINVESTAV, Ctr Invest & Estudios Avanzados, Mexico City 14000, DF, Mexico; [Contreras, J. G.; Cruz Albino, R.; Herrera Corral, G.; Montano Zetina, L.; Rodriguez Cahuantzi, M.] CINVESTAV, Ctr Invest & Estudios Avanzados, Merida, Mexico; [Alici, A.; Cifarelli, L.; De Caro, A.; De Gruttola, D.; Noferini, F.; Preghenella, R.; Revol, J. -P.; Zichichi, A.] Ctr Fermi Museo Stor Fis, Rome, Italy; [Alici, A.; Cifarelli, L.; De Caro, A.; De Gruttola, D.; Noferini, F.; Preghenella, R.; Revol, J. -P.; Zichichi, A.] Ctr Studi Ric Enrico Fermi, Rome, Italy; [Garcia-Solis, E.; Harton, A.] Chicago State Univ, Chicago, IL USA; [Li, X.] China Inst Atom Energy, Beijing, Peoples R China; [Baldisseri, A.; Borel, H.; Castellanos, J. Castillo; Charvet, J. L.; Lardeux, A.; Da Costa, H. Pereira; Rakotozafindrabe, A.] Commissariat Energie Atom, IRFU, Saclay, France; [Ahmed, I.; Ajaz, M.; Khan, K. H.; Naru, M. U.; Rauf, A. W.; Suleymanov, M.; Zaman, A.] COMSATS Inst Informat Technol, Islamabad, Pakistan; [Armesto, N.; Ferreiro, E. G.; Pajares, C.; Salgado, C. A.] Univ Santiago de Compostela, Dept Fis Particulas, Santiago De Compostela, Spain; [Armesto, N.; Ferreiro, E. G.; Pajares, C.; Salgado, C. A.] Univ Santiago de Compostela, IGFAE, Santiago De Compostela, Spain; [Altinpinar, S.; Djuvsland, O.; Haaland, O.; Huang, M.; Loenne, P. I.; Nystrand, J.; Rehman, A.; Rohrich, D.; Skjerdal, K.; Ullaland, K.; Velure, A.; Wagner, B.; Zhou, Z.] Univ Bergen, Dept Phys & Technol, Bergen, Norway; [Azmi, M. D.; Hussain, T.; Irfan, M.; Khan, M. M.; Tariq, M.] Aligarh Muslim Univ, Dept Phys, Aligarh 202002, Uttar Pradesh, India; [Buxton, J. T.; Humanic, T. J.; Kubera, A. M.; Lisa, M. A.; Salzwedel, J.; Steinpreis, M.] Ohio State Univ, Dept Phys, Columbus, OH 43210 USA; [Hwang, D. S.; Kim, S.] Sejong Univ, Dept Phys, Seoul, South Korea; [Arsene, I. C.; Batzing, P. C.; Dordic, O.; Lindal, S.; Mahmood, S. M.; Milosevic, J.; Qvigstad, H.; Richter, M.; Roed, K.; Skaali, T. B.; Tveter, T. S.; Zhao, C.] Univ Oslo, Dept Phys, Oslo, Norway; [Minervini, L. M.] Dipartimento Elettrotecn Elettron Politecn, Bari, Italy; [Meddi, F.] Univ Roma La Sapienza, Dipartimento Fis, I-00185 Rome, Italy; [Mazzoni, M. A.; Meddi, F.] Sez INFN Rome, Rome, Italy; [Casula, E. A. R.; Collu, A.; De Falco, A.; Puddu, G.; Razazi, V.; Terrevoli, C.; Usai, G. L.] Dipartimento Fis Univ, Cagliari, Italy; [Casula, E. A. R.; Cicalo, C.; Collu, A.; De Falco, A.; Masoni, A.; Puddu, G.; Razazi, V.; Siddhanta, S.; Terrevoli, C.; Usai, G. L.] Sezione Ist Nazl Fis Nucl, Cagliari, Italy; [Camerini, P.; Lea, R.; Luparello, G.; Margagliotti, G. V.; Rui, R.] Dipartimento Fis Univ, Trieste, Italy; [Camerini, P.; Fragiacomo, E.; Grion, N.; Lea, R.; Luparello, G.; Margagliotti, G. V.; Piano, S.; Rachevski, A.; Rui, R.] Sezione Ist Nazl Fis Nucl, Trieste, Italy; [Beole, S.; Bianchi, L.; Botta, E.; Morales, Y. Corrales; Ferretti, A.; Gagliardi, M.; Gallio, M.; Lattuca, A.; Leoncino, M.; Marchisone, M.; Masera, M.; Russo, R.; Shtejer, K.; Vallero, S.; Vercellin, E.] Dipartimento Fis Univ, Turin, Italy; [Agnello, M.; Aimo, I.; Alessandro, B.; Arnaldi, R.; Bagnasco, S.; Barbano, A. M.; Bedda, C.; Beole, S.; Bianchi, L.; Botta, E.; Bruna, E.; Bufalino, S.; Cerello, P.; Morales, Y. Corrales; De Marco, N.; Feliciello, A.; Ferretti, A.; Gagliardi, M.; Gallio, M.; La Pointe, S. L.; Lattuca, A.; Leoncino, M.; Manceau, L.; Marchisone, M.; Masera, M.; Oppedisano, C.; Prino, F.; Puccio, M.; Rivetti, A.; Russo, R.; Scomparin, E.; Shtejer, K.; Trogolo, S.; Vallero, S.; Vercellin, E.] Sezione Ist Nazl Fis Nucl, Turin, Italy; [Arcelli, S.; Basile, M.; Bellini, F.; Cifarelli, L.; Colocci, M.; Guerzoni, B.; Scioli, G.; Zichichi, A.] Dipartimento Fis & Astron Univ, Bologna, Italy; [Alici, A.; Antonioli, P.; Arcelli, S.; Basile, M.; Bellini, F.; Cifarelli, L.; Cindolo, F.; Colocci, M.; Guerzoni, B.; Hatzifotiadou, D.; Margotti, A.; Nania, R.; Noferini, F.; Pinazza, O.; Preghenella, R.; Scapparone, E.; Scioli, G.; Williams, M. C. S.; Zampolli, C.; Zichichi, A.] Sezione Ist Nazl Fis Nucl, Bologna, Italy; [Barbera, R.; Jacholkowski, A.; La Rocca, P.; Petta, C.; Riggi, F.; Santagati, G.] Dipartimento Fis & Astron Univ, Catania, Italy; [Badala, A.; Barbera, R.; Jacholkowski, A.; La Rocca, P.; Pappalardo, G. S.; Petta, C.; Riggi, F.; Santagati, G.] Sezione Ist Nazl Fis Nucl, Catania, Italy; [Caffarri, D.; Festanti, A.; Francescon, A.; Giubilato, P.; Jena, C.; Lunardon, M.; Morando, M.; Moretto, S.; Scarlassara, F.; Segato, G.; Soramel, F.; Terrevoli, C.; Viesti, G.] Dipartimento Fis Astron Univ, Padua, Italy; [Antinori, F.; Caffarri, D.; Dainese, A.; Fabris, D.; Festanti, A.; Francescon, A.; Giubilato, P.; Jena, C.; Lunardon, M.; Morando, M.; Moretto, S.; Scarlassara, F.; Segato, G.; Soramel, F.; Terrevoli, C.; Turrisi, R.; Viesti, G.] Sezione Ist Nazl Fis Nucl, Padua, Italy; [De Caro, A.; De Gruttola, D.; De Pasquale, S.; Girard, M. Fusco; Meninno, E.; Pagano, P.; Virgili, T.] ER Caianiello Univ, Dipartimento Fis, Salerno, Italy; [De Caro, A.; De Gruttola, D.; De Pasquale, S.; Girard, M. Fusco; Meninno, E.; Pagano, P.; Virgili, T.] Ist Nazl Fis Nucl, Grp Collegato, Salerno, Italy; [Cortese, P.; Ramello, L.; Sitta, M.] Univ Piemonte Orientale, Dipartimento Sci & Innovaz Tecnol, Alessandria, Italy; [Cortese, P.; Ramello, L.; Sitta, M.] Ist Nazl Fis Nucl, Grp Collegato, Alessandria, Italy; [Barile, F.; Bruno, G. E.; Colamaria, F.; Colella, D.; D'Erasmo, G.; Di Bari, D.; Fiore, E. M.; Ghidini, B.; Mastroserio, A.; Tangaro, M. A.] Dipartimento Interateneo Fis M Merlin, Bari, Italy; [Barile, F.; Bruno, G. E.; Colamaria, F.; Colella, D.; de Cataldo, G.; D'Erasmo, G.; Di Bari, D.; Elia, D.; Fionda, F. M.; Fiore, E. M.; Ghidini, B.; Lenti, V.; Manzari, V.; Mastroserio, A.; Minervini, L. M.; Nappi, E.; Paticchio, V.; Tangaro, M. A.] Sezione Ist Nazl Fis Nucl, Bari, Italy; [Christiansen, P.; Ljunggren, H. M.; Ortiz Velasquez, A.; Oskarsson, A.; Richert, T.; Silvermyr, D.; Sogaard, C.; Stenlund, E.; Vislavicius, V.] Lund Univ, Div Expt High Energy Phys, Lund, Sweden; [Hess, B. A.; Schmidt, H. R.; Wiechula, J.] Univ Tubingen, Tubingen, Germany; [Rinella, G. Aglieri; Akindinov, A.; Augustinus, A.; Pedrosa, F. Baltasar Dos Santos; Berzano, D.; Betev, L.; Bufalino, S.; Buncic, P.; Caffarri, D.; Carena, F.; Carena, W.; Cavicchioli, C.; Chapeland, S.; Barroso, V. Chibante; Chochula, P.; Costa, F.; Cunqueiro, L.; Di Mauro, A.; Divia, R.; Erazmus, B.; Esposito, M.; Floris, M.; Francescon, A.; Fuchs, U.; Gargiulo, C.; Gheata, A.; Gheata, M.; Giubellino, P.; Grigoras, A.; Grigoras, C.; Grosse-Oetringhaus, J. F.; Grosso, R.; Hillemanns, H.; Hristov, P.; Ionita, C.; Kalweit, A.; Keil, M.; Kluge, A.; Kofarago, M.; Kowalski, M.; Kryshen, E.; Kugathasan, T.; Lakomov, I.; Laudi, E.; Legrand, I.; Mager, M.; Manzari, V.; Martinengo, P.; Milano, L.; Morsch, A.; Mueller, H.; Musa, L.; Niculescu, M.; Niedziela, J.; Ohlson, A.; Pinazza, O.; Preghenella, R.; Reidt, F.; Riedler, P.; Rossi, A.; Safarik, K. .; Schukraft, J.; Schutz, Y.; Shahoyan, R.; Sielewicz, K. M.; Szczepankiewicz, A.; Tauro, A.; Telesca, A.; Van Hoorne, J. W.; Vyvre, P. Vande; Volpe, G.; von Haller, B.; Vranic, D.; Weber, M.; Zimmermann, M. B.] CERN, European Org Nucl Res, CH-1211 Geneva, Switzerland; [Dahms, T.; Fabbietti, L.; Gasik, P.; Vorobyev, I.] Tech Univ Munich, Excellence Cluster Universe, D-80290 Munich, Germany; [Alme, J.; Erdal, H. A.; Helstrup, H.; Hetland, K. F.; Kileng, B.] Bergen Univ Coll, Fac Engn, Bergen, Norway; [Meres, M.; Pikna, M.; Sitar, B.; Strmen, P.; Szabo, A.; Szarka, I.] Comenius Univ, Fac Math Phys & Informat, Bratislava, Slovakia; [Adam, J.; Bielcik, J.; Broz, M.; Cepila, J.; Contreras, J. G.; Eyyubova, G.; Krelina, M.; Petracek, V.; Schulc, M.; Spacek, M.] Czech Tech Univ, Fac Nucl Sci & Phys Engn, CR-11519 Prague, Czech Republic; [Bombara, M.; Kravcakova, A.; Vrlakova, J.] Safarik Univ, Fac Sci, Kosice, Slovakia; [Langoy, R.; Lien, J.] Buskerud & Vestfold Univ Coll, Fac Technol, Vestfold, Norway; [Alt, T.; Bach, M.; de Cuveland, J.; Eschweiler, D.; Gorbunov, S.; Hartmann, H.; Hutter, D.; Kirsch, S.; Kisel, I.; Kollegger, T.; Kretz, M.; Krzewicki, M.; Kulakov, I.; Lindenstruth, V.; Rettig, F.; Rohr, D.; Zyzak, M.] Goethe Univ Frankfurt, Frankfurt Inst Adv Studies, D-60054 Frankfurt, Germany; [Baek, Y. W.; Jung, H.; Kim, D. W.; Kim, J. S.; Kim, M.] Gangneung Wonju Natl Univ, Kangnung, South Korea; [Bhattacharjee, B.; Hussain, N.] Gauhati Univ, Dept Phys, Gauhati, India; [Brucken, E. J.; Hilden, T. E.; Mieskolainen, M. M.; Rasanen, S. S.] Helsinki Inst Phys, Helsinki, Finland; [Okubo, T.; Shigaki, K.; Sugitate, T.; Yano, S.] Hiroshima Univ, Hiroshima, Japan; [Agrawal, N.; Behera, N. K.; Dash, S.; Meethaleveedu, G. Koyithatta; Kumar, L.; Nandi, B. K.; Pandey, A. K.; Pant, D.; Varma, R.] Indian Inst Technol, Bombay 400076, Maharashtra, India; [Mishra, A. N.; Pareek, P.; Roy, A.; Sahoo, P.; Sahoo, R.] Indian Inst Technol Indore, Indore, Madhya Pradesh, India; [Kweon, M. J.] Inha Univ, Inchon, South Korea; [del Valle, Z. Conesa; Das, I.; Espagnon, B.; Hadjidakis, C.; Lakomov, I.; Suire, C.; Takaki, J. D. Tapia] Univ Paris 11, CNRS, IN2P3, Inst Phys Nucl Orsay, F-91405 Orsay, France; [Boettger, S.; Breitner, T.; Engel, H.; Ramirez, A. Gomez; Kebschull, U.; Lara, C.] Goethe Univ Frankfurt, Inst Informat, D-60054 Frankfurt, Germany; [Appelshaeuser, H.; Arslandok, M.; Bailhache, R.; Bartsch, E.; Beck, H.; Blume, C.; Book, J.; Broker, T. A.; Buesching, H.; Dillenseger, P.; Doenigus, B.; Heckel, S. T.; Kamin, J.; Klein, C.; Lehnert, J.; Luettig, P.; Marquard, M.; Ozdemir, M.; Peskov, V.; Rascanu, B. T.; Reichelt, P.; Renfordt, R.; Sahlmuller, B.; Schuchmann, S.; Peloni, A. Tarantola; Toia, A.] Goethe Univ Frankfurt, Inst Kernphys, Frankfurt, Germany; [Anielski, J.; Bathen, B.; Feldkamp, L.; Haake, R.; Heide, M.; Klein-Boesing, C.; Muehlheim, D.; Passfeld, A.; Wessels, J. P.; Westerhoff, U.; Wilde, M.; Zimmermann, M. B.] Univ Munster, Inst Kernphys, D-48149 Munster, Germany; [Belikov, I.; Hippolyte, B.; Kuhn, C.; Maire, A.; Molnar, L.; Roy, C.; Castro, X. Sanchez] Univ Strasbourg, CNRS, IN2P3, Inst Pluridisciplinaire Hubert Curien, Strasbourg, France; [Finogeev, D.; Furs, A.; Guber, F.; Karavichev, O.; Karavicheva, T.; Karpechev, E.; Konevskikh, A.; Kurepin, A.; Kurepin, A. B.; Maevskaya, A.; Reshetin, A.; Shabanov, A.] Acad Sci, Inst Nucl Res, Moscow, Russia; [Bertens, R. A.; Bianchin, C.; Bjelogrlic, S.; Caliva, A.; Dobrin, A.; Dubla, A.; Grelli, A.; Keijdener, D. L. D.; Leogrande, E.; Lodato, D. F.; Luparello, G.; Margutti, J.; Mischke, A.; Mohammadi, N.; Nooren, G.; Peitzmann, T.; Reicher, M.; Rocco, E.; Snellings, R. J. M.; Thomas, D.; Van der Maarel, J.; van Leeuwen, M.; Veen, A. M.; Veldhoen, M.; Wang, H.; Zhou, Y.] Univ Utrecht, Inst Subat Phys, Utrecht, Netherlands; [Akindinov, A.; Kiselev, S.; Mal'Kevich, D.; Mikhaylov, K.; Nedosekin, A.; Sultanov, R.; Voloshin, K.; Zhigareva, N.] Inst Theoret & Expt Phys, Moscow 117259, Russia; [Kalinak, P.; Kralik, I.; Krivda, M.; Musinsky, J.; Sandor, L.; Vala, M.] Slovak Acad Sci, Inst Expt Phys, Kosice 04353, Slovakia; [Mares, J.; Zavada, P.] Acad Sci Czech Republic, Inst Phys, Prague, Czech Republic; [Baral, R. C.; Sahoo, S.; Sahu, P. K.; Sharma, N.] Inst Phys, Bhubaneswar 751007, Orissa, India; [Danu, A.; Felea, D.; Gheata, M.; Haiduc, M.; Mitu, C. M.; Niculescu, M.; Ristea, C.; Sevcenco, A.; Stan, I.; Zgura, I. S.] Inst Space Sci, Bucharest, Romania; [Cuautle, E.; Jimenez Bustamante, R. T.; Maldonado Cervantes, I.; Nellen, L.; Ortiz Velasquez, A.; Paic, G.] Univ Nacl Autonoma Mexico, Inst Ciencias Nucl, Mexico City 04510, DF, Mexico; [Alfaro Molina, R.; Belmont-Moreno, E.; Grabski, V.; Menchaca-Rocha, A.; Sandoval, A.; Serradilla, E.] Univ Nacl Autonoma Mexico, Inst Fis, Mexico City 01000, DF, Mexico; [Bossu, F.; Buthelezi, Z.; Foertsch, S.; Murray, S.; Senosi, K.; Steyn, G.; Vilakazi, Z.] Natl Res Fdn, iThemba LABS, Somerset West, South Africa; [Batyunya, B.; Grigoryan, S.; Malinina, L.; Mikhaylov, K.; Nomokonov, P.; Rogochaya, E.; Vodopyanov, A.; Zaporozhets, S.] Joint Inst Nucl Res, Dubna, Russia; [Oh, S. K.; Seo, J.] Konkuk Univ, Seoul, South Korea; [Ahn, S. U.; Jang, H. J.; Kim, D. W.] Korea Inst Sci & Technol Informat, Taejon, South Korea; [Uysal, A. Karasu; Okatan, A.] KTO Karatay Univ, Konya, Turkey; [Barret, V.; Bastid, N.; Camejo, A. Batista; Crochet, P.; Dupieux, P.; Li, S.; Lopez, X.; Manso, F.; Porteboeuf-Houssais, S.; Rosnet, P.; Palomo, L. Valencia; Vulpescu, B.] Univ Clermont Ferrand, Univ Blaise Pascal, CNRS, Phys Corpusculaire Lab,IN2P3, Clermont Ferrand, France; [Balbastre, G. Conesa; Faivre, J.; Furget, C.; Guernane, R.; Kox, S.; Real, J. S.; Silvestre, C.; Vauthier, A.] Univ Grenoble Alpes, CNRS, IN2P3, Lab Phys Subat & Cosmol, Grenoble, France; [Bianchi, N.; Diaz, L. Calero; Di Nezza, P.; Gianotti, P.; Muccifora, V.; Reolon, A. R.; Ronchetti, F.; Sakai, S.; Spiriti, E.] Ist Nazl Fis Nucl, Lab Nazl Frascati, I-00044 Frascati, Italy; [Ricci, R. A.; Venaruzzo, M.] Ist Nazl Fis Nucl, Lab Nazl Legnaro, I-35020 Legnaro, Italy; [Bock, F.; Fasel, M.; Gangadharan, D. R.; Jacobs, P. M.; Loizides, C.; Ploskon, M.; Symons, T. J. M.; Thaeder, J.; Zhang, X.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Soltz, R.] Lawrence Livermore Natl Lab, Livermore, CA USA; [Belyaev, V.; Bogdanov, A.; Grigoriev, V.; Ippolitov, M.; Kaplin, V.; Kondratyeva, N.; Loginov, V.; Peresunko, D.] Moscow Engn Phys Inst, Moscow 115409, Russia; [Deloff, A.; Dobrowolski, T.; Ilkiv, I.; Kurashvili, P.; Redlich, K.; Siemiarczuk, T.; Stefanek, G.; Wilk, G.] Natl Ctr Nucl Studies, Warsaw, Poland; [Andrei, C.; Berceanu, I.; Bercuci, A.; Herghelegiu, A.; Petrovici, M.; Pop, A.; Schiaua, C.; Tarzila, M. G.] Natl Inst Phys & Nucl Engn, Bucharest, Romania; [Biswas, S.; Kumar, L.; Mohanty, B.; Nayak, K.; Singh, R.; Singha, S.] Natl Inst Sci Educ & Res, Bhubaneswar, Orissa, India; [Bearden, I. G.; Bilandzic, A.; Boggild, H.; Chojnacki, M.; Christensen, C. H.; Gaardhoje, J. J.; Gulbrandsen, K.; Hansen, A.; Nielsen, B. S.; Zaccolo, V.] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Botje, M.; Christakoglou, P.; Dobrin, A.; Kuijer, P. G.; Lara, C. E. Perez; Manso, A. Rodriguez] Natl Inst Subat Phys, Nikhef, Amsterdam, Netherlands; [Borri, M.; Lemmon, R. C.] STFC Daresbury Lab, Nucl Phys Grp, Daresbury, England; [Adamova, D.; Bielcikova, J.; Ferencei, J.; Krizek, F.; Kucera, V.; Kushpil, S.; Pospisil, J.; Sumbera, M.; Vajzer, M.; Vanat, T.] Acad Sci Czech Republic, Inst Nucl Phys, CZ-25068 Rez, Czech Republic; [Cormier, T. M.; Silvermyr, D.] Oak Ridge Natl Lab, Oak Ridge, TN USA; [Berdnikov, Y.; Ivanov, V.; Khanzadeev, A.; Malaev, M.; Nikulin, V.; Riabov, V.; Samsonov, V.; Zhalov, M.] Petersburg Nucl Phys Inst, Gatchina, Russia; [Cherney, M.; Nilsen, B. S.; Poghosyan, M. G.; Seger, J. E.] Creighton Univ, Dept Phys, Omaha, NE 68178 USA; [Aggarwal, M. M.; Bhati, A. K.; Kumar, L.; Parmar, S.; Rathee, D.] Panjab Univ, Dept Phys, Chandigarh 160014, India; [Ganoti, P.; Roukoutakis, F.; Spyropoulou-Stassinaki, M.; Vasileiou, M.] Univ Athens, Dept Phys, Athens, Greece; [Cleymans, J.; Dietel, T.] Univ Cape Town, Dept Phys, ZA-7925 Cape Town, South Africa; [Bala, R.; Bhasin, A.; Bhat, I. R.; Gupta, A.; Gupta, R.; Mahajan, S.; Rajput, S.; Sambyal, S.; Sharma, A.; Singh, R.] Univ Jammu, Dept Phys, Jammu 180004, India; [Raniwala, R.; Raniwala, S.] Univ Rajasthan, Dept Phys, Jaipur 302004, Rajasthan, India; [Ball, M.; Dahms, T.; Fabbietti, L.; Gasik, P.; Vorobyev, I.] Tech Univ Munich, Dept Phys, D-80290 Munich, Germany; [Anguelov, V.; Bock, F.; Busch, O.; Fleck, M. G.; Glaessel, P.; Klein, J.; Knichel, M. L.; Leardini, L.; Lu, X. -G.; Perez, J. Mercado; Oeschler, H.; Oyama, K.; Pachmayer, Y.; Reidt, F.; Reygers, K.; Schicker, R.; Stachel, J.; Stiller, J. H.; Voelkl, M. A.; Wang, Y.; Wilkinson, J.; Windelband, B.; Winn, M.; Zimmermann, A.] Heidelberg Univ, Inst Phys, Heidelberg, Germany; [Aimo, I.] Politecn Torino, Turin, Italy; [Browning, T. A.; Scharenberg, R. P.; Srivastava, B. K.] Purdue Univ, W Lafayette, IN 47907 USA; [Borissov, A.; Choi, K.; Chung, S. U.; Seo, J.; Song, J.; Yoo, I. -K.] Pusan Natl Univ, Pusan 609735, South Korea; [Andronic, A.; Averbeck, R.; Braun-Munzinger, P.; Foka, P.; Frankenfeld, U.; Garabatos, C.; Ivanov, M.; Koehler, M. K.; Kollegger, T.; Krzewicki, M.; Lippmann, C.; Malzacher, P.; Marin, A.; Martin, N. A.; Masciocchi, S.; Miskowiec, D.; Nicassio, M.; Onderwaater, J.; Otwinowski, J.; Park, W. J.; Schmidt, C.; Schwarz, K.; Schweda, K.; Selyuzhenkov, I.; Thaeder, J.; Vranic, D.; Wagner, J.; Weber, S. G.] GSI Helmholtzzentrum Schwerionenforsch, Div Res, D-64291 Darmstadt, Germany; [Andronic, A.; Averbeck, R.; Braun-Munzinger, P.; Foka, P.; Frankenfeld, U.; Garabatos, C.; Ivanov, M.; Koehler, M. K.; Kollegger, T.; Krzewicki, M.; Lippmann, C.; Malzacher, P.; Marin, A.; Martin, N. A.; Masciocchi, S.; Miskowiec, D.; Nicassio, M.; Onderwaater, J.; Otwinowski, J.; Park, W. J.; Schmidt, C.; Schwarz, K.; Selyuzhenkov, I.; Thaeder, J.; Vranic, D.; Wagner, J.; Weber, S. G.] GSI Helmholtzzentrum Schwerionenforsch, ExtreMe Matter Inst EMMI, D-64291 Darmstadt, Germany; [Anticic, T.] Rudjer Boskovic Inst, Zagreb, Croatia; [Budnikov, D.; Filchagin, S.; Ilkaev, R.; Kuryakin, A.; Mamonov, A.; Nazarenko, S.; Punin, V.; Tumkin, A.; Vinogradov, Y.; Vyushin, A.; Zaviyalov, N.] Russian Fed Nucl Ctr, VNIIEF, Sarov, Russia; [Aleksandrov, D.; Blau, D.; Fokin, S.; Ippolitov, M.; Kucheriaev, Y.; Manko, V.; Nikolaev, S.; Nikulin, S.; Nikulin, V.; Nyanin, A.; Peresunko, D.; Ryabinkin, E.; Sibiriak, Y.; Vasiliev, A.; Vinogradov, A.; Yasnopolskiy, S.; Yushmanov, I.] Russian Res Ctr, Kurchatov Inst, Moscow, Russia; [Chattopadhyay, S.; Das, D.; Das, I.; Khan, P.; Paul, B.; Roy, P.; Sinha, T.] Saha Inst Nucl Phys, Kolkata, India; [Alexandre, D.; Barnby, L. S.; Evans, D.; Hanratty, L. D.; Jones, P. G.; Jusko, A.; Krivda, M.; Lietava, R.; Baillie, O. Villalobos] Univ Birmingham, Sch Phys & Astron, Birmingham, W Midlands, England; [Calvo Villar, E.; Gago, A. M.] Pontificia Univ Catolica Peru, Dept Ciencias, Secc Fis, Lima, Peru; [Evdokimov, S.; Kharlov, Y.; Kondratyuk, E.; Patalakha, D. I.; Petrov, V.; Polichtchouk, B.; Sadovsky, S.; Shangaraev, A.] NRC Kurchatov Inst, SSC IHEP, Protvino, Russia; [Aphecetche, L.; Batigne, G.; Erazmus, B.; Estienne, M.; Germain, M.; Blanco, J. Martin; Garcia, G. Martinez; Massacrier, L.; De Godoy, D. A. Moreira; Morreale, A.; Pillot, P.; Ronflette, L.; Schutz, Y.; Shabetai, A.; Stocco, D.; Wang, M.; Zhu, J.] Univ Nantes, CNRS, IN2P3, Ecole Mines Nantes,SUBATECH, Nantes, France; [Kobdaj, C.; Poonsawat, W.] Suranaree Univ Technol, Nakhon Ratchasima, Thailand; [Gotovac, S.; Mudnic, E.; Vickovic, L.] Tech Univ Split FESB, Split, Croatia; [Bartke, J.; Figiel, J.; Gladysz-Dziadus, E.; Goerlich, L.; Kowalski, M.; Matyja, A.; Mayer, C.; Otwinowski, J.; Rybicki, A.; Sputowska, I.] Polish Acad Sci, Henryk Niewodniczanski Inst Nucl Phys, Krakow, Poland; [Knospe, A. G.; Markert, C.; Thomas, D.] Univ Texas Austin, Dept Phys, Austin, TX 78712 USA; [Leon Monzon, I.; Podesta-Lerma, P. L. M.] Univ Autonoma Sinaloa, Culiacan, Mexico; [Alves Garcia Prado, C.; Bregant, M.; Cosentino, M. R.; De, S.; Domenicis Gimenez, D.; Jahnke, C.; Lagana Fernandes, C.; Mas, A.; Munhoz, M. G.; Oliveira Da Silva, A. C.; De Oliveira Filho, E. Pereira; Seeder, K. S.; Suaide, A. A. P.; de Toledo, A. Szanto; Zanoli, H. J. C.] Univ Sao Paulo, Sao Paulo, Brazil; [Chinellato, D. D.; Dash, A.; Takahashi, J.] Univ Estadual Campinas, UNICAMP, Campinas, SP, Brazil; [Bellwied, R.; Bianchi, L.; Jayarathna, P. H. S. Y.; Jena, S.; Mcdonald, D.; Ng, F.; Pinsky, L.; Piyarathna, D. B.; Timmins, A. R.; Weber, M.] Univ Houston, Houston, TX USA; [Chang, B.; Kim, D. J.; Kral, J.; Rak, J.; Slupecki, M.; Snellman, T. W.; Trzaska, W. H.; Vargyas, M.; Viinikainen, J.] Univ Jyvaskyla, Jyvaskyla, Finland; [Chartier, M.; Figueredo, M. A. S.; Norman, J.; Romita, R.] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [Castro, A. J.; Martashvili, I.; Mazer, J.; Nattrass, C.; Read, K. F.; Scott, R.; Sharma, N.; Sorensen, S.] Univ Tennessee, Knoxville, TN USA; [Vilakazi, Z.] Univ Witwatersrand, Johannesburg, South Africa; [Gunji, T.; Hamagaki, H.; Hayashi, S.; Sekiguchi, Y.; Terasaki, K.; Tsuji, T.; Yamaguchi, Y.] Univ Tokyo, Tokyo, Japan; [Bhom, J.; Chujo, T.; Esumi, S.; Inaba, M.; Kobayashi, T.; Miake, Y.; Sano, M.; Tanaka, N.; Watanabe, D.; Yokoyama, H.] Univ Tsukuba, Tsukuba, Ibaraki, Japan; [Planinic, M.; Poljak, N.; Simatovic, G.; Utrobicic, A.] Univ Zagreb, Zagreb 41000, Croatia; [Cheshkov, C.; Cheynis, B.; Ducroux, L.; Grossiord, J. -Y.; Teyssier, B.; Tieulent, R.; Uras, A.] Univ Lyon 1, CNRS, IN2P3, IPN Lyon, F-69622 Villeurbanne, France; [Altsybeev, I.; Feofilov, G.; Kolojvari, A.; Kondratiev, V.; Kovalenko, V.; Vechernin, V.; Vinogradov, L.; Zarochentsev, A.] St Petersburg State Univ, V Fock Inst Phys, St Petersburg 199034, Russia; [Ahammed, Z.; Alam, S. N.; Basu, S.; Chattopadhyay, S.; Choudhury, S.; De, S.; Dubey, A. K.; Ghosh, P.; Kar, S.; Khan, S. A.; Mitra, J.; Mohanty, B.; Muhuri, S.; Mukherjee, M.; Nayak, T. K.; Pal, S. K.; Saini, J.; Sarkar, D.; Singaraju, R.; Singha, S.; Sinha, B. C.; Viyogi, Y. P.] Ctr Variable Energy Cyclotron, Kolkata, India; [Milosevic, J.] Vinca Inst Nucl Sci, Belgrade, Serbia; [Graczykowski, L. K.; Janik, M. A.; Kisiel, A.; Oleniacz, J.; Pawlak, T.; Pluta, J.; Szymanski, M.; Zaborowska, A.; Zbroszczyk, H.] Warsaw Univ Technol, Warsaw, Poland; [Belmont, R.; Loggins, V. R.; Pan, J.; Pruneau, C. A.; Pujahari, P.; Putschke, J.; Reed, R. J.; Saleh, M. A.; Verweij, M.; Voloshin, S. A.; Yaldo, C. G.] Wayne State Univ, Detroit, MI USA; [Barnafoeldi, G. G.; Bencedi, G.; Berenyi, D.; Boldizsar, L.; Denes, E.; Hamar, G.; Kiss, G.; Levai, P.; Lowe, A.; Olah, L.; Pochybova, S.; Varga, D.] Hungarian Acad Sci, Wigner Res Ctr Phys, Budapest, Hungary; [Aiola, S.; Aronsson, T.; Caines, H.; Connors, M. E.; Ehlers, R. J.; Harris, J. W.; Majka, R. D.; Mulligan, J. D.; Oh, S.; Reed, R. J.; Schuster, T.; Smirnov, N.] Yale Univ, New Haven, CT USA; [Kang, J. H.; Kim, B.; Kim, H.; Kim, M.; Kim, T.; Kwon, Y.; Song, M.] Yonsei Univ, Seoul 120749, South Korea; [Keidel, R.] Fachhsch Worms, Zentrum Technol Transfer & Telekommunikat ZTT, Worms, Germany	Adam, J (reprint author), Czech Tech Univ, Fac Nucl Sci & Phys Engn, CR-11519 Prague, Czech Republic.		Martynov, Yevgen/L-3009-2015; HAMAGAKI, HIDEKI/G-4899-2014; Pshenichnov, Igor/A-4063-2008; Guber, Fedor/I-4271-2013; Zarochentsev, Andrey/J-6253-2013; Altsybeev, Igor/K-6687-2013; Vinogradov, Leonid/K-3047-2013; Kondratiev, Valery/J-8574-2013; Vechernin, Vladimir/J-5832-2013; Naru, Muhammad Umair/N-5547-2015; Graczykowski, Lukasz/O-7522-2015; Janik, Malgorzata/O-7520-2015; Krizek, Filip/G-8967-2014; Bielcikova, Jana/G-9342-2014; Vajzer, Michal/G-8469-2014; Ferencei, Jozef/H-1308-2014; Sumbera, Michal/O-7497-2014; Kovalenko, Vladimir/C-5709-2013; Barnby, Lee/G-2135-2010; Barbera, Roberto/G-5805-2012; Bruna, Elena/C-4939-2014; Bregant, Marco/I-7663-2012; Karasu Uysal, Ayben/K-3981-2015; Adamova, Dagmar/G-9789-2014; Kucera, Vit/G-8459-2014	Dainese, Andrea/0000-0002-2166-1874; Turrisi, Rosario/0000-0002-5272-337X; Masera, Massimo/0000-0003-1880-5467; De Pasquale, Salvatore/0000-0001-9236-0748; Paticchio, Vincenzo/0000-0002-2916-1671; Martynov, Yevgen/0000-0003-0753-2205; Beole', Stefania/0000-0003-4673-8038; Pshenichnov, Igor/0000-0003-1752-4524; Guber, Fedor/0000-0001-8790-3218; Zarochentsev, Andrey/0000-0002-3502-8084; Altsybeev, Igor/0000-0002-8079-7026; Vinogradov, Leonid/0000-0001-9247-6230; Kondratiev, Valery/0000-0002-0031-0741; Vechernin, Vladimir/0000-0003-1458-8055; Naru, Muhammad Umair/0000-0001-6489-0784; Janik, Malgorzata/0000-0002-3356-3438; Sumbera, Michal/0000-0002-0639-7323; Kovalenko, Vladimir/0000-0001-6012-6615; Barnby, Lee/0000-0001-7357-9904; Barbera, Roberto/0000-0001-5971-6415; Bruna, Elena/0000-0001-5427-1461; Karasu Uysal, Ayben/0000-0001-6297-2532; 			Abelev BI, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.172301; Abreu P, 1991, Z PHYS C PART FIELDS, V50, P185; ALBROW MG, 1978, NUCL PHYS B, V145, P305, DOI 10.1016/0550-3213(78)90088-3; ALICE collaboration, 2012, JHEP, V07, P116; ALPGARD K, 1983, PHYS LETT B, V123, P361, DOI 10.1016/0370-2693(83)91218-2; Amelin NS, 2001, EUR PHYS J C, V22, P149, DOI 10.1007/s100520100761; Skands PZ, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.074018; CAPELLA A, 1994, PHYS REP, V236, P225, DOI 10.1016/0370-1573(94)90064-7; Vechernin VV, 2007, PHYS ATOM NUCL+, V70, P1797, DOI 10.1134/S1063778807100158; BRAUN MA, 1992, PHYS LETT B, V287, P154, DOI 10.1016/0370-2693(92)91892-D; Armesto N, 2007, NUCL PHYS A, V781, P201, DOI 10.1016/j.nuclphysa.2006.10.074; BRAUN M, 1993, NUCL PHYS B, V390, P542, DOI 10.1016/0550-3213(93)90467-4; ARMESTO N, 1995, PHYS LETT B, V344, P301, DOI 10.1016/0370-2693(94)01511-A; KAIDALOV AB, 1982, PHYS LETT B, V116, P459, DOI 10.1016/0370-2693(82)90168-X; ALEXOPOULOS T, 1995, PHYS LETT B, V353, P155, DOI 10.1016/0370-2693(95)00554-X; AKERS R, 1994, PHYS LETT B, V320, P417, DOI 10.1016/0370-2693(94)90680-7; Braun MA, 2004, EUR PHYS J C, V32, P535, DOI 10.1140/epjc/s2003-01443-6; Braun MA, 2000, PHYS LETT B, V493, P54, DOI 10.1016/S0370-2693(00)01127-8; ABRAMOVSKII VA, 1988, JETP LETT+, V47, P337; Dumitru A, 2008, NUCL PHYS A, V810, P91, DOI 10.1016/j.nuclphysa.2008.06.012; Buckley A, 2011, PHYS REP, V504, P145, DOI 10.1016/j.physrep.2011.03.005; AMELIN NS, 1994, PHYS REV LETT, V73, P2813, DOI 10.1103/PhysRevLett.73.2813; ALNER GJ, 1987, PHYS REP, V154, P247, DOI 10.1016/0370-1573(87)90130-X; Braun MA, 2000, EUR PHYS J C, V16, P349, DOI 10.1007/s100520050027; ANSORGE RE, 1988, Z PHYS C PART FIELDS, V37, P191; ATLAS collaboration, 2012, J HIGH ENERGY PHYS, V07, P019; ATLAS collaboration, 2008, J INSTRUM, V3; BRAUNSCHWEIG W, 1989, Z PHYS C PART FIELDS, V45, P193; Brogueira P, 2007, PHYS REV C, V76, DOI 10.1103/PhysRevC.76.064901; BROMBERG CM, 1974, PHYS REV D, V9, P1864, DOI 10.1103/PhysRevD.9.1864; Brun R., 1987, CERNDDEE841; CAPELLA A, 1984, PHYS REV D, V29, P2512, DOI 10.1103/PhysRevD.29.2512; CAPELLA A, 1978, PHYS REV D, V18, P4120, DOI 10.1103/PhysRevD.18.4120; DERRICK M, 1986, PHYS REV D, V34, P3304, DOI 10.1103/PhysRevD.34.3304; Engel R, 1996, PHYS REV D, V54, P4244, DOI 10.1103/PhysRevD.54.4244; ENGEL R, 1995, Z PHYS C PART FIELDS, V66, P203, DOI 10.1007/BF01496594; FOWLER GN, 1988, PHYS REV D, V37, P3127, DOI 10.1103/PhysRevD.37.3127; KAIDALOV AB, 1982, PHYS LETT B, V117, P247, DOI 10.1016/0370-2693(82)90556-1; Kovchegov YV, 2001, PHYS REV C, V63, DOI 10.1103/PhysRevC.63.024903; McLerran L. D., 2002, NUCL PHYS A, V699, P73, DOI DOI 10.1016/S0375-9474(01)01472-5; Pruneau C, 2002, PHYS REV C, V66, DOI 10.1103/PhysRevC.66.044904; Sjostrand T, 2006, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2006/05/026; UHLIG S, 1978, NUCL PHYS B, V132, P15, DOI 10.1016/0550-3213(78)90254-7; Vechernin V, 2015, NUCL PHYS A, V939, P21, DOI 10.1016/j.nuclphysa.2015.03.009; Vechernin V.V., 1997, P 20 INT BALD SEM HI, V2, P2; Vechernin V.V., 2013, POS QFTHEP 2013, V055; Wraight K, 2011, EUR PHYS J C, V71, DOI 10.1140/epjc/s10052-011-1628-z	47	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1029-8479			J HIGH ENERGY PHYS	J. High Energy Phys.	MAY 20	2015		5							097	10.1007/JHEP05(2015)097		28	Physics, Particles & Fields	Physics	CK1EL	WOS:000355949100001		
J	Morino, K; Hirata, Y; Tomioka, R; Kashima, H; Yamanishi, K; Hayashi, N; Egawa, S; Aihara, K				Morino, Kai; Hirata, Yoshito; Tomioka, Ryota; Kashima, Hisashi; Yamanishi, Kenji; Hayashi, Norihiro; Egawa, Shin; Aihara, Kazuyuki			Predicting disease progression from short biomarker series using expert advice algorithm	SCIENTIFIC REPORTS			English	Article							INTERMITTENT ANDROGEN SUPPRESSION; PROSTATE-SPECIFIC ANTIGEN; PROSPECTIVE PHASE-II; MATHEMATICAL-MODEL; HORMONE-THERAPY; TUMOR-GROWTH; RADICAL PROSTATECTOMY; SALVAGE RADIOTHERAPY; SQUID AXON; CANCER	Well-trained clinicians may be able to provide diagnosis and prognosis from very short biomarker series using information and experience gained from previous patients. Although mathematical methods can potentially help clinicians to predict the progression of diseases, there is no method so far that estimates the patient state from very short time-series of a biomarker for making diagnosis and/or prognosis by employing the information of previous patients. Here, we propose a mathematical framework for integrating other patients' datasets to infer and predict the state of the disease in the current patient based on their short history. We extend a machine-learning framework of "prediction with expert advice" to deal with unstable dynamics. We construct this mathematical framework by combining expert advice with a mathematical model of prostate cancer. Our model predicted well the individual biomarker series of patients with prostate cancer that are used as clinical samples.	[Morino, Kai; Hirata, Yoshito; Yamanishi, Kenji; Aihara, Kazuyuki] Univ Tokyo, Grad Sch Informat Sci & Technol, Tokyo 1138656, Japan; [Hirata, Yoshito; Aihara, Kazuyuki] Univ Tokyo, Inst Ind Sci, Tokyo 1538505, Japan; [Tomioka, Ryota] Toyota Technol Inst, Chicago, IL 60637 USA; [Kashima, Hisashi] Kyoto Univ, Grad Sch Informat, Kyoto 6068501, Japan; [Yamanishi, Kenji] CREST, JST, Kawaguchi, Saitama 3320012, Japan; [Hayashi, Norihiro; Egawa, Shin] Jikei Univ, Sch Med, Dept Urol, Tokyo 1058461, Japan	Morino, K (reprint author), Univ Tokyo, Grad Sch Informat Sci & Technol, Tokyo 1138656, Japan.	morino@mist.i.u-tokyo.ac.jp			JSPS KAKENHI Grant [11J07088]; MEXT KAKENHI Grant [23240019]; JST-CREST; Aihara Innovative Mathematical Modelling Project, the Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)"	We would like to express our appreciation to Dr. Nicholas Bruchovsky for valuable discussions and sharing published clinical data. This work is partially supported by JSPS KAKENHI Grant Number 11J07088, by MEXT KAKENHI Grant Number 23240019, by JST-CREST, and by the Aihara Innovative Mathematical Modelling Project, the Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)", initiated by the Council for Science and Technology Policy (CSTP). The violin data used in this study is available in the RWC Music Database (Musical Instrument Sound).	AKAKURA K, 1993, CANCER, V71, P2782, DOI 10.1002/1097-0142(19930501)71:9<2782::AID-CNCR2820710916>3.0.CO;2-Z; Hirata Y, 2010, J THEOR BIOL, V264, P517, DOI 10.1016/j.jtbi.2010.02.027; Hirata Y, 2012, J MOL CELL BIOL, V4, P127, DOI 10.1093/jmcb/mjs020; Pfister D, 2014, EUR UROL, V65, P1034, DOI 10.1016/j.eururo.2013.08.013; Jackson TL, 2004, DISCRETE CONT DYN-B, V4, P187; King CR, 2012, INT J RADIAT ONCOL, V84, P104, DOI 10.1016/j.ijrobp.2011.10.069; Hirata Y, 2010, CHAOS, V20, DOI 10.1063/1.3526968; Chernov A, 2010, LECT NOTES ARTIF INT, V6331, P255, DOI 10.1007/978-3-642-16108-7_22; Hirata Y, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.036209; Draisma G, 2009, J NATL CANCER I, V101, P374, DOI 10.1093/jnci/djp001; Jain HV, 2011, P NATL ACAD SCI USA, V108, P19701, DOI 10.1073/pnas.1115750108; Tanaka G, 2010, PHILOS T R SOC A, V368, P5029, DOI 10.1098/rsta.2010.0221; Bruchovsky N, 2007, CANCER, V109, P858, DOI 10.1002/cncr.22464; Portz T, 2012, AIP ADV, V2, DOI 10.1063/1.3697848; Bruchovsky N, 2006, CANCER, V107, P389, DOI 10.1002/cncr.21989; Ideta AM, 2008, J NONLINEAR SCI, V18, P593, DOI 10.1007/s00332-008-9031-0; IKEDA K, 1979, OPT COMMUN, V30, P257, DOI 10.1016/0030-4018(79)90090-7; Gorelik B, 2008, CANCER RES, V68, P9033, DOI 10.1158/0008-5472.CAN-08-1723; Cesa-Bianchi N., 2006, PREDICTION LEARNING; Chmielecki J., 2011, SCI TRANSL MED, V3; Goto M., 2004, P 18 INT C AC ICA 20, P1; Guo Q, 2008, INT J BIFURCAT CHAOS, V18, P3789; HENON M, 1976, COMMUN MATH PHYS, V50, P69, DOI 10.1007/BF01608556; Hazelton WD, 2011, SCI TRANSL MED, V3, P109; Hirata Y, 2012, CHAOS, V22, DOI 10.1063/1.4738191; Hirata Y, 2005, PHYS LETT A, V346, P141, DOI 10.1016/j.physleta.2005.07.081; Kronik N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015482; MEES A, 1992, PHYS LETT A, V169, P41, DOI 10.1016/0375-9601(92)90802-S; Michor F, 2005, NATURE, V435, P1267, DOI 10.1038/nature03669; NOWAK MA, 1991, SCIENCE, V254, P963, DOI 10.1126/science.1683006; Suzuki T, 2010, PHILOS T R SOC A, V368, P5045, DOI 10.1098/rsta.2010.0220; Tanaka G, 2008, PHYSICA D, V237, P2616, DOI 10.1016/j.physd.2008.03.044; Tao YS, 2010, J NONLINEAR SCI, V20, P219, DOI 10.1007/s00332-009-9056-z; Tao YS, 2009, MATH MOD METH APPL S, V19, P2177, DOI 10.1142/S021820250900408X; The U.S. Preventive Services Task Force, 2012, SCREEN PROST CANC US	35	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAY 20	2015	5								8953	10.1038/srep08953		12	Multidisciplinary Sciences	Science & Technology - Other Topics	CJ3NC	WOS:000355390100001		
J	Maheshwari, P; Mukherjee, S; Bhattacharya, D; Sen, S; Tokas, RB; Honda, Y; Basu, S; Padma, N; Pujari, PK				Maheshwari, Priya; Mukherjee, Saurabh; Bhattacharya, Debarati; Sen, Shashwati; Tokas, Raj Bahadur; Honda, Yoshihide; Basu, Saibal; Padma, Narayanan; Pujari, Pradeep Kumar			Probing Molecular Packing at Engineered Interfaces in Organic Field Effect Transistor and Its Correlation with Charge Carrier Mobility	ACS APPLIED MATERIALS & INTERFACES			English	Article						positron annihilation spectroscopy; organic semiconductors; self-assembled monolayer; interface molecular packing; field effect mobility	THIN-FILM TRANSISTORS; SPECTROSCOPY; SURFACE; GROWTH; PHTHALOCYANINE; SEMICONDUCTORS; PERFORMANCE; LAYER	Surface engineering of SiO2 dielectric using different self-assembled monolayer (SAM) has been carried out, and its effect on the molecular packing and growth tan behavior of copper phthalocyanine (CuPc) has been studied. A correlation between the growth behavior and performance of organic field effect transistors is examined. Depth profiling using positron annihilation and X-ray reflectivity techniques has been employed to characterize the interface between CuPc and the modified and/or unmodified dielectric. We observe the presence of structural defects or disorder due to disorientation of CuPc molecules on the unmodified dielectric and ordered arrangement on the modified dielectrics, consistent with the high charge carrier mobility in organic field effect transistors in the latter. The study also highlights the sensitivity of these techniques to the packing of CuPc molecules on SiO2 modified using different SAMs. Our study also signifies the sensitivity and utility of these two techniques in the characterization of buried interfaces in organic devices.	[Maheshwari, Priya; Mukherjee, Saurabh; Pujari, Pradeep Kumar] Bhabha Atom Res Ctr, Radiochem Div, Bombay 400085, Maharashtra, India; [Bhattacharya, Debarati; Basu, Saibal] Bhabha Atom Res Ctr, Div Solid State Phys, Bombay 400085, Maharashtra, India; [Sen, Shashwati; Padma, Narayanan] Bhabha Atom Res Ctr, Tech Phys Div, Bombay 400085, Maharashtra, India; [Tokas, Raj Bahadur] Bhabha Atom Res Ctr, Atom & Mol Phys Div, Bombay 400085, Maharashtra, India; [Honda, Yoshihide] Osaka Univ, Inst Sci Res, Osaka, Ibaraki, Japan	Padma, N (reprint author), Bhabha Atom Res Ctr, Tech Phys Div, Bombay 400085, Maharashtra, India.	padman@barc.gov.in; pujari@barc.gov.in					Anglin TC, 2014, J MATER CHEM C, V2, P3390, DOI 10.1039/c3tc32063d; Amin AY, 2012, J AM CHEM SOC, V134, P16548, DOI 10.1021/ja307802q; Virkar AA, 2010, ADV MATER, V22, P3857, DOI 10.1002/adma.200903193; SCHULTZ PJ, 1988, REV MOD PHYS, V60, P701, DOI 10.1103/RevModPhys.60.701; Lee YM, 2011, CURR APPL PHYS, V11, P1168, DOI 10.1016/j.cap.2011.02.013; Klauk H, 2010, CHEM SOC REV, V39, P2643, DOI 10.1039/b909902f; Xiao K, 2005, APPL PHYS A-MATER, V80, P1541, DOI 10.1007/s00339-003-2398-8; Kwak SY, 2009, ELECTROCHEM SOLID ST, V12, pG37, DOI 10.1149/1.3139526; Liscio F, 2013, ACS NANO, V7, P1257, DOI 10.1021/nn304733w; Bolognesi A, 2004, IEEE T ELECTRON DEV, V51, P1997, DOI 10.1109/TED.2004.838333; Chua LL, 2005, NATURE, V434, P194, DOI 10.1038/nature03376; de Oteyza DG, 2006, J AM CHEM SOC, V128, P15052, DOI 10.1021/ja064641r; Tiwari SP, 2012, ORG ELECTRON, V13, P18, DOI 10.1016/j.orgel.2011.09.017; Cheng HL, 2007, ADV FUNCT MATER, V17, P3639, DOI 10.1002/adfm.200700207; Yang HC, 2007, ADV MATER, V19, P2868, DOI 10.1002/adma.200700560; Gao J, 2007, J PHYS D APPL PHYS, V40, P5666, DOI 10.1088/0022-3727/40/18/022; Brauer G, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.195331; Bussolotti F, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.245410; Dannefaer S, 1997, PHYS REV B, V55, P2182, DOI 10.1103/PhysRevB.55.2182; Deman AL, 2006, MAT SCI ENG C-BIO S, V26, P421, DOI 10.1016/j.msec.2005.10.030; Di Carlo A., 2005, APPL PHYS LETT, V86; Gao J., 2009, APPL PHYS LETT, V94; Gerlach A, 2008, PHYS STATUS SOLIDI A, V205, P461, DOI 10.1002/pssa.200723411; Hayakawa R, 2010, J CHEM PHYS, V133; Hosokai T., 2010, APPL PHYS LETT, V97; Hwang D. K., 2006, APPL PHYS LETT, V89; Ito Y, 2000, RADIAT PHYS CHEM, V58, P743, DOI 10.1016/S0969-806X(00)00251-6; Kim S. H., 2010, J PHYS D, V43; Kouji Suemori K., 2007, APPL PHYS LETT, V91; Kumaki D., 2007, APPL PHYS LETT, V90; Maheshwari P, 2014, SOLID STATE COMMUN, V200, P22, DOI 10.1016/j.ssc.2014.09.001; Maheshwari P, 2012, ORG ELECTRON, V13, P1409, DOI 10.1016/j.orgel.2012.03.032; Neuhold A, 2013, ORG ELECTRON, V14, P479, DOI 10.1016/j.orgel.2012.11.016; Padma N., 2013, J NANOSCI NANOTECHNO, V13, P1; Padma N., 2013, J PHYS D, V46; Revesz AG, 2002, APPL SURF SCI, V194, P101, DOI 10.1016/S0169-4332(02)00096-X; Sinha S., 2014, J PHYS D, V47; Suzuki R, 2000, RADIAT PHYS CHEM, V58, P603, DOI 10.1016/S0969-806X(00)00226-7; Varese J., 2003, ADV FUNCT MATER, V13, P199; Yu AF, 2009, SYNTHETIC MET, V159, P1467, DOI 10.1016/j.synthmet.2009.04.001; Yuan Y., 2014, NAT COMMUN, V5	41	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1944-8244			ACS APPL MATER INTER	ACS Appl. Mater. Interfaces	MAY 20	2015	7	19					10169	10177		10.1021/acsami.5b00311		9	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Science & Technology - Other Topics; Materials Science	CI8XM	WOS:000355055000014		
J	Augusto, CRA; Navia, CE; De Oliveira, MN; Tsui, KH; Nepomuceno, AA; Kopenkin, V; Sinzi, T; Atri, D				Augusto, C. R. A.; Navia, C. E.; De Oliveira, M. N.; Tsui, K. H.; Nepomuceno, A. A.; Kopenkin, V.; Sinzi, T.; Atri, D.			OBSERVATION OF MUON EXCESS AT GROUND LEVEL IN RELATION TO GAMMA-RAY BURSTS DETECTED FROM SPACE	ASTROPHYSICAL JOURNAL			English	Article						astroparticle physics; gamma-ray burst: general; instrumentation: miscellaneous; telescopes	VERY-HIGH-ENERGY; DELAYED EMISSION; SEA-LEVEL; PROMPT; DURATION; MILAGRO; MISSION	In this paper we examine the possibility of the ground observation of the gigaelectronvolt counterparts associated with the Monitor of All-sky X-ray Image transient event (trigger 58072727) and the Swift GRB140512A event. In both cases, there was a muon excess with a statistical significance above 4s. The coordinates of the events were located in the field of view (FOV) of the Tupi muon telescopes at the time of the occurrence. Since 2013 August, the Tupi experiment has been operating a new extended array of five muon telescopes, located at ground level at (22 degrees.9S, 43 degrees.2W, 3 m above sea level). This location coincides with the South Atlantic Anomaly central region. We consider a hypothesis that the muon excess could be due to photonuclear reactions in the Earth's atmosphere induced by gamma. rays with energies above 10 GeV. We describe a data analysis for candidate events identified by internally triggered (by the Tupi experiment) as well as untriggered (dependent on external observations) modes of search. In light of the Fermi LAT (>100 MeV) gamma-ray bursts (GRBs) catalog, we examine the possibility of the ground observation of similar transient events within the FOV of the extended Tupi array and perform a systematic analysis of the Tupi data. Using a Monte Carlo simulation, we discuss the experimental conditions that allow the detection of signals from GRBs at ground level.	[Augusto, C. R. A.; Navia, C. E.; De Oliveira, M. N.; Tsui, K. H.] Univ Fed Fluminense, Inst Fis, BR-24210346 Rio De Janeiro, Brazil; [Nepomuceno, A. A.] Univ Fed Fluminense, Dept Fis Matemat ICT, BR-28890000 Rio Das Ostras, RJ, Brazil; [Sinzi, T.] Rikkyo Univ, Toshima Ku, Tokyo 171, Japan; [Atri, D.] Blue Marble Space Inst Sci, Seattle, WA 98109 USA	Augusto, CRA (reprint author), Univ Fed Fluminense, Inst Fis, BR-24210346 Rio De Janeiro, Brazil.	navia@if.uff.br			National Council for Research (CNPq) of Brazil [306605/2009-0, 01300.077189/2008-6]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [08458.009577/2011-81]	We would like to thank the referee for the thorough evaluation of the manuscript, valuable comments, and practical suggestions that have significantly improved the original text. This work is supported by the National Council for Research (CNPq) of Brazil, under grants No. 306605/2009-0 and No. 01300.077189/2008-6 and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) under grant No. 08458.009577/2011-81. This research has made use of data provided by the MAXI and Swift teams. We express our gratitude to the Goddard Space Flight Center for valuable information and data used in this study through the GCN web page (http://gcn.gsfc.nasa.gov/).	Abdo AA, 2009, ASTROPHYS J LETT, V706, pL138, DOI 10.1088/0004-637X/706/1/L138; Abdo A. A., 2009, SCI, V1688, P323; Abdo AA, 2007, ASTROPHYS J, V658, pL33, DOI 10.1086/513696; Abdo AA, 2007, ASTROPHYS J, V666, P361, DOI 10.1086/519763; Ackermann M, 2013, ASTROPHYS J SUPPL S, V209, DOI 10.1088/0067-0049/209/1/11; Preece RD, 1998, ASTROPHYS J, V506, pL23, DOI 10.1086/311644; Barth JL, 2003, IEEE T NUCL SCI, V50, P466, DOI 10.1109/TNS.2003.813131; Abdo AA, 2007, ASTROPHYS J, V664, pL91, DOI 10.1086/520717; HURLEY K, 1994, NATURE, V372, P652, DOI 10.1038/372652a0; Matsuoka M, 2009, PUBL ASTRON SOC JPN, V61, P999; Kumar P, 2008, MON NOT R ASTRON SOC, V384, P33, DOI 10.1111/j.1365-2966.2007.12621.x; Dmitriev A, 2008, ANN GEOPHYS-GERMANY, V26, P867; Gehrels N, 2004, ASTROPHYS J, V611, P1005, DOI 10.1086/422091; Augusto CRA, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/2/143; Augusto CRA, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.022001; Augusto CRA, 2010, ASTROPART PHYS, V34, P40, DOI 10.1016/j.astropartphys.2010.04.005; Augusto CRA, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.103003; Augusto CRA, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.042002; Barton C, 1997, J GEOMAGN GEOELECTR, V49, P121; Casadio S, 2011, ADV SPACE RES, V48, P1056, DOI 10.1016/j.asr.2011.05.014; Cilliers P. J., 2006, M P M CHAR ION NEUIL; De los Reyes R., 2006, IJMPA, V20, P7006; Fasso A., 2001, Physical Review D, V63, DOI 10.1103/PhysRevD.63.036002; Frontera F, 2000, ASTROPHYS J SUPPL S, V127, P59, DOI 10.1086/313316; Girolamo T. D., 2008, P 30 ICRC 3, V3, P1163; Gotz D., 2003, GCN CIRC, V2459, P1; Macmillan S, 2009, ANN GEOPHYS-ITALY, V52, P83; Mitrofanov IG, 1999, ASTROPHYS J, V523, P610, DOI 10.1086/307749; OLBERT S, 1954, PHYS REV, V96, P1400, DOI 10.1103/PhysRev.96.1400; Panaitescu A, 2000, ASTROPHYS J, V544, pL17, DOI 10.1086/317301; Pe'er A, 2004, ASTROPHYS J, V603, pL1, DOI 10.1086/382872; Racusin JL, 2008, NATURE, V455, P183, DOI 10.1038/nature07270; Soderberg AM, 2004, NATURE, V430, P648, DOI 10.1038/nature02757; Wang XY, 2001, ASTROPHYS J, V546, pL33, DOI 10.1086/318064; Zhang B, 2001, ASTROPHYS J, V559, P110, DOI 10.1086/322400	35	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	MAY 20	2015	805	1							69	10.1088/0004-637X/805/1/69		14	Astronomy & Astrophysics	Astronomy & Astrophysics	CI8BA	WOS:000354991300069		
J	Chong, SN; Imai, H; Diamond, PJ				Chong, Sze-Ning; Imai, Hiroshi; Diamond, Philip J.			WATER MASERS IN W43A: EARLY MORPHOLOGICAL CHANGES OF A FUTURE PLANETARY NEBULA	ASTROPHYSICAL JOURNAL			English	Article						circumstellar matter; masers; stars: AGB and post-AGB; stars: individual (W43A); stars: mass-loss; stars: winds, outflows	KELVIN-HELMHOLTZ INSTABILITIES; ASYMPTOTIC GIANT BRANCH; PREPLANETARY NEBULA; CIRCUMSTELLAR ENVELOPES; IRAS 18286-0959; PRECESSING JET; H2O MASERS; STARS; PROTOPLANETARY; EMISSION	We present the distribution patterns of H2O maser features in the "water fountain" source (WF) W43A and show that they are closely related to the early morphological changes in a planetary nebula (PN). Using the Very Long Baseline Array, we have detected H2O maser features in W43A in 13 epochs across > 10 yr. W43A is the only WF that has been observed for over a decade. We introduce a new cavity model scenario-a halo with a bipolar evacuated volume that has a partially enhanced wall-and compare it with the "traditional" precessing jet model particularly in terms of explaining the bow-shaped distribution patterns of H2O maser features in the most recent epochs and their temporal evolution. Long-term observations show that the distribution patterns require more than a single jet to form. Moreover, we have identified six groups of H2O maser features at both the redshifted and blueshifted sides with point symmetry. The six groups are believed to correspond to periodic mass profiles in the envelope and have recorded the mass-loss history. Together with a geometric similarity to the mid-infrared morphology of W43A, the results suggest that H2O masers can be used to trace the inner morphology and rapid temporal changes in evolved stars, especially where the PN shaping has just started.	[Chong, Sze-Ning; Imai, Hiroshi] Kagoshima Univ, Grad Sch Sci & Engn, Kagoshima 8900065, Japan; [Diamond, Philip J.] SKA Org, Jodrell Bank Observ, Macclesfield SK11 9DL, Cheshire, England	Chong, SN (reprint author), Kagoshima Univ, Grad Sch Sci & Engn, 1-21-35 Korimoto, Kagoshima 8900065, Japan.	chongsnco@gmail.com			Hayakawa Satio Fund awarded by the Astronomical Society of Japan; JSPS [20540234]	The VLBA/National Radio Astronomy Observatory is a facility of the National Science Foundation operated under a cooperative agreement by Associated Universities, Inc. This research was supported in part by a grant from the Hayakawa Satio Fund awarded by the Astronomical Society of Japan. H.I. has also been financially supported by a Grant-in-Aid for Scientific Research from JSPS (20540234). The authors wish to thank the anonymous referee for providing invaluable comments.	Imai H, 2005, ASTROPHYS J, V622, pL125, DOI 10.1086/429820; Nakashima J, 2003, PUBL ASTRON SOC JPN, V55, P229; Soker N, 2000, ASTROPHYS J, V538, P241, DOI 10.1086/309112; Beasley A. J., 1994, IAU S, V158, P105; Boboltz DA, 2007, ASTROPHYS J, V665, P680, DOI 10.1086/519067; BOWERS PF, 1980, ASTROPHYS J, V242, P1088, DOI 10.1086/158540; Chong SN, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/2/115; Claussen MJ, 2009, ASTROPHYS J, V691, P219, DOI 10.1088/0004-637X/691/1/219; Day FM, 2010, ASTROPHYS J, V713, P986, DOI 10.1088/0004-637X/713/2/986; Desmurs J.-F., 2012, IAU S, V287, P217; DIAMOND PJ, 1985, MON NOT R ASTRON SOC, V212, P1; Elitzur M., 1992, ASTRONOMICAL MASERS; Engels D, 2002, ASTRON ASTROPHYS, V388, P252, DOI 10.1051/0004-6361:20020483; Gomez J. F., 2011, APJ, V739, P14; Imai H, 2002, ASTROPHYS J, V567, P971, DOI 10.1086/338582; Imai H, 2013, ASTROPHYS J, V771, DOI 10.1088/0004-637X/771/1/47; Imai H, 2008, 9 EVN S ROL VLBI GLO, P60; Imai H, 2013, ASTROPHYS J, V773, DOI 10.1088/0004-637X/773/2/182; Imai H, 2002, NATURE, V417, P829, DOI 10.1038/nature00788; Imai H, 2007, ASTROPHYS J, V669, P424, DOI 10.1086/521350; Koning N, 2013, ASTROPHYS J, V765, DOI 10.1088/0004-637X/765/2/92; Kwok S, 2008, ASTROPHYS J, V689, P219, DOI 10.1086/592103; Lagadec E, 2011, MON NOT R ASTRON SOC, V417, P32, DOI 10.1111/j.1365-2966.2011.18557.x; LANE AP, 1987, ASTROPHYS J, V323, P756, DOI 10.1086/165869; Micono M, 1998, ASTRON ASTROPHYS, V333, P1001; Micono M, 1998, ASTRON ASTROPHYS, V333, P989; Nyman LA, 1998, ASTRON ASTROPHYS SUP, V127, P185, DOI 10.1051/aas:1998343; Richards AMS, 2012, ASTRON ASTROPHYS, V546, DOI 10.1051/0004-6361/201219514; Sahai R, 2005, ASTROPHYS J, V622, pL53, DOI 10.1086/429586; Steffen W, 2013, MON NOT R ASTRON SOC, V436, P470, DOI 10.1093/mnras/stt1583; Suarez O., 2012, IAU S, V287, P230; Suarez O, 2008, ASTROPHYS J, V689, P430, DOI 10.1086/592493; Velazquez PF, 2011, ASTROPHYS J, V734, DOI 10.1088/0004-637X/734/1/57; Walsh A. J., 2009, MNRAS, V394, P70; YOUNG K, 1992, ASTROPHYS J, V385, P265, DOI 10.1086/170934; Yung BHK, 2011, ASTROPHYS J, V741, DOI 10.1088/0004-637X/741/2/94	36	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	MAY 20	2015	805	1							53	10.1088/0004-637X/805/1/53		9	Astronomy & Astrophysics	Astronomy & Astrophysics	CI8BA	WOS:000354991300053		
J	Inoue, T; Omukai, K				Inoue, Tsuyoshi; Omukai, Kazuyuki			THERMAL INSTABILITY AND MULTI-PHASE INTERSTELLAR MEDIUM IN THE FIRST GALAXIES	ASTROPHYSICAL JOURNAL			English	Article						galaxies: formation; instabilities; shock waves; stars: formation	MOLECULAR CLOUD EVOLUTION; SUPERMASSIVE BLACK-HOLES; EARLY METAL ENRICHMENT; NEUTRAL ATOMIC PHASES; INITIAL MASS FUNCTION; STAR-FORMING CLOUDS; GALACTIC GAS CLOUD; H-II REGIONS; PRIMORDIAL STAR; BISTABLE FLOW	We examine the linear stability and nonlinear growth of the thermal instability in isobarically contracting background gas with various metallicities and far-UV (FUV) field strengths. Such a background medium can be expected for protogalactic clouds and shocked gas with metallicity Z/Z(circle dot) > 10(-4). When the H-2 cooling is suppressed by FUV fields (G(0) > 10(-3)) or the metallicity is high enough (> Z/Z(circle dot) 10(-3)), the interstellar medium (ISM) is thermally unstable in the temperature range 100-7000 K owing to the cooling by C II and O I fine-structure lines. In this case, a bi-phasic medium with a bimodal density probability distribution is formed as a consequence of the thermal instability. The characteristic scales of the thermal instability become smaller with increasing metallicity. Comparisons of the nonlinear simulations with different resolution indicates that the maximum scale of the thermal instability should be resolved with more than 60 cells to follow runaway cooling driven by the thermal instability. Under sufficiently weak FUV fields and with low metallicity, the density range of the thermal instability shrinks owing to the dominance of H-2 cooling. As the FUV intensity is reduced, the biphasic structure becomes less remarkable and eventually disappears. Our basic results suggest that, in early galaxies, (i) fragmentation by the nonlinear growth of thermal instability could determine the mass spectrum of star clusters for Z/Z(circle dot) less than or similar to 0.04, and (ii) a thermally bistable turbulent ISM like our galaxy becomes ubiquitous for Z/Z(circle dot) greater than or similar to 0.04, although the threshold metallicity depends on conditions such as thermal pressure, FUV strength, and redshift.	[Inoue, Tsuyoshi] Natl Astron Observ Japan, Div Theoret Astron, Mitaka, Tokyo 1810015, Japan; [Omukai, Kazuyuki] Tohoku Univ, Astron Inst, Aoba Ku, Sendai, Miyagi 9808578, Japan	Inoue, T (reprint author), Natl Astron Observ Japan, Div Theoret Astron, Osawa 2-21-1, Mitaka, Tokyo 1810015, Japan.	tsuyoshi.inoue@nao.ac.jp; omukai@astr.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [23740154, 26287030, 25287040]	The numerical computations were carried out on the XC30 system at the Center for Computational Astrophysics (CfCA) of the National Astronomical Observatory of Japan and in part on the K computer at the RIKEN Advanced Institute for Computational Science (No. hp120087). This work is supported by Grant-in-aids from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan (23740154, 26287030 TI; 25287040 KO).	Hennebelle P, 1999, ASTRON ASTROPHYS, V351, P309; HOLLENBACH D, 1989, ASTROPHYS J, V342, P306, DOI 10.1086/167595; Glover SCO, 2008, MON NOT R ASTRON SOC, V388, P1627, DOI 10.1111/j.1365-2966.2008.13224.x; SHAPIRO PR, 1987, ASTROPHYS J, V321, pL107, DOI 10.1086/185015; Bromm V, 2003, ASTROPHYS J, V596, P34, DOI 10.1086/377529; PARKER EN, 1953, ASTROPHYS J, V117, P431, DOI 10.1086/145707; RICHTMYER RD, 1960, COMMUN PUR APPL MATH, V13, P297, DOI 10.1002/cpa.3160130207; Hosokawa T, 2011, SCIENCE, V334, P1250, DOI 10.1126/science.1207433; BAKES ELO, 1994, ASTROPHYS J, V427, P822, DOI 10.1086/174188; Omukai K, 2003, ASTROPHYS J, V589, P677, DOI 10.1086/374810; FALL SM, 1985, ASTROPHYS J, V298, P18, DOI 10.1086/163585; Draine BT, 1996, ASTROPHYS J, V468, P269, DOI 10.1086/177689; Stacy A, 2012, MON NOT R ASTRON SOC, V422, P290, DOI 10.1111/j.1365-2966.2012.20605.x; Omukai K, 2003, ASTROPHYS J, V599, P746, DOI 10.1086/379319; SABANO Y, 1977, PUBL ASTRON SOC JPN, V29, P207; Koyama H, 2002, ASTROPHYS J, V564, pL97, DOI 10.1086/338978; Bromm V, 2001, MON NOT R ASTRON SOC, V328, P969, DOI 10.1046/j.1365-8711.2001.04915.x; Hennebelle P, 2000, ASTRON ASTROPHYS, V359, P1124; Heitsch F, 2005, ASTROPHYS J, V633, pL113, DOI 10.1086/498413; DEJONG T, 1980, ASTRON ASTROPHYS, V91, P68; FIELD GB, 1969, ASTROPHYS J, V155, pL149, DOI 10.1086/180324; Inoue T, 2009, ASTROPHYS J, V704, P161, DOI 10.1088/0004-637X/704/1/161; Heitsch F, 2008, ASTROPHYS J, V674, P316, DOI 10.1086/523697; Yoshida N, 2008, SCIENCE, V321, P669, DOI 10.1126/science.1160259; Dijkstra M, 2014, MON NOT R ASTRON SOC, V442, P2036, DOI 10.1093/mnras/stu1007; Vazquez-Semadeni E, 2007, ASTROPHYS J, V657, P870, DOI 10.1086/510771; Inoue T, 2008, ASTROPHYS J, V687, P303, DOI 10.1086/590528; Audit E, 2005, ASTRON ASTROPHYS, V433, P1, DOI 10.1051/0004-6361:20041474; Omukai K, 2005, ASTROPHYS J, V626, P627, DOI 10.1086/429955; Safranek-Shrader C, 2014, MON NOT R ASTRON SOC, V438, P1669, DOI 10.1093/mnras/stt2307; MATHIS JS, 1983, ASTRON ASTROPHYS, V128, P212; Heitsch F, 2006, ASTROPHYS J, V648, P1052, DOI 10.1086/505931; Agarwal B, 2014, MON NOT R ASTRON SOC, V443, P648, DOI 10.1093/mnras/stu1112; WOLFIRE MG, 1995, ASTROPHYS J, V443, P152, DOI 10.1086/175510; VANLEER B, 1979, J COMPUT PHYS, V32, P101, DOI 10.1016/0021-9991(79)90145-1; Koyama H, 2004, ASTROPHYS J, V602, pL25, DOI 10.1086/382478; Lee HH, 1996, ASTRON ASTROPHYS, V311, P690; Madau P, 2001, ASTROPHYS J, V555, P92, DOI 10.1086/321474; Bromm V, 1999, ASTROPHYS J, V527, pL5, DOI 10.1086/312385; GOLDSMITH PF, 1978, ASTROPHYS J, V222, P881, DOI 10.1086/156206; Banerjee R, 2009, MON NOT R ASTRON SOC, V398, P1082, DOI 10.1111/j.1365-2966.2009.15115.x; Hosokawa T, 2006, ASTROPHYS J, V646, P240, DOI 10.1086/504789; Hennebelle P, 2008, ASTROPHYS J, V684, P395, DOI 10.1086/589916; FIELD GB, 1965, ASTROPHYS J, V142, P531, DOI 10.1086/148317; HOLLENBACH D, 1979, ASTROPHYS J SUPPL S, V41, P555, DOI 10.1086/190631; Hennebelle P, 2008, ASTRON ASTROPHYS, V486, pL43, DOI 10.1051/0004-6361:200810165; Bromm V, 2002, ASTROPHYS J, V564, P23, DOI 10.1086/323947; Koyama H, 2000, ASTROPHYS J, V532, P980, DOI 10.1086/308594; Schneider R, 2002, ASTROPHYS J, V571, P30, DOI 10.1086/339917; Gnedin NY, 1997, ASTROPHYS J, V486, P581, DOI 10.1086/304548; SHAPIRO PR, 1987, ASTROPHYS J, V318, P32, DOI 10.1086/165350; BLACK JH, 1977, ASTROPHYS J SUPPL S, V34, P405, DOI 10.1086/190455; Abel T, 2002, SCIENCE, V295, P93, DOI 10.1126/science.1063991; Omukai K, 2002, MON NOT R ASTRON SOC, V332, P59, DOI 10.1046/j.1365-8711.2002.05276.x; Greif TH, 2013, MON NOT R ASTRON SOC, V434, P3408, DOI 10.1093/mnras/stt1251; Vazquez-Semadeni E, 2006, ASTROPHYS J, V643, P245, DOI 10.1086/502710; Omukai K, 2008, ASTROPHYS J, V686, P801, DOI 10.1086/591636; TIELENS AGGM, 1985, ASTROPHYS J, V291, P722, DOI 10.1086/163111; Hennebelle P, 2007, ASTRON ASTROPHYS, V465, P431, DOI 10.1051/0004-6361:20066139; Omukai K, 1998, ASTROPHYS J, V508, P141, DOI 10.1086/306395; Wolfire MG, 2003, ASTROPHYS J, V587, P278, DOI 10.1086/368016; Bromm V, 2003, ASTROPHYS J, V596, pL135, DOI 10.1086/379359; Mori M, 2002, ASTROPHYS J, V571, P40, DOI 10.1086/339913; Aota T, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/1/26; Audit E., 2010, ASTRON ASTROPHYS, V511, P76; Aykutalp A, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/2/63; Balbus SA, 1995, ASTR SOC P, V80, P328; Bialy S., 2014, ARXIV14096724; Burkert A, 2000, ASTROPHYS J, V537, P270, DOI 10.1086/308989; Corbelli E, 1997, ASTROPHYS J, V487, pL53, DOI 10.1086/310865; Federrath C., 2010, ASTRON ASTROPHYS, V512, P81; Gazol A, 2005, ASTROPHYS J, V630, P911, DOI 10.1086/430817; Gazol A, 2013, ASTROPHYS J, V765, DOI 10.1088/0004-637X/765/1/49; HABING HJ, 1968, B ASTRON I NETH, V19, P421; Heitsch F, 2001, ASTROPHYS J, V547, P280, DOI 10.1086/318335; Hennebelle P, 2007, ASTRON ASTROPHYS, V465, P445, DOI 10.1051/0004-6361:2006614; Hirano S, 2014, ASTROPHYS J, V781, DOI 10.1088/0004-637X/781/2/60; Inoue T, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/1/35; Inoue T, 2013, ASTROPHYS J LETT, V772, DOI 10.1088/2041-8205/772/2/L20; Kumar P, 2010, MON NOT R ASTRON SOC, V404, P2170, DOI 10.1111/j.1365-2966.2010.16437.x; Mckee CF, 2008, ASTROPHYS J, V681, P771, DOI 10.1086/587434; Millar TJ, 1997, ASTRON ASTROPHYS SUP, V121, P139, DOI 10.1051/aas:1997118; MURRAY SD, 1989, ASTROPHYS J, V339, P933, DOI 10.1086/167347; Nagakura T, 2009, MON NOT R ASTRON SOC, V399, P2183, DOI 10.1111/j.1365-2966.2009.15423.x; Nelson RP, 1997, ASTROPHYS J, V482, P796, DOI 10.1086/304167; Norman CA, 1997, ASTROPHYS J, V480, P145, DOI 10.1086/303940; Omukai K, 2000, ASTROPHYS J, V534, P809, DOI 10.1086/308776; PIKELNER SB, 1968, SOV ASTRON, V11, P737; Ritter JS, 2012, ASTROPHYS J, V761, DOI 10.1088/0004-637X/761/1/56; SCHWARZ J, 1972, ASTROPHYS J, V175, P673, DOI 10.1086/151588; SILK J, 1983, MON NOT R ASTRON SOC, V205, P705; Spitzer L, 1978, PHYS PROCESSES INTER; Suchkov Al. A., 1981, SOV ASTRON LETT, V7, P342; Susa H, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/1/32; Truelove J. K., 1997, APJ, V489, P179; Turk MJ, 2010, ASTROPHYS J LETT, V725, pL140, DOI 10.1088/2041-8205/725/2/L140; Vazquez-Semadeni E, 2003, LECT NOTES PHYS, V614, P213; Wishart A. W, 1979, MNRAS, V187, P59; Yamada M, 1998, ASTROPHYS J, V505, P148, DOI 10.1086/306131; YORKE HW, 1986, ANNU REV ASTRON ASTR, V24, P49, DOI 10.1146/annurev.astro.24.1.49; YOSHII Y, 1979, PUBL ASTRON SOC JPN, V31, P505; YOSHII Y, 1980, PUBL ASTRON SOC JPN, V32, P229	102	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	MAY 20	2015	805	1							73	10.1088/0004-637X/805/1/73		11	Astronomy & Astrophysics	Astronomy & Astrophysics	CI8BA	WOS:000354991300073		
J	Lewis, KM; Ochiai, H; Nagasawa, M; Ida, S				Lewis, K. M.; Ochiai, H.; Nagasawa, M.; Ida, S.			EXTRASOLAR BINARY PLANETS. II. DETECTABILITY BY TRANSIT OBSERVATIONS	ASTROPHYSICAL JOURNAL			English	Article						occultations; planets and satellites: detection; techniques: photometric	SPIN-ORBIT MISALIGNMENT; GIANT PLANETS; ECCENTRICITY DISTRIBUTION; EXOPLANETARY SYSTEM; REGULAR SATELLITES; MUTUAL TRANSITS; DOPPLER IMAGES; SCATTERING; EXOMOONS; ORIGIN	We discuss the detectability of gravitationally bound pairs of gas-giant planets (which we call "binary planets") in extrasolar planetary systems that are formed through orbital instability followed by planet-planet dynamical tides during their close encounters, based on the results of N-body simulations by Ochiai et al. (Paper I). Paper I showed that the formation probability of a binary is as much as similar to 10% for three giant planet systems that undergo orbital instability, and after post-capture long-term tidal evolution, the typical binary separation is three to five times the sum of the physical radii of the planets. The binary planets are stable during the main-sequence lifetime of solartype stars, if the stellarcentric semimajor axis of the binary is larger than 0.3 AU. We show that detecting modulations of transit light curves is the most promising observational method to detect binary planets. Since the likely binary separations are comparable to the stellar diameter, the shape of the transit light curve is different from transit to transit, depending on the phase of the binary's orbit. The transit durations and depth for binary planet transits are generally longer and deeper than those for the single planet case. We point out that binary planets could exist among the known inflated gas-giant planets or objects classified as false positive detections at orbital radii. 0.3 AU, propose a binary planet explanation for the CoRoT candidate SRc01 E2 1066, and show that binary planets are likely to be present in, and could be detected using, Kepler-quality data.	[Lewis, K. M.; Ida, S.] Tokyo Inst Technol, Earth Life Sci Inst, Meguro Ku, Tokyo 1528550, Japan; [Ochiai, H.] Tokyo Inst Technol, Earth & Planetary Sci, Meguro Ku, Tokyo 1528551, Japan; [Nagasawa, M.] Tokyo Inst Technol, Interact Res Ctr Sci, Meguro Ku, Tokyo 1528551, Japan	Lewis, KM (reprint author), Tokyo Inst Technol, Earth Life Sci Inst, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528550, Japan.	nagasawa.m.ad@m.titech.ac.jp			JSPS [23103005, 24-02764]	We are grateful for the offer of the gravitational lensing calculation program by Takahiro Sumi. We also thank Tristan Guillot and Rosemary Mardling for discussions on observations of binary planets. In addition, we thank Jessie Christiansen for advice on the Kepler pipeline. We also thank the anonymous referee for helpful comments that improved the quality of this paper. This research was supported by a grant for JSPS (23103005) Grant-in-aid for Scientific Research on Innovative Areas. K.M.L. was supported by JSPS KAKENHI grant No. 24-02764.	Strassmeier KG, 2002, ASTRON NACHR, V323, P309, DOI 10.1002/1521-3994(200208)323:3/4<309::AID-ASNA309>3.0.CO;2-U; Carter JA, 2011, SCIENCE, V331, P562, DOI 10.1126/science.1201274; Williams DM, 1997, NATURE, V385, P234, DOI 10.1038/385234a0; Sasaki T, 2010, ASTROPHYS J, V714, P1052, DOI 10.1088/0004-637X/714/2/1052; Canup RM, 2006, NATURE, V441, P834, DOI 10.1038/nature04860; Nagasawa M, 2008, ASTROPHYS J, V678, P498, DOI 10.1086/529369; Chatterjee S, 2008, ASTROPHYS J, V686, P580, DOI 10.1086/590227; Juric M, 2008, ASTROPHYS J, V686, P603, DOI 10.1086/590047; Marzari F, 2002, ICARUS, V156, P570, DOI 10.1006/icar.2001.6786; Winn JN, 2009, ASTROPHYS J, V700, P302, DOI 10.1088/0004-637X/700/1/302; Cabrera J, 2007, ASTRON ASTROPHYS, V464, P1133, DOI 10.1051/0004-6361:20066111; Chambers JE, 1996, ICARUS, V119, P261, DOI 10.1006/icar.1996.0019; Heller R, 2013, ASTROBIOLOGY, V13, P18, DOI 10.1089/ast.2012.0859; Mosqueira I, 2003, ICARUS, V163, P232, DOI 10.1016/S0019-1035(03)00077-0; Auvergne M, 2009, ASTRON ASTROPHYS, V506, P411, DOI 10.1051/0004-6361/200810860; VOGT SS, 1983, PUBL ASTRON SOC PAC, V95, P565, DOI 10.1086/131208; Mosqueira I, 2003, ICARUS, V163, P198, DOI 10.1016/S0019-1035(03)00076-9; Lin DNC, 1997, ASTROPHYS J, V477, P781, DOI 10.1086/303738; Sartoretti P, 1999, ASTRON ASTROPHYS SUP, V134, P553, DOI 10.1051/aas:1999148; Barnes JW, 2013, ASTROPHYS J, V774, DOI 10.1088/0004-637X/774/1/53; Beauge C, 2012, ASTROPHYS J, V751, DOI 10.1088/0004-637X/751/2/119; Borucki W., 2008, IAU S, P17; Erikson A, 2012, ASTRON ASTROPHYS, V539, DOI 10.1051/0004-6361/201116934; Gong YX, 2013, ASTROPHYS J LETT, V769, DOI 10.1088/2041-8205/769/1/L14; Heller R., 2012, ASTRON ASTROPHYS, V545, P8; Herrero E, 2013, ASTRON ASTROPHYS, V553, DOI 10.1051/0004-6361/201220518; Hirano T, 2012, ASTROPHYS J LETT, V759, DOI 10.1088/2041-8205/759/2/L36; Ida S, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/1/42; Kaltenegger L, 2010, ASTROPHYS J LETT, V712, pL125, DOI 10.1088/2041-8205/712/2/L125; Kipping DM, 2009, MON NOT R ASTRON SOC, V392, P181, DOI 10.1111/j.1365-2966.2008.13999.x; Kipping DM, 2009, MON NOT R ASTRON SOC, V396, P1797, DOI 10.1111/j.1365-2966.2009.14869.x; Kipping DM, 2012, MON NOT R ASTRON SOC, V421, P1166, DOI 10.1111/j.1365-2966.2011.20376.x; Lewis KM, 2013, MON NOT R ASTRON SOC, V430, P1473, DOI 10.1093/mnras/sts234; Miller BP, 2012, ASTROPHYS J, V754, DOI 10.1088/0004-637X/754/2/137; Namouni F, 2010, ASTROPHYS J LETT, V719, pL145, DOI 10.1088/2041-8205/719/2/L145; Narita N., 2009, PASJ, V61, P35; Ochiai H, 2014, ASTROPHYS J, V790, DOI 10.1088/0004-637X/790/2/92; Pagano I, 2009, EARTH MOON PLANETS, V105, P373, DOI 10.1007/s11038-009-9301-3; Pal A, 2012, MON NOT R ASTRON SOC, V420, P1630, DOI 10.1111/j.1365-2966.2011.20151.x; Pierce K, 2000, ALLENS ASTROPHYSICAL; Podsiadlowski P., 2010, ARXIV10071418; Sanchis-Ojeda R., 2012, NATUR, V7408, P449; Sanchis-Ojeda R, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/1/61; Sasaki T, 2012, ASTROPHYS J, V754, DOI 10.1088/0004-637X/754/1/51; Sato M, 2009, PUBL ASTRON SOC JPN, V61, pL29; Scandariato G., 2013, Astronomy & Astrophysics, V552, DOI 10.1051/0004-6361/201219875; Simon A, 2007, ASTRON ASTROPHYS, V470, P727, DOI 10.1051/0004-6361:20066560; VOGT SS, 1987, ASTROPHYS J, V321, P496, DOI 10.1086/165647; Zhuang QT, 2012, ASTROPHYS J, V758, DOI 10.1088/0004-637X/758/2/111	49	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	MAY 20	2015	805	1							27	10.1088/0004-637X/805/1/27		13	Astronomy & Astrophysics	Astronomy & Astrophysics	CI8BA	WOS:000354991300027		
J	Liu, T; Gu, WM; Kawanaka, N; Li, A				Liu, Tong; Gu, Wei-Min; Kawanaka, Norita; Li, Ang			VERTICAL CONVECTION IN NEUTRINO-DOMINATED ACCRETION FLOWS	ASTROPHYSICAL JOURNAL			English	Article						accretion, accretion disks; black hole physics; convection; gamma-ray burst: general; neutrinos	GAMMA-RAY BURSTS; BLACK-HOLES; JET PRECESSION; CENTRAL ENGINE; DISKS; ADVECTION; MERGERS; FLARES; SLIM; STABILITY	We present the effects of vertical convection on the structure and luminosity of the neutrino-dominated accretion flow (NDAF) around a stellar-mass black hole in spherical coordinates. We find that the convective energy transfer can suppress the radial advection in the NDAF and that the density, temperature, and opening angle are slightly changed.. As a result, the neutrino and annihilation luminosities are increased, which allows the energy requirement of gamma-ray bursts to be achieved.	[Liu, Tong; Gu, Wei-Min; Li, Ang] Xiamen Univ, Dept Astron, Xiamen 361005, Fujian, Peoples R China; [Liu, Tong; Gu, Wei-Min; Li, Ang] Xiamen Univ, Inst Theoret Phys & Astrophys, Xiamen 361005, Fujian, Peoples R China; [Liu, Tong] Chinese Acad Sci, Key Lab Struct & Evolut Celestial Objects, Kunming 650011, Yunnan, Peoples R China; [Liu, Tong; Li, Ang] Chinese Acad Sci, Inst Theoret Phys, State Key Lab Theoret Phys, Beijing 100190, Peoples R China; [Liu, Tong; Gu, Wei-Min; Li, Ang] Xiamen Univ, Joint Ctr Astrophys, SHAO XMU, Xiamen 361005, Fujian, Peoples R China; [Kawanaka, Norita] Univ Tokyo, Grad Sch Sci, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan	Liu, T (reprint author), Xiamen Univ, Dept Astron, Xiamen 361005, Fujian, Peoples R China.	tongliu@xmu.edu.cn; norita@astron.s.u-tokyo.ac.jp			National Basic Research Program of China (973 Program) [2014CB845800]; National Natural Science Foundation of China [11222328, 11233006, 11333004, 11373002, 11473022, U1331101, U1431107]; CAS Open Research Program of the Key Laboratory for the Structure and Evolution of Celestial Objects [OP201305]	This work was supported by the National Basic Research Program of China (973 Program) under grant 2014CB845800, the National Natural Science Foundation of China under grants 11222328, 11233006, 11333004, 11373002, 11473022, U1331101, and U1431107, and the CAS Open Research Program of the Key Laboratory for the Structure and Evolution of Celestial Objects under grant OP201305.	Setiawan S, 2006, ASTRON ASTROPHYS, V458, P553, DOI 10.1051/0004-6361:20054193; Kawanaka N, 2007, ASTROPHYS J, V662, P1156, DOI 10.1086/517985; Liu T, 2010, ASTROPHYS J, V709, P851, DOI 10.1088/0004-637X/709/2/851; NARAYAN R, 1995, ASTROPHYS J, V444, P231, DOI 10.1086/175599; Lei WH, 2009, ASTROPHYS J, V700, P1970, DOI 10.1088/0004-637X/700/2/1970; Kohri K, 2002, ASTROPHYS J, V577, P311, DOI 10.1086/342166; MOCHKOVITCH R, 1993, NATURE, V361, P236, DOI 10.1038/361236a0; Janiuk A, 2007, ASTROPHYS J, V664, P1011, DOI 10.1086/518761; Di Matteo T, 2002, ASTROPHYS J, V579, P706, DOI 10.1086/342832; Gu WM, 2009, PUBL ASTRON SOC JPN, V61, P1313; Narayan R, 2001, ASTROPHYS J, V557, P949, DOI 10.1086/322267; Kawanaka N, 2012, MON NOT R ASTRON SOC, V419, P713, DOI 10.1111/j.1365-2966.2011.19733.x; Gu WM, 2006, ASTROPHYS J, V643, pL87, DOI 10.1086/505140; Chen WX, 2007, ASTROPHYS J, V657, P383, DOI 10.1086/508923; Hou SJ, 2014, MON NOT R ASTRON SOC, V441, P2375, DOI 10.1093/mnras/stu682; Kohri K, 2005, ASTROPHYS J, V629, P341, DOI 10.1086/431354; ABRAMOWICZ MA, 1988, ASTROPHYS J, V332, P646, DOI 10.1086/166683; Liu T, 2012, ASTROPHYS SPACE SCI, V337, P711, DOI 10.1007/s10509-011-0887-3; Ruffert M, 1999, ASTRON ASTROPHYS, V344, P573; Popham R, 1999, ASTROPHYS J, V518, P356, DOI 10.1086/307259; Liu T, 2007, ASTROPHYS J, V661, P1025, DOI 10.1086/513689; Lee WH, 2005, ASTROPHYS J, V632, P421, DOI 10.1086/432373; Reynoso MM, 2006, ASTRON ASTROPHYS, V454, P11, DOI [10.1051/0004-6361:20054564, 10.1051/0004-6361:2004564]; Liu T, 2008, ASTROPHYS J, V676, P545, DOI 10.1086/527670; Xue L, 2005, ASTROPHYS J, V623, P372, DOI 10.1086/428338; Just O, 2015, MON NOT R ASTRON SOC, V448, P541, DOI 10.1093/mnras/stv009; Bisnovatyi-Kogan G. S., 1977, ASTRON ASTROPHYS, V59, P11; Blaes O, 2001, ASTROPHYS J, V553, P987, DOI 10.1086/320968; Caballero OL, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/2/170; Carballido A, 2011, ASTROPHYS J LETT, V727, DOI 10.1088/2041-8205/727/2/L41; Jiang YF, 2014, ASTROPHYS J, V796, DOI 10.1088/0004-637X/796/2/106; Fernandez R, 2013, MON NOT R ASTRON SOC, V435, P502, DOI 10.1093/mnras/stt1312; Gu WM, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/2/118; Gu WM, 2015, ASTROPHYS J, V799, DOI 10.1088/0004-637X/799/1/71; Hou SJ, 2014, ASTROPHYS J LETT, V781, DOI 10.1088/2041-8205/781/1/L19; Janiuk A, 2004, MON NOT R ASTRON SOC, V355, P950, DOI 10.1111/j.1365-2966.2004.08377.x; Janiuk A, 2010, ASTRON ASTROPHYS, V509, DOI 10.1051/0004-6361/200912725; Janiuk A, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/2/105; Kato S., 2008, BLACK HOLE ACCRETION; Kawabata R, 2008, ASTROPHYS J, V675, P596, DOI 10.1086/524841; Kawanaka N, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/1/31; Lazzati D, 2008, MON NOT R ASTRON SOC, V388, pL15, DOI 10.1111/j.1745-3933.2008.00490.x; Lee WH, 2009, ASTROPHYS J LETT, V699, pL93, DOI 10.1088/0004-637X/699/2/L93; Lee WH, 2004, ASTROPHYS J, V608, pL5, DOI 10.1086/422217; Lei WH, 2007, ASTRON ASTROPHYS, V468, P563, DOI 10.1051/0004-6361:20066219; Li A, 2013, ASTRON ASTROPHYS, V555, DOI 10.1051/0004-6361/201321705; Liu T, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/2/102; Liu T, 2010, ASTRON ASTROPHYS, V516, DOI 10.1051/0004-6361/200913447; Liu T, 2011, CHINESE PHYS LETT, V28, DOI 10.1088/0256-307X/28/12/129802; Liu T, 2014, ASTROPHYS J, V791, DOI 10.1088/0004-637X/791/1/69; Liu T, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/1/63; Luo Y, 2013, ASTROPHYS J, V773, DOI 10.1088/0004-637X/773/2/142; MILSOM JA, 1994, ASTROPHYS J, V421, P668, DOI 10.1086/173680; Pan Z, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/2/82; Romero GE, 2010, ASTRON ASTROPHYS, V524, DOI 10.1051/0004-6361/201014882; Sadowski A, 2009, ASTRON ASTROPHYS, V502, P7, DOI 10.1051/0004-6361/200911846; Sadowski A, 2011, ASTRON ASTROPHYS, V527, DOI 10.1051/0004-6361/201015256; Sawyer RF, 2003, PHYS REV D, V68, DOI 10.1103/PhysRevD.68.063001; Sekiguchi Y, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/1/6; SHAKURA NI, 1978, ASTRON ASTROPHYS, V62, P179; Sun MY, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/1/31; Xue L, 2013, ASTROPHYS J SUPPL S, V207, DOI 10.1088/0067-0049/207/2/23; Zhang D, 2009, ASTROPHYS J, V703, P461, DOI 10.1088/0004-637X/703/1/461	63	2	2	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	MAY 20	2015	805	1							37	10.1088/0004-637X/805/1/37		6	Astronomy & Astrophysics	Astronomy & Astrophysics	CI8BA	WOS:000354991300037		
J	Masuda, K				Masuda, Kento			SPIN-ORBIT ANGLES OF KEPLER-13Ab AND HAT-P-7b FROM GRAVITY-DARKENED TRANSIT LIGHT CURVES	ASTROPHYSICAL JOURNAL			English	Article						planets and satellites: individual (Kepler-13, KOI-13, KIC 9941, HAT-P-7, KOI-2, KIC 10666592); stars: rotation; techniques: photometric	HOT JUPITERS; EXOPLANETARY SYSTEMS; EXTRASOLAR PLANETS; STELLAR ROTATION; DWARF COMPANION; PHASE CURVES; STARS; MISALIGNMENT; EVOLUTION; ALIGNMENT	Analysis of the transit light curve deformed by the stellar gravity darkening allows us to photometrically measure both components of the spin-orbit angle psi, its sky projection lambda and inclination of the stellar spin axis i(star). In this paper, we apply the method to two transiting hot Jupiter systems monitored with the Kepler spacecraft, Kepler-13A and HAT-P-7. For Kepler-13A, we find i(star) = 81 degrees +/- 5 degrees and psi = 60 degrees +/- 2 degrees adopting the spectroscopic constraint lambda = 58.6 +/- 2.0 by Johnson et al. In our solution, the discrepancy between the above lambda and that previously reported by Barnes et al. is solved by fitting both of the parameters in the quadratic limb-darkening law. We also report the temporal variation in the orbital inclination of Kepler-13Ab, d vertical bar cos i(orb)vertical bar/dt = (-7.0 +/- 0.4) x 10(-6) days(-1), providing further evidence for the spin-orbit precession in this system. By fitting the precession model to the time series of i(orb), lambda, and i(star) obtained with the gravity-darkened model, we constrain the stellar quadrupole moment J(2)=(6.1 +/- 0.3) x 10(-5) for our new solution, which is several times smaller than J(2)=(1.66 +/- 0.08) x 10(-4) obtained for the previous one. We show that the difference can be observable in the future evolution of lambda, thus providing a possibility to test our solution with follow-up observations. The second target, HAT-P-7, is the first F-dwarf star analyzed with the gravity-darkening method. Our analysis points to a nearly pole-on configuration with psi = 101 degrees +/- 2 degrees or 87 degrees +/- 2 degrees and the gravity-darkening exponent beta consistent with 0.25. Such an observational constraint on beta can be useful for testing the theory of gravity darkening. Key words:	Univ Tokyo, Dept Phys, Tokyo 1130033, Japan	Masuda, K (reprint author), Univ Tokyo, Dept Phys, Tokyo 1130033, Japan.	masuda@utap.phys.s.u-tokyo.ac.jp			JSPS [26-7182]; Leading Graduate Course for Frontiers of Mathematical Sciences and Physics	The author is grateful to the entire Kepler team for the revolutionary data. The author wishes to thank the referee, Jason Barnes, for his valuable suggestions that improved the manuscript. The author also thanks Othman Benomar, Shoya Kamiaka, Hajime Kawahara, Masamune Oguri, and Yasushi Suto for helpful discussions and insightful comments. The data analysis was in part carried out on the common use data analysis computer system at the Astronomy Data Center, ADC, of the National Astronomical Observatory of Japan. K.M. is supported by JSPS Research Fellowships for Young Scientists (No. 26-7182) and by the Leading Graduate Course for Frontiers of Mathematical Sciences and Physics.	Ahlers JP, 2014, ASTROPHYS J, V786, DOI 10.1088/0004-637X/786/2/131; Albrecht S, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/1/18; Winn JN, 2010, ASTROPHYS J LETT, V718, pL145, DOI 10.1088/2041-8205/718/2/L145; Mandel K, 2002, ASTROPHYS J, V580, pL171, DOI 10.1086/345520; Foreman-Mackey D, 2013, PUBL ASTRON SOC PAC, V125, P306, DOI 10.1086/670067; Bate MR, 2010, MON NOT R ASTRON SOC, V401, P1505, DOI 10.1111/j.1365-2966.2009.15773.x; Meibom S, 2009, ASTROPHYS J, V695, P679, DOI 10.1088/0004-637X/695/1/679; Szabo GM, 2012, MON NOT R ASTRON SOC, V421, pL122, DOI 10.1111/j.1745-3933.2012.01219.x; Fabrycky DC, 2009, ASTROPHYS J, V696, P1230, DOI 10.1088/0004-637X/696/2/1230; Storch NI, 2014, SCIENCE, V345, P1317, DOI 10.1126/science.1254358; Lai D, 2011, MON NOT R ASTRON SOC, V412, P2790, DOI 10.1111/j.1365-2966.2010.18127.x; Pal A, 2008, ASTROPHYS J, V680, P1450, DOI 10.1086/588010; Monnier JD, 2007, SCIENCE, V317, P342, DOI 10.1126/science.1143205; Boue G, 2009, ICARUS, V201, P750, DOI 10.1016/j.icarus.2009.02.001; Barnes JW, 2009, ASTROPHYS J, V705, P683, DOI 10.1088/0004-637X/705/1/683; Barnes JW, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/1/10; Barnes JW, 2013, ASTROPHYS J, V774, DOI 10.1088/0004-637X/774/1/53; Benomar O, 2014, PUBL ASTRON SOC JPN, V66, DOI 10.1093/pasj/psu069; Borucki WJ, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/1/19; Claret A, 1998, ASTRON ASTROPHYS SUP, V131, P395, DOI 10.1051/aas:1998278; Lara FE, 2011, ASTRON ASTROPHYS, V533, DOI 10.1051/0004-6361/201117252; Lara FE, 2012, ASTRON ASTROPHYS, V547, DOI 10.1051/0004-6361/201219942; Esteves LJ, 2013, ASTROPHYS J, V772, DOI 10.1088/0004-637X/772/1/51; Esteves L. J., 2014, ARXIV14072245; Faigler S, 2015, ASTROPHYS J, V800, DOI 10.1088/0004-637X/800/1/73; Fielding D. B., 2014, ARXIV14095148; Jackson BK, 2012, ASTROPHYS J, V751, DOI 10.1088/0004-637X/751/2/112; Johnson MC, 2014, ASTROPHYS J, V790, DOI 10.1088/0004-637X/790/1/30; Li GJ, 2014, ASTROPHYS J, V794, DOI 10.1088/0004-637X/794/2/131; LUCY LB, 1967, Z ASTROPHYS, V65, P89; Lund MN, 2014, ASTRON ASTROPHYS, V570, DOI 10.1051/0004-6361/201424326; Markwardt CB, 2009, ASTR SOC P, V411, P251; Morris BM, 2013, ASTROPHYS J LETT, V764, DOI 10.1088/2041-8205/764/2/L22; Narita N, 2009, PUBL ASTRON SOC JPN, V61, pL35; Philippov AA, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/2/112; Shporer A, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/1/92; Sing DK, 2010, ASTRON ASTROPHYS, V510, DOI 10.1051/0004-6361/200913675; Southworth J, 2008, MON NOT R ASTRON SOC, V386, P1644, DOI 10.1111/j.1365-2966.2008.13145.x; Szabo GM, 2011, ASTROPHYS J LETT, V736, DOI 10.1088/2041-8205/736/1/L4; Szabo GM, 2014, MON NOT R ASTRON SOC, V437, P1045, DOI 10.1093/mnras/stt1724; Van Eylen V, 2013, ASTROPHYS J LETT, V774, DOI 10.1088/2041-8205/774/2/L19; Von Zeipel H., 1924, Monthly Notices of the Royal Astronomical Society, V84; Winn JN, 2009, ASTROPHYS J, V693, P794, DOI 10.1088/0004-637X/693/1/794; Winn JN, 2009, ASTROPHYS J LETT, V703, pL99, DOI 10.1088/0004-637X/703/2/L99; Xue YX, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/1/66; Zhou G, 2013, ASTROPHYS J LETT, V776, DOI 10.1088/2041-8205/776/2/L35	46	6	6	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	MAY 20	2015	805	1							28	10.1088/0004-637X/805/1/28		14	Astronomy & Astrophysics	Astronomy & Astrophysics	CI8BA	WOS:000354991300028		
J	Meng, HYA; Su, KYL; Rieke, GH; Rujopakarn, W; Myers, G; Cook, M; Erdelyi, E; Maloney, C; McMath, J; Persha, G; Poshyachinda, S; Reichart, DE				Meng, Huan Y. A.; Su, Kate Y. L.; Rieke, George H.; Rujopakarn, Wiphu; Myers, Gordon; Cook, Michael; Erdelyi, Emery; Maloney, Chris; McMath, James; Persha, Gerald; Poshyachinda, Saran; Reichart, Daniel E.			PLANETARY COLLISIONS OUTSIDE THE SOLAR SYSTEM: TIME DOMAIN CHARACTERIZATION OF EXTREME DEBRIS DISKS	ASTROPHYSICAL JOURNAL			English	Article						circumstellar matter; infrared: planetary systems; planets and satellites: dynamical evolution and stability; stars: individual (2MASS J08090250-4858172, 2MASS J07354269-1450422, HD 15407A, HD 23514, HD 145263, BD+20 307)	SPITZER-SPACE-TELESCOPE; SUN-LIKE STARS; WARM DUST; HYPERVELOCITY IMPACT; INFRARED VARIABILITY; SCORPIUS-CENTAURUS; CIRCUMSTELLAR DISK; PLEIADES STAR; GIANT IMPACT; MASS STARS	Luminous debris disks of warm dust in the terrestrial planet zones around solar-like stars were recently found to vary, which is indicative of ongoing large-scale collisions of rocky objects. We use Spitzer 3.6 and 4.5 mu m timeseries observations in 2012 and 2013 (extended to 2014 in one case) to monitor five more debris disks with unusually high fractional luminosities ("extreme debris disk"), including P1121 in the open cluster M47 (80 Myr), HD 15407A in the AB Dor moving group (80 Myr), HD 23514 in the Pleiades (120 Myr), HD 145263 in the Upper Sco Association (10 Myr), and the field star BD+20 307 (greater than or similar to 1 Gyr). Together with the published results for ID8 in NGC 2547 (35 Myr), this makes the first systematic time-domain investigation of planetary impacts outside the solar system. Significant variations with timescales shorter than a year are detected in five out of the six extreme debris disks we monitored. However, different systems show diverse sets of characteristics in the time domain, including long-term decay or growth, disk temperature variations, and possible periodicity.	[Meng, Huan Y. A.; Rieke, George H.; Rujopakarn, Wiphu] Univ Arizona, Dept Planetary Sci, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Meng, Huan Y. A.; Su, Kate Y. L.; Rieke, George H.] Univ Arizona, Dept Astron, Steward Observ, Tucson, AZ 85721 USA; [Rujopakarn, Wiphu] Chulalongkorn Univ, Fac Sci, Dept Phys, Bangkok 10330, Thailand; [Rujopakarn, Wiphu] Univ Tokyo, Todai Inst Adv Study, Kavli Inst Phys & Math Universe WPI, Kashiwa, Chiba 2778583, Japan; [Myers, Gordon; Cook, Michael; Erdelyi, Emery; Maloney, Chris; McMath, James; Persha, Gerald] Amer Assoc Variable Star Observers, Cambridge, MA 02138 USA; [Poshyachinda, Saran] Minist Sci & Technol, Natl Astron Res Inst Thailand Publ Org, Chiang Mai 50200, Thailand; [Reichart, Daniel E.] Univ N Carolina, Dept Phys & Astron, Chapel Hill, NC 27599 USA	Meng, HYA (reprint author), Univ Arizona, Dept Planetary Sci, Lunar & Planetary Lab, 1629 East Univ Blvd, Tucson, AZ 85721 USA.	hyameng@lpl.arizona.edu			Caltech/JPL to the University of Arizona [1255094, 1256424]; NASA [NNX10AD38G]	We acknowledge with thanks the variable star observations from the AAVSO International Database contributed by observers worldwide and used in this research. The authors would like to thank Alycia Weinberger for providing the published IRS spectrum of BD+20 307, and Rui Wang for the help in illustration preparation. This work is based on observations made with the Spitzer Space Telescope, which is operated by the Jet Propulsion Laboratory, California Institute of Technology under a contract with NASA. This work was partially supported by contracts 1255094 and 1256424 from Caltech/JPL to the University of Arizona, and by NASA Grant NNX10AD38G.	Wyatt MC, 2002, MON NOT R ASTRON SOC, V334, P589, DOI 10.1046/j.1365-8711.2002.05533.x; Rieke GH, 2004, ASTROPHYS J SUPPL S, V154, P25, DOI 10.1086/422717; Cuk M, 2012, SCIENCE, V338, P1047, DOI 10.1126/science.1225542; Houck JR, 2004, ASTROPHYS J SUPPL S, V154, P18, DOI 10.1086/423134; Gorlova N, 2004, ASTROPHYS J SUPPL S, V154, P448, DOI 10.1086/422822; Droege TF, 2006, PUBL ASTRON SOC PAC, V118, P1666, DOI 10.1086/510197; SPITZER WG, 1961, PHYS REV, V121, P1324, DOI 10.1103/PhysRev.121.1324; Skrutskie MF, 2006, ASTRON J, V131, P1163, DOI 10.1086/498708; Hog E, 2000, ASTRON ASTROPHYS, V355, pL27; Johnson BC, 2014, ICARUS, V228, P347, DOI 10.1016/j.icarus.2013.10.022; Kenyon SJ, 2005, ASTRON J, V130, P269, DOI 10.1086/430461; Plavchan P, 2008, ASTROPHYS J SUPPL S, V175, P191, DOI 10.1086/523644; Canup RM, 2012, SCIENCE, V338, P1052, DOI 10.1126/science.1226073; Canup RM, 2004, ANNU REV ASTRON ASTR, V42, P441, DOI 10.1146/annurev.astro.41.082201.113457; Johnson BC, 2012, ICARUS, V217, P416, DOI 10.1016/j.icarus.2011.11.020; Melis C, 2012, NATURE, V487, P74, DOI 10.1038/nature11210; Melis C, 2010, ASTROPHYS J LETT, V717, pL57, DOI 10.1088/2041-8205/717/1/L57; Rieke GH, 2005, ASTROPHYS J, V620, P1010, DOI 10.1086/426937; Allard F, 2011, ASTR SOC P, V448, P91; Rhee JH, 2008, ASTROPHYS J, V675, P777, DOI 10.1086/524935; Wyatt MC, 2007, ASTROPHYS J, V658, P569, DOI 10.1086/510999; DOHNANYI JS, 1969, J GEOPHYS RES, V74, P2531, DOI 10.1029/JB074i010p02531; Morishima R, 2010, ICARUS, V207, P517, DOI 10.1016/j.icarus.2009.11.038; Lisse CM, 2009, ASTROPHYS J, V701, P2019, DOI 10.1088/0004-637X/701/2/2019; Farihi J, 2009, ASTROPHYS J, V694, P805, DOI 10.1088/0004-637X/694/2/805; Kenyon SJ, 2006, ASTRON J, V131, P1837, DOI 10.1086/499807; Fazio GG, 2004, ASTROPHYS J SUPPL S, V154, P10, DOI 10.1086/422843; Ida S, 1997, NATURE, V389, P353, DOI 10.1038/38669; Morlok A, 2014, ICARUS, V239, P1, DOI 10.1016/j.icarus.2014.05.024; OUDMAIJER RD, 1992, ASTRON ASTROPHYS SUP, V96, P625; Jackson AP, 2012, MON NOT R ASTRON SOC, V425, P657, DOI 10.1111/j.1365-2966.2012.21546.x; Su KYL, 2006, ASTROPHYS J, V653, P675, DOI 10.1086/508649; Chambers JE, 2013, ICARUS, V224, P43, DOI 10.1016/j.icarus.2013.02.015; Arellano ER, 1997, ASTRON ASTROPHYS SUP, V123, P25, DOI 10.1051/aas:1997303; Artymowicz P, 1997, ANNU REV EARTH PL SC, V25, P175, DOI 10.1146/annurev.earth.25.1.175; Backman D. E., 1993, PROTOSTARS PLANETS, P1253; Balog Z, 2009, ASTROPHYS J, V698, P1989, DOI 10.1088/0004-637X/698/2/1989; Castelli F., 2004, ARXIVASTROPH0405087; Cody AM, 2014, ASTRON J, V147, DOI 10.1088/0004-6256/147/4/82; Fekel FC, 2012, ASTROPHYS J, V749, DOI 10.1088/0004-637X/749/1/7; Flaherty KM, 2013, ASTRON J, V145, DOI 10.1088/0004-6256/145/3/66; Fressin F, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/2/81; Fujiwara H, 2012, ASTROPHYS J LETT, V749, DOI 10.1088/2041-8205/749/2/L29; Fujiwara H, 2012, ASTROPHYS J LETT, V759, DOI 10.1088/2041-8205/759/1/L18; Gaspar A, 2012, ASTROPHYS J, V754, DOI 10.1088/0004-637X/754/1/74; Gaspar A, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/1/25; Gorlova N, 2007, ASTROPHYS J, V670, P516, DOI 10.1086/521671; Grigorieva A, 2007, ASTRON ASTROPHYS, V461, P537, DOI 10.1051/0004-6361:20065210; Honda M, 2003, ASTROPHYS J, V585, pL59, DOI 10.1086/374034; Honda M, 2004, ASTROPHYS J, V610, pL49, DOI 10.1086/423242; Hulot J. C., 2011, ARXIV11042185; Janson M, 2013, ASTROPHYS J, V773, DOI 10.1088/0004-637X/773/2/170; Johnson BC, 2012, ASTROPHYS J, V761, DOI 10.1088/0004-637X/761/1/45; Kallinger T, 2008, ASTRON ASTROPHYS, V481, P571, DOI 10.1051/0004-6361:20077559; Lebouteiller V, 2011, ASTROPHYS J SUPPL S, V196, DOI 10.1088/0067-0049/196/1/8; Meng HYA, 2012, ASTROPHYS J LETT, V751, DOI 10.1088/2041-8205/751/1/L17; Meng HYA, 2014, SCIENCE, V345, P1032, DOI 10.1126/science.1255153; Morales FY, 2011, ASTROPHYS J LETT, V730, DOI [10.1088/2041-8205/730/2/L29, 10.1088/0004-637X/730/2/L29]; Ofek EO, 2008, PUBL ASTRON SOC PAC, V120, P1128, DOI 10.1086/592456; Olofsson J., 2012, ASTRON ASTROPHYS, V542, P90; Pecaut MJ, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/2/154; Perryman M. A. C., 1997, ASTRON ASTROPHYS, V323, P49; Prisinzano L, 2003, ASTRON ASTROPHYS, V404, P927, DOI 10.1051/0004-6361:20030524; Quillen A. C., 2003, MNRAS, V380, P1642; Raymond S. N., 2014, PROTOSTARS PLANETS, P595; Rebull LM, 2014, ASTRON J, V148, DOI 10.1088/0004-6256/148/5/92; Reegen P, 2007, ASTRON ASTROPHYS, V467, P1353, DOI 10.1051/0004-6361:20066597; Righter K, 2011, P NATL ACAD SCI USA, V108, P19165, DOI 10.1073/pnas.1013480108; Rodriguez DR, 2012, ASTROPHYS J, V748, DOI 10.1088/0004-637X/748/1/30; Schneider A, 2013, ASTROPHYS J, V777, DOI 10.1088/0004-637X/777/1/78; Soderblom D. R., 2014, PROTOSTARS PLANETS, VVI, P219; Song IS, 2005, NATURE, V436, P363, DOI 10.1038/nature03853; Stetson PB, 1996, PUBL ASTRON SOC PAC, V108, P851, DOI 10.1086/133808; Stewart ST, 2012, ASTROPHYS J, V751, DOI 10.1088/0004-637X/751/1/32; Takasawa S, 2011, ASTROPHYS J LETT, V733, DOI 10.1088/2041-8205/733/2/L39; Warren PH, 2008, GEOCHIM COSMOCHIM AC, V72, P3562, DOI 10.1016/j.gca.2008.04.031; Weinberger AJ, 2011, ASTROPHYS J, V726, DOI 10.1088/0004-637X/726/2/72; Weinberger AJ, 2008, ASTROPHYS J LETT, V679, pL41, DOI 10.1086/589180; Wyatt MC, 2008, ANNU REV ASTRON ASTR, V46, P339, DOI 10.1146/annurev.astro.45.051806.110525; Yamamoto K, 2013, PUBL ASTRON SOC JPN, V65; Zuckerman B, 2008, ASTROPHYS J, V688, P1345, DOI 10.1086/592394; Zuckerman B, 2012, ASTROPHYS J, V758, DOI 10.1088/0004-637X/758/2/77	82	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	MAY 20	2015	805	1							77	10.1088/0004-637X/805/1/77		15	Astronomy & Astrophysics	Astronomy & Astrophysics	CI8BA	WOS:000354991300077		
J	Morishita, T; Ichikawa, T; Noguchi, M; Akiyama, M; Patel, SG; Kajisawa, M; Obata, T				Morishita, Takahiro; Ichikawa, Takashi; Noguchi, Masafumi; Akiyama, Masayuki; Patel, Shannon G.; Kajisawa, Masaru; Obata, Tomokazu			FROM DIVERSITY TO DICHOTOMY, AND QUENCHING: MILKY-WAY-LIKE AND MASSIVE-GALAXY PROGENITORS AT 0.5 < z < 3.0	ASTROPHYSICAL JOURNAL			English	Article						galaxies: evolution; galaxies: formation; galaxies: general; galaxies: high-redshift; galaxies: structure; Galaxy: evolution	STAR-FORMING GALAXIES; SIMILAR-TO 2; HIGH-REDSHIFT GALAXIES; EXTRAGALACTIC LEGACY SURVEY; NUMBER-DENSITY EVOLUTION; SINS/ZC-SINF SURVEY; DARK-MATTER HALOES; INSIDE-OUT GROWTH; STELLAR MASS; QUIESCENT GALAXIES	Using the Hubble Space Telescope (HST)/WFC3 and Advanced Camera for Surveys multi-band imaging data taken in CANDELS and 3D-HST, we study the general properties and diversity of the progenitors of the Milky Way (MWs) and local massive galaxy (MGs) at 0.5 < z < 3.0, based on a constant cumulative number density analysis. After careful data reduction and stacking analysis, we conduct a radially resolved pixel spectral energy distribution fitting to obtain the radial distributions of the stellar mass and rest-frame colors. The stellar mass of MWs increases in a self-similar way, irrespective of the radial distance, while that of MGs grows in an inside-out way where they obtain similar to 75% of the total mass at the outer (>2.5 kpc) radius since z similar to 2. Although the radial mass profiles evolve in distinct ways, the formation and quenching of the central dense region (or bulge) ahead of the formation of the outer disk are found to be common for both systems. The sudden reddening of the bulge at z similar to 1.6 and z similar to 2.4 for MWs and MGs, respectively, suggests the formation of the bulge and would give a clue to the different gas accretion histories and quenching. A new approach to evaluate the morphological diversity is conducted by using the average surface density profile and its dispersion. The variety of the radial mass profiles for MGs peaks at higher redshift (z > 2.8) and then rapidly converges to a more uniform shape at z < 1.5, while that for MWs remains in the outer region over the redshift. Compared with the observed star-formation rates and color profiles, the evolution of variety is consistently explained by the star-formation activities.	[Morishita, Takahiro; Ichikawa, Takashi; Noguchi, Masafumi; Akiyama, Masayuki; Obata, Tomokazu] Tohoku Univ, Inst Astron, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Morishita, Takahiro] Tohoku Univ, Inst Int Adv Res & Educ, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Patel, Shannon G.] Carnegie Observ, Pasadena, CA 91101 USA; [Kajisawa, Masaru] Ehime Univ, Grad Sch Sci & Engn, Matsuyama, Ehime 7908577, Japan; [Kajisawa, Masaru] Ehime Univ, Res Ctr Space & Cosm Evolut, Matsuyama, Ehime 7908577, Japan	Morishita, T (reprint author), Tohoku Univ, Inst Astron, Aoba Ku, Sendai, Miyagi 9808578, Japan.	mtakahiro@astr.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology in Japan [24253003]; Japan Society for the Promotion of Science (JSPS); NASA [NAS5-26555]	We thank an anonymous referee for the valuable and constructive comments. We would like to acknowledge Anton Koekemoer and Stijn Wuyts for their very helpful comments on data assessment and the pixel SED fitting. This work is based on observations taken by the CANDELS Multi-Cycle Treasury Program with the NASA/ESA HST and on observations taken by the 3D-HST Treasury Program (GO 12177 and 12328) with the NASA/ESA HST, both of which are operated by the Association of Universities for Research in Astronomy, Inc., under NASA contract NAS5-26555. This work has been financially supported by a Grant-in-Aid for Scientific Research (24253003) of the Ministry of Education, Culture, Sports, Science and Technology in Japan. T.M. acknowledges support from the Japan Society for the Promotion of Science (JSPS) through JSPS research fellowships for Young Scientists.	Franx M, 2008, ASTROPHYS J, V688, P770, DOI 10.1086/592431; Damjanov I, 2009, ASTROPHYS J, V695, P101, DOI 10.1088/0004-637X/695/1/101; Bruzual G, 2003, MON NOT R ASTRON SOC, V344, P1000, DOI 10.1046/j.1365-8711.2003.06897.x; OKE JB, 1983, ASTROPHYS J, V266, P713, DOI 10.1086/160817; Marchesini D, 2009, ASTROPHYS J, V701, P1765, DOI 10.1088/0004-637X/701/2/1765; Dekel A, 2009, NATURE, V457, P451, DOI 10.1038/nature07648; Tojeiro R, 2010, MON NOT R ASTRON SOC, V405, P2534, DOI 10.1111/j.1365-2966.2010.16630.x; Kormendy J, 2004, ANNU REV ASTRON ASTR, V42, P603, DOI 10.1146/annurev.astro.42.053102.134024; Kriek M, 2009, ASTROPHYS J, V700, P221, DOI 10.1088/0004-637X/700/1/221; Daddi E, 2007, ASTROPHYS J, V670, P173, DOI 10.1086/521820; Conroy C, 2009, ASTROPHYS J, V696, P620, DOI 10.1088/0004-637X/696/1/620; Cimatti A, 2008, ASTRON ASTROPHYS, V482, P21, DOI 10.1051/0004-6361:20078739; Fukugita M, 1996, ASTRON J, V111, P1748, DOI 10.1086/117915; Papovich C, 2001, ASTROPHYS J, V559, P620, DOI 10.1086/322412; Riechers DA, 2013, NATURE, V496, P329, DOI 10.1038/nature12050; Williams RJ, 2009, ASTROPHYS J, V691, P1879, DOI 10.1088/0004-637X/691/2/1879; Dekel A, 2014, MON NOT R ASTRON SOC, V438, P1870, DOI 10.1093/mnras/stt2331; Debattista VP, 2006, ASTROPHYS J, V645, P209, DOI 10.1086/504147; Oser L, 2010, ASTROPHYS J, V725, P2312, DOI 10.1088/0004-637X/725/2/2312; Zibetti S, 2009, MON NOT R ASTRON SOC, V400, P1181, DOI 10.1111/j.1365-2966.2009.15528.x; Shapley AE, 2005, ASTROPHYS J, V626, P698, DOI 10.1086/429990; Martig M, 2009, ASTROPHYS J, V707, P250, DOI 10.1088/0004-637X/707/1/250; Naab T, 2009, ASTROPHYS J LETT, V699, pL178, DOI 10.1088/0004-637X/699/2/L178; Kajisawa M, 2001, PUBL ASTRON SOC JPN, V53, P833; VILACOSTAS MB, 1992, MON NOT R ASTRON SOC, V259, P121; Bertin E, 1996, ASTRON ASTROPHYS SUP, V117, P393, DOI 10.1051/aas:1996164; van Dokkum PG, 2008, ASTROPHYS J LETT, V677, pL5, DOI 10.1086/587874; Sellwood JA, 2002, MON NOT R ASTRON SOC, V336, P785, DOI 10.1046/j.1365-8711.2002.05806.x; Haussler B, 2007, ASTROPHYS J SUPPL S, V172, P615, DOI 10.1086/518836; Brammer GB, 2008, ASTROPHYS J, V686, P1503, DOI 10.1086/591786; Trujillo I, 2007, MON NOT R ASTRON SOC, V382, P109, DOI 10.1111/j.1365-2966.2007.12388.x; Ravindranath S, 2006, ASTROPHYS J, V652, P963, DOI 10.1086/507016; CARDELLI JA, 1989, ASTROPHYS J, V345, P245, DOI 10.1086/167900; Nelson E, 2014, NATURE, V513, P394, DOI 10.1038/nature13616; Moster BP, 2013, MON NOT R ASTRON SOC, V428, P3121, DOI 10.1093/mnras/sts261; Hopkins PF, 2006, ASTROPHYS J SUPPL S, V163, P1, DOI 10.1086/499298; Casertano S, 2000, ASTRON J, V120, P2747, DOI 10.1086/316851; Madau P, 1996, MON NOT R ASTRON SOC, V283, P1388; Dekel A, 2006, MON NOT R ASTRON SOC, V368, P2, DOI 10.1111/j.1365-2966.2006.10145.x; van Dokkum PG, 2010, ASTROPHYS J, V709, P1018, DOI 10.1088/0004-637X/709/2/1018; Bezanson R, 2009, ASTROPHYS J, V697, P1290, DOI 10.1088/0004-637X/697/2/1290; Heavens A, 2004, NATURE, V428, P625, DOI 10.1038/nature02474; Szomoru D, 2010, ASTROPHYS J LETT, V714, pL244, DOI 10.1088/2041-8205/714/2/L244; Guo Q, 2010, MON NOT R ASTRON SOC, V404, P1111, DOI 10.1111/j.1365-2966.2010.16341.x; Maraston C, 2010, MON NOT R ASTRON SOC, V407, P830, DOI 10.1111/j.1365-2966.2010.16973.x; Woo J, 2015, MON NOT R ASTRON SOC, V448, P237, DOI 10.1093/mnras/stu2755; Barro G, 2014, ASTROPHYS J, V791, DOI 10.1088/0004-637X/791/1/52; Barro G, 2013, ASTROPHYS J, V765, DOI 10.1088/0004-637X/765/2/104; Behroozi PS, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/1/57; Bergemann M, 2014, ASTRON ASTROPHYS, V565, DOI 10.1051/0004-6361/201423456; Bovy J, 2012, ASTROPHYS J, V751, DOI 10.1088/0004-637X/751/2/131; Cappellari M, 2006, MON NOT R ASTRON SOC, V366, P1126, DOI 10.1111/j.1365-2966.2005.09981.x; Carollo CM, 2013, ASTROPHYS J, V773, DOI 10.1088/0004-637X/773/2/112; Chabrier G, 2003, PUBL ASTRON SOC PAC, V115, P763, DOI 10.1086/376392; Cheung E, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/2/131; Chiappini C, 2001, AM SCI, V89, P506; Conselice CJ, 2005, ASTROPHYS J, V620, P564, DOI 10.1086/426102; Cole S, 2001, MON NOT R ASTRON SOC, V326, P255, DOI 10.1046/j.1365-8711.2001.04591.x; Dickinson M, 2000, R SOC LOND PHILOS A, V358, P2001; Fan L, 2008, ASTROPHYS J LETT, V689, pL101, DOI 10.1086/595784; Ferreras I, 2014, MON NOT R ASTRON SOC, V444, P906, DOI 10.1093/mnras/stu1425; Schreiber NMF, 2014, ASTROPHYS J, V787, DOI 10.1088/0004-637X/787/1/38; Genzel R, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/1/75; Grogin NA, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/2/35; Guo YC, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/2/120; Hogbom J. A., 1974, Astronomy and Astrophysics Supplement Series, V15; Ichikawa T, 2007, PUBL ASTRON SOC JPN, V59, P1081; Kajisawa M, 2015, ASTROPHYS J, V801, DOI 10.1088/0004-637X/801/2/134; Kauffmann G, 1998, MON NOT R ASTRON SOC, V297, pL23, DOI 10.1046/j.1365-8711.1998.01708.x; Koekemoer AM, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/2/36; Kroupa P, 2001, MON NOT R ASTRON SOC, V322, P231, DOI 10.1046/j.1365-8711.2001.04022.x; Labbe I, 2003, ASTROPHYS J, V591, pL95, DOI 10.1086/377149; Lee YS, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/2/187; Leja J, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/1/33; McDermid R. M., 2015, ARXIV150103723; Morishita T, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/1/18; Moustakas J, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/1/50; Noguchi M, 1999, ASTROPHYS J, V514, P77, DOI 10.1086/306932; Noguchi M, 1998, NATURE, V392, P253, DOI 10.1038/32596; Ownsworth J. R., 2014, ARXIV14091582; Papovich C., 2014, ARXIV14123806; Patel SG, 2013, ASTROPHYS J, V778, DOI 10.1088/0004-637X/778/2/115; Patel SG, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/1/15; Peng YJ, 2010, ASTROPHYS J, V721, P193, DOI 10.1088/0004-637X/721/1/193; Poggianti B. M., 2013, Astrophysical Journal, V777, DOI 10.1088/0004-637X/777/2/125; Skelton RE, 2014, ASTROPHYS J SUPPL S, V214, DOI 10.1088/0067-0049/214/2/24; Szomoru D, 2013, ASTROPHYS J, V763, DOI 10.1088/0004-637X/763/2/73; Toyouchi D, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/1/89; Trujillo I, 2012, ASTROPHYS J, V751, DOI 10.1088/0004-637X/751/1/45; van der Wel A, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/1/28; van Dokkum PG, 2013, ASTROPHYS J LETT, V771, DOI 10.1088/2041-8205/771/2/L35; Whitaker KE, 2012, ASTROPHYS J LETT, V754, DOI 10.1088/2041-8205/754/2/L29; Wuyts S, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/2/114	93	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	MAY 20	2015	805	1							34	10.1088/0004-637X/805/1/34		19	Astronomy & Astrophysics	Astronomy & Astrophysics	CI8BA	WOS:000354991300034		
J	Murase, K; Kashiyama, K; Kiuchi, K; Bartos, I				Murase, Kohta; Kashiyama, Kazumi; Kiuchi, Kenta; Bartos, Imre			GAMMA-RAY AND HARD X-RAY EMISSION FROM PULSAR-AIDED SUPERNOVAE AS A PROBE OF PARTICLE ACCELERATION IN EMBRYONIC PULSAR WIND NEBULAE	ASTROPHYSICAL JOURNAL			English	Article						gamma-ray burst: general; pulsars: general; radiation: dynamics; radiation mechanisms: non-thermal; supernovae: general	CHERENKOV TELESCOPE ARRAY; CRAB-NEBULA; SUPERLUMINOUS SUPERNOVAE; LUMINOUS SUPERNOVAE; MILLISECOND PULSARS; BURST AFTERGLOWS; ENERGY INJECTION; NEARBY UNIVERSE; MAGNETIC-FIELD; NEUTRON-STARS	It has been suggested that some classes of luminous supernovae (SNe) and gamma-ray bursts (GRBs) are driven by newborn magnetars. Fast-rotating proto-neutron stars have also been of interest as potential sources of gravitational waves (GWs). We show that for a range of rotation periods and magnetic fields, hard X-rays and GeV gamma rays provide us with a promising probe of pulsar-aided SNe. It is observationally known that young pulsar wind nebulae (PWNe) in the Milky Way are very efficient lepton accelerators. We argue that, if embryonic PWNe satisfy similar conditions at early stages of SNe (in similar to 1-10 months after the explosion), external inverse-Compton emission via upscatterings of SN photons is naturally expected in the GeV range as well as broadband synchrotron emission. To fully take into account the Klein-Nishina effect and two-photon annihilation process that are important at early times, we perform detailed calculations including electromagnetic cascades. Our results suggest that hard X-ray telescopes such as NuSTAR can observe such early PWN emission by follow-up observations in months to years. GeV gamma-rays may also be detected by Fermi for nearby SNe, which serve as counterparts of these GW sources. Detecting the signals will give us an interesting probe of particle acceleration at early times of PWNe, as well as clues to driving mechanisms of luminous SNe and GRBs. Since the Bethe-Heitler cross section is lower than the Thomson cross section, gamma rays would allow us to study subphotospheric dissipation. We encourage searches for high-energy emission from nearby SNe, especially SNe Ibc including super-luminous objects.	[Murase, Kohta] Inst Adv Study, Princeton, NJ 08540 USA; [Murase, Kohta; Kashiyama, Kazumi] Penn State Univ, Dept Astron & Astrophys, Dept Phys, Ctr Particle & Gravitat Astrophys, University Pk, PA 16802 USA; [Kashiyama, Kazumi] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Kashiyama, Kazumi] Univ Calif Berkeley, Theoret Astrophys Ctr, Berkeley, CA 94720 USA; [Kiuchi, Kenta] Kyoto Univ, Yukawa Inst Theoret Phys, Kyoto, Kyoto 6068502, Japan; [Bartos, Imre] Columbia Univ, Columbia Astrophys Lab, Dept Phys, New York, NY 10027 USA	Murase, K (reprint author), Inst Adv Study, Olden Lane, Princeton, NJ 08540 USA.				NASA [51310.01, NAS 5-26555, NAS 8-03060]; STScI; Chandra X-ray Center [PF4-150123]; HPCI Strategic Program of Japanese MEXT [25103510, 25105508, 24244028, 24740163, hp130025, 140211]	K. M. thanks Omer Bromberg, Kunihito Ioka, Boaz Katz, and Eran Ofek for useful discussions. This work is supported by NASA through Hubble Fellowship Grant No. 51310.01, awarded by the STScI, which is operated by the Association of Universities for Research in Astronomy, Inc., for NASA, under Contract No. NAS 5-26555 (K. M.), Einstein Postdoctoral Fellowship Grant No. PF4-150123 awarded by the Chandra X-ray Center, which is operated by the Smithsonian Astrophysical Observatory, for NASA, under contract NAS 8-03060 (K. K.), and Grant-in-Aid for Scientific Research (25103510, 25105508, 24244028, 24740163) and by HPCI Strategic Program of Japanese MEXT (hp130025, 140211) (K. K.).	Acernese F., 2014, ARXIV14083978; Actis M, 2011, EXP ASTRON, V32, P193, DOI 10.1007/s10686-011-9247-0; Arons J, 2003, ASTROPHYS J, V589, P871, DOI 10.1086/374776; Ghisellini G, 2007, ASTROPHYS J, V658, pL75, DOI 10.1086/515570; deJager OC, 1996, ASTROPHYS J, V457, P253, DOI 10.1086/176726; Faucher-Giguere CA, 2006, ASTROPHYS J, V643, P332, DOI 10.1086/501516; Begelman MC, 1998, ASTROPHYS J, V493, P291, DOI 10.1086/305119; DUNCAN RC, 1992, ASTROPHYS J, V392, pL9, DOI 10.1086/186413; Medvedev AS, 2013, MON NOT R ASTRON SOC, V431, P2690, DOI 10.1093/mnras/stt369; Harry GM, 2010, CLASSICAL QUANT GRAV, V27, DOI 10.1088/0264-9381/27/8/084006; Benetti S, 2014, MON NOT R ASTRON SOC, V441, P289, DOI 10.1093/mnras/stu538; Somiya K, 2012, CLASSICAL QUANT GRAV, V29, DOI 10.1088/0264-9381/29/12/124007; Bucciantini N, 2008, MON NOT R ASTRON SOC, V383, pL25, DOI 10.1111/j.1745-3933.2007.00403.x; USOV VV, 1992, NATURE, V357, P472; Gal-Yam A, 2012, SCIENCE, V337, P927, DOI 10.1126/science.1203601; Arcavi I, 2010, ASTROPHYS J, V721, P777, DOI 10.1088/0004-637X/721/1/777; Spitkovsky A, 2006, ASTROPHYS J, V648, pL51, DOI 10.1086/507518; Tanaka SJ, 2010, ASTROPHYS J, V715, P1248, DOI 10.1088/0004-637X/715/2/1248; [Anonymous], 2002, PHYS REV D; KENNEL CF, 1984, ASTROPHYS J, V283, P694, DOI 10.1086/162356; Gaensler BM, 2006, ANNU REV ASTRON ASTR, V44, P17, DOI 10.1146/annurev.astro.44.051905.092528; Metzger BD, 2011, MON NOT R ASTRON SOC, V413, P2031, DOI 10.1111/j.1365-2966.2011.18280.x; Murase K, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.043003; Kasen D, 2010, ASTROPHYS J, V717, P245, DOI 10.1088/0004-637X/717/1/245; Inoue S, 2013, ASTROPART PHYS, V43, P252, DOI 10.1016/j.astropartphys.2013.01.004; Kakuwa J, 2012, MON NOT R ASTRON SOC, V425, P514, DOI 10.1111/j.1365-2966.2012.21490.x; Bucciantini N, 2007, MON NOT R ASTRON SOC, V380, P1541, DOI 10.1111/j.1365-2966.2007.12164.x; Dall'Osso S, 2009, MON NOT R ASTRON SOC, V398, P1869, DOI 10.1111/j.1365-2966.2008.14054.x; REES MF, 1974, MON NOT R ASTRON SOC, V167, P1; Metzger BD, 2014, MON NOT R ASTRON SOC, V437, P703, DOI 10.1093/mnras/stt1922; Dai ZG, 1998, ASTRON ASTROPHYS, V333, pL87; Gruzinov A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.021101; Murase K, 2010, MON NOT R ASTRON SOC, V402, pL54, DOI 10.1111/j.1745-3933.2009.00799.x; Zhang B, 2001, ASTROPHYS J, V552, pL35, DOI 10.1086/320255; OSTRIKER JP, 1969, ASTROPHYS J, V157, P1395, DOI 10.1086/150160; Stella L, 2005, ASTROPHYS J, V634, pL165, DOI 10.1086/498685; Thompson TA, 2004, ASTROPHYS J, V611, P380, DOI 10.1086/421969; Arons J, 2012, SPACE SCI REV, V173, P341, DOI 10.1007/s11214-012-9885-1; Lattimer JM, 2001, ASTROPHYS J, V550, P426, DOI 10.1086/319702; Nicholl M, 2013, NATURE, V502, P346, DOI 10.1038/nature12569; Murase K, 2009, PHYS REV D, V79, DOI 10.1103/PhysRevD.79.103001; Corsi A, 2009, ASTROPHYS J, V702, P1171, DOI 10.1088/0004-637X/702/2/1171; Atoyan AM, 1996, MON NOT R ASTRON SOC, V278, P525; Lyubarsky Y, 2001, ASTROPHYS J, V547, P437, DOI 10.1086/318354; Porth O, 2014, MON NOT R ASTRON SOC, V438, P278, DOI 10.1093/mnras/stt2176; Kotera K, 2013, MON NOT R ASTRON SOC, V432, P3228, DOI 10.1093/mnras/stt680; Quimby RM, 2011, NATURE, V474, P487, DOI 10.1038/nature10095; Tchekhovskoy A, 2013, MON NOT R ASTRON SOC, V435, pL1, DOI 10.1093/mnrasl/slt076; Smith N, 2011, MON NOT R ASTRON SOC, V412, P1522, DOI 10.1111/j.1365-2966.2011.17229.x; HOSHINO M, 1992, ASTROPHYS J, V390, P454, DOI 10.1086/171296; Bartos I, 2014, MON NOT R ASTRON SOC, V443, P738, DOI 10.1093/mnras/stu1205; Bartos I, 2013, CLASSICAL QUANT GRAV, V30, DOI 10.1088/0264-9381/30/12/123001; Blackman EG, 1998, ASTROPHYS J, V498, pL31, DOI 10.1086/311311; Cerutti B., 2014, ARXIV14103757; Chen T.-W., 2014, ARXIV14097728; Chevalier R. A., 1977, SUPERNOVAE, V66, P53; CHEVALIER RA, 1992, ASTROPHYS J, V395, P540, DOI 10.1086/171674; CHODOROWSKI MJ, 1992, ASTROPHYS J, V400, P181, DOI 10.1086/171984; Dermer CD, 2012, ASTROPHYS J, V755, DOI 10.1088/0004-637X/755/2/147; Fang K, 2013, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2013/03/010; Fang K., 2013, ARXIV13112044; GAISSER TK, 1987, NATURE, V329, P314, DOI 10.1038/329314a0; GOLDREIC.P, 1969, ASTROPHYS J, V157, P869, DOI 10.1086/150119; Inserra C, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/2/128; Kirk JG, 2010, PLASMA PHYS CONTR F, V52, DOI 10.1088/0741-3335/52/12/124029; Kisaka S., 2014, ARXIV14100966; Kokkotas K. D., 2008, REV MOD ASTROPHYS, V20, P140; Komissarov SS, 2007, MON NOT R ASTRON SOC, V382, P1029, DOI 10.1111/j.1365-2966.2007.12485.x; Margutti R, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/1/21; McCrum M, 2014, MON NOT R ASTRON SOC, V437, P656, DOI 10.1093/mnras/stt1923; Murase K, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.043012; Murase K, 2011, ASTROPHYS J, V732, DOI 10.1088/0004-637X/732/2/77; Nicholl M, 2014, MON NOT R ASTRON SOC, V444, P2096, DOI 10.1093/mnras/stu1579; Ofek EO, 2014, ASTROPHYS J, V781, DOI 10.1088/0004-637X/781/1/42; Ofek EO, 2013, ASTROPHYS J, V763, DOI 10.1088/0004-637X/763/1/42; OSTRIKER JP, 1971, ASTROPHYS J, V164, pL95, DOI 10.1086/180699; Perna R, 2008, MON NOT R ASTRON SOC, V384, P1638, DOI 10.1111/j.1365-2966.2007.12821.x; Sironi L, 2011, ASTROPHYS J, V741, DOI 10.1088/0004-637X/741/1/39; Soria R, 2008, ASTROPHYS J, V683, P767, DOI 10.1086/589995; Tanaka SJ, 2013, MON NOT R ASTRON SOC, V429, P2945, DOI 10.1093/mnras/sts528; Verezinskii V. S., 1978, ASTRON ASTROPHYS, V66, P325; Volonteri M, 2005, MON NOT R ASTRON SOC, V358, P913, DOI 10.1111/j.1365-2966.2005.08832.x; Vreeswijk P. M., 2014, ARXIV14098287; Wheeler JC, 2000, ASTROPHYS J, V537, P810, DOI 10.1086/309055; Woosley SE, 2010, ASTROPHYS J LETT, V719, pL204, DOI 10.1088/2041-8205/719/2/L204	85	2	2	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	MAY 20	2015	805	1							82	10.1088/0004-637X/805/1/82		13	Astronomy & Astrophysics	Astronomy & Astrophysics	CI8BA	WOS:000354991300082		
J	Tomioka, A; Tanaka, N; Yoshikawa, M; Miyake, M; Anai, S; Chihara, Y; Okajima, E; Hirayama, A; Hirao, Y; Fujimoto, K				Tomioka, Atsushi; Tanaka, Nobumichi; Yoshikawa, Motokiyo; Miyake, Makito; Anai, Satoshi; Chihara, Yoshitomo; Okajima, Eijiro; Hirayama, Akihide; Hirao, Yoshihiko; Fujimoto, Kiyohide			Risk factors of PSA progression and overall survival in patients with localized and locally advanced prostate cancer treated with primary androgen deprivation therapy	BMC CANCER			English	Article						Localized and locally advanced prostate cancer; Primary androgen deprivation therapy; Risk factors	PRIMARY HORMONAL-THERAPY; RADICAL PROSTATECTOMY; FOLLOW-UP; TRENDS; JAPAN; NARA; VETERANS; EFFICACY; CAPSURE; RATES	Background: Primary androgen deprivation therapy (PADT) has played an important role in the treatment of prostate cancer. We sought to identify factors of PSA progression in our series of patients with localized and locally advanced prostate cancer treated with PADT. Methods: Six-hundred forty-nine patients with localized and locally advanced prostate cancer who received PADT from 1998 to 2005 by Nara Uro-Oncology Research Group were enrolled. Age, T classification, stage, PSA level at diagnosis, Gleason score, laterality of cancer detected by biopsy and seminal vesicle involvement (SVI) were adopted as parameters of PSA progression. Cox's proportional hazards model was used to determine the predictive factors for PSA progression. Results: The median follow-up period and the median PSA level at diagnosis were 49 months and 15 ng/mL. The 5-year disease specific survival rate, overall survival rate and PSA progression-free survival (PFS) rate were 97.9 %, 91.9 % and 71.2 %, respectively. The univariate analysis showed that the PSA level at diagnosis, Gleason score, laterality of cancer detected by biopsy and SVI were independent predictive parameters of PSA-PFS. However, by multivariate analysis, only laterality of cancer detected by biopsy (unilateral vs. bilateral) was an independent predictive parameter of PSA-PFS (p = 0.034). The patients were classified into new risk groups base on three factors: PSA level at diagnosis, Gleason score, and laterality of cancer detected by biopsy. The PSA-PFS rates at 5-years in the low-(none or one factor), intermediate-(two factors) and high-risk (three factors) groups were 78.2 %, 62.5 % and 46.9 % (p < 0.001), respectively. Conclusion: In localized or locally advanced prostate cancer patients who received PADT, laterality of cancer detected by biopsy was a significant predictor associated with a longer PSA-PFS. Our new risk grouping indicates the usefulness of PSA-PFS.	[Tomioka, Atsushi; Tanaka, Nobumichi; Yoshikawa, Motokiyo; Miyake, Makito; Anai, Satoshi; Chihara, Yoshitomo; Okajima, Eijiro; Hirayama, Akihide; Hirao, Yoshihiko; Fujimoto, Kiyohide] Nara Med Univ, Dept Urol, Kashihara, Nara 6348522, Japan	Fujimoto, K (reprint author), Nara Med Univ, Dept Urol, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.	kiyokun@naramed-u.ac.jp					Akaza H, 2003, BJU INT, V91, P33, DOI 10.1046/j.1464-4096.2003.04014.x; Cooperberg MR, 2003, J NATL CANCER I, V95, P981; Wong YN, 2009, J CLIN ONCOL, V27, P100, DOI 10.1200/JCO.2007.14.2042; Akaza H, 2006, BJU INT, V98, P573, DOI 10.1111/j.1464-410X.2006.06349.x; Schulman CC, 2000, EUR UROL, V38, P706, DOI 10.1159/000020366; Shahinian VB, 2005, CANCER-AM CANCER SOC, V103, P1615, DOI 10.1002/cncr.20955; Tanaka N, 2010, JPN J CLIN ONCOL, V40, P588, DOI 10.1093/jjco/hyq008; Lu-Yao GL, 2008, JAMA-J AM MED ASSOC, V300, P173, DOI 10.1001/jama.300.2.173; D'Amico AV, 2007, J CLIN ONCOL, V25, P2420, DOI 10.1200/JCO.2006.09.3369; Hinotsu S, 2007, JPN J CLIN ONCOL, V37, P775, DOI 10.1093/jjco/hym098; Roach M, 2008, J CLIN ONCOL, V26, P585, DOI 10.1200/JCO.2007.13.9881; Shahinian VB, 2005, NEW ENGL J MED, V352, P154, DOI 10.1056/NEJMoa041943; Studer UE, 2006, J CLIN ONCOL, V24, P1868, DOI 10.1200/JCO.2005.04.7423; Braga-Basaria M, 2006, J CLIN ONCOL, V24, P3979, DOI 10.1200/JCO.2006.05.9741; Ueno S, 2006, INT J UROL, V13, P1494, DOI 10.1111/j.1442-2042.2006.01604.x; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; Tanaka N, 2011, INT J CLIN ONCOL, V16, P553, DOI 10.1007/s10147-011-0226-2; Weight CJ, 2008, CANCER, V112, P2195, DOI 10.1002/cncr.23421; Efstathiou JA, 2009, J CLIN ONCOL, V27, P92, DOI 10.1200/JCO.2007.12.3752; Keating NL, 2010, J NATL CANCER I, V102, P39, DOI 10.1093/jnci/djp404; Akaza H, 2010, PHARMACOLOGY, V85, P110, DOI 10.1159/000274486; Cancer Registrarion Committee of Japan Urological Association, 2005, INT J UROL, V12, P46; Cooperberg MR, 2003, J UROLOGY, V170, P905, DOI 10.1097/01.ju.0000081200.63275.0b; Egawa M, 2004, INT J UROL, V11, P304, DOI 10.1111/j.1442-2042.2004.00797.x; Huggins C, 1972, CA Cancer J Clin, V22, P232, DOI 10.3322/canjclin.22.4.232; Janoff DM, 2005, BJU INT, V96, P503, DOI 10.1111/j.1464-410X.2005.05674.x; Kitagawa Y, 2003, INT J UROL, V10, P377, DOI 10.1046/j.1442-2042.2003.00640.x; Kobayashi M, 2011, INT J CLIN ONCOL, V16, P630, DOI 10.1007/s10147-011-0232-4; Labrie F, 2002, UROLOGY, V60, P115, DOI 10.1016/S0090-4295(02)01639-4; Onozawa M, 2014, JPN J CLIN ONCOL, V44, P969, DOI 10.1093/jjco/hyu104; Tanaka N, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-588; Tanaka N, 2011, BMC UROL, V11, DOI 10.1186/1471-2490-11-6	32	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2407			BMC CANCER	BMC Cancer	MAY 20	2015	15								420	10.1186/s12885-015-1429-0		9	Oncology	Oncology	CJ0LY	WOS:000355168900001		
J	Wang, Z; Kuninobu, Y; Kanai, M				Wang, Zhen; Kuninobu, Yoichiro; Kanai, Motomu			Palladium-Catalyzed Oxirane-Opening Reaction with Arenes via C-H Bond Activation	JOURNAL OF THE AMERICAN CHEMICAL SOCIETY			English	Article							SECONDARY ALKYL-HALIDES; ROOM-TEMPERATURE; AROMATIC IMINES; VINYL EPOXIDES; ALCOHOLS; ACIDS; DERIVATIVES; ARYLATION; CLEAVAGE; INDOLES	We achieved a palladium-catalyzed C-H activation/C-C coupling reaction between arenes with a pyridyl, aminoquinolinyl, imino, or amide directing group) and oxiranes. The reaction proceeded at room temperature without any additives and tolerated a wide variety of functional groups, and the products were obtained in good to excellent yields, even on grain scale. This is the first example of a transition-metal-catalyzed intermolecular direct coupling reaction between a C-H bond of aromatic compounds and a carbon atom Of oxiranes via C-H bond activation. By using N-methoxybenzamide as a substrate, we obtained 3-substituted isochroman-l-ones in One pot. The coupling reaction proceeded with stereoretention. Kinetic isotope effect experiments suggested that C-H bond activation is the rate-determining step.	[Wang, Zhen; Kuninobu, Yoichiro; Kanai, Motomu] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Wang, Zhen; Kuninobu, Yoichiro; Kanai, Motomu] ERATO Japan Sci & Technol Agcy JST, Kanai Life Sci Catalysis Project, Bunkyo Ku, Tokyo 1130033, Japan	Kuninobu, Y (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	kuninobu@mol.f.u-tokyo.ac.jp; kanai@mol.f.u-tokyo.ac.jp	Wang, Zhen/H-9760-2014; Kuninobu, Yoichiro/N-5109-2015		ERATO from JST; Ministry of Education, Culture, Sports, Science, and Technology of Japan	This work was supported in part by ERATO from JST and Grant-in-Aid for Scientific Research (B) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Powers DC, 2009, J AM CHEM SOC, V131, P17050, DOI 10.1021/ja906935c; Kuninobu Y, 2008, B CHEM SOC JPN, V81, P1393, DOI 10.1246/bcsj.81.1393; Cui SL, 2013, CHEM SCI, V4, P3421, DOI 10.1039/c3sc51424b; Wencel-Delord J, 2013, NAT CHEM, V5, P369, DOI 10.1038/nchem.1607; Shinkaruk S, 2008, BIOORGAN MED CHEM, V16, P9383, DOI 10.1016/j.bmc.2008.08.017; Ackermann L, 2012, CHEM-EUR J, V18, P12068, DOI 10.1002/chem.201200406; Thuy-Boun PS, 2013, J AM CHEM SOC, V135, P17508, DOI 10.1021/ja409014v; Young AJ, 2008, J AM CHEM SOC, V130, P14090, DOI 10.1021/ja806867p; Neufeldt SR, 2013, ORG LETT, V15, P2302, DOI 10.1021/ol400888r; Wencel-Delord J, 2011, CHEM SOC REV, V40, P4740, DOI 10.1039/c1cs15083a; Hofmann N, 2013, J AM CHEM SOC, V135, P5877, DOI 10.1021/ja401466y; Chen X, 2006, J AM CHEM SOC, V128, P78, DOI 10.1021/ja0570943; Lewis JC, 2007, J AM CHEM SOC, V129, P5332, DOI 10.1021/ja070388z; Deprez NR, 2006, J AM CHEM SOC, V128, P4972, DOI 10.1021/ja060809x; Yu SJ, 2014, ORG LETT, V16, P1200, DOI 10.1021/ol5000764; Ackermann L, 2010, CHEM COMMUN, V46, P4866, DOI 10.1039/c0cc00778a; Chen QA, 2011, J AM CHEM SOC, V133, P428, DOI 10.1021/ja1099853; Ackermann L, 2011, CHEM REV, V111, P1315, DOI 10.1021/cr100412j; Cho SH, 2011, CHEM SOC REV, V40, P5068, DOI 10.1039/c1cs15082k; Kuninobu Y, 2013, ANGEW CHEM INT EDIT, V52, P4431, DOI 10.1002/anie.201210328; Gao K, 2012, ORG LETT, V14, P4234, DOI 10.1021/ol301934y; Zhang Q, 2014, CHEM SCI, V5, P291, DOI 10.1039/c3sc51949j; Lyons TW, 2010, CHEM REV, V110, P1147, DOI 10.1021/cr900184e; Deng GJ, 2008, ANGEW CHEM INT EDIT, V47, P6278, DOI 10.1002/anie.200801544; Zhang SY, 2015, J AM CHEM SOC, V137, P531, DOI 10.1021/ja511557h; Zhu C, 2012, CHEM-ASIAN J, V7, P1502, DOI 10.1002/asia.201200035; Deprez NR, 2009, J AM CHEM SOC, V131, P11234, DOI 10.1021/ja904116k; Zhang Y, 2014, CHEM SCI, V5, P297, DOI 10.1039/c3sc52524d; Liu ZQ, 2012, ORG LETT, V14, P3154, DOI 10.1021/ol301248d; Jijy E, 2013, CHEM COMMUN, V49, P7349, DOI 10.1039/c3cc43485k; TREMONT SJ, 1984, J AM CHEM SOC, V106, P5759, DOI 10.1021/ja00331a073; Vechorkin O, 2010, ANGEW CHEM INT EDIT, V49, P3061, DOI 10.1002/anie.200907040; Wasa M, 2010, J AM CHEM SOC, V132, P3680, DOI 10.1021/ja1010866; Huang CY, 2014, CHEM REV, V114, P8153, DOI 10.1021/cr500036t; Feng JJ, 2014, J AM CHEM SOC, V136, P8911, DOI 10.1021/ja504625m; Li XW, 2013, ANGEW CHEM INT EDIT, V52, P2577, DOI 10.1002/anie.201209887; Kuninobu Y, 2011, CHEM REV, V111, P1938, DOI 10.1021/cr100241u; Bressy C, 2005, J AM CHEM SOC, V127, P13148, DOI 10.1021/ja054472v; Lapointe D, 2009, ORG LETT, V11, P4160, DOI 10.1021/ol901689q; Topczewski JJ, 2015, CHEM SCI, V6, P70, DOI 10.1039/c4sc02591a; Kuninobu Y, 2009, ORG LETT, V11, P2711, DOI 10.1021/ol900962v; Lee DH, 2011, SCIENCE, V333, P1613, DOI 10.1126/science.1208839; Engle KM, 2012, ACCOUNTS CHEM RES, V45, P788, DOI 10.1021/ar200185g; Makida Y, 2012, ANGEW CHEM INT EDIT, V51, P4122, DOI 10.1002/anie.201200809; Arockiam PB, 2012, CHEM REV, V112, P5879, DOI [10.1021/cr300153j, 10.1021/cr300153J]; Colby DA, 2012, ACCOUNTS CHEM RES, V45, P814, DOI 10.1021/ar200190g; Ren P, 2012, ORG LETT, V14, P1748, DOI 10.1021/ol300348w; Mkhalid IAI, 2010, CHEM REV, V110, P890, DOI 10.1021/cr900206p; Chen ZL, 2012, CHEM-EUR J, V18, P8591, DOI 10.1002/chem.201201453; Xiao B, 2013, J AM CHEM SOC, V135, P616, DOI 10.1021/ja3113752; Lee DH, 2012, J AM CHEM SOC, V134, P7325, DOI 10.1021/ja302710v; Colby DA, 2010, CHEM REV, V110, P624, DOI 10.1021/cr900005n; Wang DH, 2008, J AM CHEM SOC, V130, P7190, DOI 10.1021/ja801355s; Kuninobu Y, 2006, ANGEW CHEM INT EDIT, V45, P2766, DOI 10.1002/anie.200503627; Li BJ, 2012, CHEM SOC REV, V41, P5588, DOI 10.1039/c2cs35096c; MURAI S, 1993, NATURE, V366, P529, DOI 10.1038/366529a0; Kuhl N, 2012, ANGEW CHEM INT EDIT, V51, P10236, DOI 10.1002/anie.201203269; Gao K, 2014, ADV SYNTH CATAL, V356, P1486, DOI 10.1002/adsc.201400049; Jiao L, 2011, J AM CHEM SOC, V133, P12990, DOI 10.1021/ja2055066; Gao K, 2013, J AM CHEM SOC, V135, P9279, DOI 10.1021/ja403759x; Rouquet G, 2013, ANGEW CHEM INT EDIT, V52, P11726, DOI 10.1002/anie.201301451; YAMAGUCHI M, 1983, TETRAHEDRON LETT, V24, P391, DOI 10.1016/S0040-4039(00)81416-1; Yamaguchi J, 2012, ANGEW CHEM INT EDIT, V51, P8960, DOI 10.1002/anie.201201666; Yu SJ, 2014, ORG LETT, V16, P1220, DOI 10.1021/ol500140e; Zhang YH, 2009, ANGEW CHEM INT EDIT, V48, P6097, DOI 10.1002/anie.200902262; Boezio C., 2013, Patent No. [WO 2013086229A1, 2013086229, WO 2013086229]; Feng J.-J., 2011, J AM CHEM SOC, V133, P7304; Rioz-Martinez A, 2009, EUR J ORG CHEM, P2526, DOI 10.1002/ejoc.200900084; Qi ZS, 2013, ANGEW CHEM INT EDIT, V52, P8995, DOI 10.1002/anie.201303507; Ramos HP, 2013, NAT PROD RES, V27, P2240, DOI 10.1080/14786419.2013.811659; Rukachaisirikul V, 2013, TETRAHEDRON, V69, P10711, DOI 10.1016/j.tet.2013.10.063; Shaghafi MB, 2011, ORG LETT, V13, P5188, DOI 10.1021/ol202068p; Shi ZJ, 2004, J AM CHEM SOC, V126, P5964, DOI 10.1021/ja031953a; SHIMOJIMA Y, 1985, J MED CHEM, V28, P3, DOI 10.1021/jm00379a002; Thies S, 2010, SYNLETT, P137, DOI 10.1055/s-0029-1218536; Wang JY, 2014, WORLD J MICROB BIOT, V30, P2639, DOI 10.1007/s11274-014-1686-0; Yu JQ, 2010, TOP CURR CHEM, V292, P1, DOI 10.1007/978-3-642-12356-6; Zhang H, 2014, ANGEW CHEM INT EDIT, V53, P13234, DOI 10.1002/anie.201408555	78	3	3	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0002-7863			J AM CHEM SOC	J. Am. Chem. Soc.	MAY 20	2015	137	19					6140	6143		10.1021/jacs.5b02435		4	Chemistry, Multidisciplinary	Chemistry	CI8WT	WOS:000355053100008		
J	Izgu, EC; Fahrenbach, AC; Zhang, N; Li, L; Zhang, W; Larsen, AT; Blain, JC; Szostak, JW				Izgu, Enver Cagri; Fahrenbach, Albert C.; Zhang, Na; Li, Li; Zhang, Wen; Larsen, Aaron T.; Blain, J. Craig; Szostak, Jack W.			Uncovering the Thermodynamics of Monomer Binding for RNA Replication	JOURNAL OF THE AMERICAN CHEMICAL SOCIETY			English	Article							TEMPLATE-DIRECTED SYNTHESIS; NUCLEIC-ACID; HAIRPIN OLIGONUCLEOTIDES; MOLECULAR-DYNAMICS; CIRCULAR-DICHROISM; NMR; DNA; HYDRATION; RESIDUES; COMPLEX	The nonenzymatic replication of primordial RNA is thought to have been a critical step in the origin of life. However, despite decades of effort, the poor rate and fidelity of model template copying reactions have thus far prevented an experimental demonstration of nonenzymatic RNA replication. The overall rate and fidelity of template copying depend, in part, on the affinity of free ribonucleotides to the RNA primer-template complex. We have now used H-1 NMR spectroscopy to directly measure the thermodynamic association constants, K(a)s, of the standard ribonucleotide monophosphates (rNMPs) to native RNA primer-template complexes. The binding affinities of rNMPs to duplexes with a complementary single-nucleotide overhang follow the order C > G > A > U. Notably, these monomers bind more strongly to RNA primer-template complexes than to the analogous DNA complexes. The relative binding affinities of the rNMPs for complementary RNA primer-template complexes are in good quantitative agreement with the predictions of a nearest-neighbor analysis. With respect to G:U wobble base-pairing, we find that the binding of rGMP to a primer-template complex with a 5'-U overhang is approximately 10-fold weaker than to the complementary 5'-C overhang. We also find that the binding of rGMP is only about 2-fold weaker than the binding of rAMP to 5'-U, consistent with the poor fidelity observed in the nonenzymatic copying of U residues in RNA templates. The accurate K-a measurements for ribonudeotides obtained in this study will be useful for designing higher fidelity, more effective RNA replication systems.	[Izgu, Enver Cagri; Fahrenbach, Albert C.; Zhang, Na; Li, Li; Zhang, Wen; Larsen, Aaron T.; Blain, J. Craig; Szostak, Jack W.] Massachusetts Gen Hosp, Dept Mol Biol, Howard Hughes Med Inst, Boston, MA 02114 USA; [Izgu, Enver Cagri; Fahrenbach, Albert C.; Zhang, Na; Li, Li; Zhang, Wen; Larsen, Aaron T.; Blain, J. Craig; Szostak, Jack W.] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Izgu, Enver Cagri; Fahrenbach, Albert C.; Li, Li; Zhang, Wen; Larsen, Aaron T.; Szostak, Jack W.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Fahrenbach, Albert C.; Szostak, Jack W.] Tokyo Inst Technol, Earth Life Sci Inst, Meguro Ku, Tokyo 1528550, Japan; [Szostak, Jack W.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Szostak, JW (reprint author), Massachusetts Gen Hosp, Dept Mol Biol, Howard Hughes Med Inst, 185 Cambridge St, Boston, MA 02114 USA.	szostak@molbio.mgh.harvard.edu			Research Fellowship from the Earth-Life Science Institute at the Tokyo Institute of Technology; Simons Foundation [290363]	We thank Dr. Ayan Pal, Dr. Anders Bjorkbom, and Weicheng Zhang for providing technical assistance; Dr. Aaron Engelhart, Dr. Victor Lelyveld, and Noam Prywes for helpful discussions. J.W.S. is an Investigator of the Howard Hughes Medical Institute. A.C.F. is supported by a Research Fellowship from the Earth-Life Science Institute at the Tokyo Institute of Technology. This work was supported in part by a grant (290363) from the Simons Foundation to J.W.S.	Kervio E, 2014, NUCLEIC ACIDS RES, V42, P7409, DOI 10.1093/nar/gku314; Forgan RS, 2011, CHEM REV, V111, P5434, DOI 10.1021/cr200034u; IVANOV VI, 1973, BIOPOLYMERS, V12, P89, DOI 10.1002/bip.1973.360120109; Schoning KU, 2000, SCIENCE, V290, P1347, DOI 10.1126/science.290.5495.1347; Gueron M, 1995, METHOD ENZYMOL, V261, P383; Renny JS, 2013, ANGEW CHEM INT EDIT, V52, P11998, DOI 10.1002/anie.201304157; LOHRMANN R, 1976, NATURE, V261, P342, DOI 10.1038/261342a0; Leu K, 2011, NUCLEIC ACIDS RES, V39, P8135, DOI 10.1093/nar/gkr525; TURNER DH, 1988, ANNU REV BIOPHYS BIO, V17, P167; Parker TM, 2013, J AM CHEM SOC, V135, P1306, DOI [10.1021/ja3063309, 10.1021/ja30633091]; Rajamani S, 2010, J AM CHEM SOC, V132, P5880, DOI 10.1021/ja100780p; Blain JC, 2014, ANNU REV BIOCHEM, V83, P615, DOI 10.1146/annurev-biochem-080411-124036; Holbrook JA, 1999, BIOCHEMISTRY-US, V38, P8409, DOI 10.1021/bi990043w; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Denning EJ, 2011, J COMPUT CHEM, V32, P1929, DOI 10.1002/jcc.21777; Zhang N, 2012, J AM CHEM SOC, V134, P3691, DOI 10.1021/ja212027q; Chen JL, 2012, BIOCHEMISTRY-US, V51, P3508, DOI 10.1021/bi3002709; Connors K. A., 1987, BINDING CONSTANTS ME; Conte MR, 1996, NUCLEIC ACIDS RES, V24, P3693, DOI 10.1093/nar/24.19.3693; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Diederich F., 2000, TEMPLATED ORGANIC SY; Eargle J, 2008, J MOL BIOL, V377, P1382, DOI 10.1016/j.jmb.2008.01.073; Egli M, 2010, STRUCTURE AND FUNCTION, P177, DOI 10.1007/978-90-481-2888-4_7; Fahrenbach AC, 2015, PURE APPL CHEM, V87, P205, DOI 10.1515/pac-2014-1004; GRATZER WB, 1971, BIOPOLYMERS, V10, P2607, DOI 10.1002/bip.360101220; INOUE T, 1983, SCIENCE, V219, P859, DOI 10.1126/science.6186026; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KANAVARIOTI A, 1995, J MOL EVOL, V41, P161; Kozlov IA, 2000, MOL BIOL+, V34, P781, DOI 10.1023/A:1026663422976; Lane AN, 1997, BBA-GENE STRUCT EXPR, V1350, P205, DOI 10.1016/S0167-4781(96)00161-3; LIPPENS G, 1995, J BIOMOL NMR, V5, P327, DOI 10.1007/BF00211762; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Szostak J. W., 2012, J SYST CHEM, V3, P2, DOI [DOI 10.1186/1759-2208-3-2, 10.1186/1759-2208-3-2]; WU T, 1992, J AM CHEM SOC, V114, P7963, DOI 10.1021/ja00047a001; WU TF, 1992, J AM CHEM SOC, V114, P5496, DOI 10.1021/ja00040a002	38	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0002-7863			J AM CHEM SOC	J. Am. Chem. Soc.	MAY 20	2015	137	19					6373	6382		10.1021/jacs.5b02707		10	Chemistry, Multidisciplinary	Chemistry	CI8WT	WOS:000355053100040		
J	Honma, M; Yoshiike, T; Ikeda, H; Kuriyama, K				Honma, Motoyasu; Yoshiike, Takuya; Ikeda, Hiroki; Kuriyama, Kenichi			Sleep-independent offline consolidation of response inhibition during the daytime post-training period	SCIENTIFIC REPORTS			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; AGE-RELATED-CHANGES; WORKING-MEMORY; INDIVIDUAL-DIFFERENCES; CIRCADIAN-RHYTHMS; FRONTAL-CORTEX; GO/NOGO TASK; TIME-COURSE; MOTOR; SKILL	Appropriate inhibitory response control is associated with goal-directed behavior. Sleep accelerates the offline consolidation of acquired motor skills that are explicitly predictable; however, the effect of sleep on implicit (unpredictable) motor skills remains controversial. We speculated that a key component of response inhibition skill differentiates between these skill consolidation properties because explicit prediction can minimize the inhibitory efforts in a motor skill. We explored the offline skill learning properties of response inhibition during sleep and wakefulness using auditory Go and Go/Nogo tasks. We attempted to discriminate the possible effects of time elapsed after training (12 or 24 h), post-training sleep/wake state (sleep or wakefulness), and time of day (nighttime or daytime) in 79 healthy human subjects divided into 6 groups that underwent various sleep regimens prior to training and retesting. We found that delayed response inhibition skill improvement was achieved via a simple passage of daytime, regardless of the participants' alertness level. Our results suggest that sleep-independent neuroplasticity occurs during the daytime and facilitates a delayed learning of response inhibition skill.	[Honma, Motoyasu; Yoshiike, Takuya; Ikeda, Hiroki; Kuriyama, Kenichi] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Adult Mental Hlth, Kodaira, Tokyo 1878502, Japan; [Honma, Motoyasu] Showa Univ, Sch Med, Dept Neurol, Shinagawa Ku, Tokyo 1428666, Japan; [Yoshiike, Takuya] Kanagawa Psychiat Ctr, Lab Neuromodulat, Kohnan Ku, Yokohama, Kanagawa 2330006, Japan; [Kuriyama, Kenichi] Shiga Univ Med Sci, Dept Psychiat, Otsu, Shiga 5202192, Japan	Kuriyama, K (reprint author), Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Adult Mental Hlth, 4-1-1 Ogawa Higashi, Kodaira, Tokyo 1878502, Japan.	kenichik@shiga-med.ac.jp			Japan Science and Technology (JST) Corporation [24650142, 21790235, 25670122]; Japan Foundation for Neuroscience and Mental Health; Takeda Science Foundation; SENSHIN Medical Research Foundation	We thank Sayori Koyama, Miyuki Shimazaki, and Mikiko Kimura for assistance with the experiments. This work was supported by Grants-in-Aid for Scientific research (#24650142, #21790235, and #25670122) from the Japan Science and Technology (JST) Corporation, the Japan Foundation for Neuroscience and Mental Health, the Takeda Science Foundation, and the SENSHIN Medical Research Foundation.	Adam M, 2006, SLEEP, V29, P55; Olesen PJ, 2004, NAT NEUROSCI, V7, P75, DOI 10.1038/nn1165; Rushworth MFS, 2008, ANN NY ACAD SCI, V1124, P181, DOI 10.1196/annals.1440.014; Ancoli-Israel S, 2003, SLEEP, V26, P342; Manginelli AA, 2013, NEUROIMAGE, V67, P363, DOI 10.1016/j.neuroimage.2012.11.025; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Basner M, 2011, SLEEP, V34, P581; Swick D, 2011, NEUROIMAGE, V56, P1655, DOI 10.1016/j.neuroimage.2011.02.070; Menon V, 2001, HUM BRAIN MAPP, V12, P131, DOI 10.1002/1097-0193(200103)12:3<131::AID-HBM1010>3.0.CO;2-C; Robertson EM, 2004, CURR BIOL, V14, P208, DOI 10.1016/j.cub.2004.01.027; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Goudriaan AE, 2006, ADDICTION, V101, P534, DOI 10.1111/j.1360-0443.2006.01380.x; Blair C, 2008, DEV PSYCHOPATHOL, V20, P899, DOI 10.1017/S0954579408000436; Korman M, 2007, NAT NEUROSCI, V10, P1206, DOI 10.1038/nn1959; Dijk DJ, 2000, CHRONOBIOL INT, V17, P285, DOI 10.1081/CBI-100101049; Debas K, 2010, P NATL ACAD SCI USA, V107, P17839, DOI 10.1073/pnas.1013176107; Filevich E, 2012, NEUROSCI BIOBEHAV R, V36, P1107, DOI 10.1016/j.neubiorev.2012.01.006; Wyatt JK, 1999, AM J PHYSIOL-REG I, V277, pR1152; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; KRAMER AF, 1994, PSYCHOL AGING, V9, P491, DOI 10.1037/0882-7974.9.4.491; Friedman NP, 2004, J EXP PSYCHOL GEN, V133, P101, DOI 10.1037/0096-3445.133.1.101; Fischer S, 2006, J COGNITIVE NEUROSCI, V18, P311, DOI 10.1162/089892906775990598; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930; Criaud M, 2013, NEUROSCI BIOBEHAV R, V37, P11, DOI 10.1016/j.neubiorev.2012.11.003; Fischer S, 2002, P NATL ACAD SCI USA, V99, P11987, DOI 10.1073/pnas.182178199; Hester R, 2004, CEREB CORTEX, V14, P986, DOI 10.1093/cercor/bhh059; Taylor SF, 2004, NEUROIMAGE, V21, P1045, DOI 10.1016/j.neuroimage.2003.10.032; Stahl J, 2007, CLIN NEUROPHYSIOL, V118, P581, DOI 10.1016/j.clinph.2006.10.023; Silva EJ, 2008, BEHAV NEUROSCI, V122, P928, DOI 10.1037/0735-7044.122.4.928; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Eigsti IM, 2006, PSYCHOL SCI, V17, P478, DOI 10.1111/j.1467-9280.2006.01732.x; Dimitrov M, 2003, BRAIN COGNITION, V52, P258, DOI 10.1016/S0278-2626(03)00080-0; Groman SM, 2009, NEUROSCI BIOBEHAV R, V33, P690, DOI 10.1016/j.neubiorev.2008.08.008; Song SB, 2007, J NEUROSCI, V27, P12475, DOI 10.1523/JNEUROSCI.2062-07.2007; Zhang S, 2012, HUM BRAIN MAPP, V33, P89, DOI 10.1002/hbm.21197; Gerstner JR, 2009, J NEUROSCI, V29, P12824, DOI 10.1523/JNEUROSCI.3353-09.2009; EIMER M, 1993, BIOL PSYCHOL, V35, P123, DOI 10.1016/0301-0511(93)90009-W; Song SB, 2007, LEARN MEMORY, V14, P167, DOI 10.1101/lm.437407; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Gerstner JR, 2010, NAT REV NEUROSCI, V11, P577, DOI 10.1038/nrn2881; Kuriyama K, 2004, LEARN MEMORY, V11, P705, DOI 10.1101/lm.76304; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Crone EA, 2006, P NATL ACAD SCI USA, V103, P9315, DOI 10.1073/pnas.0510088103; Hirose S, 2012, J NEUROSCI, V32, P9059, DOI 10.1523/JNEUROSCI.0540-12.2012; Arzi A, 2012, NAT NEUROSCI, V15, P1460, DOI 10.1038/nn.3193; Proulx T, 2012, TRENDS COGN SCI, V16, P285, DOI 10.1016/j.tics.2012.04.002; Scheer FAJL, 2008, J BIOL RHYTHM, V23, P353, DOI 10.1177/0748730408318081; Alderson RM, 2007, J ABNORM CHILD PSYCH, V35, P745, DOI 10.1007/s10802-007-9131-6; Baddeley A. D., 1974, PSYCHOL LEARN MOTIV, V8, P47, DOI DOI 10.1016/S0079-7421(08)60452-1; Enge S, 2014, J EXP PSYCHOL LEARN, V40, P987, DOI 10.1037/a0036165; Gaab N, 2004, NEUROREPORT, V15, P731, DOI 10.1097/01.wnr.0000113532.32218.d6; Kuriyama K, 2008, J NEUROSCI, V28, P10145, DOI 10.1523/JNEUROSCI.2039-08.2008; Lee IS, 2010, J CLIN SLEEP MED, V6, P163; Mednick SC, 2008, BEHAV BRAIN RES, V193, P79, DOI 10.1016/j.bbr.2008.04.028; Miccoli L, 2008, CHRONOBIOL INT, V25, P725, DOI 10.1080/07420520802397228; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Spencer RMC, 2006, CURR BIOL, V16, P1001, DOI 10.1016/j.cub.2006.03.094; Swick D, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-102	59	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAY 20	2015	5								10362	10.1038/srep10362		11	Multidisciplinary Sciences	Science & Technology - Other Topics	CJ3OQ	WOS:000355394100002		
J	Masuda, Y; Itoh, T; Shin, W; Kato, K				Masuda, Yoshitake; Itoh, Toshio; Shin, Woosuck; Kato, Kazumi			SnO2 Nanosheet/Nanoparticle Detector for the Sensing of 1-Nonanal Gas Produced by Lung Cancer	SCIENTIFIC REPORTS			English	Article							VOLATILE ORGANIC-COMPOUNDS; EXHALED BREATH; SENSOR; HUMIDITY	A sensor has been developed for detecting 1-nonanal gas present in the breath of lung cancer patients by combining SnO2 nanosheets with SnO2 nanoparticles and noble metal catalysts. A significant change in the electrical resistance of this sensor was observed with increasing 1-nonanal gas concentration; the resistance decreased by a factor of 1.12 within the range of 1 to 10 ppm at 300 degrees C. The recovery of the sensor's resistance after detecting 1-nonanal gas concentrations of 0.055, 0.18, 1, and 9.5 ppm was determined to be 86.1, 84.2, 80.4 and 69.2%, respectively. This high sensitivity is attributed to the accelerated oxidation of 1-nonanal molecules caused by the (101) crystal faces of the SnO2 nanosheets and should provide a simple and effective approach to the early detection of lung cancer.	[Masuda, Yoshitake; Itoh, Toshio; Shin, Woosuck; Kato, Kazumi] Natl Inst Adv Ind Sci & Technol, Moriyama Ku, Nagoya, Aichi 4638560, Japan	Masuda, Y (reprint author), Natl Inst Adv Ind Sci & Technol, Moriyama Ku, 2266-98 Anagahora, Nagoya, Aichi 4638560, Japan.	masuda-y@aist.go.jp					Mazzone PJ, 2007, THORAX, V62, P565, DOI 10.1136/thx.2006.072892; Peng G, 2009, NAT NANOTECHNOL, V4, P669, DOI 10.1038/nnano.2009.235; Mao S, 2014, J MATER CHEM A, V2, P5573, DOI 10.1039/c3ta13823b; Phillips M, 1999, LANCET, V353, P1930, DOI 10.1016/S0140-6736(98)07552-7; Jareno-Esteban JJ, 2013, ARCH BRONCONEUMOL, V49, P457, DOI 10.1016/j.arbres.2013.04.004; Westhoff M, 2009, THORAX, V64, P744, DOI 10.1136/thx.2008.099465; Masuda Y, 2012, ACS APPL MATER INTER, V4, P1666, DOI 10.1021/am201811x; Fuchs P, 2010, INT J CANCER, V126, P2663, DOI 10.1002/ijc.24970; Pan J, 2010, J PHYS CHEM C, V114, P8245, DOI 10.1021/jp101072f; Itoh T, 2010, SENSORS-BASEL, V10, P6513, DOI 10.3390/s100706513; Mao S, 2012, J MATER CHEM, V22, P11009, DOI 10.1039/c2jm30378g; Batzill M, 2004, EUROPHYS LETT, V65, P61, DOI 10.1209/epl/i2003-10044-0; Itoh T, 2008, SENSOR ACTUAT B-CHEM, V128, P512, DOI 10.1016/j.snb.2007.07.059; Kadosaki M, 2010, ELECTR COMMUN JPN, V93, P34, DOI 10.1002/ecj.10190; Itoh T, 2013, SENSOR ACTUAT B-CHEM, V187, P135, DOI 10.1016/j.snb.2012.09.097; Masuda Y., 2014, Japan patent, Patent No. [P2014-138669, 2014138669]; Masuda Y, 2013, THIN SOLID FILMS, V544, P567, DOI 10.1016/j.tsf.2012.12.067; Masuda Y, 2014, J NANOSCI NANOTECHNO, V14, P2252, DOI 10.1166/jnn.2014.8478; Mathur S, 2007, ADV ENG MATER, V9, P658, DOI 10.1002/adem.200700086; Sakai Y, 2009, J CERAM SOC JPN, V117, P1297, DOI 10.2109/jcersj2.117.1297	20	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAY 20	2015	5								UNSP 10122	10.1038/srep10122		7	Multidisciplinary Sciences	Science & Technology - Other Topics	CJ3NU	WOS:000355391900001		
J	Takeda, TA; Mu, AF; Tai, TT; Kitajima, S; Taketani, S				Takeda, Taka-aki; Mu, Anfeng; Tran Tien Tai; Kitajima, Sakihito; Taketani, Shigeru			Continuous de novo biosynthesis of haem and its rapid turnover to bilirubin are necessary for cytoprotection against cell damage	SCIENTIFIC REPORTS			English	Article							BILIVERDIN REDUCTASE; GILBERTS-SYNDROME; IRON DISTRIBUTION; OXIDATIVE STRESS; OXYGENASE-1; METABOLISM; PROTEIN; ROLES; FERROCHELATASE; PROTOPORPHYRIN	It is well known that haem serves as the prosthetic group of various haemoproteins that function in oxygen transport, respiratory chain, and drug metabolism. However, much less is known about the functions of the catabolites of haem in mammalian cells. Haem is enzymatically degraded to iron, carbon monoxide (CO), and biliverdin, which is then converted to bilirubin. Owing to difficulties in measuring bilirubin, however, the generation and transport of this end product remain unclear despite its clinical importance. Here, we used UnaG, the recently identified bilirubin-binding fluorescent protein, to analyse bilirubin production in a variety of human cell lines. We detected a significant amount of bilirubin with many non-blood cell types, which was sensitive to inhibitors of haem metabolism. These results suggest that there is a basal level of haem synthesis and its conversion into bilirubin. Remarkably, substantial changes were observed in the bilirubin generation when cells were exposed to stress insults. Since the stress-induced cell damage was exacerbated by the pharmacological blockade of haem metabolism but was ameliorated by the addition of biliverdin and bilirubin, it is likely that the de novo synthesis of haem and subsequent conversion to bilirubin play indispensable cytoprotective roles against cell damage.	[Takeda, Taka-aki; Mu, Anfeng; Tran Tien Tai; Kitajima, Sakihito; Taketani, Shigeru] Kyoto Inst Technol, Dept Biotechnol, Kyoto 6068585, Japan	Taketani, S (reprint author), Kyoto Inst Technol, Dept Biotechnol, Kyoto 6068585, Japan.	taketani@kit.ac.jp			Ministry of Health, Labour, and Welfare of Japan [H24-Nanchi-S-006]; Ministry of Education, Science, Sports, and Culture of Japan [23510256]	The authors thank Dr. Atsushi Miyawaki for the kind gift of pcDNA3-UnaG, and Ms. A. Kawazoe and Ms. C. Hori for their expert technical assistance. This study was supported in part by grants from the Ministry of Health, Labour, and Welfare of Japan (H24-Nanchi-S-006), and from the Ministry of Education, Science, Sports, and Culture of Japan (23510256).	Alam J, 2004, ANTIOXID REDOX SIGN, V6, P924, DOI 10.1089/ars.2004.6.924; Hori R, 2002, J BIOL CHEM, V277, P10712, DOI 10.1074/jbc.M107749200; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Erlinger S, 2014, GASTROENTEROLOGY, V146, P1625, DOI 10.1053/j.gastro.2014.03.047; Kovtunovych G, 2010, BLOOD, V116, P6054, DOI 10.1182/blood-2010-03-272138; Sheftel AD, 2007, J BIOL CHEM, V282, P10480, DOI 10.1074/jbc.M700240200; Sticova E, 2013, WORLD J GASTROENTERO, V19, P6398, DOI 10.3748/wjg.v19.i38.6398; Chiabrando D, 2012, J CLIN INVEST, V122, P4569, DOI 10.1172/JCI62422; Kumagai A, 2013, CELL, V153, P1602, DOI 10.1016/j.cell.2013.05.038; Baranano DE, 2001, P NATL ACAD SCI USA, V98, P10996, DOI 10.1073/pnas.191351298; TAKETANI S, 1989, FEBS LETT, V245, P173, DOI 10.1016/0014-5793(89)80215-7; Wegiel B, 2011, P NATL ACAD SCI USA, V108, P18849, DOI 10.1073/pnas.1108571108; GENTILE S, 1990, HEPATOLOGY, V12, P213, DOI 10.1002/hep.1840120206; Simon T, 2011, IMMUNOTHERAPY-UK, V3, P15, DOI [10.2217/imt.11.43, 10.2217/IMT.11.43]; Lanceta L, 2013, BIOCHEM J, V449, P189, DOI 10.1042/BJ20120936; Feng D, 2012, MOL CELL, V47, P158, DOI 10.1016/j.molcel.2012.06.026; Maines MD, 2007, ANTIOXID REDOX SIGN, V9, P2187, DOI 10.1089/ars.2007.1805; Ohgari Y, 2011, PHOTOCHEM PHOTOBIOL, V87, P1138, DOI 10.1111/j.1751-1097.2011.00950.x; Crooks DR, 2010, BLOOD, V115, P860, DOI 10.1182/blood-2009-09-243105; Arthur DM, 2012, J TOXICOL SCI, V37, P655; Dolinay T, 2012, CURR PHARM BIOTECHNO, V13, P769; GRANDCHAMP B, 1981, J BIOL CHEM, V256, P1677; Hull TD, 2014, ANTIOXID REDOX SIGN, V20, P1770, DOI 10.1089/ars.2013.5673; Igarashi K, 2014, TOHOKU J EXP MED, V232, P229; Itoh R, 2013, FEBS LETT, V587, P2131, DOI 10.1016/j.febslet.2013.05.036; Kim YS, 2005, FREE RADICAL BIO MED, V39, P558, DOI 10.1016/j.freeradbiomed.2005.04.009; LODOLA A, 1978, FEBS LETT, V90, P250, DOI 10.1016/0014-5793(78)80379-2; LONDON IM, 1950, J BIOL CHEM, V184, P351; MARTIN JF, 1976, GASTROENTEROLOGY, V70, P385; MCDONAGH AF, 1980, SCIENCE, V208, P145, DOI 10.1126/science.7361112; Origassa Clarice Silvia Taemi, 2013, World J Hepatol, V5, P541, DOI 10.4254/wjh.v5.i10.541; Paul S, 1997, P NATL ACAD SCI USA, V94, P14976; Qaisiya M, 2014, CELL SIGNAL, V26, P512, DOI 10.1016/j.cellsig.2013.11.029; Sakaino M, 2009, FEBS J, V276, P5559, DOI 10.1111/j.1742-4658.2009.07248.x; SASSA S, 1990, INT J CELL CLONING, V8, P10; Sawamoto M, 2013, PHOTOCHEM PHOTOBIOL, V89, P163, DOI 10.1111/j.1751-1097.2012.01215.x; SCHWARTZ S, 1971, J LAB CLIN MED, V78, P411; Taketani S, 2005, TOHOKU J EXP MED, V205, P297, DOI 10.1620/tjem.205.297; TAKETANI S, 1990, J BIOCHEM-TOKYO, V108, P28; Wang XY, 2008, EUR J PHARMACOL, V591, P28, DOI 10.1016/j.ejphar.2008.06.017	40	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAY 20	2015	5								10488	10.1038/srep10488		12	Multidisciplinary Sciences	Science & Technology - Other Topics	CJ3PQ	WOS:000355396700001		
J	Tsuge, K; Sato, Y; Kobayashi, Y; Gondo, M; Hasebe, M; Togashi, T; Tomita, M; Itaya, M				Tsuge, Kenji; Sato, Yukari; Kobayashi, Yuka; Gondo, Maiko; Hasebe, Masako; Togashi, Takashi; Tomita, Masaru; Itaya, Mitsuhiro			Method of preparing an equimolar DNA mixture for one-step DNA assembly of over 50 fragments	SCIENTIFIC REPORTS			English	Article							MYCOPLASMA-GENITALIUM GENOME; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; POLYETHYLENE-GLYCOL; CLONING METHOD; ONE-POT; CELL; TRANSFORMATION; LIGATION; PLASMID	In the era of synthetic biology, techniques for rapidly constructing a designer long DNA from short DNA fragments are desired. To realize this, we attempted to establish a method for one-step DNA assembly of unprecedentedly large numbers of fragments. The basic technology is the Ordered Gene Assembly in Bacillus subtilis (OGAB) method, which uses the plasmid transformation system of B. subtilis. Since this method doesn't require circular ligation products but needs tandem repeat ligation products, the degree of deviation in the molar concentration of the material DNAs is the only determinant that affects the efficiency of DNA assembly. The strict standardization of the size of plasmids that clone the DNA block and the measurement of the block in the state of intact plasmid improve the reliability of this step, with the coefficient of variation of the molar concentrations becoming 7%. By coupling this method with the OGAB method, one-step assembly of more than 50 DNA fragments becomes feasible.	[Tsuge, Kenji; Sato, Yukari; Kobayashi, Yuka; Gondo, Maiko; Hasebe, Masako; Togashi, Takashi; Tomita, Masaru; Itaya, Mitsuhiro] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata 9970017, Japan	Tsuge, K (reprint author), Keio Univ, Inst Adv Biosci, 403-1 Nipponkoku, Tsuruoka, Yamagata 9970017, Japan.	ktsuge@ttck.keio.ac.jp			Commission for the Development of Artificial Gene Synthesis Technology for Creating Innovative Biomaterials from the Ministry of Economy, Trade, and Industry (METI), Japan; JSPS [23119004]	This work was supported by the Commission for the Development of Artificial Gene Synthesis Technology for Creating Innovative Biomaterials from the Ministry of Economy, Trade, and Industry (METI), Japan; and by JSPS KAKENHI Grant Number 23119004. We thank Dr. Y. Toya of Osaka for his advice on presenting the computer simulation results.	Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Itaya M, 2008, NAT METHODS, V5, P41, DOI 10.1038/NMETH1143; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; HAYASHI K, 1985, NUCLEIC ACIDS RES, V13, P3261, DOI 10.1093/nar/13.9.3261; Nishizaki T, 2007, APPL ENVIRON MICROB, V73, P1355, DOI 10.1128/AEM.02268-06; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/nmeth.1318, 10.1038/NMETH.1318]; Dubnau D, 1999, ANNU REV MICROBIOL, V53, P217, DOI 10.1146/annurev.micro.53.1.217; ANAGNOSTOPOULOS C, 1961, J BACTERIOL, V81, P741; Hiroe A, 2012, APPL ENVIRON MICROB, V78, P3177, DOI 10.1128/AEM.07715-11; Itaya M, 2005, P NATL ACAD SCI USA, V102, P15971, DOI 10.1073/pnas.0503868102; DUGAICZYK A, 1975, J MOL BIOL, V96, P171, DOI 10.1016/0022-2836(75)90189-8; Tsuge K, 2007, J BIOTECHNOL, V129, P592, DOI 10.1016/j.jbiotec.2007.01.033; Gibson DG, 2009, NUCLEIC ACIDS RES, V37, P6984, DOI 10.1093/nar/gkp687; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Zhang YW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1288; HAYASHI K, 1986, NUCLEIC ACIDS RES, V14, P7617, DOI 10.1093/nar/14.19.7617; Ma SY, 2012, CURR OPIN CHEM BIOL, V16, P260, DOI 10.1016/j.cbpa.2012.05.001; Gibson DG, 2008, P NATL ACAD SCI USA, V105, P20404, DOI 10.1073/pnas.0811011106; Bron S, 1990, MOL BIOL METHODS BAC, P75; CANOSI U, 1981, MOL GEN GENET, V181, P434, DOI 10.1007/BF00428732; Chen SK, 2013, BIORESOURCE TECHNOL, V145, P204, DOI 10.1016/j.biortech.2013.01.115; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Itaya Mitsuhiro, 2011, Methods Enzymol, V498, P427, DOI 10.1016/B978-0-12-385120-8.00019-X; Kaneko S, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng114; Quan JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006441; ROSSI JJ, 1982, J BIOL CHEM, V257, P9226; Tsuge K, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng133	28	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAY 20	2015	5								10655	10.1038/srep10655		11	Multidisciplinary Sciences	Science & Technology - Other Topics	CJ3PS	WOS:000355396900001		
J	Yufune, S; Satoh, Y; Takamatsu, I; Ohta, H; Kobayashi, Y; Takaenoki, Y; Pages, G; Pouyssegur, J; Endo, S; Kazama, T				Yufune, Shinya; Satoh, Yasushi; Takamatsu, Isao; Ohta, Hiroyuki; Kobayashi, Yasushi; Takaenoki, Yumiko; Pages, Gilles; Pouyssegur, Jacques; Endo, Shogo; Kazama, Tomiei			Transient Blockade of ERK Phosphorylation in the Critical Period Causes Autistic Phenotypes as an Adult in Mice	SCIENTIFIC REPORTS			English	Article							DEVELOPING RAT-BRAIN; LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; NEONATAL EXPOSURE; SOCIAL BEHAVIORS; KNOCKOUT MICE; MAPK CASCADE; AMPA RATIO; DEFICITS; SEVOFLURANE	The critical period is a distinct time-window during the neonatal stage when animals display elevated sensitivity to certain environmental stimuli, and particular experiences can have profound and long-lasting effects on behaviors. Increasing evidence suggests that disruption of neuronal activity during the critical period contributes to autistic phenotype, although the pathogenic mechanism is largely unknown. Herein we show that extracellular signal-regulated protein kinases (ERKs) play important roles in proper formation of neural circuits during the critical period. Transient blockade of ERKs phosphorylation at postnatal day 6 (P6) by intraperitoneal injection of blood-brain barrier-penetrating MEK inhibitor, alpha-[amino[(4-aminophenyl)thio]methylene]-2-(trifluoromethyl) benzeneacetonitrile (SL327) caused significant increase of apoptosis in the forebrain. Furthermore, this induced long-term deleterious effects on brain functioning later in adulthood, resulting in social deficits, impaired memory and reduced long-term potentiation (LTP). Conversely, blockade of ERK phosphorylation at P14 no longer induced apoptosis, nor behavioral deficits, nor the reduced LTP. Thus, surprisingly, these effects of ERKs are strongly age-dependent, indicating that phosphorylation of ERKs during the critical period is absolutely required for proper development of brain functioning. This study provides novel insight into the mechanistic basis for neurodevelopment disorders: various neurodevelopment disorders might be generally linked to defects in ERKs signaling during the critical period.	[Yufune, Shinya; Satoh, Yasushi; Takamatsu, Isao; Takaenoki, Yumiko; Kazama, Tomiei] Natl Def Med Coll, Dept Anesthesiol, Tokorozawa, Saitama 3598513, Japan; [Ohta, Hiroyuki] Natl Def Med Coll, Dept Physiol, Tokorozawa, Saitama 3598513, Japan; [Kobayashi, Yasushi] Natl Def Med Coll, Dept Anat & Neurobiol, Tokorozawa, Saitama 3598513, Japan; [Pages, Gilles; Pouyssegur, Jacques] Univ Nice Sophia Antipolis, Ctr Antoine Lacassagne, Inst Res Canc & Aging IRCAN, F-06189 Nice, France; [Pouyssegur, Jacques] CSM, Dept Biochem, MC-98000 Monaco, Monaco; [Endo, Shogo] Tokyo Metropolitan Geriatr Hosp & Inst Gerontol, Aging Regulat Res Team, Itabashi Ku, Tokyo 1730015, Japan	Satoh, Y (reprint author), Natl Def Med Coll, Dept Anesthesiol, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.	wndlt3@gmail.com			Japan Society for the Promotion of Science, Tokyo, Japan [25293331, 15H04970]; Research Foundation for Opto-Science and Technology, Hamamatsu, Japan	We thank Ms. Kiyoko Takamiya and Mrs. Yuko Ogura (Technicians, Department of Anesthesiology, National Defense Medical College, Tokorozawa, Saitama, Japan) for their excellent technical help with this study. This work was supported by the Japan Society for the Promotion of Science, Tokyo, Japan; Grant numbers 25293331 and 15H04970 and the Research Foundation for Opto-Science and Technology, Hamamatsu, Japan.	Myme CIO, 2003, J NEUROPHYSIOL, V90, P771, DOI 10.1152/jn.00070.2003; Etherton MR, 2009, P NATL ACAD SCI USA, V106, P17998, DOI 10.1073/pnas.0910297106; Vorstman JAS, 2006, MOL PSYCHIATR, V11, P18, DOI 10.1038/sj.mp.4001757; Alter BJ, 2010, J NEUROSCI, V30, P11537, DOI 10.1523/JNEUROSCI.6103-09.2010; Yonamine R, 2013, ANESTHESIOLOGY, V118, P105, DOI 10.1097/ALN.0b013e318275146d; Satoh Y, 2007, J NEUROSCI, V27, P10765, DOI 10.1523/JNEUROSCI.0117-07.2007; Zhao SL, 2011, NAT METHODS, V8, P745, DOI 10.1038/nmeth.1668; Mazzucchelli C, 2002, NEURON, V34, P807, DOI 10.1016/S0896-6273(02)00716-X; Satoh Y, 2011, J NEUROSCI, V31, P11953, DOI 10.1523/JNEUROSCI.2349-11.2011; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Satomoto M, 2009, ANESTHESIOLOGY, V110, P628, DOI 10.1097/ALN.0b013e3181974fa2; Samuels IS, 2008, J NEUROSCI, V28, P6983, DOI 10.1523/JNEUROSCI.0679-08.2008; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Crawley JN, 2007, BRAIN PATHOL, V17, P448, DOI 10.1111/j.1750-3639.2007.00096.x; Brambrink AM, 2012, ANN NEUROL, V72, P525, DOI 10.1002/ana.23652; Kodama M, 2011, ANESTHESIOLOGY, V115, P979, DOI 10.1097/ALN.0b013e318234228b; Yon JH, 2005, NEUROSCIENCE, V135, P815, DOI 10.1016/j.euroscience.2005.03.064; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003; Pucilowska J, 2012, J NEUROSCI, V32, P8663, DOI 10.1523/JNEUROSCI.1107-12.2012; Satoh Y, 2011, J NEUROSCI, V31, P1149, DOI 10.1523/JNEUROSCI.2243-10.2011; Atkins CM, 1998, NAT NEUROSCI, V1, P602; Straiko MMW, 2009, ANESTHESIOLOGY, V110, P862, DOI 10.1097/ALN.0b013e31819b5eab; Bagetta V, 2012, J NEUROSCI, V32, P17921, DOI 10.1523/JNEUROSCI.2664-12.2012; IKONOMIDOU C, 1989, J NEUROSCI, V9, P2809; Otsubo Y, 2012, PAIN, V153, P2241, DOI 10.1016/j.pain.2012.07.020; Nelson CA, 2007, SCIENCE, V318, P1937, DOI 10.1126/science.1143921; Kolli S, 2004, J BIOL CHEM, V279, P29374, DOI 10.1074/jbc.M313955200; Takamatsu I, 2005, NEUROSCI LETT, V389, P129, DOI 10.1016/j.neulet.2005.07.043; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Selcher JC, 1999, LEARN MEMORY, V6, P478, DOI 10.1101/lm.6.5.478; Pilpel Y, 2009, J PHYSIOL-LONDON, V587, P787, DOI 10.1113/jphysiol.2008.160929; Bentires-Alj M, 2006, NAT MED, V12, P283, DOI 10.1038/nm0306-283; Creeley Catherine E, 2013, Acta Neuropathol Commun, V1, P23, DOI 10.1186/2051-5960-1-23; Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876; Knudsen EI, 2004, J COGNITIVE NEUROSCI, V16, P1412, DOI 10.1162/0898929042304796; LeBlanc JJ, 2011, NEURAL PLAST, DOI 10.1155/2011/921680; Tanaka Y, 2008, J NEUROSCI METH, V171, P118, DOI 10.1016/j.jneumeth.2008.02.021; Tozzi A, 2015, NEUROBIOL AGING, V36, P123, DOI 10.1016/j.neurobiolaging.2014.07.002	38	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAY 20	2015	5								10252	10.1038/srep10252		16	Multidisciplinary Sciences	Science & Technology - Other Topics	CJ3NZ	WOS:000355392400001		
J	Chang, K; Li, M; Wang, T; Ouyang, SX; Li, P; Liu, LQ; Ye, JH				Chang, Kun; Li, Mu; Wang, Tao; Ouyang, Shuxin; Li, Peng; Liu, Lequan; Ye, Jinhua			Drastic Layer-Number-Dependent Activity Enhancement in Photocatalytic H-2 Evolution over nMoS(2)/CdS (n 1) Under Visible Light	ADVANCED ENERGY MATERIALS			English	Article						co-catalysts; hydrogen evolution; nanomaterials; single-layer MoS2; visible light	MOS2 ULTRATHIN NANOSHEETS; EXFOLIATED METALLIC MOS2; HIGH QUANTUM EFFICIENCY; HYDROGEN-EVOLUTION; PT-PDS/CDS; EDGE SITES; GRAPHENE; NANOSTRUCTURES; NANOPARTICLES; COCATALYSTS	Exploiting noble-metal-free cocatalysts is of huge interest for photocatalytic water splitting using solar energy. As an efficient cocatalyst in photocatalysis, MoS2 is shown promise as a low-cost alternative to Pt for hydrogen evolution. Here we report a systematical study on controlled synthesis of MoS2 with layer number ranging from approximate to 1 to 112 and their activities for photocatalytic H-2 evolution over commercial CdS. A drastic increase in photocatalytic H-2 evolution is observed with decreasing MoS2 layer number. Particularly for the single-layer (SL) MoS2, the SL-MoS2/CdS sample reaches a high H-2 generation rate of approximate to 2.01 x 10(-3)m h(-1) in Na2S-Na2SO3 solutions and approximate to 2.59 x 10(-3)m h(-1) in lactic acid solutions, corresponding to an apparent quantum efficiency of 30.2% and 38.4% at 420 nm, respectively. In addition to the more exposed edges and unsaturated active S atoms, valence band-XPS and Mott-Schottky plots analysis indicate that the SL MoS2 has the more negative conduction band energy level than the H+/H-2 potential, facilitating the hydrogen reduction.	[Chang, Kun; Li, Mu; Wang, Tao; Li, Peng; Ye, Jinhua] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton WPI MANA, Tsukuba, Ibaraki 3050044, Japan; [Chang, Kun; Li, Mu; Wang, Tao; Li, Peng; Ye, Jinhua] Natl Inst Mat Sci, Environm Remediat Mat Unit, Tsukuba, Ibaraki 3050044, Japan; [Ouyang, Shuxin; Liu, Lequan; Ye, Jinhua] Tianjin Univ, Sch Mat Sci & Engn, TU NIMS Joint Res Ctr, Tianjin 300072, Peoples R China; [Ye, Jinhua] Collaborat Innovat Ctr Chem Sci & Engn Tianjin, Tianjin 300072, Peoples R China	Ye, JH (reprint author), Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton WPI MANA, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.	jinhua.ye@nims.go.jp	Wang, Tao/D-9998-2011; Li, Peng/D-3072-2013	Wang, Tao/0000-0003-4045-2434; Li, Peng/0000-0002-5715-548X	World Premier International Research Center Initiative (WPI Initiative) on Materials Nanoarchitectonics (MANA); National Basic Research Program of China (973 Program) [2014CB239301]	This work was partially supported by the World Premier International Research Center Initiative (WPI Initiative) on Materials Nanoarchitectonics (MANA) and National Basic Research Program of China (973 Program, 2014CB239301).	Sun XM, 2010, ACS NANO, V4, P3381, DOI 10.1021/nn1000386; Yu YF, 2014, NANO LETT, V14, P553, DOI 10.1021/nl403620g; Lukowski MA, 2013, J AM CHEM SOC, V135, P10274, DOI 10.1021/ja404523s; Melian EP, 2013, INT J HYDROGEN ENERG, V38, P11737, DOI 10.1016/j.ijhydene.2013.07.006; FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; Li YG, 2011, J AM CHEM SOC, V133, P7296, DOI 10.1021/ja201269b; Wang HT, 2013, P NATL ACAD SCI USA, V110, P19701, DOI 10.1073/pnas.1316792110; Xie JF, 2013, ADV MATER, V25, P5807, DOI 10.1002/adma.201302685; Chang K, 2014, ACS NANO, V8, P7078, DOI 10.1021/nn5019945; Yan HJ, 2009, J CATAL, V266, P165, DOI 10.1016/j.jcat.2009.06.024; Eda G, 2011, NANO LETT, V11, P5111, DOI 10.1021/nl201874w; Yang SB, 2013, ADV MATER, V25, P2452, DOI 10.1002/adma.201204453; Xie JF, 2013, J AM CHEM SOC, V135, P17881, DOI 10.1021/ja408329q; Rao CNR, 2013, ANGEW CHEM INT EDIT, V52, P13162, DOI 10.1002/anie.201301548; Thurston TR, 1999, J PHYS CHEM B, V103, P11, DOI 10.1021/jp982337h; Bai L, 2010, J AM CHEM SOC, V132, P2333, DOI 10.1021/ja908971d; Chang K, 2011, ACS NANO, V5, P4720, DOI 10.1021/nn200659w; Yang JH, 2012, J CATAL, V290, P151, DOI 10.1016/j.jcat.2012.03.008; Liu Y, 2013, J PHYS CHEM C, V117, P12949, DOI 10.1021/jp4009652; Yang JH, 2013, ACCOUNTS CHEM RES, V46, P1900, DOI 10.1021/ar300227e; Xiang QJ, 2012, J AM CHEM SOC, V134, P6575, DOI 10.1021/ja302846n; Ouyang SX, 2012, J AM CHEM SOC, V134, P1974, DOI 10.1021/ja210610h; Yin ZY, 2014, SMALL, V10, P3537, DOI 10.1002/smll.201400124; Li X, 2015, J MATER CHEM A, V3, P2485, DOI 10.1039/c4ta04461d; Tsuji I, 2004, J AM CHEM SOC, V126, P13406, DOI 10.1021/ja048296m; Yi ZG, 2010, NAT MATER, V9, P559, DOI [10.1038/nmat2780, 10.1038/NMAT2780]; Liao L, 2013, ADV FUNCT MATER, V23, P5326, DOI 10.1002/adfm.201300318; Matte HSSR, 2010, ANGEW CHEM INT EDIT, V49, P4059, DOI 10.1002/anie.201000009; Karunadasa HI, 2012, SCIENCE, V335, P698, DOI 10.1126/science.1215868; Smith RJ, 2011, ADV MATER, V23, P3944, DOI 10.1002/adma.201102584; Huang X, 2014, ADV MATER, V26, P2185, DOI 10.1002/adma.201304964; Mak KF, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.136805; Ding Q, 2014, J AM CHEM SOC, V136, P8504, DOI 10.1021/ja5025673; Tong H, 2012, ADV MATER, V24, P229, DOI 10.1002/adma.201102752; Kang YJ, 2012, ACS NANO, V6, P2818, DOI 10.1021/nn3003373; Chen GP, 2012, APPL CATAL A-GEN, V443, P138, DOI 10.1016/j.apcata.2012.07.033; Tan CL, 2015, CHEM SOC REV, V44, P2713, DOI 10.1039/c4cs00182f; Zhang J, 2013, PHYS CHEM CHEM PHYS, V15, P12088, DOI 10.1039/c3cp50734c; Nguyen M, 2013, NANOSCALE, V5, P1479, DOI 10.1039/c2nr34037b; Tiwari JN, 2013, NANO ENERGY, V2, P553, DOI 10.1016/j.nanoen.2013.06.009; Zhou WJ, 2013, SMALL, V9, P140, DOI 10.1002/smll.201201161; Jaramillo TF, 2007, SCIENCE, V317, P100, DOI 10.1126/science.1141483; Voiry D, 2013, NANO LETT, V13, P6222, DOI 10.1021/nl403661s; Chen JZ, 2015, ANGEW CHEM INT EDIT, V54, P1210, DOI 10.1002/anie.201410172; Kadantsev ES, 2012, SOLID STATE COMMUN, V152, P909, DOI 10.1016/j.ssc.2012.02.005; Coleman JN, 2011, SCIENCE, V331, P568, DOI 10.1126/science.1194975; Wang TY, 2013, CHEM-EUR J, V19, P11939, DOI 10.1002/chem.201301406; Xiang QJ, 2012, CHEM SOC REV, V41, P782, DOI 10.1039/c1cs15172j; Zhang J, 2012, NANO LETT, V12, P4584, DOI 10.1021/nl301831h; Tsai C, 2014, NANO LETT, V14, P1381, DOI 10.1021/nl404444k; Hinnemann B, 2005, J AM CHEM SOC, V127, P5308, DOI 10.1021/ja0504690; Chen DY, 2014, MATER TODAY, V17, P184, DOI 10.1016/j.mattod.2014.04.001; Ellis J. K., 2011, APPL PHYS LETT, P99; Huang X, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2472; Singh N, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2012-30449-7	55	4	4	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1614-6832	1614-6840		ADV ENERGY MATER	Adv. Energy Mater.	MAY 20	2015	5	10							1402279	10.1002/aenm.201402279		10	Chemistry, Physical; Energy & Fuels; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Energy & Fuels; Materials Science; Physics	CI5PN	WOS:000354810400008		
J	Watanabe, K; Hayasaka, H; Miyashita, T; Ueda, K; Akagi, K				Watanabe, Kazuyoshi; Hayasaka, Hiroyuki; Miyashita, Tatsuaki; Ueda, Kenta; Akagi, Kazuo			Dynamic Control of Full-Colored Emission and Quenching of Photoresponsive Conjugated Polymers by Photostimuli	ADVANCED FUNCTIONAL MATERIALS			English	Article							CIRCULARLY-POLARIZED FLUORESCENCE; AGGREGATION-INDUCED EMISSION; LIGHT-EMITTING-DIODES; ENERGY-TRANSFER; CHEMICAL SENSORS; MAIN-CHAIN; DIARYLETHENE; NANOPARTICLES; SWITCHES; DEVICES	A series of photoresponsive and full-colored fluorescent conjugated copolymers is synthesized by combining phenylene-and thienylene-based main chains with photochromic dithienylethene (DE) side chains. Solutions and cast films of the polymers exhibit various colored fluorescence in visible wavelengths of 400-700 nm corresponding to emissions of the conjugated main chain. The fluorescence is reversibly photoswitched between emission and quenching through DE photoisomerization using external stimuli from ultraviolet and visible light irradiation. The reprecipitation method with ultra-sonication enables the polymers to form spherical aggregates with diameters of 20-70 nm in water. After investigating and comparing the optical properties, the resulting nanosphere solutions are assumed to exist in an intermediate state between an isolated state (i.e., in solution) and an aggregated state in cast film. The majority of the nanosphere solutions also exhibit the same photoswitchable fluorescence behavior as those in the solutions and the cast films. The results demonstrate that the visible fluorescence of the conjugated copolymers is reversibly switchable between emission and quenching using the photoisomerizing DE side chain regardless of the fluorescent colors and the polymer chain aggregation.	[Watanabe, Kazuyoshi; Hayasaka, Hiroyuki; Miyashita, Tatsuaki; Ueda, Kenta; Akagi, Kazuo] Kyoto Univ, Dept Polymer Chem, Nishikyo Ku, Kyoto 6158510, Japan	Watanabe, K (reprint author), Kyoto Univ, Dept Polymer Chem, Nishikyo Ku, Kyoto 6158510, Japan.	akagi@fps.polym.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [25246002]	The authors thanked Kazuya Tamura for his valuable cooperation in synthesis and spectroscopic measurements. This work was supported by Grants-in-Aid for Science Research (A) (Grant No. 25246002) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Akagi K, 2007, B CHEM SOC JPN, V80, P649, DOI 10.1246/bcsj.80.649; Lim SJ, 2004, ANGEW CHEM INT EDIT, V43, P6346, DOI 10.1002/anie.200461172; [Anonymous], 2007, CHEM COMMUN, DOI DOI 10.1039/B610004J; Watanabe K, 2013, J MATER CHEM C, V1, P2797, DOI 10.1039/c3tc00045a; Langeveld-Voss BMW, 2000, J MOL STRUCT, V521, P285, DOI 10.1016/S0022-2860(99)00444-5; Hu RR, 2012, J MATER CHEM, V22, P232, DOI 10.1039/c1jm13556b; Hoven CV, 2008, ADV MATER, V20, P3793, DOI 10.1002/adma.200800533; Anwar N, 2013, ACS MACRO LETT, V2, P766, DOI 10.1021/mz400362g; Mukamel S, 1997, SCIENCE, V277, P781, DOI 10.1126/science.277.5327.781; BURROUGHES JH, 1990, NATURE, V347, P539, DOI 10.1038/347539a0; Tian ZY, 2010, NANOSCALE, V2, P1999, DOI 10.1039/c0nr00322k; Tian H, 2004, CHEM SOC REV, V33, P85, DOI 10.1039/b302356g; Kohler A, 1998, NATURE, V392, P903; Dimitrakopoulos CD, 2002, ADV MATER, V14, P99, DOI 10.1002/1521-4095(20020116)14:2<99::AID-ADMA99>3.0.CO;2-9; Norsten TB, 2001, J AM CHEM SOC, V123, P1784, DOI 10.1021/ja005639h; Kurokawa N, 2004, CHEMPHYSCHEM, V5, P1609, DOI 10.1002/cphc.200400117; Kaeser A, 2010, ADV MATER, V22, P2985, DOI 10.1002/adma.201000427; Kane-Maguire LAP, 2010, CHEM SOC REV, V39, P2545, DOI 10.1039/b908001p; Grimsdale AC, 2009, CHEM REV, V109, P897, DOI 10.1021/cr000013v; Harbron EJ, 2009, J PHYS CHEM C, V113, P13707, DOI 10.1021/jp9037864; Qin A, 2012, PROG POLYM SCI, V37, P182, DOI 10.1016/j.progpolymsci.2011.08.002; Li YN, 2013, ANGEW CHEM INT EDIT, V52, P13703, DOI 10.1002/anie.201306396; Finden J, 2008, ADV MATER, V20, P1998, DOI 10.1002/adma.200702455; Giordano L, 2002, J AM CHEM SOC, V124, P7481, DOI 10.1021/ja016969k; Irie M, 2000, CHEM REV, V100, P1685, DOI 10.1021/cr980069d; Berberich M, 2008, ANGEW CHEM INT EDIT, V47, P6616, DOI 10.1002/anie.200802007; Watanabe K, 2012, CHEM MATER, V24, P1011, DOI 10.1021/cm2028788; Jiang GY, 2006, CHEM MATER, V18, P235, DOI 10.1021/cm052251i; Chan YH, 2012, ANAL CHEM, V84, P9431, DOI 10.1021/ac302245t; Luo QF, 2011, POLYM CHEM-UK, V2, P2435, DOI 10.1039/c1py00167a; Zacharias P, 2009, ANGEW CHEM INT EDIT, V48, P4038, DOI 10.1002/anie.200805969; Yu J, 2000, SCIENCE, V289, P1327, DOI 10.1126/science.289.5483.1327; Liu XH, 2013, J MATER CHEM C, V1, P4713, DOI 10.1039/c3tc30886c; Fukaminato T, 2006, ADV MATER, V18, P3225, DOI 10.1002/adma.200601222; Davis CM, 2011, J PHYS CHEM C, V115, P19065, DOI 10.1021/jp206438p; Bisoyi HK, 2014, ACCOUNTS CHEM RES, V47, P3184, DOI 10.1021/ar500249k; GILAT SL, 1995, CHEM-EUR J, V1, P275, DOI 10.1002/chem.19950010504; Dudek SP, 2005, J AM CHEM SOC, V127, P11763, DOI 10.1021/ja052054k; Friend RH, 1999, NATURE, V397, P121, DOI 10.1038/16393; Bu JX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4799; Guenes S., 2007, CHEM REV, V107, P1324, DOI DOI 10.1021/CR050149Z; Harvey CP, 2011, POLYM CHEM-UK, V2, P2699, DOI 10.1039/c1py00304f; Hayasaka H, 2008, MACROMOLECULES, V41, P2341, DOI 10.1021/ma800132v; Hayasaka H, 2010, ADV FUNCT MATER, V20, P1243, DOI 10.1002/adfm.200902059; Huitema HEA, 2001, NATURE, V414, P599, DOI 10.1038/414599a; Kawai T, 2005, ADV MATER, V17, P309, DOI 10.1002/adma.200400191; Kawai T, 1999, CHEM LETT, P905, DOI 10.1246/cl.1999.905; Kawai T, 2001, CHEM COMMUN, P711, DOI 10.1039/b100330p; LangeveldVoss BMW, 1996, J AM CHEM SOC, V118, P4908, DOI 10.1021/ja9600643; Li YN, 2013, J MATER CHEM C, V1, P3917, DOI 10.1039/c3tc30611a; Matsuda K, 2004, J PHOTOCH PHOTOBIO C, V5, P169, DOI 10.1016/j.jphotochemrev.2004.07.003; McQuade DT, 2000, CHEM REV, V100, P2537, DOI 10.1021/cr9801014; Murase S, 2003, MACROMOLECULES, V36, P964, DOI 10.1021/ma021276p; Norsten TB, 2001, ADV MATER, V13, P347, DOI 10.1002/1521-4095(200103)13:5<347::AID-ADMA347>3.0.CO;2-9; Peeters E, 1997, ADV MATER, V9, P493, DOI 10.1002/adma.19970090609; Rameshbabu K, 2011, J PHYS CHEM B, V115, P3409, DOI 10.1021/jp112401k; Rameshbabu K, 2011, J MATER CHEM, V21, P15673, DOI 10.1039/c1jm13342j; Sevez G, 2007, J PHYS ORG CHEM, V20, P888, DOI 10.1002/poc.1253; Thomas SW, 2007, CHEM REV, V107, P1339, DOI 10.1021/cr0501339; Watanabe K, 2014, SCI TECHNOL ADV MAT, V15, DOI 10.1088/1468-6996/15/4/044203; Yagai S, 2012, ANGEW CHEM INT EDIT, V51, P9679, DOI 10.1002/anie.201205504; Zhang Z, 2008, ADV FUNCT MATER, V18, P302, DOI 10.1002/adfm.200700414	62	0	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1616-301X	1616-3028		ADV FUNCT MATER	Adv. Funct. Mater.	MAY 20	2015	25	19					2794	2806		10.1002/adfm.201500136		13	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CI3DC	WOS:000354626800001		
J	Nesterenko, DV; Hayashi, S; Sekkat, Z				Nesterenko, Dmitry V.; Hayashi, Shinji; Sekkat, Zouheir			Evanescent-field-coupled guided-mode sensor based on a waveguide grating	APPLIED OPTICS			English	Article							SURFACE-PLASMON RESONANCE; DIELECTRIC GRATINGS; DIFFRACTION GRATINGS; RADIATION MODES; GAS-DETECTION; WHITE-LIGHT; ILLUMINATION; IMPROVEMENT; REFLECTION; FILTERS	A guided-mode (GM) sensor with a dielectric waveguide grating formed on a thin reflective film using Kretschmann configuration is proposed. Numerical results based on a finite-element method approach indicate a significant resolution improvement due to the excitation of a GM supported by the waveguide grating-sensing media system. The applicability of the waveguide theory to the design of waveguide gratings is validated by a comparison to the exact electromagnetic theory. Strong localization of an electromagnetic field in the sensing media within the grating with intensity enhancement up to two orders of magnitude is demonstrated. The sensor has potential for biological sensing and imaging applications. (C) 2015 Optical Society of America	[Nesterenko, Dmitry V.; Hayashi, Shinji; Sekkat, Zouheir] Moroccan Fdn Sci Innovat & Res MAScIR, Opt & Photon Ctr, Rabat 10100, Morocco; [Sekkat, Zouheir] Univ Mohammed 5, Dept Chem, Fac Sci, Rabat, Morocco; [Sekkat, Zouheir] Osaka Univ, Grad Sch Engn, Osaka 5850871, Japan	Nesterenko, DV (reprint author), Moroccan Fdn Sci Innovat & Res MAScIR, Opt & Photon Ctr, Rabat 10100, Morocco.	d.nesterenko@mascir.com					Magnusson R, 2011, SENSORS-BASEL, V11, P1476, DOI 10.3390/s110201476; WANG SS, 1993, APPL OPTICS, V32, P2606, DOI 10.1364/AO.32.002606; WANG SS, 1990, J OPT SOC AM A, V7, P1470, DOI 10.1364/JOSAA.7.001470; TIEN PK, 1970, J OPT SOC AM, V60, P1325; Homola J, 2008, CHEM REV, V108, P462, DOI 10.1021/cr068107d; Bahrami F, 2013, OPT EXPRESS, V21, P20863, DOI 10.1364/OE.21.020863; Tibuleac S, 1997, J OPT SOC AM A, V14, P1617, DOI 10.1364/JOSAA.14.001617; Awazu K, 2007, OPT EXPRESS, V15, P2592, DOI 10.1364/OE.15.002592; Byun KM, 2007, APPL OPTICS, V46, P5703, DOI 10.1364/AO.46.005703; Choi JM, 2014, OPT EXPRESS, V22, P5977, DOI 10.1364/OE.22.005977; Choi SH, 2009, APPL OPTICS, V48, P2924, DOI 10.1364/AO.48.002924; Foland S, 2010, OPT LETT, V35, P3871, DOI 10.1364/OL.35.003871; Fujimaki M, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/9/095503; Fujimaki M., 2009, SYNTHESIOLOGY, V2, P142; Homola J., 2006, SURFACE PLASMON RESO, P251; Jung WK, 2013, J BIOMED NANOTECHNOL, V9, P685, DOI 10.1166/jbn.2013.1521; Kim NH, 2014, APPL PHYS B-LASERS O, V114, P347, DOI 10.1007/s00340-013-5522-2; Kizel V. A., 1973, OTRAZHENIE SVETA; KNOLL W, 1991, MRS BULL, V16, P29; Komarevskiy N, 2013, PROG ELECTROMAGN RES, V139, P799, DOI 10.2528/PIER13041707; Kretschmann E., 1968, RAD DECAY NONRADIA A, V23a; Lee KJ, 2007, IEEE SENS J, V7, P409, DOI 10.1109/JSEN.2006.890129; Lenaerts C, 2005, APPL OPTICS, V44, P6017, DOI 10.1364/AO.44.006017; Marcuse D. M., 1974, THEORY DIELECTRIC OP; MOSTELLE.LP, 1968, J OPT SOC AM, V58, P511; Nesterenko D V, 2011, Optoelectronics, Instrumentation and Data Processing, V47, DOI 10.3103/S8756699011010109; Nesterenko DV, 2013, PLASMONICS, V8, P1585, DOI 10.1007/s11468-013-9575-1; NYLANDER C, 1982, SENSOR ACTUATOR, V3, P79; OSTERFELD M, 1993, APPL PHYS LETT, V62, P2310, DOI 10.1063/1.109401; Otto A., 1971, Optics Communications, V3, DOI 10.1016/0030-4018(71)90017-4; Palik E. D., 1985, HDB OPTICAL CONSTANT; Park S, 2003, OPT LETT, V28, P1870, DOI 10.1364/OL.28.001870; RYTOV SM, 1956, SOV PHYS JETP-USSR, V2, P466; Shen S, 2007, J OPT SOC AM A, V24, P225, DOI 10.1364/JOSAA.24.000225; Song JC, 2012, OPT LETT, V37, P3915	35	1	1	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1559-128X	2155-3165		APPL OPTICS	Appl. Optics	MAY 20	2015	54	15					4889	4894		10.1364/AO.54.004889		6	Optics	Optics	CI6UL	WOS:000354898100037		
J	Aartsen, MG; Ackermann, M; Adams, J; Aguilar, JA; Ahlers, M; Ahrens, M; Altmann, D; Anderson, T; Arguelles, C; Arlen, TC; Auffenberg, J; Bai, X; Barwick, SW; Baum, V; Bay, R; Beatty, JJ; Tjus, JB; Becker, KH; BenZvi, S; Berghaus, P; Berley, D; Bernardini, E; Bernhard, A; Besson, DZ; Binder, G; Bindig, D; Bissok, M; Blaufuss, E; Blumenthal, J; Boersma, DJ; Bohm, C; Bos, F; Bose, D; Boser, S; Botner, O; Brayeur, L; Bretz, HP; Brown, AM; Buzinsky, N; Casey, J; Casier, M; Cheung, E; Chirkin, D; Christov, A; Christy, B; Clark, K; Classen, L; Clevermann, F; Coenders, S; Cowen, DF; Silva, AHC; Daughhetee, J; Davis, JC; Day, M; de Andre, JPAM; De Clercq, C; De Ridder, S; Desiati, P; de Vries, KD; de With, M; DeYoung, T; Diaz-Velez, JC; Dunkman, M; Eagan, R; Eberhardt, B; Ehrhardt, T; Eichmann, B; Eisch, J; Euler, S; Evenson, PA; Fadiran, O; Fazely, AR; Fedynitch, A; Feintzeig, J; Felde, J; Filimonov, K; Finley, C; Fischer-Wasels, T; Flis, S; Frantzen, K; Fuchs, T; Gaisser, TK; Gaior, R; Gallagher, J; Gerhardt, L; Gier, D; Gladstone, L; Glusenkamp, T; Goldschmidt, A; Golup, G; Gonzalez, JG; Goodman, JA; Gora, D; Grant, D; Gretskov, P; Groh, JC; Gross, A; Ha, C; Haack, C; Ismail, AH; Hallen, P; Hallgren, A; Halzen, F; Hanson, K; Hebecker, D; Heereman, D; Heinen, D; Helbing, K; Hellauer, R; Hellwig, D; Hickford, S; Hill, GC; Hoffman, KD; Hoffmann, R; Homeier, A; Hoshina, K; Huang, F; Huelsnitz, W; Hulth, PO; Hultqvist, K; Ishihara, A; Jacobi, E; Jacobsen, J; Japaridze, GS; Jero, K; Jlelati, O; Jurkovic, M; Kaminsky, B; Kappes, A; Karg, T; Karle, A; Kauer, M; Keivani, A; Kelley, JL; Kheirandish, A; Kiryluk, J; Klas, J; Klein, SR; Kohne, JH; Kohnen, G; Kolanoski, H; Koob, A; Kopke, L; Kopper, C; Kopper, S; Koskinen, DJ; Kowalski, M; Kriesten, A; Krings, K; Kroll, G; Kroll, M; Kunnen, J; Kurahashi, N; Kuwabara, T; Labare, M; Lanfranchi, JL; Larsen, DT; Larson, MJ; Lesiak-Bzdak, M; Leuermann, M; Lunemann, J; Madsen, J; Maggi, G; Maruyama, R; Mase, K; Matis, HS; Maunu, R; McNally, F; Meagher, K; Medici, M; Meli, A; Meures, T; Miarecki, S; Middell, E; Middlemas, E; Milke, N; Miller, J; Mohrmann, L; Montaruli, T; Morse, R; Nahnhauer, R; Naumann, U; Niederhausen, H; Nowicki, SC; Nygren, DR; Obertacke, A; Odrowski, S; Olivas, A; Omairat, A; O'Murchadha, A; Palczewski, T; Paul, L; Penke, O; Pepper, JA; de los Heros, CP; Pfendner, C; Pieloth, D; Pinat, E; Posselt, J; Price, PB; Przybylski, GT; Putz, J; Quinnan, M; Radel, L; Rameez, M; Rawlins, K; Redl, P; Rees, I; Reimann, R; Relich, M; Resconi, E; Rhode, W; Richman, M; Riedel, B; Robertson, S; Rodrigues, JP; Rongen, M; Rott, C; Ruhe, T; Ruzybayev, B; Ryckbosch, D; Saba, SM; Sander, HG; Sandroos, J; Santander, M; Sarkar, S; Schatto, K; Scheriau, F; Schmidt, T; Schmitz, M; Schoenen, S; Schoneberg, S; Schonwald, A; Schukraft, A; Schulte, L; Schulz, O; Seckel, D; Sestayo, Y; Seunarine, S; Shanidze, R; Smith, MWE; Soldin, D; Spiczak, GM; Spiering, C; Stamatikos, M; Stanev, T; Stanisha, NA; Stasik, A; Stezelberger, T; Stokstad, RG; Stossl, A; Strahler, EA; Strom, R; Strotjohann, NL; Sullivan, GW; Taavola, H; Taboada, I; Tamburro, A; Tepe, A; Ter-Antonyan, S; Terliuk, A; Tesic, G; Tilav, S; Toale, PA; Tobin, MN; Tosi, D; Tselengidou, M; Unger, E; Usner, M; Vallecorsa, S; van Eijndhoven, N; Vandenbroucke, J; van Santen, J; Vehring, M; Voge, M; Vraeghe, M; Walck, C; Wallraff, M; Weaver, C; Wellons, M; Wendt, C; Westerhoff, S; Whelan, BJ; Whitehorn, N; Wichary, C; Wiebe, K; Wiebusch, CH; Williams, DR; Wissing, H; Wolf, M; Wood, TR; Woschnagg, K; Xu, DL; Xu, XW; Xu, Y; Yanez, JP; Yodh, G; Yoshida, S; Zarzhitsky, P; Ziemann, J; Zoll, M				Aartsen, M. G.; Ackermann, M.; Adams, J.; Aguilar, J. A.; Ahlers, M.; Ahrens, M.; Altmann, D.; Anderson, T.; Arguelles, C.; Arlen, T. C.; Auffenberg, J.; Bai, X.; Barwick, S. W.; Baum, V.; Bay, R.; Beatty, J. J.; Tjus, J. Becker; Becker, K. -H.; BenZvi, S.; Berghaus, P.; Berley, D.; Bernardini, E.; Bernhard, A.; Besson, D. Z.; Binder, G.; Bindig, D.; Bissok, M.; Blaufuss, E.; Blumenthal, J.; Boersma, D. J.; Bohm, C.; Bos, F.; Bose, D.; Boeser, S.; Botner, O.; Brayeur, L.; Bretz, H. -P.; Brown, A. M.; Buzinsky, N.; Casey, J.; Casier, M.; Cheung, E.; Chirkin, D.; Christov, A.; Christy, B.; Clark, K.; Classen, L.; Clevermann, F.; Coenders, S.; Cowen, D. F.; Silva, A. H. Cruz; Daughhetee, J.; Davis, J. C.; Day, M.; de Andre, J. P. A. M.; De Clercq, C.; De Ridder, S.; Desiati, P.; de Vries, K. D.; de With, M.; DeYoung, T.; Diaz-Valez, J. C.; Dunkman, M.; Eagan, R.; Eberhardt, B.; Ehrhardt, T.; Eichmann, B.; Eisch, J.; Euler, S.; Evenson, P. A.; Fadiran, O.; Fazely, A. R.; Fedynitch, A.; Feintzeig, J.; Felde, J.; Filimonov, K.; Finley, C.; Fischer-Wasels, T.; Flis, S.; Frantzen, K.; Fuchs, T.; Gaisser, T. K.; Gaior, R.; Gallagher, J.; Gerhardt, L.; Gier, D.; Gladstone, L.; Gluesenkamp, T.; Goldschmidt, A.; Golup, G.; Gonzalez, J. G.; Goodman, J. A.; Gora, D.; Grant, D.; Gretskov, P.; Groh, J. C.; Gross, A.; Ha, C.; Haack, C.; Ismail, A. Haj; Hallen, P.; Hallgren, A.; Halzen, F.; Hanson, K.; Hebecker, D.; Heereman, D.; Heinen, D.; Helbing, K.; Hellauer, R.; Hellwig, D.; Hickford, S.; Hill, G. C.; Hoffman, K. D.; Hoffmann, R.; Homeier, A.; Hoshina, K.; Huang, F.; Huelsnitz, W.; Hulth, P. O.; Hultqvist, K.; Ishihara, A.; Jacobi, E.; Jacobsen, J.; Japaridze, G. S.; Jero, K.; Jlelati, O.; Jurkovic, M.; Kaminsky, B.; Kappes, A.; Karg, T.; Karle, A.; Kauer, M.; Keivani, A.; Kelley, J. L.; Kheirandish, A.; Kiryluk, J.; Klaes, J.; Klein, S. R.; Koehne, J. -H.; Kohnen, G.; Kolanoski, H.; Koob, A.; Koepke, L.; Kopper, C.; Kopper, S.; Koskinen, D. J.; Kowalski, M.; Kriesten, A.; Krings, K.; Kroll, G.; Kroll, M.; Kunnen, J.; Kurahashi, N.; Kuwabara, T.; Labare, M.; Lanfranchi, J. L.; Larsen, D. T.; Larson, M. J.; Lesiak-Bzdak, M.; Leuermann, M.; Luenemann, J.; Madsen, J.; Maggi, G.; Maruyama, R.; Mase, K.; Matis, H. S.; Maunu, R.; McNally, F.; Meagher, K.; Medici, M.; Meli, A.; Meures, T.; Miarecki, S.; Middell, E.; Middlemas, E.; Milke, N.; Miller, J.; Mohrmann, L.; Montaruli, T.; Morse, R.; Nahnhauer, R.; Naumann, U.; Niederhausen, H.; Nowicki, S. C.; Nygren, D. R.; Obertacke, A.; Odrowski, S.; Olivas, A.; Omairat, A.; O'Murchadha, A.; Palczewski, T.; Paul, L.; Penke, O.; Pepper, J. A.; de los Heros, C. Perez; Pfendner, C.; Pieloth, D.; Pinat, E.; Posselt, J.; Price, P. B.; Przybylski, G. T.; Puetz, J.; Quinnan, M.; Raedel, L.; Rameez, M.; Rawlins, K.; Redl, P.; Rees, I.; Reimann, R.; Relich, M.; Resconi, E.; Rhode, W.; Richman, M.; Riedel, B.; Robertson, S.; Rodrigues, J. P.; Rongen, M.; Rott, C.; Ruhe, T.; Ruzybayev, B.; Ryckbosch, D.; Saba, S. M.; Sander, H. -G.; Sandroos, J.; Santander, M.; Sarkar, S.; Schatto, K.; Scheriau, F.; Schmidt, T.; Schmitz, M.; Schoenen, S.; Schoeneberg, S.; Schoenwald, A.; Schukraft, A.; Schulte, L.; Schulz, O.; Seckel, D.; Sestayo, Y.; Seunarine, S.; Shanidze, R.; Smith, M. W. E.; Soldin, D.; Spiczak, G. M.; Spiering, C.; Stamatikos, M.; Stanev, T.; Stanisha, N. A.; Stasik, A.; Stezelberger, T.; Stokstad, R. G.; Stoessl, A.; Strahler, E. A.; Stroem, R.; Strotjohann, N. L.; Sullivan, G. W.; Taavola, H.; Taboada, I.; Tamburro, A.; Tepe, A.; Ter-Antonyan, S.; Terliuk, A.; Tesic, G.; Tilav, S.; Toale, P. A.; Tobin, M. N.; Tosi, D.; Tselengidou, M.; Unger, E.; Usner, M.; Vallecorsa, S.; van Eijndhoven, N.; Vandenbroucke, J.; van Santen, J.; Vehring, M.; Voge, M.; Vraeghe, M.; Walck, C.; Wallraff, M.; Weaver, Ch.; Wellons, M.; Wendt, C.; Westerhoff, S.; Whelan, B. J.; Whitehorn, N.; Wichary, C.; Wiebe, K.; Wiebusch, C. H.; Williams, D. R.; Wissing, H.; Wolf, M.; Wood, T. R.; Woschnagg, K.; Xu, D. L.; Xu, X. W.; Xu, Y.; Yanez, J. P.; Yodh, G.; Yoshida, S.; Zarzhitsky, P.; Ziemann, J.; Zoll, M.			SEARCH FOR PROMPT NEUTRINO EMISSION FROM GAMMA-RAY BURSTS WITH ICECUBE	ASTROPHYSICAL JOURNAL LETTERS			English	Article						gamma-ray burst: general; neutrinos	HIGH-ENERGY NEUTRINOS; 1ST 2 YEARS; COSMIC-RAYS; SPECTRAL CATALOG; MUON NEUTRINOS; ACCELERATION; TELESCOPE; MISSION; SIMULATIONS; FIREBALLS	We present constraints derived from a search of four years of IceCube data for a prompt neutrino flux from gammaray bursts (GRBs). A single low-significance neutrino, compatible with the atmospheric neutrino background, was found in coincidence with one of the 506 observed bursts. Although GRBs have been proposed as candidate sources for ultra-high-energy cosmic rays, our limits on the neutrino flux disfavor much of the parameter space for the latest models. We also find that no more than similar to 1% of the recently observed astrophysical neutrino flux consists of prompt emission from GRBs that are potentially observable by existing satellites.	[Aartsen, M. G.; Hill, G. C.; Robertson, S.; Whelan, B. J.] Univ Adelaide, Sch Chem & Phys, Adelaide, SA 5005, Australia; [Ackermann, M.; Berghaus, P.; Bernardini, E.; Bernhard, A.; Bretz, H. -P.; Silva, A. H. Cruz; Gluesenkamp, T.; Gora, D.; Jacobi, E.; Kaminsky, B.; Karg, T.; Kowalski, M.; Middell, E.; Mohrmann, L.; Nahnhauer, R.; Schoenwald, A.; Shanidze, R.; Spiering, C.; Stasik, A.; Stoessl, A.; Strotjohann, N. L.; Terliuk, A.; Usner, M.; Yanez, J. P.] DESY, D-15735 Zeuthen, Germany; [Adams, J.; Brown, A. M.] Univ Canterbury, Dept Phys & Astron, Christchurch 1, New Zealand; [Aguilar, J. A.; Hanson, K.; Heereman, D.; Meures, T.; O'Murchadha, A.; Pinat, E.] Univ Libre Bruxelles, Fac Sci, B-1050 Brussels, Belgium; [Ahlers, M.; Arguelles, C.; BenZvi, S.; Chirkin, D.; Day, M.; Desiati, P.; Diaz-Valez, J. C.; Eisch, J.; Fadiran, O.; Feintzeig, J.; Gladstone, L.; Halzen, F.; Hoshina, K.; Jacobsen, J.; Jero, K.; Karle, A.; Kauer, M.; Kelley, J. L.; Kheirandish, A.; Larsen, D. T.; McNally, F.; Middlemas, E.; Morse, R.; Rees, I.; Rodrigues, J. P.; Santander, M.; Tobin, M. N.; Tosi, D.; Vandenbroucke, J.; van Santen, J.; Weaver, Ch.; Wellons, M.; Wendt, C.; Westerhoff, S.; Whitehorn, N.] Univ Wisconsin, Dept Phys, Madison, WI 53706 USA; [Ahlers, M.; Arguelles, C.; BenZvi, S.; Chirkin, D.; Day, M.; Desiati, P.; Diaz-Valez, J. C.; Eisch, J.; Fadiran, O.; Feintzeig, J.; Gladstone, L.; Halzen, F.; Hoshina, K.; Jacobsen, J.; Jero, K.; Karle, A.; Kauer, M.; Kelley, J. L.; Kheirandish, A.; Larsen, D. T.; McNally, F.; Middlemas, E.; Morse, R.; Rees, I.; Rodrigues, J. P.; Santander, M.; Tobin, M. N.; Tosi, D.; Vandenbroucke, J.; van Santen, J.; Weaver, Ch.; Wellons, M.; Wendt, C.; Westerhoff, S.; Whitehorn, N.] Univ Wisconsin, Wisconsin IceCube Particle Astrophys Ctr, Madison, WI 53706 USA; [Ahrens, M.; Bohm, C.; Finley, C.; Flis, S.; Hulth, P. O.; Hultqvist, K.; Walck, C.; Wolf, M.; Zoll, M.] Stockholm Univ, Oskar Klein Ctr, SE-10691 Stockholm, Sweden; [Ahrens, M.; Bohm, C.; Finley, C.; Flis, S.; Hulth, P. O.; Hultqvist, K.; Walck, C.; Wolf, M.; Zoll, M.] Stockholm Univ, Dept Phys, SE-10691 Stockholm, Sweden; [Altmann, D.; Classen, L.; Kappes, A.; Tselengidou, M.] Univ Erlangen Nurnberg, Erlangen Ctr Astroparticle Phys, D-91058 Erlangen, Germany; [Anderson, T.; Arlen, T. C.; Cowen, D. F.; Dunkman, M.; Eagan, R.; Groh, J. C.; Huang, F.; Keivani, A.; Lanfranchi, J. L.; Quinnan, M.; Smith, M. W. E.; Stanisha, N. A.; Tesic, G.] Penn State Univ, Dept Phys, University Pk, PA 16802 USA; [Auffenberg, J.; Bissok, M.; Blumenthal, J.; Gier, D.; Gretskov, P.; Haack, C.; Hallen, P.; Heinen, D.; Hellwig, D.; Koob, A.; Kriesten, A.; Leuermann, M.; Paul, L.; Penke, O.; Puetz, J.; Raedel, L.; Reimann, R.; Rongen, M.; Schoenen, S.; Schukraft, A.; Vehring, M.; Wallraff, M.; Wichary, C.; Wiebusch, C. H.] Rhein Westfal TH Aachen, Inst Phys, D-52056 Aachen, Germany; [Bai, X.] South Dakota Sch Mines & Technol, Dept Phys, Rapid City, SD 57701 USA; [Barwick, S. W.; Yodh, G.] Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA; [Baum, V.; Boeser, S.; Eberhardt, B.; Ehrhardt, T.; Koepke, L.; Kroll, G.; Luenemann, J.; Sander, H. -G.; Schatto, K.; Wiebe, K.] Johannes Gutenberg Univ Mainz, Inst Phys, D-55099 Mainz, Germany; [Bay, R.; Binder, G.; Filimonov, K.; Gerhardt, L.; Ha, C.; Klein, S. R.; Miarecki, S.; Price, P. B.; Woschnagg, K.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Beatty, J. J.; Davis, J. C.; Pfendner, C.; Stamatikos, M.] Ohio State Univ, Dept Phys, Columbus, OH 43210 USA; [Beatty, J. J.; Davis, J. C.; Pfendner, C.; Stamatikos, M.] Ohio State Univ, Ctr Cosmol & Astro Particle Phys, Columbus, OH 43210 USA; [Beatty, J. J.] Ohio State Univ, Dept Astron, Columbus, OH 43210 USA; [Tjus, J. Becker; Bos, F.; Eichmann, B.; Fedynitch, A.; Kroll, M.; Saba, S. M.; Schoeneberg, S.] Ruhr Univ Bochum, Fak Phys & Astron, D-44780 Bochum, Germany; [Becker, K. -H.; Bindig, D.; Fischer-Wasels, T.; Helbing, K.; Hickford, S.; Hoffmann, R.; Klaes, J.; Kopper, S.; Naumann, U.; Obertacke, A.; Omairat, A.; Posselt, J.; Soldin, D.; Tepe, A.] Univ Wuppertal, Dept Phys, D-42119 Wuppertal, Germany; [Berley, D.; Blaufuss, E.; Cheung, E.; Christy, B.; Felde, J.; Goodman, J. A.; Hellauer, R.; Hoffman, K. D.; Huelsnitz, W.; Maunu, R.; Meagher, K.; Olivas, A.; Redl, P.; Richman, M.; Schmidt, T.; Sullivan, G. W.; Wissing, H.] Univ Maryland, Dept Phys, College Pk, MD 20742 USA; [Bernhard, A.; Coenders, S.; Gross, A.; Jurkovic, M.; Krings, K.; Resconi, E.; Schulz, O.; Sestayo, Y.] Tech Univ Munich, D-85748 Garching, Germany; [Besson, D. Z.] Univ Kansas, Dept Phys & Astron, Lawrence, KS 66045 USA; [Binder, G.; Gerhardt, L.; Goldschmidt, A.; Ha, C.; Klein, S. R.; Matis, H. S.; Miarecki, S.; Nygren, D. R.; Przybylski, G. T.; Stezelberger, T.; Stokstad, R. G.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Boersma, D. J.; Botner, O.; Euler, S.; Hallgren, A.; de los Heros, C. Perez; Stroem, R.; Taavola, H.; Unger, E.] Uppsala Univ, Dept Phys & Astron, SE-75120 Uppsala, Sweden; [Bose, D.; Rott, C.] Sungkyunkwan Univ, Dept Phys, Suwon 440746, South Korea; [Brayeur, L.; Casier, M.; De Clercq, C.; de Vries, K. D.; Golup, G.; Kunnen, J.; Maggi, G.; Miller, J.; Strahler, E. A.; van Eijndhoven, N.] Vrije Univ Brussel, Dienst ELEM, B-1050 Brussels, Belgium; [Buzinsky, N.; Grant, D.; Kopper, C.; Nowicki, S. C.; Odrowski, S.; Riedel, B.; Wood, T. R.] Univ Alberta, Dept Phys, Edmonton, AB T6G 2E1, Canada; [Casey, J.; Daughhetee, J.; Taboada, I.] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA; [Casey, J.; Daughhetee, J.; Taboada, I.] Georgia Inst Technol, Ctr Relativist Astrophys, Atlanta, GA 30332 USA; [Christov, A.; Montaruli, T.; Rameez, M.; Vallecorsa, S.] Univ Geneva, Dept Phys Nucl & Corpusculaire, CH-1211 Geneva, Switzerland; [Clark, K.] Univ Toronto, Dept Phys, Toronto, ON M5S 1A7, Canada; [Clevermann, F.; Frantzen, K.; Fuchs, T.; Koehne, J. -H.; Milke, N.; Pieloth, D.; Rhode, W.; Ruhe, T.; Scheriau, F.; Schmitz, M.; Ziemann, J.] TU Dortmund Univ, Dept Phys, D-44221 Dortmund, Germany; [Cowen, D. F.] Penn State Univ, Dept Astron & Astrophys, University Pk, PA 16802 USA; [de Andre, J. P. A. M.; DeYoung, T.] Michigan State Univ, Dept Phys & Astron, E Lansing, MI 48824 USA; [De Ridder, S.; Ismail, A. Haj; Jlelati, O.; Labare, M.; Meli, A.; Ryckbosch, D.; Vraeghe, M.] Univ Ghent, Dept Phys & Astron, B-9000 Ghent, Belgium; [de With, M.; Hebecker, D.; Kolanoski, H.; Kowalski, M.] Humboldt Univ, Inst Phys, D-12489 Berlin, Germany; [Evenson, P. A.; Gaisser, T. K.; Gonzalez, J. G.; Ruzybayev, B.; Seckel, D.; Stanev, T.; Tamburro, A.; Tilav, S.] Univ Delaware, Bartol Res Inst, Newark, DE 19716 USA; [Evenson, P. A.; Gaisser, T. K.; Gonzalez, J. G.; Ruzybayev, B.; Seckel, D.; Stanev, T.; Tamburro, A.; Tilav, S.] Univ Delaware, Dept Phys & Astron, Newark, DE 19716 USA; [Fazely, A. R.; Ter-Antonyan, S.; Xu, X. W.] Southern Univ, Dept Phys, Baton Rouge, LA 70813 USA; [Gaior, R.; Ishihara, A.; Kuwabara, T.; Mase, K.; Relich, M.; Yoshida, S.] Chiba Univ, Dept Phys, Chiba 2638522, Japan; [Gallagher, J.] Univ Wisconsin, Dept Astron, Madison, WI 53706 USA; [Homeier, A.; Schulte, L.; Voge, M.] Univ Bonn, Inst Phys, D-53115 Bonn, Germany; [Japaridze, G. S.] Clark Atlanta Univ, CTSPS, Atlanta, GA 30314 USA; [Kauer, M.; Maruyama, R.] Yale Univ, Dept Phys, New Haven, CT 06520 USA; [Kiryluk, J.; Lesiak-Bzdak, M.; Niederhausen, H.; Xu, Y.] SUNY Stony Brook, Dept Phys & Astron, Stony Brook, NY 11794 USA; [Kohnen, G.] Univ Mons, B-7000 Mons, Belgium; [Koskinen, D. J.; Larson, M. J.; Medici, M.; Sarkar, S.] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Kurahashi, N.] Drexel Univ, Dept Phys, Philadelphia, PA 19104 USA; [Madsen, J.; Seunarine, S.; Spiczak, G. M.] Univ Wisconsin, Dept Phys, River Falls, WI 54022 USA; [Palczewski, T.; Pepper, J. A.; Toale, P. A.; Williams, D. R.; Xu, D. L.; Zarzhitsky, P.] Univ Alabama, Dept Phys & Astron, Tuscaloosa, AL 35487 USA; [Rawlins, K.] Univ Alaska Anchorage, Dept Phys & Astron, Anchorage, AK 99508 USA; [Sarkar, S.] Univ Oxford, Dept Phys, Oxford OX1 3NP, England; [Hoshina, K.] Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, Tokyo 1130032, Japan; [Stamatikos, M.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA	Aartsen, MG (reprint author), Univ Adelaide, Sch Chem & Phys, Adelaide, SA 5005, Australia.		Koskinen, David/G-3236-2014; Maruyama, Reina/A-1064-2013; Beatty, James/D-9310-2011; Sarkar, Subir/G-5978-2011; 	Koskinen, David/0000-0002-0514-5917; Maruyama, Reina/0000-0003-2794-512X; Schukraft, Anne/0000-0002-9112-5479; Groh, John/0000-0001-9880-3634; Larsen, Dag Toppe/0000-0002-9898-2174; Sarkar, Subir/0000-0002-3542-858X; Strotjohann, Nora Linn/0000-0002-4667-6730	U.S. National Science Foundation-office of Polar Programs; U.S. National Science Foundation-physics Division; University of Wisconsin Alumni Research Foundation; Grid Laboratory Of Wisconsin (GLOW) grid infrastructure at the University of Wisconsin-Madison; Open Science Grid (OSG) grid infrastructure; U.S. Department of Energy; National Energy Research Scientific Computing Center; Louisiana Optical Network Initiative (LONI) grid computing resources; Natural Sciences and Engineering Research Council of Canada; WestGrid and Compute/Calcul Canada; Swedish Research Council; Swedish Polar Research Secretariat; Swedish National Infrastructure for Computing (SNIC); Knut and Alice Wallenberg Foundation, Sweden; German Ministry for Education and Research (BMBF); Deutsche Forschungsgemeinschaft (DFG); Helmholtz Alliance for Astroparticle Physics (HAP); Research Department of Plasmas with Complex Interactions (Bochum), Germany; Fund for Scientific Research (FNRS-FWO); FWO Odysseus programme; Flanders Institute to encourage scientific and technological research in industry (IWT); Belgian Federal Science Policy Office (Belspo); University of Oxford, United Kingdom; Marsden Fund, New Zealand; Australian Research Council; Japan Society for Promotion of Science (JSPS); Swiss National Science Foundation (SNSF), Switzerland; National Research Foundation of Korea (NRF); Danish National Research Foundation, Denmark (DNRF)	We acknowledge the support from the following agencies: U.S. National Science Foundation-office of Polar Programs, U.S. National Science Foundation-physics Division, University of Wisconsin Alumni Research Foundation, the Grid Laboratory Of Wisconsin (GLOW) grid infrastructure at the University of Wisconsin-Madison, the Open Science Grid (OSG) grid infrastructure; U.S. Department of Energy, and National Energy Research Scientific Computing Center, the Louisiana Optical Network Initiative (LONI) grid computing resources; Natural Sciences and Engineering Research Council of Canada, WestGrid and Compute/Calcul Canada; Swedish Research Council, Swedish Polar Research Secretariat, Swedish National Infrastructure for Computing (SNIC), and Knut and Alice Wallenberg Foundation, Sweden; German Ministry for Education and Research (BMBF), Deutsche Forschungsgemeinschaft (DFG), Helmholtz Alliance for Astroparticle Physics (HAP), Research Department of Plasmas with Complex Interactions (Bochum), Germany; Fund for Scientific Research (FNRS-FWO), FWO Odysseus programme, Flanders Institute to encourage scientific and technological research in industry (IWT), Belgian Federal Science Policy Office (Belspo); University of Oxford, United Kingdom; Marsden Fund, New Zealand; Australian Research Council; Japan Society for Promotion of Science (JSPS); the Swiss National Science Foundation (SNSF), Switzerland; National Research Foundation of Korea (NRF); Danish National Research Foundation, Denmark (DNRF).	Aartsen MG, 2014, J INSTRUM, V9, DOI 10.1088/1748-0221/9/03/P03009; Aartsen MG, 2015, PHYS REV D, V91, DOI 10.1103/PhysRevD.91.022001; Abbasi R, 2010, NUCL INSTRUM METH A, V618, P139, DOI 10.1016/j.nima.2010.03.102; Abbasi R, 2011, ASTROPHYS J, V732, DOI 10.1088/0004-637X/732/1/18; Achterberg A, 2007, PHYS REV D, V75, DOI 10.1103/PhysRevD.75.102001; Adrian-Martinez S, 2013, ASTRON ASTROPHYS, V559, DOI 10.1051/0004-6361/201322169; Ahrens J, 2004, NUCL INSTRUM METH A, V524, P169, DOI 10.1016/j.nima.2004.01.065; VIETRI M, 1995, ASTROPHYS J, V453, P883, DOI 10.1086/176448; Mucke A, 2000, COMPUT PHYS COMMUN, V124, P290, DOI 10.1016/S0010-4655(99)00446-4; Winkler C, 2003, ASTRON ASTROPHYS, V411, pL1, DOI 10.1051/0004-6361:20031288; Waxman E, 1997, PHYS REV LETT, V78, P2292, DOI 10.1103/PhysRevLett.78.2292; Feldman GJ, 1998, PHYS REV D, V57, P3873, DOI 10.1103/PhysRevD.57.3873; Murase K, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.101302; Murase K, 2006, ASTROPHYS J, V651, pL5, DOI 10.1086/509323; Aartsen MG, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.101101; WAXMAN E, 1995, PHYS REV LETT, V75, P386, DOI 10.1103/PhysRevLett.75.386; Liang EW, 2007, ASTROPHYS J, V662, P1111, DOI 10.1086/517959; Braun J, 2008, ASTROPART PHYS, V29, P299, DOI 10.1016/j.astropartphys.2008.02.007; Ahlers M, 2011, ASTROPART PHYS, V35, P87, DOI 10.1016/j.astropartphys.2011.05.008; SHEMI A, 1990, ASTROPHYS J, V365, pL55, DOI 10.1086/185887; Hurley K, 2010, AIP CONF PROC, V1279, P330, DOI 10.1063/1.3509301; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Feroci M, 2007, NUCL INSTRUM METH A, V581, P728, DOI 10.1016/j.nima.2007.07.147; Abbasi R, 2012, NATURE, V484, P351, DOI 10.1038/nature11068; Abbasi R, 2010, ASTROPHYS J, V710, P346, DOI 10.1088/0004-637X/710/1/346; Hummer S, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.231101; Abbasi R, 2009, NUCL INSTRUM METH A, V601, P294, DOI 10.1016/j.nima.2009.01.001; Achterberg A, 2006, ASTROPART PHYS, V26, P155, DOI 10.1016/j.astropartphys.2006.06.007; Meszaros P, 2006, REP PROG PHYS, V69, P2259, DOI 10.1088/0034-4885/69/8/R01; Zhang B, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.121101; Abbasi R, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.141101; Gehrels N, 2004, ASTROPHYS J, V611, P1005, DOI 10.1086/422091; Rees MJ, 2005, ASTROPHYS J, V628, P847, DOI 10.1086/430818; Asano K, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/1/54; Baerwald P., 2014, APH, V62, P66; Goldstein A, 2012, ASTROPHYS J SUPPL S, V199, DOI 10.1088/0067-0049/199/1/19; Gruber D, 2014, ASTROPHYS J SUPPL S, V211, DOI 10.1088/0067-0049/211/1/12; He HN, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/1/29; Katz Boaz, 2009, Journal of Cosmology and Astroparticle Physics, V2009, DOI 10.1088/1475-7516/2009/03/020; Paciesas WS, 2012, ASTROPHYS J SUPPL S, V199, DOI 10.1088/0067-0049/199/1/18; Piran T, 2004, REV MOD PHYS, V76, P1143, DOI 10.1103/RevModPhys.76.1143; von Kienlin A, 2014, ASTROPHYS J SUPPL S, V211, DOI 10.1088/0067-0049/211/1/13; Winter W, 2014, ASTRON ASTROPHYS, V569, DOI 10.1051/0004-6361/201423745; Zhang B, 2011, ASTROPHYS J, V726, DOI 10.1088/0004-637X/726/2/90	44	3	4	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	2041-8205	2041-8213		ASTROPHYS J LETT	Astrophys. J. Lett.	MAY 20	2015	805	1							L5	10.1088/2041-8205/805/1/L5		7	Astronomy & Astrophysics	Astronomy & Astrophysics	CI4VS	WOS:000354752600005		
J	Naito, T; Mino, Y; Aoki, Y; Hirano, K; Shimoyama, K; Ogawa, N; Kagawa, Y; Kawakami, J				Naito, Takafumi; Mino, Yasuaki; Aoki, Yuki; Hirano, Kumi; Shimoyama, Kumiko; Ogawa, Noriyoshi; Kagawa, Yoshiyuki; Kawakami, Junichi			ABCB1 genetic variant and its associated tacrolimus pharmacokinetics affect renal function in patients with rheumatoid arthritis	CLINICA CHIMICA ACTA			English	Article						Tacrolimus; Rheumatoid arthritis; ABCB1; Genetic variant; CYP3A5; Renal function	TRANSPLANT PATIENTS; P-GLYCOPROTEIN; DOUBLE-BLIND; CALCINEURIN INHIBITORS; LIVER-TRANSPLANT; CYP3A5; POLYMORPHISMS; MDR1; EFFICACY; NEPHROTOXICITY	Background: This study aimed to evaluate the blood exposure of and clinical responses to tacrolimus based on genetic variants of CYP3A5 and ABCB1 in patients with rheumatoid arthritis. Methods: Seventy rheumatoid arthritis patients treated with oral tacrolimus once daily were enrolled. Blood concentrations of tacrolimus and its major metabolite 13-O-demethylate at 12 h after dosing were determined. The relationships between the tacrolimus pharmacokinetics and efficacy, renal function, and CYP3A5 and ABCB1 genotypes were evaluated. Results: Dose-normalized blood concentration of tacrolimus was significantly higher in the CYP3A5*3/*3 group than in the *1 allele carrier group. A lower metabolic ratio of 13-O-demethylate to tacrolimus was observed in the CYP3A5*3/*3 group. The ABCB1 3435TT group had higher dose-normalized blood concentrations of tacrolimus and 13-O-demethylate. The blood tacrolimus concentration was inversely correlated with the estimated glomerular filtration rate (eGFR). ABCB1 C3435T but not CYP3A5 genotype had decreased eGFR. Patients lacking the CYP3A5*3 allele had a higher incidence of tacrolimus withdrawal. Conclusion: CYP3A5*3 increased the blood exposure of tacrolimus through its metabolic reduction. ABCB1 C3435T led to a higher blood exposure of tacrolimus and its major metabolite. The ABCB1 genetic variant and its associated tacrolimus pharmacoldnetics affected renal function in rheumatoid arthritis patients. (C) 2015 Elsevier B.V. All rights reserved.	[Naito, Takafumi; Mino, Yasuaki; Aoki, Yuki; Hirano, Kumi; Kawakami, Junichi] Hamamatsu Univ, Sch Med, Dept Hosp Pharm, Hamamatsu, Shizuoka 4313192, Japan; [Aoki, Yuki; Kagawa, Yoshiyuki] Univ Shizuoka, Grad Sch Pharmaceut Sci, Dept Clin Pharmaceut & Pharm Practice, Shizuoka, Shizuoka, Japan; [Shimoyama, Kumiko; Ogawa, Noriyoshi] Hamamatsu Univ, Sch Med, Dept Rheumatol, Hamamatsu, Shizuoka 4313192, Japan	Naito, T (reprint author), Hamamatsu Univ, Sch Med, Dept Hosp Pharm, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	naitou@hama-med.ac.jp			JSPS KAKENHI [23926010]	This work was supported by JSPS KAKENHI Grant Number 23926010.	Kuypers DRJ, 2007, CLIN PHARMACOL THER, V82, P711, DOI 10.1038/sj.clpt.6100216; Ekberg H, 2007, NEW ENGL J MED, V357, P2562, DOI 10.1056/NEJMoa067411; Zheng HX, 2003, AM J TRANSPLANT, V3, P477, DOI 10.1034/j.1600-6143.2003.00077.x; SAEKI T, 1993, J BIOL CHEM, V268, P6077; Hesselink DA, 2003, CLIN PHARMACOL THER, V74, P245, DOI 10.1016/S0009-9236(03)00168-1; Olyaei AJ, 1999, DRUG SAFETY, V21, P471, DOI 10.2165/00002018-199921060-00004; Hawwa AF, 2009, BRIT J CLIN PHARMACO, V68, P413, DOI 10.1111/j.1365-2125.2009.03461.x; Haufroid V, 2004, PHARMACOGENETICS, V14, P147, DOI 10.1097/01.pfc.0000114719.42625.e8; Haufroid V, 2006, AM J TRANSPLANT, V6, P2706, DOI 10.1111/j.1600-6143.2006.01518.x; Lamba J, 2006, CLIN PHARMACOL THER, V79, P325, DOI 10.1016/j.clpt.2005.11.013; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; Naesens M, 2009, J AM SOC NEPHROL, V20, P2468, DOI 10.1681/ASN.2009020192; Fukuen S, 2002, PHARMACOGENETICS, V12, P331, DOI 10.1097/00008571-200206000-00009; Fukudo M, 2008, PHARMACOGENET GENOM, V18, P413, DOI 10.1097/FPC.0b013e3282f9ac01; Mai I, 2004, BRIT J CLIN PHARMACO, V58, P548, DOI 10.1111/j.1365-2125.2004.02182.x; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Bottiger Y, 1999, BRIT J CLIN PHARMACO, V48, P445; Fleischmann R, 2006, EXPERT OPIN PHARMACO, V7, P91, DOI 10.1517/14656566.7.1.91; Furst DE, 2002, ARTHRITIS RHEUM, V46, P2020, DOI 10.1002/art.10427; Gijsen VMGJ, 2012, ANN TRANSPL, V17, P111; Gonschior AK, 1996, CLIN CHEM, V42, P1426; Hebert Mary F., 2003, Pharmacogenetics, V13, P661, DOI 10.1097/00008571-200311000-00002; Hirano K, 2012, CLIN CHIM ACTA, V414, P120, DOI 10.1016/j.cca.2012.07.018; Hirano K, 2011, CLIN BIOCHEM, V44, P397, DOI 10.1016/j.clinbiochem.2010.12.020; Hosohata K, 2009, PHARM RES-DORD, V26, P1590, DOI 10.1007/s11095-009-9867-5; Kamdem LK, 2005, CLIN CHEM, V51, P1374, DOI 10.1373/clinchem.2005.050047; Kondo H, 2004, J RHEUMATOL, V31, P243; Kremer JM, 2003, ARTHRITIS RHEUM, V48, P2763, DOI 10.1002/art.11257; Lundy SK, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2107; Macphee IAM, 2002, TRANSPLANTATION, V74, P1486, DOI 10.1097/01.TP.0000045761.71385.9F; Morita Y, 2008, MOD RHEUMATOL, V18, P379, DOI 10.1007/s10165-008-0071-y; Park HJ, 2007, CLIN PHARMACOL THER, V81, P539, DOI 10.1038/sj.clpt.6100046; Tsujimura S, 2008, ANN RHEUM DIS, V67, P380, DOI 10.1136/ard.2007.070821; Yocum DE, 2003, ARTHRITIS RHEUM, V48, P3328, DOI 10.1002/art.11363	34	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	MAY 20	2015	445						79	84		10.1016/j.cca.2015.03.021		6	Medical Laboratory Technology	Medical Laboratory Technology	CI8LP	WOS:000355024100015		
J	Taira, C; Matsuda, K; Yamaguchi, A; Uehara, M; Sugano, M; Okumura, N; Honda, T				Taira, Chiaki; Matsuda, Kazuyuki; Yamaguchi, Akemi; Uehara, Masayuki; Sugano, Mitsutoshi; Okumura, Nobuo; Honda, Takayuki			Rapid single nucleotide polymorphism based method for hematopoietic chimerism analysis and monitoring using high-speed droplet allele-specific PCR and allele-specific quantitative PCR	CLINICA CHIMICA ACTA			English	Article						HSCT; SNP; Droplet-AS-PCR; AS-qPCR	STEM-CELL TRANSPLANTATION; POLYMERASE-CHAIN-REACTION; AMPLIFICATION MUTATION ASSAY; TANDEM REPEAT ANALYSIS; MIXED CHIMERISM; FLUORESCENCE DETECTION; DONOR; GENE; QUANTIFICATION; MARKERS	Background: Chimerism analysis is important for the evaluation of engraftment and predicting relapse following hematopoietic stem cell transplantation (HSCT). We developed a chimerism analysis for single nucleotide polymorphisms (SNPs), including rapid screening of the discriminable donor/recipient alleles using droplet allele-specific PCR (droplet-AS-PCR) pre-HSCT and quantitation of recipient DNA using AS-quantitative PCR (AS-qPCR) following HSCT. Methods: SNP genotyping of 20 donor/recipient pairs via droplet-AS-PCR and the evaluation of the informativity of 5 SNP markers for chimerism analysis were performed. Samples from six follow-up patients were analyzed to assess the chimerism via AS-qPCR. These results were compared with that determined by short tandem repeat PCR (STR-PCR). Results: Droplet-AS-PCR could determine genotypes within 8 min. The total informativity using all 5 loci was 95% (19/20). AS-qPCR provided the percentage of recipient DNA in all 6 follow-up patients without influence of the stutter peak or the amplification efficacy, which affected the STR-PCR results. Conclusion: The droplet-AS-PCR had an advantage over STR-PCR in terms of rapidity and simplicity for screening before HSCT. Furthermore, AS-qPCR had better accuracy than STR-PCR for quantification of recipient DNA following HSCT. The present chimerism assay compensates for the disadvantages of STR-PCR and is readily performable in clinical laboratories. (C) 2015 Elsevier B.V. All rights reserved.	[Taira, Chiaki; Matsuda, Kazuyuki; Sugano, Mitsutoshi; Honda, Takayuki] Shinshu Univ Hosp, Dept Lab Med, Matsumoto, Nagano 3908621, Japan; [Yamaguchi, Akemi; Uehara, Masayuki] Seiko Epson Corp, Core Technol Dev Ctr, Fujimi, Gumma, Japan; [Okumura, Nobuo] Shinshu Univ, Sch Hlth Sci, Dept Biomed Lab Sci, Lab Clin Chem & Immunol, Matsumoto, Nagano 390, Japan	Matsuda, K (reprint author), Shinshu Univ Hosp, Dept Lab Med, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	kmatsuda@shinshu-u.ac.jp					Mickelson DM, 2011, BONE MARROW TRANSPL, V46, P84, DOI 10.1038/bmt.2010.55; Matsuda K, 2010, BRIT J HAEMATOL, V148, P593, DOI 10.1111/j.1365-2141.2009.07968.x; Nollet F, 2001, BONE MARROW TRANSPL, V28, P511, DOI 10.1038/sj.bmt.1703162; Taira C, 2011, CLIN CHIM ACTA, V412, P53, DOI 10.1016/j.cca.2010.09.011; Liesveld JL, 2008, BONE MARROW TRANSPL, V42, P297, DOI 10.1038/bmt.2008.212; Lion T, 2012, LEUKEMIA, V26, P1821, DOI 10.1038/leu.2012.66; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Andreani M, 2014, TISSUE ANTIGENS, V83, P137, DOI 10.1111/tan.12313; Sueki A, 2013, CLIN CHIM ACTA, V415, P276, DOI [10.1016/j.cca.2012.10.059, 10.1016/j.cca2012.10.059]; Thiede C, 1999, BONE MARROW TRANSPL, V23, P1055, DOI 10.1038/sj.bmt.1701779; Taira C, 2012, CLIN CHIM ACTA, V413, P516, DOI 10.1016/j.cca.2011.11.017; Taira C, 2013, CLIN CHIM ACTA, V424, P39, DOI 10.1016/j.cca.2013.04.024; Chang YJ, 2013, BLOOD REV, V27, P55, DOI 10.1016/j.blre.2012.11.002; Matsuda K, 2012, CLIN CHIM ACTA, V413, P1742, DOI 10.1016/j.cca.2012.06.026; Koldehoff M, 2006, AM J HEMATOL, V81, P735, DOI 10.1002/ajh.20693; Buno I, 2005, HAEMATOL-HEMATOL J, V90, P1373; Cha R S, 1992, PCR Methods Appl, V2, P14; Chen DP, 2011, CLIN CHIM ACTA, V412, P625, DOI 10.1016/j.cca.2010.12.018; Chen DP, 2008, ANN CLIN LAB SCI, V38, P264; Gineikiene E, 2009, J MOL DIAGN, V11, P66, DOI 10.2353/jmoldx.2009.080039; Glaab WE, 1999, MUTAT RES-FUND MOL M, V430, P1, DOI 10.1016/S0027-5107(99)00147-5; Kreyenberg H, 2003, LEUKEMIA, V17, P237, DOI 10.1038/sj.leu.2402761; Maas F, 2003, LEUKEMIA, V17, P621, DOI 10.1038/sj.leu.2402856; Matsuda K, 2004, CLIN CHEM, V50, P2411, DOI 10.1373/clinchem.2004.037580; Odriozola A, 2012, CLIN CHIM ACTA, V413, P548, DOI 10.1016/j.cca.2011.11.022; Walsh PS, 1996, NUCLEIC ACIDS RES, V24, P2807, DOI 10.1093/nar/24.14.2807; Watzinger F, 2006, LEUKEMIA, V20, P1448, DOI 10.1038/sj.leu.2404267	27	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	MAY 20	2015	445						101	106		10.1016/j.cca.2015.03.018		6	Medical Laboratory Technology	Medical Laboratory Technology	CI8LP	WOS:000355024100019		
J	Hirama, T; Mogi, H; Egashira, H; Yamamoto, E; Kukisaki, S; Hagiwara, K; Takei, O				Hirama, Takashi; Mogi, Hajime; Egashira, Hitoshi; Yamamoto, Eiji; Kukisaki, Shigenari; Hagiwara, Koichi; Takei, Osamu			A pressure-driven column-based technique for the efficient extraction of DNA from respiratory samples	CLINICA CHIMICA ACTA			English	Article						Real-time PCR; DNA extraction; Pressure; HIRA-TAN; Column	REAL-TIME PCR; SYSTEM; SPUTUM; ASSAY	Currently molecular techniques are a broadly accepted tool for diagnosis and are able to benefit patients in clinical practice. The polymerase chain reaction (PCR) has been especially incorporated into practical applications that are already in widespread use across the globe. With regard to the initial DNA extraction from clinically relevant samples, a number of commercially available kits are commonly used and are also designed to be easy to handle and less labor-intensive. In this study, the pressure system extracting DNA in column-based kit was developed, and its utility was compared with the centrifuge method using sputum from patients who were diagnosed with pneumonia. Also, due to the compact size and rapid processing time, the practical application of the pressure-based system incorporated into an automated pipetting machine was evaluated through clinical study. Our data suggests that DNA extraction by pressure was capable of serving as a substitute for the centrifuge method, and the compact and automatic nature of the pressure system device provided rapid and valuable information for clinical practice. (C) 2015 Elsevier B.V. All rights reserved.	[Hirama, Takashi; Egashira, Hitoshi; Hagiwara, Koichi] Saitama Med Univ, Dept Resp Med, Moroyama, Saitama 3500495, Japan; [Hirama, Takashi] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 0A4, Canada; [Mogi, Hajime; Yamamoto, Eiji; Kukisaki, Shigenari; Takei, Osamu] Lifetech Co Ltd, Iruma, Saitama 3580014, Japan	Hirama, T (reprint author), Saitama Med Univ, Dept Resp Med, 38 Morohongo, Moroyama, Saitama 3500495, Japan.	mycobacteriumtuberculosis@hotmail.com			Adaptable and Seamless Technology Transfer Program through Target-driven R&D from the Japan Science and Technology Agency [AS2321117F]; Japan Society for the Promotion of Science [23790918]	The authors have declared that no competing interests exist. This work was supported by the Adaptable and Seamless Technology Transfer Program through Target-driven R&D (AS2321117F) from the Japan Science and Technology Agency and Grant-in-Aid for Young Scientists (B) (No. 23790918) from the Japan Society for the Promotion of Science. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. In addition, the manuscript has been reviewed by all of the authors and is not being submitted to any other journals. All of the authors have declared that no competing interests exist.	Aldous WK, 2005, J CLIN MICROBIOL, V43, P2471, DOI 10.1128/JCM.43.5.2471-2473.2005; Yang GY, 2011, J VIROL METHODS, V171, P195, DOI 10.1016/j.jviromet.2010.10.024; Zhang YX, 2011, LAB CHIP, V11, P1545, DOI 10.1039/c0lc00502a; Hwang KY, 2011, LAB CHIP, V11, P3649, DOI 10.1039/c1lc20692c; Chotirmall SH, 2014, INT J BIOCHEM CELL B, V52, P161, DOI [10.1016/j.biocel.2014.03.001, 10.1016/j.bioce1.2014.03.001]; Queipo-Ortuno MI, 2008, EUR J CLIN MICROBIOL, V27, P109, DOI 10.1007/s10096-007-0409-y; Deng Jikui, 2013, Virologica Sinica, V28, P97, DOI 10.1007/s12250-013-3312-y; Bouchara JP, 2009, J CLIN MICROBIOL, V47, P142, DOI 10.1128/JCM.01668-08; Hirama T, 2014, RESP MED, V108, P395, DOI 10.1016/j.rmed.2013.11.018; Hirama T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024474; Lee AV, 2011, J CLIN VIROL, V52, P339, DOI 10.1016/j.jcv.2011.08.016; Li J, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-189; PICOT R, 1978, THORAX, V33, P235, DOI 10.1136/thx.33.2.235; Wilson D, 2004, NATION, V279, P42	14	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	MAY 20	2015	445						122	126		10.1016/j.cca.2015.03.023		5	Medical Laboratory Technology	Medical Laboratory Technology	CI8LP	WOS:000355024100022		
J	Nakamura, M; Iso, H; Kitamura, A; Imano, H; Kiyama, M; Yokoyama, S; Kayamori, Y; Koyama, I; Nishimura, K; Nakai, M; Dasti, M; Vesper, HW; Teramoto, T; Miyamoto, Y				Nakamura, Masakazu; Iso, Hiroyasu; Kitamura, Akihiko; Imano, Hironori; Kiyama, Masahiko; Yokoyama, Shinji; Kayamori, Yuzo; Koyama, Isao; Nishimura, Kunihiro; Nakai, Michikazu; Dasti, Mahnaz; Vesper, Hubert W.; Teramoto, Tamio; Miyamoto, Yoshihiro			Total cholesterol performance of Abell-Levy-Brodie-Kendall reference measurement procedure: Certification of Japanese in-vitro diagnostic assay manufacturers through CDC's Cholesterol Reference Method Laboratory Network	CLINICA CHIMICA ACTA			English	Article						TC; AK RMP; Certification; CRMLN; CDC	DILUTION MASS-SPECTROMETRY; CORONARY-HEART-DISEASE; HIGH BLOOD CHOLESTEROL; ADULT TREATMENT PANEL; SERUM-CHOLESTEROL; EDUCATION-PROGRAM; DEFINITIVE METHOD; EXPERT PANEL; STANDARDIZATION; GLYCEROL	Background: Accurate measurement of total cholesterol (TC) is important for cardiovascular disease risk management. The US Centers for Disease Control and Prevention (CDC) and Cholesterol Reference Method Laboratory Network (CRMLN) perform Abell-Levy-Brodie-Kendall (AK) reference measurement procedure (RMP) for TC as a secondary reference method, and implement Certification Protocol for Manufacturers. Japanese CRMLN laboratory at Osaka performed the AK RMP for 22 years, and conducted TC certification for reagent/calibrator/instrument systems of six Japanese manufacturers every 2 years for 16 years. Osaka TC performance was examined and compared to CDC's reference values. Methods: AK RMP involved sample hydrolysis, cholesterol extraction, and determination of cholesterol levels by spectrophotometry. The Certification Protocol for Manufacturers includes comparison with AK RMP using at least 40 fresh specimens. Demonstration of average bias <= 3% and total coefficient of variation <= 3% qualified an analytical system for certification. Results: In the AK RMP used in the Osaka CRMLN laboratory, the regression equation for measuring TC was y (Osaka) = 1.000x (CDC) + 0.032 (n = 619, R-2 = 1.000). Six Japanese manufacturers had allowable performance for certification. Conclusions: The AK RMP for TC measurement was accurate, precise, and stable for 22 years. Six Japanese manufacturers were certified for 16 years. (C) 2015 Elsevier B.V. All rights reserved.	[Nakamura, Masakazu; Koyama, Isao] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Cardiol, Lipid Reference Lab, Suita, Osaka 5658565, Japan; [Iso, Hiroyasu; Kitamura, Akihiko; Imano, Hironori] Osaka Univ, Grad Sch Med, Dept Social Med, Publ Hlth, Suita, Osaka 565, Japan; [Kiyama, Masahiko] Osaka Ctr Canc & Cardiovasc Dis Prevent, Osaka, Japan; [Yokoyama, Shinji] Chubu Univ, Nutr Hlth Sci Res Ctr, Kasugai, Aichi 487, Japan; [Kayamori, Yuzo] Kyushu Univ, Fac Med Sci, Dept Hlth Sci, Fukuoka 812, Japan; [Nishimura, Kunihiro; Nakai, Michikazu] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Med & Epidemiol Informat, Suita, Osaka 5658565, Japan; [Dasti, Mahnaz; Vesper, Hubert W.] Ctr Dis Control & Prevent, Div Sci Lab, Natl Ctr Environm Hlth, Atlanta, GA USA; [Teramoto, Tamio] Teikyo Univ, Teikyo Acad Res Ctr, Tokyo, Japan; [Miyamoto, Yoshihiro] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Cardiol, Dept Prevent Med & Epidemiol Informat, Suita, Osaka 5658565, Japan	Nakamura, M (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Prevent Cardiol, Lipid Reference Lab, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.	nakamura.masakazu.hp@ncvc.go.jp			Health and Labour Sciences Research Grant, Japan (Comprehensive Research on Lifestyle-Related Diseases Including Cardiovascular Diseases and Diabetes Mellitus) from the Ministry of Health, Labour, and Welfare of Japan	This work was supported by a Health and Labour Sciences Research Grant, Japan (Comprehensive Research on Lifestyle-Related Diseases Including Cardiovascular Diseases and Diabetes Mellitus) from the Ministry of Health, Labour, and Welfare of Japan. The authors would like to thank Dr. Katsuyuki Nakajima and Dr. Ikunosuke Sakurabayashi for their valuable comments and discussion, and Ms. Yukari Ichikawa for her excellent help in providing the references and manuscript.	[Anonymous], 1999, C37A CLIN LAB STAND; RICHMOND W, 1973, CLIN CHEM, V19, P1350; WESTGARD JO, 1973, CLIN CHEM, V19, P49; [Anonymous], 2012, EUR HEART J, V33, P635; MYERS GL, 1989, CLIN LAB MED, V9, P105; ALLAIN CC, 1974, CLIN CHEM, V20, P470; [Anonymous], 2004, TOT CHOL CERT PROT M; CLEEMAN JI, 1988, ARCH INTERN MED, V148, P36; Kitamura A, 2008, J AM COLL CARDIOL, V52, P71, DOI 10.1016/j.jacc.2008.02.075; [Anonymous], 1995, EP9A NCCLS, V15; [Anonymous], 1982, PROC PROP CHOL REF M; [Anonymous], 1990, NIH PUBLICATION, V90-2964; ABELL LL, 1952, J BIOL CHEM, V195, P357; [Anonymous], 1988, CLIN CHEM, V34, P193; BENNETT ST, 1992, CLIN CHEM, V38, P651; BERNERT JT, 1992, J CHROMATOGR-BIOMED, V578, P1, DOI 10.1016/0378-4347(92)80218-F; BLAND JM, 1986, LANCET, V1, P307; Certification Protocol for Clinical Laboratories, 2004, CHOL REF METH LAB NE; COOPER GR, 1988, CLIN CHEM, V34, pB95; Edwards SH, 2011, CLIN CHEM, V57, P614, DOI 10.1373/clinchem.2010.158766; Edwards SH, 2012, CLIN CHEM, V58, P768, DOI 10.1373/clinchem.2011.177063; ELLERBE P, 1989, ANAL CHEM, V61, P1718, DOI 10.1021/ac00190a025; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Japan Atherosclerosis Society, 2012, JAP ATH SOC GUID PRE; Koyama I, 2010, CLIN CHEM S56, pA186; RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P351; Nakamura Masakazu, 2003, J Atheroscler Thromb, V10, P145; PELLETIER O, 1987, CLIN CHEM, V33, P1403; SIEKMANN L, 1991, EUR J CLIN CHEM CLIN, V29, P277; Warnick GR, 2002, CLIN CHEM, V48, P11; ZAK B, 1990, MICROCHEM J, V41, P251, DOI 10.1016/0026-265X(90)90128-R; ZAK B, 1977, CLIN CHEM, V23, P1201	32	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	MAY 20	2015	445						127	132		10.1016/j.cca.2015.03.026		6	Medical Laboratory Technology	Medical Laboratory Technology	CI8LP	WOS:000355024100023		
J	Sun, LO; Brady, CM; Cahill, H; Al-Khindi, T; Sakuta, H; Dhande, OS; Noda, M; Huberman, AD; Nathans, J; Kolodkin, AL				Sun, Lu O.; Brady, Colleen M.; Cahill, Hugh; Al-Khindi, Timour; Sakuta, Hiraki; Dhande, Onkar S.; Noda, Masaharu; Huberman, Andrew D.; Nathans, Jeremy; Kolodkin, Alex L.			Functional Assembly of Accessory Optic System Circuitry Critical for Compensatory Eye Movements	NEURON			English	Article							RETINAL GANGLION-CELLS; LAMINA-RESTRICTED PROJECTION; HIPPOCAMPAL MOSSY FIBERS; AXON GUIDANCE; OPTOKINETIC REFLEX; TRANSGENIC MICE; MUTANT MICE; MECHANISMS; PLEXIN-A2; MOTION	Accurate motion detection requires neural circuitry that compensates for global visual field motion. Select subtypes of retinal ganglion cells perceive image motion and connect to the accessory optic system (AOS) in the brain, which generates compensatory eye movements that stabilize images during slow visual field motion. Here, we show that the murine transmembrane semaphorin 6A (Sema6A) is expressed in a subset of On direction-selective ganglion cells (On DSGCs) and is required for retino-recipient axonal targeting to the medial terminal nucleus (MTN) of the AOS. Plexin A2 and A4, two Sema6A binding partners, are expressed in MTN cells, attract Sema6A(+) On DSGC axons, and mediate MTN targeting of Sema6A(+) RGC projections. Furthermore, Sema6A/Plexin-A2/A4 signaling is required for the functional output of the AOS. These data reveal molecular mechanisms underlying the assembly of AOS circuits critical for moving image perception.	[Sun, Lu O.; Brady, Colleen M.; Al-Khindi, Timour; Kolodkin, Alex L.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Cahill, Hugh; Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet,Dept Neurosci,Dept Ophthalm, Baltimore, MD 21205 USA; [Sakuta, Hiraki; Noda, Masaharu] Natl Inst Basic Biol, Div Mol Neurosci, Okazaki, Aichi 4448787, Japan; [Dhande, Onkar S.; Huberman, Andrew D.] Univ Calif San Diego, Dept Ophthalmol, Div Biol Sci, Dept Neurosci,Neurobiol Sect, San Diego, CA 92093 USA	Kolodkin, AL (reprint author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	kolodkin@jhmi.edu	Sun, Lu/P-9339-2015	Sun, Lu/0000-0002-9293-7241	NIH [RO1 EY022157-01]; Pew Scholar Award	We thank Drs. Samer Hattar, Rebecca James, and Bredan Lilley for helpful comments on the manuscript. We also thank Marley Jamason for analysis of whole-mount RGC projections, Dontais Johnson for technical assistance, and members of the A.L.K. laboratory for assistance and discussions. This work was supported by NIH RO1 EY022157-01 and a Pew Scholar Award (A.D.H.); A.L.K. and J.N. are investigators of the Howard Hughes Medical Institute.	Andermatt I, 2014, DEVELOPMENT, V141, P3709, DOI 10.1242/dev.112185; Huberman AD, 2008, NEURON, V59, P425, DOI 10.1016/j.neuron.2008.07.018; Matsuoka RL, 2011, NATURE, V470, P259, DOI 10.1038/nature09675; Tawarayama H, 2010, J NEUROSCI, V30, P7049, DOI 10.1523/JNEUROSCI.0073-10.2010; McLaughlin T, 2005, ANNU REV NEUROSCI, V28, P327, DOI 10.1146/annurev.neuro.28.061604.135714; Renaud J, 2008, NAT NEUROSCI, V11, P440, DOI 10.1038/nn2064; Furuta Y, 2000, GENESIS, V26, P130, DOI 10.1002/(SICI)1526-968X(200002)26:2<130::AID-GENE9>3.0.CO;2-I; Rivlin-Etzion M, 2011, J NEUROSCI, V31, P8760, DOI 10.1523/JNEUROSCI.0564-11.2011; Sanes JR, 2010, NEURON, V66, P15, DOI 10.1016/j.neuron.2010.01.018; Osterhout JA, 2011, NEURON, V71, P632, DOI 10.1016/j.neuron.2011.07.006; Suto F, 2007, NEURON, V53, P535, DOI 10.1016/j.neuron.2007.01.028; Nie D, 2010, NAT NEUROSCI, V13, P163, DOI 10.1038/nn.2477; Kay JN, 2011, J NEUROSCI, V31, P7753, DOI 10.1523/JNEUROSCI.0907-11.2011; Toyofuku T, 2004, NAT CELL BIOL, V6, P1204, DOI 10.1038/ncb1193; Osterhout JA, 2014, CELL REP, V8, P1006, DOI 10.1016/j.celrep.2014.06.063; Huberman AD, 2009, NEURON, V62, P327, DOI 10.1016/j.neuron.2009.04.014; Matsuoka RL, 2011, NEURON, V71, P460, DOI 10.1016/j.neuron.2011.06.009; Badea TC, 2009, NEURON, V61, P852, DOI 10.1016/j.neuron.2009.01.020; Thompson H, 2006, J NEUROSCI, V26, P8082, DOI 10.1523/JNEUROSCI.1342-06.2006; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Robles E, 2012, CURR OPIN NEUROBIOL, V22, P799, DOI 10.1016/j.conb.2012.04.014; Dhande OS, 2014, CURR OPIN NEUROBIOL, V24, P133, DOI 10.1016/j.conb.2013.08.006; Schmitt AM, 2006, NATURE, V439, P31, DOI 10.1038/nature04334; Pequignot MO, 2003, DEV DYNAM, V228, P231, DOI 10.1002/dvdy.10376; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; SIMPSON JI, 1984, ANNU REV NEUROSCI, V7, P13; Cahill H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002055; Culican SM, 2009, MOL CELL NEUROSCI, V41, P304, DOI 10.1016/j.mcn.2009.04.001; FREDERICKS CA, 1988, BRAIN RES, V454, P116, DOI 10.1016/0006-8993(88)90809-8; Haupt C, 2008, FRONT BIOSCI-LANDMRK, V13, P3136, DOI 10.2741/2915; Jeong S, 2012, NEURON, V76, P721, DOI 10.1016/j.neuron.2012.09.018; Komiyama T, 2007, CELL, V128, P399, DOI 10.1016/j.cell.2006.12.028; Kubo F, 2014, NEURON, V81, P1344, DOI 10.1016/j.neuron.2014.02.043; Little GE, 2009, PLOS BIOL, V7, P756, DOI 10.1371/journal.pbio.1000098; Masseck OA, 2009, ANN NY ACAD SCI, V1164, P430, DOI 10.1111/j.1749-6632.2009.03854.x; Osterhout JA, 2015, NEURON, V86, P985, DOI 10.1016/j.neuron.2015.04.005; PAK MW, 1987, J COMP NEUROL, V258, P435, DOI 10.1002/cne.902580311; Riccomagno MM, 2014, NEURON, V81, P779, DOI 10.1016/j.neuron.2014.01.036; Rünker Annette E, 2008, Neural Dev, V3, P34, DOI 10.1186/1749-8104-3-34; Sun LO, 2013, SCIENCE, V342, P590, DOI 10.1126/science.1241974; Sweeney LB, 2011, NEURON, V72, P734, DOI 10.1016/j.neuron.2011.09.026; Yonehara K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004320; Yonehara K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001533; Yu L, 2010, J NEUROSCI, V30, P12151, DOI 10.1523/JNEUROSCI.1494-10.2010	44	2	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 20	2015	86	4					971	984		10.1016/j.neuron.2015.03.064		14	Neurosciences	Neurosciences & Neurology	CI6OB	WOS:000354878400012		
J	Osterhout, JA; Stafford, BK; Nguyen, PL; Yoshihara, Y; Huberman, AD				Osterhout, Jessica A.; Stafford, Benjamin K.; Nguyen, Phong L.; Yoshihara, Yoshihiro; Huberman, Andrew D.			Contactin-4 Mediates Axon-Target Specificity and Functional Development of the Accessory Optic System	NEURON			English	Article							RETINAL GANGLION-CELLS; AMYLOID PRECURSOR PROTEIN; MOLECULAR-MECHANISMS; SYNAPTIC LAMINAE; GENETIC-ANALYSIS; MOUSE RETINA; PROJECTIONS; EXPERIENCE; EXPRESSION; SYNAPSES	The mammalian eye-to-brain pathway includes more than 20 parallel circuits, each consisting of precise long-range connections between specific sets of retinal ganglion cells (RGCs) and target structures in the brain. The mechanisms that drive assembly of these parallel connections and the functional implications of their specificity remain unresolved. Here we show that in the absence of contactin 4 (CNTN4) or one of its binding partners, amyloid precursor protein (APP), a subset of direction-selective RGCs fail to target the nucleus of the optic tract (NOT)-the accessory optic system (AOS) target controlling horizontal image stabilization. Conversely, ectopic expression of CNTN4 biases RGCs to arborize in the NOT, and that process also requires APP. Our data reveal critical and novel roles for CNTN4/APP in promoting target-specific axon arborization, and they highlight the importance of this process for functional development of a behaviorally relevant parallel visual pathway.	[Osterhout, Jessica A.; Stafford, Benjamin K.; Nguyen, Phong L.; Huberman, Andrew D.] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA; [Stafford, Benjamin K.; Nguyen, Phong L.; Huberman, Andrew D.] Univ Calif San Diego, Sch Med, Neurosci Dept, La Jolla, CA 92093 USA; [Huberman, Andrew D.] Univ Calif San Diego, Sch Med, Dept Ophthalmol, La Jolla, CA 92093 USA; [Yoshihara, Yoshihiro] RIKEN, Brain Sci Inst, Wako, Saitama 3510198, Japan	Huberman, AD (reprint author), Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, 9500 Gilman Dr, La Jolla, CA 92093 USA.	ahuberman@ucsd.edu			NIH [RO1 EY022157]; E. Matilda Ziegler Foundation; Pew Scholar Award; National Science Foundation Graduate Research Fellowship [DGE-1144086]	We thank Dr. Onkar Dhande, Dr. Lu Sun, and Dr. Alex Kolodkin for helpful comments and suggestions on an earlier version of this manuscript; Jared Sewell and Dr. Jeff Long for technical assistance with biochemistry experiments; Tomomi Kaneko-Goto for creating the CNTN4 reagents, including the knockout mouse, CNTN4 antibody, and overexpression plasmid; and Pritha P. Multani for histology help. This work was supported by NIH RO1 EY022157 (A.D.H.), the E. Matilda Ziegler Foundation (A.D.H.), a Pew Scholar Award (A.D.H.), and National Science Foundation Graduate Research Fellowship under grant DGE-1144086 (J.A.O.).	Lichtman JW, 2011, SCIENCE, V334, P618, DOI 10.1126/science.1209168; Zuko A, 2013, EUR J PHARMACOL, V719, P63, DOI 10.1016/j.ejphar.2013.07.016; Cang JH, 2013, ANNU REV NEUROSCI, V36, P51, DOI 10.1146/annurev-neuro-062012-170341; Dhande OS, 2013, J NEUROSCI, V33, P17797, DOI 10.1523/JNEUROSCI.2778-13.2013; Fernandez T, 2008, AM J HUM GENET, V82, P1385, DOI 10.1016/j.ajhg.2008.04.021; Olsen O, 2014, J NEUROSCI, V34, P6438, DOI 10.1523/JNEUROSCI.3522-13.2014; Walsh DM, 2007, BIOCHEM SOC T, V35, P416; Stafford BK, 2014, J NEUROSCI, V34, P1942, DOI 10.1523/JNEUROSCI.4461-13.2014; Osterhout JA, 2011, NEURON, V71, P632, DOI 10.1016/j.neuron.2011.07.006; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Luo LQ, 2007, NEURON, V56, P284, DOI 10.1016/j.neuron.2007.10.014; Kay JN, 2011, J NEUROSCI, V31, P7753, DOI 10.1523/JNEUROSCI.0907-11.2011; Yamagata M, 2012, J NEUROSCI, V32, P14402, DOI 10.1523/JNEUROSCI.3193-12.2012; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Shimoda Y, 2009, CELL ADHES MIGR, V3, P64, DOI 10.4161/cam.3.1.7764; Wei W, 2010, NAT PROTOC, V5, P1347, DOI 10.1038/nprot.2010.106; Elstrott J, 2008, NEURON, V58, P499, DOI 10.1016/j.neuron.2008.03.013; Osterhout JA, 2014, CELL REP, V8, P1006, DOI 10.1016/j.celrep.2014.06.063; YOSHIHARA Y, 1995, J NEUROBIOL, V28, P51, DOI 10.1002/neu.480280106; Huberman AD, 2009, NEURON, V62, P327, DOI 10.1016/j.neuron.2009.04.014; Borghuis BG, 2013, J NEUROSCI, V33, P10972, DOI 10.1523/JNEUROSCI.1241-13.2013; Robles E, 2012, CURR OPIN NEUROBIOL, V22, P799, DOI 10.1016/j.conb.2012.04.014; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Roohi J, 2009, J MED GENET, V46, P176, DOI 10.1136/jmg.2008.057505; Zuko A, 2011, ADV PROTEIN CHEM STR, V84, P143, DOI 10.1016/B978-0-12-386483-3.00001-X; Sanes JR, 2009, ANNU REV CELL DEV BI, V25, P161, DOI 10.1146/annurev.cellbio.24.110707.175402; Schmidt ERE, 2014, NEURON, V83, P372, DOI 10.1016/j.neuron.2014.05.036; HOFBAUER A, 1985, J COMP NEUROL, V234, P465, DOI 10.1002/cne.902340405; Baier H, 2013, ANNU REV CELL DEV BI, V29, P385, DOI 10.1146/annurev-cellbio-101011-155748; Dhande OS, 2014, CURR OPIN NEUROBIOL, V24, P133, DOI 10.1016/j.conb.2013.08.006; Joo WJ, 2013, NEURON, V78, P673, DOI 10.1016/j.neuron.2013.03.022; SIMPSON JI, 1984, ANNU REV NEUROSCI, V7, P13; Ashrafi S, 2014, NEURON, V81, P120, DOI 10.1016/j.neuron.2013.10.060; Huberman AD, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001743; Kaneko-Goto T., 2008, NEURON, V57, P834; Kerner B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028477; Masseck OA, 2009, ANN NY ACAD SCI, V1164, P430, DOI 10.1111/j.1749-6632.2009.03854.x; Morin Lawrence P, 2014, J Comp Neurol, V522, P3733, DOI 10.1002/cne.23635; Omori T, 2005, NEUROSCI LETT, V389, P25, DOI 10.1016/j.neulet.2005.07.005; Osterfield M, 2008, DEVELOPMENT, V135, P1189, DOI 10.1242/dev.007401; PAK MW, 1987, J COMP NEUROL, V258, P435, DOI 10.1002/cne.902580311; Prusky GT, 2008, J NEUROSCI, V28, P9817, DOI 10.1523/JNEUROSCI.1940-08.2008; Reinhard C, 2005, EMBO J, V24, P3996, DOI 10.1038/sj.emboj.7600860; Ringstedt T, 2000, J NEUROSCI, V20, P4983; Robles E, 2014, CURR BIOL, V24, P2085, DOI 10.1016/j.cub.2014.07.080; Sun LO, 2015, NEURON, V86, P971, DOI 10.1016/j.neuron.2015.03.064; Sweeney NT, 2014, J NEUROSCI, V34, P5447, DOI 10.1523/JNEUROSCI.0035-14.2014; Tschetter WW, 2013, J NEUROSCI, V33, P5362, DOI 10.1523/JNEUROSCI.5229-12.2013; Tschetter Wayne W, 2011, Front Syst Neurosci, V5, P44, DOI 10.3389/fnsys.2011.00044; Wang LP, 2009, J NEUROSCI, V29, P12909, DOI 10.1523/JNEUROSCI.2128-09.2009; Yonehara K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004320	51	2	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 20	2015	86	4					985	999		10.1016/j.neuron.2015.04.005		15	Neurosciences	Neurosciences & Neurology	CI6OB	WOS:000354878400013		
J	Saita, Y; Shinto, H; Nomura, T				Saita, Yusuke; Shinto, Hironobu; Nomura, Takanori			Holographic Shack-Hartmann wavefront sensor based on the correlation peak displacement detection method for wavefront sensing with large dynamic range	OPTICA			English	Article							SPATIAL LIGHT-MODULATOR; ADAPTIVE OPTICS SYSTEM; BIT-ERROR-RATE; ASTIGMATIC MICROLENSES; LASER COMMUNICATIONS; EXPANSION; ALGORITHM; EYES	A method to expand the dynamic range for a Shack - Hartmann wavefront sensor (SHWFS) is proposed. An SHWFS consists of a microlens array and an image sensor, and it has been widely used to measure the wavefront aberration of a lightwave in various fields. However, a very large aberrated wave cannot be correctly measured due to the finite dynamic range that depends on the diameter of each microlens. The proposed method enables an SHWFS to measure wavefronts with larger aberrations by applying holography and pattern matching technologies. For measurement of a spherical wave, the proposed method is compared with a conventional one by numerical simulations and optical experiments. Their results confirm the performance of the proposed method. (C) 2015 Optical Society of America	[Saita, Yusuke; Nomura, Takanori] Wakayama Univ, Fac Syst Engn, Wakayama 6408510, Japan; [Shinto, Hironobu] Wakayama Univ, Grad Sch Syst Engn, Wakayama 6408510, Japan	Saita, Y (reprint author), Wakayama Univ, Fac Syst Engn, 930 Sakaedani, Wakayama 6408510, Japan.	saita@sys.wakayama-u.ac.jp					Zhang Y, 2005, OPT EXPRESS, V13, P4792, DOI 10.1364/OPEX.13.004792; Pfund J, 1998, OPT LETT, V23, P995, DOI 10.1364/OL.23.000995; FOY R, 1985, ASTRON ASTROPHYS, V152, pL29; Lindlein N, 2001, OPT ENG, V40, P837, DOI 10.1117/1.1357193; NOLL RJ, 1976, J OPT SOC AM, V66, P207, DOI 10.1364/JOSA.66.000207; Wizinowich PL, 2006, PUBL ASTRON SOC PAC, V118, P297, DOI 10.1086/499290; Seifert L, 2003, P SOC PHOTO-OPT INS, V5144, P250, DOI 10.1117/12.499543; Lindlein N, 2002, OPT ENG, V41, P529, DOI 10.1117/1.1430724; Lindlein N, 2000, OPT ENG, V39, P2220, DOI 10.1117/1.1304846; Tyson RK, 2002, J OPT SOC AM A, V19, P753, DOI 10.1364/JOSAA.19.000753; Hofer H, 2001, OPT EXPRESS, V8, P631; Roorda A, 2002, OPT EXPRESS, V10, P405, DOI 10.1364/OE.10.000405; Groening S, 2000, APPL OPTICS, V39, P561, DOI 10.1364/AO.39.000561; HUBIN N, 1993, SCIENCE, V262, P1390, DOI 10.1126/science.262.5138.1390; Lee JW, 2005, APPL OPTICS, V44, P4838, DOI 10.1364/AO.44.004838; Li M. X. C., 2010, J BIOMED OPT, V15; Liang JZ, 1997, J OPT SOC AM A, V14, P2884, DOI 10.1364/JOSAA.14.002884; Lukin V. P., 2009, Atmospheric and Oceanic Optics, V22, DOI 10.1134/S1024856009030154; Rha J, 2002, P SOC PHOTO-OPT INS, V4493, P80, DOI 10.1117/12.454698; Takami H, 2004, PUBL ASTRON SOC JPN, V56, P225; Tyson RK, 2003, APPL OPTICS, V42, P4239, DOI 10.1364/AO.42.004239; Yoon Geunyoung, 2006, J Biomed Opt, V11, P30502	22	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	2334-2536			OPTICA	Optica	MAY 20	2015	2	5					411	415		10.1364/OPTICA.2.000411		5	Optics	Optics	CI6KH	WOS:000354867400004		
J	Yasui, T; Iyonaga, Y; Hsieh, YD; Sakaguchi, Y; Hindle, F; Yokoyama, S; Araki, T; Hashimoto, M				Yasui, Takeshi; Iyonaga, Yuki; Hsieh, Yi-Da; Sakaguchi, Yoshiyuki; Hindle, Francis; Yokoyama, Shuko; Araki, Tsutomu; Hashimoto, Mamoru			Super-resolution discrete Fourier transform spectroscopy beyond time-window size limitation using precisely periodic pulsed radiation	OPTICA			English	Article							DOMAIN SPECTROSCOPY; TERAHERTZ; SUBMILLIMETER; RESOLUTION; COMBS	Fourier transform spectroscopy (FTS) has been widely used in a variety of fields due to its high signal-to-noise ratio, simultaneous acquisition of a broad spectrum, and versatility for different radiation sources. Further improvement of the spectroscopic performance will widen its scope of applications. Here, we demonstrate improved spectral resolution by overcoming the time-window size limitation using a mode-locked terahertz (THz) pulse train as precisely periodic pulsed radiation in discrete Fourier transform spectroscopy (dFTS). Since infinitesimal resolution can be achieved at harmonic components of its repetition frequency 1/T when the time-window size is exactly matched to the repetition period T, a combination of dFTS with a spectral interleaving technique achieves a spectral resolution limited only by the spectral interleaving interval. Linewidths narrower than 1/(50T) are fully resolved by THz-dFTS, allowing rotational-transition absorption lines of low-pressure molecular gases to be attributed within a 1.25 MHz band. (C) 2015 Optical Society of America	[Yasui, Takeshi; Iyonaga, Yuki; Hsieh, Yi-Da; Sakaguchi, Yoshiyuki; Yokoyama, Shuko; Araki, Tsutomu; Hashimoto, Mamoru] Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan; [Yasui, Takeshi; Hsieh, Yi-Da] Univ Tokushima, Inst Technol & Sci, Tokushima 7708506, Japan; [Yasui, Takeshi; Hsieh, Yi-Da] JST, ERATO, MINOSHIMA Intelligent Opt Synthesizer Project, Tokushima 7708506, Japan; [Hindle, Francis] Univ Littoral Cote dOpale, Lab Physicochim Atmosphere, F-59140 Dunkerque, France; [Yokoyama, Shuko] Micro Opt Co Ltd, Nishikyo Ku, Kyoto 6101104, Japan	Yasui, T (reprint author), Osaka Univ, Grad Sch Engn Sci, 1-3 Machikaneyama, Toyonaka, Osaka 5608531, Japan.	yasui.takeshi@tokushima-u.ac.jp	Hindle, Francis/B-3261-2009	Hindle, Francis/0000-0001-9925-4497	Canon Foundation; Japan Science and Technology Corporation (JST); Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Osaka University	Canon Foundation; Japan Science and Technology Corporation (JST); Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Osaka University.	Keilmann F, 2004, OPT LETT, V29, P1542, DOI 10.1364/OL.29.001542; Pickett HM, 1998, J QUANT SPECTROSC RA, V60, P883, DOI 10.1016/S0022-4073(98)00091-0; Schiller S, 2002, OPT LETT, V27, P766, DOI 10.1364/OL.27.000766; Bruchhausen A, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.077401; Janke C, 2005, OPT LETT, V30, P1405, DOI 10.1364/OL.30.001405; Yasui T, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2209718; Mittleman DM, 1998, APPL PHYS B-LASERS O, V67, P379, DOI 10.1007/s003400050520; Roy J, 2012, OPT EXPRESS, V20, P21932, DOI 10.1364/OE.20.021932; Baumann E, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.062513; Bernhardt B, 2010, NAT PHOTONICS, V4, P55, DOI 10.1038/NPHOTON.2009.217; Bracewell R. N., 1999, FOURIER TRANSFORM IT; Farrar T. C., 1971, PULSE FOURIER TRANSF; Griffiths P. R., 2007, FOURIER TRANSFORM IN; Hsieh YD, 2013, IEEE T THZ SCI TECHN, V3, P322, DOI 10.1109/TTHZ.2013.2250333; Hsieh YD, 2014, SCI REP-UK, V4, DOI 10.1038/srep03816; Jacquet P., 2009, FOURIER TRANSFORM SP; Kruppa G. H., 2006, FOURIER TRANSFORM MA; Matsuura S, 1998, J MOL SPECTROSC, V187, P97, DOI 10.1006/jmsp.1997.7486; Mittleman D. M., 2003, SENSING THZ RAD; Pearson JC, 1996, ASTROPHYS J, V471, P1067, DOI 10.1086/178034; Seta T, 2008, J QUANT SPECTROSC RA, V109, P144, DOI 10.1016/j.jqsrt.2007.06.004; Sigrist M., 1994, AIR MONITORING SPECT; Yasui T, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2008379	23	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	2334-2536			OPTICA	Optica	MAY 20	2015	2	5					460	467		10.1364/OPTICA.2.000460		8	Optics	Optics	CI6KH	WOS:000354867400012		
J	Mtsuko, D; Koshio, A; Yudasaka, M; Iijima, S; Ahlskog, M				Mtsuko, D.; Koshio, A.; Yudasaka, M.; Iijima, S.; Ahlskog, M.			Measurements of the transport gap in semiconducting multiwalled carbon nanotubes with varying diameter and length	PHYSICAL REVIEW B			English	Article							GRAPHENE NANORIBBONS; ELECTRONS	Low temperature transport in multiwalled carbon nanotubes (MWNTs) has been studied at different diameters and lengths, within 2-10 nm, and 0.3-3.5 mu m, respectively. In a majority of the samples, semiconductivity showed up as a transport gap in the gate voltage controlled conduction, but metallic MWNTs are found in all diameters. The transport gap is seen to be quantitatively determined by a diameter dependent band gap, and length dependent localization of charge carriers. The band gap of semiconducting MWNTs is estimated to be smaller than that extrapolated from the conventional expression applicable to semiconducting single wall carbon nanotubes. The results constitute a systematical study on size dependent transport and especially of semiconductivity in MWNTs.	[Mtsuko, D.; Ahlskog, M.] Univ Jyvaskyla, Nanosci Ctr, FI-40014 Jyvaskyla, Finland; [Koshio, A.; Yudasaka, M.; Iijima, S.] NEC Res Ctr, Tsukuba, Ibaraki 3058501, Japan	Ahlskog, M (reprint author), Univ Jyvaskyla, Nanosci Ctr, POB 35 YFL, FI-40014 Jyvaskyla, Finland.	ahlskog@jyu.fi			Academy of Finland [SA-7122008]	This paper was supported by the Academy of Finland (Grant No. SA-7122008). We thank Claudia Gomes da Rocha, Trinity College Dublin, for constructive discussions.	Ahlskog M, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.155408; Collins PG, 2001, PHYS REV LETT, V86, P3128, DOI 10.1103/PhysRevLett.86.3128; Frank S, 1998, SCIENCE, V280, P1744, DOI 10.1126/science.280.5370.1744; Baringhaus J, 2014, NATURE, V506, P349, DOI 10.1038/nature12952; Kwon YK, 1998, PHYS REV B, V58, P16001, DOI 10.1103/PhysRevB.58.R16001; Yoon YG, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.073407; Charlier JC, 2007, REV MOD PHYS, V79, P677, DOI 10.1103/RevModPhys.79.677; Schonenberger C, 1999, APPL PHYS A-MATER, V69, P283, DOI 10.1007/s003390051003; Zhou CW, 2000, PHYS REV LETT, V84, P5604, DOI 10.1103/PhysRevLett.84.5604; Bouilly D, 2011, ACS NANO, V5, P4927, DOI 10.1021/nn201024u; Raquet B, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.046803; Gallagher P, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.115409; Minot ED, 2004, NATURE, V428, P536, DOI 10.1038/nature02425; Nanot S, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.256801; Cumings J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.086801; Huang JY, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.236802; Kuemmeth F, 2008, NATURE, V452, P448, DOI 10.1038/nature06822; Han MY, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.056801; Wang XR, 2011, NAT NANOTECHNOL, V6, P563, DOI [10.1038/nnano.2011.138, 10.1038/NNANO.2011.138]; Narita A, 2014, NAT CHEM, V6, P126, DOI [10.1038/nchem.1819, 10.1038/NCHEM.1819]; MARIANER S, 1992, PHYS REV B, V46, P13100, DOI 10.1103/PhysRevB.46.13100; Buitelaar MR, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.156801; Villalpando-Paez F, 2008, NANO LETT, V8, P3879, DOI 10.1021/nl802306t; Purewal MS, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.186808; Koshio A, 2002, CHEM PHYS LETT, V356, P595, DOI 10.1016/S0009-2614(02)00432-3; Bourlon B, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.176806; Che YC, 2014, SEMICOND SCI TECH, V29, DOI 10.1088/0268-1242/29/7/073001; Federov G., 2010, APPL PHYS LETT, V96; Gao B, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.085410; Guttinger J, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/12/126502; Han MY, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.206805; Hansson A, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.075406; Jackman H, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4861605; Jhang SH, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.096802; Jorio A., 2008, CARBON NANOTUBES; Kanda A., 2004, PHYS REV LETT, V92; Koshio A, 2007, J PHYS CHEM C, V111, P10, DOI 10.1021/jp0672914; Laid E. A., ARXIV14036113; Lassagne B, 2007, PHYS REV LETT, V98, DOI [10.1103/PhysRevLett.98.176802, 10.1103/PhysRevLett.98.t76802]; Makaev DV, 2006, JETP LETT+, V84, P335, DOI 10.1134/S0021364006180123; Moon S, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.176804; Roche S, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.121401; Rodin AS, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.125447; Schouteden K, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/48/485401; Shklovskii B I, 1984, ELECT PROPERTIES DOP; Stojetz B, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.186802; Tarkiainen R, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.033402; Tison Y, 2008, ACS NANO, V2, P2113, DOI 10.1021/nn800483k; Triozon F, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.121410; Tunney MA, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.075406; Wang SD, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.121407; Zolyomi V, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.245403	52	0	0	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	MAY 20	2015	91	19							195426	10.1103/PhysRevB.91.195426		8	Physics, Condensed Matter	Physics	CI7YF	WOS:000354982200004		
J	Yanagihara, H; Kamita, H; Honda, S; Inoue, J; Kita, E; Itoh, H; Mibu, K				Yanagihara, H.; Kamita, H.; Honda, S.; Inoue, J.; Kita, Eiji; Itoh, H.; Mibu, Ko			Antiferromagnetic coupling and impurity effects at junctions between Fe3O4 and Fe(001) layers	PHYSICAL REVIEW B			English	Article							MAGNETIZATION PROCESS; SUPERLATTICES; TRANSITION; INTERFACES; BEHAVIOR; FILMS	We investigated the strong antiferromagnetic (AF) interlayer exchange coupling (IEC) at junctions between Fe(001) and Fe3O4(001) epitaxial films and the effects of an insertion layer of Mn or Co. In addition, we developed a nonlinear least-squares-fit technique to analyze the details of the magnetization processes and to distill the IEC constants. The analyses were performed by taking into account bilinear and biquadratic exchange couplings with a twisted magnetization state. The fitting results suggest the existence of significant distributions in bilinear and/or biquadratic IECs, which can originate from nonuniform stacking of atoms at the interface. The insertion of a Co layer with a thickness in the range of zero to two monolayers between the Fe3O4(001) and the Fe(001) layers significantly affects the magnetic-hysteresis (M-H) processes, whereas the insertion of a Mn layer does not. A quantitative fitting analysis of M-H curves suggests that the inserted thin Mn layer does not affect the AF-IEC significantly, whereas the Co layer suppresses the AF coupling and in fact is preferable for achieving ferromagnetic coupling, which is consistent with the tendency predicted by our theoretical model regarding impurity effects for the IEC of Fe/Fe3O4(001).	[Yanagihara, H.; Kamita, H.; Honda, S.; Inoue, J.; Kita, Eiji] Univ Tsukuba, Inst Appl Phys, Tsukuba, Ibaraki 3058573, Japan; [Itoh, H.] Kansai Univ, Dept Pure & Appl Phys, Suita, Osaka 5648680, Japan; [Mibu, Ko] Nagoya Inst Technol, Grad Sch Engn, Nagoya, Aichi 4668555, Japan	Yanagihara, H (reprint author), Univ Tsukuba, Inst Appl Phys, Tsukuba, Ibaraki 3058573, Japan.	yanagiha@bk.tsukuba.ac.jp	Mibu, Ko/E-2277-2014	Mibu, Ko/0000-0002-6416-1028	Ministry of Education, Culture, Sports, Science, and Technology, Japan	H.Y. thanks S. Mitani for his guidance regarding previous studies on the twisted spin model. Magnetization measurements were performed at the Cryogenic Divisions of the Research Facility Center, University of Tsukuba. This work was supported by the Elements Science and Technology Project of Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Margulies DT, 1997, PHYS REV LETT, V79, P5162, DOI 10.1103/PhysRevLett.79.5162; PARKIN SSP, 1991, PHYS REV LETT, V67, P3598, DOI 10.1103/PhysRevLett.67.3598; FULLERTON EE, 1995, PHYS REV LETT, V75, P330, DOI 10.1103/PhysRevLett.75.330; Nogues J, 1999, J MAGN MAGN MATER, V192, P203, DOI 10.1016/S0304-8853(98)00266-2; Faure-Vincent J, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.107206; Margulies DT, 1996, PHYS REV B, V53, P9175, DOI 10.1103/PhysRevB.53.9175; Wu HC, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2919081; Eerenstein W, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.014428; Ishii H, 1999, ADV MATER, V11, P605, DOI 10.1002/(SICI)1521-4095(199906)11:8<605::AID-ADMA605>3.0.CO;2-Q; Yang JJ, 2008, NAT NANOTECHNOL, V3, P429, DOI 10.1038/nnano.2008.160; Hwang HY, 2012, NAT MATER, V11, P103, DOI [10.1038/nmat3223, 10.1038/NMAT3223]; Katayama T, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2349321; Bland J. A. C., 2005, ULTRATHIN MAGNETIC S; Bland J. A. C., 1994, ULTRATHIN MAGNETIC S; CAMLEY RE, 1988, PHYS REV B, V37, P3413, DOI 10.1103/PhysRevB.37.3413; Coey J. M. D., 2009, MAGNETISM MAGNETIC M, P625; Inoue J, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.184431; Kida T, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.104407; Mibu K., 2012, HYPERFINE INTERACT, V217, P127; MOTOKAWA M, 1990, PROG THEOR PHYS SUPP, P537; MOTOKAWA M, 1991, J PHYS SOC JPN, V60, P1355, DOI 10.1143/JPSJ.60.1355; Orozco A, 1999, PHYS REV LETT, V83, P1680, DOI 10.1103/PhysRevLett.83.1680; Press W.H., 1992, NUMERICAL RECIPES C; Rohrig M., 1991, PHYS STATUS SOLIDI A, V125, P635; Yanagihara H., 2007, J APPL PHYS, V101; Yanagihara H, 2013, J APPL PHYS, V113, DOI 10.1063/1.4795842; Yanagihara H, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.111303; Yanagihara H, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/6/064011	28	0	0	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	MAY 20	2015	91	17							174423	10.1103/PhysRevB.91.174423		6	Physics, Condensed Matter	Physics	CI7YA	WOS:000354981500004		
J	Zhu, TS; Ertekin, E				Zhu, Taishan; Ertekin, Elif			Resolving anomalous strain effects on two-dimensional phonon flows: The cases of graphene, boron nitride, and planar superlattices	PHYSICAL REVIEW B			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; THERMAL-CONDUCTIVITY; CARBON NANOTUBES; HEAT-CONDUCTION; LAYER GRAPHENE; TRANSPORT; SYSTEMS	The physics of thermal transport on strained, two-dimensional (2D) materials graphene, boron nitride, and their superlattices is analyzed by molecular dynamics, lattice dynamics, and numerical solutions to Boltzmann transport equation. The thermal conductivity of thesematerials is found to be highly sensitive to tensile strain, and the strain dependence itself is also highly dependent on the sample total length. Both finite-sized systems (varying from similar to 100 to 300 nm long) as well as infinitely long systems are considered. In contrast to the typical reduction of thermal conductivity with strain exhibited by bulk 3D materials, the thermal conductivity initially increases to a peak value, after which it then decreases with further strain. Modal decomposition of the phonon spectrum shows that the nonmonotonic behavior arises from a competition between in-plane softening and flexural stiffening of phonons. The length sensitivity arises from the nature of the linear/quadratic dispersion of the in-plane/flexural modes and their distinct scattering selection rules: longer systems favor out-of-plane flexural phonon stiffening while smaller systems favor in-plane phonon softening. Additionally, we show that this competition occurs in concert with a strain-induced transition in the nature of the phonon flow from ballistic dominant to diffusive dominant. Overall these effects give rise to a complex dependence of thermal conductivity on strain and sample size.	[Zhu, Taishan; Ertekin, Elif] Univ Illinois, Dept Mech Sci & Engn, Urbana, IL 61820 USA; [Ertekin, Elif] Kyushu Univ, Int Inst Carbon Neutral Energy Res WPI I2CNER, Nishi Ku, Fukuoka 8190395, Japan	Ertekin, E (reprint author), Univ Illinois, Dept Mech Sci & Engn, Urbana, IL 61820 USA.	ertekin@illinois.edu			National Science Foundation [CBET-1250192, OCI-0725070, ACI-1238993, ACI-1053575]; state of Illinois; Illinois Campus Computing Cluster	We are grateful to D. Donadio for valuable and insightful discussions. We also acknowledge A. Chernatynskiy for valuable discussions regarding the BTE calculations. This work is supported by the National Science Foundation through Grant No. CBET-1250192. Various computational resources were used in this work: this research is part of the Blue Waters sustained-petascale computing project, which is supported by the National Science Foundation (Grants No. OCI-0725070 and No. ACI-1238993) and the state of Illinois. Blue Waters is a joint effort of the University of Illinois at Urbana-Champaign and its National Center for Supercomputing Applications. Additional resources were provided by (i) the Extreme Science and Engineering Discovery Environment (XSEDE) allocation DMR-140007, which is supported by National Science Foundation Grant No. ACI-1053575, and (ii) the Illinois Campus Computing Cluster.	Lindsay L, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.205441; Hu M, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.195417; Balandin AA, 2011, NAT MATER, V10, P569, DOI [10.1038/nmat3064, 10.1038/NMAT3064]; Pereira LFC, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.125424; Wei N, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/10/105705; Hu L, 2011, J APPL PHYS, V110, DOI 10.1063/1.3660234; Balandin AA, 2012, MATER TODAY, V15, P266, DOI 10.1016/S1369-7021(12)70117-7; Bonini N, 2012, NANO LETT, V12, P2673, DOI 10.1021/nl202694m; McGaughey AJH, 2004, INT J HEAT MASS TRAN, V47, P1783, DOI 10.1016/j.ijheatmasstransfer.2003.11.002; Shiomi J, 2008, JPN J APPL PHYS, V47, P2005, DOI 10.1143/JJAP.47.2005; Li XB, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.245318; Salaway RN, 2014, INT J HEAT MASS TRAN, V70, P954, DOI 10.1016/j.ijheatmasstransfer.2013.11.065; Ghosh S, 2010, NAT MATER, V9, P555, DOI [10.1038/nmat2753, 10.1038/NMAT2753]; TERSOFF J, 1988, PHYS REV B, V37, P6991, DOI 10.1103/PhysRevB.37.6991; Pei QX, 2013, J APPL PHYS, V114, DOI 10.1063/1.4815960; Nika DL, 2012, NANO LETT, V12, P3238, DOI 10.1021/nl301230g; Wolfing B, 2001, PHYS REV LETT, V86, P4350, DOI 10.1103/PhysRevLett.86.4350; TERSOFF J, 1989, PHYS REV B, V39, P5566, DOI 10.1103/PhysRevB.39.5566; Lindsay L, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.155421; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; IKESHOJI T, 1994, MOL PHYS, V81, P251, DOI 10.1080/00268979400100171; Gale JD, 2003, MOL SIMULAT, V29, P291, DOI 10.1080/0892702031000104887; Bird G. A., 1994, MOL GAS DYNAMICS DIR; Bonaccorso F., 2015, SCIENCE, V347, P6217; Chernatynskiy A, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.134301; Park M, 2013, J APPL PHYS, V114, DOI 10.1063/1.4817175; Parrish KD, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.235201; Xu XF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4689; Zhai XC, 2011, EPL-EUROPHYS LETT, V96, DOI 10.1209/0295-5075/96/16002; Zhu TS, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.195209; Zhu TS, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.036308; Zhu TS, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.056316	32	1	1	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	MAY 20	2015	91	20							205429	10.1103/PhysRevB.91.205429		8	Physics, Condensed Matter	Physics	CI7YG	WOS:000354982300007		
J	Diriken, J; Patronis, N; Andreyev, A; Antalic, S; Bildstein, V; Blazhev, A; Darby, IG; De Witte, H; Eberth, J; Elseviers, J; Fedosseev, VN; Flavigny, F; Fransen, C; Georgiev, G; Gernhauser, R; Hess, H; Huyse, M; Jolie, J; Kroll, T; Krucken, R; Lutter, R; Marsh, BA; Mertzimekis, T; Muecher, D; Orlandi, R; Pakou, A; Raabe, R; Randisi, G; Reiter, P; Roger, T; Seidlitz, M; Seliverstov, M; Sotty, C; Tornqvist, H; Van De Walle, J; Van Duppen, P; Voulot, D; Warr, N; Wenander, F; Wimmer, K				Diriken, J.; Patronis, N.; Andreyev, A.; Antalic, S.; Bildstein, V.; Blazhev, A.; Darby, I. G.; De Witte, H.; Eberth, J.; Elseviers, J.; Fedosseev, V. N.; Flavigny, F.; Fransen, Ch.; Georgiev, G.; Gernhauser, R.; Hess, H.; Huyse, M.; Jolie, J.; Kroell, Th.; Kruecken, R.; Lutter, R.; Marsh, B. A.; Mertzimekis, T.; Muecher, D.; Orlandi, R.; Pakou, A.; Raabe, R.; Randisi, G.; Reiter, P.; Roger, T.; Seidlitz, M.; Seliverstov, M.; Sotty, C.; Tornqvist, H.; Van De Walle, J.; Van Duppen, P.; Voulot, D.; Warr, N.; Wenander, F.; Wimmer, K.			Experimental study of the Ni-66(d, p) Ni-67 one-neutron transfer reaction	PHYSICAL REVIEW C			English	Article							SHELL-MODEL CALCULATIONS; PROTON-HOLE STATES; NUCLEAR-STRUCTURE; NICKEL ISOTOPES; REX-ISOLDE; ELASTIC-SCATTERING; EXOTIC NUCLEI; NI-ISOTOPES; RICH NUCLEI; DECAY	The quasi-SU(3) sequence of the positive parity nu g(9/2), d(5/2), s(1/2) orbitals above the N = 40 shell gap are assumed to induce strong quadrupole collectivity in the neutron-rich Fe (Z = 26) and Cr (Z = 24) isotopes below the nickel region. In this paper the position and strength of these single-particle orbitals are characterized in the neighborhood of Ni-68 (Z = 28, N = 40) through the Ni-66(d, p)Ni-67 one-neutron transfer reaction at 2.95 MeV/nucleon in inverse kinematics, performed at the REX-ISOLDE facility in CERN. A combination of the Miniball gamma-array and T-REX particle-detection setup was used and a delayed coincidence technique was employed to investigate the 13.3-mu s isomer at 1007 keV in Ni-67. Excited states up to an excitation energy of 5.8MeV have been populated. Feeding of the nu g(9/2) (1007 keV) and nu d(5/2) (2207 keV and 3277 keV) positive-parity neutron states and negative parity (nu pf) states have been observed at low excitation energy. The extracted relative spectroscopic factors, based on a distorted-wave Born approximation analysis, show that the d(5/2) single-particle strength is mostly split over these two excited states. The results are also compared to the distribution of the proton single-particle strength in the 90Zr region (Z = 40, N = 50).	[Diriken, J.; Patronis, N.; Andreyev, A.; Darby, I. G.; De Witte, H.; Elseviers, J.; Flavigny, F.; Huyse, M.; Orlandi, R.; Raabe, R.; Randisi, G.; Roger, T.; Seliverstov, M.; Van Duppen, P.] Katholieke Univ Leuven, Inst Kern & Stralingsfys, B-3001 Louvain, Belgium; [Diriken, J.] Belgian Nucl Res Ctr SCK CEN, B-2400 Mol, Belgium; [Patronis, N.; Pakou, A.] Univ Ioannina, Dept Phys, GR-45110 Ioannina, Greece; [Patronis, N.; Pakou, A.] Univ Ioannina, HINP, GR-45110 Ioannina, Greece; [Andreyev, A.] Univ York, Dept Phys, York YO10 5DD, N Yorkshire, England; [Andreyev, A.; Orlandi, R.] Japan Atom Energy Agcy, Adv Sci Res Ctr, Tokai, Ibaraki 3191195, Japan; [Antalic, S.] Comenius Univ, Dept Nucl Phys & Biophys, Bratislava 84248, Slovakia; [Bildstein, V.; Gernhauser, R.; Kroell, Th.; Kruecken, R.; Muecher, D.; Wimmer, K.] Tech Univ Munich, Phys Dept E12, D-85748 Garching, Germany; [Blazhev, A.; Eberth, J.; Fransen, Ch.; Hess, H.; Jolie, J.; Reiter, P.; Seidlitz, M.; Warr, N.] Univ Cologne, IKP, D-50937 Cologne, Germany; [Fedosseev, V. N.; Marsh, B. A.; Seliverstov, M.; Voulot, D.; Wenander, F.] CERN, AB Dept, CH-1211 Geneva 23, Switzerland; [Georgiev, G.; Sotty, C.] Univ Paris 11, UMR8609, CNRS IN2P3, CSNSM, F-91405 Orsay, France; [Lutter, R.] Univ Munich, Fak Phys, D-85748 Garching, Germany; [Mertzimekis, T.] NCSR Demokritos, INP, GR-15310 Ag Paraskevi Athens, Greece; [Orlandi, R.] Univ West Scotland, Sch Engn, Paisley PA1 2BE, Renfrew, Scotland; [Orlandi, R.] Scottish Univ Phys Alliance, Edinburgh, Midlothian, Scotland; [Tornqvist, H.; Van De Walle, J.] CERN, PH Dept, CH-1211 Geneva 23, Switzerland	Diriken, J (reprint author), Katholieke Univ Leuven, Inst Kern & Stralingsfys, Celestijnenlaan 200D, B-3001 Louvain, Belgium.		Mertzimekis, Theo/A-3287-2008	Mertzimekis, Theo/0000-0001-9191-7903	FWO (Fonds Wetenschappelijk Onderzoek - Vlaanderen) (Belgium) [GOA/2010/010]; Interuniversity Attraction Poles Programme initiated by the Belgian Science Policy Office [P7/12]; European Commission [RII3-CT-2010-262010]; European Research Council [ERC-2011-AdG-291561-HELIOS]; Slovak Research and Development Agency [APVV-0105-10]; BMBF [06KY9136I, 05P12PKFNE, 06MT7178, 06MT9156]; Maier-Leibnitz-Laboratorium, Garching	This work was funded by FWO (Fonds Wetenschappelijk Onderzoek - Vlaanderen) (Belgium), GOA/2010/010 (BOF KU Leuven), the Interuniversity Attraction Poles Programme initiated by the Belgian Science Policy Office (BriX network P7/12), the European Commission within the Seventh Framework Programme through I3-ENSAR (Contract No. RII3-CT-2010-262010), the European Research Council (Grant No. ERC-2011-AdG-291561-HELIOS), the Slovak Research and Development Agency (Grant No. APVV-0105-10), BMBF under Contracts No. 06KY9136I, No. 05P12PKFNE, No. 06MT7178, and No. 06MT9156, and the Maier-Leibnitz-Laboratorium, Garching.	ANFINSEN TR, 1970, NUCL PHYS A, VA157, P561, DOI 10.1016/0375-9474(70)90233-2; Ferrer R, 2010, PHYS REV C, V81, DOI 10.1103/PhysRevC.81.044318; Agostinelli S, 2003, NUCL INSTRUM METH A, V506, P250, DOI 10.1016/S0168-9002(03)01368-8; Otsuka T, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.032501; STERNGLASS EJ, 1957, PHYS REV, V108, P1, DOI 10.1103/PhysRev.108.1; An HX, 2006, PHYS REV C, V73, DOI 10.1103/PhysRevC.73.054605; THOMPSON IJ, 1988, COMPUT PHYS REP, V7, P167, DOI 10.1016/0167-7977(88)90005-6; Daugas JM, 2011, PHYS REV C, V83, DOI 10.1103/PhysRevC.83.054312; Otsuka T, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.232502; GIROD M, 1988, PHYS REV C, V37, P2600, DOI 10.1103/PhysRevC.37.2600; Lenzi SM, 2010, PHYS REV C, V82, DOI 10.1103/PhysRevC.82.054301; Schiffer JP, 2013, PHYS REV C, V87, DOI 10.1103/PhysRevC.87.034306; Recchia F, 2012, PHYS REV C, V85, DOI 10.1103/PhysRevC.85.064305; Koning AJ, 2003, NUCL PHYS A, V713, P231, DOI 10.1016/S0375-9474(02)01321-0; Rahaman S, 2007, EUR PHYS J A, V34, P5, DOI 10.1140/epja/i2007-10489-y; MILLENER DJ, 1982, PHYS REV C, V26, P1167, DOI 10.1103/PhysRevC.26.1167; BRODA R, 1995, PHYS REV LETT, V74, P868, DOI 10.1103/PhysRevLett.74.868; Timofeyuk NK, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.112501; LI PC, 1987, NUCL PHYS A, V469, P393, DOI 10.1016/0375-9474(87)90028-5; Ljungvall J, 2010, PHYS REV C, V81, DOI 10.1103/PhysRevC.81.061301; Li XH, 2008, NUCL PHYS A, V801, P43, DOI 10.1016/j.nuclphysa.2007.12.004; Baugher T, 2012, PHYS REV C, V86, DOI 10.1103/PhysRevC.86.011305; Grzywacz R, 1998, PHYS REV LETT, V81, P766, DOI 10.1103/PhysRevLett.81.766; Caurier E, 2002, EUR PHYS J A, V15, P145, DOI 10.1140/epja/i2001-10243-7; Sieja K, 2012, PHYS REV C, V85, DOI 10.1103/PhysRevC.85.051301; MACFARLANE MH, 1960, REV MOD PHYS, V32, P567, DOI 10.1103/RevModPhys.32.567; Ames F, 2005, NUCL INSTRUM METH A, V538, P17, DOI 10.1016/j.nima.2004.08.119; Schiffer JP, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.022501; Sorlin O, 2003, EUR PHYS J A, V16, P55, DOI 10.1140/epja/i2002-10069-9; Wang M, 2012, CHINESE PHYS C, V36, P1603, DOI 10.1088/1674-1137/36/12/003; Crawford HL, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.242701; Hannawald M, 1999, PHYS REV LETT, V82, P1391, DOI 10.1103/PhysRevLett.82.1391; MEDSKER LR, 1975, PHYS REV C, V12, P1516, DOI 10.1103/PhysRevC.12.1516; Fedoseyev VN, 2000, HYPERFINE INTERACT, V127, P409, DOI 10.1023/A:1012609515865; Bildstein V, 2012, EUR PHYS J A, V48, DOI 10.1140/epja/i2012-12085-6; CHOWDHUR.MS, 1973, NUCL PHYS A, VA205, P454, DOI 10.1016/0375-9474(73)90699-4; COSMAN ER, 1967, PHYS REV, V163, P1134, DOI 10.1103/PhysRev.163.1134; Diriken J, 2014, PHYS LETT B, V736, P533, DOI 10.1016/j.physletb.2014.08.004; Duflo J, 1999, PHYS REV C, V59, pR2347, DOI 10.1103/PhysRevC.59.R2347; Eberth J, 2003, AIP CONF PROC, V656, P349; Endt P. M., 1979, Atomic Data and Nuclear Data Tables, V23, DOI 10.1016/0092-640X(79)90020-2; Fransen C, 2011, J PHYS CONF SER, V312, DOI 10.1088/1742-6596/312/9/092025; FULMER RH, 1964, PHYS REV B, V133, pB955, DOI 10.1103/PhysRev.133.B955; FULMER RH, 1963, PHYS REV, V131, P2133, DOI 10.1103/PhysRev.131.2133; Gade A, 2010, PHYS REV C, V81, DOI 10.1103/PhysRevC.81.051304; Georgiev G, 2002, J PHYS G NUCL PARTIC, V28, P2993, DOI 10.1088/0954-3899/28/12/308; Han YL, 2006, PHYS REV C, V74, DOI 10.1103/PhysRevC.74.044615; HARDER A, 1993, Z PHYS A-HADRON NUCL, V345, P143, DOI 10.1007/BF01293337; Hoteling N, 2010, PHYS REV C, V82, DOI 10.1103/PhysRevC.82.044305; HUTTLIN GA, 1974, NUCL PHYS A, VA227, P389, DOI 10.1016/0375-9474(74)90766-0; JI XD, 1989, PHYS REV C, V40, P389, DOI 10.1103/PhysRevC.40.389; JOHNSON NR, 1956, PHYS REV, V102, P831, DOI 10.1103/PhysRev.102.831; Jokinen A, 1997, NUCL INSTRUM METH B, V126, P95, DOI 10.1016/S0168-583X(97)01078-1; KNOPFLE KT, 1970, NUCL PHYS A, VA159, P642, DOI 10.1016/0375-9474(70)90863-8; KOUZES RT, 1978, PHYS REV C, V18, P1587, DOI 10.1103/PhysRevC.18.1587; LOHR JM, 1974, NUCL PHYS A, VA232, P381, DOI 10.1016/0375-9474(74)90627-7; Lunardi S, 2007, PHYS REV C, V76, DOI 10.1103/PhysRevC.76.034303; Mach H, 2003, NUCL PHYS A, V719, p213C, DOI 10.1016/S0375-9474(03)00920-5; MIYAHARA H, 1993, NUCL INSTRUM METH A, V324, P219, DOI 10.1016/0168-9002(93)90979-R; Morillon B, 2007, PHYS REV C, V76, DOI 10.1103/PhysRevC.76.044601; Mukhamedzhanov AM, 2005, PHYS REV C, V72, DOI 10.1103/PhysRevC.72.017602; Nguyen NB, 2010, PHYS REV C, V82, DOI 10.1103/PhysRevC.82.014611; PAWLAT T, 1994, NUCL PHYS A, V574, P623, DOI 10.1016/0375-9474(94)90247-X; PEREY FG, 1963, PHYS REV, V131, P745, DOI 10.1103/PhysRev.131.745; Perru O, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.232501; Poves A, 2012, PHYS SCRIPTA, VT150, DOI 10.1088/0031-8949/2012/T150/014030; Rao R, 1999, NUCL INSTRUM METH A, V427, P170, DOI 10.1016/S0168-9002(98)01562-9; Rikovska J, 2000, PHYS REV LETT, V85, P1392, DOI 10.1103/PhysRevLett.85.1392; Rother W, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.022502; RUNTE E, 1985, NUCL PHYS A, V441, P237, DOI 10.1016/0375-9474(85)90032-6; Sawicka M, 2003, EUR PHYS J A, V16, P51, DOI 10.1140/epja/i2002-10073-1; SEEGER M, 1991, NUCL PHYS A, V533, P1, DOI 10.1016/0375-9474(91)90817-P; SEEGER M, 1992, NUCL PHYS A, V539, P223, DOI 10.1016/0375-9474(92)90268-O; Sieber T., 2002, NUCL PHYS A, V701, P656, DOI 10.1016/S0375-9474(01)01662-1; Sorlin O, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.092501; TURKIEWI.IM, 1970, NUCL PHYS A, VA143, P641, DOI 10.1016/0375-9474(70)90553-1; Van de Walle J, 2009, EUR PHYS J A, V42, P401, DOI 10.1140/epja/i2009-10814-6; VOURVOPO.G, 1971, NUCL PHYS A, VA174, P581, DOI 10.1016/0375-9474(71)90407-6; Warr N, 2013, EUR PHYS J A, V49, DOI 10.1140/epja/i2013-13040-9; Weissman L, 1999, PHYS REV C, V59, P2004, DOI 10.1103/PhysRevC.59.2004; WESOLOWSKI E, 1991, J PHYS G NUCL PARTIC, V17, P955, DOI 10.1088/0954-3899/17/6/016; Zhu S, 2012, PHYS REV C, V85, DOI 10.1103/PhysRevC.85.034336; ZUKER AP, 1995, PHYS REV C, V52, pR1741	83	0	0	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0556-2813	1089-490X		PHYS REV C	Phys. Rev. C	MAY 20	2015	91	5							054321	10.1103/PhysRevC.91.054321		15	Physics, Nuclear	Physics	CI7YJ	WOS:000354982800002		
J	Kanazawa, T; Yamamoto, N				Kanazawa, Takuya; Yamamoto, Naoki			Quasi-instantons in QCD with chiral symmetry restoration	PHYSICAL REVIEW D			English	Article							HIGH-TEMPERATURE PHASE; U(1)(A) SYMMETRY	We show, without using semiclassical approximations, that, in high-temperature QCD with chiral symmetry restoration and U(1)(A) symmetry breaking, the partition function for sufficiently light quarks can be expressed as an ensemble of noninteracting objects with topological charge that obey the Poisson statistics. We argue that the topological objects are "quasi-instantons" (rather than bare instantons) taking into account quantum effects. Our result is valid even close to the (pseudo) critical temperature of the chiral phase transition.	[Kanazawa, Takuya] RIKEN, iTHES Res Grp, Wako, Saitama 3510198, Japan; [Kanazawa, Takuya] RIKEN, Quantum Hadron Phys Lab, Wako, Saitama 3510198, Japan; [Yamamoto, Naoki] Keio Univ, Dept Phys, Yokohama, Kanagawa 2238522, Japan	Kanazawa, T (reprint author), RIKEN, iTHES Res Grp, Wako, Saitama 3510198, Japan.				RIKEN iTHES Project; JSPS KAKENHI [25887014, 26887032]	The authors thank S. Aoki, H. Fukaya, M. Laine, M. I. Buchoff, and N. H. Christ for useful discussions and correspondences. They are also grateful to the hospitality of the Central China Normal University during the workshop "High Energy Strong Interactions: A School for Young Asian Scientists," where part of this work has been carried out. This work was supported by the RIKEN iTHES Project, and JSPS KAKENHI Grants No. 25887014 and No. 26887032.	GROSS DJ, 1981, REV MOD PHYS, V53, P43, DOI 10.1103/RevModPhys.53.43; Buchoff MI, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.054514; VENEZIANO G, 1979, NUCL PHYS B, V159, P213, DOI 10.1016/0550-3213(79)90332-8; Edwards RG, 2000, PHYS REV D, V61, DOI 10.1103/PhysRevD.61.074504; Aoki S, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.114512; Cossu G, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.114514; Schafer T, 1998, REV MOD PHYS, V70, P323, DOI 10.1103/RevModPhys.70.323; 't Hooft G., 1986, PHYS REP, V142, P357; Bonati C, 2015, J HIGH ENERGY PHYS, DOI 10.1007/JHEP03(2015)006; Bonati C, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.252003; Cohen TD, 1996, PHYS REV D, V54, pR1867; Dunne GV, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.065014; Evans N, 1996, PHYS LETT B, V375, P262, DOI 10.1016/0370-2693(96)00280-8; Kanazawa T., IN PRESS; KHOZE VV, 1991, Z PHYS C PART FIELDS, V50, P155, DOI 10.1007/BF01558571; Laine M, 2004, J HIGH ENERGY PHYS; LANDAU LD, 1959, SOV PHYS JETP-USSR, V8, P70; Lee SH, 1996, PHYS REV D, V54, pR1871; LEUTWYLER H, 1992, PHYS REV D, V46, P5607, DOI 10.1103/PhysRevD.46.5607; Schafer T, 2002, PHYS REV D, V65, DOI 10.1103/PhysRevD.65.094033; Shuryak E., 1994, Comments on Nuclear and Particle Physics, V21; Son DT, 2001, PHYS LETT B, V510, P167, DOI 10.1016/S0370-2693(01)00607-4; t Hooft G., 1978, PHYS REV D, V18, P2199, DOI DOI 10.1103/PHYSREVD.14.3432; Yamamoto N, 2008, J HIGH ENERGY PHYS	24	2	2	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1550-7998	1550-2368		PHYS REV D	Phys. Rev. D	MAY 20	2015	91	10							105015	10.1103/PhysRevD.91.105015		5	Astronomy & Astrophysics; Physics, Particles & Fields	Astronomy & Astrophysics; Physics	CI7YO	WOS:000354983300009		
J	Chilukoti, HK; Kikugawa, G; Shibahara, M; Ohara, T				Chilukoti, Hari Krishna; Kikugawa, Gota; Shibahara, Masahiko; Ohara, Taku			Local thermal transport of liquid alkanes in the vicinity of alpha-quartz solid surfaces and thermal resistance over the interfaces: A molecular dynamics study	PHYSICAL REVIEW E			English	Article							INTERMOLECULAR ENERGY-TRANSFER; HEAT-CONDUCTION; SIMULATION; FLUIDS; EQUILIBRIA; DEPENDENCE	Thermal transport in liquid n-alkanes in the vicinity of alpha-quartz substrates and thermal boundary resistance between the liquid n-alkanes and the alpha-quartz substrates have been investigated using nonequilibrium molecular dynamics simulations. The study considers two liquid alkanes, methane and decane, and three crystal orientations of a-quartz substrate terminated with -H or -OH groups. The local thermal conductivity (LTC), defined in the same manner as with macroscopic thermal conductivity, is used to measure the efficiency of thermal energy transport of the liquids in the vicinity of the solid surface. The variations in the LTC of the liquid alkanes in the layered region next to the surface of the substrate were examined. The modeled LTC values of the alkanes were found to oscillate in the solid-liquid interface region. These fluctuations were typically proportional to the oscillations in the local density profile. The correlation between the thermal conductivity and density was linear in the bulk liquid region. The correlation between LTC and local density in the first adsorption layer is not a straightforward extension of that of the bulk liquid, which is mostly due to the specific molecular-scale ordering structure that occurs in the liquids formed by the proximity of the solid substrate. Thermal boundary resistance between the liquid alkanes and the quartz substrate was also evaluated. It was observed that thermal boundary resistance is relatively large when the in-plane molecular-scale structure in the first adsorption layer is sparse, and is lower when the liquid structure is dense in the adsorption layer.	[Chilukoti, Hari Krishna; Kikugawa, Gota; Ohara, Taku] Tohoku Univ, Inst Fluid Sci, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Shibahara, Masahiko] Osaka Univ, Dept Mech Engn, Suita, Osaka 5650871, Japan	Chilukoti, HK (reprint author), Tohoku Univ, Inst Fluid Sci, Mol Heat Transfer Lab, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	chilukoti@microheat.ifs.tohoku.ac.jp			Japan Society for the Promotion of Science (JSPS);  [24560218]	The work reported in this paper was partially supported by a Grant-in-Aid for Scientific Research (Grant No. 24560218) and the Global COE Program "World Center of Education and Research for Trans-Disciplinary Flow Dynamics" by the Japan Society for the Promotion of Science (JSPS). Numerical simulations were performed on the SGI Altix UV1000 and UV2000 at the Advanced Fluid Information Research Center, Institute of Fluid Science, Tohoku University.	Cahill DG, 2003, J APPL PHYS, V93, P793, DOI 10.1063/1.1524305; Kuwahara M, 2008, MICROELECTRON ENG, V85, P796, DOI 10.1016/j.mee.2007.12.053; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Ohara T, 2000, MICROSCALE THERM ENG, V4, P189; Lopes PEM, 2006, J PHYS CHEM B, V110, P2782, DOI 10.1021/jp055341j; Xue L, 2003, J CHEM PHYS, V118, P337, DOI 10.1063/1.1525806; Liu C, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3327931; Zhang MM, 2005, J PHYS CHEM B, V109, P15060, DOI 10.1021/jp0512255; Kikugawa G, 2014, INT J HEAT MASS TRAN, V78, P630, DOI 10.1016/j.ijheatmasstransfer.2014.07.040; Shenogina N, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.156101; Nakano T, 2013, J HEAT TRANS-T ASME, V135, DOI 10.1115/1.4023572; BITSANIS I, 1987, J CHEM PHYS, V87, P1733, DOI 10.1063/1.453240; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; Chilukoti HK, 2013, INT J HEAT MASS TRAN, V59, P144, DOI 10.1016/j.ijheatmasstransfer.2012.12.015; Nath SK, 1998, J CHEM PHYS, V108, P9905, DOI 10.1063/1.476429; Eslami H, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3623471; Zhou XW, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.115201; Bhatia SK, 2011, PHYS CHEM CHEM PHYS, V13, P15350, DOI 10.1039/c1cp21166h; VANDERLICK TK, 1989, J CHEM PHYS, V90, P2422, DOI 10.1063/1.455985; Xue L, 2004, INT J HEAT MASS TRAN, V47, P4277, DOI [10.1016/j.ijheatmasstransfer.2004.05.016, 10.1016/ijheatmasstransfer.2004.05.016]; SWARTZ ET, 1989, REV MOD PHYS, V61, P605, DOI 10.1103/RevModPhys.61.605; Martin MG, 1998, J PHYS CHEM B, V102, P2569, DOI 10.1021/jp972543+; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Wang SAC, 2010, INT J THERMOPHYS, V31, P1935, DOI 10.1007/s10765-008-0523-9; Torii D, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2821963; Torii D, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2719699; Keblinski P, 2005, MATER TODAY, V8, P36, DOI 10.1016/S1369-7021(05)70936-6; Kim BH, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3001926; Cui ST, 1999, J CHEM PHYS, V111, P1273, DOI 10.1063/1.479312; Patel HA, 2005, NANO LETT, V5, P2225, DOI 10.1021/nl051526q; Hu M, 2010, NANO LETT, V10, P279, DOI 10.1021/nl9034658; TODD BD, 1995, PHYS REV E, V51, P4362, DOI 10.1103/PhysRevE.51.4362; Barisik M, 2012, J COMPUT PHYS, V231, P7881, DOI 10.1016/j.jcp.2012.07.026; Barisik M, 2014, INT J THERM SCI, V77, P47, DOI 10.1016/j.ijthermalsci.2013.10.012; Ge ZB, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.186101; Haneda J., UNPUB; Hoang H, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.021202; Kikugawa G, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3077315; Kikugawa G, 2014, J HEAT TRANS-T ASME, V136, DOI 10.1115/1.4027910; Liang Z, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.041602; Liang Z, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.061603; Linstrom P. J., 2014, NIST CHEM WEBBOOK; Maruyama S., 1999, THERMAL SCI ENG, V7, P63; Murad S, 2008, CHEM PHYS LETT, V467, P110, DOI 10.1016/j.cplett.2008.10.068; Murad S, 2009, CHEM PHYS LETT, V476, P267, DOI 10.1016/j.cplett.2009.06.056; Murad S, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2905281; Nath SK, 2001, J CHEM PHYS, V115, P10837, DOI 10.1063/1.1418731; Ohara T, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3613648; Ohara T, 1999, J CHEM PHYS, V111, P9667, DOI 10.1063/1.480338; POZHAR LA, 1993, J CHEM PHYS, V99, P8970, DOI 10.1063/1.465567; Shi ZY, 2012, INT J THERM SCI, V59, P29, DOI 10.1016/j.ijthermalsci.2012.04.009; Torii D., 2009, J HEAT TRANSFER, V132	52	0	0	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1539-3755	1550-2376		PHYS REV E	Phys. Rev. E	MAY 20	2015	91	5							052404	10.1103/PhysRevE.91.052404		9	Physics, Fluids & Plasmas; Physics, Mathematical	Physics	CI7YR	WOS:000354983600002		
J	Sakaguchi, H; Okamura, K				Sakaguchi, Hidetsugu; Okamura, Kazuki			Aftershocks and Omori's law in a modified Carlson-Langer model with nonlinear viscoelasticity	PHYSICAL REVIEW E			English	Article							EARTHQUAKES; CRITICALITY; DYNAMICS	A modified Carlson-Langer model for earthquakes is proposed, which includes nonlinear viscoelasticity. Several aftershocks are generated after the main shock owing to the damping of the additional viscoelastic force. Both the Gutenberg-Richter law and Omori's law are reproduced in a numerical simulation of the modified Carlson-Langer model on a critical percolation cluster of a square lattice.	[Sakaguchi, Hidetsugu; Okamura, Kazuki] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Dept Appl Sci Elect & Mat, Kasuga, Fukuoka 8168580, Japan	Sakaguchi, H (reprint author), Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Dept Appl Sci Elect & Mat, Kasuga, Fukuoka 8168580, Japan.						BAK P, 1989, J GEOPHYS RES-SOLID, V94, P15635, DOI 10.1029/JB094iB11p15635; CARLSON JM, 1989, PHYS REV LETT, V62, P2632, DOI 10.1103/PhysRevLett.62.2632; BURRIDGE R, 1967, B SEISMOL SOC AM, V57, P341; OLAMI Z, 1992, PHYS REV LETT, V68, P1244, DOI 10.1103/PhysRevLett.68.1244; Jagla EA, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.174301; DeRubeis V, 1996, PHYS REV LETT, V76, P2599, DOI 10.1103/PhysRevLett.76.2599; DIETERIC.JH, 1972, J GEOPHYS RES, V77, P3690, DOI 10.1029/JB077i020p03690; Gutenberg B., 1954, SEISMICITY EARTH REL; Hainzl S, 1999, J GEOPHYS RES-SOL EA, V104, P7243, DOI 10.1029/1998JB900122; Ito K., 1990, J GEOPHYS RES, V95, P6835; Jagla EA, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.042129; Omori F., 1894, J COLL SCI IMP U TOK, V7, P111; Sakaguchi H, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.114006; Utsu T., 1961, GEOPHYS MAG, V30, P521, DOI DOI 10.1007/BF01592930; VIEIRA MD, 1993, PHYS REV E, V47, pR2221	15	0	0	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1539-3755	1550-2376		PHYS REV E	Phys. Rev. E	MAY 20	2015	91	5							052914	10.1103/PhysRevE.91.052914		6	Physics, Fluids & Plasmas; Physics, Mathematical	Physics	CI7YR	WOS:000354983600005		
J	Gonzalez, EB; Aritaki, M; Knutsen, H; Taniguchi, N				Gonzalez, Enrique Blanco; Aritaki, Masato; Knutsen, Halvor; Taniguchi, Nobuhiko			Effects of Large-Scale Releases on the Genetic Structure of Red Sea Bream (Pagrus major, Temminck et Schlegel) Populations in Japan	PLOS ONE			English	Article							STOCK ENHANCEMENT PROGRAMS; MULTILOCUS GENOTYPE DATA; FALSE DISCOVERY RATE; SETO INLAND SEA; LINKAGE DISEQUILIBRIUM; ACANTHOPAGRUS-SCHLEGELII; MATURITY CLASSIFICATION; PARALICHTHYS-OLIVACEUS; MITOCHONDRIAL-DNA; ANADROMOUS FISHES	Large-scale hatchery releases are carried out for many marine fish species worldwide; nevertheless, the long-term effects of this practice on the genetic structure of natural populations remains unclear. The lack of knowledge is especially evident when independent stock enhancement programs are conducted simultaneously on the same species at different geographical locations, as occurs with red sea bream (Pagrus major, Temminck et Schlegel) in Japan. In this study, we examined the putative effects of intensive offspring releases on the genetic structure of red sea bream populations along the Japanese archipelago by genotyping 848 fish at fifteen microsatellite loci. Our results suggests weak but consistent patterns of genetic divergence (F-ST = 0.002, p < 0.001). Red sea bream in Japan appeared spatially structured with several patches of distinct allelic composition, which corresponded to areas receiving an important influx of fish of hatchery origin, either released intentionally or from unintentional escapees from aquaculture operations. In addition to impacts upon local populations inhabiting semi-enclosed embayments, large-scale releases (either intentionally or from unintentional escapes) appeared also to have perturbed genetic structure in open areas. Hence, results of the present study suggest that independent large-scale marine stock enhancement programs conducted simultaneously on one species at different geographical locations may compromise native genetic structure and lead to patchy patterns in population genetic structure.	[Gonzalez, Enrique Blanco; Taniguchi, Nobuhiko] Fukuyama Univ, Res Inst Marine Bioresources, Onomichi 7222101, Japan; [Gonzalez, Enrique Blanco; Knutsen, Halvor] Univ Agder, N-4604 Kristiansand, Norway; [Gonzalez, Enrique Blanco; Knutsen, Halvor] Inst Marine Res, N-4817 His, Norway; [Aritaki, Masato] Fisheries Res Agcy, Seikai Natl Fisheries Res Inst, Coastal Fisheries & Aquaculture Div, Nagasaki 8512213, Japan; [Knutsen, Halvor] Univ Oslo, Dept Biosci, Ctr Ecol & Evolutionary Synth, N-0316 Oslo, Norway	Gonzalez, EB (reprint author), Fukuyama Univ, Res Inst Marine Bioresources, Onomichi 7222101, Japan.	enrique.blanco@uia.no	Knutsen, Halvor/A-4261-2009	Knutsen, Halvor/0000-0002-7627-7634	Japan Society for the Promotion of Science (JSPS) [18380111]; Ministry of Agriculture, Forestry, and Fisheries, Japan	This study was supported by a Grant-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science (JSPS) to Nobuhiko Taniguchi (No. 18380111) and was conducted as part of the research project "Research and Development Projects for Application in Promoting New Policy of Agriculture, Forestry, and Fisheries", funded by the Ministry of Agriculture, Forestry, and Fisheries, Japan.	Ab Ghani NI, 2012, BIOL J LINN SOC, V107, P521, DOI 10.1111/j.1095-8312.2012.01956.x; Araki H, 2007, SCIENCE, V318, P100, DOI 10.1126/science.1145621; DeWoody JA, 2000, J FISH BIOL, V56, P461, DOI 10.1006/jfbi.1999.1210; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Isobe A, 2012, OCEAN DYNAM, V62, P633, DOI 10.1007/s10236-011-0519-z; Waples RS, 2010, EVOL APPL, V3, P244, DOI 10.1111/j.1752-4571.2009.00104.x; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Hilborn R, 2003, P NATL ACAD SCI USA, V100, P6564, DOI 10.1073/pnas.1037274100; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Waples RS, 2006, CONSERV GENET, V7, P167, DOI 10.1007/s10592-005-9100-y; Pritchard JK, 2000, GENETICS, V155, P945; Fraser DJ, 2008, EVOL APPL, V1, P535, DOI 10.1111/j.1752-4571.2008.00036.x; Hansen MM, 2009, MOL ECOL, V18, P2549, DOI 10.1111/j.1365-294X.2009.04198.x; HINDAR K, 1991, CAN J FISH AQUAT SCI, V48, P945, DOI 10.1139/f91-111; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; MATSUYAMA M, 1987, MAR BIOL, V96, P163, DOI 10.1007/BF00427015; Ogoh K, 2005, MOL BIOL EVOL, V22, P1543, DOI 10.1093/molbev/msi155; Knutsen H, 2007, CAN J FISH AQUAT SCI, V64, P857, DOI 10.1139/F07-070; Goudet J, 1995, J HERED, V86, P485; Ambe D, 2004, J OCEANOGR, V60, P375, DOI 10.1023/B:JOCE.0000038343.31468.fe; Shoji J, 2007, FISHERIES SCI, V73, P1281, DOI 10.1111/j.1444-2906.2007.01466.x; Benjamini Y, 2001, ANN STAT, V29, P1165; Hess MA, 2012, MOL ECOL, V21, P5236, DOI 10.1111/mec.12046; Araki H, 2010, AQUACULTURE, V308, pS2, DOI 10.1016/j.aquaculture.2010.05.036; Kitada S, 2006, FISH RES, V80, P101, DOI 10.1016/j.fishres.2006.03.019; Olsen EM, 2004, NATURE, V428, P932, DOI 10.1038/nature02430; Keenan K, 2013, METHODS ECOL EVOL, V4, P782, DOI 10.1111/2041-210X.12067; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Gonzalez EB, 2008, AQUACULTURE, V276, P36, DOI 10.1016/j.aquaculture.2008.02.004; WARD RD, 1994, J FISH BIOL, V44, P213, DOI 10.1111/j.1095-8649.1994.tb01200.x; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Rousset F, 1997, GENETICS, V145, P1219; Laikre L, 2010, TRENDS ECOL EVOL, V25, P520, DOI 10.1016/j.tree.2010.06.013; Hansen MM, 2012, MOL ECOL, V21, P1311, DOI 10.1111/j.1365-294X.2011.05463.x; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Falush D, 2003, GENETICS, V164, P1567; Gonzalez EB, 2010, AQUACULTURE, V308, pS12, DOI 10.1016/j.aquaculture.2010.06.031; Gonzalez EB, 2012, FISHERIES SCI, V78, P603, DOI 10.1007/s12562-012-0469-5; NEI M, 1983, ANN HUM GENET, V47, P253, DOI 10.1111/j.1469-1809.1983.tb00993.x; Fisheries Agency Fisheries Research Agency National Association for the Promotion of Productive Seas, 1984, ANNUAL STATISTICS OF; FUKUHARA O, 1991, AQUACULTURE, V95, P117, DOI 10.1016/0044-8486(91)90078-L; Gonzalez EB, 2009, J APPL ICHTHYOL, V25, P407, DOI 10.1111/j.1439-0426.2009.01249.x; Gonzalez EB, 2013, MAR BIOTECHNOL, V15, P206, DOI 10.1007/s10126-012-9479-7; Goudet J, 1999, PCAGEN 1 2 1; Hamasaki K, 2010, J FISH BIOL, V77, P2123, DOI 10.1111/j.1095-8649.2010.02826.x; HORIKI N, 1992, NIPPON SUISAN GAKK, V58, P1007; Ida M, 2010, COAST MAR SCI, V34, P42; Imai T., 2005, B KANAGAWA PREFECTUR, V10, P65; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Kinoshita I, 2000, ENVIRON BIOL FISH, V57, P305, DOI 10.1023/A:1007613015063; Kitada S, 2009, AQUACULTURE, V290, P69, DOI 10.1016/j.aquaculture.2009.02.011; Kojima K, 1981, B SEIKAI REGIONAL FI, V56, P71; Kojima S, 1997, MAR ECOL PROG SER, V150, P149, DOI 10.3354/meps150149; Masuda H, 1984, THE FISHES OF THE JA; Matsuura H, 1980, B SEIKAI REG FISH RE, V55, P65; MATSUURA S, 1987, MAR BIOL, V96, P169, DOI 10.1007/BF00427016; Mori K, 1980, B SEIKAI REG FISH RE, V54, P59; Nakajima K, 2014, CANAD J FISH AQUAT S, V71, P1; Perez-Enriquez R, 2001, FISHERIES SCI, V67, P71, DOI 10.1046/j.1444-2906.2001.00201.x; Perez-Enriquez R, 1999, FISHERIES SCI, V65, P23; Ryman N, 1988, POPULATION GENETICS; Ryman N, 2001, MOL ECOL, V10, P2361, DOI 10.1046/j.0962-1083.2001.01345.x; Sekino M, 2001, MAR BIOTECHNOL, V3, P572, DOI 10.1007/s10126-001-0064-8; Shishidou H, 2008, NIPPON SUISAN GAKK, V74, P183, DOI 10.2331/suisan.74.183; Sobajima N, 1986, B KYOTO OCEA FISH SC, V10, P35; Sugaya T, 2008, FISHERIES SCI, V74, P579, DOI 10.1111/j.1444-2906.2008.01561.x; Tabata K, 1997, FISHERIES SCI, V63, P211; Takaba M, 1999, NIPPON SUISAN GAKK, V65, P200; Takeoka H, 1988, J OCEANOGR SOC JAPAN, V44, P6, DOI 10.1007/BF02303146; TANIGUCHI N, 1990, NIPPON SUISAN GAKK, V56, P1069; Taniguchi N, 2004, STOCK ENHANCEMENT SE, V2nd, P329; Tojima T, 2000, KYOTO I OCEAN FISH S, V6, P1; Umino T, 2009, FISHERIES SCI, V75, P909, DOI 10.1007/s12562-009-0118-9; Umino T, 2011, GLOBAL CHANGE: MANKIND-MARINE ENVIRONMENT INTERACTIONS, P37, DOI 10.1007/978-90-481-8630-3_7; Ward RD, 2006, FISH RES, V80, P9, DOI 10.1016/j.fishres.2006.03.009; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.2307/2408641; Zenitani H, 2009, FISHERIES SCI, V75, P55, DOI 10.1007/s12562-008-0005-9	81	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							UNSP e0125743	10.1371/journal.pone.0125743		20	Multidisciplinary Sciences	Science & Technology - Other Topics	CI7CV	WOS:000354921400045		
J	Inoue, S; Vasilevskis, EE; Pandharipande, PP; Girard, TD; Graves, AJ; Thompson, J; Shintani, A; Ely, EW				Inoue, Shigeaki; Vasilevskis, Eduard E.; Pandharipande, Pratik P.; Girard, Timothy D.; Graves, Amy J.; Thompson, Jennifer; Shintani, Ayumi; Ely, E. Wesley			The Impact of Lymphopenia on Delirium in ICU Patients	PLOS ONE			English	Article							MECHANICALLY VENTILATED PATIENTS; INTENSIVE-CARE-UNIT; TERM COGNITIVE IMPAIRMENT; CELL-DEFICIENT MICE; CRITICAL ILLNESS; PERSISTENT INFLAMMATION; ALZHEIMER-DISEASE; SEVERE SEPSIS; MORTALITY; STROKE	Background Immunosuppressed states may predispose patients to development of acute brain injury during times of critical illness. Lymphopenia is a non-specific yet commonly used bedside marker of immunosuppressed states. Methods We examined whether lymphopenia would predict development of acute brain dysfunction (delirium and/or coma) in 518 patients enrolled in the Bringing to Light the Risk Factors and Incidence of Neuropsychological Dysfunction in ICU Survivors (BRAIN-ICU) study in medical and surgical ICUs of a tertiary care, university-based medical center. Utilizing proportional odds logistic regression and Cox proportional hazards survival analysis, we assessed the relationship between pre-enrollment lymphocytes and subsequent cognitive outcomes including delirium-and coma-free days (DCFDs) and 30-day mortality. Results There were no statistically significant associations between lymphocytes and DCFDs (p = 0.17); additionally, the relationship between lymphocytes and mortality was not statistically significant (p = 0.71). Among 259 patients without history of cancer or diabetes, there was no statistically significant association between lymphocytes and DCFDs (p = 0.07). Conclusion lymphopenia, a commonly used bedside marker of immunosuppression, does not appear to be a marker of risk for acute brain injury (delirium/coma) or 30-day mortality in general medical/surgical ICU patients.	[Inoue, Shigeaki] Tokai Univ, Sch Med, Dept Emergency & Crit Care Med, Isehara, Kanagawa 25911, Japan; [Girard, Timothy D.; Ely, E. Wesley] Vanderbilt Univ, Sch Med, Dept Med, Div Allergy Pulm Crit Care Med, Nashville, TN 37212 USA; [Pandharipande, Pratik P.] Vanderbilt Univ, Sch Med, Dept Anesthesiol, Nashville, TN 37212 USA; [Graves, Amy J.; Thompson, Jennifer; Shintani, Ayumi] Vanderbilt Univ, Sch Med Nashville, Dept Biostat, Nashville, TN USA; [Vasilevskis, Eduard E.] Vanderbilt Univ, Sch Med, Dept Med, Div Gen Internal Med & Publ Hlth, Nashville, TN 37212 USA; [Vasilevskis, Eduard E.; Girard, Timothy D.; Ely, E. Wesley] Vanderbilt Univ, Sch Med, Vet Affairs Tennessee Valley Geriatr Res Educ & C, Nashville, TN 37212 USA	Inoue, S (reprint author), Tokai Univ, Sch Med, Dept Emergency & Crit Care Med, Isehara, Kanagawa 25911, Japan.	sg-inoue@is.icc.u-tokai.ac.jp		Girard, Timothy/0000-0002-9833-4871	Vanderbilt Institute for Clinical and Translational Research (VICTR); Bringing to Light the Risk Factors and Incidence of Neuropsychological Dysfunction in ICU Survivors (BRAIN-ICU) Study	This work was supported by funds from the Vanderbilt Institute for Clinical and Translational Research (VICTR) and The Bringing to Light the Risk Factors and Incidence of Neuropsychological Dysfunction in ICU Survivors (BRAIN-ICU) Study.	Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Saresella M, 2010, J ALZHEIMERS DIS, V21, P927, DOI 10.3233/JAD-2010-091696; Winters BD, 2010, CRIT CARE MED, V38, P1276, DOI 10.1097/CCM.0b013e3181d8cc1d; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Simone MJ, 2011, CNS NEUROSCI THER, V17, P506, DOI 10.1111/j.1755-5949.2010.00173.x; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; Ely EW, 2001, INTENS CARE MED, V27, P1892; Horton NJ, 2007, AM STAT, V61, P79, DOI 10.1198/000313007X172556; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Oberholzer A, 2001, SHOCK, V16, P83, DOI 10.1097/00024382-200116020-00001; Gentile LF, 2012, J TRAUMA ACUTE CARE, V72, P1491, DOI 10.1097/TA.0b013e318256e000; Lederer JA, 1999, SHOCK, V11, P153, DOI 10.1097/00024382-199903000-00001; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; Girard TD, 2012, INTENS CARE MED, V38, P1965, DOI 10.1007/s00134-012-2678-x; Chen YX, 2012, METAB BRAIN DIS, V27, P487, DOI 10.1007/s11011-012-9317-7; Girard TD, 2010, CRIT CARE MED, V38, P1513, DOI 10.1097/CCM.0b013e3181e47be1; Grissom CK, 2010, DISASTER MED PUBLIC, V4, P277, DOI 10.1001/dmp.2010.40; Sacktor N, 2009, CLIN INFECT DIS, V49, P780, DOI 10.1086/605284; Inoue S, 2013, CRIT CARE MED, V41, P810, DOI 10.1097/CCM.0b013e318274645f; Hug A, 2009, STROKE, V40, P3226, DOI 10.1161/STROKEAHA.109.557967; Hurn PD, 2007, J CEREBR BLOOD F MET, V27, P1798, DOI 10.1038/sj.jcbfm.9600482; Hotchkiss RS, 2001, J IMMUNOL, V166, P6952; Milbrandt EB, 2004, CRIT CARE MED, V32, P955, DOI 10.1097/01.CCM.0000119429.16055.92; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; Godbout J, 2005, FASEB J, V10, P1329; Golde TE, 2002, NAT MED, V8, P936, DOI 10.1038/nm0902-936; Huber PJ, 1967, P 5 BERK S MAHT STAT, V1, P211; Inoue S, 2014, CRIT CARE, V18, DOI 10.1186/cc13941; Jimenez-Ibanez EO, 2012, TOHOKU J EXP MED, V226, P213, DOI 10.1620/tjem.226.213; MEAKINS JL, 1977, ANN SURG, V186, P241, DOI 10.1097/00000658-197709000-00002; Pandharipande PP, 2010, CRIT CARE, V14, DOI 10.1186/cc8916; Pisani MA, 2009, AM J RESP CRIT CARE, V180, P1092, DOI 10.1164/rccm.200904-0537OC; Salciccioli JD, 2015, CRIT CARE, V19, DOI 10.1186/s13054-014-0731-6; Schefold JC, 2008, CRIT CARE MED, V36, P3118, DOI 10.1097/CCM.0b013e31818bdd8f; Tsuruta R, 2010, GEN HOSP PSYCHIAT, V32, P607, DOI 10.1016/j.genhosppsych.2010.09.001; White H., 1980, ECONOMETRICA, V50, P1; Weninger SC, 2001, NAT MED, V7, P527, DOI 10.1038/87839	38	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0126216	10.1371/journal.pone.0126216		11	Multidisciplinary Sciences	Science & Technology - Other Topics	CI7CV	WOS:000354921400058		
J	Saeki, I; Yamasaki, T; Tanabe, N; Iwamoto, T; Matsumoto, T; Urata, Y; Hidaka, I; Ishikawa, T; Takami, T; Yamamoto, N; Uchida, K; Terai, S; Sakaida, I				Saeki, Issei; Yamasaki, Takahiro; Tanabe, Norikazu; Iwamoto, Takuya; Matsumoto, Toshihiko; Urata, Yohei; Hidaka, Isao; Ishikawa, Tsuyoshi; Takami, Taro; Yamamoto, Naoki; Uchida, Koichi; Terai, Shuji; Sakaida, Isao			A New Therapeutic Assessment Score for Advanced Hepatocellular Carcinoma Patients Receiving Hepatic Arterial Infusion Chemotherapy	PLOS ONE			English	Article							GAMMA-CARBOXY PROTHROMBIN; ALPHA-FETOPROTEIN RESPONSE; CLINICAL-OUTCOMES; INTERFERON-ALPHA; STAGING-SYSTEM; TUMOR-MARKERS; 5-FLUOROURACIL; CISPLATIN; JAPAN; CLASSIFICATION	Background & Aims Hepatic arterial infusion chemotherapy (HAIC) is an option for treating advanced hepatocellular carcinoma (HCC). Because of the poor prognosis in HAIC non-responders, it is important to identify patients who may benefit from continuous HAIC treatment; however, there are currently no therapeutic assessment scores for this identification. Therefore, we aimed to establish a new therapeutic assessment score for such patients. Methods We retrospectively analyzed 90 advanced HCC patients with elevated baseline alpha-fetoprotein (AFP) and/or des-gamma-carboxy prothrombin (DCP) levels and analyzed various parameters for their possible use as predictors of response and survival. AFP and DCP responses were assessed after half a course of HAIC (2 weeks); a positive-response was defined as a reduction of >= 20% from baseline. Results Multivariate analysis identified DCP response (odds ratio 16.03, p < 0.001) as an independent predictor of treatment response. In multivariate analysis, Child-Pugh class A (hazard ratio [HR] 1.99, p = 0.018), AFP response (HR 2.17, p = 0.007), and DCP response (HR 1.90, p = 0.030) were independent prognostic predictors. We developed an Assessment for Continuous Treatment with HAIC (ACTH) score, including the above 3 factors, which ranged from 0 to 3. Patients stratified into two groups according to this score showed significantly different prognoses (<= 1 vs. >= 2 points: median survival time, 15.1 vs. 8.7 months; p = 0.003). Conclusions The ACTH score may be useful in the therapeutic assessment of HCC patients receiving HAIC.	[Saeki, Issei; Tanabe, Norikazu; Iwamoto, Takuya; Matsumoto, Toshihiko; Hidaka, Isao; Ishikawa, Tsuyoshi; Takami, Taro; Yamamoto, Naoki; Terai, Shuji; Sakaida, Isao] Yamaguchi Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Ube, Yamaguchi 755, Japan; [Yamasaki, Takahiro] Yamaguchi Univ, Grad Sch Med, Dept Oncol & Lab Med, Ube, Yamaguchi 755, Japan; [Urata, Yohei] Nagato Gen Hosp, Dept Internal Med, Nagato, Yamaguchi, Japan; [Uchida, Koichi] Yamaguchi Prefectural Univ, Fac Nursing & Human Nutr, Dept Human Nutr, Yamaguchi, Yamaguchi, Japan	Yamasaki, T (reprint author), Yamaguchi Univ, Grad Sch Med, Dept Oncol & Lab Med, Ube, Yamaguchi 755, Japan.	t.yama@yamaguchi-u.ac.jp					Leung TWT, 2002, CANCER, V94, P1760, DOI 10.1002/cncr.10384; Ebara M, 2005, J HEPATOL, V43, P458, DOI 10.1016/j.jhep.2005.03.033; Miyaki D, 2013, J GASTROEN HEPATOL, V28, P1834, DOI 10.1111/jgh.12311; Riaz A, 2009, J CLIN ONCOL, V27, P5734, DOI 10.1200/JCO.2009.23.1282; Ando E, 2002, CANCER, V95, P588, DOI 10.1002/cncr.10694; Shao YY, 2012, BRIT J CANCER, V107, P1672, DOI 10.1038/bjc.2012.466; Yamasaki T, 2012, HEPATOL RES, V42, P340, DOI 10.1111/j.1872-034X.2011.00938.x; Kim BK, 2011, LIVER INT, V31, P369, DOI 10.1111/j.1478-3231.2010.02368.x; Yamashita T, 2011, ONCOLOGY-BASEL, V81, P281, DOI 10.1159/000334439; Kudo M, 2003, J GASTROENTEROL, V38, P207, DOI 10.1007/s005350300038; Yamasaki T, 2005, J GASTROENTEROL, V40, P70, DOI 10.1007/s00535-004-1494-7; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep20933; Lee MH, 2012, J GASTROEN HEPATOL, V27, P313, DOI 10.1111/j.1440-1746.2011.06867.x; El-Serag HB, 2008, GASTROENTEROLOGY, V134, P1752, DOI 10.1053/j.gastro.2008.02.090; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Chevret S, 1999, J HEPATOL, V31, P133, DOI 10.1016/S0168-8278(99)80173-1; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Yamamoto K, 2009, ANN SURG ONCOL, V16, P2795, DOI 10.1245/s10434-009-0618-y; Nouso K, 2013, BRIT J CANCER, V109, P1904, DOI 10.1038/bjc.2013.542; Todo S, 2004, ANN SURG, V240, P451, DOI 10.1097/01.sla.0000137129.98894.42; Vora SR, 2009, ONCOLOGIST, V14, P717, DOI 10.1634/theoncologist.2009-0038; Zhou L, 2006, WORLD J GASTROENTERO, V12, P1175; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Miyaki D, 2012, J GASTROEN HEPATOL, V27, P1850, DOI 10.1111/j.1440-1746.2012.07276.x; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Huitzil-Melendez FD, 2010, J CLIN ONCOL, V28, P2889, DOI 10.1200/JCO.2009.25.9895; Chan SL, 2009, J CLIN ONCOL, V27, P446, DOI 10.1200/JCO.2008.18.8151; Mita Y, 1998, CANCER, V82, P1643, DOI 10.1002/(SICI)1097-0142(19980501)82:9<1643::AID-CNCR8>3.0.CO;2-B; Obi S, 2006, CANCER, V106, P1990, DOI 10.1002/cncr.21832; MATSUI O, 1993, RADIOLOGY, V188, P79; Llovet JM, 2008, J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Arii S, 2010, HEPATOL RES, V40, P667, DOI 10.1111/j.1872-034X.2010.00673.x; Toyoda H, 2012, J HEPATOL, V57, P1251, DOI 10.1016/j.jhep.2012.07.018; Park H, 2013, BIOMED RES INT, DOI 10.1155/2013/310427; Aoyagi Y, 1996, CANCER, V77, P1781; Manghisi G, 1998, HEPATOLOGY, V28, P751; Japan LCSGo, 2009, GEN RUL CLIN PATH ST, V5th; Kim BK, 2011, J CANCER RES CLIN, V137, P659, DOI 10.1007/s00432-010-0917-5; Kishi K, 1992, Radiat Med, V10, P189; Nagano H, 2011, ONCOLOGY-BASEL, V80, P63, DOI 10.1159/000328281; Okita K, 2012, HEPATO-GASTROENTEROL, V59, P533, DOI 10.5754/hge10013; Takaki-Hamabe S, 2009, HEPATOL RES, V39, P223, DOI 10.1111/j.1872-034X.2008.00458.x; Urayama N, 2011, KANZO, V52, P449; Yamasaki T, 2003, HEPATOL RES, V27, P36, DOI 10.1016/S1386-6346(03)00195-5; Yamasaki T, 2002, HEPATOL RES, V23, P7, DOI 10.1016/S1386-6346(01)00163-2	45	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0126649	10.1371/journal.pone.0126649		14	Multidisciplinary Sciences	Science & Technology - Other Topics	CI7CV	WOS:000354921400070		
J	Sasayama, K; Ochi, E; Adachi, M				Sasayama, Kensaku; Ochi, Eisuke; Adachi, Minoru			Importance of Both Fatness and Aerobic Fitness on Metabolic Syndrome Risk in Japanese Children	PLOS ONE			English	Article							SHUTTLE-RUN TEST; CARDIOVASCULAR-DISEASE MORTALITY; BODY-MASS INDEX; CARDIORESPIRATORY FITNESS; PHYSICAL-ACTIVITY; ADOLESCENTS; YOUTH; OVERWEIGHT; INSULIN; ADULTS	Associations between body mass index (BMI), peak oxygen consumption (VO2peak), and metabolic syndrome (MetS) risk factors have not been adequately studied in Japanese children. Here the relationships between these parameters and the threshold aerobic fitness level necessary for low MetS risk were determined. The participants (299 children; 140 boys and 159 girls, aged 9.1 +/- 0.3 years) were divided into four groups using the medians of predicted VO2peak (pVO2peak) and BMI. MetS risk scores were calculated using z-scores. Receiver Operating Characteristic analysis was used to determine the threshold aerobic fitness level necessary for low MetS risk. The MetS risk score of the High BMI group was significantly higher than that of the Low BMI group for both sexes (p < 0.0001). However, the High BMI/High Fitness group had a significantly lower MetS risk score than the High BMI/Low Fitness group for both sexes. The pVO2peak cut-off values for low MetS risk were 47.9 and 44.9 ml/kg/min for boys and girls, respectively. Our results suggest that improvements in both fatness and aerobic fitness are important for decreasing MetS risk. We also confirmed the pVO2peak of cut-off values necessary for low MetS risk in Japanese children.	[Sasayama, Kensaku; Adachi, Minoru] Hyogo Univ Teachers Educ, Joint Grad Sch Sci Sch Educ, Kato, Hyogo, Japan; [Ochi, Eisuke; Adachi, Minoru] Okayama Univ, Grad Sch Educ, Okayama, Japan	Ochi, E (reprint author), Okayama Univ, Grad Sch Educ, Okayama, Japan.	eisukeochi@cc.okayama-u.ac.jp					Lee CD, 1999, AM J CLIN NUTR, V69, P373; Ekelund U, 2007, DIABETOLOGIA, V50, P1832, DOI 10.1007/s00125-007-0762-5; Leger LA, 1988, J SPORT SCI, V6, P93, DOI 10.1080/02640418808729800; Chen W, 1999, AM J EPIDEMIOL, V150, P667; Ruiz JR, 2007, PEDIATR RES, V61, P350, DOI 10.1203/pdr.0b013e318030d1bd; Olds T, 2006, J SPORT SCI, V24, P1025, DOI 10.1080/02640410500432193; Eisenmann JC, 2005, INT J OBESITY, V29, P1077, DOI 10.1038/sj.ijo.0802995; Adegboye ARA, 2011, BRIT J SPORT MED, V45, P722, DOI 10.1136/bjsm.2009.068346; Suriano K, 2010, J PEDIATR-US, V157, P552, DOI 10.1016/j.jpeds.2010.04.042; Eisenmann JC, 2007, MED SCI SPORT EXER, V39, P1251, DOI 10.1249/MSS.0b013e318064c8b0; Wei M, 1999, JAMA-J AM MED ASSOC, V282, P1547, DOI 10.1001/jama.282.16.1547; Urakami T, 2007, PEDIATR RES, V61, P141, DOI 10.1203/pdr.0b013e31802d8a69; Mozumdar A, 2011, DIABETES CARE, V34, P216, DOI 10.2337/dc10-0879; Hurtig-Wennlof A, 2007, EUR J CARDIOV PREV R, V14, P575, DOI 10.1097/HJR.0b013e32808c67e3; Cruz ML, 2004, J CLIN ENDOCR METAB, V89, P108, DOI 10.1210/jc.2003-031188; Brage S, 2004, DIABETES CARE, V27, P2141, DOI 10.2337/diacare.27.9.2141; Hanson RL, 2002, DIABETES, V51, P3120, DOI 10.2337/diabetes.51.10.3120; Ishizaka N, 2005, HYPERTENS RES, V28, P27, DOI 10.1291/hypres.28.27; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Rizzo NS, 2007, J PEDIATR-US, V150, P388, DOI 10.1016/j.jpeds.2006.12.039; Cook S, 2003, ARCH PEDIAT ADOL MED, V157, P821, DOI 10.1001/archpedi.157.8.821; Boddy LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045755; Cruz Martha L, 2004, Curr Diab Rep, V4, P53, DOI 10.1007/s11892-004-0012-x; Dencker M, 2012, EUR J PEDIATR, V171, P705, DOI 10.1007/s00431-011-1617-0; Eisenmann JC, 2007, INT J PEDIATR OBES, V2, P66, DOI 10.1080/17477160601133713; Gulias-Gonzalez R, 2014, J SCHOOL HEALTH, V84, P625, DOI 10.1111/josh.12192; Jago R, 2010, MED SCI SPORT EXER, V42, P1502, DOI 10.1249/MSS.0b013e3181d322c4; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Matsuzaka A, 2004, PEDIATR EXERC SCI, V16, P113; Ng M, 2013, LANCET, V384, P766, DOI DOI 10.1016/S0140-6736(14)60460-8; Okada T, 2002, PEDIATR INT, V44, P596, DOI 10.1046/j.1442-200X.2002.01634.x; RAITAKARI OT, 1995, DIABETOLOGIA, V38, P1042, DOI 10.1007/BF00402173; Yoshinaga M, 2005, OBES RES, V13, P1135, DOI 10.1038/oby.2005.134	33	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0127400	10.1371/journal.pone.0127400		10	Multidisciplinary Sciences	Science & Technology - Other Topics	CI7CV	WOS:000354921400113		
J	Shimoshige, H; Kobayashi, H; Mizuki, T; Nagaoka, Y; Inoue, A; Maekawa, T				Shimoshige, Hirokazu; Kobayashi, Hideki; Mizuki, Toru; Nagaoka, Yutaka; Inoue, Akira; Maekawa, Toru			Effect of Polyethylene Glycol on the Formation of Magnetic Nanoparticles Synthesized by Magnetospirillum magnetotacticum MS-1	PLOS ONE			English	Article							OXYGEN-CONTROLLED FERMENTER; MAGNETOSOME FORMATION; BACTERIAL MAGNETOSOMES; GRYPHISWALDENSE MSR-1; FE3O4 NANOPARTICLES; DRUG CARRIERS; CELL BIOLOGY; IN-VIVO; GROWTH; PARTICLES	Magnetotactic bacteria (MTB) synthesize intracellular magnetic nanocrystals called magnetosomes, which are composed of either magnetite (Fe3O4) or greigite (Fe3S4) and covered with lipid membranes. The production of magnetosomes is achieved by the biomineralization process with strict control over the formation of magnetosome membrane vesicles, uptake and transport of iron ions, and synthesis of mature crystals. These magnetosomes have high potential for both biotechnological and nanotechnological applications, but it is still extremely difficult to grow MTB and produce a large amount of magnetosomes under the conventional cultural conditions. Here, we investigate as a first attempt the effect of polyethylene glycol (PEG) added to the culture medium on the increase in the yield of magnetosomes formed in Magnetospirillum magnetotacticum MS-1. We find that the yield of the formation of magnetosomes can be increased up to approximately 130 % by adding PEG200 to the culture medium. We also measure the magnetization of the magnetosomes and find that the magnetosomes possess soft ferromagnetic characteristics and the saturation mass magnetization is increased by 7 %.	[Shimoshige, Hirokazu; Mizuki, Toru; Nagaoka, Yutaka; Inoue, Akira; Maekawa, Toru] Toyo Univ, Bionano Elect Res Ctr, Kawagoe, Saitama, Japan; [Kobayashi, Hideki] Japan Agcy Marine Earth Sci & Technol, Yokosuka, Kanagawa 2370061, Japan; [Mizuki, Toru; Nagaoka, Yutaka; Inoue, Akira; Maekawa, Toru] Toyo Univ, Grad Sch Interdisciplinary New Sci, Kawagoe, Saitama, Japan	Maekawa, T (reprint author), Toyo Univ, Bionano Elect Res Ctr, Kawagoe, Saitama, Japan.	maekawa@toyo.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [S1101017]	This work was supported by a grant for the Program for the Strategic Research Foundation at Private Universities S1101017 organized by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Tanaka M, 2010, APPL ENVIRON MICROB, V76, P5526, DOI 10.1128/AEM.00589-10; Nomura T, 2012, P NATL ACAD SCI USA, V109, P8770, DOI 10.1073/pnas.1200051109; MANN S, 1984, NATURE, V310, P405, DOI 10.1038/310405a0; Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2; Yang TZ, 2005, J PHYS CHEM B, V109, P23233, DOI 10.1021/jp054291f; Jogler C, 2009, ANNU REV MICROBIOL, V63, P501, DOI 10.1146/annurev.micro.62.081307.162908; Heyen U, 2003, APPL MICROBIOL BIOT, V61, P536, DOI 10.1007/s00253-002-1219-x; Grunberg K, 2004, APPL ENVIRON MICROB, V70, P1040, DOI 10.1128/AEM.70.2.1040-1050.2004; Zhang Y, 2011, APPL ENVIRON MICROB, V77, P5851, DOI 10.1128/AEM.05962-11; Bazylinski DA, 2004, NAT REV MICROBIOL, V2, P217, DOI 10.1038/nrmicro842; Sun JB, 2008, BIOTECHNOL BIOENG, V101, P1313, DOI 10.1002/bit.22011; Xiang L, 2007, J GENE MED, V9, P679, DOI 10.1002/jgm.1068; Veronese FM, 2008, BIODRUGS, V22, P315, DOI 10.2165/00063030-200822050-00004; Hui C, 2008, J PHYS CHEM C, V112, P11336, DOI 10.1021/jp801632p; Halverson LJ, 2000, APPL ENVIRON MICROB, V66, P2414, DOI 10.1128/AEM.66.6.2414-2421.2000; Staniland S, 2008, NAT NANOTECHNOL, V3, P158, DOI 10.1038/nnano.2008.35; Yoshino T, 2008, BIOTECHNOL BIOENG, V101, P470, DOI 10.1002/bit.21912; BLAKEMORE RP, 1979, J BACTERIOL, V140, P720; Faivre D, 2008, CHEM REV, V108, P4875, DOI 10.1021/cr078258w; BLAKEMORE R, 1975, SCIENCE, V190, P377, DOI 10.1126/science.170679; Matsunaga T, 1996, BIOTECHNOL TECH, V10, P495; Sun JB, 2007, CANCER LETT, V258, P109, DOI 10.1016/j.canlet.2007.08.018; NAKAMURA C, 1995, J BIOL CHEM, V270, P28392; Li AH, 2010, J SEP SCI, V33, P3437, DOI 10.1002/jssc.201000441; MATSUNAGA T, 1987, APPL MICROBIOL BIOT, V26, P328; Moisescu C, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00049; Pan YX, 2004, CHINESE SCI BULL, V49, P2563, DOI 10.1360/982004-153; Schuler D, 2008, FEMS MICROBIOL REV, V32, P654, DOI 10.1111/j.1574-6976.2008.00116.x; Sun JB, 2008, APPL MICROBIOL BIOT, V79, P389, DOI 10.1007/s00253-008-1453-y; Wacker R, 2007, BIOCHEM BIOPH RES CO, V357, P391, DOI 10.1016/j.bbrc.2007.03.156; Yang J, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00210	31	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0127481	10.1371/journal.pone.0127481		9	Multidisciplinary Sciences	Science & Technology - Other Topics	CI7CV	WOS:000354921400123		
J	Shiomi, M; Iio, T; Kamei, K; Sharma, C; Hagita, N				Shiomi, Masahiro; Iio, Takamasa; Kamei, Koji; Sharma, Chandraprakash; Hagita, Norihiro			Effectiveness of Social Behaviors for Autonomous Wheelchair Robot to Support Elderly People in Japan	PLOS ONE			English	Article								We developed a wheelchair robot to support the movement of elderly people and specifically implemented two functions to enhance their intention to use it: speaking behavior to convey place/location related information and speed adjustment based on individual preferences. Our study examines how the evaluations of our wheelchair robot differ when compared with human caregivers and a conventional autonomous wheelchair without the two proposed functions in a moving support context. 28 senior citizens participated in the experiment to evaluate three different conditions. Our measurements consisted of questionnaire items and the coding of free-style interview results. Our experimental results revealed that elderly people evaluated our wheelchair robot higher than the wheelchair without the two functions and the human caregivers for some items.	[Shiomi, Masahiro; Iio, Takamasa; Kamei, Koji; Sharma, Chandraprakash; Hagita, Norihiro] ATR, Intelligent Robot & Commun Labs, Kyoto, Japan	Shiomi, M (reprint author), ATR, Intelligent Robot & Commun Labs, Kyoto, Japan.	m-shiomi@atr.jp			Strategic Information and Communications R & D Promotion Programme (SCOPE); Ministry of Internal Affairs and Communications [142107007]	This research was supported by the Strategic Information and Communications R & D Promotion Programme (SCOPE) and the Ministry of Internal Affairs and Communications (142107007), http://www.soumu.go.jp/main_sosiki/joho_tsusin/scope/ (TI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Piau A, 2014, J NUTR HEALTH AGING, V18, P97, DOI 10.1007/s12603-013-0356-5; Morales Y, 2013, IEEE INT C INT ROBOT, P2737, DOI 10.1109/IROS.2013.6696743; Carletta J, 1996, COMPUT LINGUIST, V22, P249; Mordoch E, 2013, MATURITAS, V74, P14, DOI 10.1016/j.maturitas.2012.10.015; Shiomi M, 2007, IEEE INTELL SYST, V22, P25, DOI 10.1109/MIS.2007.37; Kanda T, 2010, IEEE T ROBOT, V26, P897, DOI 10.1109/TRO.2010.2062550; Boucher P, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-58; Dubowsky S., 2000, P IEEE INT C ROB AUT, V1, P570, DOI 10.1109/ROBOT.2000.844114; Faria B, 2014, NEW PERSPECTIVES INF, V1; Flandorfer P., 2012, INT J POPULATION RES, P2012; Freire Bastos-Filho T, 2014, NEURAL SYST IN PRESS, V22, P567, DOI [10.1109/TNSRE.2013.2265237, DOI 10.1109/TNSRE.2013.2265237]; Graf Birgit, 2009, Journal of Computing and Information Technology - CIT, V17, DOI 10.2498/cit.1001159; Hayashi K, 2012, IEEE T AUTON MENT DE, V4, P150, DOI 10.1109/TAMD.2011.2178846; Heerink M., 2008, J PHYS AGENTS, V2, P33; How TV, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-90; Iwamura Y, 2011, ACM IEEE INT C HUM R, P449; Kanemura A, 2013, IEEE INT C INT ROBOT, P865, DOI 10.1109/IROS.2013.6696452; Kawai H, 2004, 5 ISCA SPEECH SYNTH, P179; Kim Y, 2013, COMPUT HUM BEHAV, V29, P1091, DOI 10.1016/j.chb.2012.10.001; Kobayashi Y, 2009, 2009 IEEE-RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, P2013, DOI 10.1109/IROS.2009.5353933; Morales Y, 2014, IEEE INT C INT ROBOT, P3284, DOI 10.1109/IROS.2014.6943019; Seder M, 2007, IEEE INT CONF ROBOT, P1986, DOI 10.1109/ROBOT.2007.363613; Shiomi M, 2014, INT J SOC ROBOT, V6, P443, DOI 10.1007/s12369-014-0238-y; Shiomi M, 2014, IEEE INT C HUM AG IN, P17; Tanaka H, 2013, J ROBOTICS, P2013; Thrun S., 2005, PROBABILISTIC ROBOTI; Vidal EG, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/1/016012; Yamaoka F, 2008, IEEE RSJ INT C INT R, P2685	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0128031	10.1371/journal.pone.0128031		15	Multidisciplinary Sciences	Science & Technology - Other Topics	CI7CV	WOS:000354921400142		
J	Soma, M; Mori, C				Soma, Masayo; Mori, Chihiro			The Songbird as a Percussionist: Syntactic Rules for Non-Vocal Sound and Song Production in Java Sparrows	PLOS ONE			English	Article							VOCAL-TRACT; DISPLAY; CHOREOGRAPHY; BUDGERIGARS; PERFORMANCE; COURTSHIP; PATTERNS; MANAKINS; DANCE; BIRD	Music and dance are two remarkable human characteristics that are closely related. Communication through integrated vocal and motional signals is also common in the courtship displays of birds. The contribution of songbird studies to our understanding of vocal learning has already shed some light on the cognitive underpinnings of musical ability. Moreover, recent pioneering research has begun to show how animals can synchronize their behaviors with external stimuli, like metronome beats. However, few studies have applied such perspectives to unraveling how animals can integrate multimodal communicative signals that have natural functions. Additionally, studies have rarely asked how well these behaviors are learned. With this in mind, here we cast a spotlight on an unusual animal behavior: nonvocal sound production associated with singing in the Java sparrow (Lonchura oryzivora), a songbird. We show that male Java sparrows coordinate their bill-click sounds with the syntax of their song-note sequences, similar to percussionists. Analysis showed that they produced clicks frequently toward the beginning of songs and before/after specific song notes. We also show that bill-clicking patterns are similar between social fathers and their sons, suggesting that these behaviors might be learned from models or linked to learning-based vocalizations. Individuals untutored by conspecifics also exhibited stereotypical bill-clicking patterns in relation to song-note sequence, indicating that while the production of bill clicking itself is intrinsic, its syncopation appears to develop with songs. This paints an intriguing picture in which non-vocal sounds are integrated with vocal courtship signals in a songbird, a model that we expect will contribute to the further understanding of multimodal communication.	[Soma, Masayo] Hokkaido Univ, Fac Sci, Dept Biol, Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Mori, Chihiro] Hokkaido Univ, Grad Sch Life Sci, Biosyst Sci Course, Kita Ku, Sapporo, Hokkaido 0600810, Japan	Soma, M (reprint author), Hokkaido Univ, Fac Sci, Dept Biol, Kita Ku, Kita 10,Nishi 8, Sapporo, Hokkaido 0600810, Japan.	masayo.soma@sci.hokudai.ac.jp			Japan Society for the Promotion of Science [22800002, 23680027]	The work was supported by Japan Society for the Promotion of Science Grants-in-Aid for Young Scientists (Nos. 22800002, 23680027), http://www.jsps.go.jp/english/index.html.	Dalziell AH, 2013, CURR BIOL, V23, P1132, DOI 10.1016/j.cub.2013.05.018; Brainard MS, 2002, NATURE, V417, P351, DOI 10.1038/417351a; Cooper BG, 2004, SCIENCE, V303, P544, DOI 10.1126/science.1091099; Hasegawa A, 2011, SCI REP-UK, V1, DOI 10.1038/srep00120; Prum RO, 1998, ANIM BEHAV, V55, P977, DOI 10.1006/anbe.1997.0647; Tchernichovski O, 2001, SCIENCE, V291, P2564, DOI 10.1126/science.1058522; Hile AG, 2000, ANIM BEHAV, V59, P1209, DOI 10.1006/anbe.1999.1438; Bostwick KS, 2005, SCIENCE, V309, P736, DOI 10.1126/science.1111701; Riede T, 2006, P NATL ACAD SCI USA, V103, P5543, DOI 10.1073/pnas.0601262103; Cook P, 2013, J COMP PSYCHOL, V127, P412, DOI 10.1037/a0032345; Freeberg TM, 2000, BEHAV PROCESS, V51, P177, DOI 10.1016/S0376-6357(00)00127-3; Hingee M, 2009, P ROY SOC B-BIOL SCI, V276, P4173, DOI 10.1098/rspb.2009.1110; Schachner A, 2009, CURR BIOL, V19, P831, DOI 10.1016/j.cub.2009.03.061; Hattori Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep01566; Beecher MD, 2005, TRENDS ECOL EVOL, V20, P143, DOI 10.1016/j.tree.2005.01.004; Charif R. A., 2010, RAVEN PRO 1 4 USERS; Fusani L, 2007, ETHOLOGY, V113, P964, DOI 10.1111/j.1439-0310.2007.01395.x; Fusani L, 1997, BEHAVIOUR, V134, P321, DOI 10.1163/156853997X00566; Garcia M, 2012, CONDOR, V114, P500, DOI 10.1525/cond.2012.110158; Geissmann T, 2000, ANIM BEHAV, V60, P805, DOI 10.1006/anbe.2000.1540; Goodwin D., 1982, ESTRILDID FINCHES WO; Hasegawa A, 2011, ORNITHOL SCI, V10, P73; Kagawa H, 2013, BEHAV PROCESS, V99, P138, DOI 10.1016/j.beproc.2013.07.012; Nelson BS, 2005, J EXP BIOL, V208, P297, DOI 10.1242/jeb.01378; Ota N, 2014, J AVIAN BIOL, V45, P566, DOI 10.1111/jav.00383; Patel AD, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001821; Restall R, 1996, MUNIAS AND MANNIKINS; Romero T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071365; Romero T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105963; Soma M, 2015, FRONT ECOL EVOL, V3, P4; Soma MF, 2011, ORNITHOL SCI, V10, P89; Stark RD, 1998, CONDOR, V100, P350, DOI 10.2307/1370276; Williams H, 2001, J EXP BIOL, V204, P3497	33	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0124876	10.1371/journal.pone.0124876		10	Multidisciplinary Sciences	Science & Technology - Other Topics	CI7CV	WOS:000354921400021		
J	Wada, H; Hirohashi, K; Anayama, T; Nakajima, T; Kato, T; Chan, HHL; Qiu, J; Daly, M; Weersink, R; Jaffray, DA; Irish, JC; Waddell, TK; Keshavjee, S; Yoshino, I; Yasufuku, K				Wada, Hironobu; Hirohashi, Kentaro; Anayama, Takashi; Nakajima, Takahiro; Kato, Tatsuya; Chan, Harley H. L.; Qiu, Jimmy; Daly, Michael; Weersink, Robert; Jaffray, David A.; Irish, Jonathan C.; Waddell, Thomas K.; Keshavjee, Shaf; Yoshino, Ichiro; Yasufuku, Kazuhiro			Minimally Invasive Electro-Magnetic Navigational Bronchoscopy-Integrated Near-Infrared-Guided Sentinel Lymph Node Mapping in the Porcine Lung	PLOS ONE			English	Article							INDOCYANINE GREEN; DOSE-ESCALATION; NECK-CANCER; TRIAL; HEAD; SEGMENTECTOMY; METAANALYSIS; METASTASIS; INJECTION; LOBECTOMY	Background The use of near-infrared (NIR) fluorescence imaging with indocyanine green (ICG) for sentinel lymph node (SN) mapping has been investigated in lung cancer; however, this has not been fully adapted for minimally invasive surgery (MIS). The aim of our study was to develop a minimally invasive SN mapping integrating pre-operative electro-magnetic navigational bronchoscopy (ENB)-guided transbronchial ICG injection and intraoperative NIR thoracoscopic imaging. Methods A NIR thoracoscope was used to visualize ICG fluorescence. ICG solutions in a 96-well plate and ex vivo porcine lungs were examined to optimize ICG concentrations and injection volumes. Transbronchial ICG injection (n=4) was assessed in comparison to a traditional transpleural approach (n=3), where after thoracotomy an ICG solution (100 mu L at 100 mu g/mL) was injected into the porcine right upper lobe for SN identification. For further translation into clinical use, transbronchial ICG injection prior to thoracotomy followed by NIR thoracoscopic imaging was validated (n=3). ENB was used for accurate targeting in two pigs with a pseudo-tumor. Results The ICG fluorescence at 10 mu g/mL was the brightest among various concentrations, unchanged by the distance between the thoracoscope and ICG solutions. Injected ICG of no more than 500 mu L showed a localized fluorescence area. All 7 pigs showed a bright paratracheal lymph node within 15 minutes post-injection, with persistent fluorescence for 60 minutes. The antecedent transbronchial ICG injection succeeded in SN identification in all 3 cases at the first thoracoscopic inspection within 20 minutes post-injection. The ENB system allowed accurate ICG injection surrounding the pseudo-tumors. Conclusions ENB-guided ICG injection followed by NIR thoracoscopy was technically feasible for SN mapping in the porcine lung. This promising platform may be translated into human clinical trials and is suited for MIS.	[Wada, Hironobu; Hirohashi, Kentaro; Anayama, Takashi; Nakajima, Takahiro; Kato, Tatsuya; Waddell, Thomas K.; Keshavjee, Shaf; Yasufuku, Kazuhiro] Univ Hlth Network, Toronto Gen Hosp, Div Thorac Surg, Toronto, ON, Canada; [Chan, Harley H. L.; Qiu, Jimmy; Daly, Michael; Weersink, Robert; Jaffray, David A.; Irish, Jonathan C.; Yasufuku, Kazuhiro] Univ Hlth Network, TECHNA Inst, Guided Therapeut, Toronto, ON, Canada; [Irish, Jonathan C.] Univ Toronto, Princess Margaret Hosp, Univ Hlth Network, Dept Otolaryngol Head & Neck Surg Surg Oncol, Toronto, ON, Canada; [Wada, Hironobu; Nakajima, Takahiro; Yoshino, Ichiro] Chiba Univ, Grad Sch Med, Dept Gen Thorac Surg, Chiba, Japan	Yasufuku, K (reprint author), Univ Hlth Network, Toronto Gen Hosp, Div Thorac Surg, Toronto, ON, Canada.	kazuhiro.yasufuku@uhn.ca			Intuitive Surgical Technology Research Grant Program; Honjo International Scholarship Foundation	This work was supported by the Intuitive Surgical Technology Research Grant Program 2013 to KY (http://intuitivesurgical.com/company/educational-grants/technology_grants.html). Novadaq Technologies provided the SPY scope and ICG for this work. In-house prototype electro-magnetic navigational bronchoscopy system was developed under collaboration with OLYMPUS MEDICAL SYSTEMS CORP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. HW received a research scholarship from the Honjo International Scholarship Foundation.	Anayama T, ANN THORAC IN PRESS; Riquet M, 2005, ANN THORAC SURG, V79, P225, DOI 10.1016/j.athoracsur.2004.06.081; van der Zaag ES, 2012, ANN SURG ONCOL, V19, P3449, DOI 10.1245/s10434-012-2417-0; van der Vorst JR, 2013, ORAL ONCOL, V49, P15, DOI 10.1016/j.oraloncology.2012.07.017; Daly MJ, 2006, MED PHYS, V33, P3767, DOI 10.1118/1.2349687; Jain R, 2009, J CONTROL RELEASE, V138, P90, DOI 10.1016/j.jconrel.2009.05.010; Nakamura K, 2010, JPN J CLIN ONCOL, V40, P271, DOI 10.1093/jjco/hyp156; Thompson CF, 2013, EUR ARCH OTO-RHINO-L, V270, P2115, DOI 10.1007/s00405-012-2320-0; Bao FC, 2014, EUR J CARDIO-THORAC, V46, P1, DOI 10.1093/ejcts/ezt554; Gilmore DM, 2013, ANN SURG ONCOL, V20, P2357, DOI 10.1245/s10434-013-2905-x; Allen MS, 2006, ANN THORAC SURG, V81, P1013, DOI 10.1016/j.athoracsur.2005.06.066; Nomori H, 2012, J THORAC CARDIOV SUR, V144, P87, DOI 10.1016/j.jtcvs.2012.03.034; Oh Y, 2013, J THORAC CARDIOV SUR, V146, P1509, DOI 10.1016/j.jtcvs.2013.02.044; Troyan SL, 2009, ANN SURG ONCOL, V16, P2943, DOI 10.1245/s10434-009-0594-2; Daly MJ, 2010, SPIE MED IMAGING, V7625; Gilmore DM, 2013, J THORAC CARDIOV SUR, V146, P562, DOI 10.1016/j.jtcvs.2013.04.010; Gilmore DM, 2012, J THORAC CARDIOV SUR, V144, pS80, DOI 10.1016/j.jtcvs.2012.05.072; Khullar Onkar, 2009, Semin Thorac Cardiovasc Surg, V21, P309, DOI 10.1053/j.semtcvs.2009.11.009; Khullar OV, 2013, ANN THORAC SURG, V95, P312, DOI 10.1016/j.athoracsur.2012.08.101; Lardinois D, 2003, EUR J CARDIO-THORAC, V23, P824, DOI 10.1016/S1010-7940(03)00077-0; Liptay MJ, 2009, J THORAC ONCOL, V4, P198, DOI 10.1097/JTO.0b013e318194a2c3; Melfi FMA, 2008, EUR J CARDIO-THORAC, V34, P181, DOI 10.1016/j.ejcts.2008.03.059; National Cancer Institute website, COMP DIFF TYP SURG T; Ono Takashi, 2009, Interact Cardiovasc Thorac Surg, V9, P659, DOI 10.1510/icvts.2009.214197; Taghizadeh KA, 2013, LUNG CANCER, DOI DOI 10.1016/J.LUNGCAN.2013.01.001; Takizawa H, 2012, J THORAC CARDIOV SUR, V144, P94, DOI 10.1016/j.jtcvs.2012.03.040; Takizawa H, 2014, J THORAC CARDIOV SUR, V147, pE50, DOI 10.1016/j.jtcvs.2013.12.058; Van Oostrum NHM, 2012, ACTA OBSTET GYN SCAN, V91, P174, DOI 10.1111/j.1600-0412.2011.01302.x; Yamashita S, 2011, J THORAC CARDIOV SUR, V141, P141, DOI 10.1016/j.jtcvs.2010.01.028	29	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0126945	10.1371/journal.pone.0126945		13	Multidisciplinary Sciences	Science & Technology - Other Topics	CI7CV	WOS:000354921400084		
J	Wakatsuki, M; Kato, S; Kiyohara, H; Ohno, T; Karasawa, K; Tamaki, T; Ando, K; Tsujii, H; Nakano, T; Kamada, T; Shozu, M				Wakatsuki, Masaru; Kato, Shingo; Kiyohara, Hiroki; Ohno, Tatsuya; Karasawa, Kumiko; Tamaki, Tomoaki; Ando, Ken; Tsujii, Hirohiko; Nakano, Takashi; Kamada, Tadashi; Shozu, Makio		Working Grp Gynecological Tumor	Clinical Trial of Prophylactic Extended-Field Carbon-Ion Radiotherapy for Locally Advanced Uterine Cervical Cancer (Protocol 0508)	PLOS ONE			English	Article							PARAAORTIC LYMPH-NODES; GYNECOLOGIC-ONCOLOGY-GROUP; RADIATION-THERAPY; CISPLATIN CHEMOTHERAPY; INTRACAVITARY BRACHYTHERAPY; CONCURRENT CHEMOTHERAPY; DOSE-ESCALATION; FOLLOW-UP; IRRADIATION; CARCINOMA	To evaluate the efficacy and the toxicity of prophylactic extended-field carbon-ion radiotherapy (C-ion RT, Protocol 0508) for locally advanced squamous cell carcinoma of the uterine cervix in phase I/II clinical trial. Between May 2006 and January 2012, 26 patients of Protocol 0508 were treated with C-ion RT. The numbers of patients with stage IIB, IIIB, and IVA disease were 13, 11, and 2, respectively. Twenty patients had pelvic lymph node metastases. Median tumor size was 6.1 cm (range, 4.0-10.0 cm). The treatment consisted of extended-field irradiation of 39.0 gray equivalents (GyE) in 13 fractions, and additional 15.0 GyE in 5 fractions was given to the gross tumor volume (GTV) and surrounding tissues. With regard to local boost, 18.0 GyE in 2 fractions was given to GTV only. Total dose to the cervical tumor was 72.0 GyE over 20 fractions. The median follow-up period was 37 months. Twenty-one patients had grade 1 or 2 acute gastrointestinal toxicity, but all patients completed the treatment on schedule. There were no grade 3 or higher late complications, with 8 patients having grade 1 or 2 toxicities, 1 had grade 2 gastrointestinal toxicity and 2 had grade 2 genitourinary toxicity. Four patients (15.4%) developed local recurrence, and 8 patients (30.8%) had distant metastases. The 2-year local control rate, progression-free survival rate and overall survival rate were 83.6%, 61.5% and 73.1%, respectively. There were no severe acute or late complications in this trial. Prophylactic extended-field C-ion RT for locally advanced squamous cell carcinoma of the uterine cervix was a safe treatment. Although the number of patients in this study was small, the results support further investigations to confirm the therapeutic efficacy and to avoid or reduce toxicity.	[Wakatsuki, Masaru; Karasawa, Kumiko; Tsujii, Hirohiko; Kamada, Tadashi] Natl Inst Radiol Sci, Res Ctr Charged Particle Therapy, Chiba 260, Japan; [Kato, Shingo; Tamaki, Tomoaki] Saitama Med Univ, Int Med Ctr, Dept Radiat Oncol, Saitama, Japan; [Kiyohara, Hiroki; Nakano, Takashi] Gunma Univ, Grad Sch Med, Dept Radiat Oncol, Maebashi, Gunma, Japan; [Ohno, Tatsuya] Gunma Univ, Grad Sch Med, Heavy Ion Med Ctr, Maebashi, Gunma, Japan; [Ando, Ken] Gunma Prefectural Canc Ctr, Dept Radiat Oncol, Ota, Gunma, Japan; [Shozu, Makio] Chiba Univ, Grad Sch Med, Dept Reprod Med, Chiba, Japan	Wakatsuki, M (reprint author), Natl Inst Radiol Sci, Res Ctr Charged Particle Therapy, Chiba 260, Japan.	masaru.wakatsuki@nifty.com			Research Project with Heavy Ions at the National Institute of Radiological Sciences; Japan Society for the Promotion of Science [26861026]	This work was supported by the Research Project with Heavy Ions at the National Institute of Radiological Sciences and Grant-in-Aid for Young Scientists B for Japan Society for the Promotion of Science Grant Number 26861026.	Gouy S, 2012, LANCET ONCOL, V13, pE212, DOI 10.1016/S1470-2045(12)70011-6; Tsujii H, 2012, JPN J CLIN ONCOL, V42, P670, DOI 10.1093/jjco/hys104; Eifel PJ, 2004, J CLIN ONCOL, V22, P872, DOI 10.1200/JCO.2004.07.197; Toita T, 2012, GYNECOL ONCOL, V126, P211, DOI 10.1016/j.ygyno.2012.04.036; Gandhi AK, 2013, INT J RADIAT ONCOL, V87, P542, DOI 10.1016/j.ijrobp.2013.06.2059; Beriwal S, 2007, INT J RADIAT ONCOL, V68, P166, DOI 10.1016/j.ijrobp.2006.12.023; Parker K, 2009, INT J RADIAT ONCOL, V74, P140, DOI 10.1016/j.ijrobp.2008.06.1920; COX JD, 1995, INT J RADIAT ONCOL, V31, P1341, DOI 10.1016/0360-3016(95)00060-C; Ando K, 1998, INT J RADIAT BIOL, V74, P129, DOI 10.1080/095530098141799; BERMAN ML, 1984, GYNECOL ONCOL, V19, P8, DOI 10.1016/0090-8258(84)90151-3; Kanai T, 1997, RADIAT RES, V147, P78, DOI 10.2307/3579446; Varia MA, 1998, INT J RADIAT ONCOL, V42, P1015, DOI 10.1016/S0360-3016(98)00267-3; Kanai T, 1999, INT J RADIAT ONCOL, V44, P201, DOI 10.1016/S0360-3016(98)00544-6; Poorvu PD, 2013, INT J RADIAT ONCOL, V85, P1262, DOI 10.1016/j.ijrobp.2012.10.004; Grigsby PW, 2001, INT J RADIAT ONCOL, V51, P982, DOI 10.1016/S0360-3016(01)01723-0; Kato S, 2006, INT J RADIAT ONCOL, V65, P388, DOI 10.1016/j.jrobp.2005.12.050; HAIE C, 1988, RADIOTHER ONCOL, V11, P101, DOI 10.1016/0167-8140(88)90245-9; Pearcey R, 2002, J CLIN ONCOL, V20, P966, DOI 10.1200/JCO.20.4.966; Endo M, 1996, JPN SOC THER RADIOL, V8, P231; Ferrandina G, 2014, INT J RADIAT ONCOL, V90, P778, DOI 10.1016/j.ijrobp.2014.07.033; Nakano T, 1999, CANCER J SCI AM, V5, P362; NELSON JH, 1977, AM J OBSTET GYNECOL, V128, P336; ROTMAN M, 1995, JAMA-J AM MED ASSOC, V274, P387, DOI 10.1001/jama.274.5.387; Small W, 2007, INT J RADIAT ONCOL, V68, P1081, DOI 10.1016/j.ijrobp.2007.01.026; Wakatsuki M, 2014, CANCER-AM CANCER SOC, V120, P1663, DOI 10.1002/cncr.28621; Wakatsuki M, 2014, GYNECOL ONCOL, V132, P87, DOI 10.1016/j.ygyno.2013.10.021; Wakatsuki M, 2015, J RADIAT RES, V56, P523, DOI 10.1093/jrr/rru117	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0127587	10.1371/journal.pone.0127587		11	Multidisciplinary Sciences	Science & Technology - Other Topics	CI7CV	WOS:000354921400126		
J	Zhu, B; Mizoguchi, T; Kojima, T; Nakano, H				Zhu, Bo; Mizoguchi, Takuro; Kojima, Takaaki; Nakano, Hideo			Ultra-High-Throughput Screening of an In Vitro-Synthesized Horseradish Peroxidase Displayed on Microbeads Using Cell Sorter	PLOS ONE			English	Article							FREE PROTEIN-SYNTHESIS; ESCHERICHIA-COLI; DIRECTED EVOLUTION; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL EXPRESSION; MANGANESE PEROXIDASE; CODON USAGE; ENZYME; ASSAY; AMPLIFICATION	The C1a isoenzyme of horseradish peroxidase (HRP) is an industrially important heme-containing enzyme that utilizes hydrogen peroxide to oxidize a wide variety of inorganic and organic compounds for practical applications, including synthesis of fine chemicals, medical diagnostics, and bioremediation. To develop a ultra-high-throughput screening system for HRP, we successfully produced active HRP in an Escherichia coli cell-free protein synthesis system, by adding disulfide bond isomerase DsbC and optimizing the concentrations of hemin and calcium ions and the temperature. The biosynthesized HRP was fused with a single-chain Cro (scCro) DNA-binding tag at its N-terminal and C-terminal sites. The addition of the scCro-tag at both ends increased the solubility of the protein. Next, HRP and its fusion proteins were successfully synthesized in a water droplet emulsion by using hexadecane as the oil phase and SunSoft No. 818SK as the surfactant. HRP fusion proteins were displayed on microbeads attached with double-stranded DNA (containing the scCro binding sequence) via scCro-DNA interactions. The activities of the immobilized HRP fusion proteins were detected with a tyramide-based fluorogenic assay using flow cytometry. Moreover, a model microbead library containing wild type hrp (WT) and inactive mutant (MUT) genes was screened using fluorescence-activated cell-sorting, thus efficiently enriching the WT gene from the 1: 100 (WT: MUT) library. The technique described here could serve as a novel platform for the ultra-high-throughput discovery of more useful HRP mutants and other heme-containing peroxidases.	[Zhu, Bo; Mizoguchi, Takuro; Kojima, Takaaki; Nakano, Hideo] Nagoya Univ, Grad Sch Bioagr Sci, Mol Biotechnol Lab, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Nakano, H (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Mol Biotechnol Lab, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	hnakano@agr.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [23360367, 26119707]; Program for Leading Graduate Schools "Integrative Graduate Education and Research in Green Natural Sciences", MEXT, Japan	This work was supported in part by a Grant-in-Aid for Scientific Research (B) (No. 23360367) (to HN) and a Grant-in-Aid for Scientific Research on Innovative Areas (No. 26119707) (to HN) aimed at Synthetic Biology for the Comprehension of Biological Networks from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan (http://www.mext.go.jp/), as well as the Program for Leading Graduate Schools "Integrative Graduate Education and Research in Green Natural Sciences" (http://iger.bio.nagoya-u.ac.jp/), MEXT, Japan.	Veitch NC, 2004, PHYTOCHEMISTRY, V65, P249, DOI 10.1016/j.phytochem.2003.10.022; Hopman AHN, 1998, J HISTOCHEM CYTOCHEM, V46, P771; Ninomiya R, 2014, J BIOSCI BIOENG, V117, P652, DOI 10.1016/j.jbiosc.2013.11.003; BUDWITNOVOTNY DA, 1986, CANCER RES, V46, P5419; Miyazaki-Imamura C, 2003, PROTEIN ENG, V16, P423, DOI 10.1093/protein/gzg054; Kaltenbach M, 2012, LAB CHIP, V12, P4185, DOI 10.1039/c2lc40281e; Puigbo P, 2007, NUCLEIC ACIDS RES, V35, pW126, DOI 10.1093/nar/gkm219; MOLLNES TE, 1985, SCAND J IMMUNOL, V22, P197, DOI 10.1111/j.1365-3083.1985.tb01871.x; Diamante L, 2013, PROTEIN ENG DES SEL, V26, P713, DOI 10.1093/protein/gzt039; SMITH AT, 1990, J BIOL CHEM, V265, P13335; Delvaux M, 2005, BIOSENS BIOELECTRON, V20, P1587, DOI 10.1016/j.bios.2004.07.017; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Caschera F, 2014, BIOCHIMIE, V99, P162, DOI 10.1016/j.biochi.2013.11.025; BOBROW MN, 1989, J IMMUNOL METHODS, V125, P279, DOI 10.1016/0022-1759(89)90104-X; Morawski B, 2001, BIOTECHNOL BIOENG, V76, P99, DOI 10.1002/bit.1149; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Morawski B, 2000, PROTEIN ENG, V13, P377, DOI 10.1093/protein/13.5.377; Sabourin M, 2007, YEAST, V24, P39, DOI 10.1002/yea.1431; Newmyer SL, 1996, BIOCHEMISTRY-US, V35, P12788, DOI 10.1021/bi9609331; Agresti JJ, 2010, P NATL ACAD SCI USA, V107, P4004, DOI 10.1073/pnas.0910781107; Guang HM, 2006, ACTA PHARMACOL SIN, V27, P760, DOI 10.1111/j.1745-7254.2006000336.x; Kondo A, 2000, J BIOSCI BIOENG, V90, P600, DOI 10.1263/jbb.90.600; BARTONEKROXA E, 1994, J BIOTECHNOL, V37, P133, DOI 10.1016/0168-1656(94)90004-3; Bernath K, 2005, J MOL BIOL, V345, P1015, DOI 10.1016/j.jmb.2004.11.017; Demmano G, 1996, EUR J BIOCHEM, V238, P785, DOI 10.1111/j.1432-1033.1996.0785w.x; EGOROV AM, 1991, ANN NY ACAD SCI, V646, P35; FUJIYAMA K, 1988, EUR J BIOCHEM, V173, P681, DOI 10.1111/j.1432-1033.1988.tb14052.x; Gan R, 2010, J BIOSCI BIOENG, V109, P411, DOI 10.1016/j.jbiosc.2009.10.009; Gan R, 2008, BIOTECHNOL PROGR, V24, P1107, DOI [10.1002/btpr.43, 10.1021/bp.43]; Gazaryan IG, 1999, BIOCHEM BIOPH RES CO, V262, P297, DOI 10.1006/bbrc.1999.1155; GAZARYAN IG, 1995, RUSS CHEM B+, V44, P363; Howes BD, 2001, J BIOL CHEM, V276, P40704, DOI 10.1074/jbc.M107489200; Jana R, 1998, BIOCHEMISTRY-US, V37, P6446, DOI 10.1021/bi980152v; Levy I, 2003, BIOTECHNOL BIOENG, V82, P223, DOI 10.1002/bit.10562; Lin ZL, 1999, BIOTECHNOL PROGR, V15, P467, DOI 10.1021/bp990037r; NIRENBERG M, 1961, P NATL ACAD SCI USA, V47, P1588, DOI 10.1073/pnas.47.10.1588; Nilsson MTI, 2004, BIOCHEMISTRY-US, V43, P12038, DOI 10.1021/bi049122k; ORTLEPP SA, 1989, J BIOTECHNOL, V11, P353, DOI 10.1016/0168-1656(89)90019-9; Stapleton JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015275; WELINDER KG, 1976, FEBS LETT, V72, P19, DOI 10.1016/0014-5793(76)80804-6	40	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							UNSP e0127479	10.1371/journal.pone.0127479		17	Multidisciplinary Sciences	Science & Technology - Other Topics	CI7CV	WOS:000354921400122		
J	Fujioka, H; Matsumoto, N; Ohta, R; Yamakawa, M; Shimizu, N; Kimura, T; Murai, K				Fujioka, Hiromichi; Matsumoto, Nao; Ohta, Reiya; Yamakawa, Maki; Shimizu, Nozomi; Kimura, Takashi; Murai, Kenichi			Organic synthesis based on the Beckmann fragmentation: generation of an electrophilic salt intermediate and successive C-C bond formation using Gilman reagents	TETRAHEDRON LETTERS			English	Article						Beckmann fragmentation; Electrophilic salt intermediate; Stable synthetic oxonium ion equivalent; C-C bond formation; Gilman reagent	ALKOXYCYCLOALKANONE OXIME ACETATES; REARRANGEMENT; NUCLEOPHILES; COMBINATION	The intermediate formed during the Beckmann fragmentation was successfully trapped as a collidinium salt, which was subsequently reacted with a variety of different Gilman reagents to give the corresponding addition products in good yields. Reaction mechanism was also investigated. (C) 2015 Elsevier Ltd. All rights reserved.	[Fujioka, Hiromichi; Matsumoto, Nao; Ohta, Reiya; Yamakawa, Maki; Shimizu, Nozomi; Kimura, Takashi; Murai, Kenichi] Osaka Univ, Grad Sch Pharmaceut Sci, Osaka 5650871, Japan	Fujioka, H (reprint author), Osaka Univ, Grad Sch Pharmaceut Sci, 1-6 Yamada Oka Suita, Osaka 5650871, Japan.	fujioka@phs.osaka-u.ac.jp					Krishna UM, 2010, TETRAHEDRON LETT, V51, P2148, DOI 10.1016/j.tetlet.2010.02.075; Fujioka H, 2004, J AM CHEM SOC, V126, P11800, DOI 10.1021/ja046103p; Fujioka H, 2011, TETRAHEDRON, V67, P2949, DOI 10.1016/j.tet.2011.02.048; Blaszczyk K, 2006, TETRAHEDRON, V62, P1069, DOI 10.1016/j.tet.2005.11.005; FUJIOKA H, 1991, J CHEM SOC CHEM COMM, P533, DOI 10.1039/c39910000533; FUJIOKA H, 1991, TETRAHEDRON LETT, V32, P5367, DOI 10.1016/S0040-4039(00)92387-6; Fujioka H, 2012, CHEM-ASIAN J, V7, P1925, DOI 10.1002/asia.201200234; Fujioka H, 2012, CHEM-ASIAN J, V7, P367, DOI 10.1002/asia.201100812; Fujioka H., 2006, J AM CHEM SOC, V128, P5930; Fujioka H, 2006, SYNLETT, P3077, DOI 10.1055/s-2006-951509; FUJIOKA H, 1990, TETRAHEDRON LETT, V31, P5951, DOI 10.1016/S0040-4039(00)98002-X; Fujioka H, 2007, J ORG CHEM, V72, P7898, DOI 10.1021/jo071187g; Iglesias-Arteaga MA, 2004, TETRAHEDRON LETT, V45, P4921, DOI 10.1016/j.tetlet.2004.04.119; Laxmisha MS, 2000, TETRAHEDRON LETT, V41, P3759, DOI 10.1016/S0040-4039(00)00486-X; Matsumoto K., 2009, TETRAHEDRON, V65, P10901; Minamitsuji Y, 2012, ADV SYNTH CATAL, V354, P1861, DOI 10.1002/adsc.201200290; Mukaiyama T., 1987, SYNTHESIS, P1043; Passacantilli P, 2004, EUR J ORG CHEM, P5083, DOI 10.1002/ejoc.200400498	18	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0040-4039			TETRAHEDRON LETT	Tetrahedron Lett.	MAY 20	2015	56	21					2656	2658		10.1016/j.tetlet.2015.03.089		3	Chemistry, Organic	Chemistry	CI8QI	WOS:000355036400004		
J	Osawa, A; Kaseya, Y; Koue, N; Schrader, J; Knief, C; Vorholt, JA; Sandmann, G; Shindo, K				Osawa, Ayako; Kaseya, Yui; Koue, Nao; Schrader, Jens; Knief, Claudia; Vorholt, Julia A.; Sandmann, Gerhard; Shindo, Kazutoshi			4-[2-O-11Z-Octadecenoyl-beta-glucopyranosyl]-4,4 '-diapolycopene-4,4 '-dioic acid and 4-[2-O-9Z-hexadecenoyl-beta-glucopyranosyl]-4,4 '-diapolycopene-4,4 '-dioic acid: new C-30-carotenoids produced by Methylobacterium	TETRAHEDRON LETTERS			English	Article						Carotenoid; 4,4 '-Diapolycopenedioic acid; Methylobacterium; Singlet oxygen quenching activity	ANTIOXIDATIVE ACTIVITIES; RARE CAROTENOIDS; PHYLLOSPHERE; DERIVATIVES; BACTERIA	During the course of screening for antioxidative carotenoids from bacteria, we isolated two novel C-30 carotenoids, 4-[2-O-11Z-octadecenoyl-beta-glucopyranosyl]-4,4'-diapolycopene-4,4'-dioic acid (1) and 4-[2-O-9Z-hexadecenoyl-beta-glucopyranosyl]-4,4'-diapolycopene-4,4'-dioic acid (2), from Methylobacterium strains. These compounds possessed the common structure 'beta-D-glucosyl 4,4'-diapolycopene-4,4'-dioic acid', while the fatty acid attached at the C-2 position of glucose differed. In the singlet oxygen (O-1(2)) quenching model, both 1 and 2 exhibited potent antioxidative activities (IC50: 3.2 and 3.6 mu M, respectively). (C) 2015 Elsevier Ltd. All rights reserved.	[Osawa, Ayako; Kaseya, Yui; Koue, Nao; Shindo, Kazutoshi] Japan Womens Univ, Dept Food & Nutr, Bunkyo Ku, Tokyo 1128681, Japan; [Schrader, Jens] DECHEMA Res Inst, Biochem Engn, D-60486 Frankfurt, Germany; [Knief, Claudia; Vorholt, Julia A.] ETH, Inst Microbiol, CH-8093 Zurich, Switzerland; [Sandmann, Gerhard] Goethe Univ Frankfurt, Inst Mol Biosci, Biosynth Grp, D-60438 Frankfurt, Germany	Shindo, K (reprint author), Japan Womens Univ, Dept Food & Nutr, Bunkyo Ku, 2-8-1 Mejirodai, Tokyo 1128681, Japan.	kshindo@fc.jwu.ac.jp	Knief, Claudia/H-1221-2013	Knief, Claudia/0000-0001-9939-6241			Chew EY, 2013, JAMA-J AM MED ASSOC, V309, P2005, DOI 10.1001/jama.2013.4997; Aken V. B., 2004, APPL ENVIRON MICROB, V70, P508; Anderson B., 1973, LIPIDS, V9, P185; KLEINIG H, 1979, Z NATURFORSCH C, V34, P181; MIKI W, 1991, PURE APPL CHEM, V63, P141, DOI 10.1351/pac199163010141; Shindo K, 2008, J ANTIBIOT, V61, P729, DOI 10.1038/ja.2008.86; Shimidzu N, 1996, FISHERIES SCI, V62, P134; Shindo K, 2007, APPL MICROBIOL BIOT, V74, P1350, DOI 10.1007/s00253-006-0774-y; Schrader Jens, 2009, Trends Biotechnol, V27, P107, DOI 10.1016/j.tibtech.2008.10.009; Stiefel P, 2013, APPL ENVIRON MICROB, V79, P4895, DOI 10.1128/AEM.01087-13; SATO K, 1978, FEBS LETT, V85, P207, DOI 10.1016/0014-5793(78)80456-6; Britton G., 2004, CAROTENOIDS HDB; Ito H., 1971, BIOL CHEM, V35, P1566; Kato Y, 2005, J GEN APPL MICROBIOL, V51, P287, DOI 10.2323/jgam.51.287; Kikuchi N, 2011, BIOSCI BIOTECH BIOCH, V75, P764, DOI 10.1271/bbb.100742; Knief C, 2012, ANTON LEEUW INT J G, V101, P169, DOI 10.1007/s10482-011-9650-6; Knief C, 2008, APPL ENVIRON MICROB, V74, P2218, DOI 10.1128/AEM.02532-07; Knief C, 2010, MICROB ECOL, V60, P440, DOI 10.1007/s00248-010-9725-3; Konovalova H. M., 2007, MIKROBIOLOHICHNYI ZH, V1993, P35; Osawa A, 2013, J OLEO SCI, V62, P955, DOI 10.5650/jos.62.955; Osawa A, 2011, BIOSCI BIOTECH BIOCH, V75, P2142, DOI 10.1271/bbb.110441; Sharoni Y, 2012, AM J CLIN NUTR, V96, p1173S, DOI 10.3945/ajcn.112.034645; Shindo K, 2008, J ANTIBIOT, V61, P185, DOI 10.1038/ja.2008.128; Vlahov G, 2002, J AGR FOOD CHEM, V50, P970, DOI 10.1021/jf011054a; Vorholt A. J., 2012, NAT REV MICROBIOL, V10, P828	25	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0040-4039			TETRAHEDRON LETT	Tetrahedron Lett.	MAY 20	2015	56	21					2791	2794		10.1016/j.tetlet.2015.04.042		4	Chemistry, Organic	Chemistry	CI8QI	WOS:000355036400036		
J	Tokairin, Y; Takeda, S; Kikuchi, M; Konno, H				Tokairin, Yoshinori; Takeda, Sho; Kikuchi, Mari; Konno, Hiroyuki			Synthetic study of on homophymine B: solid phase synthesis of a cyclic fragment	TETRAHEDRON LETTERS			English	Article						Homophymine B; Unusual amino acid; Anti-HIV activity; Cyclic depsipeptide	PAPUA-NEW-GUINEA; STEREOSELECTIVE-SYNTHESIS; CALLIPELTIN-A; (2R,3R,4S)-3-HYDROXY-2,4,6-TRIMETHYLHEPTANOIC ACID; ABSOLUTE STEREOCHEMISTRY; ASYMMETRIC-SYNTHESIS; THEONELLA-SWINHOEI; NATURAL-PRODUCTS; DEPSIPEPTIDES; CONFIGURATION	The synthesis of a cyclic fragment of homophymine B is described. Fmoc-derivatives of beta MOT and AHDH, which were necessary unusual amino acids for a designed cyclic depsipeptide, were prepared. The linear peptides were synthesized using Fmoc-based solid phase peptide synthesis. The designed cyclic depsipeptide was constructed via the macrolactamization between the Pip and D-Asp residues of the corresponding linear peptide with PyBOP/HOAt/DIPEA in DMF followed by global deprotection to give the cyclic fragment of homophymine B. (C) 2015 Elsevier Ltd. All rights reserved.	[Tokairin, Yoshinori; Takeda, Sho; Kikuchi, Mari; Konno, Hiroyuki] Yamagata Univ, Grad Sch Sci & Technol, Dept Biol Engn, Yonezawa, Yamagata 9928510, Japan	Konno, H (reprint author), Yamagata Univ, Grad Sch Sci & Technol, Dept Biol Engn, Yonezawa, Yamagata 9928510, Japan.				Japan Society for the Promotion of the Science [25450145]	This work was supported in part by a Grant-in aid from the Japan Society for the Promotion of the Science (25450145) to H.K.	Acevedo CM, 2001, TETRAHEDRON, V57, P6353, DOI 10.1016/S0040-4020(01)00501-4; Ratnayake AS, 2006, J NAT PROD, V69, P1582, DOI 10.1021/np060229d; Oku N, 2004, J NAT PROD, V67, P1407, DOI 10.1021/np040003f; Matsumori N, 1999, J ORG CHEM, V64, P866, DOI 10.1021/jo981810k; Okamoto N, 2001, TETRAHEDRON-ASYMMETR, V12, P1353, DOI 10.1016/S0957-4166(01)00231-2; El-Faham A, 2009, CHEM-EUR J, V15, P9404, DOI 10.1002/chem.200900615; Ford PW, 1999, J AM CHEM SOC, V121, P5899, DOI 10.1021/ja990582o; Zampella A, 1996, J AM CHEM SOC, V118, P6202, DOI 10.1021/ja954287p; Bifulco G, 2007, CHEM REV, V107, P3744, DOI 10.1021/cr030733c; Plaza A, 2007, J NAT PROD, V70, P1753, DOI 10.1021/np070306k; Guerlavais V, 2002, TETRAHEDRON-ASYMMETR, V13, P675, DOI 10.1016/S0957-4166(02)00045-9; Coello L, 2014, J NAT PROD, V77, P298, DOI 10.1021/np400888e; Cranfill DC, 2005, ORG LETT, V7, P5881, DOI 10.1021/o1052438f; Kikuchi M, 2013, TETRAHEDRON, V69, P7098, DOI 10.1016/j.tet.2013.06.027; Kikuchi M, 2014, HETEROCYCLES, V89, P1620, DOI 10.3987/COM-14-13003; Kikuchi M, 2014, ORG LETT, V16, P4324, DOI 10.1021/ol5020619; Konno H, 2007, SYNTHESIS-STUTTGART, P3666, DOI 10.1055/s-2007-990848; Ling R., 2008, J ORG CHEM, V73, P5319; Ohtaka J, 2013, CHEM PHARM BULL, V61, P245; Pelay-Gimeno M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3352; Tokairin Y, 2015, SYNTHESIS-STUTTGART, V47, P351, DOI 10.1055/s-0034-1378902; Turk JA, 2003, J ORG CHEM, V68, P7841, DOI 10.1021/jo034738l; Zampella A, 2009, ORG BIOMOL CHEM, V7, P4037, DOI 10.1039/b910015f; Zampella A, 2002, TETRAHEDRON-ASYMMETR, V13, P681, DOI 10.1016/S0957-4166(02)00178-7; Zampella A, 2002, TETRAHEDRON-ASYMMETR, V13, P1237, DOI 10.1016/S0957-4166(02)00328-2	25	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0040-4039			TETRAHEDRON LETT	Tetrahedron Lett.	MAY 20	2015	56	21					2809	2812		10.1016/j.tetlet.2015.04.044		4	Chemistry, Organic	Chemistry	CI8QI	WOS:000355036400040		
J	Kishii, N; Negishi, S; Yamada, T; Sugimura, H				Kishii, Naomi; Negishi, Saeka; Yamada, Takeshi; Sugimura, Hideyuki			Stereoselective access to (Z)-alpha,gamma-diazido-alpha,beta-unsaturated esters via Lewis acid-mediated 1,3-diazidation of alpha,alpha-dimethoxy-beta,gamma-unsaturated esters with trimethylsilyl azide	TETRAHEDRON LETTERS			English	Article						1,3-Diazidation; Trimethylsilyl azide; (Z)-2,4-Diazido-2-alkenoate; 2,2-Dimethoxy-3-alkenoate; Huisgen cycloaddition	ALPHA-DIAZOCARBONYL COMPOUNDS; VINYL AZIDES; 1,3-DICARBONYL COMPOUNDS; CLICK CHEMISTRY; HYDRAZONYL CHLORIDES; ALLYLIC AZIDES; FACILE; CYCLOADDITION; REARRANGEMENT; DERIVATIVES	The synthesis of alpha,gamma-diazido-alpha,beta-unsaturated esters is carried out via a Lewis acid-mediated 1,3-diazidation of alpha,alpha-dimethoxy-beta,gamma-unsaturated esters using two equivalents of trimethylsilyl azide. The reaction proceeds in a highly stereoselective manner to provide only the (Z)-stereoisomers of the diazide products. The optimization and scope of the new method are discussed, and the utility of the products is demonstrated in the synthesis of bis-1,2,3-triazole derivatives. (C) 2015 Elsevier Ltd. All rights reserved.	[Kishii, Naomi; Negishi, Saeka; Yamada, Takeshi; Sugimura, Hideyuki] Aoyama Gakuin Univ, Fac Sci & Technol, Dept Chem & Biosci, Chuo Ku, Sagamihara, Kanagawa 2525258, Japan	Sugimura, H (reprint author), Aoyama Gakuin Univ, Fac Sci & Technol, Dept Chem & Biosci, Chuo Ku, 5-10-1 Fuchinobe, Sagamihara, Kanagawa 2525258, Japan.	sugimura@chem.aoyama.ac.jp					Becer CR, 2009, ANGEW CHEM INT EDIT, V48, P4900, DOI 10.1002/anie.200900755; Wang YF, 2009, J AM CHEM SOC, V131, P12570, DOI 10.1021/ja905110c; MAAG H, 1992, J ORG CHEM, V57, P5823, DOI 10.1021/jo00048a010; SCRIVEN EFV, 1988, CHEM REV, V88, P297, DOI 10.1021/cr00084a001; Chen ZB, 2009, J ORG CHEM, V74, P903, DOI 10.1021/jo802159g; Feldman AK, 2005, J AM CHEM SOC, V127, P13444, DOI 10.1021/ja050622q; Wang YF, 2008, ORG LETT, V10, P5019, DOI 10.1021/ol802120u; Meldal M, 2008, CHEM REV, V108, P2952, DOI 10.1021/cr0783479; Moses JE, 2007, CHEM SOC REV, V36, P1249, DOI 10.1039/b613014n; Stokes BJ, 2007, J AM CHEM SOC, V129, P7500, DOI 10.1021/ja072219k; Padwa A, 1997, TETRAHEDRON LETT, V38, P5087, DOI 10.1016/S0040-4039(97)01133-7; Yu WW, 2013, TETRAHEDRON, V69, P1953, DOI 10.1016/j.tet.2012.11.041; Brase S, 2005, ANGEW CHEM INT EDIT, V44, P5188, DOI 10.1002/anie.200400657; Yang YY, 2008, J ORG CHEM, V73, P3928, DOI 10.1021/jo8003259; NISHIYAMA K, 1987, TETRAHEDRON, V43, P693, DOI 10.1016/S0040-4020(01)90003-1; GAGNEUX A, 1960, J AM CHEM SOC, V82, P5956, DOI 10.1021/ja01507a045; Zou HB, 2011, TETRAHEDRON, V67, P4887, DOI 10.1016/j.tet.2011.04.103; Ng EPJ, 2011, TETRAHEDRON, V67, P7728, DOI 10.1016/j.tet.2011.08.006; Hu B, 2011, ORG LETT, V13, P6362, DOI 10.1021/ol202650z; Chiba S, 2008, ORG LETT, V10, P313, DOI 10.1021/ol702727j; Yanai H, 2005, TETRAHEDRON LETT, V46, P8639, DOI 10.1016/j.tetlet.2005.10.053; Driver TG, 2010, ORG BIOMOL CHEM, V8, P3831, DOI 10.1039/c005219c; Bock VD, 2006, EUR J ORG CHEM, P51, DOI 10.1002/ejoc.200500483; Choe Y, 2005, BIOORGAN MED CHEM, V13, P2141, DOI 10.1016/j.bmc.2004.12.053; KIM S, 1994, J CHEM SOC PERK T 1, P2357, DOI 10.1039/p19940002357; KIRCHMEYER S, 1983, SYNTHESIS-STUTTGART, P500; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5; Li Y, 2011, TETRAHEDRON LETT, V52, P4161, DOI 10.1016/j.tetlet.2011.05.147; NISHIYAMA K, 1984, CHEM LETT, P455, DOI 10.1246/cl.1984.455; NISHIYAMA K, 1982, CHEM LETT, P1477, DOI 10.1246/cl.1982.1477; PANEK JS, 1992, J ORG CHEM, V57, P4063, DOI 10.1021/jo00041a002; SUGIMURA H, 1992, B CHEM SOC JPN, V65, P3209, DOI 10.1246/bcsj.65.3209; Sugimura H, 2012, TETRAHEDRON LETT, V53, P4584, DOI 10.1016/j.tetlet.2012.06.078; VANDERWE.CA, 1966, J ORG CHEM, V31, P3534, DOI 10.1021/jo01349a016; Zhang YH, 2013, TETRAHEDRON, V69, P2070, DOI 10.1016/j.tet.2012.11.062	35	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0040-4039			TETRAHEDRON LETT	Tetrahedron Lett.	MAY 20	2015	56	21					2813	2816		10.1016/j.tetlet.2015.04.047		4	Chemistry, Organic	Chemistry	CI8QI	WOS:000355036400041		
J	Torres-Rendon, JG; Femmer, T; De Laporte, L; Tigges, T; Rahimi, K; Gremse, F; Zafarnia, S; Lederle, W; Ifuku, S; Wessling, M; Hardy, JG; Walther, A				Torres-Rendon, Jose Guillermo; Femmer, Tim; De Laporte, Laura; Tigges, Thomas; Rahimi, Khosrow; Gremse, Felix; Zafarnia, Sara; Lederle, Wiltrud; Ifuku, Shinsuke; Wessling, Matthias; Hardy, John G.; Walther, Andreas			Bioactive Gyroid Scaffolds Formed by Sacrificial Templating of Nanocellulose and Nanochitin Hydrogels as Instructive Platforms for Biomimetic Tissue Engineering	ADVANCED MATERIALS			English	Article						3D printing; cellulose nanofibrils; chitin nanofibrils; hydrogel scaffolds; stem cells	NANOFIBRILLAR CELLULOSE HYDROGEL; CHITIN NANOFIBERS; IN-VITRO; NATIVE CELLULOSE; ELASTIC-MODULUS; ALPHA-CHITIN; CELL-CULTURE; REGENERATIVE MEDICINE; MECHANICAL-PROPERTIES; CRYSTALLINE REGIONS		[Torres-Rendon, Jose Guillermo; Femmer, Tim; De Laporte, Laura; Tigges, Thomas; Rahimi, Khosrow; Wessling, Matthias; Walther, Andreas] DWI Leibniz Inst Interact Mat, D-52056 Aachen, Germany; [Femmer, Tim; Wessling, Matthias] Rhein Westfal TH Aachen, Chem Proc Engn AVT CVT, D-52064 Aachen, Germany; [Gremse, Felix; Zafarnia, Sara; Lederle, Wiltrud] Rhein Westfal TH Aachen, Fac Med, Dept Expt Mol Imaging, D-52074 Aachen, Germany; [Ifuku, Shinsuke] Tottori Univ, Grad Sch Engn, Tottori 6808502, Japan; [Hardy, John G.] Queens Univ Belfast, Ctr Med Biol, Sch Pharm, Belfast BT9 7BL, Antrim, North Ireland	Hardy, JG (reprint author), Queens Univ Belfast, Ctr Med Biol, Sch Pharm, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.	johnhardyuk@gmail.com; walther@dwi.rwth-aachen.de	De Laporte, Laura/B-9980-2014; Walther, Andreas/D-4139-2009; 	Walther, Andreas/0000-0002-3662-5606; Wessling, Matthias/0000-0002-7874-5315	BMBF; BMELV; EU; federal state of North Rhine-Westphalia [EFRE 30 00 883 02]; Alexander-von-Humboldt Foundation	The authors thank B. Wang for the AFM measurements, A. Kuhne for initial confocal fluorescence microscopy, I. Bjurhager for orienting mu CT, S. Moli for supporting cell studies, and S. Rutten for supercritical drying. The authors acknowledge the BMBF for funding the AQUAMAT research group and the "ERANET Woodwisdom Program" financed by the BMELV. This work was performed in part at the Center for Chemical Polymer Technology CPT, which was supported by the EU and the federal state of North Rhine-Westphalia (Grant No. EFRE 30 00 883 02). M.W. acknowledges the support of the Alexander-von-Humboldt Foundation. A.W. gratefully acknowledges continuous support from Martin Moller.	Quick AS, 2013, MACROMOL RAPID COMM, V34, P335, DOI 10.1002/marc.201200796; Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6; Ito I, 2014, CARBOHYD POLYM, V101, P464, DOI 10.1016/j.carbpol.2013.09.074; Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049; Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6; Mori T, 1997, BIOMATERIALS, V18, P947, DOI 10.1016/S0142-9612(97)00017-3; Davis ME, 2002, NATURE, V417, P813, DOI 10.1038/nature00785; SAKURADA I, 1962, J POLYM SCI, V57, P651, DOI 10.1002/pol.1962.1205716551; Quick AS, 2014, ADV FUNCT MATER, V24, P3571, DOI 10.1002/adfm.201304030; Ifuku S, 2009, BIOMACROMOLECULES, V10, P1584, DOI 10.1021/bm900163d; Annabi N, 2014, ADV MATER, V26, P85, DOI 10.1002/adma.201303233; Goodrich JD, 2007, BIOMACROMOLECULES, V8, P252, DOI 10.1021/bm0603589; Melchels FPW, 2010, BIOMATERIALS, V31, P6909, DOI 10.1016/j.biomaterials.2010.05.068; Jin JH, 2013, ADV MATER, V25, P4482, DOI 10.1002/adma.201301429; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Reilly GC, 2010, J BIOMECH, V43, P55, DOI 10.1016/j.jbiomech.2009.09.009; Uquillas JA, 2012, ANN BIOMED ENG, V40, P1641, DOI 10.1007/s10439-012-0528-1; Matson JB, 2012, CHEM COMMUN, V48, P26, DOI 10.1039/c1cc15551b; Entcheva E, 2004, BIOMATERIALS, V25, P5753, DOI 10.1016/j.biomaterials.2004.01.024; Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5; Howling GI, 2001, BIOMATERIALS, V22, P2959, DOI 10.1016/S0142-9612(01)00042-4; Ifuku S, 2011, GREEN CHEM, V13, P1708, DOI 10.1039/c1gc15321h; Yanamala N, 2014, ACS SUSTAIN CHEM ENG, V2, P1691, DOI 10.1021/sc500153k; Lang NR, 2013, BIOPHYS J, V105, P1967, DOI 10.1016/j.bpj.2013.09.038; Saito T, 2006, BIOMACROMOLECULES, V7, P1687, DOI 10.1021/bm060154s; Backdahl H, 2008, J TISSUE ENG REGEN M, V2, P320, DOI 10.1002/term.97; Li N, 2012, P NATL ACAD SCI USA, V109, P17360, DOI 10.1073/pnas.1210072109; Rogel MR, 2008, J MATER CHEM, V18, P4233, DOI 10.1039/b804692a; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Culver JC, 2012, ADV MATER, V24, P2344, DOI 10.1002/adma.201200395; Nishino T, 1999, J POLYM SCI POL PHYS, V37, P1191, DOI 10.1002/(SICI)1099-0488(19990601)37:11<1191::AID-POLB13>3.3.CO;2-8; Meyers MA, 2008, PROG MATER SCI, V53, P1, DOI 10.1016/j.pmatsci.2007.05.002; Cardoso L, 2013, J BIOMECH, V46, P253, DOI 10.1016/j.jbiomech.2012.10.025; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Lou YR, 2014, STEM CELLS DEV, V23, P380, DOI 10.1089/scd.2013.0314; Pauloehrl T, 2012, ANGEW CHEM INT EDIT, V51, P9181, DOI 10.1002/anie.201202684; Maude S, 2013, NANOMEDICINE-UK, V8, P823, DOI [10.2217/nnm.13.65, 10.2217/NNM.13.65]; Sannino A, 2009, MATERIALS, V2, P353, DOI 10.3390/ma2020353; Walther A, 2011, ADV MATER, V23, P2924, DOI 10.1002/adma.201100580; CHUNG LY, 1994, J BIOMED MATER RES, V28, P463, DOI 10.1002/jbm.820280409; Kapfer SC, 2011, BIOMATERIALS, V32, P6875, DOI 10.1016/j.biomaterials.2011.06.012; Cai HL, 2014, BIOMACROMOLECULES, V15, P2540, DOI 10.1021/bm5003976; Benitez AJ, 2013, BIOMACROMOLECULES, V14, P4497, DOI 10.1021/bm401451m; Shu XZ, 2003, BIOMATERIALS, V24, P3825, DOI 10.1016/S0142-9612(03)00267-9; Wang M, 2013, ADV MATER, V25, P2428, DOI 10.1002/adma.201300256; Noh HK, 2006, BIOMATERIALS, V27, P3934, DOI 10.1016/j.biomaterials.2006.03.016; Kreno LE, 2012, CHEM REV, V112, P1105, DOI 10.1021/cr200324t; Paakko M, 2007, BIOMACROMOLECULES, V8, P1934, DOI 10.1021/bm061215p; Richter B, 2013, ADV MATER, V25, P6117, DOI 10.1002/adma.201302678; Aguirre CI, 2010, ADV FUNCT MATER, V20, P2565, DOI 10.1002/adfm.201000143; Renders GAP, 2007, J ANAT, V210, P239, DOI 10.1111/j.1469-7580.2007.00693.x; Bhattacharya M, 2012, J CONTROL RELEASE, V164, P291, DOI 10.1016/j.jconrel.2012.06.039; Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421; Sehaqui H, 2011, BIOMACROMOLECULES, V12, P3638, DOI 10.1021/bm2008907; Lee SK, 2004, AM J NEURORADIOL, V25, P25; Watanabe T, 2002, ADV FUNCT MATER, V12, P611, DOI 10.1002/1616-3028(20020916)12:9<611::AID-ADFM611>3.0.CO;2-3; Ke P, 2014, RSC ADV, V4, P39704, DOI 10.1039/c4ra05098c; Choi SW, 2009, ADV MATER, V21, P2997, DOI 10.1002/adma.200803504; Das P, 2012, BIOMACROMOLECULES, V13, P4205, DOI 10.1021/bm3014796; De Laporte L, 2009, MOL THER, V17, P318, DOI 10.1038/mt.2008.252; Ifuku S, 2010, BIOMACROMOLECULES, V11, P1326, DOI 10.1021/bm100109a; Lee Jaimy, 2012, Mod Healthc, V42, P24; Liska R, 2005, J APPL POLYM SCI, V97, P2286, DOI 10.1002/app.22025; Malinen MM, 2014, BIOMATERIALS, V35, P5110, DOI 10.1016/j.biomaterials.2014.03.020; Nectow AR, 2014, J BIOMED MATER RES A, V102, P420, DOI 10.1002/jbm.a.34713; Ogawa Y, 2011, CARBOHYD POLYM, V83, P1213, DOI 10.1016/j.carbpol.2010.09.025; Rolandi M, 2014, ADV COLLOID INTERFAC, V207, P216, DOI 10.1016/j.cis.2014.01.019; Saska S, 2011, INT J BIOMATER, V2011, P8, DOI DOI 10.1155/2011/175362; Torres-Rendon JG, 2014, BIOMACROMOLECULES, V15, P2709, DOI 10.1021/bm500566m; Zhao N, 2014, ADV MATER, V26, P6994, DOI 10.1002/adma.201401718	70	6	6	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0935-9648	1521-4095		ADV MATER	Adv. Mater.	MAY 20	2015	27	19					2989	2995		10.1002/adma.201405873		7	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CI1FH	WOS:000354487700004		
J	Izawa, S; Nakano, K; Suzuki, K; Hashimoto, K; Tajima, K				Izawa, Seiichiro; Nakano, Kyohei; Suzuki, Kaori; Hashimoto, Kazuhito; Tajima, Keisuke			Dominant Effects of First Monolayer Energetics at Donor/Acceptor Interfaces on Organic Photovoltaics	ADVANCED MATERIALS			English	Article						cascade energy landscape; charge recombination; charge separation; donor; acceptor interfaces; organic photovoltaics	HETEROJUNCTION SOLAR-CELLS; CHARGE SEPARATION; ELECTRIC-FIELD; DEVICES; RECOMBINATION; ENERGY; STATES; PERFORMANCE; GENERATION		[Izawa, Seiichiro; Nakano, Kyohei; Suzuki, Kaori; Tajima, Keisuke] RIKEN, CEMS, Wako, Saitama 3510198, Japan; [Izawa, Seiichiro; Hashimoto, Kazuhito] Univ Tokyo, Grad Sch Engn, Dept Appl Chem, Bunkyo Ku, Tokyo 1138656, Japan; [Tajima, Keisuke] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan	Tajima, K (reprint author), RIKEN, CEMS, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	keisuke.tajima@riken.jp	Tajima, Keisuke/D-1530-2009; Hashimoto, Kazuhito/C-5011-2012	Tajima, Keisuke/0000-0003-1590-2640; Hashimoto, Kazuhito/0000-0002-8384-8749	JST, PRESTO; JSPS	The authors thank Professor Ohkita and Dr. Tamai of Kyoto University for their advice on EL measurements. This research was supported by JST, PRESTO. S.I. thanks JSPS for financial support. The authors thank Frontier Carbon Co., Ltd. for providing bisPCBM.	O'Regan BC, 2005, J PHYS CHEM B, V109, P4616, DOI 10.1021/jp0468049; Riedel I, 2004, PHYS STATUS SOLIDI A, V201, P1332, DOI 10.1002/pssa.200404333; Jones ML, 2014, PHYS CHEM CHEM PHYS, V16, P20310, DOI 10.1039/c4cp01626b; Vandewal K, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.125204; Few S, 2015, PHYS CHEM CHEM PHYS, V17, P2311, DOI 10.1039/c4cp03663h; Gao F, 2014, PHYS CHEM CHEM PHYS, V16, P20291, DOI 10.1039/c4cp01814a; Vandewal K, 2013, MACROMOLECULES, V46, P6379, DOI 10.1021/ma400924b; Lakhwani G, 2014, ANNU REV PHYS CHEM, V65, P557, DOI 10.1146/annurev-physchem-040513-103615; Tada A, 2011, NAT MATER, V10, P450, DOI [10.1038/nmat3026, 10.1038/NMAT3026]; Jamieson FC, 2012, CHEM SCI, V3, P485, DOI 10.1039/c1sc00674f; Tan ZK, 2013, ADV MATER, V25, P4131, DOI 10.1002/adma.201300243; Bakulin AA, 2012, SCIENCE, V335, P1340, DOI 10.1126/science.1217745; Wei QS, 2009, ACS APPL MATER INTER, V1, P1865, DOI 10.1021/am9004545; Groves C, 2013, ENERG ENVIRON SCI, V6, P1546, DOI 10.1039/c3ee24455e; Grancini G, 2013, NAT MATER, V12, P29, DOI [10.1038/nmat3502, 10.1038/NMAT3502]; Lenes M, 2008, ADV MATER, V20, P2116, DOI 10.1002/adma.200702438; Vandewal K, 2014, NAT MATER, V13, P63, DOI [10.1038/nmat3807, 10.1038/NMAT3807]; Wei QS, 2009, J AM CHEM SOC, V131, P17597, DOI 10.1021/ja9057053; Shuttle CG, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2891871; Nayak PK, 2013, J PHYS CHEM LETT, V4, P1707, DOI 10.1021/jz4002339; Sweetnam S, 2014, J AM CHEM SOC, V136, P14078, DOI 10.1021/ja505463r; Jailaubekov AE, 2013, NAT MATER, V12, P66, DOI [10.1038/nmat3500, 10.1038/NMAT3500]; Sista S, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2817935; Bilby D, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4831974; Gelinas S, 2014, SCIENCE, V343, P512, DOI 10.1126/science.1246249; Izawa S, 2014, PHYS CHEM CHEM PHYS, V16, P16383, DOI 10.1039/c4cp02305f; Kinoshita Y, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2775085; Lai YC, 2012, SOL ENERG MAT SOL C, V97, P164, DOI 10.1016/j.solmat.2011.07.037; Tada A, 2012, PHYS CHEM CHEM PHYS, V14, P3713, DOI 10.1039/c2cp40198c; Zhong YF, 2014, ADV ENERGY MATER, V4, DOI 10.1002/aenm.201301332; Zhong YF, 2013, ADV MATER, V25, P1071, DOI 10.1002/adma.201203605	31	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0935-9648	1521-4095		ADV MATER	Adv. Mater.	MAY 20	2015	27	19					3025	3031		10.1002/adma.201500840		7	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CI1FH	WOS:000354487700010		
J	Hoque, M; Kawamura, K; Seki, O; Hoshi, N				Hoque, Mozammal; Kawamura, Kimitaka; Seki, Osamu; Hoshi, Naoki			Spatial distributions of dicarboxylic acids, omega-oxoacids, pyruvic acid and alpha-dicarbonyls in the remote marine aerosols over the North Pacific	MARINE CHEMISTRY			English	Article						Marine aerosols; North Pacific; Dicarboxylic acids; Oxalic acid; Water soluble organic carbon; Photochemical degradation	BIOMASS BURNING AEROSOLS; UNSATURATED FATTY-ACIDS; SOLUBLE ORGANIC-CARBON; KETOCARBOXYLIC ACIDS; ATMOSPHERIC AEROSOLS; CHEMICAL-COMPOSITION; PARTICULATE MATTER; WESTERN PACIFIC; POLAR COMPOUNDS; MOLECULAR-DISTRIBUTIONS	To better understand the sources and atmospheric processing of organic aerosols in the remote marine atmosphere, aerosol (TSP) samples were collected over the North Pacific (13 degrees 14'N-53 degrees 37'N and 140 degrees 46'E-179 degrees 54' W) in May-July, 2010 during a cruise of T/V Oshoro Maru, and studied for dicarboxylic acids (C-2-C-11), omega-oxoacids, pyruvic acid and alpha-dicarbonyls as well as organic and elemental carbon, water-soluble organic carbon and total nitrogen. Over the North Pacific, diacids are most abundant followed by omega-oxoacids and alpha-dicarbonyls. Although the molecular compositions of diacids are generally characterized by the predominance of oxalic (C-2) acid, we found a predominance of succinic (C-4) acid in four samples, which were collected in the central northern North Pacific. We consider that photochemical degradation of unsaturated fatty adds emitted from the ocean surface is the main source of C-4 over the central northern North Pacific, where Chlorophyll-a maximized during the cruise. Moreover, seven samples collected in the central northern North and western North Pacific shows predominance of malonic (C-3) acid over C-4, suggesting the photochemical degradation of C-4 to C-3. Spatial distributions of diacids, omega-oxoacids and alpha-dicarbonyls together with total carbon and water soluble total nitrogen contents showed higher abundances in the coastal western North Pacific followed by the central northern North and subtropical Pacific, signifying that continental aerosols are transported long distances to the remote marine atmosphere. (C) 2015 Elsevier B.V. All rights reserved.	[Hoque, Mozammal; Kawamura, Kimitaka; Seki, Osamu] Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 0600819, Japan; [Hoque, Mozammal] Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido 0600819, Japan; [Hoshi, Naoki] Hokkaido Univ, Fac Fisheries Sci, Sapporo, Hokkaido 0600819, Japan	Kawamura, K (reprint author), Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 0600819, Japan.	kawamura@lowtem.hokudai.ac.jp	Kawamura, Kimitaka/B-3839-2011		Japan Society for the Promotion of Science [24221001]; Hokkaido University Special Grant Program	This study was in part supported by the Japan Society for the Promotion of Science (grant-in-aid 24221001) and also by the Hokkaido University Special Grant Program for self-supported international students. We thank the NOAA Air Resource Laboratory (ARL) for the provision of the HYSPILT transport model and READY website (http://www.arl.noaa.gov/ready.php) used in this paper. We also thank the Giovanni online data system, NASA GES DISC for using their Ocean Color Radiometry Online Visualization and Analysis in this study.	Schauer JJ, 1999, ENVIRON SCI TECHNOL, V33, P1566, DOI 10.1021/es980076j; GARRETT WD, 1967, DEEP-SEA RES, V14, P221, DOI 10.1016/0011-7471(67)90007-1; Hoell JM, 1996, J GEOPHYS RES-ATMOS, V101, P1641, DOI 10.1029/95JD00622; Limbeck A, 2001, ATMOS ENVIRON, V35, P1853, DOI 10.1016/S1352-2310(00)00497-0; Andreae MO, 2001, GLOBAL BIOGEOCHEM CY, V15, P955, DOI 10.1029/2000GB001382; Jung JS, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD014339; Yao XH, 2002, ATMOS ENVIRON, V36, P2099; Carlton AG, 2009, ATMOS CHEM PHYS, V9, P4987; Miyazaki Y, 2011, ATMOS CHEM PHYS, V11, P3037, DOI 10.5194/acp-11-3037-2011; Kawamura K, 1996, ATMOS ENVIRON, V30, P1709, DOI 10.1016/1352-2310(95)00395-9; Kawamura K, 2005, ATMOS ENVIRON, V39, P1945, DOI 10.1016/j.atmosenv.2004.12.014; Gao S, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002324; KAWAMURA K, 1993, ANAL CHEM, V65, P3505, DOI 10.1021/ac00071a030; Yamasoe MA, 2000, ATMOS ENVIRON, V34, P1641, DOI 10.1016/S1352-2310(99)00329-5; Carlton AG, 2007, ATMOS ENVIRON, V41, P7588, DOI 10.1016/j.atmosenv.2007.05.035; Kawamura K, 1999, J GEOPHYS RES-ATMOS, V104, P3501, DOI 10.1029/1998JD100041; Kawamura K, 1996, J GEOPHYS RES-ATMOS, V101, P18721, DOI 10.1029/96JD01541; Wang HB, 2005, ATMOS ENVIRON, V39, P5865, DOI 10.1016/j.atmonsenv.2005.06.031; SEMPERE R, 1994, ATMOS ENVIRON, V28, P449, DOI 10.1016/1352-2310(94)90123-6; SAXENA P, 1995, J GEOPHYS RES-ATMOS, V100, P18755, DOI 10.1029/95JD01835; KAWAMURA K, 1993, ENVIRON SCI TECHNOL, V27, P2227, DOI 10.1021/es00047a033; ROGGE WF, 1991, ENVIRON SCI TECHNOL, V25, P1112, DOI 10.1021/es00018a015; Ho KF, 2006, ATMOS CHEM PHYS, V6, P4569; Cao JJ, 2003, ATMOS ENVIRON, V37, P1451, DOI 10.1016/S1352-2310(02)01002-6; KAWAMURA K, 1987, ENVIRON SCI TECHNOL, V21, P105, DOI 10.1021/es00155a014; Jang M, 1997, ENVIRON SCI TECHNOL, V31, P1046, DOI 10.1021/es960559s; Pavuluri CM, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050398; Li YC, 2010, ENVIRON CHEM, V7, P338, DOI 10.1071/EN09167; Kundu S, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD013973; Kundu S, 2010, ATMOS CHEM PHYS, V10, P2209; Saarikoski S, 2008, ATMOS CHEM PHYS, V8, P6281; GAGOSIAN RB, 1987, NATURE, V325, P800, DOI 10.1038/325800a0; TURPIN BJ, 1995, ATMOS ENVIRON, V29, P3527, DOI 10.1016/1352-2310(94)00276-Q; Kunwar B, 2014, ATMOS CHEM PHYS, V14, P1819, DOI 10.5194/acp-14-1819-2014; Kerminen VM, 1999, ATMOS ENVIRON, V33, P2089, DOI 10.1016/S1352-2310(98)00350-1; Kawamura K, 2012, BIOGEOSCIENCES, V9, P4725, DOI 10.5194/bg-9-4725-2012; Kerminen VM, 2000, J AEROSOL SCI, V31, P349, DOI 10.1016/S0021-8502(99)00063-4; FAUST BC, 1993, ENVIRON SCI TECHNOL, V27, P2517, DOI 10.1021/es00048a032; Aggarwal SG, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009365; Castro LM, 1999, ATMOS ENVIRON, V33, P2771, DOI 10.1016/S1352-2310(98)00331-8; Kawamura K, 2004, GEO SOC S P, P243; Kawamura K, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD014299; KAWAMURA K, 1987, NATURE, V325, P330, DOI 10.1038/325330a0; Warneck P, 2003, ATMOS ENVIRON, V37, P2423, DOI 10.1016/S1352-2310(03)00136-5; HATAKEYAMA S, 1987, ENVIRON SCI TECHNOL, V21, P52, DOI 10.1021/es00155a005; BANDOW H, 1985, B CHEM SOC JPN, V58, P2531, DOI 10.1246/bcsj.58.2531; Bikkina S., 2014, GEOPHYS RES LETT, V41; Chu SH, 2005, ATMOS ENVIRON, V39, P1383, DOI 10.1016/j.atmosenv.2004.11.038; Fu P, 2013, MAR CHEM, V148, P22, DOI 10.1016/j.marchem.2012.11.002; GROSJEAN D, 1978, ENVIRON SCI TECHNOL, V12, P313, DOI 10.1021/es60139a005; Hagler GSW, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2007JD008993; Ho KF, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008011; HOFFMAN EJ, 1977, GEOPHYS RES LETT, V4, P449, DOI 10.1029/GL004i010p00449; Kawamura K, 2001, J GEOPHYS RES-ATMOS, V106, P1331, DOI 10.1029/2000JD900465; Kawamura Kimitaka, 1993, Journal of Oceanography, V49, P271, DOI 10.1007/BF02269565; Kawamura K., 1991, B GLACIER RES, V9, P59; KAWAMURA K, 1995, GEOPHYS RES LETT, V22, P1253, DOI 10.1029/95GL00880; KAWAMURA K, 1990, J ATMOS CHEM, V11, P107, DOI 10.1007/BF00053670; Kawamura K., 1995, CHIKYU KAGAKU, V29, P1; Koch D, 2001, J GEOPHYS RES-ATMOS, V106, P20311, DOI 10.1029/2001JD900038; Legrand M, 1996, J GEOPHYS RES-ATMOS, V101, P4129, DOI 10.1029/95JD03296; LI SM, 1993, GEOPHYS RES LETT, V20, P45, DOI 10.1029/92GL02918; Mayol-Bracero OL, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000522; MIYAZAKI Y, 2007, J GEOPHYS RES-ATMOS, V112, DOI DOI 10.1029/2007JD009116; Mochida M, 2003, J GEOPHYS RES-ATMOS, V108, DOI [10.1029/2002JD002355, 10.1029/2002JD003249]; Naja M, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004687; Neususs C., 2002, J GEOPHYS RES, V107, P8037; Nguyen TB, 2010, ATMOS ENVIRON, V44, P1032, DOI 10.1016/j.atmosenv.2009.12.019; NORTON RB, 1983, GEOPHYS RES LETT, V10, P517, DOI 10.1029/GL010i007p00517; Peltzer E. T., 1989, CHEM OCEANOGR, V10, P281; Schuetzle D., 1975, ENVIRON SCI TECHNOL, V9, P838, DOI 10.1021/es60107a007; Sempere R, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001980; Sempere R, 1996, ATMOS ENVIRON, V30, P1609, DOI 10.1016/1352-2310(95)00436-X; SICRE MA, 1990, J GEOPHYS RES-ATMOS, V95, P3649, DOI 10.1029/JD095iD04p03649; STEPHANOU EG, 1992, NATURWISSENSCHAFTEN, V79, P128, DOI 10.1007/BF01131541; Tran NK, 2000, ATMOS ENVIRON, V34, P1845, DOI 10.1016/S1352-2310(99)00071-0; Wang GH, 2002, ATMOS ENVIRON, V36, P1941, DOI 10.1016/S1352-2310(02)00180-2; Wang HB, 2006, J ATMOS CHEM, V53, P43, DOI 10.1007/s10874-006-1479-4; Yu XY, 2009, ATMOS CHEM PHYS, V9, P6793	79	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-4203	1872-7581		MAR CHEM	Mar. Chem.	MAY 20	2015	172						1	11		10.1016/j.marchem.2015.03.003		11	Chemistry, Multidisciplinary; Oceanography	Chemistry; Oceanography	CH9GH	WOS:000354343500001		
J	Oyama, K; Watanabe, N; Yamada, T; Suzuki, M; Sekiguchi, Y; Kondo, T; Yoshida, K				Oyama, Kin-ichi; Watanabe, Noriyuki; Yamada, Tomomi; Suzuki, Masako; Sekiguchi, Yukiko; Kondo, Tadao; Yoshida, Kumi			Efficient and versatile synthesis of 5-O-acylquinic acids with a direct esterification using a p-methoxybenzyl quinate as a key intermediate	TETRAHEDRON			English	Article						5-O-Acylquinic acid; (-)-Quinic acid; PMB quinate; Esterification	STEREOCONTROLLED TOTAL-SYNTHESIS; CHLOROGENIC ACID; SEPAL-COLOR; HYDRANGEA-MACROPHYLLA; N-METHYLIMIDAZOLE; AMIDE FORMATION; SELECTIVE DEPROTECTION; CARBOXYLIC ESTERS; PROTECTING GROUPS; DERIVATIVES	An efficient and versatile synthesis of 5-O-acylquinic acids from commercially available (-)-quinic acid was accomplished. We designed p-methoxybenzyl quinate as a key intermediate, and two problems, the esterification of the sterically hindered 5-OH group for the concise divergent synthesis and the low yield of the final deprotection step, were solved. For the first problem, we improved Tanabe's method, TsCl/NMI-mediated esterification using free carboxylic acids, by the addition of i-Pr2NEt. For the second problem, we established a TFA- or BCl3/C6HMe5-catalyzed deprotection reaction for the final deprotection step. 5-O-Acylquinic acids were synthesized in seven steps with 45-60% overall yield. (C) 2014 Elsevier Ltd. All rights reserved.	[Oyama, Kin-ichi] Nagoya Univ, Res Ctr Mat Sci, Chem Instrumentat Facil, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Watanabe, Noriyuki; Yamada, Tomomi; Suzuki, Masako; Sekiguchi, Yukiko; Kondo, Tadao; Yoshida, Kumi] Nagoya Univ, Grad Sch Informat Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Oyama, K (reprint author), Nagoya Univ, Res Ctr Mat Sci, Chem Instrumentat Facil, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	oyama@nagoya-u.ac.jp; yoshidak@is.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [18032037, 24380062, 18780086]; SUNBOR (Suntory Institute for Bioorganic Research)	This work was supported financially in part by Grant in aid for scientific research in Priority Areas No. 18032037 (K.Y.), Creative Scientific Research in (B) No. 24380062 (K.Y.) and Young Scientists (B) No. 18780086 (K-i.O.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. We also express our gratitude to SUNBOR (Suntory Institute for Bioorganic Research) for the GRANT to K.-i.O.	Smarrito CM, 2008, ORG BIOMOL CHEM, V6, P986, DOI 10.1039/b719132d; Wakasugi K, 2003, ADV SYNTH CATAL, V345, P1209, DOI 10.1002/adsc.200303093; Lee ASY, 2001, TETRAHEDRON, V57, P2121; Xu JG, 2012, J AGR FOOD CHEM, V60, P11625, DOI 10.1021/jf303771s; Kondo T, 2005, TETRAHEDRON LETT, V46, P6645, DOI 10.1016/j.tetlet.2005.07.146; Okano K, 2006, J AM CHEM SOC, V128, P7136, DOI 10.1021/ja0619455; Ma CM, 2007, BIOORGAN MED CHEM, V15, P6830, DOI 10.1016/j.bmc.2007.07.038; Bouzanquet Q, 2012, J AGR FOOD CHEM, V60, P12186, DOI 10.1021/jf3034072; Nakatsuji H, 2006, ADV SYNTH CATAL, V348, P2057, DOI 10.1002/adsc.200600256; Fang NB, 2002, J AGR FOOD CHEM, V50, P3579, DOI 10.1021/jf0201327; Mori M, 2008, PHYTOCHEMISTRY, V69, P3151, DOI 10.1016/j.phytochem.2008.03.015; Boehlow TR, 2001, J ORG CHEM, V66, P3111, DOI 10.1021/jo010015v; Yoshida K, 2009, NAT PROD REP, V26, P884, DOI 10.1039/b800165k; Villarino M, 2011, J AGR FOOD CHEM, V59, P3205, DOI 10.1021/jf104251z; Lipomi DJ, 2004, ORG LETT, V6, P3533, DOI 10.1021/ol048574m; Ramesh C, 2003, J ORG CHEM, V68, P7101, DOI 10.1021/jo030088+; Desvergnes S, 2008, ORG LETT, V10, P2967, DOI 10.1021/ol8007759; Hinklin RJ, 2002, ORG LETT, V4, P1131, DOI 10.1021/ol025514c; TAKEDA K, 1985, PHYTOCHEMISTRY, V24, P2251, DOI 10.1016/S0031-9422(00)83019-8; Frank O, 2006, EUR FOOD RES TECHNOL, V222, P492, DOI 10.1007/s00217-005-0143-6; Yakura T, 2007, TETRAHEDRON, V63, P4429, DOI 10.1016/j.tet.2007.03.079; Teramachi F, 2005, J NAT PROD, V68, P794, DOI 10.1021/np0500631; Kim HJ, 2006, J NAT PROD, V69, P600, DOI 10.1021/np050447r; Sefkow M, 2001, EUR J ORG CHEM, P2735; Hemmerle H, 1997, J MED CHEM, V40, P137, DOI 10.1021/jm9607360; WILLIAMS DR, 1989, J AM CHEM SOC, V111, P1923, DOI 10.1021/ja00187a081; Crozier A, 2009, NAT PROD REP, V26, P1001, DOI 10.1039/b802662a; Hardcastle IR, 2005, J MED CHEM, V48, P7829, DOI 10.1021/jm050444b; Cartron E, 2001, J NAT PROD, V64, P480, DOI 10.1021/np000421u; Tsevegsuren N, 2007, J NAT PROD, V70, P962, DOI 10.1021/np070013r; Jaiswal R, 2010, J AGR FOOD CHEM, V58, P8722, DOI 10.1021/jf1014457; Chellappan SK, 2006, J MED CHEM, V49, P2673, DOI 10.1021/jm051196m; Kurosawa W, 2003, J AM CHEM SOC, V125, P8112, DOI 10.1021/ja036011k; Polaske NW, 2011, MACROMOLECULES, V44, P3203, DOI 10.1021/ma200296t; Armesto N, 2000, TETRAHEDRON LETT, V41, P8759, DOI 10.1016/S0040-4039(00)01507-0; Barradas S, 2012, ORG LETT, V14, P5952, DOI 10.1021/ol302858r; Cappa A, 1999, J ORG CHEM, V64, P5696, DOI 10.1021/jo990014r; Berry NG, 2009, ORG BIOMOL CHEM, V7, P2525, DOI 10.1039/b822777b; Castro CC, 2012, J AGR FOOD CHEM, V60, P7252, DOI 10.1021/jf300389v; Chan E., 2010, NUTR CANC, V62, P1044; Ela MAA, 2012, HELV CHIM ACTA, V95, P61, DOI 10.1002/hlca.201100282; Fellows IM, 2000, J AM CHEM SOC, V122, P10781, DOI 10.1021/ja0013879; Ganton MD, 2007, J ORG CHEM, V72, P574, DOI 10.1021/jo062064j; Hayashi K., 1953, MISC REP RES I NAT R, V29, P1; HAYWARD CM, 1993, J AM CHEM SOC, V115, P9345, DOI 10.1021/ja00073a083; Hsu MC, 2007, J ORG CHEM, V72, P1931, DOI 10.1021/jo061991n; KIM CU, 1985, TETRAHEDRON LETT, V26, P2027, DOI 10.1016/S0040-4039(00)94770-1; Kim KH, 2007, BIOORG MED CHEM LETT, V17, P6739, DOI 10.1016/j.bmcl.2007.10.046; Kitamura M, 1999, ANGEW CHEM INT EDIT, V38, P1229, DOI 10.1002/(SICI)1521-3773(19990503)38:9<1229::AID-ANIE1229>3.0.CO;2-B; Kobayashi Y, 2001, J ORG CHEM, V66, P2011, DOI 10.1021/jo001495d; Ma CH, 2011, J AGR FOOD CHEM, V59, P9645, DOI 10.1021/jf202028y; Matsukawa Y, 2005, J ORG CHEM, V70, P5339, DOI 10.1021/jo050407s; MONTCHAMP JL, 1994, J ORG CHEM, V59, P6999, DOI 10.1021/jo00102a025; Montchamp JL, 1996, J ORG CHEM, V61, P3897, DOI 10.1021/jo960170n; Nakatsuji H, 2008, ORG LETT, V10, P2131, DOI 10.1021/ol800480d; Nakatsuji H, 2007, TETRAHEDRON, V63, P12071, DOI 10.1016/j.tet.2007.08.117; Nandaluru PR, 2012, J ORG CHEM, V77, P8028, DOI 10.1021/jo3012682; Noratto G, 2009, J AGR FOOD CHEM, V57, P5219, DOI 10.1021/jf900259m; Ohtsuki T, 2008, PHYTOTHER RES, V22, P264, DOI 10.1002/ptr.2290; Okano K, 2008, SYNLETT, P1977, DOI 10.1055/s-2008-1077980; Oriyama T, 1998, SYNLETT, P1047; Pooter H. D., 1975, B SOC CHIM BELG, V84, P835; REGEL E, 1977, LIEBIGS ANN CHEM, P145; Robinson WE, 1996, P NATL ACAD SCI USA, V93, P6326, DOI 10.1073/pnas.93.13.6326; Sefkow M, 2001, EUR J ORG CHEM, P1137; Shoji M, 2004, ORG LETT, V6, P4535, DOI 10.1021/ol0481479; Stadlbauer S., 2012, CHEM COMMUN, P8425; Takahashi K, 2006, J ORG CHEM, V71, P4227, DOI 10.1021/jo060410r; TAKEDA K, 1990, PHYTOCHEMISTRY, V29, P1089, DOI 10.1016/0031-9422(90)85409-9; TAKEDA K, 1985, PHYTOCHEMISTRY, V24, P1207, DOI 10.1016/S0031-9422(00)81102-4; TAMURA H, 2006, J MOL NUTR FOOD RES, V50, P396; TANAKA H, 1990, TETRAHEDRON LETT, V31, P6661, DOI 10.1016/S0040-4039(00)97140-5; TORII S, 1991, J ORG CHEM, V56, P3633, DOI 10.1021/jo00011a034; Toyama-Kato Y, 2007, HETEROCYCLES, V72, P239; Twibanire JDK, 2011, ORG LETT, V13, P2988, DOI 10.1021/ol201005s; YAN L, 1995, SYNLETT, P523; Venkateswararao E, 2013, EUR J MED CHEM, V59, P31, DOI 10.1016/j.ejmech.2012.11.007; Wilsdorf M, 2013, ORG LETT, V15, P2494, DOI 10.1021/ol400972m; Yadav JS, 2000, CHEM LETT, P566, DOI 10.1246/cl.2000.566; Yoshida K, 2003, PLANT CELL PHYSIOL, V44, P262, DOI 10.1093/pcp/pcg033	80	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0040-4020			TETRAHEDRON	Tetrahedron	MAY 20	2015	71	20					3120	3130		10.1016/j.tet.2014.08.064		11	Chemistry, Organic	Chemistry	CH6LF	WOS:000354147400022		
J	Hosokawa, S; Inui, M; Kajihara, Y; Tsutsui, S; Baron, AQR				Hosokawa, S.; Inui, M.; Kajihara, Y.; Tsutsui, S.; Baron, A. Q. R.			Transverse excitations in liquid Fe, Cu and Zn	JOURNAL OF PHYSICS-CONDENSED MATTER			English	Article						liquid metals; dynamics; phonons; transverse	X-RAY-SCATTERING; DYNAMICS; BEAMLINE; METALS; FLUIDS; POINT	Transverse acoustic (TA) excitation modes were observed in inelastic x-ray scattering spectra of liquid Fe, Cu and Zn. From the analysis of current correlation functions, we concluded that TA excitation modes can experimentally be detected through the quasi-TA branches in the longitudinal current correlation spectra in these liquid metals. The microscopic elastic constants are estimated and a characteristic difference from macroscopic polycrystalline value was found in Poisson's ratio of liquid Fe, which shows an extremely softer value of similar to 0.38 compared with the macroscopic value of similar to 0.275. The lifetime of the TA modes were determined to be similar to 0.45 ps for liquid Fe and Cu and similar to 0.55 ps for liquid Zn, reflecting different interatomic correlations between liquid transition metals and non-transition metals. The propagation length of the TA modes are similar to 0.85 nm in all of liquid metals, corresponding to the size of icosahedral or similar size of cages formed instantaneously in these liquid metals.	[Hosokawa, S.] Kumamoto Univ, Grad Sch Sci & Technol, Dept Phys, Kumamoto 8608555, Japan; [Inui, M.; Kajihara, Y.] Hiroshima Univ, Grad Sch Integrated Arts & Sci, Higashihiroshima 7398521, Japan; [Tsutsui, S.; Baron, A. Q. R.] SPring 8, Japan Synchrotron Radiat Res Inst, Sayo, Hyogo 6795198, Japan; [Baron, A. Q. R.] RIKEN, RIKEN SPring Ctr 8, Mat Dynam Lab, Mikazuki, Hyogo 6795148, Japan	Hosokawa, S (reprint author), Kumamoto Univ, Grad Sch Sci & Technol, Dept Phys, Kumamoto 8608555, Japan.	hosokawa@sci.kumamoto-u.ac.jp			Japanese Society for Promotion of Science (JSPS) [26610118, 22540403, 20244061]	The authors acknowledge Prof K Matsuda, Dr A Chiba and Dr K Kimura for the help of experiments and discussion. The authors would like to acknowledge the Japanese Society for Promotion of Science (JSPS) for Grant-in-Aids for Scientific Research for the financial supports (Project Nos. 26610118, 22540403 and 20244061). The IXS experiments were performed at the beamline BL35XU in the SPring-8 with the approval of the Japan Synchrotron Radiation Research Institute (JASRI) (Proposal Nos. 2012B1277 and 2009B1074).	Tamura K, 1999, REV SCI INSTRUM, V70, P144, DOI 10.1063/1.1149556; Hosokawa S, 2008, J Phys Condens Matter, V20, P114107, DOI 10.1088/0953-8984/20/11/114107; LEVESQUE D, 1973, PHYS REV A, V7, P1690, DOI 10.1103/PhysRevA.7.1690; Hosokawa S, 2013, AIP CONF PROC, V1518, P695, DOI 10.1063/1.4794661; Hosokawa S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.105502; Di Cicco A, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.135505; HANSEN JP, 1975, PHYS REV A, V11, P1025, DOI 10.1103/PhysRevA.11.1025; Hosokawa S, 2001, REV SCI INSTRUM, V72, P1721, DOI 10.1063/1.1338487; Giordano VM, 2010, P NATL ACAD SCI USA, V107, P21985, DOI 10.1073/pnas.1006319107; Hosokawa S, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/11/112101; Hosokawa S, 2011, EUR PHYS J-SPEC TOP, V196, P85, DOI 10.1140/epjst/e2011-01420-5; Scopigno T, 2005, REV MOD PHYS, V77, P881, DOI 10.1103/RevModPhys.77.881; Hosokawa S, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.174203; NASCH PM, 1994, J GEOPHYS RES-SOL EA, V99, P4285, DOI 10.1029/93JB03111; Giordano VM, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.052201; FRANK FC, 1952, PROC R SOC LON SER-A, V215, P43, DOI 10.1098/rspa.1952.0194; KAHL G, 1994, J PHYS-CONDENS MAT, V6, P10897, DOI 10.1088/0953-8984/6/50/004; Fak B, 1997, PHYSICA B, V234, P1107, DOI 10.1016/S0921-4526(97)00121-X; Baron AQR, 2000, J PHYS CHEM SOLIDS, V61, P461, DOI 10.1016/S0022-3697(99)00337-6; Balucani U., 1994, DYNAMICS LIQUID STAT; Baron AQR, 2001, NUCL INSTRUM METH A, V467, P627, DOI 10.1016/S0168-9002(01)00431-4; Boon J., 1980, MOL HYDRODYNAMICS; Ganesh P, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.014205; Ganesh P, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.134205; Hansen J P, 2006, THEORY SIMPLE LIQUID; Hosokawa S, 2003, CHEM PHYS, V292, P253, DOI 10.1016/S0301-0104(03)00239-8; Iida T., 1993, PHYS PROPERTIES LIQU; Ioffe AF, 1960, PROGRESS SEMICONDUCT, V4, P237; Miwa D, UNPUB; Schenk T, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.075507; SHIMOJO F, 1994, J PHYS SOC JPN, V63, P1821, DOI 10.1143/JPSJ.63.1821; Simmons G., 1971, SINGLE CRYSTAL ELAST; Waseda Y., 1980, STRUCTURE NONCRYSTAL	33	2	2	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0953-8984	1361-648X		J PHYS-CONDENS MAT	J. Phys.-Condes. Matter	MAY 20	2015	27	19							194104	10.1088/0953-8984/27/19/194104		7	Physics, Condensed Matter	Physics	CH1JY	WOS:000353778800006		
J	Ifuku, S; Hori, T; Izawa, H; Morimoto, M; Saimoto, H				Ifuku, Shinsuke; Hori, Taishi; Izawa, Hironori; Morimoto, Minoru; Saimoto, Hiroyuki			Preparation of zwitterionically charged nanocrystals by surface TEMPO-mediated oxidation and partial deacetylation of alpha-chitin	CARBOHYDRATE POLYMERS			English	Article						Chitin; Nanocrystal; TEMPO-mediated oxidation; Deacetylation; Zwitterion	UNIFORM WIDTH; NANOFIBERS; CHITOSAN; SHELLS; MODEL	Zwitterionic nanocrystals were prepared by TEMPO-mediated oxidation, partial deacetylation, and subsequent mechanical disintegration of alpha-chitin. The pH dependence of the morphology, transparency, and viscosity of the nanocrystals were evaluated. After those reactions, the carboxylate and amino group contents of the chitin derivative were 0.45 and 1.26 mmol/g, respectively. After mechanical treatment, the water dispersion consisted of nanocrystals approximately 250 nm long and 10 nm thick. Under acidic and basic conditions, the water dispersions were highly transparent. On the other hand, under neutral conditions, the dispersion was turbid due to the ionic interaction between the cationic and anionic groups on the nanocrystal surface. Although the surface zwitterionic nanocrystals collected from acidic and basic dispersion were randomly oriented due to electrostatic repulsions, nanocrystals formed aggregates in neutral water due to the cationic and anionic interaction between them. Nanocrystals in neutral water had higher viscosity than those in acidic and basic water, since ionic interaction caused nanocrystal networks to form in water. (C) 2015 Elsevier Ltd. All rights reserved.	[Ifuku, Shinsuke; Hori, Taishi; Izawa, Hironori; Saimoto, Hiroyuki] Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, Minami, Tottori 6808552, Japan; [Morimoto, Minoru] Tottori Univ, Res Ctr Biosci & Technol, Minami, Tottori 6808550, Japan	Ifuku, S (reprint author), Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, 4-101 Koyama Cho, Minami, Tottori 6808552, Japan.	sifuku@chem.tottori-u.ac.jp	Izawa, Hironori/M-7037-2014	Izawa, Hironori/0000-0002-8715-8462			Ito I, 2014, CARBOHYD POLYM, V101, P464, DOI 10.1016/j.carbpol.2013.09.074; Ifuku S, 2011, CARBOHYD POLYM, V84, P762, DOI 10.1016/j.carbpol.2010.04.039; Ifuku S, 2009, BIOMACROMOLECULES, V10, P1584, DOI 10.1021/bm900163d; Goodrich JD, 2007, BIOMACROMOLECULES, V8, P252, DOI 10.1021/bm0603589; Azuma K, 2012, CARBOHYD POLYM, V87, P1399, DOI 10.1016/j.carbpol.2011.09.036; MUZZARELLI RAA, 1988, CARBOHYD POLYM, V8, P1, DOI 10.1016/0144-8617(88)90032-X; Azuma K, 2014, J BIOMED NANOTECHNOL, V10, P2891, DOI 10.1166/jbn.2014.1882; Kurita K, 2001, PROG POLYM SCI, V26, P1921, DOI 10.1016/S0079-6700(01)00007-7; Fan YM, 2010, CARBOHYD POLYM, V79, P1046, DOI 10.1016/j.carbpol.2009.10.044; Ifuku S, 2012, NANOSCALE, V4, P3308, DOI 10.1039/c2nr30383c; Azuma K, 2012, CARBOHYD POLYM, V90, P197, DOI 10.1016/j.carbpol.2012.05.023; Fan YM, 2008, BIOMACROMOLECULES, V9, P1919, DOI 10.1021/bm800178b; Gopalan N. K., 2003, BIOMACROMOLECULES, V4, P657; Ifuku S, 2014, RSC ADV, V4, P19246, DOI 10.1039/c4ra01975j; Muzzarelli R. A. A., 2012, POLYM SCI COMPREHENS, V10, P153; Muzzarelli RAA, 1999, CARBOHYD POLYM, V39, P361, DOI 10.1016/S0144-8617(99)00027-2; Zhang YQ, 2005, CARBOHYD RES, V340, P1914, DOI 10.1016/j.carres.2005.05.005	17	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0144-8617	1879-1344		CARBOHYD POLYM	Carbohydr. Polym.	MAY 20	2015	122						1	4		10.1016/j.carbpol.2014.12.060		4	Chemistry, Applied; Chemistry, Organic; Polymer Science	Chemistry; Polymer Science	CG4IQ	WOS:000353249200001		
J	Wang, YH; Wakisaka, M				Wang, Yihan; Wakisaka, Minato			Chitosan nanofibers fabricated by combined ultrasonic atomization and freeze casting	CARBOHYDRATE POLYMERS			English	Article						Chitosan nanofiber; Ultrasonic atomization; Freeze casting; Marine polysaccharides	CHITIN; FIBERS; MATS; DEPOSITION; SCAFFOLDS; HYDROGEL; POLYMERS; DESIGN	Aligned chitosan nanofibers exhibiting diameters smaller than 100 nm were easily prepared by combining ultrasonic atomization with freeze casting. A major advantage of this approach is the use of distilled water as main solvent. Scanning electron microscopy demonstrated that fiber diameter and morphology mainly depended on the atomizing tools, freezing temperature, and chitosan solution viscosity. Minimum diameter and uniform orientation were achieved using an electric flosser as an atomizing tool, liquid nitrogen as a coolant, 0.4 wt% aqueous chitosan solution (molecular weight = 22 kDa), and a small amount of lactic acid as solvent at 0 degrees C. The resulting chitosan nanofibers may find application in biomedical and food engineering. Moreover, this new technology may be applicable to other natural and synthetic water-soluble polymers. (C) 2015 Elsevier Ltd. All rights reserved.	[Wang, Yihan; Wakisaka, Minato] Kyushu Inst Technol, Grad Sch Life Sci & Syst Engn, Wakamatsu Ku, Kitakyushu, Fukuoka 8080196, Japan; [Wang, Yihan] Yangzhou Univ, Sch Food Sci & Engn, Yangzhou 225127, Jiangsu, Peoples R China	Wakisaka, M (reprint author), Kyushu Inst Technol, Grad Sch Life Sci & Syst Engn, Wakamatsu Ku, 2-4 Hibikino, Kitakyushu, Fukuoka 8080196, Japan.	wang-yihan@edulife.kyutech.ac.jp; wakisaka@life.kyutech.ac.jp			Japan Society for the Promotion of Science KAKENHI Grant [25660107]	This work was supported by a Japan Society for the Promotion of Science KAKENHI Grant (no. 25660107).	Ohkawa K, 2004, MACROMOL RAPID COMM, V25, P1600, DOI 10.1002/marc.200400253; Liu H, 2004, INT J FOOD MICROBIOL, V95, P147, DOI 10.1016/j.ijfoodmicro.2004.01.022; Kurita K, 2006, MAR BIOTECHNOL, V8, P203, DOI 10.1007/s10126-005-0097-5; Zhou YS, 2006, J APPL POLYM SCI, V102, P5692, DOI 10.1002/app.25068; Li L, 2006, CARBOHYD RES, V341, P374, DOI 10.1016/j.carres.2005.11.028; Dutta AK, 2013, CARBOHYD POLYM, V97, P363, DOI 10.1016/j.carbpol.2013.05.010; Wang XH, 2005, POLYM BULL, V55, P105, DOI 10.1007/s00289-005-0414-1; Liao HH, 2011, COLLOID SURFACE B, V84, P528, DOI 10.1016/j.colsurfb.2011.02.010; Behrens AM, 2014, ACS MACRO LETT, V3, P249, DOI 10.1021/mz500049x; Muzzarelli RAA, 2014, MAR DRUGS, V12, P5468, DOI 10.3390/md12115468; Tang XL, 2004, PHARM RES, V21, P191, DOI 10.1023/B:PHAM.0000016234.73023.75; Roller S, 1999, INT J FOOD MICROBIOL, V47, P67, DOI 10.1016/S0168-1605(99)00006-9; Badrossamay MR, 2010, NANO LETT, V10, P2257, DOI 10.1021/nl101355x; Min BM, 2004, POLYMER, V45, P7137, DOI 10.1016/j.polymer.2004.08.048; Ignatova M, 2006, CARBOHYD RES, V341, P2098, DOI 10.1016/j.carres.2006.05.006; Eroglu E, 2012, GREEN CHEM, V14, P2682, DOI 10.1039/c2gc35970g; Muzzarelli RAA, 2012, CARBOHYD POLYM, V87, P995, DOI 10.1016/j.carbpol.2011.09.063; Lee D, 2014, MACROMOL CHEM PHYS, V215, P669, DOI 10.1002/macp.201400039; Park WH, 2004, POLYMER, V45, P7151, DOI 10.1016/j.polymer.2004.08.045; Liu RF, 2014, CARBOHYD POLYM, V101, P1116, DOI 10.1016/j.carbpol.2013.10.056; Liu CX, 2005, J MEMBRANE SCI, V267, P68, DOI 10.1016/j.memsci.2005.06.001; Wang X, 2004, CARBOHYD POLYM, V56, P21, DOI 10.1016/j.carbpol.2003.11.007; Barikani M, 2014, IRAN POLYM J, V23, P307, DOI 10.1007/s13726-014-0225-z; George C. E., 1993, J APPL POLYM SCI, V50, P1773; Gutierrez MC, 2008, CHEM MATER, V20, P634, DOI 10.1021/cm702028z; Ma B, 2013, NANOMEDICINE-UK, V8, P1459, DOI [10.2217/nnm.13.132, 10.2217/NNM.13.132]; Manisara P., 2006, J BIOMAT SCI-POLYM E, V17, P547; Mukai SR, 2011, ADSORPTION, V17, P49, DOI 10.1007/s10450-010-9286-2; Muzzarelli R. A. A., 2012, POLYM SCI COMPREHENS, V10, P153; Ohkawa K, 2002, TEXT RES J, V72, P120, DOI 10.1177/004051750207200205; Peppin SSL, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.238301; Seo H, 2005, POLYM J, V37, P391, DOI 10.1295/polymj.37.391; Shin SR, 2006, MATER RES SOC SYMP P, V915, P11; Spender J, 2012, NANO LETT, V12, P3857, DOI 10.1021/nl301983d; Wang YH, 2014, PROG CHEM, V26, P1821, DOI 10.7536/PC140636; Watanabe K, 2011, MACROMOL MATER ENG, V296, P568, DOI 10.1002/mame.201000408; Wu TH, 2013, PROC SPIE, V8923, DOI 10.1117/12.2035311	37	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0144-8617	1879-1344		CARBOHYD POLYM	Carbohydr. Polym.	MAY 20	2015	122						18	25		10.1016/j.carbpol.2014.12.080		8	Chemistry, Applied; Chemistry, Organic; Polymer Science	Chemistry; Polymer Science	CG4IQ	WOS:000353249200004		
J	Abdelaziz, AA; Seto, T; Abdel-Salam, M; Ishijima, T; Otani, Y				Abdelaziz, Ayman A.; Seto, Takafumi; Abdel-Salam, M.; Ishijima, Tatsuo; Otani, Yoshio			Influence of applied voltage waveforms on the performance of surface dielectric barrier discharge reactor for decomposition of naphthalene	JOURNAL OF PHYSICS D-APPLIED PHYSICS			English	Article						surface dielectric barrier discharge; decomposition of naphthalene; applied voltage waveform	PULSED CORONA DISCHARGES; ATMOSPHERIC-PRESSURE; GAS-DISCHARGE; PLASMA; NITROGEN; ACTUATOR; AIR	This paper is aimed at investigating the effect of applied voltage waveform on the surface dielectric barrier discharge (SDBD) in order to improve its capability in decomposing naphthalene in air. Five symmetric waveforms (sine, sinc, square, pulse and triangle) are used in this study in addition to two asymmetric waveforms (positive-and negative-ramp). The results show that the discharge activity is strongly affected by the applied voltage waveform, where the SDBD in case of the sine and triangle waveforms is more filamentary when compared with the other waveforms. Although the discharge period of the sine and triangle waveforms is high, the rms value of its current is lower than that in the case of the square and pulse waveforms. The SDBD reactor is more efficient to decompose the naphthalene when it operates in filamentary mode than that in diffuse-like mode. This is why the highest decomposition efficiency and energy efficiency are achieved in sine and triangle waveforms. Furthermore, the positive-and the negative-ramp applied-voltage waveforms have a similar effect on the decomposition process.	[Abdelaziz, Ayman A.] Assiut Univ, Fac Sci, Dept Phys, Assiut 71516, Egypt; [Abdelaziz, Ayman A.; Ishijima, Tatsuo] Kanazawa Univ, Res Ctr Sustainable Energy & Technol, Kanazawa, Ishikawa 9201192, Japan; [Seto, Takafumi; Otani, Yoshio] Kanazawa Univ, Sch Nat Syst, Kanazawa, Ishikawa 9201192, Japan; [Abdel-Salam, M.] Assiut Univ, Dept Elect Engn, Assiut 71516, Egypt	Abdelaziz, AA (reprint author), Assiut Univ, Fac Sci, Dept Phys, Assiut 71516, Egypt.	a.abdelaziz@science.au.edu.eg	Seto, Takafumi/D-2874-2012; OTANI, Yoshio/L-3581-2015	OTANI, Yoshio/0000-0002-5751-6898			Abdelaziz AA, 2014, PLASMA CHEM PLASMA P, V34, P1371, DOI 10.1007/s11090-014-9578-5; Abdelaziz AA, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/11/115201; Abdelaziz AA, 2013, J HAZARD MATER, V246, P26, DOI 10.1016/j.jhazmat.2012.12.005; OKAZAKI S, 1993, J PHYS D APPL PHYS, V26, P889, DOI 10.1088/0022-3727/26/5/025; Williamson JM, 2006, J PHYS D APPL PHYS, V39, P4400, DOI 10.1088/0022-3727/39/20/016; Bunce NJ, 1997, ENVIRON SCI TECHNOL, V31, P2252, DOI 10.1021/es960813g; Balcon N, 2009, J ELECTROSTAT, V67, P140, DOI 10.1016/j.elstat.2009.01.019; Laroussi M, 2004, J APPL PHYS, V96, P3028, DOI 10.1063/1.1777392; Wang L, 2007, ENVIRON SCI TECHNOL, V41, P2803, DOI 10.1021/es0628102; KEITH LH, 1979, ENVIRON SCI TECHNOL, V13, P416, DOI 10.1021/es60152a601; Kotsonis M, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/4/045204; Liu SH, 2001, J PHYS D APPL PHYS, V34, P1632, DOI 10.1088/0022-3727/34/11/312; Wang HC, 2009, J ELECTROSTAT, V67, P547, DOI 10.1016/j.elstat.2008.11.004; Kogelschatz U, 2002, IEEE T PLASMA SCI, V30, P1400, DOI 10.1109/TPS.2002.804201; Enloe CL, 2004, AIAA J, V42, P589, DOI 10.2514/1.2305; Gaunt LF, 2006, IEEE T PLASMA SCI, V34, P1257, DOI 10.1109/TPS.2006.878381; Jolibois J, 2009, IEEE T DIELECT EL IN, V16, P758, DOI 10.1109/TDEI.2009.5128516; Atsushi K, 2013, PLASMA SOURCES SCI T, V22; Benard N, 2012, APPL PHYS LETT, V100; Bityurin VA, 2009, IEEE T PLASMA SCI, V37, P911, DOI 10.1109/TPS.2009.2019756; Blajan M, 2009, J I ELECTROSTAT JPN, V33, P8; Bogaczyk M, 2013, EUR PHYS J D, V67, P1; Dann T, 1989, PMD8914 QUEB POLL ME; Harvey R G, 1997, POLYCYCLIC AROMATIC; Kotsonis M, 2011, J APPL PHYS, V110; Lim Mun Sup, 2012, Environmental Engineering Research, V17, P89; Liu SH, 2003, J PHYS D APPL PHYS, V36, P1565, DOI 10.1088/0022-3727/36/13/321; Manirakiza E, 2012, AEROSOL SCI TECHNOL, V47, P60; Matsumoto T, 2012, NONTHERMAL PLASMA TE; Nair SA, 2003, FUEL PROCESS TECHNOL, V84, P161, DOI 10.1016/S0378-3820(03)00053-5; Ni M J, 2011, J ZHEJIANG UNIV-SC A, V12, P71; Oda T, 2008, INT J PLASMA ENV SCI, V2, P50, DOI DOI 10.1541/IEEJFMS.127.145; Ogata A, 2002, PLASMA CHEM PLASMA P, V22, P686; Osawa N, 2011, EUR PHYS J-APPL PHYS, V55, DOI 10.1051/epjap/2010100439; Ostapczuk A, 2008, PLASMA CHEM PLASMA P, V28, P483, DOI 10.1007/s11090-008-9144-0; Pal U N, 2012, J THEOR APPL PHYS, V6, P1; Takashima K, 2007, IJPEST, V1, P14; Yu L, 2010, J PHYS CHEM A, V114, P360, DOI 10.1021/jp905082s; Zhang S, 2013, J APPL PHYS, V114	39	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0022-3727	1361-6463		J PHYS D APPL PHYS	J. Phys. D-Appl. Phys.	MAY 20	2015	48	19							195201	10.1088/0022-3727/48/19/195201		9	Physics, Applied	Physics	CG5RE	WOS:000353350800010		
J	Tsuji, H; Hayashi, T				Tsuji, Hideto; Hayashi, Toshiki			Hydrolytic degradation and crystallization behavior of linear 2-armed and star-shaped 4-armed poly(L-lactide)s: Effects of branching architecture and crystallinity	JOURNAL OF APPLIED POLYMER SCIENCE			English	Article						biodegradable; biomaterials; biopolymers and renewable polymers; crystallization; degradation	PHOSPHATE-BUFFERED SOLUTION; LACTIC-ACID; IN-VITRO; PHYSICAL-PROPERTIES; POLY(LACTIC ACID); STEREOCOMPLEX; MORPHOLOGY; POLYMERS; 1-ARM; PLA	Linear aliphatic polyesters composed of two poly(l-lactide) arms attached to 1,3-propanediol and star-shaped ones composed of four poly(l-lactide) arms attached to pentaerythritol (2-L and 4-L polymers, respectively) with number-average molecular weight (M-n)=1.4-8.4 x 10(4)g/mol were hydrolytically degraded at 37 degrees C and pH=7.4. The effects of the branching architecture and crystallinity on the hydrolytic degradation and crystalline morphology change were investigated. The degradation mechanism of initially amorphous and crystallized 2-L polymers changed from bulk degradation to surface degradation with decreasing initial M-n; in contrast, initially crystallized higher molecular weight 4-L polymer degraded via bulk degradation, while the degradation mechanism of other 4-L polymers could not be determined. The hydrolytic-degradation rates monitored by molecular-weight decreases decreased significantly with increasing branch architecture and/or higher number of hydroxyl groups per unit mass. The hydrolytic degradation rate determined from the molecular weight decrease was higher for initially crystallized samples than for initially amorphous samples; however, that of 2-L polymers monitored by weight loss was larger for initially amorphous samples than for initially crystallized samples. Initially amorphous 2-L polymers with an M-n below 3.5 x 10(4)g/mol crystallized during hydrolytic degradation. In contrast, the branching architecture disturbed crystallization of initially amorphous 4-L polymers during hydrolytic degradation. All initially crystallized 2-L and 4-L polymers had -form crystallites before hydrolytic degradation, which did not change during hydrolytic degradation. During hydrolytic degradation, the glass transition temperatures of initially amorphous and crystallized 2-L and 4-L polymers and the cold crystallization temperatures of initially amorphous 2-L and 4-L polymers showed similar changes to those reported for 1-armed poly(l-lactide). (c) 2015 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 2015, 132, 41983.	[Tsuji, Hideto; Hayashi, Toshiki] Toyohashi Univ Technol, Grad Sch Engn, Dept Environm & Life Sci, Toyohashi, Aichi 4418580, Japan	Tsuji, H (reprint author), Toyohashi Univ Technol, Grad Sch Engn, Dept Environm & Life Sci, Tempaku Cho, Toyohashi, Aichi 4418580, Japan.	tsuji@ens.tut.ac.jp			21st Century COE Program, "Ecological Engineering for Homeostatic Human Activities," from the Ministry of Education, Culture, Sports, Science and Technology (Japan)	This research was partly supported by The 21st Century COE Program, "Ecological Engineering for Homeostatic Human Activities," from the Ministry of Education, Culture, Sports, Science and Technology (Japan).	Tsuji H, 2000, POLYM DEGRAD STABIL, V67, P179, DOI 10.1016/S0141-3910(99)00111-1; Sakamoto Y, 2013, POLYMER, V54, P2422, DOI 10.1016/j.polymer.2013.02.044; Tsuji H, 2008, POLYMER, V49, P1385, DOI 10.1016/j.polymer.2008.01.029; TSUJI H, 1995, POLYMER, V36, P2709, DOI 10.1016/0032-3861(95)93647-5; Wasanasuk K, 2011, POLYMER, V52, P6097, DOI 10.1016/j.polymer.2011.10.046; Andersson SR, 2012, BIOMACROMOLECULES, V13, P1212, DOI 10.1021/bm300196h; Pan P, 2008, J APPL POLYM SCI, V107, P54, DOI 10.1002/app.27102; Zhang JM, 2007, MACROMOLECULES, V40, P1049, DOI 10.1021/ma061693s; Bouapao L, 2009, POLYMER, V50, P4007, DOI 10.1016/j.polymer.2009.06.040; VERT M, 1995, J MACROMOL SCI PURE, VA32, P787, DOI 10.1080/10601329508010289; Sakamoto Y, 2013, MACROMOL CHEM PHYS, V214, P776, DOI 10.1002/macp.201200657; Fukushima K, 2006, POLYM INT, V55, P626, DOI 10.1002/pi.2010; Tsuji H, 2000, J APPL POLYM SCI, V77, P1452, DOI 10.1002/1097-4628(20000815)77:7<1452::AID-APP7>3.0.CO;2-S; LEENSLAG JW, 1987, BIOMATERIALS, V8, P311, DOI 10.1016/0142-9612(87)90121-9; Sodergard A, 2002, PROG POLYM SCI, V27, P1123, DOI 10.1016/S0079-6700(02)00012-6; Duek EAR, 1999, POLYMER, V40, P6465, DOI 10.1016/S0032-3861(98)00846-5; Garlotta D, 2001, J POLYM ENVIRON, V9, P63, DOI 10.1023/A:1020200822435; Tsuji H, 2005, MACROMOL BIOSCI, V5, P569, DOI 10.1002/mabi.200500062; Slager J, 2003, ADV DRUG DELIVER REV, V55, P549, DOI 10.1016/S0169-409X(03)00042-5; Kawai T, 2007, MACROMOLECULES, V40, P9463, DOI 10.1021/ma070082c; Auras R, 2010, WILEY SERIES POLYM E; desJong S. J., 2001, POLYMER, V42, P2795; Fu CH, 2010, POLYM DEGRAD STABIL, V95, P485, DOI 10.1016/j.polymdegradstab.2010.01.007; Hartmann M. H., 1998, BIOPOLYMERS RENEWABL, P367; KHARAS GB, 1994, PLASTICS MICROBES, P93; Kim S. H., 1993, STUDIES POLYM SCI, V12, P464; LI SM, 1990, J MATER SCI-MATER M, V1, P198, DOI 10.1007/BF00701077; MATSUSUE Y, 1992, J BIOMED MATER RES, V26, P1553, DOI 10.1002/jbm.820261203; Schwach G, 1999, INT J BIOL MACROMOL, V25, P283, DOI 10.1016/S0141-8130(99)00043-4; Tsuji H, 2011, POLYM DEGRAD STABIL, V96, P2229, DOI 10.1016/j.polymdegradstab.2011.09.003; Tsuji H, 2014, POLYM DEGRAD STABIL, V102, P59, DOI 10.1016/j.polymdegradstab.2014.02.003; Tsuji H, 2010, WILEY SERIES POLYM E, P345; Tsuji H., 2009, BIODEGRADABLE POLYM, P165; Vert M., 2004, ENCY BIOMATERIALS BI, V2, P1254; Yuan WZ, 2005, POLYM DEGRAD STABIL, V87, P503, DOI 10.1016/j.polymdegradstab.2004.10.007	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-8995	1097-4628		J APPL POLYM SCI	J. Appl. Polym. Sci.	MAY 20	2015	132	20							41983	10.1002/app.41983		13	Polymer Science	Polymer Science	CB9QA	WOS:000349965600013		
J	Erdmenger, J; Herwerth, B; Klug, S; Meyer, R; Schalm, K				Erdmenger, Johanna; Herwerth, Benedikt; Klug, Steffen; Meyer, Rene; Schalm, Koenraad			S-wave superconductivity in anisotropic holographic insulators	JOURNAL OF HIGH ENERGY PHYSICS			English	Article						Holography and condensed matter physics (AdS/CMT); Gauge-gravity correspondence	SUM-RULE; TEMPERATURE	Within gauge/gravity duality, we consider finite density systems in a helical lattice dual to asymptotically anti-de Sitter space-times with Bianchi VII symmetry. These systems can become an anisotropic insulator in one direction while retaining metallic behavior in others. To this model, we add a U(1) charged scalar and show that below a critical temperature, it forms a spatially homogeneous condensate that restores isotropy in a new superconducting ground state. We determine the phase diagram in terms of the helix parameters and perform a stability analysis on its IR fixed point corresponding to a finite density condensed phase at zero temperature. Moreover, by analyzing fluctuations about the gravity background, we study the optical conductivity. Due to the lattice, this model provides an example for a holographic insulator-superfluid transition in which there is no unrealistic delta-function peak in the normal phase DC conductivity. Our results suggest that in the zero temperature limit, all degrees of freedom present in the normal phase condense. This, together with the breaking of translation invariance, has implications for Homes' and Uemuras's relations. This is of relevance for applications to real world condensed matter systems. We find a range of parameters in this system where Homes' relation holds.	[Erdmenger, Johanna; Herwerth, Benedikt] Max Planck Inst Phys & Astrophys, Werner Heisenberg Inst, D-80805 Munich, Germany; [Herwerth, Benedikt] Max Planck Inst Quantum Opt, D-85748 Garching, Germany; [Klug, Steffen; Schalm, Koenraad] Leiden Univ, Inst Lorentz Theoret Phys, NL-2300 RA Leiden, Netherlands; [Meyer, Rene] Univ Tokyo, Todai Inst Adv Study, Kavli Inst Phys & Math Universe WPI, Kashiwa, Chiba 2778568, Japan	Erdmenger, J (reprint author), Max Planck Inst Phys & Astrophys, Werner Heisenberg Inst, Fohringer Ring 6, D-80805 Munich, Germany.	jke@mpp.mpg.de; benedikt.herwerth@mpq.mpg.de; klug@lorentz.leidenuniv.nl; rene.meyer@ipmu.jp; kschalm@lorentz.leidenuniv.nl		Klug, Steffen/0000-0002-4521-2053	VICI grant of the Netherlands Organization for Scientific Research (NWO); Netherlands Organization for Scientific Research/Ministry of Science and Education (NWO/OCW); Foundation for Research into Fundamental Matter (FOM); John Templeton foundation; World Premier International Research Center Initiative (WPI), MEXT, Japan	We would like to thank Aristomenis Donos, Blaise Gouteraux, Sean Hartnoll, Elias Kiritsis and Jan Zaanen for helpful discussions during the course of this work. SK and KS are very grateful to Department of Physics at Harvard University for extensive hospitality. KS is supported in part by a VICI grant of the Netherlands Organization for Scientific Research (NWO), by the Netherlands Organization for Scientific Research/Ministry of Science and Education (NWO/OCW) and by the Foundation for Research into Fundamental Matter (FOM). SK is supported by a grant from the John Templeton foundation. The opinions expressed in this publication are those of the authors and do not necessarily reflect the views of the John Templeton foundation. The work of RM was supported by World Premier International Research Center Initiative (WPI), MEXT, Japan.	Andrade T., ARXIV14126521; Andrade T, 2014, J HIGH ENERGY PHYS, DOI 10.1007/JHEP05(2014)101; Tallon JL, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.180504; Donos A, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.211601; FERRELL RA, 1958, PHYS REV, V109, P1398, DOI 10.1103/PhysRev.109.1398; Koga J, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.104024; UEMURA YJ, 1989, PHYS REV LETT, V62, P2317, DOI 10.1103/PhysRevLett.62.2317; Hartnoll SA, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.144502; Basov DN, 2005, REV MOD PHYS, V77, P721, DOI 10.1103/RevModPhys.77.721; Horowitz GT, 2011, LECT NOTES PHYS, V828, P313, DOI 10.1007/978-3-642-04864-7_10; Ling Y, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.091602; Myers RC, 1999, PHYS REV D, V60, DOI 10.1103/PhysRevD.60.046002; Liu YR, 2012, NEURAL PROCESS LETT, V36, P1, DOI 10.1007/s11063-012-9219-z; Hartnoll SA, 2015, NAT PHYS, V11, P54, DOI 10.1038/NPHYS3174; Ooguri H, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.126001; Homes CC, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.134517; Kovtun PK, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.111601; Ammon M, 2011, PHYS LETT B, V706, P94, DOI 10.1016/j.physletb.2011.10.067; Horowitz GT, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.126008; Homes CC, 2004, NATURE, V430, P539, DOI 10.1038/nature02673; Phillips P, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.107002; Hartnoll SA, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.031601; TINKHAM M, 1959, PHYS REV LETT, V2, P331, DOI 10.1103/PhysRevLett.2.331; Domokos SK, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.141602; Basu P, 2010, PHYS LETT B, V689, P45, DOI 10.1016/j.physletb.2010.04.042; Balasubramanian V, 1999, COMMUN MATH PHYS, V208, P413, DOI 10.1007/s002200050764; Blake M, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.071602; Hartnoll SA, 2008, PHYS REV D, V77, DOI 10.1103/PhysRevD.77.106009; Nakamura S, 2010, PHYS REV D, V81, DOI 10.1103/PhysRevD.81.044018; Withers B, 2013, CLASSICAL QUANT GRAV, V30, DOI 10.1088/0264-9381/30/15/155025; Skenderis K, 2002, CLASSICAL QUANT GRAV, V19, P5849, DOI 10.1088/0264-9381/19/22/306; BREITENLOHNER P, 1982, ANN PHYS-NEW YORK, V144, P249, DOI 10.1016/0003-4916(82)90116-6; Bu YY, 2013, J HIGH ENERGY PHYS, DOI 10.1007/JHEP03(2013)165; Charmousis C, 2010, J HIGH ENERGY PHYS, DOI 10.1007/JHEP11(2010)151; Donos A., ARXIV12122998; Donos A, 2015, PHYS REV D, V91, DOI 10.1103/PhysRevD.91.066003; Donos A, 2014, J HIGH ENERGY PHYS, DOI 10.1007/JHEP09(2014)038; Donos A., 2013, JHEP, V05, P059; Donos A, 2013, NAT PHYS, V9, P648, DOI 10.1038/NPHYS2701; Donos A, 2011, J HIGH ENERGY PHYS, DOI 10.1007/JHEP08(2011)140; Donos A, 2014, J HIGH ENERGY PHYS, DOI 10.1007/JHEP04(2014)040; Donos A, 2011, J HIGH ENERGY PHYS, DOI 10.1007/JHEP12(2011)091; Donos A, 2014, J HIGH ENERGY PHYS, DOI 10.1007/JHEP06(2014)007; Dordevic SV, 2013, SCI REP-UK, V3, DOI 10.1038/srep01713; Erdmenger J, 2012, J HIGH ENERGY PHYS, DOI 10.1007/JHEP01(2012)059; Erdmenger J., IN PRESS; Erdmenger J, 2013, J HIGH ENERGY PHYS, DOI 10.1007/JHEP04(2013)049; Erdmenger J, 2012, J HIGH ENERGY PHYS, DOI 10.1007/JHEP10(2012)021; Gouteraux B, 2013, J HIGH ENERGY PHYS, DOI 10.1007/JHEP04(2013)053; Gouteraux B, 2014, J HIGH ENERGY PHYS, DOI 10.1007/JHEP04(2014)181; Gulotta DR, 2011, J HIGH ENERGY PHYS, DOI 10.1007/JHEP01(2011)148; Hartnoll SA, 2008, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2008/12/015; Horowitz GT, 2013, J HIGH ENERGY PHYS, DOI 10.1007/JHEP06(2013)087; Horowitz GT, 2012, J HIGH ENERGY PHYS, DOI 10.1007/JHEP11(2012)102; Horowitz GT, 2009, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2009/11/015; Horowitz GT, 2012, J HIGH ENERGY PHYS, DOI 10.1007/JHEP07(2012)168; Iizuka N, 2013, J HIGH ENERGY PHYS, DOI 10.1007/JHEP03(2013)126; Iizuka N, 2012, J HIGH ENERGY PHYS, DOI 10.1007/JHEP07(2012)193; Kaminski M, 2010, J HIGH ENERGY PHYS, DOI 10.1007/JHEP02(2010)021; Karch A, 2006, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2006/04/015; Kim KY, 2015, J HIGH ENERGY PHYS, DOI 10.1007/JHEP04(2015)152; Klug S., IN PRESS; Ling Y, 2013, J HIGH ENERGY PHYS, DOI 10.1007/JHEP07(2013)045; Ling Y, 2015, J HIGH ENERGY PHYS, P1, DOI 10.1007/JHEP02(2015)059; Lippert M, 2015, J HIGH ENERGY PHYS, DOI 10.1007/JHEP01(2015)023; Lucas A, 2015, J HIGH ENERGY PHYS, DOI 10.1007/JHEP03(2015)071; Press W.H., 1992, NUMERICAL RECIPES C; Son D. T., 2002, JHEP, V09, P042; Taylor M, 2014, EUR PHYS J C, V74, DOI 10.1140/epjc/s10052-014-3176-9; van der Marel D, 2003, NATURE, V425, P271, DOI 10.1038/nature01978; Vegh D., ARXIV13010537; Withers B, 2014, J HIGH ENERGY PHYS, DOI 10.1007/JHEP09(2014)102; Zaanen J, 2004, NATURE, V430, P512, DOI 10.1038/430512a	73	5	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1029-8479			J HIGH ENERGY PHYS	J. High Energy Phys.	MAY 19	2015		5							094	10.1007/JHEP05(2015)094		60	Physics, Particles & Fields	Physics	CU4BS	WOS:000363471700003		
J	Helo, JC; Hirsch, M; Ota, T; dos Santos, FAF				Helo, J. C.; Hirsch, M.; Ota, T.; Fereira dos Santos, F. A.			Double beta decay and neutrino mass models	JOURNAL OF HIGH ENERGY PHYSICS			English	Article						Beyond Standard Model; Neutrino Physics	STERILE NEUTRINOS; PARITY VIOLATION; LEPTON NUMBER; TEV-SCALE; SUPERSYMMETRY; SUPERFORMULA; CONSTRAINTS; LEPTOQUARK; COSMOLOGY; MIXINGS	Neutrinoless double beta decay allows to constrain lepton number violating extensions of the standard model. If neutrinos are Majorana particles, the mass mechanism will always contribute to the decay rate, however, it is not a priori guaranteed to be the dominant contribution in all models. Here, we discuss whether the mass mechanism dominates or not from the theory point of view. We classify all possible (scalar-mediated) short-range contributions to the decay rate according to the loop level, at which the corresponding models will generate Majorana neutrino masses, and discuss the expected relative size of the different contributions to the decay rate in each class. Our discussion is general for models based on the SM group but does not cover models with an extended gauge. We also work out the phenomenology of one concrete 2-loop model in which both, mass mechanism and short-range diagram, might lead to competitive contributions, in some detail.	[Helo, J. C.] Univ Tecn Federico Santa Maria, Ctr Cient Tecnol Valparaiso, Valparaiso, Chile; [Hirsch, M.] Univ Valencia, CSIC, Inst Fis Corpuscular, AHEP Grp, E-46071 Valencia, Spain; [Ota, T.] Saitama Univ, Dept Phys, Saitama 3388570, Japan; [Fereira dos Santos, F. A.] Pontificia Univ Catolica Rio de Janeiro, Dept Fis, BR-22451900 Rio De Janeiro, Brazil	Helo, JC (reprint author), Univ Tecn Federico Santa Maria, Ctr Cient Tecnol Valparaiso, Casilla 110-V, Valparaiso, Chile.	juancarlos.helo@usm.cl; mahirsch@ific.uv.es; toshi@mail.saitama-u.ac.jp; fabio.alex@fis.puc-rio.br	Hirsch, Martin/K-7605-2014		Spanish grants [FPA2014-58183-P, Multidark CSD2009-00064, PROMETEOII/2014/084]; Fondecyt (Chile) [11121557]; CONICYT (Chile) [791100017]; JSPS [2610 5503]; Brazilian Research Council CNPq	T.O. is grateful to Prof. Junji Hisano for insightful comments on flavour structure of the effective interactions. J.C.H. thanks the IFIC for hospitality during his stay. Work supported by the Spanish grants FPA2014-58183-P and Multidark CSD2009-00064 (MINECO), and PROMETEOII/2014/084 (Generalitat Valenciana), by Fondecyt (Chile) under grants 11121557 and by CONICYT (Chile) project 791100017. The research of T.O. is supported by JSPS Grants-in-Aid for Scientific Research on Innovative Areas Unification and Development of the Neutrino Science Frontier Number 2610 5503. The research of F.A.P.S. is supported by the Brazilian Research Council CNPq.	Casas JA, 2001, NUCL PHYS B, V618, P171, DOI 10.1016/S0550-3213(01)00475-8; WEINBERG S, 1979, PHYS REV LETT, V43, P1566, DOI 10.1103/PhysRevLett.43.1566; Gando A, 2012, PHYS REV C, V85, DOI 10.1103/PhysRevC.85.045504; Babu KS, 2001, NUCL PHYS B, V619, P667, DOI 10.1016/S0550-3213(01)00504-1; Hirsch M, 2006, PHYS LETT B, V642, P106, DOI 10.1016/j.physletb.2006.09.012; Haba N, 2011, PHYS LETT B, V705, P98, DOI 10.1016/j.physletb.2011.09.103; HIRSCH M, 1995, PHYS REV LETT, V75, P17, DOI 10.1103/PhysRevLett.75.17; LAZARIDES G, 1981, NUCL PHYS B, V181, P287, DOI 10.1016/0550-3213(81)90354-0; Li YF, 2012, PHYS LETT B, V706, P406, DOI 10.1016/j.physletb.2011.11.054; MAGG M, 1980, PHYS LETT B, V94, P61, DOI 10.1016/0370-2693(80)90825-4; Agostini M, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.122503; Ma E, 1998, PHYS REV LETT, V81, P1171, DOI 10.1103/PhysRevLett.81.1171; Wong YYY, 2011, ANNU REV NUCL PART S, V61, P69, DOI 10.1146/annurev-nucl-102010-130252; Gando A, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.062502; MINKOWSKI P, 1977, PHYS LETT B, V67, P421, DOI 10.1016/0370-2693(77)90435-X; Mahanta U, 2000, PHYS REV D, V62, DOI 10.1103/PhysRevD.62.073009; Mitra M, 2012, NUCL PHYS B, V856, P26, DOI 10.1016/j.nuclphysb.2011.10.035; CHENG TP, 1980, PHYS REV D, V22, P2860, DOI 10.1103/PhysRevD.22.2860; Pas H, 1999, PHYS LETT B, V453, P194, DOI 10.1016/S0370-2693(99)00330-5; FOOT R, 1989, Z PHYS C PART FIELDS, V44, P441, DOI 10.1007/BF01415558; HIRSCH M, 1994, Z PHYS A-HADRON NUCL, V347, P151, DOI 10.1007/BF01292371; Steinbrink N, 2013, NEW J PHYS, V15, DOI [10.1088/1367-2630/15/11/113020, 10.1088/136-2630/15/11/113020]; Pas H, 2001, PHYS LETT B, V498, P35, DOI 10.1016/S0370-2693(00)01359-9; Merle A, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.113004; Hirsch M, 1996, PHYS LETT B, V378, P17, DOI 10.1016/0370-2693(96)00419-4; Arnold R, 2010, EUR PHYS J C, V70, P927, DOI 10.1140/epjc/s10052-010-1481-5; Hirsch M, 1999, NUCL PHYS B, V557, P60, DOI 10.1016/S0550-3213(99)00368-5; MOHAPATRA RN, 1981, PHYS REV D, V23, P165, DOI 10.1103/PhysRevD.23.165; Lesgourgues J, 2006, PHYS REP, V429, P307, DOI 10.1016/j.physrep.2006.04.001; Albert JB, 2014, NATURE, V510, P229, DOI 10.1038/nature13432; MOHAPATRA RN, 1986, PHYS REV D, V34, P3457, DOI 10.1103/PhysRevD.34.3457; Angel PW, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.073007; Hannestad S, 2010, PROG PART NUCL PHYS, V65, P185, DOI 10.1016/j.ppnp.2010.07.001; Babu KS, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.073005; Ma E, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.011802; Ali A, 2007, PHYS REV D, V76, DOI 10.1103/PhysRevD.76.093009; MUTO K, 1989, Z PHYS A-HADRON NUCL, V334, P187, DOI 10.1007/BF01294219; Kohda M, 2013, PHYS LETT B, V718, P1436, DOI 10.1016/j.physletb.2012.12.048; Lavoura L, 2003, EUR PHYS J C, V29, P191, DOI 10.1140/epjc/s2003-01212-7; Dudley B, 2009, PHYS REV D, V79, DOI 10.1103/PhysRevD.79.013014; Brahmachari B, 2002, PHYS LETT B, V536, P259, DOI 10.1016/S0370-2693(02)01869-5; Adam J, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.201801; SCHECHTER J, 1980, PHYS REV D, V22, P2227, DOI 10.1103/PhysRevD.22.2227; Hirsch M, 1996, PHYS REV D, V54, pR4207; de Gouvea A, 2008, PHYS REV D, V77, DOI 10.1103/PhysRevD.77.013008; WETTERICH C, 1981, NUCL PHYS B, V187, P343, DOI 10.1016/0550-3213(81)90279-0; MOHAPATRA RN, 1980, PHYS REV LETT, V44, P912, DOI 10.1103/PhysRevLett.44.912; Haba N, 2010, EUR PHYS J C, V69, P481, DOI 10.1140/epjc/s10052-010-1414-3; Meroni A, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.053002; Gustafsson M, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.013012; Ma E, 2001, PHYS REV LETT, V86, P2502, DOI 10.1103/PhysRevLett.86.2502; Lopez-Pavon J, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.093007; Chen CS, 2007, PHYS REV D, V75, DOI 10.1103/PhysRevD.75.053004; BABU KS, 1995, PHYS REV LETT, V75, P2276, DOI 10.1103/PhysRevLett.75.2276; Dev PSB, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.091301; Blennow M, 2010, J HIGH ENERGY PHYS, DOI 10.1007/JHEP07(2010)096; Bonnet F, 2013, J HIGH ENERGY PHYS, DOI 10.1007/JHEP03(2013)055; Bonnet F, 2012, J HIGH ENERGY PHYS, DOI 10.1007/JHEP07(2012)153; Bonnet F, 2014, J HIGH ENERGY PHYS, DOI 10.1007/JHEP04(2014)090; Chakrabortty J., 2012, JHEP, V08, P008; Choubey S, 2012, J HIGH ENERGY PHYS, DOI 10.1007/JHEP05(2012)017; CMS collaboration, CMSPASEXO12041; Khachatryan V, 2014, PHYS LETT B, V739, P229, DOI 10.1016/j.physletb.2014.10.063; CMS Collaboration, CMSPASEXO12042; Sierra DA, 2015, J HIGH ENERGY PHYS, DOI 10.1007/JHEP03(2015)040; del Aguila F, 2012, J HIGH ENERGY PHYS, DOI 10.1007/JHEP06(2012)146; Deppisch FF, 2012, J PHYS G NUCL PARTIC, V39, DOI 10.1088/0954-3899/39/12/124007; Dev P. S. B., ARXIV14051399; Doi M., 1985, PROG THEOR PHYS SUPP, V83, P1, DOI 10.1143/PTPS.83.1; Duerr M, 2011, J HIGH ENERGY PHYS, DOI 10.1007/JHEP06(2011)091; Faessler A, 2012, J PHYS G NUCL PARTIC, V39, DOI 10.1088/0954-3899/39/12/124006; Faessler A, 1998, PHYS REV D, V58, DOI 10.1103/PhysRevD.58.115004; Faessler A, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.096010; Farzan Y, 2013, J HIGH ENERGY PHYS, DOI 10.1007/JHEP03(2013)107; Forero DV, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.093006; Gell-Mann M., 1979, C P C, V790927, P315; Girardi I, 2013, J HIGH ENERGY PHYS, DOI 10.1007/JHEP11(2013)146; Gu PH, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.093016; Helo JC, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.011901; Helo JC, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.073011; Hirsch M, 1996, PHYS LETT B, V372, P181, DOI 10.1016/0370-2693(96)00050-0; Sierra DA, 2008, PHYS REV D, V77, DOI 10.1103/PhysRevD.77.055011; Huang WC, 2014, EUR PHYS J C, V74, DOI 10.1140/epjc/s10052-014-2853-z; King SF, 2014, J HIGH ENERGY PHYS, DOI 10.1007/JHEP11(2014)124; Menendez J, 2011, J PHYS CONF SER, V312, DOI 10.1088/1742-6596/312/7/072005; Pascoli S., 2014, PHYS REV D, V90; SCHECHTER J, 1982, PHYS REV D, V25, P2951, DOI 10.1103/PhysRevD.25.2951; Shimizu I., 2014, NEUTR 2014 BOST US J; Yanagida T., 1979, C P C, V7902131, P95	89	7	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1029-8479			J HIGH ENERGY PHYS	J. High Energy Phys.	MAY 19	2015		5							092	10.1007/JHEP05(2015)092		40	Physics, Particles & Fields	Physics	CU4BS	WOS:000363471700001		
J	Tajitsu, Y				Tajitsu, Y.			Sensing Complicated Motion of Human Body Using Piezoelectric Chiral Polymer Fiber	FERROELECTRICS			English	Article						sensor; chiral polymer; Piezoelectric polymer; poly-L-lactic acid; fiber		Toward sensing the complicated motion of the human body, we have developed a new soft and flexible fiber sensor assembled from piezoelectric poly-L-lactic acid (PLLA) fibers (PLLA fiber sensor). As an early stage of this study, we attempted to detect the pulse rate and observe the motion of a human arm using the PLLA fiber sensor. First, we prepared left-hand and right-hand helical torsion coils (PLLA fiber left-hand and right-hand coils), which were formed by drawing a PLLA fiber with a drawing ratio of ten. As a result, we found that the pulse rate could be measured with extremely high accuracy by the PLLA fiber sensor. At the same time, we were able to detect the rotation of the forearm and upper arm using PLLA fiber sensors.	Kansai Univ, Grad Sch Sci & Engn, Dept Elect Engn, Suita, Osaka 5648680, Japan	Tajitsu, Y (reprint author), Kansai Univ, Grad Sch Sci & Engn, Dept Elect Engn, 3-3-35 Yamate, Suita, Osaka 5648680, Japan.	tajitsu@kansai-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [2528059]; COE grant from Kansai University	This work was supported in part by a Grant-in-Aid for Scientific Research (No. 2528059) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and a COE grant from Kansai University.	Tajitsu Y, 2013, IEEE T ULTRASON FERR, V60, P1625, DOI 10.1109/TUFFC.2013.2744; Fukada E, 2000, IEEE T ULTRASON FERR, V47, P1277, DOI 10.1109/58.883516; Chawla K. K., 1998, FIBROUS MAT; Galetti P., 1988, MED APPL PIEZOELECTR; Ito S, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.09LD16; Nalwa Hari Singh, 1995, FERROELECTRIC POLYM; Smela E., 2009, BIOMEDICAL APPL ELEC; Tajitsu Y., 2008, IEEE T ULTRASON FERR, V55, P1277; Wang T. T., 1988, APPL FERROELECTRIC P	9	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0015-0193	1563-5112		FERROELECTRICS	Ferroelectrics	MAY 19	2015	480	1			SI		32	38		10.1080/00150193.2015.1012410		7	Materials Science, Multidisciplinary; Physics, Condensed Matter	Materials Science; Physics	CM0JQ	WOS:000357364600005		
J	Suzuki, N; Sasaya, T; Choi, IR				Suzuki, Nobuhiro; Sasaya, Takahide; Choi, Il-Ryong			Editorial: Viruses threatening stable production of cereal crops	FRONTIERS IN MICROBIOLOGY			English	Editorial Material						cereal; rice; phytoreovirus; tenuivirus; luteovirus; polerovirus; insectvector	CRISIS		[Suzuki, Nobuhiro] Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama, Japan; [Sasaya, Takahide] Natl Agr & Food Res Org, Kyushu Okinawa Agr Res Ctr, Koshi, Japan; [Choi, Il-Ryong] Int Rice Res Inst, Plant Breeding Genet & Biotechnol Div, Los Banos, Philippines	Choi, IR (reprint author), Int Rice Res Inst, Plant Breeding Genet & Biotechnol Div, Los Banos, Philippines.	i.choi@irri.org					Headey D, 2008, AGR ECON-BLACKWELL, V39, P375, DOI 10.1111/j.1574-0862.2008.00345.x; Budot BO, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00026; Chen HY, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00206; Hiraguri A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00210; Krueger EN, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00205; Miyazaki N, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00306; Nuruzzaman M, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00248; Otuka A, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00309; Sasaya T, 2014, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00409; Satoh K, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00313; Ta HA, 2013, VIRUS GENES, V46, P383, DOI 10.1007/s11262-012-0845-3; Uehara-Ichiki T, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00289; von Braun J, 2008, NATURE, V456, P701, DOI 10.1038/456701a; Zhou GH, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00270	14	0	0	FRONTIERS RESEARCH FOUNDATION	LAUSANNE	PO BOX 110, LAUSANNE, 1015, SWITZERLAND	1664-302X			FRONT MICROBIOL	Front. Microbiol.	MAY 19	2015	6								470	10.3389/fmicb.2015.00470		3	Microbiology	Microbiology	CK5HM	WOS:000356254300002		
J	Kononenko, AV; Lee, NCO; Liskovykh, M; Masumoto, H; Earnshaw, WC; Larionov, V; Kouprina, N				Kononenko, Artem V.; Lee, Nicholas C. O.; Liskovykh, Mikhail; Masumoto, Hiroshi; Earnshaw, William C.; Larionov, Vladimir; Kouprina, Natalay			Generation of a conditionally self-eliminating HAC gene delivery vector through incorporation of a tTA(VP64) expression cassette	NUCLEIC ACIDS RESEARCH			English	Article							HUMAN ARTIFICIAL CHROMOSOMES; TRANSFORMATION-ASSOCIATED RECOMBINATION; SACCHAROMYCES-CEREVISIAE; GENOMIC LOCI; STEM-CELLS; DNA; YEAST; CENTROMERE; TRANSGENE; CLONING	Human artificial chromosome (HAC)-based vectors represent an alternative technology for gene delivery and expression with a potential to overcome the problems caused by virus-based vectors. The recently developed alphoid(tetO)-HAC has an advantage over other HAC vectors because it can be easily eliminated from cells by inactivation of the HAC kinetochore via binding of chromatin modifiers, tTA or tTS, to its centromeric tetO sequences. This provides a unique control for phenotypes induced by genes loaded into the HAC. The alphoid(tetO)-HAC elimination is highly efficient when a high level of chromatin modifiers as tetR fusion proteins is achieved following transfection of cells by a retrovirus vector. However, such vectors are potentially mutagenic and might want to be avoided under some circumstances. Here, we describe a novel system that allows verification of phenotypic changes attributed to expression of genes from the HAC without a transfection step. We demonstrated that a single copy of tTA(VP64) carrying four tandem repeats of the VP16 domain constitutively expressed from the HAC is capable to generate chromatin changes in the HAC kinetochore that are not compatible with its function. To adopt the alphoid(tetO)-HAC for routine gene function studies, we constructed a new TAR-BRV-tTA(VP64) cloning vector that allows a selective isolation of a gene of interest from genomic DNA in yeast followed by its direct transfer to bacterial cells and subsequent loading into the loxP site of the alphoid(tetO)-HAC in hamster CHO cells from where the HAC may be MMCT-transferred to the recipient human cells.	[Kononenko, Artem V.; Lee, Nicholas C. O.; Liskovykh, Mikhail; Larionov, Vladimir; Kouprina, Natalay] NCI, Dev Therapeut Branch, Bethesda, MD 20892 USA; [Masumoto, Hiroshi] Kazusa DNA Res Inst, Dept Frontier Res, Lab Cell Engn, Kisarazu, Chiba 2920818, Japan; [Earnshaw, William C.] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	Kouprina, N (reprint author), NCI, Dev Therapeut Branch, Bethesda, MD 20892 USA.	larionov@mail.nih.gov; kouprinn@mail.nih.gov			Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research, USA; Kazusa DNA Research Institute Foundation; Wellcome Trust [073915]; NIH	Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research, USA (V.L., N.K.); Kazusa DNA Research Institute Foundation (H.M.); Wellcome Trust of which W.C.E. is a Principal Research Fellow [073915]. Funding for open access charge: NIH.	Kazuki Y, 2011, MOL THER, V19, P1591, DOI 10.1038/mt.2011.136; Kuroiwa Y, 2009, NAT BIOTECHNOL, V27, P173, DOI 10.1038/nbt.1521; SMITH AJH, 1995, NAT GENET, V9, P376, DOI 10.1038/ng0495-376; SIKORSKI RS, 1989, GENETICS, V122, P19; Larionov V, 1996, P NATL ACAD SCI USA, V93, P491, DOI 10.1073/pnas.93.1.491; Bergmann JH, 2011, EMBO J, V30, P328, DOI 10.1038/emboj.2010.329; Larionov V, 1997, P NATL ACAD SCI USA, V94, P7384, DOI 10.1073/pnas.94.14.7384; Kouprina N, 2008, NAT PROTOC, V3, P371, DOI 10.1038/nprot.2008.5; Pikaart MI, 1998, GENE DEV, V12, P2852, DOI 10.1101/gad.12.18.2852; Beerli RR, 1998, P NATL ACAD SCI USA, V95, P14628, DOI 10.1073/pnas.95.25.14628; Kouprina N, 2006, NAT REV GENET, V7, P805, DOI 10.1038/nrg1943; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Kouprina N, 2013, CELL MOL LIFE SCI, V70, P1135, DOI 10.1007/s00018-012-1113-3; Ito M, 2009, TRANSPL P, V41, P422, DOI 10.1016/j.transproceed.2008.10.023; Nakano M, 2008, DEV CELL, V14, P507, DOI 10.1016/j.devcel.2008.02.001; Ohzeki J, 2012, EMBO J, V31, P2391, DOI 10.1038/emboj.2012.82; Bergmann JH, 2012, J CELL SCI, V125, P411, DOI 10.1242/jcs.090639; Kouprina N, 2014, EXPERT OPIN DRUG DEL, V11, P517, DOI 10.1517/17425247.2014.882314; Auriche C, 2002, EMBO REP, V3, P862, DOI 10.1093/embo-reports/kvf174; Ayabe F, 2005, J HUM GENET, V50, P592, DOI 10.1007/s10038-005-0300-6; Basu J, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-21; Basu J, 2006, PEDIATR CLIN N AM, V53, P843, DOI 10.1016/j.pcl.2006.08.013; Bergmann JH, 2012, CHROMOSOME RES, V20, P505, DOI 10.1007/s10577-012-9293-0; Breman AM, 2008, MOL THER, V16, P315, DOI 10.1038/sj.mt.6300361; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Cardinale S, 2009, MOL BIOL CELL, V20, P4194, DOI 10.1091/mbc.E09-06-0489; Ebersole T, 2011, CELL CYCLE, V10, P2779, DOI 10.4161/cc.10.16.17092; Hasegawa Y., 2014, CHROMOSOMA, V2014, P1; Hiratsuka M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025961; Hoshiya H, 2009, MOL THER, V17, P309, DOI 10.1038/mt.2008.253; Iida Y, 2010, DNA RES, V17, P293, DOI 10.1093/dnares/dsq020; Iida Y, 2014, ACS SYNTH BIOL, V3, P83, DOI 10.1021/sb400166j; Ikeno M, 2002, GENES CELLS, V7, P1021, DOI 10.1046/j.1365-2443.2002.00580.x; Kazuki Y, 2008, GENE THER, V15, P617, DOI 10.1038/sj.gt.3303091; Kazuki Y., 2009, MOL THER, V18, P386, DOI DOI 10.1038/MT.2009.274; Kim JH, 2011, P NATL ACAD SCI USA, V108, P20048, DOI 10.1073/pnas.1114483108; Kim JH, 2009, GENOME RES, V19, P533, DOI 10.1101/gr.086496.108; KOI M, 1989, JPN J CANCER RES, V80, P413; Kononenko AV, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku870; Kononenko AV, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt205; Kouprina N, 2012, ACS SYNTH BIOL, V1, P590, DOI 10.1021/sb3000436; Kuroiwa Yoshimi, 2000, Nature Biotechnology, V18, P1086, DOI 10.1038/80287; Lee NC, 2013, CELL MOL LIFE SCI, V70, P3723, DOI 10.1007/s00018-013-1362-9; Li LP, 2013, NAT PROTOC, V8, P1567, DOI 10.1038/nprot.2013.093; Miyamoto K., 2013, TRANSGENIC RES, V23, P317; Monaco ZL, 2006, BIOCHEM SOC T, V34, P324; Oshimura M, 2013, ELS; Raab JR, 2012, EMBO J, V31, P330, DOI 10.1038/emboj.2011.406; Rocchi L, 2010, HUM GENE THER, V21, P1077, DOI 10.1089/hum.2009.225; Sander A, 2000, CELL TISSUE RES, V301, P397, DOI 10.1007/s004410000247; Suzuki N, 2006, J BIOL CHEM, V281, P26615, DOI 10.1074/jbc.M603053200; Tedesco FS, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003541; Tedesco FS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002342; Voet T, 2003, GENOMICS, V82, P596, DOI 10.1016/S0888-7543(03)00112-5; Yakura Y, 2013, BIOCHEM BIOPH RES CO, V431, P336, DOI 10.1016/j.bbrc.2012.12.096; Yamada H, 2008, J HUM GENET, V53, P447, DOI 10.1007/s10038-008-0268-0	58	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	MAY 19	2015	43	9							e57	10.1093/nar/gkv124		14	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CK0XK	WOS:000355928800001		
J	Nakamura, T; Yabuta, Y; Okamoto, I; Aramaki, S; Yokobayashi, S; Kurimoto, K; Sekiguchi, K; Nakagawa, M; Yamamoto, T; Saitou, M				Nakamura, Tomonori; Yabuta, Yukihiro; Okamoto, Ikuhiro; Aramaki, Shinya; Yokobayashi, Shihori; Kurimoto, Kazuki; Sekiguchi, Kiyotoshi; Nakagawa, Masato; Yamamoto, Takuya; Saitou, Mitinori			SC3-seq: a method for highly parallel and quantitative measurement of single-cell gene expression	NUCLEIC ACIDS RESEARCH			English	Article							OLIGONUCLEOTIDE MICROARRAY ANALYSIS; PLURIPOTENT STEM-CELLS; COMPLEX BIOLOGICAL PROCESSES; MESSENGER-RNA-SEQ; CDNA AMPLIFICATION; MOUSE EMBRYO; TRANSCRIPTOMICS; DIFFERENTIATION; SPECIFICATION; LANDSCAPE	Single-cell mRNA sequencing (RNA-seq) methods have undergone rapid development in recent years, and transcriptome analysis of relevant cell populations at single-cell resolution has become a key research area of biomedical sciences. We here present single-cell mRNA 3-prime end sequencing (SC3-seq), a practical methodology based on PCR amplification followed by 3-prime-end enrichment for highly quantitative, parallel and cost-effective measurement of gene expression in single cells. The SC3-seq allows excellent quantitative measurement of mRNAs ranging from the 10,000-cell to 1-cell level, and accordingly, allows an accurate estimate of the transcript levels by a regression of the read counts of spike-in RNAs with defined copy numbers. The SC3-seq has clear advantages over other typical single-cell RNA-seq methodologies for the quantitative measurement of transcript levels and at a sequence depth required for the saturation of transcript detection. The SC3-seq distinguishes four distinct cell types in the peri-implantation mouse blastocysts. Furthermore, the SC3-seq reveals the heterogeneity in human-induced pluripotent stem cells (hiPSCs) cultured under on-feeder as well as feeder-free conditions, demonstrating a more homogeneous property of the feeder-free hiPSCs. We propose that SC3-seq might be used as a powerful strategy for single-cell transcriptome analysis in a broad range of investigations in biomedical sciences.	[Nakamura, Tomonori; Yabuta, Yukihiro; Okamoto, Ikuhiro; Aramaki, Shinya; Yokobayashi, Shihori; Kurimoto, Kazuki; Saitou, Mitinori] Kyoto Univ, Grad Sch Med, Dept Anat & Cell Biol, Sakyo Ku, Kyoto 6068501, Japan; [Nakamura, Tomonori; Yabuta, Yukihiro; Okamoto, Ikuhiro; Aramaki, Shinya; Yokobayashi, Shihori; Kurimoto, Kazuki; Saitou, Mitinori] JST, ERATO, Sakyo Ku, Kyoto 6068501, Japan; [Yokobayashi, Shihori; Nakagawa, Masato; Yamamoto, Takuya; Saitou, Mitinori] Kyoto Univ, Ctr iPS Cell Res & Applicat, Sakyo Ku, Kyoto 6068507, Japan; [Sekiguchi, Kiyotoshi] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Yamamoto, Takuya; Saitou, Mitinori] Kyoto Univ, Inst Integrated Cell Mat Sci, Sakyo Ku, Kyoto 6068501, Japan	Saitou, M (reprint author), Kyoto Univ, Grad Sch Med, Dept Anat & Cell Biol, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	saitou@anat2.med.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; JST-ERATO	Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan; JST-ERATO. Funding for open access charge: Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan; JST-ERATO.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Hashimshony T, 2012, CELL REPORTS, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kivioja T, 2012, NAT METHODS, V9, P72, DOI [10.1038/nmeth.1778, 10.1038/NMETH.1778]; Kurimoto K, 2010, CURR OPIN GENET DEV, V20, P470, DOI 10.1016/j.gde.2010.06.003; Grun D, 2014, NAT METHODS, V11, P637, DOI [10.1038/nmeth.2930, 10.1038/NMETH.2930]; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Schrode N, 2013, GENESIS, V51, P219, DOI 10.1002/dvg.22368; Okita K, 2013, STEM CELLS, V31, P458, DOI 10.1002/stem.1293; Kurimoto K, 2008, GENE DEV, V22, P1617, DOI 10.1101/gad.1649908; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/nmeth.1315, 10.1038/NMETH.1315]; Fujioka T, 2004, INT J DEV BIOL, V48, P1149, DOI 10.1387/ijdb.041852tf; Tang FC, 2010, NAT PROTOC, V5, P516, DOI 10.1038/nprot.2009.236; Islam S, 2014, NAT METHODS, V11, P163, DOI [10.1038/nmeth.2772, 10.1038/NMETH.2772]; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; El-Hashash AHK, 2010, MECH DEVELOP, V127, P1, DOI 10.1016/j.mod.2009.09.004; Kurimoto K, 2007, NAT PROTOC, V2, P739, DOI 10.1038/nprot.2007.79; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Hayashi K, 2012, SCIENCE, V338, P971, DOI 10.1126/science.1226889; Pereira PNG, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-48; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Kawaguchi A, 2008, DEVELOPMENT, V135, P3113, DOI 10.1242/dev.022616; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Streets AM, 2014, P NATL ACAD SCI USA, V111, P7048, DOI 10.1073/pnas.1402030111; BRADY G, 1990, Methods in Molecular and Cellular Biology, V2, P17; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kurimoto K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl050; Martin M., 2011, EMBNET J, V17, P10, DOI DOI 10.14806/EJ.17.1.200; Miyazaki T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2231; Nakagawa M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03594; Ohnishi Y, 2014, NAT CELL BIOL, V16, P27, DOI 10.1038/ncb2881; Ohta S, 2013, CELL REP, V5, P357, DOI 10.1016/j.celrep.2013.09.016; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Saitou M, 2008, REPROD BIOMED ONLINE, V16, P26; Saliba AE, 2014, NUCLEIC ACIDS RES, V42, P8845, DOI 10.1093/nar/gku555; Sasagawa Y, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r31	43	3	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	MAY 19	2015	43	9							e60	10.1093/nar/gkv134		17	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CK0XK	WOS:000355928800004		
J	Saito, K; Ito, K				Saito, Kazuki; Ito, Koichi			Genetic analysis of L123 of the tRNA-mimicking eukaryote release factor eRF1, an amino acid residue critical for discrimination of stop codons	NUCLEIC ACIDS RESEARCH			English	Article							TERMINATION FACTOR ERF1; BOUND EF1-ALPHA COMPLEX; VARIANT-CODE ORGANISMS; TRANSLATION TERMINATION; MESSENGER-RNA; PEPTIDE RELEASE; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; N DOMAIN	In eukaryotes, the tRNA-mimicking polypeptide-chain release factor, eRF1, decodes stop codons on the ribosome in a complex with eRF3; this complex exhibits striking structural similarity to the tRNAeEF1A-GTP complex. Although amino acid residues or motifs of eRF1 that are critical for stop codon discrimination have been identified, the details of the molecular mechanisms involved in the function of the ribosomal decoding site remain obscure. Here, we report analyses of the position-123 amino acid of eRF1 (L123 in Saccharomyces cerevisiae eRF1), a residue that is phylogenetically conserved among species with canonical and variant genetic codes. In vivo readthrough efficiency analysis and genetic growth complementation analysis of the residue-123 systematic mutants suggested that this amino acid functions in stop codon discrimination in a manner coupled with eRF3 binding, and distinctive from previously reported adjacent residues. Furthermore, aminoglycoside antibiotic sensitivity analysis and ribosomal docking modeling of eRF1 in a quasi-A/T state suggested a functional interaction between the side chain of L123 and ribosomal residues critical for codon recognition in the decoding site, as a molecular explanation for coupling with eRF3. Our results provide insights into the molecular mechanisms underlying stop codon discrimination by a tRNA-mimicking protein on the ribosome.	[Saito, Kazuki; Ito, Koichi] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Kashiwa, Chiba 2778562, Japan	Ito, K (reprint author), Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Kashiwa, Chiba 2778562, Japan.	itokoichi@k.u-tokyo.ac.jp			JSPS [24-6837];  [25291020]	Grant-in-Aid for Scientific Research, Ministry of Education, Culture, Sports, Science and Technology [25291020 to K.I.]; Grant-in-Aid for JSPS Fellows, JSPS [24-6837 to K.S.]. Funding for open access charge: Grant-in-Aid for Scientific Research, Ministry of Education, Culture, Sports, Science and Technology [25291020 to K.I.]; Grant-in-Aid for JSPS Fellows, JSPS [24-6837 to K.S.].	Eliseev B, 2011, NUCLEIC ACIDS RES, V39, P599, DOI 10.1093/nar/gkq759; Alkalaeva EZ, 2006, CELL, V125, P1125, DOI 10.1016/j.cell.2006.04.035; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Chavatte L, 2003, EMBO J, V22, P1644, DOI 10.1093/emboj/cdg146; Song HW, 2000, CELL, V100, P311, DOI 10.1016/S0092-8674(00)80667-4; Cheng Z, 2009, GENE DEV, V23, P1106, DOI 10.1101/gad.1770109; Chavatte L, 2002, EMBO J, V21, P5302, DOI 10.1093/emboj/cdf484; Kolosov P, 2005, NUCLEIC ACIDS RES, V33, P6418, DOI 10.1093/nar/gki927; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Kisselev L, 2003, EMBO J, V22, P175, DOI 10.1093/emboj/cdg017; Mitkevich VA, 2006, NUCLEIC ACIDS RES, V34, P3947, DOI 10.1093/nar/gkl549; Kim OTP, 2005, GENE, V346, P277, DOI 10.1016/j.gene.2004.11.046; Fan-Minogue H, 2008, RNA, V14, P148, DOI 10.1261/rna.805208; Inagaki Y, 2000, MOL BIOL EVOL, V17, P882; Ito K, 2000, NATURE, V403, P680; Conard SE, 2012, RNA, V18, P1210, DOI 10.1261/rna.031997.111; Frolova L, 1996, RNA, V2, P334; Fan-Minogue H, 2008, MOL CELL, V30, P599, DOI 10.1016/j.molcel.2008.03.020; Blanchet S, 2015, NUCLEIC ACIDS RES, V43, P3298, DOI 10.1093/nar/gkv154; Wada M, 2014, NUCLEIC ACIDS RES, V42, P7851, DOI 10.1093/nar/gku493; Bertram G, 2000, RNA, V6, P1236, DOI 10.1017/S1355838200000777; Li Y, 2013, PROTIST, V164, P440, DOI 10.1016/j.protis.2013.02.004; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Korostelev A, 2010, EMBO J, V29, P2577, DOI 10.1038/emboj.2010.139; Lekomtsev S, 2007, P NATL ACAD SCI USA, V104, P10824, DOI 10.1073/pnas.0703887104; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Harger JW, 2003, RNA, V9, P1019, DOI 10.1261/rna.5930803; Seit-Nebi A, 2002, EMBO REP, V3, P881, DOI 10.1093/embo-reports/kvf178; Carter AP, 2000, NATURE, V407, P340; Frolova LY, 1999, RNA, V5, P1014, DOI 10.1017/S135583829999043X; Dunkle JA, 2010, ANNU REV BIOPHYS, V39, P227, DOI 10.1146/annurev.biophys.37.032807.125954; Wong LE, 2012, NUCLEIC ACIDS RES, V40, P5751, DOI 10.1093/nar/gks192; Salas-Marco J, 2006, MOL CELL BIOL, V26, P438, DOI 10.1128/MCB.26.2.438-447.2006; Atkinson GC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-290; Bulygin KN, 2010, RNA, V16, P1902, DOI 10.1261/rna.2066910; Bulygin KN, 2011, NUCLEIC ACIDS RES, V39, P7134, DOI 10.1093/nar/gkr376; Eyler DE, 2013, J BIOL CHEM, V288, P29530, DOI 10.1074/jbc.M113.487090; Freistroffer DV, 1997, EMBO J, V16, P4126, DOI 10.1093/emboj/16.13.4126; Goldstein AL, 1999, YEAST, V15, P507, DOI 10.1002/(SICI)1097-0061(199904)15:6<507::AID-YEA369>3.0.CO;2-P; Inagaki Y, 2002, NUCLEIC ACIDS RES, V30, P532, DOI 10.1093/nar/30.2.532; Ito K, 2002, P NATL ACAD SCI USA, V99, P8494, DOI 10.1073/pnas.142690099; Kim OTP, 2008, GENE, V417, P51, DOI 10.1016/j.gene.2008.03.018; Kobayashi K, 2012, NUCLEIC ACIDS RES, V40, P9319, DOI 10.1093/nar/gks660; Kobayashi K, 2010, P NATL ACAD SCI USA, V107, P17575, DOI 10.1073/pnas.1009598107; Merritt GH, 2010, NUCLEIC ACIDS RES, V38, P5479, DOI 10.1093/nar/gkq338; Saito K, 2010, P NATL ACAD SCI USA, V107, P19242, DOI 10.1073/pnas.1009599107; Youngman EM, 2007, MOL CELL, V28, P533, DOI 10.1016/j.molcel.2007.09.015	47	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	MAY 19	2015	43	9					4591	4601		10.1093/nar/gkv376		11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CK0XK	WOS:000355928800023		
J	Asano, N; Kato, K; Nakamura, A; Komoda, K; Tanaka, I; Yao, M				Asano, Nozomi; Kato, Koji; Nakamura, Akiyoshi; Komoda, Keisuke; Tanaka, Isao; Yao, Min			Structural and functional analysis of the Rpf2-Rrs1 complex in ribosome biogenesis	NUCLEIC ACIDS RESEARCH			English	Article							SMALL NUCLEOLAR RIBONUCLEOPROTEIN; PROTEIN L11-BINDING PROTEIN; SACCHAROMYCES-CEREVISIAE; STRUCTURE REFINEMENT; EUKARYOTIC RIBOSOME; ASSEMBLY FACTORS; BINDING DOMAIN; RNA; SUBUNIT; SERVER	Proteins Rpf2 and Rrs1 are required for 60S ribosomal subunit maturation. These proteins are necessary for the recruitment of three ribosomal components (5S ribosomal RNA [rRNA], RpL5 and RpL11) to the 90S ribosome precursor and subsequent 27SB pre-rRNA processing. Here we present the crystal structure of the Aspergillus nidulans (An) Rpf2-Rrs1 core complex. The core complex contains the tightly interlocked N-terminal domains of Rpf2 and Rrs1. The Rpf2 N-terminal domain includes a Brix domain characterized by similar N-and C-terminal architecture. The long alpha-helix of Rrs1 joins the C-terminal half of the Brix domain as if it were part of a single molecule. The conserved proline-rich linker connecting the N- and C-terminal domains of Rrs1 wrap around the side of Rpf2 and anchor the C-terminal domain of Rrs1 to a specific site on Rpf2. In addition, gel shift analysis revealed that the Rpf2-Rrs1 complex binds directly to 5S rRNA. Further analysis of Rpf2-Rrs1 mutants demonstrated that Saccha-romyces cerevisiae Rpf2 R236 (corresponds to R238 of AnRpf2) plays a significant role in this binding. Based on these studies and previous reports, we have proposed a model for ribosomal component recruitment to the 90S ribosome precursor.	[Asano, Nozomi; Kato, Koji; Komoda, Keisuke; Yao, Min] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido 0600810, Japan; [Kato, Koji; Nakamura, Akiyoshi; Komoda, Keisuke; Tanaka, Isao; Yao, Min] Hokkaido Univ, Fac Adv Life Sci, Sapporo, Hokkaido 0600810, Japan	Yao, M (reprint author), Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido 0600810, Japan.	yao@castor.sci.hokudai.ac.jp	yao, min/F-5287-2011; Komoda, Keisuke/O-9651-2015	yao, min/0000-0003-1687-5904; Komoda, Keisuke/0000-0002-9563-1061	Ministry of Education, Culture, Sports, Science and Technology of Japan [25291008]	Grant-in-Aid for Scientific Research in a Priority Area (B) [25291008 to M. Yao] from the Ministry of Education, Culture, Sports, Science and Technology of Japan. Funding for open access charge: Grant-in-Aid for Scientific Research in a Priority Area ( B) [25291008 to M. Yao] from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0; Ng CL, 2005, EMBO REP, V6, P140, DOI 10.1038/sj.embor.7400328; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Shastry S, 2010, CURR BIOL, V20, P939, DOI 10.1016/j.cub.2010.03.065; Zhang JY, 2007, GENE DEV, V21, P2580, DOI 10.1101/gad.1569307; Gadal O, 2002, J CELL BIOL, V157, P941, DOI 10.1083/jcb.200111039; Gerczei T, 2004, P NATL ACAD SCI USA, V101, P15301, DOI 10.1073/pnas.0406819101; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Joseph N, 1999, NUCLEIC ACIDS RES, V27, P4533, DOI 10.1093/nar/27.23.4533; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Kressler D, 1999, MOL CELL BIOL, V19, P7897; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; George RA, 2002, PROTEIN ENG, V15, P871, DOI 10.1093/protein/15.11.871; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Goldenberg O, 2009, NUCLEIC ACIDS RES, V37, pD323, DOI 10.1093/nar/gkn822; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Woolford JL, 2013, GENETICS, V195, P643, DOI 10.1534/genetics.113.153197; Asano N, 2014, ACTA CRYSTALLOGR F, V70, P1649, DOI 10.1107/S2053230X14024182; Durante-Rodriguez G, 2010, J BIOL CHEM, V285, P35694, DOI 10.1074/jbc.M110.143503; Eisenhaber F, 2001, TRENDS BIOCHEM SCI, V26, P345, DOI 10.1016/S0968-0004(01)01851-5; Granneman S, 2003, NUCLEIC ACIDS RES, V31, P1877, DOI 10.1093/nar/gkg300; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Horigome C, 2011, EMBO J, V30, P3799, DOI 10.1038/emboj.2011.267; Hsieh YC, 2007, BIOCHEM J, V408, P387, DOI 10.1042/BJ20070968; Lee SJ, 1999, MOL CELL BIOL, V19, P5441; Leidig C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4491; Miyoshi K, 2002, J BIOL CHEM, V277, P18334, DOI 10.1074/jbc.M201667200; Miyoshi K, 2004, FEBS LETT, V565, P106, DOI 10.1016/j.febslet.2004.03.087; Morita D, 2002, J BIOL CHEM, V277, P28780, DOI 10.1074/jbc.M203399200; Nariai M, 2005, NUCLEIC ACIDS RES, V33, P4553, DOI 10.1093/nar/gki772; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Tsuno A, 2000, MOL CELL BIOL, V20, P2066, DOI 10.1128/MCB.20.6.2066-2074.2000; Wehner KA, 2002, MOL CELL, V9, P329, DOI 10.1016/S1097-2765(02)00438-0; WOOTTON JC, 1989, PROTEIN ENG, V2, P535, DOI 10.1093/protein/2.7.535; YEH LCC, 1990, J MOL BIOL, V211, P699, DOI 10.1016/0022-2836(90)90071-S	41	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	MAY 19	2015	43	9					4746	4757		10.1093/nar/gkv305		12	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CK0XK	WOS:000355928800036		
J	Patil, SS; Harpale, KV; Shinde, AD; Khare, RT; Koinkar, PM; More, MA				Patil, Sandip S.; Harpale, Kashmira V.; Shinde, Akansha D.; Khare, Ruchita T.; Koinkar, Pankaj M.; More, Mahendra A.			Facile synthesis of cadmium sulphide-polyaniline (CdS-PANI) nanocomposite and its field emission investigations	JOURNAL OF POLYMER RESEARCH			English	Article						CdS-Polyaniline; Nanocomposite; TEM; Field emission	WALLED CARBON NANOTUBES; COMPOSITES; POLYPYRROLE; NANOFIBERS; NANOWIRES; PROPERTY; POLYMERS	A simple two step chemical route has been employed to synthesize cadmium sulphide - polyaniline (CdS-PANI) nanocomposite. In the first step PANI nanotubes are synthesized by oxidative polymerization followed by deposition of CdS nanoparticles on them. In order to investigate the structural, chemical and optical properties of the CdS-PANI nanocomposite, various characterization techniques have been used. The microscopic analysis reveals that the PANI nanotubes having length in several microns with cavity diameter of 10 to 20 nm are decorated with CdS nanoparticles of 5 to 10 nm. The XRD spectrum indicates formation of crystalline hexagonal phase of CdS, supported by the SAED pattern obtained during TEM analysis. The FTIR and UV-visible spectra confirm formation of the conducting phase of PANI. The field emission studies of the CdS-PANI nanocomposite indicate low turn on field of 1.4 V/mu m, corresponding to emission current density 1 mu A/cm(2), and emission current density of 5.5 mA/cm(2) has been drawn at an applied field of 3.8 V/mu m. Furthermore the emission current is observed to be fairly stable at the preset values over long term duration. The enhanced field emission properties, exhibited in terms of low turn on field, and delivery of very high emission current density at relatively lower applied field, are attributed to the nanometric dimensions of the PANI nanotubes and CdS nanoparticles, and modulation of electronic properties due to formation of heterojunction. The overall field emission results propose the CdS-PANI nanocomposite as a promising material for field emission based devices.	[Patil, Sandip S.] Modern Coll Arts Sci & Commerce, Dept Phys, Pune 411005, Maharashtra, India; [Patil, Sandip S.; Harpale, Kashmira V.; Shinde, Akansha D.; Khare, Ruchita T.; More, Mahendra A.] Savitribai Phule Pune Univ, Dept Phys, Ctr Adv Studies Mat Sci & Solid State Phys, Pune 411007, Maharashtra, India; [Koinkar, Pankaj M.] Univ Tokushima, CICEE, Tokushima, Tokushima, Japan	Patil, SS (reprint author), Modern Coll Arts Sci & Commerce, Dept Phys, Pune 411005, Maharashtra, India.	sandippatil1712@gmail.com; mam@physics.unipune.ac.in			BARC, Mumbai	Sandip S. Patil, like to acknowledge BARC, Mumbai for financial support. The field emission studies have been carried out as part of the CNQS activity of Savitribai Phule Pune University.	Querner C, 2004, J AM CHEM SOC, V126, P11574, DOI 10.1021/ja047882c; Xi YY, 2005, CHEM PHYS LETT, V412, P60, DOI 10.1016/j.cplett.2005.06.087; Wu CG, 1996, CHEM MATER, V8, P1992, DOI 10.1021/cm9600236; Kim BH, 2005, SYNTHETIC MET, V150, P279, DOI 10.1016/j.synthmet.2005.02.012; Kim WH, 2002, APPL PHYS LETT, V80, P3844, DOI 10.1063/1.1480100; Ameen S, 2012, CHEM ENG J, V181, P806, DOI 10.1016/j.cej.2011.11.111; Jeon SS, 2011, POLYMER, V52, P652, DOI 10.1016/j.polymer.2010.12.021; Yan HL, 2006, NANOTECHNOLOGY, V17, P3446, DOI 10.1088/0957-4484/17/14/017; Seoudi R, 2010, SYNTHETIC MET, V160, P479, DOI 10.1016/j.synthmet.2009.11.035; Li GC, 2004, MACROMOLECULES, V37, P2683, DOI 10.1021/ma035891k; Long YZ, 2011, PROG POLYM SCI, V36, P1415, DOI 10.1016/j.progpolymsci.2011.04.001; Wang CW, 2001, CHEM PHYS LETT, V341, P431, DOI 10.1016/S0009-2614(01)00509-7; Luo CH, 2011, MACROMOLECULES, V44, P6899, DOI 10.1021/ma201350m; Ramgir NS, 2006, NANOTECHNOLOGY, V17, P2730, DOI 10.1088/0957-4484/17/11/003; Arya SK, 2011, BIOSENS BIOELECTRON, V28, P166, DOI 10.1016/j.bios.2011.07.015; Patil SS, 2012, RSC ADV, V2, P5822, DOI 10.1039/c2ra01294d; Chih-YK MSS, 2011, ENERG ENVIRON SCI, V4, P2316; Cosmin L, 2010, PROG POLYM SCI, V35, P1403; Dutta K, 2007, J APPL PHYS, V101; Fowler RH, 1928, P R SOC LOND A-CONTA, V119, P173, DOI 10.1098/rspa.1928.0091; Gopalakrishnan K., 2012, ARCH PHYS RES, V3, P315; Jaroslav S, 2006, POLYMER, V47, P8253; Kim BH, 2003, APPL PHYS LETT, V83, P539, DOI 10.1063/1.1592004; Mehdi SN, 2014, J POLYM RES, V21, P416; Miroslava T, 2006, J PHYS CHEM B, V110, P9461; Miroslava T, 2011, PURE APPL CHEM, V83, P1803; Musa I, 1998, NATURE, V395, P362; Nair R, 2009, SOLID STATE COMMUN, V149, P150, DOI 10.1016/j.ssc.2008.10.034; Osterloh FE, 2003, NANO LETT, V3, P125, DOI 10.1021/nl025739g; Patil SS, 2012, POLYM ADVAN TECHNOL, V23, P215, DOI 10.1002/pat.1854; Patil SS, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.41401; Patil SS, 2011, J ELECTROCHEM SOC, V158, pE63, DOI 10.1149/1.3582525; Rakhi RB, 2008, APPL SURF SCI, V254, P6770, DOI 10.1016/j.apsusc.2008.04.094; Rakhi RB, 2009, J EXP NANOSCI, V4, P67, DOI 10.1080/17458080802610868; Ting TH, 2013, J POLYM RES, V20, DOI 10.1007/s10965-013-0127-3	35	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1022-9760	1572-8935		J POLYM RES	J. Polym. Res.	MAY 19	2015	22	6							113	10.1007/s10965-015-0746-y		8	Polymer Science	Polymer Science	CJ8NV	WOS:000355760700001		
J	Kubo, T; Kanemori, K; Kusumoto, R; Kawai, T; Sueyoshi, K; Naito, T; Otsuka, K				Kubo, Takuya; Kanemori, Koichi; Kusumoto, Risa; Kawai, Takayuki; Sueyoshi, Kenji; Naito, Toyohiro; Otsuka, Koji			Simple and Effective Label-Free Capillary Electrophoretic Analysis of Sugars by Complexation Using Quinoline Boronic Acids	ANALYTICAL CHEMISTRY			English	Article							PHYSIOLOGICAL PH; AQUEOUS-SOLUTION; WATER; RECOGNITION; GLUCOSE; BINDING; SENSOR; CHROMATOGRAPHY; POLYOLS; CANCER	An effective Separation and detection:procedure for sugars by capillary electrophoresis (CE) using a complexation between quinolineboranic acid (QBA) and multiple hydroxyl structure of sugar alcohol is reported We investigated the variation of fluorescence Spectra:of a variety of QBAs With sorbitol rat a wide range of pH conditions and then found that 5-isoQBA strongly enhanced the fluorescence intensity by the complexatien at basic pH conditions. The other Sugar alcohols, having multiple hydroxyls also revealed the enhancement of the fluorescence intensity with 5-isoQBA, Whereas the alternation of the intensity was not found in the sugars such as glucose. After optimization of the 5-isoQBA concentration and pH of the buffered solution in CE analysis, 6 sugar alcohols were successfully separated in the order based on the formation constants with 5-isoQBA, which were calculated from the variation, of the fluorescence intensity with each sugar alcohol, and -5-isoQBA. Furthermore, the limits of detection for sorbitol and xylitol by the CE method were estimated at 15 and 27 mu M, respectively.	[Kubo, Takuya; Kanemori, Koichi; Kusumoto, Risa; Naito, Toyohiro; Otsuka, Koji] Kyoto Univ, Grad Sch Engn, Nishikyo Ku, Katsura, Kyoto 6158510, Japan; [Kawai, Takayuki] RIKEN, Quantitat Biol Ctr, Lab Integrated Biodevice Unit, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Sueyoshi, Kenji] Osaka Prefecture Univ, Grad Sch Engn, Dept Appl Chem, Sakai, Osaka 5998531, Japan	Kubo, T (reprint author), Kyoto Univ, Grad Sch Engn, Nishikyo Ku, Katsura, Kyoto 6158510, Japan.	kubo@anchem.mc.kyoto-u.ac.jp			Japan Society for the Promotion of Science [25620111, 24350039]	This research was partly supported by the Grant-in Aid for Scientific Research (Nos. 25620111 and 24350039) from the Japan Society for the Promotion of Science. We specially thank Prof. Philip Britz-McKibbin, Department of Chemistry and Chemical Biology, McMaster University, for helpful discussion.	Georgiou I, 2009, ACCOUNTS CHEM RES, V42, P756, DOI 10.1021/ar800262v; Wang SS, 2014, CHEM SCI, V5, P1135, DOI 10.1039/c3sc52986j; Ren LB, 2009, J CHROMATOGR A, V1216, P4768, DOI 10.1016/j.chroma.2009.04.036; Yang WQ, 2003, BIOORG MED CHEM LETT, V13, P1019, DOI 10.1016/S0960-894X(03)00086-6; Ellis GA, 2012, J AM CHEM SOC, V134, P3631, DOI 10.1021/ja210719s; HAGLUND C, 1986, BRIT J CANCER, V53, P197, DOI 10.1038/bjc.1986.35; Wu X, 2013, CHEM SOC REV, V42, P8032, DOI 10.1039/c3cs60148j; Dowlut M, 2006, J AM CHEM SOC, V128, P4226, DOI 10.1021/ja057798c; Shen QJ, 2011, LUMINESCENCE, V26, P494, DOI 10.1002/bio.1258; Shen PF, 2014, ANAL CHEM, V86, P5323, DOI 10.1021/ac5001338; Malykh YN, 2001, BIOCHIMIE, V83, P623, DOI 10.1016/S0300-9084(01)01303-7; Franzen S, 2003, J PHYS CHEM B, V107, P12942, DOI 10.1021/jp027457a; Guo ZQ, 2012, CHEM COMMUN, V48, P5956, DOI 10.1039/c2cc31985c; Jin S, 2008, CHEM-EUR J, V14, P2795, DOI 10.1002/chem.200701785; Nakajima K, 2010, GLYCOBIOLOGY, V20, P865, DOI 10.1093/glycob/cwq044; Fei F, 2010, ANAL BIOANAL CHEM, V398, P1349, DOI 10.1007/s00216-010-4038-4; YOON J, 1992, J AM CHEM SOC, V114, P5874, DOI 10.1021/ja00040a067; Yang WQ, 2005, TETRAHEDRON LETT, V46, P7981, DOI 10.1016/j.tetlet.2005.09.074; Stefansson M, 1996, J CHROMATOGR A, V720, P127, DOI 10.1016/0021-9673(95)00276-6; Wong CM, 2008, APPL MICROBIOL BIOT, V78, P927, DOI 10.1007/s00253-008-1407-4; Arimori S, 2002, ORG LETT, V4, P4249, DOI 10.1021/ol026802b; Arimori S, 2002, TETRAHEDRON LETT, V43, P911, DOI 10.1016/S0040-4039(01)02290-0; Bi X., 2013, ANAL CHEM, V86, P959; Cao HS, 2002, ORG LETT, V4, P1503, DOI 10.1021/ol025723x; Cheng YF, 2010, CHEM-EUR J, V16, P13528, DOI 10.1002/chem.201000637; Hansen Jon Stefan, 2013, Biosensors (Basel), V3, P400, DOI 10.3390/bios3040400; Kaiser C, 2008, CHEM COMMUN, P338, DOI 10.1039/b714215c; Kitahara KI, 2009, J CHROMATOGR A, V1216, P7415, DOI 10.1016/j.chroma.2009.03.061; Li L, 2013, ANGEW CHEM INT EDIT, V125, P7599; Minami T, 2014, CHEM COMMUN, V50, P15613, DOI 10.1039/c4cc07498j; Oikari S, 2014, J CHROMATOGR A, V1323, P82, DOI 10.1016/j.chroma.2013.11.004; STEFANSSON M, 1993, CHROMATOGRAPHIA, V35, P55, DOI 10.1007/BF02278557; Trail PA, 2003, CANCER IMMUNOL IMMUN, V52, P328, DOI 10.1007/s00262-002-0352-9; Xue CH, 2008, CHEM-EUR J, V14, P1648, DOI 10.1002/chem.200701376; Zheng SL, 2007, TETRAHEDRON, V63, P5427, DOI 10.1016/j.tet.2007.04.035	35	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0003-2700	1520-6882		ANAL CHEM	Anal. Chem.	MAY 19	2015	87	10					5068	5073		10.1021/acs.analchem.5b00998		6	Chemistry, Analytical	Chemistry	CI8YN	WOS:000355057700010		
J	Tominaga, M; Sasaki, A; Togami, M				Tominaga, Masato; Sasaki, Aiko; Togami, Makoto			Laccase Bioelectrocatalyst at a Steroid-Type Biosurfactant-Modified Carbon Nanotube Interface	ANALYTICAL CHEMISTRY			English	Article							DIRECT ELECTRON-TRANSFER; BILIRUBIN OXIDASE; OXYGEN REDUCTION; MULTICOPPER OXIDASES; TRAMETES-VERSICOLOR; GOLD ELECTRODE; O-2 REDUCTION; BIOFUEL CELL; FUEL-CELLS; GRAPHITE	Achieving oxygen. reduction at high positive potentials with fast heterogeneous electron transfer is desirable for the biocathode of fuel cells based on enzymes. Here, we present an effective interface for obtaining direct electron transfer from a laccase (Lac)-based cathode for O-2 reduction, starting from a potential very dose to the redox equilibrium potential of the oxygen/water couple. The interface between Lac and single-walled carbon nanotubes was improved by modification with the steroid biosurfactant sodium cholate. The heterogeneous electron-transfer rate between the type-1 Cu site of Lac and the modified electrode was determined to be 3000 s(-1). The electron-transfer rate was sensitive to the side chain of the steroid biosurfactant, and the rate decreased more than 10-fold when sodium deoxycholate was used as the side chain.	[Tominaga, Masato; Sasaki, Aiko; Togami, Makoto] Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto 8608555, Japan; [Tominaga, Masato] Kumamoto Inst Photoelectro Organ, Kumamoto 8620901, Japan	Tominaga, M (reprint author), Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto 8608555, Japan.	masato@gpo.kumamoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [24550159]	This work was financially supported by a Grant-in-Aid for Scientific Research (24550159) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Dwivedi UN, 2011, J MOL CATAL B-ENZYM, V68, P117, DOI 10.1016/j.molcatb.2010.11.002; Piontek K, 2002, J BIOL CHEM, V277, P37663, DOI 10.1074/jbc.M204571200; Lorcher S, 2013, CHEMPHYSCHEM, V14, P2112, DOI 10.1002/cphc.201300069; Qiu HJ, 2009, J PHYS CHEM C, V113, P2521, DOI 10.1021/jp8090304; Barton SC, 2004, CHEM REV, V104, P4867, DOI 10.1021/cr020719k; TUINSTRA F, 1970, J CHEM PHYS, V53, P1126, DOI 10.1063/1.1674108; Norskov JK, 2004, J PHYS CHEM B, V108, P17886, DOI 10.1021/jp047349j; Mano N, 2013, BIOSENS BIOELECTRON, V50, P478, DOI 10.1016/j.bios.2013.07.014; Shleev S, 2005, BIOCHEM J, V385, P745; WATANABE N, 1964, J ELECTROCHEM SOC, V111, P615, DOI 10.1149/1.2426194; Leech D, 2012, ELECTROCHIM ACTA, V84, P223, DOI 10.1016/j.electacta.2012.02.087; Tominaga M, 2008, PHYS CHEM CHEM PHYS, V10, P6928, DOI 10.1039/b809737b; Pang HL, 2010, ELECTROCHIM ACTA, V55, P6611, DOI 10.1016/j.electacta.2010.06.013; Wenseleers W, 2004, ADV FUNCT MATER, V14, P1105, DOI 10.1002/adfm.200400130; Shleev S, 2005, BIOSENS BIOELECTRON, V20, P2517, DOI 10.1016/j.bios.2004.10.003; Sugimoto Y, 2015, BIOSENS BIOELECTRON, V63, P138, DOI 10.1016/j.bios.2014.07.025; Cracknell JA, 2008, CHEM REV, V108, P2439, DOI 10.1021/cr0680639; Leger C, 2008, CHEM REV, V108, P2379, DOI 10.1021/cr0680742; Shleev S, 2012, ELECTROANAL, V24, P1524, DOI 10.1002/elan.201200188; Katsounaros I, 2014, ANGEW CHEM INT EDIT, V53, P102, DOI 10.1002/anie.201306588; Jorio A, 2001, PHYS REV LETT, V86, P1118, DOI 10.1103/PhysRevLett.86.1118; Santucci R, 1998, BIOCHEM J, V332, P611; Kamitaka Y, 2007, PHYS CHEM CHEM PHYS, V9, P1793, DOI 10.1039/b617650j; Jeon MK, 2012, J POWER SOURCES, V216, P400, DOI 10.1016/j.jpowsour.2012.05.107; Vaz-Dominguez C, 2008, BIOSENS BIOELECTRON, V24, P531, DOI 10.1016/j.bios.2008.05.002; Kataura H, 1999, SYNTHETIC MET, V103, P2555, DOI 10.1016/S0379-6779(98)00278-1; Shleev S, 2005, BIOELECTROCHEMISTRY, V67, P115, DOI 10.1016/j.bioelechem.2005.02.004; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; Wei W, 2012, ELECTROCHEM COMMUN, V22, P181, DOI 10.1016/j.elecom.2012.06.021; Blanford CF, 2007, CHEM COMMUN, P1710, DOI 10.1039/b703114a; BRATSCH SG, 1989, J PHYS CHEM REF DATA, V18, P1; Gutierrez-Sanchez C, 2012, J AM CHEM SOC, V134, P17212, DOI 10.1021/ja307308j; Ishibashi A, 2006, CHEM-EUR J, V12, P7595, DOI 10.1002/chem.200600326; Johnson DL, 2003, BIOCHEMISTRY-US, V42, P10229, DOI 10.1021/bi034268p; Jones MB, 1999, ANAL BIOCHEM, V268, P126, DOI 10.1006/abio.1998.3064; Jonsson-Niedziolka M, 2010, ELECTROCHIM ACTA, V55, P8744, DOI 10.1016/j.electacta.2010.07.101; Liu H., 2011, NAT COMMUN, V309, P1; Matijosyte I, 2008, INORG CHIM ACTA, V361, P1202, DOI 10.1016/j.ica.2007.05.029; Ramasamy RP, 2010, CHEM COMMUN, P6045; Saito R., 2000, PHYS REV B, V61, P13202; Sakamoto S, 2013, CHEM-ASIAN J, V8, P2680, DOI 10.1002/asia.201300716; Tominaga M, 2012, J PHYS CHEM C, V116, P9498, DOI 10.1021/jp2112473; Tominaga M, 2014, ANAL CHEM, V86, P5053, DOI 10.1021/ac500700h; Tsujimura S, 2005, J ELECTROANAL CHEM, V576, P113, DOI 10.1016/j.jelechem.2004.09.031	44	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0003-2700	1520-6882		ANAL CHEM	Anal. Chem.	MAY 19	2015	87	10					5417	5421		10.1021/acs.analchem.5b00858		5	Chemistry, Analytical	Chemistry	CI8YN	WOS:000355057700055		
J	Katayama, S; Sueyoshi, N; Kameshita, I				Katayama, Syouichi; Sueyoshi, Noriyuki; Kameshita, Isamu			Critical Determinants of Substrate Recognition by Cyclin-Dependent Kinase-like 5 (CDKL5)	BIOCHEMISTRY			English	Article							PROTEIN-KINASE; RETT-SYNDROME; MEDIATED ENDOCYTOSIS; DOWN-SYNDROME; MECP2 GENE; IDENTIFICATION; SPECIFICITY; MUTATIONS; RETARDATION; EXPRESSION	Cyclin-dependent (CDKL5) is a Ser/Thr protein kinase known to be associated-With X-linked neurodevelopmental disorders. In a previous study, we identified amphiphysin 1 (Amphl) as a potential substrate for CDKL5 and identified a single phosphorylation site at Ser-293. In this study, we investigated the molecular mechanisms of substrate recognition by CDKL5 using Amphl as a model substrate. Amphl served as an efficient CDKL5 substrate) whereas Amph2, a structurally related homologue of Amphl, was not phosphorylated by CDKL5. The sequence around the Amphl phosphorylation site is RPR(293)SPSQ, while the corresponding sequence in Amph2 is IPK(332)SPSQ, To define the amino,Amph2 acid sequence specificity of the substrate, various point mutants of Amphl and Amph2 were prepared and phosphorylated by CDKL5. Both 1 283 413 588 Amph2(I329R) and' Amphl served as efficient CDKL5 substrates, but Amphl (R290I) Did not, indicating that the arginyl residue at the P -3 position is critical for substrate recognition: With regard to prolyl residues around the phosphorylation site of Amphl, Pro-291 at the P 2 position, but not Pro-294 at the P +1 position, is indispensable for phosphorylation by CDKL5. Phosphorylation experiments using various deletion mutants of Amphl revealed that the proline-rich domain (PRD) (amino acids 247-315) alone was not phosphorylated by CDKL5. In contrast, Amph1(247-385), which comprised the PR) and CLAP domains, served as an efficient CDKL5 substrate. These results) taken together, suggest that both the phosphorylation site sequence (RPXSX) and the CLAP domain structure in Amphl play crucial roles in recognition and phosphorylation by CDKL5.	[Katayama, Syouichi; Sueyoshi, Noriyuki; Kameshita, Isamu] Kagawa Univ, Fac Agr, Dept Life Sci, Miki, Kagawa 7610795, Japan	Kameshita, I (reprint author), Kagawa Univ, Fac Agr, Dept Life Sci, Ikenobe 2393, Miki, Kagawa 7610795, Japan.	kamesita@ag.kagawa-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25350978]	This work was supported in part by a grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant 25350978 to I.K.).	Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; IMAI Y, 1991, NUCLEIC ACIDS RES, V19, P2785, DOI 10.1093/nar/19.10.2785; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Evans JC, 2005, EUR J HUM GENET, V13, P1113, DOI 10.1038/sj.ejhg.5201451; Wang ITJ, 2012, P NATL ACAD SCI USA, V109, P21516, DOI 10.1073/pnas.1216988110; Ricciardi S, 2012, NAT CELL BIOL, V14, P911, DOI 10.1038/ncb2566; Cheadle JP, 2000, HUM MOL GENET, V9, P1119, DOI 10.1093/hmg/9.7.1119; Mari F, 2005, HUM MOL GENET, V14, P1935, DOI 10.1093/hmg/ddi198; Kameshita I, 2008, BIOCHEM BIOPH RES CO, V377, P1162, DOI 10.1016/j.bbrc.2008.10.113; Di Paolo G, 2002, NEURON, V33, P789, DOI 10.1016/S0896-6273(02)00601-3; Himpel S, 2000, J BIOL CHEM, V275, P2431, DOI 10.1074/jbc.275.4.2431; Murakami N, 2006, J BIOL CHEM, V281, P23712, DOI 10.1074/jbc.M513497200; Shimomura S, 2007, ARCH BIOCHEM BIOPHYS, V463, P218, DOI 10.1016/j.abb.2007.03.036; Soundararajan M, 2013, STRUCTURE, V21, P986, DOI 10.1016/j.str.2013.03.012; Wigge P, 1998, TRENDS NEUROSCI, V21, P339, DOI 10.1016/S0166-2236(98)01264-8; Kameshita I, 2003, ANAL BIOCHEM, V322, P215, DOI 10.1016/j.ab.2003.08.014; Rusconi L, 2008, J BIOL CHEM, V283, P30101, DOI 10.1074/jbc.M804613200; Tao J, 2004, AM J HUM GENET, V75, P1149, DOI 10.1086/426460; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; Bertani I, 2006, J BIOL CHEM, V281, P32048, DOI 10.1074/jbc.M606325200; Bienvenu T., 2011, MOL SYNDROMOL, V2, P137; Buyse IM, 2000, AM J HUM GENET, V67, P1428, DOI 10.1086/316913; HERRING BP, 1992, J BIOL CHEM, V267, P25945; Ishida A, 2001, J BIOCHEM, V129, P745; Kameshita I, 2014, J BIOCHEM, V156, P147, DOI 10.1093/jb/mvu025; Kammoun F, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.014480; Katayama S, 2012, J BIOCHEM, V152, P347, DOI 10.1093/jb/mvs075; Lin C, 2005, HUM MOL GENET, V14, P3775, DOI 10.1093/hmg/ddi391; Mok J., 2011, SCI SIGNAL, V3, pra12; Montini E, 1998, GENOMICS, V51, P427, DOI 10.1006/geno.1998.5391; NAIRN AC, 1987, J BIOL CHEM, V262, P17299; Ramjaun AR, 1997, J BIOL CHEM, V272, P16700, DOI 10.1074/jbc.272.26.16700; Rmjaun A R., 1997, J BIOL CHEM, V272, P16700; Sekiguchi M, 2013, ARCH BIOCHEM BIOPHYS, V535, P257, DOI 10.1016/j.abb.2013.04.012; Senga Y, 2011, ANAL BIOCHEM, V408, P345, DOI 10.1016/j.ab.2010.08.036; Shang WH, 2004, J BIOL CHEM, V279, P40890, DOI 10.1074/jbc.M404527200; Wigge P, 1997, MOL BIOL CELL, V8, P2003	37	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0006-2960			BIOCHEMISTRY-US	Biochemistry	MAY 19	2015	54	19					2975	2987		10.1021/bi501308k		13	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CI8YQ	WOS:000355058000005		
J	Feldman, JL; Dittenhafer-Reed, KE; Kudo, N; Thelen, JN; Ito, A; Yoshida, M; Denu, JM				Feldman, Jessica L.; Dittenhafer-Reed, Kristin E.; Kudo, Norio; Thelen, Julie N.; Ito, Akihiro; Yoshida, Minoru; Denu, John M.			Kinetic and Structural Basis for Acyl-Group Selectivity and NAD(+) Dependence in Sirtuin-Catalyzed Deacylation	BIOCHEMISTRY			English	Article							POSTTRANSLATIONAL MODIFICATION; HISTONE/PROTEIN DEACETYLASES; LYSINE PROPIONYLATION; PROTEIN ACYLATION; CRYSTAL-STRUCTURE; ENZYME-KINETICS; ADP-RIBOSE; MECHANISM; ACETYLATION; HISTONES	Acylation of lysine is an important protein modification regulating diverse biological processes. It was recently demonstrated that members of the human Sirtuin family are capable of catalyzing long chain deacylation, in addition to the well-known NAD(+)-dependent deacetylation activity [Feldman) J. L., Baeza, J., and Denu, J. M. (2013) J. Biol. Chem. 288, 31350-31356]. Here we provide a detailed kinetic and structural analysis that describes the interdependence of NAD(+)-binding and acyl-group selectivity for a diverse series of human Sirtuins, SIRT1-SIRT3 and SIRT6. Steady-state and rapid-quench kinetic analyses indicated that differences in NAD(+) saturation and susceptibility to nicotinamide inhibition reflect unique kinetic behavior displayed by each Sirtuin and depend on acyl substrate chain length. Though the rate of nudeophilic attack of the 2'-hydroxyl on the C1'-O-alkylimidate intermediate varies with acyl substrate chain length, this step remains rate-determining for SIRT2 and SIRT3; however, for SIRT6, this step is no longer rate-limiting for long chain substrates. Cocrystallization of SIRT2 with myristoylated peptide and NAD(+) yielded a co-complex Structure with reaction product 2'-O-myristoyl-ADP-ribose, revealing a latent hydrophobic cavity to accommodate the long Chain acyl group, and suggesting a general mechanism for long chain deacylation. Comparing two separately determined co-complex structures containing either a Myristoylated peptide or 2'-O-Myristoyl-ADP-ribose indicates the are conformational changes at the myristoyl-ribose linkage with minimal structural differences in the enzyme active site. During the deacylation reaction, the fatty acyl group is held in a relatively fixed position. We describe a kinetic and structural model to explain how various Sirtuins display unique acyl substrate preferences and how different reaction kinetics influence NAD(+) dependence. The biological implications are discussed.	[Feldman, Jessica L.; Dittenhafer-Reed, Kristin E.; Denu, John M.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53715 USA; [Thelen, Julie N.; Denu, John M.] Univ Wisconsin, Wisconsin Inst Discovery, Madison, WI 53715 USA; [Kudo, Norio; Yoshida, Minoru] RIKEN Ctr Sustainable Resource Sci, Seed Cpds Exploratory Unit Drug Discovery Platfor, Wako, Saitama 3510198, Japan; [Ito, Akihiro; Yoshida, Minoru] RIKEN Ctr Sustainable Resource Sci, Chem Genom Res Grp, Wako, Saitama 3510198, Japan; [Yoshida, Minoru] JST, CREST Res Project, Kawaguchi, Saitama 3320012, Japan	Denu, JM (reprint author), Univ Wisconsin, Dept Biomol Chem, Madison, WI 53715 USA.	yoshidam@riken.jp; jmdenu@wisc.edu	Yoshida, Minoru/C-8049-2014		National Institutes of Health (NIH) [5T32GM08349, GM06538]; Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT) from The Ministry of Education, Culture, Sports, Science and Technology of Japan; National Science Foundation [9520868]	This work was supported by National Institutes of Health (NIH) Traineeship 5T32GM08349 (K.E.D.-R.), NIH Grant GM06538 (J.M.D.), and the Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT) from The Ministry of Education, Culture, Sports, Science and Technology of Japan (A.I.). The purchase of the Bruker REFLEXII instrument in 1996 was partially funded by National Science Foundation Award 9520868 to the University of Wisconsin-Madison Department of Chemistry.	Jackson MD, 2003, J BIOL CHEM, V278, P50985, DOI 10.1074/jbc.M306552200; Zhang K, 2009, J PROTEOME RES, V8, P900, DOI 10.1021/pr8005155; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Tan MJ, 2014, CELL METAB, V19, P605, DOI 10.1016/j.cmet.2014.03.014; Min JR, 2001, CELL, V105, P269, DOI 10.1016/S0092-8674(01)00317-8; Pan PW, 2011, J BIOL CHEM, V286, P14575, DOI 10.1074/jbc.M111.218990; Wagner GR, 2014, MOL CELL, V54, P5, DOI 10.1016/j.molcel.2014.03.027; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Garrity J, 2007, J BIOL CHEM, V282, P30239, DOI 10.1074/jbc.M704409200; Weinert BT, 2013, MOL CELL, V51, P265, DOI 10.1016/j.molcel.2013.06.003; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; He WJ, 2012, TRENDS ENDOCRIN MET, V23, P467, DOI 10.1016/j.tem.2012.07.004; Jiang H, 2013, NATURE, V496, P110, DOI 10.1038/nature12038; Zhang QH, 2002, SCIENCE, V295, P1895; Moniot S, 2013, J STRUCT BIOL, V182, P136, DOI 10.1016/j.jsb.2013.02.012; Xie ZY, 2012, MOL CELL PROTEOMICS, V11, P100, DOI 10.1074/mcp.M111.015875; Northrop DB, 1998, J CHEM EDUC, V75, P1153; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Finnin MS, 2001, NAT STRUCT BIOL, V8, P621, DOI 10.1038/89668; Sanders BD, 2010, BBA-PROTEINS PROTEOM, V1804, P1604, DOI 10.1016/j.bbapap.2009.09.009; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Yamagata K, 2014, STRUCTURE, V22, P345, DOI 10.1016/j.str.2013.12.001; Avalos JL, 2004, MOL CELL, V13, P639, DOI 10.1016/S1097-2765(04)00082-6; Borra MT, 2004, BIOCHEMISTRY-US, V43, P9877, DOI 10.1021/bi049592e; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Nikiforov A, 2011, J BIOL CHEM, V286, P21767, DOI 10.1074/jbc.M110.213298; Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002; Zhou YY, 2012, J BIOL CHEM, V287, P28307, DOI 10.1074/jbc.M112.384511; Zhang ZH, 2011, NAT CHEM BIOL, V7, P58, DOI [10.1038/nchembio.495, 10.1038/NCHEMBIO.495]; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Borra MT, 2002, J BIOL CHEM, V277, P12632, DOI 10.1074/jbc.M111830200; Wu J, 2009, BIOORGAN MED CHEM, V17, P1381, DOI 10.1016/j.bmc.2008.12.014; Liu B, 2009, J BIOL CHEM, V284, P32288, DOI 10.1074/jbc.M109.045856; Feldman JL, 2013, J BIOL CHEM, V288, P31350, DOI 10.1074/jbc.C113.511261; CLELAND WW, 1975, BIOCHEMISTRY-US, V14, P3220, DOI 10.1021/bi00685a029; Cook P. F., 2007, ENZYME KINETICS MECH; Fischer F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045098; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peng C., 2011, MOL CELL PROTEOMICS, V10; Smith BC, 2007, J AM CHEM SOC, V129, P5802, DOI 10.1021/ja070162w; Teng YB, 2015, SCI REP-UK, V5, DOI 10.1038/srep08529; Weinert BT, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134766; Zhu AY, 2012, ACS CHEM BIOL, V7, P155, DOI 10.1021/cb200230x	46	4	4	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0006-2960			BIOCHEMISTRY-US	Biochemistry	MAY 19	2015	54	19					3037	3050		10.1021/acs.biochem.5b00150		14	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CI8YQ	WOS:000355058000010		
J	Ihara, M; Kitamura, T; Kumar, V; Park, CB; Ihara, MO; Lee, SJ; Yamashita, N; Miyagawa, S; Iguchi, T; Okamoto, S; Suzuki, Y; Tanaka, H				Ihara, Masaru; Kitamura, Tomokazu; Kumar, Vimal; Park, Chang-Beom; Ihara, Mariko O.; Lee, Sang-Jung; Yamashita, Naoyuki; Miyagawa, Shinichi; Iguchi, Taisen; Okamoto, Seiichiro; Suzuki, Yutaka; Tanaka, Hiroaki			Evaluation of Estrogenic Activity of Wastewater: Comparison Among In Vitro ER alpha Reporter Gene Assay, In Vivo Vitellogenin Induction, and Chemical Analysis	ENVIRONMENTAL SCIENCE & TECHNOLOGY			English	Article							WIDESPREAD SEXUAL DISRUPTION; MEDAKA ORYZIAS-LATIPES; SEWAGE-TREATMENT; ENDOCRINE DISRUPTORS; BINARY-MIXTURES; TREATMENT WORKS; STW EFFLUENT; WILD FISH; REMOVAL; RESPONSES	The in vitro estrogen receptor (ER) reporter gene assay has long been used to measure estrogenic activity in wastewater. In a previous study, we demonstrated that the assay represents net estrogenic activity in the balance between estrogenic and antiestrogenic activities in waste:water. However, it remained unclear whether the net estrogenic activity measured by the in vitro ER alpha reporter gene assay can predict the in vivo estrogenic effect of wastewater. To determine this, we measured the following: estrogenic and antiestrogenic activities of wastewater and reclaimed water by the in vitro ER alpha reporter gene assay, expression of vitellogenin-1 (vtg1) and choriogenin-H (chgH) in male medaka (Oryzias latipes) by quantitative real-time PCR, and estrone, 17 beta-estradiol, estriol, and 17 alpha-ethynylestradiol concentrations chemically to predict estrogenic activity. The net estrogenic activity measured by the in vitro medaka ER alpha reporter gene assay predicted the in vivo vtg1/chgH expression in male medaka more accurately than the concentrations of estrogens. These results also mean that in vivo vtg1/chgH expression in male medaka is determined by the balance between estrogenic and antiestrogenic activities. The in vitro medaka ER alpha reporter gene assay also predicted in vivo vtg1/chgH expression on male medaka better than the human ER alpha reporter gene assay.	[Ihara, Masaru; Kumar, Vimal; Ihara, Mariko O.; Lee, Sang-Jung; Yamashita, Naoyuki; Tanaka, Hiroaki] Kyoto Univ, Grad Sch Engn, Res Ctr Environm Qual Management, Otsu, Shiga 5200811, Japan; [Kitamura, Tomokazu; Park, Chang-Beom; Okamoto, Seiichiro; Suzuki, Yutaka] Publ Works Res Inst, Tsukuba, Ibaraki 3058516, Japan; [Kumar, Vimal] Univ South Bohemia Ceske Budejovice, Fac Fisheries & Protect Waters, South Bohemian Res Ctr Aquaculture & Biodivers Hy, Res Inst Fish Culture & Hydrobiol, Vodnany 38925, Czech Republic; [Park, Chang-Beom] Korea Inst Sci & Technol Europe, Environm & Bio Grp, D-66123 Saarbrucken, Germany; [Miyagawa, Shinichi; Iguchi, Taisen] Grad Univ Adv Studies, Okazaki Inst Integrat Biosci, Natl Inst Basic Biol, Natl Inst Nat Sci,SOKENDAI, Okazaki, Aichi 4448787, Japan; [Miyagawa, Shinichi; Iguchi, Taisen] Grad Univ Adv Studies, Dept Basic Biol, Fac Life Sci, SOKENDAI, Okazaki, Aichi 4448787, Japan	Ihara, M (reprint author), Kyoto Univ, Grad Sch Engn, Res Ctr Environm Qual Management, 1-2 Yumihama, Otsu, Shiga 5200811, Japan.	ihara@biwa.eqc.kyoto-u.ac.jp; htanaka@biwa.eqc.kyoto-u.ac.jp	Hatwal, Vimal/F-7934-2015		UK-Japan cooperative project of the Ministry of the Environment, Japan; Japan Science and Technology Agency's Core Research for Evolutional Science and Technology (CREST) research promotion program; Ministry of Education, Culture, Sport, Science and Technology; project "CENAKVA" [Z.1.05/2.1.00/01.0024]; project "CENAKVA II" (under the NPU I program) [LO1205]; Czech Science Foundation [P503/12/P165]	We thank Ms. K. Nakano for technical assistance. This work was supported by a UK-Japan cooperative project of the Ministry of the Environment, Japan; the Japan Science and Technology Agency's Core Research for Evolutional Science and Technology (CREST) research promotion program; and grants from the Ministry of Education, Culture, Sport, Science and Technology. V.K. gratefully acknowledges the projects "CENAKVA" (CZ.1.05/2.1.00/01.0024), "CENAKVA II" (LO1205 under the NPU I program) and the project of Czech Science Foundation (P503/12/P165).	Desbrow C, 1998, ENVIRON SCI TECHNOL, V32, P1549, DOI 10.1021/es9707973; Snyder SA, 2007, DESALINATION, V202, P156, DOI 10.1016/j.desa1.2005.12.052; Tyler CR, 2005, ENVIRON SCI TECHNOL, V39, P2599, DOI 10.1021/es0488939; Hotchkiss AK, 2008, TOXICOL SCI, V105, P235, DOI 10.1093/toxsci/kfn030; Falconer IR, 2006, ENVIRON TOXICOL, V21, P181, DOI 10.1002/tox.20172; Sun LW, 2011, AQUAT TOXICOL, V105, P629, DOI 10.1016/j.aquatox.2011.08.024; Pawlowski S, 2003, TOXICOL SCI, V75, P57, DOI 10.1093/toxsci/kfg162; Kortenkamp A, 2007, ENVIRON HEALTH PERSP, V115, P98, DOI 10.1289/ehp.9357; Jobling S, 1998, ENVIRON SCI TECHNOL, V32, P2498, DOI 10.1021/es9710870; Routledge EJ, 1998, ENVIRON SCI TECHNOL, V32, P1559, DOI 10.1021/es970796a; Johnson Andrew, 2007, Environmental Sciences, V14, P319; Escher BI, 2011, ENVIRON SCI TECHNOL, V45, P5387, DOI 10.1021/es201153k; Sun LW, 2009, AQUAT TOXICOL, V93, P83, DOI 10.1016/j.aquatox.2009.03.010; Legler J, 2002, ENVIRON SCI TECHNOL, V36, P4410, DOI 10.1021/es010323a; Jobling S, 2006, ENVIRON HEALTH PERSP, V114, P32, DOI 10.1289/ehp.8050; Kunz PY, 2006, TOXICOL SCI, V90, P349, DOI 10.1093/toxsci/kfj082; Kumar V, 2009, CHEMOSPHERE, V77, P1440, DOI 10.1016/j.chemosphere.2009.08.052; Conroy O, 2007, SCI TOTAL ENVIRON, V382, P311, DOI 10.1016/j.scitotenv.2007.04.033; Stalter D, 2011, WATER RES, V45, P1015, DOI 10.1016/j.watres.2010.10.008; Tanaka H, 2001, WATER SCI TECHNOL, V43, P125; Bergman A, 2013, STATE SCI ENDOCRINE; Conroy O, 2005, ENVIRON SCI TECHNOL, V39, P2287, DOI 10.1021/es049490b; Damstra T., 2002, WHOPCSEDC022 UN ENV; Dang ZC, 2011, TOXICOL LETT, V201, P152, DOI 10.1016/j.toxlet.2010.12.020; Evans RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043606; Henneberg A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098307; Hoffmann F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044715; Hu ZF, 2014, DESALINATION, V336, P18, DOI 10.1016/j.desal.2013.12.027; Ihara M, 2014, ENVIRON SCI TECHNOL, V48, P6366, DOI 10.1021/es5014938; Lange A., 2011, AQUAT TOXICOL, V109, P250; Matsui S, 2000, WATER SCI TECHNOL, V42, P173; Tang X, 2013, CHEMOSPHERE, V93, P2562, DOI 10.1016/j.chemosphere.2013.09.073; Thorpe KL, 2006, ENVIRON HEALTH PERSP, V114, P90, DOI 10.1289/ehp.8059	33	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0013-936X	1520-5851		ENVIRON SCI TECHNOL	Environ. Sci. Technol.	MAY 19	2015	49	10					6319	6326		10.1021/acs.est.5b01027		8	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CI8YT	WOS:000355058300058		
J	Watanabe, K; Nagao, D; Ishii, H; Konno, M				Watanabe, Kanako; Nagao, Daisuke; Ishii, Haruyuki; Konno, Mikio			Rattle-Type Colloidal Crystals Composed of Spherical Hollow Particles Containing an Anisotropic, Movable Core	LANGMUIR			English	Article							SOL-GEL METHOD; PHOTONIC CRYSTALS; MAGNETIC COLLOIDS; SILICA SPHERES; GOLD NANORODS; SHELL; FACILE; CUBES; FIELD	Controls over the position and orientation of anisotropic particles in their assemblies are intriguing issues for functional colloidal crystals that are switchable with external fields such as electric and magnetic fields. We propose a novel approach for the fabrication of rattle-type colloidal crystals containing an anisotropic, movable core surrounded by a void space that allows rearrangement of the anisotropic core in the assembly. In the fabrication, multilayered core-shell particles composed of a titania core, polystyrene shell, and silica shell were prepared and then heated at 500 degrees C for 4 h to selectively remove the middle layer of polystyrene. The heating treatment induced deformation of spherical titania cores in the compartment of silica shells, while the void space required for the orientation and relocation of anisotropic core was generated. The rattle particles fabricated were self-assembled by a simple dip-coating to form an arrangement of the spherical yolk/shell particles incorporating an anisotropic core. Brownian motion of the anisotropic cores observed with an optical microscope showed that the assembly of rattle-type particles had the potential to control location and orientation of the anisotropic cores in the shell compartment by application of external fields.	[Watanabe, Kanako; Nagao, Daisuke; Ishii, Haruyuki; Konno, Mikio] Tohoku Univ, Dept Chem Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan	Nagao, D (reprint author), Tohoku Univ, Dept Chem Engn, Aoba Ku, 6-6-07 Aoba, Sendai, Miyagi 9808579, Japan.	nagao@mickey.che.tohoku.ac.jp; konno@mickey.che.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (JSPS KAKENHI) [25600001, 26286019]	This research was mainly supported by the Ministry of Education, Culture, Sports, Science and Technology (JSPS KAKENHI Grant Nos. 25600001 and 26286019).	Ahn J, 2013, B KOREAN CHEM SOC, V34, P3456, DOI 10.5012/bkcs.2013.34.11.3456; Demirors AF, 2009, CHEM MATER, V21, P979, DOI 10.1021/cm803250w; Liu J, 2011, CHEM COMMUN, V47, P12578, DOI 10.1039/c1cc13658e; SUGIMOTO T, 1992, J COLLOID INTERF SCI, V152, P587, DOI 10.1016/0021-9797(92)90062-Q; Ge JP, 2007, J AM CHEM SOC, V129, P8974, DOI 10.1021/ja0736461; Ding T, 2009, ADV MATER, V21, P1936, DOI 10.1002/adma.200803564; Mine E, 2005, J COLLOID INTERF SCI, V291, P162, DOI 10.1016/j.jcis.2005.04.077; Ohnuma A, 2009, J AM CHEM SOC, V131, P1352, DOI 10.1021/ja8079934; Zhang L, 2009, LANGMUIR, V25, P2711, DOI 10.1021/la803546r; Busbee BD, 2003, ADV MATER, V15, P414, DOI 10.1002/adma.200390095; Chen D, 2009, ADV MATER, V21, P3804, DOI 10.1002/adma.200900599; Lou XW, 2008, ADV MATER, V20, P3987, DOI 10.1002/adma.200800854; Lou XW, 2007, ADV MATER, V19, P3328, DOI 10.1002/adma.200700357; Zhang LY, 2012, CHEM-EUR J, V18, P12512, DOI 10.1002/chem.201200030; Kuijk A, 2011, J AM CHEM SOC, V133, P2346, DOI 10.1021/ja109524h; Sugimoto T, 2008, J PHYS CHEM C, V112, P18760, DOI 10.1021/jp8029506; Lee SH, 2009, SMALL, V5, P1957, DOI 10.1002/smll.200900135; Ni R, 2012, SOFT MATTER, V8, P8826, DOI 10.1039/c2sm25813g; Pastoriza-Santos I, 2006, CHEM MATER, V18, P2465, DOI 10.1021/cm060293g; van Anders G, 2014, P NATL ACAD SCI USA, V111, pE4812, DOI 10.1073/pnas.1418159111; Rossi L, 2011, SOFT MATTER, V7, P4139, DOI 10.1039/c0sm01246g; Meijer JM, 2012, LANGMUIR, V28, P7631, DOI 10.1021/la3007052; van Blaaderen A, 2013, EUR PHYS J-SPEC TOP, V222, P2895, DOI 10.1140/epjst/e2013-02065-0; VANBLAADEREN A, 1993, J COLLOID INTERF SCI, V156, P1, DOI 10.1006/jcis.1993.1073; Okada A, 2013, LANGMUIR, V29, P9004, DOI 10.1021/la401646t; Forster JD, 2011, ACS NANO, V5, P6695, DOI 10.1021/nn202227f; Kobayashi Y, 2007, J CERAM SOC JPN, V115, P661, DOI 10.2109/jcersj2.115.661; Marechal M, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3552951; Priebe M, 2014, CHEM-EUR J, V20, P1; Tierno P, 2014, PHYS CHEM CHEM PHYS, V16, P23515, DOI 10.1039/c4cp03099k	30	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0743-7463			LANGMUIR	Langmuir	MAY 19	2015	31	19					5306	5310		10.1021/acs.langmuir.5b01148		5	Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science, Multidisciplinary	Chemistry; Materials Science	CI8YL	WOS:000355057500007		
J	Matsunaga, S; Yamada, T; Kobayashi, T; Kawai, M				Matsunaga, Soichiro; Yamada, Taro; Kobayashi, Toshihide; Kawai, Maki			Scanning Tunneling Microscope Observation of the Phosphatidylserine Domains in the Phosphatidylcholine Monolayer	LANGMUIR			English	Article							MOLECULAR-DYNAMICS SIMULATION; LATERAL PHASE SEPARATIONS; MEMBRANE DOMAINS; MODEL MEMBRANES; PHOSPHOLIPID-VESICLES; ELECTRON-TRANSFER; SINGLE-MOLECULE; LIPID RAFTS; ANNEXIN-V; BILAYER	A mixed monolayer of 1,2-dihexanoyl-sn-glycero-3-phospho-L-serine (DHPS) and 1,2-dihexanoyl-sn-glycero-3-phosphocholine (DHPC) on an 1-octanethiol-modified gold substrate was visualized on the nanometer scale using in situ scanning tunneling microscopy (STM) in aqueous solution. DHPS clusters were evident as spotty domains. STM enabled us to distinguish DHPS molecules from DHPC molecules depending on their electronic structures. The signal of the DHPS domains was abolished by neutralization with Ca2+. The addition of the PS + Ca2+-binding protein of annexin V to the Ca2+-treated monolayer gave a number of spots corresponding to a single annexin V molecule.	[Matsunaga, Soichiro; Kawai, Maki] Univ Tokyo, Dept Adv Mat Sci, Kashiwa, Chiba 2778561, Japan; [Yamada, Taro; Kobayashi, Toshihide] RIKEN, Lipid Biol Lab, Wako, Saitama 3510198, Japan	Matsunaga, S (reprint author), Univ Tokyo, Dept Adv Mat Sci, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778561, Japan.	somatsunaga@gmail.com; maki@k.u-tokyo.ac.jp			RIKEN President Discretionary Fund; Lipid Dynamics Program of RIKEN; Integrated Lipidology Program of RIKEN; Ministry of Education, Culture, Sports, Science and Technology of Japan; KAKENHI [19360024, 25293015]; Japan Society for the Promotion of Science	This study was financially supported in part by the RIKEN President Discretionary Fund (2004-2006, 2010-2012), the Lipid Dynamics Program and Integrated Lipidology Program of RIKEN, and Grants-in-Aid for Scientific Research on the Promotion of Novel Interdisciplinary Fields Based on Nanotechnology and Materials from the Ministry of Education, Culture, Sports, Science and Technology of Japan. This work was also supported by KAKENHI (grant nos. 19360024 and 25293015). S.M. acknowledges support from Research Fellowships for Young Scientists of the Japan Society for the Promotion of Science. We thank RIKEN, Japan, for an allocation of supercomputing resources on the RIKEN Integrated Cluster of Clusters (RICC) system.	Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439; Wydro P, 2012, COLLOID SURFACE B, V93, P174, DOI 10.1016/j.colsurfb.2011.12.035; Wang JL, 2004, BBA-GEN SUBJECTS, V1673, P75, DOI 10.1016/j.bbagen.2004.03.013; London E, 2005, BBA-MOL CELL RES, V1746, P203, DOI 10.1016/j.bbamcr.2005.09.002; Zhang JD, 2008, CHEM REV, V108, P2737, DOI 10.1021/cr068073+; van Genderen HO, 2008, BBA-MOL CELL RES, V1783, P953, DOI 10.1016/j.bbamcr.2008.01.030; Delley B, 2000, J CHEM PHYS, V113, P7756, DOI 10.1063/1.1316015; Pandit SA, 2002, BIOPHYS J, V82, P1818; Giocondi MC, 2004, ULTRAMICROSCOPY, V100, P135, DOI 10.1016/j.ultramic.2003.11.002; Tero R, 2006, PHYS CHEM CHEM PHYS, V8, P3885, DOI 10.1039/b606052h; Sonnino S, 2013, CURR MED CHEM, V20, P4; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; GUCKENBERGER R, 1994, SCIENCE, V266, P1538, DOI 10.1126/science.7985024; Veatch SL, 2005, BBA-MOL CELL RES, V1746, P172, DOI 10.1016/j.bbamcr.2005.06.010; Fairn GD, 2011, J CELL BIOL, V194, P257, DOI 10.1083/jcb.201012028; DELLEY B, 1990, J CHEM PHYS, V92, P508, DOI 10.1063/1.458452; NEWTON C, 1978, BIOCHIM BIOPHYS ACTA, V506, P281, DOI 10.1016/0005-2736(78)90398-X; Ramstedt B, 2006, BBA-BIOMEMBRANES, V1758, P1945, DOI 10.1016/j.bbamem.2006.05.020; Goksu EI, 2009, BBA-BIOMEMBRANES, V1788, P254, DOI 10.1016/j.bbamem.2008.08.021; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Ros U, 2013, BBA-BIOMEMBRANES, V1828, P2757, DOI 10.1016/j.bbamem.2013.08.001; Delley B, 1996, J PHYS CHEM-US, V100, P6107, DOI 10.1021/jp952713n; DEMANGE P, 1994, TRENDS BIOCHEM SCI, V19, P272, DOI 10.1016/0968-0004(94)90002-7; Doyle AW, 2004, LANGMUIR, V20, P8961, DOI 10.1021/la0484220; FAN FRF, 1995, SCIENCE, V270, P1849, DOI 10.1126/science.270.5243.1849; Garcia-Saez AJ, 2010, BBA-BIOMEMBRANES, V1798, P766, DOI 10.1016/j.bbamem.2009.09.016; HAMELIN A, 1989, J ELECTROANAL CHEM, V272, P241, DOI 10.1016/0022-0728(89)87084-6; HAMELIN A, 1990, J ELECTROANAL CHEM, V285, P249, DOI 10.1016/0022-0728(90)87125-4; HUANG JY, 1993, BIOPHYS J, V64, P413; HULLINMATSUDA F, 2014, CELL DEV BIOL, V31, P48; ITO T, 1974, BIOCHIM BIOPHYS ACTA, V352, P29, DOI 10.1016/0005-2736(74)90176-X; KAY JG, 2013, LIPID MEDIATED PROTE, V991, P177; Matsunaga S, 2007, ELECTROCHEM COMMUN, V9, P645, DOI 10.1016/j.elecom.2006.10.047; Matsunaga S, 2009, LANGMUIR, V25, P8200, DOI 10.1021/la900616c; OHNISHI S, 1974, BIOCHEMISTRY-US, V13, P881, DOI 10.1021/bi00702a008; Ross M, 2001, LANGMUIR, V17, P2437, DOI 10.1021/la001617x; SILVIUS JR, 1984, BIOCHEMISTRY-US, V23, P3241, DOI 10.1021/bi00309a019; Tarek M, 1999, BIOPHYS J, V77, P964; Tu K, 1995, BIOPHYS J, V69, P2558; Twardowski M, 2003, LANGMUIR, V19, P9781, DOI 10.1021/la0349018; Twardowski M, 2004, LANGMUIR, V20, P175, DOI 10.1021/la035074d; Vie V, 2010, BBA-BIOMEMBRANES, V1798, P1503, DOI 10.1016/j.bbamem.2010.04.005; WALKER JH, 1992, BIOCHEM SOC T, V20, P828; Wang T., 2011, BIOCHEMISTRY-US, V51, P74; Wiesendanger R., 1994, SCANNING PROBE MICRO; Zhang JD, 2012, FEBS LETT, V586, P526, DOI 10.1016/j.febslet.2011.10.023	46	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0743-7463			LANGMUIR	Langmuir	MAY 19	2015	31	19					5449	5455		10.1021/acs.langmuir.5b00859		7	Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science, Multidisciplinary	Chemistry; Materials Science	CI8YL	WOS:000355057500023		
J	Wu, JJ; Zhang, D; Niwa, H; Harada, Y; Oshima, M; Ofuchi, H; Nabae, Y; Okajima, T; Ohsaka, T				Wu, Jiajia; Zhang, Da; Niwa, Hideharu; Harada, Yoshihisa; Oshima, Masaharu; Ofuchi, Hironori; Nabae, Yuta; Okajima, Takeyoshi; Ohsaka, Takeo			Enhancement in Kinetics of the Oxygen Reduction Reaction on a Nitrogen-Doped Carbon Catalyst by Introduction of Iron via Electrochemical Methods	LANGMUIR			English	Article							HIGH ELECTROCATALYTIC ACTIVITY; RAY-ABSORPTION-SPECTROSCOPY; ELECTROLYTE FUEL-CELLS; TRANSITION-METAL; ACTIVE-SITES; PERFORMANCE; GRAPHENE; ELECTRODEPOSITION; ACID; ORR	The iron (Fe) electrodeposition-electrochemical dissolution has been employed on nitrogen-doped carbon material (P-PI) prepared via multi-step pyrolysis of a polyimide precursor to achieve the introduction of Fe species, and its influence on the oxygen reduction reaction (ORR) is investigated by cyclic and rotating ring-disk electrode voltammetry in 0.5 M H2SO4. After the electrochemical treatment, the overpotential and H2O2 production percentage of ORR on the P-PI are decreased and the number of electrons transferred is increased in the meanwhile. In combination with the results of X-ray absorption fine structure spectra, the presence of Fe-N-x sites (Fe ions coordinated by nitrogen) is believed to be responsible for the improved ORR performance. Further kinetic analysis indicates that a two-electron reduction of O-2 is predominant on the untreated P-PI with coexistence of a direct four-electron transformation of O-2 to H2O, while the introduction of Fe species leads to a larger increase in the rate constant for the four-electron reduction than that for the two-electron process, being in good agreement with the view that Fe-N-x sites are active for four-electron ORR.	[Wu, Jiajia; Zhang, Da; Okajima, Takeyoshi; Ohsaka, Takeo] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Elect Chem, Yokohama, Kanagawa 2268502, Japan; [Wu, Jiajia] Chinese Acad Sci, Key Lab Marine Environm Corros & Biofouling, Qingdao 266071, Shandong, Peoples R China; [Zhang, Da] Shanghai Second Polytech Univ, Sch Environm & Mat Engn, Shanghai 201209, Peoples R China; [Niwa, Hideharu; Harada, Yoshihisa] Univ Tokyo, Inst Solid State Phys, Chiba 2778581, Japan; [Niwa, Hideharu; Harada, Yoshihisa; Oshima, Masaharu] Univ Tokyo, Synchrotron Radiat Res Org, Sayo, Hyogo 6795198, Japan; [Ofuchi, Hironori] Japan Synchrotron Radiat Res Inst, Sayo, Hyogo 6795198, Japan; [Nabae, Yuta] Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Organ & Polymer Mat, Tokyo 1528552, Japan	Ohsaka, T (reprint author), Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Elect Chem, 4259 Nagatsuta, Yokohama, Kanagawa 2268502, Japan.	ohsaka@echem.titech.ac.jp			New Energy and Industrial Technology Development Organization (NEDO), Japan	This work was financially supported by the New Energy and Industrial Technology Development Organization (NEDO), Japan. The synchrotron radiation experiments were performed at SPring-8 with the approval of the Japan Synchrotron Radiation Research Institute (JASRI) (Proposal 2014A1752) and jointly by the Synchrotron Radiation Research Organization and the University of Tokyo (Proposal 2014A7403). The authors thank Prof. T. Fuchigami and Dr. A. Muthukrishnan for helpful discussion.	Yan J, 2014, J POWER SOURCES, V245, P772, DOI 10.1016/j.jpowsour.2013.07.003; Olson TS, 2010, J ELECTROCHEM SOC, V157, pB54, DOI 10.1149/1.3248003; Gong KP, 2009, SCIENCE, V323, P760, DOI 10.1126/science.1168049; ALONSOVANTE N, 1995, ELECTROCHIM ACTA, V40, P567, DOI 10.1016/0013-4686(94)00377-D; Nabae Y, 2014, J MATER CHEM A, V2, P11561, DOI 10.1039/c4ta01828a; Ganesan S, 2014, PHYS CHEM CHEM PHYS, V16, P4576, DOI 10.1039/c3cp54751e; Li YG, 2012, NAT NANOTECHNOL, V7, P394, DOI [10.1038/nnano.2012.72, 10.1038/NNANO.2012.72]; Kobayashi M, 2012, ELECTROCHIM ACTA, V74, P254, DOI 10.1016/j.electacta.2012.04.075; Faubert G, 1999, ELECTROCHIM ACTA, V44, P2589, DOI 10.1016/S0013-4686(98)00382-X; Zarpellon J, 2007, ELECTROCHIM ACTA, V53, P2002, DOI 10.1016/j.electacta.2007.08.058; Choi CH, 2014, APPL CATAL B-ENVIRON, V144, P760, DOI 10.1016/j.apcatb.2013.08.021; Ravel B, 2005, J SYNCHROTRON RADIAT, V12, P537, DOI 10.1107/S0909049505012719; Yu DS, 2010, J AM CHEM SOC, V132, P15127, DOI 10.1021/ja105617z; Wei W, 2014, ANGEW CHEM INT EDIT, V53, P1570, DOI 10.1002/anie.201307319; Geng DS, 2011, ENERG ENVIRON SCI, V4, P760, DOI 10.1039/c0ee00326c; Lefevre M, 2002, J PHYS CHEM B, V106, P8705, DOI 10.1021/jp020267f; Wu G, 2011, SCIENCE, V332, P443, DOI 10.1126/science.1200832; Sahraie NR, 2014, J AM CHEM SOC, V136, P14486, DOI 10.1021/ja506553r; Tylus U, 2014, J PHYS CHEM C, V118, P8999, DOI 10.1021/jp500781v; HSUEH KL, 1983, J ELECTROANAL CHEM, V153, P79, DOI 10.1016/S0022-0728(83)80007-2; Lin L, 2014, J AM CHEM SOC, V136, P11027, DOI 10.1021/ja504696r; Byon HR, 2011, CHEM MATER, V23, P3421, DOI 10.1021/cm2000649; Kramm UI, 2014, J AM CHEM SOC, V136, P978, DOI 10.1021/ja410076f; Liu G, 2009, APPL CATAL B-ENVIRON, V93, P156, DOI 10.1016/j.apcatb.2009.09.025; Liu RL, 2010, ANGEW CHEM INT EDIT, V49, P2565, DOI 10.1002/anie.200907289; Ferrandon M, 2012, J PHYS CHEM C, V116, P16001, DOI 10.1021/jp302396g; Grujicic D, 2005, ELECTROCHIM ACTA, V50, P4405, DOI 10.1016/j.electacta.2005.02.013; Parvez K, 2012, ACS NANO, V6, P9541, DOI 10.1021/nn302674k; Nallathambi V, 2008, J POWER SOURCES, V183, P34, DOI 10.1016/j.jpowsour.2008.05.020; Arcovito A, 2007, AIP CONF PROC, V882, P306; Cao R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3076; DAMJANOV.A, 1966, J CHEM PHYS, V45, P4057, DOI 10.1063/1.1727457; Diaz SL, 2008, ELECTROCHIM ACTA, V53, P7426, DOI 10.1016/j.electacta.2008.01.015; Meguro S, 2000, J ELECTROCHEM SOC, V147, P3003, DOI 10.1149/1.1393639; Muthukrishnan A, 2015, CATAL SCI TECHNOL, V5, P475, DOI 10.1039/c4cy01001a; ROE AL, 1984, J AM CHEM SOC, V106, P1676, DOI 10.1021/ja00318a021; Subias G, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.155103; Wang P, 2007, J ELECTROANAL CHEM, V611, P87, DOI 10.1016/j.jelechem.2007.08.008; You CH, 2015, NANOSCALE, V7, P3780, DOI 10.1039/c4nr06749e	39	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0743-7463			LANGMUIR	Langmuir	MAY 19	2015	31	19					5529	5536		10.1021/acs.langmuir.5b00310		8	Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science, Multidisciplinary	Chemistry; Materials Science	CI8YL	WOS:000355057500033		
J	Oka, N; Yoshino, K; Yamamoto, K; Takahashi, H; Li, S; Sugimachi, T; Nakano, K; Suda, Y; Kato, T				Oka, Noriyuki; Yoshino, Kayoko; Yamamoto, Kouji; Takahashi, Hideki; Li, Shuguang; Sugimachi, Toshiyuki; Nakano, Kimihiko; Suda, Yoshihiro; Kato, Toshinori			Greater Activity in the Frontal Cortex on Left Curves: A Vector-Based fNIRS Study of Left and Right Curve Driving	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; DORSOLATERAL PREFRONTAL CORTEX; TRANSCRANIAL MAGNETIC STIMULATION; BLOOD-FLOW; DECISION-MAKING; PREMOTOR CORTEX; CEREBRAL-CORTEX; LEFT-HANDEDNESS; BRAIN ACTIVITY; EYE-MOVEMENT	Objectives In the brain, the mechanisms of attention to the left and the right are known to be different. It is possible that brain activity when driving also differs with different horizontal road alignments (left or right curves), but little is known about this. We found driver brain activity to be different when driving on left and right curves, in an experiment using a large-scale driving simulator and functional near-infrared spectroscopy (fNIRS). Research Design and Methods The participants were fifteen healthy adults. We created a course simulating an expressway, comprising straight line driving and gentle left and right curves, and monitored the participants under driving conditions, in which they drove at a constant speed of 100 km/h, and under non-driving conditions, in which they simply watched the screen (visual task). Changes in hemoglobin concentrations were monitored at 48 channels including the prefrontal cortex, the premotor cortex, the primary motor cortex and the parietal cortex. From orthogonal vectors of changes in deoxyhemoglobin and changes in oxyhemoglobin, we calculated changes in cerebral oxygen exchange, reflecting neural activity, and statistically compared the resulting values from the right and left curve sections. Results Under driving conditions, there were no sites where cerebral oxygen exchange increased significantly more during right curves than during left curves (p > 0.05), but cerebral oxygen exchange increased significantly more during left curves (p < 0.05) in the right premotor cortex, the right frontal eye field and the bilateral prefrontal cortex. Under non-driving conditions, increases were significantly greater during left curves (p < 0.05) only in the right frontal eye field. Conclusions Left curve driving was thus found to require more brain activity at multiple sites, suggesting that left curve driving may require more visual attention than right curve driving. The right frontal eye field was activated under both driving and non-driving conditions.	[Oka, Noriyuki; Yoshino, Kayoko; Kato, Toshinori] KatoBrain Co Ltd, Dept Brain Environm Res, Tokyo, Japan; [Yamamoto, Kouji] Cent Nippon Expressway Co Ltd, Dept Environm Engn, Tokyo Branch, Tokyo, Japan; [Takahashi, Hideki] Cent Nippon Expressway Co Ltd, Dept Environm Engn, Nagoya, Aichi, Japan; [Li, Shuguang; Sugimachi, Toshiyuki; Nakano, Kimihiko; Suda, Yoshihiro] Univ Tokyo, Inst Ind Sci, Tokyo, Japan	Kato, T (reprint author), KatoBrain Co Ltd, Dept Brain Environm Res, Tokyo, Japan.	kato@katobrain.com			NEXCO	The experiment and research expenses were funded by NEXCO. The funders had role in study design, data collection, and decision to publish. The funders had no role in data analysis and preparation of the manuscript.	Fisk GD, 2002, ARCH PHYS MED REHAB, V83, P469, DOI 10.1053/apmr.2002.31179; Gamlin PD, 2000, NATURE, V407, P1003, DOI 10.1038/35039506; Debaere F, 2004, NEUROIMAGE, V21, P1416, DOI 10.1016/j.neuroimage.2003.12.011; Takahashi T, 2011, NEUROIMAGE, V57, P991, DOI 10.1016/j.neuroimage.2011.05.012; Uchiyama Y, 2012, TRANSPORT RES F-TRAF, V15, P25, DOI 10.1016/j.trf.2011.11.002; Hong KS, 2014, BIOMED OPT EXPRESS, V5, P1778, DOI 10.1364/BOE.5.001778; Julien C, 2006, CARDIOVASC RES, V70, P12, DOI 10.1016/j.caridores.2005.11.008; QUIGLEY FL, 1983, AM J OCCUP THER, V37, P474; Thomas LC, 2013, PHYS THER, V93, P1563, DOI 10.2522/ptj.20120477; Calhoun VD, 2002, HUM BRAIN MAPP, V16, P158, DOI 10.1002/hbm.10032; Horikawa E, 2005, BRAIN COGNITION, V58, P166, DOI 10.1016/j.bandc.2004.10.002; HEILMAN KM, 1980, NEUROLOGY, V30, P327; Kinsbourne M, 1977, Adv Neurol, V18, P41; LAND MF, 1994, NATURE, V369, P742, DOI 10.1038/369742a0; HARDYCK C, 1977, PSYCHOL BULL, V84, P385, DOI 10.1037//0033-2909.84.3.385; DAMASIO AR, 1980, NEUROPSYCHOLOGIA, V18, P123, DOI 10.1016/0028-3932(80)90058-5; Naseer N, 2013, NEUROSCI LETT, V553, P84, DOI 10.1016/j.neulet.2013.08.021; Chouinard PA, 2006, NEUROSCIENTIST, V12, P143, DOI 10.1177/1073858405284255; Schweizer TA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00053; van't Wout M, 2005, NEUROREPORT, V16, P1849; Korner-Bitensky N, 2000, AM J PHYS MED REHAB, V79, P253, DOI 10.1097/00002060-200005000-00007; Mayhew JEW, 1996, NEUROIMAGE, V4, P183, DOI 10.1006/nimg.1996.0069; Calhoun VD, 2012, NEUROIMAGE, V59, P25, DOI 10.1016/j.neuroimage.2011.06.037; Vingerhoets G, 2012, HUM BRAIN MAPP, V33, P763, DOI 10.1002/hbm.21247; Graydon FX, 2004, TRANSPORT RES F-TRAF, V7, P271, DOI 10.1016/j.trf.2004.09.006; Richter W, 1997, NEUROREPORT, V8, P1257, DOI 10.1097/00001756-199703240-00040; Kirilina E, 2012, NEUROIMAGE, V61, P70, DOI 10.1016/j.neuroimage.2012.02.074; Benarroch EE, 2005, BASIC NEUROSCIENCES, P501; Cho SS, 2012, BRAIN STIMUL, V5, P116, DOI 10.1016/j.brs.2012.03.007; Choi E, 2010, 811366 DOT HS; Fukushima K, 2000, J NEUROPHYSIOL, V83, P563; Giglia Giuseppe, 2014, Funct Neurol, V29, P189; Goldberg ME, 1991, PRINCIPLES NEURAL SC, P672; Hong KS, 2015, NEUROSCI LETT, V587, P87, DOI 10.1016/j.neulet.2014.12.029; Husain M, 1996, J NEUROL, V243, P652, DOI 10.1007/BF00878662; Institute for Traffic Accident Research and Data Analysis, 2007, ACC AR CAUS MIS TRAF, P67; Jancke L, 2008, NEUROREPORT, V19, P1127, DOI 10.1097/WNR.0b013e3283056521; Japan Safe Driving Center, 1988, STUD ACT SIT TRAFF A; KASHIWAGI A, 1990, BRAIN, V113, P1005, DOI 10.1093/brain/113.4.1005; Kato T, 2014, 20 ANN M HUM BRAIN M; Kato T, 2006, Patent No. [WO/2006/009178, 2003068070, WO/2003/068070]; Khan M., 2014, INT J DISTRIB SENS N, V2014, P8, DOI DOI 10.3389/FNHUM.2014.00001; Konen CS, 2004, NEUROIMAGE, V22, P304, DOI 10.1016/j.neuroimage.2003.12.039; Liu T, 2012, NEUROSCI LETT, V506, P220, DOI 10.1016/j.neulet.2011.11.009; Mars F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043858; Matusmoto K, 2011, 46 C JPTA MIYAZ JAP; Mazer BL, 2001, AM J OCCUP THER, V55, P552; Ministry of Land Infrastructure Transport and Tourism Japan, 1970, Article 15 of the Road Structure Ordinance (radius of curve), Patent No. [2006009178, WO/2006/009178]; Naseer N, 2015, FRONT HUM NEUROSCI, V9, P1, DOI [10.3389/fnhum.2015.00001, DOI 10.3389/FNHUM.2015.00001]; National Highway Traffic Safety Administration, 2008, NAT MOT VEH CRASH CA; National Police Agency, 2013, OCC TRAFF ACC; Pierrot-Deseilligny C, 2004, CURR OPIN NEUROL, V17, P17, DOI 10.1097/00019052-200402000-00005; Praeg E, 2005, NEUROREPORT, V16, P1715, DOI 10.1097/01.wnr.0000183333.36488.1c; Sano M, 2013, NEUROREPORT, V24, P935, DOI 10.1097/WNR.0000000000000008; Schubotz RI, 2003, NEUROIMAGE S1, V20, P20; Simms B, 1985, BR J OCCUP THER, V48, P363; Society of Osaka traffic Scientific Research, 2000, STUD TRAFF SAF NEW T, P159; Sugawara K, 2013, BRAIN TOPOGR, V26, P581, DOI 10.1007/s10548-013-0299-5; Tsunashima H, 2009, COMPUT INTELL NEUROS, DOI 10.1155/2009/164958; Wu YJ, 2014, BRAIN COGNITION, V91, P87, DOI 10.1016/j.bandc.2014.09.002; Yoshino K, 2012, NEUROREPORT, V23, P947, DOI 10.1097/WNR.0b013e328359833b; Yoshino K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00895; Yoshino K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00882	63	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0127594	10.1371/journal.pone.0127594		21	Multidisciplinary Sciences	Science & Technology - Other Topics	CI7BT	WOS:000354918600068		
J	Squires, JE; Shivakumar, P; Mourya, R; Bessho, K; Walters, S; Bezerra, JA				Squires, James E.; Shivakumar, Pranavkumar; Mourya, Reena; Bessho, Kazuhiko; Walters, Stephanie; Bezerra, Jorge A.			Natural Killer Cells Promote Long-Term Hepatobiliary Inflammation in a Low-Dose Rotavirus Model of Experimental Biliary Atresia	PLOS ONE			English	Article							REGULATORY T-CELLS; BILE-DUCT INJURY; GENE-EXPRESSION; EPITHELIAL INJURY; HEPATIC CD8(+); MURINE MODEL; LYMPHOCYTES; OBSTRUCTION; LIVER; MICE	Biliary atresia is a rapidly progressive obstructive cholangiopathy of infants. Mechanistic studies in the mouse model of Rhesus rotavirus (RRV)-induced biliary atresia have linked the importance of effector lymphocytes to the pathogenesis of extrahepatic bile duct (EHBD) injury and obstruction in experimental biliary atresia; however, studies of the progressive liver injury have been limited by early death of newborn mice. Here, we aimed to determine 1) if a lower inoculum of RRV induces obstruction of EHBDs while allowing for ongoing liver inflammation, and 2) if NK cells regulate intrahepatic injury. The administration of 0.25x10(6) fluorescence forming units of RRV induced an obstructive extrahepatic cholangiopathy, but allowed for restoration of the duct epithelium, increased survival, and the development of a progressive intrahepatic inflammatory injury with molecular and cellular signatures equivalent to the traditional infectious model. Investigating the mechanisms of liver injury, we found that NK cell depletion at the onset of jaundice decreased liver inflammation, suppressed the expression of fibrosis and inflammation/immunity genes, lowered plasma ALT and bilirubin and improved survival. Conclusions Lower inoculation of RRV-induced progressive liver injury and fibrosis via NK cells. These findings point to the potential use of NK cell-depleting strategies to block progression of liver disease in biliary atresia.	[Squires, James E.; Shivakumar, Pranavkumar; Mourya, Reena; Walters, Stephanie; Bezerra, Jorge A.] Univ Cincinnati, Coll Med, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Cincinnati, OH 45220 USA; [Squires, James E.; Shivakumar, Pranavkumar; Mourya, Reena; Walters, Stephanie; Bezerra, Jorge A.] Cincinnati Childrens Hosp Med Ctr, Pediat Liver Care Ctr, Cincinnati, OH 45229 USA; [Bessho, Kazuhiko] Osaka Univ, Div Pediat, Osaka, Japan	Bezerra, JA (reprint author), Univ Cincinnati, Coll Med, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Cincinnati, OH 45220 USA.	jorge.bezerra@cchmc.org			American Liver Foundation/American Association; Faculty Transition; National Institutes of Health [DK83781, DK078392];  [T32 -DK007727]	This work was supported by two grants from the American Liver Foundation/American Association for Postdoctoral Research (to J.E.S.) and Faculty Transition (to P.S.), and by the National Institutes of Health grants DK83781 (to J.A.B.), DK078392 (Gene and Protein Expression Core and the Integrative Morphology Core of the Digestive Disease Research Center in Cincinnati; to J.A.B.), and the T32 -DK007727 (to J.E.S.).	Shivakumar P, 2009, J CLIN INVEST, V119, P2281, DOI 10.1172/JCI38879; Sokol RJ, 2001, SEMIN LIVER DIS, V21, P517, DOI 10.1055/s-2001-19032; Bessho K, 2014, HEPATOLOGY, V60, P211, DOI 10.1002/hep.27045; Bessho K, 2011, ANNU REV MED, V62, P171, DOI 10.1146/annurev-med-042909-093734; Petersen C, 1997, J PEDIATR SURG, V32, P1190, DOI 10.1016/S0022-3468(97)90680-1; RIEPENHOFFTALTY M, 1993, PEDIATR RES, V33, P394; Sira MM, 2012, EUR J GASTROEN HEPAT, V24, P1227, DOI 10.1097/MEG.0b013e328356aee4; Li J, 2011, J CLIN INVEST, V121, P4244, DOI 10.1172/JCI57728; Salazar-Mather TP, 1998, J EXP MED, V187, P1, DOI 10.1084/jem.187.1.1; Shivakumar P, 2007, GASTROENTEROLOGY, V133, P268, DOI 10.1053/j.gastro.2007.04.031; Shivakumar P, 2004, J CLIN INVEST, V114, P322, DOI 10.1172/jci200421153; Petersen C, 2012, SEMIN PEDIATR SURG, V21, P185, DOI 10.1053/j.sempedsurg.2012.05.002; Carvalho E, 2005, GASTROENTEROLOGY, V129, P713, DOI 10.1053/j.gastro.205.05.052; Feldman AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073644; Guo CB, 2012, PEDIATR RES, V71, P638, DOI 10.1038/pr.2012.17; Lages CS, 2012, HEPATOLOGY, V56, P219, DOI 10.1002/hep.25662; Leonhardt J, 2006, PEDIATR SURG INT, V22, P84, DOI 10.1007/s00383-005-1589-0; Locaputo S, 1999, HEPATOLOGY, V29, P1106, DOI 10.1002/hep.510290434; Mack CL, 2005, CLIN IMMUNOL, V115, P200, DOI 10.1016/j.clim.2005.01.012; MCINTYRE KW, 1986, J EXP MED, V164, P1667, DOI 10.1084/jem.164.5.1667; Miethke AG, 2010, J HEPATOL, V52, P718, DOI 10.1016/j.jhep.2009.12.027; Okamura A, 2013, J CLIN PATHOL, V66, P99, DOI 10.1136/jclinpath-2012-201097; Qiu YR, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004011; Saxena V, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002069; Shivakumar P, 2014, J HEPATOL, V60, P370, DOI 10.1016/j.jhep.2013.09.021	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0127191	10.1371/journal.pone.0127191		15	Multidisciplinary Sciences	Science & Technology - Other Topics	CI7BT	WOS:000354918600053		
J	Suzuki, M; Aki, A; Mizuki, T; Maekawa, T; Usami, R; Morimoto, H				Suzuki, Masashi; Aki, Atsushi; Mizuki, Toru; Maekawa, Toru; Usami, Ron; Morimoto, Hisao			Encouragement of Enzyme Reaction Utilizing Heat Generation from Ferromagnetic Particles Subjected to an AC Magnetic Field	PLOS ONE			English	Article							THERMOSENSITIVE POLYMER GELS; COLD-ADAPTED ENZYMES; IRON-OXIDE; BETA-GALACTOSIDASE; CANDIDA-RUGOSA; NANOPARTICLES; IMMOBILIZATION; HYPERTHERMIA; LIPASE; STABILITY	We propose a method of activating an enzyme utilizing heat generation from ferromagnetic particles under an ac magnetic field. We immobilize alpha-amylase on the surface of ferromagnetic particles and analyze its activity. We find that when alpha-amylase/ferromagnetic particle hybrids, that is, ferromagnetic particles, on which alpha-amylase molecules are immobilized, are subjected to an ac magnetic field, the particles generate heat and as a result, alpha-amylase on the particles is heated up and activated. We next prepare a solution, in which alpha-amylase/ferromagnetic particle hybrids and free, nonimmobilized chitinase are dispersed, and analyze their activities. We find that when the solution is subjected to an ac magnetic field, the activity of alpha-amylase immobilized on the particles increases, whereas that of free chitinase hardly changes; in other words, only alpha-amylase immobilized on the particles is selectively activated due to heat generation from the particles.	[Suzuki, Masashi; Mizuki, Toru; Maekawa, Toru; Usami, Ron; Morimoto, Hisao] Toyo Univ, Grad Sch Interdisciplinary New Sci, Kawagoe, Saitama, Japan; [Aki, Atsushi; Mizuki, Toru; Maekawa, Toru; Usami, Ron; Morimoto, Hisao] Toyo Univ, Bionano Elect Res Ctr, Kawagoe, Saitama, Japan	Morimoto, H (reprint author), Toyo Univ, Grad Sch Interdisciplinary New Sci, Kawagoe, Saitama, Japan.	morimoto@toyo.jp			Grant for Program for Strategic Research Foundation at Private Universities [S1101017]; Japanese Society for the Promotion of Science [22560209]	This study was supported by a Grant for the Program for the Strategic Research Foundation at Private Universities S1101017 organized by the Ministry of Education, Culture, Sports, Science and Technology in Japan (http://www.mext.go.jp/english/) and a Grant-in-Aid for Scientific Research, 22560209, organized by the Japanese Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aki A, 2008, J APPL PHYS, V104, DOI 10.1063/1.3010307; Peyer KE, 2013, NANOSCALE, V5, P1259, DOI 10.1039/c2nr32554c; Groudieva T, 2004, EXTREMOPHILES, V8, P475, DOI 10.1007/s00792-004-0409-0; Mukhopadhyay K, 2003, LANGMUIR, V19, P3858, DOI 10.1021/la0268202; Guardia P, 2012, ACS NANO, V6, P3080, DOI 10.1021/nn2048137; Klyachko NL, 2012, ANGEW CHEM INT EDIT, V51, P12016, DOI 10.1002/anie.201205905; Dias JT, 2013, ANGEW CHEM INT EDIT, V52, P11526, DOI 10.1002/anie.201305835; Marshall CJ, 1997, TRENDS BIOTECHNOL, V15, P359, DOI 10.1016/S0167-7799(97)01086-X; Morimoto H, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.021403; Fortin JP, 2007, J AM CHEM SOC, V129, P2628, DOI 10.1021/ja067457e; Kuo CH, 2012, CARBOHYD POLYM, V87, P2538, DOI 10.1016/j.carbpol.2011.11.026; Baraban L, 2013, ACS NANO, V7, P1360, DOI 10.1021/nn305726m; Gerday C, 2000, TRENDS BIOTECHNOL, V18, P103, DOI 10.1016/S0167-7799(99)01413-4; Ranjbakhsh E, 2012, CHEM ENG J, V179, P272, DOI 10.1016/j.cej.2011.10.097; Tsang SC, 2006, J PHYS CHEM B, V110, P16914, DOI 10.1021/jp062275s; Deng HT, 2004, LANGMUIR, V20, P10168, DOI 10.1021/la0484624; Tierno P, 2008, J PHYS CHEM B, V112, P16525, DOI 10.1021/jp808354n; Kalkan NA, 2012, J APPL POLYM SCI, V123, P707, DOI 10.1002/app.34504; Riedinger A, 2013, NANO LETT, V13, P2399, DOI 10.1021/nl400188q; Mizuki T, 2010, BIOCHEM BIOPH RES CO, V393, P779, DOI 10.1016/j.bbrc.2010.02.081; Sing CE, 2010, P NATL ACAD SCI USA, V107, P535, DOI 10.1073/pnas.0906489107; Asuri P, 2007, LANGMUIR, V23, P12318, DOI 10.1021/la702091c; Bae S, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2420769; Baker I, 2006, J APPL PHYS, V99, DOI 10.1063/1.2171960; Chien LJ, 2008, BIOTECHNOL BIOENG, V100, P223, DOI 10.1002/bit.21750; Coey J.M.D., 2010, MAGNETISM MAGNETIC M; HABERDIT.W, 1967, NATURE, V213, P72, DOI 10.1038/213072a0; Jayhooni SMH, 2013, SUPERLATTICE MICROST, V58, P205, DOI 10.1016/j.spmi.2013.03.004; Kato N, 1998, MAT SCI ENG C-BIO S, V6, P291, DOI 10.1016/S0928-4931(98)00065-4; Lide D. R., 1995, CRC HDB CHEM PHYS; Lund AH, 1996, NUCLEIC ACIDS RES, V24, P800, DOI 10.1093/nar/24.4.800; Ming Ma, 2004, Journal of Magnetism and Magnetic Materials, V268, DOI 10.1016/S0304-8853(03)00426-8; Maciel JC, 2012, J MAGN MAGN MATER, V324, P1312, DOI 10.1016/j.jmmm.2011.11.017; Mary APR, 2010, NANOSCALE RES LETT, V5, P1706, DOI 10.1007/s11671-010-9729-4; Matsumoto M, 2003, BIOCHEM ENG J, V14, P75, DOI 10.1016/S1369-703X(02)00138-9; Matsune H, 2006, CHEM LETT, V35, P1356, DOI 10.1246/cl.2006.1356; Mizuki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066528; Nakagawa T, 2003, LETT APPL MICROBIOL, V37, P154, DOI 10.1046/j.1472-765X.2003.01369.x; Park HJ, 2011, COLLOID SURFACE B, V83, P198, DOI 10.1016/j.colsurfb.2010.11.006; Shahsavarani H, 2012, BIOTECHNOL ADV, V30, P1289, DOI 10.1016/j.biotechadv.2011.09.002; Skumiel A, 2013, INT J THERMOPHYS, V34, P655, DOI 10.1007/s10765-012-1380-0; Takahashi F, 1997, J FERMENT BIOENG, V83, P152, DOI 10.1016/S0922-338X(97)83574-X; Uygun DA, 2012, J APPL POLYM SCI, V123, P2574, DOI 10.1002/app.33879	43	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0127673	10.1371/journal.pone.0127673		11	Multidisciplinary Sciences	Science & Technology - Other Topics	CI7BT	WOS:000354918600073		
J	Yukiura, H; Kano, K; Kise, R; Inoue, A; Aoki, J				Yukiura, Hiroshi; Kano, Kuniyuki; Kise, Ryoji; Inoue, Asuka; Aoki, Junken			Autotaxin Overexpression Causes Embryonic Lethality and Vascular Defects	PLOS ONE			English	Article							LYSOPHOSPHATIDIC ACID PRODUCTION; LYSOPHOSPHOLIPASE-D ACTIVITY; LPA-PRODUCING ENZYME; ENDOTHELIAL NOTCH; ANGIOGENESIS; MOUSE; GENE; IDENTIFICATION; EXPRESSION; REGRESSION	Autotaxin (ATX) is a secretory protein, which converts lysophospholipids to lysophosphatidic acid (LPA), and is essential for embryonic vascular formation. ATX is abundantly detected in various biological fluids and its level is elevated in some pathophysiological conditions. However, the roles of elevated ATX levels remain to be elucidated. In this study, we generated conditional transgenic (Tg) mice overexpressing ATX and examined the effects of excess LPA signalling. We found that ATX overexpression in the embryonic period caused severe vascular defects and was lethal around E9.5. ATX was conditionally overexpressed in the neonatal period using the Cre/loxP system, which resulted in a marked increase in the plasma LPA level. This resulted in retinal vascular defects including abnormal vascular plexus and increased vascular regression. Our findings indicate that the ATX level must be carefully regulated to ensure coordinated vascular formation	[Yukiura, Hiroshi; Kano, Kuniyuki; Kise, Ryoji; Inoue, Asuka; Aoki, Junken] Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi, Japan; [Inoue, Asuka] Japan Sci & Technol Agcy, PREST, Kawaguchi, Saitama, Japan; [Aoki, Junken] Japan Sci & Technol Agcy, CREST, Tokyo, Japan	Aoki, J (reprint author), Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, 6-3 Aoba, Sendai, Miyagi, Japan.	jaoki@m.tohoku.ac.jp			CREST (Japan Science and technology Corporation), Science, Sports, and Culture of Japan	This research was supported by grants from CREST (Japan Science and technology Corporation to JA), Science, Sports, and Culture of Japan to JA.	Nakai Y, 2011, CLIN BIOCHEM, V44, P576, DOI 10.1016/j.clinbiochem.2011.03.128; Kanegae Y, 1996, GENE, V181, P207, DOI 10.1016/S0378-1119(96)00516-1; Moolenaar WH, 2013, BBA-MOL CELL BIOL L, V1831, P13, DOI 10.1016/j.bbalip.2012.09.013; Inoue A, 2011, EMBO J, V30, P4248, DOI 10.1038/emboj.2011.296; Yukiura H, 2011, J BIOL CHEM, V286, P43972, DOI 10.1074/jbc.M111.301093; Stahl A, 2010, INVEST OPHTH VIS SCI, V51, P2813, DOI 10.1167/iovs.10-5176; Masuda A, 2011, CLIN CHIM ACTA, V412, P1944, DOI 10.1016/j.cca.2011.06.039; Smyth SS, 2008, BBA-MOL CELL BIOL L, V1781, P563, DOI 10.1016/j.bbalip.2008.05.008; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; Masuda A, 2008, BRIT J HAEMATOL, V143, P60, DOI 10.1111/j.1365-2141.2008.07325.x; Aoki J, 2008, BBA-MOL CELL BIOL L, V1781, P513, DOI 10.1016/j.bbalip.2008.06.005; Tammela T, 2011, NAT CELL BIOL, V13, P1202, DOI 10.1038/ncb2331; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; Watanabe N, 2007, J CLIN GASTROENTEROL, V41, P616, DOI 10.1097/01.mcg.0000225642.90898.0e; Kondo M, 2014, CLIN CHIM ACTA, V433, P128, DOI 10.1016/j.cca.2014.03.006; Kawamoto S, 2000, FEBS LETT, V470, P263, DOI 10.1016/S0014-5793(00)01338-7; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Pitulescu ME, 2010, NAT PROTOC, V5, P1518, DOI 10.1038/nprot.2010.113; STRACKE ML, 1992, J BIOL CHEM, V267, P2524; Tanaka M, 2006, J BIOL CHEM, V281, P25822, DOI 10.1074/jbc.M605142200; Ferry G, 2007, FEBS LETT, V581, P3572, DOI 10.1016/j.febslet.2007.06.064; Koike S, 2011, DEV DYNAM, V240, P413, DOI 10.1002/dvdy.22543; Phng LK, 2009, DEV CELL, V16, P70, DOI 10.1016/j.devcel.2008.12.009; Guarani V, 2011, NATURE, V473, P234, DOI 10.1038/nature09917; Lin ME, 2010, PROSTAG OTH LIPID M, V91, P130, DOI 10.1016/j.prostaglandins.2009.02.002; Nakanaga K, 2010, J BIOCHEM, V148, P13, DOI 10.1093/jb/mvq052; Baffert F, 2006, AM J PHYSIOL-HEART C, V290, pH547, DOI 10.1152/ajpheart.00616.2005; Escalante-Alcalde D, 2003, DEVELOPMENT, V130, P4623, DOI 10.1242/dev.00635; Im E, 2010, MOL CELL BIOL, V30, P2401, DOI 10.1128/MCB.01275-09; Nakao Momoko, 2014, J Invest Dermatol, V134, P1745, DOI 10.1038/jid.2014.24; Ohtsuki M, 2006, J BIOL CHEM, V281, P36420, DOI 10.1074/jbc.M607975200; Tokumura A, 2007, LIFE SCI, V80, P1641, DOI 10.1016/j.lfs.2006.12.041; Tokumura A, 2002, BIOL REPROD, V67, P1386, DOI 10.1095/biolreprod.102.004051; Yang SY, 2002, CLIN EXP METASTAS, V19, P603, DOI 10.1023/A:1020950420196	35	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							UNSP e0126734	10.1371/journal.pone.0126734		11	Multidisciplinary Sciences	Science & Technology - Other Topics	CI7BT	WOS:000354918600042		
J	Chiang, PH; Chien, TC; Chen, CC; Yanagawa, Y; Lien, CC				Chiang, Po-Han; Chien, Ta-Chun; Chen, Chih-Cheng; Yanagawa, Yuchio; Lien, Cheng-Chang			ASIC-dependent LTP at multiple glutamatergic synapses in amygdala network is required for fear memory	SCIENTIFIC REPORTS			English	Article							SENSING ION CHANNELS; LONG-TERM POTENTIATION; HIPPOCAMPAL INTERNEURONS; SYNAPTIC PLASTICITY; ACTIVATED CURRENTS; NEURONAL-ACTIVITY; LATERAL AMYGDALA; ACID; EXPRESSION; MICE	Genetic variants in the human ortholog of acid-sensing ion channel-1a subunit (ASIC1a) gene are associated with panic disorder and amygdala dysfunction. Both fear learning and activity-induced long-term potentiation (LTP) of cortico-basolateral amygdala (BLA) synapses are impaired in ASIC1a-null mice, suggesting a critical role of ASICs in fear memory formation. In this study, we found that ASICs were differentially expressed within the amygdala neuronal population, and the extent of LTP at various glutamatergic synapses correlated with the level of ASIC expression in postsynaptic neurons. Importantly, selective deletion of ASIC1a in GABAergic cells, including amygdala output neurons, eliminated LTP in these cells and reduced fear learning to the same extent as that found when ASIC1a was selectively abolished in BLA glutamatergic neurons. Thus, fear learning requires ASIC-dependent LTP at multiple amygdala synapses, including both cortico-BLA input synapses and intra-amygdala synapses on output neurons.	[Chiang, Po-Han; Lien, Cheng-Chang] Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan; [Lien, Cheng-Chang] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan; [Chien, Ta-Chun] Acad Sinica, Inst Biomed Sci, Taiwan Int Grad Program, Program Mol Med, Taipei 115, Taiwan; [Chen, Chih-Cheng] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Yanagawa, Yuchio] Gunma Univ, Grad Sch Med, Dept Genet & Behav Neurosci, Maebashi, Gumma 3718511, Japan; [Yanagawa, Yuchio] JST, CREST, Maebashi, Gumma 3718511, Japan; [Lien, Cheng-Chang] Natl Yang Ming Univ, Brain Res Ctr, Taipei 112, Taiwan	Lien, CC (reprint author), Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan.	cclien@ym.edu.tw			Ministry of Education; Taiwan Ministry of Science and Technology [MOST 102-2321-B-010-019, 103-2321-B-010-010, 100-2320-B-010-014-MY3]; MEXT of Japan and Takeda Science Foundation; Aim for the Top University Plan; National Health Research Institutes [NHRI-EX103-10105NI]	We thank Dr. Mu-Ming Poo for critically reading the manuscript, Dr. Xuan-Mao Chen and Dr. Yu-Chao Liu for commenting on an earlier version of this manuscript, and members of the Lien laboratory for discussions on the data. This work was supported by grants from the Ministry of Education, Aim for the Top University Plan, National Health Research Institutes (NHRI-EX103-10105NI), Taiwan Ministry of Science and Technology (MOST 102-2321-B-010-019; 103-2321-B-010-010; 100-2320-B-010-014-MY3), and the MEXT of Japan and Takeda Science Foundation (Y.Y.).	Viviani D, 2011, SCIENCE, V333, P104, DOI 10.1126/science.1201043; Sosulina L, 2010, J NEUROPHYSIOL, V104, P617, DOI 10.1152/jn.00207.2010; Coryell MW, 2007, BIOL PSYCHIAT, V62, P1140, DOI 10.1016/j.biopsycli.2007.05.008; Coryell MW, 2008, J NEUROSCI, V28, P13738, DOI 10.1523/JNEUROSCI.3907-08.2008; Wolff SBE, 2014, NATURE, V509, P453, DOI 10.1038/nature13258; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Kreple CJ, 2014, NAT NEUROSCI, V17, P1083, DOI 10.1038/nn.3750; Sherwood TW, 2011, J NEUROSCI, V31, P9723, DOI 10.1523/JNEUROSCI.1665-11.2011; Duvarci S, 2011, J NEUROSCI, V31, P289, DOI 10.1523/JNEUROSCI.4985-10.2011; Lien CC, 2002, J PHYSIOL-LONDON, V538, P405, DOI 10.1013/jphysiol.2001.013066; Wemmie JA, 2004, P NATL ACAD SCI USA, V101, P3621, DOI 10.1073/pnas.0308753101; Lien CC, 2003, J NEUROSCI, V23, P2058; Gentet LJ, 2000, BIOPHYS J, V79, P314; Wu PY, 2013, J NEUROSCI, V33, P1828, DOI 10.1523/JNEUROSCI.4132-12.2013; Price MP, 2000, NATURE, V407, P1007; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; MCDONALD AJ, 1982, J COMP NEUROL, V208, P401, DOI 10.1002/cne.902080409; Baron A, 2008, J NEUROSCI, V28, P1498, DOI 10.1523/JNEUROSCI.4975-07.2008; Baron A, 2002, J PHYSIOL-LONDON, V539, P485, DOI 10.1013/jphysiol.2001.014837; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Sah P, 2008, ANN NY ACAD SCI, V1129, P88, DOI 10.1196/annals.1417.020; Du JY, 2014, P NATL ACAD SCI USA, V111, P8961, DOI 10.1073/pnas.1407018111; Lingueglia E, 2007, J BIOL CHEM, V282, P17325, DOI 10.1074/jbc.R700011200; de la Rosa DA, 2003, J PHYSIOL-LONDON, V546, P77, DOI 10.1113/jphysiol.2002.030692; Weng JY, 2010, J NEUROSCI, V30, P6548, DOI 10.1523/JNEUROSCI.0582-10.2010; Zha XM, 2009, J NEUROSCI, V29, P8438, DOI 10.1523/JNEUROSCI.1284-09.2009; Price MP, 2014, GENES BRAIN BEHAV, V13, P179, DOI 10.1111/gbb.12108; Askwith CC, 2004, J BIOL CHEM, V279, P18296, DOI 10.1074/jbc.M312145200; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Pare D, 2012, CURR OPIN NEUROBIOL, V22, P717, DOI 10.1016/j.conb.2012.02.014; Duvarci S, 2014, NEURON, V82, P966, DOI 10.1016/j.neuron.2014.04.042; Waldmann R, 1998, CURR OPIN NEUROBIOL, V8, P418, DOI 10.1016/S0959-4388(98)80070-6; Pare D, 2003, ANN NY ACAD SCI, V985, P78; Chen XM, 2005, J GEN PHYSIOL, V126, P71, DOI 10.1085/jgp.200509303; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Li HH, 2013, NAT NEUROSCI, V16, P332, DOI 10.1038/nn.3322; Cauli B, 2000, P NATL ACAD SCI USA, V97, P6144, DOI 10.1073/pnas.97.11.6144; Likhtik E, 2008, NATURE, V454, P642, DOI 10.1038/nature07167; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Price MP, 1996, J BIOL CHEM, V271, P7879; Boiko N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091326; Chan CF, 2013, J PHYSIOL-LONDON, V591, P4843, DOI 10.1113/jphysiol.2013.257113; Chen XM, 2007, J PHYSIOL-LONDON, V579, P657, DOI 10.1113/jphysiol.2006.120733; CHESLER M, 1992, TRENDS NEUROSCI, V15, P396, DOI 10.1016/0166-2236(92)90191-A; Fourcaudot E, 2009, NAT NEUROSCI, V12, P1093, DOI 10.1038/nn.2378; Fu Y, 2007, J NEUROPHYSIOL, V97, P937, DOI 10.1152/jn.00349.2006; Hille B, 2001, ION CHANNELS EXCITAB; Humeau Y, 2007, J NEUROSCI, V27, P10947, DOI 10.1523/JNEUROSCI.2603-07.2007; Jasnow AM, 2009, J NEUROPHYSIOL, V101, P1494, DOI 10.1152/jn.91149.2008; Lin YC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012665; Lopez de Armentia M., 2007, J PHYSL, V581, P961, DOI 10.1113/jphysiol.2006.121822; Smoller JW, 2014, BIOL PSYCHIAT, V76, P902, DOI 10.1016/j.biopsych.2013.12.018; Song C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060154; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Watabe AM, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-11	57	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAY 19	2015	5								10143	10.1038/srep10143		14	Multidisciplinary Sciences	Science & Technology - Other Topics	CJ2DN	WOS:000355294500001		
J	Stone, A; Jain, H; Dierolf, V; Sakakura, M; Shimotsuma, Y; Miura, K; Hirao, K; Lapointe, J; Kashyap, R				Stone, Adam; Jain, Himanshu; Dierolf, Volkmar; Sakakura, Masaaki; Shimotsuma, Yasuhiko; Miura, Kiyotaka; Hirao, Kazuyuki; Lapointe, Jerome; Kashyap, Raman			Direct laser-writing of ferroelectric single-crystal waveguide architectures in glass for 3D integrated optics	SCIENTIFIC REPORTS			English	Article							SPACE-SELECTIVE PRECIPITATION; FEMTOSECOND LASER; DEVICES; PULSES; GROWTH; NM	Direct three-dimensional laser writing of amorphous waveguides inside glass has been studied intensely as an attractive route for fabricating photonic integrated circuits. However, achieving essential nonlinear-optic functionality in such devices will also require the ability to create high-quality single-crystal waveguides. Femtosecond laser irradiation is capable of crystallizing glass in 3D, but producing optical-quality single-crystal structures suitable for waveguiding poses unique challenges that are unprecedented in the field of crystal growth. In this work, we use a high angular-resolution electron diffraction method to obtain the first conclusive confirmation that uniform single crystals can be grown inside glass by femtosecond laser writing under optimized conditions. We confirm waveguiding capability and present the first quantitative measurement of power transmission through a laser-written crystal-in-glass waveguide, yielding loss of 2.64 dB/cm at 1530 nm. We demonstrate uniformity of the crystal cross-section down the length of the waveguide and quantify its birefringence. Finally, as a proof-of-concept for patterning more complex device geometries, we demonstrate the use of dynamic phase modulation to grow symmetric crystal junctions with single-pass writing.	[Stone, Adam; Jain, Himanshu] Lehigh Univ, Dept Mat Sci & Engn, Bethlehem, PA 18015 USA; [Dierolf, Volkmar] Lehigh Univ, Dept Phys, Bethlehem, PA 18015 USA; [Sakakura, Masaaki] Kyoto Univ, Off Soc Acad Collaborat Innovat, Kyoto 6158245, Japan; [Shimotsuma, Yasuhiko; Miura, Kiyotaka; Hirao, Kazuyuki] Kyoto Univ, Dept Chem Mat, Nishikyo Ku, Kyoto 6158510, Japan; [Lapointe, Jerome; Kashyap, Raman] Polytech Montreal, Dept Engn Phys, Montreal, PQ H3C 3A7, Canada; [Kashyap, Raman] Polytech Montreal, Dept Elect Engn, Montreal, PQ H3C 3A7, Canada	Jain, H (reprint author), Lehigh Univ, Dept Mat Sci & Engn, 5 East Packer Ave, Bethlehem, PA 18015 USA.	h.jain@lehigh.edu			National Science Foundation [DMR-0906763]; International Materials Institute for New Functionality in Glass (IMI-NFG program) [DMR-0844014]	We are grateful to the National Science Foundation for the work at Lehigh University (DMR-0906763) as well as initiating and supporting our international collaborations through the International Materials Institute for New Functionality in Glass (IMI-NFG program under grant No. DMR-0844014).	Dai Y, 2008, OPT EXPRESS, V16, P3912, DOI 10.1364/OE.16.003912; Miura K, 2000, OPT LETT, V25, P408, DOI 10.1364/OL.25.000408; Yu B, 2004, J OPT SOC AM B, V21, P83, DOI 10.1364/JOSAB.21.000083; Zhu B, 2007, OPT EXPRESS, V15, P6069, DOI 10.1364/OE.15.006069; Nasu Y, 2005, OPT LETT, V30, P723, DOI 10.1364/OL.30.7.000723; Yonesaki Y, 2005, J NON-CRYST SOLIDS, V351, P885, DOI 10.1016/j.jnoncrysol.2005.01.076; Shah L, 2005, OPT EXPRESS, V13, P1999, DOI 10.1364/OPEX.13.001999; Shribak M, 2003, APPL OPTICS, V42, P3009, DOI 10.1364/AO.42.003009; Stone A, 2013, J OPT SOC AM B, V30, P1234, DOI 10.1364/JOSAB.30.001234; Nolte S, 2003, APPL PHYS A-MATER, V77, P109, DOI 10.1007/s00339-003-2088-6; Kowalevicz AM, 2005, OPT LETT, V30, P1060, DOI 10.1364/OL.30.001060; NODA J, 1986, J LIGHTWAVE TECHNOL, V4, P1071, DOI 10.1109/JLT.1986.1074847; FIENUP JR, 1982, APPL OPTICS, V21, P2758, DOI 10.1364/AO.21.002758; Lapointe J, 2014, OPT EXPRESS, V22, P15473, DOI 10.1364/OE.22.015473; Dai Y, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2734919; Takahashi Y, 2001, J APPL PHYS, V89, P5282, DOI 10.1063/1.1360699; Ams M, 2005, OPT EXPRESS, V13, P5676, DOI 10.1364/OPEX.13.005676; Liu Y, 2009, OPT LETT, V34, P136; Hunsperger R.G., 2002, INTEGRATED OPTICS TH; Kaminow IP, 2008, J LIGHTWAVE TECHNOL, V26, P994, DOI 10.1109/JLT.2008.922149; Lu B, 2005, J CRYST GROWTH, V285, P76, DOI 10.1016/j.jcrysgro.2005.07.047; Miura K., 2008, APPL PHYS A, V93, P138; Pospiech M, 2010, OPT EXPRESS, V18, P6994, DOI 10.1364/OE.18.006994; Shimotsuma Y, 2006, J NON-CRYST SOLIDS, V352, P646, DOI [10.1016/j.jnoncrysol.2005.11.060, 10.1016/j.noncrysol.2005.11.060]	24	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAY 19	2015	5								10391	10.1038/srep10391		10	Multidisciplinary Sciences	Science & Technology - Other Topics	CJ2GB	WOS:000355301100001		
J	Yamagata, A; Sato, Y; Goto-Ito, S; Uemura, T; Maeda, A; Shiroshima, T; Yoshida, T; Fukai, S				Yamagata, Atsushi; Sato, Yusuke; Goto-Ito, Sakurako; Uemura, Takeshi; Maeda, Asami; Shiroshima, Tomoko; Yoshida, Tomoyuki; Fukai, Shuya			Structure of Slitrk2-PTP delta complex reveals mechanisms for splicing-dependent trans-synaptic adhesion	SCIENTIFIC REPORTS			English	Article							PROTEIN-TYROSINE PHOSPHATASES; SYNAPSE DEVELOPMENT; PTP-SIGMA; DELTA	Selective binding between pre- and postsynaptic adhesion molecules can induce synaptic differentiation. Here we report the crystal structure of a synaptogenic trans-synaptic adhesion complex between Slit and Trk-like family member 2 (Slitrk2) and receptor protein tyrosine phosphatase (RPTP) delta. The structure and site-directed mutational analysis revealed the structural basis of splicing-dependent adhesion between Slitrks and type IIa RPTPs for inducing synaptic differentiation.	[Yamagata, Atsushi; Sato, Yusuke; Goto-Ito, Sakurako; Maeda, Asami; Shiroshima, Tomoko; Fukai, Shuya] Univ Tokyo, Synchrotron Radiat Res Org, Div Life Sci, Struct Biol Lab, Tokyo 1130032, Japan; [Yamagata, Atsushi; Sato, Yusuke; Goto-Ito, Sakurako; Maeda, Asami; Shiroshima, Tomoko; Fukai, Shuya] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan; [Yamagata, Atsushi; Sato, Yusuke; Fukai, Shuya] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Chiba 2778501, Japan; [Yamagata, Atsushi; Sato, Yusuke; Goto-Ito, Sakurako; Uemura, Takeshi; Maeda, Asami; Shiroshima, Tomoko; Fukai, Shuya] JST, CREST, Saitama 3320012, Japan; [Uemura, Takeshi] Shinshu Univ, Sch Med, Dept Mol & Cellular Physiol, Nagano 3908621, Japan; [Uemura, Takeshi] Shinshu Univ, Inst Biomed Sci, Interdisciplinary Cluster Cutting Edge Res, Nagano 3908621, Japan; [Yoshida, Tomoyuki] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Mol Neurosc, Toyama 9300194, Japan; [Yoshida, Tomoyuki] JST, PRESTO, Kawaguchi, Saitama 3320012, Japan	Fukai, S (reprint author), Univ Tokyo, Synchrotron Radiat Res Org, Div Life Sci, Struct Biol Lab, Tokyo 1130032, Japan.	toyoshid@med.u-toyama.ac.jp; fukai@iam.u-tokyo.ac.jp			PRESTO, JST; CREST, JST;  [22121003];  [25117711];  [25112505];  [24247014];  [25293057];  [26640038];  [25650018];  [24570126];  [24687012]	We thank the beam-line staffs at BL41XU of SPring8 (Hyogo, Japan) for technical help during data collection. This work was supported by Grant-in-Aid for Scientific Research on Innovative Areas 22121003 (S.F.), 25117711 (Y.S.) and 25112505 (Y.S.), Grant-in-Aid for Scientific Research (A) 24247014 (S.F.), Grant-in-Aid for Scientific Research (B) 25293057 (T.Y.), Grant-in-Aid for challenging Exploratory Research 26640038 (T.Y.) and 25650018 (S.G.-I.), Grant-in-Aid for Scientific Research (C) 24570126 (A.Y.), Grant-in-Aid for Young Scientists (A) 24687012 (Y.S.), PRESTO, JST (T.Y.) and CREST, JST (S.F. and T.U.).	Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Coles CH, 2011, SCIENCE, V332, P484, DOI 10.1126/science.1200840; Piton A, 2011, Mol Psychiatry, V16, P867, DOI 10.1038/mp.2010.54; Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; He XLL, 2003, NEURON, V38, P177, DOI 10.1016/S0896-6273(03)00232-0; Takahashi H, 2013, TRENDS NEUROSCI, V36, P522, DOI 10.1016/j.tins.2013.06.002; Um JW, 2013, TRENDS CELL BIOL, V23, P465, DOI 10.1016/j.tcb.2013.07.004; Takahashi H, 2012, NAT NEUROSCI, V15, P389, DOI 10.1038/nn.3040; Yoshida T, 2011, J NEUROSCI, V31, P13485, DOI 10.1523/JNEUROSCI.2136-11.2011; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Aruga J, 2003, MOL CELL NEUROSCI, V24, P117, DOI 10.1016/S1044-7431(03)00129-5; Takahashi H, 2011, NEURON, V69, P287, DOI 10.1016/j.neuron.2010.12.024; Yim YS, 2013, P NATL ACAD SCI USA, V110, P4057, DOI 10.1073/pnas.1209881110; Proenca CC, 2011, TRENDS NEUROSCI, V34, P143, DOI 10.1016/j.tins.2011.01.001; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Laskowski R. A., 1993, J APPL CRYSTALLOGR, V26, P9; Otwinowski Z., 1997, METHOD ENZYMOL, V276, P20; Smith EN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002134; Um JW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6423; Vagin A. T. A., 1997, J APPL CRYSTALLOGR, V30, P4; Woo J, 2009, NAT NEUROSCI, V12, P428, DOI 10.1038/nn.2279; Yoshida T, 2012, J NEUROSCI, V32, P2588, DOI 10.1523/JNEUROSCI.4637-11.2012; Zuchner S, 2006, Mol Psychiatry, V11, P887, DOI 10.1038/sj.mp.4001898	24	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAY 19	2015	5								9686	10.1038/srep09686		6	Multidisciplinary Sciences	Science & Technology - Other Topics	CJ2CN	WOS:000355291900001		
J	Zhu, QC; Yu, ZQ; Kabashima, T; Yin, S; Dragusha, S; El-Mahdy, AFM; Ejupi, V; Shibata, T; Kai, M				Zhu, Qinchang; Yu, Zhiqiang; Kabashima, Tsutomu; Yin, Sheng; Dragusha, Shpend; El-Mahdy, Ahmed F. M.; Ejupi, Valon; Shibata, Takayuki; Kai, Masaaki			Fluorometric assay for phenotypic differentiation of drug-resistant HIV mutants	SCIENTIFIC REPORTS			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PRECOLUMN FLUORESCENCE DERIVATIZATION; PERFORMANCE LIQUID-CHROMATOGRAPHY; TRYPTOPHAN-CONTAINING PEPTIDES; INHIBITOR CROSS-RESISTANCE; ANTIRETROVIRAL THERAPY; PROTEASE INHIBITORS; VIROLOGICAL FAILURE; HIV-1-INFECTED PATIENTS; SELECTIVE DETERMINATION	Convenient drug-resistance testing of viral mutants is indispensable to effective treatment of viral infection. We developed a novel fluorometric assay for phenotypic differentiation of drug-resistant mutants of human immunodeficiency virus-I protease (HIV-PR) which uses enzymatic and peptide-specific fluorescence (FL) reactions and high-performance liquid chromatography (HPLC) of three HIV-PR substrates. This assay protocol enables use of non-purified enzyme sources and multiple substrates for the enzymatic reaction. In this study, susceptibility of HIV mutations to drugs was evaluated by selective formation of three FL products after the enzymatic HIV-PR reaction. This proof-of-concept study indicates that the present HPLC-FL method could be an alternative to current phenotypic assays for the evaluation of HIV drug resistance.	[Zhu, Qinchang; Yu, Zhiqiang; Kabashima, Tsutomu; Yin, Sheng; Dragusha, Shpend; El-Mahdy, Ahmed F. M.; Ejupi, Valon; Shibata, Takayuki; Kai, Masaaki] Nagasaki Univ, Fac Pharmaceut Sci, Grad Sch Biomed Sci, Nagasaki 8528521, Japan	Kai, M (reprint author), Nagasaki Univ, Fac Pharmaceut Sci, Grad Sch Biomed Sci, 1-14 Bunkyo Machi, Nagasaki 8528521, Japan.	ms-kai@nagasaki-u.ac.jp		EL-Mahdy, Ahmed/0000-0002-5237-750X	Ministry of Education, Culture, Sports and Technology of Japan; Global Center of Excellence Program in Nagasaki University	This work was financially supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports and Technology of Japan, and was partly supported by the Global Center of Excellence Program in Nagasaki University.	Kabashima T, 2008, PEPTIDES, V29, P356, DOI 10.1016/j.peptides.2007.11.014; JACOBSEN H, 1995, VIROLOGY, V206, P527, DOI 10.1016/S0042-6822(95)80069-7; Mofenson LM, 2010, CLIN INFECT DIS, V50, pS130, DOI 10.1086/651484; Yu ZQ, 2010, ANAL BIOCHEM, V397, P197, DOI 10.1016/j.ab.2009.10.030; Wittayanarakul K, 2005, BIOPHYS J, V88, P867, DOI 10.1529/biophysj.104.046110; Luebbert J, 2012, CLIN INFECT DIS, V55, P441, DOI 10.1093/cid/cis438; O'Loughlin TL, 2006, MOL BIOL EVOL, V23, P764, DOI 10.1093/molbev/msj098; Hirsch MS, 2003, CLIN INFECT DIS, V37, P113, DOI 10.1086/375597; Zennou V, 1998, J VIROL, V72, P3300; Rhee SY, 2010, ANTIMICROB AGENTS CH, V54, P4253, DOI 10.1128/AAC.00574-10; Aberg JA, 2014, CLIN INFECT DIS, V58, pE1, DOI 10.1093/cid/cit665; Barbaro G, 2005, CURR PHARM DESIGN, V11, P1805, DOI 10.2174/1381612053764869; Shafer RW, 2008, AIDS REV, V10, P67; Petropoulos CJ, 2000, ANTIMICROB AGENTS CH, V44, P920, DOI 10.1128/AAC.44.4.920-928.2000; Li JZ, 2011, JAMA-J AM MED ASSOC, V305, P1327, DOI 10.1001/jama.2011.375; KELLAM P, 1994, ANTIMICROB AGENTS CH, V38, P23; Beerenwinkel N, 2002, P NATL ACAD SCI USA, V99, P8271, DOI 10.1073/pnas.112177799; Pazhanisamy S, 1996, J BIOL CHEM, V271, P17979; Hertogs K, 1998, ANTIMICROB AGENTS CH, V42, P269; Richman DD, 2001, NATURE, V410, P995, DOI 10.1038/35073673; Bahia Fabianna, 2004, Braz J Infect Dis, V8, P281, DOI 10.1590/S1413-86702004000400003; Beck ZQ, 2001, J VIROL, V75, P9458, DOI 10.1128/JVI.75.19.9458-9469.2001; Bile EC, 2005, J CLIN VIROL, V32, P60, DOI 10.1016/j.jcv.2004.07.008; Cote HCF, 2001, J VIROL, V75, P589, DOI 10.1128/JVI.75.2.589-594.2001; Dauber DS, 2002, J VIROL, V76, P1359, DOI 10.1128/JVI.76.3.1359-1368.2002; Deeks SG, 1997, LANCET, V349, P1489, DOI 10.1016/S0140-6736(05)62092-2; Dunne AL, 2001, AIDS, V15, P1471, DOI 10.1097/00002030-200108170-00003; Edmonds A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001044; Gehringer H, 2003, J VIROL METHODS, V109, P143, DOI 10.1016/S0166-0934(03)00065-X; Hanna G. J., 1999, CURR INFECT DIS REP, V1, P289, DOI 10.1007/s11908-999-0032-4; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; KAI M, 1993, J CHROMATOGR A, V653, P235, DOI 10.1016/0021-9673(93)83179-V; KAI M, 1986, ANAL CHIM ACTA, V182, P177, DOI 10.1016/S0003-2670(00)82448-4; Kebe K, 2013, AIDS RES HUM RETROV, V29, P242, DOI 10.1089/aid.2011.0300; KOJIMA E, 1993, ANAL CHIM ACTA, V280, P157, DOI 10.1016/0003-2670(93)80253-H; Kolli M, 2006, VIROLOGY, V347, P405, DOI 10.1016/j.virol.2005.11.049; MENENDEZARIAS L, 1995, J BIOL CHEM, V270, P29162; Rahman MS, 2013, ANAL BIOCHEM, V433, P79, DOI 10.1016/j.ab.2012.10.018; Richman DD, 2004, J ANTIMICROB CHEMOTH, V53, P555, DOI 10.1093/jac/dkh157; RIDKY T, 1995, J BIOL CHEM, V270, P29621; Sarmati L, 2002, J CLIN MICROBIOL, V40, P335, DOI 10.1128/JCM.40.2.335-340.2002; Sen S, 2006, J POSTGRAD MED, V52, P187; Shafer RW, 2001, HIV SEQ COMPEND, V2001, P1; Smidt ML, 1997, ANTIMICROB AGENTS CH, V41, P515; Villalba N, 1999, EUR J CLIN MICROBIOL, V18, P372, DOI 10.1007/PL00015023; Yang J, 2014, J BASIC MICROB, V54, P1120, DOI 10.1002/jobm.201300415; Yasmin H, 2012, ANAL CHIM ACTA, V721, P162, DOI 10.1016/j.aca.2012.01.035; Yasmin H, 2014, SCI REP-UK, V4, DOI 10.1038/srep04950; Yasmin H, 2014, INT J PEPT RES THER, V20, P441, DOI 10.1007/s10989-014-9406-z; ZHANG GQ, 1991, CHEM PHARM BULL, V39, P126	50	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAY 19	2015	5								10323	10.1038/srep10323		9	Multidisciplinary Sciences	Science & Technology - Other Topics	CJ2FD	WOS:000355298700001		
J	Kawabata, K; Xue, JR; Ma, L; Zheng, NN				Kawabata, Kuniaki; Xue, Jianru; Ma, Liang; Zheng, Nanning			An online reference governor for mobile robot to reduce the occurrence of control input saturation	ADVANCED ROBOTICS			English	Article						time-scaling factor; reference governor; mobile robot control; trajectory tracking error index	SYSTEM	This study proposed an online reference governor for a mobile robot to reduce the occurrence of control input saturation. For following the trajectory by a mobile robot, it is one of the practical subjects to provide appropriate control reference even if any disturbances occur. We proposed a methodology to regulate the control reference iteratively based on time-scaling approach. The time-scaling approach is a method to realize to regulate time development characteristic on the given trajectory. It is difficult to model the effect of the interaction with the road surface and the trajectory tracking error is appeared as the amount of accumulated such factors. Therefore, it is a practical approach to reduce the occurrence of control input saturation based on the evaluation of the trajectory tracking error. Proposed reference governor realizes online time scaling based on the trajectory tracking error index and a smooth transition dynamics. By introducing the proposed method, the occurrence of control input saturation can be reduced in case of that the disturbances occur. For verification of our proposed method, computer simulations utilizing a stable velocity controller were conducted and the results were discussed.	[Kawabata, Kuniaki] RIKEN, RIKEN XJTU Joint Res Unit, Wako, Saitama 3510198, Japan; [Kawabata, Kuniaki; Xue, Jianru; Ma, Liang; Zheng, Nanning] Xi An Jiao Tong Univ, Inst Artificial Intelligence & Robot, Xian 710049, Shaanxi, Peoples R China	Kawabata, K (reprint author), RIKEN, RIKEN XJTU Joint Res Unit, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	kuniakik@riken.jp			NSFC of China [61273252, 91320301]; MEXT of Japan [23300074]	This work is partially supported by NSFC of China under grant number [61273252], [grant number 91320301]; KAKENHI Grant-in-Aid for Scientific Research (B), MEXT of Japan [grant number 23300074].	Jolly KG, 2009, ROBOT AUTON SYST, V57, P23, DOI 10.1016/j.robot.2008.03.009; DEWIT CC, 1992, IEEE T AUTOMAT CONTR, V37, P1791, DOI 10.1109/9.173153; Ascher UM, 1998, COMPUTER METHODS ORD, DOI [10.1137/1.9781611971392, DOI 10.1137/1.9781611971392]; DAHL O, 1990, IEEE T ROBOTIC AUTOM, V6, P554, DOI 10.1109/70.62044; Graettinger T. J., 1988, Proceedings of the 1988 American Control Conference; HAN L, 2010, P IEEE INT VEH S IV, P1036; HOLLERBACH JM, 1984, J DYN SYST-T ASME, V106, P102; Hwang HS, 2002, COMPUT IND ENG, V43, P283, DOI 10.1016/S0360-8352(02)00075-X; Kanayama Y., 1990, P IEEE INT C ROB AUT, V1, P384; KAWABATA K, 2013, P IEEE ASME INT C AD, P991; KHATIB O, 1986, INT J ROBOT RES, V5, P90, DOI 10.1177/027836498600500106; Latombe J. C., 1991, ROBOT MOTION PLANNIN, DOI [10.1007/978-1-4615-4022-9, DOI 10.1007/978-1-4615-4022-9]; Moreno-Valenzuela J., 2006, Proceedings. 2006 Conference on International Robotics and Automation (IEEE Cat. No. 06CH37729D), DOI 10.1109/ROBOT.2006.1641155; MUKAI T, 2010, P IEEE RSJ INT C INT, P5996; Paromtchik I. E., 2000, Proceedings 2000 ICRA. Millennium Conference. IEEE International Conference on Robotics and Automation. Symposia Proceedings (Cat. No.00CH37065), DOI 10.1109/ROBOT.2000.844764; Pears NE, 2001, ADV ROBOTICS, V15, P97, DOI 10.1163/156855301750095596; Schrank D.L., 2007, 2007 URBAN MOBILITY; Szadeczky-Kardoss E, 2006, P INT C INT ENG SYST, P80; Szadeczky-Kardoss E., 2009, INTELLIGENT ENG SYST, P3, DOI 10.1007/978-1-4020-8678-6_1; Tsuji T, 2002, IEEE T SYST MAN CY C, V32, P426, DOI 10.1109/TSMCC.2002.807273	20	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0169-1864	1568-5535		ADV ROBOTICS	Adv. Robot.	MAY 19	2015	29	10					671	681		10.1080/01691864.2014.1001789		11	Robotics	Robotics	CI9YW	WOS:000355128300001		
J	Sugiyama, T; Kim, YT; Oda, H				Sugiyama, Toshihiro; Kim, Yoon Taek; Oda, Hiromi			Screening for Vitamin D Deficiency	ANNALS OF INTERNAL MEDICINE			English	Letter							SKELETON; INSIGHT		[Sugiyama, Toshihiro; Kim, Yoon Taek; Oda, Hiromi] Saitama Med Univ, Saitama, Japan	Sugiyama, T (reprint author), Saitama Med Univ, Saitama, Japan.						LeBlanc ES, 2015, ANN INTERN MED, V162, P109, DOI 10.7326/M14-1659; Sugiyama T, 2015, OSTEOPOROSIS INT, V26, P1447, DOI 10.1007/s00198-014-2975-z; Sugiyama T, 2015, OSTEOPOROSIS INT, V26, P443, DOI 10.1007/s00198-014-2923-y; Sugiyama T, 2014, OSTEOPOROSIS INT, V25, P2497, DOI 10.1007/s00198-014-2798-y; Sugiyama Toshihiro, 2015, Front Endocrinol (Lausanne), V6, P6, DOI 10.3389/fendo.2015.00006	5	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 19	2015	162	10					737	738		10.7326/L15-5094-3		2	Medicine, General & Internal	General & Internal Medicine	CI8IF	WOS:000355015200034		
J	Yasuda, T; Tsuchikawa, H; Murata, M; Matsumori, N				Yasuda, Tomokazu; Tsuchikawa, Hiroshi; Murata, Michio; Matsumori, Nobuaki			Deuterium NMR of Raft Model Membranes Reveals Domain-Specific Order Profiles and Compositional Distribution	BIOPHYSICAL JOURNAL			English	Article							SOLID-STATE NMR; LIPID RAFTS; MAGNETIC-RESONANCE; TERNARY MIXTURE; CELL-MEMBRANES; PHASE-DIAGRAM; CHOLESTEROL; SPHINGOMYELIN; SPECTROSCOPY; BILAYER	In this report, we applied site-specifically deuterated N-stearoylsphingomyelins (SSMs) to raft-exhibiting ternary mixtures containing SSM, 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), and cholesterol (Chol) and successfully acquired deuterium quadrupole coupling profiles of SSM from liquid-ordered (L-o) and liquid-disordered (L-d) domains. To our knowledge, this is the first report that shows detailed lipid chain dynamics separately and simultaneously obtained from coexisting L-o and L-d domains. We also found that the quadrupole profile of the L-o phase in the ternary system was almost identical to that in the SSM-Chol binary mixture, suggesting that the order profile of the binary system is essentially applicable to more complicated membrane systems in terms of the acyl chain order. We also demonstrated that H-2 NMR spectroscopy, in combination with organic synthesis of deuterated components, could be used to reveal the accurate mole fractions of each component distributed in the L-o and L-d domains. As compared with the reported tie-line analysis of phase diagrams, the merit of our H-2 NMR analysis is that the domain-specific compositional fractions are directly attainable without experimental complexity and ambiguity. The accurate compositional distributions as well as lipid order profiles in ternary mixtures are relevant to understanding the molecular mechanism of lipid raft formation.	[Yasuda, Tomokazu; Tsuchikawa, Hiroshi; Murata, Michio; Matsumori, Nobuaki] Osaka Univ, Grad Sch Sci, Dept Chem, Toyonaka, Osaka 560, Japan; [Yasuda, Tomokazu; Murata, Michio] Japan Sci & Technol Agcy, ERATO, Lipid Act Struct Project, Toyonaka, Osaka, Japan	Matsumori, N (reprint author), Osaka Univ, Grad Sch Sci, Dept Chem, Toyonaka, Osaka 560, Japan.	matsmori@chem.kyushu-univ.jp			MEXT, Japan [25242073]; Suntory Institute for Bioorganic Research, Japan; Japan Science and Technology Agency (JST)	The authors thank Drs. Yuichi Umegawa and Naoya Inazumi, Osaka University, in our department for help in <SUP>2</SUP>H NMR measurements. This work was supported by Grants-in-Aid for Scientific Research (A) (No. 25242073) from MEXT, Japan; a grant from the Suntory Institute for Bioorganic Research, Japan; and the ERATO "Lipid Active Structure Project'' from the Japan Science and Technology Agency (JST). T.Y. as a JSPS fellow is grateful to the Japan Society for the Promotion of Science.	Martinez GV, 2004, LANGMUIR, V20, P1043, DOI 10.1021/la036063n; SEELIG J, 1977, Q REV BIOPHYS, V10, P353; Binder WH, 2003, ANGEW CHEM INT EDIT, V42, P5802, DOI 10.1002/anie.200300586; Leftin A, 2011, BBA-BIOMEMBRANES, V1808, P818, DOI 10.1016/j.bbamem.2010.11.027; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Veatch SL, 2003, BIOPHYS J, V85, P3074; de Almeida RFM, 2003, BIOPHYS J, V85, P2406, DOI 10.1016/S0006-3495(03)74664-5; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Baumgart T, 2003, NATURE, V425, P821, DOI 10.1038/nature02013; Bunge A, 2008, BIOPHYS J, V94, P2680, DOI 10.1529/biophysj.107.112904; Xu XL, 2000, BIOCHEMISTRY-US, V39, P843, DOI 10.1021/bi992543v; Silvius JR, 1996, BIOCHEMISTRY-US, V35, P15198, DOI 10.1021/bi9615506; van Duyl BY, 2003, FEBS LETT, V547, P101, DOI 10.1016/S0014-5793(03)00678-1; Farkas ER, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3483263; Matsumori N, 2012, BIOCHEMISTRY-US, V51, P8363, DOI 10.1021/bi3009399; Mehnert T, 2006, BIOPHYS J, V90, P939, DOI 10.1529/biopyhsj.105.063271; Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Veatch SL, 2004, BIOPHYS J, V86, P2910, DOI 10.1016/S0006-3495(04)74342-8; Veatch SL, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.148101; Matsumori N, 2008, J AM CHEM SOC, V130, P4757, DOI 10.1021/ja077580l; Ikonen E, 2001, CURR OPIN CELL BIOL, V13, P470, DOI 10.1016/S0955-0674(00)00238-6; Dietrich C, 2001, BIOPHYS J, V80, P1417; Kahya N, 2003, J BIOL CHEM, V278, P28109, DOI 10.1074/jbc.M302969200; THEWALT JL, 1992, BIOPHYS J, V63, P1176; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Bak M, 2000, J MAGN RESON, V147, P296, DOI 10.1006/jmre.2000.2179; Ahmed SN, 1997, BIOCHEMISTRY-US, V36, P10944, DOI 10.1021/bi971167g; Bezlyepkina N, 2013, BIOPHYS J, V104, P1456, DOI 10.1016/j.bpj.2013.02.024; Smith AK, 2009, J PHYS CHEM B, V113, P3957, DOI 10.1021/jp808412x; Yasuda T, 2014, BIOPHYS J, V106, P631, DOI 10.1016/j.bpj.2013.12.034; Veatch SL, 2003, BIOPHYS J, V84, P725; Bartels T, 2008, J AM CHEM SOC, V130, P14521, DOI 10.1021/ja801789t; Leftin A, 2014, BIOPHYS J, V107, P2274, DOI 10.1016/j.bpj.2014.07.044; Martinez GV, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.050902; SILVIUS JR, 1992, BIOCHEMISTRY-US, V31, P3398, DOI 10.1021/bi00128a014; Tsukamoto M, 2014, CHEM COMMUN, V50, P3427, DOI 10.1039/c3cc47738j; Veatch SL, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.268101; VIST MR, 1990, BIOCHEMISTRY-US, V29, P451, DOI 10.1021/bi00454a021	38	1	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0006-3495	1542-0086		BIOPHYS J	Biophys. J.	MAY 19	2015	108	10					2502	2506		10.1016/j.bpj.2015.04.008		5	Biophysics	Biophysics	CI5VF	WOS:000354827200010		
J	Sichova, J; Volenikova, A; Dinca, V; Nguyen, P; Vila, R; Sahara, K; Marec, F				Sichova, Jindra; Volenikova, Anna; Dinca, Vlad; Nguyen, Petr; Vila, Roger; Sahara, Ken; Marec, Frantisek			Dynamic karyotype evolution and unique sex determination systems in Leptidea wood white butterflies	BMC EVOLUTIONARY BIOLOGY			English	Article						Lepidoptera; Wood white butterflies; Karyotype variability; Fluorescence in situ hybridization Chromosome fusion and fission; Multiple sex chromosomes; Speciation	COMPARATIVE GENOMIC HYBRIDIZATION; TIGER SWALLOWTAIL BUTTERFLIES; MUS-MUSCULUS-DOMESTICUS; EUROPEAN CORN-BORER; SAMIA-CYNTHIA SSP; REPRODUCTIVE ISOLATION; HOLOCENTRIC CHROMOSOMES; MOLECULAR DIFFERENTIATION; GEOGRAPHICAL POPULATIONS; HELICONIUS BUTTERFLIES	Background: Chromosomal rearrangements have the potential to limit the rate and pattern of gene flow within and between species and thus play a direct role in promoting and maintaining speciation. Wood white butterflies of the genus Leptidea are excellent models to study the role of chromosome rearrangements in speciation because they show karyotype variability not only among but also within species. In this work, we investigated genome architecture of three cryptic Leptidea species (L. juvernica, L. sinapis and L. reali) by standard and molecular cytogenetic techniques in order to reveal causes of the karyotype variability. Results: Chromosome numbers ranged from 2n = 85 to 91 in L. juvernica and 2n = 69 to 73 in L. sinapis (both from Czech populations) to 2n = 51 to 55 in L. reali (Spanish population). We observed significant differences in chromosome numbers and localization of cytogenetic markers (rDNA and H3 histone genes) within the offspring of individual females. Using FISH with the (TTAGG)(n) telomeric probe we also documented the presence of multiple chromosome fusions and/or fissions and other complex rearrangements. Thus, the intraspecific karyotype variability is likely due to irregular chromosome segregation of multivalent meiotic configurations. The analysis of female meiotic chromosomes by GISH and CGH revealed multiple sex chromosomes: W(1)W(2)W(3)Z(1)Z(2)Z(3)Z(4) in L. juvernica, W(1)W(2)W(3)Z(1)Z(2)Z(3) in L. sinapis and W(1)W(2)W(3)W(4)Z(1)Z(2)Z(3)Z(4) in L. reali. Conclusions: Our results suggest a dynamic karyotype evolution and point to the role of chromosomal rearrangements in the speciation of Leptidea butterflies. Moreover, our study revealed a curious sex determination system with 3-4 W and 3-4 Z chromosomes, which is unique in the Lepidoptera and which could also have played a role in the speciation process of the three Leptidea species.	[Sichova, Jindra; Nguyen, Petr; Marec, Frantisek] CAS, Ctr Biol, Inst Entomol, Ceske Budejovice 37005, Czech Republic; [Sichova, Jindra; Volenikova, Anna; Nguyen, Petr; Marec, Frantisek] Univ South Bohemia, Fac Sci, Ceske Budejovice 37005, Czech Republic; [Dinca, Vlad] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; [Dinca, Vlad; Vila, Roger] Univ Pompeu Fabra, CSIC, Inst Biol Evolut, Barcelona 08003, Spain; [Sahara, Ken] Iwate Univ, Fac Agr, Appl Entomol Lab, Morioka, Iwate 0208550, Japan	Marec, F (reprint author), CAS, Ctr Biol, Inst Entomol, Ceske Budejovice 37005, Czech Republic.	marec@entu.cas.cz	Nguyen, Petr/G-5826-2010; Marec, Frantisek/G-7943-2014		Czech Science Foundation [14-22765S, 14-35819P]; Grant Agency of The Czech Academy of Sciences [IAA600960925]; Grant Agency of the University of South Bohemia [063/2012/P, 052/2013/P]; Spanish Ministerio de Economia y Competitividad [CGL2013-48277-P]; Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme [625997]; JSPS [23380030]; JSPS Excellent Young Researchers Overseas Visit Program [21-7147]	Our thanks go to Marie Korchova for excellent technical assistance and Leonela Carabajal Paladino for help with statistical analysis. This research was funded by Grant 14-22765S of the Czech Science Foundation, Grant IAA600960925 of the Grant Agency of The Czech Academy of Sciences, Grant 063/2012/P of the Grant Agency of the University of South Bohemia and Grant CGL2013-48277-P from the Spanish Ministerio de Economia y Competitividad. JS and AV were supported by Grant 052/2013/P of the Grant Agency of the University of South Bohemia, VD by a Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme (project no. 625997), PN by Grant 14-35819P of the Czech Science Foundation and KS by JSPS 23380030 grant and JSPS Excellent Young Researchers Overseas Visit Program (21-7147).	Ahola V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5737; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; d'Alencon E, 2010, P NATL ACAD SCI USA, V107, P7680, DOI 10.1073/pnas.0910413107; Hipp AL, 2009, BOT REV, V75, P96, DOI 10.1007/s12229-008-9022-8; Nguyen P, 2010, GENETICA, V138, P343, DOI 10.1007/s10709-009-9424-5; Noor MAF, 2001, P NATL ACAD SCI USA, V98, P12084, DOI 10.1073/pnas.221274498; Pringle EG, 2007, GENETICS, V177, P417, DOI 10.1514/genetics.107.073122; Kronforst MR, 2006, GENETICS, V174, P535, DOI 10.1534/genetics.106.059527; Van't Hof AE, 2013, HEREDITY, V110, P283, DOI 10.1038/hdy.2012.84; Nam K, 2008, GENETICS, V180, P1131, DOI 10.1534/genetics.108.090324; Rieseberg LH, 2001, TRENDS ECOL EVOL, V16, P351, DOI 10.1016/S0169-5347(01)02187-5; Nguyen P, 2013, P NATL ACAD SCI USA, V110, P6931, DOI 10.1073/pnas.1220372110; Storchova R, 2010, EVOLUTION, V64, P456, DOI 10.1111/j.1558-5646.2009.00841.x; Cabrero J, 2009, CHROMOSOME RES, V17, P397, DOI 10.1007/s10577-009-9030-5; Jiggins CD, 2001, EVOLUTION, V55, P1631; Bidau CJ, 2001, HEREDITY, V87, P305, DOI 10.1046/j.1365-2540.2001.00877.x; Melters DP, 2012, CHROMOSOME RES, V20, P579, DOI 10.1007/s10577-012-9292-1; Ellegren H, 2009, P R SOC B, V276, P361, DOI 10.1098/rspb.2008.1135; Kandul NP, 2004, SYST BIOL, V53, P278, DOI 10.1080/10635150490423692; Carling MD, 2008, EVOLUTION, V62, P2600, DOI 10.1111/j.1558-5646.2008.00477.x; BROWN KS, 1981, ANNU REV ENTOMOL, V26, P427, DOI 10.1146/annurev.en.26.010181.002235; Saetre GP, 2003, P ROY SOC B-BIOL SCI, V270, P53, DOI 10.1098/rspb.2002.2204; SHEPPARD PM, 1985, PHILOS T R SOC B, V308, P433, DOI 10.1098/rstb.1985.0066; Faria R, 2010, TRENDS ECOL EVOL, V25, P660, DOI 10.1016/j.tree.2010.07.008; Mediouni J, 2004, CARYOLOGIA, V57, P184; Carling MD, 2009, MOL ECOL, V18, P834, DOI 10.1111/j.1365-294X.2008.04038.x; Traut W, 1999, CHROMOSOMA, V108, P173, DOI 10.1007/s004120050366; Veyrunes F, 2008, GENOME RES, V18, P965, DOI 10.1101/gr.7101908; Ando T, 2004, TOP CURR CHEM, V239, P51, DOI 10.1007/b95449; Hipp AL, 2010, MOL ECOL, V19, P3124, DOI 10.1111/j.1365-294X.2010.04741.x; Bergero R, 2007, GENETICS, V175, P1945, DOI 10.1534/genetics.106.070110; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Lukhtanov VA, 2005, NATURE, V436, P385, DOI 10.1038/nature03704; Kral J, 2011, CYTOGENET GENOME RES, V133, P43, DOI 10.1159/000323497; Leary GP, 2012, P NATL ACAD SCI USA, V109, P14081, DOI 10.1073/pnas.1204661109; Yoshido A, 2005, GENETICS, V170, P675, DOI 10.1534/genetics.104.040352; Traut W, 1996, Q REV BIOL, V71, P239, DOI 10.1086/419371; Mallet J, 1999, ANNU REV ECOL SYST, V30, P201, DOI 10.1146/annurev.ecolsys.30.1.201; Sahara K, 1999, CHROMOSOME RES, V7, P449, DOI 10.1023/A:1009297729547; Jiggins CD, 2001, NATURE, V411, P302, DOI 10.1038/35077075; Rens W, 2004, P NATL ACAD SCI USA, V101, P16257, DOI 10.1073/pnas.0405702101; Zhang W, 2013, GENOME BIOL EVOL, V5, P1233, DOI 10.1093/gbe/evt090; Dopman EB, 2010, EVOLUTION, V64, P881, DOI 10.1111/j.1558-5646.2009.00883.x; BAKER RJ, 1986, P NATL ACAD SCI USA, V83, P8245, DOI 10.1073/pnas.83.21.8245; Basset P, 2006, EVOLUTION, V60, P1718; Baxter SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019315; Beldade P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000366; Blanco DR, 2014, GENETICA, V142, P119, DOI 10.1007/s10709-014-9759-4; Bures P, 2014, EVOLUTION, V68, P2412, DOI 10.1111/evo.12437; Cabral-de-Mello DC, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-88; Carpenter JE, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P115, DOI 10.1007/1-4020-4051-2_5; Castiglia R, 2005, BIOL J LINN SOC, V84, P395, DOI 10.1111/j.1095-8312.2005.00442.x; Cioffi MB, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-186; Colombo PC, 2008, EUR J ENTOMOL, V105, P59; de Lesse H., 1970, Bull. Soc. ent. Fr., V75, P64; De Prins J, 2003, LEPIDOPTERA MOTHS BU, P449; Dinca V, 2013, J EVOLUTION BIOL, V26, P2095, DOI 10.1111/jeb.12211; Dinca V, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1329; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Fukova I, 2005, GENOME, V48, P1083, DOI 10.1139/G05-063; Kral J, 2007, CHROMOSOME RES, V15, P863, DOI 10.1007/s10577-007-1169-3; Kunte K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002274; Lukhtanov VA, 2002, CHROMOSOME RES, V10, P5, DOI 10.1023/A:1014249607796; Lukhtanov VA, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-109; Macha J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-315; MAEKI KODO, 1958, JAPANESE JOUR GENETICS, V33, P283, DOI 10.1266/jjg.33.283; Marec F, 2001, HEREDITY, V87, P659, DOI 10.1046/j.1365-2540.2001.00958.x; MAREC F, 1994, GENOME, V37, P426, DOI 10.1139/g94-060; Naisbit RE, 2002, GENETICS, V161, P1517; Nei M., 2000, MOL EVOLUTION PHYLOG; Olsson SB, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-285; Prowell DP, 1998, ENDLESS FORMS, P309; Robinson R, 1971, LEPIDOPTERA GENETICS; Sahara K, 2013, INSECT BIOCHEM MOLEC, V43, P644, DOI 10.1016/j.ibmb.2013.04.003; Sahara K, 2003, GENOME, V46, P339, DOI 10.1139/G03-003; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Scriber JM, 1996, EVOLUTION, V50, P222, DOI 10.2307/2410795; Sichova J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064520; SPERLING FAH, 1994, CAN ENTOMOL, V126, P807; Suomalainen E., 1969, CHROMOSOMES TODAY, V2, P132; Traut W, 1997, CHROMOSOME RES, V5, P283, DOI 10.1023/B:CHRO.0000038758.08263.c3; TRAUT W, 1986, GENETICA, V70, P69, DOI 10.1007/BF00123216; Traut W, 2007, SEX DEV, V1, P332, DOI 10.1159/000111765; Wang JP, 2012, P NATL ACAD SCI USA, V109, P13710, DOI 10.1073/pnas.1207833109; White TA, 2010, SYST BIOL, V59, P262, DOI 10.1093/sysbio/syq004; Wrensch Dana L., 1994, P282; Yasukochi Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007465; Yoshido A, 2013, CHROMOSOME RES, V21, P149, DOI 10.1007/s10577-013-9344-1; Yoshido A, 2005, CHROMOSOMA, V114, P193, DOI 10.1007/s00412-005-0013-9; Yoshido A, 2011, HEREDITY, V106, P614, DOI 10.1038/hdy.2010.94; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3703.1.1	91	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2148			BMC EVOL BIOL	BMC Evol. Biol.	MAY 19	2015	15								89	10.1186/s12862-015-0375-4		16	Evolutionary Biology; Genetics & Heredity	Evolutionary Biology; Genetics & Heredity	CI6AT	WOS:000354841700001		
J	Chen, D; Ito, S; Yuan, H; Hyodo, T; Kadomatsu, K; Hamaguchi, M; Senga, T				Chen, Dan; Ito, Satoko; Yuan, Hong; Hyodo, Toshinori; Kadomatsu, Kenji; Hamaguchi, Michinari; Senga, Takeshi			EML4 promotes the loading of NUDC to the spindle for mitotic progression	CELL CYCLE			English	Article						EML4; mitosis; cytokinesis; spindle; kinetochore; NUDC	MICROTUBULE-ASSOCIATED PROTEIN; NUCLEAR-MOVEMENT PROTEIN; NEURONAL MIGRATION; BINDING PROTEIN; LUNG-CANCER; WD-REPEAT; EMAP; CYTOKINESIS; KINETOCHORE; DYNEIN	Echinoderm microtubule-associated protein (EMAP)-like (EML) family proteins are microtubule-associated proteins that have a conserved hydrophobic EMAP-like protein (HELP) domain and multiple WD40 domains. In this study, we examined the role of EML4, which is a member of the EML family, in cell division. Time-lapse microscopy analysis demonstrated that EML4 depletion induced chromosome misalignment during metaphase and delayed anaphase initiation. Further analysis by immunofluorescence showed that EML4 was required for the organization of the mitotic spindle and for the proper attachment of kinetochores to microtubules. We searched for EML4-associating proteins by mass spectrometry analysis and found that the nuclear distribution gene C (NUDC) protein, which is a critical factor for the progression of mitosis, was associated with EML4. This interaction was mediated by the WD40 repeat of EML4 and by the C-terminus of NUDC. In the absence of EML4, NUDC was no longer able to localize to the mitotic spindle, whereas NUDC was dispensable for EML4 localization. Our results show that EML4 is critical for the loading of NUDC onto the mitotic spindle for mitotic progression.	[Chen, Dan; Ito, Satoko; Yuan, Hong; Hyodo, Toshinori; Hamaguchi, Michinari; Senga, Takeshi] Nagoya Univ, Grad Sch Med, Div Canc Biol, Nagoya, Aichi 4648601, Japan; [Kadomatsu, Kenji] Nagoya Univ, Grad Sch Med, Dept Biochem, Showa Ku, Nagoya, Aichi 4648601, Japan	Senga, T (reprint author), Nagoya Univ, Grad Sch Med, Div Canc Biol, Nagoya, Aichi 4648601, Japan.	tsenga@med.nagoya-u.ac.jp	Kadomatsu, Kenji/G-8083-2012		Ministry of Education, Culture, Sports, Science and Technology of Japan [25650063, 2306]	This research was funded by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (25650063 and 2306 (Nanomedicine Molecular Science) to TS).	EUTENEUER U, 1981, J CELL BIOL, V89, P338, DOI 10.1083/jcb.89.2.338; Kops GJPL, 2012, CHROMOSOMA, V121, P509, DOI 10.1007/s00412-012-0378-5; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Yamada M, 2010, EMBO J, V29, P517, DOI 10.1038/emboj.2009.378; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; O'Connor V, 2004, GENE, V336, P127, DOI 10.1016/j.gene.2004.04.012; Shrestha RL, 2013, CURR BIOL, V23, P1514, DOI 10.1016/j.cub.2013.06.040; White EA, 2012, CYTOSKELETON, V69, P882, DOI 10.1002/cm.21065; Eichenmuller B, 2002, J BIOL CHEM, V277, P1301, DOI 10.1074/jbc.M106628200; Douglas ME, 2010, SEMIN CELL DEV BIOL, V21, P899, DOI 10.1016/j.semcdb.2010.08.005; Fang X, 2011, SEMIN CELL DEV BIOL, V22, P595, DOI 10.1016/j.semcdb.2011.03.002; Helmke KJ, 2013, INT REV CEL MOL BIO, V306, P83, DOI 10.1016/B978-0-12-407694-5.00003-1; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Pollmann M, 2006, EXP CELL RES, V312, P3241, DOI 10.1016/j.yexcr.2006.06.035; SUPRENANT KA, 1993, J CELL SCI, V104, P445; Mano H, 2008, CANCER SCI, V99, P2349, DOI 10.1111/j.1349-7006.2008.00972.x; Gordon DJ, 2012, NAT REV GENET, V13, P189, DOI 10.1038/nrg3123; Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Aumais JP, 2001, J NEUROSCI, V21, part. no.; Aumais JP, 2003, J CELL SCI, V116, P1991, DOI 10.1242/jcs.00412; Brisch E, 1996, J CELL SCI, V109, P2885; Cai YQ, 2009, CELL RES, V19, P1305, DOI 10.1038/cr.2009.118; Cappello S, 2011, DEV BIOL, V357, P326, DOI 10.1016/j.ydbio.2011.07.001; Eichenmuller B, 2001, CELL MOTIL CYTOSKEL, V50, P161, DOI 10.1002/cm.10002; Elad N, 2011, J CELL SCI, V124, P207, DOI 10.1242/jcs.073486; Esfahani Khashayar, 2014, Front Oncol, V4, P174, DOI 10.3389/fonc.2014.00174; Hamill DR, 1998, J BIOL CHEM, V273, P9285, DOI 10.1074/jbc.273.15.9285; Helmstaedt K, 2008, EUKARYOT CELL, V7, P1041, DOI 10.1128/EC.00071-07; Hueston JL, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-110; LI QW, 1994, J BIOL CHEM, V269, P31777; Morris SM, 1998, CURR BIOL, V8, P603, DOI 10.1016/S0960-9822(98)70232-5; Nishino M, 2006, CURR BIOL, V16, P1414, DOI 10.1016/j.cub.2006.05.052; OSMANI AH, 1990, J CELL BIOL, V111, P543, DOI 10.1083/jcb.111.2.543; Rieder CL, 2005, CHROMOSOMA, V114, P310, DOI 10.1007/s00412-005-0028-2; Riera J, 2009, CELL MOL LIFE SCI, V66, P2383, DOI 10.1007/s00018-009-0025-3; Suprenant KA, 2000, DEV GENES EVOL, V210, P2, DOI 10.1007/PL00008183; Tegha-Dunghu J, 2008, J CELL SCI, V121, P1718, DOI 10.1242/jcs.019174; Wang YC, 2014, CELL CYCLE, V13, DOI 10.4161/cc.29027; Yang YH, 2010, P NATL ACAD SCI USA, V107, P3499, DOI 10.1073/pnas.0914307107; Zhou T, 2003, DEV CELL, V5, P127, DOI 10.1016/S1534-5807(03)00186-2; Zhou TH, 2006, P NATL ACAD SCI USA, V103, P9039, DOI 10.1073/pnas.0602916103	42	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-4101	1551-4005		CELL CYCLE	Cell Cycle	MAY 19	2015	14	10					1529	1539		10.1080/15384101.2015.1026514		11	Cell Biology	Cell Biology	CI6NV	WOS:000354877800011		
J	Okamoto, A; Yabuta, N; Mukai, S; Torigata, K; Nojima, H				Okamoto, Ayumi; Yabuta, Norikazu; Mukai, Satomi; Torigata, Kosuke; Nojima, Hiroshi			Phosphorylation of CHO1 by Lats1/2 regulates the centrosomal activation of LIMK1 during cytokinesis	CELL CYCLE			English	Article						CHO1; LIMK1; Lats1; centrosome; phosphorylation; cytokinesis	KINESIN-LIKE PROTEIN; TUMOR-SUPPRESSOR; AURORA-B; CENTRAL SPINDLE; CELL-CYCLE; COFILIN PHOSPHORYLATION; MIDBODY MATRIX; ANIMAL-CELLS; MITOSIS; PATHWAY	Large tumor suppressor 1 and 2 (Lats1/2) regulate centrosomal integrity, chromosome segregation and cytokinesis. As components of the centralspindlin complex, the kinesin-like protein CHO1 and its splicing variant MKLP1 colocalize with chromosome passenger proteins and GTPases and regulate the formation of the contractile ring and cytokinesis; however, the regulatory mechanisms of CHO1/MKLP1 remain elusive. Here, we show that Lats1/2 phosphorylate Ser716 in the F-actin-interacting region of CHO1, which is absent in MKLP1. Phosphorylated CHO1 localized to the centrosomes and midbody, and the actin polymerization factor LIM-kinase 1 (LIMK1) was identified as its binding partner. Overexpression of constitutively phosphorylated and non-phosphorylated CHO1 altered the mitotic localization and activation of LIMK1 at the centrosomes in HeLa cells, leading to the inhibition of cytokinesis through excessive phosphorylation of Cofilin and mislocalization of Ect2. These results suggest that Lats1/2 stringently control cytokinesis by regulating CHO1 phosphorylation and the mitotic activation of LIMK1 on centrosomes.	[Okamoto, Ayumi; Yabuta, Norikazu; Mukai, Satomi; Torigata, Kosuke; Nojima, Hiroshi] Osaka Univ, Microbial Dis Res Inst, Dept Mol Genet, Suita, Osaka 565, Japan	Yabuta, N (reprint author), Osaka Univ, Microbial Dis Res Inst, Dept Mol Genet, Suita, Osaka 565, Japan.	nyabuta@biken.osaka-u.ac.jp			Kudo Scientific Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported in part by the Kudo Scientific Foundation (to NY), by Grant-in-Aid for Japan Society for the Promotion of Science Fellows (to AO), and by Grants-in-Aid for Scientific Research (C to NY and B to HN) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Amano T, 2002, J BIOL CHEM, V277, P22093, DOI 10.1074/jbc.M201444200; Ritchey L, 2012, CELL CYCLE, V11, P296, DOI 10.4161/cc.11.2.18734; Mishima M, 2002, DEV CELL, V2, P41, DOI 10.1016/S1534-5807(01)00110-1; Adams RR, 1998, GENE DEV, V12, P1483, DOI 10.1101/gad.12.10.1483; Piel M, 2001, SCIENCE, V291, P1550, DOI 10.1126/science.1057330; Yabuta N, 2011, CELL CYCLE, V10, P2724, DOI 10.4161/cc.10.16.16873; Normand G, 2010, ADV EXP MED BIOL, V676, P27; Kim M, 2013, EMBO J, V32, P1543, DOI 10.1038/emboj.2013.102; Yabuta N, 2013, J CELL SCI, V126, P508, DOI 10.1242/jcs.113431; Ganem NJ, 2014, CELL, V158, P833, DOI 10.1016/j.cell.2014.06.029; Khodjakov A, 2001, J CELL BIOL, V153, P237, DOI 10.1083/jcb.153.1.237; Fabbro M, 2005, DEV CELL, V9, P477, DOI 10.1016/j.devcel.2005.09.003; Nishiyama Y, 1999, FEBS LETT, V459, P159, DOI 10.1016/S0014-5793(99)01224-7; Yuce O, 2005, J CELL BIOL, V170, P571, DOI 10.1083/jcb.200501097; Nishimura Y, 2006, J CELL SCI, V119, P104, DOI 10.1242/jcs.02737; Raich WB, 1998, MOL BIOL CELL, V9, P2037; Fededa JP, 2012, NAT CELL BIOL, V14, P440, DOI 10.1038/ncb2482; Yang XL, 2004, NAT CELL BIOL, V6, P609, DOI 10.1038/ncb1140; Glotzer M, 2009, NAT REV MOL CELL BIO, V10, P9, DOI 10.1038/nrm2609; Douglas ME, 2010, CURR BIOL, V20, P927, DOI 10.1016/j.cub.2010.03.055; Aylon Y, 2006, GENE DEV, V20, P2687, DOI 10.1101/gad.1447006; Kuriyama R, 2002, J CELL BIOL, V156, P783, DOI 10.1083/jcb.200109090; Yabuta N, 2007, J BIOL CHEM, V282, P19259, DOI 10.1074/jbc.M608562200; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Chakrabarti R, 2007, CELL CYCLE, V6, P2944; Kaji N, 2003, J BIOL CHEM, V278, P33450, DOI 10.1074/jbc.M305802200; Mardin BR, 2010, NAT CELL BIOL, V12, P1166, DOI 10.1038/ncb2120; Wang WQ, 2008, J CELL SCI, V121, P1334, DOI 10.1242/jcs.018176; Toji S, 2004, GENES CELLS, V9, P383, DOI 10.1111/j.1365-9597.2004.00732.x; Minoshima Y, 2003, DEV CELL, V4, P549, DOI 10.1016/S1534-5807(03)00089-3; NISLOW C, 1992, NATURE, V359, P543, DOI 10.1038/359543a0; Guse A, 2005, CURR BIOL, V15, P778, DOI 10.1016/j.cub.2005.03.041; Joseph N, 2012, EMBO J, V31, P2604, DOI 10.1038/emboj.2012.139; Kaji N, 2008, J BIOL CHEM, V283, P4983, DOI 10.1074/jbc.M708644200; Mashiko D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03355; Matuliene J, 2002, MOL BIOL CELL, V13, P1832, DOI 10.1091/mbc.01-10-0504; Matuliene J, 2004, MOL BIOL CELL, V15, P3083, DOI 10.1091/mbc.E03-12-0888; SELLITTO C, 1988, J CELL BIOL, V106, P431, DOI 10.1083/jcb.106.2.431; Suzuki H, 2013, J CELL SCI, V126, P4358, DOI 10.1242/jcs.125815	40	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-4101	1551-4005		CELL CYCLE	Cell Cycle	MAY 19	2015	14	10					1568	1582		10.1080/15384101.2015.1026489		15	Cell Biology	Cell Biology	CI6NV	WOS:000354877800015		
J	Kasamatsu, A; Takaya, T; Mori, S; Kashio, K; Takahashi, H; Ito, T; Takamine, S; Fujiwara, S; Nishii, T; Kono, AK; Shinke, T; Hirata, K				Kasamatsu, Akira; Takaya, Tomofumi; Mori, Shumpei; Kashio, Kazuhiro; Takahashi, Hachidai; Ito, Tatsuro; Takamine, Sachiko; Fujiwara, Sei; Nishii, Tatsuya; Kono, Atsushi K.; Shinke, Toshiro; Hirata, Ken-ichi			Reconstruction of an Extracardiac Aortocoronary Collateral and Simulation of Selective Angiography With Multidetector-Row Computed Tomography	CIRCULATION			English	Editorial Material							ANASTOMOSES		[Kasamatsu, Akira; Takaya, Tomofumi; Mori, Shumpei; Kashio, Kazuhiro; Takahashi, Hachidai; Ito, Tatsuro; Takamine, Sachiko; Fujiwara, Sei; Shinke, Toshiro; Hirata, Ken-ichi] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Cardiovasc Med,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Nishii, Tatsuya; Kono, Atsushi K.] Kobe Univ, Grad Sch Med, Dept Radiol, Kobe, Hyogo 6500017, Japan	Takaya, T (reprint author), Kobe Univ, Grad Sch Med, Dept Internal Med, Div Cardiovasc Med,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	toto54@hotmail.com		Takaya, Tomofumi/0000-0001-5775-8072			BJORK L, 1966, RADIOLOGY, V87, P274; de Schlichting E, 2015, SURG RADIOL ANAT, V37, P199, DOI 10.1007/s00276-014-1362-y; Dewey M, 2007, EUR HEART J, V28, P18, DOI 10.1093/eurheartj/ehl084; Loukas M, 2011, CLIN ANAT, V24, P137, DOI 10.1002/ca.21088	4	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0009-7322	1524-4539		CIRCULATION	Circulation	MAY 19	2015	131	20					E476	E479		10.1161/CIRCULATIONAHA.114.015137		4	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CI2XC	WOS:000354610300001		
J	Hanc, P; Fujii, T; Iborra, S; Yamada, Y; Huotari, J; Schulz, O; Ahrens, S; Kjaer, S; Way, M; Sancho, D; Namba, K; Sousa, CRE				Hanc, Pavel; Fujii, Takashi; Iborra, Salvador; Yamada, Yurika; Huotari, Jatta; Schulz, Oliver; Ahrens, Susan; Kjaer, Svend; Way, Michael; Sancho, David; Namba, Keiichi; Reis e Sousa, Caetano			Structure of the Complex of F-Actin and DNGR-1, a C-Type Lectin Receptor Involved in Dendritic Cell Cross-Presentation of Dead Cell-Associated Antigens	IMMUNITY			English	Article							ELECTRON CRYOMICROSCOPY; FILAMENTS; BINDING; CLEC9A; MICE; IDENTIFICATION; PROTEINS; AFFINITY; IMMUNITY; SURFACE	DNGR-1 is a C-type lectin receptor that binds F-actin exposed by dying cells and facilitates cross-presentation of dead cell-associated antigens by dendritic cells. Here we present the structure of DNGR-1 bound to F-actin at 7.7 angstrom resolution. Unusually for F-actin binding proteins, the DNGR-1 ligand binding domain contacts three actin subunits helically arranged in the actin filament, bridging over two protofilaments, as well as two neighboring actin subunits along one protofilament. Mutation of residues predicted to mediate ligand binding led to loss of DNGR-1-dependent cross-presentation of dead cell-associated antigens, formally demonstrating that the latter depends on F-actin recognition. Notably, DNGR-1 has relatively modest affinity for F-actin but multivalent interactions allow a marked increase in binding strength. Our findings shed light on modes of actin binding by cellular proteins and reveal how extracellular detection of cytoskeletal components by dedicated receptors allows immune monitoring of loss of cellular integrity.	[Hanc, Pavel; Huotari, Jatta; Schulz, Oliver; Ahrens, Susan; Reis e Sousa, Caetano] Francis Crick Inst, Lincolns Inn Fields Lab, Immunobiol Lab, London WC2A 3LY, England; [Fujii, Takashi; Namba, Keiichi] RIKEN, Quantitat Biol Ctr, Suita, Osaka 5650871, Japan; [Fujii, Takashi; Yamada, Yurika; Namba, Keiichi] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Iborra, Salvador; Sancho, David] Ctr Nacl Invest Cardiovasc Carlos III CNIC, Madrid, Spain; [Kjaer, Svend] Francis Crick Inst, Lincolns Inn Fields Lab, Struct Biol Sci Technol Platform, London WC2A 3LY, England; [Way, Michael] Francis Crick Inst, Lincolns Inn Fields Lab, Cell Motil Lab, London WC2A 3LY, England	Sousa, CRE (reprint author), Francis Crick Inst, Lincolns Inn Fields Lab, Immunobiol Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England.	caetano@crick.ac.uk	Sancho, David/D-3433-2009; Iborra, Salvador /J-2863-2015	Sancho, David/0000-0003-2890-3984; Iborra, Salvador /0000-0002-1607-1749	Cancer Research UK; European Research Council (ERC) [AdG-2010-268670, StG-2010-260414]; JSPS KAKENHI [25000013, 25711010]; CNIC; Spanish Ministry of Economy and Competitiveness [SAF-2013-42920R]	We thank all members of the Immunobiology Laboratory for helpful discussions and suggestions. We thank the Flow Cytometry, Equipment Park, and Structural Biology Science Technology Platforms for assistance. This work was funded by Cancer Research UK, a prize from Fondation Bettencourt-Schueller, and a grant from the European Research Council (ERC Advanced Researcher Grant AdG-2010-268670) to C.R.S., and by JSPS KAKENHI Grant number 25000013 to K.N. and 25711010 to T.F. Work in the D.S. laboratory is funded by the CNIC and grants from the Spanish Ministry of Economy and Competitiveness (SAF-2013-42920R) and the European Research Council (ERC Starting Independent Researcher Grant StG-2010-260414).	Poulin LF, 2012, BLOOD, V119, P6052, DOI 10.1182/blood-2012-01-406967; Abdiche Y, 2008, ANAL BIOCHEM, V377, P209, DOI 10.1016/j.ab.2008.03.035; Iborra S, 2012, J CLIN INVEST, V122, P1628, DOI 10.1172/JCI60660; Dos Remedios CG, 2003, PHYSIOL REV, V83, P433, DOI 10.1152/physrev.00026.2002; Zelenay S, 2012, J CLIN INVEST, V122, P1615, DOI 10.1172/JCI60644; Collins BE, 2004, CURR OPIN CHEM BIOL, V8, P617, DOI 10.1016/j.cbpa.2004.10.004; Caminschi I, 2008, BLOOD, V112, P3264, DOI 10.1182/blood-2008-05-155176; Fujii T, 2010, NATURE, V467, P724, DOI 10.1038/nature09372; Topf M, 2008, STRUCTURE, V16, P295, DOI 10.1016/j.str.2007.11.016; Ahrens S, 2012, IMMUNITY, V36, P635, DOI 10.1016/j.immuni.2012.03.008; Terman JR, 2013, CURR OPIN CELL BIOL, V25, P30, DOI 10.1016/j.ceb.2012.10.009; Sancho D, 2008, J CLIN INVEST, V118, P2098, DOI [10.1172/JCI34584, 10.1172/JCI34S84]; Galkin VE, 2011, P NATL ACAD SCI USA, V108, P20568, DOI 10.1073/pnas.1110109108; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Kitov PI, 2000, NATURE, V403, P669; Huysamen C, 2008, J BIOL CHEM, V283, P16693, DOI 10.1074/jbc.M709923200; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Zelenay S, 2013, TRENDS IMMUNOL, V34, P329, DOI 10.1016/j.it.2013.03.005; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; Rouiller I, 2008, J CELL BIOL, V180, P887, DOI 10.1083/jcb.200709092; Poulin LF, 2010, J EXP MED, V207, P1261, DOI 10.1084/jem.20092618; Zhang JG, 2012, IMMUNITY, V36, P646, DOI 10.1016/j.immuni.2012.03.009; Egelman EH, 2000, ULTRAMICROSCOPY, V85, P225, DOI 10.1016/S0304-3991(00)00062-0; Galkin VE, 2008, J MOL BIOL, V376, P607, DOI 10.1016/j.jmb.2007.12.007; Galkin VE, 2008, P NATL ACAD SCI USA, V105, P1494, DOI 10.1073/pnas.0708667105; Ge P, 2014, NAT STRUCT MOL BIOL, V21, P1075, DOI 10.1038/nsmb.2907; Lilic M, 2003, SCIENCE, V301, P1918, DOI 10.1126/science.1088433; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; Thompson PM, 2014, STRUCTURE, V22, P697, DOI 10.1016/j.str.2014.03.002; WACHSSTOCK DH, 1993, BIOPHYS J, V65, P205	30	1	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 19	2015	42	5					839	849		10.1016/j.immuni.2015.04.009		11	Immunology	Immunology	CI5VH	WOS:000354827400011		
J	Hirahara, K; Onodera, A; Villarino, AV; Bonelli, M; Sciume, G; Laurence, A; Sun, HW; Brooks, SR; Vahedi, G; Shih, HY; Gutierrez-Cruz, G; Iwata, S; Suzuki, R; Mikami, Y; Okamoto, Y; Nakayama, T; Holland, SM; Hunter, CA; Kanno, Y; O'Shea, JJ				Hirahara, Kiyoshi; Onodera, Atsushi; Villarino, Alejandro V.; Bonelli, Michael; Sciume, Giuseppe; Laurence, Arian; Sun, Hong-Wei; Brooks, Stephen R.; Vahedi, Golnaz; Shih, Han-Yu; Gutierrez-Cruz, Gustavo; Iwata, Shigeru; Suzuki, Ryo; Mikami, Yohei; Okamoto, Yoshitaka; Nakayama, Toshinori; Holland, Steven M.; Hunter, Christopher A.; Kanno, Yuka; O'Shea, John J.			Asymmetric Action of STAT Transcription Factors Drives Transcriptional Outputs and Cytokine Specificity	IMMUNITY			English	Article							CD4(+) T-CELLS; INTERFERON-GAMMA; CUTTING EDGE; TH17 CELLS; IL-27; INTERLEUKIN-27; ACTIVATION; RECEPTOR; DIFFERENTIATION; INDUCTION	Interleukin-6 (IL-6) and IL-27 signal through a shared receptor subunit and employ the same downstream STAT transcription proteins, but yet are ascribed unique and overlapping functions. To evaluate the specificity and redundancy for these cytokines, we quantified their global transcriptomic changes and determined the relative contributions of STAT1 and STAT3 using genetic models and chromatin immunoprecipitation- sequencing (ChIP-seq) approaches. We found an extensive overlap of the transcriptomes induced by IL-6 and IL-27 and few examples in which the cytokines acted in opposition. Using STAT-deficient cells and T cells from patients with gain-of-function STAT1 mutations, we demonstrated that STAT3 is responsible for the overall transcriptional output driven by both cytokines, whereas STAT1 is the principal driver of specificity. STAT1 cannot compensate in the absence of STAT3 and, in fact, much of STAT1 binding to chromatin is STAT3 dependent. Thus, STAT1 shapes the specific cytokine signature superimposed upon STAT3's action.	[Hirahara, Kiyoshi; Villarino, Alejandro V.; Bonelli, Michael; Sciume, Giuseppe; Laurence, Arian; Vahedi, Golnaz; Shih, Han-Yu; Iwata, Shigeru; Mikami, Yohei; Kanno, Yuka; O'Shea, John J.] NIAMS, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA; [Sun, Hong-Wei; Brooks, Stephen R.] NIAMS, Biodata Min & Discovery Sect, NIH, Bethesda, MD 20892 USA; [Gutierrez-Cruz, Gustavo] NIAMS, Lab Muscle Stem Cells & Gene Regulat, NIH, Bethesda, MD 20892 USA; [Suzuki, Ryo] NIAMS, Lab Mol Immunogenet, NIH, Bethesda, MD 20892 USA; [Holland, Steven M.] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Hunter, Christopher A.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Hirahara, Kiyoshi] Chiba Univ, Grad Sch Med, Dept Adv Allergol Airway, Chiba 2608670, Japan; [Onodera, Atsushi; Nakayama, Toshinori] Chiba Univ, Grad Sch Med, Dept Immunol, Chiba 2608670, Japan; [Okamoto, Yoshitaka] Chiba Univ, Grad Sch Med, Dept Otorhinolaryngol, Chiba 2608670, Japan; [Nakayama, Toshinori] Core Res Evolut Sci & Technol, Japan Sci & Technol Agcy, Chiba, Chiba 2608670, Japan	Kanno, Y (reprint author), NIAMS, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA.	kannoy@mail.nih.gov; osheaj@arb.niams.nih.gov	Laurence, Arian/A-8770-2009; 	Laurence, Arian/0000-0003-0942-8292; Villarino, Alejandro/0000-0001-8068-2176; Kanno, Yuka/0000-0001-5668-9319	Intramural Research Programs of NIAMS; Ministry of Education, Culture, Sports, Science and Technology (Japan) [25893032]; Astellas Foundation for Research on Metabolic Disorders; Uehara Memorial Foundation; Osaka Foundation for Promotion of Fundamental Medical Research; Kanae Foundation for the Promotion of Medical Science; Takeda Science Foundation	We thank J. Simone, J. Lay (Flow Cytometry Section, NIAMS), and the NIAMS LACU staff for their excellent technical support. This study utilized the high-performance computational capabilities of the Helix Systems at the NIH. This work was supported by the Intramural Research Programs of NIAMS, grant from the Ministry of Education, Culture, Sports, Science and Technology (Japan; Grants-in-Aid for Research Activity start-up #25893032), The Astellas Foundation for Research on Metabolic Disorders, The Uehara Memorial Foundation, Osaka Foundation for Promotion of Fundamental Medical Research, Kanae Foundation for the Promotion of Medical Science, and Takeda Science Foundation (K.H.).	Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Qiao Y, 2013, IMMUNITY, V39, P454, DOI 10.1016/j.immuni.2013.08.009; Villarino A, 2003, IMMUNITY, V19, P645, DOI 10.1016/S1074-7613(03)00300-5; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Schiavone D, 2011, FEBS LETT, V585, P2455, DOI 10.1016/j.febslet.2011.06.020; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Qing YL, 2004, J BIOL CHEM, V279, P41679, DOI 10.1074/jbc.M406413200; Villarino AV, 2010, J IMMUNOL, V185, P6461, DOI 10.4049/jimmunol.1001343; Young A, 2012, J IMMUNOL, V189, P2079, DOI 10.4049/jimmunol.1200131; Takeda K, 1998, J IMMUNOL, V161, P4652; TAGA T, 1989, CELL, V58, P573, DOI 10.1016/0092-8674(89)90438-8; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Hibbert L, 2003, J INTERF CYTOK RES, V23, P513, DOI 10.1089/10799900360708632; Trapnell C, 2009, NAT BIOTECHNOL, V27, P455, DOI 10.1038/nbt0509-455; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Rincon M, 1997, J EXP MED, V185, P461, DOI 10.1084/jem.185.3.461; Diveu C, 2009, J IMMUNOL, V182, P5748, DOI 10.4049/jimmunol.0801162; Hirahara K, 2012, IMMUNITY, V36, P1017, DOI 10.1016/j.immuni.2012.03.024; Regis G, 2008, SEMIN CELL DEV BIOL, V19, P351, DOI 10.1016/j.semcdb.2008.06.004; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Takeda A, 2003, J IMMUNOL, V170, P4886; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Lee CK, 2002, IMMUNITY, V17, P63, DOI 10.1016/S1074-7613(02)00336-9; Gil MP, 2001, P NATL ACAD SCI USA, V98, P6680, DOI 10.1073/pnas.111163898; Imielinski M, 2009, NAT GENET, V41, P1335, DOI 10.1038/ng.489; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; Roychoudhuri R, 2013, NATURE, V498, P506, DOI 10.1038/nature12199; Whitmarsh RJ, 2011, CELL HOST MICROBE, V10, P224, DOI 10.1016/j.chom.2011.07.009; Hunter CA, 2012, IMMUNITY, V37, P960, DOI 10.1016/j.immuni.2012.11.003; Pot C, 2011, SEMIN IMMUNOL, V23, P438, DOI 10.1016/j.smim.2011.08.003; Costa-Pereira AP, 2002, P NATL ACAD SCI USA, V99, P8043, DOI 10.1073/pnas.122236099; Pflanz S, 2004, J IMMUNOL, V172, P2225; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Gil MP, 2012, BLOOD, V120, P3718, DOI 10.1182/blood-2012-05-428672; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Suto A, 2008, J EXP MED, V205, P1369, DOI 10.1084/jem.20072057; Diehl S, 2000, IMMUNITY, V13, P805, DOI 10.1016/S1074-7613(00)00078-9; Gorissen M, 2011, J ENDOCRINOL, V209, P175, DOI 10.1530/JOE-11-0033; Hu XY, 2002, NAT IMMUNOL, V3, P859, DOI 10.1038/ni828; Huang N, 2008, DNA CELL BIOL, V27, P527, DOI 10.1089/dna.2007.0715; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liongue C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032777; Lucas S, 2003, P NATL ACAD SCI USA, V100, P15047, DOI 10.1073/pnas.2536517100; Miyagi T, 2007, J EXP MED, V204, P2383, DOI 10.1084/jem.20070401; PAUL WE, 1989, CELL, V57, P521, DOI 10.1016/0092-8674(89)90121-9; van de Veerdonk FL, 2011, NEW ENGL J MED, V365, P54, DOI 10.1056/NEJMoa1100102; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	50	3	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 19	2015	42	5					877	889		10.1016/j.immuni.2015.04.014		13	Immunology	Immunology	CI5VH	WOS:000354827400014		
J	Ryu, E; Hyun, SS; Shim, C				Ryu, Eunju; Hyun, Sunghyup Sean; Shim, Changsup			Creating New Relationships Through Tourism: A Qualitative Analysis of Tourist Motivations of Older Individuals in Japan	JOURNAL OF TRAVEL & TOURISM MARKETING			English	Article						touristic communitas; liminality; tourist motivations; human relationships; Older individuals in Japan	DESTINATION LOYALTY; TRAVEL MOTIVATION; MODEL; SATISFACTION; AUTHENTICITY; EXPERIENCE; FESTIVAL; SENIORS; FUTURE; MARKET	The current study is an exploration to examine older Japanese individuals' motivations for travel. The study employed an open-ended survey and in-depth interviews in order to gain insight into the creation of human relationships through tourism. Our results show that tourism is perceived as offering extraordinary opportunities to meet new people, and to form and develop new relationships by Japanese older individuals, who experience fewer opportunities to interact with other people in their everyday lives compared to individuals in younger generations. In particular, distinct features of tourism settings, such as liminality and touristic communitas, allow older tourists to express themselves more freely by escaping from their existing relationships as well as from many social norms, hierarchies, and prohibitions.	[Ryu, Eunju] Rikkyo Univ, Dept Tourism, Niiza, Saitama 3528558, Japan; [Hyun, Sunghyup Sean] Pusan Natl Univ, Dept Tourism & Convent, Busan 609735, South Korea; [Shim, Changsup] Kadir Has Univ, Istanbul Studies Ctr, TR-34083 Istanbul, Turkey	Ryu, E (reprint author), Kadir Has Univ, Istanbul Studies Ctr, D Block,2nd Floor,Room 020,Kadir Has St, TR-34083 Istanbul, Turkey.	juya1650@hotmail.co.jp; shyun@pusan.ac.kr; tourism80@gmail.com					Andreu L., 2005, Journal of Travel & Tourism Marketing, V19, P1, DOI 10.1300/J073v19n01_01; Annear MJ, 2009, HEALTH PLACE, V15, P482, DOI 10.1016/j.healthplace.2008.09.005; Bansal H, 2004, TOURISM MANAGE, V25, P387, DOI 10.1016/S0261-5177(03)00135-3; Park KS, 2008, J TRAVEL TOUR MARK, V25, P161, DOI 10.1080/10548400802402883; Jang SC, 2006, TOURISM MANAGE, V27, P306, DOI 10.1016/j.tourman.2004.11.006; Hsu CHC, 2007, TOURISM MANAGE, V28, P1262, DOI 10.1016/j.tourinan.2006.09.015; Fleischer A, 2002, ANN TOURISM RES, V29, P106, DOI 10.1016/S0160-7383(01)00026-3; Huang L, 2003, TOURISM MANAGE, V24, P561, DOI 10.1016/S0261-5177(03)00008-6; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Crompton JL, 1997, ANN TOURISM RES, V24, P425, DOI 10.1016/S0160-7383(97)80010-2; Wang N, 1999, ANN TOURISM RES, V26, P349, DOI 10.1016/S0160-7383(98)00103-0; Jang SS, 2009, J HOSP TOUR RES, V33, P51, DOI 10.1177/1096348008329666; Prayag G, 2012, J TRAVEL TOUR MARK, V29, P665, DOI 10.1080/10548408.2012.720153; Kim K, 2008, J TRAVEL TOUR MARK, V24, P297, DOI 10.1080/10548400802156802; Yoon Y, 2005, TOURISM MANAGE, V26, P45, DOI 10.1016/j.tourman.2003.08.016; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Muramatsu N, 2011, GERONTOLOGIST, V51, P425, DOI 10.1093/geront/gnr067; Kim H, 2007, ANN TOURISM RES, V34, P181, DOI 10.1016/j.annals.2006.07.009; Uriely N, 2005, ANN TOURISM RES, V32, P199, DOI 10.1016/j.annals.2004.07.008; Backman K. F., 1999, J TOURISM RECREATION, V24, P13; Baloglu S., 1999, Journal of Travel & Tourism Marketing, V8, P81; Cabinet Office, 2012, AG SCO WHIT PAP; Cleaver M., 1999, Tourism Recreation Research, V24, P5; Dann G. M. S., 1981, Annals of Tourism Research, V8, P187, DOI 10.1016/0160-7383(81)90082-7; Dey I, 1993, QUALITATIVE DATA ANA; Fromm E., 1941, ESCAPE FREEDOM; Gorman M., 1999, AGEING DEV REPORT PO, P3; Greenberg G. M., 1999, CHOICE, V36, P662; Horneman L., 2002, Journal of Travel Research, V41, P23, DOI 10.1177/0047287502041001004; Ichihara H., 2003, PSYCHOL OF AGING; Jang SooCheong [Jang S. C. S. ], 2002, Journal of Travel & Tourism Marketing, V13, P111, DOI 10.1300/J073v13n03_06; Japan Association of Travel Agents, 2011, NUMB TRAV IND 2011; Japan Travel Bureau Foundation, 2010, TRENDS TRAV CHANG TR; Lietner M., 2004, LEISURE LATER LIFE; FODNESS D, 1994, ANN TOURISM RES, V21, P555, DOI 10.1016/0160-7383(94)90120-1; MacMillan D, 1996, J COMMUNITY PSYCHOL, V24, P315, DOI [10.1002/(SICI)1520-6629(199610)24:4<lessthan>315::AID-JCOP2<greaterthan>3.0.CO;2-T, DOI 10.1002/(SICI)1520-6629(199610)24:4<LESSTHAN>315::AID-JCOP2<GREATERTHAN>3.0.CO;2-T]; Mitani Y., 2006, J NAGOYA WOMENS U, V52, P1; Morse J. M., 2002, HDB INTERVIEW RES CO; Murphy L., 2007, Journal of Travel & Tourism Marketing, V22, P45, DOI 10.1300/J073v22n02_04; National Institute of Population and Social Security Research, 2010, HOUS PROJ JAP 2005 2; Norman W. C., 2001, Journal of Hospitality & Leisure Marketing, V8, P113, DOI 10.1300/J150v08n03_08; Oh H., 1995, ANN TOURISM RES, V6, P195; Orimo H, 2006, GERIATR GERONTOL INT, V6, P149, DOI DOI 10.1111/J.1447-0594.2006.00341.X; Patton M. Q., 1990, QUALITATIVE EVALUATI; Pearce F., 2010, COMING POPULATION CR; Reece W. S., 2004, Journal of Travel Research, V43, P11, DOI 10.1177/0047287504265507; ROEBUCK J, 1979, J SOC HIST, V12, P416; Shoemaker S., 2000, Journal of Travel Research, V39, P11; Shoemaker S., 1989, Journal of Travel Research, V27, P14, DOI 10.1177/004728758902700304; Statistics Bureau of Japan, 2012, JAP STAT YB 2012; Stone G. J., 1999, Journal of Vacation Marketing, V5, P7, DOI 10.1177/135676679900500102; Thane P., 1989, SOC HIST MED, V2, P93, DOI 10.1093/shm/2.1.93; Tohoku Regional Advancement Center, 2006, RES NEW MARK EXPL DA; Turner V., 1973, HIST RELIGIONS, V12, P191, DOI 10.1086/462677; United Nations Population Division, 2011, WORLD POP PROSP 2010; Urry John, 1990, TOURIST GAZE LEISURE; Wuest B., 2001, Journal of Hospitality & Leisure Marketing, V8, P85, DOI 10.1300/J150v08n03_06; You XinRan, 1999, Tourism Recreation Research, V24, P23; Yu E. J, 2012, NE ASIA TOURISM RES, V8, P49; Zhang Y., 2009, APPL SOCIAL RES METH	60	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	1054-8408	1540-7306		J TRAVEL TOUR MARK	J. Travel Tour. Mark.	MAY 19	2015	32	4					325	338		10.1080/10548408.2014.895478		14	Hospitality, Leisure, Sport & Tourism	Social Sciences - Other Topics	CI9QG	WOS:000355104200001		
J	Oke, Y; Boiroux, D; Miwakeichi, F; Oku, Y				Oke, Yoshihiko; Boiroux, Dimitri; Miwakeichi, Fumikazu; Oku, Yoshitaka			Stochastic activation among inspiratory cells in the pre-Botzinger complex of the rat medulla revealed by Ca2+ imaging	NEUROSCIENCE LETTERS			English	Article						Pre-Botzinger complex; Calcium imaging; Activation sequence; Rhythmic neuronal activity	RESPIRATORY RHYTHM; IN-VITRO; INTERNEURONS; PACEMAKER; NETWORK	In the pre-Botzinger complex of the ventral medulla (preBotC), a variable pattern of inspiratory neuronal output and synchronous activation of inspiratory cells can be observed. However, it is not well known whether cellular activation patterns among inspiratory cells are variable or fixed. Here, we evaluated the activation sequence of inspiratory cells during individual rhythmic bursts using calcium imaging. Onset timing and peak timing of calcium fluctuations during rhythmic bursts in individual inspiratory cells were used to evaluate the activation sequence. The sequences of both timings changed stochastically in individual rhythmic bursts, although the sequences differed between the two timings even within the same rhythmic burst. The weak correlation between these two timings might indicate that the two parameters reflect different physiological events. Furthermore, a subset of inspiratory cells was found to initially activate in the sequences of successive rhythmic bursts. These results suggest that rhythmic activation of inspiratory cells occurs with a degree of loose regularity but is not invariable with respect to the sequence of either onset or peak timing. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Oke, Yoshihiko; Boiroux, Dimitri; Oku, Yoshitaka] Hyogo Coll Med, Div Physiome, Dept Physiol, Nishinomiya, Hyogo 6638501, Japan; [Miwakeichi, Fumikazu] Inst Stat Math, Dept Stat Modeling, Tachikawa, Tokyo 1908562, Japan; [Miwakeichi, Fumikazu] Grad Univ Adv Studies, Sch Multidisciplinary Sci, Dept Stat Sci, Tachikawa, Tokyo 1908562, Japan	Oke, Y (reprint author), Hyogo Coll Med, Div Physiome, Dept Physiol, Mukogawacho 1-1, Nishinomiya, Hyogo 6638501, Japan.	okey1@hyo-med.ac.jp			Japan Society for Promotion of Science [26280109]; JST Strategic Japanese-German Cooperative Program in Computational Neuroscience	This study was supported by a Grant-in-Aid for Scientific Research B (26280109) from the Japan Society for Promotion of Science and the JST Strategic Japanese-German Cooperative Program in Computational Neuroscience.	Koshiya N, 1999, NATURE, V400, P360, DOI 10.1038/22540; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; Morgado-Valle C, 2010, J NEUROSCI, V30, P3634, DOI 10.1523/JNEUROSCI.3040-09.2010; Hartelt N, 2008, MOL CELL NEUROSCI, V37, P425, DOI 10.1016/j.mcn.2007.10.011; Boiroux D, 2014, J NEUROSCI METH, V237, P60, DOI 10.1016/j.jneumeth.2014.08.008; Carroll M.S., 2013, J NEUROPHYSIOL, V109; Feldman JL, 2006, NAT REV NEUROSCI, V7, P232, DOI 10.1038/nrn1871; Hayes JA, 2012, P NATL ACAD SCI USA, V109, P8286, DOI 10.1073/pnas.1200912109; Koizumi H, 2013, J NEUROSCI, V33, P2994, DOI 10.1523/JNEUROSCI.4427-12.2013; Okada Y, 2012, J PHYSIOL-LONDON, V590, P4933, DOI 10.1113/jphysiol.2012.231464; RICHERSON GB, 1995, EXP NEUROL, V131, P133, DOI 10.1016/0014-4886(95)90015-2; Ruangkittisakul A, 2008, J NEUROSCI, V28, P2447, DOI 10.1523/JNEUROSCI.1926-07.2008; Sasaki T, 2007, J NEUROSCI, V27, P517, DOI 10.1523/JNEUROSCI.4514-06.2007; Schnell C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026309	14	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	MAY 19	2015	595						12	17		10.1016/j.neulet.2015.04.003		6	Neurosciences	Neurosciences & Neurology	CI8NU	WOS:000355029800003		
J	Nishino, H; Watanabe, H; Kamimura, I; Yokohari, F; Mizunami, M				Nishino, Hiroshi; Watanabe, Hidehiro; Kamimura, Itsuro; Yokohari, Fumio; Mizunami, Makoto			Coarse topographic organization of pheromone-sensitive afferents from different antennal surfaces in the American cockroach	NEUROSCIENCE LETTERS			English	Article						Insects; Olfactory afferents; Glomerulus; Topographic map; Sex pheromone; Antenna	PERIPLANETA-AMERICANA; RECEPTOR NEURONS; LOBE; INSECTS; INFORMATION; PROJECTIONS; VERTEBRATES; COMPONENTS; GLOMERULI; PATTERNS	In contrast to visual, auditory, taste, and mechanosensory neuropils, in which sensory afferents are topographically organized on the basis of their peripheral soma locations, axons of cognate sensory neurons from different locations of the olfactory sense organ converge onto a small spherical neuropil (glomerulus) in the first-order olfactory center. In the cockroach Periplaneta americana, sex pheromone-sensitive afferents with somata in the antero-dorsal and postero-ventral surfaces of a long whip-like antenna are biased toward the anterior and posterior regions of a macroglomerulus, respectively. In each region, afferents with somata in the more proximal antenna project to more proximal region, relative to the axonal entry points. However, precise topography of afferents in the macroglomerulus has remained unknown. Using single and multiple neuronal stainings, we showed that afferents arising from anterior, dorsal, ventral and posterior surfaces of the proximal regions of an antenna were biased progressively from the anterior to posterior region of the macroglomerulus, reflecting chiasmatic axonal re-arrangements that occur immediately before entering the antennal lobe. Morphologies of individual afferents originating from the proximal antenna matched results of mass neuronal stainings, but their three-dimensional origins in the antenna were hardly predictable on the basis of the projection patterns. Such projection biases made by neuronal populations differ from strict somatotopic projections of antennal mechanosensory neurons in the same species, suggesting a unique sensory mechanism to process information about odor location and direction on a single antenna. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Nishino, Hiroshi] Hokkaido Univ, Res Inst Elect Sci, Sapporo, Hokkaido 0600812, Japan; [Watanabe, Hidehiro; Yokohari, Fumio] Fukuoka Univ, Fac Sci, Fukuoka 8140180, Japan; [Kamimura, Itsuro] Maxnet Co Ltd, Tokyo 1640001, Japan; [Mizunami, Makoto] Hokkaido Univ, Fac Sci, Sapporo, Hokkaido 0600810, Japan	Nishino, H (reprint author), Hokkaido Univ, Res Inst Elect Sci, Sapporo, Hokkaido 0600812, Japan.	nishino@es.hokudai.ac.jp			Ministry of Education, Science, Technology, Sports and Culture of Japan [26440175]	This work was supported by a grant from the Ministry of Education, Science, Technology, Sports and Culture of Japan to H.N. (Grant number: 26440175).	Ai H, 2004, J EXP BIOL, V207, P633, DOI 10.1242/jeb.00784; Kay LM, 2006, SEMIN CELL DEV BIOL, V17, P433, DOI 10.1016/j.semcdb.2006.04.012; SCHALLER D, 1978, CELL TISSUE RES, V191, P121; Nishino H, 2009, NEUROSCI LETT, V462, P219, DOI 10.1016/j.neulet.2009.07.012; Crimaldi JP, 2001, EXP FLUIDS, V31, P90, DOI 10.1007/s003480000263; Nishino H, 2005, J COMP NEUROL, V493, P291, DOI 10.1002/cne.20757; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Koehl MAR, 2001, SCIENCE, V294, P1948, DOI 10.1126/science.1063724; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; Wilson RI, 2013, ANNU REV NEUROSCI, V36, P217, DOI 10.1146/annurev-neuro-062111-150533; BACON JP, 1977, BRAIN RES, V138, P359, DOI 10.1016/0006-8993(77)90753-3; Berg BG, 2005, J COMP NEUROL, V486, P209, DOI 10.1002/cne.20544; BURROWS M, 1982, J COMP PHYSIOL, V145, P447; Carde RT, 2008, J CHEM ECOL, V34, P854, DOI 10.1007/s10886-008-9484-5; CHRISTENSEN TA, 1995, CHEM SENSES, V20, P313, DOI 10.1093/chemse/20.3.313; KANDEL E., 2012, PRINCIPLES NEURAL SC; Nishino H, 2007, NEUROREPORT, V18, P1765; SASS H, 1983, J COMP PHYSIOL, V152, P309; SEELINGER G, 1985, ANIM BEHAV, V33, P591, DOI 10.1016/S0003-3472(85)80083-X; Tabuchi R., 2013, P NATL ACAD SCI USA, V110, P15455; Watanabe H, 2012, J COMP NEUROL, V520, P1687, DOI 10.1002/cne.23007	21	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	MAY 19	2015	595						35	40		10.1016/j.neulet.2015.04.006		6	Neurosciences	Neurosciences & Neurology	CI8NU	WOS:000355029800007		
J	Xu, MY; Li, LN; Ohtsu, H; Pittenger, C				Xu, Meiyu; Li, Lina; Ohtsu, Hiroshi; Pittenger, Christopher			Histidine decarboxylase knockout mice, a genetic model of Tourette syndrome, show repetitive grooming after induced fear	NEUROSCIENCE LETTERS			English	Article						Tourette syndrome; Histidine decarboxylase; Histamine; Stress; Stereotypical behavior; Tics	OBSESSIVE-COMPULSIVE DISORDER; ANIMAL-MODELS; HISTAMINE; BEHAVIORS; STRESS; INHIBITION; STRIATUM; CHILDREN; MEMORY; LONG	Tics, such as are seen in Tourette syndrome (TS), are common and can cause profound morbidity, but they are poorly understood. Tics are potentiated by psychostimulants, stress, and sleep deprivation. Mutations in the gene histidine decarboxylase (Hdc) have been implicated as a rare genetic cause of TS, and Hdc knockout mice have been validated as a genetic model that recapitulates phenomenological and pathophysiological aspects of the disorder. Tic-like stereotypies in this model have not been observed at baseline but emerge after acute challenge with the psychostimulant n-amphetamine. We tested the ability of an acute stressor to stimulate stereotypies in this model, using tone fear conditioning. Hdc knockout mice acquired conditioned fear normally, as manifested by freezing during the presentation of a tone 48 h after it had been paired with a shock. During the 30 min following tone presentation, knockout mice showed increased grooming. Heterozygotes exhibited normal freezing and intermediate grooming. These data validate a new paradigm for the examination of tic-like stereotypies in animals without pharmacological challenge and enhance the face validity of the Hdc knockout mouse as a pathophysiologically grounded model of tic disorders. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Xu, Meiyu; Li, Lina; Pittenger, Christopher] Yale Univ, Dept Psychiat, New Haven, CT 06519 USA; [Ohtsu, Hiroshi] Tohoku Univ, Grad Sch Engn, Sendai, Miyagi 980, Japan; [Pittenger, Christopher] Yale Univ, Dept Psychol, New Haven, CT 06519 USA; [Pittenger, Christopher] Yale Univ, Ctr Child Study, New Haven, CT 06519 USA; [Pittenger, Christopher] Yale Univ, Interdept Neurosci Program, New Haven, CT 06519 USA	Pittenger, C (reprint author), Yale Univ, Sch Med, 34 Pk St,W315, New Haven, CT 06519 USA.	Christopher.pittenger@yale.edu			Allison Family Foundation; NIH [R01MH091861]; Tourette Syndrome Association; State of Connecticut through Ribicoff Research Facilities at the Connecticut Mental Health Center	The authors gratefully acknowledge Stacey Wilber for genotyping and mouse colony maintenance. This work was supported by the Allison Family Foundation (CP), NIH grant R01MH091861 (CP), the Tourette Syndrome Association (MX), and the State of Connecticut through its support of the Ribicoff Research Facilities at the Connecticut Mental Health Center.	Denys D, 2013, EUR NEUROPSYCHOPHARM, V23, P1423, DOI 10.1016/j.euroneuro.2013.05.012; Saka E, 2004, J NEUROSCI, V24, P7557, DOI 10.1523/JNEUROSCI.1072-04.2004; Ellender TJ, 2011, J NEUROSCI, V31, P15340, DOI 10.1523/JNEUROSCI.3144-11.2011; Lin HQ, 2007, J CHILD PSYCHOL PSYC, V48, P157, DOI 10.1111/j.1469-7610.2006.01687.x; Roessner V, 2011, EUR CHILD ADOLES PSY, V20, P173, DOI 10.1007/s00787-011-0163-7; Leckman JF, 2010, J CHILD ADOL PSYCHOP, V20, P237, DOI 10.1089/cap.2009.0118; Ercan-Sencicek AG, 2010, NEW ENGL J MED, V362, P1901, DOI 10.1056/NEJMoa0907006; Pittenger C, 2002, NEURON, V34, P447, DOI 10.1016/S0896-6273(02)00684-0; Krusong K, 2011, NEUROSCI LETT, V495, P110, DOI 10.1016/j.neulet.2011.03.050; Wong DF, 2008, NEUROPSYCHOPHARMACOL, V33, P1239, DOI 10.1038/sj.npp.1301528; Wang ZS, 2011, AM J PSYCHIAT, V168, P1326, DOI 10.1176/appi.ajp.2011.09111692; Ohtsu H, 2001, FEBS LETT, V502, P53, DOI 10.1016/S0014-5793(01)02663-1; Liu LY, 2007, HIPPOCAMPUS, V17, P634, DOI 10.1002/hipo.20305; Swerdlow NR, 2013, NEUROSCI BIOBEHAV R, V37, P1150, DOI 10.1016/j.neubiorev.2012.09.002; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104; Karagiannidis I, 2013, J MED GENET, V50, P760, DOI 10.1136/jmedgenet-2013-101637; Leckman JF, 2002, LANCET, V360, P1577, DOI 10.1016/S0140-6736(02)11526-1; Haas HL, 2008, PHYSIOL REV, V88, P1183, DOI 10.1152/physrev.00043.2007; Bloch Michael H, 2008, Curr Psychiatry Rep, V10, P323, DOI 10.1007/s11920-008-0052-z; Bornstein R A, 1990, J Neuropsychiatry Clin Neurosci, V2, P275; Buse J, 2014, BEHAV MODIF, V38, P184, DOI 10.1177/0145445514522056; Castellan Baldan Lissandra, 2014, Neuron, V81, P77, DOI 10.1016/j.neuron.2013.10.052; Cauchi RJ, 2012, TRANSL NEUROSCI, V3, P153, DOI 10.2478/s13380-012-0020-2; Davis LK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003864; Dere E, 2004, EUR J NEUROSCI, V20, P1051, DOI 10.1111/j.1460-9568.2004.03546.x; Fernandez T., 2015, NEUROGENETICS HDB CL; Fernandez TV, 2012, BIOL PSYCHIAT, V71, P392, DOI 10.1016/j.biopsych.2011.09.034; Godar SC, 2014, J NEUROSCI METH, V238, P54, DOI 10.1016/j.jneumeth.2014.09.008; Gong YX, 2010, ACTA PHARMACOL SIN, V31, P1431, DOI 10.1038/aps.2010.136; JOSHI VV, 1981, EUR J PHARMACOL, V69, P499, DOI 10.1016/0014-2999(81)90456-8; Kurlan R, 2010, NEW ENGL J MED, V363, P2332, DOI 10.1056/NEJMcp1007805; Macri S, 2013, NEUROSCI BIOBEHAV R, V37, P1085, DOI 10.1016/j.neubiorev.2013.03.014; State MW, 2011, CURR OPIN GENET DEV, V21, P302, DOI 10.1016/j.gde.2011.01.007; Paul Varghese N., 2000, Indian Journal of Experimental Biology, V38, P988; Pittenger C., 2014, ANIMAL MODELS MOVEME; Pittenger C., 2014, ANIMAL MODELS MOVEME, P748; Rapanelli M, 2014, EUR NEUROPSYCHOPHARM, V24, P1896, DOI 10.1016/j.euroneuro.2014.10.007; Reese HE, 2015, J PSYCHOSOM RES, V78, P293, DOI 10.1016/j.jpsychores.2014.08.001; Scahill L, 2001, Adv Neurol, V85, P261; Scharf JM, 2012, J AM ACAD CHILD PSY, V51, P192, DOI 10.1016/j.jaac.2011.11.004; Shmelkov SV, 2010, NAT MED, V16, P602; Williams K., 2013, NEUROBIOLOGY MENTAL, Vfourth	42	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	MAY 19	2015	595						50	53		10.1016/j.neulet.2015.03.067		4	Neurosciences	Neurosciences & Neurology	CI8NU	WOS:000355029800010		
J	Tamura, A; Matsunobu, T; Mizutari, K; Niwa, K; Kurioka, T; Kawauchi, S; Satoh, S; Hiroi, S; Satoh, Y; Nibuya, M; Tamura, R; Shiotani, A				Tamura, Atsushi; Matsunobu, Takeshi; Mizutari, Kunio; Niwa, Katsuki; Kurioka, Takaomi; Kawauchi, Satoko; Satoh, Shunichi; Hiroi, Sadayuki; Satoh, Yasushi; Nibuya, Masashi; Tamura, Risa; Shiotani, Akihiro			Low-level laser therapy for prevention of noise-induced hearing loss in rats	NEUROSCIENCE LETTERS			English	Article						Low-level laser therapy; Noise-induced hearing loss; Inducible nitric oxide synthase; Cleaved caspase-3	NITRIC-OXIDE; LIGHT THERAPY; GROWTH-FACTOR; BLOOD-FLOW; INNER-EAR; COCHLEA; IRRADIATION; EXPRESSION	Noninvasive low-level laser therapy (LLLT) is neuroprotective, but the mechanism of this effect is not fully understood. In this study, the use of LLLT as a novel treatment for noise-induced hearing loss (NIHL). is investigated. Sprague-Dawley rats were exposed to intense noise and their right ears were irradiated with an 808 nm diode laser at an output power density of 110 or 165 mW/cm(2) for a 30 min period for 5 consecutive days. Measurement of the auditory brainstem response revealed an accelerated recovery of auditory function in the groups treated with LLLT compared with the non-treatment group at days 2, 4, 7 and 14 after noise exposure. Morphological observations also revealed a significantly higher outer hair cell survival rate in the LLLT groups. Immunohistochemical analyses for inducible nitric oxide synthase (iNOS) and cleaved caspase-3 were used to examine oxidative stress and apoptosis. Strong immunoreactivities were observed in the inner ear tissues of the non-treatment group, whereas these signals were decreased in the LLLT group at 165 mW/cm(2) power density. Our findings suggest that LLLT has cytoprotective effects against NIHL via the inhibition of iNOS expression and apoptosis. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Tamura, Atsushi; Matsunobu, Takeshi; Mizutari, Kunio; Niwa, Katsuki; Kurioka, Takaomi; Shiotani, Akihiro] Natl Def Med Coll, Dept Otolaryngol Head & Neck Surg, Tokorozawa, Saitama 3590042, Japan; [Kawauchi, Satoko; Satoh, Shunichi] Natl Def Med Coll, Res Inst, Div Biomed Informat Sci, Tokorozawa, Saitama 3590042, Japan; [Hiroi, Sadayuki] Natl Def Med Coll, Dept Pathol & Lab Med, Tokorozawa, Saitama 3590042, Japan; [Satoh, Yasushi] Natl Def Med Coll, Dept Anesthesiol, Tokorozawa, Saitama 3590042, Japan; [Nibuya, Masashi] Natl Def Med Coll, Dept Psychiat, Tokorozawa, Saitama 3590042, Japan; [Tamura, Risa] Natl Def Med Coll, Dept Physiol, Tokorozawa, Saitama 3590042, Japan	Matsunobu, T (reprint author), Natl Def Med Coll, Dept Otolaryngol Head & Neck Surg, 3-2 Namiki, Tokorozawa, Saitama 3590042, Japan.	t-matsunobu@shin-tokyohospital.or.jp					Ohinata Y, 2000, BRAIN RES, V878, P163, DOI 10.1016/S0006-8993(00)02733-5; Uozumi Y, 2010, LASER SURG MED, V42, P566, DOI 10.1002/lsm.20938; Huang YY, 2009, DOSE-RESPONSE, V7, P358, DOI 10.2203/dose-response.09-027.Hamblin; Ohlemiller KK, 1999, AUDIOL NEURO-OTOL, V4, P229, DOI 10.1159/000013846; Streeter J, 2004, MITOCHONDRION, V4, P569, DOI 10.1016/j.mito.2004.07.037; AXELSSON A, 1987, HEARING RES, V31, P183, DOI 10.1016/0378-5955(87)90125-0; Nicotera TM, 2003, JARO-J ASSOC RES OTO, V4, P466, DOI 10.1007/s10162-002-3038-2; Conlan MJ, 1996, J CLIN PERIODONTOL, V23, P492, DOI 10.1111/j.1600-051X.1996.tb00580.x; Gomes LEA, 2012, PHOTOMED LASER SURG, V30, P642, DOI 10.1089/pho.2012.3242; Hsu WC, 2004, ACTA OTO-LARYNGOL, V124, P459, DOI 10.1080/00016480310000584; HULTCRANTZ E, 1979, ARCH OTO-RHINO-LARYN, V224, P103, DOI 10.1007/BF00455231; Inai S, 2012, J NIPPON MED SCH, V79, P121; Leung MCP, 2002, LASER SURG MED, V31, P283, DOI 10.1002/lsm.10096; Masuda M, 2006, BRAIN RES, V1068, P237, DOI 10.1016/j.brainres.2005.11.020; Rhee CK, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.6.068002; Salahaldin A. H., 2012, ISRN OTOLARYNGOL, V2012; Takumida M, 2002, CURR OPIN NEUROL, V15, P11, DOI 10.1097/00019052-200202000-00003; Takumida M, 2001, ACTA OTO-LARYNGOL, V121, P16, DOI 10.1080/000164801300006218; Tanaka K, 2005, EUR J PHARMACOL, V522, P116, DOI 10.1016/j.ejphar.2005.08.026; Tata DB, 2011, LASER PHOTONICS REV, V5, P1, DOI 10.1002/lpor.200900032; Teggi R, 2008, PHOTOMED LASER SURG, V26, P349, DOI 10.1089/pho.2007.2186	21	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	MAY 19	2015	595						81	86		10.1016/j.neulet.2015.03.031		6	Neurosciences	Neurosciences & Neurology	CI8NU	WOS:000355029800016		
J	Kudo, K; Fujimura, K; Onari, S; Ota, H; Nohara, M				Kudo, Kazutaka; Fujimura, Kazunori; Onari, Seiichiro; Ota, Hiromi; Nohara, Minoru			Superconductivity in MgPtSi: An orthorhombic variant of MgB2	PHYSICAL REVIEW B			English	Article							INTERMETALLIC COMPOUNDS; HIGH-PRESSURE	A ternary compound, MgPtSi, was synthesized by solid-state reaction. An examination of the compound by powder x-ray diffraction revealed that it crystallizes in the orthorhombic TiNiSi-type structure with the Pnma space group. The structure comprises alternately stacked layers of Mg and PtSi honeycomb network, which is reminiscent of MgB2, and the buckling of the honeycomb network causes orthorhombic distortion. Electrical and magnetic studies revealed that MgPtSi exhibited superconductivity with a transition temperature of 2.5 K. However, its isostructural compounds, namely, MgRhSi andMgIrSi, were not found to exhibit superconductivity.	[Kudo, Kazutaka; Fujimura, Kazunori; Onari, Seiichiro; Nohara, Minoru] Okayama Univ, Dept Phys, Okayama 7008530, Japan; [Kudo, Kazutaka; Nohara, Minoru] Okayama Univ, Res Ctr New Funct Mat Energy Prod Storage & Trans, Okayama 7008530, Japan; [Ota, Hiromi] Okayama Univ, Adv Sci Res Ctr, Dept Instrumental Anal & Cryogen, Div Instrumental Anal, Okayama 7008530, Japan	Kudo, K (reprint author), Okayama Univ, Dept Phys, Okayama 7008530, Japan.	kudo@science.okayama-u.ac.jp	KUDO, Kazutaka/B-1468-2011; NOHARA, Minoru/B-1476-2011; Onari, Seiichiro/C-2759-2015		Japan Society for the Promotion of Science (JSPS) [25400372, 26287082]	This work was partially supported by Grants-in-Aid from the Japan Society for the Promotion of Science (JSPS) (Grants No. 25400372 and No. 26287082).	Aoki D, 2001, NATURE, V413, P613, DOI 10.1038/35098048; Gurevich A, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.184515; Hirai D, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.124701; Gurevich A, 2007, PHYSICA C, V456, P160, DOI 10.1016/j.physc.2007.01.008; Kotegawa H, 2014, J PHYS SOC JPN, V83, DOI 10.7566/JPSJ.83.093702; Lorenz B, 2002, PHYSICA C, V383, P191, DOI 10.1016/S0921-4534(02)02056-7; Goryo J, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.100507; Imai M, 2002, APPL PHYS LETT, V80, P1019, DOI 10.1063/1.1448857; Izumi F, 2007, SOL ST PHEN, V130, P15; Kortus J, 2001, PHYS REV LETT, V86, P4656, DOI 10.1103/PhysRevLett.86.4656; Huy NT, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.067006; Choi HJ, 2002, NATURE, V418, P758, DOI 10.1038/nature00898; Landrum GA, 1998, INORG CHEM, V37, P5754, DOI 10.1021/ic980223e; Aoki D, 2014, J PHYS SOC JPN, V83, DOI 10.7566/JPSJ.83.094719; Biswas PK, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.180503; Blaha P., 2001, AUGMENTED PLANE WAVE; Evans MJ, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.064514; EVERS J, 1993, J SOLID STATE CHEM, V103, P45, DOI 10.1006/jssc.1993.1077; Fischer MH, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.020509; Hirai D, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.140509; Imai M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.077003; Ji SD, 2012, INORG CHEM, V51, P10300, DOI 10.1021/ic301296u; Kawashima K, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.114717; Kuroiwa S, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.014517; Matano K, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.140504; Meng RL, 2002, PHYSICA C, V382, P113, DOI 10.1016/S0921-4534(02)01208-X; Nagamatsu J, 2001, NATURE, V410, P63, DOI 10.1038/35065039; Nishikubo Y, 2011, J PHYS SOC JPN, V80, DOI 10.1143/JPSJ.80.055002; Pyon S, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.023702; Wang WS, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.094514; Wu W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6508	31	0	0	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	MAY 19	2015	91	17							174514	10.1103/PhysRevB.91.174514		5	Physics, Condensed Matter	Physics	CI7WV	WOS:000354976900005		
J	Sachdeva, R; Thakur, A; Vignale, G; Agarwal, A				Sachdeva, Rashi; Thakur, Anmol; Vignale, Giovanni; Agarwal, Amit			Plasmon modes of a massive Dirac plasma, and their superlattices	PHYSICAL REVIEW B			English	Article							GRAPHENE PLASMONICS; EXCITATIONS	We explore the collective density oscillations of a collection of charged massive Dirac particles, in one, two, and three dimensions, and their one-dimensional (1D) superlattice. We calculate the long-wavelength limit of the dynamical polarization function analytically, and use the random phase approximation to obtain the plasmon dispersion. The density dependence of the long-wavelength plasmon frequency in massive Dirac systems is found to be different compared to systems with parabolic and gapless Dirac dispersion. We also calculate the long-wavelength plasmon dispersion of a 1D metamaterial made from 1D and 2D massive Dirac plasma. Our analytical results will be useful for exploring the use of massive Dirac materials as electrostatically tunable plasmonic metamaterials and can be experimentally verified by infrared spectroscopy, as in the case of graphene. [L. Ju et al., Nat. Nanotechnol. 6, 630 (2011)].	[Sachdeva, Rashi; Thakur, Anmol; Agarwal, Amit] Indian Inst Technol, Dept Phys, Kanpur 208016, Uttar Pradesh, India; [Sachdeva, Rashi] Grad Univ, Okinawa Inst Sci & Technol, Quantum Syst Unit, Okinawa, Japan; [Vignale, Giovanni] Univ Missouri, Dept Phys, Columbia, MO 65211 USA	Sachdeva, R (reprint author), Indian Inst Technol, Dept Phys, Kanpur 208016, Uttar Pradesh, India.	amitag@iitk.ac.in	Sachdeva, Rashi/B-8839-2015		DST (Government of India); Faculty Initiation Grant by IIT Kanpur, India; NSF [DMR-1406568]	We gratefully acknowledge funding from the INSPIRE Faculty Award by DST (Government of India) (A.A.) and from the Faculty Initiation Grant by IIT Kanpur, India (A.A.). We also acknowledge financial support by NSF Grant No. DMR-1406568 (G.V.).	Agarwal A, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.155409; Agarwal A, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.077004; Ju L, 2011, NAT NANOTECHNOL, V6, P630, DOI [10.1038/nnano.2011.146, 10.1038/NNANO.2011.146]; Agarwal A, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.115135; Abedinpour SH, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.045429; Stauber T, 2014, J PHYS-CONDENS MAT, V26, DOI 10.1088/0953-8984/26/12/123201; Yoon H, 2014, NAT NANOTECHNOL, V9, P594, DOI [10.1038/nnano.2014.112, 10.1038/NNANO.2014.112]; Hwang EH, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.205405; Tame MS, 2013, NAT PHYS, V9, P329, DOI [10.1038/nphys2615, 10.1038/NPHYS2615]; Sarma SD, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.206412; Tabert CJ, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.195410; Lv M, 2013, INT J MOD PHYS B, V27, DOI 10.1142/S0217979213501774; Van Duppen B, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.035142; Wright AR, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.085411; Zhu JJ, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.085401; Hwang EH, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.205418; ANDO T, 1982, REV MOD PHYS, V54, P437, DOI 10.1103/RevModPhys.54.437; Yan HG, 2012, NAT NANOTECHNOL, V7, P330, DOI [10.1038/nnano.2012.59, 10.1038/NNANO.2012.59]; Raghu S, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.116401; Grigorenko AN, 2012, NAT PHOTONICS, V6, P749, DOI [10.1038/nphoton.2012.262, 10.1038/NPHOTON.2012.262]; Di Pietro P, 2013, NAT NANOTECHNOL, V8, P556, DOI [10.1038/nnano.2013.134, 10.1038/NNANO.2013.134]; Zhou JH, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.035114; Rodin AS, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.075422; Yan HG, 2013, NAT PHOTONICS, V7, P394, DOI 10.1038/NPHOTON.2013.57; Fei Z, 2011, NANO LETT, V11, P4701, DOI 10.1021/nl202362d; Pyatkovskiy PK, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/2/025506; Triola C, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.161408; Badalyan SM, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.195444; Chang HR, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.201411; DASSARMA S, 1982, PHYS REV B, V25, P7603, DOI 10.1103/PhysRevB.25.7603; DASSARMA S, 1985, PHYS REV B, V32, P1401, DOI 10.1103/PhysRevB.32.1401; Giuliani G., 2005, QUANTUM THEORY ELECT; Low T, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.106802; Maier S. A., 2007, PLASMONICS FUNDAMENT; Pines D., 1966, THEORY QUANTUM LIQUI; Polini M, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.081411; Wunsch B, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/12/318	37	0	0	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	MAY 19	2015	91	20							205426	10.1103/PhysRevB.91.205426		6	Physics, Condensed Matter	Physics	CI7XB	WOS:000354977600004		
J	Fu, GJ; Zhao, YM; Arima, A				Fu, G. J.; Zhao, Y. M.; Arima, A.			Quartet structure in atomic nuclei	PHYSICAL REVIEW C			English	Article							SHELL-MODEL DESCRIPTION; STRETCH SCHEME; WICK THEOREM; CLUSTERS; FORMALISM; N=Z	A quartet is a tightly bound cluster of two protons and two neutrons, similar to the a particle but occasionally with nonzero spin and/or isospin. If the interaction between two quartets is weak in given states, such states are concluded to be well represented by a quartet structure. In this paper, we study the quartet structure of eight valence nucleons in two cases. The first is a single j shell, demonstrating that the so-called stretch scheme [M. Danos and V. Gillet, Phys. Rev. Lett. 17, 703 (1966)] is very good for low-spin states with a quadruple-quadruple interaction, and is reasonably good under realistic interactions. The second case is the ground state of Pd-92 in the p(1/2)p(3/2)f(5/2)g(9/2) shell with the JUN45 effective interaction. We show that the quartet correlation is essential in the ground state of Pd-92.	[Fu, G. J.; Zhao, Y. M.; Arima, A.] Shanghai Jiao Tong Univ, Dept Phys & Astron, INPAC, Shanghai 200240, Peoples R China; [Zhao, Y. M.] Shanghai Jiao Tong Univ, IFSA Collaborat Innovat Ctr, Shanghai 200240, Peoples R China; [Arima, A.] Musashi Gakuen, Tokyo 1768534, Japan	Zhao, YM (reprint author), Shanghai Jiao Tong Univ, Dept Phys & Astron, INPAC, Shanghai 200240, Peoples R China.	ymzhao@sjtu.edu.cn	Zhao, Yu-Min/B-2601-2012		National Natural Science Foundation of China [11225524]; 973 Program of China [2013CB834401]; Science & Technology Committee of Shanghai City [11DZ2260700]; Center for High Performance Computing (HPC) at Shanghai Jiao Tong University	We thank the National Natural Science Foundation of China under Grant No. 11225524, the 973 Program of China under Grant No. 2013CB834401, and the Science & Technology Committee of Shanghai City under Grant No. 11DZ2260700. This work is also supported by the Center for High Performance Computing (HPC) at Shanghai Jiao Tong University.	CHEN JQ, 1993, NUCL PHYS A, V562, P218, DOI 10.1016/0375-9474(93)90197-6; Sambataro M, 2015, PHYS LETT B, V740, P137, DOI 10.1016/j.physletb.2014.11.036; MORINAGA H, 1956, PHYS REV, V101, P254, DOI 10.1103/PhysRev.101.254; Honma M, 2009, PHYS REV C, V80, DOI 10.1103/PhysRevC.80.064323; SCHIFFER JP, 1976, REV MOD PHYS, V48, P191, DOI 10.1103/RevModPhys.48.191; Brown BA, 2006, PHYS REV C, V74, DOI [10.1103/PhysRevC.74.061303, 10.1103/PhyRevC.74.034315]; DANOS M, 1967, PHYS REV, V161, P1034, DOI 10.1103/PhysRev.161.1034; Dobes J, 1998, PHYS REV C, V57, P688, DOI 10.1103/PhysRevC.57.688; Van Isacker P, 2013, INT J MOD PHYS E, V22, DOI 10.1142/S0218301313300282; Brown BA, 2001, PROG PART NUCL PHYS, V47, P517, DOI 10.1016/S0146-6410(01)00159-4; von Oertzen W, 2006, PHYS REP, V432, P43, DOI 10.1016/j.physrep.2006.07.001; Xu ZX, 2012, NUCL PHYS A, V877, P51, DOI 10.1016/j.nuclphysa.2011.12.005; Neergard K, 2014, PHYS REV C, V90, DOI 10.1103/PhysRevC.90.014318; Negrea D, 2014, PHYS REV C, V90, DOI 10.1103/PhysRevC.90.024322; Chen JQ, 1997, NUCL PHYS A, V626, P686, DOI 10.1016/S0375-9474(97)00502-2; CHEN JQ, 1993, NUCL PHYS A, V554, P61; Arima A, 2004, NUCL PHYS A, V738, P188, DOI 10.1016/j.nuclphysa.2004.04.030; Arima A., 1968, PROG THEOR PHYS E S, V68, P489; ARIMA A, 1971, ANN PHYS-NEW YORK, V66, P117, DOI 10.1016/0003-4916(71)90185-0; ARIMA A, 1970, PHYS REV LETT, V25, P1043, DOI 10.1103/PhysRevLett.25.1043; DANOS M, 1966, PHYS REV LETT, V17, P703, DOI 10.1103/PhysRevLett.17.703; EICHLER J, 1972, NUCL PHYS A, VA182, P33, DOI 10.1016/0375-9474(72)90200-X; Flowers B.H., 1963, Nuclear Physics, V49, DOI 10.1016/0029-5582(63)90123-8; Fu GJ, 2013, PHYS REV C, V87, DOI 10.1103/PhysRevC.87.044310; GAMBHIR YK, 1983, PHYS REV LETT, V51, P1235, DOI 10.1103/PhysRevLett.51.1235; HASEGAWA M, 1995, NUCL PHYS A, V592, P45, DOI 10.1016/0375-9474(95)00296-D; Honma M, 2004, PHYS REV C, V69, DOI 10.1103/PhysRevC.69.034335; Horiuchi H, 2004, NUCL PHYS A, V731, P329, DOI 10.1016/j.nuclphysa.2003.11.044; HORIUCHI H, 1991, NUCL PHYS A, V522, pC257; Hoyle F., 1954, ASTROPHYSICAL J SUPP, V1, P12; Johnstone IP, 2001, EUR PHYS J A, V11, P125, DOI 10.1007/s100500170077; KANADA-EN'YO Y, 1995, PHYS REV C, V52, P628, DOI 10.1103/PhysRevC.52.628; Kimura M, 2004, PHYS REV C, V69, DOI 10.1103/PhysRevC.69.051304; Qi C, 2012, PROG THEOR PHYS SUPP, P414; Sambataro M, 2013, PHYS REV C, V88, DOI 10.1103/PhysRevC.88.061303; Sandulescu N, 2012, PHYS REV C, V85, DOI 10.1103/PhysRevC.85.061303; Sandulescu N, 2012, PHYS REV C, V86, DOI 10.1103/PhysRevC.86.041302; Sen'kov RA, 2011, PHYS ATOM NUCL+, V74, P1267, DOI 10.1134/S1063778811090110; YOSHIDA S, 1961, PHYS REV, V123, P2122, DOI 10.1103/PhysRev.123.2122; Yoshinaga, 2000, PHYS REV C, V62; Zhao YM, 2014, PHYS REP, V545, P1, DOI 10.1016/j.physrep.2014.07.002	41	0	0	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0556-2813	1089-490X		PHYS REV C	Phys. Rev. C	MAY 19	2015	91	5							054318	10.1103/PhysRevC.91.054318		5	Physics, Nuclear	Physics	CI7XI	WOS:000354978800001		
J	Fu, GJ; Shen, JJ; Zhao, YM; Arima, A				Fu, G. J.; Shen, J. J.; Zhao, Y. M.; Arima, A.			Regularities in low-lying states of atomic nuclei with random interactions	PHYSICAL REVIEW C			English	Article							NEUTRON-PROTON INTERACTION; BINDING-ENERGY DIFFERENCES; SEPARATION ENERGIES; MIRROR NUCLEI; SYMMETRY; SYSTEMS; PHYSICS	In this paper we study low-lying states of atomic nuclei with random interactions, within the framework of the nuclear shell model. The distributions of R-6 versus R-4 (where R-I = E-I1(+) / E-21(+)), empirical proton-neutron interaction, and charge radius are investigated by using a two-body random ensemble. The Mallmann plot exhibits statistical correlations between R-6 and R-4. The proton-neutron interaction between the last proton and the last neutron in even-A nuclei is found to be stronger than that in odd-A nuclei, and that in N = Z nuclei is even stronger. Simple relations of nuclear charge radii for neighboring nuclei are found to survive remarkably for the random ensemble.	[Fu, G. J.; Zhao, Y. M.; Arima, A.] Shanghai Jiao Tong Univ, Dept Phys & Astron, INPAC, Shanghai 200240, Peoples R China; [Shen, J. J.] Chinese Acad Sci, Shanghai Inst Appl Phys, Shanghai 201800, Peoples R China; [Zhao, Y. M.] Shanghai Jiao Tong Univ, IFSA Collaborat Innovat Ctr, Shanghai 200240, Peoples R China; [Arima, A.] Musashi Gakuen, Tokyo 1768534, Japan	Zhao, YM (reprint author), Shanghai Jiao Tong Univ, Dept Phys & Astron, INPAC, Shanghai 200240, Peoples R China.	ymzhao@sjtu.edu.cn	Zhao, Yu-Min/B-2601-2012		National Natural Science Foundation of China [11225524]; 973 Program of China [2013CB834401]; Technology Committee of Shanghai City [11DZ2260700]	We thank the National Natural Science Foundation of China (Grant No. 11225524), the 973 Program of China (Grant No. 2013CB834401), and the Science and Technology Committee of Shanghai City (Grant No. 11DZ2260700) for financial support.	Weidenmuller HA, 2009, REV MOD PHYS, V81, P539, DOI 10.1103/RevModPhys.81.539; Wigner E, 1937, PHYS REV, V51, P106, DOI 10.1103/PhysRev.51.106; Cakirli RB, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.092501; BASU MK, 1971, PHYS REV C, V3, P992, DOI 10.1103/PhysRevC.3.992; Brenner DS, 2006, PHYS REV C, V73, DOI 10.1103/PhysRevC.73.034315; ZHANG JY, 1989, PHYS LETT B, V227, P1, DOI 10.1016/0370-2693(89)91273-2; Qi C, 2012, PHYS LETT B, V717, P436, DOI 10.1016/j.physletb.2012.10.011; VANISACKER P, 1995, PHYS REV LETT, V74, P4607, DOI 10.1103/PhysRevLett.74.4607; GARVEY GT, 1966, PHYS REV LETT, V16, P197, DOI 10.1103/PhysRevLett.16.197; Stoitsov M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.132502; BASU MK, 1971, PHYS REV C, V4, P652, DOI 10.1103/PhysRevC.4.652; Bijker R, 2000, PHYS REV C, V62, DOI 10.1103/PhysRevC.62.014303; BRENNER DS, 1990, PHYS LETT B, V243, P1, DOI 10.1016/0370-2693(90)90945-3; Brown B. A., 2005, LECT NOTES NUCL STRU; Cakirli RB, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.132501; Cakirli RB, 2010, PHYS REV C, V82, DOI 10.1103/PhysRevC.82.061304; DeShalit A., 1963, NUCL SHELL THEORY; DESHALIT A, 1957, PHYS REV, V105, P1528, DOI 10.1103/PhysRev.105.1528; Friedman WA, 2007, PHYS REV C, V76, DOI 10.1103/PhysRevC.76.057301; Fu GJ, 2013, PHYS REV C, V87, DOI 10.1103/PhysRevC.87.044309; Fu GJ, 2011, PHYS REV C, V84, DOI 10.1103/PhysRevC.84.034311; Fu GJ, 2014, PHYS REV C, V90, DOI 10.1103/PhysRevC.90.064320; Fu GJ, 2013, PHYS REV C, V88, DOI 10.1103/PhysRevC.88.037302; Gao ZC, 1999, PHYS REV C, V59, P735, DOI 10.1103/PhysRevC.59.735; GARVEY GT, 1969, REV MOD PHYS, V41, pS1, DOI 10.1103/RevModPhys.41.S1; JANECKE J, 1972, PHYS REV C, V6, P467, DOI 10.1103/PhysRevC.6.467; JANECKE J, 1974, PHYS REV C, V9, P1276, DOI 10.1103/PhysRevC.9.1276; Johnson CW, 1998, PHYS REV LETT, V80, P2749, DOI 10.1103/PhysRevLett.80.2749; Johnson CW, 2007, PHYS REV C, V75, DOI 10.1103/PhysRevC.75.047305; Lei Y, 2011, PHYS REV C, V83, DOI 10.1103/PhysRevC.83.044302; Lu Y, 2014, PHYS REV C, V90, DOI 10.1103/PhysRevC.90.064313; MALLMANN CA, 1959, PHYS REV LETT, V2, P507, DOI 10.1103/PhysRevLett.2.507; Oktem Y, 2006, PHYS REV C, V74, DOI 10.1103/PhysRevC.74.027304; Piekarewicz J, 2010, EUR PHYS J A, V46, P379, DOI 10.1140/epja/i2010-11051-8; Sun BH, 2014, PHYS REV C, V90, DOI 10.1103/PhysRevC.90.054318; Talmi I, 1993, SIMPLE MODELS COMPLE; Zeldes N, 1997, PHYS REV C, V56, pR2938; Zelevinsky V, 2004, PHYS REP, V391, P311, DOI 10.1016/j.physrep.2003.10.008; Zhao YM, 2002, PHYS REV C, V66, DOI 10.1103/PhysRevC.66.041301; Zhao YM, 2004, PHYS REV C, V70, DOI 10.1103/PhysRevC.70.054322; Zhao YM, 2004, PHYS REP, V400, P1, DOI 10.1016/j.physrep.2004.07.004; Zhao YM, 2007, PHYS REV C, V76, DOI 10.1103/PhysRevC.76.054318	42	0	0	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0556-2813	1089-490X		PHYS REV C	Phys. Rev. C	MAY 19	2015	91	5							054319	10.1103/PhysRevC.91.054319		6	Physics, Nuclear	Physics	CI7XI	WOS:000354978800002		
J	Miura, T; Seki, K				Miura, Toshiaki; Seki, Kazuhiko			Effects of surface affinity on the ordering dynamics of self-assembled monolayers of chain molecules: Transition from a parallel to a perpendicular structure	PHYSICAL REVIEW E			English	Article							MONTE-CARLO-SIMULATION; AU(111) SURFACE; POLYMER ADSORPTION; GOLD SURFACE; KINETICS; ALKANETHIOLS; STABILITY; SUBSTRATE; THIOLS; GROWTH	The effects of surface interactions on the ordering dynamics of self-assembled monolayers (SAM) of chain molecules were studied using molecular dynamics simulations. When the strength of surface-chain interactions was equal to or less than that of chain-chain interactions, domains of chain molecules adsorbed perpendicular to the surface ("upright" chains) formed on the surface. Although chain molecules adsorbed parallel to the surface ("lying" chains) were initially observed on the surface, they did not develop into two-dimensionally aligned structures. In contrast, when the strength of surface-chain interactions was at least twice that of chain-chain interactions, the proportion of upright chain molecules was initially small, and the reorientation of lying chains was observed shortly afterwards. In this case, the reorientation from lying to upright configuration developed slowly from the domain boundaries of two-dimensionally aligned structures late in the calculation period. Although the orientation processes of chain molecules on surfaces were strongly influenced by the strength of surface-chain interactions, the total adsorption rate on the surface was not. We also analyzed the maximum area of domains formed by lying chains. The development of two-dimensionally aligned domains required strong surface-chain interactions to prevent the spontaneous formation of nuclei of upright domains.	[Miura, Toshiaki; Seki, Kazuhiko] Natl Inst Adv Ind Sci & Technol, AIST Cent 2, Tsukuba, Ibaraki 3058568, Japan	Miura, T (reprint author), Natl Inst Adv Ind Sci & Technol, AIST Cent 2, 1-1 Umezono, Tsukuba, Ibaraki 3058568, Japan.						Alexiadis O, 2008, MACROMOLECULES, V41, P987, DOI 10.1021/ma071173c; Alexiadis O, 2008, J PHYS CHEM B, V112, P1198, DOI 10.1021/jp076417+; Hayashi T, 2001, J CHEM PHYS, V114, P7615, DOI 10.1063/1.1360245; Dannenberger O, 1999, J PHYS CHEM B, V103, P2202, DOI 10.1021/jp983433l; KARPOVICH DS, 1994, LANGMUIR, V10, P3315, DOI 10.1021/la00021a066; WARD AFH, 1946, J CHEM PHYS, V14, P453, DOI 10.1063/1.1724167; Klushin LI, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.022604; Ferrighi L, 2012, J PHYS CHEM C, V116, P7374, DOI 10.1021/jp210869r; Yuste SB, 2005, SIAM J NUMER ANAL, V42, P1862, DOI 10.1137/030602666; Doudevski I, 1998, PHYS REV LETT, V81, P4927, DOI 10.1103/PhysRevLett.81.4927; Ulman A, 1996, CHEM REV, V96, P1533, DOI 10.1021/cr9502357; Poirier GE, 1996, SCIENCE, V272, P1145, DOI 10.1126/science.272.5265.1145; Ahn Y, 2011, J PHYS CHEM C, V115, P10668, DOI 10.1021/jp200447k; BIERBAUM K, 1995, LANGMUIR, V11, P2143, DOI 10.1021/la00006a049; Poirier GE, 1999, LANGMUIR, V15, P1167, DOI 10.1021/la981374x; Jang YH, 2005, J AM CHEM SOC, V127, P4959, DOI 10.1021/ja0444762w; Karalus S, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.031803; Chen JZY, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.060801; Longo GS, 2012, J PHYS CHEM C, V116, P14883, DOI 10.1021/jp301378x; Gronbeck H, 2000, J AM CHEM SOC, V122, P3839, DOI 10.1021/ja993622x; Kopf A, 1996, MACROMOLECULES, V29, P1433, DOI 10.1021/ma951083k; Peterlinz KA, 1996, LANGMUIR, V12, P4731, DOI 10.1021/la9508452; Duffy DM, 2005, LANGMUIR, V21, P3850, DOI 10.1021/la0473660; Frenkel D., 1996, UNDERSTANDING MOL SI; Gronbech-Jensen N, 2003, LANGMUIR, V19, P1474, DOI 10.1021/la026344f; Han Y, 2011, LANGMUIR, V27, P11951, DOI 10.1021/la2020995; LAI PY, 1993, J CHEM PHYS, V98, P669, DOI 10.1063/1.464611; Langmuir I, 1937, J AM CHEM SOC, V59, P2400, DOI 10.1021/ja01290a091; Leng YS, 2003, J PHYS CHEM B, V107, P11940, DOI 10.1021/jp034405s; Li FS, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4806969; Miura T, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.021801; Miura T, 2003, J CHEM PHYS, V119, P6354, DOI 10.1063/1.1602069; Miura T, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.031804; Miura T., J PHYS CH B IN PRESS; Opferman MG, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.031806; OPPS SB, 2001, PHYS REV E, V63, P41602, DOI DOI 10.1103/PHYSREVE.63.041602; Podlubny I., 1999, FRACTIONAL DIFFERENT; Pool R, 2007, J PHYS CHEM C, V111, P10201, DOI 10.1021/jp071491d; Rapaport DC, 1995, ART MOL DYNAMICS SIM; Seki K, 2000, J CHEM PHYS, V113, P3441, DOI 10.1063/1.1287335; Shevade AV, 2001, LANGMUIR, V17, P7566, DOI 10.1021/la0108151; Smith GD, 2006, LANGMUIR, V22, P664, DOI 10.1021/la051750v; Swetnam A, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.062901; Tang L, 2013, J PHYS CHEM C, V117, P21234, DOI 10.1021/jp4058127; Yi T, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.062404; Yourdshahyan Y, 2002, J CHEM PHYS, V117, P825, DOI 10.1063/1.1483072; ZAJAC R, 1994, PHYS REV E, V49, P3069, DOI 10.1103/PhysRevE.49.3069; ZAJAC R, 1995, PHYS REV E, V52, P6536, DOI 10.1103/PhysRevE.52.6536; Zivkovic S, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.052131	49	1	1	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1539-3755	1550-2376		PHYS REV E	Phys. Rev. E	MAY 19	2015	91	5							052604	10.1103/PhysRevE.91.052604		12	Physics, Fluids & Plasmas; Physics, Mathematical	Physics	CI7XO	WOS:000354979600003		
J	Taniguchi, N; Fukao, K; Sotta, P; Long, DR				Taniguchi, Natsumi; Fukao, Koji; Sotta, Paul; Long, Didier R.			Dielectric relaxation of thin films of polyamide random copolymers	PHYSICAL REVIEW E			English	Article							SUPERCOOLED LIQUIDS; GLASSY DYNAMICS; ELECTRODE POLARIZATION; TEMPERATURE-DEPENDENCE; MOLECULAR-DYNAMICS; IONIC LIQUIDS; POLYMER-FILMS; SPECTROSCOPY; CONFINEMENT; VISCOSITY	We investigate the relaxation behavior of thin films of a polyamide random copolymer, PA66/6I, with various film thicknesses using dielectric relaxation spectroscopy. Two dielectric signals are observed at high temperatures, the a process and the relaxation process due to electrode polarization (the EP process). The relaxation time of the EP process has a Vogel-Fulcher-Tammann type of temperature dependence, and the glass transition temperature, T-g, evaluated from the EP process agrees very well with the Tg determined from the thermal measurements. The fragility index derived from the EP process increases with decreasing film thickness. The relaxation time and the dielectric relaxation strength of the EP process are described by a linear function of the film thickness d for large values of d, which can be regarded as experimental evidence for the validity of attributing the observed signal to the EP process. Furthermore, there is distinct deviation from this linear law for thicknesses smaller than a critical value. This deviation observed in thinner films is associated with an increase in the mobility and/or diffusion constant of the charge carriers responsible for the EP process. The a process is located in a higher-frequency region than the EP process at high temperatures but merges with the EP process at lower temperatures near the glass transition region. The thickness dependence of the relaxation time of the a process is different from that of the EP process. This suggests that there is decoupling between the segmental motion of the polymers and the translational motion of the charge carriers in confinement.	[Taniguchi, Natsumi; Fukao, Koji] Ritsumeikan Univ, Dept Phys, Kusatsu 5258577, Japan; [Sotta, Paul; Long, Didier R.] CNRS Solvay 5268, Unite Mixte Rech, Lab Polymeres & Mat Avances, F-69192 St Fons, France	Fukao, K (reprint author), Ritsumeikan Univ, Dept Phys, Noji Higashi 1-1-1, Kusatsu 5258577, Japan.	fukao.koji@gmail.com			Japan Society for the Promotion of Science [25610127, 25287108]	This work was supported by a Grant-in-Aid for Scientific Research (B) (Grant No. 25287108) and Exploratory Research (Grant No. 25610127) from the Japan Society for the Promotion of Science. The authors would like to express their cordial thanks to Solvay for supplying them with the amorphous random copolymer PA66/6I. They also thank an anonymous reviewer for the very useful comments and suggestions. The synchrotron radiation experiments were performed at the BL40B2 of SPring-8 with the approval of the Japan Synchrotron Radiation Research Institute (JASRI) (Proposals No. 2013A1173 and No. 2014A1230).	COELHO R, 1983, REV PHYS APPL, V18, P137, DOI 10.1051/rphysap:01983001803013700; Klein RJ, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2186638; KLEIN J, 1978, NATURE, V271, P143, DOI 10.1038/271143a0; Tress M, 2010, MACROMOLECULES, V43, P9937, DOI 10.1021/ma102031k; Yin HJ, 2012, MACROMOLECULES, V45, P1652, DOI 10.1021/ma202127p; Serghei A, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.184301; Zhang C, 2013, SOFT MATTER, V9, P7076, DOI 10.1039/c3sm50171j; Ediger MD, 2000, ANNU REV PHYS CHEM, V51, P99, DOI 10.1146/annurev.physchem.51.1.99; BOHMER R, 1992, PHYS REV B, V45, P10091, DOI 10.1103/PhysRevB.45.10091; Laredo E, 1997, J POLYM SCI POL PHYS, V35, P2879, DOI 10.1002/(SICI)1099-0488(199712)35:17<2879::AID-POLB11>3.0.CO;2-4; MACDONALD JR, 1953, PHYS REV, V92, P4, DOI 10.1103/PhysRev.92.4; Sangoro JR, 2012, ACCOUNTS CHEM RES, V45, P525, DOI 10.1021/ar2001809; Alcoutlabi M, 2005, J PHYS-CONDENS MAT, V17, pR461, DOI 10.1088/0953-8984/17/15/R01; Fukao K, 2000, PHYS REV E, V61, P1743, DOI 10.1103/PhysRevE.61.1743; Fulcher GS, 1925, J AM CERAM SOC, V8, P339, DOI 10.1111/j.1151-2916.1925.tb16731.x; Labahn D, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.011801; Vogel H, 1921, PHYS Z, V22, P645; Laurati M, 2012, MACROMOLECULES, V45, P1676, DOI 10.1021/ma202368x; Lu HB, 2006, J APPL POLYM SCI, V102, P3590, DOI 10.1002/app.23987; ADAM G, 1965, J CHEM PHYS, V43, P139, DOI 10.1063/1.1696442; Evans CM, 2013, MACROMOLECULES, V46, P6091, DOI 10.1021/ma401017n; CHANG I, 1994, J NON-CRYST SOLIDS, V172, P248, DOI 10.1016/0022-3093(94)90443-X; Sangoro JR, 2014, SOFT MATTER, V10, P3536, DOI 10.1039/c3sm53202j; WHITLOW SJ, 1991, MACROMOLECULES, V24, P5926, DOI 10.1021/ma00022a006; Baker WO, 1942, J AM CHEM SOC, V64, P2171, DOI 10.1021/ja01261a043; Berthier L, 2011, DYNAMICAL HETEROGENE; Blum G, 1995, ADV MATER, V7, P1017, DOI 10.1002/adma.19950071210; BOESE D, 1990, MACROMOLECULES, V23, P829, DOI 10.1021/ma00205a023; BOYD RH, 1959, J CHEM PHYS, V30, P1276, DOI 10.1063/1.1730171; CHANTREY G, 1969, J SOC DYERS COLOUR, V85, P618; Efremov MY, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.021501; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549; Fukao K, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.011803; Fulcher GS, 1925, J AM CERAM SOC, V8, P789, DOI 10.1111/j.1151-2916.1925.tb18582.x; HAVRILIA.S, 1967, POLYMER, V8, P161, DOI 10.1016/0032-3861(67)90021-3; KIHO H, 1986, POLYMER, V27, P1542, DOI 10.1016/0032-3861(86)90101-1; Kubo R., 1991, STAT PHYS; McCrum N. G., 1967, ANELASTIC DIELECTRIC; Napolitano S, 2013, EUR PHYS J E, V36, DOI 10.1140/epje/i2013-13061-8; Napolitano S., 2014, DYNAMICS GEOMETRICAL, P279; Neagu RM, 2000, J PHYS D APPL PHYS, V33, P1921, DOI 10.1088/0022-3727/33/15/323; Ngai K. L., 2004, PHYS PROPERTIES POLY, P72; Schonhals A., 2003, BROADBAND DIELECTRIC, P59; Strobl G. R., 2007, PHYS POLYM CONCEPTS, V3rd, P263; Tammann G., 1926, Z ANORG ALLG CHEM, V156, P245, DOI DOI 10.1002/ZAAC.19261560121; Wang YY, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.042308; Zaikov G. E., 1988, DIFFUSION ELECTROLYT	47	0	0	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1539-3755	1550-2376		PHYS REV E	Phys. Rev. E	MAY 19	2015	91	5							052605	10.1103/PhysRevE.91.052605		13	Physics, Fluids & Plasmas; Physics, Mathematical	Physics	CI7XO	WOS:000354979600004		
J	Wiedmann, TO; Schandl, H; Lenzen, M; Moran, D; Suh, S; West, J; Kanemoto, K				Wiedmann, Thomas O.; Schandl, Heinz; Lenzen, Manfred; Moran, Daniel; Suh, Sangwon; West, James; Kanemoto, Keiichiro			The material footprint of nations	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						raw material consumption; multiregion input-output analysis; sustainable resource management	RAW-MATERIAL EQUIVALENTS; INTERNATIONAL-TRADE; MATERIAL CONSUMPTION; CARBON FOOTPRINT; WATER FOOTPRINT; EUROPEAN-UNION; ECONOMY; INDICATORS; GROWTH; FLOWS	Metrics on resource productivity currently used by governments suggest that some developed countries have increased the use of natural resources at a slower rate than economic growth (relative decoupling) or have even managed to use fewer resources over time (absolute decoupling). Using the material footprint (MF), a consumption-based indicator of resource use, we find the contrary: Achievements in decoupling in advanced economies are smaller than reported or even nonexistent. We present a time series analysis of the MF of 186 countries and identify material flows associated with global production and consumption networks in unprecedented specificity. By calculating raw material equivalents of international trade, we demonstrate that countries' use of nondomestic resources is, on average, about threefold larger than the physical quantity of traded goods. As wealth grows, countries tend to reduce their domestic portion of materials extraction through international trade, whereas the overall mass of material consumption generally increases. With every 10% increase in gross domestic product, the average national MF increases by 6%. Our findings call into question the sole use of current resource productivity indicators in policy making and suggest the necessity of an additional focus on consumption-based accounting for natural resource use.	[Wiedmann, Thomas O.] Univ New S Wales, Sch Civil & Environm Engn, Sydney, NSW 2052, Australia; [Wiedmann, Thomas O.; Schandl, Heinz; West, James] CSIRO Ecosyst Sci, Canberra, ACT 2601, Australia; [Wiedmann, Thomas O.; Lenzen, Manfred; Moran, Daniel; Kanemoto, Keiichiro] Univ Sydney, Sch Phys A28, ISA, Sydney, NSW 2006, Australia; [Schandl, Heinz] Australian Natl Univ, Sch Sociol, Canberra, ACT 2601, Australia; [Moran, Daniel] Norwegian Univ Sci & Technol, NTNU, Programme Ind Ecol, N-7013 Trondheim, Norway; [Suh, Sangwon] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Kanemoto, Keiichiro] Tohoku Univ, Grad Sch Environm Studies, Sendai, Miyagi 9808579, Japan	Wiedmann, TO (reprint author), Univ New S Wales, Sch Civil & Environm Engn, Sydney, NSW 2052, Australia.	t.wiedmann@unsw.edu.au	Wiedmann, Thomas/C-9158-2011; Schandl, Heinz/C-5055-2008; West, James/B-5487-2011; Lenzen, Manfred/D-3161-2013	Wiedmann, Thomas/0000-0002-6395-8887; 	Commonwealth Scientific and Industrial Research Organisation's Climate Adaptation Flagship and Integrated Carbon Pathways Initiative; United Nations Environment Program (UNEP); Australian Research Council [DP0985522, DP130101293]	We thank David Fleming, Karin Hosking, and Art Langston for technical help. D.M., M.L., and K.K. thank Sebastian Juraszek, Charlotte Jarabak, and Leonardo Souza for support. Thomas Dunne and three anonymous reviewers provided very helpful comments. T.O.W., H.S., and J.W. acknowledge financial support from the Commonwealth Scientific and Industrial Research Organisation's Climate Adaptation Flagship and Integrated Carbon Pathways Initiative and the United Nations Environment Program (UNEP). D.M., M.L., and K.K. acknowledge financial support from the Australian Research Council through Discovery Projects DP0985522 and DP130101293.	Kovanda J, 2013, ENVIRON SCI POLICY, V29, P71, DOI 10.1016/j.envsci.2013.01.005; Wiedmann T, 2010, ECON SYST RES, V22, P19, DOI 10.1080/09535311003612591; Moran DD, 2013, ECOL ECON, V89, P177, DOI 10.1016/j.ecolecon.2013.02.013; Wood R, 2009, J IND ECOL, V13, P847, DOI 10.1111/j.1530-9290.2009.00177.x; Bruckner M, 2012, GLOBAL ENVIRON CHANG, V22, P568, DOI 10.1016/j.gloenvcha.2012.03.011; Weinzettel J, 2009, J IND ECOL, V13, P607, DOI 10.1111/j.1530-9290.2009.00144.x; Krausmann F, 2008, ECOL ECON, V65, P471, DOI 10.1016/j.ecolecon.2007.07.012; [Anonymous], 2011, GREEN GROWTH MON PRO; Steinberger JK, 2010, ECOL ECON, V69, P1148, DOI 10.1016/j.ecolecon.2009.12.009; Fischer-Kowalski M, 2011, J IND ECOL, V15, P855, DOI 10.1111/j.1530-9290.2011.00366.x; Wiedmann T, 2006, ECOL ECON, V56, P28, DOI 10.1016/j.ecolecon.2005.05.012; Yu Y, 2013, GLOBAL ENVIRON CHANG, V23, P1178, DOI 10.1016/j.gloenvcha.2013.04.006; Schoer K, 2012, ENVIRON SCI TECHNOL, V46, P8903, DOI 10.1021/es300434c; Feng KS, 2011, ECON SYST RES, V23, P371, DOI 10.1080/09535314.2011.638276; LEONTIEF W, 1970, REV ECON STAT, V52, P262, DOI 10.2307/1926294; Steger S, 2011, J CLEAN PROD, V19, P816, DOI 10.1016/j.jclepro.2010.08.016; Davis SJ, 2010, P NATL ACAD SCI USA, V107, P5687, DOI 10.1073/pnas.0906974107; Weisz H, 2008, J IND ECOL, V12, P629, DOI 10.1111/j.1530-9290.2008.00097.x; Dittrich M, 2012, ECOL ECON, V79, P32, DOI 10.1016/j.ecolecon.2012.04.014; Peters GP, 2010, CARBON MANAG, V1, P35, DOI 10.4155/CMT.10.1; Giljum S, 2008, ENVIRON SCI POLICY, V11, P204, DOI 10.1016/j.envsci.2007.07.005; Muradian R, 2012, GLOBAL ENVIRON CHANG, V22, P559, DOI 10.1016/j.gloenvcha.2012.03.004; Dittrich M, 2010, ECOL ECON, V69, P1838, DOI 10.1016/j.ecolecon.2010.04.023; Weinzettel J, 2013, GLOBAL ENVIRON CHANG, V23, P433, DOI 10.1016/j.gloenvcha.2012.12.010; Weinzettel J, 2011, J IND ECOL, V15, P893, DOI 10.1111/j.1530-9290.2011.00378.x; Hertwich EG, 2009, ENVIRON SCI TECHNOL, V43, P6414, DOI 10.1021/es803496a; Schandl H, 2010, GLOBAL ENVIRON CHANG, V20, P636, DOI 10.1016/j.gloenvcha.2010.06.003; Krausmann F, 2008, J IND ECOL, V12, P637, DOI 10.1111/j.1530-9290.2008.00065.x; Lenzen M, 2012, ENVIRON SCI TECHNOL, V46, P8374, DOI 10.1021/es300171x; Lenzen M, 2012, NATURE, V486, P109, DOI 10.1038/nature11145; Galli A, 2012, ECOL INDIC, V16, P100, DOI 10.1016/j.ecolind.2011.06.017; Steinberger JK, 2011, ENVIRON SCI TECHNOL, V45, P1169, DOI 10.1021/es1028537; Schandl H, 2012, J IND ECOL, V16, P352, DOI 10.1111/j.1530-9290.2011.00420.x; Lenzen M, 2006, ENERGY, V31, P181, DOI 10.1016/j.energy.2005.01.009; Steen-Olsen K, 2012, ENVIRON SCI TECHNOL, V46, P10883, DOI 10.1021/es301949t; Munoz P, 2009, J IND ECOL, V13, P881, DOI 10.1111/j.1530-9290.2009.00154.x; Krausmann F, 2009, ECOL ECON, V68, P2696, DOI 10.1016/j.ecolecon.2009.05.007; Lenzen M, 2013, ECOL ECON, V94, P78, DOI 10.1016/j.ecolecon.2013.06.018; Muller DB, 2011, ENVIRON SCI TECHNOL, V45, P182, DOI 10.1021/es102273t; Schandl H, 2009, J IND ECOL, V13, P863, DOI 10.1111/j.1530-9290.2009.00163.x; Wood R, 2009, ENERG POLICY, V37, P4943, DOI 10.1016/j.enpol.2009.06.060; Gierlinger S, 2012, J IND ECOL, V16, P365, DOI 10.1111/j.1530-9290.2011.00404.x; Ausubel JH, 2008, P NATL ACAD SCI USA, V105, P12774, DOI 10.1073/pnas.0806099105; Bringezu S, 2004, ECOL ECON, V51, P97, DOI 10.1016/j.ecolecon.2004.04.010; Wiebe KS, 2012, J IND ECOL, V16, P636, DOI 10.1111/j.1530-9290.2012.00504.x; Bleischwitz R, 2010, INT EC EC POLICY, V7, P227; Bringezu S., 2009, SUSTAINABLE RESOURCE; Dittrich M., 2012, GREEN EC WORLD IMPLI; European Commission, 2011, COM2011571; Eurostat, 2012, EUR MAT FLOW ACC DAT; Eurostat, 2012, SUST DEV IND; Eurostat, 2001, EC WID MAT FLOW ACC; Eurostat, 2011, EC WID MAT FLOW ACC; Hashimoto S, 2008, J IND ECOL, V12, P657, DOI 10.1111/j.1530-9290.2008.00072.x; Kovanda J, 2012, ECOL INDIC, V17, P88, DOI 10.1016/j.ecolind.2011.04.020; Kovanda J, 2008, J IND ECOL, V12, P721, DOI 10.1111/j.1530-9290.2008.00088.x; Lenzen M, 2001, WATER POLICY, V3, P321, DOI DOI 10.1016/S1366-7017(01)00072-1; National Research Council, 2008, MIN CRIT MIN US EC; [OECD] Organization for Economic Cooperation and Development, 2011, RES PROD G8 OECD REP; Peters GP, 2011, P NATL ACAD SCI USA, V108, P8903, DOI 10.1073/pnas.1006388108; UNEP (United Nations Environment Program), 2011, DEC NAT RES US ENV I	61	53	53	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	MAY 19	2015	112	20					6271	6276		10.1073/pnas.1220362110		6	Multidisciplinary Sciences	Science & Technology - Other Topics	CI4OD	WOS:000354729500036		
J	Hashimoto-Kataoka, T; Hosen, N; Sonobe, T; Arita, Y; Yasui, T; Masaki, T; Minami, M; Inagaki, T; Miyagawa, S; Sawa, Y; Murakami, M; Kumanogoh, A; Yamauchi-Takihara, K; Okumura, M; Kishimoto, T; Komuro, I; Shirai, M; Sakata, Y; Nakaoka, Y				Hashimoto-Kataoka, Takahiro; Hosen, Naoki; Sonobe, Takashi; Arita, Yoh; Yasui, Taku; Masaki, Takeshi; Minami, Masato; Inagaki, Tadakatsu; Miyagawa, Shigeru; Sawa, Yoshiki; Murakami, Masaaki; Kumanogoh, Atsushi; Yamauchi-Takihara, Keiko; Okumura, Meinoshin; Kishimoto, Tadamitsu; Komuro, Issei; Shirai, Mikiyasu; Sakata, Yasushi; Nakaoka, Yoshikazu			Interleukin-6/interleukin-21 signaling axis is critical in the pathogenesis of pulmonary arterial hypertension	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						pulmonary arterial hypertension; interleukin-21; interleukin-6; Th17 cells; M2 macrophage	T-CELLS; INTERLEUKIN-6 RECEPTOR; RHEUMATOID-ARTHRITIS; DOUBLE-BLIND; TH17 CELLS; INFLAMMATION; IL-21; MICE; INDUCTION; CYTOKINE	IL-6 is a multifunctional proinflammatory cytokine that is elevated in the serum of patients with pulmonary arterial hypertension (PAH) and can predict the survival of patients with idiopathic PAH (IPAH). Previous animal experiments and clinical human studies indicate that IL-6 is important in PAH; however, the molecular mechanisms of IL-6-mediated pathogenesis of PAH have been elusive. Here we identified IL-21 as a downstream target of IL-6 signaling in PAH. First, we found that IL-6 blockade by the monoclonal anti-IL-6 receptor antibody, MR16-1, ameliorated hypoxia-induced pulmonary hypertension (HPH) and prevented the hypoxia-induced accumulation of Th17 cells and M2 macrophages in the lungs. Consistently, the expression levels of IL-17 and IL-21 genes, one of the signature genes for Th17 cells, were significantly up-regulated after hypoxia exposure in the lungs of mice treated with control antibody but not in the lungs of mice treated with MR16-1. Although IL-17 blockade with an anti-IL-17A neutralizing antibody had no effect on HPH, IL-21 receptor-deficient mice were resistant to HPH and exhibited no significant accumulation of M2 macrophages in the lungs. In accordance with these findings, IL-21 promoted the polarization of primary alveolar macrophages toward the M2 phenotype. Of note, significantly enhanced expressions of IL-21 and M2 macrophage markers were detected in the lungs of IPAH patients who underwent lung transplantation. Collectively, these findings suggest that IL-21 promotes PAH in association with M2 macrophage polarization, downstream of IL-6-signaling. The IL-6/IL-21-signaling axis may be a potential target for treating PAH.	[Hashimoto-Kataoka, Takahiro; Arita, Yoh; Yasui, Taku; Masaki, Takeshi; Yamauchi-Takihara, Keiko; Sakata, Yasushi; Nakaoka, Yoshikazu] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka 5650871, Japan; [Hosen, Naoki] Osaka Univ, Grad Sch Med, Dept Canc Stem Cell Biol Funct Diagnost Sci, Suita, Osaka 5650871, Japan; [Minami, Masato; Okumura, Meinoshin] Osaka Univ, Grad Sch Med, Dept Gen Thorac Surg, Suita, Osaka 5650871, Japan; [Miyagawa, Shigeru; Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka 5650871, Japan; [Kumanogoh, Atsushi] Osaka Univ, Grad Sch Med, Dept Resp Med Allergy & Rheumat Dis, Suita, Osaka 5650871, Japan; [Sonobe, Takashi; Inagaki, Tadakatsu; Shirai, Mikiyasu] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Cardiac Physiol, Suita, Osaka 5658565, Japan; [Murakami, Masaaki] Hokkaido Univ, Inst Med Genet, Dept Mol Neuroimmunol, Sapporo, Hokkaido 0600815, Japan; [Kishimoto, Tadamitsu] Osaka Univ, Immunol Frontier Res Ctr, Lab Immune Regulat, Suita, Osaka 5650871, Japan; [Komuro, Issei] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo 1138656, Japan; [Komuro, Issei] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Saitama 3320012, Japan; [Nakaoka, Yoshikazu] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Saitama 3320012, Japan	Nakaoka, Y (reprint author), Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka 5650871, Japan.	ynakaoka@cardiology.med.osaka-u.ac.jp			Ministry of Education, Science, Sports and Culture of Japan [KAKENHI-25670386]; Precursory Research for Embryonic Science and Technology, Japan Science Technology Agency	We thank Yuka Yoshimoto and Yumi Yanagisawa for secretarial assistance; Kaori Yamamoto and Manami Sone (National Cerebral and Cardiovascular Research Center) for technical assistance; Yoshito Takeda, Yingji Jin (Osaka University), Yasunobu Arima (Hokkaido University), Hatsue Ueda, Naoki Mochizuki (National Cerebral Cardiovascular Research Center), Susumu Nakae, and Tomokazu Sumida (University of Tokyo) for helpful discussions and suggestions; Warren J. Leonard (National, Heart, Lung, and Blood Institute) for providing IL-21RKO mice; and Chugai Pharmaceutical Co. for providing the anti-IL-6R antibody MR16-1. This work was supported in part by Grant KAKENHI-25670386 from the Ministry of Education, Science, Sports and Culture of Japan (to Y.N.) and by a grant from Precursory Research for Embryonic Science and Technology, Japan Science Technology Agency (to Y.N.).	Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; HUMBERT M, 1995, AM J RESP CRIT CARE, V151, P1628; Steiner MK, 2009, CIRC RES, V104, P236, DOI 10.1161/CIRCRESAHA.108.182014; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; TUDER RM, 1994, AM J PATHOL, V144, P275; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Nishimoto N, 2004, ARTHRITIS RHEUM, V50, P1761, DOI 10.1002/art.20303; Daley E, 2008, J EXP MED, V205, P361, DOI 10.1084/jem.20071008; Dienz O, 2009, J EXP MED, V206, P69, DOI 10.1084/jem.20081571; Rabinovitch M, 2012, J CLIN INVEST, V122, P4306, DOI 10.1172/JCI60658; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Chaouat A, 2009, CHEST, V136, P678, DOI 10.1378/chest.08-2420; Tanaka T, 2012, ANNU REV PHARMACOL, V52, P199, DOI 10.1146/annurev-pharmtox-010611-134715; Takeda Y, 2011, NATURE, V479, P122, DOI 10.1038/nature10507; Shioyama W, 2011, CIRC RES, V108, P664, DOI 10.1161/CIRCRESAHA.110.232223; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Fujimoto M, 2008, ARTHRITIS RHEUM, V58, P3710, DOI 10.1002/art.24126; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Savale L, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-6; Choy EHS, 2002, ARTHRITIS RHEUM-US, V46, P3143, DOI 10.1002/art.10623; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; KISHIMOTO T, 1992, SCIENCE, V258, P593, DOI 10.1126/science.1411569; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Liu SM, 2013, J IMMUNOL, V191, P3501, DOI 10.4049/jimmunol.1301454; Hsu E, 2011, ARTHRITIS RHEUM-US, V63, P783, DOI 10.1002/art.30159; Takagi N, 1998, ARTHRITIS RHEUM, V41, P2117, DOI 10.1002/1529-0131(199812)41:12<2117::AID-ART6>3.0.CO;2-P; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Dorfmuller P, 2003, EUR RESPIR J, V22, P358, DOI 10.1183/09031936.03.00038903; Stolfi C, 2011, J EXP MED, V208, P2279, DOI 10.1084/jem.20111106; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Schermuly RT, 2011, NAT REV CARDIOL, V8, P443, DOI 10.1038/nrcardio.2011.87; Vergadi E, 2011, CIRCULATION, V123, P1986, DOI 10.1161/CIRCULATIONAHA.110.978627; Minamino T, 2001, P NATL ACAD SCI USA, V98, P8798, DOI 10.1073/pnas.161272598; Arita Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5552; Higuchi K, 2012, CIRC J, V76, P2031, DOI 10.1253/circj.CJ-11-1507; Iwanami K, 2008, ARTHRITIS RHEUM, V58, P754, DOI 10.1002/art.23222; Kishimoto T, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1916; Nakaoka Y, 2007, J CLIN INVEST, V117, P1771, DOI 10.1172/JCI30651; Ogura S, 2013, AM J PHYSIOL-HEART C, V305, pH155, DOI 10.1152/ajpheart.00169.2012; Pietra GG, 2004, J AM COLL CARDIOL, V43, p25S, DOI 10.1016/j.jacc.2004.02.033; Serada S, 2008, P NATL ACAD SCI USA, V105, P9041, DOI 10.1073/pnas.0802218105; Sonobe T, 2011, J APPL PHYSIOL, V111, P75, DOI 10.1152/japplphysiol.00205.2011; Soon E, 2010, CIRCULATION, V122, P921, DOI 10.1161/CIRCULATIONAHA.109.933762; Tuder RM, 1998, J LAB CLIN MED, V132, P16, DOI 10.1016/S0022-2143(98)90020-8	46	1	1	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	MAY 19	2015	112	20					E2677	E2686		10.1073/pnas.1424774112		10	Multidisciplinary Sciences	Science & Technology - Other Topics	CI4OD	WOS:000354729500018		
J	Okano, H; Miyawaki, A; Kasai, K				Okano, Hideyuki; Miyawaki, Atsushi; Kasai, Kiyoto			Brain/MINDS: brain-mapping project in Japan	PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES			English	Review						brain mapping by integrated neurotechnologies for disease studies; transgenic non-human primates; optogenetics; tissue clearing; super-resolution microscopy; neuropsychiatric and neurodegenerative diseases	NEUROSCIENCE RESEARCH; FLUORESCENT PROTEIN; COMMON MARMOSET; WHITE-MATTER; MOUSE-BRAIN; SCHIZOPHRENIA; VOLUME; INTACT; TISSUE; GRAY	There is an emerging interest in brain-mapping projects in countries across the world, including the USA, Europe, Australia and China. In 2014, Japan started a brain-mapping project called Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS). Brain/MINDS aims to map the structure and function of neuronal circuits to ultimately understand the vast complexity of the human brain, and takes advantage of a unique non-human primate animal model, the common marmoset (Callithrix jacchus). In Brain/MINDS, the RIKEN Brain Science Institute acts as a central institute. The objectives of Brain/MINDS can be categorized into the following three major subject areas: (i) structure and functional mapping of a non-human primate brain (the marmoset brain); (ii) development of innovative neurotechnologies for brain mapping; and (iii) human brain mapping; and clinical research. Brain/MINDS researchers are highly motivated to identify the neuronal circuits responsible for the phenotype of neurological and psychiatric disorders, and to understand the development of these devastating disorders through the integration of these three subject areas.	[Okano, Hideyuki] Brain Sci Inst RIKEN, Lab Marmoset Neural Architecture, Wako, Saitama 3510198, Japan; [Miyawaki, Atsushi] Brain Sci Inst RIKEN, Lab Cell Funct Dynam, Wako, Saitama 3510198, Japan; [Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 1608582, Japan; [Kasai, Kiyoto] Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Bunkyo Ku, Tokyo 1138655, Japan	Okano, H (reprint author), Brain Sci Inst RIKEN, Lab Marmoset Neural Architecture, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	hidokano@brain.riken.jp; matsushi@brain.riken.jp; kasaik-tky@umin.net	Okano, Hideyuki/J-5973-2013		Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)	This work has been supported by Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT).	Anderson A, 2014, NEUROIMAGE, V102, P207, DOI 10.1016/j.neuroimage.2013.12.015; Grienberger C, 2012, NEURON, V73, P862, DOI 10.1016/j.neuron.2012.02.011; Sasayama D, 2010, PSYCHIAT CLIN NEUROS, V64, P394, DOI 10.1111/j.1440-1819.2010.02102.x; Ghosh KK, 2011, NAT METHODS, V8, P871, DOI [10.1038/nmeth.1694, 10.1038/NMETH.1694]; Sasaki E, 2009, NATURE, V459, P523, DOI 10.1038/nature08090; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Hikishima K, 2011, NEUROIMAGE, V54, P2741, DOI 10.1016/j.neuroimage.2010.10.061; Tantama M, 2012, PROG BRAIN RES, V196, P235, DOI 10.1016/B978-0-444-59426-6.00012-4; Chklovskii DB, 2010, CURR OPIN NEUROBIOL, V20, P667, DOI 10.1016/j.conb.2010.08.002; Mutoh H, 2012, ACS CHEM NEUROSCI, V3, P585, DOI 10.1021/cn300041b; Miyawaki A, 2005, NEURON, V48, P189, DOI 10.1016/j.neuron.2005.10.003; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Erturk A, 2012, NAT PROTOC, V7, P1983, DOI 10.1038/nprot.2012.119; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Yamada M, 2008, RADIOLOGY, V249, P855, DOI 10.1148/radiol.2493072141; Hurd MD, 2013, NEW ENGL J MED, V368, P1326, DOI 10.1056/NEJMsa1204629; Salisbury DF, 2007, ARCH GEN PSYCHIAT, V64, P521, DOI 10.1001/archpsyc.64.5.521; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Yamazaki Y, 2011, EXP BRAIN RES, V213, P63, DOI 10.1007/s00221-011-2778-9; Fujiyoshi K, 2007, J NEUROSCI, V27, P11991, DOI 10.1523/JNEUROSCI.3354-07.2007; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Sjollema KA, 2012, METHOD CELL BIOL, V111, P157, DOI 10.1016/B978-0-12-416026-2.00009-1; Dennis EL, 2014, NEUROPSYCHOL REV, V24, P49, DOI 10.1007/s11065-014-9249-6; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Weitzman M, 2014, CURR OPIN CELL BIOL, V30, P112, DOI 10.1016/j.ceb.2014.08.004; Okano H, 2012, SEMIN FETAL NEONAT M, V17, P336, DOI 10.1016/j.siny.2012.07.002; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Kumagai A, 2013, CELL, V153, P1602, DOI 10.1016/j.cell.2013.05.038; Palmer AE, 2011, TRENDS BIOTECHNOL, V29, P144, DOI 10.1016/j.tibtech.2010.12.004; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Kandel ER, 2013, NAT REV NEUROSCI, V14, P659, DOI 10.1038/nrn3578; Kuwajima T, 2013, DEVELOPMENT, V140, P1364, DOI 10.1242/dev.091844; Kishi N, 2014, DEV GROWTH DIFFER, V56, P53, DOI 10.1111/dgd.12109; Kelly C, 2014, NEUROPSYCHOL REV, V24, P63, DOI 10.1007/s11065-014-9252-y; Shimozono S, 2013, NATURE, V496, P363, DOI 10.1038/nature12037; Kasai K, 2003, ARCH GEN PSYCHIAT, V60, P766, DOI 10.1001/archpsyc.60.8.766; Yang B, 2014, CELL, V158, P945, DOI 10.1016/j.cell.2014.07.017; Aoki Y, 2013, SCHIZOPHR RES, V147, P355, DOI 10.1016/j.schres.2013.04.029; Arosio D, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00258; Cauda F, 2014, HUM BRAIN MAPP, V35, P2073, DOI 10.1002/hbm.22313; Cyranoski D, 2014, NATURE, V514, P151, DOI 10.1038/514151a; Gonoi W, 2010, NEURORADIOLOGY, V52, P865, DOI 10.1007/s00234-009-0641-5; Hikishima K, RADIOLOGY IN PRESS; Kasai K, 2015, NEUROSCI RES, V90, P65, DOI 10.1016/j.neures.2014.11.007; Kasai K, 2013, NEUROSCI RES, V75, P89, DOI 10.1016/j.neures.2012.12.001; Kishi N, 2014, 44 ANN M NEUR 2014 W; Lichtman JW, 2014, NAT NEUROSCI, V17, P1448, DOI 10.1038/nn.3837; Lin HH, 2007, CELL, V128, P1205, DOI 10.1016/j.cell.2007.03.006; Mashiko H, 2012, J NEUROSCI, V32, P5039, DOI 10.1523/JNEUROSCI.4788-11.2012; Miesenböck Gero, 2012, Cold Spring Harb Protoc, V2012, P213, DOI 10.1101/pdb.ip067827; Mockl L, 2014, ANGEW CHEM INT EDIT, V53, P13972, DOI 10.1002/anie.201410265; Nagai T, 2013, PSYCHIATRY, V4, P115, DOI [10.3389/fpsyt.2013.00115, DOI 10.3389/FPSYT.2013.00115]; Okano H, 2015, NEUROSCI RES, V93, P3, DOI 10.1016/j.neures.2014.08.014; Paxinos G., 2012, MARMOSET BRAIN STERE; Pironti VA, 2014, BIOL PSYCHIAT, V76, P639, DOI 10.1016/j.biopsych.2013.09.025; Quintana Laura, 2011, Cold Spring Harb Protoc, V2011, P664, DOI 10.1101/pdb.prot5639; Renier N, 2014, CELL, V159, P896, DOI 10.1016/j.cell.2014.10.010; Shibata S, 2015, MICROSCOPY-JPN, V64, P57, DOI 10.1093/jmicro/dfu103; Tada M, CEREB CORTE IN PRESS, DOI [10.1093/cercor/bhu278, DOI 10.1093/CERCOR/BHU278]; Takao H, 2011, HUM BRAIN MAPP, V32, P1762, DOI 10.1002/hbm.21145; Takemoto A, NEUROSCI RE IN PRESS, DOI [10.1016/j.neures.2014.10.001, DOI 10.1016/J.NEURES.2014.10.001]; Warden MR, 2014, ANNU REV BIOMED ENG, V16, P103, DOI 10.1146/annurev-bioeng-071813-104733	64	3	3	ROYAL SOC	LONDON	6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND	0962-8436	1471-2970		PHILOS T R SOC B	Philos. Trans. R. Soc. B-Biol. Sci.	MAY 19	2015	370	1668					33	41	20140310	10.1098/rstb.2014.0310		9	Biology	Life Sciences & Biomedicine - Other Topics	CH5JH	WOS:000354071400004		
J	Kanai, R; Komura, Y; Shipp, S; Friston, K				Kanai, Ryota; Komura, Yutaka; Shipp, Stewart; Friston, Karl			Cerebral hierarchies: predictive processing, precision and the pulvinar	PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES			English	Article						neuronal computational; attention; predictive coding; precision; neuromodulation; pulvinar	SELECTIVE VISUAL-ATTENTION; NEURONAL SYNCHRONIZATION; DECISION-MAKING; FREE-ENERGY; PREFRONTAL CORTEX; MONKEY; ALPHA; OSCILLATIONS; MODULATION; GAMMA	This paper considers neuronal architectures from a computational perspective and asks what aspects of neuroanatomy and neurophysiology can be disclosed by the nature of neuronal computations? In particular, we extend current formulations of the brain as an organ of inference based upon hierarchical predictive coding and consider how these inferences are orchestrated. In other words, what would the brain require to dynamically coordinate and contextualize its message passing to optimize its computational goals? The answer that emerges rests on the delicate (modulatory) gain control of neuronal populations that select and coordinate (prediction error) signals that ascend cortical hierarchies. This is important because it speaks to a hierarchical anatomy of extrinsic (between region) connections that form two distinct classes, namely a class of driving (first-order) connections that are concerned with encoding the content of neuronal representations and a class of modulatory (second-order) connections that establish context in the form of the salience or precision ascribed to content. We explore the implications of this distinction from a formal perspective (using simulations of feature ground segregation) and consider the neurobiological substrates of the ensuing precision-engineered dynamics, with a special focus on the pulvinar and attention.	[Kanai, Ryota; Komura, Yutaka] Univ Sussex, Sch Psychol, Sackler Ctr Consciousness Sci, Brighton BN1 9QH, E Sussex, England; [Kanai, Ryota; Komura, Yutaka] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Saitama 3320012, Japan; [Komura, Yutaka] Natl Inst Adv Ind Sci & Technol, Human Technol Res Inst, Syst Neurosci, Tsukuba, Ibaraki 3058568, Japan; [Shipp, Stewart] UCL Inst Ophthalmol, London EC1V 9EL, England; [Friston, Karl] UCL, Inst Neurol, Wellcome Trust Ctr Neuroimaging, London WC1 3BG, England	Friston, K (reprint author), UCL, Inst Neurol, Wellcome Trust Ctr Neuroimaging, London WC1 3BG, England.	k.friston@ucl.ac.uk			Wellcome Trust; Japan Science and Technology Agency	K.J.F. is funded by the Wellcome Trust, and R.K. by Japan Science and Technology Agency.	Adams Rick A, 2013, Front Psychiatry, V4, P47, DOI 10.3389/fpsyt.2013.00047; Adams R. A., 2012, BRAIN STRUCT FUNCT, V218, P611, DOI DOI 10.1007/S00429-012-0475-5); Akam TE, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002760; Braver TS, 1999, BIOL PSYCHIAT, V46, P312, DOI 10.1016/S0006-3223(99)00116-X; Saalmann YB, 2009, CURR OPIN NEUROBIOL, V19, P408, DOI 10.1016/j.conb.2009.05.007; Friston KJ, 2006, J PHYSIOL-PARIS, V100, P70, DOI 10.1016/j.jphysparis.2006.10.001; Lee TS, 2003, J OPT SOC AM A, V20, P1434, DOI 10.1364/JOSAA.20.001434; Saalmann YB, 2012, SCIENCE, V337, P753, DOI 10.1126/science.1223082; Ward R, 2002, NAT NEUROSCI, V5, P99, DOI 10.1038/nn794; Roux F, 2013, J NEUROSCI, V33, P17827, DOI 10.1523/JNEUROSCI.5778-12.2013; Doya K, 2008, NAT NEUROSCI, V11, P410, DOI 10.1038/nn2077; Shipp S, 2004, TRENDS COGN SCI, V8, P223, DOI 10.1016/j.tics.2004.03.004; Komura Y, 2013, NAT NEUROSCI, V16, P749, DOI 10.1038/nn.3393; Fries P, 2008, J NEUROSCI, V28, P4823, DOI 10.1523/JNEUROSCI.4499-07.2008; Moran RJ, 2013, J NEUROSCI, V33, P8227, DOI 10.1523/JNEUROSCI.4255-12.2013; Sejnowski TJ, 2006, J NEUROSCI, V26, P1673, DOI 10.1523/JNEUROSCI.3737-05d.2006; Sherman SM, 1998, P NATL ACAD SCI USA, V95, P7121, DOI 10.1073/pnas.95.12.7121; Jones EG, 1998, NEUROSCIENCE, V85, P331, DOI 10.1016/S0306-4522(97)00581-2; Buffalo EA, 2011, P NATL ACAD SCI USA, V108, P11262, DOI 10.1073/pnas.1011284108; BENDER DB, 1981, J NEUROPHYSIOL, V46, P672; DAYAN P, 1995, NEURAL COMPUT, V7, P889, DOI 10.1162/neco.1995.7.5.889; Spaak E, 2012, CURR BIOL, V22, P2313, DOI 10.1016/j.cub.2012.10.020; Frank MJ, 2007, PHILOS T R SOC B, V362, P1641, DOI 10.1098/rstb.2007.2058; ZEKI S, 1988, NATURE, V335, P311, DOI 10.1038/335311a0; Karnath HO, 2002, BRAIN, V125, P350, DOI 10.1093/brain/awf032; Sherman SM, 2011, J NEUROPHYSIOL, V106, P1068, DOI 10.1152/jn.00429.2011; LIDOW MS, 1991, NEUROSCIENCE, V40, P657, DOI 10.1016/0306-4522(91)90003-7; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Akam T, 2010, NEURON, V67, P308, DOI 10.1016/j.neuron.2010.06.019; Barth DS, 1996, NATURE, V383, P78, DOI 10.1038/383078a0; Jones EG, 2002, PHILOS T R SOC B, V357, P1659, DOI 10.1098/rstb.2002.1168; Womelsdorf T, 2006, J PHYSIOLOGY-PARIS, V100, P182, DOI 10.1016/j.jphysparis.2007.01.005; Bosman CA, 2012, NEURON, V75, P875, DOI 10.1016/j.neuron.2012.06.037; LABERGE D, 1990, J NEUROSCI, V10, P613; Liu ZM, 2012, NEUROIMAGE, V63, P1060, DOI 10.1016/j.neuroimage.2012.08.025; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Bollimunta A, 2011, J NEUROSCI, V31, P4935, DOI 10.1523/JNEUROSCI.5580-10.2011; Cisek P, 2007, PHILOS T R SOC B, V362, P1585, DOI 10.1098/rstb.2007.2054; Purushothaman G, 2012, NAT NEUROSCI, V15, P905, DOI 10.1038/nn.3106; Hsu M, 2005, SCIENCE, V310, P1680, DOI 10.1126/science.1115327; Kastner S, 2004, J NEUROPHYSIOL, V91, P438, DOI 10.1152/jn.00553.2003; Friston KJ, 2010, MATH PROBL ENG, DOI 10.1155/2010/621670; Shipp S, 2013, TRENDS NEUROSCI, V36, P706, DOI 10.1016/j.tins.2013.09.004; ROBINSON DL, 1992, TRENDS NEUROSCI, V15, P127, DOI 10.1016/0166-2236(92)90354-B; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Contreras D, 1996, SCIENCE, V274, P771, DOI 10.1126/science.274.5288.771; Chawla D, 1999, NEURAL COMPUT, V11, P1389, DOI 10.1162/089976699300016287; Humphries MD, 2009, NEURAL NETWORKS, V22, P1174, DOI 10.1016/j.neunet.2009.07.018; Clark A, 2013, BEHAV BRAIN SCI, V36, P233, DOI [10.1017/S0140525X12000477, 10.1017/S0140525X12002440]; Bastos AM, 2012, NEURON, V76, P695, DOI 10.1016/j.neuron.2012.10.038; MUMFORD D, 1992, BIOL CYBERN, V66, P241, DOI 10.1007/BF00198477; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; DESIMONE R, 1990, COLD SH Q B, V55, P963; BENEVENTO LA, 1995, VISUAL NEUROSCI, V12, P523; Chalfin BP, 2007, J COMP NEUROL, V504, P265, DOI 10.1002/cne.21406; CHALUPA LM, 1977, BEHAV BIOL, V20, P149, DOI 10.1016/S0091-6773(77)90721-0; Clark A, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00270; CRICK F, 1984, P NATL ACAD SCI-BIOL, V81, P4586, DOI 10.1073/pnas.81.14.4586; Feldman H, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00215; Fischer J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2054; Friston KJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002327; Friston KJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000211; Gibbs J, 1999, J NEUROPHYSIOL, V83, P1510; GOLDMANRAKIC PS, 1992, J NEURAL TRANSM-GEN, P163; Gregory R. L, 1968, P ROY SOC LOND B BIO, V171, P179, DOI DOI 10.1098/RSPB.1968.0071; Helmholtz H, 1866, TREATISE ON PHYSIOLO, V3rd; Hohwy Jakob, 2013, THE PREDICTIVE MIND; Jiang J, 2013, J NEUROSCI, V33, P18438, DOI [10.1523/JNEUROSCI.3308-13.2013, DOI 10.1523/INEUROSCI.3308-13.2013)]; Shipp S., 2007, CURR BIOL, V17, P443, DOI [DOI 10.1016/J.CUB.2007.03.044, 10.1016/j.cub.2007.03.044]; Snow JC, 2009, P NATL ACAD SCI USA, V106, P4054, DOI 10.1073/pnas.0810086106; SRINIVASAN MV, 1982, PROC R SOC SER B-BIO, V216, P427, DOI 10.1098/rspb.1982.0085; Strumpf H, 2013, HUM BRAIN MAPP, V34, P1115, DOI 10.1002/hbm.21496; TROJANOWSKI JQ, 1977, EXP BRAIN RES, V28, P51; UNGERLEIDER LG, 1979, NEUROPSYCHOLOGIA, V17, P493, DOI 10.1016/0028-3932(79)90056-3; van Kerkoerle T, 2014, P NATL ACAD SCI USA, V111, P14332, DOI 10.1073/pnas.1402773111; ZIHL J, 1979, BRAIN, V102, P835, DOI 10.1093/brain/102.4.835; Zikopoulos B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000848	77	3	3	ROYAL SOC	LONDON	6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND	0962-8436	1471-2970		PHILOS T R SOC B	Philos. Trans. R. Soc. B-Biol. Sci.	MAY 19	2015	370	1668					69	81	UNSP 20140169	10.1098/rstb.2014.0169		13	Biology	Life Sciences & Biomedicine - Other Topics	CH5JH	WOS:000354071400007		
J	Lee, HS; Nakai, Y				Lee, Hak Sop; Nakai, Yu			Effect of Floods on Village Spatial Structure and Hierarchy - Hahoe Village, Korea	Landscape Research			English	Article						land-use change; Hahoe village; landscape change; cultural landscape; Traditional village; feng shui		The development of the spatial structure of a traditional Korean village and its social hierarchy is analysed using a river engineering approach to determine the relevance of river flooding and examine how floods have transformed the landscape around the village. The subject focuses on the village of Hahoe, which was registered as a World Heritage Site in August 2010 for its well-preserved traditional architecture and beautiful natural landscape. The village is located on a small plain surrounded by mountains and within a loop of the serpentine Nakdong River. As a riverside village surrounded by water on three sides, its development is assumed to have been influenced by flooding, but no study has previously investigated the correlation between village development and inundations.	[Lee, Hak Sop] Samsung Engn Co Ltd, Seoul, South Korea; [Nakai, Yu] Univ Tokyo, Dept Civil Engn, Tokyo, Japan	Nakai, Y (reprint author), Univ Tokyo, Dept Civil Engn, Tokyo, Japan.	yu@keikan.t.u-tokyo.ac.jp			Global - COE program of JSPS	This study was part of author's Ph. D dissertation (Lee, H. S., 2010), directly supervised by professor Yu Nakai, the department of Civil Engineering at the University of Tokyo and funded by Global - COE program of JSPS.	Ackerman C. T., 2005, HEC GEORAS EXTENSION; Ackerman C. T., 2002, HEC GEORAS EXTENSION; Ackerman T. C., 2011, HEC GEORAS GIS TOOLS; Weng QH, 2002, J ENVIRON MANAGE, V64, P273, DOI 10.1006/jema.2001.0509; Wang YQ, 2001, ECOL MODEL, V140, P141, DOI 10.1016/S0304-3800(01)00262-9; Baek N. D., 2005, THESIS YOUNGNAM U DA; Bevan K. J., 1984, J HYDROL, V69, P119, DOI [10.1016/0022-1694(84)90159-8, DOI 10.1016/0022-1694(84)90159-8]; Brunner G., 2008, HEC RAS RIVER ANAL S; Cho H. S., 2006, THESIS YOUNGNAM U DA; Chow V. T., 1959, OPEN CHANNEL HYDRAUL; Chow V.T., 1988, APPL HYDROLOGY; Cultural Heritage Administration of Korea, 2012, HAH VILL AND; Goodchild MF, 1996, GIS ENV MODELING PRO; Gyeongsangbukdo Province, 1979, HAH VILL RES REP; Hahoe Village Superintendent's Office, 2013, IMP FORK MAT 306; Hahoe Village Superintendent's Office, 2013, IMP FORK MAT 414; Han J., 1995, THESIS CHUNGBUK NATL; Heit M., 1991, GIS APPL NATURAL RES; Hwang H. M., 2007, HAHOE VILLAGE; Hwang K. W., 2011, INTERPRETATION LANDS; Japanese Government-General, 1925, THE FLOOD OF JOS; Japanese Government-General, 1933, THE RIV OF JOS; Japanese Government-General, 1928, CIV ENG WORKS JOS; Japanese Government-General, 1936, FLOOD S JOS; Japanese Government-General, 1923, THE RIV OF JOS; Japanese Government-General, 1931, FENG SHUI OF JOS; Japanese Government-General, 1936, BAS PLAN RIV MAINT; Kamada M, 1996, LANDSCAPE ECOL, V11, P15, DOI 10.1007/BF02087110; Kang D. J., 1997, THESIS SEOUL NATL U; Kang Y. J., 2002, J KOREAN I LANDSCAPE, V30, P1; Khee N. N., 2011, BUYONGDAE CLIFF VILA; Kim D. I., 1982, THESIS YEONGNAM U DA; Kim K. H., 2000, THESIS BUSAN NATL U; Kim S. J., 2003, THESIS PUKYONG NATL; Kim S. K., 1988, THESIS U PENNSYLVANI; Kim T. K., 1964, RES LIFE ENV CLAN VI; Kim Y. J., 1981, HOHOE VILLAGE ANDONG; Korea National Housing Corporation, 2003, APPL NAT DRAIN SYST; Kwon S. J., 2003, THESIS KOREA NATL U; Lee H. S., 2010, THESIS U TOKYO TOKYO; Lee Hak-Sop, 2010, [korea Planners Association, 국토계획], V45, P243; Lee H. S., 2011, J KOREAN I LANDSCAPE, V12, P21; Lee H. S., 2011, J ASIAN ARCHIT BUILD, V11, P1; Lee J. Y., 1987, THESIS BUSAN NATL U; Lee Y. K., 2001, FENG SHUI TRIP ANDON; Lim J. H., 1992, HOHOE VILLAGE ANDONG; Ministry of Land Transport and Maritime Affairs, 1993, FAC IND BAS MAINT PL; Ministry of Land Transport and Maritime Affairs, 1972, BAS MAINT PLAN NAKD; Ministry of Land Transport and Maritime Affairs, 1983, BAS MAINT PLAN NAKD; Ministry of Land Transport and Maritime Affairs, 1993, APP BAS MAINT PLAN N; Ministry of Land Transport and Maritime Affairs, 1993, COMPL BAS MAINT PLAN; Ministry of Land Transport and Maritime Affairs, 1972, COMPL BAS MAINT PLAN; Moon E. B., 2001, THESIS SEOUL NATL U; Oh S. J., 2002, THESIS SANGJU NATL U; Republic of Korea, 2009, NOMINATION HIST VILL; Rho P., 2003, THESIS TEXAS A M U C; Ryu H. Y., 2003, THESIS CHONGJU U CHO; Seo S. Y., 1999, LOOKING HAHOE VILLAG; Son Y. H., 2007, THESIS U TOKYO TOKYO; Son Y. H., 2003, THESIS SEOUL NATL U; Sung J. S., 2003, THESIS SEOUL NATL U; Yoo K. H., 2012, THESIS SEOUL NATL U	62	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	0142-6397	1469-9710		LANDSCAPE RES	Landsc. Res.	MAY 19	2015	40	4					411	436		10.1080/01426397.2014.918093		26	Environmental Studies; Geography	Environmental Sciences & Ecology; Geography	CG6GJ	WOS:000353395600002		
J	Sakurai, R; Jacobson, SK; Matsuda, N; Maruyama, T				Sakurai, Ryo; Jacobson, Susan K.; Matsuda, Naoko; Maruyama, Tetsuya			Assessing the impact of a wildlife education program on Japanese attitudes and behavioral intentions	ENVIRONMENTAL EDUCATION RESEARCH			English	Article						Model District Program; behavioral intention; evaluation; human-wildlife conflict; attitude; Japan	MANAGEMENT; BEAR; RISK; PERCEPTION; CONFLICT	Human-wildlife conflicts are common in agricultural communities and mountainous villages in Japan. Tochigi prefecture has one of the highest amounts of agricultural damage caused by wildlife in the country. To reduce conflicts, the Nature Preservation Division of Tochigi Prefecture launched a wildlife damage prevention program. We evaluated the effects of this program on residents' attitudes and behavioral intentions by comparing a model district receiving the treatment program to a nearby control district. We conducted a survey of all households registered either in the residential organization or telephone book in each district (n = 423), with a 46% response rate. The model district did not differ from the control except for greater perceived behavioral control regarding wildlife damage among residents in the model district (F = 3.83, df = 1, p = 0.05). An unanticipated outcome was the development of a community-based wildlife group in the model district. In both model and control districts, subjective norm (perceived social pressure to engage or not to engage in a behavior) was the strongest predictor of behavioral intentions, unlike results of studies conducted in the US.	[Sakurai, Ryo; Jacobson, Susan K.] Univ Florida, Sch Nat Resources & Environm, Dept Wildlife Ecol & Conservat, Gainesville, FL USA; [Matsuda, Naoko] Tochigi Prefectural Govt, Dept Environm & Forestry, Nat Preservat Div, Utsunomiya, Tochigi, Japan; [Maruyama, Tetsuya] Tochigi Prefectural Forest Management Off, Yaita, Japan	Sakurai, R (reprint author), Yokohama Natl Univ, Japan Soc Promot Sci, Hodogaya Ku, Environm & Informat Sci Bldg 4,Room 206, Yokohama, Kanagawa 2408501, Japan.	ryo223sak@ynu.ac.jp			JSPS KAKENHI [25338]	This project was funded by the supporting organization for Research of Agricultural and Life Science in Tokyo and JSPS KAKENHI [grant number 25338].	Ajzen I., 1980, UNDERSTANDING ATTITU; Ajzen I, 1985, ACTION CONTROL COGNI, V2, P11, DOI [10.1007/978-3-642-69746-3_2, DOI 10.1007/978-3-642-69746-3_2]; Ferraro PJ, 2006, PLOS BIOL, V4, P482, DOI 10.1371/journal.pbio.0040105; Pullin AS, 2001, CONSERV BIOL, V15, P50, DOI 10.1046/j.1523-1739.2001.99499.x; Treves A, 2009, CONSERV BIOL, V23, P1577, DOI 10.1111/j.1523-1739.2009.01242.x; Brosius JP, 1998, SOC NATUR RESOUR, V11, P157, DOI 10.1080/08941929809381069; Siegrist M, 2005, J RISK RES, V8, P145, DOI 10.1080/1366987032000105315; Darker CD, 2010, PSYCHOL HEALTH, V25, P71, DOI 10.1080/08870440902893716; Cinner JE, 2009, MAR POLICY, V33, P489, DOI 10.1016/j.marpol.2008.11.001; Sax LJ, 2003, RES HIGH EDUC, V44, P409, DOI 10.1023/A:1024232915870; Ford-Thompson AES, 2012, CONSERV BIOL, V26, P345, DOI 10.1111/j.1523-1739.2011.01819.x; Division of Rural Development of Tochigi Prefecture, 2011, AGR DAM WILDL 2010; Dunn WC, 2008, URSUS, V19, P43, DOI 10.2192/1537-6176(2008)19[43:SEIBCA]2.0.CO;2; Ernst J. A., 2009, EVALUATING ENV ED PR; Espinosa S, 2012, J ENVIRON EDUC, V43, P55, DOI 10.1080/00958964.2011.579642; Gore M. L., 2006, CORNELL U HUMAN DIME, V06-14; Gore ML, 2006, URSUS, V17, P75, DOI 10.2192/1537-6176(2006)17[75:EPFRAB]2.0.CO;2; Gore M. L., 2009, Human Dimensions of Wildlife, V14, P301, DOI 10.1080/10871200903160944; Hashimoto K., 2008, J HEALTH SCI, V30, P27; Hayabuchi Y., 2008, SPILLOVER EFFECT ENV; Hrubes D, 2001, LEISURE SCI, V23, P165, DOI 10.1080/014904001316896855; Jacobson S. K., 2009, COMMUNICATION SKILLS; Kanuma City, 2010, STAT RECORDS; Kawai M., 2009, REBELLION WILDLIFE, P15; Martin S. R., 2009, Human Dimensions of Wildlife, V14, P206, DOI 10.1080/10871200902858993; McKenzie-Mohr D., 2006, FOSTERING SUSTAINABL; Ministry of Agriculture, 2011, WILDL DAM PREV INT; Ministry of Agriculture, 2007, AGR DAM WILDL EACH P; Nature Conservation Society of Japan, 2010, CONS LAW WILDL EC AS; NTT East, 2011, HELL TOCH; Rogers Everett, 1995, DIFFUSION INNOVATION; Rossi A., 1999, HUMAN DIMENSIONS WIL, V4, P40; Rossi PH, 2004, EVALUATION SYSTEMATI; Sakurai R., 2012, KYOSEI STUDIES, V6, P380; Sakurai R, 2013, URSUS, V24, P70; Sakurai R., 2013, WILDLIFE HUMAN SOC, V1, P47; Schwartz C. C., 2006, WILDLIFE SHIRETOKO Y, P232; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Sorice M. G., 2010, Human Dimensions of Wildlife, V15, P77; Suenaga T., 2003, INTRO SOCIOPSYCHOLOG; Krasny ME, 2009, ECOL SOC, V14; Tochigi Prefecture, 2013, INT PREV WILDL DAM; Ueda G., 2012, WILDLIFE CONSERVATIO, V13, P33; Vaske J. J., 2004, HUMAN DIMENSIONS WIL, V9, P193, DOI DOI 10.1080/10871200490479981	44	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	1350-4622	1469-5871		ENVIRON EDUC RES	Environ. Educ. Res.	MAY 19	2015	21	4					542	555		10.1080/13504622.2014.898246		14	Education & Educational Research; Environmental Studies	Education & Educational Research; Environmental Sciences & Ecology	CF5VJ	WOS:000352625000003		
J	Yamashita, H				Yamashita, Hiromi			The problems with a 'fact'-focused approach in environmental communication: the case of environmental risk information about tidal flat developments in Japan	ENVIRONMENTAL EDUCATION RESEARCH			English	Article						tidal flats; environmental communication; Japan; environmental education; critical thinking	SUSTAINABLE DEVELOPMENT; EDUCATION; SCIENCE	One of the main approaches used in communicating environmental issues to citizens is conveying 'factual' information about a particular environment. However, despite previous research and recommendations made by critical environmental educators, there still seems to be a belief that the more 'factual' information one can convey, the more citizens will become aware of the issue, and this will prompt them to change their behaviours. In this article, I will argue that continuing with a 'fact'-focused practice in Japan and elsewhere could be problematic for three key reasons: (1) it ignores diversity in the 'facts' provided to people; (2) it reinforces the 'hierarchy of knowledge'; and (3) it ignores the 'myth of nature' among information receivers and senders. Key recommendations for incorporating a critical environmental education approach include utilising locally available environmental information on contentious environmental issues; investigating particular terminology used and missing information (including tacit knowledge); and encouraging critical learning about statistics and pictorial representations.	Ritsumeikan Asia Pacific Univ APU, Environm & Dev Cluster, Beppu, Oita, Japan	Yamashita, H (reprint author), Ritsumeikan Asia Pacific Univ APU, Environm & Dev Cluster, Beppu, Oita, Japan.	hiromiya@apu.ac.jp					Abe O., 2003, ED SUSTAINABLE DEV, P1; Adams J, 1995, RISK; Collins HM, 2002, SOC STUD SCI, V32, P235, DOI 10.1177/0306312702032002003; FISCHHOFF B, 1995, RISK ANAL, V15, P137, DOI 10.1111/j.1539-6924.1995.tb00308.x; [Anonymous], 2002, ENVIRON EDUC RES, DOI 10.1080/13504620220145438; Yamashita H, 2006, EDUC REV, V58, P27, DOI 10.1080/00131910500352531; [Anonymous], 2007, J ED SUSTAINABLE DEV, DOI 10.1177/097340820700100209; HUNGERFORD H, 1980, J ENVIRON EDUC, V11, P42; Latour B, 2004, CRIT INQUIRY, V30, P225, DOI 10.1086/421123; Miller S, 2001, PUBLIC UNDERST SCI, V10, P115, DOI 10.1088/0963-6625/10/1/308; Yamashita H, 2009, OCEAN COAST MANAGE, V52, P327, DOI 10.1016/j.ocecoaman.2009.04.008; Ariake Sea Fishermen and Citizens' Network, 2004, IS KANT AR IH; Ariake Sea Fishermen and Citizens' Network and Isahaya Tidal Flat Emergency Rescue Tokyo Office, 2006, SHIM NIY IS KANT TOK; Bartels CJ, 1998, J HAZARD MATER, V61, P115, DOI 10.1016/S0304-3894(98)00115-0; Blackledge A., 2008, BLACKWELL GUIDE RES, P296; Blewitt J, 2011, ENVIRON EDUC RES, V17, P719, DOI 10.1080/13504622.2011.618625; Bloor M., 2007, PRACTICE CRITICAL DI; Callaghan J. D., 1989, EFFECTIVE RISK COMMU, P3; Carruthers P., 2000, EVOLUTION HUMAN MIND; Chiba no Higata o Mamorukai, SANB NEK KAK WA IK H; Chiba no Higata o Mamorukai, SANB NEK KAK NI HIR; Clover D., 2000, NATURE TRANSFORMATIO; Davies I., 1999, GLOBAL CITIZENSHIP E; Davies L., 2005, GLOBAL CITIZENSHIP E; DECJ, 2002, KAIH KYOIK KEY WORD; Douglas M., 1992, RISK BLAME ESSAYS CU; Festinger L., 1957, THEORY COGNITIVE DIS; Fien J., 1993, ED ENV CRITICAL CURR; Fien J., 2004, KEY ISSUES SUSTAINAB, P38; Fien J., 2004, KAIHATSU KYOIKU, V49, P76; Freire P., 1970, PEDAGOGY OPPRESSED; Hesselink F., 2007, COMMUNICATION ED PUB; Hitsumoto M., 2011, OYO SYAKAIGAKU KENKY, V53, P237; Holling C. S., 1979, STUDIES CRISIS MANAG, P513; Hornig S., 1993, PUBLIC UNDERST SCI, V2, P95, DOI 10.1088/0963-6625/2/2/001; Huckle J., 2001, CITIZENSHIP SECONDAR, P144; Huckle J, 2004, HIGHER EDUCATION AND THE CHALLENGE OF SUSTAINABILITY, P33, DOI 10.1007/0-306-48515-X_4; Huckle J, 2009, GEOGRAPHY, V94, P13; Huckle J., 2008, SAGE HDB ED CITIZENS, P342; Huckle J, 2002, GEOGRAPHY, V87, P64; Huckle J, 2008, ENVIRON EDUC RES, V14, P65, DOI 10.1080/13504620701843392; Huckle J., 1996, ED SUSTAINABILITY; Huff D., 1954, LIE STAT; Ichikawa City, 2003, SANB SAIS NI MUK ICH; Irwin A., 1996, MISUNDERSTANDING SCI; Irwin A, 1995, CITIZEN SCI STUDY PE; IRWIN A, 1994, SOC STUD SCI, V24, P168, DOI 10.1177/030631279402400113; Isahaya Land Reclamation Office, 2005, WAT KUR KANT; Ishikawa S., 2001, ED ENV CRITICAL CURR, P15; Jensen B., 2002, ENVIRON EDUC RES, V8, P325, DOI DOI 10.1080/13504620220145474; Kamijyo N., 2004, KAIHATSU KYOIKU, V50, P20; Kollmuss A., 2002, ENVIRON EDUC RES, V8, P239, DOI DOI 10.1080/13504620220145401; Kusumi T., 2012, HIGH SCH SECT M COUN; Kyushu Agricultural Administration Office, IS KANT GAIY; Latour Bruno, 1987, SCI ACTION FOLLOW SC; Latour Bruno, 2004, POLITICS NATURE BRIN; Lundgren R., 2004, HDB COMMUNICATION EN; Miyokawa K., 2009, KANKYO KYOIKU MANABU; Morgan M. G., 2002, RISK COMMUNICATION M; Nagasaki Prefecture, 2002, NAG PREF NEWS IS LAN; Nitta K., 2004, KAIHATSU KYOIKU, V50, P31; Nitta K., 2003, JIZOKU KANO KAIHASTU, P22; Pepper D., 1987, ED ECOLOGY DEV CASE, P65; Pinker S., 1997, MIND WORKS; Prior L., 2003, USING DOCUMENTS SOCI; Ramsar, 2010, RAMSAR HDB, V6; Ramsar, 2008, RAMSAR CONVENTION DE; Sanbanze Laboratory, KAK MOND; Schwarz M, 1990, DIVIDED WE STAND RED; Science Council of Japan [Nihon Gakujyutsu Kaigi], 2011, RECOMM ENR ENV ED HI; Science Council of Japan [Nihon Gakujyutsu Kaigi], 2008, TEIG GAKK KYOIK CYUS; Selin E., 1987, RISK AND SOC, P151; Singh M., 1998, ENVIRON EDUC RES, V4, P341, DOI 10.1080/1350462980040308; Slovic P., 1998, RISK MODERN SOC, P181; Sterling S., 2004, SUSTAINABILITY CURRI, P43; Sterling S., 2004, KEY ISSUES SUSTAINAB, P68; Tanaka H., 2008, KAIHATSU KYOIKU JIZO; TIDE, BILL SCOTT LEARN SUS; UNICEF, 2000, CIT 400 SCH; Williams C., 1997, TERMINUS BRAIN ENV T; Yamashita Hirofumi, 1990, ASAHI NEWSPAPER 0428	81	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	1350-4622	1469-5871		ENVIRON EDUC RES	Environ. Educ. Res.	MAY 19	2015	21	4					586	611		10.1080/13504622.2014.940281		26	Education & Educational Research; Environmental Studies	Education & Educational Research; Environmental Sciences & Ecology	CF5VJ	WOS:000352625000005		
J	Wang, AH; Kawabata, K; Goto, H				Wang, Aohan; Kawabata, Kohsuke; Goto, Hiromasa			Thiophene-based chiral small bandgap pi-conjugated polymers: synthesis and optical properties	DESIGNED MONOMERS AND POLYMERS			English	Article						isothianaphthene; polycondensation; pi-stacking; chiral	ALTERNATING COPOLYMERS; CHAIN	A series of thiophene-based chiral small bandgap pi-conjugated polymers was successfully synthesized. Optical properties of the polymers were investigated by using UV-vis, photoluminescence (PL), circular dichroism (CD) spectroscopies, and specific rotation measurements. Especially, the isothianaphthene-thiophene based copolymers display 10-20nm longer absorption maximum than those of thiophene-thiophene copolymers in the UV-vis. PL measurements demonstrate that the polymer exhibit light emission. CD spectroscopy measurements reveal helical pi-stacking structure of the polymers.	[Wang, Aohan; Kawabata, Kohsuke; Goto, Hiromasa] Univ Tsukuba, Fac Pure & Appl Sci, Div Mat Sci, Tsukuba, Ibaraki 3058573, Japan	Goto, H (reprint author), Univ Tsukuba, Fac Pure & Appl Sci, Div Mat Sci, Tsukuba, Ibaraki 3058573, Japan.	gotoh@ims.tsukuba.ac.jp	Kawabata, Kohsuke/A-6053-2014		Ministry of Education, Culture, Sports, Science and Technology of Japan [25410218, 10750642]	Prof. H. Goto (Asst. Prof., at that time, in 1998) is thankful to Prof. K. Kaeriyama (Kyoto Institute of Technology) on the fruitful discussion about the aromatic type conjugated polymers on the occasion of the 47th The Society of Polymer Science, Japan (SPSJ) Symposium on Macromolecules (1998). He kindly gifted a reprint of ref. 7 to Goto, later. The analysis of the PL and the NMR was carried out with a F-4500 (Hitachi) and a JNM-ECS 400 (JEOL), respectively, at University of Tsukuba and the OPEN FACILITY, Research Facility Center for Science and Technology, University of Tsukuba. We thank Engineering Workshop of University of Tsukuba for glasswork. This work was supported by Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant #25410218, H. Goto). The early stage of this work was supported by Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant #10750642 in 1998-1999, H. Goto).	Langeveld-Voss BMW, 2000, J MOL STRUCT, V521, P285, DOI 10.1016/S0022-2860(99)00444-5; FRANKLIN RE, 1953, NATURE, V171, P740, DOI 10.1038/171740a0; SEITZ DE, 1983, SYNTHETIC COMMUN, V13, P121, DOI 10.1080/00397918308061969; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; Dong JC, 2015, J MATER CHEM C, V3, P2024, DOI 10.1039/c4tc02489c; Goto H, 2014, IOP CONF SER-MAT SCI, V54, DOI 10.1088/1757-899X/54/1/012013; Goto H, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.253901; Innami Y, 2012, MATERIALS, V5, P317, DOI 10.3390/ma5020317; Kaeriyama K, 1999, MACROMOL RAPID COMM, V20, P50, DOI 10.1002/(SICI)1521-3927(19990201)20:2<50::AID-MARC50>3.0.CO;2-S; Kawabata K, 2012, J MATER CHEM, V22, P23514, DOI 10.1039/c2jm35594a; Kuwabara J, 2013, POLYM CHEM-UK, V4, P947, DOI 10.1039/c2py20917a; MITSUNOBU O, 1981, SYNTHESIS-STUTTGART, P1, DOI 10.1055/s-1981-29317; Ohkawa S, 2013, J APPL POLYM SCI, V128, P3586, DOI 10.1002/app.38561; Otsu T., 1968, CHEM POLYM SYNTHESIS	14	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1385-772X	1568-5551		DES MONOMERS POLYM	Des. Monomers Polym.	MAY 19	2015	18	4					360	366		10.1080/15685551.2015.1012625		7	Polymer Science	Polymer Science	CE5YU	WOS:000351913100007		
J	Elsharkawy, MM; Shivanna, MB; Meera, MS; Hyakumachi, M				Elsharkawy, Mohsen Mohamed; Shivanna, Manchanahally Byrappa; Meera, Manchanahally Shivanna; Hyakumachi, Mitsuro			Mechanism of induced systemic resistance against anthracnose disease in cucumber by plant growth-promoting fungi	ACTA AGRICULTURAE SCANDINAVICA SECTION B-SOIL AND PLANT SCIENCE			English	Article						culture filtrate; Phoma sp.; defense-related enzymes; Colletotrichum orbiculare	PENICILLIUM-SIMPLICISSIMUM GP17-2; GLOMUS-MOSSEAE; MOSAIC-VIRUS; FUSARIUM-EQUISETI; PATHOGENIC FUNGI; DAMPING-OFF; CELL-WALLS; INDUCTION; TOBACCO; LIGNIFICATION	Plant growth-promoting fungi (PGPF) such as Phoma sp. (isolates GS8-1, GS8-2 and GS8-3) and non-sporulating fungus (isolate GU21-2) were tested for their ability to induce systemic resistance against Colletotrichum orbiculare in cucumber. These isolates, used as colonized barley kernels to natural soils, induced systemic resistance in the greenhouse as well as in the field. Different elicitors from PGPF such as cell walls retaining or lacking protein and lipids, cell walls lipid fraction, and three fractions of culture filtrate (CF) with different molecular weight ranges were tested for their ability to elicit the defense response of cucumber plants under controlled conditions. Cell wall fraction lacking protein and lipids and the cell wall lipid fraction from root colonizing isolates GS8-1, GS8-2, and GS8-3 protected plants against C. orbiculare. While, only cell wall lipid fraction and CF fractions of different molecular weight ranges of the isolate GU21-2 protected plants against C. orbiculare infection. Methanol-soluble substances from CF fractions with molecular weight greater than 12,000 and less than 8000 consistently protected plants against the pathogen. Germination of C. orbiculare spores decreased significantly at 72 h of incubation on leaves of PGPF-protected plants. Isolate GU21-2 was the most effective in inhibiting spore germination. On the other hand, isolates GS8-1 and GU21-2 induced lignifications in the hypocotyls of seven-day-old cucumber seedlings after challenge inoculation with C. orbiculare. Three-week-old cucumber plants treated with isolate GU21-2 and challenged with C. orbiculare showed increased activities of exo- and endo-forms of glucanase and chitinase, as well as peroxidase and polyphenol oxidase in the second true leaves. Induction treatment with isolate GS8-1 also increased the activities of these enzymes with the exception of exo-glucanase. This study shows that the inoculation of PGPF or its CF resulted in additive effect on the suppression of anthracnose disease in cucumber.	[Elsharkawy, Mohsen Mohamed] Kafrelsheikh Univ, Dept Agr Bot, Fac Agr, Kafr Al Sheikh 33516, Egypt; [Shivanna, Manchanahally Byrappa; Meera, Manchanahally Shivanna] Gifu Univ, United Grad Sch Agr Sci, Gifu 5011193, Japan; [Hyakumachi, Mitsuro] Gifu Univ, Fac Appl Biol Sci, Plant Pathol Lab, Gifu 5011193, Japan	Hyakumachi, M (reprint author), Gifu Univ, Fac Appl Biol Sci, Plant Pathol Lab, 1-1 Yanagido, Gifu 5011193, Japan.	hyakumac@cc.gifu-u.ac.jp					ANDERSON AJ, 1980, CAN J MICROBIOL, V26, P1473; VANPEER R, 1992, NETH J PLANT PATHOL, V98, P129; Chandanie WA, 2009, APPL SOIL ECOL, V41, P336, DOI 10.1016/j.apsoil.2008.12.006; HAMMERSCHMIDT R, 1982, PHYSIOL PLANT PATHOL, V20, P61, DOI 10.1016/0048-4059(82)90024-8; Koike N, 2001, EUR J PLANT PATHOL, V107, P523, DOI 10.1023/A:1011203826805; Elsharkawy MM, 2012, PLANT SOIL, V361, P397, DOI 10.1007/s11104-012-1255-y; Shimizu K, 2013, J OLEO SCI, V62, P613, DOI 10.5650/jos.62.613; VANCE CP, 1980, ANNU REV PHYTOPATHOL, V18, P259, DOI 10.1146/annurev.py.18.090180.001355; LIU L, 1995, PHYTOPATHOLOGY, V85, P695, DOI 10.1094/Phyto-85-695; Elsharkawy MM, 2012, PLANT PATHOL, V61, P964, DOI 10.1111/j.1365-3059.2011.02573.x; KEEN NT, 1983, PLANT PHYSIOL, V71, P460, DOI 10.1104/pp.71.3.460; Saldajeno MGB, 2011, ANN APPL BIOL, V159, P28, DOI 10.1111/j.1744-7348.2011.00471.x; RIDE JP, 1975, PHYSIOL PLANT PATHOL, V5, P125, DOI 10.1016/0048-4059(75)90016-8; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; WARD ER, 1991, PLANT CELL, V3, P1085; MAURHOFER M, 1994, PHYTOPATHOLOGY, V84, P139, DOI 10.1094/Phyto-84-139; OBRIEN TP, 1964, PROTOPLASMA, V59, P368, DOI 10.1007/BF01248568; BAKER R, 1978, PHYTOPATHOLOGY, V68, P1495; Bashan S, 1983, PHYSL PLANT PATHOL, V23, P137; Boller T, 1988, METHOD ENZYMOL, V161, P431; BROWN AE, 1987, J PHYTOPATHOL, V120, P298, DOI 10.1111/j.1439-0434.1987.tb00493.x; BRUESKE CH, 1980, PHYSIOL PLANT PATHOL, V16, P409; Chandanie WA, 2006, PLANT SOIL, V286, P209, DOI 10.1007/s11104-006-9038-y; Elsharkawy MM, 2014, ACTA AGR SCAND B-S P, V64, P135, DOI 10.1080/09064710.2014.888470; Elsharkawy MM, 2013, PLANT PATHOLOGY J, V29, P193, DOI [10.5423/PPJ.SI.07.2012.01, 10.5423/PPJ.SI.07.2012.0117]; HAMMERSCHMIDT R, 1984, PHYSIOL PLANT PATHOL, V24, P33, DOI 10.1016/0048-4059(84)90071-7; Hassan N, 2014, ACTA AGR SCAND B-S P, V64, P155, DOI 10.1080/09064710.2014.898783; HEINKEL CM, 1992, PHYTOPATHOLOGY, V82, P637, DOI 10.1094/Phyto-82-637; HUGHES RK, 1989, PHYSIOL MOL PLANT P, V34, P361, DOI 10.1016/0885-5765(89)90032-5; IRVING HR, 1990, PHYSIOL MOL PLANT P, V37, P355, DOI 10.1016/0885-5765(90)90118-H; Ishiba C, 1981, JPN J PHYTOPATHOL, V47, P352; KUC J, 1990, BIOLOGICAL CONTROL OF SOIL-BORNE PLANT PATHOGENS, P355; MARAIS JP, 1966, ANAL BIOCHEM, V15, P373, DOI 10.1016/0003-2697(66)90098-4; MEERA MS, 1995, CROP PROT, V14, P123, DOI 10.1016/0261-2194(95)92866-L; MEERA MS, 1995, EUR J PLANT PATHOL, V101, P421, DOI 10.1007/BF01874856; Meera MS, 1994, ANN PHYTOPATHOL SOC, V57, P301; PUTTER J, 1974, METHOD ENZYMAT AN, V2, P685; Ricci P, 1986, BIOL MOL BIOL PLAN H, P191; SCHNEIDER S, 1994, PHYSIOL MOL PLANT P, V45, P291, DOI 10.1016/S0885-5765(05)80060-8; SHERWOOD RT, 1976, PHYTOPATHOLOGY, V66, P503; STAUB TH, 1980, PHYSIOL PLANT PATHOL, V17, P389; Sudisha J., 2013, J EXP BOT, V64, P3829, DOI DOI 10.1093/JXB/ERT212; TJAMOS EC, 1979, PHYSIOL PLANT PATHOL, V15, P223, DOI 10.1016/0048-4059(79)90072-9; TUZUN S, 1989, PHYTOPATHOLOGY, V79, P979, DOI 10.1094/Phyto-79-979; VEGETTI G, 1975, Phytopathologische Zeitschrift, V84, P153; WOODWARD S, 1986, PHYSIOL MOL PLANT P, V29, P337	46	2	2	TAYLOR & FRANCIS AS	OSLO	KARL JOHANS GATE 5, NO-0154 OSLO, NORWAY	0906-4710	1651-1913		ACTA AGR SCAND B-S P	Acta Agric. Scand. Sect. B-Soil Plant Sci.	MAY 19	2015	65	4					287	299		10.1080/09064710.2014.1003248		13	Agronomy; Soil Science	Agriculture	CC6FF	WOS:000350459700001		
J	Sangare, D; Dakoure, MS; Hijikata, N; Lahmar, R; Yacouba, H; Coulibaly, L; Funamizu, N				Sangare, D.; Dakoure, M. Sou; Hijikata, N.; Lahmar, R.; Yacouba, H.; Coulibaly, L.; Funamizu, N.			Toilet compost and human urine used in agriculture: fertilizer value assessment and effect on cultivated soil properties	ENVIRONMENTAL TECHNOLOGY			English	Article						toilet compost; human urine; biofertilizers; best ratio; soil properties	OKRA ABELMOSCHUS-ESCULENTUS; WASTE-WATER; HUMAN FECES; YIELD; PHOSPHORUS; DIVERSION; NUTRIENTS; SALINITY; IMPACT; GROWTH	Toilet compost (TC) and human urine are among natural fertilizers, which raise interest due to their double advantages to combine sanitation and nutrient recovery. However, combination of urine and TC is not so spread probably because the best ratio (urine/TC) is still an issue and urine effect on soil chemical properties remains poorly documented. This study aims to determine the best ratio of urine and TC in okra cultivation, by targeting higher fertilization effect combined with lower impact on soil chemical properties. Based on Nitrogen requirement of okra, seven treatments were compared: (T0) no fertilizer, (T1) chemical fertilizer (NPK: 14-23-14), (T2) 100% urine, (T3) 100% TC, (T4) ratio of 75% urine + 25% TC, (T5) 50% urine + 50% TC and (T6) 25% urine + 75% TC. Results indicated that T4 (75% urine + 25% TC) gave the highest plant height and yield. In contrast, T2 (100% urine) gave the lowest results among all treatments, indicating toxicity effects on plant growth and associated final yield. Such toxicity is confirmed by soil chemical properties at T2 with soil acidification and significant increase in soil salinity. In contrast, application of urine together with TC mitigates soil acidification and salinity, highlighting the efficiency of urine and TC combination on soil chemical properties. However, further investigation is necessary to refine better urine/TC ratio for okra production.	[Sangare, D.; Dakoure, M. Sou; Lahmar, R.; Yacouba, H.] Int Inst Water & Environm Engn, Ouagadougou, Burkina Faso; [Sangare, D.; Coulibaly, L.] Univ Nangui Abrogoua, UFR Sci & Gest Environm, Abidjan, Cote Ivoire; [Hijikata, N.; Funamizu, N.] Hokkaido Univ, Dept Environm Engn, Kita Ku, Sapporo, Hokkaido 0608628, Japan; [Lahmar, R.] Ctr Cooperat Int Rech Agron Dev CIRAD, Montpellier, France	Sangare, D (reprint author), Int Inst Water & Environm Engn, Ouagadougou, Burkina Faso.	drissa.sangare@2ie-edu.org			JST-JICA; SATREPS	This work was supported by the JST-JICA and SATREPS.	Udert KM, 2003, WATER RES, V37, P2571, DOI 10.1016/S0043-1354(03)00065-4; TANDON HLS, 1968, SOIL SCI SOC AM PRO, V32, P48; Kemacheevakul P, 2014, ENVIRON TECHNOL, V35, P3011, DOI 10.1080/09593330.2014.929179; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Lamsal K, 1999, AGR WATER MANAGE, V41, P57, DOI 10.1016/S0378-3774(98)00116-4; Larsen TA, 2007, WATER SCI TECHNOL, V56, P229, DOI 10.2166/wst.2007.576; Akpan-Idiok AU, 2012, RESOUR CONSERV RECY, V62, P14, DOI 10.1016/j.resconrec.2012.02.003; Tungudomwongsa H, 2006, J ADV OXID TECHNOL, V9, P59; Toscano A, 2013, ENVIRON TECHNOL, V34, P2327, DOI 10.1080/09593330.2013.767284; Winker M, 2009, BIORESOURCE TECHNOL, V100, P4090, DOI 10.1016/j.biortech.2009.03.024; Tonner-Klank L, 2007, WASTE MANAGE, V27, P1144, DOI 10.1016/j.wasman.2006.04.021; Ghoulam C, 2002, ENVIRON EXP BOT, V47, P39, DOI 10.1016/S0098-8472(01)00109-5; Chapin CT, 2004, WETLANDS, V24, P186, DOI 10.1672/0277-5212(2004)024[0186:PANEOA]2.0.CO;2; Shrestha D, 2013, SCI HORTIC-AMSTERDAM, V153, P8, DOI 10.1016/j.scienta.2013.01.022; Vinneras B, 2002, BIORESOURCE TECHNOL, V84, P275, DOI 10.1016/S0960-8524(02)00054-8; Niwagaba C, 2009, ENVIRON TECHNOL, V30, P487, DOI 10.1080/09593330902788236; Khalid I, 2014, ENVIRON TECHNOL, V35, P487, DOI 10.1080/09593330.2013.833641; APHA, 1998, STANDARD METHODS EXA; Asano TFL, 2007, TCHOBANOGLOUS WATER, P959; Ayres R. M., 1996, ANAL WASTEWATER USE; Boulet R., 1976, NOTICE CARTES RESSOU, P106; Esrey SA, 2001, WATER RESOUR, V18, P43; FAO, 1997, FAO DEV SER, V2, P65; Grubben HG, 2004, PLANT RESOURCES TROP, V2, P27; Hamon S, 1977, AMELIORATION PLANTES, P313; Heinonen-Tanski H, 2005, BIORESOURCE TECHNOL, V96, P403, DOI 10.1016/j.biortech.2003.10.036; Pradhan SK, 2009, J AGR FOOD CHEM, V57, P7612, DOI 10.1021/jf9018917; Ito R, 2013, ENVIRON TECHNOL, V34, P2813, DOI 10.1080/09593330.2013.790069; Ito R., 2012, P 4 DRY TOIL C TAMP; Jonsson H, 2004, 2 STOCKH ENV I, V2, P43; Kutu FR, 2011, WASTE MANAGE RES, V29, P532, DOI 10.1177/0734242X10374900; Linden B, 1997, 1 DEP AGR RES B; Lopez ZMA, 2005, COMPOST SCI UTIL, V13, P208; Lopez ZMA, 2004, WATER RES, V38, P1327; Mnkeni PNS, 2009, WATER SA, V35, P133; Mnkeni PNS, 2008, WASTE MANAGE RES, V26, P132, DOI 10.1177/0734242X07079179; Munch EV, 2011, TECHNOLOGY REV URINE; N'Dayegamiye A, 2005, AGRSOL, V16, P135; Omotoso S. O., 2007, International Journal of Agricultural Research, V2, P614; Ozdemir S, 2013, ENVIRON TECHNOL, V34, P1497, DOI 10.1080/09593330.2012.758660; Rainey Rochelle C., 2005, Journal of Water and Health, V3, P239; Reidel EJ, 2004, J HORTIC SCI BIOTECH, V79, P906; Ritchey KD, 2008, SOIL SCI SOC AM J, V72, P626, DOI 10.2136/sssaj2007.0129; Saccd IM, 2001, PAK J BIOL SCI, V4, P949; Sebastian S. P., 2009, Australian Journal of Basic and Applied Sciences, V3, P1674; Sene M., 2013, International Research Journal of Agricultural Science and Soil Science, V3, P182; Sossou SK, 2014, ENVIRON TECHNOL, V35, P674, DOI 10.1080/09593330.2013.841268; Sou/Dakoure YM, 2013, GEODERMA, V200-201, P31; Surendra KC, 2013, ENVIRON TECHNOL, V34, P1671, DOI 10.1080/09593330.2013.824012; Unlukara A, 2008, J IRRIG DRAIN E-ASCE, V134, P160, DOI 10.1061/(ASCE)0733-9437(2008)134:2(160); WHO, 2006, GUID SAF US WAST EXC, V4	51	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0959-3330	1479-487X		ENVIRON TECHNOL	Environ. Technol.	MAY 19	2015	36	10					1291	1298		10.1080/09593330.2014.984774		8	Environmental Sciences	Environmental Sciences & Ecology	CC0RF	WOS:000350042700009		
J	Islam, MS; Ahmed, MK; Habibullah-Al-Mamun, M				Islam, Md. Saiful; Ahmed, Md. Kawser; Habibullah-Al-Mamun, Md.			Determination of Heavy Metals in Fish and Vegetables in Bangladesh and Health Implications	HUMAN AND ECOLOGICAL RISK ASSESSMENT			English	Article						fish; target hazard quotient (THQ); heavy metals; vegetables; estimated daily intake (EDI); health risk	FRESH-WATER FISH; RISK-ASSESSMENT; TRACE-ELEMENTS; SOUTH CHINA; FOOD CROPS; RIVER; CONTAMINATION; CONSUMPTION; CADMIUM; LEAD	Concentrations of six heavy metals (chromium, nickel, copper, arsenic, cadmium, and lead) in fish and vegetables were estimated to evaluate contamination levels and health risks for Bangladeshi adults. The analyzed metals varied between different species of fish and vegetables. Metals like Ni, Cd, and Pb in fish species were higher than the respective maximum allowable concentrations (MAC), whereas As, Cd, and Pb in some species of vegetables exceeded the MAC. Health risks associated with these metal intakes were evaluated in terms of dietary intake and target hazard quotients (THQs). The THQ values for individual metals were below 1 (except As for some species), suggesting that people would not experience significant health hazards if they ingest a single metal from one species of fish and/or vegetable. However, total metal THQ (TTHQ) signifies the potential non-carcinogenic health hazard to the highly exposed consumers in Bangladesh. Also, the estimation showed that the carcinogenic risk (TR) of arsenic and lead were within the acceptable range for fish but exceeded the accepted risk level for vegetables. From the health point of view, this study showed that the inhabitants who consume contaminated fish and vegetables are exposed chronically to metal pollution with carcinogenic and non-carcinogenic consequences.	[Islam, Md. Saiful; Habibullah-Al-Mamun, Md.] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Yokohama, Kanagawa 240, Japan; [Islam, Md. Saiful] Patuakhali Sci & Technol Univ, Dept Soil Sci, Dumki 8602, Patuakhali, Bangladesh; [Ahmed, Md. Kawser; Habibullah-Al-Mamun, Md.] Univ Dhaka, Dept Fisheries, Dhaka 1000, Bangladesh	Islam, MS (reprint author), Patuakhali Sci & Technol Univ, Dept Soil Sci, Dumki 8602, Patuakhali, Bangladesh.	msaifulpstu@yahoo.com					Djedjibegovic J, 2012, FOOD CHEM, V131, P469, DOI 10.1016/j.foodchem.2011.09.009; Anawar HM, 2002, ENVIRON INT, V27, P597, DOI 10.1016/S0160-4120(01)00116-7; Mansour SA, 2009, CHEMOSPHERE, V75, P601, DOI 10.1016/j.chemosphere.2009.01.058; Fryer M, 2006, ENVIRON SCI POLICY, V9, P261, DOI 10.1016/j.envsci.2005.11.011; Powers KM, 2003, NEUROLOGY, V60, P1761; Uzu G, 2011, ENVIRON SCI TECHNOL, V45, P7888, DOI 10.1021/es200374c; Sapozhnikova Y, 2005, CHEMOSPHERE, V60, P196, DOI 10.1016/j.chemosphere.2004.12.061; Burger J, 2005, ENVIRON RES, V99, P403, DOI 10.1016/j.envres.2005.02.001; Zhuang P, 2009, SCI TOTAL ENVIRON, V407, P1551, DOI 10.1016/j.scitotenv.2008.10.061; Wang XL, 2005, SCI TOTAL ENVIRON, V350, P28, DOI 10.1016/j.scitotenv.2004.09.044; Jinadasa KBPN, 1997, J ENVIRON QUAL, V26, P924; Bhuiyan MAH, 2011, ENVIRON MONIT ASSESS, V175, P633, DOI 10.1007/s10661-010-1557-6; Pan K, 2012, SCI TOTAL ENVIRON, V421, P3, DOI 10.1016/j.scitotenv.2011.03.013; Tuzen M, 2009, FOOD CHEM TOXICOL, V47, P1785, DOI 10.1016/j.fct.2009.04.029; Alam MGM, 2003, SCI TOTAL ENVIRON, V308, P83, DOI 10.1016/S0048-9697(02)00651-4; Yi YJ, 2011, ENVIRON POLLUT, V159, P2575, DOI 10.1016/j.envpol.2011.06.011; Gebrekidan A, 2013, ECOTOX ENVIRON SAFE, V95, P171, DOI 10.1016/j.ecoenv.2013.05.035; Alhashemi AH, 2012, MICROCHEM J, V104, P1, DOI 10.1016/j.microc.2012.03.002; Pandey J, 2009, ENVIRON MONIT ASSESS, V148, P61, DOI 10.1007/s10661-007-0139-8; Marti-Cid R, 2008, BIOL TRACE ELEM RES, V125, P120, DOI 10.1007/s12011-008-8162-3; Kachenko A, 2006, WATER AIR SOIL POLL, V169, P101, DOI 10.1007/s11270-006-2027-1; Forti E, 2011, TOXICOL IN VITRO, V25, P454, DOI 10.1016/j.tiv.2010.11.013; Chien LC, 2002, SCI TOTAL ENVIRON, V285, P177, DOI 10.1016/S0048-9697(01)00916-0; Song B, 2009, J ENVIRON SCI-CHINA, V21, P1702, DOI 10.1016/S1001-0742(08)62476-6; Burger J, 2002, ENVIRON RES, V89, P85, DOI 10.1006/cnrs.2002.4330; van der Oost R, 2003, ENVIRON TOXICOL PHAR, V13, P57, DOI 10.1016/S1382-6689(02)00126-6; Nadal M, 2008, HUM ECOL RISK ASSESS, V14, P780, DOI 10.1080/10807030802235235; Fang Y, 2014, FOOD CHEM, V147, P147, DOI 10.1016/j.foodchem.2013.09.116; Ahmad JU, 2010, ENVIRON MONIT ASSESS, V166, P347, DOI 10.1007/s10661-009-1006-6; Sharma RK, 2007, ECOTOX ENVIRON SAFE, V66, P258, DOI 10.1016/j.ecoenv.2005.11.007; Mapanda F, 2005, AGR ECOSYST ENVIRON, V107, P151, DOI 10.1016/j.agee.2004.11.005; Rahman MM, 2013, J HAZARD MATER, V262, P1056, DOI 10.1016/j.jhazmat.2012.06.045; Qiu YW, 2011, ECOTOX ENVIRON SAFE, V74, P284, DOI 10.1016/j.ecoenv.2010.10.008; Li QS, 2012, J HAZARD MATER, V227, P148, DOI 10.1016/j.jhazmat.2012.05.023; Duruibe JO, 2007, INT J PHYS SCI, V2, P112; Saha N, 2013, ENVIRON MONIT ASSESS, V185, P3867, DOI 10.1007/s10661-012-2835-2; Karim RA, 2008, ENVIRON MONIT ASSESS, V145, P417, DOI 10.1007/s10661-007-0050-3; Rahman MS, 2012, FOOD CHEM, V134, P1847, DOI 10.1016/j.foodchem.2012.03.099; Santos EE, 2004, SCI TOTAL ENVIRON, V327, P69, DOI 10.1016/j.scitotenv.2004.01.016; Banerjee N, 2011, TOXICOL SCI, V121, P132, DOI 10.1093/toxsci/kfr046; Bean H, 2010, INT UROL NEPHROL, V42, P409, DOI 10.1007/s11255-009-9639-5; Cronin M, 1998, MAR ENVIRON RES, V45, P225, DOI 10.1016/S0141-1136(98)00024-5; European Union, 2002, HEAV MET WAST; FAO (Food and Agriculture Organization), 2006, ARS CONT IRR WAT SOI; FAO/WHO, 2011, JOINT FAO WHO FOOD S, P1; FAO/WHO (FAO/World Health Organization), 2002, 0216 FAOWHO CSFAC CO; Gupta A, 2009, ENVIRON MONIT ASSESS, V157, P449, DOI 10.1007/s10661-008-0547-4; HIES (Household Income and Expenditure Survey), 2011, PREL REP HOUS INC EX; Islam M. M., 2009, Research Journal of Environmental Sciences, V3, P311, DOI 10.3923/rjes.2009.311.315; McCluggage D, 1991, NCS MAGAZINE; Muchuweti M., 2006, Agriculture, Ecosystems & Environment, V112, P41, DOI 10.1016/j.agee.2005.04.028; Papagiannis I, 2004, ENVIRON INT, V30, P357, DOI 10.1016/j.envint.2003.08.002; Rmalli SWA, 2005, SCI TOTAL ENVIRON, V337, P23; Sankar TV, 2006, CHEMOSPHERE, V65, P583, DOI 10.1016/j.chemosphere.2006.02.038; SHARIF AKM, 1993, SCI TOTAL ENVIRON, V138, P117, DOI 10.1016/0048-9697(93)90409-Y; SPRY DJ, 1991, ENVIRON POLLUT, V71, P243, DOI 10.1016/0269-7491(91)90034-T; Tao Yu, 2012, Ecotoxicol Environ Saf, V81, P55, DOI 10.1016/j.ecoenv.2012.04.014; USEPA, 2010, RISK BAS CONC TABL; USEPA, 1991, EPA505290001; [USEPA] United States Environmental Protection Agency, 1989, EPA540189002; Vieira C, 2011, FOOD CHEM TOXICOL, V49, P923, DOI 10.1016/j.fct.2010.12.016; WHO, 1985, WHO OFFS PUBL, V87, P1; WHO, 1995, LEAD	63	1	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1080-7039	1549-7860		HUM ECOL RISK ASSESS	Hum. Ecol. Risk Assess.	MAY 19	2015	21	4					986	1006		10.1080/10807039.2014.950172		21	Biodiversity Conservation; Environmental Sciences	Biodiversity & Conservation; Environmental Sciences & Ecology	AW9MO	WOS:000346581800008		
J	Hayashi, S				Hayashi, Shigehiko			Atomistic understanding and design of microbial opsin-based optogenetics tools	JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS			English	Meeting Abstract							MICROSCOPY		[Hayashi, Shigehiko] Kyoto Univ, Grad Sch Sci, Dept Chem, Kyoto 6068502, Japan		hayashig@kuchem.kyoto-u.ac.jp					Chuong AS, 2014, NAT NEUROSCI, V17, P1123, DOI 10.1038/nn.3752; Chen F, 2015, SCIENCE, V347, P543, DOI 10.1126/science.1260088; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/nmeth.2836, 10.1038/NMETH.2836]; Prevedel R, 2014, NAT METHODS, V11, P727, DOI [10.1038/nmeth.2964, 10.1038/NMETH.2964]; Kodandaramaiah SB, 2012, NAT METHODS, V9, P585, DOI [10.1038/nmeth.1993, 10.1038/NMETH.1993]; Boyden Edward S, 2011, F1000 Biol Rep, V3, P11, DOI 10.3410/B3-11	6	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0739-1102	1538-0254		J BIOMOL STRUCT DYN	J. Biomol. Struct. Dyn.	MAY 18	2015	33			1		67	44	44		10.1080/07391102.2015.1032680		1	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CL1FR	WOS:000356688600064		
J	Okutsu, N; Shimizu, E; Danilov, VI; Shulga, S; Kurita, N				Okutsu, Naoko; Shimizu, Eisuke; Danilov, Victor I.; Shulga, Sergiy; Kurita, Noriyuki			Attacking mechanism of H and OH radicals to DNA base pair: DFT calculations in water	JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS			English	Meeting Abstract							PORPHYRIN		[Okutsu, Naoko; Shimizu, Eisuke; Kurita, Noriyuki] Toyohashi Univ Technol, Toyohashi, Aichi 4418580, Japan; [Danilov, Victor I.; Shulga, Sergiy] Natl Acad Sci Ukraine, Kiev, Ukraine		kurita@cs.tut.ac.jp					Barkhudaryan VG, 2014, J PORPHYR PHTHALOCYA, V18, P594, DOI 10.1142/S1088424614500357; Barkhudaryan VG, 2013, J BIOMOL STRUCT DYN, V31, P55, DOI 10.1080/07391102.2013.786520; Dalyan YB, 2001, J BIOMOL STRUCT DYN, V18, P677	3	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0739-1102	1538-0254		J BIOMOL STRUCT DYN	J. Biomol. Struct. Dyn.	MAY 18	2015	33			1		140	91	92		10.1080/07391102.2015.1032769		2	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CL1FR	WOS:000356688600136		
J	Shimamura, K; Matsushita, Y; Oishi, M; Ohyama, T; Kurita, N				Shimamura, K.; Matsushita, Y.; Oishi, M.; Ohyama, T.; Kurita, N.			Effect of ligand-binding on specific interactions between DNA and regulatory protein: molecular simulations based on MD and ab initio fragment MO methods	JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS			English	Meeting Abstract									[Shimamura, K.; Matsushita, Y.; Oishi, M.; Ohyama, T.; Kurita, N.] Toyohashi Univ Technol, Toyohashi, Aichi 4418580, Japan		kurita@cs.tut.ac.jp					Ohyama T, 2011, J COMPUT CHEM, V32, P1661, DOI 10.1002/jcc.21744	1	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0739-1102	1538-0254		J BIOMOL STRUCT DYN	J. Biomol. Struct. Dyn.	MAY 18	2015	33			1		141	92	93		10.1080/07391102.2015.1032770		2	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CL1FR	WOS:000356688600137		
J	Omotuyi, IO; Olusanya, O				Omotuyi, I. O.; Olusanya, O.			Histone deacetylase (HDAC) I catalytic core Asp-His charge relay system is altered by HDAC inhibitors: atomistic simulation studies	JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS			English	Meeting Abstract									[Omotuyi, I. O.] Nagasaki Univ, Pharmacol & Therapeut Innovat, Nagasaki, Japan; [Omotuyi, I. O.] Adekunle Ajasin Univ, Dept Biochem, Akungba Akoko, Ondo State, Nigeria; [Olusanya, O.] Univ Benin, Dept Biochem, Fac Life Sci, Benin, Edo State, Nigeria		omotuyi@nagasaki-u.ac.jp						0	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0739-1102	1538-0254		J BIOMOL STRUCT DYN	J. Biomol. Struct. Dyn.	MAY 18	2015	33			1		208	140	140				1	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CL1GE	WOS:000356690000028		
J	Giguere, E; Kadoh, D				Giguere, Eric; Kadoh, Daisuke			Restoration of supersymmetry in two-dimensional SYM with sixteen supercharges on the lattice	JOURNAL OF HIGH ENERGY PHYSICS			English	Article						Extended Supersymmetry; Lattice Gauge Field Theories; Lattice Quantum Field Theory	SUPER-YANG-MILLS; EXACT EXTENDED SUPERSYMMETRY; 2,2 SQCD; FIELD-THEORIES; GAUGE-THEORIES; 2D N; FORMULATION; DIMENSIONS; BRANES	We perform lattice simulations of two-dimensional supersymmetric Yang-Mills theory with sixteen supercharges with a lattice action which has two exact supercharges (Sugino lattice action). According to the gauge/gravity duality, the theory at finite temperature is expected to be well described by the corresponding black 1-branes, at low temperature in the large N limit. We aim to confirm the duality conjecture by comparing the lattice results with the theoretical predictions obtained in the gravity side. In this article, at the beginning of this study, we examine the supersymmetric Ward-Takahashi identity to test whether the lattice action reproduces the correct continuum theory. Numerical results of the SUSY WTI strongly suggest us that any cut-off effects, which break supersymmetry, disappear in the continuum limit. In addition, we study the issue of degenerate vacua and find that the admissiblilty condition or any other constraints of the link fields which guarantee the unique vacuum are not always needed.	[Giguere, Eric] Hokkaido Univ, Dept Phys, Sapporo, Hokkaido 0600810, Japan; [Kadoh, Daisuke] High Energy Accelerator Org, KEK, KEK Theory Ctr, Tsukuba, Ibaraki 3050801, Japan	Giguere, E (reprint author), Hokkaido Univ, Dept Phys, Sapporo, Hokkaido 0600810, Japan.	eric@particle.sci.hokudai.ac.jp; kadoh@post.kek.jp					Anagnostopoulos KN, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.021601; Anderson E., 1999, SOC IND APPL MATH; Sugino F, 2009, NUCL PHYS B, V808, P292, DOI 10.1016/j.nuclphysb.2008.09.035; Cohen AG, 2003, J HIGH ENERGY PHYS; VAFA C, 1994, NUCL PHYS B, V431, P3, DOI 10.1016/0550-3213(94)90097-3; Klebanov IR, 1996, NUCL PHYS B, V475, P164, DOI 10.1016/0550-3213(96)00295-7; Maldacena J, 1999, INT J THEOR PHYS, V38, P1113, DOI 10.1023/A:1026654312961; HAWKING SW, 1976, PHYS REV D, V14, P2460, DOI 10.1103/PhysRevD.14.2460; Cohen AG, 2003, J HIGH ENERGY PHYS; D'Adda A, 2006, PHYS LETT B, V633, P645, DOI 10.1016/j.physletb.2005.12.034; Hanada M, 2014, SCIENCE, V344, P882, DOI 10.1126/science.1250122; Erickson JK, 2000, NUCL PHYS B, V582, P155, DOI 10.1016/S0550-3213(00)00300-X; Hanada M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.191602; Sakai T, 2005, PROG THEOR PHYS, V113, P843, DOI 10.1143/PTP.113.843; Pestun V, 2012, COMMUN MATH PHYS, V313, P71, DOI 10.1007/s00220-012-1485-0; Labastida JMF, 1997, NUCL PHYS B, V502, P741, DOI 10.1016/S0550-3213(97)00421-5; Clark MA, 2005, NUCL PHYS B-PROC SUP, V140, P835, DOI 10.1016/j.nuclphysbps.2004.11.192; Blau M, 1997, NUCL PHYS B, V492, P545, DOI 10.1016/S0550-3213(97)00161-2; Catterall S, 2010, J HIGH ENERGY PHYS, DOI 10.1007/JHEP04(2010)077; Catterall S, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.041502; Catterall S, 2004, J HIGH ENERGY PHYS; Catterall S, 2007, J HIGH ENERGY PHYS; Catterall S, 2013, J PHYS CONF SER, V462, DOI 10.1088/1742-6596/462/1/012022; Catterall S, 2005, J HIGH ENERGY PHYS; Catterall S, 2010, J HIGH ENERGY PHYS, DOI 10.1007/JHEP12(2010)022; Clark M. A., 2005, ALGREMEZ SOURCE CODE; D'Adda A, 2008, NUCL PHYS B, V798, P168, DOI 10.1016/j.nuclphysb.2008.01.026; Dijkgraaf R, 1997, COMMUN MATH PHYS, V185, P411, DOI 10.1007/s002200050097; Drukker N, 2006, J HIGH ENERGY PHYS; Endres MG, 2006, J HIGH ENERGY PHYS; Frommer A, 1995, INT J MOD PHYS C, V6, P627, DOI 10.1142/S0129183195000538; Gherghetta T., ARXIV10082570; Hanada M, 2011, J HIGH ENERGY PHYS, DOI 10.1007/JHEP12(2011)020; Hanada M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.151601; Hanada M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.181602; HAWKING SW, 1982, COMMUN MATH PHYS, V87, P395, DOI 10.1007/BF01206031; Herzog CP, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/34/343001; Itzhaki N, 1998, PHYS REV D, V58, DOI 10.1103/PhysRevD.58.046004; Jegerlehner B., HEPLAT9612014; Joseph A, 2014, J HIGH ENERGY PHYS, DOI 10.1007/JHEP07(2014)067; Joseph A, 2014, J HIGH ENERGY PHYS, DOI 10.1007/JHEP01(2014)093; Joseph A, 2013, J HIGH ENERGY PHYS, DOI 10.1007/JHEP09(2013)046; Kadoh D, 2009, NUCL PHYS B, V820, P99, DOI 10.1016/j.nuclphysb.2009.05.012; Kanamori I, 2009, NUCL PHYS B, V811, P420, DOI 10.1016/j.nuclphysb.2008.11.021; Kaplan DB, 2005, J HIGH ENERGY PHYS; Kaplan DB, 2003, J HIGH ENERGY PHYS; Kikukawa Y, 2009, NUCL PHYS B, V819, P76, DOI 10.1016/j.nuclphysb.2009.04.007; Klebanov I. R., HEPTH0009139; Maldacena J.M., HEPTH0309246; Matsuura S, 2014, J HIGH ENERGY PHYS, DOI 10.1007/JHEP04(2014)088; Matsuura S, 2008, J HIGH ENERGY PHYS; Polchinski J., ARXIV10106134; Sugino F, 2004, J HIGH ENERGY PHYS; Sugino F, 2006, PHYS LETT B, V635, P218, DOI 10.1016/j.physletb.2006.02.064; Sugino F, 2005, J HIGH ENERGY PHYS; Sugino F, 2004, J HIGH ENERGY PHYS	56	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1029-8479			J HIGH ENERGY PHYS	J. High Energy Phys.	MAY 18	2015		5							082	10.1007/JHEP05(2015)082		26	Physics, Particles & Fields	Physics	CL4UZ	WOS:000356952300004		
J	Aoyagi, T; Kimura, M; Yamada, N; Navarro, RR; Itoh, H; Ogata, A; Sakoda, A; Katayama, Y; Takasaki, M; Hori, T				Aoyagi, Tomo; Kimura, Makoto; Yamada, Namiha; Navarro, Ronald R.; Itoh, Hideomi; Ogata, Atsushi; Sakoda, Akiyoshi; Katayama, Yoko; Takasaki, Mitsuru; Hori, Tomoyuki			Dynamic transition of chemolithotrophic sulfur-oxidizing bacteria in response to amendment with nitrate in deposited marine sediments	FRONTIERS IN MICROBIOLOGY			English	Article						marine sediment; sulfur-oxidizing bacteria; environmental stimuli; high-throughput sequencing; the Great East Japan Earthquake in 2011	EPSILON-PROTEOBACTERIA; SULFATE REDUCTION; RIBOSOMAL-RNA; PADDY SOIL; BALTIC SEA; DIVERSITY; GENOME; IMPACT; BIOGEOCHEMISTRY; POPULATION	Although environmental stimuli are known to affect the structure and function of microbial communities, their impact on the metabolic network of microorganisms has not been well investigated. Here, geochemical analyses, high-throughput sequencing of 16S rRNA genes and transcripts, and isolation of potentially relevant bacteria were carried out to elucidate the anaerobic respiration processes stimulated by nitrate (20 mM) amendment of marine sediments. Marine sediments deposited by the Great East Japan Earthquake in 2011 were incubated anaerobically in the dark at 25 degrees C for 5 days. Nitrate in slurry water decreased gradually for 2 days, then more rapidly until its complete depletion at day 5; production of N2O followed the same pattern. From day 2 to 5, the sulfate concentration significantly increased and the sulfur content in solidphase sediments significantly decreased. These results indicated that denitrification and sulfur oxidation occurred simultaneously. Illumina sequencing revealed the proliferation of known sulfur oxidizers, i.e., Sulfurimonas sp. and Chromatiales bacteria, which accounted for approximately 43.5% and 14.8% of the total population at day 5, respectively. These oxidizers also expressed 16S rRNA to a considerable extent, whereas the other microorganisms, e.g., iron(III) reducers and methanogens, became metabolically active at the end of the incubation. Extinction dilution culture in a basalsalts medium supplemented with sulfur compounds and nitrate successfully isolated the predominant sulfur oxidizers: Sulfurimonas sp. strain HDS01 and Thioalkalispira sp. strain HDS22. Their 16S rRNA genes showed 95.2-96.7% sequence similarity to the closest cultured relatives and they grew chemolithotrophically on nitrate and sulfur. Novel sulfur-oxidizing bacteria were thus directly involved in carbon fixation under nitratereducing conditions, activating anaerobic respiration processes and the reorganization of microbial communities in the deposited marine sediments.	[Aoyagi, Tomo; Kimura, Makoto; Yamada, Namiha; Navarro, Ronald R.; Ogata, Atsushi; Hori, Tomoyuki] Natl Inst Adv Ind Sci & Technol, Environm Management Res Inst, Tsukuba, Ibaraki 3058569, Japan; [Itoh, Hideomi] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Sapporo, Hokkaido, Japan; [Sakoda, Akiyoshi] Univ Tokyo, Inst Ind Sci, Tokyo, Japan; [Katayama, Yoko] Tokyo Univ Agr & Technol, Grad Sch Agr, Tokyo, Japan; [Takasaki, Mitsuru] Ishinomaki Senshu Univ, Fac Sci, Dept Food & Environm Sci, Ishinomaki 986, Japan	Hori, T (reprint author), Natl Inst Adv Ind Sci & Technol, Environm Management Res Inst, Onogawa16-1, Tsukuba, Ibaraki 3058569, Japan.	hori-tomo@aist.go.jp			Japan Society for the Promotion of Science (JSPS) [24651089, 25701003]	We thank Akemi Katayama and Yumiko Kayashima for technical assistance. This study was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grants Number 24651089 (Grant-in-Aid for Challenging Exploratory Research) and 25701003 [Grant-in-Aid for Young Scientists (A)].	Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Braunschweig J, 2012, J MICROBIOL METH, V89, P41, DOI 10.1016/j.mimet.2012.01.021; Kotsyurbenko OR, 2007, APPL ENVIRON MICROB, V73, P2344, DOI 10.1128/AEM.02413-06; Habicht KS, 1997, GEOCHIM COSMOCHIM AC, V61, P5351, DOI 10.1016/S0016-7037(97)00311-6; Armenteros M, 2010, MAR ENVIRON RES, V70, P374, DOI 10.1016/j.marenvres.2010.08.001; Nakagawa S, 2005, ENVIRON MICROBIOL, V7, P1619, DOI 10.1111/j.1462-2920.2005.00856.x; HOLMER M, 1992, MAR ECOL PROG SER, V80, P191, DOI 10.3354/meps080191; KEMP WM, 1990, LIMNOL OCEANOGR, V35, P1545; Lydmark P, 2007, ENVIRON MICROBIOL, V9, P2220, DOI 10.1111/j.1462-2920.2007.01336.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Sievert SM, 2008, APPL ENVIRON MICROB, V74, P1145, DOI 10.1128/AEM.01844-07; Friedrich CG, 2001, APPL ENVIRON MICROB, V67, P2873, DOI 10.1128/AEM.67.7.2873-2882.2001; Grote J, 2012, P NATL ACAD SCI USA, V109, P506, DOI 10.1073/pnas.1111262109; Bottcher ME, 2000, J MARINE SYST, V25, P299, DOI 10.1016/S0924-7963(00)00023-3; Campbell BJ, 2006, NAT REV MICROBIOL, V4, P458, DOI 10.1038/nrmicro1414; Hori T, 2006, APPL ENVIRON MICROB, V72, P1623, DOI 10.1128/AEM.72.2.1623-1630.2006; Lueders T, 2002, APPL ENVIRON MICROB, V68, P2484, DOI 10.1128/AEM.68.5.2484-2494.2002; Kanno M, 2013, APPL ENVIRON MICROB, V79, P6998, DOI 10.1128/AEM.02900-13; Inui T, 2012, SOILS FOUND, V52, P856, DOI 10.1016/j.sandf.2012.11.008; Noll M, 2005, ENVIRON MICROBIOL, V7, P382, DOI 10.1111/j.1462-2920.2004.00700.x; Cardoso RB, 2006, BIOTECHNOL BIOENG, V95, P1148, DOI 10.1002/bit.21084; Kovaleva OL, 2011, FEMS MICROBIOL ECOL, V75, P37, DOI 10.1111/j.1574-6941.2010.00996.x; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Aoyagi T, 2015, ENV MICROBIOL REP, V7, P282, DOI 10.1111/1758-2229.12243; Handley KM, 2014, ENVIRON MICROBIOL, V16, P3443, DOI 10.1111/1462-2920.12453; Hansen H. P., 2007, METHODS SEAWATER ANA, P159, DOI DOI 10.1002/9783527613984.CH10; Hori T., 2014, J WATER ENV TECHNOL, V12, P357, DOI [10.2965/jwet.2014.357, DOI 10.2965/JWET.2014.357]; Hori T, 2010, ISME J, V4, P267, DOI 10.1038/ismej.2009.100; Itoh H, 2014, APPL ENVIRON MICROB, V80, P5974, DOI 10.1128/AEM.01087-14; Kunihiro T, 2011, ISME J, V5, P1818, DOI 10.1038/ismej.2011.57; Labrenz M, 2005, APPL ENVIRON MICROB, V71, P6664, DOI 10.1128/AEM.71.11.6664-6672.2005; Lane DJ, 1991, NUCL ACID TECHNIQUES, P115; Miller CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056018; Nakagawa S, 2008, FEMS MICROBIOL ECOL, V65, P1, DOI 10.1111/j.1574-6941.2008.00502.x; Ontiveros-Valencia A, 2012, ENVIRON SCI TECHNOL, V46, P11289, DOI 10.1021/es302370t; Pearson T.H., 1978, Oceanography and Marine Biology an Annual Review, V16, P229; Sorokin DY, 2006, MICROBIOL-SGM, V152, P3013, DOI 10.1099/mic.0.29106-0; Thang NM, 2013, ESTUAR COAST, V36, P98, DOI 10.1007/s12237-012-9557-0; Thomas F, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00309; Zhang Z, 2015, J SOIL SEDIMENT, V15, P1019, DOI 10.1007/s11368-015-1078-6; Zopfi J, 2004, GEOL SOC AM SPEC PAP, V379, P97, DOI DOI 10.1130/0-8137-2379-5.97	42	2	2	FRONTIERS RESEARCH FOUNDATION	LAUSANNE	PO BOX 110, LAUSANNE, 1015, SWITZERLAND	1664-302X			FRONT MICROBIOL	Front. Microbiol.	MAY 18	2015	6								426	10.3389/fmicb.2015.00426		12	Microbiology	Microbiology	CK5GL	WOS:000356251100001		
J	Konarev, DV; Troyanov, SI; Ustimenko, KA; Nakano, Y; Shestakov, AF; Otsuka, A; Yamochi, H; Saito, G; Lyubovskaya, RN				Konarev, Dmitri V.; Troyanov, Sergey I.; Ustimenko, Kseniya A.; Nakano, Yoshiaki; Shestakov, Alexander F.; Otsuka, Akihiro; Yamochi, Hideki; Saito, Gunzi; Lyubovskaya, Rimma N.			Formation of {Co(dppe)}(2){mu(2)-eta(2):eta(2)-eta(2):eta(2)-[(C-60)(2)]} Dimers Bonded by Single C-C Bonds and Bridging eta(2)-Coordinated Cobalt Atoms	INORGANIC CHEMISTRY			English	Article							ZEROVALENT COBALT; METAL-COMPLEXES; SHAPED C-120; C-60; DIMERIZATION; TEMPERATURE; FULLERENES; PRESSURE; STATE	Coordination of two bridging cobalt atoms to fullerenes by the eta(2) type in {Co(dppe)}(2){mu(2)-eta(2):eta(2)-eta(2):eta(2)- [(C-60)(2)]}center dot 3C(6)H(4)Cl(2) [1; dppe = 1,2-bis-(diphenylphosphino)ethane] triggers fullerene dimerization with the formation of two intercage C-C bonds of 1.571(4) angstrom length. Coordination-induced fullerene dimerization opens a path to the design of fullerene structures bonded by both covalent C-C bonds and eta(2)-coordination-bridged metal atoms.	[Konarev, Dmitri V.; Ustimenko, Kseniya A.; Shestakov, Alexander F.; Lyubovskaya, Rimma N.] Russian Acad Sci, Inst Problems Chem Phys, Chernogolovka 142432, Moscow Region, Russia; [Troyanov, Sergey I.; Ustimenko, Kseniya A.] Moscow MV Lomonosov State Univ, Moscow 119991, Russia; [Nakano, Yoshiaki; Otsuka, Akihiro; Yamochi, Hideki] Kyoto Univ, Res Ctr Low Temp & Mat Sci, Sakyo Ku, Kyoto 6068501, Japan; [Saito, Gunzi] Meijo Univ, Fac Agr, Tempaku Ku, Nagoya, Aichi 4688502, Japan	Konarev, DV (reprint author), Russian Acad Sci, Inst Problems Chem Phys, Chernogolovka 142432, Moscow Region, Russia.	konarev@icp.ac.ru			Russian Science Foundation [N 14-13-00028]; JSPS, Japan [15K17901, 23225005, 26288035]; JGC-S Scholarship Foundation	The work was supported by the Russian Science Foundation (Project N 14-13-00028) and Grants-in-Aid Scientific Research from JSPS, Japan (Grants 15K17901, 23225005, and 26288035). Y.N. is indebted to the JGC-S Scholarship Foundation. Theoretical calculations were performed at the Research Center for Computational Science, Okazaki, Japan, and Joint Super-computer Center of RAS, Moscow, Russia.	Konarev DV, 2013, ORGANOMETALLICS, V32, P4038, DOI 10.1021/om400392c; Laikov DN, 2005, CHEM PHYS LETT, V416, P116, DOI 10.1016/j.cplett.2005.09.046; Wang GW, 1997, NATURE, V387, P583; Konarev DV, 2014, INORG CHEM, V53, P11960, DOI 10.1021/ic501551y; Jin XL, 2002, CHEM COMMUN, P750, DOI 10.1039/b200793b; Balch AL, 1998, CHEM REV, V98, P2123, DOI 10.1021/cr960040e; Konarev DV, 2003, J AM CHEM SOC, V125, P10074, DOI 10.1021/ja035546a; FAGAN PJ, 1992, ACCOUNTS CHEM RES, V25, P134, DOI 10.1021/ar00015a006; Hashiguchi M, 2013, CARBON, V61, P418, DOI 10.1016/j.carbon.2013.04.101; Konarev DV, 2014, DALTON T, V43, P17920, DOI 10.1039/c4dt02161d; Konarev DV, 2012, RUSS CHEM REV+, V81, P336, DOI 10.1070/RC2012v081n04ABEH004273; Konarev DV, 2013, INORG CHEM, V52, P13934, DOI 10.1021/ic401577m; Konarev DV, 2006, J AM CHEM SOC, V128, P9292, DOI 10.1021/ja062143c; Moret R, 2004, EUR PHYS J B, V37, P25, DOI 10.1140/epjb/e2004-00027-y; Prassides K., 2000, PHYS FULLERENE BASED, P175; STEPHENS PW, 1994, NATURE, V370, P636, DOI 10.1038/370636a0; Sundqvist B, 2004, STRUCT BOND, V109, P85, DOI 10.1007/b94380	17	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0020-1669	1520-510X		INORG CHEM	Inorg. Chem.	MAY 18	2015	54	10					4597	4599		10.1021/acs.inorgchem.5b00637		3	Chemistry, Inorganic & Nuclear	Chemistry	CI6XR	WOS:000354908000005		
J	Chorazy, S; Arczynski, M; Nakabayashi, K; Sieklucka, B; Ohkoshi, S				Chorazy, Szymon; Arczynski, Miroslaw; Nakabayashi, Koji; Sieklucka, Barbara; Ohkoshi, Shin-ichi			Visible to Near-Infrared Emission from Ln(III)(Bis-oxazoline)-[Mo-V(CN)(8)] (Ln = Ce-Yb) Magnetic Coordination Polymers Showing Unusual Lanthanide-Dependent Sliding of Cyanido-Bridged Layers	INORGANIC CHEMISTRY			English	Article							SINGLE-MOLECULE MAGNETS; PRUSSIAN BLUE ANALOG; RED LUMINESCENCE; OPTICAL-ACTIVITY; LIGHT; COMPLEXES; BEHAVIOR; FIELD; TB; FERROMAGNETISM	Complexes of lanthanides(III) (Ce-Yb) with 2,2'-bis(2-oxazoline) (Box) combined with octacyanidomolybdate(V) gave a series of magneto-luminescent coordination polymers, {[Ln(III)(Box)(n)(DMF)(m)][Mo-V(CN)(8)]}.x(solvent) (1-12). They are built of cyanido-bridged layers of a mixed 4- and 8-metal rings topology and show unique sliding of layers dependent on a 4f metal ion. For light lanthanides, dominant phase A, {[Ln(III)(Box)(2)(DMF)(2)]-[Mo-V(CN)(8)]}.1.5MeCN (Ln = Ce, 1; Pr, 2; Nd, 3), consists of ideally aligned, not shifted layers, giving large channels (13.7 x 14.0 angstrom). Intermediate lanthanides reveal phase B, {[Ln(III)(Box)(2)(DMF)(2)] [Mo-V(CN)(8)]}.H2O (Ln = Sm, 4; Eu, 5; Gd, 6; Tb, 7; Dy, 8), of smaller pores (8.4 x 10.6 angstrom) due to layer-H2O hydrogen bonding, which induces sliding of CN-bridged layers. Heavy lanthanides show phase C, {[Ln(III)(Box)(DMF)(3)][Mo-V(CN)(8)]}.MeCN (Ln = Ho, 9; Er, 10; Tm, 11; Yb, 12), with large channels (13.7 x 13.7 angstrom) of a similar size to light lanthanides. This effect comes from the changes in Ln(III) coordination sphere affecting solvent-layer interactions. Compounds 1-12 reveal diverse emission depending on the interaction between Ln(III) and Box luminophors. For 2-5, 9, and 12, the ligand-to-metal energy-transfer-induced visible f-centered emission ranging from green for HoIII-based 9, orange from SmIII-based 4, to red for PrIII- and EuIII-containing 2 and 5, respectively. Near-infrared emission was found for 2-4, 9, and 12. Red phosphorescence of Box was detected for GdIII-based 6, whereas the selective excitation of ligand or Ln(III) excited states resulting in the switchable red to green emission was found for TbIII-based 7. The materials revealed Ln(III)-MoV magnetic coupling leading to ferromagnetism below 2.0 and 2.2 K for 4 and 7, respectively. The onset of magnetic ordering at low temperatures was found for 6 and 8. Compounds 1-12 form a unique family of cyanido-bridged materials of a bifunctional magneto-luminescence character combined with dynamic structural features.	[Chorazy, Szymon; Arczynski, Miroslaw; Sieklucka, Barbara] Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan; [Chorazy, Szymon; Nakabayashi, Koji; Ohkoshi, Shin-ichi] Jagiellonian Univ, Fac Chem, PL-30060 Krakow, Poland; [Ohkoshi, Shin-ichi] JST, CREST, Chiyoda Ku, Tokyo 1020076, Japan	Sieklucka, B (reprint author), Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	ohkoshi@chem.s.u-tokyo.ac.jp; barbara.sieklucka@uj.edu.pl			Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology Agency (JST); Advanced Photon Science Alliance (APSA) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); Global Science course from MEXT; Cryogenic Research Center, The University of Tokyo; Center for Nano Lithography and Analysis, The University of Tokyo - MEXT; JSPS (JSPS Kakenhi) [15H05697]; Polish National Science Centre [DEC-2011/01/B/ST5/00716]; Foundation for Polish Science within the START	The research was supported by the Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology Agency (JST), Advanced Photon Science Alliance (APSA) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), Global Science course from MEXT, the Cryogenic Research Center, The University of Tokyo, the Center for Nano Lithography and Analysis, The University of Tokyo, supported by MEXT, Grant-in-Aid for Specially Promoted Research of JSPS (JSPS Kakenhi grant number 15H05697), and by the Polish National Science Centre - Research Project DEC-2011/01/B/ST5/00716. S.C. acknowledges the financial support of the Foundation for Polish Science within the START fellowship (edition 2014).	Chelebaeva E, 2012, INORG CHEM, V51, P9005, DOI 10.1021/ic301144j; Pajerowski DM, 2011, CHEM MATER, V23, P3045, DOI 10.1021/cm2003337; Prins F, 2007, ANGEW CHEM INT EDIT, V46, P6081, DOI 10.1002/anie.200701847; Rueff JM, 2004, CHEM MATER, V16, P2933, DOI 10.1021/cm049792c; Chorazy S, 2014, CHEM MATER, V26, P4072, DOI 10.1021/cm501954e; Chang YS, 2007, J SOLID STATE CHEM, V180, P3076, DOI 10.1016/j.jssc.2007.07.018; Ohkoshi S, 2014, NAT PHOTONICS, V8, P65, DOI [10.1038/nphoton.2013.310, 10.1038/NPHOTON.2013.310]; Coronado E, 2004, CHEM REV, V104, P5419, DOI 10.1021/cr030641n; Herrera JM, 2004, ANGEW CHEM INT EDIT, V43, P5468, DOI 10.1002/anie.200460387; Alberola A, 2003, J AM CHEM SOC, V125, P10774, DOI 10.1021/ja035772k; Miller JS, 2011, CHEM SOC REV, V40, P3266, DOI 10.1039/c0cs00166j; Clemente-Leon M, 2011, CHEM SOC REV, V40, P473, DOI 10.1039/c0cs00111b; Biradha K, 2002, ANGEW CHEM INT EDIT, V41, P3395, DOI 10.1002/1521-3773(20020916)41:18<3395::AID-ANIE3395>3.0.CO;2-D; Przychodzen P, 2007, INORG CHEM, V46, P8924, DOI 10.1021/ic700795q; Train C, 2009, J AM CHEM SOC, V131, P16838, DOI 10.1021/ja9061568; Sorace L, 2011, CHEM SOC REV, V40, P3092, DOI 10.1039/c0cs00185f; Ohkoshi S, 2011, NAT CHEM, V3, P564, DOI 10.1038/nchem.1067; Koumousi ES, 2014, J AM CHEM SOC, V136, P15461, DOI 10.1021/ja508094h; Long J, 2011, INORG CHEM, V50, P9924, DOI 10.1021/ic201394y; Kaye SS, 2008, J AM CHEM SOC, V130, P16921, DOI 10.1021/ja803926y; Yamauchi S, 2014, INORG CHEM, V53, P5961, DOI 10.1021/ic5001599; Train C, 2008, NAT MATER, V7, P729, DOI 10.1038/nmat2256; Chorazy S, 2012, J AM CHEM SOC, V134, P16151, DOI 10.1021/ja307520k; Hiraga H, 2007, INORG CHEM, V46, P9661, DOI 10.1021/ic700727n; Chorazy S, 2014, CHEM-EUR J, V20, P7144, DOI 10.1002/chem.201304772; Woodruff DN, 2013, CHEM REV, V113, P5110, DOI 10.1021/cr400018q; Rogez G, 2011, CHEM SOC REV, V40, P1031, DOI 10.1039/c0cs00159g; Avendano C, 2010, J AM CHEM SOC, V132, P13123, DOI 10.1021/ja1041513; Train C, 2011, CHEM SOC REV, V40, P3297, DOI 10.1039/c1cs15012j; Vogler A, 2006, INORG CHIM ACTA, V359, P4130, DOI 10.1016/j.ica.2006.05.025; Ferrando-Soria J, 2012, ADV MATER, V24, P5625, DOI 10.1002/adma.201201846; Bain GA, 2008, J CHEM EDUC, V85, P532; Bunzli JCG, 2005, CHEM SOC REV, V34, P1048, DOI 10.1039/b406082m; Chorazy S, 2013, RSC ADV, V3, P1065, DOI 10.1039/c2ra23033j; Casanova D, 2004, J AM CHEM SOC, V126, P1755, DOI 10.1021/ja036479n; Maspoch D, 2007, CHEM SOC REV, V36, P770, DOI 10.1039/b501600m; Guo PH, 2013, CHEM-EUR J, V19, P8769, DOI 10.1002/chem.201300299; Dechambenoit P, 2011, CHEM SOC REV, V40, P3249, DOI 10.1039/c0cs00167h; Glaser T, 2011, CHEM COMMUN, V47, P116, DOI 10.1039/c0cc02259d; Bogani L, 2008, NAT MATER, V7, P179, DOI 10.1038/nmat2133; Long J, 2012, CHEM COMMUN, V48, P9974, DOI 10.1039/c2cc35321k; Perrier M, 2012, INORG CHEM, V51, P6425, DOI 10.1021/ic2024988; Holmes SM, 1999, J AM CHEM SOC, V121, P5593, DOI 10.1021/ja990946c; Ohkoshi S, 2007, ANGEW CHEM INT EDIT, V46, P3238, DOI 10.1002/anie.200604452; Carlin R. C., 1986, MAGNETOCHEMISTRY, P237; Chelebaeva E, 2009, INORG CHEM, V48, P5983, DOI 10.1021/ic900378d; Chorazy S, 2013, CHEM COMMUN, V49, P6731, DOI 10.1039/c3cc43195a; CORDEN BJ, 1970, INORG CHEM, V9, P356, DOI 10.1021/ic50084a038; Coronado E, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1827; Fernandez B, 2008, ADV FUNCT MATER, V18, P3931, DOI 10.1002/adfm.200800942; Halcrow M. A., 2013, SPIN CROSSOVER MAT P; Isci H, 2004, INORG CHIM ACTA, V357, P4065, DOI 10.1016/j.ica.2003.10.024; Kahn O., 1993, MOL MAGNETISM, P43; Kahn O, 1997, MOL CRYST LIQ CRYS A, V305, P1, DOI 10.1080/10587259708045043; Koziel M, 2010, INORG CHEM, V49, P4268, DOI 10.1021/ic100158g; Llunell M, 2013, SHAPE V 2 1 PROGRAM; Mukhopadhyay S. M., 2012, NANOSCALE MULTIFUNCT; Nuida T, 2005, J AM CHEM SOC, V127, P11604, DOI 10.1021/ja0535662; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Tau A. K. T., 2008, MULTIFUNCTIONAL MAT; van Pieterson L, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.045114; Zhao HH, 2007, DALTON T, P878, DOI 10.1039/b616016f; Zhou H, 2012, DALTON T, V41, P10690, DOI 10.1039/c2dt30615h; Zhu XJ, 2011, EUR J INORG CHEM, P4651, DOI 10.1002/ejic.201100481	64	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0020-1669	1520-510X		INORG CHEM	Inorg. Chem.	MAY 18	2015	54	10					4724	4736		10.1021/acs.inorgchem.5b00040		13	Chemistry, Inorganic & Nuclear	Chemistry	CI6XR	WOS:000354908000018		
J	Suzuki, YI; Suzuki, T				Suzuki, Yoshi-Ichi; Suzuki, Toshinori			Linear and circular dichroism in photoelectron angular distributions caused by electron correlation	PHYSICAL REVIEW A			English	Article							CROSS-SECTIONS; MOLECULES; PHOTOIONIZATION; ABSORPTION; CYCLOPROPANE; IONIZATION; SPECTRA; REGION; ATOMS	Electron correlation can break the symmetry of photoelectron angular distribution upon two-step ionization to a doubly degenerate ionic state via a doubly degenerate intermediate state. The interference between the two components of the intermediate state prepared using linearly and circularly polarized light is discussed for cyclopropane as an example.	[Suzuki, Yoshi-Ichi; Suzuki, Toshinori] Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto 6068502, Japan	Suzuki, YI (reprint author), Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto 6068502, Japan.	suzuki@kuchem.kyoto-u.ac.jp			Japan Society for the Promotion of Science [25410010]; "X-ray Free Electron Laser Priority Strategy Program" of the Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was supported by a Kakenhi Grant-in-Aid (Grant No. 25410010) from the Japan Society for the Promotion of Science and by the "X-ray Free Electron Laser Priority Strategy Program" of the Ministry of Education, Culture, Sports, Science and Technology, Japan.	RITCHIE B, 1976, PHYS REV A, V13, P1411, DOI 10.1103/PhysRevA.13.1411; WESTPHAL C, 1989, PHYS REV LETT, V63, P151, DOI 10.1103/PhysRevLett.63.151; Horio T, 2009, J AM CHEM SOC, V131, P10392, DOI 10.1021/ja904780b; SURRATT GT, 1977, CHEM PHYS, V23, P39, DOI 10.1016/0301-0104(77)89041-1; JACOBS VL, 1972, J PHYS B-AT MOL OPT, V5, P2257, DOI 10.1088/0022-3700/5/12/019; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; DILL D, 1974, J CHEM PHYS, V61, P692, DOI 10.1063/1.1681947; DILL D, 1976, J CHEM PHYS, V65, P1130, DOI 10.1063/1.433187; Kabachnik NM, 2007, PHYS REP, V451, P155, DOI 10.1016/j.physrep.2007.07.005; APPLING JR, 1987, J CHEM PHYS, V87, P6927, DOI 10.1063/1.453387; Briggs JS, 2000, J PHYS B-AT MOL OPT, V33, pR1, DOI 10.1088/0953-4075/33/1/201; CACELLI I, 1983, J PHYS B-AT MOL OPT, V16, P1895, DOI 10.1088/0022-3700/16/11/011; CEDERBAUM LS, 1980, PHYS SCRIPTA, V21, P481, DOI 10.1088/0031-8949/21/3-4/040; CHEREPKOV NA, 1982, CHEM PHYS LETT, V87, P344, DOI 10.1016/0009-2614(82)83600-2; CHEREPKOV NA, 1995, J PHYS B-AT MOL OPT, V28, P1221, DOI 10.1088/0953-4075/28/7/016; DILL D, 1973, PHYS REV A, V7, P1976, DOI 10.1103/PhysRevA.7.1976; DILL D, 1972, PHYS REV LETT, V29, P1203, DOI 10.1103/PhysRevLett.29.1203; Downie P, 1999, PHYS REV LETT, V82, P2864, DOI 10.1103/PhysRevLett.82.2864; DUBS RL, 1985, PHYS REV LETT, V54, P1249, DOI 10.1103/PhysRevLett.54.1249; GOLDSTEIN E, 1980, J AM CHEM SOC, V102, P6198, DOI 10.1021/ja00540a004; Griffith J. S., 2006, IRREDUCIBLE TENSOR M; Kuznetsov VV, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3574007; LUCCHESE RR, 1990, J CHEM PHYS, V92, P4203, DOI 10.1063/1.457778; Motoki S, 2002, J PHYS B-AT MOL OPT, V35, P3801, DOI 10.1088/0953-4075/35/18/302; Schmidt V., 1997, CAMBRIDGE MONOGRAPHS; SHIGEMASA E, 1992, PHYS REV A, V45, P2915, DOI 10.1103/PhysRevA.45.2915; Shiromaru H., 1984, B CHEM SOC JPN, V57, P3453; Suzuki YI, 2008, J PHYS B-AT MOL OPT, V41, DOI 10.1088/0953-4075/41/21/215204; Suzuki YI, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4765374; Suzuki YI, 2007, MOL PHYS, V105, P1675, DOI 10.1080/00268970701551864; Szabo A., 1996, MODERN QUANTUM CHEM; Walker IC, 2007, J PHYS B-AT MOL OPT, V40, P1875, DOI 10.1088/0953-4075/40/10/021; WEHLITZ R, 1993, J PHYS B-AT MOL OPT, V26, pL783, DOI 10.1088/0953-4075/26/22/002; Wilson S., 2007, ELECT CORRELATION MO, P44; Zare R. N., 1988, ANGULAR MOMENTUM UND	35	0	0	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1050-2947	1094-1622		PHYS REV A	Phys. Rev. A	MAY 18	2015	91	5							053413	10.1103/PhysRevA.91.053413		7	Optics; Physics, Atomic, Molecular & Chemical	Optics; Physics	CI7UH	WOS:000354969800009		
J	Appel, M; Scholz, CJ; Muller, T; Dittrich, M; Konig, C; Bockstaller, M; Oguz, T; Khalili, A; Antwi-Adjei, E; Schauer, T; Margulies, C; Tanimoto, H; Yarali, A				Appel, Mirjam; Scholz, Claus-Juergen; Mueller, Tobias; Dittrich, Marcus; Koenig, Christian; Bockstaller, Marie; Oguz, Tuba; Khalili, Afshin; Antwi-Adjei, Emmanuel; Schauer, Tamas; Margulies, Carla; Tanimoto, Hiromu; Yarali, Ayse			Genome-Wide Association Analyses Point to Candidate Genes for Electric Shock Avoidance in Drosophila melanogaster	PLOS ONE			English	Article							FUNCTIONAL-ANALYSIS; DISRUPTION PROJECT; NATURAL VARIATION; COMPLEX TRAITS; NETWORKS; BEHAVIOR; FLIES; TEMPERATURE; GENETICS; PAINFUL	Electric shock is a common stimulus for nociception-research and the most widely used reinforcement in aversive associative learning experiments. Yet, nothing is known about the mechanisms it recruits at the periphery. To help fill this gap, we undertook a genome-wide association analysis using 38 inbred Drosophila melanogaster strains, which avoided shock to varying extents. We identified 514 genes whose expression levels and/or sequences covaried with shock avoidance scores. We independently scrutinized 14 of these genes using mutants, validating the effect of 7 of them on shock avoidance. This emphasizes the value of our candidate gene list as a guide for follow-up research. In addition, by integrating our association results with external protein-protein interaction data we obtained a shock avoidance- associated network of 38 genes. Both this network and the original candidate list contained a substantial number of genes that affect mechanosensory bristles, which are hairlike organs distributed across the fly's body. These results may point to a potential role for mechanosensory bristles in shock sensation. Thus, we not only provide a first list of candidate genes for shock avoidance, but also point to an interesting new hypothesis on nociceptive mechanisms.	[Appel, Mirjam; Koenig, Christian; Khalili, Afshin; Antwi-Adjei, Emmanuel; Yarali, Ayse] Leibniz Inst Neurobiol, Res Grp Mol Syst Biol Learning, Magdeburg, Germany; [Appel, Mirjam; Bockstaller, Marie; Oguz, Tuba; Tanimoto, Hiromu; Yarali, Ayse] Max Planck Inst Neurobiol, D-82152 Martinsried, Germany; [Scholz, Claus-Juergen] Univ Wurzburg, IZKF, Lab Microarray Applicat, D-97070 Wurzburg, Germany; [Mueller, Tobias; Dittrich, Marcus] Univ Wurzburg, Dept Bioinformat, Bioctr, D-97070 Wurzburg, Germany; [Dittrich, Marcus] Univ Wurzburg, Inst Human Genet, D-97070 Wurzburg, Germany; [Schauer, Tamas; Margulies, Carla] Univ Munich, Butenandt Inst, Dept Physiol Chem, Munich, Germany; [Schauer, Tamas; Margulies, Carla] Univ Munich, LMU Biomed Ctr, Fac Med, Munich, Germany; [Tanimoto, Hiromu] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 980, Japan; [Yarali, Ayse] Ctr Behav Brain Sci, Magdeburg, Germany	Yarali, A (reprint author), Leibniz Inst Neurobiol, Res Grp Mol Syst Biol Learning, Magdeburg, Germany.	ayse.yarali@lin-magdeburg.de		Scholz, Claus-Jurgen/0000-0002-6406-7859	Deutche Forschungsgemeinschaft [YA272/2-1]; Max Planck Institute for Neurobiology; Leibniz Institute for Neurobiology; Studienstiftung des deutschen Volkes	This study was funded by a research grant from the Deutche Forschungsgemeinschaft to AY (YA272/2-1) (http://www.dfg.de/) and institutional support from the Max Planck Institute for Neurobiology (http://www.neuro.mpg.de/) and the Leibniz Institute for Neurobiology (http://www.linmagdeburg.de/index.jsp). MA received a PhD stipend from Studienstiftung des deutschen Volkes (http://www. studienstiftung.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Mummery-Widmer JL, 2009, NATURE, V458, P987, DOI 10.1038/nature07936; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Mackay TEC, 2006, ANNU REV GENOM HUM G, V7, P339, DOI 10.1146/annurev.genom.7.080505.115758; Anholt RRH, 2004, NAT REV GENET, V5, P838, DOI 10.1038/nrg1472; Gerber B, 2014, LEARN MEMORY, V21, P232, DOI 10.1101/lm.032995.113; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Galili DS, 2014, CURR BIOL, V24, P1712, DOI 10.1016/j.cub.2014.06.062; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Neely GG, 2010, CELL, V143, P628, DOI 10.1016/j.cell.2010.09.047; Ayroles JF, 2009, NAT GENET, V41, P299, DOI 10.1038/ng.332; Bellen HJ, 2011, GENETICS, V188, P731, DOI 10.1534/genetics.111.126995; Beisser D, 2010, BIOINFORMATICS, V26, P1129, DOI 10.1093/bioinformatics/btq089; CAREW TJ, 1981, SCIENCE, V211, P501, DOI 10.1126/science.7455692; Marygold SJ, 2013, NUCLEIC ACIDS RES, V41, pD751, DOI 10.1093/nar/gks1024; Dittrich MT, 2008, BIOINFORMATICS, V24, pI223, DOI 10.1093/bioinformatics/btn161; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Aso Y, 2010, CURR BIOL, V20, P1445, DOI 10.1016/j.cub.2010.06.048; Morozova TV, 2009, GENETICS, V183, P733, DOI 10.1534/genetics.109.107490; Appel M, 2009, ANIM BEHAV, V78, P1373, DOI 10.1016/j.anbehav.2009.09.008; Arya GH, 2010, GENETICS, V186, P1475, DOI 10.1534/genetics.110.123166; Aso Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002768; Ciapponi L, 2004, CURR BIOL, V14, P1360, DOI 10.1016/j.cub.2004.07.019; Edwards AC, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r76; Greenspan RJ, 2004, HUM MOL GENET, V13, pR267, DOI 10.1093/hmg/ddh248; Guo A, 1996, LEARN MEMORY, V3, P49, DOI 10.1101/lm.3.1.49; Harbison ST, 2009, NAT GENET, V41, P371, DOI 10.1038/ng.330; Hong ST, 2008, NATURE, V454, P771, DOI 10.1038/nature07090; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; JANAL MN, 1991, PERCEPT PSYCHOPHYS, V50, P108, DOI 10.3758/BF03212212; Leviten MW, 1996, DEV BIOL, V176, P264, DOI 10.1006/dbio.1996.0133; Pavlov I. P., 1927, CONDITIONED REFLEXES; Vergoz V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000288; Yu WJ, 2006, J CELL SCI, V119, P4793, DOI 10.1242/jcs.03174	37	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0126986	10.1371/journal.pone.0126986		18	Multidisciplinary Sciences	Science & Technology - Other Topics	CI7BG	WOS:000354917300072		
J	Grandjean, L; Iwamoto, T; Lithgow, A; Gilman, RH; Arikawa, K; Nakanishi, N; Martin, L; Castillo, E; Alarcon, V; Coronel, J; Solano, W; Aminian, M; Guezala, C; Rastogi, N; Couvin, D; Sheen, P; Zimic, M; Moore, DAJ				Grandjean, Louis; Iwamoto, Tomotada; Lithgow, Anna; Gilman, Robert H.; Arikawa, Kentaro; Nakanishi, Noriko; Martin, Laura; Castillo, Edith; Alarcon, Valentina; Coronel, Jorge; Solano, Walter; Aminian, Minoo; Guezala, Claudia; Rastogi, Nalin; Couvin, David; Sheen, Patricia; Zimic, Mirko; Moore, David A. J.			The Association between Mycobacterium Tuberculosis Genotype and Drug Resistance in Peru	PLOS ONE			English	Article							MICROSCOPIC-OBSERVATION; GENETIC DIVERSITY; VIRULENCE; STRAIN; EPIDEMIOLOGY; MODEL; ASSAY	Background The comparison of Mycobacterium tuberculosis bacterial genotypes with phenotypic, demographic, geospatial and clinical data improves our understanding of how strain lineage influences the development of drug-resistance and the spread of tuberculosis. Methods To investigate the association of Mycobacterium tuberculosis bacterial genotype with drugresistance. Drug susceptibility testing together with genotyping using both 15-loci MIRU-typing and spoligotyping, was performed on 2,139 culture positive isolates, each from a different patient in Lima, Peru. Demographic, geospatial and socio-economic data were collected using questionnaires, global positioning equipment and the latest national census. Results The Latin American Mediterranean (LAM) clade (OR 2.4, p<0.001) was significantly associated with drug-resistance and alone accounted for more than half of all drug resistance in the region. Previously treated patients, prisoners and genetically clustered cases were also significantly associated with drug-resistance (OR's 2.5, 2.4 and 1.8, p<0.001, p<0.05, p<0.001 respectively). Conclusions Tuberculosis disease caused by the LAM clade was more likely to be drug resistant independent of important clinical, genetic and socio-economic confounding factors. Explanations for this include; the preferential co-evolution of LAM strains in a Latin American population, a LAM strain bacterial genetic background that favors drug-resistance or the "founder effect" from pre-existing LAM strains disproportionately exposed to drugs.	[Grandjean, Louis] Univ London Imperial Coll Sci Technol & Med, Wellcome Ctr Clin Trop Med, London, England; [Grandjean, Louis; Lithgow, Anna; Moore, David A. J.] London Sch Hyg & Trop Med, TB Ctr, London WC1, England; [Grandjean, Louis; Lithgow, Anna; Moore, David A. J.] Dept Clin Res, London, England; [Grandjean, Louis; Gilman, Robert H.; Martin, Laura; Coronel, Jorge; Solano, Walter; Sheen, Patricia; Zimic, Mirko; Moore, David A. J.] Univ Peruana Cayetano Heredia, Lab Invest & Desarrollo, Lima, Peru; [Iwamoto, Tomotada; Arikawa, Kentaro; Nakanishi, Noriko] Kobe Inst Hlth, Dept Infect Dis, Chuo Ku, Kobe, Hyogo, Japan; [Gilman, Robert H.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Castillo, Edith] DIRESA Callao, Bellavista, Callao, Peru; [Alarcon, Valentina] TB MDR, Unidad Tecn, Lima, Peru; [Aminian, Minoo] Rensselaer Polytech Inst, TB Insight Res Grp, Troy, NY USA; [Guezala, Claudia] Naval Med Res, Unit 6, Bellavista, Callao, Peru; [Rastogi, Nalin; Couvin, David] Inst Pasteur Guadeloupe, WHO, Supranat TB Reference Lab, Abymes, Guadeloupe	Grandjean, L (reprint author), Univ London Imperial Coll Sci Technol & Med, Wellcome Ctr Clin Trop Med, St Marys Campus,Norfolk Pl, London, England.	lgrandjean@gmail.com			Wellcome Trust [WT088559MA, 078067/Z/05/Z]; Japanese Ministry of Health Science Research Grant [H24-SHINKO-IPPAN-011]; MEXT/JSPS KAKENHI Grant [24590845]	This work was supported by the Wellcome Trust [Grant Numbers WT088559MA, 078067/Z/05/Z] (www.wellcome.ac.uk), the Japanese Ministry of Health Science Research Grant (www.mhlw.go.jp) [Grant number H24-SHINKO-IPPAN-011] and an MEXT/JSPS KAKENHI Grant [Grant number 24590845]. The Wellcome Trust had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Niemann S, 2010, J CLIN MICROBIOL, V48, P3544, DOI 10.1128/JCM.00715-10; Moore DAJ, 2006, NEW ENGL J MED, V355, P1539, DOI 10.1056/NEJMoa055524; [Anonymous], 2006, EMERG INFECT DIS, V12, P736, DOI DOI 10.3201/EID1205.050400; Dormans J, 2004, CLIN EXP IMMUNOL, V137, P460, DOI 10.1111/j.1365-2249.2004.02551.x; Tsenova L, 2005, J INFECT DIS, V192, P98, DOI 10.1086/430614; Ritacco V, 2008, MEM I OSWALDO CRUZ, V103, P489, DOI 10.1590/S0074-02762008000500014; Caviedes L, 2000, J CLIN MICROBIOL, V38, P1203; Pillay M, 2007, CLIN INFECT DIS, V45, P1409, DOI 10.1086/522987; Vynnycky E, 2001, EPIDEMIOL INFECT, V126, P43; Ford CB, 2013, NAT GENET, V45, P784, DOI 10.1038/ng.2656; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406; Suarez PG, 2001, J INFECT DIS, V184, P473, DOI 10.1086/322777; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Ausubel F, 2002, SHORT PROTOCOLS IN M; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Dalla Costa ER, 2013, J CLIN MICROBIOL; Drobniewski F, 2005, JAMA-J AM MED ASSOC, V293, P2726, DOI 10.1001/jama.293.22.2726; Dymova MA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-77; Hsu AH, 2010, INT J TUBERC LUNG D, V14, P924; Instituto Nacional de Estadistica e Informatica INEI, 2007, XI DE POBLACION Y V; Instituto Nacional de Estadistica e Informatica INEI, 2005, 10 DE POBL V DE VIV; Iwamoto T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049651; Mendoza A, 2011, INT J TUBERC LUNG D, V15, P217; Mokrousov I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041318; Sebek M, 2000, INT J TUBERC LUNG D, V4, pS45; Sheen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065873; Taype CA, 2012, INFECT GENET EVOL, V12, P577, DOI 10.1016/j.meegid.2012.02.002; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160	30	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0126271	10.1371/journal.pone.0126271		12	Multidisciplinary Sciences	Science & Technology - Other Topics	CI7BG	WOS:000354917300036		
J	Nabeka, H; Shimokawa, T; Doihara, T; Saito, S; Wakisaka, H; Hamada, F; Kobayashi, N; Matsuda, S				Nabeka, Hiroaki; Shimokawa, Tetsuya; Doihara, Takuya; Saito, Shouichiro; Wakisaka, Hiroyuki; Hamada, Fumihiko; Kobayashi, Naoto; Matsuda, Seiji			A Prosaposin-Derived Peptide Alleviates Kainic Acid-Induced Brain Injury	PLOS ONE			English	Article							FACIAL-NERVE TRANSECTION; CELL-DEATH PREVENTION; IN-VIVO; QUANTITATIVE-ANALYSIS; NEUROTROPHIC FACTOR; ACTIVATOR PROTEINS; NEURONAL DAMAGE; RAT HIPPOCAMPUS; SCHWANN-CELLS; EXPRESSION	Four sphingolipid activator proteins (i.e., saposins A-D) are synthesized from a single precursor protein, prosaposin (PS), which exerts exogenous neurotrophic effects in vivo and in vitro. Kainic acid (KA) injection in rodents is a good model in which to study neurotrophic factor elevation; PS and its mRNA are increased in neurons and the choroid plexus in this animal model. An 18-mer peptide (LSELIINNATEELLIKGL; PS18) derived from the PS neurotrophic region prevents neuronal damage after ischemia, and PS18 is a potent candidate molecule for use in alleviating ischemia-induced learning disabilities and neuronal loss. KA is a glutamate analog that stimulates excitatory neurotransmitter release and induces ischemia-like neuronal degeneration; it has been used to define mechanisms involved in neurodegeneration and neuroprotection. In the present study, we demonstrate that a subcutaneous injection of 0.2 and 2.0 mg/kg PS18 significantly improved behavioral deficits of Wistar rats (n = 6 per group), and enhanced the survival of hippocampal and cortical neurons against neurotoxicity induced by 12 mg/kg KA compared with control animals. PS18 significantly protected hippocampal synapses against KA-induced destruction. To evaluate the extent of PS18- and KA-induced effects in these hippocampal regions, we performed histological evaluations using semithin sections stained with toluidine blue, as well as ordinal sections stained with hematoxylin and eosin. We revealed a distinctive feature of KA-induced brain injury, which reportedly mimics ischemia, but affects a much wider area than ischemia-induced injury: KA induced neuronal degeneration not only in the CA1 region, where neurons degenerate following ischemia, but also in the CA2, CA3, and CA4 hippocampal regions.	[Nabeka, Hiroaki; Shimokawa, Tetsuya; Doihara, Takuya; Matsuda, Seiji] Ehime Univ, Grad Sch Med, Dept Anat & Embryol, Toon, Ehime, Japan; [Saito, Shouichiro] Gifu Univ, Fac Appl Biol Sci, Lab Vet Anat, Gifu, Japan; [Wakisaka, Hiroyuki] Ehime Prefectural Univ Hlth Sci, Iyo, Ehime, Japan; [Hamada, Fumihiko] Oita Univ, Fuculty Med, Dept Human Anat, Yufu, Oita, Japan; [Kobayashi, Naoto] Ehime Univ, Grad Sch Med, Med Educ Ctr, Toon, Ehime, Japan	Nabeka, H (reprint author), Ehime Univ, Grad Sch Med, Dept Anat & Embryol, Toon, Ehime, Japan.	nabeka@m.ehime-u.ac.jp			Japan Society for the Promotion of Science [22591637, 19659380, 22591979, 25450466]; Ehime University	This study was supported in part by Grants-in-Aid for Scientific Research to SM (22591637, 19659380), NK (22591979), TS (25450466) from the Japan Society for the Promotion of Science and in part by a grant to HN from Ehime University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	SCHWOB JE, 1980, NEUROSCIENCE, V5, P991, DOI 10.1016/0306-4522(80)90181-5; Campana WM, 1998, FASEB J, V12, P307; NADLER JV, 1981, NEUROSCIENCE, V6, P2505, DOI 10.1016/0306-4522(81)90096-8; NADLER JV, 1980, BRAIN RES, V195, P47; Meyer RC, 2013, P NATL ACAD SCI USA, V110, P9529, DOI 10.1073/pnas.1219004110; LOTHMAN EW, 1981, BRAIN RES, V218, P299, DOI 10.1016/0006-8993(81)91308-1; Bortolotto ZA, 1999, NATURE, V402, P297; FERKANY JW, 1982, NATURE, V298, P757, DOI 10.1038/298757a0; ISHIZUKA N, 1995, J COMP NEUROL, V362, P17, DOI 10.1002/cne.903620103; KISHIMOTO Y, 1992, J LIPID RES, V33, P1255; Campana WM, 1996, BIOCHEM BIOPH RES CO, V229, P706, DOI 10.1006/bbrc.1996.1869; Campana WM, 1998, NEUROTOXICOLOGY, V19, P237; Chen J, 2008, NEUROSCI RES, V60, P82, DOI 10.1016/j.neures.2007.09.010; COYLE JT, 1987, CIBA F SYMP, V126, P186; Gao HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080032; Gao HL, 2013, NEUROSCIENCE, V236, P373, DOI 10.1016/j.neuroscience.2013.01.007; HEGGLI DE, 1981, BRAIN RES, V230, P253, DOI 10.1016/0006-8993(81)90405-4; HINENO T, 1991, BIOCHEM BIOPH RES CO, V176, P668, DOI 10.1016/S0006-291X(05)80236-0; Hiraiwa M, 1997, P NATL ACAD SCI USA, V94, P4778, DOI 10.1073/pnas.94.9.4778; Hiraiwa M, 1999, GLIA, V26, P353, DOI 10.1002/(SICI)1098-1136(199906)26:4<353::AID-GLIA9>3.0.CO;2-G; HIRAIWA M, 1992, P NATL ACAD SCI USA, V89, P11254, DOI 10.1073/pnas.89.23.11254; Hosoda Y, 2007, CELL TISSUE RES, V330, P197, DOI 10.1007/s00441-007-0464-9; Igase K, 1999, J CEREBR BLOOD F MET, V19, P298; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; KONDOH K, 1993, J COMP NEUROL, V334, P590, DOI 10.1002/cne.903340407; Kotani Y, 1996, J NEUROCHEM, V66, P2019; Kotani Y, 1996, J NEUROCHEM, V66, P2197; Li C, 2013, HISTOL HISTOPATHOL, V28, P875; Matsuda S, 1997, BRAIN RES, V769, P321, DOI 10.1016/S0006-8993(97)00724-5; Matsuda S, 2004, NEUROSCI RES, V49, P241, DOI 10.1016/j.neures.2004.03.002; Matsuda S, 1996, NEUROSCI RES, V26, P157, DOI 10.1016/S0168-0102(96)01088-X; Misasi R, 2004, EXP CELL RES, V298, P38, DOI 10.1016/j.yexcr.2004.04.011; Misasi R, 2001, FASEB J, V15, P467, DOI 10.1096/fj.00-0217com; Morales CR, 1998, J ANDROL, V19, P156; Nabeka H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110534; OBRIEN JS, 1991, FASEB J, V5, P301; OBRIEN JS, 1988, SCIENCE, V241, P1098, DOI 10.1126/science.2842863; OBRIEN JS, 1994, P NATL ACAD SCI USA, V91, P9593, DOI 10.1073/pnas.91.20.9593; OBRIEN JS, 1995, FASEB J, V9, P681; Ochiai T, 2008, BBA-GEN SUBJECTS, V1780, P1441, DOI 10.1016/j.bbagen.2008.07.010; OLNEY JW, 1978, NATURE, V271, P557, DOI 10.1038/271557a0; Saito S, 2014, CELL TISSUE RES, V356, P231, DOI 10.1007/s00441-013-1773-9; SANO A, 1988, J BIOL CHEM, V263, P19597; SANO A, 1989, BIOCHEM BIOPH RES CO, V165, P1191, DOI 10.1016/0006-291X(89)92728-9; SANO A, 1994, BIOCHEM BIOPH RES CO, V204, P994, DOI 10.1006/bbrc.1994.2558; SANO A, 1992, BIOCHIM BIOPHYS ACTA, V1120, P75, DOI 10.1016/0167-4838(92)90426-E; Shimokawa T, 2013, CELL TISSUE RES, V352, P685, DOI 10.1007/s00441-013-1575-0; Terashita T, 2007, NEUROSCI RES, V57, P372, DOI 10.1016/j.neures.2006.11.006; Terashita T, 2012, ACTA OTO-LARYNGOL, V133, P462; Tsuboi K, 1998, DEV BRAIN RES, V110, P249, DOI 10.1016/S0165-3806(98)00109-6; Unuma K, 2005, NEUROSCI RES, V52, P220, DOI 10.1016/j.neures.2005.03.009	51	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0126856	10.1371/journal.pone.0126856		18	Multidisciplinary Sciences	Science & Technology - Other Topics	CI7BG	WOS:000354917300057		
J	Niizato, T; Gunji, YP				Niizato, Takayuki; Gunji, Yukio-Pegio			Ongoing Processes in a Fitness Network Model under Restricted Resources	PLOS ONE			English	Article							SCALE-FREE NETWORKS; COMPLEX NETWORKS; WEB; EMERGENCE; POWER	In real networks, the resources that make up the nodes and edges are finite. This constraint poses a serious problem for network modeling, namely, the compatibility between robustness and efficiency. However, these concepts are generally in conflict with each other. In this study, we propose a new fitness-driven network model for finite resources. In our model, each individual has its own fitness, which it tries to increase. The main assumption in fitness-driven networks is that incomplete estimation of fitness results in a dynamical growing network. By taking into account these internal dynamics, nodes and edges emerge as a result of exchanges between finite resources. We show that our network model exhibits exponential distributions in the in- and out-degree distributions and a power law distribution of edge weights. Furthermore, our network model resolves the trade-off relationship between robustness and efficiency. Our result suggests that growing and anti-growing networks are the result of resolving the trade-off problem itself.	[Niizato, Takayuki] Univ Tsukuba, Fac Engn Informat & Syst, Tsukuba, Ibaraki, Japan; [Gunji, Yukio-Pegio] Waseda Univ, Sch Fundamental Sci & Engn, Tokyo, Japan	Niizato, T (reprint author), Univ Tsukuba, Fac Engn Informat & Syst, Tsukuba, Ibaraki, Japan.	t_niizato@yahoo.co.jp					Achliopatas D, 2009, SCIENCE, V1453, P323; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Broder A, 2000, COMPUT NETW, V33, P309, DOI 10.1016/S1389-1286(00)00083-9; Ergun G, 2002, PHYSICA A, V303, P261, DOI 10.1016/S0378-4371(01)00408-3; Wen GH, 2011, PHYSICA A, V390, P4012, DOI 10.1016/j.physa.2011.06.027; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Rooney N, 2012, TRENDS ECOL EVOL, V27, P40, DOI 10.1016/j.tree.2011.09.001; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Bianconi G, 2005, EUROPHYS LETT, V71, P1029, DOI 10.1209/epl/i2005-10167-2; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Emmerson M, 2004, P ROY SOC B-BIOL SCI, V271, P397, DOI 10.1098/rspb.2003.2592; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Stouffer DB, 2010, FUNCT ECOL, V24, P44, DOI 10.1111/j.1365-2435.2009.01644.x; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Barrat A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066149; Antal T, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.026103; Banconi G, 2001, EPL-EUROPHYS LETT, V54, P436; D'Souza RM, 2007, EUR PHYS J B, V59, P535, DOI 10.1140/epjb/e2007-00310-5; Dorogovtsev SN, 2009, LECT COMPLEX NETWORK; Fan Z, 2004, J CONTROL THEORY APP, V2, P60, DOI 10.1007/s11768-004-0024-8; Granovetter M., 1983, SOCIOLOGICAL THEORY, V1, P201, DOI DOI 10.2307/202051; GRANOVET.MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Li X, 2003, PHYSICA A, V328, P274, DOI 10.1016/S0378-4371(03)00604-6; Mandelbrot B., 1953, COMMUN THEORY, P486; Meusel R, 2014, P COMP PUBL 23 INT C, P427; Niizato T, 2013, BIOSYSTEMS, V111, P145, DOI 10.1016/j.biosystems.2012.12.003; Oka M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060398; Tong JY, 2011, PHYSICA A, V390, P1826, DOI 10.1016/j.physa.2010.12.024; Ulanowicz RE, 2002, BIOSYSTEMS, V64, P13, DOI 10.1016/S0303-2647(01)00170-8; Ulanowicz Robert E., 1997, ECOLOGY ASCENDENT PE; Vega YM, 2004, PHYSICA A, V343, P279, DOI 10.1016/j.physa.2004.05.033; Xu XJ, 2010, PHYSCS PROC, V3, P1795, DOI 10.1016/j.phpro.2010.07.021; Zheng DF, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.040102	34	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127284	10.1371/journal.pone.0127284		17	Multidisciplinary Sciences	Science & Technology - Other Topics	CI7BG	WOS:000354917300110		
J	Oguchi, T; Ota, M; Ito, T; Hamano, H; Arakura, N; Katsuyama, Y; Meguro, A; Kawa, S				Oguchi, Takaya; Ota, Masao; Ito, Tetsuya; Hamano, Hideaki; Arakura, Norikazu; Katsuyama, Yoshihiko; Meguro, Akira; Kawa, Shigeyuki			Investigation of Susceptibility Genes Triggering Lachrymal/Salivary Gland Lesion Complications in Japanese Patients with Type 1 Autoimmune Pancreatitis	PLOS ONE			English	Article							SCLEROSING PANCREATITIS; TRANSCRIPTION FACTORS; IGG4 CONCENTRATIONS; FERM DOMAIN; FAMILY; POLYMORPHISMS; ASSOCIATION; POPULATION; DISEASE; BENIGN	Autoimmune pancreatitis (AIP) is a unique form of chronic pancreatitis characterized by high serum IgG4 concentration and a variety of complicating extra-pancreatic lesions. In particular, lachrymal/salivary gland lesions tend to manifest in a highly active AIP disease state, and several genes are speculated to be associated with the onset of this complication. We therefore searched for candidate susceptibility genes related to lachrymal/salivary gland lesions in a genome-wide association study (GWAS) with the GeneChip Human Mapping 500k Array Set (Affymetrix, CA) that was followed by fine mapping of additional single nucleotide polymorphisms (SNPs) in strongly significant genes with TaqMan assays. Venous blood samples were obtained from 50 type 1 AIP patients with lachrymal/salivary gland lesions (A group) and 53 type 1 AIP patients without (B group). The mean values of IgG and IG4 were both significantly different (P<0.05) between the groups. SNPs that showed a significant association with the A group at the genome-wide level (P<0.0001) were identified and subsequently used in fine SNP mapping of candidate genes. In total, five SNPs had a positive association with complicated AIP (most notably rs2284932 [P=0.0000021]) and five SNPs possessed a negative association (particularly rs9371942 [P=0.00000039]). Among them, KLF7, FRMD4B, LOC101928923, and MPPED2 were further examined for complication susceptibility using additional SNPs that were not included in the GWAS. Individual genotyping of KLF7 rs2284932 revealed that the frequency of the minor C allele was significantly increased (P=0.00062, Pc=0.0018, OR=2.98, 95% CI=1.58-5.65) in group A. The minor T allele of rs4473559 in FRMD4 demonstrated a significant association in the A group (P=0.00015, OR=3.38, 95% CI=1.77-7.65). In the LOC101928923 gene, the frequency of the minor C allele of rs4379306 was significantly decreased in group A in both TaqMan and GWAS analyses. Lastly, the minor C allele of MPPED2 rs514644 carried a significantly increased risk of complications. These four genes may be linked with the onset of lachrymal/salivary gland lesions in type 1 AIP patients and require further study.	[Oguchi, Takaya; Ito, Tetsuya; Hamano, Hideaki] Shinshu Univ, Sch Med, Dept Gastroenterol, Matsumoto, Nagano 390, Japan; [Ota, Masao] Shinshu Univ, Sch Med, Dept Legal Med, Matsumoto, Nagano 390, Japan; [Arakura, Norikazu] Shinshu Univ Hosp, Endoscop Examinat Ctr, Matsumoto, Nagano, Japan; [Katsuyama, Yoshihiko] Shinshu Univ Hosp, Dept Pharm, Matsumoto, Nagano, Japan; [Meguro, Akira] Yokohama City Univ, Sch Med, Dept Ophthalmol, Yokohama, Kanagawa 232, Japan; [Kawa, Shigeyuki] Shinshu Univ, Ctr Hlth Safety & Environm Management, Matsumoto, Nagano 390, Japan	Ota, M (reprint author), Shinshu Univ, Sch Med, Dept Legal Med, Matsumoto, Nagano 390, Japan.	otamasao@shinshu-u.ac.jp			Ministry of Health, Labor, and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan [23591012]	This research was supported in part by a research grant from the Ministry of Health, Labor, and Welfare of Japan and the Ministry of Education, Culture, Sports, Science, and Technology of Japan (23591012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Kamisawa T, 2003, GUT, V52, P683, DOI 10.1136/gut.52.5.683; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Fujinaga Y, 2010, EUR J RADIOL, V76, P228, DOI 10.1016/j.ejrad.2009.06.010; Laub F, 2005, MOL CELL BIOL, V25, P5699, DOI 10.1128/MCB.25.13.5699-5711.2005; Takeda S, 2004, NEPHROL DIAL TRANSPL, V19, P474, DOI 10.1093/ndt/gfg477; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Cross AR, 2004, BBA-BIOENERGETICS, V1657, P1, DOI 10.1016/j.bbabio.2004.03.008; Umemura T, 2006, GUT, V55, P1367, DOI 10.1136/gut.2006.095059; Mazzanti C, 2004, CANCER RES, V64, P2898, DOI 10.1158/0008-5472.CAN-03-3811; Stone JH, 2012, ARTHRITIS RHEUM-US, V64, P3061, DOI 10.1002/art.34593; Ota M, 2007, IMMUNOGENETICS, V59, P45, DOI 10.1007/s00251-006-0178-2; Hamano H, 2006, J GASTROENTEROL, V41, P1197, DOI 10.1007/s00535-006-1908-9; Moleirinho S, 2013, BIOCHEM J, V452, P183, DOI 10.1042/BJ20121642; Park DH, 2008, GASTROENTEROLOGY, V134, P440, DOI 10.1053/j.gastro.2007.11.023; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Kamisawa T, 2013, GUT LIVER, V7, P394, DOI 10.5009/gnl.2013.7.4.394; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Umemura T, 2008, AM J GASTROENTEROL, V103, P588, DOI 10.1111/j.1572-0241.2007.01750.x; Dang DT, 2000, INT J BIOCHEM CELL B, V32, P1103, DOI 10.1016/S1357-2725(00)00059-5; Kawa S, 2002, GASTROENTEROLOGY, V122, P1264, DOI 10.1053/gast.2002.33022; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Hamano H, 2001, NEW ENGL J MED, V344, P732, DOI 10.1056/NEJM200103083441005; Kanazawa A, 2005, DIABETOLOGIA, V48, P1315, DOI 10.1007/s00125-005-1797-0; Hamano H, 2002, LANCET, V359, P1403, DOI 10.1016/S0140-6736(02)08359-9; Erkelens GW, 1999, LANCET, V354, P43, DOI 10.1016/S0140-6736(99)00603-0; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Finn SP, 2007, VIRCHOWS ARCH, V450, P249, DOI 10.1007/s00428-006-0348-5; Hirano K, 2009, J GASTROENTEROL, V44, P799, DOI 10.1007/s00535-009-0080-4; Kano A, 2012, PANCREAS, V41, P835, DOI [10.1097/MPA.0b013e3182480c99, DOI 10.1097/MPA.0B013E3182480C99]; Kawa S, 2013, THE AUTOIMMUNE DISEA, P935; Klarlund JK, 2001, J BIOL CHEM, V276, P40065, DOI 10.1074/jbc.M105260200; Liguori L, 2012, CELL CYCLE, V11, P569, DOI 10.4161/cc.11.3.19063; Nakazawa T, 2001, HEPATO-GASTROENTEROL, V48, P625; Ota M, 2011, DIS MARKERS, V31, P223, DOI 10.3233/DMA-2011-0820; Schuettpelz LG, 2012, BLOOD, V120, P2981, DOI 10.1182/blood-2012-02-409839; Seitz S, 2006, GENE CHROMOSOME CANC, V45, P612, DOI 10.1002/gcc.20325; Taniguchi T, 2004, GUT, V53, P770; Umemura T, 2009, HUM IMMUNOL, V70, P724; Yamamoto M, 2004, SCAND J RHEUMATOL, V33, P432, DOI 10.1080/03009740410006439; Zobel Dorit P, 2009, Eur J Endocrinol, V160, P603, DOI 10.1530/EJE-08-0688	42	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127078	10.1371/journal.pone.0127078		11	Multidisciplinary Sciences	Science & Technology - Other Topics	CI7BG	WOS:000354917300087		
J	Sato, M; Matsubara, T; Adachi, J; Hashimoto, Y; Fukamizu, K; Kishida, M; Yang, YA; Wakefield, LM; Tomonaga, T				Sato, Misako; Matsubara, Tsutomu; Adachi, Jun; Hashimoto, Yuuki; Fukamizu, Kazuna; Kishida, Marina; Yang, Yu-an; Wakefield, Lalage M.; Tomonaga, Takeshi			Differential Proteome Analysis Identifies TGF-beta-Related Pro-Metastatic Proteins in a 4T1 Murine Breast Cancer Model	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; MESENCHYMAL TRANSITION; TRANSLATION INITIATION; RECEPTOR KINASE; TISSUE SAMPLES; MAMMARY-TUMOR; SB-431542; EXPRESSION; INHIBITOR; PROLIFERATION	Transforming growth factor-beta (TGF-beta) has a dual role in tumorigenesis, acting as either a tumor suppressor or as a pro-oncogenic factor in a context-dependent manner. Although TGF-beta antagonists have been proposed as anti-metastatic therapies for patients with advanced stage cancer, how TGF-beta mediates metastasis-promoting effects is poorly understood. Establishment of TGF-beta-related protein expression signatures at the metastatic site could provide new mechanistic information and potentially allow identification of novel biomarkers for clinical intervention to discriminate TGF-beta oncogenic effects from tumor suppressive effects. In the present study, we found that systemic administration of the TGF-beta receptor kinase inhibitor, SB-431542, significantly inhibited lung metastasis from transplanted 4T1 mammary tumors in Balb/c mice. The differentially expressed proteins in the comparison of lung metastases from SB-431542 treated and control vehicle-treated groups were analyzed by a quantitative LTQ Orbitrap Velos system coupled with stable isotope dimethyl labeling. A total of 36,239 peptides from 6,694 proteins were identified, out of which 4,531 proteins were characterized as differentially expressed. A subset of upregulated proteins in the control group was validated by western blotting and immunohistochemistry. The eukaryotic initiation factor (eIF) family members constituted the most enriched protein pathway in vehicle-treated compared with SB-43512-treated lung metastases, suggesting that increased protein expression of specific eIF family members, especially eIF4A1 and eEF2, is related to the metastatic phenotype of advanced breast cancer and can be down-regulated by TGF-beta pathway inhibitors. Thus our proteomic approach identified eIF pathway proteins as novel potential mediators of TGF-beta tumor-promoting activity.	[Sato, Misako; Adachi, Jun; Hashimoto, Yuuki; Fukamizu, Kazuna; Kishida, Marina; Tomonaga, Takeshi] Proteome Res Ctr, Natl Inst Biomed Innovat, Lab Proteome Res, Saito, Osaka, Japan; [Sato, Misako] Osaka City Univ, Grad Sch Med, Dept Hepatol, Osaka 558, Japan; [Matsubara, Tsutomu] Osaka City Univ, Grad Sch Med, Dept Anat & Regenerat Biol, Osaka 558, Japan; [Yang, Yu-an; Wakefield, Lalage M.] NIH, Lab Canc Biol & Genet, Bethesda, MD 20892 USA	Sato, M (reprint author), Proteome Res Ctr, Natl Inst Biomed Innovat, Lab Proteome Res, Saito, Osaka, Japan.	mmatsubara@med.osaka-cu.ac.jp; tomonaga@nibiohn.go.jp			JSPS KAKENHI [25871241]	MS; JSPS KAKENHI grant-in-Aid for Young Scientists (B) Grant Number 25871241 (http://www.jsps.go.jp/english/e-grants/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Nasr Z, 2013, ONCOGENE, V32, P861, DOI 10.1038/onc.2012.105; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Ramirez-Valle F, 2008, J CELL BIOL, V181, P293, DOI 10.1083/jcb.200710215; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Masuda T, 2008, J PROTEOME RES, V7, P731, DOI 10.1021/pr700658q; Silvera D, 2009, NAT CELL BIOL, V11, P903, DOI 10.1038/ncb1900; Muraoka S, 2012, J PROTEOME RES, V11, P4201, DOI 10.1021/pr300322q; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Badura M, 2012, P NATL ACAD SCI USA, V109, P18767, DOI 10.1073/pnas.1203853109; Souchelnytskyi S, 2005, EXPERT REV PROTEOMIC, V2, P925, DOI 10.1586/14789450.2.6.925; Ho J, 2009, J PROTEOME RES, V8, P583, DOI 10.1021/pr8007368; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Bonafoux D, 2009, EXPERT OPIN THER PAT, V19, P1759, DOI 10.1517/13543770903397400; Nam JS, 2008, CANCER RES, V68, P3835, DOI 10.1158/0008-5472.CAN-08-0215; Lamouille S, 2007, J CELL BIOL, V178, P437, DOI 10.1083/jcb.200611146; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Halder SK, 2005, NEOPLASIA, V7, P509, DOI 10.1016/1593/neo.04640; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Lou YM, 2008, DEV DYNAM, V237, P2755, DOI 10.1002/dvdy.21658; Yellen P, 2013, CANCER LETT, V333, P239, DOI 10.1016/j.canlet.2013.01.041; Sotiriou C, 2007, NAT REV CANCER, V7, P545, DOI 10.1038/nrc2173; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Yingling JM, 2004, NAT REV DRUG DISCOV, V3, P1011, DOI 10.1038/nrd1580; Wakefield LM, 2013, NAT REV CANCER, V13, P328, DOI 10.1038/nrc3500; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; O'Shaughnessy J, 2005, ONCOLOGIST, V10, P20, DOI 10.1634/theoncologist.10-90003-20; Muraoka RS, 2002, J CLIN INVEST, V109, P1551, DOI 10.1172/JCI200215234; Hjelmeland MD, 2004, MOL CANCER THER, V3, P737; Ali NA, 2011, PROTEOMICS, V11, P3390, DOI 10.1002/pmic.201100036; Konicek BW, 2008, CELL CYCLE, V7, P2466; Matsubara T, 2012, CELL METAB, V16, P634, DOI 10.1016/j.cmet.2012.10.006; Gilles C, 1999, J CELL SCI, V112, P4615; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Shiromizu T, 2013, J PROTEOME RES, V12, P2414, DOI 10.1021/pr300825v; Bao LL, 2011, AM J PATHOL, V178, P838, DOI 10.1016/j.ajpath.2010.10.029; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Das F, 2013, J CELL PHYSIOL, V228, P1617, DOI 10.1002/jcp.24327; de la Parra C, 2012, J BIOL CHEM, V287, P41640, DOI 10.1074/jbc.M112.393470; Issa A, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3379; Matsuyama S, 2003, CANCER RES, V63, P7791; Nagaraja GM, 2012, CANCER PREV RES, V5, P122, DOI 10.1158/1940-6207.CAPR-11-0121; Nam JS, 2006, CANCER RES, V66, P6327, DOI 10.1158/0008-5472.CAN-06-0068; Narumi R, 2012, J PROTEOME RES, V11, P5311, DOI 10.1021/pr3005474; Tanaka H, 2010, ONCOL REP, V24, P1637, DOI 10.3892/or_00001028; Tao K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-228; Xue T, 2013, J PROTEOME RES	48	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0126483	10.1371/journal.pone.0126483		20	Multidisciplinary Sciences	Science & Technology - Other Topics	CI7BG	WOS:000354917300043		
J	Uchida, Y; Kanagawa, C; Takenishi, A; Harada, A; Okawa, K; Yabuno, H				Uchida, Yukiko; Kanagawa, Chie; Takenishi, Ako; Harada, Akira; Okawa, Kiyotake; Yabuno, Hiromi			How Did the Media Report on the Great East Japan Earthquake? Objectivity and Emotionality Seeking in Japanese Media Coverage	PLOS ONE			English	Article							AMERICAN; CULTURE	The Great East Japan Earthquake was a tragic event requiring critical media involvement. Since the media played an important role in conveying factual information, journalists expressed feeling that it was difficult to guarantee the objectivity of their coverage. As media coverage constructs a socio-culturally shared reality among its audience, an examination of the objectivity and emotionality of the contents of the news coverage is needed. In Study 1, we conducted an exploratory content analysis of TV and newspaper coverage from the six month period following the March 11, 2011 disaster, finding that the news media generally reported neutral and objective factual information about the event, with emotionality shown only in the commentary. In order to examine how media coverage was constructed and evaluated by journalists, in Study 2 we conducted an online survey of 115 journalists working for mass media organizations. We found that that the journalists' orientations tended to be more objective than emotional, which is consistent with the findings of Study 1. However, their evaluations of the objectivity of the published articles were low, especially for the coverage of the nuclear power plant accident, which was an accident of an unprecedented nature. The negative emotions that journalists experienced during their investigations negatively affected subsequent evaluations of the objectivity of their reporting.	[Uchida, Yukiko] Kyoto Univ, Kokoro Res Ctr, Kyoto, Kyoto, Japan; [Kanagawa, Chie; Harada, Akira; Yabuno, Hiromi] Otemon Gakukun Univ, Fac Management, Ibaraki, Osaka, Japan; [Takenishi, Ako] Hyogo Univ Teachers Educ, Kato City, Hyogo, Japan; [Okawa, Kiyotake] Teikyo Univ, Fac Liberal Arts, Hachioji, Tokyo, Japan	Uchida, Y (reprint author), Kyoto Univ, Kokoro Res Ctr, Kyoto, Kyoto, Japan.	uchida.yukiko.6m@kyoto-u.ac.jp			Kokoro Research Center Project Grant	This research was supported by Kokoro Research Center Project Grant.	Morling B, 2008, PERS SOC PSYCHOL REV, V12, P199, DOI 10.1177/1088868308318260; Uchida Y, 2014, J HAPPINESS STUD, V15, P207, DOI 10.1007/s10902-013-9463-6; Dickinson R, 2007, CULT SOCIOL, V1, P189, DOI 10.1177/1749975507078187; Erigawa S., 2011, 39 BEH SOC JAP; Hatanaka M, 2010, J TRAUMA STRESS, V23, P173, DOI 10.1002/jts.20496; Hommerich C., 2012, INT J JAPANESE SOCIO, V21, P46; Koshiro E, 1997, THE HANSHIN AWAJI EA; Markus HR, 2006, PSYCHOL SCI, V17, P103, DOI 10.1111/j.1467-9280.2006.01672.x; MORRIS MW, 1994, J PERS SOC PSYCHOL, V67, P949, DOI 10.1037/0022-3514.67.6.949; Niwa Y, 2013, TREMBLING MEDIA TV R; Nomura Research Institute, 2011, SURVEY RESEARCH ON M; Quarantelli EL, 1990, PRELIMINARY PAPER 14; Quarantelli EL, 1987, PRELIMINARY PAPER 11; Tanihara K, 2011, JOURNALISM, V6; Uchida Y, 2001, JPN J PSYCHOL, V72, P275; Ueno N, 2007, 22 JAP SOC SCI POL R; Yabuno H, 2013, OTEMON BUSINESS MANA, V19, P281; Yamanaka S, 2011, JOURNALISM, P6	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0125966	10.1371/journal.pone.0125966		15	Multidisciplinary Sciences	Science & Technology - Other Topics	CI7BG	WOS:000354917300029		
J	Watanabe, A; Kumagai, M; Mishima, T; Ito, J; Otoki, Y; Harada, T; Kato, T; Yoshida, M; Suzuki, M; Yoshida, I; Fujita, K; Watai, M; Nakagawa, K; Miyazawa, T				Watanabe, Akio; Kumagai, Momochika; Mishima, Takashi; Ito, Junya; Otoki, Yurika; Harada, Teppei; Kato, Tsuyoshi; Yoshida, Mikihiko; Suzuki, Misora; Yoshida, Izumi; Fujita, Kazuhiro; Watai, Masatoshi; Nakagawa, Kiyotaka; Miyazawa, Teruo			Toddaculin, Isolated from of Toddalia asiatica (L.) Lam., Inhibited Osteoclastogenesis in RAW 264 Cells and Enhanced Osteoblastogenesis in MC3T3-E1 Cells	PLOS ONE			English	Article							BONE-FORMATION; PARATHYROID-HORMONE; KAPPA-B; DIFFERENTIATION; EXPRESSION; OSTEOPOROSIS; BISPHOSPHONATES; MINERALIZATION; ACTIVATION; COUMARIN	Osteoporosis with bone loss is widely recognized as a major health problem. Bone homeostasis is maintained by balancing bone formation and bone resorption. The imbalance caused by increased bone resorption over bone formation can lead to various bone-related diseases such as osteoporosis and rheumatoid arthritis. Osteoclasts are the principal cells responsible for bone resorption and the main targets of anti-resorptive therapies. However, excessive inhibition of osteoclast differentiation may lead to inhibition of osteoblast differentiation. Therefore, it is important to screen for new compounds capable of inhibiting bone resorption and enhancing bone formation. Toddalia asiatica (L.) Lam. has been utilized traditionally for medicinal purposes such as the treatment of rheumatism. Currently, the extract is considered to be a good source of pharmacological agents for the treatment of bone-related diseases, but the active compounds have yet to be identified. We investigated whether toddaculin, derived from Toddalia asiatica (L.) Lam., affects both processes by inhibiting bone resorption and enhancing bone formation. Towards this end, we used pre-osteoclastic RAW 264 cells and pre-osteoblastic MC3T3-E1 cells. We found that toddaculin not only inhibited the differentiation of osteoclasts via activation of the NF-kappa B, ERK 1/2, and p38 MAPK signaling pathways, but it also induced differentiation and mineralization of osteoblasts by regulating differentiation factors. Thus, toddaculin might be beneficial for the prevention and treatment of osteoporosis.	[Watanabe, Akio; Kumagai, Momochika; Mishima, Takashi; Harada, Teppei; Yoshida, Izumi; Fujita, Kazuhiro; Watai, Masatoshi] Japan Food Res Labs, Saito Lab, Food Funct Res Team, Ibaraki, Osaka, Japan; [Watanabe, Akio; Ito, Junya; Otoki, Yurika; Nakagawa, Kiyotaka; Miyazawa, Teruo] Tohoku Univ, Grad Sch Agr Sci, Food & Biodynam Chem Lab, Sendai, Miyagi 980, Japan; [Kato, Tsuyoshi] Japan Food Res Labs, Tama Lab, Sect Appl Testing, Tama, Tokyo, Japan; [Yoshida, Mikihiko] Japan Food Res Labs, Saito Lab, Sect Nutraceut Anal, Ibaraki, Osaka, Japan; [Suzuki, Misora] Japan Food Res Labs, Tama Lab, Sect Biol Safety Res, Tama, Tokyo, Japan	Watanabe, A (reprint author), Japan Food Res Labs, Saito Lab, Food Funct Res Team, Ibaraki, Osaka, Japan.	watanabea@jfrl.or.jp					Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Beck GR, 1998, J CELL BIOCHEM, V68, P269, DOI 10.1002/(SICI)1097-4644(19980201)68:2<269::AID-JCB13>3.0.CO;2-A; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Chang J, 2009, NAT MED, V15, P682, DOI 10.1038/nm.1954; Aaseth J, 2012, J TRACE ELEM MED BIO, V26, P149, DOI 10.1016/j.jtemb.2012.03.017; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; Feng X, 2005, IUBMB LIFE, V57, P389, DOI 10.1080/15216540500137669; REDDY SV, 1995, J BONE MINER RES, V10, P601; Matsuguchi T, 2009, J BONE MINER RES, V24, P398, DOI [10.1359/jbmr.081107, 10.1359/JBMR.081107]; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Nakamura T, 2009, J NAT MED-TOKYO, V63, P15, DOI 10.1007/s11418-008-0268-6; Ishiyama M, 1997, TALANTA, V44, P1299, DOI 10.1016/S0039-9140(97)00017-9; Kono SJ, 2007, BONE, V40, P68, DOI 10.1016/j.bone.2006.07.024; Quinn JMW, 1998, ENDOCRINOLOGY, V139, P4424; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Putnam SE, 2007, PHYTOTHER RES, V21, P99, DOI 10.1002/ptr.2030; Reinholz GG, 2000, CANCER RES, V60, P6001; Yang K, 2013, J ETHNOPHARMACOL, V146, P355, DOI 10.1016/j.jep.2013.01.004; Aubin J. E., 1995, BONE, V17, p77S; Duraipandiyan V, 2006, BMC COMPLEM ALTERN M, V4, P311; Gallacher SJ, 2010, CALCIFIED TISSUE INT, V87, P469, DOI 10.1007/s00223-010-9420-x; Kitahara K, 2003, ENDOCRINOLOGY, V144, P2132, DOI 10.1210/en.2002-220996; Leboime A, 2010, JOINT BONE SPINE S2, V77, P107; Motyckova G, 2001, P NATL ACAD SCI USA, V98, P5798, DOI 10.1073/pnas.091479298; Vazquez R, 2012, PHYTOMEDICINE, V19, P737, DOI 10.1016/j.phymed.2012.03.008; Watanabe A, 2014, BIOCHEM BIOPH RES CO, V453, P787, DOI 10.1016/j.bbrc.2014.10.027	29	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127158	10.1371/journal.pone.0127158		13	Multidisciplinary Sciences	Science & Technology - Other Topics	CI7BG	WOS:000354917300098		
J	Fukagawa, H; Shimizu, T; Kamada, T; Yui, S; Hasegawa, M; Morii, K; Yamamoto, T				Fukagawa, Hirohiko; Shimizu, Takahisa; Kamada, Taisuke; Yui, Shota; Hasegawa, Munehiro; Morii, Katsuyuki; Yamamoto, Toshihiro			Highly efficient and stable organic light-emitting diodes with a greatly reduced amount of phosphorescent emitter	SCIENTIFIC REPORTS			English	Article							EXTERNAL QUANTUM EFFICIENCY; ACTIVATED DELAYED FLUORESCENCE; TRIPLET EXCHANGE ENERGY; HOST MATERIAL; TRANSIENT ANALYSIS; GREEN FLUORESCENT; DEVICES; ELECTROPHOSPHORESCENCE; MECHANISM; EMISSION	Organic light-emitting diodes (OLEDs) have been intensively studied as a key technology for next-generation displays and lighting. The efficiency of OLEDs has improved markedly in the last 15 years by employing phosphorescent emitters. However, there are two main issues in the practical application of phosphorescent OLEDs (PHOLEDs): the relatively short operational lifetime and the relatively high cost owing to the costly emitter with a concentration of about 10% in the emitting layer. Here, we report on our success in resolving these issues by the utilization of thermally activated delayed fluorescent materials, which have been developed in the past few years, as the host material for the phosphorescent emitter. Our newly developed PHOLED employing only 1 wt% phosphorescent emitter exhibits an external quantum efficiency of over 20% and a long operational lifetime of about 20 times that of an OLED consisting of a conventional host material and 1 wt% phosphorescent emitter.	[Fukagawa, Hirohiko; Shimizu, Takahisa; Yamamoto, Toshihiro] Japan Broadcasting Corp NHK, Sci & Technol Res Labs, Setagaya Ku, Tokyo 1578510, Japan; [Kamada, Taisuke; Yui, Shota] Tokyo Univ Sci, Tokyo 1628610, Japan; [Hasegawa, Munehiro; Morii, Katsuyuki] Nippon Shokubai Co Ltd, Suita, Osaka 5648512, Japan	Fukagawa, H (reprint author), Japan Broadcasting Corp NHK, Sci & Technol Res Labs, Setagaya Ku, 1-10-11 Kinuta, Tokyo 1578510, Japan.	fukagawa.h-fe@nhk.or.jp			Strategic Information and Communications R&D Promotion Programme (SCOPE) of the Ministry of Internal Affairs and Communications of Japan	The authors thank Heraeus, Holding GmbH for supplying Clevios HIL 1.5 and Kanto Chemical Co., Inc., for supplying HTEB-2. Part of this work was supported by the Strategic Information and Communications R&D Promotion Programme (SCOPE) of the Ministry of Internal Affairs and Communications of Japan.	Fan C, 2014, ANGEW CHEM INT EDIT, V53, P2147, DOI 10.1002/anie.201308046; Yook KS, 2012, ADV MATER, V24, P3169, DOI 10.1002/adma.201200627; Baldo MA, 2000, PHYS REV B, V62, P10958, DOI 10.1103/PhysRevB.62.10958; Uoyama H, 2012, NATURE, V492, P234, DOI 10.1038/nature11687; Cho YJ, 2014, ADV MATER, V26, P4050, DOI 10.1002/adma.201400347; Zhang DD, 2013, ORG ELECTRON, V14, P260, DOI 10.1016/j.orgel.2012.11.003; Udagawa K, 2014, ADV MATER, V26, P5062, DOI 10.1002/adma.201401621; Baldo MA, 2000, PHYS REV B, V62, P10967, DOI 10.1103/PhysRevB.62.10967; POPE M, 1963, J CHEM PHYS, V38, P2042, DOI 10.1063/1.1733929; Adachi C, 2001, J APPL PHYS, V90, P5048, DOI 10.1063/1.1409582; Xiao LX, 2011, ADV MATER, V23, P926, DOI 10.1002/adma.201003128; Okumoto K, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2266452; Tao Y, 2014, ADV MATER, V26, P7931, DOI 10.1002/adma.201402532; Song DD, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3527085; Seino Y, 2014, ADV MATER, V26, P1612, DOI 10.1002/adma.201304253; Kawamura Y, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.017404; Fukagawa H, 2012, ADV MATER, V24, P5099, DOI 10.1002/adma.201202167; Zhang DD, 2014, ADV FUNCT MATER, V24, P3551, DOI 10.1002/adfm.201303926; Tanaka I, 2004, CHEM PHYS LETT, V400, P86, DOI 10.1016/j.cplett.2004.08.148; Smith LH, 2004, APPL PHYS LETT, V84, P2986, DOI 10.1063/1.1712036; Zhang QS, 2014, NAT PHOTONICS, V8, P326, DOI 10.1038/NPHOTON.2014.12; Lyu YY, 2008, ADV MATER, V20, P2720, DOI 10.1002/adma.200602885; Park YS, 2013, ADV FUNCT MATER, V23, P4914, DOI 10.1002/adfm.201300547; Cheng G, 2014, CHEM SCI, V5, P4819, DOI 10.1039/c4sc01105h; Baldo MA, 1998, NATURE, V395, P151; Baldo MA, 1999, APPL PHYS LETT, V75, P4, DOI 10.1063/1.124258; Sun JW, 2014, ADV MATER, V26, P5684, DOI 10.1002/adma.201401407; Tang KC, 2004, CHEM PHYS LETT, V386, P437, DOI 10.1016/j.cplett.2004.01.098; Shin H, 2014, ADV MATER, V26, P4730, DOI 10.1002/adma.201400955; Adachi C, 2001, APPL PHYS LETT, V79, P2082, DOI 10.1063/1.1400076; Tanaka D, 2007, JPN J APPL PHYS 2, V46, pL10, DOI 10.1143/JJAP.46.L10; Fery C, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2133922; Endo A, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3558906; Kondakov DY, 2007, J APPL PHYS, V101, DOI 10.1063/1.2430922; Endo A., 2009, ADV MATER, V21, P1; Fukagawa H, 2014, ADV OPT MATER, V2, P1070, DOI 10.1002/adom.201400242; Goushi K., 2012, NATURE PHOTON, V492, P234; Li G., 2014, ADV MATER, V26, P2913; Nakanotani H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5016; Okumoto K, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2218833; Sato K, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.247401; Seo S, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.042102; TANG CW, 1987, APPL PHYS LETT, V51, P913, DOI 10.1063/1.98799; Turro N. J., 1991, MODERN MOL PHOTOCHEM, P296; Zhang DD, 2014, ADV MATER, V26, P5050, DOI 10.1002/adma.201401476	45	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAY 18	2015	5								9855	10.1038/srep09855		7	Multidisciplinary Sciences	Science & Technology - Other Topics	CJ1TW	WOS:000355268400001		
J	Iwasaki, S; Isobe, A; Miyao, Y				Iwasaki, Shinsuke; Isobe, Atsuhiko; Miyao, Yasuyuki			Fortnightly atmospheric tides forced by spring and neap tides in coastal waters	SCIENTIFIC REPORTS			English	Article							SEA-SURFACE TEMPERATURE; EAST CHINA SEAS; WIND; WINTER; PACIFIC; CLIMATE; YELLOW; WAVES	The influence of sea surface temperature (SST) on atmospheric processes over the open ocean has been well documented. However, atmospheric responses to SST in coastal waters are poorly understood. Oceanic stratification (and consequently, SST) in coastal waters largely depends on the fortnightly spring-neap tidal cycle, because of variations in vertical tidal mixing. Here we investigate how changes in SST during the fortnightly tidal cycle affect the lower-level atmosphere over the Seto Inland Sea, Japan. We use a combination of in situ measurements, satellite observations and a regional atmospheric model. We find that the SST in summer shows cool (warm) anomalies over most of the inland sea during spring (neap) tides. Additionally, surface air temperature is positively correlated with the SST as it varies during the fortnightly tidal cycle. Moreover, the fortnightly spring-neap cycle also influences the surface wind speed because the atmospheric boundary layer becomes stabilized or destabilized in response to the difference between air temperature and SST.	[Iwasaki, Shinsuke; Isobe, Atsuhiko] Kyushu Univ, Res Inst Appl Mech, Kasuga, Fukuoka 8168580, Japan; [Miyao, Yasuyuki] Kyushu Univ, Dept Earth Syst Sci & Technol, Kasuga, Fukuoka 8168580, Japan	Iwasaki, S (reprint author), Kyushu Univ, Res Inst Appl Mech, 6-1 Kasuga Koen, Kasuga, Fukuoka 8168580, Japan.	iwasaki@riam.kyushu-u.ac.jp	Kyushu, RIAM/F-4018-2015; Isobe, Atsuhiko/G-4654-2015	Isobe, Atsuhiko/0000-0002-9063-9275	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [22106002]	This work was partly supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) through a Grant-in-Aid for Scientific Research (22106002). We would like to thank the editor and three anonymous reviewers for their helpful comments and suggestions.	Nonaka M, 2003, J CLIMATE, V16, P1404, DOI 10.1175/1520-0442(2003)16<1404:COSSTA>2.0.CO;2; Iwasaki S, 2014, J CLIMATE, V27, P155, DOI 10.1175/JCLI-D-13-00117.1; SIMPSON JH, 1974, NATURE, V250, P404, DOI 10.1038/250404a0; LINDZEN RS, 1987, J ATMOS SCI, V44, P2418, DOI 10.1175/1520-0469(1987)044<2418:OTROSS>2.0.CO;2; WALLACE JM, 1989, J CLIMATE, V2, P1492, DOI 10.1175/1520-0442(1989)002<1492:TIOSST>2.0.CO;2; Shi R, 2011, BOUND-LAY METEOROL, V138, P299, DOI 10.1007/s10546-010-9555-3; Donlon CJ, 2002, J CLIMATE, V15, P353, DOI 10.1175/1520-0442(2002)015<0353:TIVOSS>2.0.CO;2; Song QT, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2006JC003680; Xie SP, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015884; Minobe S, 2008, NATURE, V452, P206, DOI 10.1038/nature06690; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; O'Neill LW, 2012, J CLIMATE, V25, P5916, DOI 10.1175/JCLI-D-11-00230.1; Chelton DB, 2001, J CLIMATE, V14, P1479, DOI 10.1175/1520-0442(2001)014<1479:OOCBSW>2.0.CO;2; Vecchi GA, 2004, J CLIMATE, V17, P1213, DOI 10.1175/1520-0442(2004)017<1213:OCITWA>2.0.CO;2; Applied Meteorology Research Division MRI, 1984, TECH REP METEOROL RE, V11, P33; Chin T. M., 2010, ALGORITHM THEORETICA; Dudhia J., 2005, PSU NCAR MESOSCALE M; EBUCHI N, 1992, J GEOPHYS RES-OCEANS, V97, P809, DOI 10.1029/91JC02452; Grell G., 1994, NCARTN398STR; Hashizume H, 2001, J GEOPHYS RES-ATMOS, V106, P10173, DOI 10.1029/2000JD900684; Pullen J, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003726; Smahrt L., 2004, BOUND-LAY METEOROL, V111, P553, DOI DOI 10.1023/B:BOUN.0000016600.63382.5F; Takeoka Hidetaka, 1993, Journal of Oceanography, V49, P369, DOI 10.1007/BF02234954	23	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAY 18	2015	5								10167	10.1038/srep10167		10	Multidisciplinary Sciences	Science & Technology - Other Topics	CJ1UL	WOS:000355270000001		
J	Jung, MC; Raga, SR; Ono, LK; Qi, YB				Jung, Min-Cherl; Raga, Sonia R.; Ono, Luis K.; Qi, Yabing			Substantial improvement of perovskite solar cells stability by pinhole-free hole transport layer with doping engineering	SCIENTIFIC REPORTS			English	Article							SPIRO-MEOTAD FILMS; VAPOR-DEPOSITION; PERFORMANCE; TETRAFLUOROTETRACYANOQUINODIMETHANE; DECAMETHYLCOBALTOCENE; INTERFACES; DOPANT; LIGHT	We fabricated perovskite solar cells using a triple-layer of n-type doped, intrinsic, and p-type doped 2,2',7,7'-tetrakis(N, N'-di-p-methoxyphenylamine)-9,9'-spirobifluorene (spiro-OMeTAD) (n-i-p) as hole transport layer (HTL) by vacuum evaporation. The doping concentration for n-type doped spiro-OMeTAD was optimized to adjust the highest occupied molecular orbital of spiro-OMeTAD to match the valence band maximum of perovskite for efficient hole extraction while maintaining a high open circuit voltage. Time-dependent solar cell performance measurements revealed significantly improved air stability for perovskite solar cells with the n-i-p structured spiro-OMeTAD HTL showing sustained efficiencies even after 840 h of air exposure.	[Jung, Min-Cherl; Raga, Sonia R.; Ono, Luis K.; Qi, Yabing] Grad Univ, Okinawa Inst Sci & Technol, Energy Mat & Surface Sci Unit EMSS, Okinawa 9040495, Japan	Qi, YB (reprint author), Grad Univ, Okinawa Inst Sci & Technol, Energy Mat & Surface Sci Unit EMSS, 1919-1 Tancha, Okinawa 9040495, Japan.	Yabing.Qi@OIST.jp	Qi, Yabing/O-7807-2014; JUNG, Min-Cherl/B-2133-2015	Qi, Yabing/0000-0002-4876-8049; JUNG, Min-Cherl/0000-0002-6073-0908	Okinawa Institute of Science and Technology Graduate University (OIST) in Japan	We would like to acknowledge the financial support from Okinawa Institute of Science and Technology Graduate University (OIST) in Japan.	Abrusci A, 2011, ENERG ENVIRON SCI, V4, P3051, DOI 10.1039/c1ee01135a; Lindblad R, 2014, J PHYS CHEM LETT, V5, P648, DOI 10.1021/jz402749f; Kojima A, 2009, J AM CHEM SOC, V131, P6050, DOI 10.1021/ja809598r; Chan CK, 2009, APPL PHYS A-MATER, V95, P7, DOI 10.1007/s00339-008-4997-x; Mitzi DB, 2001, IBM J RES DEV, V45, P29; Chen Q, 2014, J AM CHEM SOC, V136, P622, DOI 10.1021/ja411509g; Burschka J, 2013, NATURE, V499, P316, DOI 10.1038/nature12340; Hawash Z, 2015, CHEM MATER, V27, P562, DOI 10.1021/cm504022q; Im JH, 2011, NANOSCALE, V3, P4088, DOI 10.1039/c1nr10867k; Zhou HP, 2014, SCIENCE, V345, P542, DOI 10.1126/science.1254050; Eperon GE, 2014, ADV FUNCT MATER, V24, P151, DOI 10.1002/adfm.201302090; Cappel UB, 2012, NANO LETT, V12, P4925, DOI 10.1021/nl302509q; Kim HS, 2013, NANO LETT, V13, P2412, DOI 10.1021/nl400286w; Gao WY, 2003, J APPL PHYS, V94, P359, DOI 10.1063/1.1577400; Ono LK, 2014, J PHYS CHEM LETT, V5, P1374, DOI 10.1021/jz500414m; Wehrenfennig C, 2014, ADV MATER, V26, P1584, DOI 10.1002/adma.201305172; Liu MZ, 2013, NATURE, V501, P395, DOI 10.1038/nature12509; Service RF, 2013, SCIENCE, V342, P794, DOI 10.1126/science.342.6160.794; Ono LK, 2014, ENERG ENVIRON SCI, V7, P3989, DOI 10.1039/c4ee02539c; Braun S, 2007, CHEM PHYS LETT, V438, P259, DOI 10.1016/j.cplett.2007.03.005; Chan CK, 2008, ORG ELECTRON, V9, P575, DOI 10.1016/j.orgel.2008.03.003; Heo JH, 2013, NAT PHOTONICS, V7, P487, DOI 10.1038/NPHOTON.2013.80; Kim HS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00591; Leyden MR, 2014, J MATER CHEM A, V2, P18742, DOI 10.1039/c4ta04385e; Polander LE, 2014, APL MATER, V2, DOI 10.1063/1.4889843	25	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAY 18	2015	5								9863	10.1038/srep09863		5	Multidisciplinary Sciences	Science & Technology - Other Topics	CJ1TY	WOS:000355268600002		
J	Mukai, T; Hoshi, H; Ohtake, K; Takahashi, M; Yamaguchi, A; Hayashi, A; Yokoyama, S; Sakamoto, K				Mukai, Takahito; Hoshi, Hiroko; Ohtake, Kazumasa; Takahashi, Mihoko; Yamaguchi, Atsushi; Hayashi, Akiko; Yokoyama, Shigeyuki; Sakamoto, Kensaku			Highly reproductive Escherichia coli cells with no specific assignment to the UAG codon	SCIENTIFIC REPORTS			English	Article							UNNATURAL AMINO-ACIDS; PEPTIDYL-TRANSFER-RNA; RELEASE-FACTORS RF1; GENETIC-CODE; STALLED RIBOSOMES; PROTEIN-SYNTHESIS; STOP CODON; IN-VIVO; EXPRESSION; REASSIGNMENT	Escherichia coli is a widely used host organism for recombinant technology, and the bacterial incorporation of non-natural amino acids promises the efficient synthesis of proteins with novel structures and properties. In the present study, we developed E. coli strains in which the UAG codon was reserved for non-natural amino acids, without compromising the reproductive strength of the host cells. Ninety-five of the 273 UAG stop codons were replaced synonymously in the genome of E. coli BL21(DE3), by exploiting the oligonucleotide-mediated base-mismatch-repair mechanism. This genomic modification allowed the safe elimination of the UAG-recognizing cellular component (RF-1), thus leaving the remaining 178 UAG codons with no specific molecule recognizing them. The resulting strain B-95.Delta A grew as vigorously as BL21(DE3) in rich medium at 25-42 degrees C, and its derivative B-95.Delta A Delta fabR was better adapted to low temperatures and minimal media than B-95.Delta A. UAG was reassigned to synthetic amino acids by expressing the specific pairs of UAG-reading tRNA and aminoacyl-tRNA synthetase. Due to the preserved growth vigor, the B-95.Delta A strains showed superior productivities for hirudin molecules sulfonated on a particular tyrosine residue, and the Fab fragments of Herceptin containing multiple azido groups.	[Mukai, Takahito; Ohtake, Kazumasa; Takahashi, Mihoko; Yamaguchi, Atsushi; Hayashi, Akiko; Sakamoto, Kensaku] RIKEN, Ctr Life Sci Technol, Div Struct & Synthet Biol, Yokohama, Kanagawa 2300045, Japan; [Mukai, Takahito; Hoshi, Hiroko; Ohtake, Kazumasa; Yamaguchi, Atsushi; Hayashi, Akiko; Yokoyama, Shigeyuki; Sakamoto, Kensaku] RIKEN, Syst & Struct Biol Ctr, Yokohama, Kanagawa 2300045, Japan; [Yokoyama, Shigeyuki] RIKEN, Struct Biol Lab, Yokohama, Kanagawa 2300045, Japan	Sakamoto, K (reprint author), RIKEN, Ctr Life Sci Technol, Div Struct & Synthet Biol, Yokohama, Kanagawa 2300045, Japan.	kensaku.sakamoto@riken.jp			Takeda Science Foundation from the Japan Society for the Promotion of Science (JSPS) [24710232, 26291035]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Special Postdoctoral Researchers Program at RIKEN	The authors thank Drs. M. Shirouzu, T. Matsuda, and T. Matsumoto, and Ms. M. Ikeda for providing ERBB2 and the gene encoding the Herceptin Fab fragment, and also advice for Biacore experiments. This work was supported in part by the Takeda Science Foundation, Grants-in-Aid for Young Scientists (B) (24710232) and Scientific Research (C) (26291035) from the Japan Society for the Promotion of Science (JSPS), and the Platform for Drug Discovery, Informatics and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. T. M. was supported by the Special Postdoctoral Researchers Program at RIKEN.	Zhang YM, 2002, J BIOL CHEM, V277, P15558, DOI 10.1074/jbc.M201399200; Chin JW, 2002, J AM CHEM SOC, V124, P9026, DOI 10.1021/ja027007w; Sawitzke JA, 2011, J MOL BIOL, V407, P45, DOI 10.1016/j.jmb.2011.01.030; Lajoie MJ, 2013, SCIENCE, V342, P357, DOI 10.1126/science.1241459; Heinemann IU, 2012, FEBS LETT, V586, P3716, DOI 10.1016/j.febslet.2012.08.031; Mukai T, 2011, BIOCHEM BIOPH RES CO, V411, P757, DOI 10.1016/j.bbrc.2011.07.020; Wang HH, 2011, METHOD ENZYMOL, V498, P409, DOI 10.1016/B978-0-12-385120-8.00018-8; OSAWA S, 1989, J MOL EVOL, V28, P271, DOI 10.1007/BF02103422; Kthiri F, 2010, J BACTERIOL, V192, P6302, DOI 10.1128/JB.01077-10; Liu CC, 2006, NAT BIOTECHNOL, V24, P1436, DOI 10.1038/nbt1254; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Zhou JD, 2013, NUCLEIC ACIDS RES, V41, pD613, DOI 10.1093/nar/gks1235; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; Johnson DBF, 2011, NAT CHEM BIOL, V7, P779, DOI 10.1038/nchembio.657; GOEDDEL DV, 1979, P NATL ACAD SCI USA, V76, P106, DOI 10.1073/pnas.76.1.106; Lemke EA, 2014, CHEMBIOCHEM, V15, P1691, DOI 10.1002/cbic.201402362; Ohtake K, 2012, J BACTERIOL, V194, P2606, DOI 10.1128/JB.00195-12; Kim CH, 2012, J AM CHEM SOC, V134, P9918, DOI 10.1021/ja303904e; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; Assenberg R, 2013, CURR OPIN STRUC BIOL, V23, P393, DOI 10.1016/j.sbi.2013.03.008; Saxon E, 2000, SCIENCE, V287, P2007, DOI 10.1126/science.287.5460.2007; Axup JY, 2012, P NATL ACAD SCI USA, V109, P16101, DOI 10.1073/pnas.1211023109; ITAKURA K, 1977, SCIENCE, V198, P1056, DOI 10.1126/science.412251; Wang KH, 2007, NAT BIOTECHNOL, V25, P770, DOI 10.1038/nbt1314; Handa Y, 2011, NUCLEIC ACIDS RES, V39, P1739, DOI 10.1093/nar/gkq1097; RYDEN SM, 1984, MOL GEN GENET, V193, P38, DOI 10.1007/BF00327411; Mukai T, 2010, NUCLEIC ACIDS RES, V38, P8188, DOI 10.1093/nar/gkq707; Kim CH, 2013, CURR OPIN CHEM BIOL, V17, P412, DOI 10.1016/j.cbpa.2013.04.017; Guo JT, 2009, ANGEW CHEM INT EDIT, V48, P9148, DOI 10.1002/anie.200904035; Johnson DBF, 2012, ACS CHEM BIOL, V7, P1337, DOI 10.1021/cb300229q; Baba Tomoya, 2006, Mol Syst Biol, V2; BARBAS CF, 1992, P NATL ACAD SCI USA, V89, P9339; Chadani Y, 2012, MOL MICROBIOL, V86, P37, DOI 10.1111/j.1365-2958.2012.08190.x; Chadani Y, 2010, MOL MICROBIOL, V78, P796, DOI 10.1111/j.1365-2958.2010.07375.x; EyreWalker A, 1996, J MOL EVOL, V42, P73, DOI 10.1007/BF02198830; Ito K, 1998, P NATL ACAD SCI USA, V95, P8165, DOI 10.1073/pnas.95.14.8165; Ivanova N. N., SCIENCE, V344, P909; Keseler IM, 2013, NUCLEIC ACIDS RES, V41, pD605, DOI 10.1093/nar/gks1027; Lu WG, 2013, MOL BIOTECHNOL, V53, P41, DOI 10.1007/s12033-012-9511-1; Mitra A, 2011, NUCLEIC ACIDS RES, V39, pD129, DOI 10.1093/nar/gkq971; Mora L, 2007, J BIOL CHEM, V282, P35638, DOI 10.1074/jbc.M706076200; Petry S, 2005, CELL, V123, P1255, DOI 10.1016/j.cell.2005.09.039; Salgado H, 2013, NUCLEIC ACIDS RES, V41, pD203, DOI 10.1093/nar/gks1201; Tsao ML, 2005, CHEMBIOCHEM, V6, P2147, DOI 10.1002/cbic.200500314; Vakhrusheva A. A., 2008, J MOL EVOL, V72, P138	45	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAY 18	2015	5								9699	10.1038/srep09699		9	Multidisciplinary Sciences	Science & Technology - Other Topics	CJ1TD	WOS:000355266500001		
J	Ohtake, K; Yamaguchi, A; Mukai, T; Kashimura, H; Hirano, N; Haruki, M; Kohashi, S; Yamagishi, K; Murayama, K; Tomabechi, Y; Itagaki, T; Akasaka, R; Kawazoe, M; Takemoto, C; Shirouzu, M; Yokoyama, S; Sakamoto, K				Ohtake, Kazumasa; Yamaguchi, Atsushi; Mukai, Takahito; Kashimura, Hiroki; Hirano, Nobutaka; Haruki, Mitsuru; Kohashi, Sosuke; Yamagishi, Kenji; Murayama, Kazutaka; Tomabechi, Yuri; Itagaki, Takashi; Akasaka, Ryogo; Kawazoe, Masahito; Takemoto, Chie; Shirouzu, Mikako; Yokoyama, Shigeyuki; Sakamoto, Kensaku			Protein stabilization utilizing a redefined codon	SCIENTIFIC REPORTS			English	Article							GLUTATHIONE-S-TRANSFERASE; ESCHERICHIA-COLI; GENETIC-CODE; AMINO-ACIDS; STABILITY; CRYSTALLOGRAPHY; SYSTEM; DRUG	Recent advances have fundamentally changed the ways in which synthetic amino acids are incorporated into proteins, enabling their efficient and multiple-site incorporation, in addition to the 20 canonical amino acids. This development provides opportunities for fresh approaches toward addressing fundamental problems in bioengineering. In the present study, we showed that the structural stability of proteins can be enhanced by integrating bulky halogenated amino acids at multiple selected sites. Glutathione S-transferase was thus stabilized significantly (by 5.2 and 5.6 kcal/mol) with 3-chloro- and 3-bromo-L-tyrosines, respectively, incorporated at seven selected sites. X-ray crystallographic analyses revealed that the bulky halogen moieties filled internal spaces within the molecules, and formed non-canonical stabilizing interactions with the neighboring residues. This new mechanism for protein stabilization is quite simple and applicable to a wide range of proteins, as demonstrated by the rapid stabilization of the industrially relevant azoreductase.	[Ohtake, Kazumasa; Yamaguchi, Atsushi; Mukai, Takahito; Tomabechi, Yuri; Akasaka, Ryogo; Takemoto, Chie; Shirouzu, Mikako; Sakamoto, Kensaku] RIKEN, Ctr Life Sci Technol, Div Struct & Synthet Biol, Yokohama, Kanagawa 2300045, Japan; [Ohtake, Kazumasa; Yamaguchi, Atsushi; Mukai, Takahito; Tomabechi, Yuri; Itagaki, Takashi; Akasaka, Ryogo; Kawazoe, Masahito; Takemoto, Chie; Shirouzu, Mikako; Yokoyama, Shigeyuki; Sakamoto, Kensaku] RIKEN, Syst & Struct Biol Ctr, Yokohama, Kanagawa 2300045, Japan; [Kashimura, Hiroki; Hirano, Nobutaka; Haruki, Mitsuru; Kohashi, Sosuke; Yamagishi, Kenji] Nihon Univ, Coll Engn, Dept Chem Biol & Appl Chem, Koriyama, Fukushima 9638642, Japan; [Murayama, Kazutaka] Tohoku Univ, Biomed Engn Res Org, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Kawazoe, Masahito; Yokoyama, Shigeyuki] RIKEN, Struct Biol Lab, Yokohama, Kanagawa 2300045, Japan	Yokoyama, S (reprint author), RIKEN, Syst & Struct Biol Ctr, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	yokoyama@riken.jp; kensaku.sakamoto@riken.jp			Targeted Proteins Research Program; Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; JSPS KAKENHI [26870853]; Special Postdoctoral Researchers Program at RIKEN	We thank Dr. D. Kodama (Nihon University) for refraction index measurements, the beamline staff and Mr. Y. Nakamura for X-ray data collection at BL26B2 at SPring-8 (Hyogo, Japan), and Mr. H. Kato, Mr. S. Sato, and Ms. T. Nakayama for valuable discussions. This work was supported in part by the Targeted Proteins Research Program, and the Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, and was also supported by JSPS KAKENHI Grant Number 26870853. T.M. was supported by the Special Postdoctoral Researchers Program at RIKEN.	Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Lajoie MJ, 2013, SCIENCE, V342, P357, DOI 10.1126/science.1241459; Hammerling MJ, 2014, NAT CHEM BIOL, V10, P178, DOI [10.1038/nchembio.1450, 10.1038/NCHEMBIO.1450]; Johnson JA, 2010, CURR OPIN CHEM BIOL, V14, P774, DOI 10.1016/j.cbpa.2010.09.013; O'Donoghue P, 2013, NAT CHEM BIOL, V9, P594, DOI 10.1038/nchembio.1339; Mukai T, 2011, BIOCHEM BIOPH RES CO, V411, P757, DOI 10.1016/j.bbrc.2011.07.020; Johnson DBF, 2011, NAT CHEM BIOL, V7, P779, DOI 10.1038/nchembio.657; Dominguez MA, 2001, PROTEINS, V45, P55, DOI 10.1002/prot.1123; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; RYDEN SM, 1984, MOL GEN GENET, V193, P38, DOI 10.1007/BF00327411; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Kitaura K, 1999, CHEM PHYS LETT, V313, P701, DOI 10.1016/S0009-2614(99)00874-X; Edwardraja S, 2011, MOL BIOSYST, V7, P258, DOI 10.1039/c0mb00154f; Mukai T, 2010, NUCLEIC ACIDS RES, V38, P8188, DOI 10.1093/nar/gkq707; Yamagishi K, 2010, J STEROID BIOCHEM, V121, P63, DOI 10.1016/j.jsbmb.2010.03.028; Baker PJ, 2011, CHEMBIOCHEM, V12, P1845, DOI 10.1002/cbic.201100221; Buer BC, 2012, P NATL ACAD SCI USA, V109, P4810, DOI 10.1073/pnas.1120112109; Brinda KV, 2005, BIOPHYS J, V89, P4159, DOI 10.1529/biophysj.105.064485; BOWIE JU, 1989, BIOCHEMISTRY-US, V28, P7139, DOI 10.1021/bi00444a001; Holzberger B., 2010, J AM CHEM SOC, V132, P15708; Ishikawa T, 2009, CHEM PHYS LETT, V474, P195, DOI 10.1016/j.cplett.2009.04.045; Ito K, 2006, J BIOL CHEM, V281, P20567, DOI 10.1074/jbc.M513345200; Kaplan W, 1997, PROTEIN SCI, V6, P399; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; MCTIGUE MA, 1995, J MOL BIOL, V246, P21, DOI 10.1006/jmbi.1994.0061; O'Fagain C, 2011, METHODS MOL BIOL, V681, P103, DOI 10.1007/978-1-60761-913-0_7; Pace C. N., 1987, PROTEIN STRUCTURE PR, P299; Pierre L, 2009, XDSME XDS MADE EASIE; Sakamoto K, 2009, STRUCTURE, V17, P335, DOI 10.1016/j.str.2009.01.008; SCHELLMAN JA, 1978, BIOPOLYMERS, V17, P1305, DOI 10.1002/bip.1978.360170515; Sugiyama T, 2010, BIOSENS BIOELECTRON, V26, P452, DOI 10.1016/j.bios.2010.07.092; Tang Y, 2001, BIOCHEMISTRY-US, V40, P2790, DOI 10.1021/bi0022588; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V	35	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAY 18	2015	5								9762	10.1038/srep09762		6	Multidisciplinary Sciences	Science & Technology - Other Topics	CJ1TN	WOS:000355267500002		
J	Sohn, A; Kanki, T; Sakai, K; Tanaka, H; Kim, DW				Sohn, Ahrum; Kanki, Teruo; Sakai, Kotaro; Tanaka, Hidekazu; Kim, Dong-Wook			Fractal Nature of Metallic and Insulating Domain Configurations in a VO2 Thin Film Revealed by Kelvin Probe Force Microscopy	SCIENTIFIC REPORTS			English	Article							PHASE-TRANSITION; TIO2 001; MODULATION; NANOBEAMS	We investigated the surface work function (W-S) and its spatial distribution for epitaxial VO2/TiO2 thin films using Kelvin probe force microscopy (KPFM). Nearly grain-boundary-free samples allowed observation of metallic and insulating domains with distinct W-S values, throughout the metal-insulator transition. The metallic fraction, estimated from W-S maps, describes the evolution of the resistance based on a two-dimensional percolation model. The KPFM measurements also revealed the fractal nature of the domain configuration.	[Sohn, Ahrum; Kim, Dong-Wook] Ewha Womans Univ, Dept Phys, Seoul 120750, South Korea; [Kanki, Teruo; Sakai, Kotaro; Tanaka, Hidekazu] Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan	Kim, DW (reprint author), Ewha Womans Univ, Dept Phys, Seoul 120750, South Korea.	dwkim@ewha.ac.kr			Basic Science Research Program; Quantum Metamaterials Research Center (QMMRC) through the National Research Foundation of Korea Grant [NRF-2013R1A1A2063744, NRF-2008-0061893]; Japan Society for Promotion of Science (JSPS) [26246013, 25286058]; Nanotechnology Platform Project (Nanotechnology Open Facilities in Osaka University) of MEXT [F-14-OS-0010, S-14-OS-0007]	A.S. and D.K. acknowledge the support from Basic Science Research Program and the Quantum Metamaterials Research Center (QMMRC) through the National Research Foundation of Korea Grant (NRF-2013R1A1A2063744, NRF-2008-0061893). T.K., K.S. and H.T. acknowledge the support from Grant-in-Aid for Scientific Research A (No. 26246013) and Grant-in-Aid for Scientific Research B (No. 25286058) from the Japan Society for Promotion of Science (JSPS), and the Nanotechnology Platform Project (Nanotechnology Open Facilities in Osaka University) of MEXT (F-14-OS-0010, S-14-OS-0007).	Aliev VS, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4869125; Seo M, 2010, NANO LETT, V10, P2064, DOI 10.1021/nl1002153; Wu JQ, 2006, NANO LETT, V6, P2313, DOI 10.1021/nl061831r; Kanki T, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4772211; Muraoka Y, 2002, APPL PHYS LETT, V80, P583, DOI 10.1063/1.1446215; Chang YJ, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.075118; Hu B, 2011, ADV MATER, V23, P3536, DOI 10.1002/adma.201101731; Kar A, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4793537; Hilton DJ, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.226401; Nakano M, 2012, NATURE, V487, P459, DOI 10.1038/nature11296; Qazilbash MM, 2007, SCIENCE, V318, P1750, DOI 10.1126/science.1150124; Fan LL, 2014, NANO LETT, V14, P4036, DOI 10.1021/nl501480f; Sohn A, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4766292; Kats MA, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4767646; Shenoy VB, 2006, CHEMPHYSCHEM, V7, P2053, DOI 10.1002/cphc.200600188; Fath M, 1999, SCIENCE, V285, P1540, DOI 10.1126/science.285.5433.1540; Imada M, 1998, REV MOD PHYS, V70, P1039, DOI 10.1103/RevModPhys.70.1039; Lai KJ, 2010, SCIENCE, V329, P190, DOI 10.1126/science.1189925; Yin W, 2011, J APPL PHYS, V109, DOI 10.1063/1.3528167; Favaloro T, 2014, NANO LETT, V14, P2394, DOI 10.1021/nl500042x; Appavoo K, 2011, NANO LETT, V11, P1025, DOI 10.1021/nl103842v; Becker T, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.237203; Driscoll T., 2009, APPL PHYS LETT, V95; Driscoll T, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.094203; Henrich V. E., 1996, SURFACE SCI METAL OX; Kawatani K., 2014, PHYS REV B, V90; Kikuzuki T, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.144113; Kim H, 2015, SCI REP-UK, V5, DOI 10.1038/srep08531; Morrison VR, 2014, SCIENCE, V346, P445, DOI 10.1126/science.1253779; Qazilbash MM, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.165108; Ramirez JG, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4792052; Ramirez JG, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.235110; Sadewasser S., 2011, T KELVIN PROBE FORCE; Stauffer D., 1992, INTRO PERCOLATION TH; Yang T.-H., 2010, APPL PHYS LETT, V97	35	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAY 18	2015	5								10417	10.1038/srep10417		7	Multidisciplinary Sciences	Science & Technology - Other Topics	CJ1VN	WOS:000355272800001		
J	Suzuki, TN				Suzuki, Toshitaka N.			Assessment of predation risk through referential communication in incubating birds	SCIENTIFIC REPORTS			English	Article							ALARM CALLS; FUNCTIONAL REFERENCE; NEST PREDATION; INFORMATION; SIGNAL; NESTLINGS; DEFENSE; SITES	Parents of many bird species produce alarm calls when they approach and deter a nest predator in order to defend their offspring. Alarm calls have been shown to warn nestlings about predatory threats, but parents also face a similar risk of predation when incubating eggs in their nests. Here, I show that incubating female Japanese great tits, Parus minor, assess predation risk by conspecific alarm calls given outside the nest cavity. Tits produce acoustically discrete alarm calls for different nest predators: "jar" calls for snakes and "chicka" calls for other predators such as crows and martens. Playback experiments revealed that incubating females responded to "jar" calls by leaving their nest, whereas they responded to "chicka" calls by looking out of the nest entrance. Since snakes invade the nest cavity, escaping from the nest helps females avoid snake predation. In contrast, "chicka" calls are used for a variety of predator types, and therefore, looking out of the nest entrance helps females gather information about the type and location of approaching predators. These results show that incubating females derive information about predator type from different types of alarm calls, providing a novel example of functionally referential communication.	Grad Univ Adv Studies, Dept Evolutionary Studies Biosyst, Kanagawa, Japan	Suzuki, TN (reprint author), Grad Univ Adv Studies, Dept Evolutionary Studies Biosyst, Kanagawa, Japan.	toshi.n.suzuki@gmail.com			JSPS KAKENHI [25-3391]	This study was supported by JSPS KAKENHI Grant Number 25-3391.	Albrecht T, 2004, ETHOLOGY, V110, P603, DOI 10.1111/j.1439-0310.2004.00992.x; Haff TM, 2011, BIOL LETTERS, V7, P493, DOI 10.1098/rsbl.2010.1125; Magrath RD, 2010, ADV STUD BEHAV, V41, P187, DOI 10.1016/S0065-3454(10)41006-2; Amat JA, 2004, ANIM BEHAV, V67, P293, DOI 10.1016/j.anbehav.2003.06.014; Suzuki TN, 2013, WILSON J ORNITHOL, V125, P412; Gill SA, 2013, ETHOLOGY, V119, P449, DOI 10.1111/eth.12097; Suzuki TN, 2012, ANIM BEHAV, V84, P53, DOI 10.1016/j.anbehav.2012.03.030; Manser MB, 2001, P ROY SOC B-BIOL SCI, V268, P2315, DOI 10.1098/rspb.2001.1773; Manser MB, 2001, P ROY SOC B-BIOL SCI, V268, P2485, DOI 10.1098/rspb.2001.1772; Suzuki TN, 2011, CURR BIOL, V21, pR15, DOI 10.1016/j.cub.2010.11.027; Templeton CN, 2005, SCIENCE, V308, P1934, DOI 10.1126/science.1108841; Kroodsma DE, 2001, ANIM BEHAV, V61, P1029, DOI 10.1006/anbe.2000.1676; Dall SRX, 2005, TRENDS ECOL EVOL, V20, P187, DOI 10.1016/j.tree.2005.01.010; HOLM S, 1979, SCAND J STAT, V6, P65; Platzen D, 2004, P ROY SOC B-BIOL SCI, V271, P1271, DOI 10.1098/rspb.2004.2716; Suzuki TN, 2014, ANIM BEHAV, V87, P59, DOI 10.1016/j.anbehav.2013.10.009; Gill SA, 2004, BEHAV ECOL SOCIOBIOL, V56, P71, DOI 10.1007/s00265-003-0736-7; Gill SA, 1996, BEHAVIOUR, V133, P263, DOI 10.1163/156853996X00143; Martin TE, 2000, P ROY SOC B-BIOL SCI, V267, P2287; Griesser M, 2008, CURR BIOL, V18, P69, DOI 10.1016/j.cub.2007.11.069; Barnett CA, 2013, MAMM STUDY, V38, P269; Caro T., 2005, ANTIPREDATOR DEFENSE; Fasanella M, 2009, J ORNITHOL, V150, P853, DOI 10.1007/s10336-009-0406-2; Furrer RD, 2009, ANIM BEHAV, V78, P195, DOI 10.1016/j.anbehav.2009.05.002; Magrath RD, 2006, P R SOC B, V273, P2335, DOI 10.1098/rspb.2006.3610; MARTIN TE, 1995, ECOL MONOGR, V65, P101, DOI 10.2307/2937160; Meillere A., 2015, BEHAV ECOL IN PRESS; Platzen D, 2005, P ROY SOC B-BIOL SCI, V272, P1101, DOI 10.1098/rspb.2005.3055; R Core Team, 2014, R LANG ENV STAT COMP; Randler C., 2012, ACTA ETHOL, V16, P91; Ricklefs R. E., 1969, SMITHSON CONTRIB ZOO, V9, P1, DOI [DOI 10.5479/SI.00810282.9, 10.5479/si.00810282.9]; Schneider NA, 2013, BEHAV ECOL, V24, P47, DOI 10.1093/beheco/ars134; Serra C., 2010, J ORNITHOL, V152, P331; Townsend SW, 2013, ETHOLOGY, V119, P1, DOI 10.1111/eth.12015	34	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAY 18	2015	5								10239	10.1038/srep10239		6	Multidisciplinary Sciences	Science & Technology - Other Topics	CJ1UV	WOS:000355271000001		
J	Todo, K; Koga, O; Nishikawa, M; Hikida, M				Todo, Kagefumi; Koga, Orie; Nishikawa, Miwako; Hikida, Masaki			Modulation of Ig beta is essential for the B cell selection in germinal center	SCIENTIFIC REPORTS			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; HELPER T-CELLS; ANTIGEN RECEPTOR; MEMORY B; SURFACE EXPRESSION; PLASMA-CELLS; IN-VIVO; IMMUNOGLOBULIN; IL-21; AUTOIMMUNITY	The positive and negative selection of antigen-reactive B cells take place in the germinal center (GC) during an immune responses. However, the precise molecular mechanisms underlying these selection machineries, including the involvement of antigen receptor signaling molecules, remain to be elucidated. We found that expression levels of Ig alpha and Ig beta, which are the essential components of B cell antigen-receptor complex, were differentially regulated in GC B cells and that the expression of Ig beta was more prominently down-regulated in a portion of GC B cells. The suppression of Ig beta down-regulation reduced the number of GL7(+)GC B cells and the affinity maturation in T-dependent responses was markedly impaired. In addition, the disease phenotypes in autoimmune-prone mice were ameliorated by blocking of Ig beta down-regulation. These results suggest that Ig beta down-regulation is involved in the normal positive selection in GC and the accumulation of autoreactive B cells in autoimmune-prone mice.	[Todo, Kagefumi; Koga, Orie; Nishikawa, Miwako; Hikida, Masaki] Kyoto Univ, Ctr Innovat Immunoregulat Technol & Therapeut, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan	Hikida, M (reprint author), Kyoto Univ, Ctr Innovat Immunoregulat Technol & Therapeut, Grad Sch Med, Sakyo Ku, Yoshidakonoecho, Kyoto 6068501, Japan.	hikida@ak.med.kyoto-u.ac.jp					SMITH KGC, 1995, P NATL ACAD SCI USA, V92, P11628, DOI 10.1073/pnas.92.25.11628; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; HOMBACH J, 1990, NATURE, V343, P760, DOI 10.1038/343760a0; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Zhang M, 2007, J IMMUNOL, V179, P4435; Nutt SL, 2011, NAT IMMUNOL, V12, P472, DOI 10.1038/ni.2019; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Khalil AM, 2012, SCIENCE, V336, P1178, DOI 10.1126/science.1213368; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; MATSUUCHI L, 1992, P NATL ACAD SCI USA, V89, P3404, DOI 10.1073/pnas.89.8.3404; Bubier JA, 2009, P NATL ACAD SCI USA, V106, P1518, DOI 10.1073/pnas.0807309106; Hikida M, 2009, J EXP MED, V206, P681, DOI 10.1084/jem.20082100; Moisini I, 2012, J IMMUNOL, V189, P4305, DOI 10.4049/jimmunol.1200745; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Ozaki K, 2004, J IMMUNOL, V173, P5361; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; RETH M, 1992, ANNU REV IMMUNOL, V10, P97, DOI 10.1146/annurev.immunol.10.1.97; Tarlinton DM, 2000, IMMUNOL TODAY, V21, P436, DOI 10.1016/S0167-5699(00)01687-X; Hao ZY, 2008, IMMUNITY, V29, P615, DOI 10.1016/j.immuni.2008.07.016; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Kurosaki T, 2010, ANNU REV IMMUNOL, V28, P21, DOI 10.1146/annurev.immunol.021908.132541; Detanico T, 2013, AUTOIMMUNITY, V46, P102, DOI 10.3109/08916934.2012.757597; Good-Jacobson KL, 2010, NAT IMMUNOL, V11, P535, DOI 10.1038/ni.1877; Goodnow CC, 2010, NAT IMMUNOL, V11, P681, DOI 10.1038/ni.1900; Reth M, 1997, ANNU REV IMMUNOL, V15, P453, DOI 10.1146/annurev.immunol.15.1.453; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Guo BC, 2013, J IMMUNOL, V191, P670, DOI 10.4049/jimmunol.1203211; Kraus M, 2001, J EXP MED, V194, P455, DOI 10.1084/jem.194.4.455; Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Gong SC, 1996, SCIENCE, V272, P411, DOI 10.1126/science.272.5260.411; Guo WZ, 2010, J EXP MED, V207, P2225, DOI 10.1084/jem.20092712; Huang XG, 2011, PATHOL INT, V61, P122, DOI 10.1111/j.1440-1827.2010.02634.x; LI SC, 1994, INT IMMUNOL, V6, P491, DOI 10.1093/intimm/6.4.491; Malone CS, 1997, P NATL ACAD SCI USA, V94, P12314, DOI 10.1073/pnas.94.23.12314; Malone CS, 2000, J IMMUNOL, V164, P2550; Nojima T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1475; Todo K, 2014, BIOCHEM BIOPH RES CO, V445, P572, DOI 10.1016/j.bbrc.2014.02.037; Yuseff MI, 2009, TRAFFIC, V10, P629, DOI 10.1111/j.1600-0854.2009.00913.x; Zhang J, 2008, MOL MED, V14, P675, DOI 10.2119/2008-00066.Zhang	43	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAY 18	2015	5								10303	10.1038/srep10303		14	Multidisciplinary Sciences	Science & Technology - Other Topics	CJ1VC	WOS:000355271700001		
J	Fujiwara, H; Sunagawa, M; Terashima, K; Kittaka, T; Wakita, T; Muraoka, Y; Yokoya, T				Fujiwara, Hirokazu; Sunagawa, Masanori; Terashima, Kensei; Kittaka, Tomoko; Wakita, Takanori; Muraoka, Yuji; Yokoya, Takayoshi			Intrinsic spin polarized electronic structure of CrO2 epitaxial film revealed by bulk-sensitive spin-resolved photoemission spectroscopy	APPLIED PHYSICS LETTERS			English	Article							HALF-METALLIC FERROMAGNET; TEMPERATURE; CR2O3; BAND	We have performed bulk-sensitive spin-resolved photoemission spectroscopy in order to clarify the intrinsic spin-resolved electronic states of half-metallic ferromagnet CrO2. We used CrO2 epitaxial films on TiO2(100), which shows a peak at 1 eV with a clear Fermi edge, consistent with the bulk-sensitive PES spectrum for CrO2. In spin-resolved spectra at 40 K, while the Fermi edge was observed in the spin up (majority spin) state, no states at the Fermi level (EF) with an energy gap of 0.5 eV below EF were observed in the spin down (minority spin) state. At 300 K, the gap in the spin down state closes. These results are consistent with resistivity measurements and magnetic hysteresis curves of the fabricated CrO2 film, constituting spectroscopic evidence for the half-metallicity of CrO2 at low temperature and reducing the spin polarization at room temperature. We also discuss the electron correlation effects of Cr 3d. (C) 2015 AIP Publishing LLC.	[Fujiwara, Hirokazu; Sunagawa, Masanori; Terashima, Kensei; Kittaka, Tomoko; Wakita, Takanori; Muraoka, Yuji; Yokoya, Takayoshi] Okayama Univ, Surface Sci Res Lab, Okayama 7008530, Japan; [Fujiwara, Hirokazu; Sunagawa, Masanori; Terashima, Kensei; Kittaka, Tomoko; Wakita, Takanori; Muraoka, Yuji; Yokoya, Takayoshi] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan; [Terashima, Kensei; Wakita, Takanori; Muraoka, Yuji; Yokoya, Takayoshi] Okayama Univ, Res Ctr New Funct Mat Energy Prod Storage & Trans, Okayama 7008530, Japan	Fujiwara, H (reprint author), Okayama Univ, Surface Sci Res Lab, Okayama 7008530, Japan.				Program for Promoting the Enhancement of Research Universities; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [25800205]	We acknowledge M. Ogata for technical assistance. We thank T. Okuda, K. Miyamoto, and T. Kinoshita for valuable discussions. We also thank A. Ino for his ARPES data analysis program. This work was partially supported by the Program for Promoting the Enhancement of Research Universities and a Grant-in-Aid for Young Scientists (B) (No. 25800205) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT).	Cheng RH, 2001, APPL PHYS LETT, V79, P3122, DOI 10.1063/1.1416474; Korotin MA, 1998, PHYS REV LETT, V80, P4305, DOI 10.1103/PhysRevLett.80.4305; Dowben PA, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/17/171001; Dedkov YS, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.060401; KISKER E, 1985, PHYS REV B, V31, P329, DOI 10.1103/PhysRevB.31.329; KAMPER KP, 1987, PHYS REV LETT, V59, P2788, DOI 10.1103/PhysRevLett.59.2788; Katsnelson MI, 2008, REV MOD PHYS, V80, P315, DOI 10.1103/RevModPhys.80.315; SCHWARZ K, 1986, J PHYS F MET PHYS, V16, pL211, DOI 10.1088/0305-4608/16/9/002; Ji Y, 2001, PHYS REV LETT, V86, P5585, DOI 10.1103/PhysRevLett.86.5585; Jeng HT, 2002, J APPL PHYS, V92, P951, DOI 10.1063/1.1486260; Dedkov YS, 2002, APPL PHYS LETT, V80, P4181, DOI 10.1063/1.1482142; Greber T, 1997, PHYS REV LETT, V79, P4465, DOI 10.1103/PhysRevLett.79.4465; HOWNG WY, 1980, J PHYS CHEM SOLIDS, V41, P75, DOI 10.1016/0022-3697(80)90123-7; Berntsen MH, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3342120; Chioncel L, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.140406; Iwai K, 2010, J APPL PHYS, V108, DOI 10.1063/1.3471811; Seah M. P., 1979, Surface and Interface Analysis, V1, DOI 10.1002/sia.740010103; Souma S, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2818806; Sperlich M, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.235138; Ventrice CA, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/31/315207	20	0	0	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	0003-6951	1077-3118		APPL PHYS LETT	Appl. Phys. Lett.	MAY 18	2015	106	20							202404	10.1063/1.4921629		4	Physics, Applied	Physics	CI8GR	WOS:000355009400026		
J	Krasienapibal, TS; Inoue, S; Fukumura, T; Hasegawa, T				Krasienapibal, Thantip S.; Inoue, Shun; Fukumura, Tomoteru; Hasegawa, Tetsuya			Observation of magnetic domain structure in anatase (Ti,Co)O-2 thin film at room temperature	APPLIED PHYSICS LETTERS			English	Article							FERROMAGNETISM; ANISOTROPY	Magnetic domain structures in anatase (Ti,Co)O-2 (001) epitaxial thin films were observed at room temperature. Magnetic force microscopy in vacuum enabled to observe submicrometer-sized maze domain. Variation of magnetic domain structure as functions of carrier density and Co content was in accordance with that of macroscopic magnetization representing close relationship between the bulk magnetism and magnetic domain structure. With increasing carrier density and/or Co content, the magnetic domain became larger with larger magnetic force signal mostly, where the ferromagnetic transition at carrier density of similar to 2 x 10(19) cm(-3) was observed as an emergence of magnetic domain structure. Micromagnetic parameters were evaluated as functions of carrier density and Co content. (C) 2015 AIP Publishing LLC.	[Krasienapibal, Thantip S.; Inoue, Shun; Fukumura, Tomoteru; Hasegawa, Tetsuya] Univ Tokyo, Dept Chem, Tokyo 1130033, Japan; [Fukumura, Tomoteru; Hasegawa, Tetsuya] Japan Sci & Technol Agcy, CREST, Tokyo 1130033, Japan; [Fukumura, Tomoteru; Hasegawa, Tetsuya] Kanagawa Acad Sci & Technol, Kawasaki, Kanagawa 2130012, Japan	Fukumura, T (reprint author), Tohoku Univ, Sendai, Miyagi 9808577, Japan.	tomoteru.fukumura.e4@tohoku.ac.jp	Fukumura, Tomoteru/C-2081-2009	Fukumura, Tomoteru/0000-0002-8957-3520	JSPS through NEXT Program; CSTP [GR029]; JSPS [26105002]	This research was in part supported by JSPS through the NEXT Program initiated by CSTP (GR029) and JSPS Grant-in-Aid for Scientific Research (26105002).	[Anonymous], 1960, PHILIPS RES REP, V15, P7; Shono T, 2000, APPL PHYS LETT, V77, P1363, DOI 10.1063/1.1290273; Hai PN, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4764947; Ogale SB, 2010, ADV MATER, V22, P3125, DOI 10.1002/adma.200903891; Thiele JU, 1998, J APPL PHYS, V84, P5686, DOI 10.1063/1.368831; Yamanouchi M, 2004, NATURE, V428, P539, DOI 10.1038/nature02441; Okamoto S, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.024413; Yamada Y, 2011, SCIENCE, V332, P1065, DOI 10.1126/science.1202152; Dourlat A, 2008, PHYSICA E, V40, P1848, DOI 10.1016/j.physe.2007.08.037; Fukumura T, 2013, FUNCTIONAL METAL OXIDES: NEW SCIENCE AND NOVEL APPLICATIONS, P91; Fukumura Tomoteru, 2012, SPIN, V2, DOI 10.1142/S2010324712300058; Gourdon C, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.241301; Hong NH, 2005, J APPL PHYS, V97, DOI 10.1063/1.1854072; Hubert A, 1998, MAGNETIC DOMAINS; Konig J, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.184423; Krasienapibal TS, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.090305; Meng HJ, 2007, J APPL PHYS, V102, DOI 10.1063/1.2786115; RAM US, 1983, J APPL PHYS, V54, P2872, DOI 10.1063/1.332284; Yamada Y, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3669505; Yamaoka T., 2003, Journal of the Magnetics Society of Japan, V27, DOI 10.3379/jmsjmag.27.429; Yang HS, 2004, J APPL PHYS, V95, P7192, DOI 10.1063/1.1651799	21	0	0	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	0003-6951	1077-3118		APPL PHYS LETT	Appl. Phys. Lett.	MAY 18	2015	106	20							202402	10.1063/1.4921464		4	Physics, Applied	Physics	CI8GR	WOS:000355009400024		
J	Xin, YZ; Nishio, K; Saitow, K				Xin, Yunzi; Nishio, Kazuyuki; Saitow, Ken-ichi			White-blue electroluminescence from a Si quantum dot hybrid light-emitting diode	APPLIED PHYSICS LETTERS			English	Article							SILICON NANOCRYSTALS; LASER-ABLATION; DARK SPOTS; DEVICES; EMISSION; PHOTOLUMINESCENCE; NANOPARTICLES; LUMINESCENCE; DEGRADATION; ORIGIN	A silicon (Si) quantum dot (QD)-based hybrid inorganic/organic light-emitting diode (LED) was fabricated via solution processing. This device exhibited white-blue electroluminescence at a low applied voltage of 6V, with 78% of the effective emission obtained from the Si QDs. This hybrid LED produced current and optical power densities 280 and 350 times greater than those previously reported for such device. The superior performance of this hybrid device was obtained by both the prepared Si QDs and the optimized layer structure and thereby improving carrier migration through the hybrid LED and carrier recombination in the homogeneous Si QD layer. (C) 2015 AIP Publishing LLC.	[Xin, Yunzi; Nishio, Kazuyuki; Saitow, Ken-ichi] Hiroshima Univ, Grad Sch Sci, Dept Chem, Higashihiroshima 7398526, Japan; [Saitow, Ken-ichi] Hiroshima Univ, Nat Sci Ctr Basic Res & Dev N BARD, Higashihiroshima 7398526, Japan	Saitow, K (reprint author), Hiroshima Univ, Grad Sch Sci, Dept Chem, Higashihiroshima 7398526, Japan.	sai-tow@hiroshima-u.ac.jp			Funding Program for Next-Generation World-Leading Researchers of the Japan Society for the Promotion of Science (JSPS) [GR073]	This study was supported by the Funding Program for Next-Generation World-Leading Researchers (GR073) of the Japan Society for the Promotion of Science (JSPS). We acknowledge to Mr. Takuya Miyayama of ULVAC PHI for the XPS measurement and spectral analysis and reviewers for the critical reading of manuscript and constructive comments.	McElvain J, 1996, J APPL PHYS, V80, P6002, DOI 10.1063/1.363598; Wei SY, 2012, J PHYS CHEM C, V116, P3928, DOI 10.1021/jp10080k; Tan DZ, 2011, PHYS CHEM CHEM PHYS, V13, P20255, DOI 10.1039/c1cp21366k; Cheng KY, 2010, NANO LETT, V10, P1154, DOI 10.1021/nl903212y; Mashford BS, 2013, NAT PHOTONICS, V7, P407, DOI [10.1038/nphoton.2013.70, 10.1038/NPHOTON.2013.70]; Shirasaki Y, 2013, NAT PHOTONICS, V7, P13, DOI [10.1038/nphoton.2012.328, 10.1038/NPHOTON.2013.328]; BURROWS PE, 1994, APPL PHYS LETT, V65, P2922, DOI 10.1063/1.112532; Niu YH, 2007, ADV MATER, V19, P3371, DOI 10.1002/adma.200602373; Cheng KY, 2011, NANO LETT, V11, P1952, DOI 10.1021/nl2001692; Nann T, 2011, ACS NANO, V5, P5291, DOI 10.1021/nn2022974; Kitasako T, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4824844; Ledoux G, 2000, PHYS REV B, V62, P15942, DOI 10.1103/PhysRevB.62.15942; Reboredo FA, 2005, J PHYS CHEM B, V109, P1072, DOI 10.1021/jp0462254; Tan ZN, 2007, NANO LETT, V7, P3803, DOI 10.1021/nl072370s; Puzzo DP, 2011, NANO LETT, V11, P1585, DOI 10.1021/nl1044583; Brill MH, 1998, COLOR RES APPL, V23, P259, DOI 10.1002/(SICI)1520-6378(199808)23:4<259::AID-COL18>3.0.CO;2-7; Reiss P, 2009, SMALL, V5, P154, DOI 10.1002/smll.200800841; Valenta J, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/7/073022; van Buuren T, 1998, PHYS REV LETT, V80, P3803, DOI 10.1103/PhysRevLett.80.3803; Schaer M, 2001, ADV FUNCT MATER, V11, P116, DOI 10.1002/1616-3028(200104)11:2<116::AID-ADFM116>3.0.CO;2-B; Dohnalova K, 2012, SMALL, V8, P3185, DOI 10.1002/smll.201200477; Kusova K, 2010, ACS NANO, V4, P4495, DOI 10.1021/nn1005182; Tu CC, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3593382; Liew YF, 2000, APPL PHYS LETT, V77, P2650, DOI 10.1063/1.1320459; COLVIN VL, 1994, NATURE, V370, P354, DOI 10.1038/370354a0; Maier-Flaig F, 2013, NANO LETT, V13, P475, DOI 10.1021/nl3038689; Yang XY, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4769347; Saitow K, 2009, J PHYS CHEM C, V113, P8465, DOI 10.1021/jp900067s; CANHAM LT, 1990, APPL PHYS LETT, V57, P1046, DOI 10.1063/1.103561; Fairman HS, 1997, COLOR RES APPL, V22, P11, DOI 10.1002/(SICI)1520-6378(199702)22:1<11::AID-COL4>3.0.CO;2-7; Yang SK, 2011, J PHYS CHEM C, V115, P21056, DOI 10.1021/jp2075836; Sun Q, 2007, NAT PHOTONICS, V1, P717, DOI 10.1038/nphoton.2007.226; Anikeeva PO, 2009, NANO LETT, V9, P2532, DOI 10.1021/nl9002969; Liew YF, 2004, CHEM PHYS LETT, V394, P275, DOI 10.1016/j.cplett.2004.07.023; Bourdakos KN, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2909589; Dohnalova K, 2013, LIGHT-SCI APPL, V2, DOI 10.1038/lsa.2013.3; Fujihira M, 1996, APPL PHYS LETT, V68, P1787, DOI 10.1063/1.116667; Ghosh B, 2014, ADV FUNCT MATER, V24, P7151, DOI 10.1002/adfm.201401795; Khriachtchev L, 2012, INT J PHOTOENERGY, DOI 10.1155/2012/872576; KRISHNA MVR, 1992, J CHEM PHYS, V96, P873, DOI 10.1063/1.462158; Portoles MJL, 2012, J PHYS CHEM C, V116, P11315, DOI 10.1021/jp2117938	41	0	0	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	0003-6951	1077-3118		APPL PHYS LETT	Appl. Phys. Lett.	MAY 18	2015	106	20							201102	10.1063/1.4921415		5	Physics, Applied	Physics	CI8GR	WOS:000355009400002		
J	Mori, K; Watanabe, K; Sato, T; Yamashita, H				Mori, Kohsuke; Watanabe, Keitaro; Sato, Takeshi; Yamashita, Hiromi			Environmental Transmission Electron Microscopy Study of Diesel Carbon Soot Combustion under Simulated Catalytic-Reaction Conditions	CHEMPHYSCHEM			English	Article						carbon soot; catalytic combustion; electron microscopy; heterogeneous catalysis; oxidation	EXHAUST EMISSION; IN-SITU; OXIDATION; OXYGEN; OXIDE; MICROSTRUCTURE; PARTICULATE; MORPHOLOGY; BEHAVIOR; METHANE	Environmental transmission electron microscopy (ETEM) is used to monitor the catalytic combustion of diesel carbon soot upon exposure to molecular oxygen at elevated temperatures by using a gas-injection specimen heating holder. The reaction conditions simulated in the ETEM experiments reconstruct real conditions effectively. This study demonstrated for the first time that soot combustion occurs at the soot-catalyst interface for both Ag/CeO2 and Cu/BaO/La2O3 catalysts.	[Mori, Kohsuke; Yamashita, Hiromi] Osaka Univ, Grad Sch Engn, Div Mat & Mfg Sci, Suita, Osaka 5650871, Japan; [Mori, Kohsuke; Yamashita, Hiromi] Kyoto Univ, ESICB, Kyoto 6158520, Japan; [Watanabe, Keitaro; Sato, Takeshi] Hitachi High Technol, Applicat Dev Dept, Hitachinaka, Ibaraki 3120033, Japan	Mori, K (reprint author), Osaka Univ, Grad Sch Engn, Div Mat & Mfg Sci, 2-1 Yamada Oka, Suita, Osaka 5650871, Japan.	mori@mat.eng.osaka-u.ac.jp; yamashita@mat.eng.osaka-u.ac.jp			MEXT	This study was conducted under the management of "Elements Strategy Initiative for Catalysts & Batteries (ESICB)" supported by MEXT.	ANDERSON LC, 1993, J AM CHEM SOC, V115, P6322, DOI 10.1021/ja00067a055; DeLaRiva AT, 2013, J CATAL, V308, P291, DOI 10.1016/j.jcat.2013.08.018; Muller JO, 2005, CATAL TODAY, V102, P259, DOI 10.1016/j.cattod.2005.02.025; Wei YC, 2013, SMALL, V9, P3957, DOI 10.1002/smll.201301027; YAMASHITA H, 1993, ENERG FUEL, V7, P85, DOI 10.1021/ef00037a014; Simonsen SB, 2008, J CATAL, V255, P1, DOI 10.1016/j.jcat.2008.01.004; YAMASHITA H, 1991, APPL CATAL, V79, P203, DOI 10.1016/0926-860X(91)80006-K; Pizzocchero F, 2014, J PHYS CHEM C, V118, P4296, DOI 10.1021/jp500800n; Machida M, 2008, CHEM MATER, V20, P4489, DOI 10.1021/cm800832w; Jinschek JR, 2014, CHEM COMMUN, V50, P2696, DOI 10.1039/c3cc49092k; Shimizu K, 2010, APPL CATAL B-ENVIRON, V96, P169, DOI 10.1016/j.apcatb.2010.02.016; Raj A, 2011, CARBON, V49, P1516, DOI 10.1016/j.carbon.2010.12.005; Su DS, 2004, CATAL TODAY, V90, P127, DOI 10.1016/j.cattod.2004.04.017; Liu J, 2008, APPL CATAL B-ENVIRON, V84, P185, DOI 10.1016/j.apcatb.2008.03.017; Peng ZM, 2012, J CATAL, V286, P22, DOI 10.1016/j.jcat.2011.10.008; van Setten BAAL, 2001, CATAL REV, V43, P489, DOI 10.1081/CR-120001810; BAKER RTK, 1976, J CATAL, V41, P22, DOI 10.1016/0021-9517(76)90196-2; Knauer M, 2009, J PHYS CHEM A, V113, P13871, DOI 10.1021/jp905639d; Muller JO, 2006, ENVIRON SCI TECHNOL, V40, P1231, DOI 10.1021/es0512069; Belton DN, 1999, CURR OPIN SOLID ST M, V4, P97, DOI 10.1016/S1359-0286(99)80017-5; Feng XF, 2011, NANO RES, V4, P767, DOI 10.1007/s12274-011-0133-x; Guo X, 2013, APPL CATAL B-ENVIRON, V142, P278, DOI 10.1016/j.apcatb.2013.05.036; Jeguirim M, 2009, J CHEM TECHNOL BIOT, V84, P770, DOI 10.1002/jctb.2110; Kamino T, 2005, J ELECTRON MICROSC, V54, P497, DOI 10.1093/jmicro/dfi071; Mori K, 2014, J PHYS CHEM C, V118, P9078, DOI 10.1021/jp501940f; Schleicher N, 2010, J ENVIRON MONITOR, V12, P434, DOI 10.1039/b914739j; Schuster ME, 2011, J PHYS CHEM A, V115, P2568, DOI 10.1021/jp1088417; Setiabudi A, 2004, APPL CATAL B-ENVIRON, V51, P9, DOI 10.1016/j.apcath.2004.01.005; Shimokawa H, 2012, CATAL TODAY, V185, P99, DOI 10.1016/j.cattod.2011.10.030; Yamashita H., 1991, APPL CATAL, V78, pL1L6	30	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1439-4235	1439-7641		CHEMPHYSCHEM	ChemPhysChem	MAY 18	2015	16	7					1347	1351		10.1002/cphc.201402818		5	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CH9PH	WOS:000354367500004		
J	Liu, K; Korchowiec, J; Aoki, Y				Liu, Kai; Korchowiec, Jacek; Aoki, Yuriko			Intermediate Electrostatic Field for the Generalized Elongation Method	CHEMPHYSCHEM			English	Article						biomolecules; computational chemistry; electrostatic force; elongation method; quantum-chemical methods	MOLECULAR-ORBITAL METHOD; QUANTUM-MECHANICAL CALCULATION; LARGE SYSTEMS; CUTOFF TECHNIQUE; FRAGMENTATION APPROACH; LOCALIZATION SCHEME; POPULATION ANALYSIS; ENERGY; POLARIZATION; DENSITY	An intermediate electrostatic field is introduced to improve the accuracy of fragment-based quantum-chemical computational methods by including long-range polarizations of biomolecules. The point charge distribution of the intermediate field is generated by a charge sensitivity analysis that is parameterized for five different population analyses, namely, atoms-in-molecules, Hirshfeld, Mulliken, natural orbital, and Voronoi population analysis. Two model systems are chosen to demonstrate the performance of the generalized elongation method (ELG) combined with the intermediate electrostatic field. The calculations are performed for the STO-3G, 6-31G, and 6-31G(d) basis sets and compared with reference Hartree-Fock calculations. It is shown that the error in the total energy is reduced by one order of magnitude, independently of the population analyses used. This demonstrates the importance of long-range polarization in electronic-structure calculations by fragmentation techniques.	[Liu, Kai; Aoki, Yuriko] Kyushu Univ, Dept Mat Sci, Fac Engn Sci, Fukuoka 8168580, Japan; [Korchowiec, Jacek] Jagiellonian Univ, K Guminski Dept Theoret Chem, Fac Chem, PL-30060 Krakow, Poland; [Aoki, Yuriko] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	Aoki, Y (reprint author), Kyushu Univ, Dept Mat Sci, Fac Engn Sci, 6-1 Kasuga Pk, Fukuoka 8168580, Japan.	aoki.yuriko.397@m.kyushu-u.ac.jp			Group, PRESTO, Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Japan Society for the Promotion of Science (JSPS); Polish Ministry of Science and Higher Education [UMO-2011/01/B/ST4/00636]	The calculations were performed on the linux clusters of our laboratory provided by JST-CREST. Besides JST-CREST, this work was partly supported by Group, PRESTO, Japan Science and Technology Agency (JST), a Grant-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan and the Japan Society for the Promotion of Science (JSPS). The CSA work done by J. Korchowiec was supported by the Polish Ministry of Science and Higher Education (Project No. UMO-2011/01/B/ST4/00636).	Adcock S., 2000, GAUL IS OPEN SOURCE; Fedorov DG, 2012, PHYS CHEM CHEM PHYS, V14, P7562, DOI 10.1039/c2cp23784a; Zhang DW, 2003, J CHEM PHYS, V119, P3599, DOI 10.1063/1.1591727; Fedorov DG, 2014, CHEM PHYS LETT, V597, P99, DOI 10.1016/j.cplett.2014.02.029; Korchowiec J, 2009, J COMPUT CHEM, V30, P2515, DOI 10.1002/jcc.21252; MULLIKEN RS, 1955, J CHEM PHYS, V23, P1833, DOI 10.1063/1.1740588; Kohn W, 1996, PHYS REV LETT, V76, P3168, DOI 10.1103/PhysRevLett.76.3168; Li W, 2007, J PHYS CHEM A, V111, P2193, DOI 10.1021/jp067721q; IMAMURA A, 1991, J CHEM PHYS, V95, P5419, DOI 10.1063/1.461658; Makowski M, 2006, J COMPUT CHEM, V27, P1603, DOI 10.1002/jcc.20466; Liu K, 2013, CHEM PHYS LETT, V560, P66, DOI 10.1016/j.cplett.2012.12.046; Korchowiec J, 2010, INT J QUANTUM CHEM, V110, P2130, DOI 10.1002/qua.22562; Liu K, 2013, CHEM PHYS LETT, V565, P143, DOI 10.1016/j.cplett.2013.02.039; Bickelhaupt FM, 1996, ORGANOMETALLICS, V15, P2923, DOI 10.1021/om950966x; Gu FL, 2004, J CHEM PHYS, V121, P10385, DOI 10.1063/1.1812736; Aoki Y, 2012, PHYS CHEM CHEM PHYS, V14, P7640, DOI 10.1039/c2cp24033e; Guerra CF, 2004, J COMPUT CHEM, V25, P189, DOI 10.1002/jcc.10351; [Anonymous], SPART 10; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Tong Y, 2009, J AM CHEM SOC, V131, P8636, DOI 10.1021/ja901650r; Duan LL, 2010, J AM CHEM SOC, V132, P11159, DOI 10.1021/ja102735g; Gordon MS, 2012, CHEM REV, V112, P632, DOI 10.1021/cr200093j; OHNO K, 1964, THEOR CHIM ACTA, V2, P219, DOI 10.1007/BF00528281; Makowski M, 2010, J COMPUT CHEM, V31, P1733, DOI 10.1002/jcc.21462; Kitaura K, 1999, CHEM PHYS LETT, V313, P701, DOI 10.1016/S0009-2614(99)00874-X; KITAURA K, 1976, INT J QUANTUM CHEM, V10, P325, DOI 10.1002/qua.560100211; REED AE, 1985, J CHEM PHYS, V83, P735, DOI 10.1063/1.449486; AOKI Y, 1992, J CHEM PHYS, V97, P8432, DOI 10.1063/1.463413; Xiao XD, 2013, J PHYS CHEM B, V117, P14885, DOI 10.1021/jp4080866; SAEBO S, 1993, ANNU REV PHYS CHEM, V44, P213, DOI 10.1146/annurev.pc.44.100193.001241; Korchowiec J, 2005, INT J QUANTUM CHEM, V102, P785, DOI 10.1002/qua.20448; Chen W, 1996, J PHYS CHEM-US, V100, P14316, DOI 10.1021/jp960694r; HIRSHFELD FL, 1977, THEOR CHIM ACTA, V44, P129, DOI 10.1007/BF00549096; Aoki Y, 2012, AIP CONF PROC, V1504, P647, DOI 10.1063/1.4771778; Bader R F W, 1990, ATOMS MOL QUANTUM TH; Case D., 2012, AMBER 12; Churchill CDM, 2012, CHEM PHYS LETT, V554, P185, DOI 10.1016/j.cplett.2012.09.047; Collins MA, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2347710; Deev V, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1879792; Frisch M J, 2010, GAUSSIAN 09 REVISION; He X, 2014, ACCOUNTS CHEM RES, V47, P2748, DOI 10.1021/ar500077t; Isegawa M, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3624890; Ji CG, 2014, ACCOUNTS CHEM RES, V47, P2795, DOI 10.1021/ar500094n; Kuzniarowicz P., 2014, J MOL MODEL, V20, P1; Li SH, 2014, ACCOUNTS CHEM RES, V47, P2712, DOI 10.1021/ar500038z; Makowski M., 2011, J COMPUT METH SCI EN, V10, P473; Stachowicz A, 2011, J MOL MODEL, V17, P2217, DOI 10.1007/s00894-011-1006-7; Stachowicz A, 2012, STRUCT CHEM, V23, P1449, DOI 10.1007/s11224-012-0054-7; Szabo A., 1996, MODERN QUANTUM CHEM; YANG WT, 1991, PHYS REV LETT, V66, P1438, DOI 10.1103/PhysRevLett.66.1438	51	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1439-4235	1439-7641		CHEMPHYSCHEM	ChemPhysChem	MAY 18	2015	16	7					1551	1556		10.1002/cphc.201402901		6	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CH9PH	WOS:000354367500029		
J	Pakou, A; Pierroutsakou, D; Mazzocco, M; Acosta, L; Aslanoglou, X; Boiano, A; Boiano, C; Carbone, D; Cavallaro, M; Grebosz, J; Keeley, N; La Commara, M; Manea, C; Marquinez-Duran, G; Martel, I; Parascandolo, C; Rusek, K; Sanchez-Benitez, AM; Sgouros, O; Signorini, C; Soramel, F; Soukeras, V; Stiliaris, E; Strano, E; Torresi, D; Trzcinska, A; Watanabe, YX; Yamaguchi, H				Pakou, A.; Pierroutsakou, D.; Mazzocco, M.; Acosta, L.; Aslanoglou, X.; Boiano, A.; Boiano, C.; Carbone, D.; Cavallaro, M.; Grebosz, J.; Keeley, N.; La Commara, M.; Manea, C.; Marquinez-Duran, G.; Martel, I.; Parascandolo, C.; Rusek, K.; Sanchez-Benitez, A. M.; Sgouros, O.; Signorini, C.; Soramel, F.; Soukeras, V.; Stiliaris, E.; Strano, E.; Torresi, D.; Trzcinska, A.; Watanabe, Y. X.; Yamaguchi, H.			Total reaction cross sections for Li-8+Zr-90 at near-barrier energies	EUROPEAN PHYSICAL JOURNAL A			English	Article							ELASTIC-SCATTERING; INELASTIC-SCATTERING; NUCLEAR DENSITIES; COULOMB BARRIER; EXCITATION; IONS; BREAKUP; PB-208; REGION; PROBE	Total reaction cross sections for the radioactive nucleus Li-8 on Zr-90 are reported at the near-barrier energies of 18.5 and 21.5MeV, derived from quasi-elastic scattering measurements. An analysis of the quasi-elastic scattering results is performed within an optical model framework using the BDM3Y1 interaction and total reaction cross sections are deduced. These quantities, appropriately reduced, are compared with previous data obtained in elastic scattering measurements with well and weakly bound projectiles on various targets and a formula for predicting total reaction cross sections with an uncertainty of similar to 20% is obtained. Further on, the ratios of direct to total reaction cross sections are estimated for 6,8 Li on various targets and are compared with CDCC or CRC calculations. The energy dependence of the optical potential is also discussed.	[Pakou, A.; Aslanoglou, X.; Sgouros, O.; Soukeras, V.] Univ Ioannina, Dept Phys, GR-45110 Ioannina, Greece; [Pakou, A.; Aslanoglou, X.; Sgouros, O.; Soukeras, V.] Univ Ioannina, HINP, GR-45110 Ioannina, Greece; [Pierroutsakou, D.; Boiano, A.; La Commara, M.; Parascandolo, C.] Ist Nazl Fis Nucl, Sez Napoli, I-80126 Naples, Italy; [Mazzocco, M.; Soramel, F.; Strano, E.; Torresi, D.] Univ Padua, Dipartimento Fis & Astron, I-35131 Padua, Italy; [Mazzocco, M.; Manea, C.; Soramel, F.; Strano, E.; Torresi, D.] Ist Nazl Fis Nucl, Sez Padova, I-35131 Padua, Italy; [Acosta, L.; Marquinez-Duran, G.; Martel, I.] Univ Huelva, Dept Fis Aplicada, E-21071 Huelva, Spain; [Boiano, C.] Ist Nazl Fis Nucl, Sez Milano, I-20133 Milan, Italy; [Carbone, D.; Cavallaro, M.] Ist Nazl Fis Nucl, Lab Nazl Sud, I-95125 Catania, Italy; [Grebosz, J.] Henryk Niewodniczanski Inst Nucl Phys IFJ PAN, Krakow, Poland; [Keeley, N.] Natl Ctr Nucl Res, PL-05400 Otwock Warsaw, Poland; [La Commara, M.] Univ Naples Federico II, Dipartimento Sci Fis, I-80126 Naples, Italy; [Rusek, K.; Trzcinska, A.] Univ Warsaw, Heavy Ion Lab, PL-02093 Warsaw, Poland; [Sanchez-Benitez, A. M.] Univ Lisbon, Ctr Fis Nucl, P-1649003 Lisbon, Portugal; [Signorini, C.] Ist Nazl Fis Nucl, Lab Nazl Legnaro, I-35020 Legnaro, Italy; [Stiliaris, E.] Univ Athens, Inst Accelerating Syst & Applicat, GR-10679 Athens, Greece; [Stiliaris, E.] Univ Athens, Dept Phys, GR-10679 Athens, Greece; [Watanabe, Y. X.] High Energy Accelerator Res Org KEK, Inst Particle & Nucl Studies IPNS, Tsukuba, Ibaraki 3050801, Japan; [Yamaguchi, H.] Univ Tokyo, Ctr Nucl Study CNS, Wako, Saitama 3510198, Japan	Pakou, A (reprint author), Univ Ioannina, Dept Phys, POB 1186, GR-45110 Ioannina, Greece.	apakou@cc.uoi.gr	Acosta, Luis/M-1838-2014	Acosta, Luis/0000-0001-9136-1909	European Union Seventh Framework Programme FP7 [262010-ENSAR]	We would like to acknowledge warmly Massimo Loriggiola from Laboratori Nationali di Legnaro for providing the zirconium targets and, in fact, in a very short notice of time. The research leading to these results has received funding partly from the European Union Seventh Framework Programme FP7/2007-2013 under Grant Agreement No. 262010-ENSAR.	Morcelle V, 2014, PHYS LETT B, V732, P228, DOI 10.1016/j.physletb.2014.03.043; KEELEY N, 1994, NUCL PHYS A, V571, P326, DOI 10.1016/0375-9474(94)90064-7; Pakou A, 2013, PHYS REV C, V87, DOI 10.1103/PhysRevC.87.014619; Canto LF, 2009, NUCL PHYS A, V821, P51, DOI 10.1016/j.nuclphysa.2009.02.001; KHOA DT, 1995, PHYS LETT B, V342, P6, DOI 10.1016/0370-2693(94)01393-Q; Kolata JJ, 2002, PHYS REV C, V65, DOI 10.1103/PhysRevC.65.054616; Benjamim EA, 2007, PHYS LETT B, V647, P30, DOI 10.1016/j.physletb.2007.01.048; Alvarez MAG, 1999, NUCL PHYS A, V656, P187, DOI 10.1016/S0375-9474(99)00304-8; Figueira JM, 2007, PHYS REV C, V75, DOI 10.1103/PhysRevC.75.017602; Santra S, 2001, PHYS REV C, V64, DOI 10.1103/PhysRevC.64.024602; Sanchez-Benitez AM, 2008, NUCL PHYS A, V803, P30, DOI 10.1016/j.nuclphysa.2008.01.030; CHRISTENSEN PR, 1976, PHYS LETT B, V65, P19, DOI 10.1016/0370-2693(76)90524-4; Pakou A, 2009, EUR PHYS J A, V39, P187, DOI 10.1140/epja/i2008-10702-7; Canto LF, 2009, J PHYS G NUCL PARTIC, V36, DOI 10.1088/0954-3899/36/1/015109; Pakou A, 2004, PHYS REV C, V69, DOI 10.1103/PhysRevC.69.054602; Pakou A, 2007, PHYS REV C, V76, DOI 10.1103/PhysRevC.76.054601; THOMPSON IJ, 1989, NUCL PHYS A, V505, P84, DOI 10.1016/0375-9474(89)90417-X; Pakou A, 2003, PHYS LETT B, V556, P21, DOI 10.1016/S0370-2693(03)00079-0; Shorto JMB, 2009, PHYS LETT B, V678, P77, DOI 10.1016/j.physletb.2009.05.069; Di Pietro A, 2004, PHYS REV C, V69, DOI 10.1103/PhysRevC.69.044613; Kumawat H, 2008, PHYS REV C, V78, DOI 10.1103/PhysRevC.78.044617; Zadro M, 2009, PHYS REV C, V80, DOI 10.1103/PhysRevC.80.064610; THORN CE, 1977, PHYS REV LETT, V38, P384, DOI 10.1103/PhysRevLett.38.384; Farinon F, 2008, NUCL INSTRUM METH B, V266, P4097, DOI 10.1016/j.nimb.2008.05.128; Bhagwat A, 2000, EUR PHYS J A, V8, P511, DOI 10.1007/s100500070074; BRAY KH, 1972, NUCL PHYS A, VA189, P35, DOI 10.1016/0375-9474(72)90645-8; Broglia Ricardo A., 1981, HEAVY ION REACTIONS, VI; DEVRIES H, 1987, ATOM DATA NUCL DATA, V36, P495, DOI 10.1016/0092-640X(87)90013-1; Fan GW, 2014, PHYS REV C, V90, DOI 10.1103/PhysRevC.90.044321; Gasques LR, 2004, PHYS REV C, V69, DOI 10.1103/PhysRevC.69.034603; Gomes PRS, 2005, PHYS REV C, V71, DOI 10.1103/PhysRevC.71.017601; Keeley N, 2012, J PHYS CONF SER, V381, DOI 10.1088/1742-6596/381/1/012087; Keeley N, 2009, Progress in Particle and Nuclear Physics, V63, DOI 10.1016/j.ppnp.2009.05.003; KOVAR DG, 1974, NUCL PHYS A, VA231, P266, DOI 10.1016/0375-9474(74)90522-3; Pakou A, 2006, PHYS LETT B, V633, P691, DOI 10.1016/j.physletb.2005.11.088; RAYNAL J, 1981, PHYS REV C, V23, P2571, DOI 10.1103/PhysRevC.23.2571; Strano E, 2013, NUCL INSTRUM METH B, V317, P657, DOI 10.1016/j.nimb.2013.06.035; THORNTON ST, 1976, PHYS REV C, V13, P1502, DOI 10.1103/PhysRevC.13.1502; TUNG PP, 1978, PHYS REV C, V18, P1663, DOI 10.1103/PhysRevC.18.1663; VIDEBAEK F, 1977, PHYS REV C, V15, P954, DOI 10.1103/PhysRevC.15.954	40	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1434-6001	1434-601X		EUR PHYS J A	Eur. Phys. J. A	MAY 18	2015	51	5							55	10.1140/epja/i2015-15055-6		9	Physics, Nuclear; Physics, Particles & Fields	Physics	CI3AG	WOS:000354619200001		
J	Kobayashi, R; He, JF; Lansky, P				Kobayashi, Ryota; He, Jufang; Lansky, Petr			Estimation of the synaptic input firing rates and characterization of the stimulation effects in an auditory neuron	FRONTIERS IN COMPUTATIONAL NEUROSCIENCE			English	Article						synaptic inputs; statistical inference; state-space models; intracellular recordings; auditory cortex	MEMBRANE-POTENTIAL FLUCTUATIONS; VISUAL CORTICAL-NEURONS; BALANCED INHIBITION; FIRE MODELS; IN-VIVO; CONDUCTANCE; CORTEX; DYNAMICS; CELLS	To understand information processing in neuronal circuits, it is important to infer how a sensory stimulus impacts on the synaptic input to a neuron. An increase in neuronal firing during the stimulation results from pure excitation or from a combination of excitation and inhibition. Here, we develop a method for estimating the rates of the excitatory and inhibitory synaptic inputs from a membrane voltage trace of a neuron. The method is based on a modified Ornstein-Uhlenbeck neuronal model, which aims to describe the stimulation effects on the synaptic input. The method is tested using a single-compartment neuron model with a realistic description of synaptic inputs, and it is applied to an intracellular voltage trace recorded from an auditory neuron in vivo. We find that the excitatory and inhibitory inputs increase during stimulation, suggesting that the acoustic stimuli are encoded by a combination of excitation and inhibition.	[Kobayashi, Ryota] Natl Inst Informat, Principles Informat Res Div, Tokyo 1018430, Japan; [Kobayashi, Ryota] Grad Univ Adv Studies, Dept Informat, SOKENDAI, Tokyo, Japan; [He, Jufang] City Univ Hong Kong, Dept Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Lansky, Petr] Acad Sci Czech Republic, Inst Physiol, Prague, Czech Republic	Kobayashi, R (reprint author), Natl Inst Informat, Principles Informat Res Div, Chiyoda Ku, 2-1-2 Hitotsubashi, Tokyo 1018430, Japan.	r-koba@nii.ac.jp	Lansky, Petr/C-2971-2012		JSPS KAKENHI [25870915]; Ministry of Education, Science, Sports and Culture of Japan [25115728]; Hong Kong Research Grants Council; National Key Basic Research Program of China; National Natural Science Foundation of China; Charlie Lee Foundation; Fong Shu Fook Tong Foundation; Fong's Family Foundation [2012CB966300, 2013CB530900, 561111, 561212, 561410, T13-607/12R, 31300901]; Czech Science Foundation [15-08066S];  [AV0Z50110509]	This study was supported by JSPS KAKENHI Grant Number 25870915, and by a Grant-in-Aid for Scientific Research on Innovative Areas "Mesoscopic Neurocircuitry" (No. 25115728) of the Ministry of Education, Science, Sports and Culture of Japan to RK, by the Hong Kong Research Grants Council, National Key Basic Research Program of China, National Natural Science Foundation of China, Charlie Lee Foundation, Fong Shu Fook Tong Foundation and Fong's Family Foundation (2012CB966300, 2013CB530900, 561111, 561212, 561410, T13-607/12R, 31300901) to JH. PL was supported by the Grant No. AV0Z50110509 and by the Czech Science Foundation project 15-08066S. We thank S. Ditlevsen and S. Shinomoto for a critical reading of the manuscript. RK is grateful for the kind hospitality at The Czech Academy of Sciences.	ABBOTT LF, 1990, LECT NOTES PHYS, V368, P5; Monier C, 2008, J NEUROSCI METH, V169, P323, DOI 10.1016/j.jneumeth.2007.11.008; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Borg-Graham LJ, 1998, NATURE, V393, P369; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; Berg RW, 2007, SCIENCE, V315, P390, DOI 10.1126/science.1134960; Berg RW, 2013, J NEUROPHYSIOL, V110, P1021, DOI 10.1152/jn.00006.2013; Jolivet R, 2004, J NEUROPHYSIOL, V92, P959, DOI 10.1152/jn.00190.2004; Rudolph M, 2007, J NEUROSCI, V27, P5280, DOI 10.1523/JNEUROSCI.4652-06.2007; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Paninski L, 2012, J COMPUT NEUROSCI, V33, P1, DOI 10.1007/s10827-011-0371-7; Miura K, 2007, J NEUROSCI, V27, P13802, DOI 10.1523/JNEUROSCI.2452-07.2007; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Shinomoto S, 1999, NEURAL COMPUT, V11, P935, DOI 10.1162/089976699300016511; Kobayashi R, 2011, NEURAL COMPUT, V23, P3070, DOI 10.1162/NECO_a_00205; Azouz R, 2000, P NATL ACAD SCI USA, V97, P8110, DOI 10.1073/pnas.130200797; Rudolph M, 2004, J NEUROPHYSIOL, V91, P2884, DOI 10.1152/jn.01223.2003; Destexhe A, 1997, NEURAL COMPUT, V9, P503, DOI 10.1162/neco.1997.9.3.503; Bedard C, 2012, J NEUROSCI METH, V210, P3, DOI 10.1016/j.jneumeth.2011.09.010; Braitenberg V., 1998, CORTEX STAT GEOMETRY; Destexhe A, 1998, METHODS NEURONAL MOD, V2, P1; Ditlevsen S, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.011907; Gerstner W., 2002, SPIKING NEURON MODEL; Hausser M, 1997, J NEUROSCI, V17, P7606; He JF, 2003, J NEUROSCI, V23, P8281; Kim H, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.051903; Kitagawa G., 1996, LECT NOTES STAT, V116; Kobayashi R, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.011925; Kobayashi R, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/01/P01017; Kobayashi R., 2011, ADV NEURAL INFORM PR, V24, P217; Koyama S, 2005, J PHYS A-MATH GEN, V38, pL531, DOI 10.1088/0305-4470/38/29/L04; Lankarany M, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00109; Lansky P, 2001, PHYS LETT A, V285, P132, DOI 10.1016/S0375-9601(01)00340-1; Lansky P, 2008, BIOL CYBERN, V99, P253, DOI 10.1007/s00422-008-0237-x; Lansky P, 2010, J PHYSIOL-PARIS, V104, P160, DOI 10.1016/j.jphysparis.2009.11.019; Lansky P, 2006, J COMPUT NEUROSCI, V21, P211, DOI 10.1007/s10827-006-8527-6; LANSKY P, 1983, MATH BIOSCI, V67, P247, DOI 10.1016/0025-5564(83)90103-7; LANSKY P, 1992, BIOSYSTEMS, V27, P25, DOI 10.1016/0303-2647(92)90044-Y; Smith A. C., 2010, COMPUT INTEL NEUROSC, V2010, DOI [10.1155/2010/426539, DOI 10.1155/2010/426539]; Sutherland C, 2009, BIOL CYBERN, V100, P475, DOI 10.1007/s00422-009-0298-5; Tuckwell H.C., 1988, INTRO THEORETICAL NE, V2	43	0	0	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-5188			FRONT COMPUT NEUROSC	Front. Comput. Neurosci.	MAY 18	2015	9								59	10.3389/fncom.2015.00059		11	Mathematical & Computational Biology; Neurosciences	Mathematical & Computational Biology; Neurosciences & Neurology	CI8GT	WOS:000355009600001		
J	Zayets, V; Saito, H; Ando, K; Yuasa, S				Zayets, V.; Saito, H.; Ando, K.; Yuasa, S.			Long-distance propagation of a surface plasmon on the surface of a ferromagnetic metal	OPTICS EXPRESS			English	Article							OPTICAL WAVE-GUIDE; ISOLATOR	A method for the reduction of the propagation loss of surface plasmons was proposed and experimentally demonstrated. A plasmonic structure, which contains a metal and two dielectric layers of different refractive indexes, is proposed in order to optimize the optical confinement and to reduce the propagation loss of the surface plasmons. Long-distance propagation of a surface plasmon on the surface of a ferromagnetic metal was demonstrated. A low propagation loss of 0.17 dB/mu m for a surface plasmon in a Fe/MgO/AlGaAs plasmonic structure was achieved. (C) 2015 Optical Society of America	[Zayets, V.; Saito, H.; Ando, K.; Yuasa, S.] Natl Inst Adv Ind Sci & Technol, Spintron Res Ctr, Tsukuba, Ibaraki, Japan	Zayets, V (reprint author), Natl Inst Adv Ind Sci & Technol, Spintron Res Ctr, Tsukuba, Ibaraki, Japan.	v.zayets@aist.go.jp					Bian YS, 2009, OPT EXPRESS, V17, P21320, DOI 10.1364/OE.17.021320; Zayets V, 2012, MATERIALS, V5, P857, DOI 10.3390/ma5050857; Bian YS, 2015, NANOSCALE, V7, P4415, DOI 10.1039/c4nr06890d; Stanciu CD, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.047601; Shimizu H, 2006, J LIGHTWAVE TECHNOL, V24, P38, DOI 10.1109/JLT.2005.861135; Ghosh S, 2012, IEEE PHOTONIC TECH L, V24, P1653, DOI 10.1109/LPT.2012.2212426; Bian YS, 2014, LASER PHOTONICS REV, V8, P549, DOI 10.1002/lpor.201300207; Armelles G., 2013, MATERIALS, V5, P857; Hutchings DC, 2013, IEEE PHOTONICS J, V5, DOI 10.1109/JPHOT.2013.2292339; Levy M., IEEE J SEL TOP QUANT; Martin-Becerra D, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3512874; Shimizu H, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.02BG02; Sorger VJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1315; Stadler B. J. H., 2014, IEEE PHOTONICS J, V6, P1; Van Parys W, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2174106; Yayoi K, 2011, J APPL PHYS, V109, DOI 10.1063/1.3562043; Zayets V, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1953878; Zayets V, 2010, OPT LETT, V35, P931, DOI 10.1364/OL.35.000931; Zayets V, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3106637; Zayets V, 2012, J APPL PHYS, V111, DOI 10.1063/1.3677942	20	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1094-4087			OPT EXPRESS	Opt. Express	MAY 18	2015	23	10					12834	12839		10.1364/OE.23.012834		6	Optics	Optics	CI4GQ	WOS:000354706800035		
J	Yamazaki, H; Sano, A; Nagatani, M; Miyamoto, Y				Yamazaki, Hiroshi; Sano, Akihide; Nagatani, Munehiko; Miyamoto, Yutaka			Single-carrier 1-Tb/s PDM-16QAM transmission using high-speed InP MUX-DACs and an integrated OTDM modulator	OPTICS EXPRESS			English	Article							OPTICAL-TRANSMISSION; WDM TRANSMISSION	We generated a 1-Tb/s single-carrier PDM-16QAM signal using a single optical modulator with external PDM emulation. To achieve the high symbol rate of 125 Gbaud, we used high-speed InP MUX-DAC modules, each consisting of six 2: 1 MUXs and a 6-bit DAC in a single package, and an integrated optical modulator, which contains a generator of two orthogonal CSRZ pulse trains for spectrally efficient OTDM followed by IQ modulators for each tributary. The signal was received and demodulated without using any time-domain demultiplexing. Transmission over 80-km SSMF was demonstrated. (C) 2015 Optical Society of America	[Yamazaki, Hiroshi; Sano, Akihide; Nagatani, Munehiko; Miyamoto, Yutaka] NTT Corp, NTT Network Innovat Labs, Yokosuka, Kanagawa 2390847, Japan; [Yamazaki, Hiroshi; Nagatani, Munehiko] NTT Corp, NTT Device Technol Labs, Atsugi, Kanagawa 2430198, Japan	Yamazaki, H (reprint author), NTT Corp, NTT Network Innovat Labs, 1-1 Hikari No Oka, Yokosuka, Kanagawa 2390847, Japan.	yamazaki.hiroshi@lab.ntt.co.jp					Yang JA, 2002, IEEE J SEL AREA COMM, V20, P997; Weber HG, 2006, J LIGHTWAVE TECHNOL, V24, P4616, DOI 10.1109/JLT.2006.885784; Miyamoto Y, 1999, ELECTRON LETT, V35, P2041, DOI 10.1049/el:19991373; Nagatani M, 2015, ELECTRON LETT, V51, P710, DOI 10.1049/el.2015.0686; Yamazaki H, 2013, IEEE J SEL TOP QUANT, V19, DOI 10.1109/JSTQE.2013.2263120; Chang D., P OFC NFOEC 2012 LOS; Hu H, 2014, OPT EXPRESS, V22, P110, DOI 10.1364/OE.22.000110; Ishikawa G., P ECOC 1996; Kobayashi T., P OFC NFOEC 2010 SAN; Murai H, 2007, IEEE J SEL TOP QUANT, V13, P70, DOI 10.1109/JSTQE.2006.889429; Nagatani M, 2011, IEEE J SOLID-ST CIRC, V46, P2215, DOI 10.1109/JSSC.2011.2163211; O'Sullivan M., P OFC NFOEC 2012 LOS; Ohara T, 2004, IEEE PHOTONIC TECH L, V16, P650, DOI 10.1109/LPT.2003.818953; Otuya D. O., P ECOC 2014 CANN FRA; Randel S., P OFC 2014 SAN FRANC; Raybon G., P ECOC 2014 CANN FRA; Raybon G., P ECOC 2013 LOND UK; Renaudier J., P ECOC 2014 CANN FRA; Richter T, 2012, J LIGHTWAVE TECHNOL, V30, P504, DOI 10.1109/JLT.2011.2174029; Sano A., P OFC2015 LOS ANG CA; Sano A, 2009, J LIGHTWAVE TECHNOL, V27, P3706, DOI 10.1109/JLT.2009.2023369; Yamazaki H., P OFC 2015 LOS ANG C; Zhou Y. R., P OFC 2014 LOS ANG C	23	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1094-4087			OPT EXPRESS	Opt. Express	MAY 18	2015	23	10					12866	12873		10.1364/OE.23.012866		8	Optics	Optics	CI4GQ	WOS:000354706800038		
J	Isogai, R; Suzuki, S; Nakamura, K; Nakamura, Y; Takagi, H; Goto, T; Lim, PB; Inoue, M				Isogai, Ryosuke; Suzuki, Shota; Nakamura, Kazuki; Nakamura, Yuichi; Takagi, Hiroyuki; Goto, Taichi; Lim, Pang Boey; Inoue, Mitsuteru			Collinear volumetric magnetic holography with magnetophotonic microcavities	OPTICS EXPRESS			English	Article							LITHIUM-NIOBATE; STORAGE; CRYSTALS; PHOTOPOLYMER	Hologram memory is a candidate for high-capacity data storage. Magnetic holograms formed as magnetization directions have been studied to realize rewritable hologram media. Recently, we reported that the magnetophotonic microcavity (MPM) can improve diffraction efficiency because of enhanced Faraday rotation angle and deep hologram writing. In this study, we demonstrated a clear reconstructed image from magnetic holograms in an MPM medium. The structural condition of MPMs for high diffraction efficiency was investigated, and the MPM medium was actually fabricated. The image reconstructed from the MPM medium had approximately twice the brightness of that reconstructed using a monolayer film. (C)2015 Optical Society of America	[Isogai, Ryosuke; Suzuki, Shota; Nakamura, Kazuki; Nakamura, Yuichi; Takagi, Hiroyuki; Goto, Taichi; Lim, Pang Boey; Inoue, Mitsuteru] Toyohashi Univ Technol, Toyohashi, Aichi 4418580, Japan	Nakamura, Y (reprint author), Toyohashi Univ Technol, 1-1 Tempaku Cho, Toyohashi, Aichi 4418580, Japan.	nakamura@ee.tut.ac.jp			 [26220902];  [25-8942]	This work was supported in part by the Grants-in-Aid for Scientific Research (S) 26220902 and Grant-in-Aid for Japan Society for the Promotion of Science (JSPS) Fellows No. 25-8942.	CHEN FS, 1968, APPL PHYS LETT, V13, P223, DOI 10.1063/1.1652580; PSALTIS D, 1995, OPT LETT, V20, P782; Inoue M, 2006, J PHYS D APPL PHYS, V39, pR151, DOI 10.1088/0022-3727/39/8/R01; Kato H, 2003, J APPL PHYS, V93, P3906, DOI 10.1063/1.1559422; Horimai H, 2005, OPT REV, V12, P90, DOI 10.1007/s10043-004-0090-7; FAN G, 1969, J APPL PHYS, V40, P974, DOI 10.1063/1.1657805; CURTIS K, 1994, OPT LETT, V19, P993, DOI 10.1364/OL.19.000993; Takaki Y, 2009, APPL OPTICS, V48, P3255, DOI [10.1364/AO.48.003256, 10.1364/AO.48.003255]; CLOSE DH, 1969, APPL PHYS LETT, V14, P159, DOI 10.1063/1.1652756; GOODMAN JW, 1967, APPL PHYS LETT, V11, P77, DOI 10.1063/1.1755043; Horimai H, 2005, APPL OPTICS, V44, P2575, DOI 10.1364/AO.44.002575; MEZRICH RS, 1970, APPL OPTICS, V9, P2275, DOI 10.1364/AO.9.002275; WITTEKOEK S, 1975, PHYS REV B, V12, P2777, DOI 10.1103/PhysRevB.12.2777; Levy M, 2006, J APPL PHYS, V99, DOI 10.1063/1.2190072; Waldman DA, 1998, P SOC PHOTO-OPT INS, V3291, P89, DOI 10.1117/12.310591; GABOR D, 1948, NATURE, V161, P777, DOI 10.1038/161777a0; VANHEERDEN PJ, 1963, APPL OPTICS, V2, P393; Buse K, 1998, NATURE, V393, P665; SINCERBOX GT, 1995, OPT MATER, V4, P370, DOI 10.1016/0925-3467(94)00089-1; BRUECKMANN B, 1985, APPL OPTICS, V24, P2145; Coufal H. J., 2000, HOLOGRAPHIC DATA STO; Grishin A M, 2008, Journal of the Magnetics Society of Japan, V32, DOI 10.3379/msjmag.32.140; HASKAL HM, 1970, IEEE T MAGN, VMAG6, P542, DOI 10.1109/TMAG.1970.1066857; Hilaire P. S., 1992, J OPT SOC AM A, V9, P1969, DOI 10.1364/JOSAA.9.001969; Isogai R., 2014, J MAGN SOC JPN, V38, P119; Nakamura Y, 2014, J APPL PHYS, V116, DOI 10.1063/1.4895056; Nakamura Y, 2014, OPT EXPRESS, V22, P16439, DOI 10.1364/OE.22.016439	27	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1094-4087			OPT EXPRESS	Opt. Express	MAY 18	2015	23	10					13153	13158		10.1364/OE.23.013153		6	Optics	Optics	CI4GQ	WOS:000354706800066		
J	Toci, G; Pirri, A; Beitlerova, A; Shoji, Y; Yoshikawa, A; Hybler, J; Nikl, M; Vannini, M				Toci, Guido; Pirri, Angela; Beitlerova, Alena; Shoji, Yasuhiro; Yoshikawa, Akira; Hybler, Jiri; Nikl, Martin; Vannini, Matteo			Characterization of the lasing properties of a 5% Yb doped Lu2SiO5 crystal along its three principal dielectric axes	OPTICS EXPRESS			English	Article							CHARGE-TRANSFER LUMINESCENCE; THERMAL-PROPERTIES; LASER; FEMTOSECOND; ABSORPTION; NM	The laser performance of a 5% Yb doped Lu2SiO5 (Yb:LSO) has been investigated in quasi continuous-wave pumping regime along the three principal dielectric axes of the crystal, to obtain a complete characterization of its laser properties. The comparison among the obtained results for differently polarized lasers, in term of relative slope efficiency and absolute efficiency, allows the exploitability of different orientations of the material in order to be determined to obtain efficient laser sources. The laser slope efficiency and the energy conversion efficiency were similar for emission polarized along the three indicatrix axes, with noticeable maximum values of slope efficiency around 90% for polarization along the Y and Z axes. Tunable laser action has been obtained in the range 990 nm -1084 nm, with sizeable differences in the shape of the tuning curve for polarization along the X, Y and Z axes. In particular, the tuning for polarization along the Z axis is relatively flat and uniform in the range 1023 nm - 1083 nm. (C) 2015 Optical Society of America	[Toci, Guido; Vannini, Matteo] CNR, Ist Nazl Ott, I-50019 Sesto Fiorentino, FI, Italy; [Pirri, Angela] CNR, Inst Appl Phys Nello Carrara, I-50019 Sesto Fiorentino, FI, Italy; [Beitlerova, Alena; Hybler, Jiri; Nikl, Martin] Acad Sci Czech Republic, Inst Phys, Prague 16253, Czech Republic; [Shoji, Yasuhiro; Yoshikawa, Akira] Tohoku Univ, Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Yoshikawa, Akira] Tohoku Univ, New Ind Creat Hatchery Ctr NICHe, Aoba Ku, Sendai, Miyagi 9808579, Japan	Pirri, A (reprint author), CNR, Inst Appl Phys Nello Carrara, Via Madonna Piano 10, I-50019 Sesto Fiorentino, FI, Italy.	a.pirri@ifac.cnr.it			CNR-AVCR	This activity has been supported by the CNR-AVCR Joint Project 2013-2015 "Influence of composition and defects on the properties of transparent ceramics and crystals for laser and scintillator applications."	van Pieterson L, 2000, J LUMIN, V91, P177, DOI 10.1016/S0022-2313(00)00214-3; CAIRD JA, 1988, IEEE J QUANTUM ELECT, V24, P1077, DOI 10.1109/3.231; Boulon G, 2008, J ALLOY COMPD, V451, P1, DOI 10.1016/j.jallcom.2007.04.148; DELOACH LD, 1993, IEEE J QUANTUM ELECT, V29, P1179, DOI 10.1109/3.214504; Dorenbos P, 2003, J PHYS-CONDENS MAT, V15, P8417, DOI 10.1088/0953-8984/15/49/018; Beil K, 2013, OPT LETT, V38, P1966, DOI 10.1364/OL.38.001966; Siebold M, 2009, APPL PHYS B-LASERS O, V97, P327, DOI 10.1007/s00340-009-3701-y; Nikl M, 2004, OPT MATER, V26, P545, DOI 10.1016/j.optmat.2004.05.002; Jacquemet M, 2005, APPL PHYS B-LASERS O, V80, P171, DOI 10.1007/s00340-004-1698-9; Cong HJ, 2009, J APPL CRYSTALLOGR, V42, P284, DOI 10.1107/S0021889809004269; Gustafsson T, 2001, ACTA CRYSTALLOGR C, V57, P668, DOI 10.1107/S0108270101005352; Druon F, 2011, OPT MATER EXPRESS, V1, P489; Petit Y, 2013, LASER PHOTONICS REV, V7, P920, DOI 10.1002/lpor.201200078; Campos S, 2004, J PHYS-CONDENS MAT, V16, P4579, DOI 10.1088/0953-8984/16/25/015; Esposito L, 2014, J MATER CHEM C, V2, P10138, DOI 10.1039/c4tc01544d; Huang ZY, 2010, OPT EXPRESS, V18, P20979, DOI 10.1364/OE.18.020979; Jellison GE, 2012, J APPL PHYS, V112, DOI 10.1063/1.4752421; Jolly A, 2009, APPL PHYS B-LASERS O, V97, P85, DOI 10.1007/s00340-009-3577-x; Lin NN, 2013, LASER PHYS LETT, V10, DOI 10.1088/1612-2011/10/1/015103; Petit Y, 2008, OPT EXPRESS, V16, P7997, DOI 10.1364/OE.16.007997; Pirri A, 2014, OPT EXPRESS, V22, P4038, DOI 10.1364/OE.22.004038; Pirri A, 2009, OPT EXPRESS, V17, P18312, DOI 10.1364/OE.17.018312; Pirri A, 2013, LASER PHYS, V23, DOI 10.1088/1054-660X/23/9/095002; Pirri A, 2011, OPT LETT, V36, P4284, DOI 10.1364/OL.36.004284; Thibault F, 2006, OPT LETT, V31, P1555, DOI 10.1364/OL.31.001555; Thiel CW, 2011, J LUMIN, V131, P386, DOI 10.1016/j.jlumin.2010.09.025; Tian W., 2014, ADV SOLID STATE LASE; Zhang XY, 2011, LASER PHYS, V21, P1789, DOI 10.1134/S1054660X11170324	28	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1094-4087			OPT EXPRESS	Opt. Express	MAY 18	2015	23	10					13210	13221		10.1364/OE.23.013210		12	Optics	Optics	CI4GQ	WOS:000354706800071		
J	Shibahara, K; Masuda, A; Kishikawa, H; Kawai, S; Fukutoku, M				Shibahara, Kohki; Masuda, Akira; Kishikawa, Hiroki; Kawai, Shingo; Fukutoku, Mitsunori			Filtering-tolerant transmission by the Walsh-Hadamard transform for super-channel beyond 100 Gb/s	OPTICS EXPRESS			English	Article							POLARIZATION-DEPENDENT LOSS; SYSTEMS	Super-channel transmission is a promising solution to increase the capacity of a channel beyond 100 Gb/s in next-generation optical networks. The performance of a super-channel comprising multiple subcarriers, however, degrades if optical filtering distortions occur in particular subcarriers. In this paper, we propose a method that improves super-channel performance by dispersing the distortions over all subcarriers. We also numerically demonstrate that the method effectively mitigates the filteringinduced penalty suffered by super-channels. (C) 2015 Optical Society of America	[Shibahara, Kohki; Masuda, Akira; Kishikawa, Hiroki; Kawai, Shingo; Fukutoku, Mitsunori] NTT Corp, NTT Network Innovat Labs, Yokosuka, Kanagawa 2390847, Japan	Shibahara, K (reprint author), NTT Corp, NTT Network Innovat Labs, 1-1 Hikari No Oka, Yokosuka, Kanagawa 2390847, Japan.	shibahara.kouki@lab.ntt.co.jp					Kudo R, 2009, J LIGHTWAVE TECHNOL, V27, P3721, DOI 10.1109/JLT.2009.2024091; Gringeri S, 2010, IEEE COMMUN MAG, V48, P40, DOI 10.1109/MCOM.2010.5496877; Andrusier A, 2013, OPT LETT, V38, P118, DOI 10.1364/OL.38.000118; Meron E, 2010, OPT LETT, V35, P3547, DOI 10.1364/OL.35.003547; Bosco G, 2011, J LIGHTWAVE TECHNOL, V29, P53, DOI 10.1109/JLT.2010.2091254; VITERBI AJ, 1983, IEEE T INFORM THEORY, V29, P543, DOI 10.1109/TIT.1983.1056713; Aoki Y., 2012, EUR C EXH OPT COMM O; Buchali F., 2012, OPT FIB COMM C OSA O; Carena A, 2010, IEEE PHOTONIC TECH L, V22, P829, DOI 10.1109/LPT.2010.2045753; Heismann F., 2010, OPT FIB COMM C OSA C; Huang Y., 2013, SCI REP, V3, P1; Kikuchi K., 2012, EUR C EXH OPT COMM O; Mumtaz S., 2010, OPT FIB COMM C OSA C; Mumtaz S., 2010, IEEE ICC, P1; Onggosanusi EN, 2002, INT CONF ACOUST SPEE, P2369; Optical Internetworking Forum, 2004, OIFITLAMSA010; Rahn J. T., 2012, NAT FIB OPT ENG C OS; Rooyen P. V., 1995, P 1995 S PERS IND MO, P1308; Sakamaki Y., 2012, IEICE COMMUN EXPRESS, V1, P54; Shahmohammadi M, 2003, IEEE SYMP COMP COMMU, P277; Shibahara K, 2012, OPT EXPRESS, V20, pB479, DOI 10.1364/OE.20.00B479; Torrengo E., 2010, EUR C EXH OPT COMM O; Xia T., 2011, OPT FIB COMM C NAT F; Yamanaka S., 2012, P SOC PHOTO-OPT INS, V8646; Yu X. Zhou, 2009, EUR C EXH OPT COMM O	25	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1094-4087			OPT EXPRESS	Opt. Express	MAY 18	2015	23	10					13245	13254		10.1364/OE.23.013245		10	Optics	Optics	CI4GQ	WOS:000354706800074		
J	Onbasli, MC; Goto, T; Tang, A; Pan, A; Battal, E; Okyay, AK; Dionne, GF; Ross, CA				Onbasli, Mehmet C.; Goto, Taichi; Tang, Astera; Pan, Annia; Battal, Enes; Okyay, Ali K.; Dionne, Gerald F.; Ross, C. A.			Oxygen partial pressure dependence of magnetic, optical and magneto-optical properties of epitaxial cobalt-substituted SrTiO3 films	OPTICS EXPRESS			English	Article							PULSED-LASER DEPOSITION; ELECTRONIC-STRUCTURE; WAVE-GUIDES	Cobalt-substituted SrTiO3 films (SrTi0.70Co0.30O3-delta) were grown on SrTiO3 substrates using pulsed laser deposition under oxygen pressures ranging from 1 mu Torr to 20 mTorr. The effect of oxygen pressure on structural, magnetic, optical, and magneto-optical properties of the films was investigated. The film grown at 3 mu Torr has the highest Faraday rotation (FR) and magnetic saturation moment (M-s). Increasing oxygen pressure during growth reduced M-s, FR and optical absorption in the nearinfrared. This trend is attributed to decreasing Co2+ ion concentration and oxygen vacancy concentration with higher oxygen partial pressure during growth. (C) 2015 Optical Society of America	[Onbasli, Mehmet C.; Tang, Astera; Pan, Annia; Dionne, Gerald F.; Ross, C. A.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Goto, Taichi] Toyohashi Univ Technol, Dept Elect & Elect Informat Engn, Tempaku Ku, Toyohashi, Aichi 4418580, Japan; [Battal, Enes; Okyay, Ali K.] Bilkent Univ, Dept Elect & Elect Engn, TR-06800 Ankara, Turkey; [Okyay, Ali K.] Bilkent Univ, Inst Mat Sci & Nanotechnol, UNAM, TR-06800 Ankara, Turkey	Ross, CA (reprint author), MIT, Dept Mat Sci & Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	caross@mit.edu			National Science Foundation; FAME; MARCO; DARPA; MIT Center for Materials Science and Engineering Shared Experimental Facilities [DMR0819762];  [26706009];  [26600043]	This work was funded by the National Science Foundation and FAME, a STARnet Center of SRC supported MARCO and DARPA. MIT Center for Materials Science and Engineering Shared Experimental Facilities has been used, award DMR0819762. TG was supported by a Grant-in-Aid for Young Scientists (A) No. 26706009 and Challenging Exploratory Research No. 26600043.	Bi L, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/4/043044; Malo S, 2004, INORG CHEM, V43, P8169, DOI 10.1021/ic0490371; van Benthem K, 2001, J APPL PHYS, V90, P6156, DOI 10.1063/1.1415766; Plonczak P, 2011, ADV FUNCT MATER, V21, P2764, DOI 10.1002/adfm.201100251; Kim DH, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.014416; Zaman TR, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2430931; Guo YP, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/27/275201; Saitoh T, 1997, PHYS REV B, V56, P1290, DOI 10.1103/PhysRevB.56.1290; JU HL, 1995, PHYS REV B, V51, P6143, DOI 10.1103/PhysRevB.51.6143; Bi L, 2011, NAT PHOTONICS, V5, P758, DOI 10.1038/nphoton.2011.270; Shintaku T, 1998, APPL PHYS LETT, V73, P1946, DOI 10.1063/1.122331; Dotsch H, 2005, J OPT SOC AM B, V22, P240, DOI 10.1364/JOSAB.22.000240; Kan DS, 2005, NAT MATER, V4, P816, DOI 10.1038/nmat1498; Bi L., 2011, THESIS MIT; CARDONA M, 1965, PHYS REV, V140, pA651, DOI 10.1103/PhysRev.140.A651; Dionne GF, 2011, J APPL PHYS, V109, DOI 10.1063/1.3562260; Dionne GF, 2007, J APPL PHYS, V101, DOI 10.1063/1.2712318; Dionne GF, 2013, J APPL PHYS, V113, DOI 10.1063/1.4798498; Florez JM, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4729830; Gaidi M, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1942634; Goto T, 2013, J APPL PHYS, V113, DOI 10.1063/1.4800946; Herranz G, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.027207; Higuchi S, 1999, JPN J APPL PHYS 1, V38, P4122, DOI 10.1143/JJAP.38.4122; Jiang P, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3595337; Jiang P, 2012, INORG CHEM, V51, P13245, DOI 10.1021/ic301726w; Kim DH, 2012, ACS COMB SCI, V14, P179, DOI 10.1021/co2001185; Kim HS, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2977963; Kim HS, 2010, NANO LETT, V10, P597, DOI 10.1021/nl903611t; Nitadori T., 1989, CHEM MATER, V1, P215, DOI 10.1021/cm00002a010; Zaman T. R., 2004, P C LAS EL OPT SAN F, P2; Zhang X. S., 2007, PHYS REV B, V76	31	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1094-4087			OPT EXPRESS	Opt. Express	MAY 18	2015	23	10					13399	13409		10.1364/OE.23.013399		11	Optics	Optics	CI4GQ	WOS:000354706800087		
J	Wang, N; Kobayashi, T				Wang, Nan; Kobayashi, Takayoshi			Numerical calibration of the spatial overlap for subtraction microscopy	OPTICS EXPRESS			English	Article							EMISSION DIFFERENCE MICROSCOPY; PUMP-PROBE MICROSCOPY; CONFOCAL MICROSCOPY; RESOLUTION LIMIT; STED MICROSCOPY; VECTOR BEAMS; DIFFRACTION; ENHANCEMENT; BREAKING; FIELD	Recently proposed subtraction microscopy provides a simple and compact approach to enhance the spatial resolution. However, inevitable imperfect overlap of the Gaussian and donut spots could deteriorate the quality of the subtracted images, while this effect is rarely investigated quantitatively. Based on vector diffraction theory, the effects of spatial displacements on the image resolution, signal intensity, and subtraction threshold are studied with several microscope parameters here. The peakposition shift is found to be a useful and convenient parameter to inspect and calibrate the spatial overlap of excitation spots in such microscopes. (C) 2015 Optical Society of America	[Wang, Nan; Kobayashi, Takayoshi] Univ Electrocommun, Adv Ultrafast Laser Res Ctr, Chofu, Tokyo 1828585, Japan; [Wang, Nan; Kobayashi, Takayoshi] CREST, JST, Chiyoda Ku, Tokyo 1020075, Japan; [Kobayashi, Takayoshi] Natl Chiao Tung Univ, Dept Electrophys, Adv Ultrafast Laser Res Ctr, Hsinchu 300, Taiwan; [Kobayashi, Takayoshi] Osaka Univ, Inst Laser Engn, Suita, Osaka 5650971, Japan	Kobayashi, T (reprint author), Univ Electrocommun, Adv Ultrafast Laser Res Ctr, 1-5-1 Chofugaoka, Chofu, Tokyo 1828585, Japan.	kobayashi@ils.uec.ac.jp					Dehez H, 2013, OPT EXPRESS, V21, P15912, DOI 10.1364/OE.21.015912; Wang N, 2014, OPT EXPRESS, V22, P28819, DOI 10.1364/OE.22.028819; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; You ST, 2014, OPT EXPRESS, V22, P26375, DOI 10.1364/OE.22.026375; Miyazaki J, 2014, OPT EXPRESS, V22, P9024, DOI 10.1364/OE.22.009024; Rittweger E, 2009, NAT PHOTONICS, V3, P144, DOI 10.1038/NPHOTON.2009.2; Sharonov A, 2006, P NATL ACAD SCI USA, V103, P18911, DOI 10.1073/pnas.0609643104; Lerman GM, 2008, OPT EXPRESS, V16, P4567, DOI 10.1364/OE.16.004567; Segawa S, 2014, OPT LETT, V39, P4529, DOI 10.1364/OL.39.004529; Segawa S, 2014, OPT LETT, V39, P3118, DOI 10.1364/OL.39.003118; Ganic D, 2003, OPT EXPRESS, V11, P2747, DOI 10.1364/OE.11.002747; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Wang N, 2015, OPT COMMUN, V343, P28, DOI 10.1016/j.optcom.2014.12.072; Yao JJ, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.014302; Dorn R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.233901; Gordon MP, 2004, P NATL ACAD SCI USA, V101, P6462, DOI 10.1073/pnas.0401638101; Dertinger T, 2009, P NATL ACAD SCI USA, V106, P22287, DOI 10.1073/pnas.0907866106; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; RICHARDS B, 1959, PROC R SOC LON SER-A, V253, P358, DOI 10.1098/rspa.1959.0200; Deng SH, 2009, OPT EXPRESS, V17, P1714, DOI 10.1364/OE.17.001714; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Kuang CF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01441; Miyazaki J, 2014, OPT LETT, V39, P4219, DOI 10.1364/OL.39.004219	23	1	1	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1094-4087			OPT EXPRESS	Opt. Express	MAY 18	2015	23	10					13410	13422		10.1364/OE.23.013410		13	Optics	Optics	CI4GQ	WOS:000354706800088		
J	Tsujimoto, Y; Sugiura, Y; Ando, M; Katsuse, D; Ikuta, R; Yamamoto, T; Koashi, M; Imoto, N				Tsujimoto, Yoshiaki; Sugiura, Yukihiro; Ando, Makoto; Katsuse, Daisuke; Ikuta, Rikizo; Yamamoto, Takashi; Koashi, Masato; Imoto, Nobuyuki			Extracting an entangled photon pair from collectively decohered pairs at a telecommunication wavelength	OPTICS EXPRESS			English	Article							QUANTUM CRYPTOGRAPHY; STATE; COMMUNICATION; CHANNELS	We experimentally demonstrated entanglement extraction scheme by using photons at the telecommunication band for optical-fiberbased quantum communications. We generated two pairs of non-degenerate polarization entangled photons at 780 nm and 1551 nm by spontaneous parametric down-conversion and distributed the two photons at 1551 nm through a collective phase damping channel which gives the same amount of random phase shift on the two photons. Through local operation and classical communication, we extracted an entangled photon pair from two phase-disturbed photon pairs. An observed fidelity of the extracted photon pair to a maximally entangled photon pair was 0.73 +/- 0.07 which clearly shows the recovery of entanglement. (C) 2015 Optical Society of America	[Tsujimoto, Yoshiaki; Sugiura, Yukihiro; Ando, Makoto; Katsuse, Daisuke; Ikuta, Rikizo; Yamamoto, Takashi; Imoto, Nobuyuki] Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan; [Koashi, Masato] Univ Tokyo, Photon Sci Ctr, Bunkyo Ku, Tokyo 1138656, Japan	Tsujimoto, Y (reprint author), Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan.	tsujimoto@mp.es.osaka-u.ac.jp			Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST), MEXT [21102008, 25247068, 25286077, 26286068]	This work was supported by the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST), MEXT Grant-in-Aid for Scientific Research on Innovative Areas 21102008, JSPS Grant-in-Aid for Scientific Research(A) 25247068, (B) 25286077 and (B) 26286068.	Yamamoto T, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.012304; Yamamoto T, 2008, NAT PHOTONICS, V2, P488, DOI 10.1038/nphoton.2008.130; Ikuta R, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.110503; Pittman TB, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.062311; Rehacek J, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.042108; Wabnig J, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/7/073001; Bell B, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/2/023021; Kwiat PG, 2000, SCIENCE, V290, P498, DOI 10.1126/science.290.5491.498; Yamamoto T, 2003, NATURE, V421, P343, DOI 10.1038/nature01358; Zhao Z, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.014301; Mohseni M, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.187903; Bennett CH, 1996, PHYS REV A, V54, P3824, DOI 10.1103/PhysRevA.54.3824; Pan JW, 2001, NATURE, V410, P1067, DOI 10.1038/35074041; BENNETT CH, 1992, PHYS REV LETT, V69, P2881, DOI 10.1103/PhysRevLett.69.2881; HONG CK, 1987, PHYS REV LETT, V59, P2044, DOI 10.1103/PhysRevLett.59.2044; Laing A, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.012304; Stucki D, 2002, NEW J PHYS, V4, DOI 10.1088/1367-2630/4/1/341; BENNETT CH, 1992, PHYS REV LETT, V68, P557, DOI 10.1103/PhysRevLett.68.557; Zhao Z, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.207901; Mosley PJ, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.133601; Prevedel R, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.250503; BENNETT CH, 1993, PHYS REV LETT, V70, P1895, DOI 10.1103/PhysRevLett.70.1895; Wu LA, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.130501; Deutsch D, 1996, PHYS REV LETT, V77, P2818, DOI 10.1103/PhysRevLett.77.2818; Banaszek K, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.257901; Bourennane M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.107901; Bennett CH, 1996, PHYS REV A, V53, P2046, DOI 10.1103/PhysRevA.53.2046; James DFV, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.052312; Kumagai H, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.052325; Ollerenshaw JE, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.217904; Vallone G, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.060503; Yamamoto T, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/191; Zhang P, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.130501	33	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1094-4087			OPT EXPRESS	Opt. Express	MAY 18	2015	23	10					13545	13553		10.1364/OE.23.013545		9	Optics	Optics	CI4GQ	WOS:000354706800100		
J	Ma, L; Hanzawa, N; Tsujikawa, K; Aozasa, S; Yamamoto, F				Ma, Lin; Hanzawa, Nobutomo; Tsujikawa, Kyozo; Aozasa, Shinichi; Yamamoto, Fumihiko			Loss reduction in few-mode photonic crystal fiber by reducing inner surface imperfections in air holes	OPTICS EXPRESS			English	Article							TRANSMISSION; SCATTERING; ROUGHNESS; DISTANCE	We studied both theoretically and experimentally the additional loss in photonic crystal fiber (PCF) that results from inner surface imperfections such as contamination and the surface roughness of air holes. We estimated the modal loss dependence of these imperfections using a model with a "defective layer" for the first time. The theoretical studies suggest that higher order modes have a larger loss due to imperfections in the air holes. By minimizing the inner surface imperfections of the six innermost air holes, we can theoretically expect any additional loss to be reduced to a negligible level. Moreover, we examined our theoretical prediction experimentally. We fabricated few-mode PCFs by employing a suitable inner surface treatment for just the six innermost holes. As expected theoretically, the transmission loss was greatly reduced by employing these processes. The lowest transmission losses in the 1550 nm band were 0.31 dB/km for the LP01 mode and 0.43 dB/km for the LP11 mode. Our theoretical model will be useful with a view to realizing few-mode PCF with a loss comparable to that of conventional fibers. (C) 2015 Optical Society of America	[Ma, Lin; Hanzawa, Nobutomo; Tsujikawa, Kyozo; Aozasa, Shinichi; Yamamoto, Fumihiko] NTT Corp, Access Network Serv Syst Labs, Tsukuba, Ibaraki 3050805, Japan	Tsujikawa, K (reprint author), NTT Corp, Access Network Serv Syst Labs, 1-7-1 Hanabatake, Tsukuba, Ibaraki 3050805, Japan.	tujikawa.kyouzou@lab.ntt.co.jp					Roberts PJ, 2005, OPT EXPRESS, V13, P7779, DOI 10.1364/OPEX.13.007779; Richardson DJ, 2013, NAT PHOTONICS, V7, P354, DOI [10.1038/nphoton.2013.94, 10.1038/NPHOTON.2013.94]; Birks TA, 1997, OPT LETT, V22, P961, DOI 10.1364/OL.22.000961; BIRKS TA, 1995, ELECTRON LETT, V31, P1941, DOI 10.1049/el:19951306; Nagayama K, 2002, ELECTRON LETT, V38, P1168, DOI 10.1049/el:20020824; Yajima T, 2013, OPT EXPRESS, V21, P30500, DOI 10.1364/OE.21.030500; Phan-Huy MC, 2009, J LIGHTWAVE TECHNOL, V27, P1597, DOI 10.1109/JLT.2009.2020608; Hanzawa N, 2013, OPT EXPRESS, V21, P25752, DOI 10.1364/OE.21.025752; Saitoh K, 2005, OPT EXPRESS, V13, P10833, DOI 10.1364/OPEX.13.010833; Giraud A., 2009, P OECC2009; Gris-Sanchez I, 2011, OPT MATER EXPRESS, V1, P179; Hanzawa N, 2010, J LIGHTWAVE TECHNOL, V28, DOI 10.1109/JLT.2010.2052913; Kurokawa K, 2009, J LIGHTWAVE TECHNOL, V27, P1653, DOI 10.1109/JLT.2009.2014174; Mizuno T., 2014, P OFC2014; Mori T., 2012, P ECOC2012; Sakamoto T, 2011, OPT EXPRESS, V19, P478, DOI 10.1364/OE.19.00B478; Tajima K., 2007, P ECOC2007; Zhi Wang, 2003, Opt Express, V11, P39	18	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1094-4087			OPT EXPRESS	Opt. Express	MAY 18	2015	23	10					13619	13625		10.1364/OE.23.013619		7	Optics	Optics	CI4GQ	WOS:000354706800109		
J	Slezak, O; Yasuhara, R; Lucianetti, A; Mocek, T				Slezak, Ondrej; Yasuhara, Ryo; Lucianetti, Antonio; Mocek, Tomas			Wavelength dependence of magneto-optic properties of terbium gallium garnet ceramics	OPTICS EXPRESS			English	Article							THERMALLY-INDUCED DEPOLARIZATION; CRYOGENIC FARADAY ISOLATOR; HIGH-AVERAGE-POWER; VERDET CONSTANT; TGG CERAMICS; OPTICAL-PROPERTIES; TEMPERATURE; ROTATOR; LASER; COMPENSATION	The wavelength dependence of magneto-optic properties of TGG ceramics, including the Verdet constant, has been investigated experimentally. The previously obtained Verdet constant of 36.4 rad/Tm for 1064 nm wavelength and 139.6 rad/Tm for 633 nm are in good agreement with presented white light measurements. The comparison with previously reported Verdet constant and absorption coefficient values for TGG single crystal has shown very similar results. These results lead to the conclusion that TGG ceramics is a very good alternative to TGG single crystal and is a powerful approach for realizing large-aperture optical isolators which are required in high-average-power laser systems. (C) 2015 Optical Society of America	[Slezak, Ondrej; Lucianetti, Antonio; Mocek, Tomas] Acad Sci Czech Republic, Inst Phys, HiLASE Ctr, Dolni Brezany 25241, Czech Republic; [Yasuhara, Ryo] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan	Slezak, O (reprint author), Acad Sci Czech Republic, Inst Phys, HiLASE Ctr, Za Radnici 828, Dolni Brezany 25241, Czech Republic.	slezako@fzu.cz; yasuhara@nifs.ac.jp	Lucianetti, Antonio/G-7383-2014; Mocek, Tomas/G-5344-2014; Slezak, Ondrej/H-1470-2014		European Regional Development Fund; European Social Fund; Czech Republic [CZ.1.05/2.1.00/01.0027, CZ.1.07/2.3.00/20.0143, CZ.1.07/2.3.00/30.0057]; AMADA foundation; JSPS KAKENHI [26709072]	This work is co-financed by the European Regional Development Fund, the European Social Fund and the state budget of the Czech Republic (project HiLASE: CZ.1.05/2.1.00/01.0027, project DPSSLasers: CZ.1.07/2.3.00/20.0143, project Postdok: CZ.1.07/2.3.00/30.0057). This research was supported in part by a grant from AMADA foundation. Further, this work was supported by JSPS KAKENHI (Grant No. 26709072).	Kaminskii AA, 2005, LASER PHYS LETT, V2, P489, DOI 10.1002/lapl.200510033; Zheleznov DS, 2012, J OPT SOC AM B, V29, P786; Khazanov E, 2002, APPL OPTICS, V41, P483, DOI 10.1364/AO.41.000483; Yasuhara R, 2007, OPT EXPRESS, V15, P11255, DOI 10.1364/OE.15.011255; Yasuhara R, 2008, OPT LETT, V33, P1711, DOI 10.1364/OL.33.001711; Banerjee S, 2012, OPT LETT, V37, P2175, DOI 10.1364/OL.37.002175; Yoshida H, 2011, OPT EXPRESS, V19, P15181, DOI 10.1364/OE.19.015181; Divoky M, 2013, OPT ENG, V52, DOI 10.1117/1.OE.52.6.064201; Yasuhara R, 2014, OPT LETT, V39, P1145, DOI 10.1364/OL.39.001145; SLACK GA, 1971, PHYS REV B-SOLID ST, V4, P592, DOI 10.1103/PhysRevB.4.592; Bayramian A, 2008, J OPT SOC AM B, V25, pB57, DOI 10.1364/JOSAB.25.000B57; Yasuhara R, 2013, OPT LETT, V38, P1751, DOI 10.1364/OL.38.001751; BARNES NP, 1992, J OPT SOC AM B, V9, P1912, DOI 10.1364/JOSAB.9.001912; Flores JL, 2008, APPL OPTICS, V47, P4396, DOI 10.1364/AO.47.004396; Khazanov E, 2004, IEEE J QUANTUM ELECT, V40, P1500, DOI 10.1109/JQE.2004.834766; Molina P, 2011, OPT EXPRESS, V19, P11786, DOI 10.1364/OE.19.011786; Qiu JR, 1997, J NON-CRYST SOLIDS, V213, P193, DOI 10.1016/S0022-3093(97)00101-4; RAJA MYA, 1995, APPL PHYS LETT, V67, P2123, DOI 10.1063/1.114740; Sekine T, 2010, OPT EXPRESS, V18, P13927, DOI 10.1364/OE.18.013927; Snetkov IL, 2014, OPT EXPRESS, V22, P4144, DOI 10.1364/OE.22.004144; Starobor AV, 2014, IEEE J QUANTUM ELECT, V50, P749, DOI 10.1109/JQE.2014.2339230; Starobor AV, 2011, J OPT SOC AM B, V28, P1409; SUITS JC, 1966, J APPL PHYS, V37, P1391, DOI 10.1063/1.1708486; Villora EG, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3609245; Yasuhara R, 2013, OPT EXPRESS, V21, P31443, DOI 10.1364/OE.21.031443; Yasuhara R, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4904461	26	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1094-4087			OPT EXPRESS	Opt. Express	MAY 18	2015	23	10					13641	13647		10.1364/OE.23.013641		7	Optics	Optics	CI4GQ	WOS:000354706800112		
J	Wang, N; Kobayashi, T				Wang, Nan; Kobayashi, Takayoshi			Polarization modulation for fluorescence emission difference microscopy	OPTICS EXPRESS			English	Article							CONFOCAL MICROSCOPY; RESOLUTION LIMIT; OPTICAL-SYSTEMS; VECTOR BEAMS; DIFFRACTION; ENHANCEMENT; BREAKING; LIGHT; FIELD	Effects of the polarization on subtracted images in fluorescence emission difference microscopy are numerically investigated based on vector beam diffraction theory and alteration of Jones matrices. Parameters of resolution, signal loss, and amplitude of negative sidebands after subtraction are discussed along with the polarization of excitation beams and sample sizes. The effects of polarization on the ellipticity and subtraction threshold are also given. (C) 2015 Optical Society of America	[Wang, Nan; Kobayashi, Takayoshi] Univ Electrocommun, Adv Ultrafast Laser Res Ctr, Chofu, Tokyo 1828585, Japan; [Wang, Nan; Kobayashi, Takayoshi] JST, CREST, Chiyoda Ku, Tokyo 1020075, Japan; [Kobayashi, Takayoshi] Natl Chiao Tung Univ, Adv Ultrafast Laser Res Ctr, Dept Elect, Hsinchu 300, Taiwan; [Kobayashi, Takayoshi] Osaka Univ, Inst Laser Engn, Suita, Osaka 5650971, Japan	Kobayashi, T (reprint author), Univ Electrocommun, Adv Ultrafast Laser Res Ctr, 1-5-1 Chofugaoka, Chofu, Tokyo 1828585, Japan.	kobayashi@ils.uec.ac.jp					Stalder M, 1996, OPT LETT, V21, P1948, DOI 10.1364/OL.21.001948; Dehez H, 2013, OPT EXPRESS, V21, P15912, DOI 10.1364/OE.21.015912; Wang N, 2014, OPT EXPRESS, V22, P28819, DOI 10.1364/OE.22.028819; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; You ST, 2014, OPT EXPRESS, V22, P26375, DOI 10.1364/OE.22.026375; Jones RC, 1941, J OPT SOC AM, V31, P488, DOI 10.1364/JOSA.31.000488; Miyazaki J, 2014, OPT EXPRESS, V22, P9024, DOI 10.1364/OE.22.009024; Sharonov A, 2006, P NATL ACAD SCI USA, V103, P18911, DOI 10.1073/pnas.0609643104; Lerman GM, 2008, OPT EXPRESS, V16, P4567, DOI 10.1364/OE.16.004567; Segawa S, 2014, OPT LETT, V39, P4529, DOI 10.1364/OL.39.004529; Fujita K, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.228105; MCMASTER WH, 1961, REV MOD PHYS, V33, P8, DOI 10.1103/RevModPhys.33.8; Segawa S, 2014, OPT LETT, V39, P3118, DOI 10.1364/OL.39.003118; Galiani S, 2012, OPT EXPRESS, V20, P7362, DOI 10.1364/OE.20.007362; Ganic D, 2003, OPT EXPRESS, V11, P2747, DOI 10.1364/OE.11.002747; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Wang N, 2015, OPT COMMUN, V343, P28, DOI 10.1016/j.optcom.2014.12.072; Yao JJ, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.014302; Gordon MP, 2004, P NATL ACAD SCI USA, V101, P6462, DOI 10.1073/pnas.0401638101; Dertinger T, 2009, P NATL ACAD SCI USA, V106, P22287, DOI 10.1073/pnas.0907866106; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; RICHARDS B, 1959, PROC R SOC LON SER-A, V253, P358, DOI 10.1098/rspa.1959.0200; Chen Y, 2015, HISTOCHEM CELL BIOL, V143, P11, DOI 10.1007/s00418-014-1267-1; Hao XA, 2010, J OPT-UK, V12, DOI 10.1088/2040-8978/12/11/115707; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Kuang CF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01441; Wang N., OPT EXPRESS IN PRESS; Yuan CJ, 2011, APPL OPTICS, V50, pB6, DOI 10.1364/AO.50.0000B6	28	1	1	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1094-4087			OPT EXPRESS	Opt. Express	MAY 18	2015	23	10					13704	13712		10.1364/OE.23.013704		9	Optics	Optics	CI4GQ	WOS:000354706800117		
J	Habe, T; Koshino, M				Habe, Tetsuro; Koshino, Mikito			Spin-dependent refraction at the atomic step of transition-metal dichalcogenides	PHYSICAL REVIEW B			English	Article							VALLEY POLARIZATION; MONOLAYER MOS2; NANOSHEETS	We theoretically propose a spin-dependent electronic transport mechanism in which the spin-unpolarized electron beam is split into different directions depending on spins at an atomic domain boundary in nonmagnetic material. Specifically, we calculate the electronic transmission across a boundary between the monolayer and bilayer of the transition-metal dichalcogenide, and demonstrate that up-spin and down-spin electrons entering the boundary are refracted and collimated to opposite directions. The phenomenon is attributed to the strong spin-orbit interaction, the trigonally warped Fermi surface, and the different crystal symmetries between the monolayer and bilayer systems. The spin-dependent refraction suggests a potential application for a spin splitter, which spatially separates up-spin and down-spin electrons simply by passing the electric current through the boundary.	[Habe, Tetsuro; Koshino, Mikito] Tohoku Univ, Dept Phys, Sendai, Miyagi 9808578, Japan	Habe, T (reprint author), Tohoku Univ, Dept Phys, Sendai, Miyagi 9808578, Japan.				JSPS [24740193, 25107005]	We would like to thank Professor Takashi Koretsune for his help in using the QUANTUM-ESPRESSO and WANNIER90 packages. This work was supported by JSPS Grants-in-Aid for Scientific Research (Grants No. 24740193 and No. 25107005).	Kiselev AA, 2001, APPL PHYS LETT, V78, P775, DOI 10.1063/1.1347023; Feng WX, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.165108; Yamamoto M, 2014, ACS NANO, V8, P3895, DOI 10.1021/nn5007607; Klinovaja J, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.075404; ANDO T, 1991, PHYS REV B, V44, P8017, DOI 10.1103/PhysRevB.44.8017; Ohe J, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.041308; Hirsch JE, 1999, PHYS REV LETT, V83, P1834, DOI 10.1103/PhysRevLett.83.1834; Shi HL, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.155304; Yun WS, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.033305; Lee YH, 2012, ADV MATER, V24, P2320, DOI 10.1002/adma.201104798; Mostofi AA, 2008, COMPUT PHYS COMMUN, V178, P685, DOI 10.1016/j.cpc.2007.11.016; DATTA S, 1990, APPL PHYS LETT, V56, P665, DOI 10.1063/1.102730; Molina-Sanchez A, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.045412; Splendiani A, 2010, NANO LETT, V10, P1271, DOI 10.1021/nl903868w; Kumar A, 2013, MODEL SIMUL MATER SC, V21, DOI 10.1088/0965-0393/21/6/065015; Xiao D, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.196802; Mak KF, 2012, NAT NANOTECHNOL, V7, P494, DOI [10.1038/nnano.2012.96, 10.1038/NNANO.2012.96]; Mak KF, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.136805; Suzuki R, 2014, NAT NANOTECHNOL, V9, P611, DOI [10.1038/nnano.2014.148, 10.1038/NNANO.2014.148]; Jin WC, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.106801; Debbichi L, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.205311; Song Y, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.026601; Kormanyos A, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.011034; Kaneko T, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.245303; Kiselev AA, 2000, PHYS REV B, V61, P13115, DOI 10.1103/PhysRevB.61.13115; Liu GB, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.085433; Chhowalla M, 2013, NAT CHEM, V5, P263, DOI [10.1038/nchem.1589, 10.1038/NCHEM.1589]; Coleman JN, 2011, SCIENCE, V331, P568, DOI 10.1126/science.1194975; Giannozzi P, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/39/395502; ELLIOTT RJ, 1954, PHYS REV, V96, P266, DOI 10.1103/PhysRev.96.266; Nakanishi T, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.125428; Yamamoto M, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.115321; Wang QH, 2012, NAT NANOTECHNOL, V7, P699, DOI [10.1038/nnano.2012.193, 10.1038/NNANO.2012.193]; Zeng HL, 2012, NAT NANOTECHNOL, V7, P490, DOI [10.1038/nnano.2012.95, 10.1038/NNANO.2012.95]; Zhang CJ, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.205436; Cao T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1882; Cummings AW, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2364859; DYAKONOV MI, 1971, SOV PHYS JETP-USSR, V33, P1053; He JG, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.075409; Ochoa H, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.245421; Peng L, 2014, J APPL PHYS, V115, DOI 10.1063/1.4882195; Wolf E. L., 2013, GRAPHENE NEW PARADIG; Yuan HT, 2014, NAT NANOTECHNOL, V9, P851, DOI [10.1038/nnano.2014.183, 10.1038/NNANO.2014.183]	43	0	0	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	MAY 18	2015	91	20							201407	10.1103/PhysRevB.91.201407		5	Physics, Condensed Matter	Physics	CI7VK	WOS:000354972700002		
J	Kada, T; Asahi, S; Kaizu, T; Harada, Y; Kita, T; Tamaki, R; Okada, Y; Miyano, K				Kada, T.; Asahi, S.; Kaizu, T.; Harada, Y.; Kita, T.; Tamaki, R.; Okada, Y.; Miyano, K.			Two-step photon absorption in InAs/GaAs quantum-dot superlattice solar cells	PHYSICAL REVIEW B			English	Article							EFFICIENCY	We studied the two-step photon absorption (TSPA) process in InAs/GaAs quantum-dot superlattice (QDSL) solar cells. TSPA of subband-gap photons efficiently occurs when electrons are pumped from the valence band to the states above the inhomogeneously distributed fundamental states of QDSLs. The photoluminescence (PL)-excitation spectrum demonstrates an absorption edge attributed to the higher excited states of the QDSLs in between the InAs wetting layer states and the fundamental states of QDSLs. When the absorption edge of the excited state was resonantly excited, the superlinear excitation power dependence of the PL intensity demonstrated that the electron and hole created by the interband transition separately relax into QDSLs. Furthermore, time-resolved PL measurements demonstrated that the electron lifetime is extended by thereby inhibiting recombination with holes, enhancing the second subband-gap absorption.	[Kada, T.; Asahi, S.; Kaizu, T.; Harada, Y.; Kita, T.] Kobe Univ, Grad Sch Engn, Dept Elect & Elect Engn, Nada Ku, Kobe, Hyogo 6578501, Japan; [Tamaki, R.; Okada, Y.; Miyano, K.] Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo 1538904, Japan	Kada, T (reprint author), Kobe Univ, Grad Sch Engn, Dept Elect & Elect Engn, Nada Ku, 1-1 Rokkodai, Kobe, Hyogo 6578501, Japan.		Kita, Takashi/H-6884-2013; Miyano, Kenjiro/G-7534-2014		Incorporated Administrative Agency New Energy and Industrial Technology Development Organization (NEDO); Ministry of Economy, Trade and Industry (METI), Japan	This work has been partially supported by the Incorporated Administrative Agency New Energy and Industrial Technology Development Organization (NEDO), and Ministry of Economy, Trade and Industry (METI), Japan. The authors would like to thank S. Naitoh of the University of Tokyo for fabrication of the reference QD sample.	Nishikawa K, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3694284; Heitz R, 1997, PHYS REV B, V56, P10435, DOI 10.1103/PhysRevB.56.10435; Nozik AJ, 2002, PHYSICA E, V14, P115, DOI 10.1016/S1386-9477(02)00374-0; Takahashi A, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.235323; Tomic S, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.195321; Kasamatsu N, 2014, J APPL PHYS, V115, DOI 10.1063/1.4867042; Luque A, 2012, NAT PHOTONICS, V6, P146, DOI [10.1038/nphoton.2012.1, 10.1038/NPHOTON.2012.1]; Chen R, 2003, J LUMIN, V102, P510, DOI 10.1016/S0022-2313(02)00601-4; SHOCKLEY W, 1961, J APPL PHYS, V32, P510, DOI 10.1063/1.1736034; Ikeuchi Y, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.062001; Luque A, 2011, J APPL PHYS, V110, DOI 10.1063/1.3600702; Hirst LC, 2011, PROG PHOTOVOLTAICS, V19, P286, DOI 10.1002/pip.1024; Antolin E, 2010, J APPL PHYS, V108, DOI 10.1063/1.3468520; Asahi S, 2014, J APPL PHYS, V116, DOI 10.1063/1.4892826; Hu WG, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3516468; Jang YD, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3255017; Kada T., 2013, JSAP MRS JOINT UNPUB; Kita T., 2012, ENERGY CONVERSION EF, P87; Kita T, 2011, J APPL PHYS, V110, DOI 10.1063/1.3660794; Le Ru EC, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.245318; Luque A, 1997, PHYS REV LETT, V78, P5014, DOI 10.1103/PhysRevLett.78.5014; Marti A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.247701; Okada Y, 2011, J APPL PHYS, V109, DOI 10.1063/1.3533423; Seidl S, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2906900; Shoji Y, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/2/024002; Tamaki R, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4893879; Trupke T, 2004, J APPL PHYS, V96, P2347, DOI 10.1063/1.1766091; Yoshida K, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3488815	28	1	1	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	MAY 18	2015	91	20							201303	10.1103/PhysRevB.91.201303		6	Physics, Condensed Matter	Physics	CI7VK	WOS:000354972700001		
J	Kornich, V; Stano, P; Zyuzin, AA; Loss, D				Kornich, Viktoriia; Stano, Peter; Zyuzin, Alexander A.; Loss, Daniel			Voltage-induced conversion of helical to uniform nuclear spin polarization in a quantum wire	PHYSICAL REVIEW B			English	Article							FERROMAGNETISM; SEMICONDUCTORS	We study the effect of bias voltage on the nuclear spin polarization of a ballistic wire, which contains electrons and nuclei interacting via hyperfine interaction. In equilibrium, the localized nuclear spins are helically polarized due to the electron-mediated Ruderman-Kittel-Kasuya-Yosida (RKKY) interaction. Focusing here on nonequilibrium, we find that an applied bias voltage induces a uniform polarization, from both helically polarized and unpolarized spins available for spin flips. Once a macroscopic uniform polarization in the nuclei is established, the nuclear spin helix rotates with frequency proportional to the uniform polarization. The uniform nuclear spin polarization monotonically increases as a function of both voltage and temperature, reflecting a thermal activation behavior. Our predictions offer specific ways to test experimentally the presence of a nuclear spin helix polarization in semiconducting quantum wires.	[Kornich, Viktoriia; Zyuzin, Alexander A.; Loss, Daniel] Univ Basel, Dept Phys, CH-4056 Basel, Switzerland; [Stano, Peter; Loss, Daniel] RIKEN, Ctr Emergent Matter Sci, Wako, Saitama 3510198, Japan	Kornich, V (reprint author), Univ Basel, Dept Phys, Klingelbergstr 82, CH-4056 Basel, Switzerland.		Stano, Peter/C-3016-2013; Loss, Daniel/A-3721-2008	Loss, Daniel/0000-0001-5176-3073	Swiss NF; NCCR QSIT; S<SUP>3</SUP>NANO	We thank V. N. Golovach, D. Becker, B. Braunecker, L. Glazman, C. Kloeffel, T. Meng, and C. Orth for helpful discussions and acknowledge support from the Swiss NF, NCCR QSIT, and S<SUP>3</SUP>NANO.	Ohno H, 1998, SCIENCE, V281, P951, DOI 10.1126/science.281.5379.951; YOSIDA K, 1957, PHYS REV, V106, P893, DOI 10.1103/PhysRev.106.893; Braunecker B, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.165119; Dixon DC, 1997, PHYS REV B, V56, P4743, DOI 10.1103/PhysRevB.56.4743; KASUYA T, 1956, PROG THEOR PHYS, V16, P45, DOI 10.1143/PTP.16.45; Parkin SSP, 2008, SCIENCE, V320, P190, DOI 10.1126/science.1145799; Lunde AM, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.035112; Ohno H, 2000, NATURE, V408, P944, DOI 10.1038/35050040; Maciejko J, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.256803; Tatara G, 2008, PHYS REP, V468, P213, DOI 10.1016/j.physrep.2008.07.003; RUDERMAN MA, 1954, PHYS REV, V96, P99, DOI 10.1103/PhysRev.96.99; Golovach VN, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.016601; Simon P, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.045108; Simon P, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.156401; Scheller CP, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.066801; Stano P, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.195312; Trowbridge CJ, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.085122; Berger L, 1996, PHYS REV B, V54, P9353, DOI 10.1103/PhysRevB.54.9353; Braunecker B, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.116403; Chiba D, 2008, NATURE, V455, P515, DOI 10.1038/nature07318; Blum K, 1996, DENSITY MATRIX THEOR; Borhani M, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.155311; Budich JC, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.086602; Chesi S., ARXIV150303645; Chida K, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.041309; Del Maestro A, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.165440; Deviatov EV, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.115330; Dietl T, 1997, PHYS REV B, V55, pR3347; Frohlich H., 1940, Proceedings of the Royal Society of London, Series A (Mathematical and Physical Sciences), V175, DOI 10.1098/rspa.1940.0064; Hals KMD, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.174409; Herzog BE, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4892361; Kloeffel C, 2013, ANNU REV CONDEN MA P, V4, P51, DOI 10.1146/annurev-conmatphys-030212-184248; Li FX, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.107203; Machida T, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.233304; Meng T, 2014, EUR PHYS J B, V87, DOI 10.1140/epjb/e2014-50445-1; Peddibhotla P, 2013, NAT PHYS, V9, P630, DOI 10.1038/NPHYS2731; Rugar D, 2015, NAT NANOTECHNOL, V10, P120, DOI 10.1038/nnano.2014.288; Schmidt TL, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.156402; Slichter C P, 1980, PRINCIPLES MAGNETIC; Slonczewski JC, 1996, J MAGN MAGN MATER, V159, pL1, DOI 10.1016/0304-8853(96)00062-5; Zyuzin AA, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.195125	41	1	1	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	MAY 18	2015	91	19							195423	10.1103/PhysRevB.91.195423		8	Physics, Condensed Matter	Physics	CI7VJ	WOS:000354972600009		
J	Kuroda, K; Eguchi, G; Shirai, K; Shiraishi, M; Ye, M; Miyamoto, K; Okuda, T; Ueda, S; Arita, M; Namatame, H; Taniguchi, M; Ueda, Y; Kimura, A				Kuroda, Kenta; Eguchi, Gaku; Shirai, Kaito; Shiraishi, Masashi; Ye, Mao; Miyamoto, Koji; Okuda, Taichi; Ueda, Shigenori; Arita, Masashi; Namatame, Hirofumi; Taniguchi, Masaki; Ueda, Yoshifumi; Kimura, Akio			Tunable spin current due to bulk insulating property in the topological insulator Tl1-xBi1+xSe2-delta	PHYSICAL REVIEW B			English	Article							PHASE-TRANSITION; DIRAC CONE; SURFACE; BI2TE3; CONDUCTION; FIELD	The surfaces of three-dimensional topological insulators characterized by spin-helical Dirac fermions provide a fertile ground for realizing exotic phenomena, and they have the potential for wide-ranging applications. To realize most of their special properties, the Dirac point must be located near the Fermi energy with a bulk insulating property. However, this is barely achieved in most of the discovered topological insulators. It was found recently that TlBiSe2 features an in-gap Dirac point, where the upper and lower parts of the Dirac-cone surface state are both utilized. Nevertheless, investigations of the surface transport properties of this material are limited due to the lack of bulk insulating characteristics. Here, we present a realization of the bulk insulating property by tuning the composition of Tl1-xBi1+xSe2-delta without introducing guest atoms. This result promises to shed light on exotic topological phenomena on the surface.	[Kuroda, Kenta; Shirai, Kaito; Taniguchi, Masaki; Kimura, Akio] Hiroshima Univ, Grad Sch Sci, Higashihiroshima 7398526, Japan; [Eguchi, Gaku; Shiraishi, Masashi] Kyoto Univ, Dept Elect Sci & Engn, Nishikyo Ku, Kyoto 6158510, Japan; [Ye, Mao; Miyamoto, Koji; Okuda, Taichi; Arita, Masashi; Namatame, Hirofumi; Taniguchi, Masaki] Hiroshima Univ, Hiroshima Synchrotron Radiat Ctr, Higashihiroshima 7390046, Japan; [Ueda, Shigenori] Natl Inst Mat Sci, SPring 8, Synchrotron Xray Stn, Mikazuki, Hyogo 6795148, Japan; [Ueda, Yoshifumi] Kure Natl Coll Technol, Kure 7378506, Japan	Kuroda, K (reprint author), Hiroshima Univ, Grad Sch Sci, 1-3-1 Kagamiyama, Higashihiroshima 7398526, Japan.				JSPS [23340105]; Japan Society for the Promotion of Science for Young Scientists	We thank S. Zhu, T. Maegawa, and K. Shibata for technical support. The ARPES and SARPES measurements were performed at HiSOR, Hiroshima University with the approval of the Proposal Assessing Committee of HSRC (Proposal No. 12-A-24, 11-B-12). The HAXPES experiment was performed at BL15XU of SPring-8 with the approval of NIMS Synchrotron X-ray Station (Proposal No. 2012B4908). This work was partly supported by JSPS KAKENHI, a Grant-in-Aid for JSPS Scientific Research (B) (Grant No. 23340105). K.K. and G.E. acknowledge support from the Japan Society for the Promotion of Science for Young Scientists.	Ko W, 2013, SCI REP-UK, V3, DOI 10.1038/srep02656; Yu R, 2010, SCIENCE, V329, P61, DOI 10.1126/science.1187485; Fu L, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.266801; Kim S, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.136802; Li RD, 2010, NAT PHYS, V6, P284, DOI 10.1038/NPHYS1534; Jozwiak C, 2013, NAT PHYS, V9, P293, DOI 10.1038/nphys2572; Nomura K, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.166802; Okuda T, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3648102; Xu SY, 2011, SCIENCE, V332, P560, DOI 10.1126/science.1201607; Sato T, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.136802; Qu DX, 2010, SCIENCE, V329, P821, DOI 10.1126/science.1189792; Sato T, 2011, NAT PHYS, V7, P840, DOI [10.1038/nphys2058, 10.1038/NPHYS2058]; Ando Y, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.102001; Taskin AA, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.016801; Wang Y, 2012, NANO LETT, V12, P1170, DOI 10.1021/nl202920p; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Kong DS, 2011, NAT NANOTECHNOL, V6, P705, DOI [10.1038/nnano.2011.172, 10.1038/NNANO.2011.172]; Chen YL, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.266401; Park CH, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.097601; Checkelsky JG, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.196801; Arakane T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1639; Ren Z, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.241306; Chen YL, 2009, SCIENCE, V325, P178, DOI 10.1126/science.1173034; TANUMA S, 1994, SURF INTERFACE ANAL, V21, P165, DOI 10.1002/sia.740210302; Hsieh D, 2009, NATURE, V460, P1101, DOI 10.1038/nature08234; Ren Z, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.165311; Kuroda K, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.146801; Xia Y, 2009, NAT PHYS, V5, P398, DOI 10.1038/NPHYS1274; Souma S, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.216803; Eguchi G, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.201307; KIM S, 2011, N KOREAN REV, V7, P3; Kuroda K, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.076802; Muff S, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.035407; Navratil J, 2004, J SOLID STATE CHEM, V177, P1704, DOI 10.1016/j.jssc.2003.12.031; Pan ZH, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.257004; Qi XL, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1057; Sanchez-Barriga J, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.011046; Xu Y, 2014, NAT PHYS, V10, P956, DOI 10.1038/NPHYS3140; Zhang T., 2009, PHYS REV LETT, V103	39	3	3	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	MAY 18	2015	91	20							205306	10.1103/PhysRevB.91.205306		7	Physics, Condensed Matter	Physics	CI7VK	WOS:000354972700007		
J	Skowronski, W; Nozaki, T; Lam, DD; Shiota, Y; Yakushiji, K; Kubota, H; Fukushima, A; Yuasa, S; Suzuki, Y				Skowronski, Witold; Nozaki, Takayuki; Lam, Duong D.; Shiota, Yoichi; Yakushiji, Kay; Kubota, Hitoshi; Fukushima, Akio; Yuasa, Shinji; Suzuki, Yoshishige			Underlayer material influence on electric-field controlled perpendicular magnetic anisotropy in CoFeB/MgO magnetic tunnel junctions	PHYSICAL REVIEW B			English	Article							ATOMIC LAYERS	We study the dependence of the perpendicular magnetic anisotropy on the underlayer material in magnetic tunnel junction. Using several different 4d and 5d metals we identify an optimal seed layer in terms of high anisotropy, low mixing, and high thermal stability. In such systems we investigate the tunability of the anisotropy by means of electric fields. Especially, by using Was the underlayer of the CoFeB/MgO/CoFeB trilayer we could obtain good thermal stability that allows for annealing in the temperatures up to 450 degrees C, which results in high perpendicular anisotropy.	[Skowronski, Witold; Nozaki, Takayuki; Lam, Duong D.; Shiota, Yoichi; Yakushiji, Kay; Kubota, Hitoshi; Fukushima, Akio; Yuasa, Shinji; Suzuki, Yoshishige] Natl Inst Adv Ind Sci & Technol, Spintron Res Ctr, Tsukuba, Ibaraki 3058568, Japan; [Skowronski, Witold] AGH Univ Sci & Technol, Dept Elect, PL-30059 Krakow, Poland; [Suzuki, Yoshishige] Osaka Univ, Grad Sch Engn Sci, Osaka 5608531, Japan	Skowronski, W (reprint author), Natl Inst Adv Ind Sci & Technol, Spintron Res Ctr, Tsukuba, Ibaraki 3058568, Japan.	skowron@agh.edu.pl	Shiota, Yoichi/G-8440-2013		Strategic AIST integrated R&D program, "IMPULSE: Initiative for Most Power-efficient Ultra-Large-Scale data Exploration"; ImPACT Program of the Council for Science, Technology and Innovation (Cabinet Office, Government of Japan); IMPULSE: Initiative for Most Power-efficient Ultra-Large-Scale data Exploration; Foundation for Polish Science (FNP) scholarship under the START Programme; AGH University Dean's Grant	We thank E. Usuda, Y. Sato, S. Tamaru and M. Sekine for assistance with the experiment. This work was funded by the Strategic AIST integrated R&D program, "IMPULSE: Initiative for Most Power-efficient Ultra-Large-Scale data Exploration" and the ImPACT Program of the Council for Science, Technology and Innovation (Cabinet Office, Government of Japan). W.S. acknowledges a Foundation for Polish Science (FNP) scholarship under the START Programme, and AGH University Dean's Grant.	Endo M, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3429592; Skowronski W, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4765350; Worledge DC, 2014, J APPL PHYS, V115, DOI 10.1063/1.4870169; Miyakawa N, 2013, IEEE MAGN LETT, V4, DOI 10.1109/LMAG.2013.2240266; Maruyama T, 2009, NAT NANOTECHNOL, V4, P158, DOI [10.1038/nnano.2008.406, 10.1038/NNANO.2008.406]; Naik VB, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4892410; Ikeda S, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2976435; Stamps RL, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/33/333001; Liu LQ, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.186602; Wang WG, 2012, NAT MATER, V11, P64, DOI [10.1038/nmat3171, 10.1038/NMAT3171]; Pai CF, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4866965; Shiota Y, 2012, NAT MATER, V11, P39, DOI [10.1038/nmat3172, 10.1038/NMAT3172]; Bonell F, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3599492; Nozaki T, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3279157; Tulapurkar AA, 2005, NATURE, V438, P339, DOI 10.1038/nature04207; Skowronski W, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4893463; Shiota Y, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4819199; Chiba D, 2011, NAT MATER, V10, P853, DOI [10.1038/nmat3130, 10.1038/NMAT3130]; Kanai S, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4904956; An GG, 2015, ACTA MATER, V87, P259, DOI 10.1016/j.actamat.2015.01.022; Shiota Y, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4902025; Sinha J, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4811269; Miwa S, 2014, NAT MATER, V13, P50, DOI [10.1038/nmat3778, 10.1038/NMAT3778]; Weisheit M, 2007, SCIENCE, V315, P349, DOI 10.1126/science.1136629; Bae JY, 2006, J APPL PHYS, V99, DOI 10.1063/1.2170591; Barnes S. E., 2014, SCI REPORTS, V4; Koyama T, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.123001; Nozaki T, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.073005; Nozaki Takayuki, 2012, Nature Physics, V8, DOI 10.1038/nphys2298; Schellekens AJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1848; Shiota Y, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.043005; Skowronski W, 2015, APPL PHYS EXPRESS, V8, DOI 10.7567/APEX.8.053003; Tsai CC, 2014, IEEE T MAGN, V50, DOI 10.1109/TMAG.2013.2274458	33	2	2	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	MAY 18	2015	91	18							184410	10.1103/PhysRevB.91.184410		6	Physics, Condensed Matter	Physics	CI7UV	WOS:000354971200004		
J	Szwacki, NG; Majewski, JA; Dietl, T				Szwacki, N. Gonzalez; Majewski, Jacek A.; Dietl, T.			(Ga,Mn)As under pressure: A first-principles investigation	PHYSICAL REVIEW B			English	Article							DILUTE MAGNETIC SEMICONDUCTOR; ELECTRONIC-STRUCTURE; PHASE-TRANSITIONS; FERROMAGNETISM; FUNCTIONALS; DEFECTS; PHYSICS; GAAS	Electronic and magnetic properties of Ga1-xMnxAs, obtained from first-principles calculations employing the hybrid HSE06 functional, are presented for x = 6.25% and 12.5% under pressures ranging from 0 to 15 GPa. In agreement with photoemission experiments at ambient pressure, we find for x = 6.25% that nonhybridized Mn 3d levels and Mn-induced states reside about 5 and 0.4 eV below the Fermi energy, respectively. For elevated pressures, the Mn 3d levels, Mn-induced states, and the Fermi level shift toward higher energies, however the position of the Mn-induced states relative to the Fermi energy remains constant due to hybridization of the Mn 3d levels with the valence As 4p orbitals. We also evaluate, employing Monte Carlo simulations, the Curie temperature (T-C). At zero pressure, we obtain T-C = 181 K, whereas the pressure-induced changes in T-C are dT(C)/dp = +4.3 K/GPa for x = 12.5% and an estimated value of dT(C)/dp approximate to +2.2 K/GPa for x = 6.25% under pressures up to 6 GPa. The determined values of dT(C)/dp compare favorably with dT(C)/dp = +(2-3) K/GPa at p <= 1.2GPa found experimentally and estimated within the p-d Zener model for Ga0.93Mn0.07As in the regimewhere hole localization effects are of minor importance.	[Szwacki, N. Gonzalez; Majewski, Jacek A.; Dietl, T.] Univ Warsaw, Fac Phys, Inst Theoret Phys, PL-02093 Warsaw, Poland; [Dietl, T.] Polish Acad Sci, Inst Phys, PL-02668 Warsaw, Poland; [Dietl, T.] Tohoku Univ, WPI AIMR, Aoba Ku, Sendai, Miyagi 9808577, Japan	Szwacki, NG (reprint author), Univ Warsaw, Fac Phys, Inst Theoret Phys, Ul Pasteura 5, PL-02093 Warsaw, Poland.	gonz@fuw.edu.pl	Gonzalez Szwacki, Nevill/B-2643-2009; Dietl, Tomasz /C-9537-2013	Gonzalez Szwacki, Nevill/0000-0002-0518-844X; Dietl, Tomasz /0000-0003-1090-4380	European Research Council through the FunDMS Advanced Grant within the "Ideas" Seventh Framework Programme of the EC; Narodowe Centrum Nauki in Poland [2011/02/A/ST3/00125]	The work was supported by the European Research Council through the FunDMS Advanced Grant within the "Ideas" Seventh Framework Programme of the EC and Narodowe Centrum Nauki in Poland (Decision No. 2011/02/A/ST3/00125). We acknowledge the access to the computing facilities of the Interdisciplinary Center of Modeling at the University of Warsaw.	Gray AX, 2012, NAT MATER, V11, P957, DOI [10.1038/nmat3450, 10.1038/NMAT3450]; Heyd J, 2003, J CHEM PHYS, V118, P8207, DOI 10.1063/1.1564060; Fujii J, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.097201; Dietl T, 2000, SCIENCE, V287, P1019, DOI 10.1126/science.287.5455.1019; Szczytko J, 1999, PHYS REV B, V59, P12935, DOI 10.1103/PhysRevB.59.12935; Mahadevan P, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.075202; Kummel S, 2008, REV MOD PHYS, V80, P3, DOI 10.1103/RevModPhys.80.3; TROULLIER N, 1991, PHYS REV B, V43, P1993, DOI 10.1103/PhysRevB.43.1993; Wadley P, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.235208; Edmonds KW, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.037201; Ohno H, 1996, APPL PHYS LETT, V69, P363, DOI 10.1063/1.118061; Linnarsson M, 1997, PHYS REV B, V55, P6938, DOI 10.1103/PhysRevB.55.6938; Van de Walle CG, 2004, J APPL PHYS, V95, P3851, DOI 10.1063/1.1682673; Stroppa A, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.085201; Baykov VI, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.177204; Bergqvist L, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.014418; Buchachenko AA, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3292572; Csontos M., 2004, Physica Status Solidi C, DOI 10.1002/pssc.200405508; Csontos M, 2005, NAT MATER, V4, P447, DOI 10.1038/nmat1388; Di Marco I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3645; Dietl T, 2014, REV MOD PHYS, V86, DOI 10.1103/RevModPhys.86.187; Dyck JS, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2787881; Evans RFL, 2014, J PHYS-CONDENS MAT, V26, DOI 10.1088/0953-8984/26/10/103202; Freysoldt C, 2014, REV MOD PHYS, V86, DOI 10.1103/RevModPhys.86.253; GHAHRAMANI E, 1989, PHYS REV B, V40, P12516, DOI 10.1103/PhysRevB.40.12516; Grivickas P, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.073201; Gryglas-Borysiewicz M, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.153204; Heyd J, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2204597; Lim ST, 2011, J APPL PHYS, V110, DOI 10.1063/1.3610499; Masek J, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.165212; Paolo G, 2009, J PHYS CONDENS MATT, V21; Pela RR, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4718602; Peverati R, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3698285; Schlipf M, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.125142; Sjakste J, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.235216; Sliwa C, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.045202; Stroppa A, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.201201; SUSKI T, 1987, J MAGN MAGN MATER, V66, P325, DOI 10.1016/0304-8853(87)90165-X; WEI SH, 1993, PHYS REV B, V48, P6111, DOI 10.1103/PhysRevB.48.6111; WEIR ST, 1989, PHYS REV B, V39, P1280, DOI 10.1103/PhysRevB.39.1280; Willardson R., 1998, HIGH PRESSURE SEMICO; Yu PY, 2011, PHYS STATUS SOLIDI B, V248, P1077, DOI 10.1002/pssb.201000708	42	0	0	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	MAY 18	2015	91	18							184409	10.1103/PhysRevB.91.184409		6	Physics, Condensed Matter	Physics	CI7UV	WOS:000354971200003		
J	Wahila, MJ; Lebens-Higgins, ZW; Quackenbush, NF; Nishitani, J; Walukiewicz, W; Glans, PA; Guo, JH; Woicik, JC; Yu, KM; Piper, LFJ				Wahila, M. J.; Lebens-Higgins, Z. W.; Quackenbush, N. F.; Nishitani, J.; Walukiewicz, W.; Glans, P. -A.; Guo, J. -H.; Woicik, J. C.; Yu, K. M.; Piper, L. F. J.			Evidence of extreme type-III band offset at buried n-type CdO/p-type SnTe interfaces	PHYSICAL REVIEW B			English	Article							X-RAY PHOTOEMISSION; ELECTRONIC-STRUCTURE; SEMICONDUCTORS; OXIDATION	At covalent semiconductor interfaces, the band alignment is determined by the location of the band edges with respect to the charge neutrality level, but extension of this method to more ionic semiconductor systems requires further consideration. Using the charge neutrality level concept, a type-III (or broken band gap) band offset is predicted at the interface between n-type CdO and p-type SnTe. Employing hard x-ray photoelectron spectroscopy, we report on the chemical composition at the buried interface and the valence-band offset. Chemical intermixing at the interface between SnTe and CdO is found to be limited to similar to 2.5 nm in our heterojunction samples. We measure a valence-band offset of 1.95 (+/- 0.15 eV) irrespective of the layer configuration. Once the degenerate hole doping of the SnTe is considered, the measured band-edge offset agrees with the type-III offset predicted from alignment of the band edges with respect to the charge neutrality level of the semiconductors.	[Wahila, M. J.; Lebens-Higgins, Z. W.; Quackenbush, N. F.; Piper, L. F. J.] SUNY Binghamton, Dept Phys Appl Phys & Astron, Binghamton, NY 13902 USA; [Nishitani, J.; Walukiewicz, W.; Yu, K. M.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Nishitani, J.] Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan; [Glans, P. -A.; Guo, J. -H.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA 94720 USA; [Woicik, J. C.] NIST, Mat Sci & Engn Lab, Gaithersburg, MD 20899 USA; [Yu, K. M.] City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon, Hong Kong, Peoples R China	Wahila, MJ (reprint author), SUNY Binghamton, Dept Phys Appl Phys & Astron, Binghamton, NY 13902 USA.	lpiper@binghamton.edu			National Science Foundation [DMR-1409912]; Binghamton University; Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division, of the US Department of Energy [DE-AC02-05CH11231]; US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-98CH10886]; National Institute of Standards and Technology	L.F.J.P. and N.F.Q. acknowledge support from the National Science Foundation under Grant No. DMR-1409912. Z.W.L.-H. is grateful for an undergraduate Summer Scholars and Artists Award from Binghamton University. This work, carried out at LBNL in the Material Sciences Division and at the Advanced Light Source, was supported by the Director, Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division, of the US Department of Energy under Contract No. DE-AC02-05CH11231. Use of the National Synchrotron Light Source at Brookhaven National Laboratory was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. DE-AC02-98CH10886. Beamline X24a is supported by the National Institute of Standards and Technology.	Nishitani J, 2014, APPL PHYS EXPRESS, V7, DOI [10.7567/APEX.7.091201, 10.7567/AFEX.7.091201]; Jefferson PH, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2833269; Burbano M, 2011, J AM CHEM SOC, V133, P15065, DOI 10.1021/ja204639y; Dallera C, 2004, APPL PHYS LETT, V85, P4532, DOI 10.1063/1.1814441; TERSOFF J, 1985, PHYS REV B, V32, P6968, DOI 10.1103/PhysRevB.32.6968; Quackenbush NF, 2013, NANO LETT, V13, P4857, DOI 10.1021/nl402716d; King PDC, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.116808; Kapilashrami M, 2012, PHYS CHEM CHEM PHYS, V14, P10154, DOI 10.1039/c2cp41394a; Schleife A, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3059569; Zhu YK, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/19/195102; Conti G, 2013, J APPL PHYS, V113, DOI 10.1063/1.4795612; Powell CJ, 2012, J ELECTRON SPECTROSC, V185, P1, DOI 10.1016/j.elspec.2011.12.001; Piper LFJ, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.125204; Piper LFJ, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.195321; BERGGREN KF, 1981, PHYS REV B, V24, P1971, DOI 10.1103/PhysRevB.24.1971; Vazquez H, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2717165; BADRINARAYANAN S, 1984, MATER CHEM PHYS, V11, P1, DOI 10.1016/0254-0584(84)90084-1; Dingle A. C. G. R., 1978, APPL PHYS LETT, V33, P665; Flores J. O. F., 2009, ADV SOLID STATE PHYS, V48; HASHEMI T, 1988, J MATER SCI, V23, P2645, DOI 10.1007/BF01111927; Kaiser AM, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4731642; KROEMER H, 1981, JPN J APPL PHYS, V20, P9; Lee KK, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3681161; Losurdo M, 2006, J APPL PHYS, V100, DOI 10.1063/1.2216049; Luth H., 2001, SOLID SURFACES INTER; Monch W., 2004, ELECT PROPERTIES SEM; Mudd JJ, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.035203; Nagata T, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3596449; Neudachina VS, 2005, SURF SCI, V584, P77, DOI 10.1016/j.susc.2005.01.061; Nishitani J, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4896912; Papis-Polakowska E, 2012, THIN SOLID FILMS, V522, P223, DOI 10.1016/j.tsf.2012.09.014; Piper LFJ, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.165127; Piper LFJ, 2007, SUPERLATTICE MICROST, V42, P197, DOI 10.1016/j.spmi.2007.04.029; Piper LFJ, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.233305; Piper LFJ, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2214156; Speaks DT, 2010, J APPL PHYS, V107, DOI 10.1063/1.3428444; WALUKIEWICZ W, 1988, PHYS REV B, V37, P4760, DOI 10.1103/PhysRevB.37.4760; Wu J, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.201403	38	1	1	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	MAY 18	2015	91	20							205307	10.1103/PhysRevB.91.205307		7	Physics, Condensed Matter	Physics	CI7VK	WOS:000354972700008		
J	Zhang, L; Bagrets, A; Xenioti, D; Korytar, R; Schackert, M; Miyamachi, T; Schramm, F; Fuhr, O; Chandrasekar, R; Alouani, M; Ruben, M; Wulfhekel, W; Evers, F				Zhang, L.; Bagrets, A.; Xenioti, D.; Korytar, R.; Schackert, M.; Miyamachi, T.; Schramm, F.; Fuhr, O.; Chandrasekar, R.; Alouani, M.; Ruben, M.; Wulfhekel, W.; Evers, F.			Kondo effect in binuclear metal-organic complexes with weakly interacting spins	PHYSICAL REVIEW B			English	Article							SINGLE-MOLECULE MAGNETS; SCANNING-TUNNELING-MICROSCOPE; ELECTRONIC-STRUCTURE; CARBON NANOTUBES; BASIS-SET; STATES; RESONANCE; MAGNETORESISTANCE; TRANSISTOR; TRANSPORT	We report a combined experimental and theoretical study of the Kondo effect in a series of binuclear metalorganic complexes of the form [(Me(hfacac)(2))(2)(bpym)](0), with Me = nickel (II), manganese (II), zinc (II); hfacac = hexafluoroacetylacetonate, and bpym = bipyrimidine, adsorbed on Cu(100) surface. While Kondo features did not appear in the scanning tunneling spectroscopy spectra of nonmagnetic Zn-2, a zero bias resonance was resolved in magnetic Mn-2 and Ni-2 complexes. The case of Ni-2 is particularly interesting as the experiments indicate two adsorption geometries with very different properties. For Ni-2 complexes we have employed density functional theory to further elucidate the situation. Our simulations show that one geometry with relatively large Kondo temperatures T-K similar to 10 K can be attributed to distorted Ni-2 complexes, which are chemically bound to the surface via the bipyrimidine unit. The second geometrywe assign to molecular fragmentation: we suggest that the original binuclear molecule decomposes into two pieces, including Ni(hexafluoroacetylacetonate)2, when brought into contact with the Cu substrate. For both geometries our calculations support a picture of the (S = 1)-type Kondo effect emerging due to open 3d shells of the individual Ni2+ ions.	[Zhang, L.; Bagrets, A.; Xenioti, D.; Korytar, R.; Schramm, F.; Fuhr, O.; Ruben, M.; Wulfhekel, W.; Evers, F.] Karlsruhe Inst Technol, Inst Nanotechnol, D-76021 Karlsruhe, Germany; [Zhang, L.; Schackert, M.; Miyamachi, T.; Wulfhekel, W.] Karlsruhe Inst Technol, Inst Phys, D-76021 Karlsruhe, Germany; [Xenioti, D.; Alouani, M.; Ruben, M.] Inst Phys & Chim Mat Strasbourg, F-67034 Strasbourg, France; [Miyamachi, T.] Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan; [Chandrasekar, R.] Univ Hyderabad, Sch Chem, Hyderabad 500046, Andhra Pradesh, India; [Evers, F.] Karlsruhe Inst Technol, Inst Theorie Kondensierten Mat, D-76021 Karlsruhe, Germany	Zhang, L (reprint author), Karlsruhe Inst Technol, Inst Nanotechnol, D-76021 Karlsruhe, Germany.		Ruben, Mario/C-6816-2008; Korytar, Richard/H-2910-2012	Ruben, Mario/0000-0002-7718-7016; Korytar, Richard/0000-0003-4949-4147	Deutsche Forschungsgemeinschaft (DFG) [BA 4265/2-1]; French-German University; Baden-Wurttemberg Stiftung in the framework of the Kompetenznetz fur Funktionale Nanostrukturen (KFN; GENCI-CINES [2014-gem1100]	We thank K. Fink for fruitful discussions and M. Burkle for providing us with a development version of the TURBOMOLE package. A.B. acknowledges support of Deutsche Forschungsgemeinschaft (DFG) through the Research Grant No. BA 4265/2-1. W.W. and M.R. acknowledge support from the French-German University and Baden-Wurttemberg Stiftung in the framework of the Kompetenznetz fur Funktionale Nanostrukturen (KFN). D.X. and M. A. acknowledge computational resources from HPC Meso Centre of the Strasbourg University and GENCI-CINES Grant No. 2014-gem1100.	Ahlrichs R., 2014, TURBOMOLE 6 6 DEV VE; Elbing M, 2005, P NATL ACAD SCI USA, V102, P8815, DOI 10.1073/pnas.0408888102; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Ehm D, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.045117; JAYAPRAKASH C, 1981, PHYS REV LETT, V47, P737, DOI 10.1103/PhysRevLett.47.737; Wilhelm J, 2013, PHYS CHEM CHEM PHYS, V15, P6684, DOI 10.1039/c3cp44286a; Merino J, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.115404; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Liang WJ, 2002, NATURE, V417, P725, DOI 10.1038/nature00790; Kubatkin S, 2003, NATURE, V425, P698, DOI 10.1038/nature02010; Meded V, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.245415; Nygard J, 2000, NATURE, V408, P342; Gutlich P, 2000, CHEM SOC REV, V29, P419, DOI 10.1039/b003504l; KONDO J, 1964, PROG THEOR PHYS, V32, P37, DOI 10.1143/PTP.32.37; Kahle S, 2012, NANO LETT, V12, P518, DOI 10.1021/nl204141z; Meded V, 2009, SMALL, V5, P2218, DOI 10.1002/smll.200801865; Park J, 2002, NATURE, V417, P722, DOI 10.1038/nature00791; TERSOFF J, 1985, PHYS REV B, V31, P805, DOI 10.1103/PhysRevB.31.805; Parks JJ, 2010, SCIENCE, V328, P1370, DOI 10.1126/science.1186874; Ujsaghy O, 2000, PHYS REV LETT, V85, P2557, DOI 10.1103/PhysRevLett.85.2557; Lortscher E, 2006, SMALL, V2, P973, DOI 10.1002/smll.200600101; Schmaus S, 2011, NAT NANOTECHNOL, V6, P185, DOI [10.1038/nnano.2011.11, 10.1038/NNANO.2011.11]; Beljakov I, 2014, NANO LETT, V14, P3364, DOI 10.1021/nl500872c; Manoharan HC, 2000, NATURE, V403, P512, DOI 10.1038/35000508; Bork J, 2011, NAT PHYS, V7, P901, DOI [10.1038/nphys2076, 10.1038/NPHYS2076]; Vitali L, 2008, NANO LETT, V8, P3364, DOI 10.1021/nl801869b; Kouwenhoven L, 2001, PHYS WORLD, V14, P33; Plihal M, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.085404; Blum V, 2009, COMPUT PHYS COMMUN, V180, P2175, DOI 10.1016/j.cpc.2009.06.022; Wagner S, 2013, NAT NANOTECHNOL, V8, P575, DOI [10.1038/nnano.2013.133, 10.1038/NNANO.2013.133]; ANDERSON PW, 1961, PHYS REV, V124, P41, DOI 10.1103/PhysRev.124.41; Burkle M, 2013, PHYS STATUS SOLIDI B, V250, P2468, DOI 10.1002/pssb.201350212; Kummel S, 2008, REV MOD PHYS, V80, P3, DOI 10.1103/RevModPhys.80.3; Tkatchenko A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.073005; Gatteschi D, 2003, ANGEW CHEM INT EDIT, V42, P268, DOI 10.1002/anie.200390099; Deglmann P, 2002, CHEM PHYS LETT, V362, P511, DOI 10.1016/S0009-2614(02)01084-9; Knorr N, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.096804; FANO U, 1961, PHYS REV, V124, P1866, DOI 10.1103/PhysRev.124.1866; Li JT, 1998, PHYS REV LETT, V80, P2893, DOI 10.1103/PhysRevLett.80.2893; Christou G, 2000, MRS BULL, V25, P66, DOI 10.1557/mrs2000.226; Anisimov VI, 1997, J PHYS-CONDENS MAT, V9, P767, DOI 10.1088/0953-8984/9/4/002; Paaske J, 2006, NAT PHYS, V2, P460, DOI 10.1038/nphys340; Fu YS, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.256601; Bain GA, 2008, J CHEM EDUC, V85, P532; Deglmann P, 2002, J CHEM PHYS, V117, P9535, DOI 10.1063/1.1523393; Reichert J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.176804; Deglmann P, 2004, CHEM PHYS LETT, V384, P103, DOI 10.1016/j.cplett.2003.11.080; Paaske J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.176801; EICHKORN K, 1995, CHEM PHYS LETT, V242, P652, DOI 10.1016/0009-2614(95)00838-U; Madhavan V, 1998, SCIENCE, V280, P567, DOI 10.1126/science.280.5363.567; Bogani L, 2008, NAT MATER, V7, P179, DOI 10.1038/nmat2133; Jamneala T, 2000, PHYS REV B, V61, P9990, DOI 10.1103/PhysRevB.61.9990; Nagaoka K, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.077205; Dudarev SL, 1998, PHYS REV B, V57, P1505, DOI 10.1103/PhysRevB.57.1505; Arnold A, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2716664; Bagrets A, 2012, NANO LETT, V12, P5131, DOI 10.1021/nl301967t; Bagrets A, 2013, J CHEM THEORY COMPUT, V9, P2801, DOI 10.1021/ct4000263; Barquin M, 1999, TRANSIT METAL CHEM, V24, P546, DOI 10.1023/A:1006920500732; BREWER G, 1985, INORG CHEM, V24, P4580, DOI 10.1021/ic00220a030; Cavallini M, 2008, PHYS CHEM CHEM PHYS, V10, P784, DOI 10.1039/b711677b; Fernandez-Torrente I, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.217203; Gao L, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.106402; Gomez-Segura J, 2006, CHEM COMMUN, P2866, DOI 10.1039/b606276h; Hewson A. C., 1993, CAMBRIDGE STUDIES MA, V2; Hofstetter Walter, 2001, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.016803; Neel N, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.016801; Osorio EA, 2007, ADV MATER, V19, P281, DOI 10.1002/adma.200601876; Perera UGE, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.106601; SCHAFER A, 1992, J CHEM PHYS, V97, P2571; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sheldrick G. M., 1997, SHELXTL97 2; Zhang L, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3646468	72	0	0	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	MAY 18	2015	91	19							195424	10.1103/PhysRevB.91.195424		11	Physics, Condensed Matter	Physics	CI7VJ	WOS:000354972600010		
J	Hiyama, E; Isaka, M; Kamimura, M; Myo, T; Motoba, T				Hiyama, E.; Isaka, M.; Kamimura, M.; Myo, T.; Motoba, T.			Resonant states of the neutron-rich Lambda hypernucleus He-7(Lambda)	PHYSICAL REVIEW C			English	Article							NUCLEUS HE-6; BODY; SHELL; MODEL; HALO	The structure of the neutron-rich Lambda hypernucleus, He-7(Lambda) is studied within the framework of an alpha + Lambda + n + n four-body cluster model. We predict second 3/2(+) and 5/2(+) states, corresponding to a 0s Lambda coupled to the second 2(+) state of He-6, as narrow resonant states with widths of Gamma similar to 1 MeV to be at 0.03 and 0.07 MeV with respect to the alpha + Lambda + n + n threshold. From a separate estimate of the differential cross section for the Li-7(gamma, K+)He-7(Lambda) reaction, we suggest a possibility to observe these states at the Thomas Jefferson National Accelerator Facility (JLab) in the future. We also calculate the second 2(+) state of He-6 as a resonant state within the framework of an alpha + n + n three-body cluster model. Our result is 2.81 MeV with Gamma = 4.63 MeV with respect to the alpha + n + n threshold. This energy position is similar to 1 MeV higher, and with a much broader decay width, than the recent SPIRAL data. We suggest that an experiment at JLab to search for the second 3/2(+) and 5/2(+) states of He-7(Lambda) would provide an opportunity to confirm the second 2(+) state of the core nucleus He-6.	[Hiyama, E.; Isaka, M.; Kamimura, M.] RIKEN, Inst Phys & Chem Res, Nishina Ctr Accelerator Based Sci, Wako, Saitama 3510198, Japan; [Kamimura, M.] Kyushu Univ, Dept Phys, Fukuoka 8128581, Japan; [Myo, T.] Osaka Inst Technol, Gen Educ, Fac Engn, Osaka 5358585, Japan; [Motoba, T.] Osaka Electrocommun Univ, Phys Lab, Neyagawa, Osaka 5728530, Japan; [Motoba, T.] Kyoto Univ, Yukawa Inst Theoret Phys, Kyoto 6068317, Japan	Hiyama, E (reprint author), RIKEN, Inst Phys & Chem Res, Nishina Ctr Accelerator Based Sci, Wako, Saitama 3510198, Japan.				Monbukagakusho of Japan; JSPS [23224006]; RIKEN iTHES Project	The authors thank Professors S. N. Nakamura, S. Kubono. T. Nakamura, B. F. Gibson, H. Ohtsu, and Dr. Gogami for informative discussions. This work was supported by a Grant-in-Aid for Scientific Research from Monbukagakusho of Japan. The numerical calculations were performed on the HITACHI SR16000 at KEK and YITP. This work was partly supported by JSPS Grant No. 23224006 and by RIKEN iTHES Project.	SIMON B, 1972, COMMUN MATH PHYS, V27, P1, DOI 10.1007/BF01649654; AGUILAR J, 1971, COMMUN MATH PHYS, V22, P269, DOI 10.1007/BF01877510; Mougeot X, 2012, PHYS LETT B, V718, P441, DOI 10.1016/j.physletb.2012.10.054; KANADA H, 1979, PROG THEOR PHYS, V61, P1327, DOI 10.1143/PTP.61.1327; Pieper SC, 2004, PHYS REV C, V70, DOI 10.1103/PhysRevC.70.054325; COHEN S, 1965, NUCL PHYS, V73, P1, DOI 10.1016/0029-5582(65)90148-3; Hiyama E, 2009, PHYS REV C, V80, DOI 10.1103/PhysRevC.80.054321; BALSLEV E, 1971, COMMUN MATH PHYS, V22, P280, DOI 10.1007/BF01877511; Tilley DR, 2002, NUCL PHYS A, V708, P3, DOI 10.1016/S0375-9474(02)00597-3; Volya A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.052501; Hiyama E, 2003, PROG PART NUCL PHYS, V51, P223, DOI 10.1016/S0146-6410(03)00082-6; Moiseyev N, 1998, PHYS REP, V302, P212, DOI 10.1016/S0370-1573(98)00002-7; Myo T, 2011, PHYS REV C, V84, DOI 10.1103/PhysRevC.84.064306; Hiyama E, 2000, PHYS REV LETT, V85, P270, DOI 10.1103/PhysRevLett.85.270; Aoyama S, 2006, PROG THEOR PHYS, V116, P1, DOI 10.1143/PTP.116.1; Aoyama S, 2001, PROG THEOR PHYS SUPP, P35; Gogami T., 2014, THESIS TOHOKU U; Hagen G, 2005, PHYS REV C, V71, DOI 10.1103/PhysRevC.71.044314; Hiyama E, 1996, PHYS REV C, V53, P2075, DOI 10.1103/PhysRevC.53.2075; HO YK, 1983, PHYS REP, V99, P1, DOI 10.1016/0370-1573(83)90112-6; IKEDA K, 1992, NUCL PHYS A, V538, pC355; Masui H, 2014, PHYS REV C, V89, DOI 10.1103/PhysRevC.89.044317; Myo T, 2007, PHYS REV C, V76, DOI 10.1103/PhysRevC.76.054309; Myo T, 2009, PHYS REV C, V80, DOI 10.1103/PhysRevC.80.014315; Myo T, 2014, PROG PART NUCL PHYS, V79, P1, DOI 10.1016/j.ppnp.2014.08.001; Nakamura SN, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.012502; Nakamura T, 2000, PHYS LETT B, V493, P209, DOI 10.1016/S0370-2693(00)01146-1	27	1	1	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0556-2813	1089-490X		PHYS REV C	Phys. Rev. C	MAY 18	2015	91	5							054316	10.1103/PhysRevC.91.054316		6	Physics, Nuclear	Physics	CI7VM	WOS:000354972900002		
J	Nagata, K; Kashiwa, K; Nakamura, A; Nishigaki, SM				Nagata, Keitaro; Kashiwa, Kouji; Nakamura, Atsushi; Nishigaki, Shinsuke M.			Lee-Yang zero distribution of high temperature QCD and the Roberge-Weiss phase transition	PHYSICAL REVIEW D			English	Article							LATTICE QCD; FINITE-DENSITY; BARYON NUMBER	Canonical partition functions and Lee-Yang zeros of QCD at finite density and high temperature are studied. Recent lattice simulations confirm that the free energy of QCD is a quartic function of quark chemical potential at temperature slightly above pseudocritical temperature T-c, as in the case with a gas of free massless fermions. We present analytic derivation of the canonical partition functions and Lee-Yang zeros for this type of free energy using the saddle point approximation. We also perform lattice QCD simulation in a canonical approach using the fugacity expansion of the fermion determinant and carefully examine its reliability. By comparing the analytic and numerical results, we conclude that the canonical partition functions follow the Gaussian distribution of the baryon number, and the accumulation of Lee-Yang zeros of these canonical partition functions exhibit the first-order Roberge-Weiss phase transition. We discuss the validity and applicable range of the result and its implications both for theoretical and experimental studies.	[Nagata, Keitaro] High Energy Accelerator Res Org KEK, KEK Theory Ctr, Tsukuba, Ibaraki 3050801, Japan; [Kashiwa, Kouji] Kyoto Univ, Yukawa Inst Theoret Phys, Sakyo Ku, Kyoto 6068502, Japan; [Nakamura, Atsushi] Hiroshima Univ, Res Inst Informat Sci & Educ, Higashihiroshima 7398527, Japan; [Nishigaki, Shinsuke M.] Shimane Univ, Grad Sch Sci & Engn, Matsue, Shimane 6908504, Japan	Nagata, K (reprint author), High Energy Accelerator Res Org KEK, KEK Theory Ctr, Tsukuba, Ibaraki 3050801, Japan.				JSPS [00586901, 261717, 24340054, 26610072, 25400259]; MEXT SPIRE; JICFuS; HPCI System Research project [hp130058]; RICC system at RIKEN	K. N. thanks Sinya Aoki, Teiji Kunihiro, and Akira Ohnishi for discussions, Etsuko Itou for advice on error analysis and analytic calculations, and Shoji Hashimoto for comments on an early version of the manuscript. This work is supported in part by JSPS Grants-in-Aid for Scientific Research (Kakenhi) Grants No. 00586901 (K. N.), No. 261717 (K. K.), No. 24340054 and No. 26610072 (A. N.), and No. 25400259 (S. M. N.). K. N. is also supported by MEXT SPIRE and JICFuS. The lattice simulations were mainly performed on SX9 at the RCNP and CMC at Osaka University. The error analysis was done on the HPC system at RCNP. This work is also supported by the HPCI System Research project (hp130058) and RICC system at RIKEN.	Adams DH, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.162002; Aggarwal MM, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.022302; Alexandru A, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.034502; Allton CR, 2003, PHYS REV D, V68, DOI 10.1103/PhysRevD.68.014507; Ejiri S, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.074507; Adamczyk L, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.092301; Braun-Munzinger P, 2011, PHYS REV C, V84, DOI 10.1103/PhysRevC.84.064911; Allton CR, 2005, PHYS REV D, V71, DOI 10.1103/PhysRevD.71.054508; de Forcrand P, 2002, NUCL PHYS B, V642, P290, DOI 10.1016/S0550-3213(02)00626-0; Kashiwa K, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.096009; HASENFRATZ A, 1992, NUCL PHYS B, V371, P539, DOI 10.1016/0550-3213(92)90247-9; Ejiri S, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.014508; LEE TD, 1952, PHYS REV, V87, P410, DOI 10.1103/PhysRev.87.410; D'Elia M, 2003, PHYS REV D, V67, DOI 10.1103/PhysRevD.67.014505; ROBERGE A, 1986, NUCL PHYS B, V275, P734, DOI 10.1016/0550-3213(86)90582-1; Morita K, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.074020; Garg P, 2013, PHYS LETT B, V726, P691, DOI 10.1016/j.physletb.2013.09.019; Adamczyk L, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.032302; GIBBS PE, 1986, PHYS LETT B, V172, P53, DOI 10.1016/0370-2693(86)90215-7; Blythe RA, 2003, BRAZ J PHYS, V33, P464, DOI 10.1590/S0103-97332003000300008; Biskup M, 2000, PHYS REV LETT, V84, P4794, DOI 10.1103/PhysRevLett.84.4794; Ejiri S, 2006, PHYS REV D, V73, DOI 10.1103/PhysRevD.73.054502; D'Elia M, 2007, PHYS REV D, V76, DOI 10.1103/PhysRevD.76.114509; D'Elia M, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.111501; D'Elia M, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.014502; YANG CN, 1952, PHYS REV, V87, P404, DOI 10.1103/PhysRev.87.404; Cea P, 2010, PHYS REV D, V81, DOI 10.1103/PhysRevD.81.094502; Stephanov M, 1998, PHYS REV LETT, V81, P4816, DOI 10.1103/PhysRevLett.81.4816; Hatta Y, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.102003; Stephanov MA, 2006, PHYS REV D, V73, DOI 10.1103/PhysRevD.73.094508; Asakawa M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.262301; BARBOUR IM, 1988, PHYS LETT B, V215, P567, DOI 10.1016/0370-2693(88)91361-5; BARBOUR IM, 1992, NUCL PHYS B, V372, P385, DOI 10.1016/0550-3213(92)90324-5; Bonati C, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.074030; Borici A, 2004, PROG THEOR PHYS SUPP, P335; Cea P, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.094512; Danzer J, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.014502; D'Elia M., 2015, P SCI LATTICE2014, P020; de Forcrand P, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.152001; D'Elia M, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.074509; Ejiri S., 2014, PROG THEOR EXP PHYS, V2014; Kapusuta J. I., 2006, FINITE TEMPERATURE F, V2nd; Khan A. Ali, 2000, PHYS REV D, V63; Kitazawa M, 2012, PHYS REV C, V86, DOI 10.1103/PhysRevC.86.024904; Kratochvila S, 2006, PHYS REV D, V73, DOI 10.1103/PhysRevD.73.114512; de Forcrand P, 2006, NUCL PHYS B-PROC SUP, V153, P62, DOI 10.1016/j.nuclphysbps.2006.01.007; Kratochvila S, 2005, NUCL PHYS B-PROC SUP, V140, P514, DOI 10.1016/j.nuclphysbps.2004.11.148; Kratochvila S., 2005, P SCI LAT, V2005, P167; Li AY, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.054502; Miao C., 2008, POS LATTICE, P172; Morita K, 2014, EUR PHYS J C, V74, DOI 10.1140/epjc/s10052-013-2706-1; Nagata K, 2012, J HIGH ENERGY PHYS, DOI 10.1007/JHEP04(2012)092; Nagata K., 2012, PROG THEOR EXP PHYS, V2012; Nagata K, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.094027; Nagata K, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.114507; Nakamura A., ARXIV13050760; Peskin M E, 1995, INTRO QUANTUM FIELD; Sakai Y, 2008, PHYS REV D, V77, DOI 10.1103/PhysRevD.77.051901; Stephanov MA, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.052301; Stephanov MA, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.032301	60	2	2	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1550-7998	1550-2368		PHYS REV D	Phys. Rev. D	MAY 18	2015	91	9							094507	10.1103/PhysRevD.91.094507		12	Astronomy & Astrophysics; Physics, Particles & Fields	Astronomy & Astrophysics; Physics	CI7VQ	WOS:000354973300002		
J	Nakano, H; Healy, J; Lousto, CO; Zlochower, Y				Nakano, Hiroyuki; Healy, James; Lousto, Carlos O.; Zlochower, Yosef			Perturbative extraction of gravitational waveforms generated with numerical relativity	PHYSICAL REVIEW D			English	Article							ROTATING BLACK-HOLE; METRIC PERTURBATIONS; HARMONICS; PARTICLE; GAUGE; FIELD	We derive an analytical expression for extracting the gravitational waveforms at null infinity using the Weyl scalar psi(4) measured at a finite radius. Our expression is based on a series solution in orders of 1/r to the equations for gravitational perturbations about a spinning black hole. We compute this expression to order 1/r(2) and include the spin parameter a of the Kerr background. We test the accuracy of this extraction procedure by measuring the waveform for a merging black-hole binary at ten different extraction radii (in the range r/M = 75-190 and for three different resolutions in the convergence regime. We find that the extraction formula provides a set of values for the radiated energy and momenta that at finite extraction radii converges towards the expected values with increasing resolution, which is not the case for the "raw" waveform at finite radius. We also examine the phase and amplitude errors in the waveform as a function of observer location and again observe the benefits of using our extraction formula. The leading corrections to the phase are O(1/r) and to the amplitude are O(1/r(2)). This method provides a simple and practical way of estimating the waveform at infinity, and may be especially useful for scenarios such as well separated binaries, where the radiation zone is far from the sources, that would otherwise require extended simulation grids in order to extrapolate the raw waveform to infinity. Thus this method saves important computational resources and provides an estimate of errors.	[Nakano, Hiroyuki] Kyoto Univ, Dept Phys, Kyoto 6068502, Japan; [Nakano, Hiroyuki; Healy, James; Lousto, Carlos O.; Zlochower, Yosef] Rochester Inst Technol, Ctr Computat Relat & Gravitat, Rochester, NY 14623 USA; [Nakano, Hiroyuki; Healy, James; Lousto, Carlos O.; Zlochower, Yosef] Rochester Inst Technol, Sch Math Sci, Rochester, NY 14623 USA	Nakano, H (reprint author), Kyoto Univ, Dept Phys, Kyoto 6068502, Japan.			Lousto, Carlos/0000-0002-6400-9640	NSF [PHY-1305730, PHY-1212426, PHY-1229173, AST-1028087, PHY-0969855, OCI-0832606, DRL-1136221, PHY-0722703, DMS-0820923]; MEXT [24103006]	The authors gratefully acknowledge the NSF for financial support from Grants No. PHY-1305730, No. PHY-1212426, No. PHY-1229173, No. AST-1028087, No. PHY-0969855, No. OCI-0832606, and No. DRL-1136221. Computational resources were provided by XSEDE allocation TG-PHY060027N, and by NewHorizons and BlueSky Clusters at Rochester Institute of Technology, which were supported by NSF Grants No. PHY-0722703, No. DMS-0820923, No. AST-1028087, and PHY-1229173. H. N. acknowledges support by the MEXT Grant-in-Aid for Scientific Research on Innovative Areas No. 24103006.	Abrahams AM, 1998, PHYS REV LETT, V80, P1812, DOI 10.1103/PhysRevLett.80.1812; Ajith P, 2012, CLASSICAL QUANT GRAV, V29, DOI 10.1088/0264-9381/29/12/124001; Taylor NW, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.124010; Damour T, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.081503; Berti E, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.064012; Dreyer O, 2003, PHYS REV D, V67, DOI 10.1103/PhysRevD.67.024018; Boyle M, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.124045; ZERILLI FJ, 1970, PHYS REV D, V2, P2141, DOI 10.1103/PhysRevD.2.2141; Hinder I, 2014, CLASSICAL QUANT GRAV, V31, DOI 10.1088/0264-9381/31/2/025012; Campanelli M, 2006, PHYS REV D, V73, DOI 10.1103/PhysRevD.73.064005; Lousto CO, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.104057; GOLDBERG JN, 1967, J MATH PHYS, V8, P2155, DOI 10.1063/1.1705135; Nagar A, 2005, CLASSICAL QUANT GRAV, V22, pR167, DOI 10.1088/0264-9381/22/16/R01; Campanelli M, 2009, PHYS REV D, V79, DOI 10.1103/PhysRevD.79.084010; Campanelli M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.111101; Baker JG, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.111102; Babiuc MC, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.044057; Reisswig C, 2010, CLASSICAL QUANT GRAV, V27, DOI 10.1088/0264-9381/27/7/075014; Campanelli M, 1999, PHYS REV D, V59, DOI 10.1103/PhysRevD.59.124022; Tagoshi H, 1996, PHYS REV D, V54, P1439, DOI 10.1103/PhysRevD.54.1439; Hannam M, 2008, PHYS REV D, V77, DOI 10.1103/PhysRevD.77.044020; Pretorius F, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.121101; [Anonymous], ARXIV150102890; Keidl TS, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.124012; Pollney D, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.044045; Kyutoku K, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.064006; Reisswig C, 2011, CLASSICAL QUANT GRAV, V28, DOI 10.1088/0264-9381/28/19/195015; Scheel MA, 2009, PHYS REV D, V79, DOI 10.1103/PhysRevD.79.024003; REGGE T, 1957, PHYS REV, V108, P1063, DOI 10.1103/PhysRev.108.1063; Baker J, 2000, CLASSICAL QUANT GRAV, V17, pL149, DOI 10.1088/0264-9381/17/20/102; Baker J, 2002, PHYS REV D, V65, DOI 10.1103/PhysRevD.65.044001; Baker J, 2004, PHYS REV D, V69, DOI 10.1103/PhysRevD.69.027505; Baker J, 2002, PHYS REV D, V65, DOI 10.1103/PhysRevD.65.124012; Baker J, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.121103; Burko LM, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.104029; KINNERSL.W, 1969, J MATH PHYS, V10, P1195, DOI 10.1063/1.1664958; Krishnan B, 2007, PHYS REV D, V76, DOI 10.1103/PhysRevD.76.081501; Lousto CO, 2005, CLASSICAL QUANT GRAV, V22, pS543, DOI 10.1088/0264-9381/22/15/001; Lousto CO, 2005, CLASSICAL QUANT GRAV, V22, pS569, DOI 10.1088/0264-9381/22/15/002; Lousto CO, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.084015; Lousto CO, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.024001; NAKAMURA T, 1987, PROG THEOR PHYS SUPP, P1; Pazos E, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.024027; Scheel MA, 2006, PHYS REV D, V74, DOI 10.1103/PhysRevD.74.104006; Sperhake U, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.161101; Sundararajan PA, 2007, PHYS REV D, V76, DOI 10.1103/PhysRevD.76.104005; TEUKOLSK.SA, 1973, ASTROPHYS J, V185, P635, DOI 10.1086/152444; Vano-Vinuales A., ARXIV14124801; Vano-Vinuales A., ARXIV14123827; Zilhao M, 2015, PHYS REV D, V91, DOI 10.1103/PhysRevD.91.024034	50	2	2	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1550-7998	1550-2368		PHYS REV D	Phys. Rev. D	MAY 18	2015	91	10							104022	10.1103/PhysRevD.91.104022		12	Astronomy & Astrophysics; Physics, Particles & Fields	Astronomy & Astrophysics; Physics	CI7VS	WOS:000354973500007		
J	Wakayama, M; Kunihiro, T; Muroya, S; Nakamura, A; Nonaka, C; Sekiguchi, M; Wada, H				Wakayama, Masayuki; Kunihiro, Teiji; Muroya, Shin; Nakamura, Atsushi; Nonaka, Chiho; Sekiguchi, Motoo; Wada, Hiroaki		SCALAR Collaboration	Lattice QCD study of four-quark components of the isosinglet scalar mesons: Significance of disconnected diagrams	PHYSICAL REVIEW D			English	Article							HADRONS	We study the possible significance of four-quark states in the isosinglet scalar mesons (J(PC) = 0(++), I = 0) by performing two-flavor full lattice QCD simulations on an 8(3) x 16 lattice using the improved gauge action and the clover-improved Wilson quark action. In particular, we evaluate the propagators of molecular and tetraquark operators together with singly disconnected diagrams. In the computation of the singly disconnected diagrams we employ the Z(2)-noise method with the truncated eigenmode approach. We show that the quark loops given by the disconnected diagrams play an essential role in propagators of tetraquark and molecular operators.	[Wakayama, Masayuki; Nonaka, Chiho] Nagoya Univ, Dept Phys, Nagoya, Aichi 4648602, Japan; [Kunihiro, Teiji] Kyoto Univ, Dept Phys, Kyoto 6068502, Japan; [Muroya, Shin] Matsumoto Univ, Fac Comprehens Management, Matsumoto, Nagano 3901295, Japan; [Nakamura, Atsushi] Osaka Univ, RCNP, Osaka 5670047, Japan; [Nonaka, Chiho] Nagoya Univ, Kobayashi Maskawa Inst, Nagoya, Aichi 4648602, Japan; [Sekiguchi, Motoo] Kokushikan Univ, Sch Sci & Engn, Tokyo 1548515, Japan; [Wada, Hiroaki] Kokushikan Univ, Fac Polit Sci & Econ, Tokyo 1548515, Japan	Wakayama, M (reprint author), Nagoya Univ, Dept Phys, Nagoya, Aichi 4648602, Japan.				Nagoya University Program for Leading Graduate Schools "Leadership Development Program for Space Exploration and Research," [22224003]; Kurata Memorial Hitachi Science and Technology Foundation; Daiko Foundation;  [14111048];  [24340054];  [26610072];  [15H03663]	This work was supported in part by the Nagoya University Program for Leading Graduate Schools "Leadership Development Program for Space Exploration and Research," Grant-in-Aid for Scientific Research (S) (Grant No. 22224003), the Kurata Memorial Hitachi Science and Technology Foundation, and the Daiko Foundation. This work was partially supported by Grants-in-Aid for Research Activity of Matsumoto University (Grant No. 14111048). This work was supported by Grants-in-Aid for Scientific Research (Kakenhi) Grants No. 24340054, No. 26610072 and No. 15H03663. The simulation was performed on an NEC SX-9 and SX-ACE supercomputers at RCNP, Osaka University, and was conducted using the Fujitsu PRIMEHPC FX10 System (Oakleaf-FX, Oakbridge-FX) in the Information Technology Center, The University of Tokyo.	Abdel-Rehim A., 2014, 32 INT S LATT FIELD; Alexandrou C, 2013, J HIGH ENERGY PHYS, DOI 10.1007/JHEP04(2013)137; McNeile C, 2001, PHYS REV D, V63, DOI 10.1103/PhysRevD.63.114503; Alexandrou C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.222002; JAFFE RJ, 1977, PHYS REV D, V15, P267, DOI 10.1103/PhysRevD.15.267; Chen Y, 2006, PHYS REV D, V73, DOI 10.1103/PhysRevD.73.014516; Guo FK, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.074506; McNeile C, 2006, PHYS REV D, V74, DOI 10.1103/PhysRevD.74.014508; Foley J, 2005, COMPUT PHYS COMMUN, V172, P145, DOI 10.1016/j.cpc.2005.06.008; Choi SK, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.262001; Hart A, 2006, PHYS REV D, V74, DOI 10.1103/PhysRevD.74.114504; Olive KA, 2014, CHINESE PHYS C, V38, DOI 10.1088/1674-1137/38/9/090001; Mathur N, 2007, PHYS REV D, V76, DOI 10.1103/PhysRevD.76.114505; Choi SK, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.142001; Yuan CZ, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.182004; Alford M, 2000, NUCL PHYS B, V578, P367, DOI 10.1016/S0550-3213(00)00155-3; Kunihiro T, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.034504; Bondar A, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.122001; Engel GP, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.034508; Jaffe RL, 2005, PHYS REP, V409, P1, DOI 10.1016/j.physrep.2004.11.005; Khan A. Ali, 2000, PHYS REV D, V63; Loan M, 2008, EUR PHYS J C, V57, P579, DOI 10.1140/epjc/s10052-008-0689-0; Lucher M., 1991, NUCL PHYS B, VB354, P531; Lucher M., 1986, COMMUN MATH PHYS, V105, P153; Lucher M., 1986, COMMUN MATH PHYS, V104, P177; Neff H, 2001, PHYS REV D, V64, DOI 10.1103/PhysRevD.64.114509; Prelovsek S, 2009, PHYS REV D, V79, DOI 10.1103/PhysRevD.79.014503; Prelovsek S, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.094507; SHARPE SR, 1992, NUCL PHYS B, V383, P309, DOI 10.1016/0550-3213(92)90681-Z; Struckmann T, 2001, PHYS REV D, V63, DOI 10.1103/PhysRevD.63.074503; Suganuma H, 2007, PROG THEOR PHYS SUPP, P168; Wada H, 2007, PHYS LETT B, V652, P250, DOI 10.1016/j.physletb.2007.06.076; Wagner M, 2011, J HIGH ENERGY PHYS, DOI 10.1007/JHEP07(2011)016; Weinberg S., 1999, QUANTUM THEORY FIELD, VII	34	0	0	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1550-7998	1550-2368		PHYS REV D	Phys. Rev. D	MAY 18	2015	91	9							094508	10.1103/PhysRevD.91.094508		10	Astronomy & Astrophysics; Physics, Particles & Fields	Astronomy & Astrophysics; Physics	CI7VQ	WOS:000354973300003		
J	Huang, HP; Toyoizumi, T				Huang, Haiping; Toyoizumi, Taro			Advanced mean-field theory of the restricted Boltzmann machine	PHYSICAL REVIEW E			English	Article							BELIEF PROPAGATION; ALGORITHM	Learning in restricted Boltzmann machine is typically hard due to the computation of gradients of log-likelihood function. To describe the network state statistics of the restricted Boltzmann machine, we develop an advanced mean-field theory based on the Bethe approximation. Our theory provides an efficient message-passing-based method that evaluates not only the partition function (free energy) but also its gradients without requiring statistical sampling. The results are compared with those obtained by the computationally expensive sampling-based method.	[Huang, Haiping; Toyoizumi, Taro] RIKEN, Brain Sci Inst, Wako, Saitama 3510198, Japan	Huang, HP (reprint author), RIKEN, Brain Sci Inst, Wako, Saitama 3510198, Japan.	physhuang@gmail.com	Toyoizumi, Taro/G-5632-2015	Toyoizumi, Taro/0000-0001-5444-8829	RIKEN Brain Science Institute; Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) by the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)	This work was supported by RIKEN Brain Science Institute and the Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) by the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT).	Mezard M, 2001, EUR PHYS J B, V20, P217, DOI 10.1007/PL00011099; Kschischang FR, 2001, IEEE T INFORM THEORY, V47, P498, DOI 10.1109/18.910572; Heskes T, 2004, NEURAL COMPUT, V16, P2379, DOI 10.1162/0899766041941943; Bengio Y, 2013, IEEE T PATTERN ANAL, V35, P1798, DOI 10.1109/TPAMI.2013.50; Kappen HJ, 1998, NEURAL COMPUT, V10, P1137, DOI 10.1162/089976698300017386; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Hinton GE, 2002, NEURAL COMPUT, V14, P1771, DOI 10.1162/089976602760128018; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; Freund Y, 1994, TECHNICAL REPORT; Huang HP, 2014, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2014/05/P05020; Huang HP, 2013, J PHYS A-MATH THEOR, V46, DOI 10.1088/1751-8113/46/37/375002; Kabashima Y, 2003, J PHYS A-MATH GEN, V36, P11111, DOI 10.1088/0305-4470/36/43/030; Koster U, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003684; Mehta P., ARXIV14103831; Mezard M., 2009, INFORM PHYS COMPUTAT; Montanari A, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.134406; Rivoire O, 2004, EUR PHYS J B, V37, P55, DOI 10.1140/epjb/e2004-00030-4; Smolensky P., 1986, PARALLEL DISTRIBUTED, V1, P194	18	0	0	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1539-3755	1550-2376		PHYS REV E	Phys. Rev. E	MAY 18	2015	91	5							050101	10.1103/PhysRevE.91.050101		5	Physics, Fluids & Plasmas; Physics, Mathematical	Physics	CI7VX	WOS:000354974100001		
